PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Trausch-Azar, J; Leone, TC; Kelly, DP; Schwartz, AL				Trausch-Azar, Julie; Leone, Teresa C.; Kelly, Daniel P.; Schwartz, Alan L.			Ubiquitin Proteasome-dependent Degradation of the Transcriptional Coactivator PGC-1 alpha via the N-terminal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DEGRADATION; MITOCHONDRIAL BIOGENESIS; GAMMA COACTIVATOR-1; TUMOR-SUPPRESSOR; PROTEIN; MYOD; LOCALIZATION; SYSTEM; ID1; RESIDUE	PGC-1 alpha is a potent, inducible transcriptional coactivator that exerts control on mitochondrial biogenesis and multiple cellular energy metabolic pathways. PGC-1 alpha levels are controlled in a highly dynamic manner reflecting regulation at both transcriptional and post-transcriptional levels. Here, we demonstrate that PGC-1 alpha is rapidly degraded in the nucleus (t(1/2) 0.3 h) via the ubiquitin proteasome system. An N-terminal deletion mutant of 182 residues, PGC182, as well as a lysine-less mutant form, are nuclear and rapidly degraded (t(1/2) 0.5 h), consistent with degradation via the N terminus-dependent ubiquitin sub-pathway. Both PGC-1 alpha and PGC182 degradation rates are increased in cells under low serum conditions. However, a naturally occurring N-terminal splice variant of 270 residues, NT-PGC-1 alpha is cytoplasmic and stable (t(1/2) > 7 h), providing additional evidence that PGC-1 alpha is degraded in the nucleus. These results strongly suggest that the nuclear N terminus-dependent ubiquitin proteasome pathway governs PGC-1 alpha cellular degradation. In contrast, the cellular localization of NT-PCG-1 alpha results in a longer-half-life and possible distinct temporal and potentially biological actions.	[Trausch-Azar, Julie; Schwartz, Alan L.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Trausch-Azar, Julie; Schwartz, Alan L.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Trausch-Azar, Julie; Schwartz, Alan L.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst, Orlando, FL 32827 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute	Schwartz, AL (corresponding author), Washington Univ, Sch Med, Dept Pediat, CB 8116,660 S Euclid Ave, St Louis, MO 63110 USA.	schwartz@wustl.edu	Kelly, Daniel/ABG-2056-2021		National Institutes of Health [GM067620, DK045416]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045416, R01DK045416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM067620 and DK045416 (to A.L.S. and D.P.K.).	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lingbeck JM, 2003, J BIOL CHEM, V278, P1817, DOI 10.1074/jbc.M208815200; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sun L, 2008, P NATL ACAD SCI USA, V105, P3339, DOI 10.1073/pnas.0800165105; Sun LP, 2005, J BIOL CHEM, V280, P26448, DOI 10.1074/jbc.M500373200; Trausch-Azar JS, 2004, J BIOL CHEM, V279, P32614, DOI 10.1074/jbc.M403794200; Vosper JMD, 2009, J BIOL CHEM, V284, P15458, DOI 10.1074/jbc.M809366200; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	35	59	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40192	40200		10.1074/jbc.M110.131615	http://dx.doi.org/10.1074/jbc.M110.131615			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20713359	hybrid, Green Published			2022-12-27	WOS:000285185500064
J	Tang, KH; Blankenship, RE				Tang, Kuo-Hsiang; Blankenship, Robert E.			Both Forward and Reverse TCA Cycles Operate in Green Sulfur Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-CITRATE LYASE; COENZYME-A SYNTHETASE; CITRIC-ACID CYCLE; PHOTOSYNTHETIC BACTERIUM; CHLOROBIUM-LIMICOLA; REACTION-MECHANISM; CARBON METABOLISM; ENZYME; FLUOROACETATE; FLUOROCITRATE	The anoxygenic green sulfur bacteria (GSBs) assimilate CO2 autotrophically through the reductive (reverse) tricarboxylic acid (RTCA) cycle. Some organic carbon sources, such as acetate and pyruvate, can be assimilated during the phototrophic growth of the GSBs, in the presence of CO2 or HCO3-. It has not been established why the inorganic carbonis required for incorporating organic carbon for growth and how the organic carbons are assimilated. In this report, we probed carbon flux during autotrophic and mixotrophic growth of the GSB Chlorobaculum tepidum. Our data indicate the following: (a) the RTCA cycle is active during autotrophic and mixotrophic growth; (b) the flux from pyruvate to acetyl-CoA is very low and acetyl-CoA is synthesized through the RTCA cycle and acetate assimilation; (c) pyruvate is largely assimilated through the RTCA cycle; and (d) acetate can be assimilated via both of the RTCA as well as the oxidative (forward) TCA (OTCA) cycle. The OTCA cycle revealed herein may explain better cell growth during mixotrophic growth with acetate, as energy is generated through the OTCA cycle. Furthermore, the genes specific for the OTCA cycle are either absent or down-regulated during phototrophic growth, implying that the OTCA cycle is not complete, and CO2 is required for the RTCA cycle to produce metabolites in the TCA cycle. Moreover, CO2 is essential for assimilating acetate and pyruvate through the CO2-anaplerotic pathway and pyruvate synthesis from acetyl-CoA.	[Blankenship, Robert E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Blankenship, RE (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	blankenship@wustl.edu			Exobiology Program of NASA [NNX08AP62G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391] Funding Source: NIH RePORTER	Exobiology Program of NASA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant NNX08AP62G from the Exobiology Program of NASA (to R. E. B.).	BEH M, 1993, ARCH MICROBIOL, V160, P306, DOI 10.1007/BF00292082; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZH, 2004, PLANTA, V219, P48, DOI 10.1007/s00425-004-1220-y; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; EVANS MCW, 1966, P NATL ACAD SCI USA, V55, P928, DOI 10.1073/pnas.55.4.928; EVANS MCW, 1966, SCIENCE, V152, P673, DOI 10.1126/science.152.3722.673-b; GRIBBLE GW, 1973, J CHEM EDUC, V50, P460, DOI 10.1021/ed050p460; Hosoya-Matsuda N, 2009, MOL PLANT, V2, P336, DOI 10.1093/mp/ssn077; HOWELL BF, 1979, CLIN CHEM, V25, P269; Imhoff JF, 2010, PHOTOSYNTH RES, V104, P123, DOI 10.1007/s11120-009-9510-7; INOUE H, 1968, J BIOCHEM-TOKYO, V63, P89, DOI 10.1093/oxfordjournals.jbchem.a128753; Kanao T, 2002, EUR J BIOCHEM, V269, P3409, DOI 10.1046/j.1432-1033.2002.03016.x; Kanao T, 2002, EUR J BIOCHEM, V269, P1926, DOI 10.1046/j.1432-1033.2002.02849.x; KELLY DP, 2006, PROKARYOTES, V2, P441; Kim W, 2006, J BACTERIOL, V188, P6544, DOI 10.1128/JB.00523-06; Kouyianou K, 2010, PHOTOSYNTH RES, V104, P153, DOI 10.1007/s11120-010-9544-x; Kuang Y, 2007, J BIOCHEM BIOPH METH, V70, P649, DOI 10.1016/j.jbbm.2007.02.008; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699; Lebedeva NV, 2002, MICROBIOLOGY+, V71, P657, DOI 10.1023/A:1021471621183; Ma K, 1997, P NATL ACAD SCI USA, V94, P9608, DOI 10.1073/pnas.94.18.9608; MARCUS A, 1956, J BIOL CHEM, V218, P823; MOLLER D, 1987, ARCH MICROBIOL, V148, P202, DOI 10.1007/BF00414812; Ormerod J, 2003, PHOTOSYNTH RES, V76, P135, DOI 10.1023/A:1024938531382; Overmann J, 2006, PROKARYOTES, V7, P359, DOI DOI 10.1007/0-387-30747-8_13; PATEL SS, 1987, J BIOL CHEM, V262, P7132; PICKETT MW, 1994, PHOTOSYNTH RES, V41, P75, DOI 10.1007/BF02184147; Proudfoot Alex T, 2006, Toxicol Rev, V25, P213, DOI 10.2165/00139709-200625040-00002; SADLER WR, 1960, P NATL ACAD SCI USA, V46, P1328, DOI 10.1073/pnas.46.10.1328; Sattley WM, 2008, J BACTERIOL, V190, P4687, DOI 10.1128/JB.00299-08; SIREVAG R, 1970, SCIENCE, V169, P186, DOI 10.1126/science.169.3941.186; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tang KH, 2009, J BACTERIOL, V191, P3580, DOI 10.1128/JB.00110-09; VILLAFRANCA JJ, 1973, BIOCHEM BIOPH RES CO, V55, P1197, DOI 10.1016/S0006-291X(73)80021-X; WAHLUND TM, 1991, ARCH MICROBIOL, V156, P81, DOI 10.1007/BF00290978	36	48	50	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35848	35854		10.1074/jbc.M110.157834	http://dx.doi.org/10.1074/jbc.M110.157834			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20650900	Green Published, hybrid			2022-12-27	WOS:000283845300062
J	Pointon, JA; Smith, WD; Saalbach, G; Crow, A; Kehoe, MA; Banfield, MJ				Pointon, Jonathan A.; Smith, Wendy D.; Saalbach, Gerhard; Crow, Allister; Kehoe, Michael A.; Banfield, Mark J.			A Highly Unusual Thioester Bond in a Pilus Adhesin Is Required for Efficient Host Cell Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; STREPTOCOCCUS-PYOGENES; ISOPEPTIDE BONDS; STABILIZING ISOPEPTIDE; INTERNAL THIOESTER; STRUCTURAL BASIS; COMPLEMENT; PROTEIN; SURFACE; C3	Many bacterial pathogens present adhesins at the tips of long macromolecular filaments known as pili that are often important virulence determinants. Very little is known about how pili presented by Gram-positive pathogens mediate host cell binding. The crystal structure of a pilus adhesin from the important human pathogen Streptococcus pyogenes reveals an internal thioester bond formed between the side chains of a cysteine and a glutamine residue. The presence of the thioester was verified using UV-visible spectroscopy and mass spectrometry. This unusual bond has only previously been observed in thioester domains of complement and complement-like proteins where it is used to form covalent attachment to target molecules. The structure also reveals two intramolecular isopeptide bonds, one of these formed through a Lys/Asp residue pair, which are strategically positioned to confer protein stability. Removal of the internal thioester by allele-replacement mutagenesis in S. pyogenes severely compromises bacterial adhesion to model host cells. Although current paradigms of bacterial/host cell interaction envisage strong non-covalent interactions, the present study suggests cell adhesion could also involve covalent bonds.	[Pointon, Jonathan A.; Smith, Wendy D.; Kehoe, Michael A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Saalbach, Gerhard; Crow, Allister; Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kehoe, MA (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	mike.kehoe@ncl.ac.uk; mark.banfield@bbsrc.ac.uk	Banfield, Mark/C-7453-2013; Crow, Allister/F-2147-2018	Banfield, Mark/0000-0001-8921-3835; Crow, Allister/0000-0001-6856-5962	Royal Society; Medical Research Council (United Kingdom) [G0400849, G0600309]; Medical Research Council [G0500367, G0400849] Funding Source: researchfish; MRC [G0400849, G0500367] Funding Source: UKRI	Royal Society(Royal Society of London); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been funded by the Royal Society (to M.J.B.) and Medical Research Council (United Kingdom) Grant G0400849 (to M.A.K.) and Studentship G0600309 (to J.A.P.).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Budzik JM, 2009, J BIOL CHEM, V284, P12989, DOI 10.1074/jbc.M900927200; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; CHU CT, 1994, LAB INVEST, V71, P792; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontaine MC, 2003, INFECT IMMUN, V71, P3857, DOI 10.1128/IAI.71.7.3857-3865.2003; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; KLEYWEGT GJ, 2001, INT TABLES CRYSTALLO, VF; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Law SKA, 1997, PROTEIN SCI, V6, P263; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PANGBURN MK, 1992, FEBS LETT, V308, P280, DOI 10.1016/0014-5793(92)81293-U; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; SIM RB, 1981, BIOCHEM J, V193, P129, DOI 10.1042/bj1930129; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220	51	69	73	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33858	33866		10.1074/jbc.M110.149385	http://dx.doi.org/10.1074/jbc.M110.149385			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729215	Green Published, hybrid			2022-12-27	WOS:000283354000032
J	Booker, ML; Bastos, CM; Kramer, ML; Barker, RH; Skerlj, R; Sidhu, AB; Deng, XY; Celatka, C; Cortese, JF; Bravo, JEG; Llado, KNC; Serrano, AE; Angulo-Barturen, I; Jimenez-Diaz, MB; Viera, S; Garuti, H; Wittlin, S; Papastogiannidis, P; Lin, JW; Janse, CJ; Khan, SM; Duraisingh, M; Coleman, B; Goldsmith, EJ; Phillips, MA; Munoz, B; Wirth, DF; Klinger, JD; Wiegand, R; Sybertz, E				Booker, Michael L.; Bastos, Cecilia M.; Kramer, Martin L.; Barker, Robert H., Jr.; Skerlj, Renato; Sidhu, Amar Bir; Deng, Xiaoyi; Celatka, Cassandra; Cortese, Joseph F.; Bravo, Jose E. Guerrero; Llado, Keila N. Crespo; Serrano, Adelfa E.; Angulo-Barturen, Inigo; Belen Jimenez-Diaz, Maria; Viera, Sara; Garuti, Helen; Wittlin, Sergio; Papastogiannidis, Petros; Lin, Jing-wen; Janse, Chris J.; Khan, Shahid M.; Duraisingh, Manoj; Coleman, Bradley; Goldsmith, Elizabeth J.; Phillips, Margaret A.; Munoz, Benito; Wirth, Dyann F.; Klinger, Jeffrey D.; Wiegand, Roger; Sybertz, Edmund			Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-EFFICIENCY TRANSFECTION; IN-VITRO; SACCHAROMYCES-CEREVISIAE; PYRIMIDINE PATHWAY; ESCHERICHIA-COLI; RODENT MALARIA; ENZYMES; BERGHEI; BIOSYNTHESIS; IDENTIFICATION	Plasmodium falciparum, the causative agent of the most deadly form of human malaria, is unable to salvage pyrimidines and must rely on de novo biosynthesis for survival. Dihydroorotate dehydrogenase (DHODH) catalyzes the rate-limiting step in the pyrimidine biosynthetic pathway and represents a potential target for anti-malarial therapy. A high throughput screen and subsequent medicinal chemistry program identified a series of N-alkyl-5-(1H-benzimidazol-1-yl) thiophene-2-carboxamides with low nanomolar in vitro potency against DHODH from P. falciparum, P. vivax, and P. berghei. The compounds were selective for the parasite enzymes over human DHODH, and x-ray structural data on the analog Genz-667348, demonstrated that species selectivity could be attributed to amino acid differences in the inhibitor-binding site. Compounds from this series demonstrated in vitro potency against the 3D7 and Dd2 strains of P. falciparum, good tolerability and oral exposure in the mouse, and ED50 values in the 4-day murine P. berghei efficacy model of 13-21 mg/kg/day with oral twice-daily dosing. In particular, treatment with Genz-667348 at 100 mg/kg/day resulted in sterile cure. Two recent analogs of Genz-667348 are currently undergoing pilot toxicity testing to determine suitability as clinical development candidates.	[Booker, Michael L.; Bastos, Cecilia M.; Kramer, Martin L.; Barker, Robert H., Jr.; Skerlj, Renato; Celatka, Cassandra; Klinger, Jeffrey D.; Sybertz, Edmund] Genzyme Corp, Waltham, MA 02451 USA; [Sidhu, Amar Bir; Cortese, Joseph F.; Munoz, Benito; Wiegand, Roger] Harvard & MIT, Broad Inst, Cambridge, MA 02141 USA; [Bravo, Jose E. Guerrero; Llado, Keila N. Crespo; Serrano, Adelfa E.] Univ Puerto Rico, Sch Med, Dept Microbiol & Med Zool, San Juan, PR 00936 USA; [Angulo-Barturen, Inigo; Belen Jimenez-Diaz, Maria; Viera, Sara; Garuti, Helen] GlaxoSmithKline, Dis Developing World, Tres Cantos 28760, Spain; [Wittlin, Sergio; Papastogiannidis, Petros] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Wittlin, Sergio; Papastogiannidis, Petros] Univ Basel, CH-4003 Basel, Switzerland; [Lin, Jing-wen; Janse, Chris J.; Khan, Shahid M.] Leiden Univ, Med Ctr, Ctr Infect Dis, Leiden Malaria Res Grp,Dept Parasitol, NL-2333 ZA Leiden, Netherlands; [Duraisingh, Manoj; Coleman, Bradley; Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Deng, Xiaoyi; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Goldsmith, Elizabeth J.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Sanofi-Aventis; Genzyme Corporation; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; GlaxoSmithKline; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Booker, ML (corresponding author), Genzyme Corp, 153 2nd Ave, Waltham, MA 02451 USA.	michael.booker@genzyme.com	Deng, Xiaoyi/E-4394-2011	Coleman, Bradley/0000-0003-4217-508X; Lin, Jing-wen/0000-0003-3338-8788; Khan, Shahid/0000-0002-0533-4670; Janse, Chris J/0000-0002-6410-6205	National Institutes of Health [U01AI075594, AI053680]; Medicines for Malaria Venture and the Humanitarian Assistance for Neglected Diseases Initiative of Genzyme Corp; Welch Foundation [I-1257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075594, R56AI053680, R21AI053680, R01AI053680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicines for Malaria Venture and the Humanitarian Assistance for Neglected Diseases Initiative of Genzyme Corp; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants U01AI075594 and AI053680 (to M. A. P.). This work was also supported by the Medicines for Malaria Venture and the Humanitarian Assistance for Neglected Diseases Initiative of Genzyme Corp.; Supported by the Welch Foundation (Grant I-1257). Holds the Carolyn R. Bacon Professorship in Medical Science and Education.	Angulo-Barturen I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002252; Baldwin J, 2002, J BIOL CHEM, V277, P41827, DOI 10.1074/jbc.M206854200; CAROLINE DF, 1969, J BACTERIOL, V100, P1371, DOI 10.1128/JB.100.3.1371-1377.1969; CHEN JJ, 1976, ARCH BIOCHEM BIOPHYS, V176, P82, DOI 10.1016/0003-9861(76)90143-0; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Deng XY, 2009, J BIOL CHEM, V284, P26999, DOI 10.1074/jbc.M109.028589; DENISDUPHIL M, 1989, BIOCHEM CELL BIOL, V67, P612, DOI 10.1139/o89-094; EAKIN RT, 1969, ARCH BIOCHEM BIOPHYS, V134, P160, DOI 10.1016/0003-9861(69)90262-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; GERO AM, 1985, BIOCHEM MED METAB B, V34, P60, DOI 10.1016/0006-2944(85)90062-6; Giao PT, 2001, CLIN PHARMACOKINET, V40, P343, DOI 10.2165/00003088-200140050-00003; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; Hersh EV, 2004, J AM DENT ASSOC, V135, P298, DOI 10.14219/jada.archive.2004.0178; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hurt DE, 2006, BIOORG MED CHEM LETT, V16, P1610, DOI 10.1016/j.bmcl.2005.12.029; Hurt DE, 2006, ACTA CRYSTALLOGR D, V62, P312, DOI 10.1107/S0907444905042642; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Jimenez-Diaz MB, 2009, CYTOM PART A, V75A, P225, DOI 10.1002/cyto.a.20647; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Jordan DB, 2000, ARCH BIOCHEM BIOPHYS, V378, P84, DOI 10.1006/abbi.2000.1823; Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e; KENNEDY J, 1973, ARCH BIOCHEM BIOPHYS, V157, P369, DOI 10.1016/0003-9861(73)90651-6; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Knecht W, 1998, BIOCHEM PHARMACOL, V56, P1259, DOI 10.1016/S0006-2952(98)00145-2; Kocken CHM, 2002, INFECT IMMUN, V70, P655, DOI 10.1128/IAI.70.2.655-660.2002; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MILLER RW, 1969, CAN J BIOCHEM CELL B, V47, P725, DOI 10.1139/o69-110; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; National Research Council, 1996, GUID CAR US LAB AN N; Obach RS, 1997, J PHARMACOL EXP THER, V283, P46; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Patel V, 2008, J BIOL CHEM, V283, P35078, DOI 10.1074/jbc.M804990200; PETERS W, 1975, ANN TROP MED PARASIT, V69, P155, DOI 10.1080/00034983.1975.11686997; Peters W., 1987, CHEMOTHERAPY DRUG RE, P145; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Saul A, 1997, MOL BIOCHEM PARASIT, V84, P143, DOI 10.1016/S0166-6851(96)02779-X; Skophammer RG, 2007, MOL BIOL EVOL, V24, P1761, DOI 10.1093/molbev/msm096; Subbayya INS, 1997, INDIAN J MED RES, V106, P79; TAYLOR ML, 1971, J BACTERIOL, V105, P1015, DOI 10.1128/JB.105.3.1015-1027.1971; TAYLOR WH, 1964, J BACTERIOL, V88, P105, DOI 10.1128/JB.88.1.105-110.1964; VANDERPLAS J, 1983, J BACTERIOL, V153, P1027, DOI 10.1128/JB.153.2.1027-1037.1983; WILLIAMS JC, 1973, J BACTERIOL, V115, P1071, DOI 10.1128/JB.115.3.1071-1076.1973	56	107	111	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33054	33064		10.1074/jbc.M110.162081	http://dx.doi.org/10.1074/jbc.M110.162081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702404	Green Published, hybrid			2022-12-27	WOS:000283048200043
J	Da Silva, P; Rahioui, I; Laugier, C; Jouvensal, L; Meudal, H; Chouabe, C; Delmas, AF; Gressent, F				Da Silva, Pedro; Rahioui, Isabelle; Laugier, Christian; Jouvensal, Laurence; Meudal, Herve; Chouabe, Christophe; Delmas, Agnes F.; Gressent, Frederic			Molecular Requirements for the Insecticidal Activity of the Plant Peptide Pea Albumin 1 Subunit b (PA1b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTINE-KNOT MOTIF; CHEMICAL-SHIFT; 4-KDA PEPTIDE; PROTEIN; BINDING; ENTOMOTOXIN; CYCLOTIDES; ASSIGNMENT; COMPONENTS; RESIDUES	PA1b (pea albumin 1, subunit b) is a small and compact 37-amino acid protein, isolated from pea seeds (Pisum sativum), that adopts a cystine knot fold. It acts as a potent insecticidal agent against major pests in stored crops and vegetables, making it a promising bioinsecticide. Here, we investigate the influence of individual residues on the structure and bioactivity of PA1b. A collection of 13 PA1b mutants was successfully chemically synthesized in which the residues involved in the definition of PA1b amphiphilic and electrostatic characteristics were individually replaced with an alanine. The three-dimensional structure of PA1b was outstandingly tolerant of modifications. Remarkably, receptor binding and insecticidal activities were both dependent on common well defined clusters of residues located on one single face of the toxin, with Phe-10, Arg-21, Ile-23, and Leu-27 being key residues of the binding interaction. The inactivity of the mutants is clearly due to a change in the nature of the side chain rather than to a side effect, such as misfolding or degradation of the peptide, in the insect digestive tract. We have shown that a hydrophobic patch is the putative site of the interaction of PA1b with its binding site. Overall, the mutagenesis data provide major insights into the functional elements responsible for PA1b entomotoxic properties and give some clues toward a better understanding of the PA1b mode of action.	[Gressent, Frederic] Univ Lyon, INRA, INSA Lyon, IFR 41,UMR203 BF21, F-69621 Villeurbanne, France; [Jouvensal, Laurence; Meudal, Herve; Delmas, Agnes F.] Univ Orleans, CNRS, UPR 4301, Ctr Biophys Mol, F-45071 Orleans 2, France; [Jouvensal, Laurence; Meudal, Herve; Delmas, Agnes F.] INSERM, F-45071 Orleans, France; [Chouabe, Christophe] Univ Lyon 1, CNRS, UMR 5123, F-69622 Villeurbanne, France	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1		pedro.da-silva@insa-lyon.fr	Meudal, Hervé/B-5851-2016	Meudal, Hervé/0000-0002-9642-3643; GRESSENT, Frederic/0000-0002-7029-8709	INSA-Lyon; Region Centre [PA1bbio]	INSA-Lyon; Region Centre(Region Centre-Val de Loire)	This work was supported in part by INSA-Lyon and Region Centre (PA1bbio) grants.	Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; CHAGOLLALOPEZ A, 1994, J BIOL CHEM, V269, P23675; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craik DJ, 2010, CELL MOL LIFE SCI, V67, P9, DOI 10.1007/s00018-009-0159-3; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Da Silva P, 2009, BIOPOLYMERS, V92, P436, DOI 10.1002/bip.21217; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELOBEL B, 2004, Patent No. 9958695; Dun XP, 2008, PEPTIDES, V29, P891, DOI 10.1016/j.peptides.2008.01.013; Dun XP, 2007, FEBS J, V274, P751, DOI 10.1111/j.1742-4658.2006.05619.x; Grenier AM, 1997, HEREDITY, V79, P15, DOI 10.1038/hdy.1997.118; Gressent F, 2003, EUR J BIOCHEM, V270, P2429, DOI 10.1046/j.1432-1033.2003.03611.x; Gressent F, 2007, J INSECT SCI, V7; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Hanada K, 2003, EUR J BIOCHEM, V270, P2583, DOI 10.1046/j.1432-1033.2003.03627.x; HIGGINS TJV, 1986, J BIOL CHEM, V261, P1124; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jouvensal L, 2003, BIOCHEMISTRY-US, V42, P11915, DOI 10.1021/bi034803l; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Louis S, 2004, PLANT SCI, V167, P705, DOI 10.1016/j.plantsci.2004.04.018; Louis S, 2007, PHYTOCHEMISTRY, V68, P521, DOI 10.1016/j.phytochem.2006.11.032; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Rahioui I, 2007, BIOCHIMIE, V89, P1539, DOI 10.1016/j.biochi.2007.07.021; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Rosengren KJ, 2002, BIOCHEMISTRY-US, V41, P3294, DOI 10.1021/bi011932y; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Taylor WG, 2004, J AGR FOOD CHEM, V52, P7499, DOI 10.1021/jf030807l; Taylor WG, 2004, J AGR FOOD CHEM, V52, P7491, DOI 10.1021/jf030806t; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamazaki T, 2003, EUR J BIOCHEM, V270, P1269, DOI 10.1046/j.1432-1033.2003.03489.x	33	21	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32689	32694		10.1074/jbc.M110.147199	http://dx.doi.org/10.1074/jbc.M110.147199			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20660598	Green Published, hybrid			2022-12-27	WOS:000283048200003
J	Tokuhara, N; Namiki, K; Uesugi, M; Miyamoto, C; Ohgoh, M; Ido, K; Yoshinaga, T; Yamauchi, T; Kuromitsu, J; Kimura, S; Miyamoto, N; Kasuya, Y				Tokuhara, Naoki; Namiki, Kana; Uesugi, Mai; Miyamoto, Chihiro; Ohgoh, Makoto; Ido, Katsutoshi; Yoshinaga, Takashi; Yamauchi, Toshihiko; Kuromitsu, Junro; Kimura, Sadao; Miyamoto, Norimasa; Kasuya, Yoshitoshi			N-type Calcium Channel in the Pathogenesis of Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS LESIONS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MICE LACKING; ALPHA(1B) SUBUNIT; CA2+ CHANNEL; BRAIN-INJURY; CHEMOKINE EXPRESSION; CELL ACTIVATION; NERVOUS-SYSTEM; MCP-1	One of the family of voltage-gated calcium channels (VGCC), the N-type Ca2+ channel, is located predominantly in neurons and is associated with a variety of neuronal responses, including neurodegeneration. A precise mechanism for how the N-type Ca2+ channel plays a role in neurodegenerative disease, however, is unknown. In this study, we immunized N-type Ca2+ channel alpha(1B)-deficient (alpha(-/-)(1B)) mice and their wild type (WT) littermates with myelin oligodendrocyte glycoprotein 35-55 and analyzed the progression of experimental autoimmune encephalomyelitis (EAE). The neurological symptoms of EAE in the alpha(-/-)(1B) mice were less severe than in the WT mice. In conjunction with these results, sections of the spinal cord (SC) from alpha(-/-)(1B) mice revealed a reduction in both leukocytic infiltration and demyelination compared with WT mice. No differences were observed in the delayed-type hypersensitivity response, spleen cell proliferation, or cytokine production from splenocytes between the two genotypes. On the other hand, Western blot array analysis and RT-PCR revealed that a typical increase in the expression of MCP-1 in the SC showed a good correlation with the infiltration of leukocytes into the SC. Likewise, immunohistochemical analysis showed that the predominant source of MCP-1 was activated microglia. The cytokine-induced production of MCP-1 in primary cultured microglia from WT mice was significantly higher than that from alpha(-/-)(1B) mice and was significantly inhibited by a selective N-type Ca2+ channel antagonist, omega-conotoxin GVIA or a withdrawal of extracellular Ca2+. These results suggest that the N-type Ca2+ channel is involved in the pathogenesis of EAE at least in part by regulating MCP-1 production by microglia.	Chiba Univ, Grad Sch Med, Dept Biochem & Mol Pharmacol, Chiba 2608670, Japan; [Tokuhara, Naoki; Ohgoh, Makoto; Ido, Katsutoshi; Yamauchi, Toshihiko] Eisai & Co Ltd, Dept Biol Pharmacol, Neurosci Prod Creat Unit, Tsukuba, Ibaraki 3002635, Japan; [Uesugi, Mai] Eisai & Co Ltd, Dept Genom, Biomarkers & Personalized Med Core Funct Unit, Tsukuba, Ibaraki 3002635, Japan; [Miyamoto, Chihiro; Kuromitsu, Junro; Miyamoto, Norimasa] Eisai & Co Ltd, Dept Tsukuba Discovery Res, KAN Prod Creat Unit, Tsukuba, Ibaraki 3002635, Japan; [Yoshinaga, Takashi] Eisai & Co Ltd, Biopharmaceut Assessment Core Funct Unit, Dept Global Drug Safety, Tsukuba, Ibaraki 3002635, Japan	Chiba University; Eisai Co Ltd; Eisai Co Ltd; Eisai Co Ltd; Eisai Co Ltd	Kasuya, Y (corresponding author), 1-8-1 Inohana,Chuo Ku, Chiba 2608670, Japan.	kasuya@faculty.chiba-u.jp		Kimura, Sadao/0000-0001-6768-7474; Kasuya, Yoshitoshi/0000-0003-0614-5836	Ministry of Education, Science, Sports and Culture of Japan [19590529, 21390172]; Eisai Co. Ltd.	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Eisai Co. Ltd.(Eisai Co Ltd)	This work was supported in part by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan ((C), 19590529 and (B), 21390172) (to Y. K.) and the Eisai Co. Ltd.	Ayoub AE, 2003, J NEUROSCI, V23, P7759; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Beuckmann CT, 2003, J NEUROSCI, V23, P6793; Bowersox SS, 1997, BRAIN RES, V747, P343; Brabb T, 1997, J IMMUNOL, V159, P497; Brand-Schieber E, 2004, EXP NEUROL, V189, P5, DOI 10.1016/j.expneurol.2004.05.023; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fassbender K, 1998, NEUROLOGY, V51, P753, DOI 10.1212/WNL.51.3.753; FERN R, 1995, J NEUROPHYSIOL, V74, P369, DOI 10.1152/jn.1995.74.1.369; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Guo X, 2007, NEUROSCI RES, V59, P457, DOI 10.1016/j.neures.2007.08.014; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Kennedy KJ, 1998, J NEUROIMMUNOL, V92, P98, DOI 10.1016/S0165-5728(98)00187-8; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; Kornek B, 2001, BRAIN, V124, P1114, DOI 10.1093/brain/124.6.1114; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Latour I, 2003, GLIA, V41, P347, DOI 10.1002/glia.10162; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Madrigal JLM, 2009, J NEUROSCI, V29, P263, DOI 10.1523/JNEUROSCI.4926-08.2009; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; McManus CM, 1998, J IMMUNOL, V160, P1449; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Moldovan IR, 2003, J NEUROIMMUNOL, V141, P132, DOI 10.1016/S0165-5728(03)00221-2; Muller K, 2003, INFECT IMMUN, V71, P6178, DOI 10.1128/IAI.71.11.6178-6183.2003; Nygardas PT, 2000, EUR J IMMUNOL, V30, P1911, DOI 10.1002/1521-4141(200007)30:7<1911::AID-IMMU1911>3.0.CO;2-E; PLATT JL, 1983, J EXP MED, V158, P1227, DOI 10.1084/jem.158.4.1227; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Takahashi E, 2005, INT J MOL MED, V15, P937; Taneja V, 2001, NAT IMMUNOL, V2, P781, DOI 10.1038/ni0901-781; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; TRAUGOTT U, 1985, CELL IMMUNOL, V91, P240, DOI 10.1016/0008-8749(85)90047-4; TRAUGOTT U, 1989, CELL IMMUNOL, V119, P114, DOI 10.1016/0008-8749(89)90228-1; VAN BOXELDEZAIRE, 1999, ANN NEUROL, V45, P695; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Youssef S, 1999, J AUTOIMMUN, V13, P21, DOI 10.1006/jaut.1999.0306	48	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33294	33306		10.1074/jbc.M109.089805	http://dx.doi.org/10.1074/jbc.M109.089805			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720005	Green Published, hybrid			2022-12-27	WOS:000283048200065
J	Patel, S; Djerdjouri, B; Raoul-Des-Essarts, Y; Dang, PMC; El-Benna, J; Perianin, A				Patel, Satyananda; Djerdjouri, Bahia; Raoul-Des-Essarts, Yannick; Dang, Pham My-Chan; El-Benna, Jamel; Perianin, Axel			Protein Kinase B (AKT) Mediates Phospholipase D Activation via ERK1/2 and Promotes Respiratory Burst Parameters in Formylpeptide-stimulated Neutrophil-like HL-60 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE COMPONENT; PHOSPHATIDIC-ACID; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; P47(PHOX); ZETA; IDENTIFICATION; TRANSLOCATION; MECHANISMS; PHAGOCYTES	Phospholipase D (PLD), a major source of lipid second messengers (phosphatidic acid, diglycerides) in many cell types, is tightly regulated by protein kinases, but only a few of them have been identified. We show here that protein kinase B (AKT) is a novel major signaling effector of PLD activity induced by the formylpeptide f-Met-Leu-Phe (fMLP) in human neutrophil-like HL-60 cells (dHL-60 cells). AKT inhibition with the selective antagonist AKTib1/2 almost completely prevented fMLP-mediated activity of PLD, its upstream effector ERK1/2, but not p38 MAPK. Immunoprecipitation studies show that phosphorylated AKT, ERK, and PLD2 form a complex induced by fMLP, which can be prevented by AKTib1/2. In cell-free systems, AKT1 stimulated PLD activity via activation of ERK. AKT1 actually phosphorylated ERK2 as a substrate (K-m 1 mu M). Blocking AKT activation with AKTib1/2 also prevented fMLP-but not phorbol 12-myristate 13-acetate-mediated NADPH oxidase activation (respiratory burst, RB) of dHL-60 cells. Impaired RB was associated with defective membrane translocation of NADPH oxidase components p67(phox) and p47(phox), ERK, AKT1, AKT2, but not AKT3. Depletion of AKT1 or AKT2 with antisense oligonucleotides further indicates a partial contribution of both isoforms in fMLP-induced activation of ERK, PLD, and RB, with a predominant role of AKT1. Thus, formylpeptides induce sequential activation of AKT, ERK1/2, and PLD, which represents a novel signaling pathway. A major primarily role of this AKT signaling pathway also emerges in membrane recruitment of NOX2 components p47(phox), p67(phox), and ERK, which may contribute to assembly and activation of the RB motor system, NADPH oxidase.	[Djerdjouri, Bahia; Raoul-Des-Essarts, Yannick; Dang, Pham My-Chan; El-Benna, Jamel; Perianin, Axel] INSERM, CRB3, U773, Fac Med 10, F-75018 Paris, France; [Patel, Satyananda; Raoul-Des-Essarts, Yannick; Perianin, Axel] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Patel, Satyananda; Perianin, Axel] INSERM, U567, F-75014 Paris, France; [Djerdjouri, Bahia] Univ Sci & Technol Houari Boumediene, Fac Biol Sci, Algiers 16111, Algeria	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University Science & Technology Houari Boumediene	Perianin, A (corresponding author), INSERM, CRB3, U773, Fac Med 10, 16 Rue H Huchard, F-75018 Paris, France.	axel.perianin@inserm.fr	Djerdjouri, Bahia/I-2533-2019	/0000-0003-4087-1866	Universite Paris Descartes; Agence Nationale pour la Recherche	Universite Paris Descartes; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by a grant from the Universite Paris Descartes (S. P.) and l'Agence Nationale pour la Recherche.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; BONSER RW, 1991, BRIT J PHARMACOL, V103, P1237, DOI 10.1111/j.1476-5381.1991.tb12330.x; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; DANG PMC, 1994, FEBS LETT, V349, P338, DOI 10.1016/0014-5793(94)00700-4; Dang PMC, 2001, P NATL ACAD SCI USA, V98, P3001, DOI 10.1073/pnas.061029698; Di Fulvio M, 2008, CELL SIGNAL, V20, P176, DOI 10.1016/j.cellsig.2007.10.009; Djerdjouri B, 1999, BIOCHEM BIOPH RES CO, V264, P371, DOI 10.1006/bbrc.1999.1533; ElBenna J, 1996, J BIOL CHEM, V271, P6374; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Foster DA, 2003, MOL CANCER RES, V1, P789; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; Klein JB, 2000, J IMMUNOL, V164, P4286, DOI 10.4049/jimmunol.164.8.4286; KOCHS G, 1993, EUR J BIOCHEM, V216, P597, DOI 10.1111/j.1432-1033.1993.tb18179.x; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lenoir M, 2004, J IMMUNOL, V172, P7136, DOI 10.4049/jimmunol.172.11.7136; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; NACCACHE PH, 1991, CELL SIGNAL, V3, P635, DOI 10.1016/0898-6568(91)90040-2; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; OLSON SC, 1991, J BIOL CHEM, V266, P17236; Paruch S, 2005, FASEB J, V19, P142, DOI 10.1096/fj.05-3881fje; Paruch S, 2007, FASEB J, V21, P4038, DOI 10.1096/fj.06-7325com; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	42	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32055	32063		10.1074/jbc.M110.171058	http://dx.doi.org/10.1074/jbc.M110.171058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693286	hybrid, Green Published			2022-12-27	WOS:000282683000019
J	Diao, L; Li, N; Brayman, TG; Hotz, KJ; Lai, YR				Diao, Lei; Li, Na; Brayman, Timothy G.; Hotz, Kathy J.; Lai, Yurong			Regulation of MRP2/ABCC2 and BSEP/ABCB11 Expression in Sandwich Cultured Human and Rat Hepatocytes Exposed to Inflammatory Cytokines TNF-alpha, IL-6, and IL-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; DRUG TRANSPORTER EXPRESSION; ACUTE-PHASE RESPONSE; SALT EXPORT PUMP; DOWN-REGULATION; CELL-LINES; IN-VITRO; CYTOCHROME-P450 REGULATION; ABSOLUTE QUANTIFICATION; MOUSE-LIVER	In the present study MRP2/ABCC2 and BSEP/ABCB11 expression were investigated in sandwich cultured (SC) human and rat hepatocytes exposed to the proinflammatory cytokines. The investigation was also done in lipopolysaccharide (LPS)treated rats. In SC human hepatocytes, both absolute protein and mRNA levels of MRP2/ABCC2 were significantly down-regulated by TNF-alpha, IL-6, or IL-1 beta. In contrast to mRNA decrease, which was observed for BSEP/ABCB11, the protein amount was significantly increased by IL-6 or IL-1 beta. A discrepancy between the change in BSEP/ABCB11 mRNA and protein levels was encountered in SC human hepatocytes treated with proinflammatory cytokines. In SC rat hepatocytes, Mrp2/Abcc2 mRNA was down-regulated by TNF-alpha and IL-6, whereas the protein level was decreased by all three cytokines. Down-regulations of both Bsep/Abcb11 mRNA and protein levels were found in SC rat hepatocytes exposed to TNF-alpha or IL-1 beta. Administration of LPS triggered the release of the proinflammatory cytokines and caused the decrease of Mrp2/Abcc2 and Bsep/Abcb11 protein in liver at 24 h post-treatment; however, the Mrp2 and Bsep protein levels rebounded at 48 h post-LPS treatment. In total, our results indicate that proinflammatory cytokines regulate the expression of MRP2/Mrp2 and BSEP/Bsep and for the first time demonstrate the differential effects on BSEP/Bsep expression between SC human and rat hepatocytes. Furthermore, the agreement between transporter regulation in vitro in SC rat hepatocytes and in vivo in LPS-treated rats during the acute response phase demonstrates the utility of in vitro SC hepatocyte models for predicting in vivo effects.	[Diao, Lei; Li, Na; Brayman, Timothy G.; Hotz, Kathy J.; Lai, Yurong] Pfizer Inc, Groton Labs, Pfizer Global Res & Dev, Dept Pharmacokinet Dynam & Drug Metab, Groton, CT 06340 USA	Pfizer	Lai, YR (corresponding author), Pfizer Inc, Groton Lab, Pharmacokinet Dynam & Metab, Eastern Point Rd,Mail Stop 8220-2475, Groton, CT 06340 USA.	yurong.lai@pfizer.com	Lai, Yurong/GWV-6243-2022; Lai, Yurong/ABG-4485-2021	Lai, Yurong/0000-0001-9505-333X				ARIAS IM, 1993, GASTROENTEROLOGY, V104, P1558, DOI 10.1016/0016-5085(93)90371-I; Beigneux AP, 2002, BIOCHEM BIOPH RES CO, V293, P145, DOI 10.1016/S0006-291X(02)00196-1; Bi YA, 2006, DRUG METAB DISPOS, V34, P1658, DOI 10.1124/dmd.105.009118; Bow DAJ, 2008, DRUG METAB DISPOS, V36, P198, DOI 10.1124/dmd.107.018200; Donner MG, 2007, AM J PHYSIOL-GASTR L, V293, pG1134, DOI 10.1152/ajpgi.00079.2007; Elferink MGL, 2004, AM J PHYSIOL-GASTR L, V287, pG1008, DOI 10.1152/ajpgi.00071.2004; Evseenko DA, 2006, AM J PHYSIOL-REG I, V290, pR1357, DOI 10.1152/ajpregu.00630.2005; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Fardel O, 2009, EXPERT OPIN DRUG MET, V5, P1469, DOI 10.1517/17425250903304056; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Geier A, 2005, AM J PHYSIOL-GASTR L, V289, pG831, DOI 10.1152/ajpgi.00307.2004; Ghibellini G, 2007, DRUG METAB DISPOS, V35, P345, DOI 10.1124/dmd.106.012278; Goh LB, 2002, BIOCHEM PHARMACOL, V64, P1569, DOI 10.1016/S0006-2952(02)01355-2; Gomez-Lechon MJ, 2004, CURR DRUG METAB, V5, P443, DOI 10.2174/1389200043335414; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; Hartmann G, 2002, J PHARMACOL EXP THER, V303, P273, DOI 10.1124/jpet.102.039404; Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902; Le Vee M, 2008, DRUG METAB DISPOS, V36, P217, DOI 10.1124/dmd.107.016907; Le Vee M, 2009, DRUG METAB DISPOS, V37, P2228, DOI 10.1124/dmd.109.028035; Lee G, 2003, J PHARM SCI-US, V92, P2152, DOI 10.1002/jps.10493; Li N, 2008, ANAL BIOCHEM, V380, P211, DOI 10.1016/j.ab.2008.05.032; Li N, 2010, MOL PHARMACEUT, V7, P630, DOI 10.1021/mp9001574; Li N, 2009, ANAL CHEM, V81, P2251, DOI 10.1021/ac8024009; Li N, 2009, MOL PHARMACEUT, V6, P1180, DOI 10.1021/mp900044x; Liss G, 2009, EXPERT OPIN DRUG MET, V5, P843, DOI 10.1517/17425250903018904; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Morgan ET, 2002, TOXICOLOGY, V181, P207, DOI 10.1016/S0300-483X(02)00283-4; Pascussi JM, 2000, BIOCHEM BIOPH RES CO, V274, P707, DOI 10.1006/bbrc.2000.3219; Petrovic V, 2007, MOL INTERV, V7, P99, DOI 10.1124/mi.7.2.10; Renton KW, 2004, CURR DRUG METAB, V5, P235, DOI 10.2174/1389200043335559; Renton KW, 2001, PHARMACOL THERAPEUT, V92, P147, DOI 10.1016/S0163-7258(01)00165-6; ROELOFSEN H, 1995, HEPATOLOGY, V21, P1649, DOI 10.1002/hep.1840210625; Siewert E, 2004, BIOCHEM BIOPH RES CO, V322, P232, DOI 10.1016/j.bbrc.2004.07.102; Slaviero KA, 2003, LANCET ONCOL, V4, P224, DOI 10.1016/S1470-2045(03)01034-9; Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141; Trauner M, 1999, CURR OPIN GASTROEN, V15, P217, DOI 10.1097/00001574-199905000-00006; Trauner M, 1999, J GASTROEN HEPATOL, V14, P946, DOI 10.1046/j.1440-1746.1999.01982.x; Turnbull AV, 1998, ENDOCRINOLOGY, V139, P119, DOI 10.1210/en.139.1.119; Vee ML, 2009, DRUG METAB DISPOS, V37, P685, DOI DOI 10.1124/DMD.108.023630; Zhang X, 2009, CLIN PHARMACOL THER, V85, pS59; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646	41	50	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31185	31192		10.1074/jbc.M110.107805	http://dx.doi.org/10.1074/jbc.M110.107805			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20702406	hybrid, Green Published			2022-12-27	WOS:000282764600012
J	Kuhlberg, A; Haid, M; Metzger, S				Kuehlberg, Axel; Haid, Mark; Metzger, Sabine			Characterization of O-Phosphohydroxyproline in Rat alpha-Crystallin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; B-CRYSTALLIN; PROLINE HYDROXYLATION; A-CRYSTALLIN; HIF-ALPHA; PHOSPHORYLATION; COLLAGEN; KINASE; MUSCLE; HYDROXYPROLINE	Post-translational modifications have major importance for the structure and function of a multiplicity of proteins. Phosphorylation is a widespread phenomenon among eukaryotic proteins. Whereas O-phosphorylation on the side chains of serine, threonine, and tyrosine in proteins is well known and has been studied extensively, to our knowledge the endogenous phosphorylation of hydroxyproline has not previously been reported. In the present work, we provide evidence for the first time that O-phosphohydroxyproline (Hyp(P)) is a proteinogenic amino acid. To detect Hyp(P) in proteins we generated a Hyp(P)-specific polyclonal antibody. We could identify Hyp(P) in various proteins by Western blot analysis, and we characterized the sequence position of Hyp(P) in the protein alpha-crystallin A by electrospray ionization-tandem mass spectrometry. Our experiments clearly demonstrate hydroxylation and subsequent phosphorylation of a proline residue in alpha-crystallin A in the eye as well as in heart tissue of rat.	Univ Dusseldorf, Biol Med Res Ctr, D-40225 Dusseldorf, Germany; [Haid, Mark] Leibniz Inst Plant Biochem, D-06120 Halle, Saale, Germany	Heinrich Heine University Dusseldorf; Leibniz Institut fur Pflanzenbiochemie		metzger@uni-duesseldorf.de	Haid, Mark/J-4304-2019	Haid, Mark/0000-0001-6118-1333				Abgar S, 2000, EUR J BIOCHEM, V267, P5916, DOI 10.1046/j.1432-1327.2000.01646.x; ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Augusteyn Robert C, 2002, Clin Exp Optom, V85, P83; Bhat SP, 2003, PROG DRUG RES, V60, P205; Boelens WC, 1998, BBA-PROTEIN STRUCT M, V1388, P513, DOI 10.1016/S0167-4838(98)00215-5; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FERAMISCO JR, 1979, J BIOL CHEM, V254, P6987; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Hoffmann R, 1997, J PEPT RES, V49, P163; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kalume DE, 2003, CURR OPIN CHEM BIOL, V7, P64, DOI 10.1016/S1367-5931(02)00009-1; Kappe G, 2001, BBA-GENE STRUCT EXPR, V1520, P1, DOI 10.1016/S0167-4781(01)00237-8; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KNOX JP, 1995, FASEB J, V9, P1004, DOI 10.1096/fasebj.9.11.7544308; Koteiche HA, 1999, J MOL BIOL, V294, P561, DOI 10.1006/jmbi.1999.3242; KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028; Krief S, 1999, J BIOL CHEM, V274, P36592, DOI 10.1074/jbc.274.51.36592; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; MARTENSEN TM, 1984, METHOD ENZYMOL, V107, P3; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; PAQUET A, 1982, CAN J CHEM, V60, P976, DOI 10.1139/v82-146; PEARSON RB, 1988, ARCH BIOCHEM BIOPHYS, V260, P37, DOI 10.1016/0003-9861(88)90421-3; Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100; PROROK M, 1989, J BIOL CHEM, V264, P17727; Quadroni M, 2000, EXS, V88, P199; Quinlan RA, 1999, EYE, V13, P409, DOI 10.1038/eye.1999.115; ROBERTS K, 1985, J CELL SCI, P105; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; Schaefer H, 2003, ANAL BIOANAL CHEM, V376, P966, DOI 10.1007/s00216-003-1983-1; Sickmann A, 2001, PROTEOMICS, V1, P200, DOI 10.1002/1615-9861(200102)1:2<200::AID-PROT200>3.0.CO;2-V; SPECTOR A, 1984, INVEST OPHTH VIS SCI, V25, P130; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; URUSHIZAKI Y, 1985, P NATL ACAD SCI USA, V82, P3091, DOI 10.1073/pnas.82.10.3091; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; WIJFFELS GL, 1994, BIOCHEM J, V299, P781, DOI 10.1042/bj2990781; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	48	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31484	31490		10.1074/jbc.M109.035428	http://dx.doi.org/10.1074/jbc.M109.035428			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682783	hybrid, Green Published			2022-12-27	WOS:000282764600042
J	Li, CH; Chen, P; Palladino, A; Narayan, S; Russell, LK; Sayed, S; Xiong, GX; Chen, J; Stokes, D; Butt, YM; Jones, PM; Collins, HW; Cohen, NA; Cohen, AS; Nissim, I; Smith, TJ; Strauss, AW; Matschinsky, FM; Bennett, MJ; Stanley, CA				Li, Changhong; Chen, Pan; Palladino, Andrew; Narayan, Srinivas; Russell, Laurie K.; Sayed, Samir; Xiong, Guoxiang; Chen, Jie; Stokes, David; Butt, Yasmeen M.; Jones, Patricia M.; Collins, Heather W.; Cohen, Noam A.; Cohen, Akiva S.; Nissim, Itzhak; Smith, Thomas J.; Strauss, Arnold W.; Matschinsky, Franz M.; Bennett, Michael J.; Stanley, Charles A.			Mechanism of Hyperinsulinism in Short-chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Involves Activation of Glutamate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; FATTY-ACID OXIDATION; INSULIN-SECRETION; MASS-SPECTROMETRY; FASTING HYPOGLYCEMIA; METABOLISM; MUTATIONS; GENE; L-3-HYDROXYACYL-COENZYME; GLUTAMINOLYSIS	The mechanism of insulin dysregulation in children with hyperinsulinism associated with inactivating mutations of short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD) was examined in mice with a knock-out of the hadh gene (hadh(-/-)). The hadh(-/-) mice had reduced levels of plasma glucose and elevated plasma insulin levels, similar to children with SCHAD deficiency. hadh(-/-) mice were hypersensitive to oral amino acid with decrease of glucose level and elevation of insulin. Hypersensitivity to oral amino acid in hadh(-/-) mice can be explained by abnormal insulin responses to a physiological mixture of amino acids and increased sensitivity to leucine stimulation in isolated perifused islets. Measurement of cytosolic calcium showed normal basal levels and abnormal responses to amino acids in hadh(-/-) islets. Leucine, glutamine, and alanine are responsible for amino acid hypersensitivity in islets. hadh(-/-) islets have lower intracellular glutamate and aspartate levels, and this decrease can be prevented by high glucose. hadh(-/-) islets also have increased [U-C-14] glutamine oxidation. In contrast, hadh(-/-) mice have similar glucose tolerance and insulin sensitivity compared with controls. Perifused hadh(-/-) islets showed no differences from controls in response to glucose-stimulated insulin secretion, even with addition of either a medium-chain fatty acid (octanoate) or a long-chain fatty acid (palmitate). Pull-down experiments with SCHAD, anti-SCHAD, or anti-GDH antibodies showed protein-protein interactions between SCHAD and GDH. GDH enzyme kinetics of hadh(-/-) islets showed an increase in GDH affinity for its substrate, alpha-ketoglutarate. These studies indicate that SCHAD deficiency causes hyperinsulinism by activation of GDH via loss of inhibitory regulation of GDH by SCHAD.	[Li, Changhong; Chen, Pan; Palladino, Andrew; Sayed, Samir; Stokes, David; Stanley, Charles A.] Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; [Narayan, Srinivas; Chen, Jie; Bennett, Michael J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Russell, Laurie K.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Xiong, Guoxiang; Cohen, Noam A.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Butt, Yasmeen M.; Jones, Patricia M.] Univ Texas SW Med Ctr, Childrens Med Ctr, Houston, TX 75235 USA; [Collins, Heather W.; Matschinsky, Franz M.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Childrens Hosp Philadelphia, Div Child Dev & Pediat Rehabil, Philadelphia, PA 19104 USA; [Smith, Thomas J.] Danforth Plant Res Inst, St Louis, MO 63132 USA; [Strauss, Arnold W.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Saint Louis University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Donald Danforth Plant Science Center; University System of Ohio; University of Cincinnati	Stanley, CA (corresponding author), Childrens Hosp Philadelphia, Div Endocrinol, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	stanleyc@email.chop.edu	Smith, Thomas J/K-9086-2013	Smith, Thomas J/0000-0003-3528-6793; STANLEY, CHARLES/0000-0003-4881-9392; Cohen, Noam/0000-0002-9462-3932; Jones, Peter/0000-0003-1201-2335	National Institutes of Health [DK53012, DK22122, DK 53761, HL075421]; Society for Inherited Metabolic Disorders; Radioimmunoassay and Islet Cores of the Diabetes Research Center of the University of Pennsylvania School of Medicine [DK19525]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053761, P30DK019525, R01DK022122, R01DK053761, R37DK022122, R01DK053012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Inherited Metabolic Disorders; Radioimmunoassay and Islet Cores of the Diabetes Research Center of the University of Pennsylvania School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53012 (to C. A. S.), DK22122 (to F. M. M.), DK 53761 (to I. N.), HL075421 (to A. W. S.). This work was also supported by a fellowship award from Society for Inherited Metabolic Disorders (to A. P.). Additional support was provided by the Radioimmunoassay and Islet Cores of the Diabetes Research Center of the University of Pennsylvania School of Medicine (Grant DK19525) and Clinical & Translational Research Center (UL1-RR-024134). The work was presented in part at the annual meeting of Society for Inherited Metabolic Disorder (March 25-28, 2007, Nashville, Tennessee) and 69th annual meeting of American Diabetes Association (June 5-9, 2009, New Orleans).	Bennett MJ, 2006, MOL GENET METAB, V89, P74, DOI 10.1016/j.ymgme.2006.04.004; Bennett MJ, 1996, PEDIATR RES, V39, P185, DOI 10.1203/00006450-199601000-00031; Bennett MJ, 1999, PEDIATR DEVEL PATHOL, V2, P337, DOI 10.1007/s100249900132; Clayton PT, 2001, J CLIN INVEST, V108, P457; De Leon DD, 2008, J BIOL CHEM, V283, P25786, DOI 10.1074/jbc.M804372200; De Leon DD, 2007, NAT CLIN PRACT ENDOC, V3, P57, DOI 10.1038/ncpendmet0368; Filling C, 2008, BIOCHEM BIOPH RES CO, V368, P6, DOI 10.1016/j.bbrc.2007.10.188; Gao Z, 1999, DIABETES, V48, P1535, DOI 10.2337/diabetes.48.8.1535; GREGERSEN N, 1979, PEDIATR RES, V13, P977, DOI 10.1203/00006450-197909000-00005; GYLFE E, 1988, J BIOL CHEM, V263, P13750; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411; Hsu BYL, 2001, J PEDIATR-US, V138, P383, DOI 10.1067/mpd.2001.111818; Hussain K, 2005, J PEDIATR-US, V146, P706, DOI 10.1016/j.jpeds.2005.01.032; JACKSON S, 1991, PEDIATR RES, V29, P406, DOI 10.1203/00006450-199104000-00016; Jeffery CJ, 2005, MASS SPECTROM REV, V24, P772, DOI 10.1002/mas.20041; Jones PM, 2000, CLIN CHEM, V46, P149; Kapoor RR, 2009, J CLIN ENDOCR METAB, V94, P2221, DOI 10.1210/jc.2009-0423; Kelly A, 2001, J CLIN ENDOCR METAB, V86, P3724, DOI 10.1210/jc.86.8.3724; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; Li CH, 2006, J BIOL CHEM, V281, P15064, DOI 10.1074/jbc.M600994200; Martens GA, 2007, J BIOL CHEM, V282, P21134, DOI 10.1074/jbc.M700083200; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; Molven A, 2004, DIABETES, V53, P221, DOI 10.2337/diabetes.53.1.221; PASSONNEAU JV, 1993, ENZYMATIC ANAL, P274; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Stanley CA, 2004, MOL GENET METAB, V81, pS45, DOI 10.1016/j.ymgme.2003.10.013; Stanley CA, 2006, DISORDERS MITOCHONDR; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; SWEETMAN L, 1991, ORGANIC ACID ANAL, P143; TEIN I, 1991, ANN NEUROL, V30, P415, DOI 10.1002/ana.410300315; Treberg JR, 2010, ADV ENZYME REGUL, V50, P34, DOI 10.1016/j.advenzreg.2009.10.029	36	119	122	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31806	31818		10.1074/jbc.M110.123638	http://dx.doi.org/10.1074/jbc.M110.123638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670938	Green Published, hybrid			2022-12-27	WOS:000282764600072
J	Oh, E; Maejima, T; Liu, C; Deneris, E; Herlitze, S				Oh, Eugene; Maejima, Takashi; Liu, Chen; Deneris, Evan; Herlitze, Stefan			Substitution of 5-HT1A Receptor Signaling by a Light-activated G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; TRANSGENIC XENOPUS-LAEVIS; FLUORESCENT PROTEIN; SEROTONIN RECEPTOR; DARK-ADAPTATION; FUSION PROTEIN; MUTANT MICE; K+ CHANNELS; TRANSDUCTION; LOCALIZATION	Understanding serotonergic (5-HT) signaling is critical for understanding human physiology, behavior, and neuropsychiatric disease. 5-HT mediates its actions via ionotropic and metabotropic 5-HT receptors. The 5-HT1A receptor is a metabotropic G protein-coupled receptor linked to the G(i/o) signaling pathway and has been specifically implicated in the pathogenesis of depression and anxiety. To understand and precisely control 5-HT1A signaling, we created a light-activated G protein-coupled receptor that targets into 5-HT1A receptor domains and substitutes for endogenous 5-HT1A receptors. To induce 5-HT1A-like targeting, vertebrate rhodopsin was tagged with the C-terminal domain (CT) of 5-HT1A (Rh-CT5-HT1A). Rh-CT5-HT1A activates G protein-coupled inward rectifying K+ channels in response to light and causes membrane hyperpolarization in hippocampal neurons, similar to the agonist-induced responses of the 5-HT1A receptor. The intracellular distribution of Rh-CT5-HT1A resembles that of the 5-HT1A receptor; Rh-CT5-HT1A localizes to somatodendritic sites and is efficiently trafficked to distal dendritic processes. Additionally, neuronal expression of Rh-CT5-HT1A, but not Rh, decreases 5-HT1A agonist sensitivity, suggesting that Rh-CT5-HT1A and 5-HT1A receptors compete to interact with the same trafficking machinery. Finally, Rh-CT5-HT1A is able to rescue 5-HT1A signaling of 5-HT1A KO mice in cultured neurons and in slices of the dorsal raphe showing that Rh-CT5-HT1A is able to functionally compensate for native 5-HT1A. Thus, as an optogenetic tool, Rh-CT5-HT1A has the potential to directly correlate in vivo 5-HT1A signaling with 5-HT neuron activity and behavior in both normal animals and animal models of neuropsychiatric disease.	[Maejima, Takashi; Herlitze, Stefan] Ruhr Univ Bochum, Dept Gen Zool & Neurobiol, D-44780 Bochum, Germany; Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA	Ruhr University Bochum; Case Western Reserve University	Herlitze, S (corresponding author), Ruhr Univ Bochum, Dept Gen Zool & Neurobiol, D-44780 Bochum, Germany.	stefan.herlitze@rub.de		Liu, Chen/0000-0002-5922-0951	National Institutes of Health [RO1 MH062723, R01 MH081127, SBIR R43 MH083302]; National Research Service Award [F30 MH084371]; Medical Scientist Training Program [2T32 GM007250-29]; Neurosciences Training Grant [5T32 AG000271-07]; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062723, R01MH081127, F30MH084371, R43MH083302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neurosciences Training Grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 MH062723 (to E. D.), R01 MH081127 (to S. H.), and SBIR R43 MH083302 (to LucCell, Inc.). This work was also supported by National Research Service Award F30 MH084371, Medical Scientist Training Program Training Grant 2T32 GM007250-29, Neurosciences Training Grant 5T32 AG000271-07 (to E. O.), and Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (to T. M.).	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Brueggemann LI, 2002, J GEN PHYSIOL, V119, P593, DOI 10.1085/jgp.20018495; Carrel D, 2008, J NEUROSCI, V28, P8063, DOI 10.1523/JNEUROSCI.4487-07.2008; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; CORNWALL MC, 1995, J GEN PHYSIOL, V106, P543, DOI 10.1085/jgp.106.3.543; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Fain GL, 1996, TRENDS NEUROSCI, V19, P502, DOI 10.1016/S0166-2236(96)10056-4; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Jin S, 2003, FEBS LETT, V542, P142, DOI 10.1016/S0014-5793(03)00368-5; Kia HK, 1996, J COMP NEUROL, V365, P289; Kim J, 2004, J NEUROSCI METH, V133, P81, DOI 10.1016/j.jneumeth.2003.09.029; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lanfumey L, 2004, CNS NEUROL DISORD-DR, V3, P1, DOI 10.2174/1568007043482570; Leone M, 1998, NEUROREPORT, V9, P2605, DOI 10.1097/00001756-199808030-00033; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Li X, 2005, J BIOL CHEM, V280, P23945, DOI 10.1074/jbc.M414078200; Li ZZ, 1999, PHOTOCHEM PHOTOBIOL, V69, P500, DOI 10.1562/0031-8655(1999)069<0500:DORTPF>2.3.CO;2; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; Parsons LH, 2001, J NEUROCHEM, V77, P607, DOI 10.1046/j.1471-4159.2001.00254.x; Pei Y, 2008, PHYSIOLOGY, V23, P313, DOI 10.1152/physiol.00025.2008; Perkins BD, 2004, METHOD CELL BIOL, V76, P315; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; Scott-McKean Jonah J, 2008, Open Neuropsychopharmacol J, V1, P24; SELETTI B, 1995, NEUROPSYCHOPHARMACOL, V13, P93; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SOTELO C, 1990, EUR J NEUROSCI, V2, P1144, DOI 10.1111/j.1460-9568.1990.tb00026.x; Stamford JA, 2000, TRENDS NEUROSCI, V23, P459, DOI 10.1016/S0166-2236(00)01631-3; Wittemann S, 2000, J BIOL CHEM, V275, P37807, DOI 10.1074/jbc.M004653200; Xie M, 2007, J CELL BIOL, V178, P489, DOI 10.1083/jcb.200702072; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	39	95	96	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30825	30836		10.1074/jbc.M110.147298	http://dx.doi.org/10.1074/jbc.M110.147298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20643652	Green Published, hybrid			2022-12-27	WOS:000282135500050
J	Suram, S; Gangelhoff, TA; Taylor, PR; Rosas, M; Brown, GD; Bonventre, JV; Akira, S; Uematsu, S; Williams, DL; Murphy, RC; Leslie, CC				Suram, Saritha; Gangelhoff, Todd A.; Taylor, Philip R.; Rosas, Marcela; Brown, Gordon D.; Bonventre, Joseph V.; Akira, Shizuo; Uematsu, Satoshi; Williams, David L.; Murphy, Robert C.; Leslie, Christina C.			Pathways Regulating Cytosolic Phospholipase A(2) Activation and Eicosanoid Production in Macrophages by Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECEPTOR; C-TYPE LECTIN; PATTERN-RECOGNITION RECEPTOR; CELL-WALL; PROSTAGLANDIN SYNTHESIS; SCAVENGER RECEPTORS; INNATE IMMUNITY; DECTIN-1; BINDING; DOMAIN	Resident tissue macrophages are activated by the fungal pathogen Candida albicans to release eicosanoids, which are important modulators of inflammation and immune responses. Our objective was to identify the macrophage receptors engaged by C. albicans that mediate activation of group IVA cytosolic phospholipase A(2) (cPLA(2)alpha), a regulatory enzyme that releases arachidonic acid (AA) for production of prostaglandins and leukotrienes. A comparison of peritoneal macrophages from wild type and knock-out mice demonstrates that the beta-glucan receptor Dectin-1 and MyD88 regulate early release of AA and eicosanoids in response to C. albicans. However, cyclooxygenase 2 (COX2) expression and later phase eicosanoid production are defective in MyD88(-/-) but not Dectin-1(-/-) macrophages. Furthermore, C. albicans-stimulated activation of MAPK and phosphorylation of cPLA(2)alpha on Ser-505 are regulated by MyD88 and not Dectin-1. In contrast, Dectin-1 mediates MAPK activation, cPLA(2)alpha phosphorylation, and COX2 expression in response to particulate beta-glucan suggesting that other receptors engaged by C. albicans preferentially mediate these responses. Results also implicate the mannan-binding receptor Dectin-2 in regulating cPLA(2)alpha. C. albicans-stimulated MAPK activation and AA release are blocked by D-mannose and Dectin-2-specific antibody, and overexpression of Dectin-2 in RAW264.7 macrophages enhances C. albicans-stimulated MAPK activation, AA release, and COX2 expression. In addition, calcium mobilization is enhanced in RAW264.7 macrophages overexpressing Dectin-1 or -2. The results demonstrate that C. albicans engages both beta-glucan and mannan-binding receptors on macrophages that act with MyD88 to regulate the activation of cPLA(2)alpha and eicosanoid production.	[Suram, Saritha; Gangelhoff, Todd A.; Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Taylor, Philip R.; Rosas, Marcela] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 22D, Scotland; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Akira, Shizuo; Uematsu, Satoshi] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Williams, David L.] E Tennessee State Univ, James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA; [Murphy, Robert C.; Leslie, Christina C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Leslie, Christina C.] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA	National Jewish Health; Cardiff University; University of Aberdeen; Harvard University; Brigham & Women's Hospital; Osaka University; East Tennessee State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Leslie, CC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	lesliec@njhealth.org	brown, gordon/B-4249-2012; Murphy, Robert/AAO-5349-2020; Rosas Nexticapa, Marcela/HGU-1088-2022; Akira, Shizuo/C-3134-2009	Murphy, Robert/0000-0002-9430-6515; Taylor, Philip/0000-0003-0163-1421; brown, gordon/0000-0002-0287-5383	National Institutes of Health [HL34303, DK54741, GM53522]; United Kingdom Medical Research Council [G0601617]; Wellcome Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072381, R56DK054741, R01DK054741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053522] Funding Source: NIH RePORTER; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL34303 (to R. C. M. and C. C. L.), DK54741 (to J. V. B.), and GM53522 (to D. L. W.). This work was also supported by a United Kingdom Medical Research Council Senior Fellowship G0601617 (to P. R. T.) and the Wellcome Trust (to G. D. B.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Cambi A, 2008, J BIOL CHEM, V283, P20590, DOI 10.1074/jbc.M709334200; DECARVALHO MS, 1993, ARCH BIOCHEM BIOPHYS, V306, P534, DOI 10.1006/abbi.1993.1549; ENSLEY HE, 1994, CARBOHYD RES, V258, P307, DOI 10.1016/0008-6215(94)84098-9; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee SH, 2007, BIOCHEM BIOPH RES CO, V364, P996, DOI 10.1016/j.bbrc.2007.10.111; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Masuoka J, 2004, CLIN MICROBIOL REV, V17, P281, DOI 10.1128/CMR.17.2.281-310.2004; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Miyazato A, 2009, INFECT IMMUN, V77, P3056, DOI 10.1128/IAI.00840-08; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Parti RP, 2010, AM J RESP CELL MOL, V42, P415, DOI 10.1165/rcmb.2009-0110OC; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Rice PJ, 2002, J LEUKOCYTE BIOL, V72, P140; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Xia Y, 1999, J IMMUNOL, V162, P2281; Zimmerman JW, 1998, J BIOL CHEM, V273, P22014, DOI 10.1074/jbc.273.34.22014	65	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30676	30685		10.1074/jbc.M110.143800	http://dx.doi.org/10.1074/jbc.M110.143800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20643646	Green Published, hybrid			2022-12-27	WOS:000282135500036
J	Nyathi, Y; Lousa, CDM; van Roermund, CW; Wanders, RJA; Johnson, B; Baldwin, SA; Theodoulou, FL; Baker, A				Nyathi, Yvonne; Lousa, Carine De Marcos; van Roermund, Carlo W.; Wanders, Ronald J. A.; Johnson, Barbara; Baldwin, Stephen A.; Theodoulou, Frederica L.; Baker, Alison			The Arabidopsis Peroxisomal ABC Transporter, Comatose, Complements the Saccharomyces cerevisiae pxa1 pxa2 Delta Mutant for Metabolism of Long-chain Fatty Acids and Exhibits Fatty Acyl-CoA-stimulated ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-CASSETTE TRANSPORTER; HUMAN ADRENOLEUKODYSTROPHY PROTEIN; P-GLYCOPROTEIN; BETA-OXIDATION; COENZYME-A; SEEDLING DEVELOPMENT; MEMBRANE-PROTEIN; GENE-PRODUCT; YEAST; GERMINATION	The Arabidopsis ABC transporter Comatose (CTS; AtABCD1) is required for uptake into the peroxisome of a wide range of substrates for beta-oxidation, but it is uncertain whether CTS itself is the transporter or if the transported substrates are free acids or CoA esters. To establish a system for its biochemical analysis, CTS was expressed in Saccharomyces cerevisiae. The plant protein was correctly targeted to yeast peroxisomes, was assembled into the membrane with its nucleotide binding domains in the cytosol, and exhibited basal ATPase activity that was sensitive to aluminum fluoride and abrogated by mutation of a conserved Walker A motif lysine residue. The yeast pxa1 pxa2 Delta mutant lacks the homologous peroxisomal ABC transporter and is unable to grow on oleic acid. Consistent with its exhibiting a function in yeast akin to that in the plant, CTS rescued the oleate growth phenotype of the pxa1 pxa2 Delta mutant, and restored beta-oxidation of fatty acids with a range of chain lengths and varying degrees of desaturation. When expressed in yeast peroxisomal membranes, the basal ATPase activity of CTS could be stimulated by fatty acyl-CoAs but not by fatty acids. The implications of these findings for the function and substrate specificity of CTS are discussed.	[Nyathi, Yvonne; Lousa, Carine De Marcos; Johnson, Barbara; Baker, Alison] Univ Leeds, Ctr Plant Sci, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [van Roermund, Carlo W.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Pediat & Clin Chem, NL-1105 AZ Amsterdam, Netherlands; [van Roermund, Carlo W.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Dept Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Theodoulou, Frederica L.] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England	University of Leeds; University of Leeds; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Baker, A (corresponding author), Univ Leeds, Ctr Plant Sci, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	a.baker@leeds.ac.uk		De Marcos Lousa, Carine/0000-0002-5041-6261; Baker, Alison/0000-0003-2181-4057; Theodoulou, Frederica/0000-0002-8306-0716	Biotechnology and Biosciences Research Council [BB/F007299/1, BB/F007108/1]; BBSRC of the United Komgdom; BBSRC [BB/F007108/1, BB/D524875/1, BB/F007299/1, BBS/E/C/00004948] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004948, BB/F007108/1, BB/D524875/1, BB/F007299/1] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC of the United Komgdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biosciences Research Council Grants BB/F007299/1 (to A. B. and S. A. B.) and BB/F007108/1 (to F. L. T.) and a BBSRC doctoral training studentship (to Y. N.). Rothamsted Research receives support from the BBSRC of the United Komgdom.	Arai Y, 2008, PLANT CELL, V20, P3227, DOI 10.1105/tpc.108.062877; Belli S, 2009, J PHARM SCI-US, V98, P1905, DOI 10.1002/jps.21558; Carrera E, 2007, PLANT PHYSIOL, V143, P1669, DOI 10.1104/pp.107.096057; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; CONSTANTINIDES PP, 1986, ARCH BIOCHEM BIOPHYS, V250, P267, DOI 10.1016/0003-9861(86)90726-5; CONSTANTINIDES PP, 1985, J BIOL CHEM, V260, P7573; Contreras M, 1996, ARCH BIOCHEM BIOPHYS, V334, P369, DOI 10.1006/abbi.1996.0467; DAUM G, 1982, J BIOL CHEM, V257, P3075; De Marcos Lousa Carine, 2009, Commun Integr Biol, V2, P97; Dietrich D, 2009, MOL BIOL CELL, V20, P530, DOI 10.1091/mbc.E08-07-0745; Distel Ben, 2006, Methods Mol Biol, V313, P21; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; ELGERSMA Y, 1993, GENETICS, V135, P731; ERDMANN R, 1994, YEAST, V10, P1173, DOI 10.1002/yea.320100905; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Footitt S, 2007, PLANT PHYSIOL, V144, P1467, DOI 10.1104/pp.107.099903; Footitt S, 2006, J EXP BOT, V57, P2805, DOI 10.1093/jxb/erl045; Fourcade S, 2009, AM J PHYSIOL-ENDOC M, V296, pE211, DOI 10.1152/ajpendo.90736.2008; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Guimaraes CP, 2005, J HUM GENET, V50, P99, DOI 10.1007/s10038-004-0226-4; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Hayashi M, 2002, PLANT CELL PHYSIOL, V43, P1, DOI 10.1093/pcp/pcf023; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hooks MA, 2007, BIOCHEM J, V406, P399, DOI 10.1042/BJ20070258; Hunt MC, 2008, PROG LIPID RES, V47, P405, DOI 10.1016/j.plipres.2008.05.001; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kanai M, 2010, PLANT J, V62, P936, DOI 10.1111/j.1365-313X.2010.04205.x; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Kunz HH, 2009, PLANT CELL, V21, P2733, DOI 10.1105/tpc.108.064857; Landgraf P, 2003, EUR J CELL BIOL, V82, P401, DOI 10.1078/0171-9335-00331; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Linka N, 2008, PLANT CELL, V20, P3241, DOI 10.1105/tpc.108.062042; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Morita M, 2006, BIOL PHARM BULL, V29, P1836, DOI 10.1248/bpb.29.1836; Muller M, 2006, FEBS LETT, V580, P6139, DOI 10.1016/j.febslet.2006.10.012; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; Pinfield-Wells H, 2005, PLANT J, V43, P861, DOI 10.1111/j.1365-313X.2005.02498.x; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rottensteiner H, 2006, BBA-MOL CELL RES, V1763, P1527, DOI 10.1016/j.bbamcr.2006.08.012; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Saveria T, 2007, EUKARYOT CELL, V6, P1439, DOI 10.1128/EC.00084-07; Shani N, 1996, P NATL ACAD SCI USA, V93, P11901, DOI 10.1073/pnas.93.21.11901; SHANI N, 1995, P NATL ACAD SCI USA, V92, P6012, DOI 10.1073/pnas.92.13.6012; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; SIKORSKI RS, 1989, GENETICS, V122, P19; Simonsen AC, 2003, FEBS LETT, V552, P253, DOI 10.1016/S0014-5793(03)00970-0; Slocombe SP, 2009, PLANT BIOTECHNOL J, V7, P694, DOI 10.1111/j.1467-7652.2009.00435.x; Sparkes IA, 2003, PLANT PHYSIOL, V133, P1809, DOI 10.1104/pp.103.031252; Swartzman EE, 1996, J CELL BIOL, V132, P549, DOI 10.1083/jcb.132.4.549; SZENTE L, 1993, J INCLUS PHENOM MOL, V16, P339, DOI 10.1007/BF00708714; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2002, J BIOL CHEM, V277, P40142, DOI 10.1074/jbc.M205079200; Taylor KM, 1996, BIOCHEM J, V319, P255, DOI 10.1042/bj3190255; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Theodoulou FL, 2005, PLANT PHYSIOL, V137, P835, DOI 10.1104/pp.105.059352; Turner JE, 2005, J BIOL CHEM, V280, P2780, DOI 10.1074/jbc.M407291200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; VAN ROERMUND CWT, 2008, FASEB J, V22, P4201; Velamakanni S, 2008, MOL PHARMACOL, V73, P12, DOI 10.1124/mol.108.038299; Verleur N, 1997, EUR J BIOCHEM, V249, P657, DOI 10.1111/j.1432-1033.1997.00657.x; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Wittinghofer A, 1997, CURR BIOL, V7, pR682, DOI 10.1016/S0960-9822(06)00355-1; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	79	58	60	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29892	29902		10.1074/jbc.M110.151225	http://dx.doi.org/10.1074/jbc.M110.151225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20659892	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-27	WOS:000281984300026
J	Ghomashchi, F; Naika, GS; Bollinger, JG; Aloulou, A; Lehr, M; Leslie, CC; Gelb, MH				Ghomashchi, Farideh; Naika, Gajendra S.; Bollinger, James G.; Aloulou, Ahmed; Lehr, Matthias; Leslie, Christina C.; Gelb, Michael H.			Interfacial Kinetic and Binding Properties of Mammalian Group IVB Phospholipase A(2) (cPLA(2 beta)) and Comparison with the Other cPLA(2) Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE-A2; C2 DOMAIN; INHIBITORS; A(2)ALPHA; MEMBRANES; 1-INDOL-1-YL-PROPAN-2-ONES; IDENTIFICATION; CATALYSIS; FORM	The cytosolic (group IV) phospholipase A(2) (cPLA(2)s) family contains six members. We have prepared recombinant proteins for human alpha, mouse beta, human gamma, human delta, human epsilon, and mouse zeta cPLA(2)s and have studied their interfacial kinetic and binding properties in vitro. Mouse cPLA(2)beta action on phosphatidylcholine vesicles is activated by anionic phosphoinositides and cardiolipin but displays a requirement for Ca2+ only in the presence of cardiolipin. This activation pattern is explained by the effects of anionic phospholipids and Ca2+ on the interfacial binding of mouse cPLA(2)beta and its C2 domain to vesicles. Ca2+ dependent binding of mouse cPLA(2)beta to cardiolipin-containing vesicles requires a patch of basic residues near the Ca2+-binding surface loops of the C2 domain, but binding to phosphoinositide-containing vesicles does not depend on any specific cluster of basic residues. Human cPLA(2)delta also displays Ca2+- and cardiolipin-enhanced interfacial binding and activity. The lysophospholipase, phospholipase A(1), and phospholipase A(2) activities of the full set of mammalian cPLA(2)s were quantified. The relative level of these activities is very different among the isoforms, and human cPLA(2)delta stands out as having relatively high phospholipase A(1) activity. We also tested the susceptibility of all cPLA(2) family members to a panel of previously reported inhibitors of human cPLA(2)alpha and analogs of these compounds. This led to the discovery of a potent and selective inhibitor of mouse cPLA(2)beta. These in vitro studies help determine the regulation and function of the cPLA(2) family members.	[Ghomashchi, Farideh; Naika, Gajendra S.; Bollinger, James G.; Aloulou, Ahmed; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Lehr, Matthias] Univ Munster, Inst Pharmaceut & Med Chem, D-48149 Munster, Germany; [Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Munster; National Jewish Health	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Campus Box 351700, Seattle, WA 98195 USA.	gelb@chem.washington.edu		Aloulou, Ahmed/0000-0002-6637-668X; gelb, michael/0000-0001-7000-5219	National Institutes of Health [HL50040, HL61378, HL34303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303, R01HL061378, R01HL050040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL50040 (to M. H. G.) and HL61378 and HL34303 (to C. C. L.).	Ball A, 1999, P NATL ACAD SCI USA, V96, P6637, DOI 10.1073/pnas.96.12.6637; Bollinger JG, 2010, J LIPID RES, V51, P440, DOI 10.1194/jlr.D000885; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; DECARVALHO MGS, 1995, J BIOL CHEM, V270, P20439, DOI 10.1074/jbc.270.35.20439; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; EATON BR, 1976, ARCH BIOCHEM BIOPHYS, V176, P604, DOI 10.1016/0003-9861(76)90204-6; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Forster L, 2010, BIOORGAN MED CHEM, V18, P945, DOI 10.1016/j.bmc.2009.11.028; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Ghosh M, 2006, J BIOL CHEM, V281, P16615, DOI 10.1074/jbc.M601770200; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Hixon MS, 1998, BIOCHEMISTRY-US, V37, P8516, DOI 10.1021/bi980416d; LEHR M, 2009, Patent No. 7608633; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Ludwig J, 2006, J MED CHEM, V49, P2611, DOI 10.1021/jm051243a; MCKEW JC, 2004, Patent No. 6797708; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Pickard RT, 1999, J BIOL CHEM, V274, P8823, DOI 10.1074/jbc.274.13.8823; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; SENO K, 1998, Patent No. 9833797; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; Tucker DE, 2005, J LIPID RES, V46, P2122, DOI 10.1194/jlr.M500230-JLR200; ZWAAL RFA, 1975, BIOCHIM BIOPHYS ACTA, V406, P83, DOI 10.1016/0005-2736(75)90044-9	28	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36100	36111		10.1074/jbc.M110.165647	http://dx.doi.org/10.1074/jbc.M110.165647			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20705608	hybrid, Green Published			2022-12-27	WOS:000283845300086
J	Mahfoud, R; Manis, A; Binnington, B; Ackerley, C; Lingwood, CA				Mahfoud, Radhia; Manis, Adam; Binnington, Beth; Ackerley, Cameron; Lingwood, Clifford A.			A Major Fraction of Glycosphingolipids in Model and Cellular Cholesterol-containing Membranes Is Undetectable by Their Binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; HUMAN-IMMUNODEFICIENCY-VIRUS; GLOBOTRIAOSYL CERAMIDE; LIPID RAFTS; RECEPTOR FUNCTION; MONOCLONAL-ANTIBODY; SURFACE EXPRESSION; SACCHARIDE CHAINS; STEM-CELLS; RECOGNITION	Glycosphingolipids (GSLs) accumulate in cholesterol-enriched cell membrane domains and provide receptors for protein ligands. Lipid-based "aglycone" interactions can influence GSL carbohydrate epitope presentation. To evaluate this relationship, Verotoxin binding its receptor GSL, globotriaosyl ceramide (Gb(3)), was analyzed in simple GSL/cholesterol, detergent-resistant membrane vesicles by equilibrium density gradient centrifugation. Vesicles separated into two Gb(3)/cholesterol-containing populations. The lighter, minor fraction (<5% total GSL), bound VT1, VT2, IgG/IgM mAb anti-Gb(3), HIVgp120 or Bandeiraea simplicifolia lectin. Only IgM anti-Gb(3), more tolerant of carbohydrate modification, bound both vesicle fractions. Post-embedding cryo-immuno-EM confirmed these results. This appears to be a general GSL-cholesterol property, because similar receptor-inactive vesicles were separated for other GSL-protein ligand systems; cholera toxin (CTx)-GM1, HIVgp120-galactosyl ceramide/sulfatide. Inclusion of galactosyl or glucosyl ceramide (GalCer and GlcCer) rendered VT1-unreactive Gb(3)/cholesterol vesicles, VT1-reactive. We found GalCer and GlcCer bind Gb(3), suggesting GSL-GSL interaction can counter cholesterol masking of Gb(3). The similar separation of Vero cell membrane-derived vesicles into minor "binding," and major " non-binding" fractions when probed with VT1, CTx, or anti-SSEA4 (a human GSL stem cell marker), demonstrates potential physiological relevance. Cell membrane GSL masking was cholesterol- and actin-dependent. Cholesterol depletion of Vero and HeLa cells enabled differential VT1B subunit labeling of "available" and " cholesterol-masked" plasma membrane Gb(3) pools by fluorescence microscopy. Thus, the model GSL/cholesterol vesicle studies predicted two distinct membrane GSL formats, which were demonstrated within the plasma membrane of cultured cells. Cholesterol masking of most cell membrane GSLs may impinge many GSL receptor functions.	[Mahfoud, Radhia; Manis, Adam; Binnington, Beth; Lingwood, Clifford A.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Ackerley, Cameron; Lingwood, Clifford A.] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Manis, Adam; Lingwood, Clifford A.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5S 1A8, Canada; [Lingwood, Clifford A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Lingwood, CA (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cling@sickkids.ca			CIHR [MT 13747]; Ontario HIV Treatment Network; Canfar; Research Training Centre at the Research Institute, Hospital for Sick Children	CIHR(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Canfar; Research Training Centre at the Research Institute, Hospital for Sick Children	This work was supported by CIHR Grant MT 13747, grants from Ontario HIV Treatment Network and Canfar and by the Research Training Centre at the Research Institute, Hospital for Sick Children.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ACKERMAN GA, 1980, J HISTOCHEM CYTOCHEM, V28, P1334, DOI 10.1177/28.12.7014713; Angstrom J, 1998, GLYCOBIOLOGY, V8, P297, DOI 10.1093/glycob/8.4.297; Bartz R, 2008, EMBO J, V27, P948, DOI 10.1038/emboj.2008.36; BENGOECHEAALONS.MT, 2005, J P NATL ACAD SCI U, V102, P11681; BHAT S, 1991, P NATL ACAD SCI USA, V88, P7131, DOI 10.1073/pnas.88.16.7131; Binnington B, 2002, NEUROCHEM RES, V27, P807, DOI 10.1023/A:1020261125008; BOYD B, 1994, EUR J BIOCHEM, V223, P873, DOI 10.1111/j.1432-1033.1994.tb19064.x; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chen X, 2009, BIOCHEM J, V417, P525, DOI 10.1042/BJ20081385; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; CROOK SJ, 1986, BIOCHEMISTRY-US, V25, P7488, DOI 10.1021/bi00371a035; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Das P, 2003, LIFE SCI, V72, P2617, DOI 10.1016/S0024-3205(03)00163-2; Delacour D, 2005, J CELL BIOL, V169, P491, DOI 10.1083/jcb.200407073; DIBIASE A, 1990, NEUROCHEM RES, V15, P519, DOI 10.1007/BF00966210; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Fernandez C, 2004, EXP CELL RES, V300, P109, DOI 10.1016/j.yexcr.2004.06.029; Fielding CJ, 2004, BIOCHEM SOC T, V32, P65, DOI 10.1042/BST0320065; Fong CY, 2009, STEM CELL REV REP, V5, P72, DOI 10.1007/s12015-009-9054-4; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Hagerstrand H, 2006, MOL MEMBR BIOL, V23, P277, DOI 10.1080/09687860600682536; Hakomori S, 2004, ARCH BIOCHEM BIOPHYS, V426, P173, DOI 10.1016/j.abb.2004.02.032; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hammache D, 1999, J VIROL, V73, P5244, DOI 10.1128/JVI.73.6.5244-5248.1999; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006; Hinoi E, 2004, EUR J BIOCHEM, V271, P1, DOI 10.1046/j.1432-1033.2003.03907.x; Hirai M, 2005, J PHYS-CONDENS MAT, V17, pS2965, DOI 10.1088/0953-8984/17/31/025; Hutterer R, 1993, J Fluoresc, V3, P257, DOI 10.1007/BF00865274; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Jarvis RM, 2007, BIOCHEM BIOPH RES CO, V355, P944, DOI 10.1016/j.bbrc.2007.02.053; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KANNAGI R, 1983, CANCER RES, V43, P4997; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; Kawano N, 2008, BIOL REPROD, V79, P1153, DOI 10.1095/biolreprod.108.069054; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kolling GL, 2008, HISTOCHEM CELL BIOL, V130, P157, DOI 10.1007/s00418-008-0417-8; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Lingwood CA, 1996, GLYCOCONJUGATE J, V13, P495, DOI 10.1007/BF00731435; Lingwood CA, 1999, BBA-MOL BASIS DIS, V1455, P375, DOI 10.1016/S0925-4439(99)00062-9; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LIPPINCOTTSCHWA.J, 2010, R D ANNU REV BIOPHYS, V39, P559; LOWRY RR, 1968, J LIPID RES, V9, P397; Lund N, 2006, AIDS, V20, P333, DOI 10.1097/01.aids.0000206499.78664.58; Lund N, 2009, BLOOD, V113, P4980, DOI 10.1182/blood-2008-03-143396; LUNDEN BM, 1977, CHEM PHYS LIPIDS, V20, P263, DOI 10.1016/0009-3084(77)90067-6; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Mahfoud R, 2009, J LIPID RES, V50, P1744, DOI 10.1194/jlr.M800385-JLR200; Mamelak D, 2001, BIOCHEMISTRY-US, V40, P3572, DOI 10.1021/bi001643u; Manes S, 2004, TRENDS CELL BIOL, V14, P275, DOI 10.1016/j.tcb.2004.04.008; MCMULLEN TPW, 1993, BIOCHEMISTRY-US, V32, P516, DOI 10.1021/bi00053a016; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Mylvaganam M, 1999, J BIOL CHEM, V274, P20725, DOI 10.1074/jbc.274.29.20725; MYLVAGANAM M, 2003, CARBOHYDRATE BASED D, P761; NAKAKUMA H, 1992, JPN J CLIN ONCOL, V22, P308; NAKAKUMA H, 1989, FEBS LETT, V258, P230, DOI 10.1016/0014-5793(89)81660-6; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Nutikka A, 2003, GLYCOCONJUGATE J, V20, P33, DOI 10.1023/B:GLYC.0000016740.69726.fb; Nutikka Anita, 2003, Methods Mol Med, V73, P187; Nutikka Anita, 2003, Methods Mol Med, V73, P197; NYHOLM PG, 1993, BIOCHEMISTRY-US, V32, P1225, DOI 10.1021/bi00056a005; NYHOLM PG, 1993, INT J BIOL MACROMOL, V15, P43, DOI 10.1016/S0141-8130(05)80087-X; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; PELLIZZARI A, 1992, BIOCHEMISTRY-US, V31, P1363, DOI 10.1021/bi00120a011; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Rog T, 2006, BIOPHYS J, V91, P3756, DOI 10.1529/biophysj.106.080887; Sakumoto Y, 2009, ARCH HISTOL CYTOL, V72, P77, DOI 10.1679/aohc.72.77; Sato B, 2007, BIOCHEM BIOPH RES CO, V364, P838, DOI 10.1016/j.bbrc.2007.10.093; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; STEWART RJ, 1993, BIOCHEMISTRY-US, V32, P5605, DOI 10.1021/bi00072a016; STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340; STROMBERG N, 1990, J BIOL CHEM, V265, P11244; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Tam P, 2008, J CELL PHYSIOL, V216, P750, DOI 10.1002/jcp.21456; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Villard R, 2002, CHEMBIOCHEM, V3, P517, DOI 10.1002/1439-7633(20020603)3:6<517::AID-CBIC517>3.0.CO;2-N; WIELS J, 1981, P NATL ACAD SCI-BIOL, V78, P6485, DOI 10.1073/pnas.78.10.6485; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079	96	62	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36049	36059		10.1074/jbc.M110.110189	http://dx.doi.org/10.1074/jbc.M110.110189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20716521	hybrid, Green Published			2022-12-27	WOS:000283845300081
J	Pan, WW; Li, JD; Huang, SA; Papadimos, TJ; Pan, ZK; Chen, LY				Pan, Warren W.; Li, Jain-Dong; Huang, Shuang; Papadimos, Thomas J.; Pan, Zhixing K.; Chen, Ling-Yu			Synergistic Activation of NF-kappa B by Bacterial Chemoattractant and TNF alpha Is Mediated by p38 MAPK-dependent RelA Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FMET-LEU-PHE; PERIPHERAL-BLOOD MONOCYTES; SIGNAL-TRANSDUCTION PATHWAY; PROTEIN-KINASE; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; GENE-EXPRESSION; IMMUNE-SYSTEM; FMLP; RECEPTOR	In the host immune system, leukocytes are often exposed to multiple inflammation inducers. NF-kappa B is of considerable importance in leukocyte function because of its ability to activate the transcription of many proinflammatory immediate-early genes. Tremendous efforts have been made toward understanding how NF-kappa B is activated by various inducers. However, most research on NF-kappa B regulation has been focused on understanding how NF-kappa B is activated by a single inducer. This is unlike the situation in the human immune system where multiple inflammation inducers, including both exogenous and endogenous mediators, are present concurrently. We now present evidence that the formylated peptide f-Met-Leu-Phe (fMLP), a bacterial chemoattractant, synergizes with TNF alpha to induce NF-kappa B activation and the resultant inflammatory response in vitro and in vivo. The mechanism of synergistic activation of NF-kappa B by bacterial fMLP and TNF alpha may be involved in the induction of RelA acetylation, which is regulated by p38 MAPK. Thus, this study provides direct evidence for the synergistic induction of NF-kappa B-dependent inflammatory responses by both exogenous and endogenous inducers. The ability of fMLP to synergize with TNF alpha and activate NF-kappa B represents a novel and potentially important mechanism through which bacterial fMLP not only attracts leukocytes but also directly contributes to inflammation by synergizing with the endogenous mediator TNF alpha.	[Pan, Warren W.; Papadimos, Thomas J.; Pan, Zhixing K.; Chen, Ling-Yu] Univ Toledo, Med Ctr, Dept Med, Toledo, OH 43614 USA; [Li, Jain-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Huang, Shuang; Pan, Zhixing K.; Chen, Ling-Yu] Scripps Res Inst, Dept Immunol & Mol & Expt Med, La Jolla, CA 92037 USA	University System of Ohio; University of Toledo; University of Rochester; Scripps Research Institute	Pan, ZK (corresponding author), 3035 Arlington Ave, Toledo, OH 43614 USA.	kevin.pan@utoledo.edu; lingyu.chen@utoledo.edu		Li, Jian-Dong/0000-0002-5593-050X; Papadimos, Thomas/0000-0002-4024-227X; Pan, Warren/0000-0003-4931-8864	National Institutes of Health, USPHS [AI43524, M01RR00833]; Sam and Ross Stein Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI043524, R01AI043524] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Sam and Ross Stein Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI43524 from USPHS and Grant M01RR00833 (to General Clinical Research Center, Scripps Research Institute). This work was also supported in part by the Sam and Ross Stein Charitable Trust.	Adams J L, 1999, Curr Opin Drug Discov Devel, V2, P96; ALLEN R A, 1990, P83; Ayala JM, 2000, J LEUKOCYTE BIOL, V67, P869, DOI 10.1002/jlb.67.6.869; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Browning DD, 1997, J BIOL CHEM, V272, P7995, DOI 10.1074/jbc.272.12.7995; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chen Ling-Yu, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P361; Chen LY, 2009, J IMMUNOL, V182, P2518, DOI 10.4049/jimmunol.0713933; Chen LY, 2005, J BIOL CHEM, V280, P22497, DOI 10.1074/jbc.M413033200; Chen LY, 2004, BIOCHEM BIOPH RES CO, V319, P629, DOI 10.1016/j.bbrc.2004.05.038; Chen LY, 2004, J BIOL CHEM, V279, P7208, DOI 10.1074/jbc.M309542200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Huang S, 2001, J BIOL CHEM, V276, P40977, DOI 10.1074/jbc.M105242200; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009; PAN ZX, 1995, J BIOL CHEM, V270, P7787, DOI 10.1074/jbc.270.14.7787; Pan ZXK, 2000, J IMMUNOL, V164, P404, DOI 10.4049/jimmunol.164.1.404; ROT A, 1987, P NATL ACAD SCI USA, V84, P7967, DOI 10.1073/pnas.84.22.7967; Schiff DE, 1997, J LEUKOCYTE BIOL, V62, P786, DOI 10.1002/jlb.62.6.786; Schulze-Osthoff K, 1997, IMMUNOBIOLOGY, V198, P35, DOI 10.1016/S0171-2985(97)80025-3; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; SNYDERMAN R, 1988, INFLAMMATION BASIC P, P309; TRUETT AP, 1988, P NATL ACAD SCI USA, V85, P1549, DOI 10.1073/pnas.85.5.1549; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Zu YL, 1998, J IMMUNOL, V160, P1982	38	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34348	34354		10.1074/jbc.M110.109165	http://dx.doi.org/10.1074/jbc.M110.109165			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20729202	Green Published, hybrid			2022-12-27	WOS:000283659100008
J	Ogawa, H; Shionyu, M; Sugiura, N; Hatano, S; Nagai, N; Kubota, Y; Nishiwaki, K; Sato, T; Gotoh, M; Narimatsu, H; Shimizu, K; Kimata, K; Watanabe, H				Ogawa, Hiroyasu; Shionyu, Masafumi; Sugiura, Nobuo; Hatano, Sonoko; Nagai, Naoko; Kubota, Yukihiko; Nishiwaki, Kiyoji; Sato, Takashi; Gotoh, Masanori; Narimatsu, Hisashi; Shimizu, Katsuji; Kimata, Koji; Watanabe, Hideto			Chondroitin Sulfate Synthase-2/Chondroitin Polymerizing Factor Has Two Variants with Distinct Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FOLD RECOGNITION; MOLECULAR-CLONING; HEPARAN-SULFATE; CHAIN-LENGTH; ARTICULAR-CARTILAGE; PROTEOGLYCANS; GLUCURONOSYLTRANSFERASE; EXPRESSION; BINDING; SYNTHASE-3	Chondroitin sulfate (CS) is a polysaccharide consisting of repeating disaccharide units of N-acetyl-D-galactosamine and D-glucuronic acid residues, modified with sulfated residues at various positions. To date six glycosyltransferases for chondroitin synthesis have been identified, and the complex of chondroitin sulfate synthase-1 (CSS1)/chondroitin synthase-1 (ChSy-1) and chondroitin sulfate synthase-2 (CSS2)/chondroitin polymerizing factor is assumed to play a major role in CS biosynthesis. We found an alternative splice variant of mouse CSS2 in a data base that lacks the N-terminal transmembrane domain, contrasting to the original CSS2. Here, we investigated the roles of CSS2 variants. Both the original enzyme and the splice variant, designated CSS2A and CSS2B, respectively, were expressed at different levels and ratios in tissues. Western blot analysis of cultured mouse embryonic fibroblasts confirmed that both enzymes were actually synthesized as proteins and were localized in both the endoplasmic reticulum and the Golgi apparatus. Pulldown assays revealed that either of CSS2A, CSS2B, and CSS1/ChSy-1 heterogeneously and homogeneously interacts with each other, suggesting that they form a complex of multimers. In vitro glycosyltransferase assays demonstrated a reduced glucuronyltransferase activity in CSS2B and no polymerizing activity in CSS2B co-expressed with CSS1, in contrast to CSS2A co-expressed with CSS1. Radiolabeling analysis of cultured COS-7 cells overexpressing each variant revealed that, whereas CSS2A facilitated CS biosynthesis, CSS2B inhibited it. Molecular modeling of CSS2A and CSS2B provided support for their properties. These findings, implicating regulation of CS chain polymerization by CSS2 variants, provide insight in elucidating the mechanisms of CS biosynthesis.	[Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; [Shionyu, Masafumi] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Biosci, Nagahama 5260829, Japan; [Kubota, Yukihiko; Nishiwaki, Kiyoji] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda 6691337, Japan; [Sato, Takashi; Gotoh, Masanori; Narimatsu, Hisashi] Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan; [Ogawa, Hiroyasu; Shimizu, Katsuji] Gifu Univ, Dept Orthopaed Surg, Grad Sch Med, Gifu 5011194, Japan	Aichi Medical University; Kwansei Gakuin University; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University	Watanabe, H (corresponding author), Karimata 21, Nagakute, Aichi 4801195, Japan.	wannabee@aichi-med-u.ac.jp	Sato, Takashi/M-2577-2018; Narimatsu, Hisashi/M-4757-2018	Sato, Takashi/0000-0002-9973-8923; Narimatsu, Hisashi/0000-0002-8402-133X; Kubota, Yukihiko/0000-0002-8151-9888; Shionyu, Masafumi/0000-0002-0431-3456; Ogawa, Hiroyasu/0000-0002-4737-6481; Watanabe, Hideto/0000-0001-5291-0696	Japan Society for the Promotion of Science [18370061]; New Energy and Industrial Technology Development Organization	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by a grant-in-aid for Scientific Research B (to H. W., and M. S.), by Japan Society for the Promotion of Science KAKENHI Grant 18370061, and by the New Energy and Industrial Technology Development Organization.	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; BOLLET AJ, 1966, J CLIN INVEST, V45, P1170, DOI 10.1172/JCI105423; Brown MP, 2007, OSTEOARTHR CARTILAGE, V15, P1318, DOI 10.1016/j.joca.2007.04.005; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Jinek M, 2006, NAT STRUCT MOL BIOL, V13, P945, DOI 10.1038/nsmb1144; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MITCHELL D, 1982, BIOCHEM J, V202, P387, DOI 10.1042/bj2020387; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Prydz K, 2000, J CELL SCI, V113, P193; ROUGHLEY PJ, 1980, J BIOL CHEM, V255, P217; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugiura N, 2010, J BIOL CHEM, V285, P1597, DOI 10.1074/jbc.M109.023002; Suzuki N, 2006, DEV BIOL, V300, P635, DOI 10.1016/j.ydbio.2006.08.037; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200	37	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34155	34167		10.1074/jbc.M110.109553	http://dx.doi.org/10.1074/jbc.M110.109553			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729547	Green Published, hybrid			2022-12-27	WOS:000283354000061
J	Cui, YP; Cheng, XL; Zhang, C; Zhang, YY; Li, SJ; Wang, CG; Guadagno, TM				Cui, Yongping; Cheng, Xiaolong; Zhang, Ce; Zhang, Yanyan; Li, Shujing; Wang, Chuangui; Guadagno, Thomas M.			Degradation of the Human Mitotic Checkpoint Kinase Mps1 Is Cell Cycle-regulated by APC-c(Cdc20) and APC-c(Cdh1) Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLE BODY DUPLICATION; SPINDLE ASSEMBLY CHECKPOINT; CENTROSOME DUPLICATION; MEDIATED DEGRADATION; CHROMOSOME ALIGNMENT; EARLY MITOSIS; GENE MPS1; ANAPHASE; APC/C; ANEUPLOIDY	Mps1 is a dual specificity protein kinase with key roles in regulating the spindle assembly checkpoint and chromosome-microtubule attachments. Consistent with these mitotic functions, Mps1 protein levels fluctuate during the cell cycle, peaking at early mitosis and abruptly declining during mitotic exit and progression into the G(1) phase. Although evidence in budding yeast indicates that Mps1 is targeted for degradation at anaphase by the anaphase-promoting complex (APC)-c(Cdc20) complex, little is known about the regulatory mechanisms that govern Mps1 protein levels in human cells. Here, we provide evidence for the ubiquitin ligase/proteosome pathway in regulating human Mps1 levels during late mitosis through G(1) phase. First, we showed that treatment of HEK 293T cells with the proteosome inhibitor MG132 resulted in an increase in both the polyubiquitination and the accumulation of Mps1 protein levels. Next, Mps1 was shown to co-precipitate with APC and its activators Cdc20 and Cdh1 in a cell cycle-dependent manner. Consistent with this, overexpression of Cdc20 or Cdh1 led to a marked reduction of endogenous Mps1 levels during anaphase or G(1) phase, respectively. In contrast, depletion of Cdc20 or Cdh1 by RNAi treatment both led to the stabilization of Mps1 protein during mitosis or G(1) phase, respectively. Finally, we identified a single D-box motif in human Mps1 that is required for its ubiquitination and degradation. Failure to appropriately degrade Mps1 is sufficient to trigger centrosome amplification and mitotic abnormalities in human cells. Thus, our results suggest that the sequential actions of the APC-c(Cdc20) andAPC-c(Cdh1) ubiquitin ligases regulate the clearance of Mps1 levels and are critical for Mps1 functions during the cell cycle in human cells.	[Cui, Yongping; Zhang, Ce] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China; [Cui, Yongping; Zhang, Yanyan; Li, Shujing] Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Shanxi, Peoples R China; [Cheng, Xiaolong] Shanxi Med Univ, Dept Anat, Taiyuan 030001, Shanxi, Peoples R China; [Wang, Chuangui] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Guadagno, Thomas M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; East China Normal University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cui, YP (corresponding author), Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China.	cuiy0922@yahoo.com; Thomas.Guadagno@yahoo.com			Program for New Century Excellent Talents University of China [NCET-10-0872]; National Nature Science Foundation of China [30872932]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2009-8]; Bankhead Coley Program [30-15066-02-07]; Department of Defense, National Functional Genomics Center [DAMD17-02-2-0051]	Program for New Century Excellent Talents University of China(Program for New Century Excellent Talents in University (NCET)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Bankhead Coley Program; Department of Defense, National Functional Genomics Center(United States Department of Defense)	This work was supported by Program for New Century Excellent Talents University of China Grant NCET-10-0872, National Nature Science Foundation of China Grant 30872932, Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry Grant 2009-8, Trainee Development Award from Bankhead Coley Program Grant 30-15066-02-07 (to Y. C.), and the Department of Defense, National Functional Genomics Center Project Award DAMD17-02-2-0051 (to T. M. G.).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Cui YP, 2010, CANCER RES, V70, P675, DOI 10.1158/0008-5472.CAN-09-1491; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Fry AM, 2006, CELL CYCLE, V5, P1487, DOI 10.4161/cc.5.14.3003; Gilliland WD, 2005, CURR BIOL, V15, P672; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kasbek C, 2009, ENVIRON MOL MUTAGEN, V50, P654, DOI 10.1002/em.20476; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Straight PD, 2000, MOL BIOL CELL, V11, P3525, DOI 10.1091/mbc.11.10.3525; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	36	35	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32988	32998		10.1074/jbc.M110.140905	http://dx.doi.org/10.1074/jbc.M110.140905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729194	Green Published, hybrid			2022-12-27	WOS:000283048200036
J	Leloup, L; Shao, HS; Bae, YH; Deasy, B; Stolz, D; Roy, P; Wells, A				Leloup, Ludovic; Shao, Hanshuang; Bae, Yong Ho; Deasy, Bridget; Stolz, Donna; Roy, Partha; Wells, Alan			m-calpain Activation Is Regulated by Its Membrane Localization and by Its Binding to Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL-MIGRATION; SIGNALING PATHWAYS; WOUND REPAIR; INDUCIBLE PROTEIN-9; COLLOIDAL SILICA; INDUCED MOTILITY; PLASMA-MEMBRANE; KINASE; FIBROBLASTS	m-calpain plays a critical role in cell migration enabling rear de-adhesion of adherent cells by cleaving structural components of the adhesion plaques. Growth factors and chemokines regulate keratinocyte, fibroblast, and endothelial cell migration by modulating m-calpain activity. Growth factor receptors activate m-calpain secondary to phosphorylation on serine 50 by ERK. Concurrently, activated m-calpain is localized to its inner membrane milieu by binding to phosphatidylinositol 4,5-bisphosphate (PIP2). Opposing this, CXCR3 ligands inhibit cell migration by blocking m-calpain activity secondary to a PKA-mediated phosphorylation in the C2-like domain. The failure of m-calpain activation in the absence of PIP2 points to a key regulatory role, although whether this PIP2-mediated membrane localization is regulatory for m-calpain activity or merely serves as a docking site for ERK phosphorylation is uncertain. Herein, we report the effects of two CXCR3 ligands, CXCL11/IP-9/I-TAC and CXCL10/IP-10, on the EGF- and VEGF-induced redistribution of m-calpain in human fibroblasts and endothelial cells. The two chemokines block the tail retraction and, thus, the migration within minutes, preventing and reverting growth factor-induced relocalization of m-calpain to the plasma membrane of the cells. PKA phosphorylation of m-calpain blocks the binding of the protease to PIP2. Unexpectedly, we found that this was due to membrane anchorage itself and not merely serine 50 phosphorylation, as the farnesylation-induced anchorage of m-calpain triggers a strong activation of this protease, leading notably to an increased cell death. Moreover, the ERK and PKA phosphorylations have no effect on this membrane-anchored m-calpain. However, the presence of PIP2 is still required for the activation of the anchored m-calpain. In conclusion, we describe a novel mechanism of m-calpain activation by interaction with the plasma membrane and PIP2 specifically, this phosphoinositide acting as a cofactor for the enzyme. The phosphorylation of m-calpain by ERK and PKA by growth factors and chemokines, respectively, act in cells to regulate the enzyme only indirectly by controlling its redistribution.	[Leloup, Ludovic; Shao, Hanshuang; Roy, Partha; Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Bae, Yong Ho; Roy, Partha; Wells, Alan] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA; [Deasy, Bridget] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA 15261 USA; [Stolz, Donna] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Wells, Alan] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, Scaife Hall S713,3550 Terrace St, Pittsburgh, PA 15261 USA.	wellsa@upmc.edu	Bae, Yong Ho/M-8427-2015; Leloup, Ludovic/AAF-3045-2020	Bae, Yong Ho/0000-0002-1838-1652; Roy, Partha/0000-0002-4946-8531; Leloup, Ludovic/0000-0001-9369-5689; Wells, Alan/0000-0002-1637-8150	National Institutes of Health NIGMS [GM069668]; NATIONAL CANCER INSTITUTE [R01CA108607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS grant GM069668.	Allen FD, 2002, WOUND REPAIR REGEN, V10, P67, DOI 10.1046/j.1524-475X.2002.10701.x; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; BROUGHTON G, 2006, PLAST RECONSTR SU S7, V117; CHANEY LK, 1983, J BIOL CHEM, V258, P62; Chou J, 2003, EXP CELL RES, V287, P47, DOI 10.1016/S0014-4827(03)00119-8; Chou J, 2002, INT J BIOCHEM CELL B, V34, P776, DOI 10.1016/S1357-2725(01)00177-7; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Goalstone ML, 1996, J BIOL CHEM, V271, P27585, DOI 10.1074/jbc.271.44.27585; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hautaniemi S, 2005, BIOINFORMATICS, V21, P2027, DOI 10.1093/bioinformatics/bti278; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Kharait S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-9; Kulkarni S, 1999, J BIOL CHEM, V274, P21265, DOI 10.1074/jbc.274.30.21265; Kunimoto B T, 1999, Ostomy Wound Manage, V45, P56; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Moldoveanu T, 2001, BBA-PROTEIN STRUCT M, V1545, P245, DOI 10.1016/S0167-4838(00)00286-7; Nedelec B, 2000, HAND CLIN, V16, P289; Palecek SP, 1998, J CELL SCI, V111, P929; PONTREMOLI S, 1985, BIOCHEM BIOPH RES CO, V129, P389, DOI 10.1016/0006-291X(85)90163-9; RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Satish L, 2005, MOL CELL BIOL, V25, P1922, DOI 10.1128/MCB.25.5.1922-1941.2005; Satish L, 2004, WOUND REPAIR REGEN, V12, P183, DOI 10.1111/j.1067-1927.2004.012111.x; Satish L, 2003, J INVEST DERMATOL, V120, P1110, DOI 10.1046/j.1523-1747.2003.12230.x; Serrano K, 2004, CELL MOTIL CYTOSKEL, V58, P242, DOI 10.1002/cm.20011; Shao HS, 2008, WOUND REPAIR REGEN, V16, P551, DOI 10.1111/j.1524-475X.2008.00402.x; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Shiraha H, 1999, J CELL BIOL, V146, P243; Shiraha H, 2002, MOL CELL BIOL, V22, P2716, DOI 10.1128/MCB.22.8.2716-2727.2002; Smith KD, 2006, EXP CELL RES, V312, P1970, DOI 10.1016/j.yexcr.2006.02.022; Smith SD, 2003, FEBS LETT, V542, P115, DOI 10.1016/S0014-5793(03)00361-2; STOLZ DB, 1992, J CELL SCI, V103, P39; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Wells A, 1998, MICROSC RES TECHNIQ, V43, P395, DOI 10.1002/(SICI)1097-0029(19981201)43:5<395::AID-JEMT6>3.0.CO;2-T; Yates CC, 2008, AM J PATHOL, V173, P643, DOI 10.2353/ajpath.2008.070990; Yates CC, 2009, WOUND REPAIR REGEN, V17, P34, DOI 10.1111/j.1524-475X.2008.00439.x	49	61	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33549	33566		10.1074/jbc.M110.123604	http://dx.doi.org/10.1074/jbc.M110.123604			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729206	Green Published, hybrid			2022-12-27	WOS:000283048200089
J	Leroy, A; Landrieu, I; Huvent, I; Legrand, D; Codeville, B; Wieruszeski, JM; Lippens, G				Leroy, Arnaud; Landrieu, Isabelle; Huvent, Isabelle; Legrand, Dominique; Codeville, Bernadette; Wieruszeski, Jean-Michel; Lippens, Guy			Spectroscopic Studies of GSK3 beta Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-terminal Domain of Apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DISEASE-LIKE PHOSPHORYLATION; HEPARIN-BINDING-SITES; ALZHEIMERS-DISEASE; NMR-SPECTROSCOPY; TRANSGENIC MICE; HUMAN BRAIN; MAMMALIAN-CELLS; CHEMICAL-SHIFTS; NERVOUS-SYSTEM	Alzheimer disease neurons are characterized by extraneuronal plaques formed by aggregated amyloid-beta peptide and by intraneuronal tangles composed of fibrillar aggregates of the microtubule-associated Tau protein. Tau is mostly found in a hyperphosphorylated form in these tangles. Glycogen synthase kinase 3 beta (GSK3 beta) is a proline-directed kinase generally considered as one of the major players that (hyper)phosphorylates Tau. The kinase phosphorylates mainly (Ser/Thr)-Pro motifs and is believed to require a priming activity by another kinase. Here, we use an in vitro phosphorylation assay and NMR spectroscopy to characterize in a qualitative and quantitative manner the phosphorylation of Tau by GSK3 beta. We find that three residues can be phosphorylated (Ser-396, Ser-400, and Ser-404) by GSK3 beta alone, without priming. Ser-404 is essential in this process, as its mutation to Ala prevents all activity of GSK3 beta. However, priming enhances the catalytic efficacy of the kinase, as initial phosphorylation of Ser-214 by the cAMP-dependent protein kinase (PKA) leads to the rapid modification by GSK3 beta of four regularly spaced additional sites. Because the regular incorporation of negative charges by GSK3 beta leads to a potential parallel between phospho-Tau and heparin, we investigated its interaction with the heparin/low density lipoprotein receptor binding domain of human apolipoprotein E. We indeed observed an interaction between the GSK3 beta-promoted regular phospho-pattern on Tau and the apolipoprotein E fragment but none in the absence of phosphorylation or the presence of an irregular phosphorylation pattern by the prolonged activity of PKA. Apolipoprotein E is therefore able to discriminate and interact with specific phosphorylation patterns of Tau.	[Leroy, Arnaud; Landrieu, Isabelle; Huvent, Isabelle; Legrand, Dominique; Codeville, Bernadette; Wieruszeski, Jean-Michel; Lippens, Guy] Univ Sci & Tech Lille Flandres Artois, CNRS, Struct & Funct Glycobiol Unit, UMR8576, F-59655 Villeneuve Dascq, France; [Leroy, Arnaud] Univ Paris 11, Fac Pharm Chatenay Malabry, Lab Biochim Appl, F-92296 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universite Paris Saclay	Leroy, A (corresponding author), Univ Sci & Tech Lille Flandres Artois, CNRS, Struct & Funct Glycobiol Unit, UMR8576, F-59655 Villeneuve Dascq, France.	Arnaud.Leroy@univ-lille1.fr; guy.lippens@univ-lille1.fr	Legrand, Dominique/AAT-5715-2021; Landrieu, Isabelle/AAF-8495-2019	Landrieu, Isabelle/0000-0002-4883-2637; LEGRAND, Dominique/0000-0002-0814-221X; Lippens, Guy/0000-0002-8236-0901; Huvent, Isabelle/0000-0002-7241-0290	Region Nord-Pas de Calais (France); CNRS; University of Lille 1; Institut Pasteur de Lille	Region Nord-Pas de Calais (France)(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 1; Institut Pasteur de Lille	We thank Prof. Schwalbe (Frankfurt, Germany) for the PKA sample, and Dr. G. Divita for the GSK3 beta clone. The NMR facility used in this study was funded by the Region Nord-Pas de Calais (France), the CNRS, the University of Lille 1, and the Institut Pasteur de Lille.	Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Aoki K, 2003, STROKE, V34, P875, DOI 10.1161/01.STR.0000064320.73388.C6; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; Boschert U, 1999, NEUROBIOL DIS, V6, P508, DOI 10.1006/nbdi.1999.0251; BRAAK H, 1988, STAIN TECHNOL, V63, P197, DOI 10.3109/10520298809107184; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brownlees J, 1997, NEUROREPORT, V8, P3251, DOI 10.1097/00001756-199710200-00013; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Dekroon RM, 2001, GLIA, V33, P298, DOI 10.1002/1098-1136(20010315)33:4<298::AID-GLIA1028>3.0.CO;2-N; Dong J, 2001, BIOCHEMISTRY-US, V40, P2826, DOI 10.1021/bi002417n; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FIOL CJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P797, DOI 10.1016/0003-9861(88)90089-6; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Godemann R, 1999, FEBS LETT, V454, P157, DOI 10.1016/S0014-5793(99)00741-3; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hanger DP, 2009, EXPERT REV NEUROTHER, V9, P1647, DOI 10.1586/ERN.09.104; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hu YY, 2002, AM J PATHOL, V160, P1269, DOI 10.1016/S0002-9440(10)62554-0; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALAZAR A, 1989, J BIOL CHEM, V264, P8447; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; Langer T, 2004, CHEMBIOCHEM, V5, P1508, DOI 10.1002/cbic.200400129; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Lippens G, 2004, CHEMBIOCHEM, V5, P73, DOI 10.1002/cbic.200300763; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mahley Robert W., 1995, Current Opinion in Lipidology, V6, P86, DOI 10.1097/00041433-199504000-00005; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MONTEILHET C, 1993, GENE, V125, P223, DOI 10.1016/0378-1119(93)90333-X; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Peterson DW, 2010, P NATL ACAD SCI USA, V107, P2884, DOI 10.1073/pnas.0912718107; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; RICHEY PL, 1995, BIOCHEM BIOPH RES CO, V208, P657, DOI 10.1006/bbrc.1995.1389; Roses AD, 1997, NEUROBIOL DIS, V4, P170, DOI 10.1006/nbdi.1997.0161; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Sengupta A, 1997, MOL CELL BIOCHEM, V167, P99, DOI 10.1023/A:1006883924775; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; Wang JZ, 1998, FEBS LETT, V436, P28, DOI 10.1016/S0014-5793(98)01090-4; WANG QM, 1994, J BIOL CHEM, V269, P14566; WEISEMANN R, 1993, J BIOMOL NMR, V3, P113; Weisgraber Karl H., 1994, Current Opinion in Lipidology, V5, P110, DOI 10.1097/00041433-199404000-00007; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200	74	51	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33435	33444		10.1074/jbc.M110.149419	http://dx.doi.org/10.1074/jbc.M110.149419			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20679343	Green Published, hybrid			2022-12-27	WOS:000283048200078
J	Storch, J; Thumser, AE				Storch, Judith; Thumser, Alfred E.			Tissue-specific Functions in the Fatty Acid-binding Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RETINOIC ACID; PPAR-ALPHA; ADIPOCYTE; MICE; OXIDATION; INCREASES; OBESITY; FABP; DIFFERENTIATION; IDENTIFICATION	The intracellular fatty acid-binding proteins (FABPs) are abundantly expressed in almost all tissues. They exhibit high affinity binding of a single long-chain fatty acid, with the exception of liver FABP, which binds two fatty acids or other hydrophobic molecules. FABPs have highly similar tertiary structures consisting of a 10-stranded antiparallel beta-barrel and an N-terminal helix-turn-helix motif. Research emerging in the last decade has suggested that FABPs have tissue-specific functions that reflect tissue-specific aspects of lipid and fatty acid metabolism. Proposed roles for FABPs include assimilation of dietary lipids in the intestine, targeting of liver lipids to catabolic and anabolic pathways, regulation of lipid storage and lipid-mediated gene expression in adipose tissue and macrophages, fatty acid targeting to beta-oxidation pathways in muscle, and maintenance of phospholipid membranes in neural tissues. The regulation of these diverse processes is accompanied by the expression of different and sometimes multiple FABPs in these tissues and may be driven by protein-protein and protein-membrane interactions.	[Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Thumser, Alfred E.] Univ Surrey, Div Biochem Sci, Surrey GU2 7XH, England	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Surrey	Storch, J (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA.	storch@aesop.rutgers.edu; a.thumser@surrey.ac.uk		Storch, Judith/0000-0001-5482-1777; Thumser, Alfred/0000-0003-0256-8006	National Institutes of Health [DK38389]; New Jersey Agricultural Experiment Station; Faculty of Health and Medical Sciences, University of Surrey; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038389, R01DK038389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Agricultural Experiment Station; Faculty of Health and Medical Sciences, University of Surrey; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK38389 (to J.S.). This work was also supported by the New Jersey Agricultural Experiment Station (to J.S.) and the Faculty of Health and Medical Sciences, University of Surrey (to A. E. T.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Agellon LB, 2007, BBA-MOL CELL BIOL L, V1771, P1283, DOI 10.1016/j.bbalip.2007.08.004; Atshaves BP, 2010, LIPIDS, V45, P97, DOI 10.1007/s11745-009-3379-2; BAIER LJ, 1995, J CLIN INVEST, V95, P1281, DOI 10.1172/JCI117778; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Binas B, 2007, MOL CELL BIOCHEM, V299, P75, DOI 10.1007/s11010-005-9043-0; Binas B, 1999, FASEB J, V13, P805, DOI 10.1096/fasebj.13.8.805; BONEVA NB, 2010, HIPPOCAMPUS IN PRESS; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Cheon MS, 2003, J NEURAL TRANSM-SUPP, P225; Coe NR, 1999, J LIPID RES, V40, P967; DeLeon M, 1996, J NEUROSCI RES, V44, P283; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Erol E, 2003, FASEB J, V17, P347, DOI 10.1096/fj.03-0330fje; Erol E, 2004, AM J PHYSIOL-ENDOC M, V287, pE977, DOI 10.1152/ajpendo.00139.2004; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; GLOMSET JA, 2006, SCI STKE, pE6; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Hui XY, 2010, J BIOL CHEM, V285, P10273, DOI 10.1074/jbc.M109.097907; Kursula P, 2008, AMINO ACIDS, V34, P175, DOI 10.1007/s00726-006-0479-7; Lagakos W, 2009, FASEB J, V23; LAGAKOS WS, 2007, FASEB J, V21, pLB35; Layne MD, 2001, FASEB J, V15, P2733, DOI 10.1096/fj.01-0374fje; Levy E, 2009, HISTOCHEM CELL BIOL, V132, P351, DOI 10.1007/s00418-009-0608-y; Liou HL, 2002, J BIOL CHEM, V277, P1806, DOI 10.1074/jbc.M107987200; Liu JW, 2008, J NEUROCHEM, V106, P2015, DOI 10.1111/j.1471-4159.2008.05507.x; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; McIntosh AL, 2009, ARCH BIOCHEM BIOPHYS, V485, P160, DOI 10.1016/j.abb.2009.03.004; Montoudis A, 2008, J LIPID RES, V49, P961, DOI 10.1194/jlr.M700363-JLR200; Murphy EJ, 2005, BIOCHEMISTRY-US, V44, P6350, DOI 10.1021/bi047292r; MyersPayne SC, 1996, J NEUROCHEM, V66, P1648; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Owada Y, 2008, TOHOKU J EXP MED, V214, P213, DOI 10.1620/tjem.214.213; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Sanchez-Font MF, 2003, NUCLEIC ACIDS RES, V31, P2769, DOI 10.1093/nar/gkg396; Schaap FG, 1999, CIRC RES, V85, P329, DOI 10.1161/01.RES.85.4.329; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shaughnessy S, 2000, DIABETES, V49, P904, DOI 10.2337/diabetes.49.6.904; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Smith AJ, 2008, J BIOL CHEM, V283, P33536, DOI 10.1074/jbc.M806732200; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tang MK, 2004, CELL TISSUE RES, V316, P339, DOI 10.1007/s00441-004-0881-y; TRAPP BD, 1984, J NEUROCHEM, V43, P944, DOI 10.1111/j.1471-4159.1984.tb12828.x; Vassileva G, 2000, FASEB J, V14, P2040, DOI 10.1096/fj.99-0959com; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Wolfrum C, 2007, CELL MOL LIFE SCI, V64, P2465, DOI 10.1007/s00018-007-7279-4; Xie Y, 2009, J LIPID RES, V50, P977, DOI 10.1194/jlr.M800645-JLR200; Xu LZ, 1996, J BIOL CHEM, V271, P24711; YOUNG ACM, 1994, STRUCTURE, V2, P523, DOI 10.1016/S0969-2126(00)00052-6	56	219	236	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32679	32683		10.1074/jbc.R110.135210	http://dx.doi.org/10.1074/jbc.R110.135210			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20716527	Green Published, hybrid			2022-12-27	WOS:000283048200001
J	Chang, CR; Manlandro, CM; Arnoult, D; Stadler, J; Posey, AE; Hill, RB; Blackstone, C				Chang, Chuang-Rung; Manlandro, Cara Marie; Arnoult, Damien; Stadler, Julia; Posey, Ammon E.; Hill, R. Blake; Blackstone, Craig			A Lethal de Novo Mutation in the Middle Domain of the Dynamin-related GTPase Drp1 Impairs Higher Order Assembly and Mitochondrial Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; LIGHT-SCATTERING; PROTEIN DLP1; CELLULAR SENESCENCE; FUSION MEDIATORS; MAMMALIAN-CELLS; FISSION; APOPTOSIS; MORPHOLOGY; BINDING	Mitochondria dynamically fuse and divide within cells, and the proper balance of fusion and fission is necessary for normal mitochondrial function, morphology, and distribution. Drp1 is a dynamin-related GTPase required for mitochondrial fission in mammalian cells. It harbors four distinct domains: GTP-binding, middle, insert B, and GTPase effector. A lethal mutation (A395D) within the Drp1 middle domain was reported in a neonate with microcephaly, abnormal brain development, optic atrophy, and lactic acidemia (Waterham, H. R., Koster, J., van Roermund, C. W., Mooyer, P. A., Wanders, R. J., and Leonard, J. V. (2007) N. Engl. J. Med. 356, 1736-1741). Mitochondria within patient-derived fibroblasts were markedly elongated, but the molecular mechanisms underlying these findings were not demonstrated. Because the middle domain is particularly important for the self-assembly of some dynamin superfamily proteins, we tested the hypothesis that this A395D mutation, and two other middle domain mutations (G350D, G363D) were important for Drp1 tetramerization, higher order assembly, and function. Although tetramerization appeared largely intact, each of these mutations compromised higher order assembly and assembly-dependent stimulation of Drp1 GTPase activity. Moreover, mutant Drp1 proteins exhibited impaired localization to mitochondria, indicating that this higher order assembly is important for mitochondrial recruitment, retention, or both. Overexpression of these middle domain mutants markedly inhibited mitochondrial division in cells. Thus, the Drp1 A395D lethal defect likely resulted in impaired higher order assembly of Drp1 at mitochondria, leading to decreased fission, elongated mitochondria, and altered cellular distribution of mitochondria.	[Manlandro, Cara Marie; Posey, Ammon E.; Hill, R. Blake] Johns Hopkins Univ, Dept Biol & Chem, Baltimore, MD 21218 USA; [Chang, Chuang-Rung] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; [Chang, Chuang-Rung] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Arnoult, Damien] INSERM, U542, F-94807 Villejuif, France; [Arnoult, Damien] Univ Paris Sud, Hop Paul Brousse, F-94807 Villejuif, France; [Stadler, Julia; Blackstone, Craig] NINDS, Cellular Neurol Unit, Neurogenet Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Tsing Hua University; National Tsing Hua University; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hill, RB (corresponding author), Johns Hopkins Univ, Dept Biol & Chem, Baltimore, MD 21218 USA.	hill@jhu.edu; blackstc@ninds.nih.gov	Arnoult, Damien/R-2032-2018; Chang, Chuang-Rung/C-1815-2012; Posey, Ammon/H-6505-2013	Chang, Chuang-Rung/0000-0002-6124-5429; Hill, Blake/0000-0001-6228-3905	National Institutes of Health Intramural Research Program of the NINDS [5T32GM080189, 5T32GM008403, RO1GM067180]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180, T32GM080189, T32GM008403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003025] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NINDS (to C.-R.C., J.S., and C.B.), Training Grant 5T32GM080189 (to C.M.M.), Training Grant 5T32GM008403 (to A.E.P.), and Grant RO1GM067180 (to R.B.H.).	Andersson M, 2003, ANAL CHEM, V75, P4279, DOI 10.1021/ac030128+; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Hinshaw JE, 1999, CURR OPIN STRUC BIOL, V9, P260, DOI 10.1016/S0959-440X(99)80036-0; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pitts KR, 2004, J BIOL CHEM, V279, P50286, DOI 10.1074/jbc.M405531200; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Rismanchi N., 2007, MOL NEUROLOGY, P29; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Schrader M, 2006, BBA-MOL CELL RES, V1763, P531, DOI 10.1016/j.bbamcr.2006.01.004; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; Shin HW, 1999, J BIOL CHEM, V274, P2780, DOI 10.1074/jbc.274.5.2780; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tan FJ, 2008, J CELL SCI, V121, P3373, DOI 10.1242/jcs.032904; Tanaka A, 2006, EXP CELL RES, V312, P1671, DOI 10.1016/j.yexcr.2006.01.028; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Westermann B, 2008, J BIOL CHEM, V283, P13501, DOI 10.1074/jbc.R800011200; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Ye HP, 2006, ANAL BIOCHEM, V356, P76, DOI 10.1016/j.ab.2006.05.025; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	46	125	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32494	32503		10.1074/jbc.M110.142430	http://dx.doi.org/10.1074/jbc.M110.142430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696759	Green Published, hybrid			2022-12-27	WOS:000282683000063
J	Walerych, D; Gutkowska, M; Klejman, MP; Wawrzynow, B; Tracz, Z; Wiech, M; Zylicz, M; Zylicz, A				Walerych, Dawid; Gutkowska, Malgorzata; Klejman, Marcin P.; Wawrzynow, Bartosz; Tracz, Zuzanna; Wiech, Milena; Zylicz, Maciej; Zylicz, Alicja			ATP Binding to Hsp90 Is Sufficient for Effective Chaperoning of p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; WILD-TYPE P53; MOLECULAR CHAPERONE; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; COCHAPERONE AHA1; CLIENT PROTEIN; IN-VIVO; HYDROLYSIS; CYCLE	Hsp90 is a ubiquitous, ATP-dependent chaperone, essential for eukaryotes. It possesses a broad spectrum of substrates, among which is the p53 transcription factor, encoded by a tumor-suppressor gene. Here, we elucidate the role of the adenine nucleotide in the Hsp90 chaperone cycle, by taking advantage of a unique in vitro assay measuring Hsp90-dependent p53 binding to the promoter sequence. E42A and D88N Hsp90 beta variants bind but do not hydrolyze ATP, whereas E42A has increased and D88N decreased ATP affinity, compared with WT Hsp90 beta. Nevertheless, both of these mutants interact with WT p53 with a similar affinity. Surprisingly, in the case of WT, but also E42A Hsp90 beta, the presence of ATP stimulates dissociation of Hsp90-p53 complexes and results in p53 binding to the promoter sequence. D88N Hsp90 beta is not efficient in both of these reactions. Using a trap version of the chaperonin GroEL, which irreversibly captures unfolded proteins, we show that Hsp90 chaperone action on WT p53 results in a partial unfolding of the substrate. The ATP-dependent dissociation of p53-Hsp90 complex allows further folding of p53 protein to an active conformation, able to bind to the promoter sequence. Furthermore, in support of these results, the overproduction of WT or E42A Hsp90 beta stimulates transcription from the WAF1 gene promoter in H1299 cells. Altogether, our research indicates that ATP binding to Hsp90 beta is a sufficient step for effective WT p53 client protein chaperoning.	[Wiech, Milena; Zylicz, Maciej; Zylicz, Alicja] Int Inst Mol & Cell Biol Warsaw, PL-02109 Warsaw, Poland; [Gutkowska, Malgorzata; Wawrzynow, Bartosz; Wiech, Milena] PAS, M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Tracz, Zuzanna] PAS, Inst Biochem & Biophys, PL-02109 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zylicz, M (corresponding author), Int Inst Mol & Cell Biol Warsaw, Ks Trojdena Str 4, PL-02109 Warsaw, Poland.	mzylicz@iimcb.gov.pl; alicja.zylicz@iimcb.gov.pl	Wiech, Milena/AAC-5188-2020; Walerych, Dawid/I-2517-2016	Wiech, Milena/0000-0003-4388-1648; Gutkowska, Malgorzata/0000-0001-6584-7964; Tracz-Gaszewska, Zuzanna/0000-0003-1340-6379; Walerych, Dawid/0000-0002-8440-1375; Zylicz, Alicja/0000-0003-4174-3073	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported, in part, by a grant from the Polish Ministry of Science and Higher Education.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Bron P, 2008, BIOL CELL, V100, P413, DOI 10.1042/BC20070149; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; Graf C, 2009, EMBO J, V28, P602, DOI 10.1038/emboj.2008.306; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Jakob U, 1996, J BIOL CHEM, V271, P10035, DOI 10.1074/jbc.271.17.10035; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Miao RQ, 2008, ARTERIOSCL THROM VAS, V28, P105, DOI 10.1161/ATVBAHA.107.155499; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Minami Y, 1999, GENES CELLS, V4, P721, DOI 10.1046/j.1365-2443.1999.00299.x; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; Scheibel T, 1999, MOL MICROBIOL, V34, P701, DOI 10.1046/j.1365-2958.1999.01632.x; Sepehrnia B, 1996, J BIOL CHEM, V271, P15084, DOI 10.1074/jbc.271.25.15084; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Voss AK, 2000, DEVELOPMENT, V127, P1; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Walerych D, 2009, ONCOGENE, V28, P4284, DOI 10.1038/onc.2009.281; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wawrzynow A, 1996, MOL MICROBIOL, V21, P895, DOI 10.1046/j.1365-2958.1996.421404.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930	50	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32020	32028		10.1074/jbc.M110.112110	http://dx.doi.org/10.1074/jbc.M110.112110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688913	Green Published, hybrid			2022-12-27	WOS:000282683000015
J	Havranek, JJ				Havranek, James J.			Specificity in Computational Protein Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AUTOMATED DESIGN; BINDING; SELECTION; SEQUENCE; DOMAIN; ENDONUCLEASE; RECOGNITION; MUTATIONS; ALGORITHM; ACCURACY	A long-standing goal of computational protein design is to create proteins similar to those found in Nature. One motivation is to harness the exquisite functional capabilities of proteins for our own purposes. The extent of similarity between designed and natural proteins also reports on how faithfully our models represent the selective pressures that determine protein sequences. As the field of protein design shifts emphasis from reproducing native-like protein structure to function, it has become important that these models treat the notion of specificity in molecular interactions. Although specificity may, in some cases, be achieved by optimization of a desired protein in isolation, methods have been developed to address directly the desire for proteins that exhibit specific functions and interactions.	Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Havranek, JJ (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	havranek@genetics.wustl.edu			NCRR NIH HHS [K99 RR024107-01A1, R00 RR024107-04, K99 RR024107, R00 RR024107, R00 RR024107-03, R00 RR024107-02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R00RR024107, K99RR024107] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Allen BD, 2010, J COMPUT CHEM, V31, P904, DOI 10.1002/jcc.21375; Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Apgar JR, 2009, J COMPUT CHEM, V30, P2402, DOI 10.1002/jcc.21249; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Barth P, 2008, J AM CHEM SOC, V130, P12038, DOI 10.1021/ja802447e; Benos PV, 2002, BIOESSAYS, V24, P466, DOI 10.1002/bies.10073; Boas FE, 2008, J MOL BIOL, V380, P415, DOI 10.1016/j.jmb.2008.04.001; Boas FE, 2007, CURR OPIN STRUC BIOL, V17, P199, DOI 10.1016/j.sbi.2007.03.006; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Fajardo-Sanchez E, 2008, NUCLEIC ACIDS RES, V36, P2163, DOI 10.1093/nar/gkn059; Georgiev I, 2008, BIOINFORMATICS, V24, pI196, DOI 10.1093/bioinformatics/btn169; Ghirlanda G, 1998, J MOL BIOL, V281, P379, DOI 10.1006/jmbi.1998.1912; Grigoryan G, 2006, PLOS COMPUT BIOL, V2, P551, DOI 10.1371/journal.pcbi.0020063; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Havranek JJ, 2009, PROTEIN SCI, V18, P1293, DOI 10.1002/pro.142; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; HECHT MH, 1990, SCIENCE, V249, P884, DOI 10.1126/science.2392678; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Sammond DW, 2010, PROTEINS, V78, P1055, DOI 10.1002/prot.22631; Shifman JM, 2002, J MOL BIOL, V323, P417, DOI 10.1016/S0022-2836(02)00881-1; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Wang WX, 2002, P NATL ACAD SCI USA, V99, P2760, DOI 10.1073/pnas.052706199; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Yanover C, 2007, J COMPUT CHEM, V28, P2122, DOI 10.1002/jcc.20661; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	39	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31095	31099		10.1074/jbc.R110.157685	http://dx.doi.org/10.1074/jbc.R110.157685			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670934	Green Published, hybrid			2022-12-27	WOS:000282764600002
J	Yao, Y; Tsirka, SE				Yao, Yao; Tsirka, Stella E.			The C Terminus of Mouse Monocyte Chemoattractant Protein 1 (MCP1) Mediates MCP1 Dimerization while Blocking Its Chemotactic Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED ENDOCYTOSIS; CENTRAL-NERVOUS-SYSTEM; MICROGLIAL CELLS; IN-VIVO; PLASMINOGEN-ACTIVATOR; NEURONAL DEGENERATION; MULTIPLE-SCLEROSIS; AMEBOID MICROGLIA; BRAIN PARENCHYMA; RECEPTOR	The extracellular protease plasmin cleaves mouse MCP1 (monocyte chemoattractant protein 1) at lysine 104, releasing a 50-amino acid C-terminal domain. The cleavage event increases the chemotactic activity of MCP1 and, by doing so, promotes the progression of excitotoxic injury in the central nervous system in pathological settings. The mechanism through which the cleavage event enhances MCP1-mediated chemoattraction is unknown; to investigate it, we use wild-type and mutant forms of recombinant MCP1. Full-length MCP1 (FL-MCP1) is secreted by cells as a dimer or multimer. We show that a mutant truncated at the C terminus, K104Stop-MCP1, does not dimerize, revealing that the C terminus mediates the interaction. MCP1 interacts with the monocyte/microglia receptor CCR2. The interaction is critical to the function of MCP1 because CCR2(-/-) microglia do not undergo chemotaxis in response to MCP1 stimulation. We show that stimulation of microglia with FL-MCP1 or K104Stop-MCP1 triggers CCR2 internalization, whereas a mutant form unable to be cleaved at lysine 104 (K104A-MCP1) is relatively ineffective in this assay, suggesting that the C-terminal region interferes with the MCP1-CCR2 interaction. Moreover, FL-MCP1 and K104Stop-MCP1 stimulation leads to activation of Rac1, a small GTPase involved in cell migration. Conversely, MCP1-stimulated microglial migration is blocked by the Rac1 inhibitor, NSC23766, demonstrating the requirement for Rac1 effector pathways in this response. Taken together, we propose a model for MCP1 localization, activation, and function based on the initial presence and then removal of its C terminus, coupled with a requisite downstream signaling pathway from CCR2 stimulation to Rac1 activation.	[Yao, Yao; Tsirka, Stella E.] SUNY Stony Brook, Program Mol & Cellular Pharmacol, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tsirka, SE (corresponding author), SBU, Dept Pharmacol, BST8-192, Stony Brook, NY 11794 USA.	stella@pharm.stonybrook.edu	Yao, Yao/AFJ-8136-2022; Tsirka, Stella/AAD-4018-2019; Yao, Yao/G-1904-2012	Yao, Yao/0000-0001-8020-9696; 	National Institutes of Health [NS42168]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS42168.	ABROMSONLEEMAN S, 1993, J NEUROIMMUNOL, V45, P89, DOI 10.1016/0165-5728(93)90168-X; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; ANDERSSON PB, 1991, NEUROSCIENCE, V42, P201, DOI 10.1016/0306-4522(91)90159-L; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chen BP, 2001, J IMMUNOL, V167, P4585, DOI 10.4049/jimmunol.167.8.4585; Chen YL, 1999, ATHEROSCLEROSIS, V143, P115, DOI 10.1016/S0021-9150(98)00285-8; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Favre N, 2008, PROTEOMICS, V8, P4560, DOI 10.1002/pmic.200800211; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Ge SJ, 2008, J NEUROCHEM, V104, P1219, DOI 10.1111/j.1471-4159.2007.05056.x; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hailer NP, 1997, EUR J NEUROSCI, V9, P863, DOI 10.1111/j.1460-9568.1997.tb01436.x; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; Kim GH, 2008, J NEUROSURG, V109, P38, DOI 10.3171/JNS/2008/109/7/0038; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Kowala MC, 2000, ATHEROSCLEROSIS, V149, P323, DOI 10.1016/S0021-9150(99)00342-1; Kunkel SL, 1996, J LEUKOCYTE BIOL, V59, P6, DOI 10.1002/jlb.59.1.6; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lamkhioued B, 2000, AM J RESP CRIT CARE, V162, P723, DOI 10.1164/ajrccm.162.2.9901080; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; LING EA, 1979, J ANAT, V128, P847; Maghazachi AA, 2000, INT J BIOCHEM CELL B, V32, P931, DOI 10.1016/S1357-2725(00)00035-2; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Martins-Green M, 2001, INT J BIOCHEM CELL B, V33, P427, DOI 10.1016/S1357-2725(01)00029-2; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Morimoto H, 2008, CARDIOVASC RES, V78, P554, DOI 10.1093/cvr/cvn035; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ono K, 1999, BIOCHEM BIOPH RES CO, V262, P610, DOI 10.1006/bbrc.1999.1223; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; PAOLINI JF, 1994, J IMMUNOL, V153, P2704; Ray E, 1996, FEBS LETT, V378, P235, DOI 10.1016/0014-5793(95)01462-4; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Rogove AD, 1999, J CELL SCI, V112, P4007; Sheehan JJ, 2007, J NEUROSCI, V27, P1738, DOI 10.1523/JNEUROSCI.4987-06.2007; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Tillie-Leblond I, 2000, AM J RESP CRIT CARE, V162, P586, DOI 10.1164/ajrccm.162.2.9907014; Tsirka SE, 1997, J NEUROSCI, V17, P543; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; Vakili J, 2001, J IMMUNOL, V167, P3406, DOI 10.4049/jimmunol.167.6.3406; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Wu YP, 2000, AM J PATHOL, V156, P1849, DOI 10.1016/S0002-9440(10)65058-4; Yan YP, 2007, J CEREBR BLOOD F MET, V27, P1213, DOI 10.1038/sj.jcbfm.9600432; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851; Zhang Yujun, 1996, Methods (Orlando), V10, P93, DOI 10.1006/meth.1996.0083	63	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31509	31516		10.1074/jbc.M110.124891	http://dx.doi.org/10.1074/jbc.M110.124891			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682771	Green Published, hybrid			2022-12-27	WOS:000282764600045
J	Doyon, P; Servant, MJ				Doyon, Priscilla; Servant, Marc J.			Tumor Necrosis Factor Receptor-associated Factor-6 and Ribosomal S6 Kinase Intracellular Pathways Link the Angiotensin II AT1 Receptor to the Phosphorylation and Activation of the I kappa B Kinase Complex in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-BETA SUBUNIT; SIGNALING PATHWAY; TRANSCRIPTION FACTORS; TISSUE RENIN; ATHEROSCLEROSIS; INFLAMMATION; MECHANISMS; DISEASE; INVOLVEMENT; INHIBITOR	Activation of NF-kappa B transcription factors by locally produced angiotensin II (Ang II) is proposed to be involved in chronic inflammatory reactions leading to atherosclerosis development. However, a clear understanding of the signaling cascades coupling the Ang II AT1 receptors to the activation of NF-kappa B transcription factors is still lacking. Using primary cultured aortic vascular smooth muscle cells, we show that activation of the IKK complex and NF-kappa B transcription factors by Ang II is regulated by phosphorylation of the catalytic subunit IKK beta on serine residues 177 and 181 in the activation T-loop. The use of pharmacological inhibitors against conventional protein kinases C (PKCs), mitogen-activated/extracellular signal-regulated kinase (MEK) 1/2, ribosomal S6 kinase (RSK), and silencing RNA technology targeting PKC alpha, IKK beta subunit, tumor growth factor beta-activating kinase-1 (TAK1), the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor-6 (TRAF6), and RSK isoforms, demonstrates the requirement of two distinct signaling pathway for the phosphorylation of IKK beta and the activation of the IKK complex by Ang II. Rapid phosphorylation of IKK beta requires a second messenger-dependent pathway composed of PKC alpha-TRAF6-TAK1, whereas sustained phosphorylation and activation of IKK beta requires the MEK1/2-ERK1/2-RSK pathway. Importantly, simultaneously targeting components of these two pathways completely blunts the phosphorylation of IKK beta and the proinflammatory effect of the octapeptide. This is the first report demonstrating activation of TAK1 by the AT1R. We propose a model whereby TRAF6-TAK1 and ERK-RSK intracellular pathways independently and sequentially converge to the T-loop phosphorylation for full activation of IKK beta, which is an essential step in the proinflammatory activity of Ang II.	Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Servant, MJ (corresponding author), CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	marc.servant@umontreal.ca			Canadian Institutes of Health [MOP-53282]; Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Canadian Institutes of Health Research Grant MOP-53282 and the Heart and Stroke Foundation of Canada (to M. J. S.).; Supported by a studentship from the Natural Sciences and Engineering Research Council of Canada.	Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Choudhary S, 2007, MOL ENDOCRINOL, V21, P2203, DOI 10.1210/me.2006-0465; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; de Gasparo M, 2000, PHARMACOL REV, V52, P415; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Han YQ, 1999, CIRC RES, V84, P695, DOI 10.1161/01.RES.84.6.695; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Jamaluddin M, 2000, MOL ENDOCRINOL, V14, P99, DOI 10.1210/me.14.1.99; Kalra D, 2002, CIRCULATION, V105, P2198, DOI 10.1161/01.CIR.0000015603.84788.47; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin Michael, 2005, Proc Am Thorac Soc, V2, P386, DOI 10.1513/pats.200504-034SR; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; LEE MA, 1993, CIRCULATION, V87, P7; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2008, NAT IMMUNOL, V9, P231, DOI 10.1038/ni0308-231; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Miyahara T, 2004, CARDIOVASC RES, V64, P154, DOI 10.1016/j.cardiores.2004.06.014; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; SEINO Y, 1994, CYTOKINE, V6, P87, DOI 10.1016/1043-4666(94)90013-2; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; WEGENER E, 2007, SCI STKE, pPE21; Wu L, 2006, J HYPERTENS, V24, P123, DOI 10.1097/01.hjh.0000198031.30095.d1; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang LP, 2005, ARTERIOSCL THROM VAS, V25, P1148, DOI 10.1161/01.ATV.0000164624.00099.e7; Zhang LP, 2005, CIRC RES, V97, P975, DOI 10.1161/01.RES.0000190589.52286.41; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566	54	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30708	30718		10.1074/jbc.M110.126433	http://dx.doi.org/10.1074/jbc.M110.126433			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659889	hybrid, Green Published			2022-12-27	WOS:000282135500039
J	Park, JA; Drazen, JM; Tschumperlin, DJ				Park, Jin-Ah; Drazen, Jeffrey M.; Tschumperlin, Daniel J.			The Chitinase-like Protein YKL-40 Is Secreted by Airway Epithelial Cells at Base Line and in Response to Compressive Mechanical Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM YKL-40; ARTICULAR CHONDROCYTES; KINASE-C; GENE-EXPRESSION; I COLLAGEN; HB-EGF; ASTHMA; LUNG; MECHANOTRANSDUCTION; CHI3L1	The chitinase-like protein YKL-40, encoded by the CHI3L1 gene, is a biomarker and functional effector of chronic inflammatory and allergic diseases. In the lung it is associated with asthma severity and reduced lung function. The cellular sources of YKL-40 in human airways and the mechanisms regulating YKL-40 expression are poorly understood. We previously showed that mechanical stress similar to that experienced during bronchoconstriction triggers epithelial cell signaling through epidermal growth factor receptor (EGFR), fibrotic mediator release, and goblet cell hyperplasia consistent with airway remodeling in asthma. We now show that well differentiated normal human bronchial epithelial cells express CHI3L1 and secrete YKL-40 under base-line culture conditions. Mechanical stress (30-cm H2O transcellular compressive stress) applied for 3 h induces CHI3L1 expression by similar to 4-fold compared with time matched controls, resulting in increased secretion of YKL-40 by 3.6-fold 24 h after onset of the 3-h stimulus. Inhibition of EGFR or MEK1/2 (ERK kinase) significantly but incompletely attenuates mechanical stress-induced up-regulation of CHI3L1 expression in normal human bronchial epithelial cells. Direct activation of EGFR utilizing EGF-family ligands induces CHI3L1 expression. Our results reveal that human airway epithelial cells are a source of YKL-40 and demonstrate that mechanical stress potently induces CHI3L1 expression leading to increased secretion of YKL-40 protein in an EGFR and MEK1/2-dependent pathway. In the asthmatic airway mechanical stress may contribute to enhanced YKL-40 levels.	[Park, Jin-Ah; Drazen, Jeffrey M.; Tschumperlin, Daniel J.] Harvard Univ, Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Tschumperlin, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Mol & Integrat Physiol Sci Program, Dept Environm Hlth, 665 Huntington Ave,SPH1-309, Boston, MA 02115 USA.	Hdtschump@hsph.harvard.edu	Drazen, Jeffrey M/E-5841-2012	Park, Jin-Ah/0000-0002-8930-9287	National Institutes of Health [HL082856, HL88028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088028, R01HL082856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082856 and HL88028.	Allahverdian S, 2008, AM J RESP CELL MOL, V38, P153, DOI 10.1165/rcmb.2007-0173OC; Bhat KP, 2008, FEBS LETT, V582, P3193, DOI 10.1016/j.febslet.2008.08.010; Bigg HF, 2006, J BIOL CHEM, V281, P21082, DOI 10.1074/jbc.M601153200; Booth BW, 2001, AM J RESP CELL MOL, V25, P739, DOI 10.1165/ajrcmb.25.6.4659; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Chu EK, 2006, AM J RESP CELL MOL, V35, P628, DOI 10.1165/rcmb.2006-0040OC; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DE CEUNINCK F, 2001, BIOCHEM BIOPH RES CO, V285, P926; DING DJ, 1987, J APPL PHYSIOL, V62, P1324, DOI 10.1152/jappl.1987.62.3.1324; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hartl D, 2009, CURR OPIN ALLERGY CL, V9, P60, DOI 10.1097/ACI.0b013e32831f8ee0; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; Huang K, 2009, J INT MED RES, V37, P18, DOI 10.1177/147323000903700102; Iwata T, 2009, BIOCHEM BIOPH RES CO, V388, P511, DOI 10.1016/j.bbrc.2009.08.024; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2004, LUNG CANCER-J IASLC, V46, P333, DOI 10.1016/j.lungcan.2004.05.010; Johansen JS, 2001, ARTHRITIS RHEUM-US, V44, P826; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Kojic N, 2010, FASEB J, V24, P1604, DOI 10.1096/fj.09-145367; Koutroubakis IE, 2003, INT J COLORECTAL DIS, V18, P254, DOI 10.1007/s00384-002-0446-z; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Park JA, 2005, AM J PATHOL, V167, P651, DOI 10.1016/S0002-9440(10)62040-8; Park JA, 2007, AM J PATHOL, V171, P1822, DOI 10.2353/ajpath.2007.070318; Park JA, 2009, AM J RESP CELL MOL, V41, P459, DOI 10.1165/rcmb.2008-0195OC; Pungpopong S, 2008, LIVER TRANSPLANT, V14, P1294, DOI 10.1002/lt.21508; Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y; Rathcke CN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006106; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Ressler B, 2000, AM J PHYSIOL-LUNG C, V278, pL1264, DOI 10.1152/ajplung.2000.278.6.L1264; Sallee JL, 2009, J BIOL CHEM, V284, P14997, DOI 10.1074/jbc.M901901200; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Shim M, 2003, J BIOL CHEM, V278, P19674, DOI 10.1074/jbc.M301356200; Shuhui L, 2009, INT ARCH ALLERGY IMM, V149, P369, DOI 10.1159/000205583; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; Tschumperlin DJ, 2002, AM J PHYSIOL-LUNG C, V282, pL904, DOI 10.1152/ajplung.00270.2001; Wiggs BR, 1997, J APPL PHYSIOL, V83, P1814, DOI 10.1152/jappl.1997.83.6.1814; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	49	59	63	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29817	29825		10.1074/jbc.M110.103416	http://dx.doi.org/10.1074/jbc.M110.103416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650887	Green Published, hybrid			2022-12-27	WOS:000281984300017
J	Bussmann, M; Baumgart, M; Bott, M				Bussmann, Michael; Baumgart, Meike; Bott, Michael			RosR (Cg1324), a Hydrogen Peroxide-sensitive MarR-type Transcriptional Regulator of Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-TRANSFERASES; DNA-BINDING SITES; ESCHERICHIA-COLI; ANAEROBIC GROWTH; 2-COMPONENT SYSTEM; MOLECULAR ANALYSIS; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; EXPRESSION; REPRESSOR	The cg1324 gene (rosR) of Corynebacterium glutamicum encodes a MarR-type transcriptional regulator. By a comparative transcriptome analysis with DNA microarrays of a Delta rosR mutant and the wild type and subsequent EMSAs with purified RosR protein, direct target genes of RosR were identified. The narKGHJI operon, which encodes a nitrate/nitrite transporter and the dissimilatory nitrate reductase complex, was activated by RosR. All other target genes were repressed by RosR. They encode four putative monooxygenases, two putative FMN reductases, a protein of the glutathione S-transferase family, a putative polyisoprenoid-binding protein, and RosR itself. The DNA binding site of RosR was characterized as an 18-bp inverted repeat with the consensus sequence TTGTTGAY-RYRTCAACWA. The in vitro DNA binding activity of RosR was reversibly inhibited by the oxidant H2O2. Mutational analysis of the three cysteine residues present in RosR (Cys-64, Cys-92, and Cys-151) showed that these are responsible for the inhibition of DNA binding by H2O2. Adeletion mutant (Delta cg1322) lacking the putative polyisoprenoid-binding protein showed an increased sensitivity to H2O2, supporting the role of RosR in the oxidative stress response of C. glutamicum.	[Bussmann, Michael; Baumgart, Meike; Bott, Michael] Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Bott, M (corresponding author), Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany.	m.bott@fz-juelich.de	Bott, Michael/E-8004-2011; Baumgart, Meike/GWC-5464-2022; Baumgart, Meike/ABA-7414-2020	Bott, Michael/0000-0002-4701-8254; Baumgart, Meike/0000-0002-9874-1151	Health & Nutrition business unit of Evonik Degussa GmbH; German Ministry of Education and Research (BMBF)	Health & Nutrition business unit of Evonik Degussa GmbH; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Health & Nutrition business unit of Evonik Degussa GmbH and the German Ministry of Education and Research (BMBF).	Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; Brocker M, 2006, FEMS MICROBIOL LETT, V264, P205, DOI 10.1111/j.1574-6968.2006.00456.x; Brocker M, 2009, J BACTERIOL, V191, P3869, DOI 10.1128/JB.00113-09; Brune I, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-86; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DEN HENGST CD, 2008, BBA-GEN SUBJECTS, V1780, P1201; Ehira S, 2009, J BIOL CHEM, V284, P16736, DOI 10.1074/jbc.M109.009027; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Engels V, 2008, J BACTERIOL, V190, P8033, DOI 10.1128/JB.00705-08; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Frunzke J, 2008, MOL MICROBIOL, V67, P305, DOI 10.1111/j.1365-2958.2007.06020.x; Gerstmeir R, 2003, J BIOTECHNOL, V104, P99, DOI 10.1016/S0168-1656(03)00167-6; Handa N, 2005, PROTEIN SCI, V14, P1004, DOI 10.1110/ps.041183305; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Kalinowski J., 2005, HDB CORYNEBACTERIUM, V1 edn., P37, DOI [10.1201/9781420039696.pt3, DOI 10.1201/9781420039696.PT3]; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Kertesz MA, 1999, J BACTERIOL, V181, P1464, DOI 10.1128/JB.181.5.1464-1473.1999; Kinoshita S., 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Kocan M, 2006, J BACTERIOL, V188, P724, DOI 10.1128/JB.188.2.724-732.2006; Kohl TA, 2008, J BIOTECHNOL, V135, P340, DOI 10.1016/j.jbiotec.2008.05.011; Korshunov S, 2006, J BACTERIOL, V188, P6326, DOI 10.1128/JB.00554-06; KRONEMEYER W, 1995, J BACTERIOL, V177, P1152, DOI 10.1128/jb.177.5.1152-1158.1995; Krug A, 2005, J BIOL CHEM, V280, P585, DOI 10.1074/jbc.M408271200; Lange C, 2003, APPL ENVIRON MICROB, V69, P2521, DOI 10.1128/AEM.69.5.2521-2532.2003; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Leelakriangsak M, 2008, MOL MICROBIOL, V67, P1108, DOI 10.1111/j.1365-2958.2008.06110.x; Liebl W, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P796, DOI 10.1007/0-387-30743-5_30; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Nakunst D, 2007, J BACTERIOL, V189, P4696, DOI 10.1128/JB.00382-07; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Nishimura T, 2008, J BACTERIOL, V190, P3264, DOI 10.1128/JB.01801-07; Nishimura T, 2007, APPL MICROBIOL BIOT, V75, P889, DOI 10.1007/s00253-007-0879-y; Okada K, 1996, BBA-LIPID LIPID MET, V1302, P217, DOI 10.1016/0005-2760(96)00064-1; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pop SM, 2004, J BIOL CHEM, V279, P49910, DOI 10.1074/jbc.M409435200; Pop SM, 2006, J BIOL CHEM, V281, P26382, DOI 10.1074/jbc.M602158200; Russo S, 2009, J BIOL CHEM, V284, P5208, DOI 10.1074/jbc.M806591200; Sambrook J., 2001, MOL CLONING LAB MANU; Schaaf S, 2007, J BACTERIOL, V189, P5002, DOI 10.1128/JB.00121-07; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schaffer S, 2001, ELECTROPHORESIS, V22, P4404, DOI 10.1002/1522-2683(200112)22:20<4404::AID-ELPS4404>3.0.CO;2-2; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Takeno S, 2007, APPL MICROBIOL BIOT, V75, P1173, DOI 10.1007/s00253-007-0926-8; Towe S, 2007, MOL MICROBIOL, V66, P40, DOI 10.1111/j.1365-2958.2007.05891.x; Vasicova P, 1998, BIOTECHNOL TECH, V12, P743, DOI 10.1023/A:1008827609914; Vuilleumier S, 2002, APPL MICROBIOL BIOT, V58, P138, DOI 10.1007/s00253-001-0836-0; Vuilleumier S, 1997, J BACTERIOL, V179, P1431, DOI 10.1128/jb.179.5.1431-1441.1997; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Wendisch VF, 2006, J BIOTECHNOL, V124, P74, DOI 10.1016/j.jbiotec.2005.12.002; Wennerhold J, 2006, J BACTERIOL, V188, P2907, DOI 10.1128/JB.188.8.2907-2918.2006; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	61	45	47	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29305	29318		10.1074/jbc.M110.156372	http://dx.doi.org/10.1074/jbc.M110.156372			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20643656	Green Published, hybrid			2022-12-27	WOS:000281740100033
J	Wu, D; Haruta, A; Wei, QZ				Wu, Di; Haruta, Akiko; Wei, Qize			GIPC1 Interacts with MyoGEF and Promotes MDA-MB-231 Breast Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; DOMAIN-CONTAINING PROTEIN; PDZ DOMAIN; RHO-GTPASES; MYOSIN-VI; C-TERMINUS; CYTOPLASMIC DOMAIN; BINDING-PROTEIN; MIGRATION; RECEPTOR	GIPC1/synectin, a single PDZ domain-containing protein, binds to numerous proteins and is involved in multiple biological processes, including cell migration. We reported previously that MyoGEF, a guanine nucleotide exchange factor, plays a role in regulating breast cancer cell polarization and invasion. Here, we identify GIPC1 as an interacting partner of MyoGEF. Both in vitro and in vivo binding assays show that the GIPC1 PDZ domain binds to the PDZ-binding motif at the C terminus of MyoGEF. Immunofluorescence analysis shows that GIPC1 and MyoGEF colocalize to the cell leading edge. Depletion of GIPC1 by RNAi in MDA-MB-231 cells causes cells to shift from a polarized to a rounded morphology. Matrigel invasion assays show that RNAi-mediated depletion of GIPC1 dramatically decreases MDA-MB-231 cell invasion. Notably, an anti-MyoGEF peptide antibody, whose epitope is located at the C terminus of MyoGEF, interferes with GIPC1-MyoGEF complex formation. Treatment of MDA-MB-231 cells with the anti-MyoGEF peptide antibody disrupts cell polarization and invasion. Thus, our results suggest that GIPC1-MyoGEF complex formation plays an important role in regulating MDA-MB-231 breast cancer cell polarization and invasion.	[Wu, Di; Haruta, Akiko; Wei, Qize] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Wei, QZ (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	weiq@ksu.edu			National Center for Research Resources, National Institutes of Health [P20 RR015563]; Terry C. Johnson Center for Basic Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Terry C. Johnson Center for Basic Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR015563 from the National Center for Research Resources. This work was also supported by the Terry C. Johnson Center for Basic Cancer Research. This is Contribution 10-211-J from the Kansas Agricultural Experiment Station (Manhattan, KS).	Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Awan A, 2002, BIOCHEM BIOPH RES CO, V290, P1030, DOI 10.1006/bbrc.2001.6288; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Bohlson SS, 2005, J LEUKOCYTE BIOL, V77, P80, DOI 10.1189/jlb.0504305; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Cai HB, 1999, J NEUROSCI, V19, P6519; CARSBERG CJ, 1995, J CELL SCI, V108, P2905; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jeanneteau F, 2004, MOL BIOL CELL, V15, P696, DOI 10.1091/mbc.E03-05-0293; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kato H, 2004, FEBS LETT, V572, P123, DOI 10.1016/j.febslet.2004.07.017; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Liu TF, 2001, J BIOL CHEM, V276, P35768, DOI 10.1074/jbc.M103585200; Lou XJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134918; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Mellor H, 2004, CURR BIOL, V14, pR434, DOI 10.1016/j.cub.2004.05.038; MYERS KA, 1994, J BIOL CHEM, V269, P9319; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Rudchenko S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-248; Seipel K, 2001, J CELL SCI, V114, P389; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tkachenko E, 2006, CIRC RES, V98, P1398, DOI 10.1161/01.RES.0000225283.71490.5a; Ulrich F, 2009, TRAFFIC, V10, P811, DOI 10.1111/j.1600-0854.2009.00929.x; Vanni C, 2004, ONCOGENE, V23, P4098, DOI 10.1038/sj.onc.1207509; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Wei QZ, 2005, J BIOL CHEM, V280, P37790, DOI 10.1074/jbc.M502974200; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	58	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28643	28650		10.1074/jbc.M110.107649	http://dx.doi.org/10.1074/jbc.M110.107649			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20634288	Green Published, hybrid			2022-12-27	WOS:000281594000028
J	Kim, SH; Shanware, NP; Bowler, MJ; Tibbetts, RS				Kim, Sang Hwa; Shanware, Naval P.; Bowler, Michael J.; Tibbetts, Randal S.			Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; IN-VIVO; CELLULAR TOXICITY; DROSOPHILA MODEL; MUTATIONS; ALS; AGGREGATION; GENE; NEURODEGENERATION	Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that preferentially targets motor neurons. It was recently found that dominant mutations in two related RNA-binding proteins, TDP-43 (43-kDa TAR DNA-binding domain protein) and FUS/TLS (fused in sarcoma/translated in liposarcoma) cause a subset of ALS. The convergent ALS phenotypes associated with TDP-43 and FUS/TLS mutations are suggestive of a functional relationship; however, whether or not TDP-43 and FUS/TLS operate in common biochemical pathways is not known. Here we show that TDP-43 and FUS/TLS directly interact to form a complex at endogenous expression levels in mammalian cells. Binding was mediated by an unstructured TDP-43 C-terminal domain and occurred within the context of a 300-400-kDa complex that also contained C-terminal cleavage products of TDP-43 linked to neuropathology. TDP-43 C-terminal fragments were excluded from large molecular mass TDP-43 ribonucleoprotein complexes but retained FUS/TLS binding activity. The functional significance of TDP-43-FUS/TLS complexes was established by showing that RNAi silencing of either TDP-43 or FUS/TLS reduced the expression of histone deacetylase (HDAC) 6 mRNA. TDP-43 and FUS/TLS associated with HDAC6 mRNA in intact cells and in vitro, and competition experiments suggested that the proteins occupy overlapping binding sites. The combined findings demonstrate that TDP-43 and FUS/TLS form a functional complex in intact cells and suggest that convergent ALS phenotypes associated with TDP-43 and FUS/TLS mutations may reflect their participation in common biochemical processes.	[Kim, Sang Hwa; Shanware, Naval P.; Bowler, Michael J.; Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [CA124722, NS059001]; American Cancer Society; Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124722 and NS059001. This work was also supported by the American Cancer Society and a Shaw Scientist Award (to R. S. T.) from the Greater Milwaukee Foundation.	Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zinszner H, 1997, J CELL SCI, V110, P1741	44	160	165	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34097	34105		10.1074/jbc.M110.154831	http://dx.doi.org/10.1074/jbc.M110.154831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20720006	hybrid, Green Published			2022-12-27	WOS:000283354000055
J	Weiss, T; Ricard-Blum, S; Moschcovich, L; Wineman, E; Mesilaty, S; Kessler, E				Weiss, Tali; Ricard-Blum, Sylvie; Moschcovich, Laura; Wineman, Eitan; Mesilaty, Shlomit; Kessler, Efrat			Binding of Procollagen C-Proteinase Enhancer-1 (PCPE-1) to Heparin/Heparan Sulfate PROPERTIES AND ROLE IN PCPE-1 INTERACTION WITH CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NETRIN-LIKE DOMAIN; BONE MORPHOGENETIC PROTEIN-1; HEPARAN-SULFATE; RAT-HEART; EXPRESSION; COLLAGEN; GLYCOPROTEIN; METALLOPROTEINASES; IDENTIFICATION; FIBROBLASTS	Procollagen C-proteinase enhancer-1 (PCPE-1) is an extracellular matrix (ECM) glycoprotein that can stimulate procollagen processing by procollagen C-proteinases (PCPs) such as bone morphogenetic protein-1 (BMP-1). The PCPs can process additional extracellular protein precursors and play fundamental roles in developmental processes and assembly of the ECM. The stimulatory activity of PCPE-1 is restricted to the processing of fibrillar procollagens, suggesting PCPE-1 is a specific regulator of collagen deposition. PCPE-1 consists of two CUB domains that bind to the procollagen C-propeptides and are required for PCP enhancing activity, and one NTR domain that binds heparin. To understand the biological role of the NTR domain, we performed surface plasmon resonance (SPR) binding assays, cell attachment assays as well as immunofluorescence and activity assays, all indicating that the NTR domain can mediate PCPE-1 binding to cell surface heparan sulfate proteoglycans (HSPGs). The SPR data revealed binding affinities to heparin/HSPGs in the high nanomolar range and dependence on calcium. Both 3T3 mouse fibroblasts and human embryonic kidney cells (HEK-293) attached to PCPE-1, an interaction that was inhibited by heparin. Cell attachment was also inhibited by an NTR-specific antibody and the NTR fragment. Immunofluorescence analysis revealed that PCPE-Flag binds to mouse fibroblasts and heparin competes for this binding. Cell-associated PCPE-Flag stimulated procollagen processing by BMP-1 several fold. Our data suggest that through interaction with cell surface HSPGs, the NTR domain can anchor PCPE-1 to the cell membrane, permitting pericellular enhancement of PCP activity. This points to the cell surface as a physiological site of PCPE-1 action.	[Weiss, Tali; Moschcovich, Laura; Wineman, Eitan; Mesilaty, Shlomit; Kessler, Efrat] Tel Aviv Univ, Sackler Fac Med, Maurice & Gabriela Goldschleger Eye Res Inst, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Ricard-Blum, Sylvie] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, UMR 5086, F-69367 Lyon 7, France	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kessler, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, Maurice & Gabriela Goldschleger Eye Res Inst, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel.	ekessler@post.tau.ac.il		RICARD-BLUM, Sylvie/0000-0001-9263-1851	GIS Maladies Rares INSERM [A04115SP]; Israel Science Foundation [736/01, 1360/07]; European Commission [NMP2-CT-2003-504017]; Tel Aviv University Sackler Faculty of Medicine Maratier; Gothelf Foundations	GIS Maladies Rares INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Israel Science Foundation(Israel Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Tel Aviv University Sackler Faculty of Medicine Maratier; Gothelf Foundations	This work was supported by the GIS Maladies Rares INSERM Grant A04115SP (to S. R.-B.), the Israel Science Foundation (Grants 736/01 and 1360/07), the European Commission (Contract No. NMP2-CT-2003-504017), and the Tel Aviv University Sackler Faculty of Medicine Maratier and Gothelf Foundations (to E. K.).	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bekhouche M, 2010, J BIOL CHEM, V285, P15950, DOI 10.1074/jbc.M109.086447; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Faye C, 2009, J BIOL CHEM, V284, P22029, DOI 10.1074/jbc.M109.002840; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Kanaki T, 2000, BIOCHEM BIOPH RES CO, V270, P1049, DOI 10.1006/bbrc.2000.2555; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; KESSLER E, 1990, BIOCHEM BIOPH RES CO, V173, P81, DOI 10.1016/S0006-291X(05)81024-1; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kessler E., 2004, HDB PROTEOLYTIC ENZY, V1, P609; Kessler-Icekson G, 2006, INT J BIOCHEM CELL B, V38, P358, DOI 10.1016/j.biocel.2005.10.007; Kronenberg D, 2009, J BIOL CHEM, V284, P33437, DOI 10.1074/jbc.M109.046128; Liepinsh E, 2003, J BIOL CHEM, V278, P25982, DOI 10.1074/jbc.M302734200; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Morimoto H, 2008, MATRIX BIOL, V27, P211, DOI 10.1016/j.matbio.2007.11.005; Moschcovich L, 2001, EUR J BIOCHEM, V268, P2991, DOI 10.1046/j.1432-1327.2001.02189.x; Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384; Ogata I, 1997, HEPATOLOGY, V26, P611, DOI 10.1002/hep.510260312; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Ricard-Blum S, 2006, J BIOL CHEM, V281, P25195, DOI 10.1074/jbc.M603096200; Shalitin N, 2003, J CELL BIOCHEM, V90, P397, DOI 10.1002/jcb.10646; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; TAKAHARA K, 1994, J BIOL CHEM, V269, P26280; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Williamson RA, 2008, MOL BIOSYST, V4, P417, DOI 10.1039/b717901d; WINEMAN E, 2008, FEDERATION EUROPEAN; Xu H, 2000, GENOMICS, V66, P264, DOI 10.1006/geno.2000.6229; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5	38	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33867	33874		10.1074/jbc.M110.141366	http://dx.doi.org/10.1074/jbc.M110.141366			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729553	Green Published, hybrid			2022-12-27	WOS:000283354000033
J	Kamioka, Y; Yasuda, S; Fujita, Y; Aoki, K; Matsuda, M				Kamioka, Yuji; Yasuda, Shuhei; Fujita, Yoshihisa; Aoki, Kazuhiro; Matsuda, Michiyuki			Multiple Decisive Phosphorylation Sites for the Negative Feedback Regulation of SOS1 via ERK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE PHOSPHORYLATION; PROTEIN IN-VIVO; PC12 CELLS; ACTIVATION; RAS; IDENTIFICATION; SEVENLESS; PATHWAY; INSULIN; GRB2	EGF-induced activation of ERK has been extensively studied by both experimental and theoretical approaches. Here, we used a simulation model based mostly on experimentally determined parameters to study the ERK-mediated negative feedback regulation of the Rasguanine nucleotide exchange factor, son of sevenless (SOS). Because SOS1 is phosphorylated at multiple serine residues upon stimulation, we evaluated the role of the multiplicity by building two simulation models, which we termed the decisive and cooperative phosphorylation models. The two models were constrained by the duration of Ras activation and basal phosphorylation level of SOS1. Possible solutions were found only in the decisive model wherein at least three, and probably more than four, phosphorylation sites decisively suppress the SOS activity. Thus, the combination of experimental approaches and the model analysis has suggested an unexpected role of multiple phosphorylations of SOS1 in the negative regulation.	[Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Kamioka, Yuji; Fujita, Yoshihisa; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto 6068501, Japan; [Aoki, Kazuhiro] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	matsudam@lif.kyoto-u.ac.jp	Aoki, Kazuhiro/I-5483-2019	Aoki, Kazuhiro/0000-0001-7263-1555; Matsuda, Michiyuki/0000-0002-5876-9969; Fujita, Yoshihisa/0000-0002-5086-8188	Ministry of Education, Culture, Sports, Science and Technology, Japan; Sagawa Cancer Research grant; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology; Kyoto University Global Center of Excellence Program Center for Frontier Medicine	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sagawa Cancer Research grant; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology(Japan Science & Technology Agency (JST)); Kyoto University Global Center of Excellence Program Center for Frontier Medicine	This work was supported by the Cell Innovation Program and Innovative Techno-Hub for Integrated Medical Bio-imaging Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan; a Sagawa Cancer Research grant; the Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology program; and the Kyoto University Global Center of Excellence Program Center for Frontier Medicine.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; BARSAGI D, 1994, TRENDS ENDOCRIN MET, V5, P165, DOI 10.1016/1043-2760(94)90014-0; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; CHERNIACK AD, 1995, J BIOL CHEM, V270, P1485, DOI 10.1074/jbc.270.4.1485; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; CorbalanGarcia S, 1996, ONCOGENE, V12, P1063; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kiel C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000397; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kurokawa K, 2001, J BIOL CHEM, V276, P31305, DOI 10.1074/jbc.M104341200; Lockyer PJ, 1999, CURR BIOL, V9, P265, DOI 10.1016/S0960-9822(99)80116-X; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; ROZAKISADCOCK M, 1995, ONCOGENE, V11, P1417; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tachibana M, 2009, EXP CELL RES, V315, P863, DOI 10.1016/j.yexcr.2008.12.005; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; Yamada S, 2004, BIOCHEM BIOPH RES CO, V314, P1113, DOI 10.1016/j.bbrc.2004.01.009; Zhou B, 2002, J BIOL CHEM, V277, P13889, DOI 10.1074/jbc.M200377200	37	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33540	33548		10.1074/jbc.M110.135517	http://dx.doi.org/10.1074/jbc.M110.135517			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724475	Green Published, hybrid			2022-12-27	WOS:000283048200088
J	Odho, Z; Southall, SM; Wilson, JR				Odho, Zain; Southall, Stacey M.; Wilson, Jon R.			Characterization of a Novel WDR5-binding Site That Recruits RbBP5 through a Conserved Motif to Enhance Methylation of Histone H3 Lysine 4 by Mixed Lineage Leukemia Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR RECOGNITION; STRUCTURAL BASIS; CHROMATIN MODIFICATIONS; SET1 COMPLEX; WDR5; EXPRESSION; DOMAIN; MLL1; COMPASS; TRITHORAX	Histone modification is well established as a fundamental mechanism driving the regulation of transcription, replication, and DNA repair through the control of chromatin structure. Likewise, it is apparent that incorrect targeting of histone modifications contributes to misregulated gene expression and hence to developmental disorders and diseases of genomic instability such as cancer. The KMT2 family of SET domain methyltransferases, typified by mixed lineage leukemia protein-1 (MLL1), is responsible for histone H3 lysine 4 methylation, a marker of active genes. To ensure that this modification is correctly targeted, a multiprotein complex associates with the methyltransferase and directs activity. We have identified a novel interaction site on the core complex protein WD repeat protein-5 (WDR5), and we mapped the complementary site on its partner retinoblastoma-binding protein-5 (RbBP5). We have characterized this interaction by x-ray crystallography and show how it is fundamental to the assembly of the complex and to the regulation of methyltransferase activity. We show which region of RbBP5 contributes directly to mixed lineage leukemia activation, and we combine our structural and biochemical data to produce a model to show how WDR5 and RbBP5 act cooperatively to stimulate activity.	[Odho, Zain; Southall, Stacey M.; Wilson, Jon R.] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Wilson, JR (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	jon.wilson@icr.ac.uk	Wilson, Jon R/B-7362-2019	Wilson, Jon R/0000-0002-5157-5432	Institute of Cancer Research; Medical Research Council; National Health Service	Institute of Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Service	This work was supported by the Career Development Faculty Programme of the Institute of Cancer Research (to J. R. W.) and benefits from infrastructural support for structural biology at ICR by Cancer Research UK.; Supported by a studentship from the Medical Research Council.; We thank S. M. Roe for assistance with crystallography in the preliminary stages of this project and La'Verne Rennalls for assistance with protein expression in insect cells. National Institute of Health Research Biomedical Research Centre is recipient of National Health Service funding.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Assenberg R, 2008, ACTA CRYSTALLOGR F, V64, P258, DOI 10.1107/S1744309108004557; Bach C, 2009, FUTURE ONCOL, V5, P1271, DOI [10.2217/fon.09.96, 10.2217/FON.09.96]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Garapaty S, 2009, J BIOL CHEM, V284, P7542, DOI 10.1074/jbc.M805872200; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Ireton GC, 2004, ACTA CRYSTALLOGR D, V60, P601, DOI 10.1107/S0907444903029664; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Yates JA, 2010, FEBS LETT, V584, P689, DOI 10.1016/j.febslet.2010.01.022; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	53	69	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32967	32976		10.1074/jbc.M110.159921	http://dx.doi.org/10.1074/jbc.M110.159921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20716525	Green Published, hybrid			2022-12-27	WOS:000283048200034
J	Qi, YM; Schoene, NW; Lartey, FM; Cheng, WH				Qi, Yongmei; Schoene, Norberta W.; Lartey, Frederick M.; Cheng, Wen-Hsing			Selenium Compounds Activate ATM-dependent DNA Damage Response via the Mismatch Repair Protein hMLH1 in Colorectal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; WERNER-SYNDROME PROTEIN; S-PHASE CHECKPOINT; COLON-CANCER; IONIZING-RADIATION; OXIDATIVE STRESS; PROSTATE-CANCER; CYCLE ARREST; G(2) ARREST; MUTL-ALPHA	Epidemiological and animal studies indicate that selenium supplementation suppresses risk of colorectal and other cancers. The majority of colorectal cancers are characterized by a defective DNA mismatch repair (MMR). Here, we have employed the MMR-deficient HCT 116 colorectal cancer cells and the MMR-proficient HCT 116 cells with hMLH1 complementation to investigate the role of hMLH1 in selenium-induced DNA damage response, a tumorigenesis barrier. The ATM (ataxia telangiectasia mutated) protein responds to clastogens and initiates DNA damage response. We show that hMLH1 complementation sensitizes HCT 116 cells to methylseleninic acid, methylselenocysteine, and sodium selenite via reactive oxygen species and facilitates the selenium-induced oxidative 8-oxoguanine damage, DNA breaks, G(2)/M checkpoint response, and ATM pathway activation. Pretreatment of the hMLH1-complemented HCT 116 cells with the antioxidant N-acetylcysteine or 2,2,6,6-tetramethylpiperidine-1-oxyl or the ATM kinase inhibitor KU55933 suppresses hMLH1-dependent DNA damage response to selenium exposure. Selenium treatment stimulates the association between hMLH1 and hPMS2 proteins, a heterodimer critical for functional MMR, in a manner dependent on ATM and reactive oxygen species. Taken together, the results suggest a new role of selenium in mitigating tumorigenesis by targeting the MMR pathway, whereby the lack of hMLH1 renders the HCT 116 colorectal cancer cells resistant to selenium-induced DNA damage response.	[Qi, Yongmei; Lartey, Frederick M.; Cheng, Wen-Hsing] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Qi, Yongmei] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China; [Schoene, Norberta W.] USDA, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA	University System of Maryland; University of Maryland College Park; Lanzhou University; United States Department of Agriculture (USDA)	Cheng, WH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, 0112 Skinner Bldg, College Pk, MD 20742 USA.	whcheng@umd.edu			General Research Board; University of Maryland at College Park; Chinese Top University Graduate Student Studying Abroad Program; China Scholarship Council; U. S. Department of Agriculture [1235-51530-052-00D]	General Research Board; University of Maryland at College Park; Chinese Top University Graduate Student Studying Abroad Program; China Scholarship Council(China Scholarship Council); U. S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was partially supported by the General Research Board, the University of Maryland at College Park (to W.-H. C.), the Chinese Top University Graduate Student Studying Abroad Program, China Scholarship Council (to Y. Q.), and the U. S. Department of Agriculture Agricultural Research Service Project 1235-51530-052-00D (to N. W. S).	Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Arlander SJH, 2008, CANCER RES, V68, P89, DOI 10.1158/0008-5472.CAN-07-0675; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; Brown KD, 2003, NAT GENET, V33, P80, DOI 10.1038/ng1052; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Cheng WH, 2008, MOL BIOL CELL, V19, P3923, DOI 10.1091/mbc.E07-07-0698; Cheng WH, 2004, J BIOL CHEM, V279, P21169, DOI 10.1074/jbc.M312770200; Cheng WH, 2003, MOL CELL BIOL, V23, P6385, DOI 10.1128/MCB.23.18.6385-6395.2003; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Davis CD, 2002, J NUTR, V132, P292, DOI 10.1093/jn/132.2.292; Drake EN, 2006, MED HYPOTHESES, V67, P318, DOI 10.1016/j.mehy.2006.01.058; Feng Y, 1999, TOXICOL APPL PHARM, V157, P36, DOI 10.1006/taap.1999.8623; Finley JW, 2000, J NUTR, V130, P2384, DOI 10.1093/jn/130.9.2384; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Goel A, 2006, CANCER BIOL THER, V5, P529, DOI 10.4161/cbt.5.5.2654; Goulet AC, 2005, CARCINOGENESIS, V26, P109, DOI 10.1093/carcin/bgh306; Grabsch H, 2006, CLIN CANCER RES, V12, P1494, DOI 10.1158/1078-0432.CCR-05-2105; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hardman RA, 2001, CANCER RES, V61, P1392; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Huang F, 2009, FREE RADICAL BIO MED, V46, P1186, DOI 10.1016/j.freeradbiomed.2009.01.026; Hwang JT, 2006, CANCER RES, V66, P10057, DOI 10.1158/0008-5472.CAN-06-1814; IP C, 1991, CANCER RES, V51, P595; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; KOI M, 1994, CANCER RES, V54, P4308; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li GX, 2007, INT J CANCER, V120, P2034, DOI 10.1002/ijc.22480; Lin XJ, 1999, MOL PHARMACOL, V56, P390, DOI 10.1124/mol.56.2.390; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Mirzoeva OK, 2006, MOL CANCER THER, V5, P2757, DOI 10.1158/1535-7163.MCT-06-0183; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Peterson-Roth E, 2005, MOL CELL BIOL, V25, P3596, DOI 10.1128/MCB.25.9.3596-3607.2005; Plotz G, 2002, NUCLEIC ACIDS RES, V30, P711, DOI 10.1093/nar/30.3.711; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Reynolds MF, 2009, CANCER RES, V69, P1071, DOI 10.1158/0008-5472.CAN-08-2306; Rudolf E, 2008, ANTI-CANCER AGENT ME, V8, P598, DOI 10.2174/187152008785133047; SHAMBERGER RJ, 1969, CAN MED ASSOC J, V100, P682; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Shimodaira H, 2003, P NATL ACAD SCI USA, V100, P2420, DOI 10.1073/pnas.0438031100; Stewart MS, 1999, FREE RADICAL BIO MED, V26, P42, DOI 10.1016/S0891-5849(98)00147-6; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Thant AA, 2008, ANTICANCER RES, V28, P3579; Wang HT, 2003, J INORG BIOCHEM, V97, P221, DOI 10.1016/S0162-0134(03)00284-8; Waters R, 2006, EMBO REP, V7, P377, DOI 10.1038/sj.embor.7400659; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003; Yan T, 2001, CANCER RES, V61, P8290; Yanamadala S, 2003, MOL CANCER RES, V1, P747; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zeng HW, 2009, MOLECULES, V14, P1263, DOI 10.3390/molecules14031263; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200	56	41	43	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33010	33017		10.1074/jbc.M110.137406	http://dx.doi.org/10.1074/jbc.M110.137406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20709753	Green Published, hybrid			2022-12-27	WOS:000283048200038
J	Tran, QT; Mahendran, KR; Hajjar, E; Ceccarelli, M; Davin-Regli, A; Winterhalter, M; Weingart, H; Pages, JM				Tran, Que-Tien; Mahendran, Kozhinjampara R.; Hajjar, Eric; Ceccarelli, Matteo; Davin-Regli, Anne; Winterhalter, Mathias; Weingart, Helge; Pages, Jean-Marie			Implication of Porins in beta-Lactam Resistance of Providencia stuartii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; OUTER-MEMBRANE; IDENTIFICATION; ENTEROBACTERIACEAE; MUTAGENESIS; RESIDUES; PROTEUS; CEPHALOSPORINS; SUSCEPTIBILITY	An integrative approach combining biophysical and microbiological methods was used to characterize the antibiotic translocation through the outer membrane of Providencia stuartii. Two novel members of the General Bacterial Porin family of Enterobacteriaceae, named OmpPst1 and OmpPst2, were identified in P. stuartii. In the presence of ertapenem (ERT), cefepime (FEP), and cefoxitin (FOX) in growth media, several resistant derivatives of P. stuartii ATCC 29914 showed OmpPst1-deficiency. These porin-deficient strains showed significant decrease of susceptibility to beta-lactam antibiotics. OmpPst1 and OmpPst2 were purified to homogeneity and reconstituted into planar lipid bilayers to study their biophysical characteristics and their interactions with beta-lactam molecules. Determination of beta-lactam translocation through OmpPst1 and OmpPst2 indicated that the strength of interaction decreased in the order of ertapenem >> cefepime > cefoxitin. Moreover, the translocation of these antibiotics through OmpPst1 was more efficient than through OmpPst2. Heterologous expression of OmpPst1 in the porin-deficient E. coli strain BL21(DE3) omp8 was associated with a higher antibiotic susceptibility of the E. coli cells to beta-lactams compared with expression of OmpPst2. All our data enlighten the involvement of porins in the resistance of P. stuartii to beta-lactam antibiotics.	[Tran, Que-Tien; Winterhalter, Mathias; Weingart, Helge] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; [Tran, Que-Tien; Davin-Regli, Anne; Pages, Jean-Marie] Univ Mediterranee, Fac Med & Pharm, UMR MD1, F-13385 Marseille, France; [Hajjar, Eric; Ceccarelli, Matteo] Univ Cagliari, Dept Phys, CNR INFM SLACS, I-09042 Cagliari, Italy	Jacobs University; UDICE-French Research Universities; Aix-Marseille Universite; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Cagliari	Tran, QT (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Campus Ring 1, D-28759 Bremen, Germany.	q.tran@jacobs-university.de	Ceccarelli, Matteo/C-8557-2018; PAGES, jean-marie/F-2555-2013	Ceccarelli, Matteo/0000-0003-4272-902X; PAGES, jean-marie/0000-0001-7092-7977; Winterhalter, Mathias/0000-0002-1604-3318	EU [MRTN-CT-2005-019335]; COST Action [BM0701]; Universite de la Mediterannee; Universite Franco-Allemande (Deutsch- Franzosische Hochschule) Cotutelle [CT-11-06]	EU(European Commission); COST Action(European Cooperation in Science and Technology (COST)); Universite de la Mediterannee; Universite Franco-Allemande (Deutsch- Franzosische Hochschule) Cotutelle	This work was supported by EU Grant MRTN-CT-2005-019335 (Translocation), the COST Action BM0701 (Atens), the Universite de la Mediterannee and the Service de Sante des Armees, Universite Franco-Allemande (Deutsch- Franzosische Hochschule) Cotutelle CT-11-06.	Arbing MA, 2001, BIOCHEMISTRY-US, V40, P14621, DOI 10.1021/bi015611y; Arpin C, 2003, ANTIMICROB AGENTS CH, V47, P3506, DOI 10.1128/AAC.47.11.3506-3514.2003; Aubert D, 2005, ANTIMICROB AGENTS CH, V49, P3590, DOI 10.1128/AAC.49.8.3590-3592.2005; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Berezhkovskii AM, 2005, BIOPHYS J, V88, pL17, DOI 10.1529/biophysj.104.057588; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bornet C, 2004, ANTIMICROB AGENTS CH, V48, P2153, DOI 10.1128/AAC.48.6.2153-2158.2004; Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bredin J, 2003, BIOCHEM J, V376, P245, DOI 10.1042/BJ20030814; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Danelon C, 2006, BIOPHYS J, V90, P1617, DOI 10.1529/biophysj.105.075192; De Champs C, 2001, ANTIMICROB AGENTS CH, V45, P1278, DOI 10.1128/AAC.45.4.1278-1280.2001; Domenech-Sanchez A, 1999, J BACTERIOL, V181, P2726; Franceschini N, 1998, ANTIMICROB AGENTS CH, V42, P1459, DOI 10.1128/AAC.42.6.1459; Franklin K, 2001, ANTIMICROB AGENTS CH, V45, P2238, DOI 10.1128/AAC.45.8.2238-2244.2001; Galani I, 2008, J ANTIMICROB CHEMOTH, V61, P548, DOI 10.1093/jac/dkm535; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Hajjar E, 2010, BIOPHYS J, V98, P569, DOI 10.1016/j.bpj.2009.10.045; James CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005453; Lavigne JP, 2004, J CLIN MICROBIOL, V42, P3805, DOI 10.1128/JCM.42.8.3805-3808.2004; Lincopan N, 2006, J MED MICROBIOL, V55, P1611, DOI 10.1099/jmm.0.46771-0; Luzzaro F, 2006, J CLIN MICROBIOL, V44, P1659, DOI 10.1128/JCM.44.5.1659-1664.2006; Martinez-Martinez L, 1999, ANTIMICROB AGENTS CH, V43, P1669, DOI 10.1128/AAC.43.7.1669; Miriagou V, 2007, J ANTIMICROB CHEMOTH, V60, P183, DOI 10.1093/jac/dkm139; MITSUYAMA J, 1987, ANTIMICROB AGENTS CH, V31, P379, DOI 10.1128/AAC.31.3.379; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359; Murbach V, 2001, CLIN MICROBIOL INFEC, V7, P661, DOI 10.1046/j.1469-0691.2001.00336.x; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; PAGES JM, 2004, BACTERIAL EUKARYOTIC; PENNER JL, 2005, BERGEYS MANUAL SYSTE; Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k; Plante I, 2003, J ANTIMICROB CHEMOTH, V51, P787, DOI 10.1093/jac/dkg169; Prilipov A, 1998, J BACTERIOL, V180, P3388, DOI 10.1128/JB.180.13.3388-3392.1998; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; Sambrook J., 2001, MOL CLONING LAB MANU; Shiroto K, 2005, J MED MICROBIOL, V54, P1065, DOI 10.1099/jmm.0.46194-0; Simonet V, 1996, FEMS MICROBIOL LETT, V136, P91; Stock I, 1998, J MED MICROBIOL, V47, P629, DOI 10.1099/00222615-47-7-629; Thiolas A, 2004, BIOCHEM BIOPH RES CO, V317, P851, DOI 10.1016/j.bbrc.2004.03.130; Tumbarello M, 2004, J ANTIMICROB CHEMOTH, V53, P277, DOI 10.1093/jac/dkh047; Vidal S, 2005, J MED CHEM, V48, P1395, DOI 10.1021/jm049652e; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661	49	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32273	32281		10.1074/jbc.M110.143305	http://dx.doi.org/10.1074/jbc.M110.143305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20667831	Green Published, hybrid			2022-12-27	WOS:000282683000040
J	Miranda, KJ; Loeser, RF; Yammani, RR				Miranda, Keally J.; Loeser, Richard F.; Yammani, Raghunatha R.			Sumoylation and Nuclear Translocation of S100A4 Regulate IL-1 beta-mediated Production of Matrix Metalloproteinase-13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; FACTOR-KAPPA-B; ARTICULAR CHONDROCYTES; GENE-EXPRESSION; PROTEIN; METASTASIS; RECEPTOR; AP-1; LOCALIZATION; UBIQUITIN	S100A4, a member of the S100 family of proteins, plays an important role in matrix remodeling by up-regulating the expression of matrix metalloproteinases (MMPs). We have previously shown that S100A4 is overexpressed in diseased cartilage and that extracellular S100A4 stimulates MMP-13 production, a major type II collagen-degrading enzyme, via activation of receptor for advanced glycation end product signaling. In the present study, using human articular chondrocytes, we show that intracellular S100A4 translocated into the nucleus upon interleukin-1 beta (IL-1 beta) stimulation and translocation required post-translational modification of S100A4 by the sumo-1 protein. Two sumoylation sites were identified on the S100A4 molecule, Lys(22) and Lys(96). Mutation of these lysine residues abolished the ability of S100A4 to be sumoylated and to translocate into the nucleus. Blocking of sumoylation and nuclear transport of S100A4 inhibited the IL-1 beta -induced production of MMP-13. Nuclear S100A4 was bound to the promoter region of MMP-13 in IL-1 beta-treated cells. Thus, we demonstrate a novel mechanism for sumoylated S100A4 as a regulator of expression of the MMP-13 gene.	[Miranda, Keally J.; Loeser, Richard F.; Yammani, Raghunatha R.] Wake Forest Univ, Bowman Gray Sch Med, Sect Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	Yammani, RR (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	ryammani@wfubmc.edu			National Institutes of Health [P30AG21332, R01AG16697]; Wake Forest University; NATIONAL INSTITUTE ON AGING [P30AG021332, R01AG016697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P30AG21332 (to Wake Forest University Claude D Pepper Older Americans Independence Center) and R01AG16697 (to R. F. L.) and the Wake Forest University Health Sciences Venture Fund (to R.R.Y.).	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; Andrassy M, 2006, AM J PATHOL, V169, P1223, DOI 10.2353/ajpath.2006.050713; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bjornland K, 2001, J PEDIATR SURG, V36, P1040, DOI 10.1053/jpsu.2001.24735; Bjornland K, 1999, CANCER RES, V59, P4702; Cecil DL, 2008, J IMMUNOL, V180, P8378, DOI 10.4049/jimmunol.180.12.8378; Cecil DL, 2005, J IMMUNOL, V175, P8296, DOI 10.4049/jimmunol.175.12.8296; Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; Farley AR, 2009, METHOD ENZYMOL, V463, P725, DOI 10.1016/S0076-6879(09)63040-8; Flatmark K, 2003, J PATHOL, V200, P589, DOI 10.1002/path.1381; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; GRIGORIAN MS, 1993, GENE, V135, P229, DOI 10.1016/0378-1119(93)90070-J; Haugen MH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-172; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Kikuchi N, 2006, CANCER SCI, V97, P1061, DOI 10.1111/j.1349-7006.2006.00295.x; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Muehleman C, 1997, OSTEOARTHR CARTILAGE, V5, P23, DOI 10.1016/S1063-4584(97)80029-5; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; Orre LM, 2007, MOL CELL PROTEOMICS, V6, P2122, DOI 10.1074/mcp.M700202-MCP200; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; RAMIREZ VD, 1975, MOL CELL ENDOCRINOL, V3, P339, DOI 10.1016/0303-7207(75)90035-0; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Samuel S, 2007, BBA-GENE STRUCT EXPR, V1769, P525, DOI 10.1016/j.bbaexp.2007.07.003; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shlopov BV, 1997, ARTHRITIS RHEUM-US, V40, P2065, DOI 10.1002/art.1780401120; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; TAKENAGA K, 1994, CELL STRUCT FUNCT, V19, P133, DOI 10.1247/csf.19.133; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042; Yammani RR, 2009, ARTHRITIS RHEUM, V60, P792, DOI 10.1002/art.24295; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955	51	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31517	31524		10.1074/jbc.M110.125898	http://dx.doi.org/10.1074/jbc.M110.125898			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685652	Green Published, hybrid			2022-12-27	WOS:000282764600046
J	Park, J; Oh, Y; Yoo, L; Jung, MS; Song, WJ; Lee, SH; Seo, H; Chung, KC				Park, Joongkyu; Oh, Yohan; Yoo, Lang; Jung, Min-Su; Song, Woo-Joo; Lee, Sang-Hun; Seo, Hyemyung; Chung, Kwang Chul			Dyrk1A Phosphorylates p53 and Inhibits Proliferation of Embryonic Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCED PHOSPHORYLATION; INTERACTING PROTEIN KINASE-2; NEURAL PROGENITOR CELLS; CYCLIN-DEPENDENT KINASE; DOWN-SYNDROME; DNA-DAMAGE; ALZHEIMERS-DISEASE; MIRK/DYRK1B KINASE; FUNCTIONAL-LINK; BINDING PROTEIN	Down syndrome (DS) is associated with many neural defects, including reduced brain size and impaired neuronal proliferation, highly contributing to the mental retardation. Those typical characteristics of DS are closely associated with a specific gene group "Down syndrome critical region" (DSCR) on human chromosome 21. Here we investigated the molecular mechanisms underlying impaired neuronal proliferation in DS and, more specifically, a regulatory role for dual-specificity tyrosine-(Y) phosphorylation-regulated kinase 1A (Dyrk1A), a DSCR gene product, in embryonic neuronal cell proliferation. We found that Dyrk1A phosphorylates p53 at Ser-15 in vitro and in immortalized rat embryonic hippocampal progenitor H19-7 cells. In addition, Dyrk1A-induced p53 phosphorylation at Ser-15 led to a robust induction of p53 target genes (e. g. p21(CIP1)) and impaired G(1)/G(0)-S phase transition, resulting in attenuated proliferation of H19-7 cells and human embryonic stem cell-derived neural precursor cells. Moreover, the point mutation of p53-Ser-15 to alanine rescued the inhibitory effect of Dyrk1A on neuronal proliferation. Accordingly, brains from embryonic DYRK1A transgenic mice exhibited elevated levels of Dyrk1A, Ser-15 (mouse Ser-18)-phosphorylated p53, and p21(CIP1) as well as impaired neuronal proliferation. These findings suggest that up-regulation of Dyrk1A contributes to altered neuronal proliferation in DS through specific phosphorylation of p53 at Ser-15 and subsequent p21(CIP1) induction.	[Park, Joongkyu; Oh, Yohan; Yoo, Lang; Chung, Kwang Chul] Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Jung, Min-Su; Song, Woo-Joo] Inje Univ, Inst Brain Sci & Technol, Grad Program Neurosci, Pusan 633146, South Korea; [Lee, Sang-Hun] Hanyang Univ, Coll Med, Dept Biochem, Seoul 133791, South Korea; [Seo, Hyemyung] Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, Ansan 426791, Gyeonggi Do, South Korea	Yonsei University; Inje University; Hanyang University; Hanyang University	Chung, KC (corresponding author), Yonsei Univ, Dept Biol, Coll Life Sci & Biotechnol, Seongsan No 262, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Oh, Yohan/C-9107-2013; rchnds, rchnds/D-7595-2016; PARK, joohyun/D-5808-2012; lee, sang hun/Q-4650-2019; Park, Joongkyu/ADZ-1994-2022	Oh, Yohan/0000-0002-9249-8664; lee, sang hun/0000-0002-9005-5966; Park, Joongkyu/0000-0002-5675-2872				Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chinery R, 1997, NAT MED, V3, P1233, DOI 10.1038/nm1197-1233; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; CURRLE DS, 2007, JOVE-J VIS EXP, V2, P152; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; HARPER JW, 1993, CELL, V75, P805; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hofmann TG, 2000, BIOCHIMIE, V82, P1123, DOI 10.1016/S0300-9084(00)01196-2; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Knippschild U, 1997, ONCOGENE, V15, P1727, DOI 10.1038/sj.onc.1201541; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Larsen KB, 2008, ANN ANAT, V190, P421, DOI 10.1016/j.aanat.2008.05.007; LEJEUNE J, 1959, TURPIN R C R HEBD SE, V248, P1721; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Matsumura I, 1997, MOL CELL BIOL, V17, P2933, DOI 10.1128/MCB.17.5.2933; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Seidl R, 1999, NEUROSCI LETT, V260, P9, DOI 10.1016/S0304-3940(98)00945-8; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Tanzi RE, 1996, NAT MED, V2, P31, DOI 10.1038/nm0196-31; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; WISNIEWSKI KE, 1984, NEW ENGL J MED, V311, P1187; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	53	83	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31895	U919		10.1074/jbc.M110.147520	http://dx.doi.org/10.1074/jbc.M110.147520			36	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20696760	hybrid, Green Published			2022-12-27	WOS:000282764600081
J	Jin, XJ; Jin, HR; Jung, HS; Lee, SJ; Lee, JH; Lee, JJ				Jin, Xuejun; Jin, Hong Ri; Jung, Haeng Sun; Lee, Se Jeong; Lee, Jeong-Hyung; Lee, Jung Joon			An Atypical E3 Ligase Zinc Finger Protein 91 Stabilizes and Activates NF-kappa B-inducing Kinase via Lys(63)-linked Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DEPENDENT APOPTOSIS; TNF-ALPHA; CONJUGATING ENZYME; CANCER DEVELOPMENT; RECEPTOR; TRAF2; NIK; PATHWAYS; CELLS; CIAP1	The NF-kappa B transcription factors control many physiological processes, including inflammation, immunity, and apoptosis. Its activity contributes to the development of various cell malignancies. NF-kappa B-inducing kinase (NIK) plays a pivotal role in NF-kappa B activation. However, the molecular mechanism to stabilize and activate NIK remains elusive, although it is known that cIAP1/2 (cellular inhibitor of apoptosis 1 and 2) ubiquitinate NIK for degradation. Here, we report a novel NF-kappa B-related zinc finger protein 91 (ZFP91) that stabilizes and activates NIK in a ubiquitination-dependent manner. We show that ZFP91 interacts with and promotes the Lys(63)-linked ubiquitination of NIK and subsequent processing of p100 to p52. The results of in vitro biochemical assays indicate that ZFP91 functions as an E3 ligase directly to NIK. Remarkably, the ubiquitination of NIK coincides with its Thr(559) phosphorylation. Furthermore, knockdown of ZFP91 expression by RNA interference inhibits the CD40ligation-induced activation of NIK and p100 processing as well as the expression of noncanonical NF-kappa B target genes. These data clearly indicate that ZFP91 is an important regulator of the noncanonical NF-kappa B pathway.	[Jin, Xuejun; Jin, Hong Ri; Jung, Haeng Sun; Lee, Se Jeong; Lee, Jung Joon] Korea Res Inst Biosci & Biotechnol, Ctr Mol Canc Res, Ochang 363883, Chungbuk, South Korea; [Jin, Hong Ri; Lee, Jung Joon] Korea Univ Sci & Technol, Taejon 305333, South Korea; [Jin, Xuejun] Yanbian Univ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Peoples R China; [Lee, Jeong-Hyung] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, Kangwon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Yanbian University; Kangwon National University	Lee, JJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Ctr Mol Canc Res, Ochang 363883, Chungbuk, South Korea.	jjlee@kribb.re.kr			Ministry of Education and Science and Technology, Republic of Korea	Ministry of Education and Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the 21C Frontier Genome Project from the Ministry of Education and Science and Technology, Republic of Korea.	Ait-Ghezala G, 2005, MOL BRAIN RES, V140, P73, DOI 10.1016/j.molbrainres.2005.07.014; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Gomes EM, 2009, CLIN CANCER RES, V15, P1317, DOI 10.1158/1078-0432.CCR-08-1360; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hirano A, 1999, BLOOD, V93, P2999; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Lapchak PH, 2004, AM J PHYSIOL-RENAL, V287, pF512, DOI 10.1152/ajprenal.00070.2004; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Qing GL, 2005, J BIOL CHEM, V280, P40578, DOI 10.1074/jbc.M508776200; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Unoki M, 2003, INT J ONCOL, V22, P1217; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	43	68	73	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30539	30547		10.1074/jbc.M110.129551	http://dx.doi.org/10.1074/jbc.M110.129551			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20682767	Green Published, hybrid			2022-12-27	WOS:000282135500022
J	Rajanbabu, V; Pan, CY; Lee, SC; Lin, WJ; Lin, CC; Li, CL; Chen, JY				Rajanbabu, Venugopal; Pan, Chieh-Yu; Lee, Shang-Chun; Lin, Wei-Ju; Lin, Ching-Chun; Li, Chung-Leung; Chen, Jyh-Yih			Tilapia Hepcidin 2-3 Peptide Modulates Lipopolysaccharide-induced Cytokines and Inhibits Tumor Necrosis Factor-alpha through Cyclooxygenase-2 and Phosphodiesterase 4D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; RAW 264.7 MACROPHAGES; PROTEIN-KINASE; INFLAMMATORY CYTOKINES; ANTIMICROBIAL PEPTIDE; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; IMMUNE-RESPONSE; INNATE IMMUNITY	The antimicrobial peptide, tilapia hepcidin (TH) 2-3, belongs to the hepcidin family, and its antibacterial function has been reported. Here, we examined the TH2-3-mediated regulation of proinflammatory cytokines in bacterial endotoxin lipopolysaccharide (LPS)-stimulated mouse macrophages. The presence of TH2-3 in LPS-stimulated cells reduced the amount of tumor necrosis factor (TNF)-alpha secretion. From a microarray, real-time polymerase chain reaction (PCR), and cytokine array studies, we showed down-regulation of the proinflammatory cytokines TNF-alpha, interleukin (IL)-1 alpha, IL-1 beta, IL-6, and the prostaglandin synthesis gene, cyclooxygenase (COX)-2, by TH2-3. Studies with the COX-2-specific inhibitor, melaxicam, and with COX-2-overexpressing cells demonstrated the positive regulation of TNF-alpha and negative regulation of cAMP degradation-specific phosphodiesterase (PDE) 4D by COX-2. In LPS-stimulated cells, TH2-3 acts like melaxicam and down-regulates COX-2 and up-regulates PDE4D. The reduction in intracellular cAMP by TH2-3 or melaxicam in LPS-stimulated cells supports the negative regulation of PDE4D by COX-2 and TH2-3. This demonstrates that the inhibition of COX-2 is among the mechanisms through which TH2-3 controls TNF-alpha release. At 1 h after treatment, the presence of TH2-3 in LPS-stimulated cells had suppressed the induction of pERK1/2 and prevented the LPS-stimulated nuclear accumulation of NF-kappa B family proteins of p65, NF-kappa B2, and c-Rel. In conclusion, TH2-3 inhibits TNF-alpha and other proinflammatory cytokines through COX-2-, PDE4D-, and pERK1/2-dependent mechanisms.	[Rajanbabu, Venugopal; Pan, Chieh-Yu; Lee, Shang-Chun; Lin, Wei-Ju; Lin, Ching-Chun; Chen, Jyh-Yih] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi 262, Ilan, Taiwan; [Li, Chung-Leung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Rajanbabu, Venugopal; Chen, Jyh-Yih] Natl Chung Hsing Univ, Taiwan Int Grad Program, Taipei 115, Taiwan; [Rajanbabu, Venugopal; Chen, Jyh-Yih] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 402, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University	Chen, JY (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, 23-10 Dahuen Rd, Jiaushi 262, Ilan, Taiwan.	zoocjy@gate.sinica.edu.tw	Chen, Jyh-Yih/F-3412-2014; Rajanbabu, Venugopal/AAE-5576-2020	Chen, Jyh-Yih/0000-0001-7858-8236; Rajanbabu, Venugopal/0000-0001-8761-3333	Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi, Taiwan	Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi, Taiwan(Academia Sinica - Taiwan)	This work was supported by the Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica, Jiaushi, Ilan 262, Taiwan.	Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Cerioni L, 2003, FEBS LETT, V547, P92, DOI 10.1016/S0014-5793(03)00675-6; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Chen CC, 1999, J BIOL CHEM, V274, P31559, DOI 10.1074/jbc.274.44.31559; Chen CC, 1999, MOL PHARMACOL, V55, P481; Cognasse F, 2003, IMMUNOL LETT, V90, P49, DOI 10.1016/S0165-2478(03)00173-1; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; Falzacappa MVV, 2005, GENE, V364, P37, DOI 10.1016/j.gene.2005.07.020; FOURNIER T, 1995, J IMMUNOL, V155, P2123; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Godowski PJ, 2005, NAT IMMUNOL, V6, P544, DOI 10.1038/ni0605-544; HOUSLAY MD, 2003, BIOCHEM J, V15, P1; Hsieh JC, 2010, FISH SHELLFISH IMMUN, V29, P430, DOI 10.1016/j.fsi.2010.05.001; Huang PH, 2007, MOL IMMUNOL, V44, P1922, DOI 10.1016/j.molimm.2006.09.031; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jeon YJ, 2000, IMMUNOPHARMACOLOGY, V48, P173, DOI 10.1016/S0162-3109(00)00199-5; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; KOIDE M, 1993, J BIOL CHEM, V268, P24959; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lolis E, 2003, NAT REV DRUG DISCOV, V2, P635, DOI 10.1038/nrd1153; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wang GQ, 2008, J IMMUNOL, V180, P8306, DOI 10.4049/jimmunol.180.12.8306; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhang X, 2008, INFLAMM RES, V57, P524, DOI 10.1007/s00011-008-8007-8; Zhong J, 2009, P NATL ACAD SCI USA, V106, P4372, DOI 10.1073/pnas.0812642106	44	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30577	30586		10.1074/jbc.M110.137935	http://dx.doi.org/10.1074/jbc.M110.137935			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20675368	Green Published, hybrid			2022-12-27	WOS:000282135500026
J	Luo, YD; Yang, CF; Lu, WQ; Xie, R; Jin, CL; Huang, P; Wang, F; McKeehan, WL				Luo, Yongde; Yang, Chaofeng; Lu, Weiqin; Xie, Rui; Jin, Chengliu; Huang, Peng; Wang, Fen; McKeehan, Wallace L.			Metabolic Regulator beta Klotho Interacts with Fibroblast Growth Factor Receptor 4 (FGFR4) to Induce Apoptosis and Inhibit Tumor Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID SYNTHESIS; HEPARAN-SULFATE; MAMMALIAN TARGET; ENDOCRINE REGULATION; CRYSTAL-STRUCTURE; RAPAMYCIN MTOR; BREAST-CANCER; FACTOR FAMILY; PPAR-ALPHA; COMPLEX	In organs involved in metabolic homeostasis, transmembrane alpha and beta klothos direct FGFR signaling to control of metabolic pathways. Coordinate expression of beta klotho and FGFR4 is a property of mature hepatocytes. Genetic deletion of FGFR4 or beta klotho in mice disrupts hepatic cholesterol/bile acid and lipid metabolism. The deletion of FGFR4 has no effect on the proliferative response of hepatocytes after liver injury. However, its absence results in accelerated progression of dimethynitrosamine- initiated hepatocellular carcinomas, indicating that FGFR4 suppresses hepatoma proliferation. The mechanism underlying the FGFR4-mediated hepatoma suppression has not been addressed. Here we show that beta klotho expression is more consistently down-regulated in human and mouse hepatomas than FGFR4. Co-expression and activation by either endocrine FGF19 or cellular FGF1 of the FGFR4 kinase in a complex with beta klotho restricts cell population growth through induction of apoptotic cell death in both hepatic and nonhepatic cells. The beta klotho-FGFR4 partnership caused a depression of activated AKT and mammalian target of rapamycin while activating ERK1/2 that may underlie the pro-apoptotic effect. Our results show that beta klotho not only interacts with heparan sulfate-FGFR4 to form a complex with high affinity for endocrine FGF19 but also impacts the quality of downstream signaling and biological end points activated by either FGF19 or canonical FGF1. Thus the same beta klotho-heparan sulfate-FGFR4 partnership that mediates endocrine control of hepatic metabolism plays a role in cellular homeostasis and hepatoma suppression through negative control of cell population growth mediated by pro-apoptotic signaling.	[Luo, Yongde; Yang, Chaofeng; Jin, Chengliu; Wang, Fen; McKeehan, Wallace L.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Luo, Yongde; Xie, Rui; McKeehan, Wallace L.] Texas A&M Hlth Sci Ctr, IBT Prote & Nanotechnol Lab, Houston, TX 77030 USA; [Lu, Weiqin; Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center	McKeehan, WL (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	wmckeehan@ibt.tamhsc.edu	XIE, RUI/N-7325-2014		United States Public Health Service [DK56338, P50 CA140388]; Susan Komen Breast Cancer Foundation; John S. Dunn Research Foundation; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); John S. Dunn Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants DK56338 (to Y. L.) and P50 CA140388 (to W. L. M. and F. W.), the Susan Komen Breast Cancer Foundation, and the John S. Dunn Research Foundation.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barthel TK, 2007, J STEROID BIOCHEM, V103, P381, DOI 10.1016/j.jsbmb.2006.12.054; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chen PY, 2009, BIOCHEM BIOPH RES CO, V382, P424, DOI 10.1016/j.bbrc.2009.03.040; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Feng SJ, 1997, CANCER RES, V57, P5369; Ferlini C, 2007, NAT PROTOC, V2, P3111, DOI 10.1038/nprot.2007.397; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Huang CJ, 2009, J APPL METEOROL CLIM, V48, P553, DOI 10.1175/2008JAMC1818.1; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Huang XQ, 2006, CANCER RES, V66, P1481, DOI 10.1158/0008-5472.CAN-05-2412; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kan M, 1996, J BIOL CHEM, V271, P26143, DOI 10.1074/jbc.271.42.26143; KAN M, 1991, METHOD ENZYMOL, V198, P158; Kan MK, 2001, IN VITRO CELL DEV-AN, V37, P575; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2008, CURR OPIN NEPHROL HY, V17, P368, DOI 10.1097/MNH.0b013e3282ffd994; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kwiatkowski BA, 2008, J CELL PHYSIOL, V215, P803, DOI 10.1002/jcp.21365; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Lee S, 2009, INT J ONCOL, V34, P161, DOI 10.3892/ijo_00000138; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Lopez-Serra L, 2008, ONCOGENE, V27, P3556, DOI 10.1038/sj.onc.1211022; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Luo YD, 1996, J BIOL CHEM, V271, P26876, DOI 10.1074/jbc.271.43.26876; Luo YD, 2006, J CELL BIOCHEM, V97, P1241, DOI 10.1002/jcb.20724; Luo YD, 2006, J BIOL CHEM, V281, P21052, DOI 10.1074/jbc.M601559200; Luo YD, 2009, CELL SIGNAL, V21, P1370, DOI 10.1016/j.cellsig.2009.04.004; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McKeehan WL, 1999, J BIOL CHEM, V274, P21511, DOI 10.1074/jbc.274.31.21511; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Medici D, 2008, J CELL BIOL, V182, P459, DOI 10.1083/jcb.200803024; Moore DD, 2007, SCIENCE, V316, P1436, DOI 10.1126/science.1144837; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Olson DC, 1998, CELL GROWTH DIFFER, V9, P557; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Seitzer N, 2010, CANCER RES, V70, P802, DOI 10.1158/0008-5472.CAN-09-3239; SHAOUL E, 1995, ONCOGENE, V10, P1553; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Uematsu F, 2001, BIOCHEM BIOPH RES CO, V283, P791, DOI 10.1006/bbrc.2001.4850; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; WANG F, 1995, J BIOL CHEM, V270, P10222, DOI 10.1074/jbc.270.17.10222; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Wu XL, 2010, J BIOL CHEM, V285, P5165, DOI 10.1074/jbc.M109.068783; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Yu CD, 2005, J BIOL CHEM, V280, P17707, DOI 10.1074/jbc.M411771200; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482	71	41	44	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30069	30078		10.1074/jbc.M110.148288	http://dx.doi.org/10.1074/jbc.M110.148288			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20657013	Green Published, hybrid			2022-12-27	WOS:000281984300045
J	Morimoto, R; Shindou, H; Oda, Y; Shimizu, T				Morimoto, Ryo; Shindou, Hideo; Oda, Yoshiya; Shimizu, Takao			Phosphorylation of Lysophosphatidylcholine Acyltransferase 2 at Ser(34) Enhances Platelet-activating Factor Production in Endotoxin-stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAPKAP KINASE 2; P38 KINASE; ACETYLTRANSFERASE; IDENTIFICATION; BIOSYNTHESIS; PATHWAY; BINDING; ALPHA; CELLS	Platelet-activating factor (PAF) is a potent proinflammatory phospholipid mediator that elicits various cellular functions under physiological and pathological conditions. We have recently identified two enzymes involved in PAF production: lysophosphatidylcholine acyltransferase-1 (LPCAT1) and LPCAT2. We found that LPCAT2 is highly expressed in inflammatory cells and is activated by lipopolysaccharide (LPS) treatment through Toll-like receptor 4. However, the molecular mechanism for the activation remains elusive. In this study, Phos-tag SDS-PAGE revealed the LPS-induced phosphorylation of LPCAT2. Furthermore, mass spectrometry and mutagenesis analyses identified Ser(34) of LPCAT2 as the phosphorylation site to enhance the catalytic activities. The experiments using inhibitors and siRNA against MAPK cascades demonstrated that LPCAT2 phosphorylation through LPS-TLR4 signaling may directly depend on MAPK-activated protein kinase 2 (MAPKAP kinase 2 or MK2). These findings develop a further understanding of both PAF production and phospholipid remodeling triggered by inflammatory stimuli. Specific inhibition of the PAF biosynthetic activity by phosphorylated LPCAT2 will provide a novel target for the regulation of inflammatory disorders.	[Morimoto, Ryo; Shindou, Hideo; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Oda, Yoshiya] Univ Tokyo, Fac Med, Dept Metabolome, Tokyo 1130033, Japan; [Oda, Yoshiya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3328613, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Shindou, H (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Hongo 7-3-1, Tokyo 1130033, Japan.	hshindou-tky@umin.ac.jp	Shimizu, Takao/AAV-7052-2021	Morimoto, Ryo/0000-0002-5497-4666	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; (University of Tokyo) from the Japan Society for Promotion of Sciences; Center for NanoBio Integration at the University of Tokyo; Ministry of Health, Labor, and Welfare; MEXT of Japan; Uehara Memorial Foundation; Cell Science Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); (University of Tokyo) from the Japan Society for Promotion of Sciences; Center for NanoBio Integration at the University of Tokyo; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Cell Science Research Foundation(Cell Science Research Foundation, Japan)	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to T. S.) and the Global Centers of Excellence Program (University of Tokyo) from the Japan Society for Promotion of Sciences (to T. S.).; Supported by the Center for NanoBio Integration at the University of Tokyo.; Supported by Health and Labor Sciences Research Grants (Research on Allergic Disease and Immunology) from the Ministry of Health, Labor, and Welfare; by a Grant-in-Aid for Young Scientists (B) from MEXT of Japan; and by grants of the Uehara Memorial Foundation and the Cell Science Research Foundation. To whom correspondence should be addressed. Tel.: 81-3-5802-2925; Fax: 81-3-3813-8732; E-mail: hshindou-tky@umin.ac.jp.	Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; BENLEVY R, 1995, EMBO J, V14, P5920, DOI 10.1002/j.1460-2075.1995.tb00280.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cano E, 1996, ONCOGENE, V12, P805; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Hale KK, 1999, J IMMUNOL, V162, P4246; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Katayama H, 2004, RAPID COMMUN MASS SP, V18, P2388, DOI 10.1002/rcm.1637; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Nakamura T, 2010, J PROTEOME RES, V9, P1385, DOI 10.1021/pr900918h; NIETO ML, 1988, J BIOL CHEM, V263, P2217; Nixon AB, 1999, J BIOL CHEM, V274, P5469, DOI 10.1074/jbc.274.9.5469; Owen JS, 2005, BBA-MOL CELL BIOL L, V1733, P120, DOI 10.1016/j.bbalip.2004.12.016; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Smith DA, 2000, PAC HIST REV, V69, P145, DOI 10.2307/3641273; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; WYKLE RL, 1980, J BIOL CHEM, V255, P256	27	39	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29857	29862		10.1074/jbc.M110.147025	http://dx.doi.org/10.1074/jbc.M110.147025			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663880	hybrid, Green Published			2022-12-27	WOS:000281984300022
J	Musri, MM; Carmona, MC; Hanzu, FA; Kaliman, P; Gomis, R; Parrizas, M				Musri, Melina M.; Carmona, Mari Carmen; Hanzu, Felicia A.; Kaliman, Perla; Gomis, Ramon; Parrizas, Marcelina			Histone Demethylase LSD1 Regulates Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; C/EBP-ALPHA; DEVELOPMENTAL REGULATORS; GENE ACTIVATION; CELL FATE; METHYLATION; DIFFERENTIATION; PTIP; TRANSCRIPTION; ACETYLATION	Epigenetic mechanisms, in particular the enzymatic modification of histones, are a crucial element of cell differentiation, a regulated process that allows a precursor cell basically to turn into a different cell type while maintaining the same genetic equipment. We have previously described that the promoters of adipogenic genes display significant levels of dimethylation at the Lys(4) of histone H3 (H3K4) in preadipocytes, where these genes are still silenced, thus maintaining the chromatin of the precursor cell in a receptive state. Here, we show that the expression of several histone demethylases and methyltransferases increases during adipogenesis, suggesting an important role for these proteins in this process. Knockdown of the H3K4/K9 demethylase LSD1 results in markedly decreased differentiation of 3T3-L1 preadipocytes. This outcome is associated with decreased H3K4 dimethylation and increased H3K9 dimethylation at the promoter of transcription factor cebpa, whose expression must be induced > 200-fold upon stimulation of differentiation. Thus, our data suggest that LSD1 acts to maintain a permissive state of the chromatin in this promoter by opposing the action of a H3K9 methyltransferase. Knockdown of H3K9 methyltransferase SETDB1 produced the opposite results, by decreasing H3K9 dimethylation and increasing H3K4 dimethylation levels at the cebpa promoter and favoring differentiation. These findings indicate that the histone methylation status of adipogenic genes as well as the expression and function of the proteins involved in its maintenance play a crucial role in adipogenesis.	[Parrizas, Marcelina] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Endocrinol & Nutr Unit, Inst Invest Biomed August Pi & Sunyer, Lab Diabet & Obesitat, Barcelona 08036, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Parrizas, M (corresponding author), Ctr Invest Biomed Red Diabet & Enfermedades Metab, Endocrinol & Nutr Unit, Inst Invest Biomed August Pi & Sunyer, Lab Diabet & Obesitat, Casanova 143,Pl 3,Lab 334, Barcelona 08036, Spain.	badcell@gmail.com	Parrizas, Marcelina/AAS-3629-2021; Musri, Melina M/C-9078-2015	Musri, Melina M/0000-0002-9159-5497; Carmona Orozco, Mamen/0000-0001-5911-6938; Parrizas, Marcelina/0000-0003-1296-8302; Hanzu, Felicia Alexandra/0000-0002-2399-4023	Spanish Ministry of Science and Innovation (MICINN) [BFU2009-09988/BMC, SAF2007-63353, SAF2006-07382]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Spanish Ministry of Science and Innovation (MICINN) Grants BFU2009-09988/BMC (to M. P.), SAF2007-63353 (to P. K.), and SAF2006-07382 (to R. G.).	Atkinson SP, 2008, STEM CELLS, V26, P1174, DOI 10.1634/stemcells.2007-0497; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Kim D, 2009, STEM CELLS, V27, P1516, DOI 10.1002/stem.79; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liang Y, 2009, NAT MED, V15, P1312, DOI 10.1038/nm.2051; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Musri MM, 2010, ORGANOGENESIS, V6, P15, DOI 10.4161/org.6.1.10226; Musri Melina N., 2008, V456, P231, DOI 10.1007/978-1-59745-245-8_17; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Takada I, 2007, ANN NY ACAD SCI, V1116, P182, DOI 10.1196/annals.1402.034; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200	44	121	128	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30034	30041		10.1074/jbc.M110.151209	http://dx.doi.org/10.1074/jbc.M110.151209			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20656681	Green Published, hybrid			2022-12-27	WOS:000281984300041
J	Reinehr, R; Gohlke, H; Sommerfeld, A; vom Dahl, S; Haussinger, D				Reinehr, Roland; Gohlke, Holger; Sommerfeld, Annika; vom Dahl, Stephan; Haeussinger, Dieter			Activation of Integrins by Urea in Perfused Rat Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-VOLUME; FORCE-FIELD; PROTEIN; INVOLVEMENT; PROTEOLYSIS; SRC; METABOLISM; SIMULATION; RESTRAINTS; STABILITY	High concentrations of urea were shown to induce a paradoxical regulatory volume decrease response with K+ channel opening and subsequent hepatocyte shrinkage (Hallbrucker, C., vom Dahl, S., Ritter, M., Lang, F., and Haussinger, D. (1994) Pflugers Arch. 428, 552-560), although the hepatocyte plasma membrane is thought to be freely permeable to urea. The underlying mechanisms remained unclear. As shown in the present study, urea (100 mmol/liter) induced within 1 min an activation of beta(1) integrins followed by an activation of focal adhesion kinase, c-Src, p38(MAPK), extracellular signal-regulated kinases, and c-Jun N-terminal kinase. Because alpha(5)beta(1) integrin is known to act as a volume/osmosensor in hepatocytes, which becomes activated in response to hepatocyte swelling, the findings suggest that urea at high concentrations induces a nonosmotic activating perturbation of this osmosensor, thereby triggering a volume regulatory K+ efflux. In line with this, similar to hypo-osmotic hepatocyte swelling, urea induced an inhibition of hepatic proteolysis, which was sensitive to p38MAPK inhibition. Molecular dynamics simulations of a three-dimensional model of the ectodomain of alpha(5)beta(1) integrin in water, urea, or thiourea solutions revealed significant conformational changes of alpha(5)beta(1) integrin in urea and thiourea solutions, in contrast to the simulation of alpha(5)beta(1) in water. These changes lead to an unbending of the integrin structure around the genu, which may suggest activation, whereas the structures of single domains remained essentially unchanged. It is concluded that urea at high concentrations affects hepatic metabolism through direct activation of the alpha(5)beta(1) integrin system.	[Reinehr, Roland; Sommerfeld, Annika; vom Dahl, Stephan; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany; [Gohlke, Holger] Univ Dusseldorf, Dept Math & Nat Sci, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016; Dahl, Stephan vom/AAF-8456-2021	Dahl, Stephan vom/0000-0003-0481-0601	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 575]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 575 "Experimentelle Hepatologie" (Dusseldorf, Germany).	Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; GORDON JA, 1968, J BIOL CHEM, V243, P5663; GORDON JA, 1963, BIOCHEMISTRY-US, V2, P47, DOI 10.1021/bi00901a011; HALLBRUCKER C, 1994, PFLUG ARCH EUR J PHY, V428, P552, DOI 10.1007/BF00374577; HALLBRUCKER C, 1993, EUR J BIOCHEM, V211, P449, DOI 10.1111/j.1432-1033.1993.tb17570.x; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HAUSSINGER D, 1990, EUR J BIOCHEM, V188, P689, DOI 10.1111/j.1432-1033.1990.tb15451.x; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Haussinger D, 1999, GASTROENTEROLOGY, V116, P921, DOI 10.1016/S0016-5085(99)70076-4; HAUSSINGER D, 1990, BIOCHEM J, V272, P239, DOI 10.1042/bj2700039; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schliess F, 2004, J BIOL CHEM, V279, P21294, DOI 10.1074/jbc.M313901200; Sies H, 1978, Methods Enzymol, V52, P48; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Singh LR, 2009, J BIOSCIENCES, V34, P321, DOI 10.1007/s12038-009-0036-0; VOLPES R, 1993, AM J PATHOL, V142, P1483; VOM DAHL S, 2003, J BIOL CHEM, V278, P27088; VOM DAHL S, 2001, CELL PHYSIOL BIOCHEM, V11, P285; VOMDAHL S, 1991, BIOCHEM J, V280, P105, DOI 10.1042/bj2800105; VONHIPPEL PH, 1964, SCIENCE, V145, P577, DOI 10.1126/science.145.3632.577; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zou Q, 1998, PROTEINS, V31, P107, DOI 10.1002/(SICI)1097-0134(19980501)31:2<107::AID-PROT1>3.0.CO;2-J	34	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29348	29356		10.1074/jbc.M110.155135	http://dx.doi.org/10.1074/jbc.M110.155135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20643649	Green Published, hybrid			2022-12-27	WOS:000281740100037
J	Zwolak, A; Uruno, T; Piszczek, G; Hammer, JA; Tjandra, N				Zwolak, Adam; Uruno, Takehito; Piszczek, Grzegorz; Hammer, John A., III; Tjandra, Nico			Molecular Basis for Barbed End Uncapping by CARMIL Homology Domain 3 of Mouse CARMIL-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-CAPPING PROTEIN; NMR CHEMICAL-SHIFTS; STRUCTURAL BASIS; MULTIDIMENSIONAL NMR; FILAMENT NUCLEATION; CELL MORPHOLOGY; ARP2/3 COMPLEX; BINDING SITE; MYOSIN-I; IDENTIFICATION	Capping protein (CP) is a ubiquitously expressed, 62-kDa heterodimer that binds the barbed end of the actin filament with similar to 0.1 nM affinity to prevent further monomer addition. CARMIL is a multidomain protein, present from protozoa to mammals, that binds CP and is important for normal actin dynamics in vivo. The CARMIL CP binding site resides in its CAH3 domain (CARMIL homology domain 3) located at or near the protein's C terminus. CAH3 binds CP with similar to 1 nM affinity, resulting in a complex with weak capping activity (30-200 nM). Solution assays and single-molecule imaging show that CAH3 binds CP already present on the barbed end, causing a 300-fold increase in the dissociation rate of CP from the end (i.e. uncapping). Here we used nuclear magnetic resonance (NMR) to define the molecular interaction between the minimal CAH3 domain (CAH3a/b) of mouse CARMIL-1 and CP. Specifically, we show that the highly basic CAH3a subdomain is required for the high affinity interaction of CAH3 with a complementary "acidic groove" on CP opposite its actin-binding surface. This CAH3a-CP interaction orients the CAH3b subdomain, which we show is also required for potent anti-CP activity, directly adjacent to the basic patch of CP, shown previously to be required for CP association to and high affinity interaction with the barbed end. The importance of specific residue interactions between CP and CAH3a/b was confirmed by site-directed mutagenesis of both proteins. Together, these results offer a mechanistic explanation for the barbed end uncapping activity of CARMIL, and they identify the basic patch on CP as a crucial regulatory site.	[Uruno, Takehito; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] NHLBI, Biophys Core Facil, NIH, Bethesda, MD 20892 USA; [Zwolak, Adam] NYU, Sch Med, Sackler Inst Biomed Sci, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); New York University	Hammer, JA (corresponding author), NHLBI, Cell Biol Lab, NIH, 50 S Dr,Bldg 50,Rm 2306, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov; tjandran@nhlbi.nih.gov	Uruno, Takehito/AAF-7998-2019; Piszczek, Grzegorz/GYU-2029-2022	Uruno, Takehito/0000-0002-2812-9645; Hammer, John/0000-0002-2496-5179	NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006120, ZIAHL001048, ZICHL000338] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NHLBI (to J. A. H. and N. T.).	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; AMATRUDA JF, 1990, NATURE, V344, P352, DOI 10.1038/344352a0; AMATRUDA JF, 1992, J CELL BIOL, V119, P1151, DOI 10.1083/jcb.119.5.1151; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; COOPER JA, 1984, J CELL BIOL, V99, P217, DOI 10.1083/jcb.99.1.217; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; Hernandez-Valladares M, 2010, NAT STRUCT MOL BIOL, V17, P497, DOI 10.1038/nsmb.1792; HUG C, 1995, CELL, V81, P591, DOI 10.1016/0092-8674(95)90080-2; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; KOUYAMA T, 1980, EUR J BIOCHEM, V105, P279, DOI 10.1111/j.1432-1033.1980.tb04499.x; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lee WL, 1999, J BIOL CHEM, V274, P35159, DOI 10.1074/jbc.274.49.35159; Liang Y, 2009, MOL BIOL CELL, V20, P5290, DOI 10.1091/mbc.E08-10-1071; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Matsuzaka Y, 2004, GENE, V343, P291, DOI 10.1016/j.gene.2004.09.004; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Narita A, 2006, EMBO J, V25, P5626, DOI 10.1038/sj.emboj.7601395; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Remmert K, 2004, J BIOL CHEM, V279, P3068, DOI 10.1074/jbc.M308829200; Remmert K, 2009, PROTEIN EXPRES PURIF, V67, P113, DOI 10.1016/j.pep.2009.05.002; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sizonenko GI, 1996, MOL BIOL CELL, V7, P1; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Vanderzalm PJ, 2009, DEVELOPMENT, V136, P1201, DOI 10.1242/dev.026666; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; XU P, 1995, J BIOL CHEM, V270, P25316, DOI 10.1074/jbc.270.43.25316; Xu P, 1997, P NATL ACAD SCI USA, V94, P3685, DOI 10.1073/pnas.94.8.3685; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Zwolak A, 2010, J BIOL CHEM, V285, P25767, DOI 10.1074/jbc.M110.135848	56	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					29014	29026		10.1074/jbc.M110.134221	http://dx.doi.org/10.1074/jbc.M110.134221			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20630878	Green Published, hybrid			2022-12-27	WOS:000281594000066
J	Berlin, I; Schwartz, H; Nash, PD				Berlin, Ilana; Schwartz, Heather; Nash, Piers D.			Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8.STAM Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC HOMOLOGY-3 DOMAIN; TERMINAL SH3 DOMAIN; DOWN-REGULATION; BINDING MOTIF; HIGH-AFFINITY; TYROSINE KINASES; STRUCTURAL BASIS; LIGASE NRDP1; UBPY; HRS	Reversible ubiquitination of activated receptor complexes signals their sorting between recycling and degradation and thereby dictates receptor fate. The deubiquitinating enzyme ubiquitin-specific protease 8 (USP8/UBPy) has been previously implicated in the regulation of the epidermal growth factor receptor (EGFR); however, the molecular mechanisms governing its recruitment and activity in this context remain unclear. Herein, we investigate the role of USP8 in countering ligand-induced ubiquitination and down-regulation of EGFR and characterize a subset of protein-protein interaction determinants critical for this function. USP8 depletion accelerates receptor turnover, whereas loss of hepatocyte growth factor-regulated substrate (Hrs) rescues this phenotype, indicating that USP8 protects EGFR from degradation via an Hrs-dependent pathway. Catalytic inactivation of USP8 incurs EGFR hyperubiquitination and promotes receptor localization to endosomes marked by high ubiquitin content. These phenotypes require the central region of USP8, containing three extended Arg-X-X-Lys (RXXK) motifs that specify direct low affinity interactions with the SH3 domain(s) of ESCRT-0 proteins, STAM1/2. The USP8.STAM complex critically impinges on receptor ubiquitination status and modulates ubiquitin dynamics on EGFR-positive endosomes. Consequently, USP8-mediated deubiquitination slows progression of EGFR past the early-to-recycling endosome circuit in a manner dependent upon the RXXK motifs. Collectively, these findings demonstrate a role for the USP8.STAM complex as a protective mechanism regulating early endosomal sorting of EGFR between pathways destined for lysosomal degradation and recycling.	[Berlin, Ilana; Schwartz, Heather; Nash, Piers D.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Nash, PD (corresponding author), 929 E 57th St W432, Chicago, IL 60637 USA.	pdnash@uchicago.edu			American Cancer Society, Illinois Division; Concern Foundation; V Foundation; Department of Defense	American Cancer Society, Illinois Division(American Cancer Society); Concern Foundation; V Foundation; Department of Defense(United States Department of Defense)	This work was supported by the American Cancer Society, Illinois Division, the Concern Foundation, and the V Foundation Scholars Program (to P. D. N.).; Recipient of a Department of Defense (Congressionally Directed Medical Research Programs) Breast Cancer pre-doctoral fellowship.	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hu C. D., 2005, CURR PROTOC PROTEIN, P19101; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Kaneko T, 2003, J BIOL CHEM, V278, P48162, DOI 10.1074/jbc.M306677200; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Lewitzky M, 2001, ONCOGENE, V20, P1052, DOI 10.1038/sj.onc.1204202; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Lock LS, 2000, J BIOL CHEM, V275, P31536, DOI 10.1074/jbc.M003597200; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Morino C, 2004, EXP CELL RES, V297, P380, DOI 10.1016/j.yexcr.2004.03.038; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sierra MI, 2010, J BIOL CHEM, V285, P13990, DOI 10.1074/jbc.M109.061309; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004	52	63	66	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34909	34921		10.1074/jbc.M109.016287	http://dx.doi.org/10.1074/jbc.M109.016287			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736164	Green Published, hybrid			2022-12-27	WOS:000283659100065
J	Burnett, LA; Blais, EM; Unadkat, JD; Hille, B; Tilley, SL; Babcock, DF				Burnett, Lindsey A.; Blais, Edik M.; Unadkat, Jashvant D.; Hille, Bertil; Tilley, Stephen L.; Babcock, Donner F.			Testicular Expression of Adora3i2 in Adora3 Knockout Mice Reveals a Role of Mouse A3Ri2 and Human A3Ri3 Adenosine Receptors in Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; NUCLEOSIDE TRANSPORTER FAMILY; HAMSTER OVARY CELLS; SIGNALING PATHWAYS; GENE-EXPRESSION; MALE-FERTILITY; HYPERACTIVATED MOTILITY; CATECHOLAMINE AGONISTS; MAMMALIAN SPERMATOZOA; IDENTIFICATION	Adenosine is a candidate modulator of sperm motility in the female reproductive tract that increases sperm flagellar beat frequency in vitro. Past work suggested that this acceleration may involve equilibrative (ENT) and concentrative (CNT) nucleoside transporters. Here we show that Slc29a1 (ENT-1) is the predominant nucleoside transporter expressed in the mouse testis. Unexpectedly, the beat of Slc29a1-null sperm still accelerates in response to 2-chloro-2'-deoxyadenosine (Cl-dAdo). Moreover, in wild-type sperm neither blockade of CNTs by removal of external Na+, nor inhibition of ENTs with nitrobenzylthioionosine, prevents acceleration of the sperm beat by Cl-dAdo. In contrast, pertussis toxin produces strong blockade, indicating involvement of a G alpha(i/o)-coupled adenosine receptor. Although agonists selective for adenosine receptors A1R, A2aR, and A2bR are ineffective, A3R-selective agonists Cl-IB-MECA and IB-MECA do accelerate the beat. Consistent with this pharmacological profile, the predominant Adora transcripts in the testis are products of the nested Adora3i1 and Adora3i2 genes. Surprisingly, Cl-IB-MECA and Cl-dAdo still accelerate the beat of Adora3i1-null sperm indicating that the remaining Adora3i2 transcript produces an A3R that functions in sperm. When cloned Adora3i2 is heterologously expressed in tsA-201 cells, Cl-dAdo decreases forskolin-evoked accumulation of cAMP, indicating that Adora3i2 specifies a functional A3Ri2 adenosine receptor that couples through G alpha(i). Database mining reveals that mouse Adora3i2 is expressed primarily in testis, almost exclusively in spermatids. Expression of the orthologous ADORA3i3 transcript also is most prominent in human testis; presumably producing an A3Ri3 receptor that is functional in sperm and that may be a target for development of male-directed contraceptives.	[Burnett, Lindsey A.; Blais, Edik M.; Hille, Bertil; Babcock, Donner F.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Unadkat, Jashvant D.] Univ Washington, Sch Med, Dept Pharmaceut, Seattle, WA 98195 USA; [Tilley, Stephen L.] Univ N Carolina, Dept Med, Div Pulm & Crit Care Med, Chapel Hill, NC 27599 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Babcock, DF (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	donner@u.washington.edu		Babcock, Donner/0000-0002-4461-4544; Burnett, Lindsey/0000-0002-6430-4498; Unadkat, Jashvant/0000-0002-4820-8455	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [HD12629-27, U54];  [5T32-HD007453];  [NS08174];  [GM54447];  [HL071802]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD012629, T32HD007453, P50HD012629] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174, R37NS008174] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grant HD12629-27 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health through cooperative agreement U54 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (to L. A. B., E. M. B., J. D. U., B. H., and D. F. B.) and Grants 5T32-HD007453 and NS08174 (to L. A. B.), GM54447 (to J. D. U.), NS08174 (to B. H. and D. F. B.), and HL071802 (to S. L. T.).	Adeoya-Osiguwa SA, 2002, MOL REPROD DEV, V63, P245, DOI 10.1002/mrd.90009; Alexander SPH, 2006, BRIT J PHARMACOL, V147, pS1; Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baram D, 2010, J IMMUNOL, V184, P3677, DOI 10.4049/jimmunol.0901333; BERSE B, 1995, J BIOL CHEM, V270, P22101, DOI 10.1074/jbc.270.38.22101; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006844; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; de Lamirande E, 2002, MOL HUM REPROD, V8, P124, DOI 10.1093/molehr/8.2.124; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Jha KN, 2006, MOL HUM REPROD, V12, P781, DOI 10.1093/molehr/gal085; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; Johnston DS, 2008, P NATL ACAD SCI USA, V105, P8315, DOI 10.1073/pnas.0709854105; Johnston DS, 2007, ANN NY ACAD SCI, V1120, P36, DOI 10.1196/annals.1411.014; KOPF GS, 1986, J BIOL CHEM, V261, P7327; Minelli A, 2000, J HISTOCHEM CYTOCHEM, V48, P1163, DOI 10.1177/002215540004800901; Minelli A, 2008, BIOCHEM PHARMACOL, V75, P931, DOI 10.1016/j.bcp.2007.10.024; Nixon B, 2010, J CELL PHYSIOL, V224, P71, DOI 10.1002/jcp.22090; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schuh SM, 2006, BIOL REPROD, V74, P492, DOI 10.1095/biolreprod.105.047837; Schuh SM, 2007, BIOL REPROD, V77, P960, DOI 10.1095/biolreprod.107.062562; Schulte G, 2000, MOL PHARMACOL, V58, P477, DOI 10.1124/mol.58.3.477; Schulte G, 2002, MOL PHARMACOL, V62, P1137, DOI 10.1124/mol.62.5.1137; SHEN MR, 1993, CLIN EXP PHARMACOL P, V20, P527, DOI 10.1111/j.1440-1681.1993.tb01736.x; SHEN MR, 1993, J PHARM PHARMACOL, V45, P650, DOI 10.1111/j.2042-7158.1993.tb05671.x; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Westenbroek RE, 1999, DEV BIOL, V207, P457, DOI 10.1006/dbio.1998.9172; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Yu P, 2005, GENOMICS, V86, P414, DOI 10.1016/j.ygeno.2005.06.008	45	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33662	33670		10.1074/jbc.M110.156075	http://dx.doi.org/10.1074/jbc.M110.156075			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732875	Green Published, hybrid			2022-12-27	WOS:000283354000011
J	Drake, JM; Barnes, JM; Madsen, JM; Domann, FE; Stipp, CS; Henry, MD				Drake, Justin M.; Barnes, J. Matthew; Madsen, Joshua M.; Domann, Frederick E.; Stipp, Christopher S.; Henry, Michael D.			ZEB1 Coordinately Regulates Laminin-332 and beta 4 Integrin Expression Altering the Invasive Phenotype of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-MESENCHYMAL TRANSITION; CARCINOMA-CELLS; TRANSCRIPTIONAL REPRESSOR; DIFFERENTIAL EXPRESSION; ALPHA-6-BETA-4 INTEGRIN; BASEMENT-MEMBRANES; TUMOR-GROWTH; E-CADHERIN; METASTASIS; MIGRATION	Metastasis involves the invasion of cancer cells across both the extracellular matrix and cellular barriers, and an evolving theme is that epithelial-to-mesenchymal transition (EMT) may mediate invasive cellular behavior. Previously, we isolated and analyzed a subpopulation of PC-3 prostate cancer cells, TEM4-18, and found that these cells both invaded an endothelial barrier more efficiently and exhibited enhanced metastatic colonization in vivo. Transendothelial migration of these cells depended on expression of ZEB1, a known regulator of EMT. Surprisingly, these cells were much less invasive than parental PC-3 cells in assays that involve matrix barriers. Here, we report that TEM4-18 cells express significantly reduced levels of two subunits of laminin-332 (beta 3 and gamma 2) and that exogenous laminin-332, or co-culture with laminin-332-expressing cells, rescues the in vitro invasion phenotype in these cells. Stable knockdown of ZEB1 in prostate cancer cells up-regulated LAMC2 and ITGB4 mRNA and protein and resulted in a concomitant increase in Transwell migration. Using chromatin immunopre-cipitation (ChIP), we show that ZEB1 directly interacts with the promoters of LAMC2 and ITGB4. These results provide a novel molecular basis for reduced laminin-332 observed in clinical prostate cancer specimens and demonstrate a context-dependent role for EMT in invasive cellular behavior.	[Drake, Justin M.; Barnes, J. Matthew; Henry, Michael D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Henry, Michael D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Madsen, Joshua M.; Domann, Frederick E.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Stipp, Christopher S.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Domann, Frederick E.; Stipp, Christopher S.; Henry, Michael D.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Henry, MD (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, 6-510 Bowen Sci Bldg, Iowa City, IA 52242 USA.	michael-henry@uiowa.edu		Domann, Frederick/0000-0002-0489-2179; Henry, Michael/0000-0002-7871-245X; Drake, Justin/0000-0002-8329-7748	National Institutes of Health [R01 CA130916, R01 CA136664, R01 CA115438]; American Heart Association [0610074Z]; NATIONAL CANCER INSTITUTE [R01CA115438, R01CA136664, R01CA130916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA130916 (to M. D. H.), R01 CA136664 (to C. S. S.), and R01 CA115438 (to F. E. D.). This work was also supported by American Heart Association Predoctoral Fellowship 0610074Z (to J. M. D.).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Allen MV, 1998, HUM PATHOL, V29, P311, DOI 10.1016/S0046-8177(98)90109-5; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Chao C, 1996, CANCER RES, V56, P4811; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Costantino ME, 2002, BIOCHEM BIOPH RES CO, V296, P368, DOI 10.1016/S0006-291X(02)00880-X; CRESS AE, 1995, CANCER METAST REV, V14, P219, DOI 10.1007/BF00690293; DELWEL GO, 1994, MOL BIOL CELL, V5, P203, DOI 10.1091/mbc.5.2.203; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hao JS, 2001, AM J PATHOL, V158, P1129, DOI 10.1016/S0002-9440(10)64060-6; Hao JS, 1996, AM J PATHOL, V149, P1341; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; HEMLER ME, 1984, J IMMUNOL, V132, P3011; Hlubek F, 2001, CANCER RES, V61, P8089; LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MIYAZAKI K, 1993, P NATL ACAD SCI USA, V90, P11767, DOI 10.1073/pnas.90.24.11767; NAGLE RB, 1995, AM J PATHOL, V146, P1498; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; PYKE C, 1995, CANCER RES, V55, P4132; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sordat I, 1998, J PATHOL, V185, P44, DOI 10.1002/(SICI)1096-9896(199805)185:1<44::AID-PATH46>3.0.CO;2-A; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tripathi M, 2008, J BIOL CHEM, V283, P30576, DOI 10.1074/jbc.M802312200; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Udayakumar TS, 2003, CANCER RES, V63, P2292; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; Yu HM, 2004, MOL CARCINOGEN, V41, P85, DOI 10.1002/mc.20041	46	60	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33940	33948		10.1074/jbc.M110.136044	http://dx.doi.org/10.1074/jbc.M110.136044			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729552	Green Published, hybrid			2022-12-27	WOS:000283354000041
J	Ramos, I; Martin-Benito, J; Finn, R; Bretana, L; Aloria, K; Arizmendi, JM; Ausio, J; Muga, A; Valpuesta, JM; Prado, A				Ramos, Isbaal; Martin-Benito, Jaime; Finn, Ron; Bretana, Laura; Aloria, Kerman; Arizmendi, Jesus M.; Ausio, Juan; Muga, Arturo; Valpuesta, Jose M.; Prado, Adelina			Nucleoplasmin Binds Histone H2A-H2B Dimers through Its Distal Face	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN DECONDENSATION ACTIVITY; LAEVIS EGG EXTRACTS; CRYSTAL-STRUCTURE; NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY; NUCLEAR CHAPERONES; CORE HISTONES; NUCLEOSOME; DOMAIN; PHOSPHORYLATION; ACTIVATION	Nucleoplasmin (NP) is a pentameric chaperone that regulates the condensation state of chromatin extracting specific basic proteins from sperm chromatin and depositing H2A-H2B histone dimers. It has been proposed that histones could bind to either the lateral or distal face of the pentameric structure. Here, we combine different biochemical and biophysical techniques to show that natural, hyperphosphorylated NP can bind five H2A-H2B dimers and that the amount of bound ligand depends on the overall charge (phosphorylation level) of the chaperone. Three-dimensional reconstruction of NP/H2A-H2B complex carried out by electron microscopy reveals that histones interact with the chaperone distal face. Limited proteolysis and mass spectrometry indicate that the interaction results in protection of the histone fold and most of the H2A and H2B C-terminal tails. This structural information can help to understand the function of NP as a histone chaperone.	[Martin-Benito, Jaime; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain; [Muga, Arturo; Prado, Adelina] Univ Basque Country, Dept Bioquim & Biol Mol, Fac Ciencia & Tecnol, E-48080 Bilbao, Spain; [Ramos, Isbaal; Bretana, Laura; Muga, Arturo; Prado, Adelina] Univ Basque Country Euskal Herriko Unibertsitatea, CSIC, Unidad Biofis, Bilbao 48080, Spain; [Finn, Ron; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Aloria, Kerman; Arizmendi, Jesus M.] Univ Basque Country, Serv Gen Prote SGIker ProteoRed, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Victoria; University of Basque Country	Valpuesta, JM (corresponding author), CSIC, Ctr Nacl Biotecnol, Campus Univ Autonoma Madrid,Darwin 3, Madrid 28049, Spain.	jmv@cnb.csic.es; adelina.prado@ehu.es	Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017; Muga, Arturo/N-1174-2014; Aloria, Kerman/D-7321-2011	Valpuesta, José M/0000-0001-7468-8053; Muga, Arturo/0000-0003-0345-6882; Aloria, Kerman/0000-0001-7268-7700; Arizmendi, Jesus M/0000-0002-1412-4042; Martin-Benito Romero, Jaime/0000-0002-8541-4709	Ministerio de Educacion e Innovacion [BFU2007-64452, BFU2007-62382]; Universidad del Pais Vasco and Gobierno Vasco [IT-358-07]; Diputacion Foral de Bizkaia [DIPE 08/18]; Natural Sciences and Engineering Research Council [OGP-46399-07]; Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Ministerio de Ciencia e Innovacion, Gobierno Vasco/Eusko Jaularitza; European Science Foundation	Ministerio de Educacion e Innovacion; Universidad del Pais Vasco and Gobierno Vasco; Diputacion Foral de Bizkaia; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Ministerio de Ciencia e Innovacion, Gobierno Vasco/Eusko Jaularitza(Basque GovernmentMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported in part by the Ministerio de Educacion e Innovacion Grants BFU2007-64452 (to A. M.) and BFU2007-62382 (to J. M. V.), the Universidad del Pais Vasco and Gobierno Vasco Grant IT-358-07, and Diputacion Foral de Bizkaia Grant DIPE 08/18.; Recipient of Natural Sciences and Engineering Research Council Grant OGP-46399-07.; The Servicio General de Proteomica-SGIker (ProteoRed) is supported by Universidad del Pais Vasco/Euskal Herriko Unibertsitatea, Ministerio de Ciencia e Innovacion, Gobierno Vasco/Eusko Jaularitza, and European Science Foundation.	Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Arnan C, 2003, J BIOL CHEM, V278, P31319, DOI 10.1074/jbc.M305560200; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Banuelos S, 2003, J MOL BIOL, V334, P585, DOI 10.1016/j.jmb.2003.09.067; Banuelos S, 2007, J BIOL CHEM, V282, P21213, DOI 10.1074/jbc.M702842200; BOHM L, 1984, BIOSCIENCE REP, V4, P365, DOI 10.1007/BF01122502; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; COTTEN M, 1986, BIOCHEMISTRY-US, V25, P5063, DOI 10.1021/bi00366a014; DIMITROV S, 1994, J CELL BIOL, V126, P591, DOI 10.1083/jcb.126.3.591; Dimitrov S, 1996, EMBO J, V15, P5897, DOI 10.1002/j.1460-2075.1996.tb00976.x; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Eirin-Lopez JM, 2006, GENETICS, V173, P1835, DOI 10.1534/genetics.106.058990; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FRANK J, 1996, 3 DIMENSIONAL ELECT, P182; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Hierro A, 2002, BIOCHEMISTRY-US, V41, P6408, DOI 10.1021/bi020002r; Hierro A, 2001, EUR J BIOCHEM, V268, P1739; KARANTZA V, 1995, BIOCHEMISTRY-US, V34, P5988, DOI 10.1021/bi00017a028; Lee HH, 2007, PROTEINS, V69, P672, DOI 10.1002/prot.21504; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Namboodiri VMH, 2003, STRUCTURE, V11, P175, DOI 10.1016/S0969-2126(03)00007-8; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Prado A, 2004, BIOCHEM CELL BIOL, V82, P437, DOI 10.1139/O04-042; Prieto C, 2002, BIOCHEMISTRY-US, V41, P7802, DOI 10.1021/bi020120e; Ramos I, 2005, BIOCHEMISTRY-US, V44, P8274, DOI 10.1021/bi050386w; Salvany L, 2004, FEBS LETT, V576, P353, DOI 10.1016/j.febslet.2004.07.095; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIMPSON RJ, 2003, PROTEINS PROTEOMICS, P713; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Taneva SG, 2009, J MOL BIOL, V393, P448, DOI 10.1016/j.jmb.2009.08.005; Taneva SG, 2008, BIOCHEMISTRY-US, V47, P13897, DOI 10.1021/bi800975r; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	40	21	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33771	33778		10.1074/jbc.M110.150664	http://dx.doi.org/10.1074/jbc.M110.150664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20696766	Green Published, hybrid			2022-12-27	WOS:000283354000023
J	Sahawneh, MA; Ricart, KC; Roberts, BR; Bomben, VC; Basso, M; Ye, YZ; Sahawneh, J; Franco, MC; Beckman, JS; Estevez, AG				Sahawneh, Mary Anne; Ricart, Karina C.; Roberts, Blaine R.; Bomben, Valerie C.; Basso, Manuela; Ye, Yaozu; Sahawneh, John; Franco, Maria Clara; Beckman, Joseph S.; Estevez, Alvaro G.			Cu, Zn-Superoxide Dismutase Increases Toxicity of Mutant and Zinc-deficient Superoxide Dismutase by Enhancing Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON APOPTOSIS; NITRIC-OXIDE SYNTHASE; FREE-ENERGY SURFACE; ALS-LINKED SOD1; WILD-TYPE SOD1; MOTONEURON DEATH; DISULFIDE REDUCTION; TYROSINE NITRATION; CEREBRAL-ISCHEMIA	When replete with zinc and copper, amyotrophic lateral sclerosis (ALS)-associated mutant SOD proteins can protect motor neurons in culture from trophic factor deprivation as efficiently as wild-type SOD. However, the removal of zinc from either mutant or wild-type SOD results in apoptosis of motor neurons through a copper-and peroxynitrite-dependent mechanism. It has also been shown that motor neurons isolated from transgenic mice expressing mutant SODs survive well in culture but undergo apoptosis when exposed to nitric oxide via a Fas-dependent mechanism. We combined these two parallel approaches for understanding SOD toxicity in ALS and found that zinc-deficient SOD-induced motor neuron death required Fas activation, whereas the nitric oxide-dependent death of G93A SOD-expressing motor neurons required copper and involved peroxynitrite formation. Surprisingly, motor neuron death doubled when Cu,Zn-SOD protein was either delivered intracellularly to G93A SOD-expressing motor neurons or co-delivered with zinc-deficient SOD to nontransgenic motor neurons. These results could be rationalized by biophysical data showing that heterodimer formation of Cu, Zn-SOD with zinc-deficient SOD prevented the monomerization and subsequent aggregation of zinc-deficient SOD under thiol-reducing conditions. ALS mutant SOD was also stabilized by mutating cysteine 111 to serine, which greatly increased the toxicity of zinc-deficient SOD. Thus, stabilization of ALS mutant SOD by two different approaches augmented its toxicity to motor neurons. Taken together, these results are consistent with copper-containing zinc-deficient SOD being the elusive "partially unfolded intermediate" responsible	[Roberts, Blaine R.; Beckman, Joseph S.; Estevez, Alvaro G.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Sahawneh, Mary Anne; Basso, Manuela; Ye, Yaozu; Sahawneh, John; Franco, Maria Clara; Estevez, Alvaro G.] Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA; [Sahawneh, Mary Anne; Basso, Manuela; Franco, Maria Clara; Estevez, Alvaro G.] Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10022 USA; [Ricart, Karina C.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Bomben, Valerie C.] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; [Ricart, Karina C.] Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35294 USA	Oregon State University; Cornell University; Cornell University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Estevez, AG (corresponding author), Oregon State Univ, Dept Biochem & Biophys, ALS 2011, Corvallis, OR 97331 USA.	esteveza@onid.orst.edu	Basso, Manuela/AAA-9147-2020; Franco, Maria/O-7862-2015	Basso, Manuela/0000-0002-9278-8960; Roberts, Blaine/0000-0001-5466-0053	National Institutes of Health [NS36761, NS42834, NS058628, AT002034, ES00240]; Burke Medical Research Institute; New York State Spinal Cord Injury Center of Research Excellence; Amyotrophic Lateral Sclerosis Association; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT002034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036761, R01NS058628, R01NS042834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Medical Research Institute; New York State Spinal Cord Injury Center of Research Excellence; Amyotrophic Lateral Sclerosis Association; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS36761, NS42834 (to A. G. E.), NS058628, AT002034, and ES00240. This work was also supported by funds from the Burke Medical Research Institute, the New York State Spinal Cord Injury Center of Research Excellence, and the Amyotrophic Lateral Sclerosis Association (to J. S. B.).	Abe K, 1997, NEUROL RES, V19, P124; ABE K, 1995, NEUROSCI LETT, V199, P152, DOI 10.1016/0304-3940(95)12039-7; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Crow JP, 1997, J NEUROCHEM, V69, P1936; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Estevez AG, 1998, PROG BRAIN RES, V118, P269; Estevez AG, 1998, J NEUROSCI, V18, P923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Estevez AG, 2000, FREE RADICAL BIO MED, V28, P437, DOI 10.1016/S0891-5849(99)00261-0; Estevez AG, 2002, NEUROSCI LETT, V326, P201, DOI 10.1016/S0304-3940(02)00341-5; Estevez AG, 1998, J NEUROSCI, V18, P3708; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Leinweber B, 2004, FREE RADICAL BIO MED, V36, P911, DOI 10.1016/j.freeradbiomed.2003.12.021; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Marklund SL, 1997, J NEUROCHEM, V69, P675; Maroney AC, 1998, J NEUROSCI, V18, P104; Mulligan VK, 2008, J MOL BIOL, V383, P424, DOI 10.1016/j.jmb.2008.08.024; Museth AK, 2009, BIOCHEMISTRY-US, V48, P8817, DOI 10.1021/bi900703v; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; OLSEN PH, 1992, BIOCHEMISTRY-US, V31, P746, DOI 10.1021/bi00118a016; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Pehar M, 2007, J NEUROSCI, V27, P7777, DOI 10.1523/JNEUROSCI.0823-07.2007; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Prudencio M, 2009, J NEUROCHEM, V108, P1009, DOI 10.1111/j.1471-4159.2008.05839.x; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 2006, P NATL ACAD SCI USA, V103, P6007, DOI 10.1073/pnas.0508774103; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Ricart K, 2006, J NEUROCHEM, V97, P222, DOI 10.1111/j.1471-4159.2006.03739.x; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Rumfeldt JAO, 2009, J MOL BIOL, V385, P278, DOI 10.1016/j.jmb.2008.10.003; Sasaki S, 2001, J NEUROPATH EXP NEUR, V60, P839, DOI 10.1093/jnen/60.9.839; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Witan H, 2008, HUM MOL GENET, V17, P1373, DOI 10.1093/hmg/ddn025; Witan H, 2009, NEUROBIOL DIS, V36, P331, DOI 10.1016/j.nbd.2009.07.024; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200	65	32	33	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33885	33897		10.1074/jbc.M110.118901	http://dx.doi.org/10.1074/jbc.M110.118901			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20663894	Green Published, hybrid			2022-12-27	WOS:000283354000035
J	Cusdin, FS; Nietlispach, D; Maman, J; Dale, TJ; Powell, AJ; Clare, JJ; Jackson, AP				Cusdin, Fiona S.; Nietlispach, Daniel; Maman, Joseph; Dale, Timothy J.; Powell, Andrew J.; Clare, Jeffrey J.; Jackson, Antony P.			The Sodium Channel beta 3-Subunit Induces Multiphasic Gating in Na(v)1.3 and Affects Fast Inactivation via Distinct Intracellular Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTRICTION INJURY MODEL; BETA-1 SUBUNIT; AUXILIARY SUBUNIT; EXTRACELLULAR DOMAIN; NEUROPATHIC PAIN; MAMMALIAN-CELLS; SENSORY NEURONS; NERVE INJURY; DRG NEURONS; HUMAN BRAIN	Electrical excitability in neurons depends on the activity of membrane-bound voltage gated sodium channels (Na-v) that are assembled from an ion conducting alpha-subunit and often auxiliary beta-subunits. The alpha-subunit isoform Na(v)1.3 occurs in peripheral neurons together with the Na-v beta 3-subunit, both of which are coordinately up-regulated in rat dorsal root ganglion neurons after nerve injury. Here we examine the effect of the beta 3-subunit on the gating behavior of Na(v)1.3 using whole cell patch clamp electrophysiology in HEK-293 cells. We show that beta 3 depolarizes the voltage sensitivity of Na(v)1.3 activation and inactivation and induces biphasic components of the inactivation curve. We detect both a fast and a novel slower component of inactivation, and we show that the beta 3-subunit increases the fraction of channels inactivating by the slower component. Using CD and NMR spectroscopy, we report the first structural analysis of the intracellular domain of any Na-v beta-subunit. We infer the presence of a region within the beta 3-subunit intracellular domain that has a propensity to form a short amphipathic alpha-helix followed by a structurally disordered sequence, and we demonstrate a role for both of these regions in the selective stabilization of fast inactivation. The complex gating behavior induced by beta 3 may contribute to the known hyperexcitability of peripheral neurons under those physiological conditions where expression of beta 3 and Na(v)1.3 are both enhanced.	[Cusdin, Fiona S.; Nietlispach, Daniel; Maman, Joseph; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Cusdin, Fiona S.; Dale, Timothy J.; Powell, Andrew J.; Clare, Jeffrey J.] GlaxoSmithKline Inc, Stevenage SG1 2NY, Herts, England	University of Cambridge; GlaxoSmithKline	Jackson, AP (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	apj10@bioc.cam.ac.uk		Nietlispach, Daniel/0000-0003-4364-9291; Jackson, Antony Philip/0000-0002-2895-7387; Powell, Andrew/0000-0003-1540-537X	Biotechnology and Biological Sciences Research Council (UK); University of Cambridge; Biotechnology and Biological Sciences Research Council [BB/E013228/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Cambridge(University of Cambridge); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a Biotechnology and Biological Sciences Research Council (UK) Cooperative Award in Science and Engineering studentship and by funds from the University of Cambridge.	BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Black JA, 1999, J NEUROPHYSIOL, V82, P2776, DOI 10.1152/jn.1999.82.5.2776; Chen YH, 2000, EUR J NEUROSCI, V12, P4281, DOI 10.1111/j.1460-9568.2000.01336.x; Chopra SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-113; CLARK DJ, 1988, EMBO J, V7, P69, DOI 10.1002/j.1460-2075.1988.tb02784.x; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Dib-Hajj SD, 1999, PAIN, V83, P591, DOI 10.1016/S0304-3959(99)00169-4; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hakim P, 2010, ACTA PHYSIOL, V198, P47, DOI 10.1111/j.1748-1716.2009.02048.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Meadows L, 2001, J NEUROCHEM, V76, P1871, DOI 10.1046/j.1471-4159.2001.00192.x; Meadows LS, 2002, NEUROSCIENCE, V114, P745, DOI 10.1016/S0306-4522(02)00242-7; Megy S, 2004, PROTEIN SCI, V13, P3151, DOI 10.1110/ps.04745004; Merrick EC, 2010, PFLUG ARCH EUR J PHY, V460, P743, DOI 10.1007/s00424-009-0739-y; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; PATTON DE, 1994, J BIOL CHEM, V269, P17649; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shah BS, 2001, J PHYSIOL-LONDON, V534, P763, DOI 10.1111/j.1469-7793.2001.t01-1-00763.x; Shah BS, 2000, EUR J NEUROSCI, V12, P3985, DOI 10.1046/j.1460-9568.2000.00294.x; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Takahashi N, 2003, NEUROSCIENCE, V121, P441, DOI 10.1016/S0306-4522(03)00432-9; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yu EJ, 2005, BIOCHEM J, V392, P519, DOI 10.1042/BJ20050518; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	41	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33404	33412		10.1074/jbc.M110.114058	http://dx.doi.org/10.1074/jbc.M110.114058			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20675377	hybrid, Green Published			2022-12-27	WOS:000283048200075
J	Jeffries, O; Geiger, N; Rowe, ICM; Tian, LJ; McClafferty, H; Chen, L; Bi, DL; Knaus, HG; Ruth, P; Shipston, MJ				Jeffries, Owen; Geiger, Nina; Rowe, Iain C. M.; Tian, Lijun; McClafferty, Heather; Chen, Lie; Bi, Danlei; Knaus, Hans Guenther; Ruth, Peter; Shipston, Michael J.			Palmitoylation of the S0-S1 Linker Regulates Cell Surface Expression of Voltage- and Calcium-activated Potassium (BK) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; ENDOCYTIC TRAFFICKING SIGNALS; LARGE-CONDUCTANCE VOLTAGE; ALPHA-SUBUNIT; N-TERMINUS; CSS-PALM; PHOSPHORYLATION; RECEPTOR; EXCITABILITY; PREDICTION	S-Palmitoylation is rapidly emerging as an important post-translational mechanism to regulate ion channels. We have previously demonstrated that large conductance calcium-and voltage-activated potassium (BK) channels are palmitoylated within an alternatively spliced (STREX) insert. However, these studies also revealed that additional site(s) for palmitoylation must exist outside of the STREX insert, although the identity or the functional significance of these palmitoylated cysteine residues are unknown. Here, we demonstrate that BK channels are palmitoylated at a cluster of evolutionary conserved cysteine residues (Cys-53, Cys-54, and Cys-56) within the intracellular linker between the S0 and S1 transmembrane domains. Mutation of Cys-53, Cys-54, and Cys-56 completely abolished palmitoylation of BK channels lacking the STREX insert (ZERO variant). Palmitoylation allows the S0-S1 linker to associate with the plasma membrane but has no effect on single channel conductance or the calcium/voltage sensitivity. Rather, S0-S1 linker palmitoylation is a critical determinant of cell surface expression of BK channels, as steady state surface expression levels are reduced by similar to 55% in the C53:54:56 A mutant. STREX variant channels that could not be palmitoylated in the S0-S1 linker also displayed significantly reduced cell surface expression even though STREX insert palmitoylation was unaffected. Thus our work reveals the functional independence of two distinct palmitoylation-dependent membrane interaction domains within the same channel protein and demonstrates the critical role of S0-S1 linker palmitoylation in the control of BK channel cell surface expression.	[Jeffries, Owen; Geiger, Nina; Rowe, Iain C. M.; Tian, Lijun; McClafferty, Heather; Chen, Lie; Bi, Danlei; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Knaus, Hans Guenther] Med Univ Innsbruck, Div Mol & Cellular Pharmacol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Geiger, Nina; Ruth, Peter] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	University of Edinburgh; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; Chen, Lie/0000-0001-9764-4299; Rowe, Iain C M/0000-0002-0148-5332; jeffries, owen/0000-0002-8169-1100	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Korovkina VP, 2001, AM J PHYSIOL-CELL PH, V281, pC361, DOI 10.1152/ajpcell.2001.281.1.C361; Liu G, 2008, J GEN PHYSIOL, V131, P537, DOI 10.1085/jgp.200809968; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; MacDonald SHF, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-37; Marijic J, 2001, CIRC RES, V88, P210; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Saleem F, 2009, BRIT J PHARMACOL, V156, P143, DOI 10.1111/j.1476-5381.2008.00011.x; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Song M, 1999, FEBS LETT, V460, P427, DOI 10.1016/S0014-5793(99)01394-0; Sorensen MV, 2008, J PHYSIOL-LONDON, V586, P4251, DOI 10.1113/jphysiol.2008.156968; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Wu RS, 2009, J NEUROSCI, V29, P8321, DOI 10.1523/JNEUROSCI.6191-08.2009; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Zarei MM, 2007, NEUROSCIENCE, V147, P80, DOI 10.1016/j.neuroscience.2007.04.019; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	42	44	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33307	33314		10.1074/jbc.M110.153940	http://dx.doi.org/10.1074/jbc.M110.153940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20693285	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000283048200066
J	Kimura, A; Martin, C; Robinson, GW; Simone, JM; Chen, WP; Wickre, MC; O'Shea, JJ; Hennighausen, L				Kimura, Akiko; Martin, Cyril; Robinson, Gertraud W.; Simone, James M.; Chen, Weiping; Wickre, Mark C.; O'Shea, John J.; Hennighausen, Lothar			The Gene Encoding the Hematopoietic Stem Cell Regulator CCN3/NOV Is under Direct Cytokine Control through the Transcription Factors STAT5A/B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; SELF-RENEWAL; PROGENITOR CELLS; STEM/PROGENITOR CELLS; LYMPHOID DEVELOPMENT; EXPRESSION; ACTIVATION; DIFFERENTIATION; BCR/ABL; GROWTH	Cytokines control the biology of hematopoietic stem cells (HSCs) and progenitor cells in part through the transcription factors STAT5A/B. To investigate the target genes of STAT5A/B activated by cytokines in HSCs and progenitors, we performed microarray analyses using Lineage(-) Sca-1(+) c-Kit(+) (KSL) cells in the presence and absence of STAT5A/B. Stimulation with a mixture containing IL-3, IL-6, stem cell factor, thrombopoietin, and Flt3 ligand induced Ccn3/Nov mRNA over 100-fold in WT (control) but not Stat5a/b-null KSL cells. CCN3/NOV is a positive regulator of human HSC self-renewal and development of committed blood cells. Without stimulation, the Ccn3/Nov signal level was low in control KSL cells similar to Stat5a/b-null KSL cells. To determine which cytokine activates the Ccn3/Nov gene, we analyzed Lineage(-) c-Kit(+) (KL) and 32D cells using quantitative PCR and ChIP assays. Although stimulation with a mixture lacking IL-3 prevented the induction of Ccn3/Nov in control KL cells, IL-3 alone could induce Ccn3/Nov mRNA in control KL and 32D cells. ChIP assays using 32D cells revealed IL-3-induced binding of STAT5A/B to a gamma-interferon-activated sequences site in the Ccn3/Nov gene promoter. This is the first report that Ccn3/Nov is directly induced by cytokines through STAT5A/B.	[Kimura, Akiko; Martin, Cyril; Robinson, Gertraud W.; Wickre, Mark C.; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, Bethesda, MD 20892 USA; [Simone, James M.] NIAMS, Flow Cytometry Sect, Off Sci & Technol, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDK, Microarray Core Facil Genom Core Lab, Bethesda, MD 20892 USA; [O'Shea, John J.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kimura, A (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bldg 37,Rm 3016, Bethesda, MD 20892 USA.	kimuraa@mail.nih.gov	Robinson, Gertraud/I-2136-2012; Chen, Wei/GZK-7348-2022	Hennighausen, Lothar/0000-0001-8319-9841; Kimura, Akiko/0000-0001-8136-5009	NIDDK/National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041169, ZIAAR041159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000] Funding Source: NIH RePORTER	NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural program of the NIDDK/National Institutes of Health. L. H. is a participant in the WCU program (R33-10059) at Chonnam National University, Republic of Korea.	Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; de Groot RP, 1999, BLOOD, V94, P1108, DOI 10.1182/blood.V94.3.1108.415k07_1108_1112; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gupta N, 2001, J CLIN PATHOL-MOL PA, V54, P293, DOI 10.1136/mp.54.5.293; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007989; He XH, 2005, STEM CELLS DEV, V14, P188, DOI 10.1089/scd.2005.14.188; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Huttmann A, 2006, STEM CELLS, V24, P1719, DOI 10.1634/stemcells.2005-0486; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Kimura A, 2009, BLOOD, V114, P4721, DOI 10.1182/blood-2009-04-216390; Manara MC, 2002, AM J PATHOL, V160, P849, DOI 10.1016/S0002-9440(10)64908-5; Martinerie C, 2001, J CLIN ENDOCR METAB, V86, P3929, DOI 10.1210/jc.86.8.3929; McCallum L, 2009, BLOOD REV, V23, P79, DOI 10.1016/j.blre.2008.07.002; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Reindl C, 2006, BLOOD, V107, P3700, DOI 10.1182/blood-2005-06-2596; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Schuringa JJ, 2004, STEM CELLS, V22, P1191, DOI 10.1634/stemcells.2004-0033; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Sillaber C, 2000, BLOOD, V95, P2118, DOI 10.1182/blood.V95.6.2118; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Wierenga ATJ, 2006, BLOOD, V107, P4326, DOI 10.1182/blood-2005-11-4608; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102; Zhu BM, 2008, BLOOD, V112, P2071, DOI 10.1182/blood-2007-12-127480	34	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32704	32709		10.1074/jbc.M110.141804	http://dx.doi.org/10.1074/jbc.M110.141804			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720003	Green Published, hybrid			2022-12-27	WOS:000283048200005
J	Kini, V; Chavez, A; Mehta, D				Kini, Vidisha; Chavez, Alejandra; Mehta, Dolly			A New Role for PTEN in Regulating Transient Receptor Potential Canonical Channel 6-mediated Ca2+ Entry, Endothelial Permeability, and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID PHOSPHATASE-ACTIVITY; CELLS IN-VITRO; TUMOR-SUPPRESSOR; PHOSPHOLIPASE-C; PDZ DOMAIN; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; VASCULAR-PERMEABILITY; CHROMOSOME-10 PTEN; PROTEIN STABILITY; PLASMA-MEMBRANE	Phosphatase and tensin homologue (PTEN) is a dual lipid-protein phosphatase that catalyzes the conversion of phosphoinositol 3,4,5-triphosphate to phosphoinositol 4,5-bisphosphate and thereby inhibits PI3K-Akt-dependent cell proliferation, migration, and tumor vascularization. We have uncovered a previously unrecognized role for PTEN in regulating Ca2+ entry through transient receptor potential canonical channel 6 (TRPC6) that does not require PTEN phosphatase activity. We show that PTEN tail-domain residues 394-403 permit PTEN to associate with TRPC6. The inflammatory mediator thrombin promotes this association. Deletion of PTEN residues 394-403 prevents TRPC6 cell surface expression and Ca2+ entry. However, PTEN mutant, C124S, which lacks phosphatase activity, did not alter TRPC6 activity. Thrombin failed to increase endothelial monolayer permeability in the endothelial cells, transducing the Delta 394-403 PTEN mutant. Paradoxically, we also show that thrombin failed to induce endothelial cell migration and tube formation in cells transducing the Delta 394-403 PTEN mutant. Our results demonstrate that PTEN, through residues 394-403, serves as a scaffold for TRPC6, enabling cell surface expression of the channel. Ca2+ entry through TRPC6 induces an increase in endothelial permeability and directly promotes angiogenesis. Thus, PTEN is indicated to play a role beyond suppressing PI3K signaling.	[Mehta, Dolly] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mehta, D (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, 835 S Wolcott Ave, Chicago, IL 60612 USA.	dmehta@uic.edu			National Institutes of Health [HL71794, HL84153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084153, R01HL071794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL71794 and HL84153.	Adey NB, 2000, CANCER RES, V60, P35; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; Bandyopadhyay BC, 2008, J BIOL CHEM, V283, P32821, DOI 10.1074/jbc.M805382200; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Chen ZL, 2006, FASEB J, V20, P2261, DOI 10.1096/fj.06-6113com; Cheng HW, 2006, ARTERIOSCL THROM VAS, V26, P1768, DOI 10.1161/01.ATV.0000231518.86795.0f; Cioffi DL, 2006, MICROCIRCULATION, V13, P709, DOI 10.1080/10739680600930354; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Ge RL, 2009, CANCER LETT, V283, P43, DOI 10.1016/j.canlet.2009.03.023; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; Hu SY, 2009, ACTA PHARMACOL SIN, V30, P1415, DOI 10.1038/aps.2009.133; Huang J, 2005, ARTERIOSCL THROM VAS, V25, P354, DOI 10.1161/01.ATV.0000151619.54108.a5; Iwatsuki K, 2005, ONCOGENE, V24, P1129, DOI 10.1038/sj.onc.1208287; Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Koide S, 2007, AM J PHYSIOL-HEART C, V292, pH2824, DOI 10.1152/ajpheart.01221.2006; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lussier MP, 2005, J BIOL CHEM, V280, P19393, DOI 10.1074/jbc.M500391200; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Marchant JS, 2005, CURR BIOL, V15, pR493, DOI 10.1016/j.cub.2005.06.035; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mukerji N, 2007, BBA-MOL BASIS DIS, V1772, P859, DOI 10.1016/j.bbadis.2007.03.005; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Nilius Bernd, 2007, Bull Mem Acad R Med Belg, V162, P244; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003; Qiu FY, 2009, J CARDIOVASC PHARM, V53, P209, DOI 10.1097/FJC.0b013e318199f326; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Wang YJ, 2004, J IMMUNOL, V173, P6820, DOI 10.4049/jimmunol.173.11.6820; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199	67	61	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33082	33091		10.1074/jbc.M110.142034	http://dx.doi.org/10.1074/jbc.M110.142034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705603	Green Published, hybrid			2022-12-27	WOS:000283048200046
J	Sansregret, L; Gallo, D; Santaguida, M; Leduy, L; Harada, R; Nepveu, A				Sansregret, Laurent; Gallo, David; Santaguida, Marianne; Leduy, Lam; Harada, Ryoko; Nepveu, Alain			Hyperphosphorylation by Cyclin B/CDK1 in Mitosis Resets CUX1 DNA Binding Clock at Each Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HINF-D; CDP/CUX TRANSCRIPTION FACTOR; CUT HOMEODOMAIN PROTEINS; RIBOSOMAL-RNA GENES; S-PHASE; MITOTIC CHROMATIN; ACTIVE GENES; HISTONE MODIFICATIONS; CATHEPSIN-L; KINASE	The p110 CUX1 homeodomain protein participates in the activation of DNA replication genes in part by increasing the affinity of E2F factors for the promoters of these genes. CUX1 expression is very weak in quiescent cells and increases during G(1). Biochemical activities associated with transcriptional activation by CUX1 are potentiated by post-translational modifications in late G(1), notably a proteolytic processing event that generates p110 CUX1. Constitutive expression of p110 CUX1, as observed in some transformed cells, leads to accelerated entry into the S phase. In this study, we investigated the post-translation regulation of CUX1 during mitosis and the early G(1) phases of proliferating cells. We observed a major electrophoretic mobility shift and a complete inhibition of DNA binding during mitosis. We show that cyclin B/CDK1 interacts with CUX1 and phosphorylates it at multiple sites. Serine to alanine replacement mutations at 10 SP dipeptide sites were required to restore DNA binding in mitosis. Passage into G(1) was associated with the degradation of some p110 CUX1 proteins, and the remaining proteins were gradually dephosphorylated. Indirect immunofluorescence and subfractionation assays using a phospho-specific antibody showed that most of the phosphorylated protein remained in the cytoplasm, whereas the dephosphorylated protein was preferentially located in the nucleus. Globally, our results indicate that the hyperphosphorylation of CUX1 by cyclin B/CDK1 inhibits its DNA binding activity in mitosis and interferes with its nuclear localization following cell division and formation of the nuclear membrane, whereas dephosphorylation and de novo synthesis contribute to gradually restore CUX1 expression and activity in G(1).	[Nepveu, Alain] McGill Univ, Goodman Canc Ctr, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; McGill Univ Canc Pavil, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University	Nepveu, A (corresponding author), McGill Univ, Goodman Canc Ctr, Dept Biochem, 1160 Pine Ave W,Rm 410, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020		Canadian Cancer Society [019389]	Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported in part by Grant 019389 from the Canadian Cancer Society (to A. N.).	Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Ali SA, 2010, P NATL ACAD SCI USA, V107, P4165, DOI 10.1073/pnas.1000620107; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; CAELLES C, 1995, MOL CELL BIOL, V15, P6694; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Coqueret O, 1996, J BIOL CHEM, V271, P24862, DOI 10.1074/jbc.271.40.24862; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; GAUTHIERROUVIERE C, 1991, CELL REGUL, V2, P575, DOI 10.1091/mbc.2.7.575; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; GOTTESFELD JM, 1994, SCIENCE, V263, P81, DOI 10.1126/science.8272869; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; HOLTHUIS J, 1990, SCIENCE, V247, P1454, DOI 10.1126/science.2321007; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; JACK J, 1991, DEVELOPMENT, V113, P735; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; LIU S, 1992, DEV BIOL, V150, P133, DOI 10.1016/0012-1606(92)90013-7; Long JJ, 1998, MOL CELL BIOL, V18, P1467, DOI 10.1128/MCB.18.3.1467; Ludlow C, 1996, DEV BIOL, V178, P149, DOI 10.1006/dbio.1996.0205; LUSCHER B, 1992, J CELL BIOL, V118, P775, DOI 10.1083/jcb.118.4.775; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Michl P, 2006, J BIOL CHEM, V281, P15138, DOI 10.1074/jbc.M600908200; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Rizkallah R, 2009, MOL BIOL CELL, V20, P4766, DOI 10.1091/mbc.E09-04-0264; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Santaguida M, 2005, J BIOL CHEM, V280, P32712, DOI 10.1074/jbc.M505417200; Santaguida M, 2001, J BIOL CHEM, V276, P45780, DOI 10.1074/jbc.M107978200; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Truscott M, 2007, J BIOL CHEM, V282, P30216, DOI 10.1074/jbc.M702328200; Valls E, 2005, J BIOL CHEM, V280, P42592, DOI 10.1074/jbc.M507407200; VANWIJNEN AJ, 1989, J BIOL CHEM, V264, P15034; vanWijnen AJ, 1996, P NATL ACAD SCI USA, V93, P11516, DOI 10.1073/pnas.93.21.11516; VANWIJNEN AJ, 1991, J CELL PHYSIOL, V148, P174, DOI 10.1002/jcp.1041480120; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; WRIGHT KL, 1992, BIOCHEMISTRY-US, V31, P2812, DOI 10.1021/bi00125a023; Xin L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-31; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827	60	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32834	32843		10.1074/jbc.M110.156406	http://dx.doi.org/10.1074/jbc.M110.156406			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729212	Green Published, hybrid			2022-12-27	WOS:000283048200020
J	Diaz-Hernandez, M; Gomez-Ramos, A; Rubio, A; Gomez-Villafuertes, R; Naranjo, JR; Miras-Portugal, MT; Avila, J				Diaz-Hernandez, Miguel; Gomez-Ramos, Alberto; Rubio, Alicia; Gomez-Villafuertes, Rosa; Naranjo, Jose R.; Teresa Miras-Portugal, M.; Avila, Jesus			Tissue-nonspecific Alkaline Phosphatase Promotes the Neurotoxicity Effect of Extracellular Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; PROTEIN-TAU; NEURONAL CELLS; MICE; PATHOLOGY; BRAIN; POLYMERIZATION; LOCALIZATION	There is solid evidence indicating that hyperphosphorylated tau protein, the main component of intracellular neurofibrillary tangles present in the brain of Alzheimer disease patients, plays a key role in progression of this disease. However, it has been recently reported that extracellular unmodified tau protein may also induce a neurotoxic effect on hippocampal neurons by activation of M1 and M3 muscarinic receptors. In the present work we show an essential component that links both effects, which is tissue-nonspecific alkaline phosphatase (TNAP). This enzyme is abundant in the central nervous system and is mainly required to keep control of extracellular levels of phosphorylated compounds. TNAP dephosphorylates the hyperphosphorylated tau protein once it is released upon neuronal death. Only the dephosphorylated tau protein behaves as an agonist of muscarinic M1 and M3 receptors, provoking a robust and sustained intracellular calcium increase finally triggering neuronal death. Interestingly, activation of muscarinic receptors by dephosphorylated tau increases the expression of TNAP in SH-SY5Y neuroblastoma cells. An increase in TNAP activity together with increases in protein and transcript levels were detected in Alzheimer disease patients when they were compared with healthy controls.	[Teresa Miras-Portugal, M.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Gomez-Ramos, Alberto; Rubio, Alicia; Naranjo, Jose R.; Avila, Jesus] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28049, Spain; [Teresa Miras-Portugal, M.] Univ Complutense Madrid, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain; [Naranjo, Jose R.] Consejo Super Invest, Ctr Nacl Biotecnol, Madrid 28049, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Avila, J (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	javila@cbm.uam.es	Gomez-Ramos, Alberto/K-3907-2014; Avila, Jesus/I-2610-2015; Miras-Portugal, Maria Teresa/L-7137-2014; Gomez-Villafuertes, Rosa/L-7181-2014; NARANJO, Jose R/K-1950-2014; rubio, alicia/I-7487-2018	Gomez-Ramos, Alberto/0000-0001-9502-9241; Avila, Jesus/0000-0002-6288-0571; Gomez-Villafuertes, Rosa/0000-0002-7064-0906; NARANJO, Jose R/0000-0002-0270-3469; rubio, alicia/0000-0003-0897-4806; Diaz-Hernandez, Miguel/0000-0002-1952-4600	Spanish Ministry of Health [SAF 2006-02424]; CIBERNED [CB06/05/0035]; Noscira [2008/285]; Comunidad de Madrid [SAL/0202/2006, S-SAL-0253-2006]; Spanish Ministry of Science and Education [BFU2008-02699]; Fundacion Marcelino Botin; UCM-Santander Central Hispano Bank [911585-670]; Fundacion R. Areces; Consolider SICI [CSD2008-00005]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBERNED(Instituto de Salud Carlos III); Noscira; Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Science and Education(Spanish Government); Fundacion Marcelino Botin; UCM-Santander Central Hispano Bank; Fundacion R. Areces(Instituto de Salud Carlos III); Consolider SICI	This work was supported by Spanish Ministry of Health Grant SAF 2006-02424, CIBERNED Grant CB06/05/0035, Noscira Grant 2008/285, Comunidad de Madrid Grants SAL/0202/2006 and S-SAL-0253-2006, Spanish Ministry of Science and Education Grant BFU2008-02699, by the Fundacion Marcelino Botin, Consolider SICI "Spanish Ion Channel Initiative" Grant CSD2008-00005, UCM-Santander Central Hispano Bank Grant 911585-670, and by an institutional grant from Fundacion R. Areces.	Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BIEDLER JL, 1978, CANCER RES, V38, P3751; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; BONDAREFF W, 1989, NEUROBIOL AGING, V10, P709, DOI 10.1016/0197-4580(89)90007-9; BRAAK H, 1985, ACTA NEUROPATHOL, V68, P325, DOI 10.1007/BF00690836; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORREAS I, 1992, J BIOL CHEM, V267, P15721; CRAS P, 1995, ACTA NEUROPATHOL, V89, P291; Diaz-Hernandez M, 2001, EUR J NEUROSCI, V14, P918, DOI 10.1046/j.0953-816x.2001.01703.x; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Engel T, 2006, NEUROBIOL AGING, V27, P1258, DOI 10.1016/j.neurobiolaging.2005.06.010; Fonta C, 2004, CEREB CORTEX, V14, P595, DOI 10.1093/cercor/bhh021; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; FUKUTANI Y, 1995, NEUROSCI LETT, V200, P57, DOI 10.1016/0304-3940(95)12083-G; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; de Barreda EG, 2010, NEUROBIOL DIS, V37, P622, DOI 10.1016/j.nbd.2009.11.017; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2004, BRAIN RES, V1007, P57, DOI 10.1016/j.brainres.2004.01.071; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Gomez-Ramos A, 2009, EUR NEUROPSYCHOPHARM, V19, P708, DOI 10.1016/j.euroneuro.2009.04.006; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Iwata N, 2002, J NEUROSCI RES, V70, P493, DOI 10.1002/jnr.10390; OGATA S, 1988, J BIOL CHEM, V263, P10489; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Perez M, 1996, J NEUROCHEM, V67, P1183; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zimmermann Herbert, 2006, Novartis Found Symp, V276, P113	38	125	129	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32539	32548		10.1074/jbc.M110.145003	http://dx.doi.org/10.1074/jbc.M110.145003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20634292	Green Published, hybrid			2022-12-27	WOS:000282683000068
J	Ryu, H; Azuma, Y				Ryu, Hyunju; Azuma, Yoshiaki			Rod/Zw10 Complex Is Required for PIASy-dependent Centromeric SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II-ALPHA; SUMO E3 LIGASE; ROUGH-DEAL; CHROMOSOME SEGREGATION; MITOTIC CHROMOSOMES; IN-VIVO; KINETOCHORE; CHECKPOINT; CONJUGATION; PROTEINS	SUMO conjugation of cellular proteins is essential for proper progression of mitosis. PIASy, a SUMO E3 ligase, is required for mitotic SUMOylation of chromosomal proteins, yet the regulatory mechanism behind the PIASy-dependent SUMOylation during mitosis has not been determined. Using a series of truncated PIASy proteins, we have found that the N terminus of PIASy is not required for SUMO modification in vitro but is essential for mitotic SUMOylation in Xenopus egg extracts. We demonstrate that swapping the N terminus of PIASy protein with the corresponding region of other PIAS family members abolishes chromosomal binding and mitotic SUMOylation. We further show that the N-terminal domain of PIASy is sufficient for centromeric localization. We identified that the N-terminal domain of PIASy interacts with the Rod/Zw10 complex, and immunofluorescence further reveals that PIASy colocalizes with Rod/Zw10 in the centromeric region. We show that the Rod/Zw10 complex interacts with the first 47 residues of PIASy which were particularly important for mitotic SUMOylation. Finally, we show that depletion of Rod compromises the centromeric localization of PIASy and SUMO2/3 in mitosis. Together, we demonstrate a fundamental mechanism of PIASy to localize in the centromeric region of chromosome to execute centromeric SUMOylation during mitosis.	[Ryu, Hyunju; Azuma, Yoshiaki] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Azuma, Y (corresponding author), 1200 Sunnyside Ave,Haworth Hall,Rm 3037, Lawrence, KS 66045 USA.	azumay@ku.edu			National Institutes of Health/NIGMS [GM80278]; Dept. of Molecular Biosciences at the University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080278] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Dept. of Molecular Biosciences at the University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health/NIGMS Grant GM80278 and a start-up grant from the Dept. of Molecular Biosciences at the University of Kansas.	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2001, FASEB J, V15, P1825, DOI 10.1096/fj.00-0818fje; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Azuma Y, 2009, METHODS MOL BIOL, V582, P221, DOI 10.1007/978-1-60761-340-4_17; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basto R, 2004, CURR BIOL, V14, P56, DOI 10.1016/j.cub.2003.12.025; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Biggins S, 2001, GENETICS, V159, P453; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Duval D, 2003, FEBS LETT, V554, P111, DOI 10.1016/S0014-5793(03)01116-5; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; KORNBLUTH S, 2001, CURRENT PROTOCOLS CE; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Lu YJ, 2009, CELL STRUCT FUNCT, V34, P31, DOI 10.1247/csf.08040; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Ryu H, 2010, J BIOL CHEM, V285, P14415, DOI 10.1074/jbc.M109.074583; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Scaerou F, 2001, J CELL SCI, V114, P3103; Scaerou F, 1999, J CELL SCI, V112, P3757; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Suzuki R, 2009, PROTEINS, V75, P336, DOI 10.1002/prot.22243; Takahashi Y, 2003, J BIOCHEM, V133, P415, DOI 10.1093/jb/mvg054; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tolkunova E, 2007, J MOL BIOL, V374, P1200, DOI 10.1016/j.jmb.2007.09.081; Torras-Llort M, 2009, EMBO J, V28, P2337, DOI 10.1038/emboj.2009.174; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Williams BC, 2003, MOL BIOL CELL, V14, P1379, DOI 10.1091/mbc.E02-09-0624; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013	47	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32576	32585		10.1074/jbc.M110.153817	http://dx.doi.org/10.1074/jbc.M110.153817			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696768	Green Published, hybrid			2022-12-27	WOS:000282683000072
J	Xie, G; Harrison, J; Clapcote, SJ; Huang, Y; Zhang, JY; Wang, LY; Roder, JC				Xie, Gang; Harrison, John; Clapcote, Steven J.; Huang, Yun; Zhang, Jin-Yi; Wang, Lu-Yang; Roder, John C.			A New Kv1.2 Channelopathy Underlying Cerebellar Ataxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; CELL NERVE-TERMINALS; K+ CHANNEL; RAT-BRAIN; ENDOPLASMIC-RETICULUM; TRANSMITTER RELEASE; SURFACE EXPRESSION; MAMMALIAN BRAIN; PURKINJE-CELLS; ALPHA-SUBUNITS	A forward genetic screen of mice treated with the mutagen ENU identified a mutant mouse with chronic motor incoordination. This mutant, named Pingu (Pgu), carries a missense mutation, an I402T substitution in the S6 segment of the voltage-gated potassium channel Kcna2. The gene Kcna2 encodes the voltage-gated potassium channel alpha-subunit Kv1.2, which is abundantly expressed in the large axon terminals of basket cells that make powerful axo-somatic synapses onto Purkinje cells. Patch clamp recordings from cerebellar slices revealed an increased frequency and amplitude of spontaneous GABAergic inhibitory postsynaptic currents and reduced action potential firing frequency in Purkinje cells, suggesting that an increase in GABA release from basket cells is involved in the motor incoordination in Pgu mice. In line with immunochemical analyses showing a significant reduction in the expression of Kv1 channels in the basket cell terminals of Pgu mice, expression of homomeric and heteromeric channels containing the Kv1.2(I402T) alpha-subunit in cultured CHO cells revealed subtle changes in biophysical properties but a dramatic decrease in the amount of functional Kv1 channels. Pharmacological treatment with acetazolamide or transgenic complementation with wildtype Kcna2 cDNA partially rescued the motor incoordination in Pgu mice. These results suggest that independent of known mutations in Kcna1 encoding Kv1.1, Kcna2 mutations may be important molecular correlates underlying human cerebellar ataxic disease.	[Xie, Gang; Clapcote, Steven J.; Zhang, Jin-Yi; Roder, John C.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5S 1A8, Canada; [Harrison, John; Wang, Lu-Yang] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5S 1A8, Canada; [Harrison, John; Wang, Lu-Yang] Hosp Sick Children, Div Neurol, Toronto, ON M5S 1A8, Canada; [Huang, Yun] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Wang, Lu-Yang; Roder, John C.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Roder, John C.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Wang, LY (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	luyang.wang@utoronto.ca	Roder, John/G-6468-2013		Canadian Institute of Health Research (CIHR) [CIHR MOP-77809, MOP-143867, MOP-14692]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grants CIHR MOP-77809 (to J. C. R.) and MOP-143867 and MOP-14692 (to L.-Y. W.).	Arroyo EJ, 1999, J NEUROCYTOL, V28, P333, DOI 10.1023/A:1007009613484; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Bower JM, 2002, ANN NY ACAD SCI, V978, P135, DOI 10.1111/j.1749-6632.2002.tb07562.x; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; DREWE JA, 1992, J NEUROSCI, V12, P538; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hallows JL, 1998, J NEUROSCI, V18, P5682; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HWANG PM, 1993, J NEUROSCI, V13, P1569; HWANG PM, 1992, NEURON, V8, P473, DOI 10.1016/0896-6273(92)90275-I; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; Klapdor K, 1997, J NEUROSCI METH, V75, P49, DOI 10.1016/S0165-0270(97)00042-3; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; McNamara NMC, 1996, EUR J NEUROSCI, V8, P688, DOI 10.1111/j.1460-9568.1996.tb01254.x; MCNAMARA NMC, 1993, NEUROSCIENCE, V57, P1039, DOI 10.1016/0306-4522(93)90047-J; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Shamotienko O, 1999, BIOCHEMISTRY-US, V38, P16766, DOI 10.1021/bi991039n; SHENG M, 1994, J NEUROSCI, V14, P2408; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Southan AP, 2000, J NEUROSCI, V20, P114, DOI 10.1523/JNEUROSCI.20-01-00114.2000; Southan AP, 1998, J NEUROSCI, V18, P948; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Xie G, 2007, GENES BRAIN BEHAV, V6, P717, DOI 10.1111/j.1601-183X.2007.00302.x; Xu HD, 1996, J GEN PHYSIOL, V108, P405, DOI 10.1085/jgp.108.5.405; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; ZASORIN NL, 1983, NEUROLOGY, V33, P1212, DOI 10.1212/WNL.33.9.1212; Zhu J, 2001, J BIOL CHEM, V276, P39419, DOI 10.1074/jbc.M107399200	44	62	64	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32160	32173		10.1074/jbc.M110.153676	http://dx.doi.org/10.1074/jbc.M110.153676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696761	hybrid, Green Published			2022-12-27	WOS:000282683000029
J	Zhao, NN; Gao, JW; Enns, CA; Knutson, MD				Zhao, Ningning; Gao, Junwei; Enns, Caroline A.; Knutson, Mitchell D.			ZRT/IRT-like Protein 14 (ZIP14) Promotes the Cellular Assimilation of Iron from Transferrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOMA-CELLS; NONTRANSFERRIN-BOUND IRON; ACUTE-PHASE RESPONSE; RAT HEPATOCYTES; HEREDITARY HEMOCHROMATOSIS; ENDOGENOUS PROTEINS; HEPG2 CELLS; TRANSPORTER; RECEPTOR; LIVER	ZIP14 is a transmembrane metal ion transporter that is abundantly expressed in the liver, heart, and pancreas. Previous studies of HEK 293 cells and the hepatocyte cell lines AML12 and HepG2 established that ZIP14 mediates the uptake of non-transferrin-bound iron, a form of iron that appears in the plasma during pathologic iron overload. In this study we investigated the role of ZIP14 in the cellular assimilation of iron from transferrin, the circulating plasma protein that normally delivers iron to cells by receptor-mediated endocytosis. We also determined the subcellular localization of ZIP14 in HepG2 cells. We found that overexpression of ZIP14 in HEK 293T cells increased the assimilation of iron from transferrin without increasing levels of transferrin receptor 1 or the uptake of transferrin. To allow for highly specific and sensitive detection of endogenous ZIP14 in HepG2 cells, we used a targeted knock-in approach to generate a cell line expressing a FLAG-tagged ZIP14 allele. Confocal microscopic analysis of these cells detected ZIP14 at the plasma membrane and in endosomes containing internalized transferrin. HepG2 cells in which endogenous ZIP14 was suppressed by siRNA assimilated 50% less iron from transferrin compared with controls. The uptake of transferrin, however, was unaffected. We also found that ZIP14 can mediate the transport of iron at pH 6.5, the pH at which iron dissociates from transferrin within the endosome. These results suggest that endosomal ZIP14 participates in the cellular assimilation of iron from transferrin, thus identifying a potentially new role for ZIP14 in iron metabolism.	[Knutson, Mitchell D.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Gao, Junwei; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	State University System of Florida; University of Florida; Oregon Health & Science University	Knutson, MD (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, POB 110370, Gainesville, FL 32611 USA.	mknutson@ufl.edu			National Institutes of Health [DK 080706, DK 054488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067864, R01DK054488, R01DK080706, R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK 080706 (to M. D. K.) and DK 054488 (to C. A. E.).	Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; CHENEY BA, 1967, AM J PHYSIOL, V212, P376, DOI 10.1152/ajplegacy.1967.212.2.376; Chua ACG, 2004, BLOOD, V104, P1519, DOI 10.1182/blood-2003-11-3872; Chua ACG, 2008, HEPATOLOGY, V47, P1737, DOI 10.1002/hep.22180; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Gao J, 2008, J BIOL CHEM, V283, P21462, DOI 10.1074/jbc.M803150200; Georgieff MK, 2000, PLACENTA, V21, P799, DOI 10.1053/plac.2000.0566; Graham RM, 1998, EUR J BIOCHEM, V253, P139, DOI 10.1046/j.1432-1327.1998.2530139.x; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Herbison CE, 2009, AM J PHYSIOL-CELL PH, V297, pC1567, DOI 10.1152/ajpcell.00649.2008; HIRAYAMA M, 1993, HEPATOLOGY, V18, P874, DOI 10.1002/hep.1840180420; Ikuta K, 2004, INT J BIOCHEM CELL B, V36, P340, DOI 10.1016/S1357-2725(03)00258-9; Kawabata H, 2001, BLOOD, V98, P2714, DOI 10.1182/blood.V98.9.2714; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Lambe T, 2009, BLOOD, V113, P1805, DOI 10.1182/blood-2007-11-120402; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; McArdle HJ, 2008, J NEUROENDOCRINOL, V20, P427, DOI 10.1111/j.1365-2826.2008.01658.x; MORGAN EH, 1986, FASEB J, V45, P2810; MORGAN EH, 1986, BIOCHEM J, V237, P163, DOI 10.1042/bj2370163; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nomura N, 1994, DNA Res, V1, P223, DOI 10.1093/dnares/1.5.223; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; POTTER BJ, 1989, AM J PHYSIOL, V257, pG524, DOI 10.1152/ajpgi.1989.257.4.G524; Sheikh N, 2007, LAB INVEST, V87, P713, DOI 10.1038/labinvest.3700553; Shindo M, 2006, HEPATOL RES, V35, P152, DOI 10.1016/j.hepres.2006.03.011; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Trinder D, 1997, HEPATOLOGY, V26, P691, DOI 10.1053/jhep.1997.v26.pm0009303500; Trinder D, 1996, HEPATOLOGY, V23, P1512, DOI 10.1002/hep.510230631; TRINDER D, 1986, HEPATOLOGY, V6, P852, DOI 10.1002/hep.1840060508; Trinder D, 2000, GUT, V46, P270, DOI 10.1136/gut.46.2.270; TRINDER D, 1988, BIOCHIM BIOPHYS ACTA, V943, P440, DOI 10.1016/0005-2736(88)90375-6; Wang ZH, 2009, METHODS MOL BIOL, V567, P87, DOI 10.1007/978-1-60327-414-2_6; Wetli HA, 2006, CHEM BIOL, V13, P965, DOI 10.1016/j.chembiol.2006.08.005; Worthington MT, 2000, AM J PHYSIOL-GASTR L, V279, pG1265, DOI 10.1152/ajpgi.2000.279.6.G1265; Zhang AS, 2008, EXP HEMATOL, V36, P1227, DOI 10.1016/j.exphem.2008.04.014; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]	44	119	120	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32141	32150		10.1074/jbc.M110.143248	http://dx.doi.org/10.1074/jbc.M110.143248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20682781	Green Published, hybrid			2022-12-27	WOS:000282683000027
J	Barbier, P; Dorleans, A; Devred, F; Sanz, L; Allegro, D; Alfonso, C; Knossow, M; Peyrot, V; Andreu, JM				Barbier, Pascale; Dorleans, Audrey; Devred, Francois; Sanz, Laura; Allegro, Diane; Alfonso, Carlos; Knossow, Marcel; Peyrot, Vincent; Andreu, Jose M.			Stathmin and Interfacial Microtubule Inhibitors Recognize a Naturally Curved Conformation of Tubulin Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-BETA-TUBULIN; COLCHICINE ANALOGS; MAMMALIAN BRAIN; CHIRAL ISOMERS; DOUBLE RINGS; IN-VITRO; BINDING; PROTEIN; DEPOLYMERIZATION; THERMODYNAMICS	Tubulin is able to switch between a straight microtubule-like structure and a curved structure in complex with the stathmin-like domain of the RB3 protein (T(2)RB3). GTP hydrolysis following microtubule assembly induces protofilament curvature and disassembly. The conformation of the labile tubulin heterodimers is unknown. One important question is whether free GDP-tubulin dimers are straightened by GTP binding or if GTP-tubulin is also curved and switches into a straight conformation upon assembly. We have obtained insight into the bending flexibility of tubulin by analyzing the interplay of tubulin-stathmin association with the binding of several small molecule inhibitors to the colchicine domain at the tubulin intradimer interface, combining structural and biochemical approaches. The crystal structures of T(2)RB3 complexes with the chiral R and S isomers of ethyl-5-amino-2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b] pyrazin-7-yl-carbamate, show that their binding site overlaps with colchicine ring A and that both complexes have the same curvature as unliganded T(2)RB3. The binding of these ligands is incompatible with a straight tubulin structure in microtubules. Analytical ultracentrifugation and binding measurements show that tubulin-stathmin associations (T(2)RB3, T(2)Stath) and binding of ligands (R, S, TN-16, or the colchicine analogue MTC) are thermodynamically independent from one another, irrespective of tubulin being bound to GTP or GDP. The fact that the interfacial ligands bind equally well to tubulin dimers or stathmin complexes supports a bent conformation of the free tubulin dimers. It is tempting to speculate that stathmin evolved to recognize curved structures in unassembled and disassembling tubulin, thus regulating microtubule assembly.	[Peyrot, Vincent] Aix Marseille Univ, Fac Pharm, Ctr Rech Oncol Biol & Oncopharmacol, INSERM UMR 911, F-13385 Marseille 05, France; [Dorleans, Audrey; Knossow, Marcel] CNRS, Lab Enzymol & Biochim Struct, UPR3082, F-91198 Gif Sur Yvette, France; [Sanz, Laura; Alfonso, Carlos; Andreu, Jose M.] CSIC, Ctr Invest Biol, Madrid 28040, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)		pascale.barbier@univmed.fr; j.m.andreu@cib.csic.es	Barbier, Pascale/AAE-1781-2019; Devred, Francois/AAO-6337-2020; Alfonso, Carlos/K-1316-2014; peyrot, vincent/B-6365-2015	Devred, Francois/0000-0001-5990-8898; Alfonso, Carlos/0000-0001-7165-4800; Andreu, Jose M/0000-0001-8064-6933	Ministerio de Ciencia [BFU2008-00013]; FPU; Association pour la Recherche contre le Cancer [1035]	Ministerio de Ciencia(Spanish Government); FPU(Spanish Government); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grant from Ministerio de Ciencia BFU2008-00013 (to J.M.A.), a FPU fellowship (L.S.), and a grant from the Association pour la Recherche contre le Cancer n<SUP>o</SUP> 1035 (to F.D.).	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Andreu JM, 1998, BIOCHEMISTRY-US, V37, P8356, DOI 10.1021/bi9728553; ANDREU JM, 1984, BIOCHEMISTRY-US, V23, P1742, DOI 10.1021/bi00303a025; Andreu Jose Manuel, 2007, Methods Mol Med, V137, P17, DOI 10.1007/978-1-59745-442-1_2; ARAI T, 1983, FEBS LETT, V155, P273, DOI 10.1016/0014-5793(82)80619-4; Bai RL, 2000, J BIOL CHEM, V275, P40443, DOI 10.1074/jbc.M005299200; Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; Barbier P, 1998, BIOCHEMISTRY-US, V37, P758, DOI 10.1021/bi970568t; Barbier P, 1995, BIOCHEMISTRY-US, V34, P16821, DOI 10.1021/bi00051a033; Barbier P, 2001, BIOCHEMISTRY-US, V40, P13510, DOI 10.1021/bi010926z; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bennett MJ, 2009, BIOCHEMISTRY-US, V48, P4858, DOI 10.1021/bi900200q; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Cormier A, 2008, EMBO REP, V9, P1101, DOI 10.1038/embor.2008.171; DEINES C, 1994, CANCER RES, V54, P75; DeLano W.L, PYMOL MOL GRAPHICS S; Devred F, 2008, FEBS LETT, V582, P2484, DOI 10.1016/j.febslet.2008.06.035; DIAZ JF, 1994, J MOL BIOL, V238, P214, DOI 10.1006/jmbi.1994.1282; DIEZ JC, 1987, CELL MOTIL CYTOSKEL, V7, P178, DOI 10.1002/cm.970070210; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Dorleans Audrey, 2007, Methods Mol Med, V137, P235, DOI 10.1007/978-1-59745-442-1_16; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; ESNOUF RM, 1997, J MOL GRAPH MODEL, V134, P112; FITZGERALD TJ, 1976, BIOCHEM PHARMACOL, V25, P1383; Gajate C, 2000, CANCER RES, V60, P2651; Gebremichael Y, 2008, BIOPHYS J, V95, P2487, DOI 10.1529/biophysj.108.129072; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; HOWARD WD, 1986, BIOCHEMISTRY-US, V25, P8292, DOI 10.1021/bi00373a025; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KIRSCHNER MW, 1974, P NATL ACAD SCI USA, V71, P1159, DOI 10.1073/pnas.71.4.1159; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; LEYNADIER D, 1993, BIOCHEMISTRY-US, V32, P10675, DOI 10.1021/bi00091a018; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lobert S, 2007, BIOPHYS CHEM, V126, P50, DOI 10.1016/j.bpc.2006.05.023; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MELKI R, 1989, BIOCHEMISTRY-US, V28, P9143, DOI 10.1021/bi00449a028; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moores CA, 2008, J MOL BIOL, V377, P647, DOI 10.1016/j.jmb.2008.01.079; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P894, DOI 10.1021/bi00170a007; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P885, DOI 10.1021/bi00170a006; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; TEMPLE C, 1989, J MED CHEM, V32, P2089, DOI 10.1021/jm00129a012; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wyman J, 1990, BINDING LINKAGE FUNC	69	80	81	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31672	31681		10.1074/jbc.M110.141929	http://dx.doi.org/10.1074/jbc.M110.141929			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675373	Green Published, hybrid			2022-12-27	WOS:000282764600059
J	Chua, YL; Dufour, E; Dassa, EP; Rustin, P; Jacobs, HT; Taylor, CT; Hagen, T				Chua, Yee Liu; Dufour, Eric; Dassa, Emmanuel P.; Rustin, Pierre; Jacobs, Howard T.; Taylor, Cormac T.; Hagen, Thilo			Stabilization of Hypoxia-inducible Factor-1 alpha Protein in Hypoxia Occurs Independently of Mitochondrial Reactive Oxygen Species Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-OXIDASE DEFICIENCY; ALTERNATIVE OXIDASE; RESPIRATORY-CHAIN; COMPLEX-III; HUMAN-CELLS; OXIDATIVE-PHOSPHORYLATION; EXPRESSION; HIF; MECHANISM; GENERATION	The transcription factor hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a master regulator of the cellular response to low oxygen. HIF-1 alpha protein accumulates in hypoxia due to inhibition of prolyl hydroxylase enzymes, which under normoxic conditions use molecular oxygen to hydroxylate HIF-1 alpha on two conserved proline residues (Pro(402) and Pro(564)), thus targeting the protein for 26 S proteasome-dependent degradation. A functional mitochondrial electron transport chain is known to be necessary for HIF-1 alpha stabilization in hypoxia. It has been reported that reactive oxygen species (ROS), produced under hypoxia by complex III of the mitochondrial electron transport chain, play a critical role in the stabilization of the HIF-1 alpha protein, possibly by directly inhibiting prolyl hydroxylase enzymes. In contrast, we found that ROS production by complex III is not required for hypoxia-induced HIF-1 alpha stabilization. Thus, reestablishing mitochondrial oxygen consumption in the presence of a complex III inhibitor by using an artificial electron donor to complex IV or by overexpressing Ciona intestinalis alternative oxidase results in HIF-1 alpha protein stabilization in hypoxia. Furthermore, five inhibitors that target different sites of the mitochondrial electron transport chain have similar effects on the HIF-1 alpha protein half-life in hypoxia but vary in their effects on mitochondrial ROS production. Finally, ROS do not regulate prolyl hydroxylase activity directly. We conclude that HIF-1 alpha protein stabilization in hypoxia occurs independently of mitochondrial ROS production. However, mitochondria can modulate the cellular hypoxic response through altered respiratory activity, likely by regulating the cellular oxygen availability.	[Chua, Yee Liu; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Dufour, Eric; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland; [Dufour, Eric; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, Ctr Lab Med, FI-33014 Tampere, Finland; [Dassa, Emmanuel P.; Rustin, Pierre] Univ Paris 07, Fac Med Denis, F-75870 Paris, France; [Dassa, Emmanuel P.; Rustin, Pierre] Hop Robert Debre, INSERM, U676, F-75870 Paris, France; [Taylor, Cormac T.] Univ Coll Dublin 4, Conway Inst Biomed & Biochem Res, Dublin D4, Ireland	National University of Singapore; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University College Dublin	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.	bchth@nus.edu.sg	Jacobs, Howard T/G-2434-2011; Dufour, Eric/AAF-6210-2020	Jacobs, Howard/0000-0003-1895-6003; Dufour, Eric/0000-0001-6690-5329; Taylor, Cormac/0000-0002-0946-1247	Singapore National Medical Research Council; National University of Singapore; School of Medicine; Academy of Finland; INSERM; Tampere University; Sigrid Juselius Foundation	Singapore National Medical Research Council(National Medical Research Council, Singapore); National University of Singapore(National University of Singapore); School of Medicine; Academy of Finland(Academy of Finland); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Tampere University; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from the Singapore National Medical Research Council and National University of Singapore, the School of Medicine, Academy of Finland, INSERM, the Tampere University Hospital Medical Research Fund, and the Sigrid Juselius Foundation.	Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Brown ST, 2008, AM J PHYSIOL-CELL PH, V294, pC1305, DOI 10.1152/ajpcell.00007.2008; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chew EH, 2006, BIOCHEM BIOPH RES CO, V346, P242, DOI 10.1016/j.bbrc.2006.05.106; Chua YS, 2010, MOL CANCER THER, V9, P224, DOI 10.1158/1535-7163.MCT-09-1003; Dassa EP, 2009, PHYSIOL PLANTARUM, V137, P427, DOI 10.1111/j.1399-3054.2009.01248.x; Dassa EP, 2009, EMBO MOL MED, V1, P30, DOI 10.1002/emmm.200900001; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161; FANDREY J, 1994, BIOCHEM J, V303, P507, DOI 10.1042/bj3030507; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Gong YQ, 2005, AM J PHYSIOL-CELL PH, V288, pC1023, DOI 10.1152/ajpcell.00443.2004; Grishko V, 2001, FASEB J, V15, P1267, DOI 10.1096/fj.00-0755fje; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601; Hoffman DL, 2007, AM J PHYSIOL-HEART C, V292, pH101, DOI 10.1152/ajpheart.00699.2006; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; McDonald AE, 2008, FUNCT PLANT BIOL, V35, P535, DOI 10.1071/FP08025; Mehta JP, 2008, CHEST, V133, P1410, DOI 10.1378/chest.07-2984; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Rustin P, 2009, PHYSIOL PLANTARUM, V137, P362, DOI 10.1111/j.1399-3054.2009.01249.x; Schroedl C, 2002, AM J PHYSIOL-LUNG C, V283, pL922, DOI 10.1152/ajplung.00014.2002; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; Tuttle SW, 2007, J BIOL CHEM, V282, P36790, DOI 10.1074/jbc.M700327200; Van Aken O, 2009, PHYSIOL PLANTARUM, V137, P354, DOI 10.1111/j.1399-3054.2009.01240.x; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Yang SQ, 2008, J BIOL CHEM, V283, P28767, DOI 10.1074/jbc.M803013200	42	131	136	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31277	31284		10.1074/jbc.M110.158485	http://dx.doi.org/10.1074/jbc.M110.158485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675386	Green Published, hybrid			2022-12-27	WOS:000282764600022
J	Jaiswal, R; Patel, RY; Asthana, J; Jindal, B; Balaji, PV; Panda, D				Jaiswal, Richa; Patel, Ronak Y.; Asthana, Jayant; Jindal, Bhavya; Balaji, Petety V.; Panda, Dulal			E93R Substitution of Escherichia coli FtsZ Induces Bundling of Protofilaments, Reduces GTPase Activity, and Impairs Bacterial Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; MYCOBACTERIUM-TUBERCULOSIS FTSZ; ASSEMBLY DYNAMICS; FUNCTIONAL-PROPERTIES; MICROTUBULE DYNAMICS; CRYSTAL-STRUCTURE; Z-RING; POLYMERIZATION; HYDROLYSIS; SULA	Recently, we found that divalent calcium has no detectable effect on the assembly of Mycobacterium tuberculosis FtsZ (MtbFtsZ), whereas it strongly promoted the assembly of Escherichia coli FtsZ (EcFtsZ). While looking for potential calcium binding residues in EcFtsZ, we found a mutation (E93R) that strongly promoted the assembly of EcFtsZ. The mutation increased the stability and bundling of the FtsZ protofilaments and produced a dominating effect on the assembly of the wild type FtsZ (WT-FtsZ). Although E93R-FtsZ was found to bind to GTP similarly to the WT-FtsZ, it displayed lower GTPase activity than the WT-FtsZ. E93R-FtsZ complemented for its wild type counterpart as observed by a complementation test using JKD7-1/pKD3 cells. However, the bacterial cells became elongated upon overexpression of the mutant allele. We modeled the structure of E93R-FtsZ using the structures of MtbFtsZ/Methanococcus jannaschi FtsZ (MjFtsZ) dimers as templates. The MtbFtsZ-based structure suggests that the Arg93-Glu138 salt bridge provides the additional stability, whereas the effect of mutation appears to be indirect (allosteric) if the EcFtsZ dimer is similar to that of MjFtsZ. The data presented in this study suggest that an increase in the stability of the FtsZ protofilaments is detrimental for the bacterial cytokinesis.	[Jaiswal, Richa; Patel, Ronak Y.; Asthana, Jayant; Jindal, Bhavya; Balaji, Petety V.; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Asthana, Jayant/AFQ-7879-2022; Jindal, Bhavya/AAW-6369-2021	Balaji, Petety/0000-0002-6018-6957; Asthana, Dr. Jayant/0000-0002-8961-6308	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by a grant from the Department of Science and Technology, Government of India (to D. P.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Addinall SG, 1996, J BACTERIOL, V178, P7167, DOI 10.1128/jb.178.24.7167-7172.1996; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; Bates PA, 2001, PROTEINS, P39; Bates PA, 1999, PROTEINS, P47; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Cordell SC, 2003, P NATL ACAD SCI USA, V100, P7889, DOI 10.1073/pnas.1330742100; DAI K, 1994, J BACTERIOL, V176, P130, DOI 10.1128/JB.176.1.130-136.1994; DeLano W. L., 2002, PYMOL MOL GENETICS G; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Jaiswal R, 2008, PROTEIN SCI, V17, P846, DOI 10.1110/ps.083452008; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Jaiswal R, 2009, J BIOCHEM, V146, P733, DOI 10.1093/jb/mvp120; Kapoor S, 2009, EXPERT OPIN THER TAR, V13, P1037, DOI 10.1517/14728220903173257; Leung AKW, 2004, J MOL BIOL, V342, P953, DOI 10.1016/j.jmb.2004.07.061; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 2005, FEBS J, V272, P2760, DOI 10.1111/j.1742-4658.2005.04696.x; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Pednekar D, 2009, PROTEINS, V74, P155, DOI 10.1002/prot.22142; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Santra MK, 2007, PROTEINS, V67, P177, DOI 10.1002/prot.21178; Santra MK, 2005, PROTEINS, V61, P1101, DOI 10.1002/prot.20671; Santra MK, 2003, J BIOL CHEM, V278, P21336, DOI 10.1074/jbc.M301303200; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Scheffers DJ, 2000, MOL MICROBIOL, V35, P1211, DOI 10.1046/j.1365-2958.2000.01791.x; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Sossong TM, 1999, BIOCHEMISTRY-US, V38, P14843, DOI 10.1021/bi990917e; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Thilo C, 2006, J BIOL CHEM, V281, P8950, DOI 10.1074/jbc.M507121200; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	54	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31796	31805		10.1074/jbc.M110.138719	http://dx.doi.org/10.1074/jbc.M110.138719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667825	Green Published, hybrid			2022-12-27	WOS:000282764600071
J	Pradhan, M; Bembinster, LA; Baumgarten, SC; Frasor, J				Pradhan, Madhumita; Bembinster, Leslie A.; Baumgarten, Sarah C.; Frasor, Jonna			Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter Gene ABCG2 through Estrogen Receptor and NF kappa B Cooperativity at Adjacent Response Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-RESISTANCE-PROTEIN; DNA-BINDING; GLUCOCORTICOID-RECEPTOR; UP-REGULATION; TUMOR-CELLS; CROSS-TALK; ER-ALPHA; TRANSCRIPTION; INHIBITION; ACTIVATION	Constitutive activation of NF kappa B in estrogen receptor (ER)-positive breast cancer is associated with tumor recurrence and development of anti-estrogen resistance. Furthermore, a gene expression signature containing common targets for ER and NF kappa B has been identified and found to be associated with the more aggressive luminal B intrinsic subtype of ER-positive breast tumors. Here, we describe a novel mechanism by which ER and NF kappa B cooperate to up-regulate expression of one important gene from this signature, ABCG2, which encodes a transporter protein associated with the development of drug-resistant breast cancer. We and others have confirmed that this gene is regulated primarily by estrogen in an ER- and estrogen response element (ERE)-dependent manner. We found that whereas proinflammatory cytokines have little effect on this gene in the absence of 17 beta-estradiol, they can potentiate ER activity in an NF kappa B-dependent manner. ER allows the NF kappa B family member p65 to access a latent NF kappa B response element located near the ERE in the gene promoter. NF kappa B recruitment to the gene is, in turn, required to stabilize ER occupancy at the functional ERE. The result of this cooperative binding of ER and p65 at adjacent response elements leads to a major increase in both ABCG2 mRNA and protein expression. These findings indicate that estrogen and inflammatory factors can modify each other's activity through modulation of transcription factor accessibility and/or occupancy at adjacent response elements. This novel transcriptional mechanism could have important implications in breast cancer, where both inflammation and estrogen can promote cancer progression.	[Pradhan, Madhumita; Bembinster, Leslie A.; Baumgarten, Sarah C.; Frasor, Jonna] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Frasor, J (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott,MC901, Chicago, IL 60612 USA.	jfrasor@uic.edu			National Institutes of Health [CA130932-2]; NATIONAL CANCER INSTITUTE [R01CA130932] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA130932-2 (to J. F.).	Adamson AD, 2008, ENDOCRINOLOGY, V149, P687, DOI 10.1210/en.2007-1066; ANKENBAUER W, 1988, P NATL ACAD SCI USA, V85, P7526, DOI 10.1073/pnas.85.20.7526; Bodine PVN, 1999, ENDOCRINOLOGY, V140, P2439, DOI 10.1210/en.140.6.2439; BRADSHAW MS, 1991, J BIOL CHEM, V266, P16684; Buchholz TA, 2005, CLIN CANCER RES, V11, P8398, DOI 10.1158/1078-0432.CCR-05-0885; Chu S, 2004, MOL ENDOCRINOL, V18, P1919, DOI 10.1210/me.2004-0021; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; deGraffenried LA, 2004, ANN ONCOL, V15, P885, DOI 10.1093/annonc/mdh232; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Ee PLR, 2004, CANCER RES, V64, P1247, DOI 10.1158/0008-5472.CAN-03-3583; Ellwood K, 1999, MOL CELL BIOL, V19, P2613; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Feldman I, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.033; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Frasor J, 2008, ENDOCRINOLOGY, V149, P6272, DOI 10.1210/en.2008-0352; George AA, 2009, INT J BIOCHEM CELL B, V41, P214, DOI 10.1016/j.biocel.2008.09.019; Gionet N, 2009, J CELL BIOCHEM, V107, P448, DOI 10.1002/jcb.22141; Guzeloglu-Kayisli O, 2008, REPROD SCI, V15, P493, DOI 10.1177/1933719108317583; Harnish DC, 2000, ENDOCRINOLOGY, V141, P3403, DOI 10.1210/en.141.9.3403; Johnson KM, 2004, METHOD ENZYMOL, V380, P207; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; KLINGE CM, 1992, CANCER RES, V52, P1073; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; KUNSCH C, 1994, J IMMUNOL, V153, P153; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mosaffa F, 2009, INFLAMM RES, V58, P669, DOI 10.1007/s00011-009-0034-6; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Pelzer T, 2001, BIOCHEM BIOPH RES CO, V286, P1153, DOI 10.1006/bbrc.2001.5519; Quaedackers ME, 2007, MOL CELL ENDOCRINOL, V273, P42, DOI 10.1016/j.mce.2007.05.002; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; Riggins RB, 2005, MOL CANCER THER, V4, P33; Rubio MF, 2006, ONCOGENE, V25, P1367, DOI 10.1038/sj.onc.1209176; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; Sui M, 2007, CANCER RES, V67, P5337, DOI 10.1158/0008-5472.CAN-06-4582; Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; To KKW, 2008, MOL CANCER RES, V6, P151, DOI 10.1158/1541-7786.MCR-07-0175; To KKW, 2006, MOL CELL BIOL, V26, P8572, DOI 10.1128/MCB.00650-06; To KKW, 2009, MOL CANCER THER, V8, P2959, DOI 10.1158/1535-7163.MCT-09-0292; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Wang HG, 2006, AM J PHYSIOL-ENDOC M, V290, pE798, DOI 10.1152/ajpendo.00397.2005; Wang H, 2008, MOL PHARMACOL, V73, P845, DOI 10.1124/mol.107.041087; Wissink S, 2001, MOL ENDOCRINOL, V15, P543, DOI 10.1210/me.15.4.543; Zhang YH, 2006, ONCOLOGY-BASEL, V71, P446, DOI 10.1159/000108594; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	56	76	83	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31100	31106		10.1074/jbc.M110.155309	http://dx.doi.org/10.1074/jbc.M110.155309			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20705611	Green Published, hybrid			2022-12-27	WOS:000282764600003
J	Ren, JL; Albinsson, S; Hellstrand, P				Ren, Jingli; Albinsson, Sebastian; Hellstrand, Per			Distinct Effects of Voltage- and Store-dependent Calcium Influx on Stretch-induced Differentiation and Growth in Vascular Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; TRANSCRIPTION FACTOR; CARDIOVASCULAR DEVELOPMENT; ACTIN POLYMERIZATION; CELL-PROLIFERATION; GENE-EXPRESSION; MYOCARDIN; ACTIVATION; PROTEINS; KINASE	Stretch of the vascular wall stimulates smooth muscle hypertrophy by activating the MAPK and Rho/Rho kinase (ROK) pathways. We investigated the role of calcium in this response. Stretch-stimulated expression of contractile and cytoskeletal proteins in mouse portal vein was inhibited at mRNA and protein levels by blockade of voltage-dependent Ca2+ entry (VDCE). In contrast, blockade of store-operated Ca2+ entry (SOCE) did not affect smooth muscle marker expression but decreased global protein synthesis. Activation of VDCE caused membrane translocation of RhoA followed by phosphorylation of its downstream effectors LIMK-2 and cofilin-2. Stretch-activated cofilin-2 phosphorylation depended on VDCE but not on SOCE. VDCE was associated with increased mRNA expression of myocardin, myocyte enhancer factor (MEF) -2A and -2D, and smooth muscle marker genes, all of which depended on ROK activity. SOCE increased ERK1/2 phosphorylation and c-Fos expression but had no effect on phosphorylation of LIMK-2 and cofilin-2 or on myocardin and MEF2 expression. Knockdown of MEF2A or -2D eliminated the VDCE-induced activation of myocardin expression and increased basal c-Jun and c-Fos mRNA levels. These results indicate that MEF2 mediates VDCE dependent stimulation of myocardin expression via the Rho/ROK pathway. In addition, SOCE activates the expression of immediate-early genes, known to be regulated by MEF2 via Ca2+-dependent phosphorylation of histone deacetylases, but this mode of Ca2+ entry does not affect the Rho/ROK pathway. Compartmentation of Ca2+ entry pathways appears as one mechanism whereby extracellular and membrane signals influence smooth muscle phenotype regulation, with MEF2 as a focal point.	[Ren, Jingli; Albinsson, Sebastian; Hellstrand, Per] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden	Lund University	Hellstrand, P (corresponding author), Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden.	Per.Hellstrand@med.lu.se	Albinsson, Sebastian/B-4105-2010	Albinsson, Sebastian/0000-0001-6936-3967	Swedish Research Council [64X-28]; Heart-Lung Foundation; Medical Faculty, Lund University; Torsten Foundation; Ragnar Soderberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart-Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty, Lund University; Torsten Foundation; Ragnar Soderberg Foundation	This work was supported by the Swedish Research Council Grant 64X-28, the Heart-Lung Foundation, the Vascular Wall Program, Medical Faculty, Lund University, and the Torsten and Ragnar Soderberg Foundations.	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Bergdahl A, 2005, AM J PHYSIOL-CELL PH, V288, pC872, DOI 10.1152/ajpcell.00334.2004; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Cartin L, 2000, CIRC RES, V86, P760, DOI 10.1161/01.RES.86.7.760; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dreja K, 2001, J VASC RES, V38, P324, DOI 10.1159/000051063; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Golovina VA, 1999, AM J PHYSIOL-CELL PH, V277, pC343, DOI 10.1152/ajpcell.1999.277.2.C343; Gordon JW, 2009, J BIOL CHEM, V284, P19027, DOI 10.1074/jbc.M109.000539; Guibert C, 2008, PROG BIOPHYS MOL BIO, V98, P10, DOI 10.1016/j.pbiomolbio.2008.05.001; JOHANSSON B, 1976, ACTA PHYSIOL SCAND, V98, P381, DOI 10.1111/j.1748-1716.1976.tb10324.x; Kumar B, 2006, CIRC RES, V98, P557, DOI 10.1161/01.RES.0000204724.29685.db; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Lin Q, 1998, DEVELOPMENT, V125, P4565; MALMQVIST U, 1988, ACTA PHYSIOL SCAND, V133, P49, DOI 10.1111/j.1748-1716.1988.tb08380.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; OWENS GK, 1995, PHYSIOL REV, V75, P487; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pulver RA, 2004, CIRC RES, V94, P1351, DOI 10.1161/01.RES.0000127618.34500.FD; Pulver-Kaste RA, 2006, AM J PHYSIOL-HEART C, V291, pH97, DOI 10.1152/ajpheart.00753.2005; Ratz PH, 2006, EUR J PHARMACOL, V541, P177, DOI 10.1016/j.ejphar.2006.05.014; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sweeney M, 2002, AM J PHYSIOL-LUNG C, V283, pL144, DOI 10.1152/ajplung.00412.2001; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, pE48; Zeidan A, 2003, ARTERIOSCL THROM VAS, V23, P1528, DOI 10.1161/01.ATV.0000090129.75275.C2; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002	36	27	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31829	31839		10.1074/jbc.M109.097576	http://dx.doi.org/10.1074/jbc.M109.097576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675376	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000282764600074
J	Martins, VD; Okura, M; Maric, D; Engman, DM; Vieira, M; Docampo, R; Moreno, SNJ				Martins, Vicente de Paulo; Okura, Michael; Maric, Danijela; Engman, David M.; Vieira, Mauricio; Docampo, Roberto; Moreno, Silvia N. J.			Acylation-dependent Export of Trypanosoma cruzi Phosphoinositide-specific Phospholipase C to the Outer Surface of Amastigotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-FLUORESCENT PROTEIN; N-MYRISTOYLTRANSFERASE; CALCIUM HOMEOSTASIS; FLAGELLAR MEMBRANE; CA2+ OSCILLATIONS; PLASMA-MEMBRANE; TRANS-SIALIDASE; CELL INVASION; LIPID RAFTS; H+-ATPASE	Phosphoinositide phospholipase C (PI-PLC) plays an essential role in cell signaling. A unique Trypanosoma cruzi PI-PLC (TcPI-PLC) is lipid-modified in its N terminus and localizes to the plasma membrane of amastigotes. Here, we show that TcPI-PLC is located onto the extracellular phase of the plasma membrane of amastigotes and that its N-terminal 20 amino acids are necessary and sufficient to target the fused GFP to the outer surface of the parasite. Mutagenesis of the predicted acylated residues confirmed that myristoylation of a glycine residue in the 2nd position and acyl modification of a cysteine in the 4th but not in the 8th or 15th position of the coding sequence are required for correct plasma membrane localization in T. cruzi epimastigotes or amastigotes. Interestingly, mutagenesis of the cysteine at the 8th position increased its flagellar localization. When expressed as fusion constructs with GFP, the N-terminal 6 and 10 amino acids fused to GFP are predominantly located in the cytosol and concentrated in a compartment that co-localizes with a Golgi complex marker. The N-terminal 20 amino acids of TcPI-PLC associate with lipid rafts when dually acylated. Taken together, these results indicate that N-terminal acyl modifications serve as a molecular addressing system for sending TcPI-PLC to the outer surface of the cell.	[Martins, Vicente de Paulo; Docampo, Roberto; Moreno, Silvia N. J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Martins, Vicente de Paulo; Docampo, Roberto; Moreno, Silvia N. J.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Okura, Michael; Vieira, Mauricio; Docampo, Roberto; Moreno, Silvia N. J.] Univ Illinois, Dept Pathobiol, Urbana, IL 61802 USA; [Maric, Danijela; Engman, David M.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University	Moreno, SNJ (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	smoreno@cb.uga.edu	de paulo martins, vicente/H-7182-2019	de paulo martins, vicente/0000-0001-7611-861X	National Institutes of Health [AI-058297]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-058297 (to S. N. J. M.).	Agusti R, 1997, GLYCOBIOLOGY, V7, P731, DOI 10.1093/glycob/7.6.731; ANDREWS NW, 1988, J EXP MED, V167, P300, DOI 10.1084/jem.167.2.300; Benchimol M, 1998, BIOCHEM J, V332, P695, DOI 10.1042/bj3320695; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Bertello LE, 1996, MOL BIOCHEM PARASIT, V79, P143, DOI 10.1016/0166-6851(96)02645-X; BIZZOZERO OA, 1995, METHOD ENZYMOL, V250, P361; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Field H, 2000, MOL BIOCHEM PARASIT, V106, P21, DOI 10.1016/S0166-6851(99)00192-9; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; FREVERT U, 1992, INFECT IMMUN, V60, P2349, DOI 10.1128/IAI.60.6.2349-2360.1992; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; HALLAK H, 1994, J BIOL CHEM, V269, P4571; Hannun YA, 2004, CURR BIOL, V14, pR163, DOI 10.1016/j.cub.2004.01.049; Irvine R, 1996, NATURE, V380, P581, DOI 10.1038/380581a0; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; MARTINS V, 2010, INFECT IMMU IN PRESS; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; MORENO SNJ, 1992, MOL BIOCHEM PARASIT, V52, P251, DOI 10.1016/0166-6851(92)90057-Q; Mortara RA, 2001, J EUKARYOT MICROBIOL, V48, P27, DOI 10.1111/j.1550-7408.2001.tb00413.x; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Okura M, 2005, J BIOL CHEM, V280, P16235, DOI 10.1074/jbc.M414535200; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PIMENTA PFP, 1989, EUR J CELL BIOL, V50, P263; Pollevick GD, 2000, J BIOL CHEM, V275, P27671; Prasad KK, 2008, MINI-REV MED CHEM, V8, P142; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Salto ML, 2002, MOL BIOCHEM PARASIT, V119, P131, DOI 10.1016/S0166-6851(01)00392-9; Saunders CM, 2002, DEVELOPMENT, V129, P3533; SCHMATZ DM, 1982, PARASITOLOGY, V85, P115, DOI 10.1017/S0031182000054202; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Vieira M, 2005, BIOCHEM J, V392, P467, DOI 10.1042/BJ20051319; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003	45	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30906	30917		10.1074/jbc.M110.142190	http://dx.doi.org/10.1074/jbc.M110.142190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20647312	Green Published, hybrid			2022-12-27	WOS:000282135500056
J	Shin, SY; Nam, JS; Lim, Y; Lee, YH				Shin, Soon Young; Nam, Jeong-Seok; Lim, Yoongho; Lee, Young Han			TNF alpha-exposed Bone Marrow-derived Mesenchymal Stem Cells Promote Locomotion of MDA-MB-231 Breast Cancer Cells through Transcriptional Activation of CXCR3 Ligand Chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; STROMAL FIBROBLASTS; RECEPTOR CXCR3; UP-REGULATION; KAPPA-B; EXPRESSION; MYOFIBROBLASTS; CXCL10; GROWTH; RHOA	Bone marrow-derived mesenchymal stem cells (BM-MSCs) are often recruited to solid tumors, integrate into the tumor stroma, and contribute to tumor development. TNF alpha is a major inflammatory cytokine present in the tumor microenvironment and has a profound influence on the progression of tumor development. This study was aimed to investigate the role of BM-MSCs in tumor promotion in response to TNF alpha. Quantitative real-time PCR arrays show that diverse cytokines/chemokines were induced in TNF alpha-treated BM-MSCs; in particular, CXCR3 ligand chemokines, including CXCL9, CXCL10, and CXCL11, were potently induced. A serial and site-directed mutation analysis in the CXCL9, CXCL10, and CXCL11 promoters revealed that NF-kappa B binding elements were responsible for TNF alpha-induced promoter activation of CXCR3 ligand chemokines. TNF alpha stimulated NF-kappa B activity, and ectopic expression of NF-kappa B enhanced TNF alpha-induced promoter activities of the CXCR3 ligand chemokines. Gel shift and supershift assays showed that NF-kappa B was associated with CXCR3 ligand chemokine promoters in response to TNF alpha treatment. All three CXCR3 ligand chemokines enhanced the migration and invasive motility of MDA-MB-231 breast cancer cells expressing CXCR3. Treatment of MDA-MB-231 cells with CXCL10 activated small GTPase of Rho family proteins, such as RhoA and Cdc42. CXCL9-, CXCL10-, or CXCL11-induced invasive capability of MDA-MB-231 cells was completely abrogated in the presence of a neutralizing anti-CXCR3 antibody in the culture medium. Moreover, CXCL9, CXCL10, and CXCL11 stimulated the expression of MMP-9, but not MMP-2, in MDA-MB-231 cells. These results suggest that BM-MSCs promote the locomotion of breast cancer cells through CXCR3 ligand-mediated actin rearrangement by TNF alpha in the tumor microenvironment.	[Shin, Soon Young; Lee, Young Han] Konkuk Univ Hosp, Inst Biomed Sci & Technol, Seoul 143729, South Korea; [Shin, Soon Young; Lee, Young Han] Konkuk Univ, Dept Biomed Sci & Technol, Res Ctr Transcript Control, Seoul 143701, South Korea; [Lim, Yoongho] Konkuk Univ, Div Biosci & Biotechnol, Biomol Informat Ctr, Seoul 143701, South Korea; [Nam, Jeong-Seok] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Gachon University	Lee, YH (corresponding author), 1 Hwayang Dong, Seoul 143701, South Korea.	yhlee58@konkuk.ac.kr			Disease Network Research Program [2009-0084181]; Ministry of Education, Science, and Technology, Republic of Korea [20090076856]	Disease Network Research Program; Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Disease Network Research Program Grant 2009-0084181) and by Basic Science Research Program Grant 20090076856 through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology, Republic of Korea.	Ali S, 2007, CANCER METAST REV, V26, P401, DOI 10.1007/s10555-007-9073-z; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; CAMPS JL, 1990, P NATL ACAD SCI USA, V87, P75, DOI 10.1073/pnas.87.1.75; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Emura M, 2000, IN VITRO CELL DEV-AN, V36, P77; Fries M, 2003, EUR J BIOCHEM, V270, P861, DOI 10.1046/j.1432-1033.2003.03444.x; Furuya M, 2007, HUM PATHOL, V38, P1676, DOI 10.1016/j.humpath.2007.03.023; Goldberg-Bittman L, 2004, IMMUNOL LETT, V92, P171, DOI 10.1016/j.imlet.2003.10.020; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pille JY, 2005, MOL THER, V11, P267, DOI 10.1016/j.ymthe.2004.08.029; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Riccardi C, 2001, ADV EXP MED BIOL, V495, P31; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Suyama T, 2005, CANCER-AM CANCER SOC, V103, P258, DOI 10.1002/cncr.20747; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Tannenbaum CS, 1998, J IMMUNOL, V161, P927; Teichmann M, 2005, J PATHOL, V206, P68, DOI 10.1002/path.1745; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Zhao YY, 2009, EXP MOL MED, V41, P478, DOI 10.3858/emm.2009.41.7.053	50	66	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30731	30740		10.1074/jbc.M110.128124	http://dx.doi.org/10.1074/jbc.M110.128124			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20650898	Green Published, hybrid			2022-12-27	WOS:000282135500041
J	Schwindinger, WF; Mihalcik, LJM; Giger, KE; Betz, KS; Stauffer, AM; Linden, J; Herve, D; Robishaw, JD				Schwindinger, William F.; Mihalcik, Lauren J. Murphree; Giger, Kathryn E.; Betz, Kelly S.; Stauffer, Anna Maria; Linden, Joel; Herve, Denis; Robishaw, Janet D.			Adenosine A(2A) Receptor Signaling and G(olf) Assembly Show a Specific Requirement for the gamma(7) Subtype in the Striatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; TRANSLATIONAL PROFILING APPROACH; CNS CELL-TYPES; DOPAMINE-RECEPTOR; MICE LACKING; PARKINSONS-DISEASE; ADENYLYL-CYCLASE; DEFICIENT MICE; KNOCKOUT MICE; FUNCTIONAL SPECIFICITY	The adenosine A(2A) receptor (A(2A)R) is increasingly recognized as a novel therapeutic target in Parkinson disease. In striatopallidal neurons, the G-protein alpha(olf) subtype is required to couple this receptor to adenylyl cyclase activation. It is now well established that the beta gamma dimer also performs an active role in this signal transduction process. In principal, sixty distinct beta gamma dimers could arise from combinatorial association of the five known beta and 12 gamma subunit genes. However, key questions regarding which beta gamma subunit combinations exist and whether they perform specific signaling roles in the context of the organism remain to be answered. To explore these questions, we used a gene targeting approach to specifically ablate the G-protein gamma(7) subtype. Revealing a potentially new signaling paradigm, we show that the level of the gamma(7) protein controls the hierarchial assembly of a specific G-protein alpha(olf)beta(2)gamma(7) heterotrimer in the striatum. Providing a probable basis for the selectivity of receptor signaling, we further demonstrate that loss of this specific G-protein heterotrimer leads to reduced A(2A)R activation of adenylyl cyclase. Finally, substantiating an important role for this signaling pathway in pyschostimulant responsiveness, we show that mice lacking the G-protein gamma(7) subtype exhibit an attenuated behavioral response to caffeine. Collectively, these results further support the A(2A)R G-protein alpha(olf)beta(2)gamma(7) interface as a possible therapeutic target for Parkinson disease.	[Robishaw, Janet D.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Mihalcik, Lauren J. Murphree] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Betz, Kelly S.] Columbia Univ, Div Digest & Liver Dis, Dept Med, Irving Canc Res Ctr, New York, NY 10032 USA; [Linden, Joel] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Herve, Denis] INSERM, UMR S839, F-75005 Paris, France; [Herve, Denis] Univ Paris 06, F-75005 Paris, France; [Herve, Denis] Inst Fer Moulin, F-75005 Paris, France	University of Virginia; Columbia University; La Jolla Institute for Immunology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Robishaw, JD (corresponding author), 100 N Acad Ave, Danville, PA 17822 USA.	jrobishaw@geisinger.edu	HERVE, Denis/E-2929-2017; Linden, Joel/AAH-5690-2020	HERVE, Denis/0000-0003-1376-1522; 	National Institutes of Health [GM39867, HL37942]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R55HL037942, R01HL037942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039867, R29GM039867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM39867 (to J. D. R.) and HL37942 (to J. L.).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Aoyama S, 2000, J NEUROSCI, V20, P5848, DOI 10.1523/JNEUROSCI.20-15-05848.2000; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bara-Jimenez W, 2003, NEUROLOGY, V61, P293, DOI 10.1212/01.WNL.0000073136.00548.D4; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Borgkvist A, 2007, NEUROSCI BIOBEHAV R, V31, P79, DOI 10.1016/j.neubiorev.2006.03.003; CALI JJ, 1992, J BIOL CHEM, V267, P24023; Cauli O, 2005, BEHAV PHARMACOL, V16, P63, DOI 10.1097/00008877-200503000-00001; Charalambous C, 2008, J BIOL CHEM, V283, P9276, DOI 10.1074/jbc.M706275200; Chen JF, 2001, P NATL ACAD SCI USA, V98, P1970, DOI 10.1073/pnas.98.4.1970; Clifford JJ, 1998, NEUROPHARMACOLOGY, V37, P1595, DOI 10.1016/S0028-3908(98)00116-6; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Corvol JC, 2007, NEUROPSYCHOPHARMACOL, V32, P1109, DOI 10.1038/sj.npp.1301230; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; FOSTER KA, 1990, AM J PHYSIOL, V259, pH432, DOI 10.1152/ajpheart.1990.259.2.H432; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Gao X, 2007, J BIOL CHEM, V282, P294, DOI 10.1074/jbc.M607522200; GROSS W, 1991, MOL PHARMACOL, V39, P524; HANSEN CA, 1994, J CELL BIOL, V126, P811, DOI 10.1083/jcb.126.3.811; Hauser RA, 2008, MOVEMENT DISORD, V23, P2177, DOI 10.1002/mds.22095; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Herve D, 2001, J NEUROSCI, V21, P4390, DOI 10.1523/JNEUROSCI.21-12-04390.2001; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; Hildebrandt JD, 1997, BIOCHEM PHARMACOL, V54, P325, DOI 10.1016/S0006-2952(97)00269-4; Holmes A, 2004, NEUROPHARMACOLOGY, V47, P1117, DOI 10.1016/j.neuropharm.2004.07.034; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; Kelly MA, 2008, GENES BRAIN BEHAV, V7, P568, DOI 10.1111/j.1601-183X.2008.00392.x; Kelly MA, 1998, J NEUROSCI, V18, P3470; Kull B, 2000, MOL PHARMACOL, V58, P771, DOI 10.1124/mol.58.4.771; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Lee KW, 2002, J NEUROSCI, V22, P7931; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lindskog M, 2002, NATURE, V418, P774, DOI 10.1038/nature00817; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; LOHSE MJ, 1991, MOL PHARMACOL, V39, P517; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; LUTHIN DR, 1995, MOL PHARMACOL, V47, P307; LUTHIN DR, 1995, J NEUROCHEM, V65, P2072; MARIN EP, 1995, BIOCHEM J, V309, P377, DOI 10.1042/bj3090377; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; MUNTZ KH, 1992, MOL BIOL CELL, V3, P49, DOI 10.1091/mbc.3.1.49; Murphree LJ, 2002, MOL PHARMACOL, V61, P455, DOI 10.1124/mol.61.2.455; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Offermanns S, 2001, ONCOGENE, V20, P1635, DOI 10.1038/sj.onc.1204189; Popoli P, 2000, NEUROPSYCHOPHARMACOL, V22, P522, DOI 10.1016/S0893-133X(99)00144-X; Rehm A, 1997, J CELL BIOL, V137, P305, DOI 10.1083/jcb.137.2.305; Richardson M, 1999, J BIOL CHEM, V274, P13525, DOI 10.1074/jbc.274.19.13525; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Salamone John D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS130, DOI 10.1016/j.parkreldis.2008.04.017; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Schwindinger WF, 2009, AM J PHYSIOL-REG I, V297, pR1494, DOI 10.1152/ajpregu.00308.2009; SIMONDS WF, 1991, J BIOL CHEM, V266, P5363; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Stacy M, 2008, NEUROLOGY, V70, P2233, DOI 10.1212/01.wnl.0000313834.22171.17; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Tang XD, 2002, BEHAV BRAIN RES, V136, P555, DOI 10.1016/S0166-4328(02)00228-0; TOLKOVSKY AM, 1982, P NATL ACAD SCI-BIOL, V79, P213, DOI 10.1073/pnas.79.2.213; Wang Q, 1999, J BIOL CHEM, V274, P17365, DOI 10.1074/jbc.274.24.17365; Wang Q, 1997, J BIOL CHEM, V272, P26040, DOI 10.1074/jbc.272.41.26040; Wang Q, 2001, J BIOL CHEM, V276, P39386, DOI 10.1074/jbc.M104981200; WATSON JB, 1994, J NEUROSCI RES, V39, P108, DOI 10.1002/jnr.490390113; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Zahniser NR, 2000, J NEUROSCI, V20, P5949, DOI 10.1523/JNEUROSCI.20-16-05949.2000	73	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29787	29796		10.1074/jbc.M110.142620	http://dx.doi.org/10.1074/jbc.M110.142620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639202	hybrid, Green Published			2022-12-27	WOS:000281984300014
J	Cantero-Recasens, G; Gonzalez, JR; Fandos, C; Duran-Tauleria, E; Smit, LAM; Kauffmann, F; Anto, JM; Valverde, MA				Cantero-Recasens, Gerard; Gonzalez, Juan R.; Fandos, Cesar; Duran-Tauleria, Enric; Smit, Lidwien A. M.; Kauffmann, Francine; Anto, Josep M.; Valverde, Miguel A.			Loss of Function of Transient Receptor Potential Vanilloid 1 (TRPV1) Genetic Variant Is Associated with Lower Risk of Active Childhood Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY INFLAMMATION; ION-CHANNEL; EXPRESSION; CAPSAICIN	Transient receptor potential cation channels of the vanilloid subfamily (TRPV) participate in the generation of Ca2+ signals at different locations of the respiratory system, thereby controlling its correct functioning. TRPV1 expression and activity appear to be altered under pathophysiological conditions such as chronic cough and airway hypersensitivity, whereas TRPV4 single nucleotide polymorphisms (SNP) are associated with chronic obstructive pulmonary disease. However, to date, there is no information about the genetic impact of either TRPV1 or TRPV4 on asthma pathophysiology. We now report on the association of two functional SNPs, TRPV1-I585V and TRPV4-P19S, with childhood asthma. Both SNPs were genotyped in a population of 470 controls without respiratory symptoms and 301 asthmatics. Although none of the SNPs modified the risk of suffering from asthma, carriers of the TRPV1-I585V genetic variant showed a lower risk of current wheezing (odds ratio = 0.51; p = 0.01), a characteristic of active asthma, or cough (odds ratio = 0.57; p = 0.02). Functional analysis of TRPV1-I585V, using the Ca2+-sensitive dye fura-2 to measure intracellular [Ca2+] concentrations, revealed a decreased channel activity in response to two typical TRPV1 stimuli, heat and capsaicin. On the other hand, TRPV4-P19S, despite its loss-of-channel function, showed no significant association with asthma or the presence of wheezing. Our data suggest that genetically determined level of TRPV1 activity is relevant for asthma pathophysiology.	[Cantero-Recasens, Gerard; Fandos, Cesar; Valverde, Miguel A.] Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Gonzalez, Juan R.; Anto, Josep M.] Ctr Res Environm Epidemiol CREAL, Barcelona 08003, Spain; [Duran-Tauleria, Enric] Inst Prestac Assistencia Med Personal Muncipal PA, Barcelona 08015, Spain; [Duran-Tauleria, Enric; Anto, Josep M.] IMIM Hosp Mar, Inst Municipal Invest Med, Barcelona 08003, Spain; [Smit, Lidwien A. M.] Univ Utrecht, Inst Risk Assessment Sci, NL-3508 TC Utrecht, Netherlands; [Kauffmann, Francine] INSERM, U1018, F-94807 Villejuif, France	Pompeu Fabra University; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Utrecht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Valverde, MA (corresponding author), Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Parc Recerca Biomed Barcelona,Rm 343 C Dr Aiguade, Barcelona 08003, Spain.	miguel.valverde@upf.edu	Cantero-Recasens, Gerard/AAH-1697-2019; Smit, Lidwien AM/AFC-8689-2022; Gonzalez, Juan R/B-7860-2018; Cantero-Recasens, Gerard/AAE-9003-2022; Anto, J M/H-2676-2014	Cantero-Recasens, Gerard/0000-0001-6452-782X; Smit, Lidwien AM/0000-0003-0292-0946; Gonzalez, Juan R/0000-0003-3267-2146; Anto, J M/0000-0002-4736-8529; Fandos, Cesar/0000-0001-7348-1376; Valverde, Miguel A./0000-0002-6961-3361	Spanish Ministry of Science and Innovation; Plan E [SAF2009-09848, Red HERACLES RD06/0009]; Generalitat de Catalunya [2009SGR-1369]; Fundacio la Marato de TV3 [080430]; Institucio Catalana de Recerca i Estudis Avancats (ICREA)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Plan E; Generalitat de Catalunya(Generalitat de Catalunya); Fundacio la Marato de TV3; Institucio Catalana de Recerca i Estudis Avancats (ICREA)(ICREA)	This work was supported by grants from the Spanish Ministry of Science and Innovation, Fondos Europeos de Desarrollo Regional (FEDER) Funds, and Plan E (Grants SAF2009-09848 and Red HERACLES RD06/0009); Generalitat de Catalunya (Grant 2009SGR-1369); and Fundacio la Marato de TV3 (Grant 080430).; The recipient of an Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Award.	Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Delany NS, 2001, PHYSIOL GENOMICS, V4, P165, DOI 10.1152/physiolgenomics.2001.4.3.165; Doherty MJ, 2000, THORAX, V55, P643, DOI 10.1136/thorax.55.8.643; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Geppetti P, 2006, EUR J PHARMACOL, V533, P207, DOI 10.1016/j.ejphar.2005.12.063; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Guler AD, 2002, J NEUROSCI, V22, P6408; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Jia YL, 2004, AM J PHYSIOL-LUNG C, V287, pL272, DOI 10.1152/ajplung.00393.2003; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; McLeod Robbie L, 2006, Cough, V2, P10, DOI 10.1186/1745-9974-2-10; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe N, 2006, NEUROSCIENCE, V141, P1533, DOI 10.1016/j.neuroscience.2006.04.073; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zhang GF, 2008, J PHYSIOL-LONDON, V586, P5771, DOI 10.1113/jphysiol.2008.161042; Zhu GH, 2009, HUM MOL GENET, V18, P2053, DOI 10.1093/hmg/ddp111	28	85	91	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27532	27535		10.1074/jbc.C110.159491	http://dx.doi.org/10.1074/jbc.C110.159491			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20639579	Green Published, hybrid			2022-12-27	WOS:000281404100007
J	Desai, TM; Cerminara, M; Sadqi, M; Munoz, V				Desai, Tanay M.; Cerminara, Michele; Sadqi, Mourad; Munoz, Victor			The Effect of Electrostatics on the Marginal Cooperativity of an Ultrafast Folding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLTEN GLOBULE STATE; ACID DENATURATION; ENERGY LANDSCAPE; CYTOCHROME-C; DOWNHILL; DYNAMICS; THERMODYNAMICS; KINETICS; 2-STATE; MODELS	Proteins fold up by coordinating the different segments of their polypeptide chain through a network of weak cooperative interactions. Such cooperativity results in unfolding curves that are typically sigmoidal. However, we still do not know what factors modulate folding cooperativity or the minimal amount that ensures folding into specific three-dimensional structures. Here, we address these issues on BBL, a small helical protein that folds in microseconds via a marginally cooperative downhill process (Li, P., Oliva, F. Y., Naganathan, A. N., and Munoz, V. (2009) Proc. Natl. Acad. Sci. USA. 106, 103-108). Particularly, we explore the effects of salt-induced screening of the electrostatic interactions in BBL at neutral pH and in acid-denatured BBL. Our results show that electrostatic screening stabilizes the native state of the neutral and protonated forms, inducing complete refolding of acid-denatured BBL. Furthermore, without net electrostatic interactions, the unfolding process becomes much less cooperative, as judged by the broadness of the equilibrium unfolding curve and the relaxation rate. Our experiments show that the marginally cooperative unfolding of BBL can still be made twice as broad while the protein retains its ability to fold into the native three-dimensional structure in microseconds. This result demonstrates experimentally that efficient folding does not require cooperativity, confirming predictions from theory and computer simulations and challenging the conventional biochemical paradigm. Furthermore, we conclude that electrostatic interactions are an important factor in determining folding cooperativity. Thus, electrostatic modulation by pH-salt and/or mutagenesis of charged residues emerges as an attractive tool for tuning folding cooperativity.	[Munoz, Victor] CSIC, Ctr Invest Biol, CIB CSIC, Madrid 28040, Spain; [Desai, Tanay M.; Munoz, Victor] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University System of Maryland; University of Maryland College Park	Munoz, V (corresponding author), CSIC, Ctr Invest Biol, CIB CSIC, Calle Ramiro de Maeztu 9, Madrid 28040, Spain.	vmunoz@cib.csic.es	Sadqi, Mourad/J-3180-2018	Sadqi, Mourad/0000-0003-3553-3408; Cerminara, Michele/0000-0002-2131-395X	Marie Curie Excellence [MEXT-CT-2006-042334]; Spanish Ministry of Science and Innovation [BFU2008-03237, CSD2009-00088]	Marie Curie Excellence(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Marie Curie Excellence Grant MEXT-CT-2006-042334 and Grants BFU2008-03237 and CONSOLIDER CSD2009-00088 from the Spanish Ministry of Science and Innovation.	ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; ALEXANDRESCU AT, 1993, BIOCHEMISTRY-US, V32, P1707, DOI 10.1021/bi00058a003; ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Arbely E, 2009, J MOL BIOL, V387, P986, DOI 10.1016/j.jmb.2008.12.055; AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4586, DOI 10.1021/bi00839a053; BARRICK D, 1994, J MOL BIOL, V237, P588, DOI 10.1006/jmbi.1994.1257; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Callender R, 2002, CURR OPIN STRUC BIOL, V12, P628, DOI 10.1016/S0959-440X(02)00370-6; CAMACHO CJ, 1993, P NATL ACAD SCI USA, V90, P6369, DOI 10.1073/pnas.90.13.6369; CHAN HS, 1995, PHILOS T R SOC B, V348, P61, DOI 10.1098/rstb.1995.0046; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Ejtehadi MR, 2004, P NATL ACAD SCI USA, V101, P15088, DOI 10.1073/pnas.0403486101; Fersht A., 1999, STRUCTURE MECH PROTE; FINK AL, 1993, PROTEIN SCI, V2, P1155, DOI 10.1002/pro.5560020710; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Garcia-Mira MM, 2002, SCIENCE, V298, P2191, DOI 10.1126/science.1077809; GOTO Y, 1991, J MOL BIOL, V222, P679, DOI 10.1016/0022-2836(91)90504-Y; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Halskau O, 2008, P NATL ACAD SCI USA, V105, P8625, DOI 10.1073/pnas.0709881105; HAMADA D, 1994, P NATL ACAD SCI USA, V91, P10325, DOI 10.1073/pnas.91.22.10325; Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jamin M, 2001, P NATL ACAD SCI USA, V98, P6127, DOI 10.1073/pnas.111157998; Kaya H, 2003, J MOL BIOL, V326, P911, DOI 10.1016/S0022-2836(02)01434-1; Klimov DK, 1998, FOLD DES, V3, P127, DOI 10.1016/S1359-0278(98)00018-2; Klimov DK, 2002, J COMPUT CHEM, V23, P161, DOI 10.1002/jcc.10005; Knott M, 2004, CHEM PHYS, V307, P187, DOI 10.1016/j.chemphys.2004.06.014; Kouza M, 2006, J PHYS CHEM A, V110, P671, DOI 10.1021/jp053770b; Li MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268107; Li P, 2009, P NATL ACAD SCI USA, V106, P103, DOI 10.1073/pnas.0802986106; Mao SD, 2009, INT J THERMOPHYS, V30, P1510, DOI 10.1007/s10765-009-0646-7; MUN OZV, 2008, HFSP J */* D HFSP J, V2, P342; MUN OZV, 2002, INT J QUANTUM CHEM *, V90, P1522; MUN OZV, 2007, Annu Rev Biophys Bio, V36, P395; Naganathan AN, 2005, BIOCHEMISTRY-US, V44, P7435, DOI 10.1021/bi050118y; Naganathan AN, 2005, J AM CHEM SOC, V127, P480, DOI 10.1021/ja044449u; Naganathan AN, 2008, BIOCHEMISTRY-US, V47, P6752, DOI 10.1021/bi800336x; Naganathan AN, 2007, J AM CHEM SOC, V129, P5673, DOI 10.1021/ja0689740; Naganathan AN, 2006, BIOCHEMISTRY-US, V45, P8466, DOI 10.1021/bi060643c; Neuweiler H, 2009, J MOL BIOL, V390, P1060, DOI 10.1016/j.jmb.2009.05.011; Oliva FY, 2004, J AM CHEM SOC, V126, P8596, DOI 10.1021/ja048309w; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; POLAND DC, 1965, BIOPOLYMERS, V3, P401, DOI 10.1002/bip.1965.360030405; POLAND DC, 1965, J CHEM PHYS, V43, P2071, DOI 10.1063/1.1697076; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Sadqi M, 2007, NATURE, V445, pE17, DOI 10.1038/nature05645; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Sanchez-Ruiz JM, 2001, TRENDS BIOTECHNOL, V19, P132, DOI 10.1016/S0167-7799(00)01548-1; Settanni G, 2009, J MOL BIOL, V387, P993, DOI 10.1016/j.jmb.2009.02.014; Suzuki Y, 2005, J PHYS CHEM B, V109, P16503, DOI 10.1021/jp0512863; WIMBY JM, 1994, J CHEM ENG DATA, V39, P68, DOI 10.1021/je00013a019	54	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34549	34556		10.1074/jbc.M110.154021	http://dx.doi.org/10.1074/jbc.M110.154021			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20729560	Green Published, hybrid			2022-12-27	WOS:000283659100030
J	Cagnac, O; Aranda-Sicilia, MN; Leterrier, M; Rodriguez-Rosales, MP; Venema, K				Cagnac, Olivier; Nieves Aranda-Sicilia, Maria; Leterrier, Marina; Rodriguez-Rosales, Maria-Pilar; Venema, Kees			Vacuolar Cation/H+ Antiporters of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; MEMBRANE H+-ATPASE; NA+/H+-ANTIPORTER; YEAST; TRANSPORT; EXCHANGER; GENE; POTASSIUM; CA2+; SODIUM	We previously demonstrated that Saccharomyces cerevisiae vnx1 Delta mutant strains displayed an almost total loss of Na+ and K+/H+ antiporter activity in a vacuole-enriched fraction. However, using different in vitro transport conditions, we were able to reveal additional K+/H+ antiporter activity. By disrupting genes encoding transporters potentially involved in the vnx1 mutant strain, we determined that Vcx1p is responsible for this activity. This result was further confirmed by complementation of the vnx1 Delta vcx1 Delta nhx1 Delta triple mutant with Vcx1p and its inactivated mutant Vcx1p-H303A. Like the Ca2+/H+ antiporter activity catalyzed by Vcx1p, the K+/H+ antiporter activity was strongly inhibited by Cd2+ and to a lesser extend by Zn2+. Unlike as previously observed for NHX1 or VNX1, VCX1 overexpression only marginally improved the growth of yeast strain AXT3 in the presence of high concentrations of K+ and had no effect on hygromycin sensitivity. Subcellular localization showed that Vcx1p and Vnx1p are targeted to the vacuolar membrane, whereas Nhx1p is targeted to prevacuoles. The relative importance of Nhx1p, Vnx1p, and Vcx1p in the vacuolar accumulation of monovalent cations will be discussed.	[Cagnac, Olivier; Nieves Aranda-Sicilia, Maria; Leterrier, Marina; Rodriguez-Rosales, Maria-Pilar; Venema, Kees] CSIC, Dept Bioquim Biol Celular & Mol Plantas, Estn Expt Zaidin, E-18080 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Cagnac, O (corresponding author), CSIC, Dept Bioquim Biol Celular & Mol Plantas, Estn Expt Zaidin, Prof Albareda 1, E-18008 Granada, Spain.	olivier.cagnac@eez.csic.es	Rodriguez-Rosales, Maria Pilar/H-2481-2015; Venema, Kees/G-9558-2015	Venema, Kees/0000-0001-5177-6464; Rodriguez Rosales, Maria Pilar/0000-0001-7711-3239	Spanish Plan Nacional de Biotecnologia-FEDER [BIO2008-01691]; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [AGR436]; Consejo Superior de Investigaciones Cientificas JAE-Doc program; Consejo Superior de Investigaciones Cientificas I3P program	Spanish Plan Nacional de Biotecnologia-FEDER; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); Consejo Superior de Investigaciones Cientificas JAE-Doc program; Consejo Superior de Investigaciones Cientificas I3P program	This work was supported in part by Grants BIO2008-01691 from the Spanish Plan Nacional de Biotecnologia-FEDER and AGR436 from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (to M.-P. R.-R.).; Supported by a grant from Consejo Superior de Investigaciones Cientificas JAE-Doc program.; Supported by a grant from Consejo Superior de Investigaciones Cientificas I3P program.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; BLUMWALD E, 1987, METHOD ENZYMOL, V148, P115; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; De Hertogh B, 2006, GENETICS, V172, P771, DOI 10.1534/genetics.105.046813; Del Pozo L, 1999, YEAST, V15, P371, DOI 10.1002/(SICI)1097-0061(19990330)15:5<371::AID-YEA380>3.3.CO;2-G; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; DeWitt ND, 1998, J BIOL CHEM, V273, P21744, DOI 10.1074/jbc.273.34.21744; DUNN T, 1994, J BIOL CHEM, V269, P7273; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Halachmi D, 1996, FEBS LETT, V392, P194, DOI 10.1016/0014-5793(96)00799-5; Hernandez A, 2009, J BIOL CHEM, V284, P14276, DOI 10.1074/jbc.M806203200; Hirata T, 2002, J BIOCHEM, V131, P261, DOI 10.1093/oxfordjournals.jbchem.a003097; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; Kamiya T, 2004, J BIOL CHEM, V279, P812, DOI 10.1074/jbc.M309726200; Kellermayer R, 2004, FEBS LETT, V571, P55, DOI 10.1016/j.febslet.2004.06.049; Leidi EO, 2010, PLANT J, V61, P495, DOI 10.1111/j.1365-313X.2009.04073.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Martinez-Munoz GA, 2005, YEAST, V22, P689, DOI 10.1002/yea.1238; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; Morris J, 2008, PLANT PHYSIOL, V148, P1474, DOI 10.1104/pp.108.118810; Mukherjee S, 2006, BIOCHEM J, V398, P97, DOI 10.1042/BJ20060388; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; OKOROKOV LA, 1985, FEBS LETT, V192, P303, DOI 10.1016/0014-5793(85)80130-7; OKOROKOV LA, 1980, J BACTERIOL, V144, P661, DOI 10.1128/JB.144.2.661-665.1980; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PINNER E, 1992, J BIOL CHEM, V267, P11064; PINNER E, 1993, J BIOL CHEM, V268, P1729; Pittman JK, 2004, MOL MICROBIOL, V54, P1104, DOI 10.1111/j.1365-2958.2004.04332.x; Pittman JK, 2009, J BIOL CHEM, V284, P525, DOI 10.1074/jbc.M807173200; Pozos TC, 1996, MOL CELL BIOL, V16, P3730; Prior C, 1996, FEBS LETT, V387, P89, DOI 10.1016/0014-5793(96)00470-X; Radchenko MV, 2006, J BIOL CHEM, V281, P19822, DOI 10.1074/jbc.M600333200; Rodriguez-Navarro A, 2000, BBA-REV BIOMEMBRANES, V1469, P1, DOI 10.1016/S0304-4157(99)00013-1; Sambrook J., 2001, MOL CLONING LAB MANU; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; SIKORSKI RS, 1989, GENETICS, V122, P19; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Zhao J, 2009, J BIOL CHEM, V284, P34075, DOI 10.1074/jbc.M109.070235; Zhao J, 2009, J BIOL CHEM, V284, P4605, DOI 10.1074/jbc.M804462200	63	30	35	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33914	33922		10.1074/jbc.M110.116590	http://dx.doi.org/10.1074/jbc.M110.116590			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20709757	hybrid, Green Published			2022-12-27	WOS:000283354000038
J	Xiao, JX; Addabbo, RM; Lauer, JL; Fields, GB; Baum, J				Xiao, Jianxi; Addabbo, Rayna M.; Lauer, Janelle L.; Fields, Gregg B.; Baum, Jean			Local Conformation and Dynamics of Isoleucine in the Collagenase Cleavage Site Provide a Recognition Signal for Matrix Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL COLLAGEN; HUMAN NEUTROPHIL COLLAGENASE; HUMAN FIBROBLAST; STRUCTURAL-PROPERTIES; BACKBONE DYNAMICS; NMR-SPECTROSCOPY; I COLLAGEN; PEPTIDE; SEQUENCE; SPECIFICITY	The mechanism by which enzymes recognize the "uniform" collagen triple helix is not well understood. Matrix metalloproteinases ( MMPs) cleave collagen after the Gly residue of the triplet sequence Gly similar to [Ile/Leu]-[Ala/Leu] at a single, unique, position along the peptide chain. Sequence analysis of types I-III collagen has revealed a 5-triplet sequence pattern in which the natural cleavage triplets are always flanked by a specific distribution of imino acids. NMR and MMP kinetic studies of a series of homotrimer peptides that model type III collagen have been performed to correlate conformation and dynamics at, and near, the cleavage site to collagenolytic activity. A peptide that models the natural cleavage site is significantly more active than a peptide that models a potential but non-cleavable site just 2-triplets away and NMR studies show clearly that the Ile in the leading chain of the cleavage peptide is more exposed to solvent and less locally stable than the Ile in the middle and lagging chains. We propose that the unique local instability of Ile at the cleavage site in part arises from the placement of the conserved Pro at the P3 subsite. NMR studies of peptides with Pro substitutions indicate that the local dynamics of the three chains are directly modulated by their proximity to Pro. Correlation of peptide activity to NMR data shows that a single locally unstable chain at the cleavage site, rather than two or three labile chains, is more favorable for cleavage by MMP-1 and may be the determining factor for collagen recognition.	[Xiao, Jianxi; Addabbo, Rayna M.; Baum, Jean] Rutgers State Univ, BIOMAPS Inst, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Lauer, Janelle L.; Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	Rutgers State University New Brunswick; University of Texas System; University of Texas Health San Antonio	Baum, J (corresponding author), Rutgers State Univ, BIOMAPS Inst, Dept Chem & Chem Biol, 610 Taylor Rd, Piscataway, NJ 08854 USA.	jean.baum@rutgers.edu	Xiao, Jianxi/Q-8692-2017	Xiao, Jianxi/0000-0002-9863-572X; Addabbo, Rayna/0000-0001-5963-9392	National Institutes of Health [GM45302, CA98799, DE14318]; National Science Foundation [DBI-0403062, DBI-0320746]; Robert A. Welch Foundation; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM045302, R01GM045302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (GM45302, to J. B., CA98799, to G. B. F., and DE14318 COSTAR Program, to J. L. L.), the National Science Foundation (DBI-0403062 and DBI-0320746, to J. B.), and the Robert A. Welch Foundation (to G. B. F.).	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baragi VM, 1997, SCAND J GASTROENTERO, V32, P419, DOI 10.3109/00365529709025075; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cawston T, 1999, ANN NY ACAD SCI, V878, P120, DOI 10.1111/j.1749-6632.1999.tb07678.x; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Englander SW, 2001, NAT STRUCT BIOL, V8, P741, DOI 10.1038/nsb0901-741; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Fields G B, 1992, Matrix Suppl, V1, P68; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; FIELDS GB, 1987, J BIOL CHEM, V262, P6221; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GROSS J, 1980, COLLAGENASE NORMAL P; HASTY KA, 1993, MATRIX, V13, P181, DOI 10.1016/S0934-8832(11)80001-6; HIGHBERGER JH, 1979, BIOCHEM BIOPH RES CO, V89, P202, DOI 10.1016/0006-291X(79)90964-1; Huyghues-Despointes B M, 2001, Methods Mol Biol, V168, P69; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kielty C.M., 2002, CONNECTIVE TISSUE IT; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; Li YJ, 2009, J BIOL CHEM, V284, P20660, DOI 10.1074/jbc.M109.018077; Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v; MALLYA SK, 1990, BIOCHEMISTRY-US, V29, P10628, DOI 10.1021/bi00499a008; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; MILLER EJ, 1976, BIOCHEMISTRY-US, V15, P787, DOI 10.1021/bi00649a009; MILLER EJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P631, DOI 10.1016/0003-9861(76)90300-3; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Moy FJ, 1998, BIOCHEMISTRY-US, V37, P1495, DOI 10.1021/bi972181w; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Nerenberg PS, 2008, PROTEINS, V70, P1154, DOI 10.1002/prot.21687; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4; Palmer Arthur G. Iii, 1993, Current Opinion in Biotechnology, V4, P385, DOI 10.1016/0958-1669(93)90002-E; Ramachandran G N., 1967, TREATISE COLLAGEN; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Riley GP, 1995, EYE, V9, P703, DOI 10.1038/eye.1995.182; RYHANEN L, 1983, ARCH BIOCHEM BIOPHYS, V223, P562, DOI 10.1016/0003-9861(83)90621-5; Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075; VANDERREST M, 1991, BIOCHEM SOC T, V19, P820, DOI 10.1042/bst0190820; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WELGUS HG, 1982, J BIOL CHEM, V257, P1534; Woessner JF, 1998, BIOL EXTRAC, P1; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888; Xiao JX, 2009, J AM CHEM SOC, V131, P18194, DOI 10.1021/ja9056823	64	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34181	34190		10.1074/jbc.M110.128355	http://dx.doi.org/10.1074/jbc.M110.128355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20679339	hybrid, Green Published			2022-12-27	WOS:000283354000063
J	Dong, XY; Sun, XD; Guo, P; Li, QN; Sasahara, M; Ishii, Y; Dong, JT				Dong, Xue-Yuan; Sun, Xiaodong; Guo, Peng; Li, Qunna; Sasahara, Masakiyo; Ishii, Yoko; Dong, Jin-Tang			ATBF1 Inhibits Estrogen Receptor (ER) Function by Selectively Competing with AIB1 for Binding to the ER in ER-positive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; TAMOXIFEN RESISTANCE; COACTIVATOR AIB1; PROSTATE-CANCER; REGULATED TRANSCRIPTION; MAMMARY TUMORIGENESIS; EXPRESSION; PROTEIN; MUTATIONS; CANDIDATE	Loss of the q22 band of chromosome 16 is a frequent genetic event in breast cancer, and the candidate tumor suppressor gene, ATBF1, has been implicated in breast cancer by genomic deletion, transcriptional down-regulation, and association with better prognostic parameters. In addition, estrogen receptor (ER)-positive breast cancer expresses a higher level of ATBF1, suggesting a role of ATBF1 in ER-positive breast cancer. In this study, we examined whether and how ATBF1 affects the ER function in breast cancer cells. We found that ATBF1 inhibited ER-mediated gene transcription, cell growth, and proliferation in ER-positive breast cancer cells. In vitro and in vivo immuno-precipitation experiments revealed that ATBF1 interacted physically with the ER and that multiple domains in both ATBF1 and ER proteins mediated the interaction. Furthermore, we demonstrated that ATBF1 inhibited ER function by selectively competing with the steroid receptor coactivator AIB1 but not GRIP1 or SRC1 for binding to the ER. These findings not only support the concept that ATBF1 plays a tumor-suppressive role in breast cancer, they also provide a mechanism for how ATBF1 functions as a tumor suppressor in breast cancer.	[Dong, Xue-Yuan; Sun, Xiaodong; Guo, Peng; Li, Qunna; Dong, Jin-Tang] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Dong, Xue-Yuan; Sun, Xiaodong; Guo, Peng; Li, Qunna; Dong, Jin-Tang] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Sasahara, Masakiyo; Ishii, Yoko] Toyama Univ, Dept Pathol, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan	Emory University; Emory University; University of Toyama	Dong, JT (corresponding author), 1365-C Clifton Rd, Atlanta, GA 30322 USA.	j.dong@emory.edu	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019	Dong, Jin-Tang/0000-0003-2349-5782; Guo, Peng/0000-0002-4575-8443	National Institutes of Health [CA85560]; Department of Defense [W81XWH-08-1-0328]; Georgia Cancer Coalition Award [GCC130042]; NATIONAL CANCER INSTITUTE [R01CA085560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Georgia Cancer Coalition Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA85560 (to J.-T.D.). This work was also supported by Department of Defense Grant W81XWH-08-1-0328 (to X.-Y.D.) and by Georgia Cancer Coalition Award GCC130042 (to X.-Y.D.).	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BRYANT J, 2001, J NATL CANC I MONOGR, V30, P56; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cleton-Jansen AM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-105; Cottone E, 2001, INT J BIOL MARKER, V16, P151, DOI 10.1177/172460080101600301; Dobrzycka KM, 2003, ENDOCR-RELAT CANCER, V10, P517, DOI 10.1677/erc.0.0100517; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Ferguson AT, 1997, CRIT REV ONCOGENESIS, V8, P29, DOI 10.1615/CritRevOncog.v8.i1.20; Fisher B, 2001, J Natl Cancer Inst Monogr, P62; Gronwald J, 2005, INT J CANCER, V114, P230, DOI 10.1002/ijc.20723; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Hartel A, 2003, J STEROID BIOCHEM, V84, P231, DOI 10.1016/S0960-0760(03)00033-5; HENDERSON IC, 1993, CANCER-AM CANCER SOC, V71, P2127, DOI 10.1002/1097-0142(19930315)71:6+<2127::AID-CNCR2820711602>3.0.CO;2-2; Iwase H, 2003, BREAST CANCER RES TR, V80, P339, DOI 10.1023/A:1024916126532; Kai K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-262; Kuang SQ, 2005, CANCER RES, V65, P7993, DOI 10.1158/0008-5472.CAN-05-1179; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lemieux P, 1996, J STEROID BIOCHEM, V56, P87, DOI 10.1016/0960-0760(95)00269-3; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Louie MC, 2006, MOL CELL BIOL, V26, P3810, DOI 10.1128/MCB.26.10.3810-3823.2006; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Murphy TJ, 2002, METHOD ENZYMOL, V345, P539; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Singh RR, 2006, J BIOL CHEM, V281, P25612, DOI 10.1074/jbc.M604444200; Su QB, 2008, ONCOLOGY-BASEL, V75, P159, DOI 10.1159/000159267; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2007, J CANCER RES CLIN, V133, P103, DOI 10.1007/s00432-006-0148-y; Thorat MA, 2008, HISTOPATHOLOGY, V53, P634, DOI 10.1111/j.1365-2559.2008.03155.x; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Xu JY, 2006, PROSTATE, V66, P1082, DOI 10.1002/pros.20430; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang ZH, 2005, CLIN CANCER RES, V11, P193; Zhao WH, 2009, BIOCHEM BIOPH RES CO, V380, P699, DOI 10.1016/j.bbrc.2009.01.155	48	39	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32801	32809		10.1074/jbc.M110.128330	http://dx.doi.org/10.1074/jbc.M110.128330			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720010	Green Published, hybrid			2022-12-27	WOS:000283048200016
J	Foeger, NC; Marionneau, C; Nerbonne, JM				Foeger, Nicholas C.; Marionneau, Celine; Nerbonne, Jeanne M.			Co-assembly of Kv4 alpha Subunits with K+ Channel-interacting Protein 2 Stabilizes Protein Expression and Promotes Surface Retention of Channel Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; PYRAMIDAL NEURONS; VENTRICULAR HYPERTROPHY; TERMINAL DOMAIN; TRAFFICKING; MODULATION; FAMILY; IDENTIFICATION; COMPONENTS; DELETION	Members of the K+ channel-interacting protein (KChIP) family bind the distal N termini of members of the Shal subfamily of voltage-gated K+ channel (Kv4) pore-forming (alpha) subunits to generate rapidly activating, rapidly inactivating neuronal A-type (I-A) and cardiac transient outward (I-to) currents. In heterologous cells, KChIP co-expression increases cell surface expression of Kv4 alpha subunits and Kv4 current densities, findings interpreted to suggest that Kv4.KChIP complex formation enhances forward trafficking of channels (from the endoplasmic reticulum or the Golgi complex) to the surface membrane. The results of experiments here, however, demonstrate that KChIP2 increases cell surface Kv4.2 protein expression (similar to 40-fold) by an order of magnitude more than the increase in total protein (similar to 2-fold) or in current densities (similar to 3-fold), suggesting that mechanisms at the cell surface regulate the functional expression of Kv4.2 channels. Additional experiments demonstrated that KChIP2 decreases the turnover rate of cell surface Kv4.2 protein by inhibiting endocytosis and/or promoting recycling. Unexpectedly, the experiments here also revealed that Kv4.2.KChIP2 complex formation stabilizes not only (total and cell surface) Kv4.2 but also KChIP2 protein expression. This reciprocal protein stabilization and Kv4.KChIP2 complex formation are lost with deletion of the distal (10 amino acids) Kv4.2 N terminus. Taken together, these observations demonstrate that KChIP2 differentially regulates total and cell surface Kv4.2 protein expression and Kv4 current densities.	[Foeger, Nicholas C.; Marionneau, Celine; Nerbonne, Jeanne M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nerbonne, JM (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, 660 Euclid Ave,Box 8103, St Louis, MO 63110 USA.	jnerbonne@wustl.edu	Marionneau, Céline/D-4011-2015	Marionneau, Céline/0000-0003-0962-9756	National Institutes of Health [HL034161]; NHLBI, National Institutes of Health [T32-007275]; Heartland Affiliate of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Heartland Affiliate of the American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL034161 (to J. M. N.).; Supported by NHLBI, National Institutes of Health Institutional Training Grant T32-007275.; Supported by a Heartland Affiliate of the American Heart Association postdoctoral fellowship. Present address: L'Institut du Thorax, INSERM UMR-915, Institut de Recherche Therapeutique-Universite de Nantes, Nantes, France.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Han W, 2006, J BIOL CHEM, V281, P27134, DOI 10.1074/jbc.M604843200; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Hatano N, 2002, PFLUG ARCH EUR J PHY, V444, P80, DOI 10.1007/s00424-002-0798-9; Johns DC, 1999, J NEUROSCI, V19, P1691; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Li HL, 2005, J MOL CELL CARDIOL, V39, P121, DOI 10.1016/j.yjmcc.2005.03.013; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; PHELAN MC, 2007, BASIC TECHNIQUES CEL, pCH1; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salvador-Recatala V, 2006, J EXP BIOL, V209, P731, DOI 10.1242/jeb.02032; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387	37	31	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33413	33422		10.1074/jbc.M110.145185	http://dx.doi.org/10.1074/jbc.M110.145185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20709747	Green Published, hybrid			2022-12-27	WOS:000283048200076
J	Houmeida, A; Heeley, DH; Belknap, B; White, HD				Houmeida, Ahmed; Heeley, David H.; Belknap, Betty; White, Howard D.			Mechanism of Regulation of Native Cardiac Muscle Thin Filaments by Rigor Cardiac Myosin-S1 and Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; RABBIT SKELETAL-MUSCLE; COOPERATIVE EQUILIBRIUM BINDING; ACTIN-TROPONIN-TROPOMYOSIN; ACTOMYOSIN SUBFRAGMENT-1; FLUORESCENT-PROBE; SLOW SKELETAL; HEART; BOVINE; CONTRACTION	We have studied the mechanism of activation of native cardiac thin filaments by calcium and rigor myosin. The acceleration of the rate of 2' -deoxy-3'-O-(N-methylanthraniloyl) ADP (mdADP) dissociation from cardiac myosin-S1-mdADP-P-i and cardiac myosin-S1-mdADP by native cardiac muscle thin filaments was measured using double mixing stopped-flow fluorescence. Relative to inhibited thin filaments (no bound calcium or rigor S1), fully activated thin filaments (with both calcium and rigor-S1 bound) increase the rate of product dissociation from the physiologically important pre-power stroke myosinmdADP-P-i by a factor of similar to 75. This can be compared with only an similar to 6-fold increase in the rate of nucleotide diphosphate dissociation from nonphysiological myosin-mdADP by the fully activated thin filaments relative to the fully inhibited thin filaments. These results show that physiological levels of regulation are not only dependent on the state of the thin filament but also on the conformation of the myosin. Less than 2-fold regulation is due to a change in affinity of myosin-ADP-P-i for thin filaments such as would be expected by a simple "steric blocking" of the myosin-binding site of the thin filament by tropomyosin. Although maximal activation requires both calcium and rigor myosin-S1 bound to the cardiac filament, association with a single ligand produces similar to 70% maximal activation. This can be contrasted with skeletal thin filaments in which calcium alone only activated the rate of product dissociation similar to 20% of maximum, and rigor myosin produces similar to 30% maximal activation.	[Belknap, Betty; White, Howard D.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; Univ Nouakchott, Dept Biochem, Nouakchott 5026, Mauritania; [Heeley, David H.] Mem Univ, Dept Biochem, St John, NF A1B 3X9, Canada	Eastern Virginia Medical School; University of Nouakchott; Memorial University Newfoundland	White, HD (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	WhiteHD@evms.edu			National Institutes of Health [HL84604, EB00209]; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants HL84604 and EB00209 (to H. D. W.). This work was also supported by Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada research grants (to D. H. H.).	ANDERSON PAW, 1991, CIRC RES, V69, P1226, DOI 10.1161/01.RES.69.5.1226; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CabralLilly D, 1997, BIOPHYS J, V73, P1763, DOI 10.1016/S0006-3495(97)78206-7; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; COHEN C, 1975, SCI AM, V233, P36, DOI 10.1038/scientificamerican1175-36; COLLINS JH, 1975, J BIOL CHEM, V250, P5915; COLLINS JH, 1973, FEBS LETT, V36, P268, DOI 10.1016/0014-5793(73)80388-6; COOPER TA, 1985, J BIOL CHEM, V260, P1140; CUMMINS P, 1974, BIOCHEM J, V141, P43, DOI 10.1042/bj1410043; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; GRAND RJA, 1976, BIOCHEM J, V159, P633, DOI 10.1042/bj1590633; HEAD JG, 1995, EUR J BIOCHEM, V227, P694, DOI 10.1111/j.1432-1033.1995.tb20190.x; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; Heeley DH, 2002, P NATL ACAD SCI USA, V99, P16731, DOI 10.1073/pnas.252236399; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; HILL TL, 1983, P NATL ACAD SCI-BIOL, V80, P60, DOI 10.1073/pnas.80.1.60; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; HUMPHREYS JE, 1984, J MOL CELL CARDIOL, V16, P643, DOI 10.1016/S0022-2828(84)80628-8; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; KRETSINGER RH, 1975, BIOCHIM BIOPHYS ACTA, V405, P40, DOI 10.1016/0005-2795(75)90312-8; LESZYK J, 1987, BIOCHEMISTRY-US, V26, P7035, DOI 10.1021/bi00396a027; LEWIS WG, 1980, J BIOL CHEM, V255, P6854; MAK AS, 1981, J MOL BIOL, V149, P541, DOI 10.1016/0022-2836(81)90486-1; Matsumoto F, 2004, J MOL BIOL, V342, P1209, DOI 10.1016/j.jmb.2004.07.086; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Maytum R, 2003, J BIOL CHEM, V278, P6696, DOI 10.1074/jbc.M210690200; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; OHTSUKI I, 1979, J BIOCHEM, V86, P491, DOI 10.1093/oxfordjournals.jbchem.a132549; PEARLSTONE JR, 1976, P NATL ACAD SCI USA, V73, P1902, DOI 10.1073/pnas.73.6.1902; PEARLSTONE JR, 1986, J BIOL CHEM, V261, P6795; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; Spiess M, 1999, J STRUCT BIOL, V126, P98, DOI 10.1006/jsbi.1999.4111; Steffen W, 2004, P NATL ACAD SCI USA, V101, P12904, DOI 10.1073/pnas.0400227101; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2374; TOBACMAN LS, 1986, BIOCHEMISTRY-US, V25, P798, DOI 10.1021/bi00352a010; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; VANDEKERCKHOVE J, 1979, DIFFERENTIATION, V14, P123, DOI 10.1111/j.1432-0436.1979.tb01021.x; VANEERD JP, 1976, BIOCHEMISTRY-US, V15, P1171, DOI 10.1021/bi00650a033; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; WHITE HD, 1985, J BIOL CHEM, V260, P982; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; WHITE HD, 1982, METHOD ENZYMOL, V85, P698; WILKINSON JM, 1978, NATURE, V271, P31, DOI 10.1038/271031a0; WILKINSON JM, 1980, EUR J BIOCHEM, V103, P179, DOI 10.1111/j.1432-1033.1980.tb04302.x; WILLIAMS DL, 1988, BIOCHEMISTRY-US, V27, P6987, DOI 10.1021/bi00418a048; [No title captured]	54	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32760	32769		10.1074/jbc.M109.098228	http://dx.doi.org/10.1074/jbc.M109.098228			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20696756	Green Published, hybrid			2022-12-27	WOS:000283048200011
J	Jiang, YS; Huang, Y; Wong, HC; Zhou, YB; Wang, X; Yang, J; Hall, RA; Brown, EM; Yang, JJ				Jiang, Yusheng; Huang, Yun; Wong, Hing-Cheung; Zhou, Yubin; Wang, Xue; Yang, Jun; Hall, Randy A.; Brown, Edward M.; Yang, Jenny J.			Elucidation of a Novel Extracellular Calcium-binding Site on Metabotropic Glutamate Receptor 1 alpha (mGluR1 alpha) That Controls Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-BINDING SITES; CA2+-SENSING RECEPTORS; SENSING RECEPTOR; STRUCTURAL BASIS; PROTEINS; CA2+; AFFINITY; DOMAIN; CELLS; GLUTAMATE-RECEPTOR-1-ALPHA	Metabotropic glutamate receptor 1 alpha (mGluR1 alpha) exerts important effects on numerous neurological processes. Although mGluR1 alpha is known to respond to extracellular Ca2+ ([Ca2+](o)) and the crystal structures of the extracellular domains (ECDs) of several mGluRs have been determined, the calcium-binding site(s) and structural determinants of Ca2+-modulated signaling in the Glu receptor family remain elusive. Here, we identify a novel Ca2+-binding site in the mGluR1 alpha ECD using a recently developed computational algorithm. This predicted site (comprising Asp-318, Glu-325, and Asp-322 and the carboxylate side chain of the receptor agonist, Glu) is situated in the hinge region in the ECD of mGluR1 alpha adjacent to the reported Glu-binding site, with Asp-318 involved in both Glu and calcium binding. Mutagenesis studies indicated that binding of Glu and Ca2+ to their distinct but partially overlapping binding sites synergistically modulated mGluR1 alpha activation of intracellular Ca2+ ([Ca2+](i)) signaling. Mutating the Glu-binding site completely abolished Glu signaling while leaving its Ca2+-sensing capability largely intact. Mutating the predicted Ca2+-binding residues abolished or significantly reduced the sensitivity of mGluR1 alpha not only to [Ca2+](o) and [Gd3+](o) but also, in some cases, to Glu. The dual activation of mGluR1 alpha by [Ca2+](o) and Glu has important implications for the activation of other mGluR subtypes and related receptors. It also opens up new avenues for developing allosteric modulators of mGluR function that target specific human diseases.	[Yang, Jenny J.] Georgia State Univ, Dept Chem, Nat Sci Ctr 552, Atlanta, GA 30303 USA; [Wang, Xue] Georgia State Univ, Ctr Drug Design & Adv Biotechnol, Dept Comp Sci, Atlanta, GA 30303 USA; [Yang, Jun] Hangzhou Normal Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310036, Zhejiang, Peoples R China; [Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Brown, Edward M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Hangzhou Normal University; Emory University; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Nat Sci Ctr 552, Atlanta, GA 30303 USA.	chejjy@langate.gsu.edu	Jiang, Yusheng/A-1087-2016; Zhou, Yubin/D-4748-2011	Zhou, Yubin/0000-0001-7962-0517; Hall, Randy/0000-0002-8318-8728; Huang, Yun/0000-0001-5950-9168	National Institutes of Health [GM081749-01, DK078331, NS055179]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081749-01 (to J. J. Y.), DK078331 (to E. M. B.), and NS055179 (to R. A. H.).	Abe H, 2003, MOL CELL NEUROSCI, V23, P157, DOI 10.1016/S1044-7431(03)00052-6; Abe H, 2003, FEBS LETT, V545, P233, DOI 10.1016/S0014-5793(03)00569-6; Breitwieser GE, 2004, CELL CALCIUM, V35, P209, DOI 10.1016/j.ceca.2003.10.013; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chou TC, 1996, CALCUSYN WINDOWS SOF; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Deng H, 2006, PROTEINS, V64, P34, DOI 10.1002/prot.20973; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Francesconi A, 2004, J NEUROSCI RES, V75, P472, DOI 10.1002/jnr.10853; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Hardingham NR, 2006, J NEUROSCI, V26, P6337, DOI 10.1523/JNEUROSCI.5128-05.2006; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Jones LM, 2008, PROTEIN SCI, V17, P439, DOI 10.1110/ps.073328208; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kawabata S, 1998, J BIOL CHEM, V273, P17381, DOI 10.1074/jbc.273.28.17381; Kirberger M, 2008, J BIOL INORG CHEM, V13, P1169, DOI 10.1007/s00775-008-0402-7; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Kubokawa K, 1996, FEBS LETT, V392, P71, DOI 10.1016/0014-5793(96)00786-7; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Miyashita T, 2000, RECEPTOR CHANNEL, V7, P25; Mun HC, 2005, J BIOL CHEM, V280, P29067, DOI 10.1074/jbc.M500002200; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nash MS, 2001, J BIOL CHEM, V276, P19286, DOI 10.1074/jbc.M007600200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato T, 2003, J BIOL CHEM, V278, P4314, DOI 10.1074/jbc.M210278200; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Tabata T, 2004, MOL NEUROBIOL, V29, P261, DOI 10.1385/MN:29:3:261; Tabata T, 2002, MOL CELL NEUROSCI, V20, P56, DOI 10.1006/mcne.2002.1118; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Vassilev PM, 1997, BIOPHYS J, V72, P2103, DOI 10.1016/S0006-3495(97)78853-2; Wang X, 2010, PROTEIN SCI, V19, P1180, DOI 10.1002/pro.394; Wang X, 2009, PROTEINS, V75, P787, DOI 10.1002/prot.22285; Yang W, 2005, J AM CHEM SOC, V127, P2085, DOI 10.1021/ja0431307; Ye YM, 2005, J AM CHEM SOC, V127, P3743, DOI 10.1021/ja042786x; Ye YM, 2003, PROTEIN ENG, V16, P429, DOI 10.1093/protein/gzg051; Ye YM, 2001, PROTEIN ENG, V14, P1001, DOI 10.1093/protein/14.12.1001; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200	48	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33463	33474		10.1074/jbc.M110.147033	http://dx.doi.org/10.1074/jbc.M110.147033			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705606	Green Published, hybrid			2022-12-27	WOS:000283048200081
J	Zhou, X; Ma, Y; Sugiura, R; Kobayashi, D; Suzuki, M; Deng, L; Kuno, T				Zhou, Xin; Ma, Yan; Sugiura, Reiko; Kobayashi, Daiki; Suzuki, Masahiro; Deng, Lu; Kuno, Takayoshi			MAP Kinase Kinase Kinase ( MAPKKK)-dependent and -independent Activation of Sty1 Stress MAPK in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; ATF1 TRANSCRIPTION FACTOR; MCS4 RESPONSE REGULATOR; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; CELL-CYCLE; SPC1 KINASE; PATHWAY; TOXICITY; HOMOLOG	In fission yeast, the Sty1/Spc1/Phh1 mitogen-activated protein kinase (MAPK) pathway is known to be involved in multiple-stress responses. It is currently thought that the Sty1 MAPK cascade is mediated by histidine kinases and phosphorelay proteins in response to oxidative stress signals. However, studies of the exact transduction mechanism of multiple-stress responses are lacking. Thus, in response to various stimuli, we monitored the Sty1 MAPK pathway through the downstream transcription factor Atf1 in living cells using a highly sensitive luciferase reporter gene. Surprisingly, in cadmium and low glucose (LG) medium, Atf1 activation was observed even in the absence of all of the four fission yeast MAPK kinase kinases (MAPKKKs); whereas in osmotic stress, Atf1 activation was abolished. Thus, the osmotic stress likely mediates the MAPK activation via MAPKKKs, whereas a cadmium or LG condition activates the MAPKin a MAPKKK-independent manner. On the other hand, knockout of tyrosine phosphatase gene pyp1(+) abolished the Atf1 response to cadmium and LG, but not to osmotic stress, suggesting that Pyp1 is a sensor for cadmium and LG.	[Zhou, Xin; Ma, Yan; Kobayashi, Daiki; Suzuki, Masahiro; Deng, Lu; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Div Mol Pharmacol & Pharmacogenom, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogenom, Higashiosaka, Osaka 5778502, Japan	Kobe University; Kindai University (Kinki University)	Kuno, T (corresponding author), Kobe Univ, Grad Sch Med, Div Mol Pharmacol & Pharmacogenom, Dept Biochem & Mol Biol,Chuo Ku, Kusunoki Cho 6-5-1, Kobe, Hyogo 6500017, Japan.	tkuno@med.kobe-u.ac.jp			Global Centers of Excellence; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Global Centers of Excellence; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Global Centers of Excellence Program and research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aoyama K, 2000, J BACTERIOL, V182, P4868, DOI 10.1128/JB.182.17.4868-4874.2000; Avery SV, 2001, ADV APPL MICROBIOL, V49, P111, DOI 10.1016/S0065-2164(01)49011-3; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; CHO HJ, 1992, BIOCHEMISTRY-US, V31, P133, DOI 10.1021/bi00116a019; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Loewith R, 2000, J CELL SCI, V113, P153; Ma Y, 2007, CURR GENET, V52, P97, DOI 10.1007/s00294-007-0142-1; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MASUDA T, 1995, J BIOL CHEM, V270, P1979, DOI 10.1074/jbc.270.5.1979; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Nguyen AN, 2000, MOL BIOL CELL, V11, P1169, DOI 10.1091/mbc.11.4.1169; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Samejima I, 1997, EMBO J, V16, P6162, DOI 10.1093/emboj/16.20.6162; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Shieh JC, 1997, GENE DEV, V11, P1008, DOI 10.1101/gad.11.8.1008; Shiozaki K, 1997, MOL BIOL CELL, V8, P409, DOI 10.1091/mbc.8.3.409; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SHIOZAKI K, 1995, EMBO J, V14, P492, DOI 10.1002/j.1460-2075.1995.tb07025.x; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Toda T, 1996, MOL CELL BIOL, V16, P6752; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635	38	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32818	32823		10.1074/jbc.M110.135764	http://dx.doi.org/10.1074/jbc.M110.135764			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729203	hybrid, Green Published			2022-12-27	WOS:000283048200018
J	Bresnick, EH; Lee, HY; Fujiwara, T; Johnson, KD; Keles, S				Bresnick, Emery H.; Lee, Hsiang-Ying; Fujiwara, Tohru; Johnson, Kirby D.; Keles, Sunduz			GATA Switches as Developmental Drivers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSCRIPTION FACTOR GATA-1; CHROMATIN DOMAIN ACTIVATION; ZINC-FINGER PROTEIN; DNA-BINDING; GENE-EXPRESSION; ERYTHROID DEVELOPMENT; DEPENDENT REGULATION; HEMATOPOIETIC-CELLS; FACTOR INTERPLAY; GLOBIN LOCUS	Transcriptional networks orchestrate complex developmental processes. Such networks are commonly instigated by master regulators of development. Considerable progress has been made in elucidating GATA factor-dependent genetic networks that control blood cell development. GATA-2 is required for the genesis and/or function of hematopoietic stem cells, whereas GATA-1 drives the differentiation of hematopoietic progenitors into a subset of the blood cell lineages. GATA-1 directly represses Gata2 transcription, and this involves GATA-1-mediated displacement of GATA-2 from chromatin, a process termed a GATA switch. GATA switches occur at numerous loci with critical functions, indicating that they are widely utilized developmental control tools.	[Bresnick, Emery H.; Lee, Hsiang-Ying; Fujiwara, Tohru; Johnson, Kirby D.] Univ Wisconsin, Sch Med & Publ Hlth, Paul Carbone Comprehens Canc Ctr, Div Hematol Oncol,Dept Pharmacol, Madison, WI 53705 USA; [Bresnick, Emery H.; Lee, Hsiang-Ying; Fujiwara, Tohru; Johnson, Kirby D.] Univ Wisconsin, Sch Med & Publ Hlth, Paul Carbone Comprehens Canc Ctr, Dept Med, Madison, WI 53705 USA; [Keles, Sunduz] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bresnick, EH (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Paul Carbone Comprehens Canc Ctr, Div Hematol Oncol,Dept Pharmacol, Madison, WI 53705 USA.	ehbresni@wisc.edu	cheng, yong/I-4270-2012; Fujiwara, Tohru/GOG-9775-2022	Lee, Hsiang-Ying/0000-0002-1503-5818	National Institutes of Health [DK50107, DK68034]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050107, R37DK050107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK50107 and DK68034. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.; Supported by an American Heart Association predoctoral fellowship.	Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Bresnick EH, 2005, J CELL PHYSIOL, V205, P1, DOI 10.1002/jcp.20393; Bresnick EH, 2006, PROG NUCLEIC ACID RE, V81, P435, DOI 10.1016/S0079-6603(06)81011-1; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Cantor AB, 2008, J EXP MED, V205, P611, DOI 10.1084/jem.20070544; Caprioli A, 2001, DEV BIOL, V238, P64, DOI 10.1006/dbio.2001.0362; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Charron F, 1999, MOL CELL BIOL, V19, P4355; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Collavin L, 2004, P NATL ACAD SCI USA, V101, P8870, DOI 10.1073/pnas.0308605101; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Dame C, 2004, J BIOL CHEM, V279, P2955, DOI 10.1074/jbc.M310404200; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara Y, 2004, BLOOD, V103, P583, DOI 10.1182/blood-2003-08-2870; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Goodman RH, 2000, GENE DEV, V14, P1553; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Heicklen-Klein A, 2005, SEMIN CELL DEV BIOL, V16, P95, DOI 10.1016/j.semcdb.2004.10.004; Hirasawa R, 2002, J EXP MED, V195, P1379, DOI 10.1084/jem.20020170; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Johnson KD, 2007, BLOOD, V109, P5230, DOI 10.1182/blood-2007-02-072983; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Kadri Z, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000123; Katz SG, 2002, MOL CELL BIOL, V22, P3121, DOI 10.1128/MCB.22.9.3121-3128.2002; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Kim SI, 2007, MOL CELL BIOL, V27, P4551, DOI 10.1128/MCB.00235-07; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Kobayashi-Osaki M, 2005, MOL CELL BIOL, V25, P7005, DOI 10.1128/MCB.25.16.7005-7020.2005; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lee HY, 2009, MOL CELL, V36, P984, DOI 10.1016/j.molcel.2009.11.005; LEE ME, 1991, J BIOL CHEM, V266, P16188; LEONARD M, 1993, BLOOD, V82, P1071; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Lurie LJ, 2008, BIOCHEMISTRY-US, V47, P859, DOI 10.1021/bi701692p; Ma GT, 1997, DEVELOPMENT, V124, P907; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Martowicz ML, 2005, J BIOL CHEM, V280, P1724, DOI 10.1074/jbc.M406038200; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Minegishi N, 1999, BLOOD, V93, P4196, DOI 10.1182/blood.V93.12.4196.412k23_4196_4207; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Newton A, 2001, J BIOL CHEM, V276, P35794, DOI 10.1074/jbc.M106256200; NG YK, 1994, DEVELOPMENT, V120, P3257; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; ORKIN SH, 1992, BLOOD, V80, P575; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Pedone PV, 1997, EMBO J, V16, P2874, DOI 10.1093/emboj/16.10.2874; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PEVNY L, 1995, DEVELOPMENT, V121, P163; Pope NJ, 2010, NUCLEIC ACIDS RES, V38, P2190, DOI 10.1093/nar/gkp1159; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; Snow JW, 2009, J BIOL CHEM, V284, P29310, DOI 10.1074/jbc.M109.043497; SNOW JW, 2010, PLOS GENET IN PRESS; Song HH, 2009, J BIOL CHEM, V284, P29109, DOI 10.1074/jbc.M109.041145; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; WILSON DB, 1990, MOL CELL BIOL, V10, P4854, DOI 10.1128/MCB.10.9.4854; Wozniak RJ, 2008, MOL CELL BIOL, V28, P6681, DOI 10.1128/MCB.01061-08; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105; Zhou YH, 2000, DEVELOPMENT, V127, P3829	100	197	201	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31087	31093		10.1074/jbc.R110.159079	http://dx.doi.org/10.1074/jbc.R110.159079			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670937	Green Published, hybrid			2022-12-27	WOS:000282764600001
J	Fong, JE; Le Nihouannen, D; Komarova, SV				Fong, Jenna E.; Le Nihouannen, Damien; Komarova, Svetlana V.			Tumor-supportive and Osteoclastogenic Changes Induced by Breast Cancer-derived Factors Are Reversed by Inhibition of gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE METASTASIS; RANK LIGAND; TGF-BETA; KAPPA-B; CELLS; OSTEOBLASTS; EXPRESSION; DIFFERENTIATION; OSTEOPROTEGERIN; PRECURSORS	During breast cancer metastasis to bone, tumor cells home to bone marrow, likely targeting the stem cell niche, and stimulate osteoclasts, which mediate osteolysis required for tumor expansion. Although osteoblasts contribute to the regulation of the hematopoietic stem cell niche and control osteoclastogenesis through production of proresorptive cytokine RANKL(receptor activator of NF-kappa B ligand), their role in cancer metastases to bone is not fully understood. C57BL/6J mouse bone marrow cells were treated for 3-12 days with ascorbic acid (50 mu g/ml) in the presence or absence of 10% medium conditioned by breast carcinoma cells MDA-MB-231, 4T1, or MCF7. Treatment with cancer-derived factors resulted in a sustained 40-60% decrease in osteoblast differentiation markers, compared with treatment with ascorbic acid alone, and induced an osteoclastogenic change in the RANKL/osteoprotegerin ratio. Importantly, exposure of bone cells to breast cancer-derived factors stimulated the subsequent attachment of cancer cells to immature osteoblasts. Inhibition of gamma-secretase using pharmacological inhibitors DAPT and Compound E completely reversed cancer-induced osteoclastogenesis as well as cancer-induced enhancement of cancer cell attachment, identifying gamma-secretase activity as a key mediator of these effects. Thus, we have uncovered osteoblasts as critical intermediary of premetastatic signaling by breast cancer cells and pinpointed gamma-secretase as a robust target for developing therapeutics potentially capable of reducing both homing and progression of cancer metastases to bone.	[Fong, Jenna E.; Le Nihouannen, Damien; Komarova, Svetlana V.] McGill Univ, Fac Dent, Montreal, PQ H3A 1A4, Canada	McGill University	Komarova, SV (corresponding author), 740 Dr Penfield Ave 2201, Montreal, PQ H3A 1A4, Canada.	svetlana.komarova@mcgill.ca		LE NIHOUANNEN, Damien/0000-0003-1539-5183	Institute for Musculoskeletal Health and Arthritis/Canadian Institute for Health Research; Canadian Institute for Health Research in Skeletal Health Research; McGill University; Canadian Arthritis Network; les Fonds de la Recherche en Sante du Quebec	Institute for Musculoskeletal Health and Arthritis/Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Health Research in Skeletal Health Research(Canadian Institutes of Health Research (CIHR)); McGill University; Canadian Arthritis Network; les Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Institute for Musculoskeletal Health and Arthritis/Canadian Institute for Health Research.; Supported by the Canadian Institute for Health Research Training Program in Skeletal Health Research and by McGill University.; Supported by the Canadian Institute for Health Research Training Program in Skeletal Health Research, the Canadian Arthritis Network, and les Fonds de la Recherche en Sante du Quebec.	Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Baldock PA, 2006, J BONE MINER RES, V21, P1618, DOI 10.1359/JBMR.060714; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Canalis E, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe17; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Fromigue O, 2001, J BONE MINER RES, V16, P1600, DOI 10.1359/jbmr.2001.16.9.1600; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Guo YB, 2008, BONE, V43, P386, DOI 10.1016/j.bone.2008.03.026; HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER METAST REV, V25, P521, DOI 10.1007/s10555-006-9036-9; KIM CJ, 2004, BREAST COMPREHENSIVE; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Lau YS, 2007, BREAST CANCER RES TR, V105, P7, DOI 10.1007/s10549-006-9438-y; Mendoza M, 2009, INT J BIOCHEM CELL B, V41, P1452, DOI 10.1016/j.biocel.2009.01.015; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Neiva K, 2005, BRAZ J MED BIOL RES, V38, P1449, DOI 10.1590/S0100-879X2005001000001; Phadke PA, 2006, CLIN CANCER RES, V12, P1431, DOI 10.1158/1078-0432.CCR-05-1806; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Shiozawa Y, 2008, LEUKEMIA, V22, P941, DOI 10.1038/leu.2008.48; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stenbeck G, 2002, SEMIN CELL DEV BIOL, V13, P285, DOI 10.1016/S1084952102000587; STEWART AF, 1982, J CLIN ENDOCR METAB, V55, P219, DOI 10.1210/jcem-55-2-219; Taichman RS, 1998, STEM CELLS, V16, P7, DOI 10.1002/stem.160007; TAUBE T, 1994, BONE, V15, P161, DOI 10.1016/8756-3282(94)90703-X; Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Tiedemann K, 2009, J BIOL CHEM, V284, P33662, DOI 10.1074/jbc.M109.010785; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200	52	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31427	31434		10.1074/jbc.M110.114496	http://dx.doi.org/10.1074/jbc.M110.114496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20679341	Green Published, hybrid			2022-12-27	WOS:000282764600037
J	Nam, SY; Seo, HH; Park, HS; An, S; Kim, JY; Yang, KH; Kim, CS; Jeong, M; Jin, YW				Nam, Seon Young; Seo, Hyung Ho; Park, Hyung Sun; An, Sungkwan; Kim, Ji-Young; Yang, Kwang Hee; Kim, Cha Soon; Jeong, Meeseon; Jin, Young-Woo			Phosphorylation of CLK2 at Serine 34 and Threonine 127 by AKT Controls Cell Survival after Ionizing Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFICITY PROTEIN-KINASES; LOW-DOSE RADIATION; INDUCED APOPTOSIS; PHOSPHATIDYLINOSITOL 3-KINASE; INTRANUCLEAR DISTRIBUTION; ACTIVATION; PATHWAY; PROLIFERATION; INDUCTION; FAMILY	AKT phosphorylates components of the intrinsic cell survival machinery and promotes survival to various stimuli. In the present study, we identified CDC-like kinase 2 (CLK2) as a new substrate of AKT activation and elucidated its role in cell survival to ionizing radiation. AKT directly binds to and phosphorylates CLK2 on serine 34 and threonine 127, in vitro and in vivo. CLK2 phosphorylation was detected in HeLa cells overexpressing active AKT. In addition, we demonstrated that ionizing radiation induces CLK2 phosphorylation via AKT activation. In contrast, the suppression of endogenous AKT expression by siRNA inhibited CLK2 phosphorylation in response to 2 gray of gamma-ray or insulin. Furthermore, we examined the effect of CLK2 on the survival of irradiated CCD-18Lu cells overexpressing Myc-CLK2. CLK2 overexpression significantly increased cell growth and inhibited cell death induced by 2 gray. The role of CLK2 in cell survival to ionizing radiation was dependent on the phosphorylation of serine 34 and threonine 127. Our results suggest that AKT activation controls cell survival to ionizing radiation by phosphorylating CLK2, revealing an important regulatory mechanism required for promoting cell survival.	[Kim, Cha Soon; Jeong, Meeseon; Jin, Young-Woo] Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Res Inst, Seoul 132703, South Korea; [An, Sungkwan] Konkuk Univ, Funct Genoproteome Res Ctr, Seoul 143701, South Korea	Korea Hydro & Nuclear Power; Konkuk University	Nam, SY (corresponding author), 388-1 Ssangmun Dong, Seoul 132703, South Korea.	seonynam@khnp.co.kr			Korea Hydro & Nuclear Power Co., Ltd. [E09NS02]; Ministry of Knowledge Economy, Republic of Korea [R-2006-1-043]	Korea Hydro & Nuclear Power Co., Ltd.; Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This work was supported by Grant E09NS02 from Korea Hydro & Nuclear Power Co., Ltd. and Grant R-2006-1-043 from the Ministry of Knowledge Economy, Republic of Korea.	BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; Choi KM, 2007, ONCOL REP, V17, P1183; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; DOUVILLE E, 1994, CANCER METAST REV, V13, P1, DOI 10.1007/BF00690414; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gu QY, 2004, RADIAT RES, V161, P692, DOI 10.1667/RR3158; HANES J, 1994, J MOL BIOL, V244, P665, DOI 10.1006/jmbi.1994.1763; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; Hu YX, 2005, EMBO J, V24, P3543, DOI 10.1038/sj.emboj.7600823; JOHNSON KW, 1991, J BIOL CHEM, V266, P3402; Kim CS, 2007, J RADIAT RES, V48, P407, DOI 10.1269/jrr.07032; Kim SJ, 1998, BIOCHEM MOL BIOL INT, V46, P187; Krasilnikov M, 1999, MOL CARCINOGEN, V24, P64, DOI 10.1002/(SICI)1098-2744(199901)24:1<64::AID-MC9>3.0.CO;2-2; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Li W, 2004, EXP HEMATOL, V32, P1088, DOI 10.1016/j.exphem.2004.07.015; LINDBERG RA, 1992, TRENDS BIOCHEM SCI, V17, P114, DOI 10.1016/0968-0004(92)90248-8; Lu PJ, 1998, BIOCHEMISTRY-US, V37, P5738, DOI 10.1021/bi972551g; Marchisio M, 1998, BIOCHEM BIOPH RES CO, V253, P346, DOI 10.1006/bbrc.1998.9787; Mishra KP, 2004, J ENVIRON PATHOL TOX, V23, P61, DOI 10.1615/JEnvPathToxOncol.v23.i1.60; Moeslein FM, 1999, J BIOL CHEM, V274, P26697, DOI 10.1074/jbc.274.38.26697; MYERS MP, 1994, MOL CELL BIOL, V14, P6954, DOI 10.1128/MCB.14.10.6954; Nayler O, 1998, J BIOL CHEM, V273, P34341, DOI 10.1074/jbc.273.51.34341; Nayler O, 1997, BIOCHEM J, V326, P693, DOI 10.1042/bj3260693; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Park HS, 2009, EUR J CELL BIOL, V88, P563, DOI 10.1016/j.ejcb.2009.05.004; Pollycove M, 2003, HUM EXP TOXICOL, V22, P290, DOI 10.1191/0960327103ht365oa; Portess DI, 2007, CANCER RES, V67, P1246, DOI 10.1158/0008-5472.CAN-06-2985; Soderlund K, 2005, INT J ONCOL, V26, P25; Suzuki K, 2001, CANCER RES, V61, P5396; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wang GJ, 2000, TOXICOL SCI, V53, P369, DOI 10.1093/toxsci/53.2.369; Wang ZB, 2007, CELL BIOL INT, V31, P1353, DOI 10.1016/j.cellbi.2007.05.009	36	26	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31157	31163		10.1074/jbc.M110.122044	http://dx.doi.org/10.1074/jbc.M110.122044			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682768	Green Published, hybrid			2022-12-27	WOS:000282764600009
J	Zhang, XP; Liu, F; Wang, W				Zhang, Xiao-Peng; Liu, Feng; Wang, Wei			Coordination between Cell Cycle Progression and Cell Fate Decision by the p53 and E2F1 Pathways in Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; P53-MDM2 FEEDBACK LOOP; TUMOR-SUPPRESSOR; P53-DEPENDENT APOPTOSIS; IONIZING-RADIATION; S-PHASE; ACTIVATION; PROTEIN; DEATH; MDM2	After DNA damage, cells must decide between different fates including growth arrest, DNA repair, and apoptosis. Both p53 and E2F1 are transcription factors involved in the decision process. However, the mechanism for cross-talk between the p53 and E2F1 pathways still remains unclear. Here, we proposed a four-module kinetic model of the decision process and explored the interplay between these two pathways in response to ionizing radiation via computer simulation. In our model the levels of p53 and E2F1 separately exhibit pulsatile and switching behaviors. Upon DNA damage, p53 is first activated, whereas E2F1 is inactivated, leading to cell cycle arrest in the G(1) phase. We found that the ultimate decision between cell life and death is determined by the number of p53 pulses depending on the extent of DNA damage. For repairable DNA damage, the cell can survive and reenter the S phase because of the activation of E2F1 and inactivation of p53. For irreparable DNA damage, growth arrest is overcome by growth factors, and activated p53 and E2F1 cooperate to initiate apoptosis. We showed that E2F1 promotes apoptosis by up-regulating the proapoptotic cofactors of p53 and procaspases. It was also revealed that deregulated E2F1 by oncogene activation can make cells sensitive to DNA damage even in low serum medium. Our model consistently recapitulates the experimental observations of the intricate relationship between p53 and E2F1 in the DNA damage response. This work underscores the significance of E2F1 in p53-mediated cell fate decision and may provide clues to cancer therapy.	[Liu, Feng; Wang, Wei] Nanjing Univ, Dept Phys, Nanjing 210093, Peoples R China; Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Peoples R China	Nanjing University; Nanjing University	Liu, F (corresponding author), Nanjing Univ, Dept Phys, Nanjing 210093, Peoples R China.	fliu@nju.edu.cn; wangwei@nju.edu.cn	Liu, Feng/E-1462-2011; Zhang, Xiao-Peng/E-1973-2011	Zhang, Xiao-Peng/0000-0001-8170-1236; Liu, Feng/0000-0001-9560-8518; Zhang, Xiao-Peng/0000-0002-0183-2760	National Basic Research Program of China [2007CB814806]; National Natural Science Foundation of China [10604028]; Natural Science Foundation of Jiangsu Province [SBK200910089]; Jiangsu Planned Projects for Postdoctoral Research Funds [0204003443]; Program for New Century Excellent Talents in Universities [NCET-08-0269]; Scientific Research Foundation for the Returned Overseas Chinese Scholars	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Planned Projects for Postdoctoral Research Funds; Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the National Basic Research Program of China (2007CB814806), the National Natural Science Foundation of China (10604028), the Natural Science Foundation of Jiangsu Province (SBK200910089), the Jiangsu Planned Projects for Postdoctoral Research Funds (0204003443), the Program for New Century Excellent Talents in Universities (NCET-08-0269), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars.	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Al Rashid ST, 2005, CANCER RES, V65, P10810, DOI 10.1158/0008-5472.CAN-05-0729; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bill CA, 1997, MUTAT RES-DNA REPAIR, V385, P21, DOI 10.1016/S0921-8777(97)00040-2; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bonner WM, 2003, P NATL ACAD SCI USA, V100, P4973, DOI 10.1073/pnas.1031538100; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chickarmane V, 2007, SIAM J APPL DYN SYST, V6, P61, DOI 10.1137/060653925; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Elkon R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-110; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Garner E, 2008, CELL CYCLE, V7, P277, DOI 10.4161/cc.7.3.5328; Gartel AL, 2002, MOL CANCER THER, V1, P639; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Landers JE, 1997, CANCER RES, V57, P3562; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; McKay BC, 2002, DNA REPAIR, V1, P811, DOI 10.1016/S1568-7864(02)00109-X; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Mouri K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005131; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; NEVINS JR, 1992, SCIENCE, V258, P424; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Pfeuty B, 2008, CELL CYCLE, V7, P3246, DOI 10.4161/cc.7.20.6853; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Rief N, 2002, J BIOL CHEM, V277, P20572, DOI 10.1074/jbc.M200265200; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Stanelle J, 2006, TRENDS MOL MED, V12, P177, DOI 10.1016/j.molmed.2006.02.002; Stewart RD, 2001, RADIAT RES, V156, P365, DOI 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tang W, 1999, CANCER RES, V59, P2562; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wee KB, 2006, BIOPHYS J, V91, P857, DOI 10.1529/biophysj.105.077693; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yang TT, 1997, ONCOGENE, V14, P1511, DOI 10.1038/sj.onc.1200979; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	70	41	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31571	31580		10.1074/jbc.M110.134650	http://dx.doi.org/10.1074/jbc.M110.134650			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685653	Green Published, hybrid			2022-12-27	WOS:000282764600051
J	Kiselak, EA; Shen, XN; Song, JM; Gude, DR; Wang, JN; Brody, SL; Strauss, JF; Zhang, ZB				Kiselak, Elizabeth Anne; Shen, Xuening; Song, Jingmei; Gude, David Roberto; Wang, Jiannan; Brody, Steven L.; Strauss, Jerome F., III; Zhang, Zhibing			Transcriptional Regulation of an Axonemal Central Apparatus Gene, Sperm-associated Antigen 6, by a SRY-related High Mobility Group Transcription Factor, S-SOX5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS PF16; MAMMALIAN ORTHOLOGUE; CARTILAGE FORMATION; FLAGELLAR MOTILITY; RECEPTOR-ALPHA; SOX5 L-SOX5; LONG FORM; EXPRESSION; PROTEIN; MICE	SOX5 is a transcription factor with homology to the high mobility group box region of the testis-determining factor, SRY. Both the mouse and human SOX5 genes encode a 48-kDa SOX5 protein (S-SOX5) that is only present in tissues containing cells with motile cilia/flagella. The mammalian sperm-associated antigen 6 gene (SPAG6) encodes an axoneme central apparatus protein. Because human and mouse SPAG6 gene promoters contain multiple potential binding sites for SOX5, SPAG6 gene regulation by S-SOX5 was investigated in BEAS-2B cells, a line derived from human bronchial cells. Like FOXJ1, a transcription factor known to be essential for motile ciliogenesis, S-SOX5 stimulated mouse and human SPAG6 promoter function in BEAS-2B cells, but the effect was abrogated when the SOX5 binding sites were mutated or deleted. S-SOX5 and FOXJ1 functioned cooperatively in stimulating SPAG6 promoter activity. The SPAG6 message was up-regulated when S-SOX5 was over-expressed in BEAS-2B cells, and silencing of S-SOX5 by RNA interference down-regulated SPAG6 transcripts. Chromatin immunoprecipitation and EMSA experiments demonstrated that S-SOX5 associates with the SPAG6 promoter directly. The present study demonstrates that SPAG6 is a S-SOX5 target gene, indicating a key role for S-SOX5 in the formation and function of motile cilia.	[Kiselak, Elizabeth Anne; Shen, Xuening; Song, Jingmei; Gude, David Roberto; Wang, Jiannan; Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA; [Brody, Steven L.; Zhang, Zhibing] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Virginia Commonwealth University; Washington University (WUSTL)	Zhang, ZB (corresponding author), 11028A Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA.	zzhang4@vcu.edu	Nagarkatti-Gude, David/AAF-6996-2020		National Institutes of Health [HD37416]; National Institutes of Health through NICHD [IF3IHD0G2314-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD37416 (to J.F.S. III).; Supported by National Institutes of Health F31 Predoctoral Fellowship IF3IHD0G2314-01 through the NICHD.	Blaise R, 1999, J BIOL CHEM, V274, P9327, DOI 10.1074/jbc.274.14.9327; Blatt EN, 1999, AM J RESP CELL MOL, V21, P168, DOI 10.1165/ajrcmb.21.2.3691; Bonnelye E, 2007, ENDOCRINOLOGY, V148, P1195, DOI 10.1210/en.2006-0962; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Brody SL, 1997, GENOMICS, V45, P509, DOI 10.1006/geno.1997.4970; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Budde LM, 2002, MOL BIOL CELL, V13, P4179, DOI 10.1091/mbc.01-07-0373; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chew LJ, 2009, J NEUROSCI RES, V87, P3277, DOI 10.1002/jnr.22128; Christiano AM, 2008, CELL STEM CELL, V3, P3, DOI 10.1016/j.stem.2008.06.014; Degnan BM, 2009, CURR OPIN GENET DEV, V19, P591, DOI 10.1016/j.gde.2009.09.008; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; Donner AL, 2007, DEV BIOL, V303, P784, DOI 10.1016/j.ydbio.2006.10.047; Dy P, 2008, GENESIS, V46, P294, DOI 10.1002/dvg.20392; GONZALEZ IL, 1986, AM J HUM GENET, V38, P419; Haag J, 2008, PATHOBIOLOGY, V75, P195, DOI 10.1159/000124980; Hiraoka Y, 1998, BBA-GENE STRUCT EXPR, V1399, P40, DOI 10.1016/S0167-4781(98)00086-4; Horowitz E, 2005, MOL HUM REPROD, V11, P307, DOI 10.1093/molehr/gah163; Ikeda T, 2002, GENE, V298, P59, DOI 10.1016/S0378-1119(02)00927-7; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Lonergan KM, 2006, AM J RESP CELL MOL, V35, P651, DOI 10.1165/rcmb.2006-0056OC; Hernandez-Hernandez JM, 2009, J MOL BIOL, V394, P1, DOI 10.1016/j.jmb.2009.08.057; Neilson LI, 1999, GENOMICS, V60, P272, DOI 10.1006/geno.1999.5914; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Phochanukul N, 2010, INT J BIOCHEM CELL B, V42, P453, DOI 10.1016/j.biocel.2009.06.013; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Smith EF, 2000, CELL MOTIL CYTOSKEL, V46, P157, DOI 10.1002/1097-0169(200007)46:3<157::AID-CM1>3.0.CO;2-D; Smith EF, 1996, J CELL BIOL, V132, P359, DOI 10.1083/jcb.132.3.359; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Wunderle VM, 1996, GENOMICS, V36, P354, DOI 10.1006/geno.1996.0474; Xu WM, 2009, MOL BIOL REP, V36, P1187, DOI 10.1007/s11033-008-9296-2; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002; Zhang ZB, 2001, MOL PHARMACOL, V60, P480; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189	48	48	56	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30496	30505		10.1074/jbc.M110.121590	http://dx.doi.org/10.1074/jbc.M110.121590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20668334	Green Published, hybrid			2022-12-27	WOS:000282135500017
J	Li, HM; Wang, ZL; Wang, BP; Guo, QX; Dolios, G; Tabuchi, K; Hammer, RE; Sudhof, TC; Wang, R; Zheng, H				Li, Hongmei; Wang, Zilai; Wang, Baiping; Guo, Qinxi; Dolios, Georgia; Tabuchi, Katsuhiko; Hammer, Robert E.; Suedhof, Thomas C.; Wang, Rong; Zheng, Hui			Genetic Dissection of the Amyloid Precursor Protein in Developmental Function and Amyloid Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MICE LACKING; BETA; APP; PRESENILIN-1; PEPTIDES; DEFICITS; ALPHA	Proteolytic processing of the amyloid precursor protein (APP) generates large soluble APP derivatives, beta-amyloid (A beta) peptides, and APP intracellular domain. Expression of the extracellular sequences of APP or its Caenorhabditis elegans counterpart has been shown to be sufficient in partially rescuing the CNS phenotypes of the APP-deficient mice and the lethality of the apl-1 null C. elegans, respectively, leaving open the question as what is the role of the highly conserved APP intracellular domain? To address this question, we created an APP knock-in allele in which the mouse A beta sequence was replaced by the human A beta. A frameshift mutation was introduced that replaced the last 39 residues of the APP sequence. We demonstrate that the C-terminal mutation does not overtly affect APP processing and amyloid pathology. In contrast, crossing the mutant allele with APP-like protein 2 (APLP2)-null mice results in similar neuromuscular synapse defects and early postnatal lethality as compared with mice doubly deficient in APP and APLP2, demonstrating an indispensable role of the APP C-terminal domain in these development activities. Our results establish an essential function of the conserved APP intracellular domain in developmental regulation, and this activity can be genetically uncoupled from APP processing and A beta pathogenesis.	[Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Wang, Zilai; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Guo, Qinxi; Zheng, Hui] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Li, Hongmei; Tabuchi, Katsuhiko; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Dolios, Georgia; Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Suedhof, Thomas C.] Stanford Univ, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Stanford University; Howard Hughes Medical Institute; Stanford University	Zheng, H (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza,MS BCM 230, Houston, TX 77030 USA.	huiz@bcm.edu	Wang, Rong/A-8721-2009; Guo, Qinxi/J-1473-2014; Li, Hongmei/L-2595-2013	Guo, Qinxi/0000-0003-4320-6757; Li, Hongmei/0000-0002-4952-1734; Hammer, Robert E./0000-0001-5487-7551	National Institutes of Health [AG020670, AG032051, NS061777, MH52804]; Alzheimer's Association [IIRG-05-14824]; Baylor College of Medicine Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center [HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804, R01MH052804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032051, R01AG020670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Baylor College of Medicine Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG020670 and AG032051 (to H.Z.), NS061777 (to R.W.), and MH52804 (to T.C.S.). This work was also supported by Alzheimer's Association Grant IIRG-05-14824 (to R.W.).; We thank N. Aithmitti and X. Chen for expert technical assistance and members of the Zheng laboratory for stimulating discussions. We are grateful to the Baylor College of Medicine Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (HD024064) for support in confocal imaging.	Back S, 2007, J NEUROSCI RES, V85, P2580, DOI 10.1002/jnr.21239; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kohler C, 2005, NEUROBIOL DIS, V20, P528, DOI 10.1016/j.nbd.2005.04.009; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lehman EJH, 2003, HUM MOL GENET, V12, P2949, DOI 10.1093/hmg/ddg322; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	31	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30598	30605		10.1074/jbc.M110.137729	http://dx.doi.org/10.1074/jbc.M110.137729			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20693289	Green Published, hybrid			2022-12-27	WOS:000282135500028
J	Pancholi, V; Boel, G; Jin, H				Pancholi, Vijay; Boel, Gregory; Jin, Hong			Streptococcus pyogenes Ser/Thr Kinase-regulated Cell Wall Hydrolase Is a Cell Division Plane-recognizing and Chain-forming Virulence Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; RHEUMATIC HEART-DISEASE; GRAM-POSITIVE BACTERIA; BINDING-PROTEIN; SERINE/THREONINE KINASE; FUNCTIONAL-ANALYSIS; RESPONSE REGULATOR; SURFACE-PROTEINS; GENE; IDENTIFICATION	Cell division and cell wall synthesis are closely linked complex phenomena and play a crucial role in the maintenance and regulation of bacterial virulence. Eukaryotic-type Ser/Thr kinases reported in prokaryotes, including that in group A Streptococcus (GAS) (Streptococcus pyogenes Ser/Thr kinase (SP-STK)), regulate cell division, growth, and virulence. The mechanism of this regulation is, however, unknown. In this study, we demonstrated that SP-STK-controlled cell division is mediated under the positive regulation of secretory protein that possesses a cysteine and histidine-dependent aminohydrolases/peptidases (CHAP) domain with functionally active cell wall hydrolase activity (henceforth named as CdhA (CHAP-domain-containing and chain-forming cell wall hydrolase). Deletion of the CdhA-encoding gene resulted in severe cell division and growth defects in GAS mutants. The mutant expressing the truncated CdhA (devoid of the CHAP domain), although displayed no such defects, it became attenuated for virulence in mice and highly susceptible to cell wall-acting antibiotics, as observed for the mutant lacking CdhA. When CdhA was overexpressed in the wild-type GAS as well as in heterologous strains, Escherichia coli and Staphylococcus aureus, we observed a distinct increase in bacterial chain length. Our data reveal that CdhA is a multifunctional protein with a major function of the N-terminal region as a cell division plane-recognizing domain and that of the C-terminal CHAP domain as a virulence-regulating domain. CdhA is thus an important therapeutic target.	[Pancholi, Vijay; Boel, Gregory; Jin, Hong] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Pancholi, V (corresponding author), 420 W 12th Ave,TMRF 288A, Columbus, OH 43210 USA.	vijay.pancholi@osumc.edu	Boel, Gregory/N-4623-2016; Pancholi, Vijay/E-3810-2011	Boel, Gregory/0000-0001-9900-6493; 	National Institutes of Health [AI64912]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI64912 (to V. P.).	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Barendt SM, 2009, J BACTERIOL, V191, P3024, DOI 10.1128/JB.01505-08; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Borges F, 2005, J BACTERIOL, V187, P2737, DOI 10.1128/JB.187.8.2737-2746.2005; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Carapetis JR, 2008, CIRCULATION, V118, P2748, DOI 10.1161/CIRCULATIONAHA.108.774307; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Fagan PK, 2001, INFECT IMMUN, V69, P4851, DOI 10.1128/IAI.69.8.4851-4857.2001; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; FISCHETTI VA, 2006, GRAM POSITIVE PATHOG, P12; Hoe NP, 2002, P NATL ACAD SCI USA, V99, P7646, DOI 10.1073/pnas.112039899; Humann J, 2009, J INNATE IMMUN, V1, P88, DOI 10.1159/000181181; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; JOHNSON DR, 1992, J INFECT DIS, V166, P374, DOI 10.1093/infdis/166.2.374; JONES KF, 1986, J EXP MED, V164, P1226, DOI 10.1084/jem.164.4.1226; Krause RM, 2002, INDIAN J MED RES, V115, P215; Le Breton Y, 2002, CURR MICROBIOL, V45, P434, DOI 10.1007/s00284-002-3714-3; Lepeuple AS, 1998, APPL ENVIRON MICROB, V64, P4142; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Loughman JA, 2007, MOL MICROBIOL, V64, P269, DOI 10.1111/j.1365-2958.2007.05663.x; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Mattos-Graner RO, 2001, INFECT IMMUN, V69, P6931, DOI 10.1128/IAI.69.11.6931-6941.2001; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; Musser JM, 1998, BIOMED RES REP, P185; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; PANCHOLI V, 2006, GRAM POSITIVE PATHOG, P100; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Reinscheid DJ, 2003, FEMS MICROBIOL LETT, V221, P73, DOI 10.1016/S0378-1097(03)00167-8; Reinscheid DJ, 2001, J BACTERIOL, V183, P1175, DOI 10.1128/JB.183.4.1175-1183.2001; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Rodriguez-Iturbe B, 2008, J AM SOC NEPHROL, V19, P1855, DOI 10.1681/ASN.2008010092; Rosch JW, 2007, MOL MICROBIOL, V64, P257, DOI 10.1111/j.1365-2958.2007.05667.x; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schubert K, 2000, ARCH MICROBIOL, V173, P21, DOI 10.1007/s002030050003; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shah IM, 2010, MOL MICROBIOL, V75, P1232, DOI 10.1111/j.1365-2958.2010.07046.x; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Smith DJ, 2003, INFECT IMMUN, V71, P1179, DOI 10.1128/IAI.71.3.1179-1184.2003; Steer AC, 2002, J PAEDIATR CHILD H, V38, P229, DOI 10.1046/j.1440-1754.2002.00772.x; STEVENS DL, 1995, EMERG INFECT DIS, V1, P69, DOI 10.3201/eid0103.950301; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOLLERMAN GH, 1957, J EXP MED, V106, P345, DOI 10.1084/jem.106.3.345; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Teng F, 2003, INFECT IMMUN, V71, P5033, DOI 10.1128/IAI.71.9.5033-5041.2003	67	28	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30861	30874		10.1074/jbc.M110.153825	http://dx.doi.org/10.1074/jbc.M110.153825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20643653	Green Published, hybrid			2022-12-27	WOS:000282135500053
J	Chen, QF; Westfall, CS; Hicks, LM; Wang, SP; Jez, JM				Chen, Qingfeng; Westfall, Corey S.; Hicks, Leslie M.; Wang, Shiping; Jez, Joseph M.			Kinetic Basis for the Conjugation of Auxin by a GH3 Family Indole-acetic Acid-Amido Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN TIR1; GENE-EXPRESSION; SALICYLIC-ACID; STEADY-STATE; PHYSCOMITRELLA-PATENS; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; DEFENSE RESPONSES; ESCHERICHIA-COLI; COA SYNTHETASE	The GH3 family of acyl-acid-amido synthetases catalyze the ATP-dependent formation of amino acid conjugates to modulate levels of active plant hormones, including auxins and jasmonates. Initial biochemical studies of various GH3s show that these enzymes group into three families based on sequence relationships and acyl-acid substrate preference (I, jasmonate-conjugating; II, auxin- and salicylic acid-conjugating; III, benzoate-conjugating); however, little is known about the kinetic and chemical mechanisms of these enzymes. Here we use GH3-8 from Oryza sativa (rice; OsGH3-8), which functions as an indoleacetic acid (IAA)-amido synthetase, for detailed mechanistic studies. Steady-state kinetic analysis shows that the OsGH3-8 requires either Mg2+ or Mn2+ for maximal activity and is specific for aspartate but accepts asparagine as a substrate with a 45-fold decrease in catalytic efficiency and accepts other auxin analogs, including phenylacetic acid, indole butyric acid, and naphthaleneacetic acid, as acyl-acid substrates with 1.4-9-fold reductions in k(cat)/K-m relative to IAA. Initial velocity and product inhibition studies indicate that the enzyme uses a Bi Uni Uni Bi Ping Pong reaction sequence. In the first half-reaction, ATP binds first followed by IAA. Next, formation of an adenylated IAA intermediate results in release of pyrophosphate. The second half-reaction begins with binding of aspartate, which reacts with the adenylated intermediate to release IAA-Asp and AMP. Formation of a catalytically competent adenylated-IAA reaction intermediate was confirmed by mass spectrometry. These mechanistic studies provide insight on the reaction catalyzed by the GH3 family of enzymes to modulate plant hormone action.	[Westfall, Corey S.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Hicks, Leslie M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Washington University (WUSTL); Huazhong Agricultural University; Donald Danforth Plant Science Center	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Hicks, Leslie M/E-8015-2010; chen, qingfeng/J-6844-2017	Hicks, Leslie M/0000-0002-8008-3998; 	Huazhong Agricultural University-Donald Danforth Plant Science Center Joint Laboratory [B07041]; National Natural Science Foundation of China [30930063]	Huazhong Agricultural University-Donald Danforth Plant Science Center Joint Laboratory; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the 111 Program (B07041) for the Huazhong Agricultural University-Donald Danforth Plant Science Center Joint Laboratory. This work was also supported by National Natural Science Foundation of China Grant 30930063 (to S. W.).	ALLENDE CC, 1970, J BIOL CHEM, V245, P93; Bierfreund NM, 2004, J PLANT PHYSIOL, V161, P823, DOI 10.1016/j.jplph.2003.12.010; Black PN, 2000, J BIOL CHEM, V275, P38547, DOI 10.1074/jbc.M006413200; Bovee ML, 2003, BIOCHEMISTRY-US, V42, P15102, DOI 10.1021/bi0355701; Chen QF, 2009, ANAL BIOCHEM, V390, P149, DOI 10.1016/j.ab.2009.04.027; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Fan F, 2007, BIOCHEMISTRY-US, V46, P11421, DOI 10.1021/bi7011492; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P36, DOI 10.1007/s10142-005-0142-5; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Khan S, 2007, PLANTA, V226, P21, DOI 10.1007/s00425-006-0462-2; Khan S, 2007, PLANT SIGNAL BEHAV, V2, P483, DOI 10.4161/psb.2.6.4498; KIM YS, 1994, BIOCHEM J, V297, P327, DOI 10.1042/bj2970327; Lahey KA, 2004, MOL PLANT MICROBE IN, V17, P1394, DOI 10.1094/MPMI.2004.17.12.1394; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Liu KD, 2005, PLANT MOL BIOL, V58, P447, DOI 10.1007/s11103-005-6505-4; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ludwig-Muller J, 2009, NEW PHYTOL, V181, P323, DOI 10.1111/j.1469-8137.2008.02677.x; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; PAPAS TS, 1971, J BIOL CHEM, V246, P5924; Park JE, 2007, PLANT CELL PHYSIOL, V48, P1236, DOI 10.1093/pcp/pcm086; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; PFLEIDERER G, 1960, BIOCHEM Z, V333, P302; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Reddy SM, 2006, NEW PHYTOL, V170, P391, DOI 10.1111/j.1469-8137.2006.01677.x; Roux C, 1997, FEBS LETT, V419, P131, DOI 10.1016/S0014-5793(97)01447-6; Segel IH, 1975, ENZYME KINETICS BEHA; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Tanaka S, 2002, PLANT CELL PHYSIOL, V43, P281, DOI 10.1093/pcp/pcf033; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Wang H, 2008, PLANT GROWTH REGUL, V56, P225, DOI 10.1007/s10725-008-9313-4; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zhang ZQ, 2008, PLANT SIGNAL BEHAV, V3, P537, DOI 10.4161/psb.3.8.5748; Zheng RJ, 2001, BIOCHEMISTRY-US, V40, P12904, DOI 10.1021/bi011522+	50	65	67	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29780	29786		10.1074/jbc.M110.146431	http://dx.doi.org/10.1074/jbc.M110.146431			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639576	Green Published, hybrid			2022-12-27	WOS:000281984300013
J	Sander, J; Nowaczyk, M; Buchta, J; Dau, H; Vass, I; Deak, Z; Dorogi, M; Iwai, M; Rogner, M				Sander, Julia; Nowaczyk, Marc; Buchta, Joachim; Dau, Holger; Vass, Imre; Deak, Zsuzsanna; Dorogi, Marta; Iwai, Masako; Roegner, Matthias			Functional Characterization and Quantification of the Alternative PsbA Copies in Thermosynechococcus elongatus and Their Role in Photoprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; THERMOPHILIC CYANOBACTERIUM; CHARGE RECOMBINATION; FLUORESCENCE; ADAPTATION; RESOLUTION; PATHWAYS; PCC-7942; PROTEIN; GENES	The D1 protein (PsbA) of photosystem II (PSII) from Thermosynechococcus elongatus is encoded by a psbA gene family that is typical of cyanobacteria. Although the transcription of these three genes has been studied previously (Kos, P. B., Deak, Z., Cheregi, O., and Vass, I. (2008) Biochim. Biophys. Acta 1777, 74-83), the protein quantification had not been possible due to the high sequence identity between the three PsbA copies. The successful establishment of a method to quantify the PsbA proteins on the basis of reverse phase-LC-electrospray mass ionization-MS/MS (RP-LC-ESI-MS/MS) enables an accurate comparison of transcript and protein level for the first time ever. Upon high light incubation, about 70% PsbA3 could be detected, which closely corresponds to the transcript level. It was impossible to detect any PsbA2 under all tested conditions. The construction of knock-out mutants enabled for the first time a detailed characterization of both whole cells and also isolated PSII complexes. PSII complexes of the Delta psbA1/psbA2 mutant contained only copy PsbA3, whereas only PsbA1 could be detected in PSII complexes from the Delta psbA3 mutant. In whole cells as well as in isolated complexes, a shift of the free energy between the redox pairs in the PsbA3 complexes in comparison with PsbA1 could be detected by thermoluminescence and delayed fluorescence measurements. This change is assigned to a shift of the redox potential of pheophytin toward more positive values. Coincidentally, no differences in the Q(A)-Q(B) electron transfer could be observed in flash-induced fluorescence decay or prompt fluorescence measurements. In conclusion, PsbA3 complexes yield a better protection against photoinhibition due to a higher probability of the harmless dissipation of excess energy.	[Sander, Julia; Nowaczyk, Marc; Roegner, Matthias] Ruhr Univ Bochum, D-44780 Bochum, Germany; [Sander, Julia] Max Planck Inst Bioinorgan Chem, D-45413 Mulheim, Germany; [Buchta, Joachim; Dau, Holger] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Vass, Imre; Deak, Zsuzsanna; Dorogi, Marta] Biol Res Ctr, Inst Plant Biol, H-6726 Szeged, Hungary; [Iwai, Masako] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Tokyo 1628601, Japan	Ruhr University Bochum; Max Planck Society; Free University of Berlin; Hungarian Academy of Sciences; Hungarian Biological Research Center; Tokyo University of Science	Rogner, M (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44780 Bochum, Germany.	Matthias.Roegner@rub.de	Vass, Imre/AAS-6171-2021; Nowaczyk, Marc/D-4214-2014	Vass, Imre/0000-0003-4987-7842; Nowaczyk, Marc/0000-0002-9269-0672; Iwai, Masako/0000-0001-6121-7543; Dau, Holger/0000-0001-6482-7494	German Research Council; Deutsche Forschungsgemeinschaft [SFB 480, C1]; European Union (SOLAR-H)	German Research Council(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (SOLAR-H)(European Commission)	This work was supported by grants from the German Research Council, Deutsche Forschungsgemeinschaft (SFB 480, Project C1), and the European Union (SOLAR-H).	Buchta J, 2007, BBA-BIOENERGETICS, V1767, P565, DOI 10.1016/j.bbabio.2007.04.003; Campbell D, 1998, P NATL ACAD SCI USA, V95, P364, DOI 10.1073/pnas.95.1.364; Cser K, 2007, BBA-BIOENERGETICS, V1767, P233, DOI 10.1016/j.bbabio.2007.01.022; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haussmann U, 2009, PROTEOMICS, V9, P3635, DOI 10.1002/pmic.200900025; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; Kuhl H, 2000, J BIOL CHEM, V275, P20652, DOI 10.1074/jbc.M001321200; KULKARNI RD, 1994, J BACTERIOL, V176, P959, DOI 10.1128/JB.176.4.959-965.1994; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Muhlenhoff U, 1996, MOL GEN GENET, V252, P93, DOI 10.1007/s004389670011; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Sane PV, 2002, J BIOL CHEM, V277, P32739, DOI 10.1074/jbc.M200444200; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916	17	41	41	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29851	29856		10.1074/jbc.M110.127142	http://dx.doi.org/10.1074/jbc.M110.127142			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663887	Green Published, hybrid			2022-12-27	WOS:000281984300021
J	Wen, XY; Li, YJ; Liu, YH				Wen, Xiaoyan; Li, Yingjian; Liu, Youhua			Opposite Action of Peroxisome Proliferator-activated Receptor-gamma in Regulating Renal Inflammation FUNCTIONAL SWITCH BY ITS LIGAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; NF-KAPPA-B; PPAR-GAMMA; KIDNEY; ALPHA; SUMOYLATION; CELLS; PIOGLITAZONE; RANTES/CCL5; MECHANISMS	Peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists, a new class of antidiabetic agents, have been shown to possess antiinflammatory activity. In this study, we investigated the molecular mechanism by which PPAR gamma agonists inhibit proinflammatory cytokine expression in rat glomerular mesangial cells. Both natural and synthetic PPAR gamma agonists potently inhibited RANTES (regulated upon activation, normal T cell expressed and secreted) and monocyte chemoattractant protein- 1 expression induced by TNF-alpha in mesangial cells, which was dependent on NF-kappa B signaling. However, PPAR gamma agonists had little effect on TNF-alpha-triggered I kappa B alpha phosphorylation and its subsequent degradation, p65 phosphorylation, and nuclear translocation. In the absence of PPAR gamma ligand, TNF-alpha induced a physical interaction between nuclear p65 and PPAR gamma, as demonstrated by co-immunoprecipitation. Such an interaction was mediated by the C-terminal region of p65. Activation of PPAR gamma by its agonist prevented PPAR gamma p65 complex formation. Chromatin immunoprecipitation assay revealed that TNF-alpha induced p65 binding to the cis-acting kappa B elements in rat RANTES promoter, whereas disruption of PPAR gamma p65 by its agonist blocked p65 interaction with its cognate kappa B sites. Knockdown of PPAR gamma via siRNA strategy completely abolished TNF-alpha-mediated p65 binding to kappa B sites and negated RANTES induction, suggesting that unliganded PPAR gamma is obligatory for NF-kappa B signaling. Consistently, overexpression of PPAR gamma in the absence of its ligand sensitized mesangial cells to TNF-alpha stimulation. These results uncover a paradoxical action of the unliganded and ligand-activated PPAR gamma in regulating NF-kappa B signaling and demonstrate PPAR gamma ligand as a molecular switch that controls its ability to modulate inflammatory responses in opposite directions.	[Wen, Xiaoyan; Li, Yingjian; Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, YH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, S-405 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	liuy@upmc.edu		Liu, Youhua/0000-0002-4740-805X	National Institutes of Health [DK061408, DK064005, DK071040]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064005, R01DK071040, R01DK061408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061408, DK064005, and DK071040.	Buroker NE, 2009, FEBS J, V276, P3247, DOI 10.1111/j.1742-4658.2009.07039.x; Calkin AC, 2006, NEPHROL DIAL TRANSPL, V21, P2399, DOI 10.1093/ndt/gfl212; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Fogo AB, 2008, CURR OPIN NEPHROL HY, V17, P282, DOI 10.1097/MNH.0b013e3282f9b1c0; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X; Guan YF, 2001, KIDNEY INT, V60, P14, DOI 10.1046/j.1523-1755.2001.00766.x; Haberstroh U, 2002, KIDNEY INT, V62, P1264, DOI 10.1046/j.1523-1755.2002.00572.x; Haraguchi Kazutaka, 2003, Clin Exp Nephrol, V7, P27, DOI 10.1007/s101570300003; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hounoki H, 2008, BONE, V42, P765, DOI 10.1016/j.bone.2007.11.016; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; Jiang JG, 2001, J BIOL CHEM, V276, P25049, DOI 10.1074/jbc.M101611200; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kim EK, 2007, INT J BIOCHEM CELL B, V39, P1260, DOI 10.1016/j.biocel.2007.04.005; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li YJ, 2006, J AM SOC NEPHROL, V17, P54, DOI 10.1681/ASN.2005030257; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lu XH, 2004, J CELL BIOCHEM, V92, P833, DOI 10.1002/jcb.20143; Ma LJ, 2001, KIDNEY INT, V59, P1899, DOI 10.1046/j.1523-1755.2001.0590051899.x; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pocock J, 2003, J IMMUNOL, V170, P6280, DOI 10.4049/jimmunol.170.12.6280; Pritts EA, 2002, J CLIN ENDOCR METAB, V87, P1841, DOI 10.1210/jc.87.4.1841; Rangan G, 2009, FRONT BIOSCI-LANDMRK, V14, P3496, DOI 10.2741/3467; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ruan XZ, 2008, AM J PHYSIOL-RENAL, V294, pF1032, DOI 10.1152/ajprenal.00152.2007; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Toblli JE, 2009, NEPHROL DIAL TRANSPL, V24, P2384, DOI 10.1093/ndt/gfp103; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Wan HY, 2008, BIOMED PHARMACOTHER, V62, P466, DOI 10.1016/j.biopha.2007.10.012; Wen XY, 2005, AM J PATHOL, V167, P947, DOI 10.1016/S0002-9440(10)61185-6; Wu J, 2009, FRONT BIOSCI-LANDMRK, V14, P995, DOI 10.2741/3291; Yang HC, 2009, J AM SOC NEPHROL, V20, P2380, DOI 10.1681/ASN.2008111138; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zelcer N, 2005, CELL METAB, V2, P273, DOI 10.1016/j.cmet.2005.10.004	44	25	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29981	29988		10.1074/jbc.M110.110908	http://dx.doi.org/10.1074/jbc.M110.110908			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663893	Green Published, hybrid			2022-12-27	WOS:000281984300035
J	Cooke, A; Prigge, A; Wickens, M				Cooke, Amy; Prigge, Andrew; Wickens, Marvin			Translational Repression by Deadenylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEADENYLATION; CCR4-NOT COMPLEX; TRANSCRIPTION FACTOR; MEIOTIC MATURATION; CAF1 PROTEINS; IN-VITRO; YEAST; INITIATION; DEGRADATION; POLYMERASE	The CCR4-CAF1-NOT complex is a major cytoplasmic deadenylation complex in yeast and mammals. This complex associates with RNA-binding proteins and microRNAs to repress translation of target mRNAs. We sought to determine how CCR4 and CAF1 participate in repression and control of maternal mRNAs using Xenopus laevis oocytes. We show that Xenopus CCR4 and CAF1 enzymes are active deadenylases and repress translation of an adenylated mRNA. CAF1 also represses translation independent of deadenylation. The deadenylation-independent repression requires a 5' cap structure on the mRNA; however, deadenylation does not. We suggest that mere recruitment of CAF1 is sufficient for repression, independent of deadenylation.	[Cooke, Amy; Prigge, Andrew; Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Cooke, Amy] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	wickens@biochem.wisc.edu		Prigge, Andrew/0000-0003-4454-5152	National Institutes of Health [GM31892, GM50942]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031892, R01GM031892, R01GM050942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31892 and GM50942 (to M. W.). This work was also supported by an National Institutes of Health Molecular Biosciences Training Grant (to A. C.).	Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Berthet C, 2004, MOL CELL BIOL, V24, P5808, DOI 10.1128/MCB.24.13.5808-5820.2004; Bianchin C, 2005, RNA, V11, P487, DOI 10.1261/rna.7135305; Chen JJ, 2001, J MOL BIOL, V314, P683, DOI 10.1006/jmbi.2001.5162; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Dickson KS, 2001, J BIOL CHEM, V276, P41810, DOI 10.1074/jbc.M103030200; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Finoux AL, 2006, J BIOL CHEM, V281, P25940, DOI 10.1074/jbc.M600132200; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gorgoni B, 2005, RNA, V11, P1030, DOI 10.1261/rna.7281305; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Molin L, 2005, GENE, V358, P73, DOI 10.1016/j.gene.2005.05.023; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Morris JZ, 2005, DEVELOPMENT, V132, P1165, DOI 10.1242/dev.01672; Nakamura T, 2004, NAT GENET, V36, P528, DOI 10.1038/ng1344; Omer AD, 2009, MOL CELL, V35, P739, DOI 10.1016/j.molcel.2009.09.003; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Standart N, 2007, GENE DEV, V21, P1975, DOI 10.1101/gad.1591507; Suzuki A, 2010, P NATL ACAD SCI USA, V107, P3594, DOI 10.1073/pnas.0908664107; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Thompson SR, 2000, MOL CELL BIOL, V20, P2129, DOI 10.1128/MCB.20.6.2129-2137.2000; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; Wagner E, 2007, MOL CELL BIOL, V27, P1686, DOI 10.1128/MCB.01483-06; Wakiyama M, 2010, PROG MOL SUBCELL BIO, V50, P85, DOI 10.1007/978-3-642-03103-8_6; Westmoreland TJ, 2004, EUKARYOT CELL, V3, P430, DOI 10.1128/EC.3.2.430-446.2004; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wickens M, 2000, COLD SPRING HARBOR M, V39, P295; Wickens M, 2003, SCIENCE, V300, P753, DOI 10.1126/science.1084512; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	53	92	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28506	28513		10.1074/jbc.M110.150763	http://dx.doi.org/10.1074/jbc.M110.150763			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20634287	Green Published, hybrid			2022-12-27	WOS:000281594000014
J	Fresquet, M; Jowitt, TA; Stephen, LA; Ylostalo, J; Briggs, MD				Fresquet, Maryline; Jowitt, Thomas A.; Stephen, Louise A.; Yloestalo, Joni; Briggs, Michael D.			Structural and Functional Investigations of Matrilin-1 A-domains Reveal Insights into Their Role in Cartilage ECM Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEIN; EXTRACELLULAR-MATRIX; SKELETAL DEVELOPMENT; MOLECULAR-BASIS; COLLAGEN-VI; FORMS; MICE; BIGLYCAN; INTEGRIN; FIBRIL	Matrilin-1 is expressed predominantly in cartilage and co-localizes with matrilin-3 with which it can form hetero-oligomers. We recently described novel structural and functional features of the matrilin-3 A-domain (M3A) and demonstrated that it bound with high affinity to type II and IX collagens. Interactions preferentially occurred in the presence of Zn2+ suggesting that matrilin-3 has acquired a requirement for specific metal ions for activation and/or molecular associations. To understand the interdependence of matrilin-1/-3 hetero-oligomers in extracellular matrix (ECM) interactions, we have extended these studies to include the two matrilin-1 A-domains (i.e. M1A1 and M1A2 respectively). In this study we have identified new characteristics of the matrilin-1 A-domains by describing their glycosylation state and the effect of N-glycan chains on their structure, thermal stability, and protein-protein interactions. Initial characterization revealed that N-glycosylation did not affect secretion of these two proteins, nor did it alter their folding characteristics. However, removal of the glycosylation decreased their thermal stability. We then compared the effect of different cations on binding between both M1A domains and type II and IX collagens and showed that Zn2+ also supports their interactions. Finally, we have demonstrated that both M1A1 domains and biglycan are essential for the association of the type II.VI collagen complex. We predict that a potential role of the matrilin-1/-3 hetero-oligomer might be to increase multivalency, and therefore the ability to connect various ECM components. Differing affinities could act to regulate the integrated network, thus coordinating the organization of the macromolecular structures in the cartilage ECM.	[Fresquet, Maryline; Jowitt, Thomas A.; Stephen, Louise A.; Briggs, Michael D.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Yloestalo, Joni] Tulane Univ Hlth Sci, Ctr Gene Therapy, New Orleans, LA 70123 USA	University of Manchester; Tulane University	Briggs, MD (corresponding author), Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	mike.briggs@manchester.ac.uk	Ylostalo, Joni/AAH-9457-2019	Ylostalo, Joni/0000-0001-9746-1994; Fresquet, Maryline/0000-0001-9530-6392; Stephen, Louise/0000-0001-6795-0383; Jowitt, Thomas/0000-0002-4045-0933	Wellcome Trust [071161/Z/03/Z, 084353/Z/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by Grants 071161/Z/03/Z and 084353/Z/07/Z from the Wellcome Trust.	Aszodi A, 1999, MOL CELL BIOL, V19, P7841; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Dixon Matthew C, 2008, J Biomol Tech, V19, P151; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; DWEK RA, 1995, BIOCHEM SOC T, V23, P1; Ehlen HWA, 2009, J BIOL CHEM, V284, P21545, DOI 10.1074/jbc.M109.016568; Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200; Fresquet M, 2007, J BIOL CHEM, V282, P34634, DOI 10.1074/jbc.M705301200; GRENNAN DM, 1980, NEW ZEAL MED J, V91, P47; Huang XM, 1999, DEV DYNAM, V216, P434, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<434::AID-DVDY11>3.3.CO;2-O; Johansson JA, 2005, BIOMACROMOLECULES, V6, P1353, DOI 10.1021/bm0493741; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Kleemann-Fischer D, 2001, ARCH BIOCHEM BIOPHYS, V387, P209, DOI 10.1006/abbi.2000.2256; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Nicolae C, 2007, J BIOL CHEM, V282, P22163, DOI 10.1074/jbc.M610994200; PAULSSON M, 1979, BIOCHEM J, V183, P539, DOI 10.1042/bj1830539; PAULSSON M, 1981, BIOCHEM J, V197, P367, DOI 10.1042/bj1970367; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Romijn RA, 2003, J BIOL CHEM, V278, P15035, DOI 10.1074/jbc.M208977200; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Tams JW, 2001, BIOCHEM BIOPH RES CO, V286, P701, DOI 10.1006/bbrc.2001.5455; Ueda T, 1996, J BIOCHEM-TOKYO, V119, P157; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Wu JJ, 1998, J BIOL CHEM, V273, P17433, DOI 10.1074/jbc.273.28.17433; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zhang Yue, 2008, J Orthop Surg Res, V3, P21, DOI 10.1186/1749-799X-3-21	32	14	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34048	34061		10.1074/jbc.M110.154443	http://dx.doi.org/10.1074/jbc.M110.154443			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729554	Green Published, hybrid			2022-12-27	WOS:000283354000051
J	Plasari, G; Edelmann, S; Hogger, F; Dusserre, Y; Mermod, N; Calabrese, A				Plasari, Genta; Edelmann, Simone; Hoegger, Florence; Dusserre, Yves; Mermod, Nicolas; Calabrese, Alessandra			Nuclear Factor I-C Regulates TGF-beta-dependent Hair Follicle Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL STEM-CELLS; GAMMA-GLUTAMYL-TRANSPEPTIDASE; TOOTH ROOT DEVELOPMENT; SONIC-HEDGEHOG; COLORIMETRIC ASSAY; ANAGEN INDUCTION; SKIN APPENDAGE; LEF-1 PROMOTER; BINDING SITES; GROWTH-PHASE	Skin appendages such as teeth and hair share several common signaling pathways. The nuclear factor IC(NFI-C) transcription factor has been implicated in tooth development, but a potential role in hair growth had not been assessed. In this study we found that NFI-C regulates the onset of the hair growth cycle. NFIC-/- mice were delayed in the transition from the telogen to anagen phase of the hair follicle cycle after either experimental depilation or spontaneous hair loss. Lack of NFI-C resulted in delayed induction of the sonic hedgehog, Wnt5a, and Lef1 gene expression, which are key regulators of the hair follicle growth initiation. NFI-C-/- mice also showed elevated levels of transforming growth factor beta 1 (TGF-beta 1), an inhibitor of keratinocyte proliferation, and of the cell cycle inhibitor p21 at telogen. Reduced expression of Ki67, a marker of cell proliferation, was noted at the onset of anagen, indicating impaired activation of the hair progenitor cells. These findings implicate NFI-C in the repression of TGF-beta 1 signaling during telogen stage, resulting in the delay of progenitor cell proliferation and hair follicle regeneration in NFI-C-deficient mice. Taken together with prior observations, these findings also designate NFI-C as a regulator of adult progenitor cell proliferation and of postnatal tissue growth or regeneration.	[Mermod, Nicolas] Univ Lausanne, Inst Biotechnol, Mol Biotechnol Lab, Stn 6, CH-1015 Lausanne, Switzerland	University of Lausanne	Mermod, N (corresponding author), Univ Lausanne, Inst Biotechnol, Mol Biotechnol Lab, Stn 6, CH-1015 Lausanne, Switzerland.	Nicolas.Mermod@unil.ch			University of Lausanne	University of Lausanne	This work was supported by the University of Lausanne.	Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Argyris T S, 1968, Adv Morphog, V7, P1; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Botchkarev VA, 2003, J INVEST DERM SYMP P, V8, P46, DOI 10.1046/j.1523-1747.2003.12171.x; Budd PS, 1997, MAMM GENOME, V8, P631, DOI 10.1007/s003359900527; CAMERON R, 1978, CANCER RES, V38, P823; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DEYOUNG LM, 1978, CANCER RES, V38, P3697; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; GRONOSTAJSKI RM, 1985, MOL CELL BIOL, V5, P964, DOI 10.1128/MCB.5.5.964; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; JACOBS WLW, 1971, CLIN CHIM ACTA, V31, P175, DOI 10.1016/0009-8981(71)90375-5; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; KAWABE TT, 1994, J INVEST DERMATOL, V103, P122, DOI 10.1111/1523-1747.ep12391894; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Lefever T, 2010, J CELL SCI, V123, P128, DOI 10.1242/jcs.053835; Liu XM, 2004, J INVEST DERMATOL, V123, P264, DOI 10.1111/j.0022-202X.2004.23201.x; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Matsuo K, 2003, ARCH DERMATOL RES, V295, P33, DOI 10.1007/s00403-003-0384-9; Mikkola ML, 2006, J MAMMARY GLAND BIOL, V11, P187, DOI 10.1007/s10911-006-9029-x; Mikkola ML, 2007, CELL CYCLE, V6, P285, DOI 10.4161/cc.6.3.3798; Muller-Rover S, 1999, EXP DERMATOL, V8, P237; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; NEBL G, 1994, J BIOL CHEM, V269, P7371; Nordlund JJ, 2007, DERMATOL CLIN, V25, P271, DOI 10.1016/j.det.2007.04.001; Ouellet S, 2006, NUCLEIC ACIDS RES, V34, P6472, DOI 10.1093/nar/gkl861; Park JC, 2007, J PERIODONTOL, V78, P1795, DOI 10.1902/jop.2007.060363; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; PERSIJN JP, 1971, CLIN CHIM ACTA, V35, P239, DOI 10.1016/0009-8981(71)90318-4; Plasari G, 2009, MOL CELL BIOL, V29, P6006, DOI 10.1128/MCB.01921-08; Qiao W, 2006, ONCOGENE, V25, P207, DOI 10.1038/sj.onc.1209029; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Sano S, 2000, P NATL ACAD SCI USA, V97, P13824, DOI 10.1073/pnas.240303097; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Viallard J F, 2001, Cancer Radiother, V5, P109, DOI 10.1016/S1278-3218(01)00087-7; Werner S, 2000, EXP CELL RES, V254, P80, DOI 10.1006/excr.1999.4726; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544	62	19	22	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34115	34125		10.1074/jbc.M110.120659	http://dx.doi.org/10.1074/jbc.M110.120659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729551	hybrid, Green Published			2022-12-27	WOS:000283354000057
J	Liao, CC; Tsai, CY; Chang, WC; Lee, WH; Wang, JM				Liao, Ching-Chun; Tsai, Connie Y.; Chang, Wen-Chang; Lee, Wen-Hwa; Wang, Ju-Ming			RB center dot E2F1 Complex Mediates DNA Damage Responses through Transcriptional Regulation of ZBRK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL BINDING-PROTEIN; CELL-CYCLE CHECKPOINTS; P53-DEPENDENT APOPTOSIS; REPRESSION; PROMOTER; EXPRESSION; PATHWAY; PRB; PHOSPHORYLATION; COREPRESSOR	RB plays an essential role in DNA damage-induced growth arrest and regulates the expression of several factors essential for DNA repair machinery. However, how RB coordinates DNA damage response through transcriptional regulation of genes involved in growth arrest remains largely unexplored. We examined whether RB can mediate the response to DNA damage through modulation of ZBRK1, a zinc finger-containing transcriptional repressor that can modulate the expression of GADD45A, a DNA damage response gene, to induce cell cycle arrest in response to DNA damage. We found that the ZBRK1 promoter contains an authentic E2F-recognition sequence that specifically binds E2F1, but not E2F4 or E2F6, together with chromatin remodeling proteins CtIP and CtBP to form a repression complex that suppresses ZBRK1 transcription. Furthermore, loss of RB-mediated transcriptional repression led to an increase in ZBRK1 transcript levels, correlating with increased sensitivity to ultraviolet (UV) and methyl methanesulfonate-induced DNA damage. Taken together, these results suggest that the RB center dot CtIP (CtBP interacting protein)/CtBP (C terminus-binding protein) /E2F1 complex plays a critical role in ZBRK1 transcriptional repression, and loss of this repression may contribute to cellular sensitivity of DNA damage, ultimately leading to carcinogenesis.	[Tsai, Connie Y.; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chang, Wen-Chang] Natl Cheng Kung Univ, Inst Pharmacol, Coll Med, Tainan 70101, Taiwan; [Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Biosignal Transduct, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan	University of California System; University of California Irvine; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	whlee@uci.edu; yumingw@mail.ncku.edu.tw	wang, ju-ming/A-1875-2011; Lee, Wen-Hwa/C-2519-2014		National Institutes of Health [CA94170]; NSC (Taiwan) [98-2320-B-006-036-MY3]; National Cheng Kung University [C007]; NATIONAL CANCER INSTITUTE [R01CA094170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSC (Taiwan)(Ministry of Science and Technology, Taiwan); National Cheng Kung University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA94170 (to W.-H. L., who serves on the Board of Directors of GeneTex, Inc. and has an equity interest), NSC Grant 98-2320-B-006-036-MY3 (Taiwan) and National Cheng Kung University landmark Grant C007 (to J.-M. W.), and the Fund for Open Access publication provided by NSC Grant 98-2320-B-006-036-MY3 (Taiwan).	Ahmed KM, 2010, J BIOL CHEM, V285, P4464, DOI 10.1074/jbc.M109.062265; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bosco EE, 2004, NUCLEIC ACIDS RES, V32, P25, DOI 10.1093/nar/gkg919; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feuerhahn S, 2008, TRENDS GENET, V24, P467, DOI 10.1016/j.tig.2008.07.003; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Furuta S, 2006, CANCER CELL, V10, P13, DOI 10.1016/j.ccr.2006.05.022; Garcia V, 2005, J PATHOL, V206, P92, DOI 10.1002/path.1751; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hofferer M, 1999, NUCLEIC ACIDS RES, V27, P491, DOI 10.1093/nar/27.2.491; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Jun DY, 2008, BBA-GENE REGUL MECH, V1779, P356, DOI 10.1016/j.bbagrm.2008.03.013; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Koipally J, 2002, J BIOL CHEM, V277, P23143, DOI 10.1074/jbc.M202079200; Lin LF, 2010, CANCER RES, V70, P192, DOI 10.1158/0008-5472.CAN-09-2641; Liu F, 2006, MOL CELL BIOL, V26, P3124, DOI 10.1128/MCB.26.8.3124-3134.2006; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; MORGENBESSER SD, 1994, NATURE, V371, P72, DOI 10.1038/371072a0; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OHTANIFUJITA N, 1994, ONCOGENE, V9, P1703; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Subramanian T, 2003, FEBS LETT, V540, P255, DOI 10.1016/S0014-5793(03)00275-8; Tanaka M, 2002, J BIOL CHEM, V277, P10719, DOI 10.1074/jbc.M108252200; Wang JM, 2005, MOL BIOL CELL, V16, P3365, DOI 10.1091/mbc.E05-02-0105; Wang WL, 1997, MOL CELL ENDOCRINOL, V133, P49, DOI 10.1016/S0303-7207(97)00142-1; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; Wu LL, 2000, MOL CELL BIOL, V20, P7059, DOI 10.1128/MCB.20.19.7059-7067.2000; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yun JH, 2003, MOL CELL BIOL, V23, P7305, DOI 10.1128/MCB.23.20.7305-7314.2003; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	56	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33134	33143		10.1074/jbc.M110.143461	http://dx.doi.org/10.1074/jbc.M110.143461			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20713352	hybrid, Green Published			2022-12-27	WOS:000283048200051
J	Zhang, XM; Lam, KSL; Ye, HY; Chung, SK; Zhou, MY; Wang, Y; Xu, AM				Zhang, Xinmei; Lam, Karen S. L.; Ye, Hongying; Chung, Sookja K.; Zhou, Mingyan; Wang, Yu; Xu, Aimin			Adipose Tissue-specific Inhibition of Hypoxia-inducible Factor 1 alpha Induces Obesity and Glucose Intolerance by Impeding Energy Expenditure in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; GROWTH-FACTOR; MACROPHAGE INFILTRATION; CHRONIC INFLAMMATION; GENE-EXPRESSION; TRANSGENIC MICE; ANGIOGENESIS; ADIPOCYTES; HYPERLIPIDEMIA	Hypoxia in adipose tissue has been postulated as a possible contributor to obesity-related chronic inflammation, insulin resistance, and metabolic dysfunction. HIF1 alpha (hypoxia-inducible factor 1 alpha), a master signal mediator of hypoxia response, is elevated in obese adipose tissue. However, the role of HIF1 alpha in obesity-related pathologies remains to be determined. Here we show that transgenic mice with adipose tissue-selective expression of a dominant negative version of HIF1 alpha developed more severe obesity and were more susceptible to high fat diet-induced glucose intolerance and insulin resistance compared with their wild type littermates. Obesity in the transgenic mice was attributed to impaired energy expenditure and reduced thermogenesis. Histological examination of interscapular brown adipose tissue (BAT) in the transgenic mice demonstrated a markedly increased size of lipid droplets and decreased mitochondrial density in adipocytes, a phenotype similar to that in white adipose tissue. These changes in BAT of the transgenic mice were accompanied by decreased mitochondrial biogenesis and reduced expression of key thermogenic genes. In the transgenic mice, angiogenesis in BAT was decreased but was little affected in white adipose tissue. These findings support an indispensable role of HIF1 alpha in maintaining the thermogenic functions of BAT, possibly through promoting angiogenesis and mitochondrial biogenesis in this tissue.	[Zhang, Xinmei; Lam, Karen S. L.; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Xinmei; Lam, Karen S. L.; Chung, Sookja K.; Wang, Yu; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Ageing, Hong Kong, Hong Kong, Peoples R China; [Chung, Sookja K.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Zhou, Mingyan; Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Ye, Hongying] Fudan Univ, Hua Shan Hosp, Dept Endocrinol, Shanghai 200040, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Fudan University	Xu, AM (corresponding author), L8-40,New Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	Xu, Aimin/D-3291-2013	Xu, Aimin/0000-0002-0668-033X; wang, yu/0000-0001-8697-2940	Research Grants Council of Hong Kong [HKU 7645/06M]; Collaborative Research Fund [HKU 2/07C]; Natural Science Foundation of China [30600300]; University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Collaborative Research Fund; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Hong Kong(University of Hong Kong)	This work was supported by Research Grants Council of Hong Kong General Research Fund Grant HKU 7645/06M and Collaborative Research Fund Grant HKU 2/07C, Natural Science Foundation of China Grant 30600300, and an Outstanding Young Researcher Award from the University of Hong Kong (to A. X.).	Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; BUKOWIECKI L, 1980, AM J PHYSIOL, V239, pE422, DOI 10.1152/ajpendo.1980.239.6.E422; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Chen BY, 2006, BIOCHEM BIOPH RES CO, V341, P549, DOI 10.1016/j.bbrc.2006.01.004; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Fredriksson JM, 2000, J BIOL CHEM, V275, P13802, DOI 10.1074/jbc.275.18.13802; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hemmeryckx B, 2008, ENDOCRINOLOGY, V149, P2176, DOI 10.1210/en.2007-1272; Hensley LL, 2003, J BIOL CHEM, V278, P32702, DOI 10.1074/jbc.M304200200; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Trayhurn P, 2008, BRIT J NUTR, V100, P227, DOI 10.1017/S0007114508971282; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Valet P, 2000, J BIOL CHEM, V275, P34797, DOI 10.1074/jbc.M005210200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	39	78	80	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32869	32877		10.1074/jbc.M110.135509	http://dx.doi.org/10.1074/jbc.M110.135509			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20716529	Green Published, hybrid			2022-12-27	WOS:000283048200024
J	Zhang, ZQ; Bryan, JL; DeLassus, E; Chang, LW; Liao, WM; Sandell, LJ				Zhang, Zhiqi; Bryan, Jennifer L.; DeLassus, Elizabeth; Chang, Li-Wei; Liao, Weiming; Sandell, Linda J.			CCAAT/Enhancer-binding Protein beta and NF-kappa B Mediate High Level Expression of Chemokine Genes CCL3 and CCL4 by Human Chondrocytes in Response to IL-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR CHONDROCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; CD-RAP GENE; MESSENGER-RNA; MIP-1-BETA PRODUCTION; IKK-BETA; IN-VITRO; CARTILAGE; ALPHA; ACTIVATION	A large set of chemokines is highly up-regulated in human chondrocytes in response to IL-1 beta (Sandell, L.J., Xing, X., Franz, C., Davies, S., Chang, L. W., and Patra, D. (2008) Osteoarthr. Cartil. 16, 1560-1571). To investigate the mechanism of transcriptional regulation, deletion constructs of selected chemokine gene promoters, the human CCL3 (MIP-1 alpha) and CCL4 (MIP-1 beta), were transfected into human chondrocytes with or without IL-1 beta. The results show that an IL-1 beta-responsive element is located between bp -300 and -140 of the CCL3 promoter and between bp -222 and -100 of the CCL4 promoter. Because both of these elements contain CCAAT/enhancer-binding protein beta (C/EBP beta) motifs, the function of C/EBP beta was examined. IL-1 beta stimulated the expression of C/EBP beta, and the direct binding of C/EBP beta to the C/EBP beta motif was confirmed by EMSA and ChIP analyses. The -300 bp CCL3 promoter and -222 bp CCL4 promoter were strongly up-regulated by co-transfection with the C/EBP beta expression vector. Mutation of the C/EBP beta motif and reduction of C/EBP beta expression by siRNA decreased the up-regulation. Additionally, another cytokine-related transcription factor, NF-kappa B, was also shown to be involved in the up-regulation of chemokines in response to IL-1 beta, and the binding site was identified. The regulation of C/EBP beta and NF-kappa B was confirmed by the inhibition by C/EBP beta and NF-kappa B and by transfection with C/EBP beta and NF-kappa B expression vectors in the presence or absence of IL-1 beta. Taken together, our results suggest that C/EBP beta and NF-kappa B are both involved in the IL-1 beta-responsive up-regulation of chemokine genes in human chondrocytes. Time course experiments indicated that C/EBP beta gradually and steadily induces chemokine up-regulation, whereas NF-kappa B activity was highest at the early stage of chemokine up-regulation.	[Zhang, Zhiqi; Bryan, Jennifer L.; DeLassus, Elizabeth; Sandell, Linda J.] Washington Univ, Sch Med, Dept Orthopaed Surg, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Chang, Li-Wei] Washington Univ, Sch Med, Dept Pathol & Immunol, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Sandell, Linda J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Zhang, Zhiqi; Liao, Weiming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Guangzhou 510080, Guangdong, Peoples R China	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Sun Yat Sen University	Sandell, LJ (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, 660 S Euclid Ave,CB 8233, St Louis, MO 63110 USA.	sandelll@wustl.edu			National Institutes of Health, NIAMS [R01 AR050847, R01 AR036994, R01 65554]; Center for Musculoskeletal Research [P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036994, R01AR045550, P30AR057235, R01AR050847] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center for Musculoskeletal Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grants R01 AR050847 and R01 AR036994, R01 65554 and ARRA Supplement, and Center for Musculoskeletal Research P30 AR057235.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Amos N, 2006, RHEUMATOLOGY, V45, P1201, DOI 10.1093/rheumatology/kel078; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Borzi RM, 2000, ARTHRITIS RHEUM, V43, P1734, DOI 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Choi SJ, 2003, BLOOD, V101, P3778, DOI 10.1182/blood-2002-08-2641; Davies SR, 2007, GENOME RES, V17, P1438, DOI 10.1101/gr.6224007; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; El-Asmar B, 2009, J MOL ENDOCRINOL, V42, P131, DOI 10.1677/JME-08-0016; Fukui N, 2003, J BONE JOINT SURG AM, V85A, P59, DOI 10.2106/00004623-200300003-00011; Fukui N, 2006, J BIOL CHEM, V281, P27229, DOI 10.1074/jbc.M603385200; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Haringman JJ, 2004, ANN RHEUM DIS, V63, P1186, DOI 10.1136/ard.2004.020529; He YC, 2002, J BIOL CHEM, V277, P19530, DOI 10.1074/jbc.M201126200; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Imamura T, 2005, J BIOL CHEM, V280, P16625, DOI 10.1074/jbc.M411469200; Imamura T, 2008, ARTHRITIS RHEUM-US, V58, P1366, DOI 10.1002/art.23438; Kristiansson E, 2009, MOL BIOL EVOL, V26, P1299, DOI 10.1093/molbev/msp040; Lakshmanan U, 2007, J IMMUNOL, V179, P8480, DOI 10.4049/jimmunol.179.12.8480; Lee JH, 2009, OSTEOARTHR CARTILAGE, V17, P613, DOI 10.1016/j.joca.2008.08.007; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lu KT, 2006, BLOOD, V108, P3769, DOI 10.1182/blood-2006-03-008839; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Martel-Pelletier J, 1999, FRONT BIOSCI, V4, pD694; McAlinden A, 2007, J BIOL CHEM, V282, P24444, DOI 10.1074/jbc.M702717200; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Miyamoto K, 2009, BIOCHEM BIOPH RES CO, V383, P373, DOI 10.1016/j.bbrc.2009.04.020; Okazaki K, 2006, J CELL BIOCHEM, V97, P857, DOI 10.1002/jcb.20648; Okazaki K, 2002, J BIOL CHEM, V277, P31526, DOI 10.1074/jbc.M202815200; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Radolph EH, 2005, CURR PHARM DESIGN, V11, P613, DOI 10.2174/1381612053381963; Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; Sow FB, 2009, J LEUKOCYTE BIOL, V86, P1247, DOI 10.1189/jlb.1208719; Tebo JM, 2000, J BIOL CHEM, V275, P12987, DOI 10.1074/jbc.275.17.12987; TIKU K, 1992, CELL IMMUNOL, V140, P1, DOI 10.1016/0008-8749(92)90172-L; Tseng PC, 2008, BIOCHEM PHARMACOL, V76, P1121, DOI 10.1016/j.bcp.2008.08.023; Venza I, 2009, J BIOL CHEM, V284, P4191, DOI 10.1074/jbc.M805429200; Yamasaki K, 2009, ARTHRITIS RHEUM-US, V60, P1035, DOI 10.1002/art.24404; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang ZQ, 2010, ARTHRITIS RHEUM-US, V62, P1993, DOI 10.1002/art.27473; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	54	48	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33092	33103		10.1074/jbc.M110.130377	http://dx.doi.org/10.1074/jbc.M110.130377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702408	hybrid, Green Published			2022-12-27	WOS:000283048200047
J	Altmann, M; Linder, P				Altmann, Michael; Linder, Patrick			Power of Yeast for Analysis of Eukaryotic Translation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TEMPERATURE-SENSITIVE MUTANTS; DEPENDENT RNA HELICASE; CAP-BINDING PROTEIN; AMINO-ACID CONTROL; CELL-FREE SYSTEM; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; START CODON; FACTOR-4A; ATP		[Linder, Patrick] Univ Geneva, Dept Microbiol & Mol Med, Ctr Med Univ, CH-1211 Geneva 4, Switzerland; [Altmann, Michael] Univ Bern, IBMM, CH-3012 Bern, Switzerland	University of Geneva; University of Bern	Linder, P (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, Ctr Med Univ, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	patrick.linder@unige.ch			Swiss National Science Foundation; Universities of Bern and Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Universities of Bern and Geneva	This work was supported by the Swiss National Science Foundation and the Universities of Bern and Geneva. This is the second article in the Thematic Minireview Series on Protein Synthesis. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	ALTMANN M, 1985, BIOCHEMISTRY-US, V24, P6085, DOI 10.1021/bi00343a009; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; ALTMANN M, 1993, EMBO J, V12, P3997, DOI 10.1002/j.1460-2075.1993.tb06077.x; ALTMANN M, 1989, MOL CELL BIOL, V9, P4467, DOI 10.1128/MCB.9.10.4467; ALTMANN M, 1989, J BIOL CHEM, V264, P12145; ALTMANN M, 1987, MOL CELL BIOL, V7, P998, DOI 10.1128/MCB.7.3.998; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; Ashe MP, 2001, EMBO J, V20, P6464, DOI 10.1093/emboj/20.22.6464; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; BEDARD DP, 1981, CURR GENET, V4, P205, DOI 10.1007/BF00420500; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; BLUM S, 1992, P NATL ACAD SCI USA, V89, P7664, DOI 10.1073/pnas.89.16.7664; BLUM S, 1989, P NATL ACAD SCI USA, V86, P6043, DOI 10.1073/pnas.86.16.6043; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; CIGAN AM, 1988, SCIENCE, V242, P93, DOI 10.1126/science.3051379; CIGAN AM, 1989, P NATL ACAD SCI USA, V86, P2784, DOI 10.1073/pnas.86.8.2784; COPPOLECCHIA R, 1993, EMBO J, V12, P4005, DOI 10.1002/j.1460-2075.1993.tb06078.x; Danaie P, 1999, BIOCHEM J, V340, P135, DOI 10.1042/0264-6021:3400135; de la Cruz J, 1998, RNA, V4, P1268, DOI 10.1017/S1355838298981158; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Deloche O, 2004, MOL CELL, V13, P357, DOI 10.1016/S1097-2765(04)00008-5; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; EDERY I, 1983, J BIOL CHEM, V258, P1398; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GRIFO JA, 1982, J BIOL CHEM, V257, P5246; HANICJOYCE PJ, 1987, J BIOL CHEM, V262, P2845; HANICJOYCE PJ, 1985, GENETICS, V110, P591; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; HARTWELL LH, 1968, J BACTERIOL, V96, P1664, DOI 10.1128/JB.96.5.1664-1671.1968; HARTWELL LH, 1969, P NATL ACAD SCI USA, V62, P468, DOI 10.1073/pnas.62.2.468; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 2006, LANDMARK PAPERS YEAS, P85; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; JAMIESON DJ, 1991, NATURE, V349, P715, DOI 10.1038/349715a0; JAMIESON DJ, 1991, MOL MICROBIOL, V5, P805, DOI 10.1111/j.1365-2958.1991.tb00753.x; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Palmer LK, 2005, MOL BIOL CELL, V16, P3727, DOI 10.1091/mbc.E05-02-0127; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PRAT A, 1990, BIOCHIM BIOPHYS ACTA, V1050, P140, DOI 10.1016/0167-4781(90)90155-U; RAY BK, 1985, J BIOL CHEM, V260, P7651; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; Rousseau D, 1996, ONCOGENE, V13, P2415; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; SACHS A, 1993, J BIOL CHEM, V268, P22955; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; Saville SP, 2006, ANTIMICROB AGENTS CH, V50, P3312, DOI 10.1128/AAC.00628-06; SCHMID SR, 1991, MOL CELL BIOL, V11, P3463, DOI 10.1128/MCB.11.7.3463; SEAL SN, 1983, P NATL ACAD SCI-BIOL, V80, P6562, DOI 10.1073/pnas.80.21.6562; Sezen B, 2009, GENE DEV, V23, P1559, DOI 10.1101/gad.524209; SHERMAN F, 1980, CELL, V20, P215, DOI 10.1016/0092-8674(80)90249-4; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Verlhac MH, 1997, EMBO J, V16, P6812, DOI 10.1093/emboj/16.22.6812; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248	71	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31907	31912		10.1074/jbc.R110.144196	http://dx.doi.org/10.1074/jbc.R110.144196			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693283	hybrid, Green Published			2022-12-27	WOS:000282683000002
J	Deng, JJ; Liao, XY; Yang, HX; Zhang, XY; Hua, ZC; Masuda, T; Goto, F; Yoshihara, T; Zhao, GH				Deng, Jianjun; Liao, Xiayun; Yang, Haixia; Zhang, Xiangyu; Hua, Zichun; Masuda, Taro; Goto, Fumiyuki; Yoshihara, Toshihiro; Zhao, Guanghua			Role of H-1 and H-2 Subunits of Soybean Seed Ferritin in Oxidative Deposition of Iron in Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PISUM-SATIVUM FERRITIN; H-CHAIN FERRITIN; PLANT FERRITIN; TREMATOMUS-BERNACCHII; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; FE(II) OXIDATION; CORE FORMATION; HORSE SPLEEN; IN-VITRO	Naturally occurring phytoferritin is a heteropolymer consisting of two different H-type subunits, H-1 and H-2. Prior to this study, however, the function of the two subunits in oxidative deposition of iron in ferritin was unknown. The data show that, upon aerobic addition of 48-200 Fe2+/shell to apoferritin, iron oxidation occurs only at the diiron ferroxidase center of recombinant H1 (rH-1). In addition to the diiron ferroxidase mechanism, such oxidation is catalyzed by the extension peptide (a specific domain found in phytoferritin) of rH-2, because the H-1 subunit is able to remove Fe3+ from the center to the inner cavity better than the H-2 subunit. These findings support the idea that the H-1 and H-2 subunits play different roles in iron mineralization in protein. Interestingly, at medium iron loading (200 irons/shell), wild-type (WT) soybean seed ferritin (SSF) exhibits a stronger activity in catalyzing iron oxidation (1.10 +/- 0.13 mu M iron/subunit/s) than rH-1 (0.59 +/- 0.07 mu M iron/subunit/s) and rH-2 (0.48 +/- 0.04 mu M iron/subunit/s), demonstrating that a synergistic interaction exists between the H-1 and H-2 subunits in SSF during iron mineralization. Such synergistic interaction becomes considerably stronger at high iron loading (400 irons/shell) as indicated by the observation that the iron oxidation activity of WT SSF is similar to 10 times larger than those of rH-1 and rH-2. This helps elucidate the widespread occurrence of heteropolymeric ferritins in plants.	[Masuda, Taro] Kyoto Univ, Lab Food Qual Design & Dev, Div Agron & Hort Sci, Grad Sch Agr, Kyoto 6110011, Japan; China Agr Univ, Beijing 100083, Peoples R China; [Zhao, Guanghua] China Agr Univ, ACC Joint Lab Space Food, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Zhang, Xiangyu; Hua, Zichun] Nanjing Univ, Coll Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; [Zhang, Xiangyu; Hua, Zichun] Nanjing Univ, Coll Life Sci, Dept Biochem, Nanjing 210093, Peoples R China; [Goto, Fumiyuki; Yoshihara, Toshihiro] Cent Res Inst Elect Power Ind, Biotechnol Sect, Environm Sci Res Lab, Chiba 2701194, Japan	Kyoto University; China Agricultural University; China Agricultural University; Nanjing University; Nanjing University; Central Research Institute of Electric Power Industry - Japan	Masuda, T (corresponding author), Kyoto Univ, Lab Food Qual Design & Dev, Div Agron & Hort Sci, Grad Sch Agr, Kyoto 6110011, Japan.	masutaro@kais.kyoto-u.ac.jp; gzhao1000@yahoo.com	Jianjun, Deng/U-5306-2019; Zhao, Guanghua/GSE-4215-2022; Masuda, Taro/G-4276-2011; Yang, Haixia/AAH-3819-2020	Jianjun, Deng/0000-0002-3057-6997; Yang, Haixia/0000-0002-4410-9257; Masuda, Taro/0000-0002-5549-375X	National Natural Science Foundation of China [30972045]; Chinese Universities Scientific Fund [2009-3-10]; Innovation Fund for Graduate Students [15059203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; Innovation Fund for Graduate Students	This project was supported by National Natural Science Foundation of China Grant 30972045, Chinese Universities Scientific Fund Grant 2009-3-10, and Innovation Fund for Graduate Students Grant 15059203.	Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; Bou-Abdallah F, 2005, J AM CHEM SOC, V127, P3885, DOI 10.1021/ja044355k; Bou-Abdallah F, 2005, J MOL BIOL, V347, P543, DOI 10.1016/j.jmb.2005.01.007; Cavallo S, 1998, PROTEIN SCI, V7, P427; Chiaraluce R, 2000, EUR J BIOCHEM, V267, P5733, DOI 10.1046/j.1432-1327.2000.01639.x; CRICHTON RR, 1978, J MOL CATAL, V4, P75; Crichton RR, 1996, J BIOL INORG CHEM, V1, P567, DOI 10.1007/s007750050093; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Fu XP, 2010, BIOCHEM J, V427, P313, DOI 10.1042/BJ20100015; Giorgi A, 2008, ARCH BIOCHEM BIOPHYS, V478, P69, DOI 10.1016/j.abb.2008.06.022; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; Kang S, 2008, J AM CHEM SOC, V130, P16527, DOI 10.1021/ja807655t; Kopp DA, 2002, CURR OPIN CHEM BIOL, V6, P568, DOI 10.1016/S1367-5931(02)00366-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Li CR, 2009, BIOCHIMIE, V91, P1475, DOI 10.1016/j.biochi.2009.08.007; Li CR, 2009, J BIOL CHEM, V284, P16743, DOI 10.1074/jbc.M109.011528; Li CR, 2009, BIOCHIMIE, V91, P230, DOI 10.1016/j.biochi.2008.09.008; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; LOBREAUX S, 1991, BIOCHEM J, V274, P601, DOI 10.1042/bj2740601; LOBREAUX S, 1992, PLANT MOL BIOL, V19, P563, DOI 10.1007/BF00026783; LOBREAUX S, 1992, BIOCHEM J, V288, P931, DOI 10.1042/bj2880931; MACARA IG, 1972, BIOCHEM J, V126, P151, DOI 10.1042/bj1260151; Masuda T, 2001, J BIOL CHEM, V276, P19575, DOI 10.1074/jbc.M011399200; Masuda T, 2007, PROTEIN EXPRES PURIF, V56, P237, DOI 10.1016/j.pep.2007.07.011; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Mignogna G, 2002, EUR J BIOCHEM, V269, P1600, DOI 10.1046/j.1432-1327.2002.02762.x; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; PETERMAN BF, 1979, ANAL BIOCHEM, V93, P442, DOI 10.1016/S0003-2697(79)80176-1; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Theil EC, 2004, ANNU REV NUTR, V24, P327, DOI 10.1146/annurev.nutr.24.012003.132212; TREFFRY A, 1992, FEBS LETT, V302, P108, DOI 10.1016/0014-5793(92)80417-F; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P253, DOI 10.1042/bj3050253; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; WICKS RE, 1993, BIOCHEM BIOPH RES CO, V192, P813, DOI 10.1006/bbrc.1993.1487; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200; Zhao GH, 2003, BIOCHEMISTRY-US, V42, P3142, DOI 10.1021/bi027357v; Zhao GH, 2010, BBA-GEN SUBJECTS, V1800, P815, DOI 10.1016/j.bbagen.2010.01.009; Zhelev N, 2005, BIOTECHNOL BIOTECHNO, V19, P3, DOI DOI 10.1080/13102818.2005.10817219	43	32	36	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32075	32086		10.1074/jbc.M110.130435	http://dx.doi.org/10.1074/jbc.M110.130435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702403	Green Published, hybrid			2022-12-27	WOS:000282683000021
J	Hong, WC; Amara, SG				Hong, Weimin C.; Amara, Susan G.			Membrane Cholesterol Modulates the Outward Facing Conformation of the Dopamine Transporter and Alters Cocaine Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; AMINOBUTYRIC-ACID TRANSPORTER; TRANSMEMBRANE DOMAIN-I; LIPID RAFTS; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; CRYSTAL-STRUCTURE; CELL-MEMBRANES; PROTEIN; PHOSPHORYLATION	Clearance of synaptically released dopamine is regulated by the plasmalemmal dopamine transporter (DAT), an integral membrane protein that resides within a complex lipid milieu. Here we demonstrate that cholesterol, a major component of the lipid bilayer, can modulate the conformation of DAT and alter cocaine binding to DAT. In striatal synaptosomes and transfected cells, DAT was in cholesterol-rich membrane fractions after mild detergent extraction. After increasing the membrane cholesterol content by treatment of water-soluble cholesterol (cholesterol mixed with methyl-beta-cyclodextrin), we observed an increase in DAT binding B-max values for cocaine analogs [H-3]WIN35428 and [I-125]RTI-55, but similar levels of DAT proteins on the cell surface were shown by surface biotinylation assays. Membrane cholesterol addition also markedly enhanced the accessibility of cysteine sulfhydryl moieties in DAT as probed by a membrane-impermeable maleimide-biotin conjugate. We identified cysteine 306, a juxtamembrane residue on transmembrane domain 6 (TM6) of DAT, as the intrinsic residue exhibiting enhanced reactivity. Similar effects on DAT cysteine accessibility and radioligand binding were observed with addition of zinc, a reagent known to promote the outward facing conformation of DAT. Using substituted cysteine mutants on various positions likely to be extracellular, we identified additional residues located on TM1, TM6, TM7, and TM12 of DAT that are sensitive to alterations in the membrane cholesterol content. Our findings in transfected cells and native tissues support the hypothesis that DAT adopts an outward facing conformation in a cholesterol-rich membrane environment, suggesting a novel modulatory role of the surrounding membrane lipid milieu on DAT function.	[Hong, Weimin C.; Amara, Susan G.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Amara, SG (corresponding author), Univ Pittsburgh, Dept Neurobiol, 6068 BST3,3501 5th Ave, Pittsburgh, PA 15213 USA.	amaras@pitt.edu		Amara, Susan/0000-0001-8914-1106	National Institutes of Health [DA007595]; Parkinson's Disease Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007595, R37DA007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA007595 (to S. G. A.). This work was also supported by a postdoctoral fellowship from the Parkinson's Disease Foundation (to W. C. H.).	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Barrantes FJ, 2007, J NEUROCHEM, V103, P72, DOI 10.1111/j.1471-4159.2007.04719.x; BOJA JW, 1992, NEUROREPORT, V3, P247, DOI 10.1097/00001756-199203000-00007; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DALZIEL AW, 1980, FEBS LETT, V122, P193, DOI 10.1016/0014-5793(80)80435-2; Fairman WA, 1998, NAT NEUROSCI, V1, P105, DOI 10.1038/355; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; GRACZ LM, 1995, J PHARMACOL EXP THER, V273, P1224; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Ingram SL, 2000, J NEUROSCI, V20, P550, DOI 10.1523/JNEUROSCI.20-02-00550.2000; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Liang YJ, 2009, J NEUROCHEM, V109, P981, DOI 10.1111/j.1471-4159.2009.06034.x; MADRAS BK, 1989, MOL PHARMACOL, V36, P518; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; NORTH P, 1983, J BIOL CHEM, V258, P1242; Nunez E, 2008, J NEUROCHEM, V105, P2080, DOI 10.1111/j.1471-4159.2008.05292.x; Padmanabhan S, 2008, EUR J NEUROSCI, V28, P2017, DOI 10.1111/j.1460-9568.2008.06496.x; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Reith MEA, 2001, J BIOL CHEM, V276, P29012, DOI 10.1074/jbc.M011785200; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; SHOUFFANI A, 1990, J BIOL CHEM, V265, P6002; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200	40	103	106	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32616	32626		10.1074/jbc.M110.150565	http://dx.doi.org/10.1074/jbc.M110.150565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688912	hybrid, Green Published			2022-12-27	WOS:000282683000076
J	Bui, M; Gilady, SY; Fitzsimmons, REB; Benson, MD; Lynes, EM; Gesson, K; Alto, NM; Strack, S; Scott, JD; Simmen, T				Bui, Michael; Gilady, Susanna Y.; Fitzsimmons, Ross E. B.; Benson, Matthew D.; Lynes, Emily M.; Gesson, Kevin; Alto, Neal M.; Strack, Stefan; Scott, John D.; Simmen, Thomas			Rab32 Modulates Apoptosis Onset and Mitochondria-associated Membrane (MAM) Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TRAIL-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; OXIDATIVE-METABOLISM; CA2+ CONCENTRATION; IN-VITRO; PHOSPHORYLATION; CALCIUM; COMPLEX; CAMP	The mitochondria-associated membrane (MAM) has emerged as an endoplasmic reticulum (ER) signaling hub that accommodates ER chaperones, including the lectin calnexin. At the MAM, these chaperones control ER homeostasis but also play a role in the onset of ER stress-mediated apoptosis, likely through the modulation of ER calcium signaling. These opposing roles of MAM-localized chaperones suggest the existence of mechanisms that regulate the composition and the properties of ER membrane domains. Our results now show that the GTPase Rab32 localizes to the ER and mitochondria, and we identify this protein as a regulator of MAM properties. Consistent with such a role, Rab32 modulates ER calcium handling and disrupts the specific enrichment of calnexin on the MAM, while not affecting the ER distribution of protein-disulfide isomerase and mitofusin-2. Furthermore, Rab32 determines the targeting of PKA to mitochondrial and ER membranes and through its overexpression or inactivation increases the phosphorylation of Bad and of Drp1. Through a combination of its functions as a PKA-anchoring protein and a regulator of MAM properties, the activity and expression level of Rab32 determine the speed of apoptosis onset.	[Simmen, Thomas] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Alto, Neal M.] Univ Texas SW, Dept Microbiol, Dallas, TX 75390 USA; [Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Strack, Stefan] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Alberta; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; University of Iowa	Simmen, T (corresponding author), Univ Alberta, Fac Med & Dent, Dept Cell Biol, Sch Mol & Syst Med, Med Sci Bldg,Rm 5-65, Edmonton, AB T6G 2H7, Canada.	Thomas.Simmen@ualberta.ca		Fitzsimmons, Ross/0000-0002-4856-6252; Strack, Stefan/0000-0002-6175-7280	Alberta Health Services/Alberta Cancer Board [24170]; Natural Sciences and Engineering Research Council of Canada [386757-2010]; NCIC/CCSRI [17291/2010-700306]; Alberta Heritage Foundation for Medical Research [200500396]; Terry Fox Foundation; National Institutes of Health [R01 DK54441, R01 NS043254, NS056244, NS057714]; Alberta Health Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS056244, R01NS043254, R01NS056244, R01NS057714] Funding Source: NIH RePORTER	Alberta Health Services/Alberta Cancer Board; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NCIC/CCSRI; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Terry Fox Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Health Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Alberta Health Services/Alberta Cancer Board Grant 24170, Natural Sciences and Engineering Research Council of Canada Grant 386757-2010, NCIC/CCSRI Grants 17291/2010-700306, Alberta Heritage Foundation for Medical Research Scholarship 200500396, and by The Terry Fox Foundation. This work was also supported, in whole or in part, by National Institutes of Health Grant R01 DK54441 (to the Scott laboratory) and Grants R01 NS043254, NS056244, and NS057714 (to the Strack laboratory).; Supported by Alberta Health Services Studentships.	Affaitati A, 2003, J BIOL CHEM, V278, P4286, DOI 10.1074/jbc.M209941200; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; Audhya A, 2007, J CELL BIOL, V178, P43, DOI 10.1083/jcb.200701139; Bao XK, 2002, EUR J BIOCHEM, V269, P259, DOI 10.1046/j.0014-2956.2001.02645.x; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cohen-Solal KA, 2003, BBA-PROTEINS PROTEOM, V1651, P68, DOI 10.1016/S1570-9639(03)00236-X; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Gilady SY, 2010, CELL STRESS CHAPERON, V15, P619, DOI 10.1007/s12192-010-0174-1; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kang YC, 2004, CELL DEATH DIFFER, V11, P1287, DOI 10.1038/sj.cdd.4401489; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Laude AJ, 2009, FEBS J, V276, P1800, DOI 10.1111/j.1742-4658.2009.06927.x; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Osibow K, 2006, BIOCHEM J, V396, P173, DOI 10.1042/BJ20060099; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; Turner MD, 1997, J BIOL CHEM, V272, P13479, DOI 10.1074/jbc.272.21.13479; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Youker RT, 2009, BIOCHEM J, V421, P1, DOI 10.1042/BJ20081016	60	119	120	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31590	31602		10.1074/jbc.M110.101584	http://dx.doi.org/10.1074/jbc.M110.101584			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670942	hybrid, Green Published			2022-12-27	WOS:000282764600053
J	Chen, YW; Wang, JK; Chou, FP; Chen, CY; Rorke, EA; Chen, LM; Chai, KX; Eckert, RL; Johnson, MD; Lin, CY				Chen, Ya-Wen; Wang, Jehng-Kang; Chou, Feng-Pai; Chen, Chiu-Yuan; Rorke, Ellen A.; Chen, Li-Mei; Chai, Karl X.; Eckert, Richard L.; Johnson, Michael D.; Lin, Chen-Yong			Regulation of the Matriptase-Prostasin Cell Surface Proteolytic Cascade by Hepatocyte Growth Factor Activator Inhibitor-1 during Epidermal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE ICHTHYOSIS; SERINE-PROTEASE INHIBITOR; HYPOTRICHOSIS SYNDROME; EPITHELIAL-CELLS; BARRIER FUNCTION; DOMAIN; LOCALIZATION; PURIFICATION; EXPRESSION; REQUIRES	Matriptase, a membrane-tethered serine protease, plays essential roles in epidermal differentiation and barrier function, largely mediated via its activation of prostasin, a glycosylphosphatidylinositol-anchored serine protease. Matriptase activity is tightly regulated by its inhibitor hepatocyte growth factor activator inhibitor-1 (HAI-1) such that free active matriptase is only briefly available to act on its substrates. In the current study we provide evidence for how matriptase activates prostasin under this tight control by HAI-1. When primary human keratinocytes are induced to differentiate in a skin organotypic culture model, both matriptase and prostasin are constitutively activated and then inhibited by HAI-1. These processes also occur in HaCaT human keratinocytes when matriptase activation is induced by exposure of the cells to a pH 6.0 buffer. Using this acid-inducible activation system we demonstrate that prostatin activation is suppressed by matriptase knockdown and by blocking matriptase activation with sodium chloride, suggesting that prostatin activation is dependent on matriptase in this system. Kinetics studies further reveal that the timing of autoactivation of matriptase, prostasin activation, and inhibition of both enzymes by HAI-1 binding are closely correlated. These data suggest that, during epidermal differentiation, the matriptase-prostasin proteolytic cascade is tightly regulated by two mechanisms: 1) prostasin activation temporally coupled to matriptase autoactivation and 2) HAI-1 rapidly inhibiting not only active matriptase but also active prostasin, resulting in an extremely brief window of opportunity for both active matriptase and active prostasin to act on their substrates.	[Chou, Feng-Pai; Rorke, Ellen A.; Eckert, Richard L.; Lin, Chen-Yong] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Chen, Ya-Wen; Chou, Feng-Pai; Lin, Chen-Yong] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Ya-Wen] Univ Maryland, Grad Program Life Sci, Baltimore, MD 21201 USA; [Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 114, Taiwan; [Chen, Chiu-Yuan] Nanhua Univ, Grad Inst Nat Healing Sci, Chiayi, Taiwan; [Chen, Li-Mei; Chai, Karl X.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Johnson, Michael D.] Georgetown Univ, Dept Oncol, Lombardi Canc Comprehens Ctr, Washington, DC 20057 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Defense Medical Center; Nanhua University; State University System of Florida; University of Central Florida; Georgetown University	Lin, CY (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, 655 W Baltimore St,BRB 10-027, Baltimore, MD 21201 USA.	cylin@som.umaryland.edu	Feng-Pai, Chou/AGS-4250-2022	Chen, Ya-Wen/0000-0003-2382-8444; johnson, Michael/0000-0001-6260-7586	National Institutes of Health [R01-CA-104944, R01-CA-123223]; Florida Biomedical Research Program [06NIR-03]; Susan G. Komen for the Cure [BCTR0707538]; NATIONAL CANCER INSTITUTE [R01CA123223, R01CA104944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Biomedical Research Program; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA-104944 (to C.-Y.L.) and R01-CA-123223 (to M.D.J. and C.-Y.L.). This work was also supported by the Florida Biomedical Research Program (Grant 06NIR-03 to L.-M. C.) and the Susan G. Komen for the Cure (Grant BCTR0707538 to K. X. C.).	Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Avrahami L, 2008, CLIN GENET, V74, P47, DOI 10.1111/j.1399-0004.2008.01006.x; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Chen M, 2007, BIOCH BIOPHYS ACTA; Chen MQ, 2007, BBA-MOL CELL RES, V1773, P1133, DOI 10.1016/j.bbamcr.2007.04.013; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; MYERBURG MM, 2010, AM J RESP C IN PRESS; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Stark Hans-Jurgen, 2004, Biol Proced Online, V6, P55, DOI 10.1251/bpo72; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; YU JX, 1994, J BIOL CHEM, V269, P18843	33	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31755	31762		10.1074/jbc.M110.150367	http://dx.doi.org/10.1074/jbc.M110.150367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20696767	hybrid, Green Published			2022-12-27	WOS:000282764600067
J	Kanagawa, M; Omori, Y; Sato, S; Kobayashi, K; Miyagoe-Suzuki, Y; Takeda, S; Endo, T; Furukawa, T; Toda, T				Kanagawa, Motoi; Omori, Yoshihiro; Sato, Shigeru; Kobayashi, Kazuhiro; Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi; Endo, Tamao; Furukawa, Takahisa; Toda, Tatsushi			Post-translational Maturation of Dystroglycan Is Necessary for Pikachurin Binding and Ribbon Synaptic Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; BETA-DYSTROGLYCAN; LAMININ-BINDING; SKELETAL-MUSCLE; PHOTORECEPTOR TERMINALS; GLYCOSYLATION DEFECTS; MUTATIONS; MICE	Pikachurin, the most recently identified ligand of dystroglycan, plays a crucial role in the formation of the photoreceptor ribbon synapse. It is known that glycosylation of dystroglycan is necessary for its ligand binding activity, and hypoglycosylation is associated with a group of muscular dystrophies that often involve eye abnormalities. Because little is known about the interaction between pikachurin and dystroglycan and its impact on molecular pathogenesis, here we characterize the interaction using deletion constructs and mouse models of muscular dystrophies with glycosylation defects (Large(myd) and POMGnT1-deficient mice). Pikachurin-dystroglycan binding is calcium-dependent and relatively less sensitive to inhibition by heparin and high NaCl concentration, as compared with other dystroglycan ligand proteins. Using deletion constructs of the laminin globular domains in the pikachurin C terminus, we show that a certain steric structure formed by the second and the third laminin globular domains is necessary for the pikachurin-dystroglycan interaction. Binding assays using dystroglycan deletion constructs and tissue samples from Large-deficient (Large(myd)) mice show that Large-dependent modification of dystroglycan is necessary for pikachurin binding. In addition, the ability of pikachurin to bind to dystroglycan prepared from POMGnT1-deficient mice is severely reduced, suggesting that modification of the GlcNAc-beta 1,2-branch on O-mannose is also necessary for the interaction. Immunofluorescence analysis reveals a disruption of pikachurin localization in the photoreceptor ribbon synapse of these model animals. Together, our data demonstrate that post-translational modification on O-mannose, which is mediated by Large and POMGnT1, is essential for pikachurin binding and proper localization, and suggest that their disruption underlies the molecular pathogenesis of eye abnormalities in a group of muscular dystrophies.	[Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Omori, Yoshihiro; Sato, Shigeru; Furukawa, Takahisa] Japan Sci & Technol Agcy, Osaka Biosci Inst, Dept Dev Biol, Suita, Osaka 5650874, Japan; [Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878502, Japan; [Endo, Tamao] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan	Kobe University; Japan Science & Technology Agency (JST); National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute of Gerontology	Toda, T (corresponding author), 7-5-1 Kusunoki Chou,Chuo Ku, Kobe, Hyogo 6500017, Japan.	toda@med.kobe-u.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Kanagawa, Motoi/0000-0003-0984-6398	Ministry of Health, Labor, and Welfare of Japan [20B-13]; Research on Psychiatric and Neurological Diseases and Mental Health [H20-016]; Japan Society for the Promotion of Science [21790318, 20056020]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research on Psychiatric and Neurological Diseases and Mental Health; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Ministry of Health, Labor, and Welfare of Japan Intramural Research Grant for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry 20B-13, Research on Psychiatric and Neurological Diseases and Mental Health Grant H20-016 (to T. T.), Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (B) 21790318, and Grant-in-aid for Scientific Research on Priority Areas 20056020 (to M. K.).	Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Blank M, 1999, EUR J NEUROSCI, V11, P2121, DOI 10.1046/j.1460-9568.1999.00636.x; Blank M, 1997, J COMP NEUROL, V389, P668; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Chiba A, 1997, J BIOL CHEM, V272, P2156; CIBIS GW, 1993, INVEST OPHTH VIS SCI, V34, P3646; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; DSOUZA VN, 1995, HUM MOL GENET, V4, P837, DOI 10.1093/hmg/4.5.837; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673; Jastrow H, 2006, INVEST OPHTH VIS SCI, V47, P17, DOI 10.1167/iovs.05-0597; Kameya S, 1997, HUM MOL GENET, V6, P2195, DOI 10.1093/hmg/6.13.2195; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Koulen P, 1998, J NEUROSCI RES, V51, P735, DOI 10.1002/(SICI)1097-4547(19980315)51:6<735::AID-JNR7>3.0.CO;2-C; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Michele DE, 2009, CIRC RES, V105, P984, DOI 10.1161/CIRCRESAHA.109.199489; Miyagoe-Suzuki Y, 2009, MECH DEVELOP, V126, P107, DOI 10.1016/j.mod.2008.12.001; MONTANARO F, 1995, J NEUROSCI RES, V42, P528, DOI 10.1002/jnr.490420411; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Pillers DAH, 1999, HUM GENET, V105, P2, DOI 10.1007/s004390051056; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Satz JS, 2009, J NEUROSCI, V29, P13136, DOI 10.1523/JNEUROSCI.0474-09.2009; SIGESMUND DA, 1994, OPHTHALMOLOGY, V101, P856; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	45	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31208	31216		10.1074/jbc.M110.116343	http://dx.doi.org/10.1074/jbc.M110.116343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682766	Green Published, hybrid			2022-12-27	WOS:000282764600015
J	Rosenfeld, RJ; Bonaventura, J; Szymczyna, BR; MacCoss, MJ; Arvai, AS; Yates, JR; Tainer, JA; Getzoff, ED				Rosenfeld, Robin J.; Bonaventura, Joseph; Szymczyna, Blair R.; MacCoss, Michael J.; Arvai, Andrew S.; Yates, John R., III; Tainer, John A.; Getzoff, Elizabeth D.			Nitric-oxide Synthase Forms N-NO-pterin and S-NO-Cys IMPLICATIONS FOR ACTIVITY, ALLOSTERY, AND REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGENASE DIMER; NITROSOTRYPTOPHAN DERIVATIVES; ELECTRON-TRANSFER; NMR-SPECTROSCOPY; STRUCTURAL BASIS; NITROSYLATION; TETRAHYDROBIOPTERIN; BINDING; NITROSOTHIOLS; GLUTATHIONE	Inducible nitric-oxide synthase (iNOS) produces biologically stressful levels of nitric oxide (NO) as a potent mediator of cellular cytotoxicity or signaling. Yet, how this nitrosative stress affects iNOS function in vivo is poorly understood. Here we define two specific non-heme iNOS nitrosation sites discovered by combining UV-visible spectroscopy, chemiluminescence, mass spectrometry, and x-ray crystallography. We detected auto-S-nitrosylation during enzymatic turnover by using chemiluminescence. Selective S-nitrosylation of the ZnS4 site, which bridges the dimer interface, promoted a dimer-destabilizing order-to-disorder transition. The nitrosated iNOS crystal structure revealed an unexpected N-NO modification on the pterin cofactor. Furthermore, the structurally defined N-NO moiety is solvent-exposed and available to transfer NO to a partner. We investigated glutathione (GSH) as a potential transnitrosation partner because the intracellular GSH concentration is high and NOS can form S-nitrosoglutathione. Our computational results predicted a GSH binding site adjacent to the N-NO-pterin. Moreover, we detected GSH binding to iNOS with saturation transfer difference NMR spectroscopy. Collectively, these observations resolve previous paradoxes regarding this uncommon pterin cofactor in NOS and suggest means for regulating iNOS activity via N-NO-pterin and S-NO-Cys modifications. The iNOS self-nitrosation characterized here appears appropriate to help control NO production in response to cellular conditions.	[Rosenfeld, Robin J.; Szymczyna, Blair R.; Arvai, Andrew S.; Tainer, John A.; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [MacCoss, Michael J.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Bonaventura, Joseph] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Bonaventura, Joseph] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Bonaventura, Joseph] Bonaventis Res Inst, Rincon, PR 00677 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Duke University; Duke University	Getzoff, ED (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	edg@scripps.edu	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429	National Institutes of Health [R01-HL58883, RR011823]; Skaggs Institute for Chemical Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL58883 (to E. D. G.) and RR011823 (to J.R.Y.) and the Skaggs Institute for Chemical Biology (to R.J.R.).	Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; Aoyagi M, 2001, BIOCHEMISTRY-US, V40, P12826, DOI 10.1021/bi011183k; ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YS, 2002, BIOCHEMISTRY-US, V41, P4618, DOI 10.1021/bi011877t; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Connolly S, 2004, J MED CHEM, V47, P3320, DOI 10.1021/jm031035n; Crane BR, 2000, BIOCHEMISTRY-US, V39, P4608, DOI 10.1021/bi992409a; Crane BR, 1999, EMBO J, V18, P6271, DOI 10.1093/emboj/18.22.6271; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; Dijkers PF, 2009, MOL BIOL CELL, V20, P4083, DOI 10.1091/mbc.E09-05-0362; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Erwin PA, 2006, J BIOL CHEM, V281, P151, DOI 10.1074/jbc.M510421200; Erwin PA, 2005, J BIOL CHEM, V280, P19888, DOI 10.1074/jbc.M413058200; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garcin ED, 2008, NAT CHEM BIOL, V4, P700, DOI 10.1038/nchembio.115; Gorren ACF, 2002, CURR DRUG METAB, V3, P133, DOI 10.2174/1389200024605154; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Harbrecht BG, 1997, ANN SURG, V225, P76, DOI 10.1097/00000658-199701000-00009; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HOFMANN H, 1995, BIOCHEMISTRY-US, V34, P13443, DOI 10.1021/bi00041a023; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; HURSHMAN AR, 1995, BIOCHEMISTRY-US, V34, P5627, DOI 10.1021/bi00016a038; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kirsch M, 2007, ORG BIOMOL CHEM, V5, P3889, DOI 10.1039/b713377b; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Li D, 2006, J BIOL CHEM, V281, P8197, DOI 10.1074/jbc.M507328200; LOWEMA CK, 1990, ACTA CRYSTALLOGR C, V46, P1853, DOI 10.1107/S0108270189013739; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mayer B, 1998, J BIOL CHEM, V273, P3264, DOI 10.1074/jbc.273.6.3264; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mitchell DA, 2005, BIOCHEMISTRY-US, V44, P4636, DOI 10.1021/bi0474463; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panda K, 2003, J BIOL CHEM, V278, P37122, DOI 10.1074/jbc.M304456200; Panda K, 2002, J BIOL CHEM, V277, P31020, DOI 10.1074/jbc.M203749200; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Perry JJP, 2007, NEUROSCIENCE, V145, P1280, DOI 10.1016/j.neuroscience.2006.10.045; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Reif A, 1999, J BIOL CHEM, V274, P24921, DOI 10.1074/jbc.274.35.24921; Rosenfeld RJ, 2002, BIOCHEMISTRY-US, V41, P13915, DOI 10.1021/bi026313j; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Schreiter ER, 2007, J BIOL CHEM, V282, P19773, DOI 10.1074/jbc.M701363200; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Slama-Schwok A, 2002, J BIOL CHEM, V277, P7581, DOI 10.1074/jbc.M108657200; Sonnenschein K, 2004, J BIOL CHEM, V279, P45433, DOI 10.1074/jbc.M405987200; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; STUEHR DJ, 1990, BIOCHEM BIOPH RES CO, V168, P558, DOI 10.1016/0006-291X(90)92357-6; Stuehr DJ, 1996, METHOD ENZYMOL, V268, P324; Venketaraman V, 2003, INFECT IMMUN, V71, P1864, DOI 10.1128/IAI.71.4.1864-1871.2003; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wei CC, 2003, J BIOL CHEM, V278, P46668, DOI 10.1074/jbc.M307682200; Wei CC, 2003, BIOCHEMISTRY-US, V42, P1969, DOI 10.1021/bi026898h; Woodward JJ, 2010, J AM CHEM SOC, V132, P5105, DOI 10.1021/ja909378n; Zhang YY, 1996, J BIOL CHEM, V271, P14271, DOI 10.1074/jbc.271.24.14271	70	27	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31581	31589		10.1074/jbc.M109.072496	http://dx.doi.org/10.1074/jbc.M109.072496			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20659888	Green Published, hybrid			2022-12-27	WOS:000282764600052
J	Tranell, A; Fenyo, EM; Schwartz, S				Tranell, Anna; Fenyo, Eva Maria; Schwartz, Stefan			Serine- and Arginine-rich Proteins 55 and 75 (SRp55 and SRp75) Induce Production of HIV-1 vpr mRNA by Inhibiting the 5 '-Splice Site of Exon 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS TYPE-16; SPLICING FACTOR SF2/ASF; GENE-EXPRESSION; TAT EXON-2; HNRNP A1; UNTRANSLATED REGION; FUNCTIONAL-ANALYSIS; SILENCER ELEMENT/; EPITHELIAL-CELLS	HIV-1 non-coding exon 3 can either be spliced to exons 4, 4a, 4b, 4c, and 5 to generate tat, rev, and nef mRNAs or remain unspliced to produce the 13a7 vpr mRNA. Here we show that serine-and arginine-rich proteins 55 and 75 (SRp55 and SRp75) inhibit splicing from the 5'-splice site of exon 3 thereby causing an accumulation of the partially unspliced 13a7 vpr mRNA. In contrast, serine- and arginine-rich protein 40 (SRp40) induces splicing from exon 3 to exon 4, thereby promoting the production of the 1347 tat mRNA. We demonstrate that SRp55 stimulates vpr mRNA production by interacting with the previously identified HIV-1 splicing enhancer named GAR and inhibiting its function. This inhibition requires both serine arginine-rich and RNA-binding domains of SRp55, indicating that production of HIV-1 vpr mRNA depends on the interaction of SRp55 with an unknown factor.	[Tranell, Anna; Schwartz, Stefan] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, BMC, S-75123 Uppsala, Sweden; [Fenyo, Eva Maria] Lund Univ, Dept Lab Med, S-22362 Lund, Sweden; [Schwartz, Stefan] Dublin Inst Technol, Dublin 8, Ireland	Uppsala University; Lund University; Technological University Dublin	Schwartz, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, BMC, Box 582,Husargatan 3, S-75123 Uppsala, Sweden.	stefan.schwartz@imbim.uu.se						ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; AMENDT BA, 1995, MOL CELL BIOL, V15, P6480; AMENDT BA, 1994, MOL CELL BIOL, V14, P3960, DOI 10.1128/MCB.14.6.3960; ARRIGO SJ, 1990, J VIROL, V64, P4585, DOI 10.1128/JVI.64.9.4585-4588.1990; ARYA SK, 1986, P NATL ACAD SCI USA, V83, P2209, DOI 10.1073/pnas.83.7.2209; Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Caputi M, 2004, J VIROL, V78, P6517, DOI 10.1128/JVI.78.12.6517-6526.2004; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Collier B, 2002, J VIROL, V76, P2739, DOI 10.1128/JVI.76.6.2739-2752.2002; Domsic JK, 2003, MOL CELL BIOL, V23, P8762, DOI 10.1128/MCB.23.23.8762-8772.2003; DYHRMIKKELSEN H, 1995, J BIOL CHEM, V270, P24060, DOI 10.1074/jbc.270.41.24060; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; Exline CM, 2008, J VIROL, V82, P3921, DOI 10.1128/JVI.01558-07; GUATELLI JC, 1990, J VIROL, V64, P4093, DOI 10.1128/JVI.64.9.4093-4098.1990; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Jacquenet S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-33; Jacquenet S, 2001, J BIOL CHEM, V276, P40464, DOI 10.1074/jbc.M104070200; Kammler S, 2001, RNA, V7, P421, DOI 10.1017/S1355838201001212; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Madsen JM, 2005, J VIROL, V79, P10478, DOI 10.1128/JVI.79.16.10478-10486.2005; Maldarelli F, 1998, VIRUS RES, V53, P39, DOI 10.1016/S0168-1702(97)00130-5; Mandal D, 2009, J VIROL, V83, P6067, DOI 10.1128/JVI.02231-08; Marchand V, 2002, J MOL BIOL, V323, P629, DOI 10.1016/S0022-2836(02)00967-1; MAYEDA A, 1993, MOL CELL BIOL, V13, P2993, DOI 10.1128/MCB.13.5.2993; OREILLY MM, 1995, VIROLOGY, V213, P373, DOI 10.1006/viro.1995.0010; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Rush M, 2005, J VIROL, V79, P12002, DOI 10.1128/JVI.79.18.12002-12015.2005; SCHWARTZ S, 1991, VIROLOGY, V183, P677, DOI 10.1016/0042-6822(91)90996-O; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; Si ZH, 1998, MOL CELL BIOL, V18, P5404, DOI 10.1128/MCB.18.9.5404; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; TAN W, 1995, J VIROL, V69, P2932, DOI 10.1128/JVI.69.5.2932-2945.1995; TAN W, 1995, J VIROL, V69, P5607, DOI 10.1128/JVI.69.9.5607-5620.1995; Tange TO, 2001, EMBO J, V20, P5748; Wiklund L, 2002, J BIOL CHEM, V277, P40462, DOI 10.1074/jbc.M205929200; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zheng ZM, 2004, J BIOMED SCI, V11, P278, DOI 10.1159/000077096	48	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31537	31547		10.1074/jbc.M109.077453	http://dx.doi.org/10.1074/jbc.M109.077453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685659	Green Published, hybrid			2022-12-27	WOS:000282764600048
J	Yao, WJ; Sung, LA				Yao, Weijuan; Sung, Lanping Amy			Erythrocyte Tropomodulin Isoforms with and without the N-terminal Actin-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; TROPOMYOSIN-BINDING; ALPHA-SPECTRIN; POINTED ENDS; CYTOSKELETAL PROTEIN; JUNCTIONAL COMPLEX; MEMBRANE SKELETON; MOUSE; GENE; EXPRESSION	Erythrocyte tropomodulin (E-Tmod or Tmod1) of 41 kDa is a tropomyosin (TM)-binding protein that caps the slow-growing end of the actin filaments. Its N-terminal half is flexible, whereas the C-terminal half has a single domain structure. E-Tmod/TM5 complex may function as a "molecular ruler" generating actin protofilaments of similar to 37 nm. Here we report the discovery of a short isoform of 29 kDa that lacks the N-terminal actin-binding domain (N-ABD) but retains the C-terminal actin-binding domain (C-ABD). E-Tmod29 can be generated by alternative splicing from an upstream promoter or by multiple transcriptional start sites from a downstream promoter. Promoter switching leads to a surge of E-Tmod41 in reticulocytes, which degrades quickly in the cytosol. We expressed recombinant isoforms in Escherichia coli and tested their binding toward TM5, G-actin, and F-actin. Solid-phase binding assays show that, without the N-terminal 102 residues, E-Tmod29 binds to TM5 or G-actin more strongly than E-Tmod41 does, but barely binds to F-actin after TM5 binding. Differential bindings explain the distinct localizations of E-Tmod29 in the cytosol and E-Tmod41 on the membrane. Sequential bindings and immunofluorescent staining further suggest that 1) TM5 binding to E-Tmod41 may open up the flexible N-terminal half, exposing N-ABD and unblocking C-ABD; 2) N-ABD binds to F-actin and C-ABD binds to G-actin; and 3) F-actin binding to N-ABD may prevent G-actin from binding to C-ABD. E-Tmod29 may thus modulate the availability of TM5 and G-actin for E-Tmod41 to construct the protofilament-based membrane skeletal network for circulating erythrocytes.	[Yao, Weijuan; Sung, Lanping Amy] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Sung, LA (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	amysung@bioeng.ucsd.edu			National Institutes of Health [PO1 HL43026-11]; Whitaker Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL043026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitaker Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant (PO1 HL43026-11). This research utilized the Biotech Core and Instrumentation Core in the Bioengineering Department established with the support from the Whitaker Foundation.	Allingham JS, 2005, P NATL ACAD SCI USA, V102, P14527, DOI 10.1073/pnas.0502089102; Almenar-Queralt A, 1999, J BIOL CHEM, V274, P28466, DOI 10.1074/jbc.274.40.28466; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; BALDINI M, 1960, BLOOD, V15, P614, DOI 10.1182/blood.V15.5.614.614; CHASIS JA, 1989, BLOOD, V74, P1112, DOI 10.1182/blood.V74.3.1112.1112; Chishti A H, 1998, Curr Opin Hematol, V5, P116; CHO YJ, 1990, J BIOL CHEM, V265, P538; Chu X, 2000, GENE, V256, P271, DOI 10.1016/S0378-1119(00)00327-9; Chu X, 2003, AM J PHYSIOL-HEART C, V284, pH1827, DOI 10.1152/ajpheart.00947.2002; CHU ZL, 1994, BLOOD, V84, P1992; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; CONBOY JG, 1988, P NATL ACAD SCI USA, V85, P9062, DOI 10.1073/pnas.85.23.9062; CORSI D, 1995, J BIOL CHEM, V270, P8928, DOI 10.1074/jbc.270.15.8928; Costa DB, 2005, BLOOD, V106, P4367, DOI 10.1182/blood-2005-05-1813; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; DISCHER DE, 1995, J CELL BIOL, V130, P897, DOI 10.1083/jcb.130.4.897; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; FOWLER VM, 1993, J CELL BIOL, V120, P411, DOI 10.1083/jcb.120.2.411; FOWLER VM, 1990, J CELL BIOL, V111, P471, DOI 10.1083/jcb.111.2.471; FOWLER VM, 1987, J BIOL CHEM, V262, P12792; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Gallagher PG, 1997, J BIOL CHEM, V272, P19220, DOI 10.1074/jbc.272.31.19220; Gallagher PG, 2006, WILLIAMS HEMATOLOGY, P571; Galluzzi L, 2000, EUR J BIOCHEM, V267, P2812, DOI 10.1046/j.1432-1327.2000.01322.x; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Gutierrez E, 2007, J MEMBRANE BIOL, V219, P93, DOI 10.1007/s00232-007-9065-5; HANSPAL M, 1992, SEMIN HEMATOL, V29, P305; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; ITO M, 1995, DEV BIOL, V167, P317, DOI 10.1006/dbio.1995.1026; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; KORSGREN C, 1991, P NATL ACAD SCI USA, V88, P4840, DOI 10.1073/pnas.88.11.4840; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kostyukova AS, 2001, BIOPHYS J, V81, P345, DOI 10.1016/S0006-3495(01)75704-9; Lavie L, 2004, GENOME RES, V14, P2253, DOI 10.1101/gr.2745804; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; Parra MK, 2003, BLOOD, V101, P4164, DOI 10.1182/blood-2002-06-1796; SCHOFIELD AE, 1994, BLOOD, V84, P2000; SHEN BW, 1984, J CELL BIOL, V99, P810, DOI 10.1083/jcb.99.3.810; SUNG LA, 1994, BIOCHEM BIOPH RES CO, V201, P627, DOI 10.1006/bbrc.1994.1747; Sung LA, 2000, BLOOD, V95, P1473, DOI 10.1182/blood.V95.4.1473.004k50_1473_1480; Sung LA, 2003, ANN BIOMED ENG, V31, P1314, DOI 10.1114/1.1635820; SUNG LA, 1992, J BIOL CHEM, V267, P2616; SUNG LPA, 1992, BLOOD, V79, P2763; Sussman MA, 1998, J CLIN INVEST, V101, P51, DOI 10.1172/JCI1167; URSITTI JA, 1994, J CELL SCI, V107, P1633; Vera C, 2000, ARCH BIOCHEM BIOPHYS, V378, P16, DOI 10.1006/abbi.2000.1802; Vera C, 2005, ARCH BIOCHEM BIOPHYS, V444, P130, DOI 10.1016/j.abb.2005.10.002; Vera C, 2005, ANN BIOMED ENG, V33, P1387, DOI 10.1007/s10439-005-4698-y; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; WOO MK, 1994, J CELL SCI, V107, P1359; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yao W, 2007, GENE EXPR PATTERNS, V8, P36, DOI 10.1016/j.modgep.2007.08.002; Yun S, 2007, BIOCHEM BIOPH RES CO, V363, P727, DOI 10.1016/j.bbrc.2007.09.033; Zhu Q, 2007, BIOPHYS J, V93, P386, DOI 10.1529/biophysj.106.094383	57	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31408	31417		10.1074/jbc.M110.130278	http://dx.doi.org/10.1074/jbc.M110.130278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675374	Green Published, hybrid			2022-12-27	WOS:000282764600035
J	Schmid, A; Sutto, Z; Schmid, N; Novak, L; Ivonnet, P; Horvath, G; Conner, G; Fregien, N; Salathe, M				Schmid, Andreas; Sutto, Zoltan; Schmid, Nathalie; Novak, Lisa; Ivonnet, Pedro; Horvath, Gabor; Conner, Gregory; Fregien, Nevis; Salathe, Matthias			Decreased Soluble Adenylyl Cyclase Activity in Cystic Fibrosis Is Related to Defective Apical Bicarbonate Exchange and Affects Ciliary Beat Frequency Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; CARBONIC-ANHYDRASE; BRONCHIAL EPITHELIUM; SUBMUCOSAL GLANDS; LIQUID SECRETION; INTRACELLULAR PH; HCO3-TRANSPORT; EXPRESSION; CFTR; MICE	Human airway cilia contain soluble adenylyl cyclase (sAC) that produces cAMP upon HCO3-/CO2 stimulation to increase ciliary beat frequency (CBF). Because apical HCO3-exchange depends on cystic fibrosis transmembrane conductance regulator (CFTR), malfunctioning CFTR might impair sAC-mediated CBF regulation in cells from patients with cystic fibrosis (CF). By Western blot, sAC isoforms are equally expressed in normal and CF airway epithelial cells, but CBF decreased more in CF than normal cells upon increased apical HCO3-/CO2 exposure in part because of greater intracellular acidification from unbalanced CO2 influx (estimated by 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) fluorescence). Importantly, ciliated cell-specific cAMP production (estimated by FRET fluorescence ratio changes of tagged cAMP-dependent protein kinase (PKA) subunits expressed under a ciliated cell-specific promoter) in response to increased apical HCO3-/CO2 perfusion was higher in normal compared with CF cells. Inhibition of bicarbonate influx via CFTR (CFTR(inh)172) and inhibition of sAC (KH7) and PKA activation (H89) led to larger CBF declines in normal cells, now comparable with changes seen in CF cells. These inhibitors also reduced FRET changes in normal cells to the level of CF cells with the expected exception of H89, which does not prevent dissociation of the fluorescently tagged PKA subunits. Basolateral permeabilization and subsequent perfusion with HCO3-/CO2 rescued CBF and FRET changes in CF cells to the level of normal cells. These results suggest that CBF regulation by sAC-produced cAMP could be impaired in CF, thereby possibly contributing to mucociliary dysfunction in this disease, at least during disease exacerbations when airway acidification is common.	[Schmid, Andreas; Sutto, Zoltan; Schmid, Nathalie; Novak, Lisa; Ivonnet, Pedro; Horvath, Gabor; Conner, Gregory; Salathe, Matthias] Univ Miami, Div Pulm & Crit Care, Miami, FL 33136 USA; [Conner, Gregory; Fregien, Nevis] Univ Miami, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Sutto, Zoltan; Horvath, Gabor] Semmelweis Univ, Dept Resp Med, H-1125 Budapest, Hungary	University of Miami; University of Miami; Semmelweis University	Schmid, A (corresponding author), 1600 NW 10th Ave,RMSB 7051, Miami, FL 33136 USA.	aschmid@med.miami.edu	Conner, Gregory/AAI-1285-2021	Conner, Gregory/0000-0003-2217-2252; Salathe, Matthias/0000-0001-9092-4861	National Institutes of Health [R01 HL89399, HL-60644]; FAMRI; James and Esther King Florida Biomedical Research Program Team Science Project Grant from the State of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060644, R01HL089399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI; James and Esther King Florida Biomedical Research Program Team Science Project Grant from the State of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL89399 and HL-60644. This work was also supported by FAMRI and by a James and Esther King Florida Biomedical Research Program Team Science Project Grant from the State of Florida.	Ballard ST, 1999, AM J PHYSIOL-LUNG C, V277, pL694, DOI 10.1152/ajplung.1999.277.4.L694; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DE PALMA M, 2002, METHOD ENZYMOL, V346, P514; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Han H, 2005, J EXP MED, V202, P353, DOI 10.1084/jem.20050778; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; KHURI RN, 1974, PFLUG ARCH EUR J PHY, V349, P295, DOI 10.1007/BF00588415; KJALLQUIST A, 1969, ACTA PHYSIOL SCAND, V76, P485; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Kreindler JL, 2009, AM J PHYSIOL-LUNG C, V296, pL257, DOI 10.1152/ajplung.00344.2007; Leinonen JS, 2004, J HISTOCHEM CYTOCHEM, V52, P1107, DOI 10.1369/jhc.4a6282.2004; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Loriol C, 2008, CELL PHYSIOL BIOCHEM, V22, P15, DOI 10.1159/000149780; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; Nomura M, 2006, CELL MOTIL CYTOSKEL, V63, P582, DOI 10.1002/cm.20147; Okamura HO, 1996, HISTOCHEM CELL BIOL, V106, P257; Ostrowski LE, 2007, GENE THER, V14, P1492, DOI 10.1038/sj.gt.3302994; Ostrowski LE, 2003, MOL THER, V8, P637, DOI 10.1016/S1525-0016(03)00221-1; Paradiso AM, 2003, J PHYSIOL-LONDON, V548, P203, DOI 10.1113/jphysiol.2002.034447; Reddy M M, 2001, JOP, V2, P212; Reddy MM, 2003, NATURE, V423, P756, DOI 10.1038/nature01694; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUTLAND J, 1981, THORAX, V36, P654, DOI 10.1136/thx.36.9.654; SAHLIN K, 1978, J APPL PHYSIOL, V45, P474, DOI 10.1152/jappl.1978.45.3.474; Salathe M, 1999, J PHYSIOL-LONDON, V520, P851, DOI 10.1111/j.1469-7793.1999.00851.x; SALATHE M, 1993, AM J RESP CELL MOL, V9, P306, DOI 10.1165/ajrcmb/9.3.306; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Schmid A, 2006, J CELL SCI, V119, P4176, DOI 10.1242/jcs.03181; Singh AK, 2000, J PHARMACOL EXP THER, V292, P778; SPICER SS, 1982, J HISTOCHEM CYTOCHEM, V30, P864, DOI 10.1177/30.9.6813372; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Sun XC, 2003, AM J PHYSIOL-CELL PH, V284, pC1114, DOI 10.1152/ajpcell.00400.2002; Sutto Z, 2004, J PHYSIOL-LONDON, V560, P519, DOI 10.1113/jphysiol.2004.068171; Trout L, 1998, AM J PHYSIOL-LUNG C, V275, pL1095, DOI 10.1152/ajplung.1998.275.6.L1095; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	54	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29998	30007		10.1074/jbc.M110.113621	http://dx.doi.org/10.1074/jbc.M110.113621			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639512	Green Published, hybrid			2022-12-27	WOS:000281984300037
J	Toth, B; Csanady, L				Toth, Balazs; Csanady, Laszlo			Identification of Direct and Indirect Effectors of the Transient Receptor Potential Melastatin 2 (TRPM2) Cation Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; HYDROGEN-PEROXIDE; INTRACELLULAR CALCIUM; EMERGING ROLES; T-LYMPHOCYTES; CELL-DEATH; ACTIVATION; LTRPC2; BRAIN	Transient receptor potential melastatin 2 (TRPM2) is a Ca2+ permeable cation channel involved in physiological and pathophysiological processes linked to oxidative stress. TRPM2 channels are co-activated by intracellular Ca2+ and ADP-ribose (ADPR) but also modulated in intact cells by several additional factors. Superfusion of TRPM2-expressing cells with H2O2 or intracellular dialysis of cyclic ADPR (cADPR) or nicotinic acid adenine dinucleotide phosphate (NAADP) activates, whereas dialysis ofAMPinhibits, TRPM2 whole-cell currents. Additionally, H2O2, cADPR, and NAADP enhance ADPR sensitivity of TRPM2 currents in intact cells. Because in whole-cell recordings the entire cellular machinery for nucleotide and Ca2+ homeostasis is intact, modulators might affect TRPM2 activity either directly, by binding to TRPM2, or indirectly, by altering the local concentrations of the primary ligands ADPR and Ca2+. To identify direct modulators of TRPM2, we have studied the effects of H2O2, AMP, cADPR, NAADP, and nicotinic acid adenine dinucleotide in inside-out patches from Xenopus oocytes expressing human TRPM2, by directly exposing the cytosolic faces of the patches to these compounds. H2O2 (1mM) and enzymatically purified cADPR (10 mu M) failed to activate, whereas AMP (200 mu M) failed to inhibit TRPM2 currents. NAADP was a partial agonist (maximal efficacy, similar to 50%), and nicotinic acid adenine dinucleotide was a full agonist, but both had very low affinities (K-0.5 = 104 and 35 mu M). H2O2, cADPR, and NAADP did not enhance activation by ADPR. Considering intracellular concentrations of these compounds, none of them are likely to directly affect the TRPM2 channel protein in a physiological context.	[Toth, Balazs; Csanady, Laszlo] Semmelweis Univ, Dept Med Biochem, H-1094 Budapest, Hungary	Semmelweis University	Csanady, L (corresponding author), Semmelweis Univ, Dept Med Biochem, Tuzolto U 37-47, H-1094 Budapest, Hungary.	laszlo.csanady@eok.sote.hu	Csanády, László/O-5784-2017	Csanády, László/0000-0002-6547-5889	Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [F 68143]	Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) Grant F 68143 (to L. C.).	Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Brasen JC, 2010, CELL CALCIUM, V47, P339, DOI 10.1016/j.ceca.2010.01.005; Churamani D, 2004, BIOCHEM J, V380, P449, DOI 10.1042/BJ20031754; Csanady L, 2004, J GEN PHYSIOL, V123, P743, DOI 10.1085/jgp.200309008; Csanady L, 2003, BIOPHYS J, V85, P313, DOI 10.1016/S0006-3495(03)74476-2; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Heiner I, 2006, BIOCHEM J, V398, P225, DOI 10.1042/BJ20060183; Higashida H, 1997, J BIOL CHEM, V272, P31272, DOI 10.1074/jbc.272.50.31272; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; TAKAHASHI K, 1995, FEBS LETT, V371, P204, DOI 10.1016/0014-5793(95)00914-U; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	34	74	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30091	30102		10.1074/jbc.M109.066464	http://dx.doi.org/10.1074/jbc.M109.066464			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650899	Green Published, hybrid			2022-12-27	WOS:000281984300047
J	Wolny, PM; Banerji, S; Gounou, C; Brisson, AR; Day, AJ; Jackson, DG; Richter, RP				Wolny, Patricia M.; Banerji, Suneale; Gounou, Celine; Brisson, Alain R.; Day, Anthony J.; Jackson, David G.; Richter, Ralf P.			Analysis of CD44-Hyaluronan Interactions in an Artificial Membrane System INSIGHTS INTO THE DISTINCT BINDING PROPERTIES OF HIGH AND LOW MOLECULAR WEIGHT HYALURONAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYALURONAN-BINDING; PERICELLULAR MATRIX; CELL-SURFACE; QCM-D; CD44; RECEPTOR; DOMAIN; ADSORPTION; PROMOTES; PERSISTENCE	CD44 is a major cell surface receptor for the large polydisperse glycosaminoglycan hyaluronan (HA). Binding of the long and flexible HA chains is thought to be stabilized by the multivalent nature of the sugar molecule. In addition, high and low molecular weight forms of HA provoke distinct proinflammatory and anti-inflammatory effects upon binding to CD44 and can deliver either proliferative or antiproliferative signals in appropriate cell types. Despite the importance of such interactions, however, neither the stoichiometry of multivalent HA binding at the cell surface nor the molecular basis for functional distinction between different HA size categories is understood. Here we report on the design of a supported lipid bilayer system that permits quantitative analysis of multivalent binding through presentation of CD44 in a stable, natively oriented manner and at controlled density. Using this system in combination with biophysical techniques, we show that the amount of HA binding to bilayers that are densely coated with CD44 increases as a function of HA size, with half-maximal saturation at similar to 30 kDa. Moreover, reversible binding was confined to the smaller HA species (molecular weight of <= 10 kDa), whereas the interaction was essentially irreversible with larger polymers. The amount of bound HA decreased with decreasing receptor surface density, but the stability of binding was not affected. From a physico-chemical perspective, the binding properties of HA share many similarities with the typical behavior of a flexible polymer as it adsorbs onto a homogeneously attractive surface. These findings provide new insight into the multivalent nature of CD44-HA interactions and suggest a molecular basis for the distinct biological properties of different size fractions of hyaluronan.	[Richter, Ralf P.] CIC Bioma GUNE, Biosurfaces Unit, Ctr Invest Cooperat Biomat, Donostia San Sebastian 20009, Spain; [Wolny, Patricia M.; Richter, Ralf P.] Max Planck Inst Met Res, D-70569 Stuttgart, Germany; [Banerji, Suneale; Jackson, David G.] Univ Oxford, Med Res Council Human Immunol Unit, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; [Gounou, Celine; Brisson, Alain R.] Univ Bordeaux 1, ENITAB, Lab Imagerie Mol & Nanobiotechnol, Inst Europeen Chim & Biol,UMR 5248 CBMN,CNRS, F-33402 Talence, France; [Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	CIC biomaGUNE; Max Planck Society; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; University of Manchester	Richter, RP (corresponding author), CIC Bioma GUNE, Biosurfaces Unit, Ctr Invest Cooperat Biomat, Paseo Miramon 182, Donostia San Sebastian 20009, Spain.	rrichter@cicbiomagune.es	Richter, Ralf Peter/B-3343-2013; Day, Anthony/O-1658-2015; biomaGUNE, CIC/J-9136-2014	Richter, Ralf Peter/0000-0003-3071-2837; Day, Anthony/0000-0002-1415-3134; , david/0000-0002-4133-9364; banerji, suneale/0000-0002-1179-3152; biomaGUNE, CIC/0000-0001-7690-0660	German Federal Ministry of Education and Research [0315157]; Spanish Ministry of Science and Innovation [MAT2008-04192, RYC2009-04275]; Department of Industry of the Basque Government; Max-Planck-Society; MRC [MC_U137884182] Funding Source: UKRI; Medical Research Council [G1000800c, MC_U137884182] Funding Source: researchfish	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Department of Industry of the Basque Government; Max-Planck-Society(Max Planck SocietyFoundation CELLEX); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by German Federal Ministry of Education and Research Grant 0315157, Spanish Ministry of Science and Innovation Grants MAT2008-04192 and RYC2009-04275, the Department of Industry of the Basque Government, and the Max-Planck-Society (to R.P.R. and P.M.W.).	Alves CS, 2008, AM J PHYSIOL-CELL PH, V294, pC907, DOI 10.1152/ajpcell.00463.2007; ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Benes M, 2004, LANGMUIR, V20, P10129, DOI 10.1021/la048811u; BERAT R, 2007, THESIS U BORDEAUX 1; Bingen P, 2008, ANAL CHEM, V80, P8880, DOI 10.1021/ac8011686; Boehm H, 2009, SOFT MATTER, V5, P4331, DOI 10.1039/b905574f; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Camenisch TD, 2000, AM J RESP CELL MOL, V23, P431, DOI 10.1165/ajrcmb.23.4.f201; Chen JA, 2010, MICRON, V41, P198, DOI 10.1016/j.micron.2009.11.002; Clark RA, 1996, J CELL BIOL, V134, P1075, DOI 10.1083/jcb.134.4.1075; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; De Gennes P.-G., 1979, SCALING CONCEPTS POL; DE LA MOTTE CA, 2003, AM J PATHOL, V163, P121; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; English NM, 1998, CANCER RES, V58, P3736; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Fleer G. J., 1998, POLYM INTERFACES; Gribbon P, 2000, BIOCHEM J, V350, P329, DOI 10.1042/0264-6021:3500329; HAYNES BF, 1991, CANCER CELL-MON REV, V3, P347; Johannsmann D, 2009, ANAL CHEM, V81, P8167, DOI 10.1021/ac901381z; Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3; KNUDSON W, 1991, J CELL SCI, V99, P227; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Kuhner M, 1996, LANGMUIR, V12, P4866, DOI 10.1021/la960282+; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Lata S, 2006, J AM CHEM SOC, V128, P6, DOI 10.1021/ja054700l; LEE GM, 1993, J CELL BIOL, V123, P1899, DOI 10.1083/jcb.123.6.1899; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; Mahoney DJ, 2001, GLYCOBIOLOGY, V11, P1025, DOI 10.1093/glycob/11.12.1025; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Nijenhuis N, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025014; PERSCHL A, 1995, EUR J IMMUNOL, V25, P495, DOI 10.1002/eji.1830250228; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Richter RP, 2005, BIOPHYS J, V89, P3372, DOI 10.1529/biophysj.105.064337; Richter RP, 2004, LANGMUIR, V20, P4609, DOI 10.1021/la049827n; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schilling J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021901; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takahashi R, 1999, BIOPOLYMERS, V50, P87, DOI 10.1002/(SICI)1097-0282(199907)50:1<87::AID-BIP8>3.3.CO;2-B; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Vats K, 2010, ACS CHEM BIOL, V5, P393, DOI 10.1021/cb900303s; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wolny PM, 2010, LANGMUIR, V26, P1029, DOI 10.1021/la902226b; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	64	151	156	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30170	30180		10.1074/jbc.M110.137562	http://dx.doi.org/10.1074/jbc.M110.137562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663884	Green Published, hybrid			2022-12-27	WOS:000281984300054
J	Joseph, PRB; Sarmiento, JM; Mishra, AK; Das, ST; Garofalo, RP; Navarro, J; Rajarathnam, K				Joseph, Prem Raj B.; Sarmiento, Jose M.; Mishra, Anurag K.; Das, Sandhya T.; Garofalo, Roberto P.; Navarro, Javier; Rajarathnam, Krishna			Probing the Role of CXC Motif in Chemokine CXCL8 for High Affinity Binding and Activation of CXCR1 and CXCR2 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; IMPROVED SENSITIVITY; LIGAND SELECTIVITY; STRUCTURAL BASIS; CC-CHEMOKINE; FACTOR-I; INTERLEUKIN-8; DIMER; MONOMER; OLIGOMERIZATION	All chemokines share a common structural scaffold that mediate a remarkable variety of functions from immune surveillance to organogenesis. Chemokines are classified as CXC or CC on the basis of conserved cysteines, and the two subclasses bind distinct sets of GPCR class of receptors and also have markedly different quaternary structures, suggesting that the CXC/CC motif plays a prominent role in both structure and function. For both classes, receptor activation involves interactions between chemokine N-loop and receptor N-domain residues (Site-I), and between chemokine N-terminal and receptor extracellular/transmembrane residues (Site-II). We engineered a CC variant (labeled as CC-CXCL8) of the chemokine CXCL8 by deleting residue X (CXC -> CC), and found its structure is essentially similar to WT. In stark contrast, CC-CXCL8 bound poorly to its cognate receptors CXCR1 and CXCR2 (K-i > 1 mu M). Further, CC-CXCL8 failed to mobilize Ca2+ in CXCR2-expressing HL-60 cells or recruit neutrophils in a mouse lung model. However, most interestingly, CC-CXCL8 mobilizes Ca2+ in neutrophils and in CXCR1-expressing HL-60 cells. Compared with the WT, CC-CXCL8 binds CXCR1 N-domain with only similar to 5-fold lower affinity indicating that the weak binding to intact CXCR1 must be due to its weak binding at Site-II. Nevertheless, this level of binding is sufficient for receptor activation indicating that affinity and activity are separable functions. We propose that the CXC motif functions as a conformational switch that couples Site-I and Site-II interactions for both receptors, and that this coupling is critical for high affinity binding but differentially regulates activation.	[Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Sarmiento, Jose M.; Navarro, Javier] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Garofalo, Roberto P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Garofalo, Roberto P.; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Navarro, Javier; Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	krrajara@utmb.edu	DAS, SANDHYA/I-1763-2018; Garofalo, Roberto P./AAF-7385-2022; Garofalo, Roberto P./ABL-2322-2022	Navarro, Javier/0000-0001-7098-4373	National Institutes of Health [R01AI069152]; John Sealy Endowment Fund [R01GM081798]; McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Sealy Endowment Fund; McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI069152, the John Sealy Endowment Fund (to K. R.), R01GM081798 (to J. N.), and a McLaughlin Fellowship (to S. T. D.). J. M. S. is on leave from the Instituto de Fisiologia, Universidad Austral de Chile, Valdivia, Chile.	Ahuja SK, 1996, J BIOL CHEM, V271, P225, DOI 10.1074/jbc.271.1.225; BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; Case D, 2006, AMBER 9; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; DELANO WL, 2002, PYMOL USERS MANUAL D; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Fernando H, 2007, FEBS J, V274, P241, DOI 10.1111/j.1742-4658.2006.05579.x; Frevert CW, 2003, AM J RESP CELL MOL, V28, P464, DOI 10.1165/rcmb.2002-0084OC; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; Kagiampakis I, 2008, BIOCHEMISTRY-US, V47, P10637, DOI 10.1021/bi702288a; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Lee MC, 2005, BIOPHYS J, V88, P3133, DOI 10.1529/biophysj.104.058446; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Lowman HB, 1997, PROTEIN SCI, V6, P598; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rajagopalan L, 2007, BIOPHYS J, V93, P2129, DOI 10.1529/biophysj.107.108761; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; RAJARATHNAM K, 1995, BIOCHEMISTRY-US, V34, P12983, DOI 10.1021/bi00040a008; Rajarathnam K, 1999, BIOCHEMISTRY-US, V38, P7653, DOI 10.1021/bi990033v; Rajarathnam K, 2001, J BIOL CHEM, V276, P4909, DOI 10.1074/jbc.M005085200; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Suetomi K, 1999, J BIOL CHEM, V274, P11768, DOI 10.1074/jbc.274.17.11768; Swaminathan GJ, 2003, STRUCTURE, V11, P521, DOI 10.1016/S0969-2126(03)00070-4; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Xanthou G, 2003, EUR J IMMUNOL, V33, P2927, DOI 10.1002/eji.200324235; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	42	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29262	29269		10.1074/jbc.M110.146555	http://dx.doi.org/10.1074/jbc.M110.146555			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630874	hybrid, Green Published			2022-12-27	WOS:000281740100028
J	Aubert, D; MacDonald, DK; Valvano, MA				Aubert, Daniel; MacDonald, Douglas K.; Valvano, Miguel A.			BcsK(C) Is an Essential Protein for the Type VI Secretion System Activity in Burkholderia cenocepacia That Forms an Outer Membrane Complex with BcsL(B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEPACIA COMPLEX; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; PATHOGENICITY ISLAND; BIOFILM FORMATION; CLINICAL ISOLATE; SIGNAL PEPTIDES; FAMILY PROTEIN	The type VI secretion system (T6SS) contributes to the virulence of Burkholderia cenocepacia, an opportunistic pathogen causing serious chronic infections in patients with cystic fibrosis. BcsK(C) is a highly conserved protein among the T6SSs in Gram-negative bacteria. Here, we show that BcsK(C) is required for Hcp secretion and cytoskeletal redistribution in macrophages upon bacterial infection. These two phenotypes are associated with a functional T6SS in B. cenocepacia. Experiments employing a bacterial two-hybrid system and pulldown assays demonstrated that BcsK(C) interacts with BcsL(B), another conserved T6SS component. Internal deletions within BcsK(C) revealed that its N-terminal domain is necessary and sufficient for interaction with BcsL(B). Fractionation experiments showed that BcsK(C) can be in the cytosol or tightly associated with the outer membrane and that BcsK(C) and BcsL(B) form a high molecular weight complex anchored to the outer membrane that requires BcsF(H) (a ClpV homolog) to be assembled. Together, our data show that BcsK(C)/BcsL(B) interaction is essential for the T6SS activity in B. cenocepacia.	[Aubert, Daniel; MacDonald, Douglas K.; Valvano, Miguel A.] Univ Western Ontario, Siebens Drake Med Res Inst, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Valvano, Miguel A.] Univ Western Ontario, Siebens Drake Med Res Inst, Dept Med, Infect Dis Res Grp, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Valvano, MA (corresponding author), Univ Western Ontario, Siebens Drake Med Res Inst, Dept Microbiol & Immunol, Dent Sci Bldg 3014, London, ON N6A 5C1, Canada.	mvalvano@uwo.ca	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641	Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research in partnership with the Association of Medical Microbiology and Infectious Disease Canada	Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research in partnership with the Association of Medical Microbiology and Infectious Disease Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Cystic Fibrosis Foundation (to M. A. V.).; Supported by a postdoctoral fellowship from the Canadian Institutes of Health Research in partnership with the Association of Medical Microbiology and Infectious Disease Canada.; Canada Research Chair in Infectious Diseases and Microbial Pathogenesis. Recipient of a Senior Researcher Training Award from the Canadian Cystic Fibrosis Foundation. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, Dental Sciences Bldg. 3014, University of Western Ontario, London, Ontario N6A 5C1, Canada. Tel.: 519-661-3427; Fax: 519-661-3499; E-mail: mvalvano@uwo.ca.	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; Das Soumita, 2003, In Silico Biology, V3, P287; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Khajanchi BK, 2009, MICROBIOL-SGM, V155, P3518, DOI 10.1099/mic.0.031575-0; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Mahenthiralingam E, 2001, CLIN INFECT DIS, V33, P1469, DOI 10.1086/322684; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; MOODY MF, 1967, J MOL BIOL, V25, P167, DOI 10.1016/0022-2836(67)90136-2; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; PUTNAM SL, 1975, ANAL BIOCHEM, V63, P350, DOI 10.1016/0003-2697(75)90357-7; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Reik R, 2005, J CLIN MICROBIOL, V43, P2926, DOI 10.1128/JCM.43.6.2926-2928.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Speert DP, 2002, EMERG INFECT DIS, V8, P181; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	55	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35988	35998		10.1074/jbc.M110.120402	http://dx.doi.org/10.1074/jbc.M110.120402			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20729192	Green Published, hybrid			2022-12-27	WOS:000283845300075
J	Ayuso, MI; Hernandez-Jimenez, M; Martin, ME; Salinas, M; Alcazar, A				Ayuso, Maria I.; Hernandez-Jimenez, Macarena; Martin, Maria E.; Salinas, Matilde; Alcazar, Alberto			New Hierarchical Phosphorylation Pathway of the Translational Repressor eIF4E-binding Protein 1 (4E-BP1) in Ischemia-Reperfusion Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; MOLECULAR-MECHANISMS; MAMMALIAN TARGET; DOWN-REGULATION; PHAS-I; DEPENDENT PHOSPHORYLATION; 4E-BINDING PROTEIN-1; PHOSPHATASE 2A; RAPAMYCIN MTOR; (S/T)P SITES	Eukaryotic initiation factor (eIF) 4E-binding protein 1 (4E-BP1) is a translational repressor that is characterized by its capacity to bind specifically to eIF4E and inhibit its interaction with eIF4G. Phosphorylation of 4E-BP1 regulates eIF4E availability, and therefore, cap-dependent translation, in cell stress. This study reports a physiological study of 4E-BP1 regulation by phosphorylation using control conditions and a stress-induced translational repression condition, ischemia-reperfusion (IR) stress, in brain tissue. In control conditions, 4E-BP1 was found in four phosphorylation states that were detected by two-dimensional gel electrophoresis and Western blotting, which corresponded to Thr(69)-phosphorylated alone, Thr(69)- and Thr(36)/Thr(45)-phosphorylated, all these plus Ser(64) phosphorylation, and dephosphorylation of the sites analyzed. In control or IR conditions, no Thr(36)/Thr(45) phosphorylation alone was detected without Thr(69) phosphorylation, and neither was Ser(64) phosphorylation without Thr(36)/Thr(45)/Thr(69) phosphorylation detected. Ischemic stress induced 4E-BP1 dephosphorylation at Thr(69), Thr(36)/Thr(45), and Ser(64) residues, with 4E-BP1 remaining phosphorylated at Thr(69) alone or dephosphorylated. In the subsequent reperfusion, 4E-BP1 phosphorylation was induced at Thr(36)/Thr(45) and Ser(64), in addition to Thr(69). Changes in 4E-BP1 phosphorylation after IR were according to those found for Akt and mammalian target of rapamycin (mTOR) kinases. These results demonstrate a new hierarchical phosphorylation for 4E-BP1 regulation in which Thr(69) is phosphorylated first followed by Thr(36)/Thr(45) phosphorylation, and Ser(64) is phosphorylated last. Thr(69) phosphorylation alone allows binding to eIF4E, and subsequent Thr(36)/Thr(45) phosphorylation was sufficient to dissociate 4E-BP1 from eIF4E, which led to eIF4E-4G interaction. These data help to elucidate the physiological role of 4E-BP1 phosphorylation in controlling protein synthesis.	[Ayuso, Maria I.; Hernandez-Jimenez, Macarena; Martin, Maria E.; Salinas, Matilde; Alcazar, Alberto] Hosp Ramon & Cajal, Dept Invest, E-28034 Madrid, Spain	Hospital Universitario Ramon y Cajal	Alcazar, A (corresponding author), Hosp Ramon & Cajal, Dept Invest, Ctra Colmenar,Km 9-1, E-28034 Madrid, Spain.	alberto.alcazar@hrc.es	Ayuso, Maria Irene/C-9435-2015; Martín, María/HDL-9512-2022; Martín, María/ACU-3685-2022	Ayuso, Maria Irene/0000-0003-0046-3657; Martín, María/0000-0002-3204-1726; Hernandez Jimenez, Macarena/0000-0003-3329-3965; MARTIN, M. ELENA/0000-0003-2131-874X	Spanish Ministry of Science and Innovation [FIS08/0761, RETICS-RD06/0026/008]; Regional Government of Madrid	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid	This work was supported by Institute of Health Carlos III (ISCIII) Grants FIS08/0761 and RETICS-RD06/0026/008 from the Spanish Ministry of Science and Innovation, including a predoctoral position for M. I. A.; A researcher from Fundacion de Investigacion Biomedica del Hospital Universitario Ramon y Cajal (FIBio-HRC) supported by the Regional Government of Madrid.	Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; BURDA J, 1994, BIOCHEM J, V302, P335, DOI 10.1042/bj3020335; Cid C, 2003, FASEB J, V17, P409, DOI 10.1096/fj.03-0606fje; Cid C, 2007, PROTEOMICS, V7, P3207, DOI 10.1002/pmic.200700214; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Damjanac M, 2008, NEUROBIOL DIS, V29, P354, DOI 10.1016/j.nbd.2007.09.008; de la Vega CM, 2001, BIOCHEM J, V357, P819; Ermoian RP, 2009, J NEURO-ONCOL, V91, P19, DOI 10.1007/s11060-008-9683-5; Ferguson G, 2003, J BIOL CHEM, V278, P47459, DOI 10.1074/jbc.M307949200; Garcia-Bonilla L, 2007, J NEUROCHEM, V103, P1368, DOI 10.1111/j.1471-4159.2007.04844.x; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Heesom KJ, 1999, FEBS LETT, V457, P489, DOI 10.1016/S0014-5793(99)01094-7; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Li Q, 2007, EXP NEUROL, V204, P840, DOI 10.1016/j.expneurol.2007.01.005; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin ME, 2000, BIOCHEM J, V351, P327, DOI 10.1042/0264-6021:3510327; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Proud CG, 1997, BIOCHEM J, V328, P329; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Quevedo C, 2000, J BIOL CHEM, V275, P19192, DOI 10.1074/jbc.M000238200; Quevedo C, 2002, BIOCHEM BIOPH RES CO, V291, P560, DOI 10.1006/bbrc.2002.6479; Raghuraman G, 2009, ANTIOXID REDOX SIGN, V11, P1777, DOI [10.1089/ars.2008.2368, 10.1089/ARS.2008.2368]; Raught B., 2007, TRANSLATIONAL CONTRO, P369; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rocic P, 2003, J BIOL CHEM, V278, P36973, DOI 10.1074/jbc.M302099200; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; TsukiyamaKohara K, 1996, GENOMICS, V38, P353, DOI 10.1006/geno.1996.0638; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2003, MOL CELL BIOL, V23, P1546, DOI 10.1128/MCB.23.5.1546-1557.2003; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5	49	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34355	34363		10.1074/jbc.M110.135103	http://dx.doi.org/10.1074/jbc.M110.135103			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736160	hybrid, Green Published			2022-12-27	WOS:000283659100009
J	Aoki, S; Thomas, A; Decaffmeyer, M; Brasseur, R; Epand, RM				Aoki, Satoko; Thomas, Annick; Decaffmeyer, Marc; Brasseur, Robert; Epand, Richard M.			The Role of Proline in the Membrane Re-entrant Helix of Caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; LIPID DROPLETS; MEDIATED ENDOCYTOSIS; CHOLESTEROL-BINDING; PROTEOMIC ANALYSIS; VESICLE FORMATION; TRANSPORT; INTERNALIZATION; EXPRESSION	Caveolin-1 has a segment of hydrophobic amino acids comprising approximately residues 103-122. We have performed an in silico analysis of the conformational preference of this segment of caveolin-1 using PepLook. We find that there is one main group of stable conformations corresponding to a hydrophobic U bent model that would not traverse the membrane. Furthermore, the calculations predict that substituting the Pro(110) residue with an Ala will change the conformation to a straight hydrophobic helix that would traverse the membrane. We have expressed the P110A mutant of caveolin-1, with a FLAG tag at the N terminus, in HEK 293 cells. We evaluate the topology of the proteins with confocal immunofluorescence microscopy in these cells. We find that FLAG tag at the N terminus of the wild type caveolin-1 is not reactive with antibodies unless the cell membrane is permeabilized with detergent. This indicates that in these cells, the hydrophobic segment of this protein is not transmembrane but takes up a bent conformation, making the protein monotopic. In contrast, the FLAG tag at the N terminus of the P110A mutant is equally exposed to antibodies, before and after membrane permeabilization. We also find that the P110A mutation causes a large reduction of endocytosis of caveolae, cellular lipid accumulation, and lipid droplet formulation. In addition, we find that this mutation markedly reduces the ability of caveolin-1 to form structures with the characteristic morphology of caveolae or to partition into the detergent-resistant membranes of these cells. Thus, the single Pro residue in the membrane-inserting segment of caveolin-1 plays an important role in both the membrane topology and localization of the protein as well as its functions.	[Thomas, Annick; Decaffmeyer, Marc; Brasseur, Robert] ULg Gembloux AgrobioTech, Ctr Biophys Mol Numer, B-5030 Gembloux, Belgium; McMaster Univ, Hlth Sci Ctr, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	University of Liege; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba		epand@mcmaster.ca	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	Government of Canada; Natural Sciences and Engineering Research Council of Canada [9848]; Canadian Post-Doctoral Research Fellowships	Government of Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Post-Doctoral Research Fellowships	This work was supported by the Government of Canada, by Canadian Post-Doctoral Research Fellowships 2008-09 and by Natural Sciences and Engineering Research Council of Canada Grant 9848.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BRASAEMLE DL, 2006, CURR PROTOC CELL BIO, V3; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Decaffmeyer M, 2008, J MOL BIOL, V383, P797, DOI 10.1016/j.jmb.2008.08.076; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Ducarme P, 1998, PROTEINS, V30, P357, DOI 10.1002/(SICI)1097-0134(19980301)30:4<357::AID-PROT3>3.0.CO;2-G; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Fielding CJ, 2003, BBA-BIOMEMBRANES, V1610, P219, DOI 10.1016/S0005-2736(03)00020-8; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; GHITESCU L, 1992, J CELL BIOL, V117, P745, DOI 10.1083/jcb.117.4.745; Gleizes PE, 1996, EUR J CELL BIOL, V71, P144; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Karsan A, 2005, J PROTEOME RES, V4, P349, DOI 10.1021/pr049824w; Lahtinen U, 2003, FEBS LETT, V538, P85, DOI 10.1016/S0014-5793(03)00135-2; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Listenberger L. L., 2007, CURR PROTOC CELL BIO, V24.2; Listenberger LL, 2008, CURR BIOL, V18, pR237, DOI 10.1016/j.cub.2008.01.010; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lobie PE, 1999, EXP CELL RES, V246, P47, DOI 10.1006/excr.1998.4288; MacLellan DL, 2005, PROTEOMICS, V5, P4733, DOI 10.1002/pmic.200500044; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Marks DL, 2008, HISTOCHEM CELL BIOL, V130, P819, DOI 10.1007/s00418-008-0509-5; Marks DL, 2005, METHODS, V36, P186, DOI 10.1016/j.ymeth.2004.12.001; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Okamoto Y, 2000, J BIOL CHEM, V275, P6439, DOI 10.1074/jbc.275.9.6439; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pohl J, 2002, J LIPID RES, V43, P1390, DOI 10.1194/jlr.M100404-JLR200; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Robenek MJ, 2004, FASEB J, V18, P866, DOI 10.1096/fj.03-0782fje; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simard JR, 2010, J LIPID RES, V51, P914, DOI 10.1194/jlr.M900251; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; SINGH RD, 2007, CURR PROTOC CELL BIO, V24; Skretting G, 1999, J CELL SCI, V112, P3899; Solomon KR, 1998, BIOCHEM J, V334, P325, DOI 10.1042/bj3340325; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Stan RV, 2002, MICROSC RES TECHNIQ, V57, P350, DOI 10.1002/jemt.10089; Thomas A, 2006, PROTEINS, V65, P889, DOI 10.1002/prot.21151; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123; Uawithya P, 1998, BIOCHEM MOL BIOL INT, V44, P825; Uittenbogaard A, 2000, J BIOL CHEM, V275, P25595, DOI 10.1074/jbc.M003401200; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Wharton J, 2005, J BIOL CHEM, V280, P13483, DOI 10.1074/jbc.M413891200; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Zhuang LY, 2002, CANCER RES, V62, P2227	75	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33371	33380		10.1074/jbc.M110.153569	http://dx.doi.org/10.1074/jbc.M110.153569			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729193	hybrid, Green Published			2022-12-27	WOS:000283048200072
J	Huang, H; Zhao, K; Arnett, DR; Fanning, E				Huang, Hao; Zhao, Kun; Arnett, Diana R.; Fanning, Ellen			A Specific Docking Site for DNA Polymerase alpha-Primase on the SV40 Helicase Is Required for Viral Primosome Activity, but Helicase Activity Is Dispensable	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE T-ANTIGEN; REPLICATION PROTEIN-A; ORIGIN-BINDING DOMAIN; LARGE TUMOR-ANTIGEN; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; FUNCTIONAL INTERACTIONS; MUTATIONAL ANALYSIS; PRIMER SYNTHESIS; STRAND SYNTHESIS	Replication of simian virus 40 (SV40) DNA, a model for eukaryotic chromosomal replication, can be reconstituted in vitro using the viral helicase (large tumor antigen, or Tag) and purified human proteins. Tag interacts physically with two cellular proteins, replication protein A and DNA polymerase alpha-primase (pol-prim), constituting the viral primosome. Like the well characterized primosomes of phages T7 and T4, this trio of proteins coordinates parental DNA unwinding with primer synthesis to initiate the leading strand at the viral origin and each Okazaki fragment on the lagging strand template. We recently determined the structure of a previously unrecognized pol-prim domain (p68N) that docks on Tag, identified the p68N surface that contacts Tag, and demonstrated its vital role in primosome function. Here, we identify the p68N-docking site on Tag by using structure-guided mutagenesis of the Tag helicase surface. A charge reverse substitution in Tag disrupted both p68N-binding and primosome activity but did not affect docking with other pol-prim subunits. Unexpectedly, the substitution also disrupted Tag ATPase and helicase activity, suggesting a potential link between p68N docking and ATPase activity. To assess this possibility, we examined the primosome activity of Tag with a single residue substitution in the Walker B motif. Although this substitution abolished ATPase and helicase activity as expected, it did not reduce pol-prim docking on Tag or primosome activity on single-stranded DNA, indicating that Tag ATPase is dispensable for primosome activity in vitro.	[Huang, Hao; Zhao, Kun; Arnett, Diana R.; Fanning, Ellen] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Fanning, E (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	Ellen.fanning@vanderbilt.edu			National Institutes of Health [GM52948, P30 CA068485]; Vanderbilt University; Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM52948 (to E. F.) and P30 CA068485 (to the Vanderbilt-Ingram Cancer Center). This work was also supported by Vanderbilt University and the Alexander von Humboldt Foundation.	Ahuja D, 2009, J VIROL, V83, P8781, DOI 10.1128/JVI.00621-09; Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bochkareva E, 2006, EMBO J, V25, P5961, DOI 10.1038/sj.emboj.7601452; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; Bullock PA, 1997, CRIT REV BIOCHEM MOL, V32, P503, DOI 10.3109/10409239709082001; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; Conger KL, 1999, J BIOL CHEM, V274, P2696, DOI 10.1074/jbc.274.5.2696; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Cuesta I, 2010, J MOL BIOL, V397, P1276, DOI 10.1016/j.jmb.2010.02.042; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15345, DOI 10.1021/bi9810959; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; Luo XL, 1996, NAT STRUCT BIOL, V3, P1034, DOI 10.1038/nsb1296-1034; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Marians KJ, 2008, NAT STRUCT MOL BIOL, V15, P125, DOI 10.1038/nsmb0208-125; Masterson PJ, 1998, J VIROL, V72, P7407, DOI 10.1128/JVI.72.9.7407-7419.1998; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Meinke G, 2007, PLOS BIOL, V5, P144, DOI 10.1371/journal.pbio.0050023; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; MURAKAMI Y, 1986, P NATL ACAD SCI USA, V83, P6347, DOI 10.1073/pnas.83.17.6347; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; PARK P, 1994, P NATL ACAD SCI USA, V91, P8700, DOI 10.1073/pnas.91.18.8700; Pyle AM, 2009, CELL, V139, P458, DOI 10.1016/j.cell.2009.10.016; Reese DK, 2006, J VIROL, V80, P12248, DOI 10.1128/JVI.01201-06; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; SCHNEIDER C, 1994, MOL CELL BIOL, V14, P3176, DOI 10.1128/MCB.14.5.3176; Simmons DT, 2000, ADV VIRUS RES, V55, P75, DOI 10.1016/S0065-3527(00)55002-7; Smelkova NV, 1997, J VIROL, V71, P8766, DOI 10.1128/JVI.71.11.8766-8773.1997; SPENCE SL, 1994, VIROLOGY, V204, P200, DOI 10.1006/viro.1994.1524; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Weisshart K, 2000, J BIOL CHEM, V275, P17328, DOI 10.1074/jbc.M000717200; Weisshart K, 1998, J VIROL, V72, P9771, DOI 10.1128/JVI.72.12.9771-9781.1998; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	74	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33475	33484		10.1074/jbc.M110.156240	http://dx.doi.org/10.1074/jbc.M110.156240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20685648	Green Published, hybrid			2022-12-27	WOS:000283048200082
J	Iwai, A; Shiozaki, T; Kawai, T; Akira, S; Kawaoka, Y; Takada, A; Kida, H; Miyazaki, T				Iwai, Atsushi; Shiozaki, Takuya; Kawai, Taro; Akira, Shizuo; Kawaoka, Yoshihiro; Takada, Ayato; Kida, Hiroshi; Miyazaki, Tadaaki			Influenza A Virus Polymerase Inhibits Type I Interferon Induction by Binding to Interferon beta Promoter Stimulator 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; RIG-I; NS1 PROTEIN; IFN-BETA; ENDONUCLEASE ACTIVITY; ADAPTER PROTEIN; MONOCLONAL-ANTIBODIES; ANTIVIRAL RESPONSES; TRANSGENIC MICE	Type I interferons (IFNs) are known to be critical factors in the activation of host antiviral responses and are also important in protection from influenza A virus infection. Especially, the RIG-I- and IPS-1-mediated intracellular type I IFN-inducing pathway is essential in the activation of antiviral responses in cells infected by influenza A virus. Previously, it has been reported that influenza A virus NS1 is involved in the inhibition of this pathway. We show in this report that the influenza A virus utilizes another critical inhibitory mechanism in this pathway. In fact, the viral polymerase complex exhibited an inhibitory activity on IFN beta promoter activation mediated by RIG-I and IPS-1, and this activity was not competitive with the function of NS1. Co-immunoprecipitation analysis revealed that each polymerase subunit bound to IPS-1 in mammalian cells, and each subunit inhibited the activation of IFN beta promoter by IPS-1 independently. In addition, by a combinational expression of each polymerase subunit, IPS-1-induced activation of IFN beta promoter was more efficiently inhibited by the expression of PB2 or PB2-containing complex. Moreover, the expression of PB2 inhibited the transcription of the endogenous IFN beta gene induced after influenza A virus infection. These findings demonstrate that the viral polymerase plays an important role for regulating host anti-viral response through the binding to IPS-1 and inhibition of IFN beta production.	[Iwai, Atsushi; Shiozaki, Takuya; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Global Epidemiol, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Kawai, Taro; Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Kida, Hiroshi] Hokkaido Univ, Microbiol Lab, Dept Dis Control, Grad Sch Vet Med,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Miyazaki, Tadaaki] OIE, Reference Lab Highly Pathogen Avian Influenza, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Osaka University; Osaka University; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; University of Tokyo; Hokkaido University	Miyazaki, T (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Kita Ku, North 20,West 10, Sapporo, Hokkaido 0010020, Japan.	miyazaki@czc.hokudai.ac.jp	Miyazaki, Tadaaki/D-9368-2012; Kida, Hiroshi/F-7244-2012; Takada, Ayato/A-6679-2012; Iwai, Atsushi/I-6469-2019; Akira, Shizuo/C-3134-2009	Iwai, Atsushi/0000-0002-1491-4693; Kawai, Taro/0000-0001-7510-4662	Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Science and Technology Agency	Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and by a grant from the Japan Science and Technology Agency.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Diamond MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000452; DJEU JY, 1982, J EXP MED, V156, P1222, DOI 10.1084/jem.156.4.1222; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; GARBER EA, 1991, VIROLOGY, V180, P754, DOI 10.1016/0042-6822(91)90088-S; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; HAGEN M, 1994, J VIROL, V68, P1509, DOI 10.1128/JVI.68.3.1509-1515.1994; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hatta M, 2000, ARCH VIROL, V145, P1947, DOI 10.1007/s007050070068; Hatta M, 2000, ARCH VIROL, V145, P895, DOI 10.1007/s007050050682; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Honda A, 2001, J BIOL CHEM, V276, P31179, DOI 10.1074/jbc.M102856200; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Hwang JS, 2000, J VIROL, V74, P4074, DOI 10.1128/JVI.74.9.4074-4084.2000; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kirk P, 2005, IMMUNITY, V23, P347, DOI 10.1016/j.immuni.2005.09.008; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; KOLB E, 1992, J VIROL, V66, P1709, DOI 10.1128/JVI.66.3.1709-1716.1992; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; LAZAROWITZ SG, 1971, VIROLOGY, V46, P830, DOI 10.1016/0042-6822(71)90084-5; Leahy MB, 2001, J VIROL, V75, P134, DOI 10.1128/JVI.75.1.134-142.2001; Leahy MB, 2001, J VIROL, V75, P7042, DOI 10.1128/JVI.75.15.7042-7049.2001; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Li HM, 2009, CELL DEATH DIFFER, V16, P1615, DOI 10.1038/cdd.2009.97; Li ML, 1998, EMBO J, V17, P5844, DOI 10.1093/emboj/17.19.5844; Marcus PI, 2005, J VIROL, V79, P2880, DOI 10.1128/JVI.79.5.2880-2890.2005; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MEIEREWERT H, 1974, J VIROL, V14, P1083, DOI 10.1128/JVI.14.5.1083-1091.1974; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Papon L, 2009, VIROLOGY, V393, P311, DOI 10.1016/j.virol.2009.08.009; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	64	98	102	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32064	32074		10.1074/jbc.M110.112458	http://dx.doi.org/10.1074/jbc.M110.112458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699220	hybrid, Green Published			2022-12-27	WOS:000282683000020
J	Wilkinson, BM; Brownsword, JK; Mousley, CJ; Stirling, CJ				Wilkinson, Barrie M.; Brownsword, Judith K.; Mousley, Carl J.; Stirling, Colin J.			Sss1p Is Required to Complete Protein Translocon Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SEC61P; TRANSPORT; COMPONENT; ENCODES; GENE	Protein translocation across the endoplasmic reticulum membrane occurs at the Sec61 translocon. This has two essential subunits, the channel-forming multispanning membrane protein Sec61p/Sec61 alpha and the tail-anchored Sss1p/Sec61 gamma, which has been proposed to "clamp" the channel. We have analyzed the function of Sss1p using a series of domain mutants and found that both the cytosolic and transmembrane clamp domains of Sss1p are essential for protein translocation. Our data reveal that the cytosolic domain is required for Sec61p interaction but that the transmembrane clamp domain is required to complete activation of the translocon after precursor targeting to Sec61p.	[Wilkinson, Barrie M.; Brownsword, Judith K.; Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Mousley, Carl J.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Manchester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk		Mousley, Carl/0000-0002-0192-7030	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; ESNAULT Y, 1993, EMBO J, V12, P4083, DOI 10.1002/j.1460-2075.1993.tb06092.x; ESNAULT Y, 1994, J BIOL CHEM, V269, P27478; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; SIKORSKI RS, 1989, GENETICS, V122, P19; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wilkinson BM, 1997, EMBO J, V16, P4549, DOI 10.1093/emboj/16.15.4549; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	25	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32671	32677		10.1074/jbc.M110.128256	http://dx.doi.org/10.1074/jbc.M110.128256			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20709746	hybrid, Green Published			2022-12-27	WOS:000282683000081
J	Wen, Y; Li, J; Yao, WM; Xiong, MQ; Hong, J; Peng, Y; Xiao, GF; Lin, DH				Wen, Yi; Li, Jun; Yao, Wenming; Xiong, Minqian; Hong, Jing; Peng, Yu; Xiao, Gengfu; Lin, Donghai			Unique Structural Characteristics of the Rabbit Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; LINEAR EXTRAPOLATION METHOD; NMR SOLUTION STRUCTURE; MOLECULAR-DYNAMICS; BACKBONE DYNAMICS; SPIN-RELAXATION; BINDING SITES; HEAT-CAPACITY; CELLULAR PRP	Rabbits are one of the few mammalian species that appear to be resistant to transmissible spongiform encephalopathies due to the structural characteristics of the rabbit prion protein (RaPrPC) itself. Here, we determined the solution structures of the recombinant protein RaPrPC-(91-228) and its S173N variant and detected the backbone dynamics of their structured C-terminal domains-(121-228). In contrast to many other mammalian PrP(C)s, loop 165-172, which connects beta-sheet-2 and alpha-helix-2, is well-defined in RaPrPC. For the first time, order parameters S-2 are obtained for residues in this loop region, indicating that loop 165-172 of RaPrPC is highly ordered. Compared with the wild-type RaPrPC, less hydrogen bonds form in the S173N variant. The NMR dynamics analysis reveals a distinct increase in the structural flexibility of loop 165-172 and helix-3 after the S173N substitution, implying that the S173N substitution disturbs the long range interaction of loop 165-172 with helix-3, which further leads to a marked decrease in the global conformational stability. Significantly, RaPrPC possesses a unique charge distribution, carrying a continuous area of positive charges on the surface, which is distinguished from other PrP(C)s. The S173N substitution causes visible changes of the charge distribution around the recognition sites for the hypothetical protein X. Our results suggest that the ordered loop 165-172 and its interaction with helix-3, together with the unique distribution of surface electrostatic potential, significantly contribute to the unique structural characteristics of RaPrPC.	[Wen, Yi; Li, Jun; Yao, Wenming; Xiong, Minqian; Hong, Jing; Peng, Yu; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, Shanghai 201203, Peoples R China; [Xiao, Gengfu] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen 361005, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Wuhan University; Xiamen University	Lin, DH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, 555 Zu Chongzhi Rd, Shanghai 201203, Peoples R China.	dhlin@mail.shcnc.ac.cn	li, jun/A-1197-2011; Lin, Donghai/A-1482-2011	Wuthrich, Kurt/0000-0001-8739-6965; Peng, Yu/0000-0003-2039-9015	National Natural Science Foundation of China [30730026, 30570352]; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China [2009ZX09301-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China	This work was supported by grants from the National Natural Science Foundation of China (30730026 and 30570352) and the National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China (2009ZX09301-001).	ALONSO DOV, 1991, BIOCHEMISTRY-US, V30, P5974, DOI 10.1021/bi00238a023; Bae SH, 2009, BIOCHEMISTRY-US, V48, P8120, DOI 10.1021/bi900923b; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Billeter M, 1997, P NATL ACAD SCI USA, V94, P7281, DOI 10.1073/pnas.94.14.7281; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calzolai L, 2000, P NATL ACAD SCI USA, V97, P8340, DOI 10.1073/pnas.97.15.8340; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Colombo MC, 2008, PROTEINS, V70, P1084, DOI 10.1002/prot.21604; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Dayie KT, 1996, ANNU REV PHYS CHEM, V47, P243, DOI 10.1146/annurev.physchem.47.1.243; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Dima RI, 2004, P NATL ACAD SCI USA, V101, P15335, DOI 10.1073/pnas.0404235101; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Hornemann S, 2004, EMBO REP, V5, P1159, DOI 10.1038/sj.embor.7400297; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kaneko K, 1997, J MOL BIOL, V270, P574, DOI 10.1006/jmbi.1997.1135; KANEKO K, 1995, P NATL ACAD SCI USA, V92, P11160, DOI 10.1073/pnas.92.24.11160; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li J, 2007, J BIOMOL NMR, V38, P181, DOI 10.1007/s10858-006-9115-9; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; PRIVALOV PL, 1992, J MOL BIOL, V224, P715, DOI 10.1016/0022-2836(92)90555-X; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Santini S, 2004, CELL MOL LIFE SCI, V61, P951, DOI 10.1007/s00018-003-3455-3; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vassallo N, 2003, J NEUROCHEM, V86, P538, DOI 10.1046/j.1471-4159.2003.01882.x; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xu HM, 2006, J BACTERIOL, V188, P1509, DOI 10.1128/JB.188.4.1509-1517.2006; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang JP, 2010, J THEOR BIOL, V264, P119, DOI 10.1016/j.jtbi.2010.01.024; Zhang JP, 2009, J BIOMOL STRUCT DYN, V27, P159, DOI 10.1080/07391102.2009.10507305; Zhang M, 1998, J BIOL CHEM, V273, P21714, DOI 10.1074/jbc.273.34.21714; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200; Zidar J, 2008, J CHEM INF MODEL, V48, P283, DOI 10.1021/ci700226c; Ziegler J, 2003, J BIOL CHEM, V278, P50175, DOI 10.1074/jbc.M305234200	85	66	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31682	31693		10.1074/jbc.M110.118844	http://dx.doi.org/10.1074/jbc.M110.118844			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20639199	Green Published, hybrid			2022-12-27	WOS:000282764600060
J	Bukur, J; Herrmann, F; Handke, D; Recktenwald, C; Seliger, B				Bukur, Juergen; Herrmann, Felix; Handke, Diana; Recktenwald, Christian; Seliger, Barbara			Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; HLA CLASS-I; COORDINATED DOWN-REGULATION; HUMAN-LEUKOCYTE ANTIGEN; RENAL-CELL CARCINOMA; MOLECULAR-MECHANISMS; CHROMATIN MODIFIERS; IMMUNE-RESPONSES; INTERFERON-GAMMA; GENE-EXPRESSION	HER-2/neu overexpression in tumor cells caused abnormalities of MHC class I surface expression due to impaired expression of components of the antigen-processing machinery (APM) including the low molecular weight proteins, the transporter associated with antigen processing (TAP), and the chaperone tapasin, whereas the expression of MHC class I heavy chain as well as beta(2)-microglobulin was only marginally affected. This oncogene-mediated deficient APM component expression could be reverted by interferon-gamma treatment, suggesting a deregulation rather than structural alterations as underlying molecular mechanisms. To determine the level of regulation, the transcriptional activity of APM components was analyzed in HER-2/neu(-) and HER-2/neu(+) cells. All major APM components were transcriptionally down-regulated in HER-2/neu(+) when compared with HER-2/neu(-) cells, which was accompanied by a reduced binding of RNA polymerase II to the APM promoters. Site-directed mutagenesis of the p300- and E2F-binding sites in the APM promoters did not reconstitute the oncogene-mediated decreased transcription rate with the exception of tapasin, which was restored in HER-2/neu(+) cells to levels of wild type tapasin promoter activity in HER-2/neu(-) fibroblasts. The E2F-directed control of tapasin expression was further confirmed by chromatin immunoprecipitation analyses showing that E2F1 and p300 bind to the tapasin and APM promoters in both cell lines. Moreover, siRNA-mediated silencing of E2F1 was associated with an increased tapasin expression, whereas transient overexpression of E2F1 launch a reduced tapasin transcription, suggesting that E2F1 is an essential transcription factor for tapasin.	[Bukur, Juergen; Herrmann, Felix; Handke, Diana; Recktenwald, Christian; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, D-06112 Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Seliger, B (corresponding author), Magdeburger Str 2, D-06112 Halle, Saale, Germany.	Barbara.Seliger@medizin.uni-halle.de		Seliger, Barbara/0000-0002-5544-4958; Recktenwald, Christian Viktor/0000-0003-1710-1863	Deutsche Forschungsgemeinschaft (DFG) [SE-589/11-1, 11-2, SE-581/9-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Grant SE-589/11-1, 11-2 and Grant SE-581/9-2.	Abarca-Heidemann K, 2002, IMMUNOL LETT, V83, P197, DOI 10.1016/S0165-2478(02)00104-9; ADAMS PD, 1995, SEMIN CANCER BIOL, V6, P99, DOI 10.1006/scbi.1995.0013; Agrawal S, 2000, J HEMATOTH STEM CELL, V9, P795, DOI 10.1089/152581600750062237; Aptsiauri N, 2008, CANCER IMMUNOL IMMUN, V57, P1727, DOI 10.1007/s00262-008-0532-3; Ares M, 2005, CELL, V120, P163, DOI 10.1016/j.cell.2005.01.002; Arons E, 2001, J IMMUNOL, V166, P3942, DOI 10.4049/jimmunol.166.6.3942; Atkins D, 2004, INT J CANCER, V109, P265, DOI 10.1002/ijc.11681; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; Bennett EM, 1999, J IMMUNOL, V162, P5049; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Brucet M, 2004, GENES IMMUN, V5, P26, DOI 10.1038/sj.gene.6364035; Bruno S, 2003, BLOOD, V101, P3514, DOI 10.1182/blood-2002-11-3335; Cabrera CM, 2005, INT J CANCER, V113, P611, DOI 10.1002/ijc.20526; Cabrera CM, 2003, TISSUE ANTIGENS, V61, P211, DOI 10.1034/j.1399-0039.2003.00020.x; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Chang CC, 2006, J BIOL CHEM, V281, P18763, DOI 10.1074/jbc.M511525200; Chatterjee-Kishore M, 1998, J BIOL CHEM, V273, P16177, DOI 10.1074/jbc.273.26.16177; Choudhury A, 2004, INT J CANCER, V108, P71, DOI 10.1002/ijc.11497; Delp K, 2000, BONE MARROW TRANSPL, V25, pS88, DOI 10.1038/sj.bmt.1702363; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dissemond J, 2003, ARCH DERMATOL RES, V295, P43, DOI 10.1007/s00403-003-0393-8; Doody GM, 2007, J IMMUNOL, V179, P7614, DOI 10.4049/jimmunol.179.11.7614; Dovhey SE, 2000, CANCER RES, V60, P5789; EPPERSON DE, 1992, J IMMUNOL, V149, P3297; Facoetti A, 2005, CLIN CANCER RES, V11, P8304, DOI 10.1158/1078-0432.CCR-04-2588; FERRONE S, 1995, IMMUNOL TODAY, V16, P487, DOI 10.1016/0167-5699(95)80033-6; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; Fujita T, 2009, FEBS LETT, V583, P2893, DOI 10.1016/j.febslet.2009.07.050; Garbi N, 2005, IMMUNOL REV, V207, P77, DOI 10.1111/j.0105-2896.2005.00303.x; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Garcia-Lora A, 2003, INT J CANCER, V106, P521, DOI 10.1002/ijc.11241; Garrido C, 2010, CANCER IMMUNOL IMMUN, V59, P13, DOI 10.1007/s00262-009-0716-5; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Gobin SJP, 1997, J IMMUNOL, V158, P3587; Gobin SJP, 1999, J IMMUNOL, V163, P1428; Griffioen M, 1998, MOL IMMUNOL, V35, P829, DOI 10.1016/S0161-5890(98)00074-1; Guo Y, 2002, INT IMMUNOL, V14, P189, DOI 10.1093/intimm/14.2.189; Handen Jeffrey S., 1997, Frontiers in Bioscience (online), V2, pC9; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Herberg JA, 1998, EUR J IMMUNOL, V28, P459, DOI 10.1002/(SICI)1521-4141(199802)28:02<459::AID-IMMU459>3.3.CO;2-Q; Herrmann F, 2004, CANCER RES, V64, P215, DOI 10.1158/0008-5472.CAN-2522-2; Herrmann F, 2003, IMMUNOGENETICS, V55, P379, DOI 10.1007/s00251-003-0597-2; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Jung D, 1999, SCAND J IMMUNOL, V50, P242; Khan ANH, 2008, CANCER IMMUNOL IMMUN, V57, P647, DOI 10.1007/s00262-007-0402-4; KISHI F, 1993, GENE, V133, P243; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; Lou YM, 2005, CANCER RES, V65, P7926, DOI 10.1158/0008-5472.CAN-04-3977; Maleno I, 2002, CANCER IMMUNOL IMMUN, V51, P389, DOI 10.1007/s00262-002-0296-0; Mehta AM, 2009, GENE CHROMOSOME CANC, V48, P410, DOI 10.1002/gcc.20648; Min W, 1996, J IMMUNOL, V156, P3174; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Moschonas A, 2008, MOL CELL BIOL, V28, P6208, DOI 10.1128/MCB.00611-08; NEVINS JR, 1992, NATURE, V358, P375, DOI 10.1038/358375a0; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Pupa SM, 1999, ONCOGENE, V18, P651, DOI 10.1038/sj.onc.1202363; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Raffaghello L, 2005, ONCOGENE, V24, P4634, DOI 10.1038/sj.onc.1208594; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Rescigno M, 2007, BBA-REV CANCER, V1776, P108, DOI 10.1016/j.bbcan.2007.07.003; RESTIFO NP, 1993, J EXP MED, V177, P265, DOI 10.1084/jem.177.2.265; Romero JM, 2005, INT J CANCER, V113, P605, DOI 10.1002/ijc.20499; RotemYehudar R, 1996, J EXP MED, V183, P499, DOI 10.1084/jem.183.2.499; Rouyez MC, 2005, J IMMUNOL, V174, P3948, DOI 10.4049/jimmunol.174.7.3948; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Seliger B, 2001, TISSUE ANTIGENS, V57, P39, DOI 10.1034/j.1399-0039.2001.057001039.x; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Seliger B, 2001, CANCER RES, V61, P8647; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; Sers C, 2009, INT J CANCER, V125, P1626, DOI 10.1002/ijc.24557; Setiadi AF, 2007, MOL CELL BIOL, V27, P7886, DOI 10.1128/MCB.01547-07; Setiadi AF, 2008, CANCER RES, V68, P9601, DOI 10.1158/0008-5472.CAN-07-5270; Smahel M, 2001, BRIT J CANCER, V84, P374, DOI 10.1054/bjoc.2000.1615; Takahashi Y, 2000, GENE DEV, V14, P804; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; van den Elsen PJ, 1998, IMMUNOL TODAY, V19, P308, DOI 10.1016/S0167-5699(98)01287-0; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; Vertegaal ACO, 2003, J BIOL CHEM, V278, P139, DOI 10.1074/jbc.M206267200; Vertuani S, 2009, CANCER IMMUNOL IMMUN, V58, P653, DOI 10.1007/s00262-008-0587-1; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; Ye Q, 2010, TISSUE ANTIGENS, V75, P30, DOI 10.1111/j.1399-0039.2009.01390.x; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	89	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30419	30426		10.1074/jbc.M109.094284	http://dx.doi.org/10.1074/jbc.M109.094284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663889	hybrid, Green Published			2022-12-27	WOS:000282135500008
J	Karbat, I; Ilan, N; Zhang, JZ; Cohen, L; Kahn, R; Benveniste, M; Scheuer, T; Catterall, WA; Gordon, D; Gurevitz, M				Karbat, Izhar; Ilan, Nitza; Zhang, Joel Z.; Cohen, Lior; Kahn, Roy; Benveniste, Morris; Scheuer, Todd; Catterall, William A.; Gordon, Dalia; Gurevitz, Michael			Partial Agonist and Antagonist Activities of a Mutant Scorpion beta-Toxin on Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-SENSOR; ALPHA-SUBUNIT; NA+ CHANNELS; ION CHANNELS; DOMAIN-II; ACTIVATION; BINDING; HIGHLIGHTS; INSECT; LOOP	Scorpion beta-toxin 4 from Centruroides suffusus suffusus (Css4) enhances the activation of voltage-gated sodium channels through a voltage sensor trapping mechanism by binding the activated state of the voltage sensor in domain II and stabilizing it in its activated conformation. Here we describe the antagonist and partial agonist properties of a mutant derivative of this toxin. Substitution of seven different amino acid residues for Glu(15) in Css4 yielded toxin derivatives with both increased and decreased affinities for binding to neurotoxin receptor site 4 on sodium channels. Css4(E15R) is unique among this set of mutants in that it retained nearly normal binding affinity but lost its functional activity for modification of sodium channel gating in our standard electrophysiological assay for voltage sensor trapping. More detailed analysis of the functional effects of Css4(E15R) revealed weak voltage sensor trapping activity, which was very rapidly reversed upon repolarization and therefore was not observed in our standard assay of toxin effects. This partial agonist activity of Css4(E15R) is observed clearly in voltage sensor trapping assays with brief (5 ms) repolarization between the conditioning prepulse and the test pulse. The effects of Css4(E15R) are fit well by a three-step model of toxin action involving concentration-dependent toxin binding to its receptor site followed by depolarization-dependent activation of the voltage sensor and subsequent voltage sensor trapping. Because it is a partial agonist with much reduced efficacy for voltage sensor trapping, Css4(E15R) can antagonize the effects of wild-type Css4 on sodium channel activation and can prevent paralysis by Css4 when injected into mice. Our results define the first partial agonist and antagonist activities for scorpion toxins and open new avenues of research toward better understanding of the structure-function relationships for toxin action on sodium channel voltage sensors and toward potential toxin-based therapeutics to prevent lethality from scorpion envenomation.	[Zhang, Joel Z.; Scheuer, Todd; Catterall, William A.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Benveniste, Morris] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA	University of Washington; University of Washington Seattle; Tel Aviv University; Morehouse School of Medicine	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu			National Institutes of Health [1 U01 NS058039-01]; United States-Israel Binational Agricultural Research and Development [IS-3928-06]; Israeli Science Foundation [1008/05]; German-Israeli Foundation for Scientific Research and Development [G-770-242.1/2002]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development; Israeli Science Foundation(Israel Science Foundation); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 U01 NS058039-01 (to W. A. C. and M. G.). This research was also supported by United States-Israel Binational Agricultural Research and Development Grant IS-3928-06 (to M. G., D. G., and W. A. C.), by Israeli Science Foundation Grant 1008/05 (to D. G. and M. G.), and by German-Israeli Foundation for Scientific Research and Development Grant G-770-242.1/2002 (to D. G.).	Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Gilles N, 2000, J NEUROCHEM, V75, P1735, DOI 10.1046/j.1471-4159.2000.0751735.x; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Karbat I, 2004, FASEB J, V18, P683, DOI 10.1096/fj.03-0733com; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0	20	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30531	30538		10.1074/jbc.M110.150888	http://dx.doi.org/10.1074/jbc.M110.150888			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20682774	Green Published, hybrid			2022-12-27	WOS:000282135500021
J	Palmier, MO; Fulcher, YG; Bhaskaran, R; Duong, VQ; Fields, GB; Van Doren, SR				Palmier, Mark O.; Fulcher, Yan G.; Bhaskaran, Rajagopalan; Duong, Vinh Q.; Fields, Gregg B.; Van Doren, Steven R.			NMR and Bioinformatics Discovery of Exosites That Tune Metalloelastase Specificity for Solubilized Elastin and Collagen Triple Helices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE ELASTASE; SUBSTRATE-SPECIFICITY; CATALYTIC DOMAIN; CIGARETTE-SMOKE; ACTIVE-SITE; MATRIX METALLOPROTEINASE-12; ELASTOLYTIC ACTIVITY; HUMAN TROPOELASTIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	The catalytic domain of metalloelastase (matrix metalloproteinase-12 or MMP-12) is unique among MMPs in exerting high proteolytic activity upon fibrils that resist hydrolysis, especially elastin from lungs afflicted with chronic obstructive pulmonary disease or arteries with aneurysms. How does the MMP-12 catalytic domain achieve this specificity? NMR interface mapping suggests that alpha-elastin species cover the primed subsites, a strip across the beta-sheet from beta-strand IV to the II-III loop, and a broad bowl from helix A to helix C. The many contacts may account for the comparatively high affinity, as well as embedding of MMP-12 in damaged elastin fibrils in vivo. We developed a strategy called BINDSIght, for bioinformatics and NMR discovery of specificity of interactions, to evaluate MMP-12 specificity without a structure of a complex. BINDSIght integration of the interface mapping with other ambiguous information from sequences guided choice mutations in binding regions nearer the active site. Single substitutions at each of ten locations impair specific activity toward solubilized elastin. Five of them impair release of peptides from intact elastin fibrils. Eight lesions also impair specific activity toward triple helices from collagen IV or V. Eight sites map to the "primed" side in the III-IV, V-B, and S1' specificity loops. Two map to the "unprimed" side in the IV-V and B-C loops. The ten key residues circumscribe the catalytic cleft, form an exosite, and are distinctive features available for targeting by new diagnostics or therapeutics.	[Palmier, Mark O.; Fulcher, Yan G.; Bhaskaran, Rajagopalan; Duong, Vinh Q.; Van Doren, Steven R.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Missouri System; University of Missouri Columbia; University of Texas System; University of Texas Health San Antonio	Van Doren, SR (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.	vandorens@missouri.edu		Van Doren, Steven/0000-0003-2838-4598; Fulcher, Yan/0000-0002-7060-3523; Bhaskaran, Raj/0000-0001-8008-9962	National Institutes of Health [R01 GM57289, RR022341, R01 CA098799]; University of Missouri; Robert A. Welch Foundation; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM57289 (to S. R. V.). The 800-MHz NMR spectrometer was purchased with funding from NIH Grant RR022341 and the University of Missouri. THP development was supported by NIH Grant R01 CA098799 and the Robert A. Welch Foundation (to G. B. F.).	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Arumugam S, 1998, BIOCHEMISTRY-US, V37, P9650, DOI 10.1021/bi980128h; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Bertini I, 2009, CHEM-EUR J, V15, P7842, DOI 10.1002/chem.200901009; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Bhaskaran R, 2007, J MOL BIOL, V374, P1333, DOI 10.1016/j.jmb.2007.10.028; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Churg A, 2003, AM J RESP CRIT CARE, V167, P1083, DOI 10.1164/rccm.200212-1396OC; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; COX BA, 1973, BIOCHIM BIOPHYS ACTA, V317, P209, DOI 10.1016/0005-2795(73)90215-8; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Fu JY, 2001, PROTEIN EXPRES PURIF, V21, P268, DOI 10.1006/prep.2000.1376; Garimella R, 2006, BIOCHEMISTRY-US, V45, P6917, DOI 10.1021/bi060411d; Goddard T. D., 2000, SPARKY; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; HUEBNER PF, 1976, ANAL BIOCHEM, V74, P419, DOI 10.1016/0003-2697(76)90222-0; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; HUNNINGHAKE GW, 1981, SCIENCE, V212, P925, DOI 10.1126/science.7233186; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; KELLER S, 1971, BIOCHEM MED METAB B, V5, P342, DOI 10.1016/0006-2944(71)90038-X; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Lang R, 2001, J MOL BIOL, V312, P731, DOI 10.1006/jmbi.2001.4954; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lee GI, 2003, P NATL ACAD SCI USA, V100, P11261, DOI 10.1073/pnas.2031918100; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Liang XY, 2010, BIOPHYS J, V99, P273, DOI 10.1016/j.bpj.2010.04.002; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Linsenmayer TF, 1998, PROG RETIN EYE RES, V17, P231; LIOTTA LA, 1981, BIOCHEM BIOPH RES CO, V98, P184, DOI 10.1016/0006-291X(81)91886-6; Liu MZ, 2004, ARTHRITIS RHEUM-US, V50, P3112, DOI 10.1002/art.20567; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; MECHAM RP, 1980, CONNECT TISSUE RES, V7, P247, DOI 10.3109/03008208009152360; Mihalek I, 2006, BIOINFORMATICS, V22, P1656, DOI 10.1093/bioinformatics/btl157; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Moy FJ, 2002, J AM CHEM SOC, V124, P12658, DOI 10.1021/ja027391x; Nar H, 2001, J MOL BIOL, V312, P743, DOI 10.1006/jmbi.2001.4953; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; NIEDZWIECKI L, 1992, BIOCHEMISTRY-US, V31, P12618, DOI 10.1021/bi00165a011; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; ODELL BL, 1966, NATURE, V209, P401, DOI 10.1038/209401a0; Oue S, 1999, J BIOL CHEM, V274, P2344, DOI 10.1074/jbc.274.4.2344; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; PARKS WC, 1990, AM J RESP CELL MOL, V2, P399, DOI 10.1165/ajrcmb/2.5.399; PARTRIDGE SM, 1966, NATURE, V209, P399, DOI 10.1038/209399b0; PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011; Pepe A, 2005, MATRIX BIOL, V24, P96, DOI 10.1016/j.matbio.2005.01.004; PODRAZKY V, 1968, BIOCHIM BIOPHYS ACTA, V160, P277, DOI 10.1016/0005-2795(68)90104-9; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Saarialho-Kere U, 1999, J INVEST DERMATOL, V113, P664, DOI 10.1046/j.1523-1747.1999.00731.x; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; Shipley JM, 1996, J BIOL CHEM, V271, P4335; STARCHER B, 1995, CONNECT TISSUE RES, V31, P133, DOI 10.3109/03008209509028401; Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050; STARCHER BC, 1976, ANAL BIOCHEM, V74, P441, DOI 10.1016/0003-2697(76)90224-4; Steele DL, 2000, PROTEIN ENG, V13, P397, DOI 10.1093/protein/13.6.397; Taddese S, 2008, MATRIX BIOL, V27, P420, DOI 10.1016/j.matbio.2008.02.001; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014; Tomatis PE, 2005, P NATL ACAD SCI USA, V102, P13761, DOI 10.1073/pnas.0503495102; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; URRY DW, 1969, NATURE, V222, P795, DOI 10.1038/222795a0; Vaalamo M, 1998, AM J PATHOL, V152, P1005; Valenca SS, 2004, TOXICOL PATHOL, V32, P351, DOI 10.1080/01926230490431466; Van Doren SR, 2011, BIOL EXTRACELL MATR, P123, DOI 10.1007/978-3-642-16861-1_6; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Vos CMP, 2003, J NEUROIMMUNOL, V138, P106, DOI 10.1016/S0165-5728(03)00036-5; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Williams J W, 1979, Methods Enzymol, V63, P437; Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006; YE QZ, 1992, BIOCHEMISTRY-US, V31, P11231, DOI 10.1021/bi00160a038; Zheng XH, 2007, PROTEIN EXPRES PURIF, V56, P160, DOI 10.1016/j.pep.2007.05.005	92	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30918	30930		10.1074/jbc.M110.136903	http://dx.doi.org/10.1074/jbc.M110.136903			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663866	Green Published, hybrid			2022-12-27	WOS:000282135500057
J	Patterson-Fortin, J; Shao, G; Bretscher, H; Messick, TE; Greenberg, RA				Patterson-Fortin, Jeffrey; Shao, Genze; Bretscher, Heidi; Messick, Troy E.; Greenberg, Roger A.			Differential Regulation of JAMM Domain Deubiquitinating Enzyme Activity within the RAP80 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; STRUCTURAL BASIS; BRCA1; BINDING; METALLOPROTEASE; RECOGNITION; DEGRADATION; CHECKPOINTS; PROTEASOME	BRCC36 is a JAMM (JAB1/MPN/Mov34 metalloenzyme) domain, lysine 63-ubiquitin (K63-Ub)-specific deubiquitinating enzyme (DUB) and a member of two protein complexes: the DNA damage-responsive BRCA1-RAP80 complex, and the cytoplasmic BRCC36 isopeptidase complex (BRISC). The presence of several identical constituents in both complexes suggests common regulatory mechanisms and potential competition between K63-Ub-related signaling in cytoplasmic and nuclear compartments. Surprisingly, we discover that BRCC36 DUB activity requires different interactions within the context of each complex. Abraxas and BRCC45 were essential for BRCC36 DUB activity within the RAP80 complex, whereas KIAA0157/Abro was the only interaction required for DUB activity within the BRISC. Poh1 also required protein interactions for activity, suggesting a common regulatory mechanism for JAMM domain DUBs. Finally, BRISC deficiency enhanced formation of the BRCA1-RAP80 complex in vivo, increasing BRCA1 levels at DNA double strand breaks. These findings reveal that JAMM domain DUB activity and K63-Ub levels are regulated by multiple mechanisms within the cell.	[Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Patterson-Fortin, Jeffrey] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Greenberg, RA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, 421 Curie Blvd,513 BRB 2-3, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu		Bretscher, Heidi/0000-0001-5927-4880; Patterson-Fortin, Jeffrey/0000-0001-8493-8060; Messick, Troy/0000-0001-7914-1524	National Institutes of Health, NCI [1R01CA138835-01, 1K08CA106597-01, 3K08CA106597-04S1]; Canadian Institutes for Health Research; Center of Excellence in Environmental Toxicology; University Research Foundation of the University of Pennsylvania; American Cancer Society; Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [K08CA106597, R01CA138835] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Center of Excellence in Environmental Toxicology; University Research Foundation of the University of Pennsylvania; American Cancer Society(American Cancer Society); Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant 1R01CA138835-01 and K08 awards 1K08CA106597-01 and 3K08CA106597-04S1 (to R. A. G.).; Supported in part by a Doctoral Research Award from the Canadian Institutes for Health Research.; Supported in part by funds from the Center of Excellence in Environmental Toxicology and the University Research Foundation of the University of Pennsylvania. Present address: Vironika, 3601 Spruce St., G63, Philadelphia, PA 19104.; Supported by an American Cancer Society research scholar grant, the Sidney Kimmel Foundation Scholar Award, and funds from the Abramson Family Cancer Research Institute. To whom correspondence should be addressed: Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, 421 Curie Blvd., 513 BRB II/III, Philadelphia, PA 19104-6160. Tel.: 215-746-2738; Fax: 215-573-2486; E-mail: rogergr@mail.med.upenn.edu.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Greenberg RA, 2008, CHROMOSOMA, V117, P305, DOI 10.1007/s00412-008-0154-8; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yan J, 2007, NUCLEIC ACIDS RES, V35, P1673, DOI 10.1093/nar/gkl1112; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	48	59	61	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30971	30981		10.1074/jbc.M110.135319	http://dx.doi.org/10.1074/jbc.M110.135319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20656689	hybrid, Green Published			2022-12-27	WOS:000282135500062
J	Galello, F; Portela, P; Moreno, S; Rossi, S				Galello, Fiorella; Portela, Paula; Moreno, Silvia; Rossi, Silvia			Characterization of Substrates That Have a Differential Effect on Saccharomyces cerevisiae Protein Kinase A Holoenzyme Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PYRUVATE-KINASE; CATALYTIC SUBUNIT; SPECIFICITY DETERMINANTS; PHOSPHORYLATION SITES; DEPENDENT ACTIVATION; GLOBAL ANALYSIS; IN-VIVO; CAMP; PKA; IDENTIFICATION	The specificity in phosphorylation by kinases is determined by the molecular recognition of the peptide target sequence. In Saccharomyces cerevisiae, the protein kinase A(PKA) specificity determinants are less studied than in mammalian PKA. The catalytic turnover numbers of the catalytic subunits isoforms Tpk1 and Tpk2 were determined, and both enzymes are shown to have the same value of 3 s(-1). We analyze the substrate behavior and sequence determinants around the phosphorylation site of three protein substrates, Pyk1, Pyk2, and Nth1. Nth1 protein is a better substrate than Pyk1 protein, and both are phosphorylated by either Tpk1 or Tpk2. Both enzymes also have the same selectivity toward the protein substrates and the peptides derived from them. The three substrates contain one or more Arg-Arg-X-Ser consensus motif, but not all of them are phosphorylated. The determinants for specificity were studied using the peptide arrays. Acidic residues in the position P + 1 or in the N-terminal flank are deleterious, and positive residues present beyond P-2 and P-3 favor the catalytic reaction. A bulky hydrophobic residue position P + 4 an acidic residue, equivalent to the one in the inhibitory sequence of Bcy1, the yeast regulatory subunit of PKA. The substrate effect in the holoenzyme activation was analyzed, and we demonstrate that peptides and protein substrates sensitized the holoenzyme to activation by cAMP in different degrees, depending on their sequences. The results also suggest that protein substrates are better co-activators than peptide substrates.	[Rossi, Silvia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab QB1, RA-1428 Buenos Aires, DF, Argentina	University of Buenos Aires	Rossi, S (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab QB1, Ciudad Univ Pab 2 Piso 4, RA-1428 Buenos Aires, DF, Argentina.	srossi@qb.fcen.uba.ar		Rossi, Silvia/0000-0001-6996-0622	Agencia Nacional de Promocion Cientfica y Tecnologica [PICT 38212]; University of Buenos Aires [UBA X-197]; Consejo Nacional de Investigaciones Cientficas y Tecnicas [PIP5239]	Agencia Nacional de Promocion Cientfica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientficas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Agencia Nacional de Promocion Cientfica y Tecnologica (PICT 38212), from the University of Buenos Aires (UBA X-197), and from the Consejo Nacional de Investigaciones Cientficas y Tecnicas (PIP5239).	Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Choi MG, 2005, J BIOL CHEM, V280, P26105, DOI 10.1074/jbc.M503551200; Deminoff SJ, 2009, GENETICS, V182, P529, DOI 10.1534/genetics.109.102178; DENIS CL, 1991, J BIOL CHEM, V266, P17932; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KEMP BE, 1977, J BIOL CHEM, V252, P4888; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; Lieser SA, 2005, BBA-PROTEINS PROTEOM, V1754, P191, DOI 10.1016/j.bbapap.2005.07.024; Loog M, 2005, BBA-PROTEINS PROTEOM, V1747, P261, DOI 10.1016/j.bbapap.2004.11.016; MAZON MJ, 1993, EUR J BIOCHEM, V213, P501, DOI 10.1111/j.1432-1033.1993.tb17787.x; Mesecar AD, 1997, BIOCHEMISTRY-US, V36, P6803, DOI 10.1021/bi962870s; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Portela P, 2006, CELL SIGNAL, V18, P1072, DOI 10.1016/j.cellsig.2005.09.001; Portela P, 2002, J BIOL CHEM, V277, P30477, DOI 10.1074/jbc.M201094200; Portela P, 2006, BIOCHEM J, V396, P117, DOI 10.1042/BJ20051642; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rinaldi J, 2008, ARCH BIOCHEM BIOPHYS, V480, P95, DOI 10.1016/j.abb.2008.09.014; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Sherman F., 1981, METHODS YEAST GENETI; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005; UNO I, 1983, J BIOL CHEM, V258, P867; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; WALSH D A, 1992, Current Opinion in Cell Biology, V4, P241, DOI 10.1016/0955-0674(92)90039-F; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wera S, 1999, BIOCHEM J, V343, P621, DOI 10.1042/0264-6021:3430621; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; YANG SM, 1995, BIOCHEMISTRY-US, V34, P6267, DOI 10.1021/bi00019a002; Zaremberg V, 2000, ARCH BIOCHEM BIOPHYS, V381, P74, DOI 10.1006/abbi.2000.1948; Zetterqvist O.Z., 1990, PEPTIDES PROTEIN PHO, P171; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	50	21	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29770	29779		10.1074/jbc.M110.120378	http://dx.doi.org/10.1074/jbc.M110.120378			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639203	Green Published, hybrid			2022-12-27	WOS:000281984300012
J	Li, YQ; Gou, MY; Sun, Q; Hua, JA				Li, Yongqing; Gou, Mingyue; Sun, Qi; Hua, Jian			Requirement of Calcium Binding, Myristoylation, and Protein-Protein Interaction for the Copine BON1 Function in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2 DOMAIN; PLASMA-MEMBRANE; CELL-DEATH; GROWTH; EXPRESSION; FAMILY; IDENTIFICATION; GENES	Copines are highly conserved proteins with lipid-binding activities found in animals, plants, and protists. They contain two calcium-dependent phospholipid binding C2 domains at the amino terminus and a VWA domain at the carboxyl terminus. The biological roles of most copines are not understood and the biochemical properties required for their functions are largely unknown. The Arabidopsis copine gene BON1/CPN1 is a negative regulator of cell death and defense responses. Here we probed the potential biochemical activities of BON1 through mutagenic studies. We found that mutations of aspartates in the C2 domains did not alter plasma membrane localization but compromised BON1 activity. Mutation at putative myristoylation residue glycine 2 altered plasma membrane localization of BON1 and rendered BON1 inactive. Mass spectrometry analysis of BON1 further suggests that the N-peptide of BON1 is modified. Furthermore, mutations that affect the interaction between BON1 and its functional partner BAP1 abolished BON1 function. This analysis reveals an unanticipated regulation of copine protein localization and function by calcium and lipid modification and suggests an important role in protein-protein interaction for the VWA domain of copines.	[Li, Yongqing; Gou, Mingyue; Hua, Jian] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; [Sun, Qi] Cornell Univ, Biocomp Serv Unit, Ithaca, NY 14853 USA	Cornell University; Cornell University	Hua, JA (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA.	yongqing@berkeley.edu; jh299@cornell.edu	Gou, Mingyue/AAE-2018-2021		National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by a grant from the National Science Foundation (to J. H.).	Banci L, 2002, J BIOL CHEM, V277, P12988, DOI 10.1074/jbc.M106875200; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Caudell EG, 2000, BIOCHEMISTRY-US, V39, P13034, DOI 10.1021/bi001250v; Church DL, 2003, GENETICS, V165, P563; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Damer CK, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-46; Damer CK, 2007, EUKARYOT CELL, V6, P430, DOI 10.1128/EC.00322-06; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; DE VRIES JS, 2006, PLANT J, V45, P31; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Hua J, 2001, GENE DEV, V15, P2263, DOI 10.1101/gad.918101; Jambunathan N, 2001, PLANT CELL, V13, P2225, DOI 10.1105/tpc.13.10.2225; James P, 1996, GENETICS, V144, P1425; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kierszniowska S, 2009, MOL CELL PROTEOMICS, V8, P612, DOI 10.1074/mcp.M800346-MCP200; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Liu JX, 2005, PLANTA, V221, P85, DOI 10.1007/s00425-004-1413-4; Mosher RA, 2006, PLANT CELL, V18, P1750, DOI 10.1105/tpc.105.039677; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagasaki N, 2008, FEBS J, V275, P2267, DOI 10.1111/j.1742-4658.2008.06379.x; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Thompson GA, 2000, PROG LIPID RES, V39, P19, DOI 10.1016/S0163-7827(99)00014-4; Tomsig JL, 2004, BIOCHEM J, V378, P1089, DOI 10.1042/BJ20031654; Tomsig JL, 2003, J BIOL CHEM, V278, P10048, DOI 10.1074/jbc.M212632200; Tomsig JL, 2000, BIOCHEMISTRY-US, V39, P16163, DOI 10.1021/bi0019949; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Yang HJ, 2006, PLANT J, V48, P238, DOI 10.1111/j.1365-313X.2006.02869.x; Yang SH, 2006, PLANT J, V45, P166, DOI 10.1111/j.1365-313X.2005.02585.x; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260	34	17	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29884	29891		10.1074/jbc.M109.066100	http://dx.doi.org/10.1074/jbc.M109.066100			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20634289	Green Published, hybrid			2022-12-27	WOS:000281984300025
J	Mathes, E; Wang, L; Komives, E; Ghosh, G				Mathes, Erika; Wang, Lily; Komives, Elizabeth; Ghosh, Gourisankar			Flexible Regions within I kappa B alpha Create the Ubiquitin-independent Degradation Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME PATHWAY; PROTEIN-TURNOVER; PHOSPHORYLATION; ACTIVATION; PEPTIDE; COMPLEX; BINDING; DOMAIN; COMMON; UV	Homeostatic regulation of NF-kappa B requires the continuous synthesis of I kappa B alpha and its rapid degradation by the proteasome through a ubiquitin-independent pathway. We previously showed that the ubiquitin-independent degradation signal of unbound I kappa B alpha was located in the C-terminal PEST region, and we have now identified a single tyrosine, Tyr-289, and determined that the hydrophobic character of the tyrosine is important for the rapid turnover of I kappa B alpha. The sequence composition of the PEST peptide surrounding this Tyr-289 imposes a distinct polyproline II conformation. Enhancing the polyproline II helix formation correlates with slower degradation rates of unbound I kappa B alpha. We have further identified a degradation signal located within the 5th ankyrin repeat that is functional once the C terminus is removed. Both the C-terminal and 5th ankyrin repeat degradation signals have inherent flexibility and specific hydrophobic residue(s), which together constitute the ubiquitin-independent degradation signal for I kappa B alpha.	[Mathes, Erika; Wang, Lily; Komives, Elizabeth; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gghosh@ucsd.edu			National Institutes of Health [T32 CA009523]; NRSA [5P01GM071862-04]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Award T32 CA009523, Ruth L. Kirschstein award from NRSA (to E. M.), and Grant 5P01GM071862-04 (to G. G.).	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Chandra S, 2008, J BIOL CHEM, V283, P23950, DOI 10.1074/jbc.M800467200; Croy CH, 2004, PROTEIN SCI, V13, P1767, DOI 10.1110/ps.04731004; Ferreiro DU, 2007, J MOL BIOL, V365, P1201, DOI 10.1016/j.jmb.2006.11.044; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kroll M, 1997, ONCOGENE, V15, P1841, DOI 10.1038/sj.onc.1201560; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; McElhinny JA, 1996, MOL CELL BIOL, V16, P899; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Pando MP, 2000, J BIOL CHEM, V275, P21278, DOI 10.1074/jbc.M002532200; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Schwarz EM, 1996, MOL CELL BIOL, V16, P3554; Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163; Shringarpure R, 2002, FREE RADICAL BIO MED, V32, P1084, DOI 10.1016/S0891-5849(02)00824-9; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Truhlar SME, 2008, J MOL BIOL, V380, P67, DOI 10.1016/j.jmb.2008.02.053; Truhlar SME, 2006, P NATL ACAD SCI USA, V103, P18951, DOI 10.1073/pnas.0605794103	30	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32927	32936		10.1074/jbc.M110.107326	http://dx.doi.org/10.1074/jbc.M110.107326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682784	Green Published, hybrid			2022-12-27	WOS:000283048200030
J	Gentzsch, M; Dang, H; Dang, Y; Garcia-Caballero, A; Suchindran, H; Boucher, RC; Stutts, MJ				Gentzsch, Martina; Dang, Hong; Dang, Yan; Garcia-Caballero, Agustin; Suchindran, Hamsa; Boucher, Richard C.; Stutts, M. Jackson			The Cystic Fibrosis Transmembrane Conductance Regulator Impedes Proteolytic Stimulation of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID VOLUME; SODIUM-CHANNEL; GAMMA-SUBUNIT; SERINE PROTEASES; XENOPUS-OOCYTES; ACTIVATING PROTEASE; NASAL EPITHELIUM; AIRWAY EPITHELIA; IN-VIVO; ENAC	Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) that prevent its proper folding and trafficking to the apical membrane of epithelial cells. Absence of cAMP-mediated Cl- secretion in CF airways causes poorly hydrated airway surfaces in CF patients, and this condition is exacerbated by excessive Na+ absorption. The mechanistic link between missing CFTR and increased Na+ absorption in airway epithelia has remained elusive, although substantial evidence implicates hyperactivity of the epithelial Na+ channel (ENaC). ENaC is known to be activated by selective endoproteolysis of the extracellular domains of its alpha- and gamma-subunits, and it was recently reported that ENaC and CFTR physically associate in mammalian cells. We confirmed this interaction in oocytes by co-immunoprecipitation and found that ENaC associated with wild-type CFTR was protected from proteolytic cleavage and stimulation of open probability. In contrast, Delta F508 CFTR, the most common mutant protein in CF patients, failed to protect ENaC from proteolytic cleavage and stimulation. In normal airway epithelial cells, ENaC was contained in the anti-CFTR immunoprecipitate. In CF airway epithelial cultures, the proportion of full-length to total alpha-ENaC protein signal was consistently reduced compared with normal cultures. Our results identify limiting proteolytic cleavage of ENaC as a mechanism by which CFTR down-regulates Na+ absorption.	[Gentzsch, Martina; Dang, Hong; Dang, Yan; Garcia-Caballero, Agustin; Suchindran, Hamsa; Boucher, Richard C.; Stutts, M. Jackson] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Gentzsch, Martina] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Boucher, Richard C.; Stutts, M. Jackson] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gentzsch, M (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 6109A Thur Ston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	gentzsch@med.unc.edu	Gentzsch, Martina/AAY-1815-2021		National Institutes of Health [5P01HL034322, 5R01HL080561, 5P30DK065988]; Cystic Fibrosis Foundation [R026-CR07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322, R01HL080561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P01HL034322 and 5R01HL080561. Work performed by the Cell Culture Core and the Molecular Biology Core was supported by Cystic Fibrosis Foundation Grant R026-CR07 and National Institutes of Health Grant 5P30DK065988.	Bachhuber T, 2005, J BIOL CHEM, V280, P31587, DOI 10.1074/jbc.M504347200; Benharouga Mohamed, 2002, Methods Mol Med, V70, P229; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; Berdiev BK, 2009, MOL BIOSYST, V5, P123, DOI 10.1039/b810471a; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; CHINET TC, 1994, AM J PHYSIOL, V266, pC1061, DOI 10.1152/ajpcell.1994.266.4.C1061; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Coote K, 2009, J PHARMACOL EXP THER, V329, P764, DOI 10.1124/jpet.108.148155; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ji HL, 2000, J BIOL CHEM, V275, P27947; Jiang QS, 2000, J BIOL CHEM, V275, P13266, DOI 10.1074/jbc.275.18.13266; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; Konig J, 2001, EMBO REP, V2, P1047, DOI 10.1093/embo-reports/kve232; Konstas AA, 2003, PFLUG ARCH EUR J PHY, V445, P513, DOI 10.1007/s00424-002-0957-z; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; Lu C, 2007, J CYST FIBROS, V6, P419, DOI 10.1016/j.jcf.2007.03.001; Mall M, 1999, AM J PHYSIOL-GASTR L, V277, pG709, DOI 10.1152/ajpgi.1999.277.3.G709; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Nagel G, 2005, J PHYSIOL-LONDON, V564, P671, DOI 10.1113/jphysiol.2004.079046; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; Riordan JR, 1999, AM J HUM GENET, V64, P1499, DOI 10.1086/302429; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Verkman AS, 2001, AM J PHYSIOL-LUNG C, V281, pL306, DOI 10.1152/ajplung.2001.281.2.L306; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200	47	73	74	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32227	32232		10.1074/jbc.M110.155259	http://dx.doi.org/10.1074/jbc.M110.155259			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20709758	hybrid, Green Published			2022-12-27	WOS:000282683000035
J	Qin, L; Zhang, M				Qin, Li; Zhang, Ming			Maspin Regulates Endothelial Cell Adhesion and Migration through an Integrin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE B/AKT; MAMMARY EPITHELIAL-CELLS; PROSTATE-CANCER CELLS; LINKED KINASE; TUMOR-SUPPRESSOR; ACTIN CYTOSKELETON; EXTRACELLULAR-MATRIX; ANDROGEN RECEPTOR; FOCAL COMPLEXES; RHO-GTPASES	Maspin has been identified as a potent angiogenesis inhibitor. However, the molecular mechanism responsible for its anti-angiogenic property is unclear. In this study, we examined the effect of maspin on endothelial cell (EC) adhesion and migration in a cell culture system. We found that maspin was expressed in blood vessels ECs and human umbilical vein endothelial cells (HUVECs). Maspin significantly enhanced HUVEC cell adhesion to various matrix proteins. This effect was dependent on the activation of integrin beta(1), which subsequently led to distribution pattern changes of vinculin and F-actin. These results indicated that maspin affects cell adhesion and cytoskeleton reorganization through an integrin signal transduction pathway. Analysis of HUVECs following maspin treatment revealed increased integrin-linked kinase activities and phosphorylated FAK levels, consistent with increased cell adhesion. Interestingly, when HUVECs were induced to migrate by migration stimulatory factor bFGF, active Rac1 and cdc42 small GTPase levels were decreased dramatically at 30 min following maspin treatment. Using phosphorylated FAK at Tyr(397) as an indicator of focal adhesion disassembly, maspin-treated HUVECs had elevated FAK phosphorylation compared with the mock treated control. The results were a reduction in focal adhesion disassembly and the retardation in EC migration. This study uncovers a mechanism by which maspin exerts its effect on EC adhesion and migration through an integrin signal transduction pathway.	[Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Baylor College of Medicine	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Mol Pharmacol & Biol Chem, Lurie 6-115,303 E Super St, Chicago, IL 60611 USA.	m-zhang@northwestern.edu		Qin, Li/0000-0003-0099-4992	National Institutes of Health from the NCI [CA79736]; Northwestern University; NATIONAL CANCER INSTITUTE [R01CA079736] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA79736 from the NCI and the Northwestern University Zell fund (to M.Z.).	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Andriani F, 2001, JNCI-J NATL CANCER I, V93, P1314, DOI 10.1093/jnci/93.17.1314; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bass R, 2009, J BIOL CHEM, V284, P27712, DOI 10.1074/jbc.M109.038919; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Boosani CS, 2007, BLOOD, V110, P1168, DOI 10.1182/blood-2007-01-066282; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Cascone I, 2003, J BIOL CHEM, V278, P50702, DOI 10.1074/jbc.M307234200; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Chun SJ, 2003, J CELL BIOL, V163, P397, DOI 10.1083/jcb.200304154; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Ellis PD, 2003, J VASC RES, V40, P234, DOI 10.1159/000071887; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Impagnatiello MA, 1997, TRANSPL P, V29, P1110, DOI 10.1016/S0041-1345(96)00450-2; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Ngamkitidechakul C, 2001, INVEST OPHTH VIS SCI, V42, P3135; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; PEMBERTON PA, 1995, J BIOL CHEM, V270, P15832, DOI 10.1074/jbc.270.26.15832; Pemberton PA, 1997, J HISTOCHEM CYTOCHEM, V45, P1697, DOI 10.1177/002215549704501213; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pezzatini S, 2007, BONE, V41, P523, DOI 10.1016/j.bone.2007.06.016; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Rovida E, 2005, BIOL CHEM, V386, P919, DOI 10.1515/BC.2005.107; Sager R, 1996, CURR TOP MICROBIOL, V213, P51; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; SHENG SJ, 1994, J BIOL CHEM, V269, P30988; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yatabe Y, 2004, ONCOGENE, V23, P4041, DOI 10.1038/sj.onc.1207557; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Zhang M, 1997, MOL MED, V3, P49, DOI 10.1007/BF03401667; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	53	43	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32360	32369		10.1074/jbc.M110.131045	http://dx.doi.org/10.1074/jbc.M110.131045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20713357	Green Published, hybrid			2022-12-27	WOS:000282683000049
J	Soetandyo, N; Ye, YH				Soetandyo, Nia; Ye, Yihong			The p97 ATPase Dislocates MHC Class I Heavy Chain in US2-expressing Cells via a Ufd1-Npl4-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; RETRO-TRANSLOCATION; DEUBIQUITINATING ENZYME; MISFOLDED PROTEINS; LIGASE MK3; ER; COMPLEX; CYTOSOL	The human cytomegalovirus (HCMV) protein US2 hijacks the endoplasmic reticulum (ER)-associated degradation machinery to dispose of MHC class I heavy chain (HC) at the ER. This process requires retrotranslocation of newly synthesized HC molecules from the ER membrane into the cytosol, but the mechanism underlying the dislocation reaction has been elusive. Here we establish an in vitro permeabilized cell assay that recapitulates the retrotranslocation of MHC HC in US2-expressing cells. Using this assay, we demonstrate that the dislocation process requires ATP and ubiquitin, as expected. The retrotranslocation also involves the p97 ATPase. However, the mechanism by which p97 dislocates MHC class I HC in US2 cells is distinct from that in US11 cells: the dislocation reaction in US2 cells is independent of the p97 cofactor Ufd1-Npl4. Our results suggest that different retrotranslocation mechanisms can employ distinct p97 ATPase complexes to dislocate substrates.	[Soetandyo, Nia; Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ye, YH (corresponding author), 5 Ctr Dr, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov			National Institutes of Health, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health grant from the Intramural Research Program, NIDDK.	Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Kikkert M, 2001, BIOCHEM J, V358, P369, DOI 10.1042/0264-6021:3580369; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; LEE SO, EMBO J, V29, P363; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2003, MOL BIOL CELL, V14, P3690, DOI 10.1091/mbc.E03-03-0192; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Oresic K, 2009, J BIOL CHEM, V284, P5905, DOI 10.1074/jbc.M807568200; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2006, J BIOL CHEM, V281, P8636, DOI 10.1074/jbc.M513920200; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, ESSAYS BIOCHEM, V41, P99, DOI 10.1042/EB0410099; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	44	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32352	32359		10.1074/jbc.M110.131649	http://dx.doi.org/10.1074/jbc.M110.131649			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702414	Green Published, hybrid			2022-12-27	WOS:000282683000048
J	Murarka, A; Clomburg, JM; Moran, S; Shanks, JV; Gonzalez, R				Murarka, Abhishek; Clomburg, James M.; Moran, Sean; Shanks, Jacqueline V.; Gonzalez, Ramon			Metabolic Analysis of Wild-type Escherichia coli and a Pyruvate Dehydrogenase Complex (PDHC)-deficient Derivative Reveals the Role of PDHC in the Fermentative Metabolism of Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCOCCUS-FAECALIS; MICROBIAL-METABOLISM; FORMATE-LYASE; IN-VIVO; GLYCEROL; FLUXES; C-13; NMR; QUANTIFICATION; GROWTH	Pyruvate is located at a metabolic junction of assimilatory and dissimilatory pathways and represents a switch point between respiratory and fermentative metabolism. In Escherichia coli, the pyruvate dehydrogenase complex (PDHC) and pyruvate formate-lyase are considered the primary routes of pyruvate conversion to acetyl-CoA for aerobic respiration and anaerobic fermentation, respectively. During glucose fermentation, the in vivo activity of PDHC has been reported as either very low or undetectable, and the role of this enzyme remains unknown. In this study, a comprehensive characterization of wild-type E. coli MG1655 and a PDHC-deficient derivative (Pdh) led to the identification of the role of PDHC in the anaerobic fermentation of glucose. The metabolism of these strains was investigated by using a mixture of C-13-labeled and -unlabeled glucose followed by the analysis of the labeling pattern in protein-bound amino acids via two-dimensional C-13, H-1 NMR spectroscopy. Metabolite balancing, biosynthetic C-13 labeling of proteinogenic amino acids, and isotopomer balancing all indicated a large increase in the flux of the oxidative branch of the pentose phosphate pathway (ox-PPP) in response to the PDHC deficiency. Because both ox-PPP and PDHC generate CO2 and the calculated CO2 evolution rate was significantly reduced in Pdh, it was hypothesized that the role of PDHC is to provide CO2 for cell growth. The similarly negative impact of either PDHC or ox-PPP deficiencies, and an even more pronounced impairment of cell growth in a strain lacking both ox-PPP and PDHC, provided further support for this hypothesis. The three strains exhibited similar phenotypes in the presence of an external source of CO2, thus confirming the role of PDHC. Activation of formate hydrogen-lyase (which converts formate to CO2 and H-2) rendered the PDHC deficiency silent, but its negative impact reappeared in a strain lacking both PDHC and formate hydrogen-lyase. A stoichiometric analysis of CO2 generation via PDHC and ox-PPP revealed that the PDHC route is more carbon-and energy-efficient, in agreement with its beneficial role in cell growth.	[Murarka, Abhishek; Clomburg, James M.; Gonzalez, Ramon] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Moran, Sean] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Gonzalez, Ramon] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Shanks, Jacqueline V.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA	Rice University; Rice University; Rice University; Iowa State University	Gonzalez, R (corresponding author), 6100 Main St,MS-362, Houston, TX 77005 USA.	Ramon.Gonzalez@rice.edu	Murarka, Abhishek/AAF-3594-2020; Shanks, Jacqueline/ABE-5353-2020; Gonzalez, Ramon/B-1961-2010	Shanks, Jacqueline/0000-0001-9947-0181	National Science Foundation [BES-0331388/BES-0601549, EEC-0813570]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Grants BES-0331388/BES-0601549 and EEC-0813570.	Abdel-Hamid AM, 2001, MICROBIOL-SGM, V147, P1483, DOI 10.1099/00221287-147-6-1483; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bagramyan K, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1159, DOI 10.1023/B:BIRY.0000009129.18714.a4; Cronan J. E., 2006, ECOSAL ESCHERICHIA C; Cronan Jr. JE, 2008, ECOSAL ESCHERICHIA C; DANSON MJ, 1978, BIOCHEM J, V175, P193, DOI 10.1042/bj1750193; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dharmadi Y, 2005, J CHROMATOGR A, V1070, P89, DOI 10.1016/j.chroma.2005.02.075; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; Downs DM, 2006, ANNU REV MICROBIOL, V60, P533, DOI 10.1146/annurev.micro.60.080805.142308; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Gonzalez R, 2003, BIOTECHNOL BIOENG, V82, P152, DOI 10.1002/bit.10556; Grivet JP, 2009, PROG NUCL MAG RES SP, V54, P1, DOI 10.1016/j.pnmrs.2008.02.001; Harris R. K., 1983, NUCL MAGNETIC RESONA; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang YS, 2004, J BACTERIOL, V186, P4921, DOI 10.1128/JB.186.15.4921-4930.2004; Klapa MI, 1999, BIOTECHNOL BIOENG, V62, P375, DOI 10.1002/(SICI)1097-0290(19990220)62:4<375::AID-BIT1>3.3.CO;2-F; LACOURSIERE A, 1986, APPL MICROBIOL BIOT, V23, P404; MAYER C, 2005, ECOSAL ESCHERICHIA C; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Miller J.H., 1972, EXPT MOL GENETICS; Murarka A, 2008, APPL ENVIRON MICROB, V74, P1124, DOI 10.1128/AEM.02192-07; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nielsen J, 2003, J BACTERIOL, V185, P7031, DOI 10.1128/JB.185.24.7031-7035.2003; NIELSEN J, 2003, BIOREACTION ENG PRIN, P47; REPASKE R, 1978, J BACTERIOL, V135, P1162, DOI 10.1128/JB.135.3.1162-1164.1978; ROMEO T, 2005, ECOSAL ESCHERICHIA C; Sambrook J., 2002, MOL CLONING LAB MANU; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Sawers RG, 2004, ECOSAL ESCHERICHIA C; Self WT, 2004, J BACTERIOL, V186, P580, DOI 10.1128/JB.186.2.580-587.2004; SMITH MW, 1983, J BACTERIOL, V156, P81, DOI 10.1128/JB.156.1.81-88.1983; SNOEP JL, 1990, ARCH MICROBIOL, V154, P50; SNOEP JL, 1993, FEMS MICROBIOL LETT, V114, P279, DOI 10.1016/0378-1097(93)90284-9; Sriram G, 2004, PLANT PHYSIOL, V136, P3043, DOI 10.1104/pp.104.050625; Sriram G, 2004, METAB ENG, V6, P116, DOI 10.1016/j.ymben.2004.02.003; Sriram G, 2007, PHYTOCHEMISTRY, V68, P2243, DOI 10.1016/j.phytochem.2007.04.009; STAUFFER GV, 2004, ECOSAL ESCHERICHIA C; Stephanopoulos GN, 1998, METABOLIC ENG PRINCI, P309, DOI DOI 10.1016/B978-012666260-3/50009-1; Szyperski T, 1996, TRENDS BIOTECHNOL, V14, P453, DOI 10.1016/S0167-7799(96)10056-1; SZYPERSKI T, 1995, EUR J BIOCHEM, V232, P433, DOI 10.1111/j.1432-1033.1995.433zz.x; Szyperski T, 1998, Q REV BIOPHYS, V31, P41, DOI 10.1017/S0033583598003412; VARENNE S, 1975, MOL GEN GENET, V141, P181, DOI 10.1007/BF00267683; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Yazdani SS, 2008, METAB ENG, V10, P340, DOI 10.1016/j.ymben.2008.08.005	47	25	28	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31548	31558		10.1074/jbc.M110.121095	http://dx.doi.org/10.1074/jbc.M110.121095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667837	Green Published, hybrid			2022-12-27	WOS:000282764600049
J	Swenerton, RK; Knudsen, GM; Sajid, M; Kelly, BL; McKerrow, JH				Swenerton, Ryan K.; Knudsen, Giselle M.; Sajid, Mohammed; Kelly, Ben L.; McKerrow, James H.			Leishmania Subtilisin Is a Maturase for the Trypanothione Reductase System and Contributes to Disease Pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED GENE DELETION; HOST-CELL INVASION; IN-GEL DIGESTION; TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; PROTEASES; IDENTIFICATION; GLYCOPROTEIN; PROTEINS; HAMSTERS	Proteases are a ubiquitous group of enzymes that play key roles in the life cycle of parasites, in the host-parasite relationship, and in the pathogenesis of parasitic diseases. Furthermore, proteases are druggable targets for the development of new antiparasitic therapy. The subtilisin protease (SUB; Clan SB, family S8) of Leishmania donovani was cloned and found to possess a unique catalytic triad. This gene was then deleted by gene knock-out, which resulted in reduced ability by the parasite to undergo promastigote to amastigote differentiation in vitro. Electron microscopy of SUB knock-out amastigotes revealed abnormal membrane structures, retained flagella, and increased binucleation. SUB-deficient Leishmania displayed reduced virulence in both hamster and murine infection models. Histology of spleens from SUB knock-out-infected hamsters revealed the absence of psammoma body calcifications indicative of the granulomatous lesions that occur during Leishmania infection. To delineate the specific role of SUB in parasite physiology, two-dimensional gel electrophoresis was carried out on SUB-/- versus wild-type parasites. SUB knock-out parasites showed altered regulation of the terminal peroxidases of the trypanothione reductase system. Leishmania and other trypanosomatids lack glutathione reductase, and therefore rely on the novel trypanothione reductase system to detoxify reactive oxygen intermediates and to maintain redox homeostasis. The predominant tryparedoxin peroxidases were decreased in SUB-/- parasites, and higher molecular weight isoforms were present, indicating altered processing. In addition, knock-out parasites showed increased sensitivity to hydroperoxide. These data suggest that subtilisin is the maturase for tryparedoxin peroxidases and is necessary for full virulence.	Univ Calif San Francisco, Sandler Ctr Drug Discovery, Dept Pathol, San Francisco, CA 94158 USA; [Knudsen, Giselle M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Sajid, Mohammed] Leiden Univ, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Kelly, Ben L.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol, New Orleans, LA 70112 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	McKerrow, JH (corresponding author), 1700 4th St,Box 2550,UCSF QB3, San Francisco, CA 94158 USA.	James.McKerrow@ucsf.edu		Swenerton, Ryan/0000-0002-0994-752X	National Science Foundation; Sandler Foundation; National Institutes of Health National Center for Research Resources [NIH NCRR P41RR001614]; National Institutes of Health [NCRR RR012961]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR012961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Sandler Foundation; National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Science Foundation Graduate Research Fellowship and the Sandler Foundation.; We graciously thank Margaret Mays at the UCSF Morphology Core for tissue histology, K. C. Lim in the UCSF Dept. of Pathology for his help with the hamster infections, and Rick Fetter for the electron microscopy. Mass spectrometry analysis was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at UCSF (A. L. Burlingame, Director) supported by the Biomedical Research Technology Program of the National Institutes of Health National Center for Research Resources, NIH NCRR P41RR001614, and National Institutes of Health NCRR RR012961.	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Bal G, 2003, BIOORG MED CHEM LETT, V13, P2875, DOI 10.1016/S0960-894X(03)00579-1; Barale JC, 1999, P NATL ACAD SCI USA, V96, P6445, DOI 10.1073/pnas.96.11.6445; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; Emanuelsson O, 2003, J MOL BIOL, V330, P443, DOI 10.1016/S0022-2836(03)00553-9; Flohe L, 2002, METHOD ENZYMOL, V347, P244; FLOHE L, 2007, SUBCELLULAR BIOCH, V44, P231; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Joshi PB, 1998, MOL MICROBIOL, V27, P519, DOI 10.1046/j.1365-2958.1998.00689.x; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; JOSHI PB, 1995, GENE, V156, P145, DOI 10.1016/0378-1119(95)00042-5; KAHL LP, 1991, AM J TROP MED HYG, V44, P218, DOI 10.4269/ajtmh.1991.44.218; Kim K, 2004, ACTA TROP, V91, P69, DOI 10.1016/j.actaropia.2003.11.016; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; LACALLE RA, 1989, GENE, V79, P375, DOI 10.1016/0378-1119(89)90220-5; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4; Maniatis T., 1982, MOL CLONING LAB MANU; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Miller SA, 2003, MOL MICROBIOL, V49, P883, DOI 10.1046/j.1365-2958.2003.03604.x; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; SACKS DL, 1985, J IMMUNOL, V135, P564; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; *SCI WORK GROUP LE, 2004, REP SCI WORK GROUP M; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; SMITH K, 1991, MOL BIOCHEM PARASIT, V48, P109, DOI 10.1016/0166-6851(91)90170-B; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; WALLIS AE, 1987, J EXP MED, V166, P1814, DOI 10.1084/jem.166.6.1814; WILSON ME, 1987, J PARASITOL, V73, P55, DOI 10.2307/3282344; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Wyllie S, 2006, ACTA TROP, V97, P364, DOI 10.1016/j.actatropica.2006.01.004; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	46	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31120	31129		10.1074/jbc.M110.114462	http://dx.doi.org/10.1074/jbc.M110.114462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675366	hybrid, Green Published			2022-12-27	WOS:000282764600005
J	Dagdanova, A; Ilchenko, S; Notari, S; Yang, QW; Obrenovich, ME; Hatcher, K; McAnulty, P; Huang, LQ; Zou, WQ; Kong, QZ; Gambetti, P; Chen, SG				Dagdanova, Ayuna; Ilchenko, Serguei; Notari, Silvio; Yang, Qiwei; Obrenovich, Mark E.; Hatcher, Kristen; McAnulty, Peter; Huang, Lequn; Zou, Wenquan; Kong, Qingzhong; Gambetti, Pierluigi; Chen, Shu G.			Characterization of the Prion Protein in Human Urine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRUNCATED FORMS; SCRAPIE PRION; NEUROBLASTOMA-CELLS; CULTURED-CELLS; PRP; IDENTIFICATION; BIOSYNTHESIS; INFECTIVITY; EXCRETION	The presence of the prion protein (PrP) in normal human urine is controversial and currently inconclusive. This issue has taken a special relevance because prion infectivity has been demonstrated in urine of animals carrying experimental or naturally occurring prion diseases, but the actual presence and tissue origin of the infectious prion have not been determined. We used immunoprecipitation, one-and two-dimensional electrophoresis, and mass spectrometry to prove definitely the presence of PrP in human urine and its post-translational modifications. We show that urinary PrP (uPrP) is truncated mainly at residue 112 but also at other residues up to 122. This truncation makes uPrP undetectable with some commonly used antibodies to PrP. uPrP is glycosylated and carries an anchor which, at variance with that of cellular PrP, lacks the inositol-associated phospholipid moiety, indicating that uPrP is probably shed from the cell surface. The detailed characterization of uPrP reported here definitely proves the presence of PrP in human urine and will help determine the origin of prion infectivity in urine.	[Dagdanova, Ayuna; Notari, Silvio; Yang, Qiwei; Obrenovich, Mark E.; Hatcher, Kristen; Zou, Wenquan; Kong, Qingzhong; Gambetti, Pierluigi; Chen, Shu G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ilchenko, Serguei] Case Western Reserve Univ, Ctr Prote & Mass Spectrometry, Cleveland, OH 44106 USA; [McAnulty, Peter] Nonclin Consultancy, DK-4000 Roskilde, Denmark; [Huang, Lequn] Nanjing Univ, Sch Med, Nanjing 210093, Peoples R China	Case Western Reserve University; Case Western Reserve University; Nanjing University	Gambetti, P (corresponding author), Case Western Reserve Univ, Dept Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	pierluigi.gambetti@case.edu; shu.chen@case.edu	Zou, Wenquan/ABF-2875-2020; Chen, Shu G./AAK-7301-2021; Chen, Shu/Z-2943-2019; Zou, Wenquan/GWQ-3489-2022; Chen, Shu G./O-4750-2014	Chen, Shu G./0000-0001-7180-3001; Chen, Shu G./0000-0001-7180-3001	National Institutes of Health [AG14359]; Centers for Disease Control and Prevention [UR8/CCU515004]; Department of Agriculture National Research Initiative [2002-35201-2608]; Department of Defense [DAMD17-03-1-0283]; Charles S. Britton Fund; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Agriculture National Research Initiative; Department of Defense(United States Department of Defense); Charles S. Britton Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG14359. This work was also supported by Centers for Disease Control and Prevention Grant UR8/CCU515004, Department of Agriculture National Research Initiative Grant 2002-35201-2608, Department of Defense National Prion Research Program Grant DAMD17-03-1-0283, and by the Charles S. Britton Fund.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baldwin MA, 2005, METHOD ENZYMOL, V405, P172, DOI 10.1016/S0076-6879(05)05008-1; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Ecroyd H, 2004, BIOL REPROD, V71, P993, DOI 10.1095/biolreprod.104.029801; *ED TEAM, 2007, EUROSURVEILLANCE, V12; Furukawa H, 2004, J BIOL CHEM, V279, P23661, DOI 10.1074/jbc.M400187200; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Gregori L, 2008, J VIROL METHODS, V149, P251, DOI 10.1016/j.jviromet.2008.01.028; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Harris DA, 1996, CURR TOP MICROBIOL, V207, P77; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Head MW, 2005, NEUROLOGY, V64, P1794, DOI 10.1212/01.WNL.0000161842.68793.8A; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; MacGregor I, 1999, VOX SANG, V77, P88; Maddison BC, 2007, BIOCHEM BIOPH RES CO, V353, P195, DOI 10.1016/j.bbrc.2006.12.006; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Narang HK, 2005, EXP BIOL MED, V230, P343, DOI 10.1177/153537020523000508; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Parizek P, 2001, J BIOL CHEM, V276, P44627, DOI 10.1074/jbc.M107458200; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Rane NS, 2010, J CELL BIOL, V188, P515, DOI 10.1083/jcb.200911115; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Serban A, 2004, J BIOL CHEM, V279, P48817, DOI 10.1074/jbc.M409107200; Shaked GM, 2001, J BIOL CHEM, V276, P31479, DOI 10.1074/jbc.C100278200; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; TAGLIAVINI F, 1992, BIOCHEM BIOPH RES CO, V184, P1398, DOI 10.1016/S0006-291X(05)80038-5; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812; Zhao HX, 2006, VIRUS RES, V115, P43, DOI 10.1016/j.virusres.2005.07.004; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	54	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30489	30495		10.1074/jbc.M110.161794	http://dx.doi.org/10.1074/jbc.M110.161794			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20670940	Green Published, hybrid			2022-12-27	WOS:000282135500016
J	Cheng, X; Xu, Z; Wang, JF; Zhai, YL; Lu, YJ; Liang, C				Cheng, Xue; Xu, Zhen; Wang, Jiafeng; Zhai, Yuanliang; Lu, Yongjun; Liang, Chun			ATP-dependent Pre-replicative Complex Assembly Is Facilitated by Adk1p in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; NUCLEOTIDE-BINDING SITE; DNA-REPLICATION; ADENYLATE KINASE; SACCHAROMYCES-CEREVISIAE; MCM PROTEINS; CELL-CYCLE; CDC6; INITIATION; ORC	Pre-replicative complex (pre-RC) assembly is a critical part of the mechanism that controls the initiation of DNA replication, and ATP binding and hydrolysis by multiple pre-RC proteins are essential for pre-RC assembly and activation. Here, we demonstrate that Adk1p (adenylate kinase 1 protein) plays an important role in pre-RC assembly in Saccharomyces cerevisiae. Isolated from a genetic screen, adk1(G20S) cells with a mutation within the nucleotide-binding site were defective in replication initiation. adk1 Delta cells were viable at 25 degrees C but not at 37 degrees C. Flow cytometry indicated that both the adk1-td (temperature-inducible degron) and adk1(G20S) mutants were defective in S phase entry. Furthermore, Adk1p bound to chromatin throughout the cell cycle and physically interacted with Orc3p, whereas the Adk1(G20S) protein had a reduced ability to bind chromatin and Orc3p without affecting the cellular ATP level. In addition, Adk1p associated with replication origins by ChIP assay. Finally, Adk1-td protein depletion prevented pre-RC assembly during the M-to-G(1) transition. Wesuggest that Adk1p regulates ATP metabolism on pre-RC proteins to promote pre-RC assembly and activation.	[Liang, Chun] Hong Kong Univ Sci & Technol, Div Life Sci, Sect Biochem & Cell Biol, Kowloon, Hong Kong, Peoples R China; [Wang, Jiafeng; Lu, Yongjun; Liang, Chun] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Canc Res, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Sun Yat Sen University; Hong Kong University of Science & Technology	Liang, C (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Sect Biochem & Cell Biol, Kowloon, Hong Kong, Peoples R China.	bccliang@ust.hk		Zhai, Yuanliang/0000-0002-8897-6416	Hong Kong Research Grants Council [HKUST6115/04M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by Hong Kong Research Grants Council Grant HKUST6115/04M (to C.L.).	BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BROSH RM, 1995, J BACTERIOL, V177, P5612, DOI 10.1128/jb.177.19.5612-5621.1995; BUENO A, 1992, EMBO J, V11, P2167, DOI 10.1002/j.1460-2075.1992.tb05276.x; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; Gu YJ, 2005, J BIOL CHEM, V280, P18604, DOI 10.1074/jbc.M500847200; Han Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007155; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; Herbig U, 1999, MOL BIOL CELL, V10, P2631, DOI 10.1091/mbc.10.8.2631; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Kan JS, 2008, J BIOL CHEM, V283, P33803, DOI 10.1074/jbc.C800182200; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Klemm RD, 2001, P NATL ACAD SCI USA, V98, P8361, DOI 10.1073/pnas.131006898; KONRAD M, 1993, J BIOL CHEM, V268, P11326; KONRAD M, 1988, J BIOL CHEM, V263, P19468; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lei M, 1996, MOL CELL BIOL, V16, P5081; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; LOO S, 1995, MOL BIOL CELL, V6, P741, DOI 10.1091/mbc.6.6.741; Neuwald AF, 1999, GENOME RES, V9, P27; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Ren H, 2005, P NATL ACAD SCI USA, V102, P303, DOI 10.1073/pnas.0407459102; SCHRICKER R, 1992, MOL GEN GENET, V233, P363, DOI 10.1007/BF00265432; SCHRICKER R, 1992, GENE, V122, P111, DOI 10.1016/0378-1119(92)90038-Q; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Stryer L., 1988, BIOCHEMISTRY-US; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; VAN ROMPAY AR, 1999, EUR J BIOCHEM, V261, P509; Wang B, 1999, J BIOL CHEM, V274, P8291, DOI 10.1074/jbc.274.12.8291; Wang JF, 2010, BIOCHEM BIOPH RES CO, V395, P336, DOI 10.1016/j.bbrc.2010.04.006; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149; Yoneda T, 1998, MOL BRAIN RES, V62, P187, DOI 10.1016/S0169-328X(98)00249-6; ZHAI Y, 2010, J CELL SCI IN PRESS; Zhang YX, 2002, CELL, V109, P849, DOI 10.1016/S0092-8674(02)00805-X; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	50	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29974	29980		10.1074/jbc.M110.161455	http://dx.doi.org/10.1074/jbc.M110.161455			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20659900	Green Published, hybrid			2022-12-27	WOS:000281984300034
J	Sarparanta, J; Blandin, G; Charton, K; Vihola, A; Marchand, S; Milic, A; Hackman, P; Ehler, E; Richard, I; Udd, B				Sarparanta, Jaakko; Blandin, Gaelle; Charton, Karine; Vihola, Anna; Marchand, Sylvie; Milic, Astrid; Hackman, Peter; Ehler, Elisabeth; Richard, Isabelle; Udd, Bjarne			Interactions with M-band Titin and Calpain 3 Link Myospryn (CMYA5) to Tibial and Limb-girdle Muscular Dystrophies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC CALPAIN; SARCOMERIC M-BAND; SKELETAL-MUSCLE; IMMUNOELECTRON MICROSCOPY; PROTEIN MYOSPRYN; BINDING PARTNER; TERMINAL REGION; GENE-EXPRESSION; DISTAL MYOPATHY; KINASE DOMAIN	Mutations in the Cterminus of titin, situated at the M-band of the striated muscle sarcomere, cause tibial muscular dystrophy (TMD) and limb-girdle muscular dystrophy (LGMD) type 2J. Mutations in the protease calpain 3 (CAPN3), in turn, lead to LGMD2A, and secondary CAPN3 deficiency in LGMD2J suggests that the pathomechanisms of the diseases are linked. Yeast two-hybrid screens carried out to elucidate the molecular pathways of TMD/LGMD2J and LGMD2A resulted in the identification of myospryn (CMYA5, cardiomyopathy-associated 5) as a binding partner for both M-band titin and CAPN3. Additional yeast two-hybrid and coimmunoprecipitation studies confirmed both interactions. The interaction of myospryn and M-band titin was supported by localization of endogenous and transfected myospryn at the M-band level. Coexpression studies showed that myospryn is a proteolytic substrate for CAPN3 and suggested that myospryn may protect CAPN3 from autolysis. Myospryn is a muscle-specific protein of the tripartite motif superfamily, reported to function in vesicular trafficking and protein kinaseAsignaling and implicated in the pathogenesis of Duchenne muscular dystrophy. The novel interactions indicate a role for myospryn in the sarcomeric M-band and may be relevant for the molecular pathomechanisms of TMD/LGMD2J and LGMD2A.	[Sarparanta, Jaakko] Univ Helsinki, Folkhalsan Inst Genet, Biomedicum Helsinki C307B, FI-00014 Helsinki, Finland; [Hackman, Peter; Udd, Bjarne] Univ Helsinki, Dept Med Genet, Haartman Inst, FI-00014 Helsinki, Finland; [Blandin, Gaelle; Charton, Karine; Marchand, Sylvie; Milic, Astrid; Richard, Isabelle] Genethon CNRS UMR8587, F-91000 Evry, France; [Ehler, Elisabeth] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Ehler, Elisabeth] Kings Coll London, Div Cardiovasc, London SE1 1UL, England; [Udd, Bjarne] Tampere Univ Hosp & Med Sch, Dept Neurol, Tampere 33520, Finland; [Udd, Bjarne] Vaasa Cent Hosp, Dept Neurol, Vaasa 65130, Finland	University of Helsinki; University of Helsinki; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; University of London; King's College London; University of London; King's College London; Tampere University; Tampere University Hospital; Vaasa Central Hospital	Sarparanta, J (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Biomedicum Helsinki C307B, POB 63, FI-00014 Helsinki, Finland.	jaakko.sarparanta@helsinki.fi	Charton, Karine/J-5705-2013; Sarparanta, Jaakko/AAQ-1713-2020; charton, karine/AAU-4926-2021; Richard, isabelle/J-8298-2013; Blandin, Gaelle/N-9745-2013	Charton, Karine/0000-0001-7419-140X; Sarparanta, Jaakko/0000-0002-5497-5255; charton, karine/0000-0001-7419-140X; Blandin, Gaelle/0000-0003-2790-9524; Ehler, Elisabeth/0000-0001-5646-5964	Association Francaise Contre les Myopathies; Folkhalsan Research Foundation; Academy of Finland; The Sigrid Juselius Foundation; University of Helsinki Research Foundation; EMBO [ASTF 13-08]; MRC [G0400153] Funding Source: UKRI; Medical Research Council [G0400153] Funding Source: researchfish	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Folkhalsan Research Foundation; Academy of Finland(Academy of Finland); The Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Association Francaise Contre les Myopathies (to B.U. and I.R.), the Folkhalsan Research Foundation, the Academy of Finland, The Sigrid Juselius Foundation (to B. U.), and University of Helsinki Research Foundation and EMBO Short Term Fellowship ASTF 13-08 (to J.S.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Benson MA, 2004, J BIOL CHEM, V279, P10450, DOI 10.1074/jbc.M312664200; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Duguez S, 2006, FEBS J, V273, P3427, DOI 10.1111/j.1742-4658.2006.05351.x; Durham JT, 2006, J BIOL CHEM, V281, P6841, DOI 10.1074/jbc.M510499200; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Granzier H, 2007, MUSCLE NERVE, V36, P740, DOI 10.1002/mus.20886; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hackman P, 2008, NEUROMUSCULAR DISORD, V18, P922, DOI 10.1016/j.nmd.2008.07.010; Haravuori H, 2001, NEUROLOGY, V56, P869, DOI 10.1212/WNL.56.7.869; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Kinbara K, 1997, ARCH BIOCHEM BIOPHYS, V342, P99, DOI 10.1006/abbi.1997.0108; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Kouloumenta A, 2007, J BIOL CHEM, V282, P35211, DOI 10.1074/jbc.M704733200; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lange S, 2005, J MOL BIOL, V345, P289, DOI 10.1016/j.jmb.2004.10.040; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Ojima K, 2005, J MUSCLE RES CELL M, V26, P409, DOI 10.1007/s10974-005-9023-8; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; PORTER GA, 1992, J CELL BIOL, V117, P997, DOI 10.1083/jcb.117.5.997; Reynolds JG, 2008, J BIOL CHEM, V283, P8070, DOI 10.1074/jbc.C700221200; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Sarparanta J, 2008, J MUSCLE RES CELL M, V29, P177, DOI 10.1007/s10974-008-9165-6; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tinsley CL, 2005, NEUROMUSCULAR DISORD, V15, P717; Tkatchenko AV, 2001, NEUROMUSCULAR DISORD, V11, P269, DOI 10.1016/S0960-8966(00)00198-X; Udd B, 2005, NEUROLOGY, V64, P636, DOI 10.1212/01.WNL.0000151853.50144.82; UDD B, 1991, MUSCLE NERVE, V14, P1050, DOI 10.1002/mus.880141103; UDD B, 1993, ARCH NEUROL-CHICAGO, V50, P604, DOI 10.1001/archneur.1993.00540060044015; VAN DEN BERGH PYK, 2003, ANN NEUROL, V54, P248; VAN DER VEN PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149	48	43	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30304	30315		10.1074/jbc.M110.108720	http://dx.doi.org/10.1074/jbc.M110.108720			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20634290	Green Published, hybrid			2022-12-27	WOS:000281984300066
J	Spinale, FG; Mukherjee, R; Zavadzkas, JA; Koval, CN; Bouges, S; Stroud, RE; Dobrucki, LW; Sinusas, AJ				Spinale, Francis G.; Mukherjee, Rupak; Zavadzkas, Juozas A.; Koval, Christine N.; Bouges, Shenikqua; Stroud, Robert E.; Dobrucki, Lawrence W.; Sinusas, Albert J.			Cardiac Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase Causes Adverse Myocardial Remodeling following Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-VENTRICULAR FUNCTION; TGF-BETA; HEART-FAILURE; 1-MATRIX METALLOPROTEINASE; ACTIVATION; MICE; INHIBITION; MATRIX-METALLOPROTEINASE-9; TRANSCRIPTION; FIBROBLASTS	The membrane type-1 matrix metalloproteinase (MT1MMP) is a unique member of the MMP family, but induction patterns and consequences of MT1-MMP overexpression (MT1-MMPexp), in a left ventricular (LV) remodeling process such as myocardial infarction (MI), have not been explored. MT1-MMP promoter activity (murine luciferase reporter) increased 20-fold at 3 days and 50-fold at 14 days post-MI. MI was then induced in mice with cardiac restricted MT1-MMPexp (n = 58) and wild type (WT, n = 60). Post-MI survival was reduced (67% versus 46%, p < 0.05), and LV ejection fraction was lower in the post-MI MT1-MMPexp mice compared with WT (41 +/- 2 versus 32 +/- 2%, p < 0.05). In the post-MI MT1-MMPexp mice, LV myocardial MMP activity, as assessed by radiotracer uptake, and MT1-MMP-specific proteolytic activity using a specific fluorogenic assay were both increased by 2-fold. LV collagen content was increased by nearly 2-fold in the post-MI MT1-MMPexp compared with WT. Using a validated fluorogenic construct, it was discovered that MT1-MMP proteolytically processed the pro-fibrotic molecule, latency-associated transforming growth factor-1 binding protein (LTBP-1), and MT1-MMP-specific LTBP-1 proteolytic activity was increased by 4-fold in the post-MIMT1-MMPexp group. Early and persistent MT1-MMP promoter activity occurred post-MI, and increased myocardial MT1-MMP levels resulted in poor survival, worsening of LV function, and significant fibrosis. A molecular mechanism for the adverse LV matrix remodeling with MT1-MMP induction is increased processing of pro-fibrotic signaling molecules. Thus, a proteolytically diverse portfolio exists for MT1-MMP within the myocardium and likely plays a mechanistic role in adverse LV remodeling.	[Spinale, Francis G.; Mukherjee, Rupak; Zavadzkas, Juozas A.; Koval, Christine N.; Bouges, Shenikqua; Stroud, Robert E.] Med Univ S Carolina, Charleston, SC 29425 USA; [Spinale, Francis G.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA; [Dobrucki, Lawrence W.; Sinusas, Albert J.] Yale Univ, Sch Med New Haven, New Haven, CT 06510 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Yale University	Sinusas, AJ (corresponding author), Room 625,770 MUSC Complex,114 Doughty St, Charleston, SC 29425 USA.	wilburnm@musc.edu	Sinusas, Albert J/A-7235-2009; Dobrucki, Wawrzyniec L/D-3987-2009	Dobrucki, Wawrzyniec L/0000-0002-6807-217X	National Institutes of Health [HL057952, HL059165, HL078825]; Veterans Affairs Health Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078650, P01HL078825, R01HL057952, R01HL059165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Health Administration(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL057952, HL059165, and HL078825. This work was also supported by a Merit Award from the Veterans Affairs Health Administration.	Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Deschamps AM, 2005, CIRCULATION, V111, P1166, DOI 10.1161/01.CIR.0000157149.71297.3A; GULICK J, 1991, J BIOL CHEM, V266, P9180; Guo C, 2003, J BIOL CHEM, V278, P46699, DOI 10.1074/jbc.M307238200; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Ikonomidis JS, 2005, AM J PHYSIOL-HEART C, V288, pH149, DOI 10.1152/ajpheart.00370.2004; King MK, 2003, CIRC RES, V92, P177, DOI 10.1161/01.RES.0000052312.41419.55; Koli K, 2001, MICROSC RES TECHNIQ, V52, P354, DOI 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Matsusaka H, 2006, HYPERTENSION, V47, P711, DOI 10.1161/01.HYP.0000208840.30778.00; Mukherjee R, 2006, AM J PHYSIOL-HEART C, V291, pH2216, DOI 10.1152/ajpheart.01343.2005; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Sodek KL, 2007, BRIT J CANCER, V97, P358, DOI 10.1038/sj.bjc.6603863; Spinale FG, 2000, CIRCULATION, V102, P1944, DOI 10.1161/01.CIR.102.16.1944; Spinale FG, 1998, CIRC RES, V82, P482, DOI 10.1161/01.RES.82.4.482; Spinale FG, 2009, CIRC-HEART FAIL, V2, P351, DOI 10.1161/CIRCHEARTFAILURE.108.844845; Spruill LS, 2007, AM J PHYSIOL-CELL PH, V293, pC1362, DOI 10.1152/ajpcell.00545.2006; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Su HL, 2005, CIRCULATION, V112, P3157, DOI 10.1161/CIRCULATIONAHA.105.583021; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tatti O, 2008, EXP CELL RES, V314, P2501, DOI 10.1016/j.yexcr.2008.05.018; Vanhoutte D, 2006, CARDIOVASC RES, V69, P604, DOI 10.1016/j.cardiores.2005.10.002; Wilson EM, 2003, CIRCULATION, V107, P2857, DOI 10.1161/01.CIR.0000068375.40887.FA	30	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30316	30327		10.1074/jbc.M110.158196	http://dx.doi.org/10.1074/jbc.M110.158196			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20643648	hybrid, Green Published			2022-12-27	WOS:000281984300067
J	Berg, TJ; Gastonguay, AJ; Lorimer, EL; Kuhnmuench, JR; Li, RS; Fields, AP; Williams, CL				Berg, Tracy J.; Gastonguay, Adam J.; Lorimer, Ellen L.; Kuhnmuench, John R.; Li, Rongshan; Fields, Alan P.; Williams, Carol L.			Splice Variants of SmgGDS Control Small GTPase Prenylation and Membrane Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GERANYLGERANYLTRANSFERASE-I; RAS PROTEINS; NUCLEAR-LOCALIZATION; MOLECULAR-CLONING; BINDING PROTEINS; POLYBASIC REGION; GROWTH-FACTOR; CANCER CELLS; IDENTIFICATION	Ras and Rho small GTPases possessing a C-terminal polybasic region (PBR) are vital signaling proteins whose misregulation can lead to cancer. Signaling by these proteins depends on their ability to bind guanine nucleotides and their prenylation with a geranylgeranyl or farnesyl isoprenoid moiety and subsequent trafficking to cellular membranes. There is little previous evidence that cellular signals can restrain nonprenylated GTPases from entering the prenylation pathway, leading to the general belief that PBR-possessing GTPases are prenylated as soon as they are synthesized. Here, we present evidence that challenges this belief. We demonstrate that insertion of the dominant negative mutation to inhibit GDP/GTP exchange diminishes prenylation of Rap1A and RhoA, enhances prenylation of Rac1, and does not detectably alter prenylation of K-Ras. Our results indicate that the entrance and passage of these small GTPases through the prenylation pathway is regulated by two splice variants of SmgGDS, a protein that has been reported to promote GDP/GTP exchange by PBR-possessing GTPases and to be up-regulated in several forms of cancer. We show that the previously characterized 558-residue SmgGDS splice variant (SmgGDS-558) selectively associates with prenylated small GTPases and facilitates trafficking of Rap1A to the plasma membrane, whereas the less well characterized 607-residue SmgGDS splice variant (SmgGDS-607) associates with nonprenylated GTPases and regulates the entry of Rap1A, RhoA, and Rac1 into the prenylation pathway. These results indicate that guanine nucleotide exchange and interactions with SmgGDS splice variants can regulate the entrance and passage of PBR-possessing small GTPases through the prenylation pathway.	[Williams, Carol L.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Kuhnmuench, John R.; Li, Rongshan] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Li, Rongshan] Plus Diagnost, Union, NJ 07083 USA; [Fields, Alan P.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Medical College of Wisconsin; Medical College of Wisconsin; Mayo Clinic	Williams, CL (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	williams@mcw.edu			National Institutes of Health, NCI [R01 CA136799, R01 CA081436-12]; National Institutes of Health, NIGMS [R01 GM069700]; Rock River Cancer Research Foundation; Advancing a Healthier Wisconsin; Wisconsin Breast Cancer Showhouse; V-Foundation; American Lung Association/LUNGevity; National Cancer Center; NATIONAL CANCER INSTITUTE [R01CA136799, R01CA081436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069700] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Rock River Cancer Research Foundation; Advancing a Healthier Wisconsin; Wisconsin Breast Cancer Showhouse; V-Foundation; American Lung Association/LUNGevity; National Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA136799 from NCI (to C. L. W.), R01 GM069700 from NIGMS (to C. L. W.), and R01 CA081436-12 from NCI (to A. P. F.). This work was also supported by Rock River Cancer Research Foundation (to C. L. W.), Advancing a Healthier Wisconsin (to R. L. and C. L. W.), the Wisconsin Breast Cancer Showhouse (to C. L. W.), the V-Foundation (to A. P. F.), and the American Lung Association/LUNGevity (to A. P. F.).; Recipient of a training grant from the National Cancer Center.	Baron RA, 2008, BIOCHEM J, V415, P67, DOI 10.1042/BJ20080662; BUSS JE, 1991, MOL CELL BIOL, V11, P1523, DOI 10.1128/MCB.11.3.1523; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; FARNSWORTH CC, 1990, SCIENCE, V247, P320, DOI 10.1126/science.2296721; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; FINEGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448, DOI 10.1073/pnas.88.10.4448; Goalstone ML, 1998, J BIOL CHEM, V273, P23892, DOI 10.1074/jbc.273.37.23892; Goalstone ML, 2001, J BIOL CHEM, V276, P12805, DOI 10.1074/jbc.M009443200; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; JOLY A, 1991, J BIOL CHEM, V266, P13495; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; KATAYAMA M, 1991, J BIOL CHEM, V266, P12639; KIKUCHI A, 1992, ONCOGENE, V7, P289; KINSELLA BT, 1991, J BIOL CHEM, V266, P9786; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; Parmeggiani F, 2008, J MOL BIOL, V376, P1282, DOI 10.1016/j.jmb.2007.12.014; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Peterson YK, 2006, J BIOL CHEM, V281, P12445, DOI 10.1074/jbc.M600168200; Philips MR, 2007, J CLIN INVEST, V117, P1223, DOI 10.1172/JCI32108; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Regala RP, 2008, CANCER RES, V68, P5888, DOI 10.1158/0008-5472.CAN-08-0438; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; Rodriguez-Viciana P, 2005, COLD SH Q B, V70, P461, DOI 10.1101/sqb.2005.70.044; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Sebti SM, 2004, SEMIN ONCOL, V31, P28, DOI 10.1053/j.seminoncol.2003.12.012; Shin EY, 2006, J BIOL CHEM, V281, P35954, DOI 10.1074/jbc.M602399200; Strassheim D, 2000, J BIOL CHEM, V275, P6699, DOI 10.1074/jbc.275.10.6699; Swanson KM, 2006, CURR CANCER DRUG TAR, V6, P15, DOI 10.2174/156800906775471743; Takakura A, 2000, MOL BIOL CELL, V11, P1875, DOI 10.1091/mbc.11.5.1875; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Thill R, 2008, J CELL BIOCHEM, V104, P1760, DOI 10.1002/jcb.21740; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456; Zhou XP, 2008, P NATL ACAD SCI USA, V105, P17181, DOI 10.1073/pnas.0800846105	52	56	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35255	35266		10.1074/jbc.M110.129916	http://dx.doi.org/10.1074/jbc.M110.129916			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20709748	Green Published, hybrid			2022-12-27	WOS:000283845300003
J	Thibodeau, PH; Richardson, JM; Wang, W; Millen, L; Watson, J; Mendoza, JL; Du, K; Fischman, S; Senderowitz, H; Lukacs, GL; Kirk, K; Thomas, PJ				Thibodeau, Patrick H.; Richardson, John M., III; Wang, Wei; Millen, Linda; Watson, Jarod; Mendoza, Juan L.; Du, Kai; Fischman, Sharon; Senderowitz, Hanoch; Lukacs, Gergely L.; Kirk, Kevin; Thomas, Philip J.			The Cystic Fibrosis-causing Mutation Delta F508 Affects Multiple Steps in Cystic Fibrosis Transmembrane Conductance Regulator Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; MULTIDRUG ABC TRANSPORTER; IN-VIVO; CONFORMATIONAL MATURATION; ENDOPLASMIC-RETICULUM; CFTR; PROTEIN; RESCUE; MUTANT; ATP	The deletion of phenylalanine 508 in the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator is directly associated with > 90% of cystic fibrosis cases. This mutant protein fails to traffic out of the endoplasmic reticulum and is subsequently degraded by the proteasome. The effects of this mutation may be partially reversed by the application of exogenous osmolytes, expression at low temperature, and the introduction of second site suppressor mutations. However, the specific steps of folding and assembly of full-length cystic fibrosis transmembrane conductance regulator (CFTR) directly altered by the disease-causing mutation are unclear. To elucidate the effects of the Delta F508 mutation, on various steps in CFTR folding, a series of misfolding and suppressor mutations in the nucleotide binding and transmembrane domains were evaluated for effects on the folding and maturation of the protein. The results indicate that the isolated NBD1 responds to both the Delta F508 mutation and intradomain suppressors of this mutation. In addition, identification of a novel second site suppressor of the defect within the second transmembrane domain suggests that Delta F508 also effects interdomain interactions critical for later steps in the biosynthesis of CFTR.	[Thibodeau, Patrick H.; Richardson, John M., III; Millen, Linda; Watson, Jarod; Mendoza, Juan L.; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Mendoza, Juan L.] Univ Texas SW Med Ctr Dallas, Mol Biophys Grad Program, Dallas, TX 75390 USA; [Wang, Wei; Kirk, Kevin] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Du, Kai; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Fischman, Sharon; Senderowitz, Hanoch] Epix Pharmaceut, Lexington, MA 02421 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham; McGill University	Thomas, PJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Philip.Thomas@UTSouthwestern.edu	Thomas, Philip J/F-7115-2012	Mendoza, Juan/0000-0001-6972-7476; Thibodeau, Patrick/0000-0002-6790-144X; Lukacs, Gergely/0000-0003-0900-0675	National Institutes of Health NIDDK [49835, 75302]; Cystic Fibrosis Foundation; Canadian Cystic Fibrosis Foundation; Canadian Foundation of Innovation; Canada Research Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Canadian Cystic Fibrosis Foundation; Canadian Foundation of Innovation(Canada Foundation for Innovation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grants 49835 (to P.J.T.) and 75302 (to G.L.L.). This work was also supported by the Cystic Fibrosis Foundation (to P.J.T.) and the Canadian Cystic Fibrosis Foundation (to G.L.L.). The authors declare they have competing financial interests. The beta-galactosidase assay has been licensed to Reata Pharmaceuticals by The University of Texas Southwestern Medical Center at Dallas. P.J.T. is a founding scientist of Reata Pharmaceuticals.; Supported by the Canadian Foundation of Innovation and recipient of a Canada Research Chair.	Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Chiaw PK, 2009, CHEM BIOL, V16, P520, DOI 10.1016/j.chembiol.2009.04.005; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DORK T, 1991, HUM GENET, V87, P441; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Krasnov KV, 2008, HUM MUTAT, V29, P1364, DOI 10.1002/humu.20866; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Pollet JF, 2000, BBA-MOL BASIS DIS, V1500, P59, DOI 10.1016/S0925-4439(99)00088-5; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Stidham Rhesa D, 2003, Methods Mol Biol, V205, P155; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Wilken S, 1996, MOL MICROBIOL, V22, P655, DOI 10.1046/j.1365-2958.1996.d01-1724.x; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200; Zhang Yimao, 2002, Methods Mol Med, V70, P257	44	135	136	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35825	35835		10.1074/jbc.M110.131623	http://dx.doi.org/10.1074/jbc.M110.131623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20667826	Green Published, hybrid			2022-12-27	WOS:000283845300060
J	Tran, AX; Dong, CJ; Whitfield, C				Tran, An X.; Dong, Changjiang; Whitfield, Chris			Structure and Functional Analysis of LptC, a Conserved Membrane Protein Involved in the Lipopolysaccharide Export Pathway in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ENVELOPE BIOGENESIS; BACTERIAL OUTER-MEMBRANE; INNER-MEMBRANE; CRYSTAL-STRUCTURES; BINDING-PROTEIN; COG DATABASE; LIPID-A; TRANSPORT; COMPLEX; IDENTIFICATION	LptC is a conserved bitopic inner membrane protein from Escherichia coli involved in the export of lipopolysaccharide from its site of synthesis in the cytoplasmic membrane to the outer membrane. LptC forms a complex with the ATP-binding cassette transporter, LptBFG, which is thought to facilitate the extraction of lipopolysaccharide from the inner membrane and release it into a translocation pathway that includes the putative periplasmic chaperone LptA. Cysteine modification experiments established that the catalytic domain of LptC is oriented toward the periplasm. The structure of the periplasmic domain is described at a resolution of 2.2-angstrom from x-ray crystallographic data. The periplasmic domain of LptC consists of a twisted boat structure with two beta-sheets in apposition to each other. The beta-sheets contain seven and eight antiparallel beta-strands, respectively. This structure bears a high degree of resemblance to the crystal structure of LptA. Like LptA, LptC binds lipopolysaccharide in vitro. In vitro, LptA can displace lipopolysaccharide from LptC (but not vice versa), consistent with their locations and their proposed placement in a unidirectional export pathway.	[Tran, An X.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Dong, Changjiang] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland	University of Guelph; University of St Andrews	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca			Canadian Institutes of Health Research; Wellcome Trust	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Canadian Institutes of Health Research (to C. W.) and a Wellcome Trust Career Development Fellowship (to C. D.).	Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; CORPET F, 1998, NUCLEIC ACIDS RES, V22, P10881; COWTAN K, 1994, INT CCP4 ESF EACBM N, V31, P34; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVENS PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Fu DX, 1998, J BIOL CHEM, V273, P17962, DOI 10.1074/jbc.273.28.17962; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LESLIE AGW, 1998, J APPL CRYSTALLOGR, V30, P1036; Ma B, 2008, P NATL ACAD SCI USA, V105, P13823, DOI 10.1073/pnas.0807028105; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohtsu I, 2004, BIOSCI BIOTECH BIOCH, V68, P458, DOI 10.1271/bbb.68.458; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pristovsek P, 2005, J MED CHEM, V48, P7911, DOI 10.1021/jm050762a; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Taniguchi N, 2008, J BIOL CHEM, V283, P8538, DOI 10.1074/jbc.M800026200; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tefsen B, 2005, J BIOL CHEM, V280, P4504, DOI 10.1074/jbc.M409259200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	59	102	106	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33529	33539		10.1074/jbc.M110.144709	http://dx.doi.org/10.1074/jbc.M110.144709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720015	hybrid, Green Published			2022-12-27	WOS:000283048200087
J	Gebhardt, FM; Mitrovic, AD; Gilbert, DF; Vandenberg, RJ; Lynch, JW; Dodd, PR				Gebhardt, Florian M.; Mitrovic, Ann D.; Gilbert, Daniel F.; Vandenberg, Robert J.; Lynch, Joseph W.; Dodd, Peter R.			Exon-skipping Splice Variants of Excitatory Amino Acid Transporter-2 (EAAT2) Form Heteromeric Complexes with Full-length EAAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DEPENDENT ASPARTATE TRANSPORTER; NEURONAL GLUTAMATE TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; PYROCOCCUS-HORIKOSHII; ENDOPLASMIC-RETICULUM; INDIVIDUAL SUBUNITS; RAT-BRAIN; GLT-1; PROTEIN	The glial transporter excitatory amino acid transporter-2 (EAAT2) is the main mediator of glutamate clearance in brain. The wild-type transporter (EAAT2wt) forms trimeric membrane complexes in which each protomer functions autonomously. Several EAAT2 variants are found in control and Alzheimer-diseased human brains; their expression increases with pathological severity. These variants might alter EAAT2wt-mediated transport by abrogating membrane trafficking, or by changing the configuration or functionality of the assembled transporter complex. HEK293 cells were transfected with EAAT2wt; EAAT2b, a C-terminal variant; or either of two exon-skipping variants: alone or in combination. Surface biotinylation studies showed that only the exon-7 deletion variant was not trafficked to the membrane when transfected alone, and that all variants could reach the membrane when co-transfected with EAAT2wt. Fluorescence resonance energy transfer (FRET) studies showed that co-transfected EAAT2wt and EAAT2 splice variants were expressed in close proximity. Glutamate transporter function was measured using a whole cell patch clamp technique, or by changes in membrane potential indexed by a voltage-sensitive fluorescent dye (FMP assay): the two methods gave comparable results. Cells transfected with EAAT2wt or EAAT2b showed glutamate-dependent membrane potential changes consistent with functional expression. Cells transfected with EAAT2 exon-skipping variants alone gave no response to glutamate. Co-transfection of EAAT2wt(or EAAT2b) and splice variants in various ratios significantly raised glutamate EC50 and decreased Hill coefficients. We conclude that exon-skipping variants form heteromeric complexes with EAAT2wt or EAAT2b that traffic to the membrane but show reduced glutamate-dependent activity. This could allow glutamate to accumulate extracellularly and promote excitotoxicity.	[Gebhardt, Florian M.; Dodd, Peter R.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Gilbert, Daniel F.; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Gilbert, Daniel F.; Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Mitrovic, Ann D.; Vandenberg, Robert J.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Mitrovic, Ann D.; Vandenberg, Robert J.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Queensland; University of Queensland; University of Queensland; University of Sydney; University of Sydney	Dodd, PR (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Bldg 76,Coopers Rd,St Lucia Campus, Brisbane, Qld 4072, Australia.	p.dodd@uq.edu.au	Dodd, Peter Ronald/A-4865-2010; Lynch, Joseph/C-8636-2009; Gilbert, Daniel F./F-8714-2011; Vandenberg, Robert John/E-6018-2016	Dodd, Peter Ronald/0000-0001-5970-0181; Vandenberg, Robert John/0000-0003-1523-4814; /0000-0003-4431-4741	Alzheimer's Association (USA) [RG1-96-005]; Judith Jane Mason and Harold Stannett Williams Memorial Foundation; University of Queensland; University of Sydney; National Health and Medical Research Council of Australia; Australian Research Council	Alzheimer's Association (USA)(Alzheimer's Association); Judith Jane Mason and Harold Stannett Williams Memorial Foundation; University of Queensland(University of Queensland); University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported in part by Alzheimer's Association (USA) Grant RG1-96-005 and the Judith Jane Mason and Harold Stannett Williams Memorial Foundation.; Recipient of an International Post-graduate Research Scholarship from the University of Queensland.; Recipient of a Rolf Edgar Lake Fellowship from the University of Sydney.; Supported by The National Health and Medical Research Council of Australia and the Australian Research Council.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dunlop J, 1999, BRIT J PHARMACOL, V128, P1485, DOI 10.1038/sj.bjp.0702945; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Gilbert DF, 2009, J BIOMOL SCREEN, V14, P944, DOI 10.1177/1087057109339523; Gonzalez-Gonzalez IM, 2008, J NEUROCHEM, V105, P1834, DOI 10.1111/j.1471-4159.2008.05281.x; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Holmseth S, 2009, NEUROSCIENCE, V162, P1055, DOI 10.1016/j.neuroscience.2009.03.048; Honig LS, 2000, NEUROLOGY, V55, P1082, DOI 10.1212/WNL.55.8.1082; Horiuchi M, 2001, P NATL ACAD SCI USA, V98, P1448, DOI 10.1073/pnas.041329498; Jensen AA, 2005, EUR J PHARMACOL, V521, P39, DOI 10.1016/j.ejphar.2005.08.002; Jensen AA, 2004, BIOCHEM PHARMACOL, V67, P2115, DOI 10.1016/j.bcp.2004.02.013; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KINGSTON RE, 2003, CURR PROTOC MOL BIOL, P1; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meyer T, 1998, J NEUROL NEUROSUR PS, V65, P954, DOI 10.1136/jnnp.65.6.954; Mitrovic AD, 1998, J BIOL CHEM, V273, P14698, DOI 10.1074/jbc.273.24.14698; Munch C, 2002, J NEUROCHEM, V82, P594, DOI 10.1046/j.1471-4159.2002.01012.x; Otis TS, 1998, J NEUROSCI, V18, P7099; Peacey E, 2009, MOL PHARMACOL, V75, P1062, DOI 10.1124/mol.108.052829; Pow DV, 2009, NEUROCHEM RES, V34, P1748, DOI 10.1007/s11064-009-9957-0; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; Reye P, 2002, GLIA, V38, P246, DOI 10.1002/glia.10059; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Schmitt A, 2002, NEUROSCIENCE, V109, P45, DOI 10.1016/S0306-4522(01)00451-1; Scott HA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.008; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sullivan R, 2004, GLIA, V45, P155, DOI 10.1002/glia.10317; Toki H, 1998, J NEUROCHEM, V71, P913; Torres-Salazar D, 2006, J NEUROSCI, V26, P7513, DOI 10.1523/JNEUROSCI.4545-05.2006; UtsunomiyaTate N, 1997, FEBS LETT, V416, P312, DOI 10.1016/S0014-5793(97)01232-5; Vallejo-Illarramendi A, 2005, J NEUROCHEM, V95, P341, DOI 10.1111/j.1471-4159.2005.03370.x; VANEERSEL J, 2006, P AUST NEUROSCI SOC, V17, P80; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	47	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31313	31324		10.1074/jbc.M110.153494	http://dx.doi.org/10.1074/jbc.M110.153494			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20688910	hybrid, Green Published			2022-12-27	WOS:000282764600026
J	Honda, A; Hirose, M; Hatori, M; Matoba, S; Miyoshi, H; Inoue, K; Ogura, A				Honda, Arata; Hirose, Michiko; Hatori, Masanori; Matoba, Shogo; Miyoshi, Hiroyuki; Inoue, Kimiko; Ogura, Atsuo			Generation of Induced Pluripotent Stem Cells in Rabbits POTENTIAL EXPERIMENTAL MODELS FOR HUMAN REGENERATIVE MEDICINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSFER; GENE-EXPRESSION; LINES; DERIVATION; DIFFERENTIATION; FERTILIZATION; SPERM	Human induced pluripotent stem (iPS) cells have the potential to establish a new field of promising regenerative medicine. Therefore, the safety and the efficiency of iPS-derived cells must be tested rigorously using appropriate animal models before human trials can commence. Here, we report the establishment of rabbit iPS cells as the first human-type iPS cells generated from a small laboratory animal species. Using lentiviral vectors, four human reprogramming genes (c-MYC, KLF4, SOX2, and OCT3/4) were introduced successfully into adult rabbit liver and stomach cells. The resulting rabbit iPS cells closely resembled human iPS cells; they formed flattened colonies with sharp edges and proliferated indefinitely in the presence of basic FGF. They expressed the endogenous pluripotency markers c-MYC, KLF4, SOX2, OCT3/4, and NANOG, whereas the introduced human genes were completely silenced. Using in vitro differentiating conditions, rabbit iPS cells readily differentiated into ectoderm, mesoderm, and endoderm. They also formed teratomas containing a variety of tissues of all three germ layers in immunodeficient mice. Thus, the rabbit iPS cells fulfilled all of the requirements for the acquisition of the fully reprogrammed state, showing high similarity to their embryonic stem cell counterparts we generated recently. However, their global gene expression analysis revealed a slight but rigid difference between these two types of rabbit pluripotent stem cells. The rabbit model should enable us to compare iPS cells and embryonic stem cells under the same standardized conditions in evaluating their ultimate feasibility for pluripotent cell-based regenerative medicine in humans.	[Honda, Arata; Hirose, Michiko; Hatori, Masanori; Matoba, Shogo; Miyoshi, Hiroyuki; Inoue, Kimiko; Ogura, Atsuo] RIKEN BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Honda, Arata; Hatori, Masanori] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Inoue, Kimiko; Ogura, Atsuo] 4 Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Ogura, Atsuo] Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med 5, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; Japan Science & Technology Agency (JST); University of Tokyo	Honda, A (corresponding author), RIKEN BioResource Ctr, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	a-honda@rtc.riken.jp; ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014; Miyoshi, Hiroyuki/G-9808-2013; MATOBA, Shogo/D-9995-2016	Ogura, Atsuo/0000-0003-0447-1988; MATOBA, Shogo/0000-0003-0474-232X	PRESTO of the Japan Science and Technology Agency	PRESTO of the Japan Science and Technology Agency	This work was supported by PRESTO of the Japan Science and Technology Agency and a grant-in-aid for scientific research (B).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Armstrong L, 2000, MECH DEVELOP, V97, P109, DOI 10.1016/S0925-4773(00)00423-8; BIGGERS JD, 1991, J REPROD FERTIL, V93, P173; Bosze Z, 2003, TRANSGENIC RES, V12, P541, DOI 10.1023/A:1025816809372; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; CHANG MC, 1959, NATURE, V184, P466, DOI 10.1038/184466a0; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Familari M, 2006, MOL REPROD DEV, V73, P123, DOI 10.1002/mrd.20376; Fan JL, 2003, PHARMACOL THERAPEUT, V99, P261, DOI 10.1016/S0163-7258(03)00069-X; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; GRAVES KH, 1993, MOL REPROD DEV, V36, P424, DOI 10.1002/mrd.1080360404; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Honda A, 2008, REPROD BIOMED ONLINE, V17, P706, DOI 10.1016/S1472-6483(10)60320-3; Honda A, 2009, EXP CELL RES, V315, P2033, DOI 10.1016/j.yexcr.2009.01.024; Inoue Kimiko, 2002, Cloning and Stem Cells, V4, P311, DOI 10.1089/153623002321024989; Intawicha P, 2009, CLONING STEM CELLS, V11, P27, DOI 10.1089/clo.2008.0040; KASAI M, 1992, BIOL REPROD, V46, P1042, DOI 10.1095/biolreprod46.6.1042; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Koestenbauer S, 2006, AM J REPROD IMMUNOL, V55, P169, DOI 10.1111/j.1600-0897.2005.00354.x; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Liu JL, 2004, BIOL REPROD, V70, P1776, DOI 10.1095/biolreprod.103.025957; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Martins-Taylor K, 2010, J CELL BIOCHEM, V109, P16, DOI 10.1002/jcb.22402; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ogonuki N, 2005, MOL REPROD DEV, V72, P411, DOI 10.1002/mrd.20363; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Shiomi Masashi, 2004, J Atheroscler Thromb, V11, P184; Sparman M, 2009, STEM CELLS, V27, P1255, DOI 10.1002/stem.60; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Weekers F, 2002, ENDOCRINOLOGY, V143, P764, DOI 10.1210/en.143.3.764; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935; Wu YH, 2010, STEM CELL RES, V4, P180, DOI 10.1016/j.scr.2010.02.003; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	51	120	136	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31362	31369		10.1074/jbc.M110.150540	http://dx.doi.org/10.1074/jbc.M110.150540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670936	hybrid, Green Published			2022-12-27	WOS:000282764600030
J	Kozoriz, MG; Church, J; Ozog, MA; Naus, CC; Krebs, C				Kozoriz, Michael G.; Church, John; Ozog, Mark A.; Naus, Christian C.; Krebs, Claudia			Temporary Sequestration of Potassium by Mitochondria in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING CONNEXIN43; BASAL FOREBRAIN NEURONS; CENTRAL-NERVOUS-SYSTEM; K-ATP CHANNELS; CARDIOMYOCYTE MITOCHONDRIA; PERMEABILITY TRANSITION; CULTURED ASTROCYTES; ENDOTHELIAL-CELLS; MOUSE ASTROCYTES; PLASMA-MEMBRANE	Increases in extracellular potassium concentration ([K+](o)), which can occur during neuronal activity and under pathological conditions such as ischemia, lead to a variety of potentially detrimental effects on neuronal function. Although astrocytes are known to contribute to the clearance of excess K+ (o), the mechanisms are not fully understood. We examined the potential role of mitochondria in sequestering K+ in astrocytes. Astrocytes were loaded with the fluorescent K+ indicator PBFI and release of K+ from mitochondria into the cytoplasm was examined after uncoupling the mitochondrial membrane potential with carbonyl cyanide m-chlorophenylhydrazone (CCCP). Under the experimental conditions employed, transient applications of elevated [K+](o) led to increases in K+ within mitochondria, as assessed by increases in the magnitudes of cytoplasmic [K+] ([K+](i)) transients evoked by brief exposures to CCCP. When mitochondrial K+ sequestration was impaired by prolonged application of CCCP, there was a robust increase in [K+](i) upon exposure to elevated [K+](o). Blockade of plasmalemmal K+ uptake routes by ouabain, Ba2+, or a mixture of voltage-activated K+ channel inhibitors reduced K+ uptake into mitochondria. Also, reductions in mitochondrial K+ uptake occurred in the presence of mito-K-ATP channel inhibitors. Rises in [K+](i) evoked by brief applications of CCCP following exposure to high [K+](o) were also reduced by gap junction blockers and in astrocytes isolated from connexin43-null mice, suggesting that connexins also play a role in K+ uptake into astrocyte mitochondria. We conclude that mitochondria play a key role in K+ (o) handling by astrocytes.	[Kozoriz, Michael G.; Church, John; Ozog, Mark A.; Naus, Christian C.; Krebs, Claudia] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Naus, CC (corresponding author), 2350 Hlth Sci Mall,Rm 1352, Vancouver, BC V6T 1Z3, Canada.	cnaus@interchange.ubc.ca		Kozoriz, Michael/0000-0003-1434-8588	Heart and Stroke Foundation of British Columbia and Yukon; Canadian Institutes of Health Research [MOP-77616]; Canadian Institutes of Health Research-Vancouver Coastal Health Research Institute; Michael Smith Foundation for Health Research	Heart and Stroke Foundation of British Columbia and Yukon; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research-Vancouver Coastal Health Research Institute(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by a Grant-in-aid from the Heart and Stroke Foundation of British Columbia and Yukon (to C. C. N. and C. K.) and Operating Grant MOP-77616 from the Canadian Institutes of Health Research (to J. C.).; Supported by a Canadian Institutes of Health Research-Vancouver Coastal Health Research Institute UBC MD/PhD Studentship Award and by the Michael Smith Foundation for Health Research.	Azarias G, 2008, GLIA, V56, P342, DOI 10.1002/glia.20619; Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boengler K, 2005, CARDIOVASC RES, V67, P234, DOI 10.1016/j.cardiores.2005.04.014; Boengler K, 2009, BASIC RES CARDIOL, V104, P141, DOI 10.1007/s00395-009-0007-5; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Chen KC, 2000, BIOPHYS J, V78, P2776, DOI 10.1016/S0006-3495(00)76822-6; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Garlid KD, 1997, CIRC RES, V81, P1072; Garlid KD, 1996, BBA-BIOENERGETICS, V1275, P123, DOI 10.1016/0005-2728(96)00061-8; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Goubaeva F, 2007, BIOCHEM BIOPH RES CO, V352, P97, DOI 10.1016/j.bbrc.2006.10.177; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Hansson MJ, 2010, J BIOL CHEM, V285, P741, DOI 10.1074/jbc.M109.017731; Holthoff K, 2000, GLIA, V29, P288, DOI 10.1002/(SICI)1098-1136(20000201)29:3<288::AID-GLIA10>3.0.CO;2-8; Iacobas DA, 2003, PHYSIOL GENOMICS, V15, P177, DOI 10.1152/physiolgenomics.00062.2003; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Juthberg SKA, 1997, CELL MOL NEUROBIOL, V17, P367, DOI 10.1023/A:1026331226241; KASNER SE, 1992, AM J PHYSIOL, V262, P462; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kolikova J, 2006, BRAIN CELL BIOL, V35, P75, DOI 10.1007/s11068-006-9000-1; Korge P, 2005, AM J PHYSIOL-HEART C, V289, pH66, DOI 10.1152/ajpheart.01296.2004; Kowaltowski AJ, 2002, J BIOL CHEM, V277, P42802, DOI 10.1074/jbc.M207765200; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Kubota T, 2005, BBA-MOL CELL RES, V1744, P19, DOI 10.1016/j.bbamcr.2004.10.013; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; LEVI AJ, 1994, J CARDIOVASC ELECTR, V5, P241; Li H, 2002, AM J PHYSIOL-HEART C, V282, pH2124, DOI 10.1152/ajpheart.01028.2001; Lian XY, 2004, BRAIN RES, V1012, P177, DOI 10.1016/j.brainres.2004.04.011; Liu D, 2003, J NEUROCHEM, V86, P966, DOI 10.1046/j.1471-4159.2003.01913.x; Ljubkovic M, 2006, J PHYSIOL-LONDON, V577, P17, DOI 10.1113/jphysiol.2006.118299; McLaughlin CW, 2001, AM J PHYSIOL-CELL PH, V281, pC865, DOI 10.1152/ajpcell.2001.281.3.C865; Metea MR, 2007, J NEUROSCI, V27, P2468, DOI 10.1523/JNEUROSCI.3204-06.2007; MINTA A, 1989, J BIOL CHEM, V264, P19449; Miro-Casas E, 2009, CARDIOVASC RES, V83, P747, DOI 10.1093/cvr/cvp157; Murchison D, 2004, CELL CALCIUM, V36, P61, DOI 10.1016/j.ceca.2003.11.010; Murchison D, 2000, BRAIN RES, V854, P139, DOI 10.1016/S0006-8993(99)02297-0; Murphy E, 2009, CIRC RES, V104, P292, DOI 10.1161/CIRCRESAHA.108.189050; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Naus CCG, 1997, J NEUROSCI RES, V49, P528, DOI 10.1002/(SICI)1097-4547(19970901)49:5<528::AID-JNR3>3.0.CO;2-D; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; OLSON JE, 1986, J CELL PHYSIOL, V128, P209, DOI 10.1002/jcp.1041280211; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; Park KS, 2002, PFLUG ARCH EUR J PHY, V443, P344, DOI 10.1007/s004240100703; Pivovarova NB, 1999, J NEUROSCI, V19, P6372; Poburko D, 2004, CELL CALCIUM, V35, P509, DOI 10.1016/j.ceca.2004.01.020; Poburko D, 2007, CIRC RES, V101, P1030, DOI 10.1161/CIRCRESAHA.107.155531; Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612; PYSH JJ, 1972, BRAIN RES, V36, P1, DOI 10.1016/0006-8993(72)90762-7; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Reyes RC, 2008, J NEUROSCI, V28, P9682, DOI 10.1523/JNEUROSCI.3484-08.2008; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de; Rose CR, 1996, J PHYSIOL-LONDON, V491, P291, DOI 10.1113/jphysiol.1996.sp021216; Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, pH1967, DOI 10.1152/ajpheart.00338.2004; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sato T, 1998, CIRC RES, V83, P110, DOI 10.1161/01.RES.83.1.110; Sheldon C, 2004, J NEUROSCI, V24, P11057, DOI 10.1523/JNEUROSCI.2829-04.2004; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Stys PK, 1997, J NEUROCHEM, V68, P1920; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; WALZ W, 1992, NEUROSCI LETT, V135, P243, DOI 10.1016/0304-3940(92)90446-E; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; Xu L, 2009, NEUROBIOL DIS, V34, P291, DOI 10.1016/j.nbd.2009.01.010; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yang MK, 2009, J PHARMACOL SCI, V109, P222, DOI 10.1254/jphs.08132FP; ZOETEWEIJ JP, 1994, BIOCHEM J, V299, P539, DOI 10.1042/bj2990539	77	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31107	31119		10.1074/jbc.M109.082073	http://dx.doi.org/10.1074/jbc.M109.082073			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667836	Green Published, hybrid			2022-12-27	WOS:000282764600004
J	Majumder, A; Govindasamy, L; Magis, A; Kiss, R; Polgar, T; Baskin, R; Allan, RW; Agbandje-McKenna, M; Reuther, GW; Keseru, GM; Bisht, KS; Sayeski, PP				Majumder, Anurima; Govindasamy, Lakshmanan; Magis, Andrew; Kiss, Robert; Polgar, Timea; Baskin, Rebekah; Allan, Robert W.; Agbandje-McKenna, Mavis; Reuther, Gary W.; Keseru, Gyoergy M.; Bisht, Kirpal S.; Sayeski, Peter P.			Structure-Function Correlation of G6, a Novel Small Molecule Inhibitor of Jak2 INDISPENSABILITY OF THE STILBENOID CORE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE JAK2; TRANS-RESVERATROL; CELL-LINES; MUTATION; IDENTIFICATION; PICEATANNOL; ACTIVATION; APOPTOSIS; DOMAINS; DEFINES	Somatic mutations in the Jak2 protein, such as V617F, cause aberrant Jak/STAT signaling and can lead to the development of myeloproliferative neoplasms. This discovery has led to the search for small molecule inhibitors that target Jak2. Using structure-based virtual screening, our group recently identified a novel small molecule inhibitor of Jak2 named G6. Here, we identified a structure-function correlation of this compound. Specifically, five derivative compounds of G6 having structural similarity to the original lead compound were obtained and analyzed for their ability to (i) inhibit Jak2-V617F-mediated cell growth, (ii) inhibit the levels of phospho-Jak2, phospho-STAT3, and phospho-STAT5; (iii) induce apoptosis in human erythroleukemia cells; and (iv) suppress pathologic cell growth of Jak2-V617F-expressing human bone marrow cells ex vivo. Additionally, we computationally examined the interactions of these compounds with the ATP-binding pocket of the Jak2 kinase domain. We found that the stilbenoid core-containing derivatives of G6 significantly inhibited Jak2-V617F-mediated cell proliferation in a time- and dose-dependent manner. They also inhibited phosphorylation of Jak2, STAT3, and STAT5 proteins within cells, resulting in higher levels of apoptosis via the intrinsic apoptotic pathway. Finally, the stilbenoid derivatives inhibited the pathologic growth of Jak2-V617F-expressing human bone marrow cells ex vivo. Collectively, our data demonstrate that G6 has a stilbenoid core that is indispensable for maintaining its Jak2 inhibitory potential.	[Majumder, Anurima; Baskin, Rebekah; Sayeski, Peter P.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Govindasamy, Lakshmanan; Agbandje-McKenna, Mavis] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Allan, Robert W.] Univ Florida, Coll Med, Dept Pathol & Lab Med, Gainesville, FL 32610 USA; [Magis, Andrew] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Kiss, Robert] Heriot Watt Univ, Dept Chem Engn, Edinburgh EH14 4A5, Midlothian, Scotland; [Polgar, Timea; Keseru, Gyoergy M.] Budapest Univ Technol & Econ, Dept Gen & Analyt Chem, H-1111 Budapest, Hungary; [Reuther, Gary W.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 32610 USA; [Bisht, Kirpal S.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Urbana-Champaign; Heriot Watt University; Budapest University of Technology & Economics; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Sayeski, PP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, POB 100274, Gainesville, FL 32610 USA.	psayeski@ufl.edu	Polgár, Tímea/A-2089-2013; Reuther, Gary/AFR-2892-2022	Polgár, Tímea/0000-0002-1367-6128; Kiss, Robert/0000-0002-2879-6325; Magis, Andrew/0000-0003-0576-677X; Keseru, Gyorgy M/0000-0003-1039-7809	National Institutes of Health [R01-HL67277]; Biomedical Research Support Program; Howard Hughes Medical Institute; University of Florida/Moffitt Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Support Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Florida/Moffitt Cancer Center(University of Florida); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL67277. This work was also supported by a Biomedical Research Support Program for Medical Schools Award to the University of Florida College of Medicine by the Howard Hughes Medical Institute, a University of Florida Opportunity Fund Award, and a University of Florida/Moffitt Cancer Center Collaborative Initiative Award.	Akwabi-Ameyaw A, 2008, BIOORG MED CHEM LETT, V18, P4339, DOI 10.1016/j.bmcl.2008.06.073; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Antonysamy S, 2009, BIOORG MED CHEM LETT, V19, P279, DOI 10.1016/j.bmcl.2008.08.064; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Belleri M, 2005, MOL PHARMACOL, V67, P1451, DOI 10.1124/mol.104.009043; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; DeLano W.L, PYMOL MOL GRAPHICS S; Dodds EC, 1938, NATURE, V141, P247, DOI 10.1038/141247b0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Gosslau A, 2005, BRIT J CANCER, V92, P513, DOI 10.1038/sj.bjc.6602300; Griesinger F, 2005, GENE CHROMOSOME CANC, V44, P329, DOI 10.1002/gcc.20235; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; Kimura Y, 2005, IN VIVO, V19, P37; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Larrosa M, 2004, EUR J NUTR, V43, P275, DOI 10.1007/s00394-004-0471-5; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pradhan A, 2010, J BIOL CHEM, V285, P16651, DOI 10.1074/jbc.M109.071191; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Swanson-Mungerson M, 2003, J ANTIMICROB CHEMOTH, V52, P152, DOI 10.1093/jac/dkg306; Szabo G, 2009, BIOORG MED CHEM LETT, V19, P3471, DOI 10.1016/j.bmcl.2009.05.010; Till JH, 2001, J BIOL CHEM, V276, P10049, DOI 10.1074/jbc.M010161200; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	45	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31399	31407		10.1074/jbc.M110.168211	http://dx.doi.org/10.1074/jbc.M110.168211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667821	Green Published, hybrid			2022-12-27	WOS:000282764600034
J	Mitschke, L; Parthier, C; Schroder-Tittmann, K; Coy, J; Ludtke, S; Tittmann, K				Mitschke, Lars; Parthier, Christoph; Schroeder-Tittmann, Kathrin; Coy, Johannes; Luedtke, Stefan; Tittmann, Kai			The Crystal Structure of Human Transketolase and New Insights into Its Mode of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHATE-DEPENDENT ENZYME; THIAMIN CATALYSIS; UP-REGULATION; EXPRESSION; PROTEIN; SITE; CRYSTALLOGRAPHY; IDENTIFICATION; CONTRIBUTES; INHIBITORS	The crystal structure of human transketolase (TKT), a thiamine diphosphate (ThDP) and Ca2+-dependent enzyme that catalyzes the interketol transfer between ketoses and aldoses as part of the pentose phosphate pathway, has been determined to 1.75 angstrom resolution. The recombinantly produced protein crystallized in space group C2 containing one monomer in the asymmetric unit. Two monomers form the homodimeric biological assembly with two identical active sites at the dimer interface. Although the protomer exhibits the typical three (alpha/beta)-domain structure and topology reported for TKTs from other species, structural differences are observed for several loop regions and the linker that connects the PP and Pyr domain. The cofactor and substrate binding sites of human TKT bear high resemblance to those of other TKTs but also feature unique properties, including two lysines and a serine that interact with the beta-phosphate of ThDP. Furthermore, Gln(189) spans over the thiazolium moiety of ThDP and replaces an isoleucine found in most non-mammalian TKTs. The side chain of Gln(428) forms a hydrogen bond with the 4'-amino group of ThDP and replaces a histidine that is invariant in all non-mammalian TKTs. All other amino acids involved in substrate binding and catalysis are strictly conserved. Besides a steady-state kinetic analysis, microscopic equilibria of the donor half-reaction were characterized by an NMR-based intermediate analysis. These studies reveal that formation of the central 1,2-dihydroxyethyl-ThDP carbanion-enamine intermediate is thermodynamically favored with increasing carbon chain length of the donor ketose substrate. Based on the structure of human transketolase and sequence alignments, putative functional properties of the related transketolase-like proteins TKTL1 and -2 are discussed in light of recent findings suggesting that TKTL1 plays a role in cancerogenesis.	[Tittmann, Kai] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Coy, Johannes] TAVARGENIX GmbH, D-64293 Darmstadt, Germany; [Luedtke, Stefan; Tittmann, Kai] Univ Gottingen, Albrecht von Haller Inst, D-37077 Gottingen, Germany; [Luedtke, Stefan; Tittmann, Kai] Univ Gottingen, Gottingen Ctr Mol Biosci, Dept Bioanalyt, D-37077 Gottingen, Germany	Martin Luther University Halle Wittenberg; University of Gottingen; University of Gottingen	Tittmann, K (corresponding author), Ernst Caspari Haus,Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ktittma@gwdg.de			Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the "Fonds der Chemischen Industrie" (stipend to S. L.) and the Deutsche Forschungsgemeinschaft-funded Gottingen Graduate School for Neurosciences and Molecular Biosciences (to K. T.).	Asztalos P, 2007, BIOCHEMISTRY-US, V46, P12037, DOI 10.1021/bi700844m; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boros LG, 1997, CANCER RES, V57, P4242; Bykova IA, 2001, BIOCHEM BIOPH RES CO, V280, P845, DOI 10.1006/bbrc.2000.4199; CALINGASAN NY, 1995, J NEUROCHEM, V64, P1034; Cascante M, 2000, NUTR CANCER, V36, P150, DOI 10.1207/S15327914NC3602_2; Charmantray F, 2009, J MOL CATAL B-ENZYM, V57, P6, DOI 10.1016/j.molcatb.2008.06.005; Coy JF, 1996, GENOMICS, V32, P309, DOI 10.1006/geno.1996.0124; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedler E, 2002, P NATL ACAD SCI USA, V99, P591, DOI 10.1073/pnas.022510999; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Gerhardt S, 2003, PLANT PHYSIOL, V132, P1941, DOI 10.1104/pp.103.020982; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; Heroux M, 1996, METAB BRAIN DIS, V11, P81, DOI 10.1007/BF02080933; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kluger R, 2008, CHEM REV, V108, P1797, DOI 10.1021/cr068444m; Le Huerou Y, 2008, BIOORG MED CHEM LETT, V18, P505, DOI 10.1016/j.bmcl.2007.11.100; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; LITLECHILD J, 1995, ACTA CRYSTALLOGR D, V51, P1074, DOI 10.1107/S0907444995005415; Liu SQ, 2008, RAPID COMMUN MASS SP, V22, P3172, DOI 10.1002/rcm.3725; NIKKOLA M, 1994, J MOL BIOL, V238, P387, DOI 10.1006/jmbi.1994.1299; Nilsson U, 1997, J BIOL CHEM, V272, P1864, DOI 10.1074/jbc.272.3.1864; NIXON PF, 1984, EUR J CLIN INVEST, V14, P278, DOI 10.1111/j.1365-2362.1984.tb01181.x; Sax CM, 1996, J BIOL CHEM, V271, P33568, DOI 10.1074/jbc.271.52.33568; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P1297, DOI 10.1016/S1357-2725(98)00095-8; Schenk G, 1997, J MOL EVOL, V44, P552, DOI 10.1007/PL00006179; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P369, DOI 10.1016/S1357-2725(97)00154-4; SCHNEIDER G, 1989, J BIOL CHEM, V264, P21619; Schneider G, 1998, BBA-PROTEIN STRUCT M, V1385, P387, DOI 10.1016/S0167-4838(98)00082-X; Shin YK, 2009, ELECTROPHORESIS, V30, P2182, DOI 10.1002/elps.200800806; Sigrun L, 2006, TUMOR BIOL, V27, P48; Singleton CK, 1996, BIOCHEMISTRY-US, V35, P15865, DOI 10.1021/bi9616920; Soh Y, 1998, BIOCHEM J, V333, P367, DOI 10.1042/bj3330367; SPRENGER GA, 1995, EUR J BIOCHEM, V230, P525; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P2206, DOI 10.1016/j.bmcl.2007.11.101; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P509, DOI 10.1016/j.bmcl.2007.11.098; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Tittmann K, 2009, J MOL CATAL B-ENZYM, V61, P93, DOI 10.1016/j.molcatb.2009.02.019; Wikner C, 1997, BIOCHEMISTRY-US, V36, P15643, DOI 10.1021/bi971606b; Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078; Xu ZP, 2002, MOL CELL BIOL, V22, P6142, DOI 10.1128/MCB.22.17.6142-6147.2002; Zhao F, 2010, ONCOGENE, V29, P2962, DOI 10.1038/onc.2010.67; Zhao YL, 2009, J NEUROCHEM, V111, P537, DOI 10.1111/j.1471-4159.2009.06341.x	49	75	78	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31559	31570		10.1074/jbc.M110.149955	http://dx.doi.org/10.1074/jbc.M110.149955			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667822	Green Published, hybrid			2022-12-27	WOS:000282764600050
J	Sun, Y; Prasad, M; Gao, TA; Wang, XF; Zhu, QL; D'Souza, R; Feng, JQ; Qin, CL				Sun, Yao; Prasad, Monica; Gao, Tian; Wang, Xiaofang; Zhu, Qinglin; D'Souza, Rena; Feng, Jian Q.; Qin, Chunlin			Failure to Process Dentin Matrix Protein 1 (DMP1) into Fragments Leads to Its Loss of Function in Osteogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; ACIDIC PHOSPHOPROTEIN; PHOSPHATE HOMEOSTASIS; DMP1-DEFICIENT MICE; MINERALIZED TISSUES; BONE; EXPRESSION; ROLES; IDENTIFICATION; VITRO	Dentin matrix protein 1 (DMP1), an acidic protein important to the formation of bone and dentin, primarily exists as the processed NH2-terminal and COOH-terminal fragments in the extracellular matrix of the two tissues. Previous in vitro studies showed that the substitution of residue Asp(213) by Ala(213) (D213A) at a cleavage site blocked the processing of mouse DMP1 in cells. In this study, we generated transgenic mice expressing mutant D213A-DMP1 (WT/D213A-Tg mice) to test the hypothesis that the proteolytic processing of DMP1 is an activation step essential to osteogenesis. By crossbreeding WT/D213A-Tg mice with Dmp1 knock-out (Dmp1-KO) mice, we obtained mice expressing D213A-DMP1 in a Dmp1-KO background; these mice will be referred to as "Dmp1-KO/D213A-Tg" mice. Biochemical, radiological, and morphological approaches were used to characterize the skeletal phenotypes of Dmp1-KO/D213A-Tg mice compared with wild-type mice, Dmp1-KO mice, and Dmp1-KO mice expressing the normal Dmp1 transgene. Protein chemistry analyses showed that DMP1 was barely cleaved in the bone of the Dmp1-KO/D213A-Tg mice, indicating that D213A substitution effectively blocked the proteolytic processing of DMP1 in vivo. While the expression of the normal Dmp1 transgene completely rescued the phenotypic skeletal changes of the Dmp1-KO mice, the expression of the mutant D213A-Dmp1 transgene failed to do so. These results indicate that the full-length form of DMP1 is an inactive precursor and its proteolytic processing is an activation step essential to the biological functions of this protein in osteogenesis.	[Sun, Yao; Prasad, Monica; Gao, Tian; Wang, Xiaofang; Zhu, Qinglin; D'Souza, Rena; Feng, Jian Q.; Qin, Chunlin] Texas A&M Univ Syst Hlth Sci Ctr, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Qin, CL (corresponding author), 3302 Gaston Ave, Dallas, TX 75246 USA.	cqin@bcd.tamhsc.edu		D'Souza, Rena/0000-0002-1505-5173; sun, yao/0000-0002-4323-0506; Wang, Xiaofang/0000-0002-7370-7192	National Institutes of Health [DE 005092, DE015209]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE005092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE 005092 (to C. Q.) and DE015209 (to J.Q.F.).	Baba O, 2004, MATRIX BIOL, V23, P371, DOI 10.1016/j.matbio.2004.07.008; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Filanti C, 2000, J BONE MINER RES, V15, P2154, DOI 10.1359/jbmr.2000.15.11.2154; Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gericke A, 2010, J DENT RES, V89, P355, DOI 10.1177/0022034510363250; Hirst KL, 1997, J DENT RES, V76, P754, DOI 10.1177/00220345970760030701; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; MacDougall M, 1998, J BONE MINER RES, V13, P422, DOI 10.1359/jbmr.1998.13.3.422; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; Maciejewska I, 2009, J HISTOCHEM CYTOCHEM, V57, P155, DOI 10.1369/jhc.2008.952630; Peng T, 2009, CELLS TISSUES ORGANS, V189, P192, DOI 10.1159/000151373; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2006, J BIOL CHEM, V281, P8034, DOI 10.1074/jbc.M512964200; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Tartaix PH, 2004, J BIOL CHEM, V279, P18115, DOI 10.1074/jbc.M314114200; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; von Marschall Z, 2008, J BIOL CHEM, V283, P32730, DOI 10.1074/jbc.M804283200; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	28	38	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31713	31722		10.1074/jbc.M110.137059	http://dx.doi.org/10.1074/jbc.M110.137059			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663874	Green Published, hybrid			2022-12-27	WOS:000282764600063
J	Mayfield, JA; Frederick, RE; Streit, BR; Wencewicz, TA; Ballou, DP; DuBois, JL				Mayfield, Jeffery A.; Frederick, Rosanne E.; Streit, Bennett R.; Wencewicz, Timothy A.; Ballou, David P.; DuBois, Jennifer L.			Comprehensive Spectroscopic, Steady State, and Transient Kinetic Studies of a Representative Siderophore-associated Flavin Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-HYDROXYBENZOATE HYDROXYLASE; BIOCHEMICAL-CHARACTERIZATION; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; ORNITHINE HYDROXYLASE; ASPERGILLUS-FUMIGATUS; IRON; BIOSYNTHESIS; FAD; LYSINE	Many siderophores used for the uptake and intracellular storage of essential iron contain hydroxamate chelating groups. Their biosyntheses are typically initiated by hydroxylation of the primary amine side chains of L-ornithine or L-lysine. This reaction is catalyzed by members of a widespread family of FAD-dependent monooxygenases. Here the kinetic mechanism for a representative family member has been extensively characterized by steady state and transient kinetic methods, using heterologously expressed N-5-L-ornithine monooxygenase from the pathogenic fungus Aspergillus fumigatus. Spectroscopic data and kinetic analyses suggest a model in which a molecule of hydroxylatable substrate serves as an activator for the reaction of the reduced flavin and O-2. The rate acceleration is only similar to 5-fold, a mild effect of substrate on formation of the C4a-hydroperoxide that does not influence the overall rate of turnover. The effect is also observed with the bacterial ornithine monooxygenase PvdA. The C4a-hydroperoxide is stabilized in the absence of hydroxylatable substrate by the presence of bound NADP(+) (t(1/2) = 33 min, 25 degrees C, pH 8). NADP(+) therefore is a likely regulator of O-2 and substrate reactivity in the siderophore-associated monooxygenases. Aside from the activating effect of the hydroxylatable substrate, the siderophore-associated monooxygenases share a kinetic mechanism with the hepatic microsomal flavin monooxygenases and bacterial Baeyer-Villiger monooxygenases, with which they share only moderate sequence homology and from which they are distinguished by their acute substrate specificity. The remarkable specificity of the N-5-L-ornithine monooxygenase-catalyzed reaction suggests added means of reaction control beyond those documented in related well characterized flavoenzymes.	[Mayfield, Jeffery A.; Frederick, Rosanne E.; Streit, Bennett R.; Wencewicz, Timothy A.; DuBois, Jennifer L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Ballou, David P.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Notre Dame; University of Michigan System; University of Michigan	DuBois, JL (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 251 Nieuwland Hall, Notre Dame, IN 46556 USA.	jdubois@nd.edu		Streit, Bennett/0000-0001-9174-7019	National Institutes of Health [T32GM075762, GM20877]; National Science Foundation [CHE-0741793]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020877, R01GM020877, F32GM020877, R01GM090260, T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32GM075762 (a Chemistry-Biochemistry-Biology Interface Program Training Grant, which funded fellowships for T. A. W. and R. E. F.) and GM20877 (to D. P. B.).; We thank Prof. Marvin J. Miller for intellectual and material contributions toward the synthesis and characterization of L-Orn-OH. We thank Dr. Alexander Gehrke of the Hans Knoll Institute (Jena, Germany) for the kind gift of A. fumigatus from which genomic DNA was extracted. Amy Zercher gave technical assistance in cloning the sidA gene. We thank Garrett Moraski for technical assistance and for helpful discussions and Barrie Entsch (University of New England, New South Wales, Australia) for critical reading of the manuscript. NMR facilities were provided by the Lizzadro Magnetic Resonance Research Center at the University of Notre Dame, and mass spectrometry was provided by the University of Notre Dame Mass Spectrometry and Proteomics Facility (N. Sevova, Dr. W. Boggess, and Dr. M. V. Joyce; supported by National Science Foundation Grant CHE-0741793).	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ballou D. P., 1982, FLAVINS FLAVOPROTEIN, P301; BEATY NB, 1980, J BIOL CHEM, V255, P3817; BEATY NB, 1981, J BIOL CHEM, V256, P4619; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; COOK PF, 2007, ENZYME KINETICS MECH, P1; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P1; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Dick S, 1999, J PROTEIN CHEM, V18, P893, DOI 10.1023/A:1020639514998; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Ferreras JA, 2005, NAT CHEM BIOL, V1, P29, DOI 10.1038/nchembio706; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fraaije MW, 2002, FEBS LETT, V518, P43, DOI 10.1016/S0014-5793(02)02623-6; Frederick RE, 2009, BIOMETALS, V22, P583, DOI 10.1007/s10534-009-9236-1; Ge L, 2006, J BACTERIOL, V188, P7205, DOI 10.1128/JB.00949-06; Haas H, 2003, APPL MICROBIOL BIOT, V62, P316, DOI 10.1007/s00253-003-1335-2; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; ISOWA Y, 1972, B CHEM SOC JPN, V45, P1461, DOI 10.1246/bcsj.45.1461; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; JONES KC, 1986, J BIOL CHEM, V261, P2553; JONES KC, 1985, THESIS U MICHIGAN AN; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lin YM, 1999, J ORG CHEM, V64, P7451, DOI 10.1021/jo990769y; LITTLE DI, 1982, EUR J BIOCHEM, V124, P499; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P995, DOI 10.1111/j.1432-1033.1993.tb17846.x; Macheroux P, 1999, METH MOL B, V131, P1; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; Marrone L, 1997, BBA-PROTEIN STRUCT M, V1343, P263, DOI 10.1016/S0167-4838(97)00129-5; MCDOUGALL S, 1984, J BACTERIOL, V159, P300, DOI 10.1128/JB.159.1.300-305.1984; Meneely KM, 2007, BIOCHEMISTRY-US, V46, P11930, DOI 10.1021/bi700932q; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; NAEGELI HU, 1978, HELV CHIM ACTA, V61, P2088, DOI 10.1002/hlca.19780610615; Neres J, 2008, J MED CHEM, V51, P5349, DOI 10.1021/jm800567v; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; POLONSKI T, 1974, TETRAHEDRON LETT, P2453; POULSEN LL, 1995, CHEM-BIOL INTERACT, V96, P57, DOI 10.1016/0009-2797(94)03583-T; POULSEN LL, 1979, J BIOL CHEM, V254, P6449; Putignani L, 2004, BIOCHEM BIOPH RES CO, V313, P245, DOI 10.1016/j.bbrc.2003.11.116; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Somu RV, 2006, J MED CHEM, V49, P31, DOI 10.1021/jm051060o; STEENNIS PJ, 1973, FEBS LETT, V36, P177, DOI 10.1016/0014-5793(73)80363-1; Stevens DA, 2000, CLIN INFECT DIS, V30, P696, DOI 10.1086/313756; STORER AC, 1975, BIOCHEM J, V151, P361, DOI 10.1042/bj1510361; STRONG RK, 2005, LIPOCALINS, P204; THARIATH A, 1993, J BACTERIOL, V175, P589, DOI 10.1128/JB.175.3.589-596.1993; TOMLINSON G, 1971, ANAL BIOCHEM, V44, P670, DOI 10.1016/0003-2697(71)90258-2; WALSH CT, 1988, ANGEW CHEM INT EDIT, V27, P333, DOI 10.1002/anie.198803331; Walz AJ, 2007, ORG BIOMOL CHEM, V5, P1621, DOI 10.1039/b703116e; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wyatt MK, 1998, BIOCHEMISTRY-US, V37, P5930, DOI 10.1021/bi972622b; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	65	44	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30375	30388		10.1074/jbc.M110.157578	http://dx.doi.org/10.1074/jbc.M110.157578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20650894	Green Published, hybrid			2022-12-27	WOS:000282135500004
J	Teixeira, CC; Liu, YX; Thant, LM; Pang, J; Palmer, G; Alikhani, M				Teixeira, Cristina C.; Liu, Yuexun; Thant, Lwin M.; Pang, Jason; Palmer, Glyn; Alikhani, Mani			Foxo1, a Novel Regulator of Osteoblast Differentiation and Skeletogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FKHR; GENE-EXPRESSION; SKELETAL-MUSCLE; BONE-FORMATION; STEM-CELLS; OSTEOGENIC DIFFERENTIATION; MYOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; INSULIN SENSITIVITY; PARATHYROID-HORMONE	Skeletogenesis depends on the activity of bone-forming cells derived from mesenchymal cells. The pathways that control mesenchymal cell differentiation are not well understood. We propose that Foxo1 is an early molecular regulator during mesenchymal cell differentiation into osteoblasts. In mouse embryos, Foxo1 expression is higher in skeletal tissues, while Foxo1 silencing has a drastic impact on skeletogenesis and craniofacial development, specially affecting pre-maxilla, nasal bone, mandible, tibia, and clavicle. Similarly, Foxo1 activity and expression increase in mouse mesenchymal cells under the influence of osteogenic stimulants. In addition, silencing Foxo1 blocks the expression of osteogenic markers such as Runx2, alkaline phosphatase, and osteocalcin and results in decreased culture calcification even in the presence of strong osteogenic stimulants. Conversely, the expression of these markers increases significantly in response to Foxo1 overexpression. One mechanism through which Foxo1 affects mesenchymal cell differentiation into osteoblasts is through regulation of a key osteogenic transcription factor, Runx2. Indeed, our results show that Foxo1 directly interacts with the promoter of Runx2 and regulates its expression. Using a tibia organ culture model, we confirmed that silencing Foxo1 decreases the expression of Runx2 and impairs bone formation. Furthermore, our data reveals that Runx2 and Foxo1 interact with each other and cooperate in the transcriptional regulation of osteoblast markers. In conclusion, our in vitro, ex vivo, and in vivo results strongly support the notion that Foxo1 is an early molecular regulator in the differentiation of mesenchymal cells into osteoblast.	[Alikhani, Mani] NYU, Coll Dent, Dept Orthodont, New York, NY 10010 USA; [Teixeira, Cristina C.; Thant, Lwin M.; Pang, Jason; Palmer, Glyn] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA	New York University; New York University	Alikhani, M (corresponding author), NYU, Coll Dent, Dept Orthodont, 345 E 24th St,Rm 850, New York, NY 10010 USA.	mani.alikhani@nyu.edu			National Institutes of Health, NIDCR [5K08DE017426, R03DE019499]; Muscular Skeletal Repair and Regeneration Center at Hospital for Special Surgery, NIH [AR046121]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019499, K08DE017426] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Muscular Skeletal Repair and Regeneration Center at Hospital for Special Surgery, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants 5K08DE017426 and R03DE019499 from NIDCR. This work was also supported by the Muscular Skeletal Repair and Regeneration Center at Hospital for Special Surgery supported by NIH Grant AR046121.	AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Alikhani M, 2007, AM J PHYSIOL-CELL PH, V292, pC850, DOI 10.1152/ajpcell.00356.2006; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Birkenkamp KU, 2003, J IMMUNOL, V171, P1623, DOI 10.4049/jimmunol.171.4.1623; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Franceschi RT, 2004, CELLS TISSUES ORGANS, V176, P95, DOI 10.1159/000075031; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gilde AJ, 2003, ACTA PHYSIOL SCAND, V178, P425, DOI 10.1046/j.1365-201X.2003.01161.x; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gratsch TE, 2003, GENESIS, V37, P12, DOI 10.1002/gene.10221; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hatta M, 2002, INT J MOL MED, V9, P147; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kaestner KH, 2000, GENE DEV, V14, P142; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Maiese K, 2008, TRENDS MOL MED, V14, P219, DOI 10.1016/j.molmed.2008.03.002; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; OWEN ME, 1987, J CELL SCI, V87, P731; Peng SL, 2007, AUTOIMMUNITY, V40, P462, DOI 10.1080/08916930701464913; Polter A, 2009, BIOL PSYCHIAT, V65, P150, DOI 10.1016/j.biopsych.2008.08.005; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Ropelle ER, 2009, J PHYSIOL-LONDON, V587, P2341, DOI 10.1113/jphysiol.2009.170050; Scherr M, 2007, CELL CYCLE, V6, P444, DOI 10.4161/cc.6.4.3807; Serra R, 1999, J CELL BIOL, V145, P783, DOI 10.1083/jcb.145.4.783; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Teixeira CC, 2005, BONE, V37, P37, DOI 10.1016/j.bone.2005.03.010; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yasui A, 2007, BIOCHEM BIOPH RES CO, V364, P358, DOI 10.1016/j.bbrc.2007.10.013	56	95	105	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31055	31065		10.1074/jbc.M109.079962	http://dx.doi.org/10.1074/jbc.M109.079962			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20650891	hybrid, Green Published			2022-12-27	WOS:000282135500070
J	Csepeggi, C; Jiang, M; Frolov, A				Csepeggi, Chad; Jiang, Min; Frolov, Andrey			Somatic Cell Plasticity and Niemann-Pick Type C2 Protein ADIPOCYTE DIFFERENTIATION AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; CCAAT/ENHANCER-BINDING PROTEINS; TRANSCRIPTION FACTOR FOXO1; ALPHA GENE-EXPRESSION; NF-KAPPA-B; PPAR-GAMMA; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; CARDIOVASCULAR-DISEASE	The phenotypic stability of somatic cells is essential for the maintenance of both structural and functional organ integrity of the adult human body. Deregulated cell plasticity could result in the development of debilitating diseases such as cancer, fibrosis, atherosclerosis, obesity, and type 2 diabetes. We have previously demonstrated that a nonsense mutation in the NPC2 gene, which encodes ubiquitous, highly conserved, secretory protein with unknown function, leads to activation of human skin fibroblasts. The activated fibroblasts, also known as myofibroblasts, have the properties of mesenchymal stem cells and are able to differentiate along the mesodermal and endodermal lineages. Here we show that NPC2-null, but not the normal skin fibroblasts, possess characteristics of adipogenic progenitors as demonstrated by their specific gene expression pattern as well as the ability for efficient differentiation into white adipocytes. The presence of NPC2 in mature white adipocytes was also necessary for their maintenance because silencing NPC2 in differentiated cells by siRNA stimulated PPARG expression, which was followed by a shift toward a more favorable, brown adipocyte-like metabolic state characterized by up-regulated lipolysis and increased insulin sensitivity. It appears that NPC2 controls both the adipogenesis and the metabolic state of mature white adipocytes through a common mechanism that is linked to activation of FGFR2 that could be followed by induction of PPARG expression. Altogether, the current study highlights NPC2 as a novel intracrine/autocrine factor that controls adipocyte differentiation and function as well as potential therapeutic target for the treatment of type 2 diabetes and related metabolic disorders.	[Csepeggi, Chad; Jiang, Min; Frolov, Andrey] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Frolov, A (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Dis, 231 Albert Sabin Way,ML 0542,CVC 4928,POB 670542, Cincinnati, OH 45267 USA.	andrey.frolov@uc.edu			American Heart Association; University of Cincinnati; Dept. of Internal Medicine	American Heart Association(American Heart Association); University of Cincinnati; Dept. of Internal Medicine	This work was supported by an American Heart Association Scientist Development Grant and the University of Cincinnati Millennium Fund and the Dept. of Internal Medicine Start-Up Fund (to A.F.).	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Chehab FF, 2008, ENDOCRINOLOGY, V149, P925, DOI 10.1210/en.2007-1355; Chew CH, 2007, INT J BIOCHEM CELL B, V39, P1975, DOI 10.1016/j.biocel.2007.05.015; Chinetti-Gbaguidi G, 2005, J LIPID RES, V46, P2717, DOI 10.1194/jlr.M500326-JLR200; Di-Poi N, 2005, J BIOL CHEM, V280, P38700, DOI 10.1074/jbc.M507782200; Festuccia WT, 2006, DIABETOLOGIA, V49, P2427, DOI 10.1007/s00125-006-0336-y; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hammarstedt A, 2005, DIABETOLOGIA, V48, P96, DOI 10.1007/s00125-004-1612-3; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Junker JPE, 2010, CELLS TISSUES ORGANS, V191, P105, DOI 10.1159/000232157; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; Li XL, 2006, P NATL ACAD SCI USA, V103, P17432, DOI 10.1073/pnas.0607939103; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Newell FS, 2006, FASEB J, V20, P2615, DOI 10.1096/fj.05-5710fje; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Tafuri SR, 1996, ENDOCRINOLOGY, V137, P4706, DOI 10.1210/en.137.11.4706; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yamasaki S, 2004, RHEUMATOLOGY, V43, P448, DOI 10.1093/rheumatology/keh092; Yamasaki S, 2002, CLIN EXP IMMUNOL, V129, P379, DOI 10.1046/j.1365-2249.2002.01876.x	52	13	13	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30347	30354		10.1074/jbc.M110.135939	http://dx.doi.org/10.1074/jbc.M110.135939			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650896	hybrid, Green Published			2022-12-27	WOS:000281984300070
J	Aalto, AP; Poranen, MM; Grimes, JM; Stuart, DI; Bamford, DH				Aalto, Antti P.; Poranen, Minna M.; Grimes, Jonathan M.; Stuart, David I.; Bamford, Dennis H.			In Vitro Activities of the Multifunctional RNA Silencing Polymerase QDE-1 of Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INTERFERENCE; EXPRESSION; PROTEIN; REPLICATION; INTERACTS; PATHWAY; SIRNAS; GENES; DICER	QDE-1 is an RNA-and DNA-dependent RNA polymerase that has functions in the RNA silencing and DNA repair pathways of the filamentous fungus Neurospora crassa. The crystal structure of the dimeric enzyme has been solved, and the fold of its catalytic core is related closely to that of eukaryotic DNA-dependent RNA polymerases. However, the specific activities of this multifunctional enzyme are still largely unknown. In this study, we characterized the in vitro activities of the N-terminally truncated QDE-1 Delta N utilizing structure-based mutagenesis. Our results indicate that QDE-1 displays five distinct catalytic activities, which can be dissected by mutating critical amino acids or by altering reaction conditions. Our data also suggest that the RNA-and DNA-dependent activities have different modes for the initiation of RNA synthesis, which may reflect the mechanism that enables the polymerase to discriminate between template nucleic acids. Moreover, we show that QDE-1 is a highly potent terminal nucleotidyltransferase. Our results suggest that QDE-1 is able to regulate its activity mode depending on the template nucleic acid. This work extends our understanding of the biochemical properties of the QDE-1 enzyme and related RNA polymerases.	[Bamford, Dennis H.] Univ Helsinki, Bioctr 2, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Bamford, Dennis H.] Univ Helsinki, Bioctr 2, Dept Biosci, FIN-00014 Helsinki, Finland; [Grimes, Jonathan M.; Stuart, David I.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England	University of Helsinki; University of Helsinki; University of Oxford	Bamford, DH (corresponding author), Univ Helsinki, Bioctr 2, Inst Biotechnol, POB 56, FIN-00014 Helsinki, Finland.	dennis.bamford@helsinki.fi		Bamford, Dennis/0000-0002-6438-8118; Stuart, David/0000-0002-3426-4210; Grimes, Jonathan Mark/0000-0001-9698-0389; Poranen, Minna/0000-0002-4775-3670	Academy of Finland Finnish Centre of Excellence [1129684]; United Kingdom Medical Research Council and SPINE2COMPLEXES [LSHGCT-2006-031220]; MRC [G0500365, G1000099] Funding Source: UKRI; Medical Research Council [G1000099, G0500365] Funding Source: researchfish	Academy of Finland Finnish Centre of Excellence(Academy of Finland); United Kingdom Medical Research Council and SPINE2COMPLEXES(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Academy of Finland Finnish Centre of Excellence Programme 2006-2011 (1129684, to D. H. B.) and by the United Kingdom Medical Research Council and SPINE2COMPLEXES (LSHGCT-2006-031220).	Catalanotto C, 2006, FEMS MICROBIOL LETT, V254, P182, DOI 10.1111/j.1574-6968.2005.00037.x; Catalanotto C, 2004, MOL CELL BIOL, V24, P2536, DOI 10.1128/MCB.24.6.2536-2545.2004; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Forrest EC, 2004, NUCLEIC ACIDS RES, V32, P2123, DOI 10.1093/nar/gkh530; Fulci V, 2007, CURR OPIN MICROBIOL, V10, P199, DOI 10.1016/j.mib.2007.03.016; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goldoni M, 2004, FUNGAL GENET BIOL, V41, P1016, DOI 10.1016/j.fgb.2004.08.002; GOTTLIEB P, 1992, J VIROL, V66, P2611, DOI 10.1128/JVI.66.5.2611-2616.1992; Laurila MRL, 2005, J STRUCT BIOL, V149, P111, DOI 10.1016/j.jsb.2004.10.001; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nolan T, 2008, NUCLEIC ACIDS RES, V36, P532, DOI 10.1093/nar/gkm1071; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pickford A, 2003, CURR GENET, V42, P220, DOI 10.1007/s00294-002-0351-6; Poranen MM, 2008, J VIROL, V82, P9254, DOI 10.1128/JVI.01044-08; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Sambrook J., 2001, MOL CLONING LAB MANU; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Yang HY, 2001, J VIROL, V75, P11088, DOI 10.1128/JVI.75.22.11088-11095.2001	36	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29367	29374		10.1074/jbc.M110.139121	http://dx.doi.org/10.1074/jbc.M110.139121			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20647305	hybrid, Green Published			2022-12-27	WOS:000281740100039
J	Lewis, NE; Marty, NJ; Kathir, KM; Rajalingam, D; Kight, AD; Daily, A; Kumar, TKS; Henry, RL; Goforth, RL				Lewis, Nathaniel E.; Marty, Naomi J.; Kathir, Karuppanan Muthusamy; Rajalingam, Dakshinamurthy; Kight, Alicia D.; Daily, Anna; Kumar, Thallapuranam Krishnaswamy Suresh; Henry, Ralph L.; Goforth, Robyn L.			A Dynamic cpSRP43-Albino3 Interaction Mediates Translocase Regulation of Chloroplast Signal Recognition Particle (cpSRP)-targeting Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; HARVESTING CHLOROPHYLL PROTEINS; THYLAKOID MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; POSTTRANSLATIONAL INTEGRATION; HOMOLOG ALBINO3; BACTERIAL YIDC; OXA1 COMPLEX; GTPASE CYCLE; INSERTION	The chloroplast signal recognition particle (cpSRP) and its receptor, chloroplast FtsY (cpFtsY), form an essential complex with the translocase Albino3 (Alb3) during post-translational targeting of light-harvesting chlorophyll-binding proteins (LHCPs). Here, we describe a combination of studies that explore the binding interface and functional role of a previously identified cpSRP43-Alb3 interaction. Using recombinant proteins corresponding to the C terminus of Alb3 (Alb3-Cterm) and various domains of cpSRP43, we identify the ankyrin repeat region of cpSRP43 as the domain primarily responsible for the interaction with Alb3-Cterm. Furthermore, we show Alb3-Cterm dissociates a cpSRP.LHCP targeting complex in vitro and stimulates GTP hydrolysis by cpSRP54 and cpFtsY in a strictly cpSRP43-dependent manner. These results support a model in which interactions between the ankyrin region of cpSRP43 and the C terminus of Alb3 promote distinct membrane-localized events, including LHCP release from cpSRP and release of targeting components from Alb3.	[Lewis, Nathaniel E.; Marty, Naomi J.; Kight, Alicia D.; Henry, Ralph L.; Goforth, Robyn L.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Kathir, Karuppanan Muthusamy; Rajalingam, Dakshinamurthy; Daily, Anna; Kumar, Thallapuranam Krishnaswamy Suresh; Goforth, Robyn L.] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Henry, RL (corresponding author), Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA.	rahenry@uark.edu; Robyn.Goforth@uark.edu	Kumar, Suresh Thallapuranam/R-5606-2016; KUMAR, P. SURESH/AAT-8951-2020; Kumar, Dr Suresh/HHZ-2615-2022	Kumar, Suresh Thallapuranam/0000-0001-7262-1373; KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553	National Institutes of Health, NCRR [P20 RR15569]; Department of Energy [DE-FG02-01ER15161]; Arkansas Biosciences Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER	National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy(United States Department of Energy (DOE)); Arkansas Biosciences Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR15569 (R. L. G. and T. K. S. K.) from the NCRR. This work was also supported by Department of Energy Grant DE-FG02-01ER15161 (to R. L. H. and T. K. S. K.) and the Arkansas Biosciences Institute.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Chu FX, 2004, P NATL ACAD SCI USA, V101, P16454, DOI 10.1073/pnas.0407456101; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CLINE K, 1989, J BIOL CHEM, V264, P14225; Dalbey RE, 2004, BBA-MOL CELL RES, V1694, P37, DOI 10.1016/j.bbamcr.2004.03.009; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Hermkes R, 2006, FEBS LETT, V580, P3107, DOI 10.1016/j.febslet.2006.04.055; Hutin C, 2002, PLANT J, V29, P531, DOI 10.1046/j.0960-7412.2001.01211.x; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jaru-Ampornpan P, 2009, MOL BIOL CELL, V20, P3965, DOI 10.1091/mbc.E08-10-0989; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Jonas-Straube E, 2001, J BIOL CHEM, V276, P24654, DOI 10.1074/jbc.M100153200; Kathir KM, 2008, J MOL BIOL, V381, P49, DOI 10.1016/j.jmb.2008.05.065; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kogata N, 1999, FEBS LETT, V447, P329, DOI 10.1016/S0014-5793(99)00305-1; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Mandon EC, 2003, J CELL BIOL, V162, P575, DOI 10.1083/jcb.200303143; Marty NJ, 2009, J BIOL CHEM, V284, P14891, DOI 10.1074/jbc.M900775200; MILLER JD, 1993, CIBA F SYMP, V176, P147; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; PAYAN LA, 1991, J CELL BIOL, V112, P603, DOI 10.1083/jcb.112.4.603; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; Roselin LS, 2010, BIOTECHNOL J, V5, P85, DOI 10.1002/biot.200900092; Rutschow H, 2008, PLANT PHYSIOL, V148, P156, DOI 10.1104/pp.108.124545; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schunemann D, 2004, CURR GENET, V44, P295, DOI 10.1007/s00294-003-0450-z; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Stuart RA, 2002, BBA-MOL CELL RES, V1592, P79, DOI 10.1016/S0167-4889(02)00266-5; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; Woolhead CA, 2001, J BIOL CHEM, V276, P40841, DOI 10.1074/jbc.M106523200; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x; Yi L, 2005, MOL MEMBR BIOL, V22, P101, DOI 10.1080/09687860500041718; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	55	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34220	34230		10.1074/jbc.M110.160093	http://dx.doi.org/10.1074/jbc.M110.160093			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729200	Green Published, hybrid			2022-12-27	WOS:000283354000067
J	Rampersad, SN; Ovens, JD; Huston, E; Umana, MB; Wilson, LS; Netherton, SJ; Lynch, MJ; Baillie, GS; Houslay, MD; Maurice, DH				Rampersad, Sarah N.; Ovens, Jeffrey D.; Huston, Elaine; Umana, M. Bibiana; Wilson, Lindsay S.; Netherton, Stuart J.; Lynch, Martin J.; Baillie, George S.; Houslay, Miles D.; Maurice, Donald H.			Cyclic AMP Phosphodiesterase 4D (PDE4D) Tethers EPAC1 in a Vascular Endothelial Cadherin (VE-Cad)-based Signaling Complex and Controls cAMP-mediated Vascular Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; TYROSINE PHOSPHORYLATION; BARRIER FUNCTION; EXCHANGE FACTOR; CELL JUNCTIONS; VE-CADHERIN; PKA; ACTIVATION; ADHESION; INTEGRITY	Vascular endothelial cell (VEC) permeability is largely dependent on the integrity of vascular endothelial cadherin (VE-cadherin or VE-Cad)-based intercellular adhesions. Activators of protein kinase A (PKA) or of exchange protein activated by cAMP (EPAC) reduce VEC permeability largely by stabilizing VE-Cad-based intercellular adhesions. Currently, little is known concerning the nature and composition of the signaling complexes that allow PKA or EPAC to regulate VE-Cad-based structures and through these actions control permeability. Using pharmacological, biochemical, and cell biological approaches we identified and determined the composition and functionality of a signaling complex that coordinates cAMP-mediated control of VE-Cad-based adhesions and VEC permeability. Thus, we report that PKA, EPAC1, and cyclic nucleotide phosphodiesterase 4D (PDE4D) enzymes integrate into VE-Cad-based signaling complexes in human arterial endothelial cells. Importantly, we show that protein-protein interactions between EPAC1 and PDE4D serve to foster their integration into VE-Cad-based complexes and allow robust local regulation of EPAC1-based stabilization of VE-Cad-based adhesions. Of potential translational importance, we mapped the EPAC1 peptide motif involved in binding PDE4D and show that a cell-permeable variant of this peptide antagonizes EPAC1-PDE4D binding and directly alters VEC permeability. Collectively, our data indicate that PDE4D regulates both the activity and subcellular localization of EPAC1 and identify a novel mechanism for regulated EPAC1 signaling in these cells.	[Umana, M. Bibiana; Netherton, Stuart J.; Maurice, Donald H.] Queens Univ, Dept Pharmacol & Toxicol, Kingston, ON K7L 3N6, Canada; [Rampersad, Sarah N.; Ovens, Jeffrey D.; Wilson, Lindsay S.; Maurice, Donald H.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Huston, Elaine; Lynch, Martin J.; Baillie, George S.; Houslay, Miles D.] Univ Glasgow, Inst Biomed & Life Sci, Mol Pharmacol Grp, Glasgow, Lanark, Scotland	Queens University - Canada; McMaster University; Queens University - Canada; University of Glasgow	Maurice, DH (corresponding author), Queens Univ, Dept Pharmacol & Toxicol, Botterell Hall,A208, Kingston, ON K7L 3N6, Canada.	mauriced@queensu.ca	Houslay, Miles/AAM-5281-2020; Maurice, Donald/AAE-9332-2019; Houslay, Miles D/A-6825-2011	Houslay, Miles/0000-0002-3826-8091	Canadian Institutes for Health Sciences [MOP-57699]; Medical Research Council (UK) [G0600765]; European Union [LSHB-CT-2006-037189]; Fondation Leducq [06CVD02]; MRC [G0600765] Funding Source: UKRI; Medical Research Council [G0600765] Funding Source: researchfish	Canadian Institutes for Health Sciences(Canadian Institutes of Health Research (CIHR)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Grants MOP-57699 from the Canadian Institutes for Health Sciences, G0600765 from the Medical Research Council (UK), LSHB-CT-2006-037189 from the European Union, and 06CVD02 from the Fondation Leducq (to M. D. H.).	Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Moya EMG, 2009, CELL SIGNAL, V21, P1727, DOI 10.1016/j.cellsig.2009.08.006; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hudry-Clergeon H, 2005, FASEB J, V19, P512, DOI 10.1096/fj.04-2202com; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Liu F, 2001, AM J PHYSIOL-LUNG C, V280, pL1309, DOI 10.1152/ajplung.2001.280.6.L1309; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Lorenowicz MJ, 2008, EUR J CELL BIOL, V87, P779, DOI 10.1016/j.ejcb.2008.05.004; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Netherton SJ, 2007, CIRC RES, V101, P768, DOI 10.1161/CIRCRESAHA.106.146159; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; Raymond DR, 2007, CELL SIGNAL, V19, P2507, DOI 10.1016/j.cellsig.2007.08.005; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	40	74	78	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33614	33622		10.1074/jbc.M110.140004	http://dx.doi.org/10.1074/jbc.M110.140004			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732872	Green Published, hybrid			2022-12-27	WOS:000283354000006
J	Harrus, D; Ahmed-El-Sayed, N; Simister, PC; Miller, S; Triconnet, M; Hagedorn, CH; Mahias, K; Rey, FA; Astier-Gin, T; Bressanelli, S				Harrus, Deborah; Ahmed-El-Sayed, Neveen; Simister, Philip C.; Miller, Steve; Triconnet, Martine; Hagedorn, Curt H.; Mahias, Kathleen; Rey, Felix A.; Astier-Gin, Therese; Bressanelli, Stephane			Further Insights into the Roles of GTP and the C Terminus of the Hepatitis C Virus Polymerase in the Initiation of RNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO INITIATION; CRYSTAL-STRUCTURE; IN-VITRO; NS5B POLYMERASE; CDNA-CLONE; REPLICATION; IDENTIFICATION; INHIBITION; MECHANISM; COMPLEX	The hepatitis C virus (HCV) NS5b protein is an RNA-dependent RNA polymerase essential for replication of the viral RNA genome. In vitro and presumably in vivo, NS5b initiates RNA synthesis by a de novo mechanism. Different structural elements of NS5b have been reported to participate in RNA synthesis, especially a so-called "beta-flap" and a C-terminal segment (designated "linker") that connects the catalytic core of NS5b to a transmembrane anchor. High concentrations of GTP have also been shown to stimulate de novo RNA synthesis by HCV NS5b. Here we describe a combined structural and functional analysis of genotype 1 HCV-NS5b of strains H77 (subtype 1a), for which no structure has been previously reported, and J4 (subtype 1b). Our results highlight the linker as directly involved in lifting the first boundary to processive RNA synthesis, the formation of the first dinucleotide primer. The transition from this first dinucleotide primer state to processive RNA synthesis requires removal of the linker and of the beta-flap with which it is shown to strongly interact in crystal structures of HCV NS5b. We find that GTP specifically stimulates this transition irrespective of its incorporation in neosynthesized RNA.	[Harrus, Deborah; Simister, Philip C.; Triconnet, Martine; Rey, Felix A.; Bressanelli, Stephane] CNRS UPR3296, Lab Virol Mol & Struct, F-91198 Gif Sur Yvette, France; [Ahmed-El-Sayed, Neveen; Mahias, Kathleen; Astier-Gin, Therese] Univ Bordeaux 2, IFR66, CNRS UMR 52342, F-33076 Bordeaux, France; [Miller, Steve; Hagedorn, Curt H.] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite de Bordeaux; University of Kansas; University of Kansas Medical Center	Bressanelli, S (corresponding author), CNRS UPR3296, Lab Virol Mol & Struct, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	stephane.bressanelli@vms.cnrs-gif.fr	Rey, Felix/B-6497-2012	Rey, Felix/0000-0002-9953-7988; Bressanelli, Stephane/0000-0002-0921-6727; Harrus, Deborah/0000-0002-7651-672X	National Institutes of Health [RO1 CA63640]; Agence Nationale de Recherche sur le Sida et les Hepatites Virales [AO 2008, CSS4]; Egyptian Ministry of Education; NATIONAL CANCER INSTITUTE [R01CA063640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherche sur le Sida et les Hepatites Virales(ANRSFrench National Research Agency (ANR)); Egyptian Ministry of Education(Ministry of Higher Education & Scientific Research (MHESR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA63640 (to C. H. H.). This work was also supported in part by Agence Nationale de Recherche sur le Sida et les Hepatites Virales Grants AO 2008, CSS4 (to S. B.) and AO 2008, CSS4 (T. A.-G.) and predoctoral (to D. H. and K. M.) and postdoctoral (to P. C. S.) fellowships.; Supported by a Ph.D. fellowship from the Egyptian Ministry of Education.	Adachi T, 2002, BBA-PROTEINS PROTEOM, V1601, P38, DOI 10.1016/S1570-9639(02)00433-8; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Astier-Gin T, 2005, FEBS J, V272, P3872, DOI 10.1111/j.1742-4658.2005.04804.x; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cai ZH, 2004, J VIROL, V78, P3633, DOI 10.1128/JVI.78.7.3633-3643.2004; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; D'Abramo CM, 2006, J BIOL CHEM, V281, P24991, DOI 10.1074/jbc.M600474200; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Ellis DA, 2009, BIOORG MED CHEM LETT, V19, P6047, DOI 10.1016/j.bmcl.2009.09.051; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Ivashkina N, 2002, J VIROL, V76, P13088, DOI 10.1128/JVI.76.24.13088-13093.2002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lescar J, 2009, CURR OPIN STRUC BIOL, V19, P759, DOI 10.1016/j.sbi.2009.10.011; Lohmann V, 1999, J BIOL CHEM, V274, P10807, DOI 10.1074/jbc.274.16.10807; Lou H, 2003, VIROLOGY, V317, P65, DOI 10.1016/j.virol.2003.08.038; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Masante C, 2008, J GEN VIROL, V89, P212, DOI 10.1099/vir.0.83067-0; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; Reigadas S, 2001, EUR J BIOCHEM, V268, P5857, DOI 10.1046/j.0014-2956.2001.02532.x; Rockway TW, 2006, BIOORG MED CHEM LETT, V16, P3833, DOI 10.1016/j.bmcl.2006.04.022; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Schneider TR, 2004, ACTA CRYSTALLOGR D, V60, P2269, DOI 10.1107/S0907444904023492; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Yanagi M, 1998, VIROLOGY, V244, P161, DOI 10.1006/viro.1998.9092; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	49	62	63	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32906	32918		10.1074/jbc.M110.151316	http://dx.doi.org/10.1074/jbc.M110.151316			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729191	hybrid, Green Published			2022-12-27	WOS:000283048200028
J	Iyappan, S; Wollscheid, HP; Rojas-Fernandez, A; Marquardt, A; Tang, HC; Singh, RK; Scheffner, M				Iyappan, Saravanakumar; Wollscheid, Hans-Peter; Rojas-Fernandez, Alejandro; Marquardt, Andreas; Tang, Hao-Cheng; Singh, Rajesh K.; Scheffner, Martin			Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC LETHALITY; IN-VIVO; NUCLEOLAR-LOCALIZATION; ALLOSTERIC ACTIVATION; MDM2-DEFICIENT MICE; P53 INHIBITION; REGULATE P53; UBIQUITYLATION; DEGRADATION; RESCUE	The related RING domain proteins MdmX and Mdm2 are best known for their role as negative regulators of the tumor suppressor p53. However, although Mdm2 functions as a ubiquitin ligase for p53, MdmX does not have appreciable ubiquitin ligase activity. In this study, we performed a mutational analysis of the RING domain of MdmX, and we identified two distinct regions that, when replaced by the respective regions of Mdm2, turn MdmX into an active ubiquitin ligase for p53. Mdm2 and MdmX form homodimers as well as heterodimers with each other. One of the regions identified localizes to the dimer interface indicating that subtle conformational changes in this region either affect dimer stability and/or the interaction with the ubiquitin-conjugating enzyme UbcH5b. The second region contains the cryptic nucleolar localization signal of Mdm2 but is also assumed to be involved in the interaction with UbcH5b. Here, we show that this region has a significant impact on the ability of respective MdmX mutants to functionally interact with UbcH5b in vitro supporting the notion that this region serves two distinct functional purposes, nucleolar localization and ubiquitin ligase activity. Finally, evidence is provided to suggest that the RING domain of Mdm2 not only binds to UbcH5b but also acts as an allosteric activator of UbcH5b.	[Iyappan, Saravanakumar; Wollscheid, Hans-Peter; Rojas-Fernandez, Alejandro; Tang, Hao-Cheng; Scheffner, Martin] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Iyappan, Saravanakumar; Wollscheid, Hans-Peter; Rojas-Fernandez, Alejandro; Tang, Hao-Cheng; Scheffner, Martin] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Marquardt, Andreas] Univ Konstanz, Prote Facil, D-78457 Constance, Germany; [Singh, Rajesh K.] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA	University of Konstanz; University of Konstanz; University of Konstanz; University System of Maryland; University of Maryland College Park	Scheffner, M (corresponding author), Univ Konstanz, Dept Biol, Box 642, D-78457 Constance, Germany.	martin.scheffner@uni-konstanz.de	Scheffner, Martin/K-2940-2012; Fernandez, Alejandro Rojas/K-3291-2014	Scheffner, Martin/0000-0003-2229-0128; Fernandez, Alejandro Rojas/0000-0002-6004-5425	Deutsche Forschungsgemeinschaft; European Union Network of Excellence RUBICON	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union Network of Excellence RUBICON(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft and by the European Union Network of Excellence RUBICON.	Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Dang JJ, 2002, CANCER RES, V62, P1222; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finch RA, 2002, CANCER RES, V62, P3221; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li CG, 2002, MOL CELL BIOL, V22, P7562, DOI 10.1128/MCB.22.21.7562-7571.2002; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JC, 2004, CELL CYCLE, V3, P900; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Migliorini D, 2002, J BIOL CHEM, V277, P7318, DOI 10.1074/jbc.M108795200; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Singh RK, 2007, J BIOL CHEM, V282, P10901, DOI 10.1074/jbc.M610879200; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103	45	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33065	33072		10.1074/jbc.M110.115113	http://dx.doi.org/10.1074/jbc.M110.115113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705607	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000283048200044
J	Boland, MP; Hatty, CR; Separovic, F; Hill, AF; Tew, DJ; Barnham, KJ; Haigh, CL; James, M; Masters, CL; Collins, SJ				Boland, Martin P.; Hatty, Claire R.; Separovic, Frances; Hill, Andrew F.; Tew, Deborah J.; Barnham, Kevin J.; Haigh, Cathryn L.; James, Michael; Masters, Colin L.; Collins, Steven J.			Anionic Phospholipid Interactions of the Prion Protein N Terminus Are Minimally Perturbing and Not Driven Solely by the Octapeptide Repeat Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; LIPID-PEROXIDATION; RELAXATION-TIME; COPPER-BINDING; METAL-IONS; CELL-LINE; PHOSPHATIDYLSERINE; SURFACE	Although the N terminus of the prion protein (PrPC) has been shown to directly associate with lipid membranes, the precise determinants, biophysical basis, and functional implications of such binding, particularly in relation to endogenously occurring fragments, are unresolved. To better understand these issues, we studied a range of synthetic peptides: specifically those equating to the N1 (residues 23-110) and N2 (23-89) fragments derived from constitutive processing of PrPC and including those representing arbitrarily defined component domains of the N terminus of mouse prion protein. Utilizing more physiologically relevant large unilamellar vesicles, fluorescence studies at synaptosomal pH (7.4) showed absent binding of all peptides to lipids containing the zwitterionic headgroup phos-phatidylcholine and mixtures containing the anionic headgroups phosphatidylglycerol or phosphatidylserine. At pH 5, typical of early endosomes, quartz crystal microbalance with dissipation showed the highest affinity binding occurred with N1 and N2, selective for anionic lipid species. Of particular note, the absence of binding by individual peptides representing component domains underscored the importance of the combination of the octapeptide repeat and the N-terminal polybasic regions for effective membrane interaction. In addition, using quartz crystal microbalance with dissipation and solid-state NMR, we characterized for the first time that both N1 and N2 deeply insert into the lipid bilayer with minimal disruption. Potential functional implications related to cellular stress responses are discussed.	[Boland, Martin P.; Tew, Deborah J.; Barnham, Kevin J.; Haigh, Cathryn L.; Collins, Steven J.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Boland, Martin P.; Hill, Andrew F.; Tew, Deborah J.; Barnham, Kevin J.; Haigh, Cathryn L.; Masters, Colin L.; Collins, Steven J.] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia; [Separovic, Frances] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Hill, Andrew F.; Tew, Deborah J.; Barnham, Kevin J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Hatty, Claire R.; James, Michael] Australian Nucl Sci & Technol Org, Bragg Inst, Lucas Heights, NSW 2234, Australia; [Hatty, Claire R.] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; [James, Michael] Univ New S Wales, Sch Chem, Kensington, NSW 2052, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Australian Nuclear Science & Technology Organisation; University of Sydney; University of New South Wales Sydney	Collins, SJ (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.	stevenjc@unimelb.edu.au	Separovic, Frances/D-9698-2011; Hill, Andrew F./AAH-2854-2020; James, Michael/A-8960-2011; Hill, Andrew F/B-4527-2009; Hill, Andrew F./GZL-4124-2022	Separovic, Frances/0000-0002-6484-2763; James, Michael/0000-0002-4918-2998; Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; Haigh, Cathryn/0000-0001-7591-1149; Hatty, Claire/0000-0003-4870-9820	Australian Nuclear Science and Technology Organisation/University of Melbourne; National Health and Medical Research Council [400202]	Australian Nuclear Science and Technology Organisation/University of Melbourne(University of Melbourne); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by an Australian Nuclear Science and Technology Organisation/University of Melbourne collaboration grant.; Supported by National Health and Medical Research Council fellowships with further funding from National Health and Medical Research Council Program Grant 400202.	Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; BEVERS EM, 1989, BIOCHEMISTRY-US, V28, P2382, DOI 10.1021/bi00432a007; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Castegna A, 2004, BRAIN RES, V1004, P193, DOI 10.1016/j.brainres.2004.01.036; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Christ K, 2008, J MEMBRANE BIOL, V226, P9, DOI 10.1007/s00232-008-9134-4; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; Dong SL, 2007, BIOPOLYMERS, V88, P840, DOI 10.1002/bip.20860; DUFOURC EJ, 1992, BIOPHYS J, V61, P42, DOI 10.1016/S0006-3495(92)81814-3; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FADOK VA, 1992, J IMMUNOL, V148, P2207; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; Farge E, 1995, BIOPHYS J, V69, P2501, DOI 10.1016/S0006-3495(95)80120-7; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Haigh CL, 2009, CELL RES, V19, P1062, DOI 10.1038/cr.2009.86; Haigh CL, 2009, J CELL SCI, V122, P1518, DOI 10.1242/jcs.043604; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Johnson RT, 2005, LANCET NEUROL, V4, P635, DOI 10.1016/S1474-4422(05)70192-7; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200; Koenig BW, 1996, LANGMUIR, V12, P1343, DOI 10.1021/la950580r; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lau TL, 2006, J MOL BIOL, V356, P759, DOI 10.1016/j.jmb.2005.11.091; Lau TL, 2007, BBA-BIOMEMBRANES, V1768, P2400, DOI 10.1016/j.bbamem.2007.05.004; Mechler A, 2007, BIOPHYS J, V93, P3907, DOI 10.1529/biophysj.107.116525; Miura T, 1999, BIOCHEMISTRY-US, V38, P11560, DOI 10.1021/bi9909389; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; MURPHY EJ, 1993, LIPIDS, V28, P67, DOI 10.1007/BF02536364; MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757; Oglecka K, 2008, BBA-BIOMEMBRANES, V1778, P206, DOI 10.1016/j.bbamem.2007.09.034; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PLAGER DA, 1994, BIOCHEMISTRY-US, V33, P7005, DOI 10.1021/bi00188a033; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pukala TL, 2007, BIOCHEMISTRY-US, V46, P3576, DOI 10.1021/bi062306+; Re F, 2008, FEBS LETT, V582, P215, DOI 10.1016/j.febslet.2007.12.003; Rimon G, 1997, J NEUROSCI RES, V48, P563, DOI 10.1002/(SICI)1097-4547(19970615)48:6<563::AID-JNR9>3.0.CO;2-8; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; Separovic F, 2000, CHEM PHYS LIPIDS, V107, P159, DOI 10.1016/S0009-3084(00)00168-7; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang XH, 2006, J BIOL CHEM, V281, P13559, DOI 10.1074/jbc.M512306200; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zeng FN, 2003, J NEUROCHEM, V84, P480, DOI 10.1046/j.1471-4159.2003.01529.x	67	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32282	32292		10.1074/jbc.M110.123398	http://dx.doi.org/10.1074/jbc.M110.123398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679345	Green Published, hybrid			2022-12-27	WOS:000282683000041
J	Lee, J; Lee, J; Jung, E; Kim, YS; Roh, K; Jung, KH; Park, D				Lee, Jongsung; Lee, Jienny; Jung, Eunsun; Kim, Young-Soo; Roh, Kyungbaeg; Jung, Kyung-Hwan; Park, Deokhoon			Ultraviolet A Regulates Adipogenic Differentiation of Human Adipose Tissue-derived Mesenchymal Stem Cells via Up-regulation of Kruppel-like Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR; IRRADIATION; EXPRESSION; OBESITY; 8-METHOXYPSORALEN; FIBROBLASTS; INHIBITION; LKLF; UVB	Adipocyte dysfunction is strongly associated with the development of obesity, which is a major risk factor for many disorders, including diabetes, hypertension, and heart disease. This study shows that ultraviolet A (UVA) inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells and its action mechanisms. The mRNA levels of peroxidase proliferator-activated receptor (PPAR) gamma and CCAAT/enhancer-binding protein alpha (C/EBP alpha), but not CCAAT/enhancer-binding protein ((C/EBP) beta and delta, were reduced by UVA. Moreover, the mRNA levels of PPAR gamma target genes (lipoprotein lipase (LPL), CD36, adipocyte protein (aP2), and liver X receptor alpha (LXR)) were down-regulated by UVA. Additionally, attempts to elucidate a possible mechanism underlying the UVA-mediated effects revealed that UVA induced migration inhibitory factor (MIF) gene expression, and this was mediated through activation of AP-1 (especially JNK and p42/44 MAPK) and nuclear factor-kappa B. In addition, reduced adipogenesis by UVA was recovered upon the treatment with anti-MIF antibodies. AMP-activated protein kinase phosphorylation and up-regulation of Kruppel-like factor 2 (KLF2) were induced by UVA. Taken together, these findings suggest that the inhibition of adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by UVA occurs primarily through the reduced expression of PPAR gamma, which is mediated by up-regulation of KLF2 via the activation of MIF-AMP-activated protein kinase signaling.	[Lee, Jongsung; Lee, Jienny; Jung, Eunsun; Kim, Young-Soo; Roh, Kyungbaeg; Park, Deokhoon] Biospectrum Life Sci Inst, Songnam 462807, Gyunggi Do, South Korea; [Jung, Kyung-Hwan] Chungju Natl Univ, Dept Biotechnol, Jeungpyung 368701, Chungbuk, South Korea		Park, D (corresponding author), Biospectrum Life Sci Inst, Songnam 462807, Gyunggi Do, South Korea.	pdh@biospectrum.com						Alessi MC, 2003, PATHOPHYSIOL HAEMO T, V33, P290, DOI 10.1159/000083816; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bray G A, 2001, Rev Endocr Metab Disord, V2, P403, DOI 10.1023/A:1011808701117; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x; Cabrijan L, 2008, COLLEGIUM ANTROPOL, V32, P53; Chapman MJ, 2003, ATHEROSCLEROSIS, V171, P1, DOI 10.1016/S0021-9150(03)00156-4; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Halliday GM, 2008, PHOTOCHEM PHOTOBIOL, V84, P35, DOI 10.1111/j.1751-1097.2007.00212.x; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; KOZAK LP, 1974, J BIOL CHEM, V249, P7775; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; La C, 2006, J MEMBRANE BIOL, V210, P43, DOI 10.1007/s00232-005-0844-6; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Lee J, 2007, BRIT J DERMATOL, V157, P242, DOI 10.1111/j.1365-2133.2007.07934.x; MALININ GI, 1995, BIOCHEM BIOPH RES CO, V207, P877, DOI 10.1006/bbrc.1995.1267; MARCH KL, 1993, CIRCULATION, V87, P184, DOI 10.1161/01.CIR.87.1.184; Martini CN, 2009, MOL CELL ENDOCRINOL, V298, P42, DOI 10.1016/j.mce.2008.10.023; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Noonan FP, 2009, J INVEST DERMATOL, V129, P1608, DOI 10.1038/jid.2009.116; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Potapovich AI, 2009, BRIT J PHARMACOL, V158, P1236, DOI 10.1111/j.1476-5381.2009.00401.x; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tanabe Y, 2004, J CELL SCI, V117, P3605, DOI 10.1242/jcs.01207; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tyrrell RM, 2006, PROG BIOPHYS MOL BIO, V92, P86, DOI 10.1016/j.pbiomolbio.2006.02.002; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Yamauchi T, 2003, NEPHROL DIAL TRANSPL, V18, P1842, DOI 10.1093/ndt/gfg261; Young A, 2009, ARTERIOSCL THROM VAS, V29, P1902, DOI 10.1161/ATVBAHA.109.193540; Zhong JL, 2010, PHOTOCH PHOTOBIO SCI, V9, P18, DOI 10.1039/b9pp00068b	34	31	31	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32647	32656		10.1074/jbc.M110.135830	http://dx.doi.org/10.1074/jbc.M110.135830			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693579	hybrid, Green Published			2022-12-27	WOS:000282683000079
J	Waldron, KJ; Firbank, SJ; Dainty, SJ; Perez-Rama, M; Tottey, S; Robinson, NJ				Waldron, Kevin J.; Firbank, Susan J.; Dainty, Samantha J.; Perez-Rama, Monica; Tottey, Steve; Robinson, Nigel J.			Structure and Metal Loading of a Soluble Periplasm Cuproprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; COPPER CHAPERONE; OXALATE DECARBOXYLASE; THYLAKOID MEMBRANE; BACILLUS-SUBTILIS; MOLECULAR-BASIS; GENE-PRODUCTS; TRANSPORT	A copper-trafficking pathway was found to enable Cu2+ occupancy of a soluble periplasm protein, CucA, even when competing Zn2+ is abundant in the periplasm. Here, we solved the structure of CucA (a new cupin) and found that binding of Cu2+, but not Zn2+, quenches the fluorescence of Trp(165), which is adjacent to the metal site. Using this fluorescence probe, we established that CucA becomes partly occupied by Zn2+ following exposure to equimolar Zn2+ and Cu2+. Cu2(2+)-CucA is more thermodynamically stable than Zn2+-CucA but k((Zn -> Cu) exchange) is slow, raising questions about how the periplasm contains solely the Cu2+ form. We discovered that a copper-trafficking pathway involving two copper transporters (CtaA and PacS) and a metallochaperone (Atx1) is obligatory for Cu2+-CucA to accumulate in the periplasm. There was negligible CucA protein in the periplasm of Delta ctaA cells, but the abundance of cucA transcripts was unaltered. Crucially, Delta ctaA cells overaccumulate low M-r copper complexes in the periplasm, and purified apoCucA can readily acquire Cu2+ from Delta ctaA periplasm extracts, but in vivo apoCucA fails to come into contact with these periplasmic copper pools. Instead, copper traffics via a cytoplasmic pathway that is coupled to CucA translocation to the periplasm.	[Waldron, Kevin J.; Firbank, Susan J.; Dainty, Samantha J.; Perez-Rama, Monica; Tottey, Steve; Robinson, Nigel J.] Univ Newcastle Med Sch, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Robinson, NJ (corresponding author), Univ Newcastle Med Sch, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	n.j.robinson@ncl.ac.uk	Waldron, Kevin/J-2368-2016; Waldron, Kevin John/HHM-8983-2022; Robinson, Nigel J/J-6363-2012	Waldron, Kevin/0000-0002-5577-7357; Waldron, Kevin John/0000-0002-5577-7357; Robinson, Nigel J/0000-0001-5586-1092	Biotechnology and Biological Sciences Research Council PMS Committee [BBS/B/02576, BB/E001688/1]; BBSRC [BB/E001688/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001688/1, BBS/B/02576] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council PMS Committee(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council PMS Committee Grants BBS/B/02576 and BB/E001688/1.	Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Brantner CA, 2000, CURR MICROBIOL, V40, P132, DOI 10.1007/s002849910026; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Hassani BK, 2010, J BIOL CHEM, V285, P19330, DOI 10.1074/jbc.M110.116020; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Just VJ, 2004, J BIOL CHEM, V279, P19867, DOI 10.1074/jbc.M313820200; KANAMARU K, 1994, MOL MICROBIOL, V13, P369, DOI 10.1111/j.1365-2958.1994.tb00430.x; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Lin SJ, 1997, J BIOL CHEM, V272, P9215; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nies DH, 2007, MOL MICROBIOLOGY HEA, V6, P117, DOI DOI 10.1007/7171_2006_075; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; ODERMATT A, 1994, BIOCHEM BIOPH RES CO, V202, P44, DOI 10.1006/bbrc.1994.1891; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; PHUNG LT, 1994, P NATL ACAD SCI USA, V91, P9651, DOI 10.1073/pnas.91.20.9651; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rajalahti T, 2007, J PROTEOME RES, V6, P2420, DOI 10.1021/pr0605973; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Schneider D, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-39; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299; Tottey S, 2002, J BIOL CHEM, V277, P5490, DOI 10.1074/jbc.M105857200; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Whittaker MM, 2006, BIOPHYS J, V90, P598, DOI 10.1529/biophysj.105.071308; ZHANG L, 1992, J BIOL CHEM, V267, P19054	40	22	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32504	32511		10.1074/jbc.M110.153080	http://dx.doi.org/10.1074/jbc.M110.153080			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702411	hybrid, Green Published			2022-12-27	WOS:000282683000064
J	Drury, GL; Di Marco, S; Dormoy-Raclet, V; Desbarats, J; Gallouzi, IE				Drury, Gillian L.; Di Marco, Sergio; Dormoy-Raclet, Virginie; Desbarats, Julie; Gallouzi, Imed-Eddine			FasL Expression in Activated T Lymphocytes Involves HuR-mediated Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN HUR; AU-RICH ELEMENT; MESSENGER-RNA STABILITY; TNF-ALPHA; KINASE-C; CELL-ACTIVATION; ELAV PROTEINS; PHOSPHORYLATION; GENE; REGION	A prolonged activation of the immune system is one of the main causes of hyperproliferation of lymphocytes leading to defects in immune tolerance and autoimmune diseases. Fas ligand (FasL), a member of the TNF superfamily, plays a crucial role in controlling this excessive lymphoproliferation by inducing apoptosis in T cells leading to their rapid elimination. Here, we establish that posttranscriptional regulation is part of the molecular mechanisms that modulate FasL expression, and we show that in activated T cells FasL mRNA is stable. Our sequence analysis indicates that the FasL 3'-untranslated region (UTR) contains two AU-rich elements (AREs) that are similar in sequence and structure to those present in the 3'-UTR of TNF-alpha mRNA. Through these AREs, the FasL mRNA forms a complex with the RNA-binding protein HuR both in vitro and ex vivo. Knocking down HuR in HEK 293 cells prevented the phorbol 12-myristate 13-acetate-induced expression of a GFP reporter construct fused to the FasL 3'-UTR. Collectively, our data demonstrate that the posttranscriptional regulation of FasL mRNA by HuR represents a novel mechanism that could play a key role in the maintenance and proper functioning of the immune system.	[Di Marco, Sergio; Dormoy-Raclet, Virginie; Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Di Marco, Sergio; Dormoy-Raclet, Virginie; Gallouzi, Imed-Eddine] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Gallouzi, IE (corresponding author), McGill Univ, Dept Biochem, McIntyre Bldg,Rm 906A,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	imed.gallouzi@mcgill.ca		Desbarats, Julie/0000-0002-2495-7152; Di Marco, Sergio/0000-0002-4039-0600	Fonds de Recherche en Sante du Quebec; Canadian Cancer Society Research Institute [018125]; Canadian Cancer Society (formerly National Cancer Institute of Canada); Tier II Canada Research Chair	Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Cancer Society (formerly National Cancer Institute of Canada); Tier II Canada Research Chair	This work was supported by a Fonds de Recherche en Sante du Quebec Doctoral Research Award (to G. L. D.) and by Operating Grant 018125 from the Canadian Cancer Society Research Institute (to I.-E. G.).; Research Fellow of the Terry Fox Foundation through an award from the Canadian Cancer Society (formerly National Cancer Institute of Canada).; Recipient of a Tier II Canada Research Chair. To whom correspondence should be addressed: Dept. of Biochemistry, McGill University, McIntyre Bldg., Rm. 906A, 3655 Promenade Sir William Osler, Montreal, Quebec H3G 1Y6, Canada. Fax: 1-514-398-7384; E-mail: imed.gallouzi@mcgill.ca.	Antic D, 1998, J CELL SCI, V111, P183; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Atasoy U, 1998, J CELL SCI, V111, P3145; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bol GF, 1997, BBA-MOL CELL RES, V1358, P307, DOI 10.1016/S0167-4889(97)00073-6; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Chemnitz J, 2009, EUR J IMMUNOL, V39, P267, DOI 10.1002/eji.200838619; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Chien EJ, 2001, J CELL BIOCHEM, V81, P604, DOI 10.1002/jcb.1089; Chow WA, 2000, J IMMUNOL, V164, P3512, DOI 10.4049/jimmunol.164.7.3512; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Di Marco S, 2001, NUCLEIC ACIDS RES, V29, P863, DOI 10.1093/nar/29.4.863; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Ford GS, 1999, J IMMUNOL, V162, P4037; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Hsu SC, 1999, EUR J IMMUNOL, V29, P2948, DOI 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0; HUANG HS, 1991, J COMP PATHOL, V105, P191, DOI 10.1016/S0021-9975(08)80075-8; Jacob CO, 1996, J IMMUNOL, V156, P3043; Jacobs DB, 1996, LIFE SCI, V58, P2083, DOI 10.1016/0024-3205(96)00202-0; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Karray S, 2004, J IMMUNOL, V172, P2118, DOI 10.4049/jimmunol.172.4.2118; KATSANOU V, 2006, ERNST SCHERING FOUND, V4, P37; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Li-Weber M, 1999, EUR J IMMUNOL, V29, P3017, DOI 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO;2-R; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Sakai K, 2003, MOL IMMUNOL, V39, P879, DOI 10.1016/S0161-5890(03)00007-5; Senju S, 1996, INT IMMUNOL, V8, P423, DOI 10.1093/intimm/8.3.423; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; TOBLER A, 1988, J CLIN INVEST, V81, P1819, DOI 10.1172/JCI113525; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	16	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31130	31138		10.1074/jbc.M110.137919	http://dx.doi.org/10.1074/jbc.M110.137919			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675370	Green Published, hybrid			2022-12-27	WOS:000282764600006
J	Lysechko, TL; Cheung, SMS; Ostergaard, HL				Lysechko, Tara L.; Cheung, Samuel M. S.; Ostergaard, Hanne L.			Regulation of the Tyrosine Kinase Pyk2 by Calcium Is through Production of Reactive Oxygen Species in Cytotoxic T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROTEIN-KINASE; HYDROGEN-PEROXIDE; CELL-ACTIVATION; PHOSPHORYLATION; RECEPTOR; CA2+; ASSOCIATION; P56(LCK); CLONING	Pyk2 was identified as a Ca2+-dependent kinase, however, the regulation of Pyk2 by Ca2+ in T cells remains controversial. We found that Ca2+ mobilization preferentially induced Pyk2 phosphorylation in cytotoxic T lymphocytes (CTL). Furthermore, Pyk2 phosphorylation in CTL was not absolutely Ca2+ dependent but relied on the strength of T cell receptor stimulation. Ionomycin-stimulated Pyk2 phosphorylation did not require calmodulin activity, because phosphorylation was not inhibited by the calmodulin inhibitor W7, and we detected no Ca2+-regulated association between Pyk2 and calmodulin. Ca2+-stimulated Pyk2 phosphorylation was dependent on Src-family kinase activity, even at the Pyk2 autophosphorylation site. We sought to identify a Ca2+-regulated pathway that could trigger Pyk2 phosphorylation in T cells and found that ionomycin stimulated the production of reactive oxygen species and an H2O2 scavenger inhibited ionomycin-induced Pyk2 phosphorylation. Additionally, H2O2 induced strong Erk activation and ionomycin-stimulated Pyk2 phosphorylation was Erk dependent. These data support the conclusion that Ca2+ mobilization induces the production of reactive oxygen species, which in turn activate the Erk pathway, leading to Src-family kinase-dependent Pyk2 phosphorylation. Our data demonstrate that Pyk2 is not a Ca2+ dependent kinase in T cells but instead, increased intracellular Ca2+ induces Pyk2 phosphorylation through production of reactive oxygen species. These findings are consistent with the possibility that Pyk2 acts as an early sensor of numerous extracellular signals that trigger a Ca2+ flux and/or reactive oxygen species to amplify tyrosine phosphorylation signaling events.	[Lysechko, Tara L.; Cheung, Samuel M. S.; Ostergaard, Hanne L.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Ostergaard, HL (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	hanne.ostergaard@ualberta.ca			Canadian Cancer Society [017111]; AHFMR; Canadian Institutes of Health	Canadian Cancer Society(Canadian Cancer Society (CCS)); AHFMR(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Cancer Society Grant 017111.; Supported by a studentship from AHFMR. Present address: Afexa Life Sciences Inc., 9604 20th Ave., Edmonton, AB T6N 1G1, Canada.; Supported by a Canadian Institutes of Health Research Doctoral Award.	Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Berg NN, 1998, J IMMUNOL, V161, P2919; Berg NN, 1997, J IMMUNOL, V159, P1753; BLAKELY A, 1987, J EXP MED, V166, P1070, DOI 10.1084/jem.166.4.1070; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Daou GB, 2004, FREE RADICAL BIO MED, V37, P208, DOI 10.1016/j.freeradbiomed.2004.04.018; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Frank GD, 2000, BIOCHEM BIOPH RES CO, V270, P761, DOI 10.1006/bbrc.2000.2505; Franklin RA, 2000, MOL IMMUNOL, V37, P675, DOI 10.1016/S0161-5890(00)00087-0; Ganju RK, 1997, J EXP MED, V185, P1055, DOI 10.1084/jem.185.6.1055; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Guo J, 2004, NEUROSCI LETT, V355, P177, DOI 10.1016/j.neulet.2003.10.076; Hardwick JS, 1997, J BIOL CHEM, V272, P25429, DOI 10.1074/jbc.272.41.25429; Herzog H, 1996, GENOMICS, V32, P484, DOI 10.1006/geno.1996.0149; Hiregowdara D, 1997, J BIOL CHEM, V272, P10804; Hirotani S, 2004, J MOL CELL CARDIOL, V36, P799, DOI 10.1016/j.yjmcc.2004.03.002; JOUNG I, 1995, P NATL ACAD SCI USA, V92, P5778, DOI 10.1073/pnas.92.13.5778; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Katagiri T, 2000, J BIOL CHEM, V275, P19645, DOI 10.1074/jbc.M909828199; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li X, 1999, J BIOL CHEM, V274, P8917, DOI 10.1074/jbc.274.13.8917; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Ma EA, 1997, EUR J IMMUNOL, V27, P329, DOI 10.1002/eji.1830270147; MASON MJ, 1991, J BIOL CHEM, V266, P20856; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; OSTERGAARD H, 1987, J IMMUNOL, V139, P3573; Ostergaard HL, 2005, IMMUNOL RES, V31, P267, DOI 10.1385/IR:31:3:267; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; Raja S, 1997, J BIOL CHEM, V272, P10941; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rodriguez-Fernandez JL, 2002, J LEUKOCYTE BIOL, V71, P520; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsuchida M, 1999, EUR J IMMUNOL, V29, P2354, DOI 10.1002/(SICI)1521-4141(199907)29:07<2354::AID-IMMU2354>3.0.CO;2-P; WATTS JD, 1993, J BIOL CHEM, V268, P23275; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993	49	19	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31174	31184		10.1074/jbc.M110.118265	http://dx.doi.org/10.1074/jbc.M110.118265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20688918	Green Published, hybrid			2022-12-27	WOS:000282764600011
J	Vostrikov, VV; Daily, AE; Greathouse, DV; Koeppe, RE				Vostrikov, Vitaly V.; Daily, Anna E.; Greathouse, Denise V.; Koeppe, Roger E., II			Charged or Aromatic Anchor Residue Dependence of Transmembrane Peptide Tilt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; ALPHA-HELICAL PEPTIDES; HYDROPHOBIC MISMATCH; MEMBRANE-PROTEINS; LIPID-BILAYERS; TRYPTOPHAN RESIDUES; GEOMETRIC ANALYSIS; FLANKING RESIDUES; ROTATION ANGLES; H-2 NMR	The membrane-spanning segments of integral membrane proteins often are flanked by aromatic or charged amino acid residues, which may "anchor" the transmembrane orientation. Single spanning transmembrane peptides such as those of the WALP family, acetyl-GWW(LA)(n)LWWA-amide, furthermore adopt a moderate average tilt within lipid bilayer membranes. To understand the anchor residue dependence of the tilt, we introduce Leu-Ala "spacers" between paired anchors and in some cases replace the outer tryptophans. The resulting peptides, acetyl-GX(2)ALW(LA)(6)LWLAX(22)A-amide, have Trp, Lys, Arg, or Gly in the two X positions. The apparent average orientations of the core helical sequences were determined in oriented phosphatidylcholine bilayer membranes of varying thickness using solid-state H-2 NMR spectroscopy. When X is Lys, Arg, or Gly, the direction of the tilt is essentially constant in different lipids and presumably is dictated by the tryptophans (Trp(5) and Trp(19)) that flank the inner helical core. The Leu-Ala spacers are no longer helical. The magnitude of the apparent helix tilt furthermore scales nicely with the bilayer thickness except when X is Trp. When X is Trp, the direction of tilt is less well defined in each phosphatidylcholine bilayer and varies up to 70 degrees among 1,2-dioleoyl-sn-glycero-3-phosphocholine, 1,2-dimyristoyl-sn-glycero-3-phosphocholine, and 1,2-dilauroyl-sn-glycero-3-phosphocholine bilayer membranes. Indeed, the X = Trp case parallels earlier observations in which WALP family peptides having multiple Trp anchors show little dependence of the apparent tilt magnitude on bilayer thickness. The results shed new light on the interactions of arginine, lysine, tryptophan, and even glycine at lipid bilayer membrane interfaces.	[Vostrikov, Vitaly V.; Daily, Anna E.; Greathouse, Denise V.; Koeppe, Roger E., II] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Koeppe, RE (corresponding author), Univ Arkansas, Dept Chem & Biochem, 119 Chem Bldg, Fayetteville, AR 72701 USA.	rk2@uark.edu	Vostrikov, Vitaly/B-4986-2008; Vossen, Val/O-8144-2019	Vostrikov, Vitaly/0000-0001-9598-0600; Vossen, Val/0000-0001-9598-0600; Koeppe, Roger/0000-0003-0676-6413	National Science Foundation [MCB-0841227]; Arkansas Biosciences Institute; National Institutes of Health [RR 15569]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Arkansas Biosciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Science Foundation Grant MCB-0841227 and by the Arkansas Biosciences Institute.; The NMR facility was supported by National Institutes of Health Grant RR 15569.	Aisenbrey C, 2004, J AM CHEM SOC, V126, P16676, DOI 10.1021/ja0468675; CHAKRABARTTY A, 1993, BIOCHEMISTRY-US, V32, P5560, DOI 10.1021/bi00072a010; Chiang CS, 2005, BIOCHEMISTRY-US, V44, P12589, DOI 10.1021/bi050750r; Daily AE, 2008, BIOPHYS J, V94, P480, DOI 10.1529/biophysj.106.097543; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; de Planque MRR, 1999, J BIOL CHEM, V274, P20839, DOI 10.1074/jbc.274.30.20839; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; DEPLANQUE MR, 2002, J A BIOCH, V41, P8396; DEPLANQUE MR, 1998, J A BIOCH, V37, P9333; Esteban-Martin S, 2007, BIOPHYS J, V93, P4278, DOI 10.1529/biophysj.107.113043; Esteban-Martin S, 2009, BIOCHEMISTRY-US, V48, P11441, DOI 10.1021/bi901017y; Esteban-Martin S, 2009, BIOPHYS J, V96, P3233, DOI 10.1016/j.bpj.2008.12.3950; Gibbons WJ, 2006, BIOPHYS J, V90, P1249, DOI 10.1529/biophysj.105.067884; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Greathouse D V, 1999, Methods Enzymol, V294, P525; Hautbergue GM, 2008, J MAGN RESON, V191, P335, DOI 10.1016/j.jmr.2007.12.017; Holt A, 2010, BIOPHYS J, V98, P1864, DOI 10.1016/j.bpj.2010.01.016; Holt A, 2009, BIOPHYS J, V97, P2258, DOI 10.1016/j.bpj.2009.07.042; Isidro-Llobet A, 2009, CHEM REV, V109, P2455, DOI 10.1021/cr800323s; Killian JA, 1996, BIOCHEMISTRY-US, V35, P1037, DOI 10.1021/bi9519258; Kovacs FA, 2000, J MOL BIOL, V295, P117, DOI 10.1006/jmbi.1999.3322; Morein S, 2002, BIOPHYS J, V82, P1405, DOI 10.1016/S0006-3495(02)75495-7; Nomura K, 2005, BIOPHYS J, V89, P4067, DOI 10.1529/biophysj.105.070292; OCONNELL AM, 1990, SCIENCE, V250, P1256, DOI 10.1126/science.1700867; Ozdirekcan S, 2007, J AM CHEM SOC, V129, P15174, DOI 10.1021/ja073784q; Ozdirekcan S, 2005, BIOCHEMISTRY-US, V44, P1004, DOI 10.1021/bi0481242; Page RC, 2008, STRUCTURE, V16, P787, DOI 10.1016/j.str.2008.02.018; Page RC, 2009, PROTEIN SCI, V18, P134, DOI 10.1002/pro.24; SEPAROVIC F, 1994, BIOPHYS J, V67, P1495, DOI 10.1016/S0006-3495(94)80623-X; Stopar D, 2006, CHEM PHYS LIPIDS, V141, P83, DOI 10.1016/j.chemphyslip.2006.02.023; Strandberg E, 2004, BIOPHYS J, V86, P3709, DOI 10.1529/biophysj.103.035402; Strandberg E, 2002, BIOCHEMISTRY-US, V41, P7190, DOI 10.1021/bi012047i; Strandberg E, 2009, BIOPHYS J, V96, P3223, DOI 10.1016/j.bpj.2009.02.040; Stromstedt AA, 2009, BBA-BIOMEMBRANES, V1788, P1916, DOI 10.1016/j.bbamem.2009.06.001; TENKORTENAAR PBW, 1986, INT J PEPT PROT RES, V27, P398; Thomas R, 2009, BIOCHEMISTRY-US, V48, P11883, DOI 10.1021/bi9016395; van der Wel PCA, 2007, BIOCHEMISTRY-US, V46, P7514, DOI 10.1021/bi700082v; van der Wel PCA, 2002, BIOPHYS J, V83, P1479, DOI 10.1016/S0006-3495(02)73918-0; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Vostrikov VV, 2008, J AM CHEM SOC, V130, P12584, DOI 10.1021/ja803734k; Vostrikov VV, 2010, J AM CHEM SOC, V132, P5803, DOI 10.1021/ja100598e; Vostrikov VV, 2009, BIOPHYS J, V96, p454A, DOI 10.1016/j.bpj.2008.12.2333; White SH, 2005, CURR OPIN STRUC BIOL, V15, P378, DOI 10.1016/j.sbi.2005.07.004; YAU WM, 1998, S H BIOCH, V37, P14713	44	55	55	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31723	31730		10.1074/jbc.M110.152470	http://dx.doi.org/10.1074/jbc.M110.152470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667827	Green Published, hybrid			2022-12-27	WOS:000282764600064
J	Yan, W; Si, Y; Slaymaker, S; Li, JC; Zheng, HL; Young, DL; Aslanian, A; Saunders, L; Verdin, E; Charo, IF				Yan, Wei; Si, Yue; Slaymaker, Sarah; Li, Jiachen; Zheng, Huili; Young, David L.; Aslanian, Ara; Saunders, Laura; Verdin, Eric; Charo, Israel F.			Zmynd15 Encodes a Histone Deacetylase-dependent Transcriptional Repressor Essential for Spermiogenesis and Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERM-CELL APOPTOSIS; GENE-EXPRESSION; HYPERACTIVATED MOTILITY; SPERMATOGENIC CELLS; CAUSES INFERTILITY; TRANSGENIC MICE; PROTEIN; TESTIS; MOUSE; DIFFERENTIATION	Spermatogenesis is a complex process through which male germ line stem cells undergo a multi-step differentiation program and sequentially become spermatogonia, spermatocytes, spermatids, and eventually spermatozoa. In this process, transcription factors act as switches that precisely regulate the expression of genes that in turn control the developmental program of male germ cells. Transcription factors identified to be essential for normal haploid gene expression all display transcription-activating effects and thus serve as the "on" switch for haploid gene expression. Here, we report that ZMYND15 acts as a histone deacetylase-dependent transcriptional repressor and controls normal temporal expression of haploid cell genes during spermiogenesis. Inactivation of Zmynd15 results in early activation of transcription of numerous important haploid genes including Prm1, Tnp1, Spem1, and Catpser3; depletion of late spermatids; and male infertility. ZMYND15 represents the first transcriptional repressor identified to be essential for sperm production and male fertility.	[Si, Yue; Slaymaker, Sarah; Aslanian, Ara; Charo, Israel F.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Yan, Wei; Li, Jiachen; Zheng, Huili; Young, David L.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Saunders, Laura; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yan, W (corresponding author), Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	wyan@medicine.nevada.edu; icharo@gladstone.ucsf.edu	Yan, Wei/G-1618-2011; Verdin, Eric/AAB-7999-2019; Yan, Wei/AAH-7943-2019	Verdin, Eric/0000-0003-3703-3183	National Institutes of Health [HL 52773, HL 63894, HD 048855, HD 05028, P20-RR-016464]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050281, R03HD048855] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052773, R01HL063894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 52773 and HL 63894 (to I. F. C.) and HD 048855 and HD 05028 (to W.Y.). This work was also supported by National Institutes of Health Grant P20-RR-016464 (to the Nevada Genomic Center).	Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Aslanian AM, 2006, CIRCULATION, V114, P583, DOI 10.1161/CIRCULATIONAHA.105.540583; Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hecht N B, 1988, Prog Clin Biol Res, V267, P291; HECHT NB, 1990, J REPROD FERTIL, V88, P679, DOI 10.1530/jrf.0.0880679; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; JIN JL, 2005, BIOL REPROD; LAHDETIE J, 1986, MUTAT RES, V172, P255, DOI 10.1016/0165-1218(86)90063-7; Lin YN, 2005, SEMIN REPROD MED, V23, P201, DOI 10.1055/s-2005-872448; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Pinnoji RC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-56; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; ROBINSON MO, 1989, P NATL ACAD SCI USA, V86, P8437, DOI 10.1073/pnas.86.21.8437; Sassone-Corsi P, 1998, SEMIN CELL DEV BIOL, V9, P475, DOI 10.1006/scdb.1998.0200; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; Weiss J, 2003, MOL CELL BIOL, V23, P8084, DOI 10.1128/MCB.23.22.8084-8091.2003; Wu MH, 2003, GENE EXPR PATTERNS, V3, P231, DOI 10.1016/S1567-133X(03)00036-X; Yan W, 2004, P NATL ACAD SCI USA, V101, P7793, DOI 10.1073/pnas.0308025101; Yan W, 2002, MECH DEVELOP, V118, P247, DOI 10.1016/S0925-4773(02)00261-7; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhang LP, 1999, BIOL REPROD, V60, P1329, DOI 10.1095/biolreprod60.6.1329; Zhang Y, 2004, BIOINFORMATICS, V20, P2390, DOI 10.1093/bioinformatics/bth256; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, pD156, DOI 10.1093/nar/gkl782; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104	51	40	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31418	31426		10.1074/jbc.M110.116418	http://dx.doi.org/10.1074/jbc.M110.116418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675388	Green Published, hybrid			2022-12-27	WOS:000282764600036
J	Zhou, RF; Kabra, R; Olson, DR; Piper, RC; Snyder, PM				Zhou, Ruifeng; Kabra, Rajesh; Olson, Diane R.; Piper, Robert C.; Snyder, Peter M.			Hrs Controls Sorting of the Epithelial Na+ Channel between Endosomal Degradation and Recycling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; SODIUM-CHANNEL; LIDDLES-SYNDROME; MULTIVESICULAR BODIES; MEMBRANE-PROTEINS; UBIQUITIN-BINDING; WW DOMAINS; NEDD4-2; LIGASE; PHOSPHORYLATION	Epithelial Na+ absorption is regulated by Nedd4-2, an E3 ubiquitin ligase that reduces expression of the epithelial Na+ channel (ENaC) at the cell surface. Defects in this regulation cause Liddle syndrome, an inherited form of hypertension. Previous work found that Nedd4-2 functions through two distinct effects on trafficking, enhancing both ENaC endocytosis and ENaC degradation in lysosomes. To investigate the mechanism by which Nedd4-2 targets ENaC to lysosomes, we tested the role of hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), a component of the endosomal sorting complexes required for transport (ESCRT)-0 complex. We found that alpha-, beta-, and gamma ENaC each interact with Hrs. These interactions were enhanced by Nedd4-2 and were dependent on the catalytic function of Nedd4-2 as well as its WW domains. Mutation of ENaC PY motifs, responsible for inherited hypertension (Liddle syndrome), decreased Hrs binding to ENaC. Moreover, binding of ENaC to Hrs was reduced by dexamethasone/serum- and glucocorticoid-inducible kinase and cAMP, which are signaling pathways that inhibit Nedd4-2. Nedd4-2 bound to Hrs and catalyzed Hrs ubiquitination but did not alter Hrs protein levels. Expression of a dominant negative Hrs lacking its ubiquitin-interacting motif (Hrs-Delta UIM) increased ENaC surface expression and current. This occurred through reduced degradation of the cell surface pool of proteolytically activated ENaC, which enhanced its recycling to the cell surface. In contrast, Hrs-Delta UIM had no effect on degradation of uncleaved inactive channels. The data support a model in which Nedd4-2 induces binding of ENaC to Hrs, which mediates the sorting decision between ENaC degradation and recycling.	[Snyder, Peter M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Piper, Robert C.; Snyder, Peter M.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu		Piper, Robert/0000-0001-9995-5699	National Institutes of Health [HL058812]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058812, R29HL058812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL058812 (to P. M. S. and R. C. P.).	Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Raiborg C, 2001, J CELL SCI, V114, P2255; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	41	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30523	30530		10.1074/jbc.M110.150755	http://dx.doi.org/10.1074/jbc.M110.150755			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20675381	hybrid, Green Published			2022-12-27	WOS:000282135500020
J	Apostol, MI; Sawaya, MR; Cascio, D; Eisenberg, D				Apostol, Marcin I.; Sawaya, Michael R.; Cascio, Duilio; Eisenberg, David			Crystallographic Studies of Prion Protein (PrP) Segments Suggest How Structural Changes Encoded by Polymorphism at Residue 129 Modulate Susceptibility to Human Prion Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CROSS-BETA SPINE; CONFORMATIONAL CONVERSION; NMR STRUCTURE; GENOTYPE; VARIANT; MODEL; REPLICATION; DOMAIN; CJD	A single nucleotide polymorphism (SNP) in codon 129 of the human prion gene, leading to a change from methionine to valine at residue 129 of prion protein (PrP), has been shown to be a determinant in the susceptibility to prion disease. However, the molecular basis of this effect remains unexplained. In the current study, we determined crystal structures of prion segments having either Met or Val at residue 129. These 6-residue segments of PrP centered on residue 129 are "steric zippers," pairs of interacting beta-sheets. Both structures of these " homozygous steric zippers" reveal direct intermolecular interactions between Met or Val in one sheet and the identical residue in the mating sheet. These two structures, plus a structure-based model of the heterozygous Met-Val steric zipper, suggest an explanation for the previously observed effects of this locus on prion disease susceptibility and progression.	[Apostol, Marcin I.; Sawaya, Michael R.; Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, UCLA DOE Inst, Dept Chem & Biochem, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Eisenberg, D (corresponding author), 201 Boyer Hall,Box 951570,611 Charles Young Dr E, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu			National Institutes of Health; Ruth L. Kirschstein National Research [GM007185]; National Science Foundation; Department of Defense; Howard Hughes Medical Institute; UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health grant (to D.E.) and Ruth L. Kirschstein National Research Service Award GM007185 (to M.I.A.). This work was also supported by grants from the National Science Foundation, Department of Defense, and Howard Hughes Medical Institute (to D.E.) and the UCLA Dissertation Year Fellowship (to M.I.A.).	Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baskakov I, 2005, FEBS LETT, V579, P2589, DOI 10.1016/j.febslet.2005.03.075; Brandel JP, 2003, LANCET, V362, P128, DOI 10.1016/S0140-6736(03)13867-6; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghani AC, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Hall D, 2004, J MOL BIOL, V336, P775, DOI 10.1016/j.jmb.2003.12.004; Hirschler J, 1996, ACTA CRYSTALLOGR D, V52, P806, DOI 10.1107/S0907444996001813; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jones EM, 2006, J BIOL CHEM, V281, P8190, DOI 10.1074/jbc.M513417200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaski D, 2009, LANCET, V374, P2128, DOI 10.1016/S0140-6736(09)61568-3; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Lewis PA, 2006, J GEN VIROL, V87, P2443, DOI 10.1099/vir.0.81630-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; NGUYEN JT, 1995, J MOL BIOL, V252, P412, DOI 10.1006/jmbi.1995.0507; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Panegyres PK, 2001, ARCH NEUROL-CHICAGO, V58, P1899, DOI 10.1001/archneur.58.11.1899; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Petchanikow C, 2001, FEBS LETT, V509, P451, DOI 10.1016/S0014-5793(01)03147-7; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	49	49	49	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29671	29675		10.1074/jbc.C110.158303	http://dx.doi.org/10.1074/jbc.C110.158303			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20685658	Green Published, hybrid			2022-12-27	WOS:000281984300001
J	Nakagawa, M; Ueyama, M; Tsuruta, H; Uno, T; Kanamaru, K; Mikami, B; Yamagata, H				Nakagawa, Masataka; Ueyama, Megumi; Tsuruta, Hiroki; Uno, Tomohide; Kanamaru, Kengo; Mikami, Bunzo; Yamagata, Hiroshi			Functional Analysis of the Cucumisin Propeptide as a Potent Inhibitor of Its Mature Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN-LIKE PROTEASE; INTRAMOLECULAR CHAPERONE; CLEAVAGE SPECIFICITY; SERINE PROTEASES; STRUCTURAL BASIS; MELON FRUITS; AQUALYSIN-I; GENE; PATHWAY; BPN'	Cucumisin is a subtilisin-like serine protease (subtilase) that is found in the juice of melon fruits (Cucumis melo L.). It is synthesized as a preproprotein consisting of a signal peptide, NH2-terminal propeptide, and 67-kDa protease domain. We investigated the role of this propeptide (88 residues) in the cucumisin precursor. Complementary DNAs encoding the propeptides of cucumisin, two other plant subtilases (Arabidopsis ARA12 and rice RSP1), and bacterial subtilisin E were expressed in Escherichia coli independently of their mature enzymes. The cucumisin propeptide strongly inhibited cucumisin in a competitive manner with a K-i value of 6.2 +/- 0.55 nM. Interestingly, cucumisin was also strongly inhibited by ARA12 and RSP1 propeptides but not by the subtilisin E propeptide. In contrast, the propeptides of cucumisin, ARA12, and RSP1 did not inhibit subtilisin. Deletion analysis clearly showed that two hydrophobic regions, Asn(32)-Met(38) and Gly(97)-Leu(103), in the cucumisin propeptide were important for its inhibitory activity. Site-directed mutagenesis also confirmed the role of a Val(36)-centerd hydrophobic cluster within the Asn(32)-Met(38) region in cucumisin inhibition. Circular dichroism spectroscopy revealed that the cucumisin propeptide had a secondary structure without a cognate protease domain and that the thermal unfolding of the propeptide at 90 degrees C was only partial and reversible. A tripeptide, Ile(35)-Val(36)-Tyr(37), in the Asn(32)-Met(38) region was thought to contribute toward the formation of a proper secondary structure necessary for cucumisin inhibition. This is the first report on the function and structural information of the propeptide of a plant serine protease.	[Yamagata, Hiroshi] Kobe Univ, Grad Sch Agr Sci, Biochem Lab, Nada Ku, Kobe, Hyogo 6578501, Japan; [Tsuruta, Hiroki] Kobe Univ, Off Collaborat Res & Technol Dev, Nada Ku, Kobe, Hyogo 6578501, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kobe University; Kobe University; Kyoto University	Yamagata, H (corresponding author), Kobe Univ, Grad Sch Agr Sci, Biochem Lab, Nada Ku, Rokkodaicho 1-1, Kobe, Hyogo 6578501, Japan.	yamagata@kobe-u.ac.jp	Tsuruta, Hiroki/M-7668-2016; Kanamaru, Kengo/GNP-8187-2022	Tsuruta, Hiroki/0000-0003-2739-8488; Kanamaru, Kengo/0000-0002-6844-0841	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. Y.).	Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Antao CM, 2005, PLANT PHYSIOL BIOCH, V43, P637, DOI 10.1016/j.plaphy.2005.05.001; BAKER D, 1992, PROTEINS, V12, P339, DOI 10.1002/prot.340120406; Beers EP, 2004, PHYTOCHEMISTRY, V65, P43, DOI 10.1016/j.phytochem.2003.09.005; Boyd PM, 2002, BBA-PROTEIN STRUCT M, V1596, P269, DOI 10.1016/S0167-4838(02)00228-5; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P76; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Groves MR, 1998, PROTEINS, V32, P504, DOI 10.1002/(SICI)1097-0134(19980901)32:4<504::AID-PROT8>3.0.CO;2-F; Hamilton JMU, 2003, BIOCHEM J, V370, P57, DOI 10.1042/BJ20021125; Huang HW, 1997, PROTEIN ENG, V10, P1227, DOI 10.1093/protein/10.10.1227; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Jean L, 2003, J BIOL CHEM, V278, P28572, DOI 10.1074/jbc.M303827200; Kojima S, 2005, FEBS LETT, V579, P4430, DOI 10.1016/j.febslet.2005.06.083; Kojima S, 1998, J MOL BIOL, V277, P1007, DOI 10.1006/jmbi.1998.1671; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LI YY, 1995, J BIOL CHEM, V270, P25127, DOI 10.1074/jbc.270.42.25127; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Liu XW, 2001, SEED SCI RES, V11, P55, DOI 10.1079/SSR200060; Marie-Claire C, 2001, J MOL BIOL, V305, P151, DOI 10.1006/jmbi.2000.4233; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Neuteboom LW, 1999, PLANT MOL BIOL, V39, P273, DOI 10.1023/A:1006104205959; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RIBEIRO A, 1995, PLANT CELL, V7, P785, DOI 10.1105/tpc.7.6.785; Sabala I, 1997, PHYSIOL PLANTARUM, V99, P316, DOI 10.1034/j.1399-3054.1997.990215.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sasakawa H, 2002, J MOL BIOL, V317, P159, DOI 10.1006/jmbi.2002.5412; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STAHL ML, 1984, J BACTERIOL, V158, P411, DOI 10.1128/JB.158.2.411-418.1984; Takagi H, 2001, FEBS LETT, V508, P210, DOI 10.1016/S0014-5793(01)03053-8; TAYLOR MAJ, 1995, PROTEIN ENG, V8, P59, DOI 10.1093/protein/8.1.59; Tornero P, 1996, P NATL ACAD SCI USA, V93, P6332, DOI 10.1073/pnas.93.13.6332; UCHIKOBA T, 1995, J BIOCHEM-TOKYO, V117, P1126, DOI 10.1093/oxfordjournals.jbchem.a124817; YAMAGATA H, 1989, AGR BIOL CHEM TOKYO, V53, P1009, DOI 10.1080/00021369.1989.10869404; Yamagata H, 2000, BIOSCI BIOTECH BIOCH, V64, P1947, DOI 10.1271/bbb.64.1947; Yamagata H, 2002, J BIOL CHEM, V277, P11582, DOI 10.1074/jbc.M109946200; YAMAGATA H, 1994, J BIOL CHEM, V269, P32725	48	21	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29797	29807		10.1074/jbc.M109.083162	http://dx.doi.org/10.1074/jbc.M109.083162			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639575	Green Published, hybrid			2022-12-27	WOS:000281984300015
J	Tseng, W; Graham, LS; Geng, YF; Reddy, A; Lu, JX; Effros, RB; Demer, L; Tintut, Y				Tseng, Wendy; Graham, Lucia S.; Geng, Yifan; Reddy, Aneela; Lu, Jinxiu; Effros, Rita B.; Demer, Linda; Tintut, Yin			PKA-induced Receptor Activator of NF-kappa B Ligand (RANKL) Expression in Vascular Cells Mediates Osteoclastogenesis but Not Matrix Calcification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM OSTEOPROTEGERIN LEVELS; LOW-DENSITY-LIPOPROTEIN; HUMAN CAROTID ARTERIES; BONE-FORMATION; IN-VIVO; PLASMA OSTEOPROTEGERIN; HEMODIALYSIS-PATIENTS; DIFFERENTIATION; ATHEROSCLEROSIS; PATHWAY	Vascular calcification is a predictor of cardiovascular mortality and is prevalent in patients with atherosclerosis and chronic renal disease. It resembles skeletal osteogenesis, and many bone cells as well as bone-related factors involved in both formation and resorption have been localized in calcified arteries. Previously, we showed that aortic medial cells undergo osteoblastic differentiation and matrix calcification both spontaneously and in response to PKA agonists. The PKA signaling pathway is also involved in regulating bone resorption in skeletal tissue by stimulating osteoblast-production of osteoclast regulating cytokines, including receptor-activator of nuclear kappa B ligand (RANKL) and interleukins. Therefore, we investigated whether PKA activators regulate osteoclastogenesis in aortic smooth muscle cells (SMC). Treatment of murine SMC with the PKA agonist forskolin stimulated RANKL expression at both mRNA and protein levels. Forskolin also stimulated expression of interleukin-6 but not osteoprotegerin (OPG), an inhibitor of RANKL. Consistent with these results, osteoclastic differentiation was induced when monocytic preosteoclasts (RAW264.7) were cocultured with forskolin- treated aortic SMC. Oxidized phospholipids also slightly induced RANKL expression in T lymphocytes, another potential source of RANKL in the vasculature. Because previous studies have shown that RANKL treatment alone induces matrix calcification of valvular and vascular cells, we next examined whether RANKL mediates forskolin-induced matrix calcification by aortic SMC. RANKL inhibition with OPG had little or no effect on osteoblastic differentiation and matrix calcification of aortic SMC. These findings suggest that, as in skeletal tissues, PKA activation induces bone resorptive factors in the vasculature and that aortic SMC calcification specifically induced by PKA, is not mediated by RANKL.	[Tintut, Yin] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, Los Angeles, CA 90095 USA; [Tseng, Wendy] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; [Graham, Lucia S.; Effros, Rita B.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lu, Jinxiu; Demer, Linda] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Demer, Linda] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tintut, Y (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, A2-237,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ytintut@mednet.ucla.edu	Demer, Linda L/I-5770-2013	Demer, Linda L/0000-0002-9618-6895	NIDDK [R01DK081346]; NHLBI [R01HL081202]; NIA [AG023720]; F31AG023838; Whit-come Summer Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG023838, R01AG023720] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); F31AG023838; Whit-come Summer Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK081346 (to Y. T.) from the NIDDK, Grant R01HL081202 (to L. D.) from the NHLBI, Grant AG023720 (to R. B. E.) from the NIA, and a Fellowship Grant F31AG023838 (to L. S. G.). This work was also supported by a Whit-come Summer Research Fellowship (to W. T.).	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Canfield AE, 2000, FEBS LETT, V487, P267, DOI 10.1016/S0014-5793(00)02363-2; Cassady AI, 2003, J BONE MINER RES, V18, P1901, DOI 10.1359/jbmr.2003.18.10.1901; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Gopalakrishnan R, 2001, ENDOCRINOLOGY, V142, P4379, DOI 10.1210/en.142.10.4379; Graham LS, 2009, CLIN IMMUNOL, V133, P265, DOI 10.1016/j.clim.2009.07.011; Huang MS, 2008, BIOCHEM BIOPH RES CO, V374, P553, DOI 10.1016/j.bbrc.2008.07.062; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Jeziorska M, 1998, J PATHOL, V185, P10; Jeziorska M, 1998, VIRCHOWS ARCH, V433, P559, DOI 10.1007/s004280050289; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Kondo H, 2002, J BONE MINER RES, V17, P1667, DOI 10.1359/jbmr.2002.17.9.1667; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Simpson CL, 2007, CARDIOVASC PATHOL, V16, P29, DOI 10.1016/j.carpath.2006.07.001; Morena M, 2006, J AM SOC NEPHROL, V17, P262, DOI 10.1681/ASN.2005030260; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283; Nitta K, 2004, NEPHROL DIAL TRANSPL, V19, P1886, DOI 10.1093/ndt/gfh263; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Rasmussen LM, 2006, EUR J ENDOCRINOL, V154, P75, DOI 10.1530/eje.1.02049; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Siddappa R, 2009, TISSUE ENG PT A, V15, P2135, DOI 10.1089/ten.tea.2008.0512; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Tintut Y, 2005, J MOL CELL CARDIOL, V39, P389, DOI 10.1016/j.yjmcc.2005.03.019; Tintut Y, 1998, J BIOL CHEM, V273, P7547, DOI 10.1074/jbc.273.13.7547; Vanderborght A, 2004, J RHEUMATOL, V31, P1483; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Yamate T, 1997, ENDOCRINOLOGY, V138, P3047, DOI 10.1210/en.138.7.3047; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636	43	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29925	29931		10.1074/jbc.M110.117366	http://dx.doi.org/10.1074/jbc.M110.117366			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663885	Green Published, hybrid			2022-12-27	WOS:000281984300029
J	Cen, B; Mahajan, S; Zemskova, M; Beharry, Z; Lin, YW; Cramer, SD; Lilly, MB; Kraft, AS				Cen, Bo; Mahajan, Sandeep; Zemskova, Marina; Beharry, Zanna; Lin, Ying-Wei; Cramer, Scott D.; Lilly, Michael B.; Kraft, Andrew S.			Regulation of Skp2 Levels by the Pim-1 Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; SCF UBIQUITIN LIGASE; CELL-CYCLE; S-PHASE; PHOSPHORYLATION; DEGRADATION; CANCER; LOCALIZATION; PHOSPHATASE; ACTIVATION	The Pim-1 protein kinase plays an important role in regulating both cell growth and survival and enhancing transformation by multiple oncogenes. The ability of Pim-1 to regulate cell growth is mediated, in part, by the capacity of this protein kinase to control the levels of the p27, a protein that is a critical regulator of cyclin-dependent kinases that mediate cell cycle progression. To understand how Pim-1 is capable of regulating p27 protein levels, we focused our attention on the SCFSkp2 ubiquitin ligase complex that controls the rate of degradation of this protein. We found that expression of Pim-1 increases the level of Skp2 through direct binding and phosphorylation of multiple sites on this protein. Along with known Skp2 phosphorylation sites including Ser(64) and Ser(72), we have identified Thr(417) as a unique Pim-1 phosphorylation target. Phosphorylation of Thr(417) controls the stability of Skp2 and its ability to degrade p27. Additionally, we found that Pim-1 regulates the anaphase-promoting complex or cyclosome (APC/C complex) that mediates the ubiquitination of Skp2. Pim-1 phosphorylates Cdh1 and impairs binding of this protein to another APC/C complex member, CDC27. These modifications inhibit Skp2 from degradation. Marked increases in Skp2 caused by these mechanisms lower cellular p27 levels. Consistent with these observations, we show that Pim-1 is able to cooperate with Skp2 to signal S phase entry. Our data reveal a novel Pim-1 kinase-dependent signaling pathway that plays a crucial role in cell cycle regulation.	[Cen, Bo; Kraft, Andrew S.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Mahajan, Sandeep; Kraft, Andrew S.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Zemskova, Marina] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Beharry, Zanna] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Lin, Ying-Wei] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Cramer, Scott D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Cramer, Scott D.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; [Lilly, Michael B.] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92868 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of California System; University of California Irvine	Kraft, AS (corresponding author), 86 Jonathan Lucas St, Charleston, SC 29425 USA.	kraft@musc.edu		Beharry, Zanna/0000-0002-3900-8523; Zemskova, Marina/0000-0002-1454-3714	Department of Defense [W8IXWH-08, W81XWH-10-1-0249];  [1P30-CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085196] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Department of Defense Grants W8IXWH-08 and W81XWH-10-1-0249. The flow cytometry core received support from 1P30-CA138313.	Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Balkovetz DF, 1999, INT REV CYTOL, V186, P225; Barclay WW, 2005, PROSTATE, V63, P291, DOI 10.1002/pros.20193; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Beharry Z, 2009, MOL CANCER THER, V8, P1473, DOI 10.1158/1535-7163.MCT-08-1037; Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; Bullock AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007112; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cen B, 2009, J BIOL CHEM, V284, P5265, DOI 10.1074/jbc.M804531200; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Jacobs MD, 2005, J BIOL CHEM, V280, P13728, DOI 10.1074/jbc.M413155200; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Kumar A, 2005, J MOL BIOL, V348, P183, DOI 10.1016/j.jmb.2005.02.039; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Roh M, 2005, J BIOL CHEM, V280, P40568, DOI 10.1074/jbc.M509369200; Roh M, 2003, CANCER RES, V63, P8079; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shim EH, 2003, CANCER RES, V63, P1583; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; VAN LEUKEN R, 2008, BBA-REV CANCER, V1786, P49; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang W, 2003, J BIOL CHEM, V278, P32390, DOI 10.1074/jbc.M305241200; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Xia ZP, 2009, J MED CHEM, V52, P74, DOI 10.1021/jm800937p; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200; Zhang H, 2003, HEPATOLOGY, V38, P305, DOI 10.1053/jhep.2003.50345; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	61	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29128	29137		10.1074/jbc.M110.137240	http://dx.doi.org/10.1074/jbc.M110.137240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20663873	Green Published, hybrid			2022-12-27	WOS:000281740100013
J	Shen, XC; Xi, G; Radhakrishnan, Y; Clemmons, DR				Shen, Xinchun; Xi, Gang; Radhakrishnan, Yashwanth; Clemmons, David R.			PDK1 Recruitment to the SHPS-1 Signaling Complex Enhances Insulin-like Growth Factor-I-stimulated AKT Activation and Vascular Smooth Muscle Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; DEPENDENT TYROSINE PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; PDK1-INTERACTING PROTEIN; P85 SUBUNIT; SRC KINASE; RECEPTOR; BINDING; IDENTIFICATION; LOCALIZATION	In vascular smooth muscle cells, exposed to hyperglycemia and insulin-like growth factor-I (IGF-I), SHPS-1 functions as a scaffold protein, and a signaling complex is assembled that leads to AKT activation. However, the underlying mechanism by which formation of this complex activates the kinase that phosphorylates AKT (Thr(308)) is unknown. Therefore, we investigated the mechanism of PDK1 recruitment to the SHPS-1 signaling complex and the consequences of disrupting PDK1 recruitment for downstream signaling. Our results show that following IGF-I stimulation, PDK1 is recruited to SHPS-1, and its recruitment is mediated by Grb2, which associates with SHPS-1 via its interaction with Pyk2, a component of the SHPS-1-associated complex. A proline-rich sequence in PDK1 bound to an Src homology 3 domain in Grb2 in response to IGF-I. Disruption of Grb2-PDK1 by expression of either a Grb2 Src homology 3 domain or a PDK1 proline to alanine mutant inhibited PDK1 recruitment to SHPS-1, leading to impaired IGF-I-stimulated AKT Thr(308) phosphorylation. Following its recruitment to SHPS-1, PDK1 was further activated via Tyr(373/376) phosphorylation, and this was required for a maximal increase in PDK1 kinase activity and AKT-mediated FOXO3a Thr(32) phosphorylation. PDK1 recruitment was also required for IGF-I to prevent apoptosis that occurred in response to hyperglycemia. Assembly of the Grb2-PDK1 complex on SHPS-1 was specific for IGF-I signaling because inhibiting PDK1 recruitment to SHPS-1 had no effect on EGF-stimulated AKT Thr(308) phosphorylation. These findings reveal a novel mechanism for recruitment of PDK1 to the SHPS-1 signaling complex, which is required for IGF-I-stimulated AKT Thr(308) phosphorylation and inhibition of apoptosis.	[Shen, Xinchun; Xi, Gang; Radhakrishnan, Yashwanth; Clemmons, David R.] Univ N Carolina, Sch Med, Dept Med, Div Endocrinol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Clemmons, DR (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	endo@med.unc.edu	Xi, Gang/C-1498-2011		National Institutes of Health [HL56850, AG022331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56850 and AG022331.	Alberobello AT, 2010, J BIOL CHEM, V285, P6563, DOI 10.1074/jbc.M109.097410; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Allen RT, 2005, APOPTOSIS, V10, P525, DOI 10.1007/s10495-005-1882-3; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Chun J, 2005, BIOCHEM BIOPH RES CO, V326, P136, DOI 10.1016/j.bbrc.2004.10.208; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; Flynn P, 2000, CURR BIOL, V10, P1439, DOI 10.1016/S0960-9822(00)00801-0; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Guo JF, 2006, CIRC RES, V99, P1367, DOI 10.1161/01.RES.0000252830.01581.fd; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; King CC, 2004, J BIOL CHEM, V279, P37518, DOI 10.1074/jbc.M405340200; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kurata A, 2008, CANCER SCI, V99, P1827, DOI 10.1111/j.1349-7006.2008.00874.x; Kwon M, 2006, ENDOCRINOLOGY, V147, P1458, DOI 10.1210/en.2005-1115; Lawlor MA, 2001, J CELL SCI, V114, P2903; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; PARKER A, 1995, ENDOCRINOLOGY, V136, P2470, DOI 10.1210/en.136.6.2470; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Radhakrishnan Y, 2010, J BIOL CHEM, V285, P15682, DOI 10.1074/jbc.M109.092270; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SHEN X, 2010, CELL MOL LI IN PRESS; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Steiler TL, 2003, ENDOCRINOLOGY, V144, P5259, DOI 10.1210/en.2003-0447; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	55	15	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29416	29424		10.1074/jbc.M110.155325	http://dx.doi.org/10.1074/jbc.M110.155325			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20643654	Green Published, hybrid			2022-12-27	WOS:000281740100044
J	Mathias, A; Duc, M; Favre, L; Benyacoub, J; Blum, S; Corthesy, B				Mathias, Amandine; Duc, Melanie; Favre, Laurent; Benyacoub, Jalil; Blum, Stephanie; Corthesy, Blaise			Potentiation of Polarized Intestinal Caco-2 Cell Responsiveness to Probiotics Complexed with Secretory IgA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EPITHELIAL-CELLS; DENDRITIC CELLS; IMMUNE-RESPONSE; IN-VIVO; COMMENSAL BACTERIA; MUCOSAL SURFACES; GUT; COMPONENT; HOMEOSTASIS	The precise mechanisms underlying the interaction between intestinal bacteria and the host epithelium lead to multiple consequences that remain poorly understood at the molecular level. Deciphering such events can provide valuable information as to the mode of action of commensal and probiotic microorganisms in the gastrointestinal environment. Potential roles of such microorganisms along the privileged target represented by the mucosal immune system include maturation prior, during and after weaning, and the reduction of inflammatory reactions in pathogenic conditions. Using human intestinal epithelial Caco-2 cell grown as polarized monolayers, we found that association of a Lactobacillus or a Bifidobacterium with nonspecific secretory IgA (SIgA) enhanced probiotic adhesion by a factor of 3.4-fold or more. Bacteria alone or in complex with SIgA reinforced transepithelial electrical resistance, a phenomenon coupled with increased phosphorylation of tight junction proteins zonula occludens-1 and occludin. In contrast, association with SIgA resulted in both enhanced level of nuclear translocation of NF-kappa B and production of epithelial polymeric Ig receptor as compared with bacteria alone. Moreover, thymic stromal lymphopoietin production was increased upon exposure to bacteria and further enhanced with SIgA-based complexes, whereas the level of pro-inflammatory epithelial cell mediators remained unaffected. Interestingly, SIgA-mediated potentiation of the Caco-2 cell responsiveness to the two probiotics tested involved Fab-independent interaction with the bacteria. These findings add to the multiple functions of SIgA and underscore a novel role of the antibody in interaction with intestinal bacteria.	[Mathias, Amandine; Duc, Melanie; Corthesy, Blaise] CHU Vaudois, R&D Lab, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Favre, Laurent; Benyacoub, Jalil; Blum, Stephanie] Nestec Res Ctr, Dept Nutr & Hlth, CH-1000 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Nestle SA	Corthesy, B (corresponding author), Univ State Hosp CHUV, R&D Lab, Dept Immunol & Allergy, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch			Swiss Science Research Foundation [3200-122039]; Nestec Research Center	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF)); Nestec Research Center	This work was supported by Research Grant 3200-122039 from the Swiss Science Research Foundation and the Nestec Research Center.	Blumer N, 2007, CURR OPIN GASTROEN, V23, P655; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Cottet S, 2002, J BIOL CHEM, V277, P33978, DOI 10.1074/jbc.M201726200; Crottet P, 1999, BIOCHEM J, V341, P299, DOI 10.1042/0264-6021:3410299; Crottet P, 1998, J IMMUNOL, V161, P5445; Crottet P, 1999, J BIOL CHEM, V274, P31445, DOI 10.1074/jbc.274.44.31445; Favre L, 2005, J IMMUNOL, V175, P2793, DOI 10.4049/jimmunol.175.5.2793; Favre LI, 2003, J CHROMATOGR B, V786, P143, DOI 10.1016/S1570-0232(02)00723-7; Guarner F, 2006, DIGESTION, V73, P5, DOI 10.1159/000089775; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; KRAMER DR, 1995, J IMMUNOL, V154, P2051; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; MITSUOKA T, 1992, NUTR REV, V50, P438, DOI 10.1111/j.1753-4887.1992.tb02499.x; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Pasparakis M, 2008, MUCOSAL IMMUNOL, V1, pS54, DOI 10.1038/mi.2008.53; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Resta-Lenert S, 2006, GASTROENTEROLOGY, V130, P731, DOI 10.1053/j.gastro.2005.12.015; RINDISBACHER L, 1995, J BIOL CHEM, V270, P14220, DOI 10.1074/jbc.270.23.14220; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Thierry AC, 2009, CLIN EXP ALLERGY, V39, P527, DOI 10.1111/j.1365-2222.2008.03185.x; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x	38	48	54	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33906	33913		10.1074/jbc.M110.135111	http://dx.doi.org/10.1074/jbc.M110.135111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729211	Green Published, hybrid			2022-12-27	WOS:000283354000037
J	Tang, J; Bouyer, P; Mykoniatis, A; Buschmann, M; Matlin, KS; Matthews, JB				Tang, Jun; Bouyer, Patrice; Mykoniatis, Andreas; Buschmann, Mary; Matlin, Karl S.; Matthews, Jeffrey B.			Activated PKC delta and PKC epsilon Inhibit Epithelial Chloride Secretion Response to cAMP via Inducing Internalization of the Na+-K+-2Cl(-) Cotransporter NKCC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MYRISTOYLATED PSEUDOSUBSTRATE PEPTIDE; CLATHRIN-DEPENDENT PATHWAY; MEDIATED RNA INTERFERENCE; NA-K-2CL COTRANSPORTER; MAMMALIAN-CELLS; APICAL MEMBRANE; CARDIAC MYOCYTES; TIGHT JUNCTIONS; ION SECRETION	The basolateral Na+-K+-2Cl(-)cotransporter (NKCC1) is a key determinant of transepithelial chloride secretion and dysregulation of chloride secretion is a common feature of many diseases including secretory diarrhea. We have previously shown that activation of protein kinase C (PKC) markedly reduces transepithelial chloride secretion in human colonic T84 cells, which correlates with both functional inhibition and loss of the NKCC1 surface expression. In the present study, we defined the specific roles of PKC isoforms in regulating epithelial NKCC1 and chloride secretion utilizing adenoviral vectors that express shRNAs targeting human PKC isoforms (alpha,delta,epsilon) (shPKCs) or LacZ (shLacZ, non-targeting control). After 72 h of adenoviral transduction, protein levels of the PKC isoforms in shPKCs-T84 cells were decreased by similar to 90% compared with the shLacZ-control. Activation of PKCs by phorbol 12-myristate 13-acetate (PMA) caused a redistribution of NKCC1 immuno-staining from the basolateral membrane to intracellular vesicles in both shLacZ- and shPKC alpha-T84 cells, whereas the effect of PMA was not observed in shPKC delta- and shPKC epsilon- cells. These results were further confirmed by basolateral surface biotinylation. Furthermore, activation of PKCs by PMA inhibited cAMP-stimulated chloride secretion in the uninfected, shLacZ- and shPKC alpha-T84 monolayers, but the inhibitory effect was significantly attenuated in shPKC delta- and shPKC epsilon-T84 monolayers. In conclusion, the activated novel isoforms PKC delta or PKC epsilon, but not the conventional isoform PKC alpha, inhibits transepithelial chloride secretion through inducing internalization of the basolateral surface NKCC1. Our study reveals that the novel PKC isoform-regulated NKCC1 surface expression plays an important role in the regulation of chloride secretion.	[Tang, Jun; Bouyer, Patrice; Mykoniatis, Andreas; Buschmann, Mary; Matlin, Karl S.; Matthews, Jeffrey B.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago	Tang, J (corresponding author), 5841 S Maryland Ave,MC 5029, Chicago, IL 60637 USA.	juntang@uchicago.edu; jmatthews@uchicago.edu			National Institutes of Health, NIDDK [DK-48010]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK048010, R01DK048010] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-48010 from the NIDDK (to J. B. M.).	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bataille AM, 2008, AM J PHYSIOL-REG I, V295, pR2024, DOI 10.1152/ajpregu.90471.2008; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Broughman JR, 2006, AM J PHYSIOL-GASTR L, V291, pG318, DOI 10.1152/ajpgi.00355.2005; Broughman JR, 2006, AM J PHYSIOL-GASTR L, V291, pG331, DOI 10.1152/ajpgi.00356.2005; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chappe F, 2008, J PHARMACOL EXP THER, V327, P226, DOI 10.1124/jpet.108.141143; Chappell AE, 2008, FASEB J, V22, P2023, DOI 10.1096/fj.07-099697; Chen YF, 2006, HYPERTENSION, V47, P230, DOI 10.1161/01.HYP.0000200259.01947.bb; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Del Castillo IC, 2005, AM J PHYSIOL-CELL PH, V289, pC1332, DOI 10.1152/ajpcell.00580.2004; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; DHARMSATHAPHORN K, 1985, J CLIN INVEST, V75, P462, DOI 10.1172/JCI111721; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Farokhzad OC, 1999, J CELL PHYSIOL, V181, P489, DOI 10.1002/(SICI)1097-4652(199912)181:3<489::AID-JCP13>3.0.CO;2-7; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Geibel JP, 2005, ANNU REV PHYSIOL, V67, P471, DOI 10.1146/annurev.physiol.67.031103.153530; Ghadimi D, 2010, INFLAMM BOWEL DIS, V16, P410, DOI 10.1002/ibd.21057; Ghartey-Tagoe EB, 2006, INT J PHARMACEUT, V315, P122, DOI 10.1016/j.ijpharm.2006.02.022; Gonzalez MI, 2005, J NEUROCHEM, V94, P1180, DOI 10.1111/j.1471-4159.2005.03330.x; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; HALM DR, 1990, TXB SECRETORY DIARRH, P47; Harris TE, 1999, MOL CELL ENDOCRINOL, V155, P61, DOI 10.1016/S0303-7207(99)00114-8; Hassan HA, 2007, AM J PHYSIOL-CELL PH, V292, pC1485, DOI 10.1152/ajpcell.00447.2006; Huang B, 2005, HUM GENE THER, V16, P618, DOI 10.1089/hum.2005.16.618; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; Irnaten M, 2008, CELL CALCIUM, V44, P441, DOI 10.1016/j.ceca.2008.02.007; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jobbagy Z, 1999, J BIOL CHEM, V274, P7067, DOI 10.1074/jbc.274.11.7067; Johnson JA, 2004, LIFE SCI, V74, P3153, DOI 10.1016/j.lfs.2003.11.016; Karatas-Wulf U, 2009, NEUROSCIENCE, V161, P794, DOI 10.1016/j.neuroscience.2009.04.017; Keely SJ, 2003, AM J PHYSIOL-CELL PH, V284, pC339, DOI 10.1152/ajpcell.00144.2002; Krotova K, 2006, BRIT J PHARMACOL, V148, P732, DOI 10.1038/sj.bjp.0706777; Kuwano Y, 2006, AM J PHYSIOL-CELL PH, V290, pC433, DOI 10.1152/ajpcell.00135.2005; LEBENTHAL E, 1990, TXB SECRETORY DIARRH; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Liedtke CM, 2002, AM J PHYSIOL-LUNG C, V282, pL1151, DOI 10.1152/ajplung.00143.2001; Lim S, 2008, LIFE SCI, V82, P733, DOI 10.1016/j.lfs.2008.01.005; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Matthews JB, 1998, J CLIN INVEST, V101, P2072, DOI 10.1172/JCI1042; Matthews JB, 2002, WORLD J SURG, V26, P826, DOI 10.1007/s00268-002-4059-z; MATTHEWS JB, 1993, AM J PHYSIOL, V265, pC1109, DOI 10.1152/ajpcell.1993.265.4.C1109; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Mykoniatis A, 2010, AM J PHYSIOL-CELL PH, V298, pC85, DOI 10.1152/ajpcell.00118.2009; OMAHONY F, 2008, M J PHYSL CELL PHYSL, V294, pC1362; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; Pitcher MH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-17; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; Rinne Andreas, 2009, V515, P107, DOI 10.1007/978-1-59745-559-6_7; Rotmann A, 2004, J BIOL CHEM, V279, P54185, DOI 10.1074/jbc.M409556200; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sen A, 2007, EPILEPSY RES, V74, P220, DOI 10.1016/j.eplepsyres.2007.01.004; Shen CX, 2003, FEBS LETT, V539, P111, DOI 10.1016/S0014-5793(03)00209-6; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Smith L, 2008, J BIOL CHEM, V283, P22147, DOI 10.1074/jbc.M801752200; Song JC, 2001, AM J PHYSIOL-CELL PH, V281, pC649, DOI 10.1152/ajpcell.2001.281.2.C649; Song JC, 1999, AM J PHYSIOL-CELL PH, V277, pC1239, DOI 10.1152/ajpcell.1999.277.6.C1239; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Takeshita F, 2006, CANCER SCI, V97, P689, DOI 10.1111/j.1349-7006.2006.00234.x; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Yue W, 2009, MOL PHARMACEUT, V6, P134, DOI 10.1021/mp800100e; Zhang Q, 2008, J BIOL CHEM, V283, P32570, DOI 10.1074/jbc.M800298200	73	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34072	34085		10.1074/jbc.M110.137380	http://dx.doi.org/10.1074/jbc.M110.137380			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732874	Green Published, hybrid			2022-12-27	WOS:000283354000053
J	Bustamante, N; Campillo, NE; Garcia, E; Gallego, C; Pera, B; Diakun, GP; Saiz, JL; Garcia, P; Diaz, JF; Menendez, M				Bustamante, Noemi; Campillo, Nuria E.; Garcia, Ernesto; Gallego, Cristina; Pera, Benet; Diakun, Gregory P.; Saiz, Jose Luis; Garcia, Pedro; Diaz, J. Fernando; Menendez, Margarita			Cpl-7, a Lysozyme Encoded by a Pneumococcal Bacteriophage with a Novel Cell Wall-binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; PROTEIN SECONDARY STRUCTURE; HUMAN GUT MICROBIOTA; LYTIC ENZYMES; STREPTOCOCCUS-PNEUMONIAE; HYDRODYNAMIC PROPERTIES; SOLUTION SCATTERING; SEQUENCE ALIGNMENT; STRUCTURAL BASIS; PHAGE	Bacteriophage endolysins include a group of new antibacterials reluctant to development of resistance. We present here the first structural study of the Cpl-7 endolysin, encoded by pneumococcal bacteriophage Cp-7. It contains an N-terminal catalytic module (CM) belonging to the GH25 family of glycosyl hydrolases and a C-terminal region encompassing three identical repeats of 42 amino acids (CW_7 repeats). These repeats are unrelated to choline-targeting motifs present in other cell wall hydrolases produced by Streptococcus pneumoniae and its bacteriophages, and are responsible for the protein attachment to the cell wall. By combining different biophysical techniques and molecular modeling, a three-dimensional model of the overall protein structure is proposed, consistent with circular dichroism and sequence-based secondary structure prediction, small angle x-ray scattering data, and Cpl-7 hydrodynamic behavior. Cpl-7 is an similar to 115-angstrom long molecule with two well differentiated regions, corresponding to the CM and the cell wall binding region (CWBR), arranged in a lateral disposition. The CM displays the (beta alpha)(5)beta(3) barrel topology characteristic of the GH25 family, and the impact of sequence differences with the CM of the Cpl-1 lysozyme in substrate binding is discussed. The CWBR is organized in three tandemly assembled three-helical bundles whose dispositions remind us of a super-helical structure. Its approximate dimensions are 60 x 20 x 20 angstrom and presents a concave face that might constitute the functional region involved in bacterial surface recognition. The distribution of CW_7 repeats in the sequences deposited in the Entrez Database have been examined, and the results drastically expanded the antimicrobial potential of the Cpl-7 endolysin.	[Saiz, Jose Luis; Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, Madrid 28006, Spain; [Bustamante, Noemi; Garcia, Ernesto; Gallego, Cristina; Saiz, Jose Luis; Garcia, Pedro; Menendez, Margarita] CSIC, CIBER Enfermedades Resp, Madrid 28006, Spain; [Campillo, Nuria E.] CSIC, Inst Quim Med, Madrid 28006, Spain; [Garcia, Ernesto; Pera, Benet; Garcia, Pedro; Diaz, J. Fernando] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Diakun, Gregory P.] CCLRC Daresbury Lab, Warrington WA4 4AD, Cheshire, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); STFC Daresbury Laboratory	Menendez, M (corresponding author), CSIC, Inst Quim Fis Rocasolano, Serrano 119, Madrid 28006, Spain.	mmenendez@iqfr.csic.es	Campillo, Nuria E/J-8810-2014; Díaz, J. Fernando/U-3532-2017; Díaz, J. Fernando/M-6853-2019; García, Pedro/L-2808-2017; Menendez, Margarita/M-1795-2014	Díaz, J. Fernando/0000-0003-2743-3319; Díaz, J. Fernando/0000-0003-2743-3319; García, Pedro/0000-0001-6717-8717; Menendez, Margarita/0000-0002-3267-4443; Gallego Paramo, Cristina/0000-0003-1510-186X; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; /0000-0002-9948-2665	Ministerio de Ciencia e Innovacion [BFU2006-10288, SAF2009-10824, BIO2007-61336, BFU2009-10052]; Comunidad de Madrid; CIBER de Enfermedades Respiratorias (CIBERES); Initiative of the ISCIII; Glycodynamics Network [FP6-UE MCTN-CT-2005-019561]; European Community [48086]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); CIBER de Enfermedades Respiratorias (CIBERES); Initiative of the ISCIII; Glycodynamics Network; European Community(European Commission)	This work was supported by Grants BFU2006-10288, SAF2009-10824, BIO2007-61336, and BFU2009-10052 from Ministerio de Ciencia e Innovacion, Grant BIPPED-CM from the Comunidad de Madrid, the CIBER de Enfermedades Respiratorias (CIBERES), an initiative of the ISCIII, Glycodynamics Network Grant FP6-UE MCTN-CT-2005-019561, and European Community beam time Proposal 48086.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Buey RM, 2009, LECT NOTES PHYS, V776, P245, DOI 10.1007/978-3-540-95968-7_12; Buey RM, 2007, J MOL BIOL, V365, P411, DOI 10.1016/j.jmb.2006.09.091; Chacon P, 1998, BIOPHYS J, V74, P2760, DOI 10.1016/S0006-3495(98)77984-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Davies MR, 2007, J BACTERIOL, V189, P2646, DOI 10.1128/JB.01590-06; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; DIAZ E, 1991, J BIOL CHEM, V266, P5464; Donovan DM, 2008, FEMS MICROBIOL LETT, V287, P22, DOI 10.1111/j.1574-6968.2008.01287.x; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GARCIA JL, 1987, J VIROL, V61, P2573; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; GARCIA P, 1990, GENE, V86, P81, DOI 10.1016/0378-1119(90)90116-9; Garcia P, 2005, PHAGES THEIR ROLE BA, P335; Garneau JE, 2008, VIROLOGY, V373, P298, DOI 10.1016/j.virol.2007.12.002; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; INOUYE S, 1985, NUCLEIC ACIDS RES, V13, P3101, DOI 10.1093/nar/13.9.3101; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Jado I, 2003, J ANTIMICROB CHEMOTH, V52, P967, DOI 10.1093/jac/dkg485; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu S, 2007, PROTEINS, V68, P636, DOI 10.1002/prot.21459; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loeffler JM, 2003, INFECT IMMUN, V71, P6199, DOI 10.1128/IAI.71.11.6199-6204.2003; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; McCullers JA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030028; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Monterroso B, 2008, J BIOL CHEM, V283, P28618, DOI 10.1074/jbc.M802808200; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Perez-Dorado I, 2007, J BIOL CHEM, V282, P24990, DOI 10.1074/jbc.M704317200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pritchard DG, 2007, APPL ENVIRON MICROB, V73, P7150, DOI 10.1128/AEM.01783-07; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ragone S, 2008, EMBO J, V27, P2259, DOI 10.1038/emboj.2008.145; Regeard C, 2005, APPL ENVIRON MICROB, V71, P2955, DOI 10.1128/AEM.71.6.2955-2961.2005; Rodriguez-Cerrato V, 2007, J ANTIMICROB CHEMOTH, V60, P1159, DOI 10.1093/jac/dkm342; Rodriguez-Cerrato V, 2007, ANTIMICROB AGENTS CH, V51, P3371, DOI 10.1128/AAC.00137-07; SANZ JM, 1992, MOL MICROBIOL, V6, P921, DOI 10.1111/j.1365-2958.1992.tb01542.x; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Silva-Martin N, 2010, ACTA CRYSTALLOGR F, V66, P670, DOI 10.1107/S1744309110006718; Solis D, 2009, SUGAR CODE FUNDAMENT, P233; Speicher David W., 1994, Methods (Orlando), V6, P262, DOI 10.1006/meth.1994.1028; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turroni F, 2008, ANTON LEEUW INT J G, V94, P35, DOI 10.1007/s10482-008-9232-4; Valas RE, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-30; Varea J, 2004, J BIOL CHEM, V279, P43697, DOI 10.1074/jbc.M407067200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang Y, 2009, CURR MICROBIOL, V58, P609, DOI 10.1007/s00284-009-9379-x; Witzenrath M, 2009, CRIT CARE MED, V37, P642, DOI 10.1097/CCM.0b013e31819586a6; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869	69	35	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33184	33196		10.1074/jbc.M110.154559	http://dx.doi.org/10.1074/jbc.M110.154559			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720016	Green Published, hybrid			2022-12-27	WOS:000283048200056
J	Desuzinges-Mandon, E; Arnaud, O; Martinez, L; Huche, F; Di Pietro, A; Falson, P				Desuzinges-Mandon, Elodie; Arnaud, Ophelie; Martinez, Lorena; Huche, Frederic; Di Pietro, Attilio; Falson, Pierre			ABCG2 Transports and Transfers Heme to Albumin through Its Large Extracellular Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER RESISTANCE PROTEIN; CIRCULAR-DICHROISM SPECTRA; ETCH VIRUS PROTEASE; MULTIDRUG TRANSPORTER; SECONDARY STRUCTURE; EFFLUX PUMP; CELL-LINES; STEM-CELLS; DIFFERENTIATION; INHIBITION	ABCG2 is an ATP-binding cassette (ABC) transporter preferentially expressed by immature human hematopoietic progenitors. Due to its role in drug resistance, its expression has been correlated with a protection role against protoporhyrin IX (PPIX) accumulation in stem cells under hypoxic conditions. We show here that zinc mesoporphyrin, a validated fluorescent heme analog, is transported by ABCG2. We also show that the ABCG2 large extracellular loop ECL3 constitutes a porphyrin-binding domain, which strongly interacts with heme, hemin, PPIX, ZnPPIX, CoPPIX, and much less efficiently with pheophorbide a, but not with vitamin B12. K-d values are in the range 0.5-3.5 mu M, with heme displaying the highest affinity. Nonporphyrin substrates of ABCG2, such as mitoxantrone, doxo/ daunorubicin, and riboflavin, do not bind to ECL3. Single-point mutations H583A and C603A inside ECL3 prevent the binding of hemin but hardly affect that of iron-free PPIX. The extracellular location of ECL3 downstream from the transport sites suggests that, after membrane translocation, hemin is transferred to ECL3, which is strategically positioned to release the bound porphyrin to extracellular partners. We show here that human serum albumin could be one of these possible partners as it removes hemin bound to ECL3 and interacts with ABCG2, with a K-d of about 3 mu M.	[Desuzinges-Mandon, Elodie; Arnaud, Ophelie; Martinez, Lorena; Huche, Frederic; Di Pietro, Attilio; Falson, Pierre] Univ Lyon 1, UMR CNRS 5086, IBCP,Equipe Labellise Ligue 2009, ABC Transporters & Multidrug Resistance Lab,IFR 1, F-69367 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Falson, P (corresponding author), Univ Lyon 1, UMR CNRS 5086, IBCP,Equipe Labellise Ligue 2009, ABC Transporters & Multidrug Resistance Lab,IFR 1, 7 Passage Vercors, F-69367 Lyon, France.	p.falson@ibcp.fr		Falson, Pierre/0000-0002-9760-4577	Centre National de la Recherche Scientifique (CNRS); University Lyon 1 [UMR5086]; Agence Nationale de la Recherche (ANR) [ANR-06-BLANC- 0420, ANR-06-PCVI-0019-01, ANR-09-PIRI-0002-01]; Association pour la Recherche sur le Cancer (ARC); Ligue Nationale Contre le Cancer Labelisation	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Lyon 1; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer Labelisation	This work was supported by the Centre National de la Recherche Scientifique (CNRS) and University Lyon 1 (UMR5086). This work was also supported by Agence Nationale de la Recherche (ANR) Contracts ANR-06-BLANC- 0420, ANR-06-PCVI-0019-01, and ANR-09-PIRI-0002-01, the Association pour la Recherche sur le Cancer (ARC), which funded the thesis of E. D.-M., and the Ligue Nationale Contre le Cancer Labelisation 2009.	Ahmed-Belkacem A, 2005, CANCER RES, V65, P4852, DOI 10.1158/0008-5472.CAN-04-1817; Ahmed-Belkacem A, 2007, J MED CHEM, V50, P1933, DOI 10.1021/jm061450q; Allen JD, 2002, MOL CANCER THER, V1, P417; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BALIGA BS, 1993, CELL PROLIFERAT, V26, P519, DOI 10.1111/j.1365-2184.1993.tb00030.x; Bhatia A, 2005, BIOCHEMISTRY-US, V44, P10893, DOI 10.1021/bi0503807; Bihorel S, 2007, J NEUROCHEM, V102, P1749, DOI 10.1111/j.1471-4159.2007.04808.x; Boumendjel A, 2007, BIOORGAN MED CHEM, V15, P2892, DOI 10.1016/j.bmc.2007.02.017; Dean M, 2001, J LIPID RES, V42, P1007; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FALSON P, 1993, BIOCHEMISTRY-US, V32, P10387, DOI 10.1021/bi00090a014; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186; Kage K, 2005, CANCER SCI, V96, P866, DOI 10.1111/j.1349-7006.2005.00126.x; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Li SD, 2006, ACTA BIOCH BIOPH SIN, V38, P63, DOI 10.1111/j.1745-7270.2006.00127.x; Li YF, 2007, J MOL GRAPH MODEL, V25, P837, DOI 10.1016/j.jmgm.2006.08.005; Litman T, 2000, J CELL SCI, V113, P2011; Maliepaard M, 2001, CANCER RES, V61, P3458; Mohanty AK, 2003, PROTEIN EXPRES PURIF, V27, P109, DOI 10.1016/S1046-5928(02)00589-2; Montigny C, 2004, BBA-BIOMEMBRANES, V1660, P53, DOI 10.1016/j.bbamem.2003.10.013; Monzani E, 2001, BBA-PROTEIN STRUCT M, V1547, P302, DOI 10.1016/S0167-4838(01)00192-3; MULLEREBERHARD U, 1993, AM J HEMATOL, V42, P59, DOI 10.1002/ajh.2830420112; Nicolle E, 2009, ADV DRUG DELIVER REV, V61, P34, DOI 10.1016/j.addr.2008.10.004; Ozvegy C, 2001, BIOCHEM BIOPH RES CO, V285, P111, DOI 10.1006/bbrc.2001.5130; Ozvegy-Laczka C, 2008, J BIOL CHEM, V283, P26059, DOI 10.1074/jbc.M803230200; Polgar O, 2004, BIOCHEMISTRY-US, V43, P9448, DOI 10.1021/bi0497953; Polgar O, 2006, BIOCHEMISTRY-US, V45, P5251, DOI 10.1021/bi0521590; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Ross DD, 1999, J NATL CANCER I, V91, P429, DOI 10.1093/jnci/91.5.429; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; SASSA S, 1988, SEMIN HEMATOL, V25, P312; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SCHEIDT WR, 1987, METAL COMPLEXES TETR, V1, P1; Seamon JA, 2006, MOL CANCER THER, V5, P2459, DOI 10.1158/1535-7163.MCT-06-0339; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trometer C, 2010, METHODS MOL BIOL, V601, P105, DOI 10.1007/978-1-60761-344-2_7; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; van Herwaarden AE, 2006, TRENDS PHARMACOL SCI, V27, P10, DOI 10.1016/j.tips.2005.11.007; van Herwaarden AE, 2007, MOL CELL BIOL, V27, P1247, DOI 10.1128/MCB.01621-06; Wang Xin, 2005, Antiviral Chemistry & Chemotherapy, V16, P213; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhu YH, 1999, BIOCHEM BIOPH RES CO, V258, P87, DOI 10.1006/bbrc.1999.0586	58	68	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33123	33133		10.1074/jbc.M110.139170	http://dx.doi.org/10.1074/jbc.M110.139170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705604	hybrid, Green Published			2022-12-27	WOS:000283048200050
J	Dong, HP; Liu, LH; Zou, G; Zhao, YW; Li, Z; Lim, SP; Shi, PY; Li, HM				Dong, Hongping; Liu, Lihui; Zou, Gang; Zhao, Yiwei; Li, Zhong; Lim, Siew Pheng; Shi, Pei-Yong; Li, Hongmin			Structural and Functional Analyses of a Conserved Hydrophobic Pocket of Flavivirus Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; YELLOW-FEVER VIRUS; RNA-STIMULATED NTPASE; NO-KNOWN-VECTOR; NS5 METHYLTRANSFERASE; CRYSTAL-STRUCTURE; MESSENGER-RNA; POLYMERASE NS5; DOMAIN; CAP	The flavivirus methyltransferase (MTase) sequentially methylates the N7 and 2'-O positions of the viral RNA cap (GpppA-RNA -> m(7)GpppA-RNA -> m(7)GpppAm-RNA), using S-adenosyl-L-methionine (AdoMet) as a methyl donor. We report here that sinefungin (SIN), an AdoMet analog, inhibits several flaviviruses through suppression of viral MTase. The crystal structure of West Nile virus MTase in complex with SIN inhibitor at 2.0-angstrom resolution revealed a flavivirus-conserved hydrophobic pocket located next to the AdoMet-binding site. The pocket is functionally critical in the viral replication and cap methylations. In addition, the N7 methylation efficiency was found to correlate with the viral replication ability. Thus, SIN analogs with modifications that interact with the hydrophobic pocket are potential specific inhibitors of flavivirus MTase.	[Dong, Hongping; Zou, Gang; Lim, Siew Pheng; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Li, Hongmin] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12201 USA	Novartis; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Shi, PY (corresponding author), Novartis Inst Trop Dis, 10 Biopolis Rd, Singapore 138670, Singapore.	pei_yong.shi@novartis.com	Li, Hongmin/ABI-2439-2020; Lim, Siew Pheng/P-8528-2016; Zou, Gang/J-1833-2014; Pheng, Lim Siew/AAG-4368-2021	Li, Hongmin/0000-0002-8684-5308; Zou, Gang/0000-0001-9607-7827; Pheng, Lim Siew/0000-0002-7377-5662; Li, Zhong/0000-0002-1039-7000	National Institutes of Health [AI07079201A1, AI061193]; Department of Energy; New York Structural Biology Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI007079, U01AI061193, R01AI094335, R21AI070792, R37AI007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); New York Structural Biology Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI07079201A1 ( to H.L.) and AI061193 ( to P.-Y.S. and H.L.).; We thank A. Verschoor for a critical reading of the manuscript and the Wadsworth Macromolecular Crystallography Core for facility usage. Diffraction data for this study were measured at beamline X4A of National Synchrotron Light Source, which is supported by the Department of Energy, by grants from the National Institutes of Health, and by the New York Structural Biology Center.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Assenberg R, 2007, J GEN VIROL, V88, P2228, DOI 10.1099/vir.0.82757-0; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Bhattacharya D, 2008, VIROLOGY, V380, P276, DOI 10.1016/j.virol.2008.07.013; Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028; Bollati M, 2009, BIOCHEM BIOPH RES CO, V382, P200, DOI 10.1016/j.bbrc.2009.03.008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8; DeLano W.L, PYMOL MOL GRAPHICS S; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P742, DOI 10.1073/pnas.72.2.742; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Jansson AM, 2009, ACTA CRYSTALLOGR D, V65, P796, DOI 10.1107/S0907444909017260; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003; Mastrangelo E, 2007, PROTEIN SCI, V16, P1133, DOI 10.1110/ps.072758107; MUTHUKRISHNAN S, 1975, NATURE, V255, P33, DOI 10.1038/255033a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Puig-Basagoiti F, 2006, ANTIMICROB AGENTS CH, V50, P1320, DOI 10.1128/AAC.50.4.1320-1329.2006; RAY BK, 1985, J BIOL CHEM, V260, P7651; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; WENGLER G, 1981, VIROLOGY, V113, P544, DOI 10.1016/0042-6822(81)90182-3; Wu H, 2008, PROTEINS, V72, P519, DOI 10.1002/prot.22065; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	45	43	45	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32586	32595		10.1074/jbc.M110.129197	http://dx.doi.org/10.1074/jbc.M110.129197			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685660	hybrid, Green Published			2022-12-27	WOS:000282683000073
J	Lee, JM; Seo, WY; Song, KH; Chanda, D; Kim, YD; Kim, DK; Lee, MW; Ryu, D; Kim, YH; Noh, JR; Lee, CH; Chiang, JYL; Koo, SH; Choi, HS				Lee, Ji-Min; Seo, Woo-Young; Song, Kwang-Hoon; Chanda, Dipanjan; Kim, Yong Deuk; Kim, Don-Kyu; Lee, Min-Woo; Ryu, Dongryeol; Kim, Yong-Hoon; Noh, Jung-Ran; Lee, Chul-Ho; Chiang, John Y. L.; Koo, Seung-Hoi; Choi, Hueng-Sik			AMPK-dependent Repression of Hepatic Gluconeogenesis via Disruption of CREB center dot CRTC2 Complex by Orphan Nuclear Receptor Small Heterodimer Partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CREB COACTIVATOR CRTC2; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; BINDING-PROTEIN; SHP; INSULIN; METFORMIN; TORC2; PHOSPHORYLATION	Orphan nuclear receptor small heterodimer partner (SHP) plays a key role in transcriptional repression of gluconeogenic enzyme gene expression. Here, we show that SHP inhibited protein kinase A-mediated transcriptional activity of cAMP-response element-binding protein (CREB), a major regulator of glucose metabolism, to modulate hepatic gluconeogenic gene expression. Deletion analysis of phosphoenolpyruvate carboxykinase (PEPCK) promoter demonstrated that SHP inhibited forskolin-mediated induction of PEPCK gene transcription via inhibition of CREB transcriptional activity. In vivo imaging demonstrated that SHP inhibited CREB-regulated transcription coactivator 2 (CRTC2)-mediated cAMP-response element-driven promoter activity. Furthermore, overexpression of SHP using adenovirus SHP decreased CRTC2-dependent elevations in blood glucose levels and PEPCK or glucose-6-phosphatase (G6Pase) expression in mice. SHP and CREB physically interacted and were co-localized in vivo. Importantly, SHP inhibited both wild type CRTC2 and S171A (constitutively active form of CRTC2) coactivator activity and disrupted CRTC2 recruitment on the PEPCK gene promoter. In addition, metformin or overexpression of a constitutively active form of AMPK (Ad-CA-AMPK) inhibited S171A-mediated PEPCK and G6Pase gene expression, and hepatic glucose production and knockdown of SHP partially relieved the metformin- and Ad-CA-AMPK-mediated repression of hepatic gluconeogenic enzyme gene expression in primary rat hepatocytes. In conclusion, our results suggest that a delayed effect of metformin-mediated induction of SHP gene expression inhibits CREB-dependent hepatic gluconeogenesis.	[Lee, Ji-Min; Chanda, Dipanjan; Kim, Yong Deuk; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea; [Seo, Woo-Young; Lee, Min-Woo; Ryu, Dongryeol; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Seo, Woo-Young; Lee, Min-Woo; Ryu, Dongryeol; Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Song, Kwang-Hoon; Chiang, John Y. L.] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Song, Kwang-Hoon; Chiang, John Y. L.] Northeastern Ohio Univ Coll Med & Pharm, Coll Pharm, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Kim, Yong-Hoon; Noh, Jung-Ran; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Chiang, John Y. L./G-2658-2011; Chanda, Dipanjan/AAU-3996-2021; Koo, Seung-Hoi/E-2763-2015; Ryu, Dongryeol/AAQ-3642-2020	Chiang, John Y. L./0000-0001-9360-7650; Chanda, Dipanjan/0000-0003-0685-187X; Koo, Seung-Hoi/0000-0001-8769-2879; Ryu, Dongryeol/0000-0001-5905-6760	Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A100588]; Ministry of Education, Science, and Technology [20100019512]; Brain Korea 21 program; National Institutes of Health [DK44442, DK58379]; Korean government (MEST) [2009-0090321, 2010-0015098]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044442, R01DK058379, R37DK058379, R56DK044442] Funding Source: NIH RePORTER	Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Ministry for Health, Welfare, and Family Affairs, Republic of Korea, Korea Healthcare Technology R&D Project Grant A100588 and National Research Foundation of Korea (NRF) Future-based Technology Development Program (BIO Fields) Grant 20100019512, funded by the Ministry of Education, Science, and Technology.; Supported by the Brain Korea 21 program.; Supported by National Institutes of Health Grants DK44442 and DK58379.; Supported by NRF Grants 2009-0090321 and 2010-0015098, funded by the Korean government (MEST). To whom correspondence may be addressed: Dept. of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 300, Republic of Korea. Tel.: 82-31-299-6122; Fax: 82-31-299-6239; E-mail: shkoo@med.skku.ac.kr.	Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Borgius LJ, 2002, J BIOL CHEM, V277, P49761, DOI 10.1074/jbc.M205641200; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Gobinet J, 2001, BIOCHEMISTRY-US, V40, P15369, DOI 10.1021/bi011384o; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Jiang YW, 2001, P NATL ACAD SCI USA, V98, P10102, DOI 10.1073/pnas.131200398; Johansson L, 1999, J BIOL CHEM, V274, P345, DOI 10.1074/jbc.274.1.345; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim JY, 2004, MOL ENDOCRINOL, V18, P776, DOI 10.1210/me.2003-0311; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Park MJ, 2007, BIOCHEM J, V402, P567, DOI 10.1042/BJ20061549; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Seel WG, 1998, MOL ENDOCRINOL, V12, P1551, DOI 10.1210/mend.12.10.0184; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song KH, 2007, HEPATOLOGY, V46, P1993, DOI 10.1002/hep.21878; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200	42	112	115	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32182	32191		10.1074/jbc.M110.134890	http://dx.doi.org/10.1074/jbc.M110.134890			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688914	Green Published, hybrid			2022-12-27	WOS:000282683000031
J	Ferreiro, I; Barragan, M; Gubern, A; Ballestar, E; Joaquin, M; Posas, F				Ferreiro, Isabel; Barragan, Montserrat; Gubern, Albert; Ballestar, Esteban; Joaquin, Manel; Posas, Francesc			The p38 SAPK Is Recruited to Chromatin via Its Interaction with Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; GENE-EXPRESSION; C-FOS; REGULATORY MECHANISMS; SIGNAL-TRANSDUCTION; OSMOTIC-STRESS; UV-LIGHT; IN-VIVO; PATHWAYS	In mammals, the stress-activated protein kinase (SAPK) p38 coordinates a rapid and complex transcriptional program to adapt to sudden changes in the extracellular environment. Although a number of genes have been reported to be under the control of p38, the basic mechanisms of transcriptional regulation by this SAPK remain uncharacterized. Here we show that in response to osmotic shock, anisomycin- or TNF alpha-activated p38 SAPK is recruited to stress-induced genes. The MAPKK MKK6 is also found at stress-responsive promoters. The recruitment of RNA polymerase II complex to the target promoters requires p38 activity. Moreover, when tethered to DNA as a LexA fusion protein, p38 activates transcription in a stress-regulated manner. Thus, p38 activity allows for recruitment of RNA polymerase and transcription initiation. p38 directly phosphorylates and interacts with the transcription factor Elk1. p38 activity is necessary for the recruitment of Elk1 to the c-Fos promoter, and knocking down Elk1 by siRNAs compromises both p38 recruitment to the c-Fos promoter and c-Fos transcriptional up-regulation upon osmostress. In addition, p38 recruitment to the osmoinducible gene Cox2 and the TNF alpha target gene IL8 is mediated by the transcription factors AP1 and NF kappa B, respectively. Therefore, anchoring of active SAPK to target genes is mediated by transcription factors. The presence of active p38 at open reading frames also suggests the involvement of the SAPK in elongation. Taken together, SAPK recruitment to target genes appears to be a broad mechanism to regulate transcription that has been preserved from yeast to mammals.	Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signalling Res Grp, Barcelona 08003, Spain; [Ballestar, Esteban] Inst Invest Biomed Bellvitge IDIBELL, PEBC, Chromatin & Dis Grp, Lhospitalet De Llobregat 08907, Spain	Pompeu Fabra University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)		manel.joaquin@upf.edu; francesc.posas@upf.edu	BARRAGAN, Montse/AFQ-1145-2022; Joaquin, Manel/E-2216-2015; Ballestar, Esteban/ABG-8561-2020; Joaquin, Manel/O-6533-2019; BARRAGAN, Montse/AAL-6772-2020; Posas, Francesc/K-1364-2013; Gubern, Albert/C-9902-2011	Joaquin, Manel/0000-0001-8973-5916; Joaquin, Manel/0000-0001-8973-5916; Posas, Francesc/0000-0002-4164-7076; Gubern, Albert/0000-0001-6458-1498; Ballestar, Esteban/0000-0002-1400-2440; Barragan, Montserrat/0000-0001-8859-6643	MICINN [BFU2007-66503, BFU2010-15939, CSD2007-0015]; European Commission [ERAS-CT-2003-980409]; Fundacion Marcelino Botin and Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia (Generalitat de Catalunya); Ministerio de Ciencia e Innovacion (MICINN); "Ramon y Cajal" program	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacion Marcelino Botin and Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Ramon y Cajal" program(Spanish Government)	This work was supported by MICINN Grants BFU2007-66503 and BFU2010-15939 (to M.J.) and BIO2009-07762, Consolider Ingenio 2010 programme (Grant CSD2007-0015) and through contract No. ERAS-CT-2003-980409 of the European Commission, DG Research, FP6 as part of a EURYI scheme award (to F. P.). This work was also supported by the Fundacion Marcelino Botin and Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia (Generalitat de Catalunya) (to F. P. laboratory).; Recipient of a PhD fellowship (FPI) from the Ministerio de Ciencia e Innovacion (MICINN).; Supported by the "Ramon y Cajal" program.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Ambrosino C, 2003, MOL CELL BIOL, V23, P370, DOI 10.1128/MCB.23.1.370-381.2003; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Jandhyala DM, 2008, CELL MICROBIOL, V10, P1468, DOI 10.1111/j.1462-5822.2008.01139.x; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Lawrence MC, 2009, P NATL ACAD SCI USA, V106, P22181, DOI 10.1073/pnas.0912596106; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Vicent Guillermo P, 2009, Nucl Recept Signal, V7, pe008, DOI 10.1621/nrs.07008; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang XS, 2005, J BIOL CHEM, V280, P19298, DOI 10.1074/jbc.M413059200; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WHITMARSH AJ, 2007, J BIOCHIM BIOPHYS AC, V1773, P1285; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF1, DOI 10.1152/ajprenal.1999.277.1.F1; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	39	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31819	31828		10.1074/jbc.M110.155846	http://dx.doi.org/10.1074/jbc.M110.155846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682780	Green Published, hybrid			2022-12-27	WOS:000282764600073
J	Montserret, R; Saint, N; Vanbelle, C; Salvay, AG; Simorre, JP; Ebel, C; Sapay, N; Renisio, JG; Bockmann, A; Steinmann, E; Pietschmann, T; Dubuisson, J; Chipot, C; Penin, F				Montserret, Roland; Saint, Nathalie; Vanbelle, Christophe; Salvay, Andres Gerardo; Simorre, Jean-Pierre; Ebel, Christine; Sapay, Nicolas; Renisio, Jean-Guillaume; Boeckmann, Anja; Steinmann, Eike; Pietschmann, Thomas; Dubuisson, Jean; Chipot, Christophe; Penin, Francois			NMR Structure and Ion Channel Activity of the p7 Protein from Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATION; 3-DIMENSIONAL STRUCTURE; IN-VITRO; SECONDARY STRUCTURE; IMINOSUGAR DERIVATIVES; INFECTIOUS VIRUS; MEMBRANE-PROTEIN; AQUEOUS-SOLUTION; CHEMICAL-SHIFTS; LIPID-BILAYERS	The small membrane protein p7 of hepatitis C virus forms oligomers and exhibits ion channel activity essential for virus infectivity. These viroporin features render p7 an attractive target for antiviral drug development. In this study, p7 from strain HCV-J (genotype 1b) was chemically synthesized and purified for ion channel activity measurements and structure analyses. p7 forms cation-selective ion channels in planar lipid bilayers and at the single-channel level by the patch clamp technique. Ion channel activity was shown to be inhibited by hexamethylene amiloride but not by amantadine. Circular dichroism analyses revealed that the structure of p7 is mainly alpha-helical, irrespective of the membrane mimetic medium (e.g. lysolipids, detergents, or organic solvent/water mixtures). The secondary structure elements of the monomeric form of p7 were determined by H-1 and C-13 NMR in trifluoroethanol/water mixtures. Molecular dynamics simulations in a model membrane were combined synergistically with structural data obtained from NMR experiments. This approach allowed us to determine the secondary structure elements of p7, which significantly differ from predictions, and to propose a three-dimensional model of the monomeric form of p7 associated with the phospholipid bilayer. These studies revealed the presence of a turn connecting an unexpected N-terminal alpha-helix to the first transmembrane helix, TM1, and a long cytosolic loop bearing the dibasic motif and connecting TM1 to TM2. These results provide the first detailed experimental structural framework for a better understanding of p7 processing, oligomerization, and ion channel gating mechanism.	[Sapay, Nicolas; Renisio, Jean-Guillaume; Boeckmann, Anja; Penin, Francois] Univ Lyon, IBCP, UMR 5086, CNRS,BioSci Gerland Lyon Sud IFR128, F-69367 Lyon 07, France; [Saint, Nathalie] INSERM, UMR 554, CNRS, Ctr Biochim Struct,UMR 5048, F-34090 Montpellier, France; [Salvay, Andres Gerardo; Simorre, Jean-Pierre; Ebel, Christine] Univ Grenoble 1, Inst Biol Struct, UMR 5075, CEA,CNRS, F-38000 Grenoble, France; [Steinmann, Eike; Pietschmann, Thomas] Twincore Ctr Expt & Clin Infect Res, Dept Expt Virol, D-30625 Hannover, Germany; [Dubuisson, Jean] Univ Lille Nord France, INSERM, U1019, Inst Pasteur Lille,CNRS,UMR 8204, F-59021 Lille, France; Univ Henri Poincare, CNRS, UMR 7565, Equipe Dynam Assemblages Membranaires, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Helmholtz Association; Helmholtz-Center for Infection Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine	Penin, F (corresponding author), Univ Lyon, IBCP, UMR 5086, CNRS,BioSci Gerland Lyon Sud IFR128, 7 Passage Vercors, F-69367 Lyon 07, France.	f.penin@ibcp.fr	Saint, Nathalie/S-5286-2016; Salvay, Andrés Gerardo/AAC-8505-2021; Pietschmann, Thomas/E-9241-2015; Böckmann, Anja/AAW-6276-2021; Dubuisson, Jean/E-6813-2016	Saint, Nathalie/0000-0001-5219-9486; Pietschmann, Thomas/0000-0001-5138-6239; Böckmann, Anja/0000-0001-8149-7941; Salvay, Andres/0000-0003-4020-1336; Ebel, Christine/0000-0002-6912-500X; simorre, jean-pierre/0000-0002-7943-1342; Dubuisson, Jean/0000-0003-1626-7693; Steinmann, Eike/0000-0002-3654-9965	CNRS; European Commission [LSHM-CT-2004-503359]; French National Agency for Research on AIDS and Viral Hepatitis	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Commission(European CommissionEuropean Commission Joint Research Centre); French National Agency for Research on AIDS and Viral Hepatitis(ANRS)	This work was supported by CNRS and grants from the European Commission (LSHM-CT-2004-503359, VIRGIL Network of Excellence on Antiviral Drug Resistance) (to J.D. and F. P.) and the French National Agency for Research on AIDS and Viral Hepatitis (to F. P. and J.D.). An oral presentation (O-101) of the main part of this work was done at the 13th International Meeting on Hepatitis C and related Viruses (Cairns, Australia, August 2006).	Biggin PC, 2001, CURR BIOL, V11, pR364, DOI 10.1016/S0960-9822(01)00195-6; Brohm C, 2009, J VIROL, V83, P11682, DOI 10.1128/JVI.00691-09; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Carrere-Kremer S, 2004, J BIOL CHEM, V279, P41384, DOI 10.1074/jbc.M406315200; Carrere-Kremer S, 2002, J VIROL, V76, P3720, DOI 10.1128/JVI.76.8.3720-3730.2002; Castelain S, 2007, J MED VIROL, V79, P144, DOI 10.1002/jmv.20772; Chew CF, 2009, BIOPHYS J, V96, pL10, DOI 10.1016/j.bpj.2008.10.004; Chew CF, 2008, BIOPHYS J, V95, P5627, DOI 10.1529/biophysj.108.139477; Chipot C, 1996, J AM CHEM SOC, V118, P11217, DOI 10.1021/ja961379l; Clarke D, 2006, J BIOL CHEM, V281, P37057, DOI 10.1074/jbc.M602434200; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Cook GA, 2010, EUR BIOPHYS J BIOPHY, V39, P1097, DOI 10.1007/s00249-009-0533-y; Cordes FS, 2002, BIOCHEMISTRY-US, V41, P7359, DOI 10.1021/bi025518p; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Favier A, 2002, J MOL BIOL, V317, P131, DOI 10.1006/jmbi.2002.5397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fischer WB, 2000, BIOPOLYMERS, V53, P529, DOI 10.1002/(SICI)1097-0282(200006)53:7<529::AID-BIP1>3.0.CO;2-6; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Grice AL, 1997, FEBS LETT, V405, P299, DOI 10.1016/S0014-5793(97)00198-1; Griffin SDC, 2004, J GEN VIROL, V85, P451, DOI 10.1099/vir.0.19634-0; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Griffin S, 2008, HEPATOLOGY, V48, P1779, DOI 10.1002/hep.22555; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haqshenas G, 2007, VIROLOGY, V360, P17, DOI 10.1016/j.virol.2006.10.014; Helluin O, 1997, BBA-BIOMEMBRANES, V1330, P284, DOI 10.1016/S0005-2736(97)00139-9; HODGKIN AL, 1947, J PHYSIOL-LONDON, V106, P341, DOI 10.1113/jphysiol.1947.sp004216; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isherwood BJ, 2005, J GEN VIROL, V86, P667, DOI 10.1099/vir.0.80737-0; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuiken C, 2006, HEPATOLOGY, V43, P1157, DOI 10.1002/hep.21162; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Dain AC, 1998, J BIOL CHEM, V273, P12116, DOI 10.1074/jbc.273.20.12116; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Luik P, 2009, P NATL ACAD SCI USA, V106, P12712, DOI 10.1073/pnas.0905966106; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MEDVEDEVA S, 1993, FEBS LETT, V333, P251, DOI 10.1016/0014-5793(93)80664-G; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Meshkat Z, 2009, J VIRAL HEPATITIS, V16, P187, DOI 10.1111/j.1365-2893.2008.01064.x; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Montal M, 2003, FEBS LETT, V552, P47, DOI 10.1016/S0014-5793(03)00849-4; Montserret R, 1999, BIOCHEMISTRY-US, V38, P6479, DOI 10.1021/bi9900222; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Park SH, 2006, BIOPHYS J, V91, P3032, DOI 10.1529/biophysj.106.087106; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; Patargias G, 2006, J MED CHEM, V49, P648, DOI 10.1021/jm050721e; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Penin F, 1997, J MOL BIOL, V270, P496, DOI 10.1006/jmbi.1997.1123; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; Saint N, 2003, PEPTIDES, V24, P1779, DOI 10.1016/j.peptides.2003.09.015; Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676; Saint Nathalie, 2009, V510, P125, DOI 10.1007/978-1-59745-394-3_10; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; SALVAY AG, 2006, PROGR COLLOID POLYM, V131, P399; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; StGelais C, 2007, ANTIVIR RES, V76, P48, DOI 10.1016/j.antiviral.2007.05.001; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; THANABAL V, 1994, J BIOMOL NMR, V4, P47; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Van Melckebeke H, 2003, J MOL BIOL, V333, P711, DOI 10.1016/j/jmb.2003.09.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	77	109	110	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31446	31461		10.1074/jbc.M110.122895	http://dx.doi.org/10.1074/jbc.M110.122895			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667830	Green Published, hybrid			2022-12-27	WOS:000282764600039
J	Hayashida, T; Jones, JCR; Lee, CK; Schnaper, HW				Hayashida, Tomoko; Jones, Jonathan C. R.; Lee, Carrie K.; Schnaper, H. William			Loss of beta 1-Integrin Enhances TGF-beta 1-induced Collagen Expression in Epithelial Cells via Increased alpha v beta 3-Integrin and Rac1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; HUMAN MESANGIAL CELLS; HUMAN-LUNG FIBROBLASTS; FOCAL ADHESION KINASE; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; MAP-KINASE; MYOFIBROBLAST DIFFERENTIATION; INTEGRIN ALPHA-V-BETA-3; SIGNAL-TRANSDUCTION	Transforming growth factor beta(TGF-beta) promotes tissue fibrosis via the receptor-specific Smad pathway and non-canonical pathways. We recently reported that TGF-beta 1-stimulated collagen expression by cultured kidney cells requires integrin-dependent activation of focal adhesion kinase (FAK) and consequent ERK MAP kinase activity leading to Smad3 linker region phosphorylation. Here, we defined a role for alpha v beta 3-integrin in this non-canonical pathway. A human kidney tubular cell line in which beta 1-integrin was knocked down (beta 1-k/d) demonstrated enhanced type I collagen mRNA expression and promoter activity. A second shRNA to either alpha v-integrin or beta 3-integrin, but not to another alpha v-binding partner, beta 6-integrin, abrogated the enhanced COL1A2 promoter activity in beta 1-k/d cells. Although alpha v beta 3-integrin surface expression levels were not different, alpha v beta 3-integrins colocalized with sites of focal adhesion significantly more in beta 1-k/d cells, and activated alpha v beta 3-integrin was detected only in beta 1-k/d cells. Further, the collagen response was decreased by a function-blocking antibody or a peptide inhibitor of alpha v beta 3-integrin. In cells lacking alpha v beta 3-integrin, the responses were attenuated, whereas the response was enhanced in alpha v beta 3-overexpressing cells. Rac1 and ERK, previously defined mediators for this non-canonical pathway, showed increased activities in beta 1-k/d cells. Finally, inhibition of alpha v beta 3-integrin decreased Rac1 activity and COL1A2 promoter activity in beta 1-k/d cells. Together, our results indicate that decreasing beta 1 chain causes alpha v beta 3-integrin to become functionally dominant and promotes renal cell fibrogenesis via Rac1-mediated ERK activity.	[Hayashida, Tomoko; Lee, Carrie K.; Schnaper, H. William] Northwestern Univ, Feinberg Sch Med, Div Kidney Dis, Dept Pediat, Chicago, IL 60611 USA; [Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Hayashida, Tomoko; Schnaper, H. William] Childrens Mem Res Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Hayashida, T (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Kidney Dis, Dept Pediat, Pediat W-140,320 E Super St,Searle 4-491, Chicago, IL 60611 USA.	hayashida@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922; Hayashida, Tomoko/0000-0002-4160-7859	National Institutes of Health through NIDDK [DK49362, DK68637]; NCI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068637, R01DK049362, R01DK075663, R56DK049362] Funding Source: NIH RePORTER	National Institutes of Health through NIDDK; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK49362 and DK68637 through the NIDDK. This work was also supported by the flow cytometry and cell imaging facilities of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, supported by NCI Grant.	Adler S, 1999, AM J MED, V107, P371, DOI 10.1016/S0002-9343(99)00233-8; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Borza CM, 2006, J BIOL CHEM, V281, P20932, DOI 10.1074/jbc.M601147200; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; HEINO J, 1989, J BIOL CHEM, V264, P21806; Hubchak SC, 2009, AM J PHYSIOL-RENAL, V297, pF1316, DOI 10.1152/ajprenal.00345.2009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kagami S, 1996, EXP CELL RES, V229, P1, DOI 10.1006/excr.1996.0336; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Ly DP, 2003, J BIOL CHEM, V278, P21878, DOI 10.1074/jbc.M212538200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Ortega-Velazquez R, 2003, FASEB J, V17, P1529, DOI 10.1096/fj.02-0785fje; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Poncelet AC, 1999, KIDNEY INT, V56, P1354, DOI 10.1046/j.1523-1755.1999.00680.x; Pozzi A, 2008, DEV BIOL, V316, P288, DOI 10.1016/j.ydbio.2008.01.022; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; ROBERTS CJ, 1988, J BIOL CHEM, V263, P4586; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Srivatsa SS, 1997, CARDIOVASC RES, V36, P408, DOI 10.1016/S0008-6363(97)00184-3; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359; Zinchuk O, 2005, MOL VIS, V11, P114	52	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30741	30751		10.1074/jbc.M110.105700	http://dx.doi.org/10.1074/jbc.M110.105700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20650890	hybrid, Green Published			2022-12-27	WOS:000282135500042
J	Lakshminarasimhan, M; Madzelan, P; Nan, R; Milkovic, NM; Wilson, MA				Lakshminarasimhan, Mahadevan; Madzelan, Peter; Nan, Ruth; Milkovic, Nicole M.; Wilson, Mark A.			Evolution of New Enzymatic Function by Structural Modulation of Cysteine Reactivity in Pseudomonas fluorescens Isocyanide Hydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; ESCHERICHIA-COLI HSP31; SACCHAROMYCES-CEREVISIAE; INTRACELLULAR PROTEASE; ISONITRILE HYDRATASE; SULFINIC ACID; HUMAN DJ-1; DEGRADATION; MEMBER; SUPERFAMILY	Isocyanide (formerly isonitrile) hydratase (EC 4.2.1.103) is an enzyme of the DJ-1 superfamily that hydrates isocyanides to yield the corresponding N-formamide. In order to understand the structural basis for isocyanide hydratase (ICH) catalysis, we determined the crystal structures of wild-type and several site-directed mutants of Pseudomonas fluorescens ICH at resolutions ranging from 1.0 to 1.9 angstrom. We also developed a simple UV-visible spectrophotometric assay for ICH activity using 2-naphthyl isocyanide as a substrate. ICH contains a highly conserved cysteine residue (Cys(101)) that is required for catalysis and interacts with Asp(17), Thr(102), and an ordered water molecule in the active site. Asp(17) has carboxylic acid bond lengths that are consistent with protonation, and we propose that it activates the ordered water molecule to hydrate organic isocyanides. In contrast to Cys(101) and Asp(17), Thr(102) is tolerant of mutagenesis, and the T102V mutation results in a substrate-inhibited enzyme. Although ICH is similar to human DJ-1 (1.6 angstrom C-alpha root mean square deviation), structural differences in the vicinity of Cys(101) disfavor the facile oxidation of this residue that is functionally important in human DJ-1 but would be detrimental to ICH activity. The ICH active site region also exhibits surprising conformational plasticity and samples two distinct conformations in the crystal. ICH represents a previously uncharacterized clade of the DJ-1 superfamily that possesses a novel enzymatic activity, demonstrating that the DJ-1 core fold can evolve diverse functions by subtle modulation of the environment of a conserved, reactive cysteine residue.	[Wilson, Mark A.] Univ Nebraska, Beadle Ctr N164, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Wilson, MA (corresponding author), Univ Nebraska, Beadle Ctr N164, Dept Biochem, Lincoln, NE 68588 USA.	mwilson13@unl.edu		Lakshminarasimhan, Mahadevan/0000-0001-9475-4927	National Institutes of Health [P20 RR017675-08, R01 GM092999-01]; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health, National Center for Research Resources [RR007707]; National Science Foundation [DBI-0619764]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707, P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR017675-08 and R01 GM092999-01 (to M. A. W.). Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract DE-AC02-06CH11357. Use of the BioCARS Sector 14 was supported by the National Institutes of Health, National Center for Research Resources, under Grant RR007707. The Beckman-Coulter XL-I analytical ultracentrifuge was acquired with National Science Foundation Grant DBI-0619764.	Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brockway LO, 1936, J AM CHEM SOC, V58, P2516, DOI 10.1021/ja01303a044; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esteve-Nunez A, 2001, MICROBIOL MOL BIOL R, V65, P335, DOI 10.1128/MMBR.65.3.335-352.2001; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fioravanti E, 2008, BIOCHEMISTRY-US, V47, P11581, DOI 10.1021/bi800882v; FURUKAWA K, 1986, J BACTERIOL, V166, P392, DOI 10.1128/jb.166.2.392-398.1986; Goda M, 2002, J BIOL CHEM, V277, P45860, DOI 10.1074/jbc.M208571200; Goda M, 2001, J BIOL CHEM, V276, P23480, DOI 10.1074/jbc.M007856200; Gordy W, 1942, J AM CHEM SOC, V64, P2952, DOI 10.1021/ja01264a063; Graille M, 2004, STRUCTURE, V12, P839, DOI 10.1016/S0969-2126(04)00113-3; Halio SB, 1996, J BACTERIOL, V178, P2605, DOI 10.1128/jb.178.9.2605-2612.1996; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Huai Q, 2003, FEBS LETT, V549, P171, DOI 10.1016/S0014-5793(03)00764-6; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedras MSC, 2009, PHYTOCHEMISTRY, V70, P394, DOI 10.1016/j.phytochem.2009.01.005; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; PRIJAMBADA ID, 1995, APPL ENVIRON MICROB, V61, P2020, DOI 10.1128/AEM.61.5.2020-2022.1995; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Rakus JF, 2008, BIOCHEMISTRY-US, V47, P9944, DOI 10.1021/bi800914r; SCHEUER PJ, 1992, ACCOUNTS CHEM RES, V25, P433, DOI 10.1021/ar00022a001; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SMITH CD, 1995, MOL PHARMACOL, V47, P241; Sung KS, 2001, TETRAHEDRON LETT, V42, P4845, DOI 10.1016/S0040-4039(01)00863-2; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Yanagisawa D, 2008, J CEREBR BLOOD F MET, V28, P563, DOI 10.1038/sj.jcbfm.9600553; Yeh JI, 1998, ACTA CRYSTALLOGR D, V54, P479, DOI 10.1107/S0907444998004697; ZAPF S, 1995, J ANTIBIOT, V48, P36, DOI 10.7164/antibiotics.48.36	57	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29651	29661		10.1074/jbc.M110.147934	http://dx.doi.org/10.1074/jbc.M110.147934			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630867	Green Published, hybrid			2022-12-27	WOS:000281740100066
J	Liang, WX; Deutscher, MP				Liang, Wenxing; Deutscher, Murray P.			A Novel Mechanism for Ribonuclease Regulation TRANSFER-MESSENGER RNA (tmRNA) AND ITS ASSOCIATED PROTEIN SmpB REGULATE THE STABILITY OF RNase R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; QUALITY-CONTROL; GROWTH; BINDING; STRESS; PHASE; DECAY	The amount of RNase R, an important degradative exoribonuclease, increases 3-10-fold under a variety of stress conditions. This elevation is due to posttranslational regulation in which the highly unstable RNase R protein becomes stabilized during stress. Here we identify two components of the transtranslation machinery, transfer-messenger RNA (tmRNA) and SmpB, that are responsible for the short half-life of RNase R in exponential phase cells. The absence of either lengthens the half-life of RNase R in vivo >6-fold. SmpB directly interacts with RNase R in vitro and is stimulated by tmRNA. The C-terminal region of RNase R, encompassing its basic region and adjacent S1 domain are required for the interaction; their removal eliminates binding and stabilizes RNase R in vivo. However, the binding of SmpB and tmRNA does not alter RNase R activity. These data define a previously unknown regulatory process in which the stability of an RNase is determined by its interaction with an RNA and an RNA-associated protein.	[Liang, Wenxing; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Liang, Wenxing/E-7133-2012		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317 (to M. P. D.).	Andrade JM, 2006, MOL MICROBIOL, V60, P219, DOI 10.1111/j.1365-2958.2006.05092.x; Awano N, 2010, J BACTERIOL, V192, P1344, DOI 10.1128/JB.01368-09; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cairrao F, 2003, MOL MICROBIOL, V50, P1349, DOI 10.1046/j.1365-2958.2003.03766.x; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Chen CL, 2005, J BIOL CHEM, V280, P34393, DOI 10.1074/jbc.C500333200; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Karzai AW, 2001, P NATL ACAD SCI USA, V98, P3040, DOI 10.1073/pnas.051628298; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Liang WX, 2009, CELL RES, V19, P307, DOI 10.1038/cr.2008.317; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sundermeier T, 2008, METHOD ENZYMOL, V447, P329, DOI 10.1016/S0076-6879(08)02217-9; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; Withey J, 1999, J BACTERIOL, V181, P2148, DOI 10.1128/JB.181.7.2148-2157.1999	23	36	37	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29054	29058		10.1074/jbc.C110.168641	http://dx.doi.org/10.1074/jbc.C110.168641			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20688916	Green Published, hybrid			2022-12-27	WOS:000281740100006
J	Finsterwald, C; Fiumelli, H; Cardinaux, JR; Martin, JL				Finsterwald, Charles; Fiumelli, Hubert; Cardinaux, Jean-Rene; Martin, Jean-Luc			Regulation of Dendritic Development by BDNF Requires Activation of CRTC1 by Glutamate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE COINCIDENCE DETECTOR; NEUROTROPHIC FACTOR; CORTICAL-NEURONS; SYNAPTIC PLASTICITY; SIGNALING PATHWAYS; NUCLEAR TRANSPORT; GENE-EXPRESSION; C-FOS; CREB; GROWTH	Dendritic growth is essential for the establishment of a functional nervous system. Among extrinsic signals that control dendritic development, substantial evidence indicates that BDNF regulates dendritic morphology. However, little is known about the underlying mechanisms by which BDNF controls dendritic growth. In this study, we show that the MAPK signaling pathway and the transcription factor cAMP response element-binding protein (CREB) mediate the effects of BDNF on dendritic length and complexity. However, phosphorylation of CREB alone is not sufficient for the stimulation of dendritic growth by BDNF. Thus, using a mutant form of CREB unable to bind CREB-regulated transcription coactivator (CRTC1), we demonstrate that this effect also requires a functional interaction between CREB and CRTC1. Moreover, inhibition of CRTC1 expression by shRNA-mediated knockdown abolished BDNF-induced dendritic growth of cortical neurons. Interestingly, we found that nuclear translocation of CRTC1 results from activation of NMDA receptors by glutamate, a process that is essential for the effects of BDNF on dendritic development. Together, these data identify a previously unrecognized mechanism by which CREB and the coactivator CRTC1 mediate the effects of BDNF on dendritic growth.	[Martin, Jean-Luc] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland; [Cardinaux, Jean-Rene; Martin, Jean-Luc] Univ Lausanne, Ctr Psychiat Neurosci, CH-1008 Prilly, Switzerland; [Cardinaux, Jean-Rene] Univ Lausanne, Univ Med Ctr, Dept Psychiat, Serv Child & Adolescent Psychiat, CH-1008 Prilly, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne	Martin, JL (corresponding author), Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland.	jean-luc.martin@unil.ch	Cardinaux, Jean-René/G-5391-2012	Cardinaux, Jean-René/0000-0001-6423-0014; Martin, Jean-Luc/0000-0002-5082-4687	Swiss National Science Foundation [31003A-124783, 3100A0-120699]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31003A-124783 (to J.-L.M.) and 3100A0-120699 (to J.-R.C.).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Benavides-Piccione R, 2004, PROG NEUROBIOL, V74, P111, DOI 10.1016/j.pneurobio.2004.08.001; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Burkhalter J, 2007, J BIOL CHEM, V282, P5152, DOI 10.1074/jbc.M608548200; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deng J, 2009, NEUROSCIENCE, V159, P1023, DOI 10.1016/j.neuroscience.2009.01.073; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Horch HW, 1999, NEURON, V23, P353; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; LORIAUX MM, 1993, P NATL ACAD SCI USA, V90, P9046, DOI 10.1073/pnas.90.19.9046; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Takei N, 1998, J BIOL CHEM, V273, P27620, DOI 10.1074/jbc.273.42.27620; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	39	55	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28587	28595		10.1074/jbc.M110.125740	http://dx.doi.org/10.1074/jbc.M110.125740			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20639200	Green Published, hybrid			2022-12-27	WOS:000281594000022
J	Pang, ZP; Xu, W; Cao, P; Sudhof, TC				Pang, Zhiping P.; Xu, Wei; Cao, Peng; Suedhof, Thomas C.			Calmodulin Suppresses Synaptotagmin-2 Transcription in Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATORY SYNAPSE FORMATION; PROTEIN-KINASE-II; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; CALCIUM SENSITIVITY; GENE-TRANSCRIPTION; CA2+ SENSOR; BINDING; CHANNELS; ACTIVATION	Calmodulin (CaM) is a ubiquitous Ca2+ sensor protein that plays a pivotal role in regulating innumerable neuronal functions, including synaptic transmission. In cortical neurons, most neurotransmitter release is triggered by Ca2+ binding to synaptotagmin-1; however, a second delayed phase of release, referred to as asynchronous release, is triggered by Ca2+ binding to an unidentified secondary Ca2+ sensor. To test whether CaM could be the enigmatic Ca2+ sensor for asynchronous release, we now use in cultured neurons short hairpin RNAs that suppress expression of similar to 70% of all neuronal CaM isoforms. Surprisingly, we found that in synaptotagmin-1 knock-out neurons, the CaM knockdown caused a paradoxical rescue of synchronous release, instead of a block of asynchronous release. Gene and protein expression studies revealed that both in wild-type and in synaptotagmin-1 knock-out neurons, the CaM knockdown altered expression of >200 genes, including that encoding synaptotagmin-2. Synaptotagmin-2 expression was increased several-fold by the CaM knockdown, which accounted for the paradoxical rescue of synchronous release in synaptotagmin-1 knock-out neurons by the CaM knockdown. Interestingly, the CaM knockdown primarily activated genes that are preferentially expressed in caudal brain regions, whereas it repressed genes in rostral brain regions. Consistent with this correlation, quantifications of protein levels in adult mice uncovered an inverse relationship of CaM and synaptotagmin-2 levels in mouse forebrain, brain stem, and spinal cord. Finally, we employed molecular replacement experiments using a knockdown rescue approach to show that Ca2+ binding to the C-lobe but not the N-lobe of CaM is required for suppression of synaptotagmin-2 expression in cortical neurons. Our data describe a previously unknown, Ca2+/CaM-dependent regulatory pathway that controls the expression of synaptic proteins in the rostral-caudal neuraxis.	[Pang, Zhiping P.; Xu, Wei; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Xu, Wei; Cao, Peng; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Pang, ZP (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	zpang@stanford.edu	Pang, Zhiping/AAF-5757-2020	Pang, Zhiping/0000-0002-6183-1233	National Institutes of Mental Health; National Alliance for Research on Schizophrenia and Depression	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression(NARSAD)	This work was supported, in whole or in part, by a National Institutes of Mental Health Grant (to T.C.S.). This work was also supported by awards from National Alliance for Research on Schizophrenia and Depression (to Z.P.P.).	BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Berton F, 1997, J NEUROSCI, V17, P1206; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; DELORENZO RJ, 1981, CELL CALCIUM, V2, P365, DOI 10.1016/0143-4160(81)90026-9; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GREENBERG ME, 1992, J PHYSIOLOGY-PARIS, V86, P99, DOI 10.1016/S0928-4257(05)80013-0; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Nakagawa Y, 2006, J MOL CELL CARDIOL, V41, P1010, DOI 10.1016/j.yjmcc.2006.08.010; NGHIEM P, 1994, NATURE, V371, P347, DOI 10.1038/371347a0; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; STEINHARDT RA, 1982, NATURE, V295, P154, DOI 10.1038/295154a0; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; TELEMAN A, 1986, BIOCHIM BIOPHYS ACTA, V873, P204, DOI 10.1016/0167-4838(86)90047-6; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320	44	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33930	33939		10.1074/jbc.M110.150151	http://dx.doi.org/10.1074/jbc.M110.150151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729199	hybrid, Green Published			2022-12-27	WOS:000283354000040
J	Lugari, A; Betzi, S; Decroly, E; Bonnaud, E; Hermant, A; Guillemot, JC; Debarnot, C; Borg, JP; Bouvet, M; Canard, B; Morelli, X; Lecine, P				Lugari, Adrien; Betzi, Stephane; Decroly, Etienne; Bonnaud, Emmanuel; Hermant, Aurelie; Guillemot, Jean-Claude; Debarnot, Claire; Borg, Jean-Paul; Bouvet, Mickael; Canard, Bruno; Morelli, Xavier; Lecine, Patrick			Molecular Mapping of the RNA Cap 2 '-O-Methyltransferase Activation Interface between Severe Acute Respiratory Syndrome Coronavirus nsp10 and nsp16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; SARS-CORONAVIRUS; MURINE CORONAVIRUS; VIRUS; METHYLTRANSFERASE; IDENTIFICATION; TRANSCRIPTION; GENOME; REPLICATION; MUTAGENESIS	Several protein-protein interactions within the SARS-CoV proteome have been identified, one of them being between nonstructural proteins nsp10 and nsp16. In this work, we have mapped key residues on the nsp10 surface involved in this interaction. Alanine-scanning mutagenesis, bioinformatics, and molecular modeling were used to identify several "hot spots," such as Val(42), Met(44), Ala(71), Lys(93), Gly(94), and Tyr(96), forming a continuous protein-protein surface of about 830 A 2, bearing very conserved amino acids among coronaviruses. Because nsp16 carries RNA cap 2'-O-methyltransferase (2'O-MTase) activity only in the presence of its interacting partner nsp10 (Bouvet, M., Debarnot, C., Imbert, I., Selisko, B., Snijder, E. J., Canard, B., and Decroly, E. (2010) PLoS Pathog. 6, e1000863), functional consequences of mutations on this surface were evaluated biochemically. Most changes that disrupted the nsp10-nsp16 interaction without structural perturbations were shown to abrogate stimulation of nsp16 RNA cap 2'O-MTase activity. More strikingly, the Y96A mutation abrogates stimulation of nsp16 2'O-MTase activity, whereas Y96F overstimulates it. Thus, the nsp10-nsp16 interface may represent an attractive target for antivirals against human and animal pathogenic coronaviruses.	[Lugari, Adrien; Betzi, Stephane; Morelli, Xavier] CNRS, F-13402 Marseille 20, France; [Lugari, Adrien; Betzi, Stephane; Morelli, Xavier] Aix Marseille Univ, IMR Lab UPR 3243, Inst Microbiol Mediterannee, F-13402 Marseille 20, France; [Decroly, Etienne; Guillemot, Jean-Claude; Debarnot, Claire; Bouvet, Mickael; Canard, Bruno] CNRS, F-13288 Marseille, France; [Decroly, Etienne; Guillemot, Jean-Claude; Debarnot, Claire; Bouvet, Mickael; Canard, Bruno] Univ Aix Marseille 1, UMR 6098, ESIL Case 925, F-13288 Marseille, France; [Decroly, Etienne; Guillemot, Jean-Claude; Debarnot, Claire; Bouvet, Mickael; Canard, Bruno] Univ Aix Marseille 2, UMR 6098, ESIL Case 925, F-13288 Marseille, France; [Bonnaud, Emmanuel; Hermant, Aurelie; Borg, Jean-Paul; Lecine, Patrick] INSERM, UMR891, Ctr Rech Cancerol Marseille, F-13009 Marseille, France; [Bonnaud, Emmanuel; Hermant, Aurelie; Borg, Jean-Paul; Lecine, Patrick] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Bonnaud, Emmanuel; Hermant, Aurelie; Borg, Jean-Paul; Lecine, Patrick] Univ Mediterranee, F-13007 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite	Lecine, P (corresponding author), Baylor Inst Immunol Res, INSERM, UMR899, 3434 Live Oak St, Dallas, TX 75024 USA.	patrick.lecine@inserm.fr	morelli, xavier/A-9218-2016; Betzi, Stephane/AAC-6103-2022; Borg, Jean-Paul/AAX-8096-2020; Lecine, Patrick/H-9338-2016	morelli, xavier/0000-0001-8101-7901; Betzi, Stephane/0000-0001-5935-5058; Borg, Jean-Paul/0000-0001-8418-3382; Lecine, Patrick/0000-0002-8091-7286; DECROLY, Etienne/0000-0002-6046-024X; Bouvet-Gueguen, Mickael/0000-0001-6541-689X; Lugari, Adrien/0000-0001-8337-6043; Canard, Bruno/0000-0003-4924-1991	European Union [LSHG-CT-2004-511960]; European Commission [SP22-CT-2004-511064]; French National Research agency [ANR-08-MIEN-032]; Fondation pour la Recherche Medicale; Direction Generale de l'Armement [07co404]	European Union(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); French National Research agency(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Direction Generale de l'Armement	This work was supported, at its initial phase, by the VIZIER integrated project (LSHG-CT-2004-511960) of the European Union 6th Framework and the Euro-Asian SARS-DTV Network (SP22-CT-2004-511064) from the European Commission specific research and technological development program "Integrating and Strengthening the European Research Area" and then by the French National Research agency, under reference "ANR-08-MIEN-032," the Fondation pour la Recherche Medicale (Programme Equipe FRM) (to B. C.), and Direction Generale de l'Armement Contract 07co404.	Almazan F, 2006, J VIROL, V80, P10900, DOI 10.1128/JVI.00385-06; ARMSTRONG CM, 2005, MODULAR SCALE YEAST, V4; BAKER SC, 1993, J VIROL, V67, P6056, DOI 10.1128/JVI.67.10.6056-6063.1993; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bouvet M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000863; Campanacci V, 2003, ACTA CRYSTALLOGR D, V59, P1628, DOI 10.1107/S0907444903016779; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; Donaldson EF, 2007, J VIROL, V81, P6356, DOI 10.1128/JVI.02805-06; Donaldson EF, 2007, J VIROL, V81, P7086, DOI 10.1128/JVI.00049-07; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; Imberta I, 2008, VIRUS RES, V133, P136, DOI 10.1016/j.virusres.2007.11.017; Issad Tarik, 2006, V332, P195; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Joseph JS, 2006, J VIROL, V80, P7894, DOI 10.1128/JVI.00467-06; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; LAI MMC, 1982, ADV EXP MED BIOL, V142, P69; LEMBO F, 2009, TECAN J, V1, P14; LU YQ, 1995, J VIROL, V69, P3554, DOI 10.1128/JVI.69.6.3554-3559.1995; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Matthes N, 2006, FEBS LETT, V580, P4143, DOI 10.1016/j.febslet.2006.06.061; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Pan JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003299; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Peyrane F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1119; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06; Sawicki SG, 2005, PLOS PATHOG, V1, P310, DOI 10.1371/journal.ppat.0010039; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Su D, 2006, J VIROL, V80, P7902, DOI 10.1128/JVI.00483-06; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; van Vliet ALW, 2002, EMBO J, V21, P6571, DOI 10.1093/emboj/cdf635; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; VIDAL M, 1997, YEAST 2 HYBRID SYSTE, P109; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; von Grotthuss M, 2003, CELL, V113, P701, DOI 10.1016/S0092-8674(03)00424-0; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang HL, 1996, VIROLOGY, V217, P527, DOI 10.1006/viro.1996.0147; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	46	44	46	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33230	33241		10.1074/jbc.M110.120014	http://dx.doi.org/10.1074/jbc.M110.120014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20699222	Green Published, hybrid			2022-12-27	WOS:000283048200060
J	Onishi, RM; Park, SJ; Hanel, W; Ho, AW; Maitra, A; Gaffen, SL				Onishi, Reiko M.; Park, Sangmi J.; Hanel, Walter; Ho, Allen W.; Maitra, Amarnath; Gaffen, Sarah L.			SEF/IL-17R (SEFIR) Is Not Enough AN EXTENDED SEFIR DOMAIN IS REQUIRED FOR IL-17RA-MEDIATED SIGNAL TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-17 RECEPTOR; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; ADAPTER PROTEIN; FAMILY-MEMBERS; HOST-DEFENSE; TARGET GENES; C/EBP-BETA; T-CELLS; INTERLEUKIN-17	IL-17, the hallmark cytokine of the Th17 population, mediates immunity to extracellular pathogens and promotes autoimmune immunopathology. The signaling mechanisms triggered by the IL-17 receptor (IL-17RA) and related receptors are strikingly different from other cytokine subclasses. Namely, IL-17Rs contain a conserved SEF/IL-17R (SEFIR) subdomain that engages Act1, leading to activation of TRAF6, NF-kappa B, and other events. Although the SEFIR is critical for signaling, the molecular details of the functional subdomains within IL-17RA remain poorly characterized. Here, we provide a detailed structure-function analysis delineating the C-terminal boundary of the SEFIR-containing region of IL-17RA. We show that functionality of this domain requires a large extension to the previously identified SEFIR motif. In contrast to the SEFIR, this extension is not conserved among IL-17R family members. Surprisingly, Act1 recruitment is not sufficient for downstream signaling activation, whereas ubiquitination of TRAF6 correlates tightly with functional receptors. We further demonstrate that IL-17RA exhibits signaling properties that are nonredundant with other IL-17R family members. Finally, we report that IL-17 signals synergistically with lymphotoxin-alpha 3, using the same signaling motifs within IL-17RA. These studies provide new insight into the structure-function relationships of IL-17RA and reveal distinct signaling differences among IL-17R family members.	Univ Pittsburgh, Dept Med, Div Clin Immunol & Rheumatol, Pittsburgh, PA 15261 USA; [Hanel, Walter; Ho, Allen W.; Maitra, Amarnath; Gaffen, Sarah L.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gaffen, SL (corresponding author), Univ Pittsburgh, Div Rheumatol, S703 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	sig65@pitt.edu	Ho, Allen/B-3017-2011	Ho, Allen/0000-0002-5861-0552	National Institutes of Health [AR054389]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR054389 (to S. L. G.).	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XX, 2008, CYTOKINE, V41, P105, DOI 10.1016/j.cyto.2007.09.015; Linden A., 2007, SCI STKE, V2007, pre4, DOI DOI 10.1126/STKE.3982007RE4; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Rong ZL, 2009, CELL RES, V19, P208, DOI 10.1038/cr.2008.320; Ruddy MJ, 2004, J LEUKOCYTE BIOL, V76, P135, DOI 10.1189/jlb.0204065; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	42	38	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32751	32759		10.1074/jbc.M110.121418	http://dx.doi.org/10.1074/jbc.M110.121418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729198	Green Published, hybrid			2022-12-27	WOS:000283048200010
J	Petersen, JL; Ronan, PJ				Petersen, Jason L.; Ronan, Patrick J.			Critical Role of 7,8-Didemethyl-8-hydroxy-5-deazariboflavin for Photoreactivation in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA PHOTOLYASE; ESCHERICHIA-COLI; COENZYME F-420; 8-HYDROXY-5-DEAZAFLAVIN-REDUCING HYDROGENASE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; NUCLEAR TRANSFORMATION; 2ND CHROMOPHORE; RADICAL SAM; FLAVIN; ENZYME	DNA photolyases use two noncovalently bound chromophores to catalyze photoreactivation, the blue light-dependent repair of DNA that has been damaged by ultraviolet light. FAD is the catalytic chromophore for all photolyases and is essential for photoreactivation. The identity of the second chromophore is often 7,8-didemethyl-8-hydroxy-5-deazariboflavin (FO). Under standard light conditions, the second chromophore is considered nonessential for photoreactivation because DNA photolyase bound to only FAD is sufficient to catalyze the repair of UV-damaged DNA. phr1 is a photoreactivation-deficient strain of Chlamydomonas. In this work, the PHR1 gene of Chlamydomonas was cloned through molecular mapping and shown to encode a protein similar to known FO synthases. Additional results revealed that the phr1 strain was deficient in an FO-like molecule and that this deficiency, as well as the phr1 photoreactivation deficiency, could be rescued by transformation with DNA constructs containing the PHR1 gene. Furthermore, expression of a PHR1 cDNA in Escherichia coli produced a protein that generated a molecule with characteristics similar to FO. Together, these results indicate that the Chlamydomonas PHR1 gene encodes an FO synthase and that optimal photoreactivation in Chlamydomonas requires FO, a molecule known to serve as a second chromophore for DNA photolyases.	Avera Res Inst, Basic Res Div, Sioux Falls, SD 57105 USA; [Petersen, Jason L.; Ronan, Patrick J.] Sioux Falls Vet Affairs Med Ctr, Res & Dev, Sioux Falls, SD 57117 USA; [Petersen, Jason L.] Univ S Dakota, Dept Internal Med, Sioux Falls, SD 57105 USA; [Ronan, Patrick J.] Univ S Dakota, Neurosci Grp, Sanford Sch Med, Sioux Falls, SD 57105 USA	University of South Dakota; University of South Dakota	Petersen, JL (corresponding author), Vet Affairs Med Ctr, Res & Dev 151,2501 W 22nd St, Sioux Falls, SD 57117 USA.	Jason.Petersen@avera.org		Petersen, Jason/0000-0003-4939-5149	NCRR [P20RR015567]; Avera Research Institute (Sioux Falls, SD); Great Plains Medical Research Foundation [GPMRF-001-2009]; Sioux Falls Veterans Affairs Medical Center (Sioux Falls, SD); NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015567] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Avera Research Institute (Sioux Falls, SD); Great Plains Medical Research Foundation; Sioux Falls Veterans Affairs Medical Center (Sioux Falls, SD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR015567 from the NCRR (to P.J.R.). This work was also supported by Avera Research Institute (Sioux Falls, SD), the Great Plains Medical Research Foundation Grant GPMRF-001-2009 (to J.L.P.), and with resources and the use of facilities at the Sioux Falls Veterans Affairs Medical Center (Sioux Falls, SD).	Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Beukers R, 2008, DNA REPAIR, V7, P530, DOI 10.1016/j.dnarep.2007.11.010; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; COX JL, 1985, MUTAT RES, V146, P249, DOI 10.1016/0167-8817(85)90065-3; DAVIES WEA, 1971, J PHYS D APPL PHYS, V4, P318, DOI 10.1088/0022-3727/4/2/318; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; EKER AP, 1988, BIOCHEMISTRY-US, V27, P1758, DOI 10.1021/bi00405a056; EKER APM, 1981, PHOTOCHEM PHOTOBIOL, V33, P65, DOI 10.1111/j.1751-1097.1981.tb04298.x; EKER APM, 1990, J BIOL CHEM, V265, P8009; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FOX JA, 1987, BIOCHEMISTRY-US, V26, P4219, DOI 10.1021/bi00388a007; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glas AF, 2009, P NATL ACAD SCI USA, V106, P11540, DOI 10.1073/pnas.0812665106; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; GROSS CH, 1988, CURR GENET, V13, P503, DOI 10.1007/BF02427756; Grossman AR, 2003, EUKARYOT CELL, V2, P1137, DOI 10.1128/EC.2.6.1137-1150.2003; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; HAMMALVAREZ S, 1989, J BIOL CHEM, V264, P9649; HARRIS E, 1989, CHLAMYDOMONAS SOURCE, P608; HEELIS PF, 1987, BIOCHEMISTRY-US, V26, P4634, DOI 10.1021/bi00389a007; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; Jain M, 2007, NUCLEIC ACIDS RES, V35, P2074, DOI 10.1093/nar/gkm081; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; JORNS MS, 1987, BIOCHEMISTRY-US, V26, P6810, DOI 10.1021/bi00395a034; JORNS MS, 1990, BIOCHEMISTRY-US, V29, P552, DOI 10.1021/bi00454a032; KIENER A, 1989, J BIOL CHEM, V264, P13880; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kleiner O, 1999, EUR J BIOCHEM, V264, P161, DOI 10.1046/j.1432-1327.1999.00590.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MICHEL R, 1995, EUR J BIOCHEM, V233, P727, DOI 10.1111/j.1432-1033.1995.727_3.x; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V49, P805, DOI 10.1111/j.1751-1097.1989.tb05578.x; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P5706, DOI 10.1021/bi00476a010; Peccia J, 2001, APPL ENVIRON MICROB, V67, P4225, DOI 10.1128/AEM.67.9.4225-4232.2001; Petersen JL, 1999, PLANT MOL BIOL, V40, P1063, DOI 10.1023/A:1006279720960; Petersen JL, 2001, NUCLEIC ACIDS RES, V29, P4472, DOI 10.1093/nar/29.21.4472; PETERSEN JL, 2001, CHLAMYDOMONAS GENES; Rymarquis LA, 2005, PLANT PHYSIOL, V137, P557, DOI 10.1104/pp.104.054221; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; Schein AI, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e82; Shrager J, 2003, PLANT PHYSIOL, V131, P401, DOI 10.1104/pp.016899; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; TAKAO M, 1989, PHOTOCHEM PHOTOBIOL, V50, P633, DOI 10.1111/j.1751-1097.1989.tb04319.x; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d	51	10	10	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32467	32475		10.1074/jbc.M110.146050	http://dx.doi.org/10.1074/jbc.M110.146050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696762	hybrid, Green Published			2022-12-27	WOS:000282683000060
J	Wang, YT; Pan, YJ; Cho, CC; Lin, BC; Su, LH; Huang, YC; Sun, CH				Wang, Yi-Ting; Pan, Yu-Jiao; Cho, Chao-Cheng; Lin, Bo-Chi; Su, Li-Hsin; Huang, Yu-Chang; Sun, Chin-Hung			A Novel Pax-like Protein Involved in Transcriptional Activation of Cyst Wall Protein Genes in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA COMPLEX REVEALS; PAIRED DOMAIN; CELL-GROWTH; PRIMITIVE EUKARYOTE; CRYSTAL-STRUCTURE; BINDING-SITES; EXPRESSION; IDENTIFICATION; DIFFERENTIATION; ENCYSTATION	Giardia lamblia differentiates into infectious cysts to survive outside of the host. It is of interest to identify factors involved in up-regulation of cyst wall proteins (CWPs) during this differentiation. Pax proteins are important regulators of development and cell differentiation in Drosophila and vertebrates. No member of this gene family has been reported to date in yeast, plants, or protozoan parasites. We have identified a pax-like gene (pax1) encoding a putative paired domain in the G. lamblia genome. Epitope-tagged Pax1 localized to nuclei during both vegetative growth and encystation. Recombinant Pax1 specifically bound to the AT-rich initiator elements of the encystation-induced cwp1 to -3 and myb2 genes. Interestingly, overexpression of Pax1 increased cwp1 to -3 and myb2 gene expression and cyst formation. Deletion of the C-terminal paired domain or mutation of the basic amino acids of the paired domain resulted in a decrease of the transactivation function of Pax1. Our results indicate that the Pax family has been conserved during evolution, and Pax1 could up-regulate the key encystation-induced genes to regulate differentiation of the protozoan eukaryote, G. lamblia.	[Wang, Yi-Ting; Pan, Yu-Jiao; Cho, Chao-Cheng; Lin, Bo-Chi; Su, Li-Hsin; Huang, Yu-Chang; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [NSC 96-2320-B-002-040-MY3, NSC 98-2320-B-002-018-MY2]; National Health Research Institutes in Taiwan [NHRI-EX98-9510NC, NHRI-EX99-9510NC]; Department of Medical Research of National Taiwan University Hospital; National Taiwan University	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); Department of Medical Research of National Taiwan University Hospital; National Taiwan University(National Taiwan University)	This work was supported by National Science Council Grants NSC 96-2320-B-002-040-MY3 and NSC 98-2320-B-002-018-MY2 and National Health Research Institutes Grants NHRI-EX98-9510NC and NHRI-EX99-9510NC in Taiwan and was also supported in part by the Department of Medical Research of National Taiwan University Hospital and the Aim for the Top University Program of National Taiwan University.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; CAI JX, 1994, MECH DEVELOP, V47, P139, DOI 10.1016/0925-4773(94)90086-8; CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Chiu PW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000677; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Frost V, 2008, CRIT REV BIOCHEM MOL, V43, P371, DOI [10.1080/10409230802486208, 10.1080/10409230802486208 ]; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; Gosmain Y, 2007, J BIOL CHEM, V282, P35024, DOI 10.1074/jbc.M702795200; HAGMAN J, 1994, CURR OPIN IMMUNOL, V6, P222, DOI 10.1016/0952-7915(94)90095-7; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; Iwahara J, 2002, EMBO J, V21, P1197, DOI 10.1093/emboj/21.5.1197; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kalousova A, 1999, BIOCHEM BIOPH RES CO, V259, P510, DOI 10.1006/bbrc.1999.0809; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Nornes S, 1996, J BIOL CHEM, V271, P26914, DOI 10.1074/jbc.271.43.26914; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Pan YJ, 2009, J BIOL CHEM, V284, P17975, DOI 10.1074/jbc.M109.012047; Pellizzari L, 1999, BIOCHEM J, V337, P253, DOI 10.1042/0264-6021:3370253; Phelps DE, 1996, J BIOL CHEM, V271, P7978, DOI 10.1074/jbc.271.14.7978; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Stuart ET, 1996, CELL GROWTH DIFFER, V7, P405; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; Van Keulen H, 1998, J EUKARYOT MICROBIOL, V45, P637, DOI 10.1111/j.1550-7408.1998.tb04560.x; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1	77	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32213	32226		10.1074/jbc.M110.156620	http://dx.doi.org/10.1074/jbc.M110.156620			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699219	Green Published, hybrid			2022-12-27	WOS:000282683000034
J	Palmieri, LD; Lima, LMTR; Freire, JBB; Bleicher, L; Polikarpov, I; Almeida, FCL; Foguel, D				Palmieri, Leonardo de C.; Lima, Luis Mauricio T. R.; Freire, Juliana B. B.; Bleicher, Lucas; Polikarpov, Igor; Almeida, Fabio C. L.; Foguel, Debora			Novel Zn2+-binding Sites in Human Transthyretin IMPLICATIONS FOR AMYLOIDOGENESIS AND RETINOL-BINDING PROTEIN RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL AMYLOID POLYNEUROPATHY; INDUCED CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ZINC-BINDING; AGGREGATION; FIBRILS; PRESSURE; IDENTIFICATION; RESOLUTION; INSIGHTS	Human transthyretin (TTR) is a homotetrameric protein involved in several amyloidoses. Zn2+ enhances TTR aggregation in vitro, and is a component of ex vivo TTR amyloid fibrils. We report the first crystal structure of human TTR in complex with Zn2+ at pH 4.6-7.5. All four structures reveal three tetra-coordinated Zn2+-binding sites (ZBS 1-3) per monomer, plus a fourth site (ZBS 4) involving amino acid residues from a symmetry-related tetramer that is not visible in solution by NMR.Zn2+ binding perturbs loop E-alpha-helix-loop F, the region involved in holo-retinol-binding protein (holo-RBP) recognition, mainly at acidic pH; TTR affinity for holo-RBP decreases similar to 5-fold in the presence of Zn2+. Interestingly, this same region is disrupted in the crystal structure of the amyloidogenic intermediate of TTR formed at acidic pH in the absence of Zn2+. HNCO and HNCA experiments performed in solution at pH 7.5 revealed that upon Zn2+ binding, although the alpha-helix persists, there are perturbations in the resonances of the residues that flank this region, suggesting an increase in structural flexibility. While stability of the monomer of TTR decreases in the presence of Zn2+, which is consistent with the tertiary structural perturbation provoked by Zn2+ binding, tetramer stability is only marginally affected by Zn2+. These data highlight structural and functional roles of Zn2+ in TTR-related amyloidoses, as well as in holo-RBP recognition and vitamin A homeostasis.	[Palmieri, Leonardo de C.; Freire, Juliana B. B.; Almeida, Fabio C. L.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil; [Lima, Luis Mauricio T. R.] Univ Fed Rio de Janeiro, Fac Farm, Dept Med, BR-21941590 Rio De Janeiro, Brazil; [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol Jiri Jo, Dept Med, BR-21941590 Rio De Janeiro, Brazil; [Bleicher, Lucas; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Lima, LMTR (corresponding author), Fac Farm UFRJ, Av Carlos Chagas Filho 373,CCS,Bss34, BR-21941902 Rio De Janeiro, Brazil.	mauricio@pharma.ufrj.br; foguel@bioqmed.ufrj.br	Bleicher, Lucas/AAH-9397-2021; Bleicher, Lucas/R-5153-2019; Polikarpov, Igor/D-2575-2012; Palmieri, Leonardo C/A-9341-2013; Lima, Luis Mauricio/AAL-2098-2021; Bleicher, Lucas/B-7967-2013; Almeida, Fabio/O-4989-2018	Bleicher, Lucas/0000-0001-7121-4952; Bleicher, Lucas/0000-0001-7121-4952; Almeida, Fabio/0000-0001-6046-7006; Polikarpov, Igor/0000-0001-9496-4174; Foguel, Debora/0000-0001-7312-7115; TR Lima, Luis Mauricio/0000-0001-6020-0504	CNPq; CAPES; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by CNPq (INCT-Bioimagem e Biologia Estrutural), CAPES Nanobiotec-Brasil 04-2008, and FAPERJ (to D. F. and L. M. T. R. L.).; Supported by a fellowship from CNPq, CAPES PNPD-2009, and FAPERJ.	Ando Yukio, 2005, Medical Molecular Morphology, V38, P142, DOI 10.1007/s00795-005-0288-1; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; BLAKE CCF, 1974, J MOL BIOL, V88, P1, DOI 10.1016/0022-2836(74)90291-5; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; COUTSELINIS A, 1977, CLIN CHEM, V23, P915; Davis DP, 2001, J MOL BIOL, V313, P1021, DOI 10.1006/jmbi.2001.5092; Deng NJ, 2006, BIOPHYS J, V90, P3865, DOI 10.1529/biophysj.105.064444; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Foguel D, 2005, PROTEIN PEPTIDE LETT, V12, P245, DOI 10.2174/0929866053587200; Ghosh M, 2004, BIOCHEM J, V378, P317, DOI 10.1042/BJ20031706; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; HERBERT J, 1993, NEUROLOGY, V43, pA175; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Inoue S, 1998, J STRUCT BIOL, V124, P1, DOI 10.1006/jsbi.1998.4052; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Keller R. L. J., 2004, THESIS ETH ZURICH ZU; Kingsbury JS, 2007, ANAL CHEM, V79, P1990, DOI 10.1021/ac061546s; Kuser P, 2008, PROTEINS, V72, P731, DOI 10.1002/prot.21956; LAI Z, 1996, J W BIOCH, V35, P6470; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lima LMTR, 2004, EUR J BIOCHEM, V271, P3580, DOI 10.1111/j.0014-2956.2004.04295.x; Liu K, 2000, NAT STRUCT BIOL, V7, P754; Liu K, 2000, J MOL BIOL, V303, P555, DOI 10.1006/jmbi.2000.4164; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MARTONE RL, 1993, AMYLOID AMYLOIDOSIS, P517; Monaco HL, 2000, BBA-PROTEIN STRUCT M, V1482, P65, DOI 10.1016/S0167-4838(00)00140-0; OKUNEWICK JP, 1963, NATURE, V198, P966, DOI 10.1038/198966a0; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Palha JA, 2002, CLIN CHEM LAB MED, V40, P1292, DOI 10.1515/CCLM.2002.223; Pasquato N, 2007, J MOL BIOL, V366, P711, DOI 10.1016/j.jmb.2006.11.076; Rance M, 1999, J MAGN RESON, V136, P92, DOI 10.1006/jmre.1998.1626; RICCIO P, 1995, NEUROCHEM RES, V20, P1107, DOI 10.1007/BF00995566; Rodriguez-Rodriguez C, 2009, J AM CHEM SOC, V131, P1436, DOI 10.1021/ja806062g; Bachega JFR, 2009, PROTEINS, V77, P26, DOI 10.1002/prot.22412; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; SCOTT BJ, 1983, CLIN CHEM, V29, P629; Sebastiao MP, 1998, J BIOL CHEM, V273, P24715, DOI 10.1074/jbc.273.38.24715; Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002; Susuki S, 2008, AMYLOID, V15, P108, DOI 10.1080/13506120802006013; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147; White JT, 2001, P NATL ACAD SCI USA, V98, P13019, DOI 10.1073/pnas.241406698; Wilkinson-White LE, 2007, BIOCHEMISTRY-US, V46, P9123, DOI 10.1021/bi700607z; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang MF, 2005, BIOPHYS J, V89, P433, DOI 10.1529/biophysj.105.059642; Zanotti G, 2008, FEBS J, V275, P5841, DOI 10.1111/j.1742-4658.2008.06705.x; ZHANG Q, 2003, J W BIOCH, V42, P8756	58	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31731	31741		10.1074/jbc.M110.157206	http://dx.doi.org/10.1074/jbc.M110.157206			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20659897	Green Published, hybrid			2022-12-27	WOS:000282764600065
J	Omoe, K; Nunomura, W; Kato, H; Li, ZJ; Igarashi, O; Araake, M; Sano, K; Ono, HK; Abe, Y; Hu, DL; Nakane, A; Kiyono, H; Takakuwa, Y; Shinagawa, K; Uchiyama, T; Imanishi, K				Omoe, Katsuhiko; Nunomura, Wataru; Kato, Hidehito; Li, Zhong-Juan; Igarashi, Osamu; Araake, Minako; Sano, Keigo; Ono, Hisaya K.; Abe, Yohei; Hu, Dong-Liang; Nakane, Akio; Kiyono, Hiroshi; Takakuwa, Yuichi; Shinagawa, Kunihiro; Uchiyama, Takehiko; Imanishi, Ken'ichi			High Affinity of Interaction between Superantigen and T Cell Receptor V beta Molecules Induces a High Level and Prolonged Expansion of Superantigen-reactive CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC-SHOCK-SYNDROME; STAPHYLOCOCCAL-ENTEROTOXIN; BACTERIAL SUPERANTIGENS; CRYSTAL-STRUCTURE; ACTIVATION; INDUCTION; TCR; SPECIFICITY; DETERMINES; SELECTION	In mice implanted with an osmotic pump filled with the superantigen (SAG) staphylococcal enterotoxin A (SEA), the V beta 3(+)CD4(+) T cells exhibited a high level of expansion whereas the V beta 11(+)CD4(+) T cells exhibited a mild level of expansion. In contrast, in mice implanted with an osmotic pump filled with SE-like type P (SElP, 78.1% homologous with SEA), the V beta 11(+)CD4(+) T cells exhibited a high level of expansion while the V beta 3(+)CD4(+) T cells exhibited a low level of expansion, suggesting that the level of the SAG-induced response is determined by the affinities between the TCR V beta molecules and SAG. Analyses using several hybrids of SEA and SElP showed that residue 206 of SEA determines the response levels of V beta 3(+)CD4(+) and V beta 11(+)CD4(+) T cells both in vitro and in vivo. Analyses using the above-mentioned hybrids showed that the binding affinities between SEA and the V beta 3/V beta 11 beta chains and between SEA-MHC class II-molecule complex and V beta 3(+)/V beta 11(+) CD4(+) T cells determines the response levels of the SAG-reactive T cells both in vitro and in vivo.	[Kato, Hidehito; Li, Zhong-Juan; Araake, Minako; Sano, Keigo; Imanishi, Ken'ichi] Tokyo Womens Med Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1628666, Japan; [Nunomura, Wataru; Takakuwa, Yuichi] Tokyo Womens Med Univ, Sch Med, Dept Biochem, Tokyo 1628666, Japan; [Omoe, Katsuhiko; Ono, Hisaya K.; Abe, Yohei; Shinagawa, Kunihiro] Iwate Univ, Fac Agr, Dept Vet Med, Morioka, Iwate 0208550, Japan; [Igarashi, Osamu; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Aomori 0368562, Japan; [Hu, Dong-Liang; Nakane, Akio] Hirosaki Univ, Sch Med, Dept Bacteriol, Aomori 0368562, Japan; [Uchiyama, Takehiko] Tokiwa Univ, Coll Human Sci, Ibaraki 3108585, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Iwate University; University of Tokyo; Hirosaki University	Imanishi, K (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	imanis17@research.twmu.ac.jp	Kiyono, Hiroshi/AAC-6735-2022; Ono, Hisaya/F-5296-2013; Ono, Hisaya/P-3595-2019					Abe J, 1997, J CLIN INVEST, V99, P1823, DOI 10.1172/JCI119349; Andersen PS, 2001, J BIOL CHEM, V276, P33452, DOI 10.1074/jbc.M103750200; Antonsson P, 1997, J IMMUNOL, V158, P4245; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Baker MD, 2004, INT J MED MICROBIOL, V293, P529, DOI 10.1078/1438-4221-00298; Bueno C, 2006, IMMUNITY, V25, P67, DOI 10.1016/j.immuni.2006.04.012; Chen LQ, 2002, J IMMUNOL, V168, P3817, DOI 10.4049/jimmunol.168.8.3817; De Marzi MC, 2004, EUR J BIOCHEM, V271, P4075, DOI 10.1111/j.1432-1033.2004.04345.x; FRIEDMAN ME, 1971, J BACTERIOL, V106, P289, DOI 10.1128/JB.106.1.289-291.1971; Fukui Y, 1997, IMMUNITY, V6, P401, DOI 10.1016/S1074-7613(00)80283-6; Hu DL, 2003, INFECT IMMUN, V71, P567, DOI 10.1128/IAI.71.1.567-570.2003; HUDSON KR, 1993, J EXP MED, V177, P175, DOI 10.1084/jem.177.1.175; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; IRWIN MJ, 1992, NATURE, V359, P841, DOI 10.1038/359841a0; Koyanagi M, 2004, INT IMMUNOL, V16, P315, DOI 10.1093/intimm/dxh027; Kuroda K, 1996, J IMMUNOL, V157, P1422; Lamphear JG, 1996, J IMMUNOL, V156, P2178; Li ZJ, 2009, MICROBIOL IMMUNOL, V53, P451, DOI 10.1111/j.1348-0421.2009.00136.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Matsuda Y, 2003, EMERG INFECT DIS, V9, P387, DOI 10.3201/eid0903.020360; Matsuda Y, 2008, MICROBIOL IMMUNOL, V52, P513, DOI 10.1111/j.1348-0421.2008.00071.x; MOLLICK JA, 1993, J EXP MED, V177, P283, DOI 10.1084/jem.177.2.283; Nunomura W, 2006, FRONT BIOSCI-LANDMRK, V11, P1522, DOI 10.2741/1901; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; Omoe K, 2005, INFECT IMMUN, V73, P5540, DOI 10.1128/IAI.73.9.5540-5546.2005; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; Tsukamoto H, 2006, EUR J IMMUNOL, V36, P1926, DOI 10.1002/eji.200535803; Uchiyama T., 2006, COMPREHENSIVE SOURCE, V3rd, P830, DOI [10.1016/B978-012088445-2/50055-X, DOI 10.1016/B978-012088445-2/50055-X]; Uchiyama T, 2007, SUPERANTIGENS: MOLECULAR BASIS FOR THEIR ROLE IN HUMAN DISEASES, P77; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; YAN XJ, 1993, J IMMUNOL, V150, P3873	37	7	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30427	30435		10.1074/jbc.M110.140871	http://dx.doi.org/10.1074/jbc.M110.140871			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663890	hybrid, Green Published			2022-12-27	WOS:000282135500009
J	Thi, MM; Suadicani, SO; Spray, DC				Thi, Mia M.; Suadicani, Sylvia O.; Spray, David C.			Fluid Flow-induced Soluble Vascular Endothelial Growth Factor Isoforms Regulate Actin Adaptation in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MARROW STROMAL CELLS; SHEAR-STRESS; BONE-FORMATION; EXPRESSION; VEGF; DIFFERENTIATION; ANGIOGENESIS; NEUROPILIN-1; CYTOSKELETON	Although load-induced mechanical signals play a key role in bone formation and maintenance of bone mass and structure, the cellular mechanisms involved in the translation of these signals are still not well understood. Recent identification of a novel flow-induced mechanosignaling pathway involving VEGF in osteoblasts and the known VEGF regulation of actin reorganization in various cell types has led us to hypothesize that fluid shear stress-induced Vegf up-regulation underlies the actin cytoskeleton adaptation observed in osteoblasts during mechanotransduction. Our results show that MC3T3-E1 cells secrete significant VEGF in response to 5 h of pulsatile fluid shear stress (PFSS; 5 dynes/cm(2) at 1 Hz), whereas expression of VEGF receptors (VEGFR-1, VEGFR-2, or NRP1) is unaffected. These receptors, in particular VEGFR-2, participate in PFSS-induced VEGF release. Exposure to flow-conditioned medium or exogenous VEGF significantly induces stress fiber formation in osteoblasts that is comparable with PFSS-induced stress fiber formation, whereas VEGF knockdown abrogates this response to PFSS, thereby providing evidence that flow-induced VEGF release plays a role in actin polymerization. Using neutralizing antibodies against the receptors and VEGF isoforms, we found that soluble VEGFs, in particular VEGF(164), play a crucial role in transient stress fiber formation during osteoblast mechanotransduction, most likely through VEGFR-2 and NRP1. Based on these data we conclude that flow-induced VEGF release from osteoblasts regulates osteoblast actin adaptation during mechanotransduction and that VEGF paracrine signaling may provide potent cross-talk among bone cells and endothelial cells that is essential for fracture healing, bone remodeling, and osteogenesis.	Yeshiva Univ Albert Einstein Coll Med, Dept Orthopaed Surg, Bronx, NY 10461 USA; [Thi, Mia M.; Suadicani, Sylvia O.; Spray, David C.] Yeshiva Univ Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Suadicani, Sylvia O.] Yeshiva Univ Albert Einstein Coll Med, Dept Urol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Spray, DC (corresponding author), 1300 Morris Pk Ave,Kennedy Ctr Rm 840, Bronx, NY 10461 USA.	mia.thi@einstein.yu.edu	Thi, Mia Mia/K-8772-2019	Spray, David/0000-0001-8368-5073	National Institutes of Health [F32HL082130, AHA0735377N, NS041282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL082130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32HL082130, AHA0735377N, and NS041282.	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Faure C, 2008, BONE, V42, P1092, DOI 10.1016/j.bone.2008.02.011; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fuh G, 2000, J BIOL CHEM, V275, P26690; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701; Gong Chunhong, 2004, Angiogenesis, V7, P313, DOI 10.1007/s10456-004-7960-2; HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258; Harper J, 2001, J CELL BIOCHEM, V81, P82, DOI 10.1002/1097-4644(20010401)81:1<82::AID-JCB1025>3.0.CO;2-P; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; MAES C, 2007, VEGF DEV, P1; Milkiewicz M, 2007, J PHYSIOL-LONDON, V583, P753, DOI 10.1113/jphysiol.2007.136325; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Petersen W, 2004, J ORTHOP RES, V22, P847, DOI 10.1016/j.orthres.2003.11.009; Reich K M, 1991, AM J PHYSIOL, V261, P428; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Saunders MM, 2001, AM J PHYSIOL-CELL PH, V281, pC1917, DOI 10.1152/ajpcell.2001.281.6.C1917; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Sharp LA, 2009, ANN BIOMED ENG, V37, P445, DOI 10.1007/s10439-008-9632-7; Singh SP, 2007, J AM COLL SURGEONS, V204, P426, DOI 10.1016/j.jamcollsurg.2006.11.019; Smith JD, 2001, ENDOTHELIUM-J ENDOTH, V8, P41, DOI 10.3109/10623320109063156; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stoletov KV, 2004, EXP CELL RES, V295, P258, DOI 10.1016/j.yexcr.2004.01.008; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Thi MM, 2007, ANN NY ACAD SCI, V1117, P73, DOI 10.1196/annals.1402.020; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; Thi MM, 2003, AM J PHYSIOL-CELL PH, V284, pC389, DOI 10.1152/ajpcell.00052.2002; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tombran-Tink J, 2004, BIOCHEM BIOPH RES CO, V316, P573, DOI 10.1016/j.bbrc.2004.02.076; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8; Young SRL, 2009, J BONE MINER RES, V24, P411, DOI 10.1359/JBMR.081102; Zelzer E, 2002, DEVELOPMENT, V129, P1893	43	21	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30931	30941		10.1074/jbc.M110.114975	http://dx.doi.org/10.1074/jbc.M110.114975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20682775	Green Published, hybrid			2022-12-27	WOS:000282135500058
J	Nagao, R; Moriguchi, A; Tomo, T; Niikura, A; Nakajima, S; Suzuki, T; Okumura, A; Iwai, M; Shen, JR; Ikeuchi, M; Enami, I				Nagao, Ryo; Moriguchi, Akira; Tomo, Tatsuya; Niikura, Ayako; Nakajima, Saori; Suzuki, Takehiro; Okumura, Akinori; Iwai, Masako; Shen, Jian-Ren; Ikeuchi, Masahiko; Enami, Isao			Binding and Functional Properties of Five Extrinsic Proteins in Oxygen-evolving Photosystem II from a Marine Centric Diatom, Chaetoceros gracilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; 12 KDA PROTEIN; CYTOCHROME C-550; CHLAMYDOMONAS-REINHARDTII; CROSS-RECONSTITUTION; THYLAKOID MEMBRANES; CYANIDIUM-CALDARIUM; EVOLUTION SYSTEM; RED ALGA; COMPLEXES	Oxygen-evolving photosystem II (PSII) isolated from a marine centric diatom, Chaetoceros gracilis, contains a novel extrinsic protein (Psb31) in addition to four red algal type extrinsic proteins of PsbO, PsbQ', PsbV, and PsbU. In this study, the five extrinsic proteins were purified from alkaline Tris extracts of the diatom PSII by anion and cation exchange chromatographic columns at different pH values. Reconstitution experiments in various combinations with the purified extrinsic proteins showed that PsbO, PsbQ', and Psb31 rebound directly to PSII in the absence of other extrinsic proteins, indicating that these extrinsic proteins have their own binding sites in PSII intrinsic proteins. On the other hand, PsbV and PsbU scarcely rebound to PSII alone, and their effective bindings required the presence of all of the other extrinsic proteins. Interestingly, PSII reconstituted with Psb31 alone considerably restored the oxygen evolving activity in the absence of PsbO, indicating that Psb31 serves as a substitute in part for PsbO in supporting oxygen evolution. A significant difference found between PSIIs reconstituted with Psb31 and with PsbO is that the oxygen evolving activity of the former is scarcely stimulated by Cl- and Ca2+ ions but that of the latter is largely stimulated by these ions, although rebinding of PsbV and PsbU activated oxygen evolution in the absence of Cl- and Ca2+ ions in both the former and latter PSIIs. Based on these results, we proposed a model for the association of the five extrinsic proteins with intrinsic proteins in diatom PSII and compared it with those in PSIIs from the other organisms.	[Nagao, Ryo; Iwai, Masako; Ikeuchi, Masahiko] Univ Tokyo, Dept Life Sci Biol, Grad Sch Art & Sci, Meguro Ku, Tokyo 1538902, Japan; [Moriguchi, Akira; Tomo, Tatsuya; Nakajima, Saori; Enami, Isao] Tokyo Univ Sci, Dept Biol, Fac Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Niikura, Ayako; Shen, Jian-Ren] Okayama Univ, Div Biosci, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Suzuki, Takehiro] RIKEN, Biomol Characterizat Team, Discovery Res Inst, Wako, Saitama 3510198, Japan; [Okumura, Akinori] Nihon Univ, Dept Integrated Sci Phys & Biol, Coll Humanities & Sci, Setagaya Ku, Tokyo 1568550, Japan	University of Tokyo; Tokyo University of Science; Okayama University; RIKEN; Nihon University	Enami, I (corresponding author), Univ Tokyo, Dept Life Sci Biol, Grad Sch Art & Sci, Meguro Ku, Tokyo 1538902, Japan.	enami@rs.noda.tus.ac.jp	Okumura, Akinori/AAT-4389-2021; Shen, Jian-Ren/B-2558-2011; Okumura, Akinori/B-6456-2017; Suzuki, Takehiro/B-3210-2013; Tomo, Tatsuya/K-7680-2012; NAGAO, Ryo/D-4117-2012	Okumura, Akinori/0000-0002-3977-6207; Okumura, Akinori/0000-0002-3977-6207; Tomo, Tatsuya/0000-0002-9369-1941; NAGAO, Ryo/0000-0001-8212-3001; Iwai, Masako/0000-0001-6121-7543	Ministry of Education of Japan [18570049, 21570038, 22370017]	Ministry of Education of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education of Japan 18570049 (to I. E.) and 21570038 and 22370017 (to T. T.), and Research Fellow (to R. N.) from the Japan Society for the Promotion of Science.	BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; BRICKER TM, 2007, PHOTOSYSTEM, V2, P95; Enami I, 2005, FEBS J, V272, P5020, DOI 10.1111/j.1742-4658.2005.04912.x; Enami I, 1998, BIOCHEMISTRY-US, V37, P2787, DOI 10.1021/bi9724624; Enami I, 2003, PLANT CELL PHYSIOL, V44, P820, DOI 10.1093/pcp/pcg106; ENAMI I, 1989, BIOCHIM BIOPHYS ACTA, V977, P33, DOI 10.1016/S0005-2728(89)80006-4; Enami I, 2000, PLANT CELL PHYSIOL, V41, P1354, DOI 10.1093/pcp/pcd069; ENAMI I, 1994, BBA-BIOENERGETICS, V1185, P75, DOI 10.1016/0005-2728(94)90195-3; Enami I, 1995, BBA-BIOENERGETICS, V1232, P208, DOI 10.1016/0005-2728(95)00122-0; Enami I, 2008, PHOTOSYNTH RES, V98, P349, DOI 10.1007/s11120-008-9343-9; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GHANOTAKIS DF, 1985, FEBS LETT, V192, P1, DOI 10.1016/0014-5793(85)80030-2; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; IKEUCHI M, 1988, FEBS LETT, V241, P99, DOI 10.1016/0014-5793(88)81039-1; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kashino Y, 2006, J BIOL CHEM, V281, P20834, DOI 10.1074/jbc.M603188200; KUWABARA T, 1982, PLANT CELL PHYSIOL, V23, P533, DOI 10.1093/oxfordjournals.pcp.a076378; MIYAO M, 1984, FEBS LETT, V168, P118, DOI 10.1016/0014-5793(84)80218-5; MIYAO M, 1983, BIOCHIM BIOPHYS ACTA, V725, P87, DOI 10.1016/0005-2728(83)90227-X; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; MIYAO M, 1989, BIOCHIM BIOPHYS ACTA, V977, P315, DOI 10.1016/S0005-2728(89)80086-6; Nagao R, 2007, BBA-BIOENERGETICS, V1767, P1353, DOI 10.1016/j.bbabio.2007.10.007; Nagao R, 2010, BBA-BIOENERGETICS, V1797, P160, DOI 10.1016/j.bbabio.2009.09.008; Ohta H, 2003, EUR J BIOCHEM, V270, P4156, DOI 10.1046/j.1432-1033.2003.03810.x; Okumura A, 2008, BBA-BIOENERGETICS, V1777, P1545, DOI 10.1016/j.bbabio.2008.09.004; Ono T, 1999, BIOCHEMISTRY-US, V38, P8778, DOI 10.1021/bi982949s; ONO T, 1984, FEBS LETT, V168, P281, DOI 10.1016/0014-5793(84)80263-X; ONO TA, 1983, FEBS LETT, V164, P255, DOI 10.1016/0014-5793(83)80297-X; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; SHEN JR, 1995, BIOCHEMISTRY-US, V34, P12661, DOI 10.1021/bi00039a023; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Summerfield TC, 2005, BIOCHEMISTRY-US, V44, P805, DOI 10.1021/bi048394k; Suzuki T, 2005, PHOTOSYNTH RES, V84, P239, DOI 10.1007/s11120-004-7760-y; Suzuki T, 2004, PLANT CELL PHYSIOL, V45, P1168, DOI 10.1093/pcp/pch131; Suzuki T, 2003, PLANT CELL PHYSIOL, V44, P76, DOI 10.1093/pcp/pcg010; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0	43	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29191	29199		10.1074/jbc.M110.146092	http://dx.doi.org/10.1074/jbc.M110.146092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630872	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000281740100019
J	Wang, CR; Yoo, Y; Fan, HP; Kim, E; Guan, KL; Guan, JL				Wang, Chenran; Yoo, Youngdong; Fan, Huaping; Kim, Eunjung; Guan, Kun-Liang; Guan, Jun-Lin			Regulation of Integrin beta 1 Recycling to Lipid Rafts by Rab1a to Promote Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; PLASMA-MEMBRANE; N-WASP; PROTEIN; TRAFFICKING; ADHESION; VESICLES; MOTILITY; COMPLEX; BINDING	Rab1a is a member of the Rab family of small GTPases with a well characterized function in the regulation of vesicle trafficking from the endoplasmic reticulum to the Golgi apparatus and within Golgi compartments. The integrin family heterodimeric transmembrane proteins serve as major receptors for extracellular matrix proteins, which play essential roles in cell adhesion and migration. Although effects on intracellular trafficking of integrins or other key cargos by Rab1a could influence cell migration, the regulatory mechanisms linking Rab1a to cell migration are not well understood. Here, we report identification of Rab1a as a novel regulator of cell migration using an unbiased RNAi screen targeting GTPases. Inhibition of Rab1a reduced integrin-mediated cell adhesion and spreading on fibronectins, reduced integrin beta 1 localization to lipid rafts, and decreased recycling of integrin beta 1 to the plasma membrane. Analysis of Rab1a effector molecules showed that p115 mediated Rab1a regulation of integrin recycling and lipid raft localization in cell migration. Taken together, these results suggest a novel function for Rab1a in the regulation of cell migration through controlling integrin beta 1 recycling and localization to lipid rafts via a specific downstream effector pathway.	[Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Kim, Eunjung; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kim, Eunjung; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Guan, JL (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA.	jlguan@umich.edu	wang, chenran/N-6629-2013; Guan, Kun-Liang/ADK-7088-2022; Fan, Huaping/B-8762-2012		National Institutes of Health [HL073394]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grant HL073394 (to J.-L. G.).	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Collins RN, 2003, MOL MEMBR BIOL, V20, P105, DOI 10.1080/0968768031000085892; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; DEL POZO MA, 2004, CELL CYCLE, V3, P725; DEL POZO MA, 2004, SCIENCE, V303, P839; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Holleran BJ, 2003, J LEUKOCYTE BIOL, V73, P243, DOI 10.1189/jlb.0902439; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Huttenlocher A, 2005, NAT CELL BIOL, V7, P336, DOI 10.1038/ncb0405-336; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; Leitinger B, 2002, J CELL SCI, V115, P963; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Manes S, 2006, MOL MEMBR BIOL, V23, P59, DOI 10.1080/09687860500430069; Manes S, 2000, IUBMB LIFE, V49, P89; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SZTUL E, 1993, J BIOL CHEM, V268, P1876; Vassilieva EV, 2008, AM J PHYSIOL-GASTR L, V295, pG965, DOI 10.1152/ajpgi.00082.2008; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; WU CY, 1995, J CELL SCI, V108, P2511; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Yoo YD, 2006, J BIOL CHEM, V281, P15352, DOI 10.1074/jbc.M511825200	49	72	77	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29398	29405		10.1074/jbc.M110.141440	http://dx.doi.org/10.1074/jbc.M110.141440			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639577	Green Published, hybrid			2022-12-27	WOS:000281740100042
J	Vallur, AC; Maizels, N				Vallur, Aarthy C.; Maizels, Nancy			Complementary Roles for Exonuclease 1 and Flap Endonuclease 1 in Maintenance of Triplet Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SECONDARY STRUCTURES; DEPENDENT MANNER; DNA METABOLISM; G4 DNA; EXPANSION; YEAST; FRAGILITY; REPAIR; INSTABILITY	Trinucleotide repeats can form stable secondary structures that promote genomic instability. To determine how such structures are resolved, we have defined biochemical activities of the related RAD2 family nucleases, FEN1 (Flap endonuclease 1) and EXO1 (exonuclease 1), on substrates that recapitulate intermediates in DNA replication. Here, we show that, consistent with its function in lagging strand replication, human (h) FEN1 could cleave 5'-flaps bearing structures formed by CTG or CGG repeats, although less efficiently than unstructured flaps. hEXO1 did not exhibit endonuclease activity on 5'-flaps bearing structures formed by CTG or CGG repeats, although it could excise these substrates. Neither hFEN1 nor hEXO1 was affected by the stem-loops formed by CTG repeats interrupting duplex regions adjacent to 5'-flaps, but both enzymes were inhibited by G4 structures formed by CGG repeats in analogous positions. Hydroxyl radical footprinting showed that hFEN1 binding caused hypersensitivity near the flap/duplex junction, whereas hEXO1 binding caused hypersensitivity very close to the 5'-end, correlating with the predominance of hFEN1 endonucleolytic activity versus hEXO1 exonucleolytic activity on 5'-flap substrates. These results show that FEN1 and EXO1 can eliminate structures formed by trinucleotide repeats in the course of replication, relying on endonucleolytic and exonucleolytic activities, respectively. These results also suggest that unresolved G4 DNA may prevent key steps in normal post-replicative DNA processing.	[Vallur, Aarthy C.; Maizels, Nancy] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maizels, N (corresponding author), Univ Washington, Sch Med, Dept Immunol, HSB H474A,1959 NE Pacific St, Seattle, WA 98195 USA.	maizels@u.washington.edu			National Institutes of Health [PO1 CA77852]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 CA77852 (to N. M.).	Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; Daee DL, 2007, MOL CELL BIOL, V27, P102, DOI 10.1128/MCB.01167-06; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Hou CX, 2009, NAT STRUCT MOL BIOL, V16, P869, DOI 10.1038/nsmb.1638; Kovtun IV, 2001, BIOCHEM CELL BIOL, V79, P325, DOI 10.1139/bcb-79-3-325; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lee S, 2002, EXP MOL MED, V34, P313, DOI 10.1038/emm.2002.44; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Lin YF, 2009, MOL CARCINOGEN, V48, P350, DOI 10.1002/mc.20488; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu Y, 2003, J BIOL CHEM, V278, P13728, DOI 10.1074/jbc.M212061200; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Sun XM, 2003, DNA REPAIR, V2, P925, DOI 10.1016/S1568-7864(03)00093-4; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Vallur AC, 2008, P NATL ACAD SCI USA, V105, P16508, DOI 10.1073/pnas.0805327105; Vallur AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008908; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; White PJ, 1999, MOL CELL BIOL, V19, P5675; Wilson DM, 1998, NUCLEIC ACIDS RES, V26, P3762, DOI 10.1093/nar/26.16.3762; Yang JH, 2007, GENE, V393, P110, DOI 10.1016/j.gene.2007.01.025	39	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28514	28519		10.1074/jbc.M110.132738	http://dx.doi.org/10.1074/jbc.M110.132738			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20643645	Green Published, hybrid			2022-12-27	WOS:000281594000015
J	Park, UH; Kim, EJ; Um, SJ				Park, Ui-Hyun; Kim, Eun-Joo; Um, Soo-Jong			A Novel Cytoplasmic Adaptor for Retinoic Acid Receptor (RAR) and Thyroid Receptor Functions as a Derepressor of RAR in the Absence of Retinoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR HORMONE-RECEPTORS; CO-REPRESSOR; STRUCTURAL BASIS; BINDING DOMAIN; P53 FAMILY; IN-VIVO; IDENTIFICATION; PROTEIN; LOCALIZATION; RECRUITMENT	In most mammalian cells, the retinoic acid receptor (RAR) is nuclear rather than cytoplasmic, regardless of its cognate ligand, retinoic acid (RA). In testis Sertoli cells, however, RAR is retained in the cytoplasm and moves to the nucleus only when RA is supplied. This led us to identify a protein that regulates the translocation of RAR. From yeast two-hybrid screening, we identified a novel RAR-interacting protein called CART1 (cytoplasmic adaptor for RAR and TR). Systematic interaction assays using deletion mutants showed that the C-terminal CoRNR box of CART1 was responsible for the interaction with the NCoR binding region of RAR and TR. Such interaction was impaired in the presence of ligand RA, as further determined by GST pull-down assays in vitro and immunoprecipitation assays in vivo. Fluorescence microscopy showed that unliganded RAR was captured by CART1 in the cytoplasm, whereas liganded RAR was liberated and moved to the nucleus. Overexpression of CART1 blocked the transcriptional repressing activity of unliganded apo RAR, mediated by corepressor NCoR in the nucleus. CART1 siRNA treatment in a mouse Sertoli cell line, TM4, allowed RAR to move to the nucleus and blocked the derepressing function of CART1, suggesting that CART1 might be a cytoplasmic, testis-specific derepressor of RAR.	[Kim, Eun-Joo] Dankook Univ, Dept Mol Biol, Yongin 448701, Gyeonggi Do, South Korea; [Park, Ui-Hyun; Um, Soo-Jong] Sejong Univ, Dept Biosci & Biotechnol, Seoul 143747, South Korea	Dankook University; Sejong University	Kim, EJ (corresponding author), Dankook Univ, Dept Mol Biol, Yongin 448701, Gyeonggi Do, South Korea.	nbrejk@dankook.ac.kr; umsj@sejong.ac.kr			NRF MEST, Republic of Korea [2007-0053438, 2008-0057731, 2009-0064593]	NRF MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through NRF MEST Grants 2007-0053438 and 2008-0057731 (to S.-J.U.) and 2009-0064593 (to E.-J.K.), Republic of Korea.	Akmal KM, 1998, ENDOCRINOLOGY, V139, P1239, DOI 10.1210/en.139.3.1239; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; Baumann CT, 2001, J BIOL CHEM, V276, P11237, DOI 10.1074/jbc.M011112200; Braun KW, 2000, J BIOL CHEM, V275, P4145, DOI 10.1074/jbc.275.6.4145; BRENT G A, 1989, New Biologist, V1, P329; Bunn CF, 2001, MOL ENDOCRINOL, V15, P512, DOI 10.1210/mend.15.4.0619; CHAMBON P, 1995, RECENT PROG HORM RES, V50, P317; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; Davis PJ, 2008, STEROIDS, V73, P1013, DOI 10.1016/j.steroids.2007.12.030; DeFranco Donald B., 1999, Cell Biochemistry and Biophysics, V30, P1, DOI 10.1007/BF02737882; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Hager GL, 2000, J STEROID BIOCHEM, V74, P249, DOI 10.1016/S0960-0760(00)00100-X; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; Mackem S, 2001, J BIOL CHEM, V276, P45501, DOI 10.1074/jbc.C100269200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; McKenna NJ, 1999, J STEROID BIOCHEM, V69, P3, DOI 10.1016/S0960-0760(98)00144-7; Moore JMR, 2005, MOL CELL PROTEOMICS, V4, P475, DOI 10.1074/mcp.R500001-MCP200; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Prekeris R, 2001, J BIOL CHEM, V276, P38966, DOI 10.1074/jbc.M106133200; Schonteich E, 2007, EUR J CELL BIOL, V86, P417, DOI 10.1016/j.ejcb.2007.05.004; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Shin OH, 1999, J BIOL CHEM, V274, P36609, DOI 10.1074/jbc.274.51.36609; Tiwari AK, 2008, CELL BIOL INT, V32, P1158, DOI 10.1016/j.cellbi.2008.04.002; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wei LN, 2003, ANNU REV PHARMACOL, V43, P47, DOI 10.1146/annurev.pharmtox.43.100901.140301; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wolgemuth D J, 2007, Soc Reprod Fertil Suppl, V63, P11; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yamashita S, 1998, HISTOL HISTOPATHOL, V13, P255, DOI 10.14670/HH-13.255	42	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34269	34278		10.1074/jbc.M110.143008	http://dx.doi.org/10.1074/jbc.M110.143008			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736163	hybrid, Green Published			2022-12-27	WOS:000283354000072
J	Suh, MH; Meyer, PA; Gu, MG; Ye, P; Zhang, MC; Kaplan, CD; Lima, CD; Fu, JH				Suh, Man-Hee; Meyer, Peter A.; Gu, Meigang; Ye, Ping; Zhang, Mincheng; Kaplan, Craig D.; Lima, Christopher D.; Fu, Jianhua			A Dual Interface Determines the Recognition of RNA Polymerase II by RNA Capping Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; C-TERMINAL DOMAIN; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; IN-VIVO; PROCESSING FACTORS; SHUTTLE VECTORS; HEAT-SHOCK; PHOSPHORYLATION	RNA capping enzyme (CE) is recruited specifically to RNA polymerase II (Pol II) transcription sites to facilitate cotrans-criptional 5 '-capping of pre-mRNA and other Pol II transcripts. The current model to explain this specific recruitment of CE to Pol II as opposed to Pol I and Pol III rests on the interaction between CE and the phosphorylated C-terminal domain (CTD) of Pol II largest subunit Rpb1 and more specifically between the CE nucleotidyltransferase domain and the phosphorylated CTD. Through biochemical and diffraction analyses, we demonstrate the existence of a distinctive stoichiometric complex between CE and the phosphorylated Pol II (Pol IIO). Analysis of the complex revealed an additional and unexpected polymerase-CE interface (PCI) located on the multihelical Foot domain of Rpb1. We name this interface PCI1 and the previously known nucleotidyltransferase/phosphorylated CTD interface PCI2. Although PCI1 and PCI2 individually contribute to only weak interactions with CE, a dramatically stabilized and stoichiometric complex is formed when PCI1 and PCI2 are combined in cis as they occur in an intact phosphorylated Pol II molecule. Disrupting either PCI1 or PCI2 by alanine substitution or deletion diminishes CE association with Pol II and causes severe growth defects in vivo. Evidence from manipulating PCI1 indicates that the Foot domain contributes to the specificity in CE interaction with Pol II as opposed to Pol I and Pol III. Our results indicate that the dual interface based on combining PCI1 and PCI2 is required for directing CE to Pol II elongation complexes.	[Suh, Man-Hee; Meyer, Peter A.; Ye, Ping; Zhang, Mincheng; Fu, Jianhua] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Gu, Meigang; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Kaplan, Craig D.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Medical College of Wisconsin; Memorial Sloan Kettering Cancer Center; Texas A&M University System; Texas A&M University College Station	Fu, JH (corresponding author), Med Coll Wisconsin, Dept Biochem, 303 Basic Sci Bldg, Milwaukee, WI 53226 USA.	jfu@mcw.edu	Kaplan, Craig/AAO-4500-2021	Kaplan, Craig/0000-0002-7518-695X; Lima, Christopher/0000-0002-9163-6092	National Institutes of Health [GM064651, GM061906]; Cornell University, Ithaca [NY 14853]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064651, R01GM061906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell University, Ithaca; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM064651 ( to J. F.).; Supported by the National Institutes of Health Grant GM061906.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; Buratowski S, 2005, NATURE, V435, P1174, DOI 10.1038/4351174b; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chen CY, 2009, P NATL ACAD SCI USA, V106, P127, DOI 10.1073/pnas.0811689106; Chiu YL, 2002, MOL CELL, V10, P585, DOI 10.1016/S1097-2765(02)00630-5; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COPPOLA JA, 1983, P NATL ACAD SCI-BIOL, V80, P1251, DOI 10.1073/pnas.80.5.1251; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gu MG, 2010, STRUCTURE, V18, P216, DOI 10.1016/j.str.2009.12.009; Guarino LA, 1998, J VIROL, V72, P10003, DOI 10.1128/JVI.72.12.10003-10010.1998; Guiguen A, 2007, EMBO J, V26, P1552, DOI 10.1038/sj.emboj.7601627; GUNNERY S, 1995, MOL CELL BIOL, V15, P3597; HAGLER J, 1992, SCIENCE, V255, P983, DOI 10.1126/science.1546295; Hausmann S, 2003, J BIOL CHEM, V278, P30487, DOI 10.1074/jbc.M303060200; Ho CK, 1998, J BIOL CHEM, V273, P9577, DOI 10.1074/jbc.273.16.9577; Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2; Hong SW, 2009, P NATL ACAD SCI USA, V106, P14276, DOI 10.1073/pnas.0903642106; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; Kim HJ, 2004, MOL CELL BIOL, V24, P6184, DOI 10.1128/MCB.24.14.6184-6193.2004; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Lo HJ, 1998, MOL CELL BIOL, V18, P665, DOI 10.1128/MCB.18.2.665; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Meyer PA, 2006, STRUCTURE, V14, P973, DOI 10.1016/j.str.2006.04.003; Meyer PA, 2009, J BIOL CHEM, V284, P12933, DOI 10.1074/jbc.M809199200; Moteki S, 2002, MOL CELL, V10, P599, DOI 10.1016/S1097-2765(02)00660-3; Myers LC, 2002, MOL CELL, V10, P883, DOI 10.1016/S1097-2765(02)00644-5; Natalizio BJ, 2009, J BIOL CHEM, V284, P8683, DOI 10.1074/jbc.M806919200; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Pei Y, 2003, J BIOL CHEM, V278, P7180, DOI 10.1074/jbc.M211713200; Pei Y, 2002, J BIOL CHEM, V277, P19639, DOI 10.1074/jbc.M200015200; Pei Y, 2001, J BIOL CHEM, V276, P28075, DOI 10.1074/jbc.M102170200; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Reyes-Reyes M, 2007, MOL CELL BIOL, V27, P926, DOI 10.1128/MCB.01361-06; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider S, 2010, MOL CELL BIOL, V30, P2353, DOI 10.1128/MCB.00116-10; Schwer B, 1996, RNA, V2, P574; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; SIKORSKI RS, 1989, GENETICS, V122, P19; Spahr H, 2009, P NATL ACAD SCI USA, V106, P9185, DOI 10.1073/pnas.0903361106; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Ursic D, 2008, RNA BIOL, V5, P1; WEST ML, 1995, GENETICS, V140, P1223; WOYCHIK NA, 1990, GENE DEV, V4, P313, DOI 10.1101/gad.4.3.313; Yue ZY, 1997, P NATL ACAD SCI USA, V94, P12898, DOI 10.1073/pnas.94.24.12898; Yuryev A, 1996, GENETICS, V143, P661; Zhou MS, 2003, P NATL ACAD SCI USA, V100, P12666, DOI 10.1073/pnas.1835726100	73	25	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34027	34038		10.1074/jbc.M110.145110	http://dx.doi.org/10.1074/jbc.M110.145110			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20720002	hybrid, Green Published			2022-12-27	WOS:000283354000049
J	Allsopp, RC; Lalo, U; Evans, RJ				Allsopp, Rebecca C.; Lalo, Ulyana; Evans, Richard J.			Lipid Raft Association and Cholesterol Sensitivity of P2X1-4 Receptors for ATP CHIMERAS AND POINT MUTANTS IDENTIFY INTRACELLULAR AMINO-TERMINAL RESIDUES INVOLVED IN LIPID REGULATION OF P2X1 RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLYL-CYCLASE; GATED CHANNELS; P2X(7) RECEPTORS; CELLS; DESENSITIZATION; DISRUPTION; CAVEOLAE; DOMAIN; PHOSPHOINOSITIDES; PALMITOYLATION	Cholesterol-rich lipid rafts act as signaling microdomains and can regulate receptor function. We have shown in HEK293 cells recombinant P2X1-4 receptors (ATP-gated ion channels) are expressed in lipid rafts. Localization to flotillin-rich lipid rafts was reduced by the detergent Triton X-100. This sensitivity to Triton X-100 was concentration-and subunit-dependent, demonstrating differential association of P2X1-4 receptors with lipid rafts. The importance of raft association to ATP-evoked P2X receptor responses was determined in patch clamp studies. The cholesterol-depleting agents methyl-beta-cyclodextrin or filipin disrupt lipid rafts and reduced P2X1 receptor currents by > 90%. In contrast, ATP-evoked P2X2-4 receptor currents were unaffected by lipid raft disruption. To determine the molecular basis of cholesterol sensitivity, we generated chimeric receptors replacing portions of the cholesterol-sensitive P2X1 receptor with the corresponding region from the insensitive P2X2 receptor. These chimeras identified the importance of the intracellular amino-terminal region between the conserved protein kinase C site and the first transmembrane segment for the sensitivity to cholesterol depletion. Mutation of any of the variant residues between P2X1 and P2X2 receptors in this region in the P2X1 receptor (residues 20-23 and 27-29) to cysteine removed cholesterol sensitivity. Cholesterol depletion did not change the ATP sensitivity or cell surface expression of P2X1 receptors. This suggests that cholesterol is normally needed to facilitate the opening/gating of ATP-bound P2X1 receptor channels, and mutations in the pre-first transmembrane segment region remove this requirement.	[Allsopp, Rebecca C.; Lalo, Ulyana; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Bernier LP, 2008, MOL PHARMACOL, V74, P785, DOI 10.1124/mol.108.047019; Bernier LP, 2008, J NEUROSCI, V28, P12938, DOI 10.1523/JNEUROSCI.3038-08.2008; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Chaumont S, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162329; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DALZIEL AW, 1980, FEBS LETT, V122, P193, DOI 10.1016/0014-5793(80)80435-2; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Garcia-Marcos M, 2006, J LIPID RES, V47, P705, DOI 10.1194/jlr.M500408-JLR200; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Jacobs C, 2004, FEBS LETT, V565, P70, DOI 10.1016/j.febslet.2004.03.076; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jindrichova M, 2009, J NEUROCHEM, V109, P923, DOI 10.1111/j.1471-4159.2009.06021.x; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Liu Y, 2006, BIOTECHNOL ADV, V24, P1, DOI 10.1016/j.biotechadv.2005.04.002; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ostrom RS, 2002, MOL PHARMACOL, V61, P473, DOI 10.1124/mol.61.3.473; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Paukert M, 2001, J BIOL CHEM, V276, P21077, DOI 10.1074/jbc.M101465200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Ralevic V, 1998, PHARMACOL REV, V50, P413; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Vacca F, 2004, J NEUROSCI RES, V76, P653, DOI 10.1002/jnr.20069; Vacca F, 2009, J NEUROCHEM, V109, P1031, DOI 10.1111/j.1471-4159.2009.06029.x; Vial C, 2006, BIOCHEM BIOPH RES CO, V343, P415, DOI 10.1016/j.bbrc.2006.02.174; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Waheed AA, 2002, J BIOL CHEM, V277, P32409, DOI 10.1074/jbc.C200383200; Wen HR, 2009, J NEUROCHEM, V108, P331, DOI 10.1111/j.1471-4159.2008.05761.x; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200	47	39	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32770	32777		10.1074/jbc.M110.148940	http://dx.doi.org/10.1074/jbc.M110.148940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20699225	Green Published, hybrid			2022-12-27	WOS:000283048200012
J	Arana-Argaez, VE; Delgado-Rizo, V; Pizano-Martinez, OE; Martinez-Garcia, EA; Martin-Marquez, BT; Munoz-Gomez, A; Petri, MH; Armendariz-Borunda, J; Espinosa-Ramirez, G; Zuniga-Tamayo, DA; Herrera-Esparza, R; Vazquez-Del Mercado, M				Arana-Argaez, Victor E.; Delgado-Rizo, Vidal; Pizano-Martinez, Oscar E.; Martinez-Garcia, Erika A.; Martin-Marquez, Beatriz T.; Munoz-Gomez, Andrea; Petri, Marcelo H.; Armendariz-Borunda, Juan; Espinosa-Ramirez, Guillermo; Zuniga-Tamayo, Diego A.; Herrera-Esparza, Rafael; Vazquez-Del Mercado, Monica			Inhibitors of MAPK Pathway ERK1/2 or p38 Prevent the IL-1 beta-induced Up-regulation of SRP72 Autoantigen in Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ACTIVATED PROTEIN-KINASE; IDIOPATHIC INFLAMMATORY MYOPATHIES; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; KAPPA-B; TRANSLOCATION; SEQUENCE; RECEPTOR; APOPTOSIS	Phosphorylation is the most important post-translational event at a cellular level that is regulated by protein kinases. MAPK is a key player in the important cellular signaling pathway. It has been hypothesized that phosphorylation might have a role in the induction of break tolerance against some autoantigens such as SRP72. The aim of this study was to explore the pathways of phosphorylation and overexpression of the SRP72 polypeptide, using an in vitro model of Jurkat cells stimulated by recombinant human (rh) IL-1 beta in the presence of MAPK inhibitors. We used Jurkat cells as a substrate stimulated with rhIL-1 beta in the presence of MAPK inhibitors at different concentrations in a time course in vitro experiment by immunoprecipitation, immunoprecipitation-Western blotting, and real time PCR. Our results showed that rhIL-1 beta causes up-regulation of protein expression and phosphorylation of SRP72 in Jurkat cells. Inhibitors of the MAPK pathway ERK1/2 or p38 alpha/beta down-regulate the expression of SRP72 autoantigen in Jurkat cells stimulated by rhIL-1 beta. Our results highlight the importance of studying the pathways of activation and overexpression of autoantigens. It will be necessary to perform careful research on various kinases pathways, including MAPK in dermatomyositis and other rheumatic diseases, to help to explain the routes of activation and inhibition of autoantigens. The understanding of this process may help to develop new therapies to prevent and control the loss of tolerance toward own normal proteins.	[Arana-Argaez, Victor E.; Martinez-Garcia, Erika A.; Martin-Marquez, Beatriz T.; Munoz-Gomez, Andrea; Petri, Marcelo H.; Espinosa-Ramirez, Guillermo; Zuniga-Tamayo, Diego A.; Vazquez-Del Mercado, Monica] Univ Guadalajara, Inst Invest Reumatol & Sistema Musculo Esquelet, Ctr Univ Ciencias Salud, Guadalajara 44340, Jalisco, Mexico; [Munoz-Gomez, Andrea] Univ Autonoma Guadalajara, Guadalajara 45129, Jalisco, Mexico; [Armendariz-Borunda, Juan] Univ Guadalajara, Inst Biol Mol Med, Ctr Univ Ciencias Salud, Dept Biol Mol & Genom, Guadalajara 44340, Jalisco, Mexico; [Herrera-Esparza, Rafael] Univ Autonoma Zacatecas, Zacatecas 98000, Mexico; [Vazquez-Del Mercado, Monica] Hosp Civil Dr Juan I Menchaca, Dept Reumatol, Div Med Interna, Guadalajara 44340, Jalisco, Mexico	Universidad de Guadalajara; Universidad Autonoma de Guadalajara; Universidad de Guadalajara; Universidad Autonoma de Zacatecas	Vazquez-Del Mercado, M (corresponding author), Univ Guadalajara, Inst Invest Reumatol & Sistema Musculo Esquelet, Ctr Univ Ciencias Salud, Sierra Mojada 950,Edificio P, Guadalajara 44340, Jalisco, Mexico.	dravme@hotmail.com	Armendáriz-Borunda, Juan/AAU-1471-2021; Arana-Argaez, Victor/AAT-3634-2020; Pizano, Oscar/AGR-5765-2022; Martínez-Garcia, Erika Aurora/V-4409-2017; del Mercado, Monica Vazquez/F-5856-2017	Martínez-Garcia, Erika Aurora/0000-0001-6486-1086; del Mercado, Monica Vazquez/0000-0002-3823-4676; PIZANO, OSCAR/0000-0003-3635-7071; Arana Argaez, Victor Ermilo/0000-0003-1434-1677; Espinosa-Ramirez, Guillermo/0000-0001-9573-8806; Martin-Marquez, Beatriz Teresita/0000-0002-6756-4316; Petri, Marcelo/0000-0002-6892-2680	COECyTJAL [PS-2009-420]	COECyTJAL	This work was supported by COECyTJAL Grant PS-2009-420 (to M. V.-D. M.).	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; ARANAARGAEZ VE, 2009, BIOQUIMIA, V34, P77; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bui N, 1999, BIOL CHEM, V380, P135, DOI 10.1515/BC.1999.021; Buskiewicz IA, 2009, RNA, V15, P44, DOI 10.1261/rna.1285609; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CONNOLLY T, 1993, J CELL BIOL, V123, P799, DOI 10.1083/jcb.123.4.799; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Paepe B, 2008, FRONT BIOSCI-LANDMRK, V13, P2548, DOI 10.2741/2866; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; Dodeller F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1905; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; Gerner C, 2002, MOL CELL PROTEOMICS, V1, P528, DOI 10.1074/mcp.M200026-MCP200; Giordano TJ, 2001, AM J PATHOL, V159, P1231, DOI 10.1016/S0002-9440(10)62509-6; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Inoue T, 2006, P NATL ACAD SCI USA, V103, P5484, DOI 10.1073/pnas.0509188103; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; Kamachi M, 2002, J EXP MED, V196, P1213, DOI 10.1084/jem.20021167; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; LINGAPPA VR, 1978, J BIOL CHEM, V253, P8667; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MIGLIACCIO G, 1992, J CELL BIOL, V117, P15, DOI 10.1083/jcb.117.1.15; Mitchell MD, 2007, AM J PHYSIOL-HEART C, V292, pH1139, DOI 10.1152/ajpheart.00881.2005; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; RAPIEJKO PJ, 1994, MOL BIOL CELL, V5, P887, DOI 10.1091/mbc.5.8.887; RAPIEJKO PJ, 1992, J CELL BIOL, V117, P493, DOI 10.1083/jcb.117.3.493; Romisch K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1895; Rutjes SA, 1999, CELL DEATH DIFFER, V6, P976, DOI 10.1038/sj.cdd.4400571; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Sheryanna A, 2007, J AM SOC NEPHROL, V18, P1167, DOI 10.1681/ASN.2006010050; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Utz PJ, 2000, ARTHRITIS RES, V2, P101, DOI 10.1186/ar75; Utz PJ, 1998, ARTHRITIS RHEUM, V41, P1152, DOI 10.1002/1529-0131(199807)41:7<1152::AID-ART3>3.0.CO;2-L; Utz PJ, 1998, J BIOL CHEM, V273, P35362, DOI 10.1074/jbc.273.52.35362; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025; Yao YX, 2006, J IMMUNOL, V177, P70, DOI 10.4049/jimmunol.177.1.70	49	22	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32824	32833		10.1074/jbc.M110.121087	http://dx.doi.org/10.1074/jbc.M110.121087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729213	Green Published, hybrid			2022-12-27	WOS:000283048200019
J	Tooley, LD; Zamurs, LK; Beecher, N; Baker, NL; Peat, RA; Adams, NE; Bateman, JF; North, KN; Baldock, C; Lamande, SR				Tooley, Leona D.; Zamurs, Laura K.; Beecher, Nicola; Baker, Naomi L.; Peat, Rachel A.; Adams, Naomi E.; Bateman, John F.; North, Kathryn N.; Baldock, Clair; Lamande, Shireen R.			Collagen VI Microfibril Formation Is Abolished by an alpha 2(VI) von Willebrand Factor Type A Domain Mutation in a Patient with Ullrich Congenital Muscular Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETHLEM-MYOPATHY; VONWILLEBRAND-FACTOR; ALPHA-3(VI) CHAIN; LIGAND-BINDING; SEQUENCE-ANALYSIS; GLOBULAR DOMAINS; I-DOMAIN; DOMINANT; INTEGRIN; IDENTIFICATION	Collagen VI is an extracellular protein that most often contains the three genetically distinct polypeptide chains, alpha 1(VI), alpha 2(VI), and alpha 3(VI), although three recently identified chains, alpha 4(VI), alpha 5(VI), and alpha 6(VI), may replace alpha 3(VI) in some situations. Each chain has a triple helix flanked by N- and C-terminal globular domains that share homology with the von Willebrand factor type A (VWA) domains. During biosynthesis, the three chains come together to form triple helical monomers, which then assemble into dimers and tetramers. Tetramers are secreted from the cell and align end-to-end to form microfibrils. The precise molecular mechanisms responsible for assembly are unclear. Mutations in the three collagen VI genes can disrupt collagen VI biosynthesis and matrix organization and are the cause of the inherited disorders Bethlem myopathy and Ullrich congenital muscular dystrophy. We have identified a Ullrich congenital muscular dystrophy patient with compound heterozygous mutations in alpha 2(VI). The first mutation causes skipping of exon 24, and the mRNA is degraded by nonsense-mediated decay. The second mutation is a two-amino acid deletion in the C1 VWA domain. Recombinant C1 domains containing the deletion are insoluble and retained intracellularly, indicating that the mutation has detrimental effects on domain folding and structure. Despite this, mutant alpha 2(VI) chains retain the ability to associate into monomers, dimers, and tetramers. However, we show that secreted mutant tetramers containing structurally abnormal C1 VWA domains are unable to associate further into microfibrils, directly demonstrating the critical importance of a correctly folded alpha 2(VI) C1 domain in microfibril formation.	[Tooley, Leona D.; Zamurs, Laura K.; Baker, Naomi L.; Adams, Naomi E.; Bateman, John F.; Lamande, Shireen R.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Tooley, Leona D.; Lamande, Shireen R.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Royal Childrens Hosp, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Beecher, Nicola; Baldock, Clair] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PL, Lancs, England; [Peat, Rachel A.; North, Kathryn N.] Univ Sydney, Childrens Hosp Westmead, Neurogenet Res Unit, Westmead, NSW 2145, Australia; [Peat, Rachel A.; North, Kathryn N.] Univ Sydney, Discipline Paediat & Child Hlth, Westmead, NSW 2145, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of Manchester; University of Sydney; University of Sydney	Lamande, SR (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	shireen.lamande@mcri.edu.au	North, Kathryn N/K-6476-2012	North, Kathryn N/0000-0003-0841-8009; Bateman, John/0000-0001-8542-0730; Lamande, Shireen/0000-0003-2938-2711; Baldock, Clair/0000-0003-3497-1959	National Health and Medical Research Council of Australia [491252]; Biotechnology and Biological Sciences Research Council [BB/D008662/1]; Murdoch Childrens Research Institute; Melbourne University; BBSRC [BB/D008662/1] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Murdoch Childrens Research Institute; Melbourne University(University of Melbourne); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Health and Medical Research Council of Australia Grant 491252 (to S. R. L. and J. F. B.), Biotechnology and Biological Sciences Research Council Grant BB/D008662/1 (to N. B.), and the Murdoch Childrens Research Institute.; Supported by a Melbourne University Research Scholarship.	BAJT ML, 1994, J BIOL CHEM, V269, P20913; Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0; Ball SG, 2001, J BIOL CHEM, V276, P7422, DOI 10.1074/jbc.M002816200; BONALDO P, 1989, J BIOL CHEM, V264, P5575; BRUNS RR, 1986, J CELL BIOL, V103, P393, DOI 10.1083/jcb.103.2.393; Camacho V.O., 2001, P NATL ACAD SCI USA, V98, P7516, DOI DOI 10.1073/PNAS.121027598; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; DOLIANA R, 1990, J CELL BIOL, V111, P2197, DOI 10.1083/jcb.111.5.2197; Doliana R, 1998, MATRIX BIOL, V16, P427, DOI 10.1016/S0945-053X(98)90015-4; Fitzgerald J, 2001, J BIOL CHEM, V276, P187, DOI 10.1074/jbc.M008173200; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Foley AR, 2009, NEUROMUSCULAR DISORD, V19, P813, DOI 10.1016/j.nmd.2009.09.010; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Giusti B, 2005, ANN NEUROL, V58, P400, DOI 10.1002/ana.20586; Gualandi F, 2009, NEUROLOGY, V73, P1883, DOI 10.1212/WNL.0b013e3181c3fd2a; Ishikawa H, 2004, NEUROLOGY, V62, P620, DOI 10.1212/01.WNL.0000113023.84421.00; Ishikawa H, 2002, NEUROLOGY, V59, P920, DOI 10.1212/WNL.59.6.920; Kamata T, 1999, J BIOL CHEM, V274, P32108, DOI 10.1074/jbc.274.45.32108; KAMATA T, 1994, J BIOL CHEM, V269, P9659; Kielty Cay M., 1993, P103; LAMANDE S, 2002, J BIOL CHEM, V277, P1848; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Lamande SR, 1999, J BIOL CHEM, V274, P21817, DOI 10.1074/jbc.274.31.21817; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Lampe AK, 2005, J MED GENET, V42, P108, DOI 10.1136/jmg.2004.023754; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Pace RA, 2008, ANN NEUROL, V64, P294, DOI 10.1002/ana.21439; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; Peat RA, 2007, NEUROMUSCULAR DISORD, V17, P547, DOI 10.1016/j.nmd.2007.03.017; Sasaki T, 2000, FASEB J, V14, P761, DOI 10.1096/fasebj.14.5.761; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; SPISSINGER T, 1995, MATRIX BIOL, V14, P499, DOI 10.1016/0945-053X(95)90007-1; Vanegas OC, 2002, MUSCLE NERVE, V25, P513, DOI 10.1002/mus.10100; Wilson R, 2002, J BIOL CHEM, V277, P12516, DOI 10.1074/jbc.M112044200; Zhang RZ, 2010, J BIOL CHEM, V285, P10005, DOI 10.1074/jbc.M109.093666; Zhang RZ, 2002, J BIOL CHEM, V277, P43557, DOI 10.1074/jbc.M207696200	45	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33567	33576		10.1074/jbc.M110.152520	http://dx.doi.org/10.1074/jbc.M110.152520			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729548	Green Published, hybrid			2022-12-27	WOS:000283048200090
J	Barbieri, CM; Mack, TR; Robinson, VL; Miller, MT; Stock, AM				Barbieri, Christopher M.; Mack, Timothy R.; Robinson, Victoria L.; Miller, Matthew T.; Stock, Ann M.			Regulation of Response Regulator Autophosphorylation through Interdomain Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL PHOSPHATE; RECEIVER DOMAIN; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURES; PHOSPHORYLATION; ACTIVATION; DYNAMICS; CHEY	DNA-binding response regulators (RRs) of the OmpR/PhoB subfamily alternate between inactive and active conformational states, with the latter having enhanced DNA-binding affinity. Phosphorylation of an aspartate residue in the receiver domain, usually via phosphotransfer from a cognate histidine kinase, stabilizes the active conformation. Many of the available structures of inactive OmpR/PhoB family proteins exhibit extensive interfaces between the N-terminal receiver and C-terminal DNA-binding domains. These interfaces invariably involve the alpha 4-beta 5-alpha 5 face of the receiver domain, the locus of the largest differences between inactive and active conformations and the surface that mediates dimerization of receiver domains in the active state. Structures of receiver domain dimers of DrrB, DrrD, and MtrA have been determined, and phosphorylation kinetics were analyzed. Analysis of phosphotransfer from small molecule phosphodonors has revealed large differences in autophosphorylation rates among OmpR/PhoB RRs. RRs with substantial domain interfaces exhibit slow rates of phosphorylation. Rates are greatly increased in isolated receiver domain constructs. Such differences are not observed between autophosphorylation rates of full-length and isolated receiver domains of a RR that lacks interdomain interfaces, and they are not observed in histidine kinase-mediated phosphotransfer. These findings suggest that domain interfaces restrict receiver domain conformational dynamics, stabilizing an inactive conformation that is catalytically incompetent for phosphotransfer from small molecule phosphodonors. Inhibition of phosphotransfer by domain interfaces provides an explanation for the observation that some RRs cannot be phosphorylated by small molecule phosphodonors in vitro and provides a potential mechanism for insulating some RRs from small molecule-mediated phosphorylation in vivo.	[Stock, Ann M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Barbieri, Christopher M.; Mack, Timothy R.; Robinson, Victoria L.; Stock, Ann M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Mack, Timothy R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Grad Sch Biomed Sci, Piscataway, NJ 08854 USA; [Barbieri, Christopher M.; Robinson, Victoria L.; Stock, Ann M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Miller, Matthew T.] Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Stock, AM (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.	stock@cabm.rutgers.edu		Barbieri, Christopher/0000-0002-3266-0201; Stock, Ann/0000-0002-0446-8079	National Institutes of Health [R37GM047958]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37GM047958 (to A. M. S.).	Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; BACHHAWAT P, 2005, THESIS U MED DENT NE; Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bouche S, 1998, MOL MICROBIOL, V27, P787, DOI 10.1046/j.1365-2958.1998.00725.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckler DR, 2000, ANAL BIOCHEM, V283, P222, DOI 10.1006/abio.2000.4639; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Da Re S, 2002, PROTEIN SCI, V11, P2644, DOI 10.1110/ps.0220402; Da Re SS, 1999, FEBS LETT, V457, P323, DOI 10.1016/S0014-5793(99)01057-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser JS, 2007, MOL MICROBIOL, V65, P319, DOI 10.1111/j.1365-2958.2007.05785.x; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gardino AK, 2003, J MOL BIOL, V331, P245, DOI 10.1016/S0022-2836(03)00733-2; Gardino AK, 2007, METHOD ENZYMOL, V423, P149, DOI 10.1016/S0076-6879(07)23006-X; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Kato H, 2008, BIOSCI BIOTECH BIOCH, V72, P1072, DOI 10.1271/bbb.70816; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; MCCLEARY WR, 1993, J BACTERIOL, V175, P2793, DOI 10.1128/JB.175.10.2793-2798.1993; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nohaile M, 1997, J MOL BIOL, V273, P299, DOI 10.1006/jmbi.1997.1296; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Schar J, 2005, J BACTERIOL, V187, P3100, DOI 10.1128/JB.187.9.3100-3109.2005; Schuster M, 2001, P NATL ACAD SCI USA, V98, P6003, DOI 10.1073/pnas.101571298; Simonovic M, 2001, J BIOL CHEM, V276, P28637, DOI 10.1074/jbc.C100295200; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Wemmer DE, 2005, J BACTERIOL, V187, P8229, DOI 10.1128/JB.187.24.8229-8230.2005; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Zhao HY, 2009, ACTA CRYSTALLOGR F, V65, P719, DOI 10.1107/S1744309109022696	62	45	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32325	32335		10.1074/jbc.M110.157164	http://dx.doi.org/10.1074/jbc.M110.157164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702407	Green Published, hybrid			2022-12-27	WOS:000282683000045
J	Gong, QM; Stump, MR; Dunn, AR; Deng, V; Zhou, ZF				Gong, Qiuming; Stump, Matthew R.; Dunn, A. Russell; Deng, Vivianne; Zhou, Zhengfeng			Alternative Splicing and Polyadenylation Contribute to the Generation of hERG1 C-terminal Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA POLYADENYLATION; LONG-QT SYNDROME; K+ CHANNEL; I-KR; CARDIAC-ARRHYTHMIA; POTASSIUM CHANNEL; TUMOR-CELLS; GENES; EXPRESSION; SITE	The human ether-a-go-go-related gene 1 (hERG1) encodes the pore-forming subunit of the rapidly activating delayed rectifier potassium channel. Several hERG1 isoforms with different N- and C-terminal ends have been identified. The hERG1a, hERG1b, and hERG1-3.1 isoforms contain the full-length C terminus, whereas the hERG1(USO) isoforms, hERG1a(USO) and hERG1b(USO), lack most of the C-terminal domain and contain a unique C-terminal end. The mechanisms underlying the generation of hERG1(USO) isoforms are not understood. We show that hERG1 isoforms with different C-terminal ends are generated by alternative splicing and polyadenylation of hERG1 pre-mRNA. We identified an intrinsically weak, noncanonical poly(A) signal, AGUAAA, within intron 9 of hERG1 that modulates the expression of hERG1a and hERG1a(USO). Replacing AGUAAA with the strong, canonical poly(A) signal AAUAAA resulted in the predominant production of hERG1a(USO) and a marked decrease in hERG1 current. In contrast, eliminating the intron 9 poly(A) signal or increasing the strength of 5' splice site led to the predominant production of hERG1a and a significant increase inhERG1 current. We found significant variation in the relative abundance of hERG1 C-terminal isoforms in different human tissues. Taken together, these findings suggest that post-transcriptional regulation of hERG1 pre-mRNA may represent a novel mechanism to modulate the expression and function of hERG1 channels.	[Gong, Qiuming; Stump, Matthew R.; Dunn, A. Russell; Deng, Vivianne; Zhou, Zhengfeng] Oregon Hlth & Sci Univ, Dept Med, Div Cardiovasc Med, Portland, OR 97239 USA	Oregon Health & Science University	Zhou, ZF (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhouzh@ohsu.edu			National Institutes of Health [HL-68854]; Collins Trust; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collins Trust; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-68854 (to Z. Z.) and a Collins Trust Medical grant.; Supported by an American Heart Association postdoctoral fellowship.	Aydar E, 2006, J MEMBRANE BIOL, V211, P115, DOI 10.1007/s00232-006-0010-9; Brackenridge S, 1997, NUCLEIC ACIDS RES, V25, P2326, DOI 10.1093/nar/25.12.2326; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Gong QM, 2008, J MOL CELL CARDIOL, V44, P502, DOI 10.1016/j.yjmcc.2008.01.002; Gong QM, 2007, CIRCULATION, V116, P17, DOI 10.1161/CIRCULATIONAHA.107.708818; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Iseli C, 2002, GENOME RES, V12, P1068, DOI 10.1101/gr.62002; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Larsen AP, 2010, PFLUG ARCH EUR J PHY, V460, P803, DOI 10.1007/s00424-010-0855-8; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; LeesMiller JP, 1997, CIRC RES, V81, P719; London B, 1997, CIRC RES, V81, P870; Luo XB, 2008, AM J PHYSIOL-HEART C, V294, pH1371, DOI 10.1152/ajpheart.01026.2007; Pan ZH, 2006, GENE, V366, P325, DOI 10.1016/j.gene.2005.09.024; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; Salles FJ, 1999, METH MOL B, V118, P441; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Thomas CP, 2007, FASEB J, V21, P3885, DOI 10.1096/fj.07-8809com; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Trudeau MC, 1996, SCIENCE, V272, P1087; Tseng GN, 2001, J MOL CELL CARDIOL, V33, P835, DOI 10.1006/jmcc.2000.1317; van der Putten HHAGM, 2006, J THROMB HAEMOST, V4, P2285, DOI 10.1111/j.1538-7836.2006.02102.x; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	36	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32233	32241		10.1074/jbc.M109.095695	http://dx.doi.org/10.1074/jbc.M109.095695			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693282	Green Published, hybrid			2022-12-27	WOS:000282683000036
J	Del Rizzo, PA; Couture, JF; Dirk, LMA; Strunk, BS; Roiko, MS; Brunzelle, JS; Houtz, RL; Trievel, RC				Del Rizzo, Paul A.; Couture, Jean-Francois; Dirk, Lynnette M. A.; Strunk, Bethany S.; Roiko, Marijo S.; Brunzelle, Joseph S.; Houtz, Robert L.; Trievel, Raymond C.			SET7/9 Catalytic Mutants Reveal the Role of Active Site Water Molecules in Lysine Multiple Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRODUCT SPECIFICITY; METHYLTRANSFERASE SET7/9; STRUCTURAL BASIS; MECHANISM; DYNAMICS	SET domain lysine methyltransferases (KMTs) methylate specific lysine residues in histone and non-histone substrates. These enzymes also display product specificity by catalyzing distinct degrees of methylation of the lysine epsilon-amino group. To elucidate the molecular mechanism underlying this specificity, we have characterized the Y245A and Y305F mutants of the human KMT SET7/9 (also known as KMT7) that alter its product specificity from a monomethyltransferase to a di- and a trimethyltransferase, respectively. Crystal structures of these mutants in complex with peptides bearing unmodified, mono-, di-, and trimethylated lysines illustrate the roles of active site water molecules in aligning the lysine epsilon-amino group for methyl transfer with S-adenosylmethionine. Displacement or dissociation of these solvent molecules enlarges the diameter of the active site, accommodating the increasing size of the methylated epsilon-amino group during successive methyl transfer reactions. Together, these results furnish new insights into the roles of active site water molecules in modulating lysine multiple methylation by SET domain KMTs and provide the first molecular snapshots of the mono-, di-, and trimethyl transfer reactions catalyzed by these enzymes.	[Trievel, Raymond C.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Couture, Jean-Francois] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Dirk, Lynnette M. A.; Houtz, Robert L.] Univ Kentucky, Dept Hort, Plant Physiol Biochem Mol Biol Program, Lexington, KY 40546 USA; [Brunzelle, Joseph S.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Ctr Synchrotron Res, Life Sci Collaborat Access Team, Argonne, IL 60439 USA	University of Michigan System; University of Michigan; University of Ottawa; University of Kentucky; Northwestern University	Trievel, RC (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu		Strunk, Bethany/0000-0003-2337-4614	National Institutes of Health, NIDDK [DK020572]; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; American Recovery and Reinvestment Act [R01 GM073839, GM073839-04S1]; Department of Energy [DE-FG02-92ER20075]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073839] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; American Recovery and Reinvestment Act; Department of Energy(United States Department of Energy (DOE)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge S. Schiebold for assistance in protein expression, purification, and crystallization and S. Anderson and R. Sanishvili for their assistance with x-ray data collection. We also thank S. Bulfer and S. Horowitz for reading the manuscript and providing useful comments. This work utilized the Protein Structure Facility of the Michigan Diabetes Research and Training Center, University of Michigan, supported by National Institutes of Health Grant DK020572, NIDDK. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract DE-AC02-06CH11357. GM/CA CAT has been funded in whole or in part by National Institutes of Health NCI Grant Y1-CO-1020 and NIGMS Grant Y1-GM-1104. Use of the LS-CAT Sector 21 was supported by Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor Grant 085P1000817 for the support of this research program.; This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073839 (to R. C. T.) and National Institutes of Health Administrative Supplement GM073839-04S1 (to R. C. T.) funded through the American Recovery and Reinvestment Act. This work was also supported by Department of Energy Grant DE-FG02-92ER20075 (to R. L. H.).; Supported by a Canadian Institutes of Health Research postdoctoral fellowship.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandra A, 2002, J PHYS CHEM B, V106, P6779, DOI 10.1021/jp020659m; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Couture JF, 2006, J BIOL CHEM, V281, P19280, DOI 10.1074/jbc.M602257200; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Guardia E, 2005, J MOL LIQ, V117, P63, DOI 10.1016/j.molliq.2004.08.004; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Masatsugu T, 2009, BIOCHEM BIOPH RES CO, V381, P22, DOI 10.1016/j.bbrc.2009.01.185; Morgunkova A, 2006, CELL CYCLE, V5, P1308, DOI 10.4161/cc.5.12.2820; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105; Zhang X, 2007, BIOCHEMISTRY-US, V46, P14838, DOI 10.1021/bi7014579	43	46	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31849	31858		10.1074/jbc.M110.114587	http://dx.doi.org/10.1074/jbc.M110.114587			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675860	Green Published, hybrid			2022-12-27	WOS:000282764600076
J	Ohmori, T; Kashiwakura, Y; Ishiwata, A; Madoiwa, S; Mimuro, J; Furukawa, Y; Sakata, Y				Ohmori, Tsukasa; Kashiwakura, Yuji; Ishiwata, Akira; Madoiwa, Seiji; Mimuro, Jun; Furukawa, Yusuke; Sakata, Yoichi			Vinculin Is Indispensable for Repopulation by Hematopoietic Stem Cells, Independent of Integrin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BONE-MARROW; LINKED KINASE; FETAL LIVER; N-CADHERIN; TALIN ROD; ACTIVATION; ADHESION; BINDING; NICHE	Vinculin is a highly conserved actin-binding protein that is localized in integrin-mediated focal adhesion complexes. Although critical roles have been proposed for integrins in hematopoietic stem cell (HSC) function, little is known about the involvement of intracellular focal adhesion proteins in HSC functions. This study showed that the ability of c-Kit(+)Sca1(+)Lin(-) HSCs to support reconstitution of hematopoiesis after competitive transplantation was severely impaired by lentiviral transduction with short hairpin RNA sequences for vinculin. The potential of these HSCs to differentiate into granulocytic and monocytic lineages, to migrate toward stromal cell-derived factor 1 alpha, and to home to the bone marrow in vivo were not inhibited by the loss of vinculin. However, the capacities to form long term culture-initiating cells and cobblestone-like areas were abolished in vinculin-silenced c-Kit(+)Sca1(+)Lin(-) HSCs. In contrast, adhesion to the extracellular matrix was inhibited by silencing of talin-1, but not of vinculin. Whole body in vivo luminescence analyses to detect transduced HSCs confirmed the role of vinculin in long term HSC reconstitution. Our results suggest that vinculin is an indispensable factor determining HSC repopulation capacity, independent of integrin functions.	[Sakata, Yoichi] Jichi Med Univ, Ctr Mol Med, Res Div Cell & Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Furukawa, Yusuke] Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi 3290498, Japan	Jichi Medical University; Jichi Medical University	Ohmori, T (corresponding author), Yakushiji 3311-1 Shimotsuke, Shimotsuke, Tochigi 3290498, Japan.	tohmori@jichi.ac.jp; yoisaka@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418; OHMORI, TSUKASA/0000-0001-5082-6394	Mitsubishi Pharma Research Foundation; Japanese Ministry of Education and Science; Japanese Ministry of Health, Labour and Welfare;  [20591155];  [21591249];  [21790920]	Mitsubishi Pharma Research Foundation; Japanese Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); ; ; 	This work was supported by Grants from the Mitsubishi Pharma Research Foundation; Grants-in-Aid for Scientific Research (20591155, 21591249, and 21790920) and the Support Program for Strategic Research Infrastructure from the Japanese Ministry of Education and Science; and Health, Labour and Science Research Grants for Research on HIV/AIDS and Research on Intractable Diseases from the Japanese Ministry of Health, Labour and Welfare.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Honda S, 2009, BLOOD, V113, P5304, DOI 10.1182/blood-2008-07-169136; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Nakauchi H, 2001, ANN NY ACAD SCI, V938, P18; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Ogaeri T, 2009, STEM CELLS, V27, P1120, DOI 10.1002/stem.42; OHMORI T, 2010, BIOCH BIOPH IN PRESS; Ohmori T, 2007, ARTERIOSCL THROM VAS, V27, P2266, DOI 10.1161/ATVBAHA.107.149872; Ohmori T, 2006, FASEB J, V20, P1522, DOI 10.1096/fj.05-5161fje; OKADA S, 1992, BLOOD, V80, P3044; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Prevost N, 2009, BLOOD, V113, P447, DOI 10.1182/blood-2008-06-162032; Priestley GV, 2007, BLOOD, V109, P109, DOI 10.1182/blood-2006-06-026427; Qian H, 2007, BLOOD, V110, P2399, DOI 10.1182/blood-2006-10-051276; Rawls AS, 2007, BLOOD, V110, P2414, DOI 10.1182/blood-2006-03-007112; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schwartz MA, 2009, SCIENCE, V323, P588, DOI 10.1126/science.1169414; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takizawa H, 2010, J CLIN INVEST, V120, P179, DOI 10.1172/JCI39503; Tucker KL, 2008, BLOOD, V112, P4523, DOI 10.1182/blood-2008-03-148502; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Voura EB, 1997, EXP HEMATOL, V25, P1172; Xu WM, 1998, DEVELOPMENT, V125, P327; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yokota T, 1998, BLOOD, V91, P3263, DOI 10.1182/blood.V91.9.3263.3263_3263_3272; Zamir E, 2001, J CELL SCI, V114, P3583; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	50	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31763	31773		10.1074/jbc.M109.099085	http://dx.doi.org/10.1074/jbc.M109.099085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663867	Green Published, hybrid			2022-12-27	WOS:000282764600068
J	Song, IY; Palle, K; Gurkar, A; Tateishi, S; Kupfer, GM; Vaziri, C				Song, Ihn Young; Palle, Komaraiah; Gurkar, Aditi; Tateishi, Satoshi; Kupfer, Gary M.; Vaziri, Cyrus			Rad18-mediated Translesion Synthesis of Bulky DNA Adducts Is Coupled to Activation of the Fanconi Anemia DNA Repair Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; CROSS-LINK REPAIR; HOMOLOGOUS RECOMBINATION; MONOUBIQUITINATED PCNA; REPLICATION FORKS; POLYMERASE SWITCH; DAMAGE RESPONSE; HUMAN-CELLS; Y-FAMILY; PROTEIN	Fanconi anemia (FA) is a cancer susceptibility syndrome characterized by sensitivity to DNA-damaging agents. The FA proteins (FANCs) are implicated in DNA repair, although the precise mechanisms by which FANCs process DNA lesions are not fully understood. An epistatic relationship between the FA pathway and translesion synthesis (TLS, a post-replication DNA repair mechanism) has been suggested, but the basis for cross-talk between the FA and TLS pathways is poorly understood. We show here that ectopic overexpression of the E3 ubiquitin ligase Rad18 (a central regulator of TLS) induces DNA damage-independent mono-ubiquitination of proliferating cell nuclear antigen (PCNA) (a known Rad18 substrate) and FANCD2. Conversely, DNA damage-induced mono-ubiquitination of both PCNA and FANCD2 is attenuated in Rad18-deficient cells, demonstrating that Rad18 contributes to activation of the FA pathway. WT Rad18 but not an E3 ubiquitin ligase-deficient Rad18 C28F mutant fully complements both PCNA ubiquitination and FANCD2 activation in Rad18-depleted cells. Rad18-induced mono-ubiquitination of FANCD2 is not observed in FA core complex-deficient cells, demonstrating that Rad18 E3 ligase activity alone is insufficient for FANCD2 ubiquitylation. Instead, Rad18 promotes FA core complex-dependent FANCD2 ubiquitination in a manner that is secondary to PCNA mono-ubiquitination. Taken together, these results demonstrate a novel Rad18-dependent mechanism that couples activation of the FA pathway with TLS.	[Palle, Komaraiah; Vaziri, Cyrus] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Song, Ihn Young; Gurkar, Aditi] Boston Univ, Sch Med, Grad Program Genet & Genom, Boston, MA 02118 USA; [Tateishi, Satoshi] Kumamoto Univ, Inst Mol Embryogenesis & Genet, Kumamoto 8620976, Japan; [Kupfer, Gary M.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA	University of North Carolina; University of North Carolina Chapel Hill; Boston University; Kumamoto University; Yale University	Vaziri, C (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, 614 Brinkhous Bullitt Bldg, Chapel Hill, NC 27599 USA.	cyrus_vaziri@med.unc.edu		Gurkar, Aditi/0000-0003-4338-0624	National Institutes of Health [ES09558, ES12917, R01 HL063776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009558, R01ES012917, P30ES010126, R29ES009558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES09558 and ES12917 (to C. V.) and Grant R01 HL063776 (to G. M. K.).	Adar S, 2009, NUCLEIC ACIDS RES, V37, P5737, DOI 10.1093/nar/gkp632; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Barkley LR, 2007, CELL BIOCHEM BIOPHYS, V47, P392, DOI 10.1007/s12013-007-0032-7; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Friedberg EC, 2006, MOL CELL, V22, P150, DOI 10.1016/j.molcel.2006.04.002; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gurtan AM, 2006, DNA REPAIR, V5, P1119, DOI 10.1016/j.dnarep.2006.05.009; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Howlett NG, 2009, J BIOL CHEM, V284, P28935, DOI 10.1074/jbc.M109.016352; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huttner D, 2008, CELL CYCLE, V7, P3629, DOI 10.4161/cc.7.23.7166; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; PAPADOPOULO D, 1990, PROG CLIN BIOL RES, V340, P241; PAPADOPOULO D, 1990, P NATL ACAD SCI USA, V87, P8383, DOI 10.1073/pnas.87.21.8383; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Shiomi N, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl979; Song IY, 2010, CELL CYCLE, V9, P2375, DOI 10.4161/cc.9.12.11900; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Tsuji Y, 2008, GENES CELLS, V13, P343, DOI 10.1111/j.1365-2443.2008.01176.x; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yan S, 2009, J CELL BIOL, V184, P793, DOI 10.1083/jcb.200810185; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006; Zhang J, 2008, CELL CYCLE, V7, P407, DOI 10.4161/cc.7.3.5156; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	46	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31525	31536		10.1074/jbc.M110.138206	http://dx.doi.org/10.1074/jbc.M110.138206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675655	Green Published, hybrid			2022-12-27	WOS:000282764600047
J	Alonso, AD; Di Clerico, J; Li, B; Corbo, CP; Alaniz, ME; Grundke-Iqbal, I; Iqbal, K				Alonso, Alejandra D.; Di Clerico, John; Li, Bin; Corbo, Christopher P.; Alaniz, Maria E.; Grundke-Iqbal, Inge; Iqbal, Khalid			Phosphorylation of Tau at Thr(212), Thr(231), and Ser(262) Combined Causes Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER NEUROFIBRILLARY DEGENERATION; PROTEIN-TAU; ABNORMAL PHOSPHORYLATION; MICROTUBULE-BINDING; DOWN-SYNDROME; FRONTOTEMPORAL DEMENTIA; HYPERPHOSPHORYLATED TAU; FUNCTIONAL-LINK; IN-VITRO	Abnormal hyperphosphorylation of the microtubule-associated protein Tau is a hallmark of Alzheimer disease and related diseases called tauopathies. As yet, the exact mechanism by which this pathology causes neurodegeneration is not understood. The present study provides direct evidence that Tau abnormal hyperphosphorylation causes its aggregation, breakdown of the microtubule network, and cell death and identifies phosphorylation sites involved in neurotoxicity. We generated pseudophosphorylated Tau proteins by mutating Ser/Thr to Glu and, as controls, to Ala. These mutations involved one, two, or three pathological phosphorylation sites by site-directed mutagenesis using as backbones the wild type or FTDP-17 mutant R406W Tau. Pseudophosphorylated and corresponding control Tau proteins were expressed transiently in PC12 and CHO cells. We found that a single phosphorylation site alone had little influence on the biological activity of Tau, except Thr(212), which, upon mutation to Glu in the R406W background, induced Tau aggregation in cells, suggesting phosphorylation at this site along with a modification on the C-terminal of the protein facilitates self-assembly of Tau. The expression of R406W Tau pseudophosphorylated at Thr(212), Thr(231), and Ser(262) triggered caspase-3 activation in as much as 85% of the transfected cells, whereas the corresponding value for wild type pseudophosphorylated Tau was 30%. Cells transfected with pseudophosphorylated Tau became TUNEL-positive.	[Alonso, Alejandra D.; Corbo, Christopher P.; Alaniz, Maria E.] CUNY Coll Staten Isl, Dept Biol, Staten Isl, NY 10314 USA; [Alonso, Alejandra D.; Corbo, Christopher P.; Alaniz, Maria E.] CUNY Coll Staten Isl, Ctr Dev Neurosci, Staten Isl, NY 10314 USA; [Alonso, Alejandra D.; Corbo, Christopher P.; Alaniz, Maria E.] CUNY, Staten Isl, NY USA; [Di Clerico, John; Li, Bin; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA	City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; Institute for Basic Research in Developmental Disabilities	Alonso, AD (corresponding author), CUNY Coll Staten Isl, Dept Biol, 2800 Victory Blvd, Staten Isl, NY 10314 USA.	Alejandra.Alonso@csi.cuny.edu			National Institutes of Health [AG019158, AG028538, R15AG034524-01]; New York State Office of Mental Retardation and Developmental Disabilities; Alzheimer's Association (Chicago, IL) [IIRG-06-25836, IIRG-09-133206]; Professional Staff Congress-City University of New York [62909-00 40, 80209-0416]; NATIONAL INSTITUTE ON AGING [R01AG028538, R01AG019158, R15AG034524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office of Mental Retardation and Developmental Disabilities; Alzheimer's Association (Chicago, IL)(Alzheimer's Association); Professional Staff Congress-City University of New York; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG019158 and AG028538 (to K. I.) and R15AG034524-01 (to A. D. A.). This work was also supported by the New York State Office of Mental Retardation and Developmental Disabilities; Alzheimer's Association (Chicago, IL) Grants IIRG-06-25836 (to K. I.) and IIRG-09-133206 (to A. D. A.); and Professional Staff Congress-City University of New York Research Award 62909-00 40 (to A. D. A.) and 80209-0416 (to A. D. A.).	Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; ALONSO AD, 1995, MOL BRAIN RES, V31, P194, DOI 10.1016/0169-328X(95)00051-S; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2001, J BIOL CHEM, V276, P37967; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alonso AD, 2008, CURR ALZHEIMER RES, V5, P375, DOI 10.2174/156720508785132307; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRADY RM, 1995, NEUROBIOL AGING, V16, P479; BRANDT R, 1994, J BIOL CHEM, V269, P11776; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Fath T, 2002, J NEUROSCI, V22, P9733; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; HUNDELT M, 2009, NEUROBIOL A IN PRESS; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jenkins SM, 1997, BRAIN RES, V767, P305, DOI 10.1016/S0006-8993(97)00615-X; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KREMER L, 1988, ANAL BIOCHEM, V175, P91, DOI 10.1016/0003-2697(88)90365-X; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leschik J, 2007, J NEUROCHEM, V101, P1303, DOI 10.1111/j.1471-4159.2006.04435.x; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Necula M, 2004, J BIOL CHEM, V279, P49694, DOI 10.1074/jbc.M405527200; Perez M, 1996, J NEUROCHEM, V67, P1183; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Santa-Maria I, 2005, BBA-MOL BASIS DIS, V1740, P472, DOI 10.1016/j.bbadis.2004.11.024; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Sengupta A, 2006, NEUROCHEM RES, V31, P1473, DOI 10.1007/s11064-006-9205-9; Singh TJ, 1996, FEBS LETT, V387, P145, DOI 10.1016/0014-5793(96)00485-1; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Tatebayashi Y, 1999, J NEUROSCI, V19, P5245; Vandebroek T, 2005, BIOCHEMISTRY-US, V44, P11466, DOI 10.1021/bi0506775; Wai MSM, 2009, BIOGERONTOLOGY, V10, P457, DOI 10.1007/s10522-008-9189-8; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Zhou LX, 2006, BIOCHEM BIOPH RES CO, V348, P637, DOI 10.1016/j.bbrc.2006.07.099	59	140	148	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30851	30860		10.1074/jbc.M110.110957	http://dx.doi.org/10.1074/jbc.M110.110957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663882	hybrid, Green Published			2022-12-27	WOS:000282135500052
J	Kamiya, Y; Miyazono, K; Miyazawa, K				Kamiya, Yuto; Miyazono, Kohei; Miyazawa, Keiji			Smad7 Inhibits Transforming Growth Factor-beta Family Type I Receptors through Two Distinct Modes of Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEIN RECEPTORS; SPECIFICITY; DOMAIN; ROLES; IDENTIFICATION; ANTAGONIST; PATHWAYS; ELEMENTS; SMURF1; MAD	The inhibitory Smads (I-Smads), i.e. Smad6 and Smad7, are negative regulators of transforming growth factor-beta (TGF-beta) family signaling. I-Smads inhibit TGF-beta family signaling principally through physical interaction with type I receptors (activin receptor-like kinases), so as to compete with receptor-regulated Smads (R-Smads) for activation. However, how I-Smads interact with type I receptors is not well understood. In the present study, we found that Smad7 has two modes of interaction with type I receptors. One is through a three-finger-like structure in the MH2 domain, consisting of residues 331-361, 379-387, and the L3 loop. The other is through a basic groove in the MH2 domain (Mochizuki, T., Miyazaki, H., Hara, T., Furuya, T., Imamura, T., Watabe, T., and Miyazono, K. (2004) J. Biol. Chem. 279, 31568-31574). We also found that Smad6 principally utilizes a basic groove in the MH2 domain for interaction with type I receptors. Smad7 thus has an additional mode of interaction with TGF-beta family type I receptors not possessed by Smad6, which may play roles in mediating the inhibitory effects unique to Smad7.	[Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan; Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan	University of Yamanashi; University of Tokyo	Miyazawa, K (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan.	keiji-miyazawa@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014		KAKENHI; Ministry of Education, Culture, Sports, Science, and Technology of Japan	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by KAKENHI Grants-in-aid for Scientific Research and the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kamiya Y, 2008, FEBS LETT, V582, P2496, DOI 10.1016/j.febslet.2008.05.052; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; NAKAO A, 2006, SMAD SIGNAL TRANSDUC, P379; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; RAFTERY LA, 2006, SMAD SIGNAL TRANSDUC, P55, DOI DOI 10.1007/1-4020-4709-6_3; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	32	47	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30804	30813		10.1074/jbc.M110.166140	http://dx.doi.org/10.1074/jbc.M110.166140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663871	Green Published, hybrid			2022-12-27	WOS:000282135500048
J	Li, MJ; Yin, YC; Hua, H; Sun, XM; Luo, T; Wang, JA; Jiang, YF				Li, Minjing; Yin, Yancun; Hua, Hui; Sun, Xiangming; Luo, Ting; Wang, Jiao; Jiang, Yangfu			The Reciprocal Regulation of gamma-Synuclein and IGF-I Receptor Expression Creates a Circuit That Modulates IGF-I Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; CANCER-CELL-SURVIVAL; HUMAN BREAST-CANCER; GENE CPG ISLAND; COLORECTAL-CANCER; PROSTATE-CANCER; PLASMA-LEVELS; COLON-CANCER; INSULIN; METASTASIS	Insulin-like growth factor (IGF) system plays important roles in carcinogenesis and maintenance of the malignant phenotype. Signaling through the IGF-I receptor (IGF-IR) has been shown to stimulate the growth and motility of a wide range of cancer cells. gamma-Synuclein (SNCG) is primarily expressed in peripheral neurons but also overexpressed in various cancer cells. Overexpression of SNCG correlates with tumor progression. In the present study we demonstrated a reciprocal regulation of IGF-I signaling and SNCG expression. IGF-I induced SNCG expression in various cancer cells. IGF-IR knockdown or IGF-IR inhibitor repressed SNCG expression. Both phosphatidylinositol 3-kinase and mitogen-activated protein kinase were involved in IGF-I induction of SNCG expression. Interestingly, SNCG knockdown led to proteasomal degradation of IGF-IR, thereby decreasing the steady-state levels of IGF-IR. Silencing of SNCG resulted in a decrease in ligand-induced phosphorylation of IGF-IR and its downstream signaling components, including insulin receptor substrate (IRS), Akt, and ERK1/2. Strikingly, SNCG physically interacted with IGF-IR and IRS-2. Silencing of IRS-2 impaired the interaction between SNCG and IGF-IR. Finally, SNCG knockdown suppressed IGF-I-induced cell proliferation and migration. These data reveal that SNCG and IGF-IR are mutually regulated by each other. SNCG blockade may suppress IGF-I-induced cell proliferation and migration. Conversely, IGF-IR inhibitors may be of utility in suppressing the aberrant expression of SNCG in cancer cells and thereby block its pro-tumor effects.	[Jiang, Yangfu] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Sect Signal Transduct & Mol Targeted Therapy, Chengdu 610041, Peoples R China; [Luo, Ting] Sichuan Univ, W China Hosp, Ctr Canc, Chengdu 610041, Peoples R China; [Wang, Jiao] Chengdu Univ Tradit Chinese Med, Sch Basic Med, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University; Chengdu University of Traditional Chinese Medicine	Jiang, YF (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Sect Signal Transduct & Mol Targeted Therapy, Chengdu 610041, Peoples R China.	jyangfu@scu.edu.cn	Jiang, Yangfu/AAX-2645-2020	Jiang, Yangfu/0000-0002-8696-2651; Yin, Yancun/0000-0003-2755-9595; Li, Minjing/0000-0001-9276-4654	National Natural Science Foundation of China [30672360]; Sichuan Science and Technology Program [2007Q14-036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science and Technology Program	This work was supported by National Natural Science Foundation of China Grant 30672360 and the Sichuan Science and Technology Program (2007Q14-036).	Bach LA, 1995, DIABETES REV, V3, P38; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; CHIOU ST, 1992, BIOCHEM BIOPH RES CO, V183, P524, DOI 10.1016/0006-291X(92)90513-K; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Dunn SE, 1998, CANCER RES, V58, P3353; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Grey A, 2003, ENDOCRINOLOGY, V144, P4886, DOI 10.1210/en.2003-0350; Guo J, 2007, INT J CANCER, V121, P1296, DOI 10.1002/ijc.22763; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Gupta A, 2003, CANCER RES, V63, P664; Hakam A, 1999, HUM PATHOL, V30, P1128, DOI 10.1016/S0046-8177(99)90027-8; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hellawell GO, 2002, CANCER RES, V62, P2942; Hibi T, 2009, CLIN CANCER RES, V15, P2864, DOI 10.1158/1078-0432.CCR-08-2946; Hu H, 2009, CLIN CANCER RES, V15, P5485, DOI 10.1158/1078-0432.CCR-08-2491; Hua H, 2009, J PATHOL, V217, P507, DOI 10.1002/path.2465; ISAKSSON OGP, 1987, ENDOCR REV, V8, P426, DOI 10.1210/edrv-8-4-426; Ji HJ, 1997, CANCER RES, V57, P759; Jia TL, 1999, CANCER RES, V59, P742; Jiang YF, 2003, CANCER RES, V63, P3899; Jiang YF, 2004, CANCER RES, V64, P4539, DOI 10.1158/0008-5472.CAN-03-3650; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Liu HY, 2005, CANCER RES, V65, P7635, DOI 10.1158/0008-5472.CAN-05-1089; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; LUND PK, 1986, J BIOL CHEM, V261, P4539; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; MONNIER D, 1994, MOL CELL ENDOCRINOL, V104, P139, DOI 10.1016/0303-7207(94)90116-3; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Pan ZZ, 2006, INT J ONCOL, V29, P1201; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; PEYRAT JP, 1993, EUR J CANCER, V29A, P492, DOI 10.1016/S0959-8049(05)80137-6; PRAGER D, 1994, P NATL ACAD SCI USA, V91, P2181, DOI 10.1073/pnas.91.6.2181; Reinmuth N, 2002, LAB INVEST, V82, P1377, DOI 10.1097/01.LAB.0000032411.41603.C2; Resnik JL, 1998, CANCER RES, V58, P1159; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Shen JJ, 2007, MOL CARCINOGEN, V46, P331, DOI 10.1002/mc.20256; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Valverde AM, 1998, MOL ENDOCRINOL, V12, P688, DOI 10.1210/me.12.5.688; Wu YP, 2002, CANCER RES, V62, P1030; Yanagawa N, 2004, CLIN CANCER RES, V10, P2447, DOI 10.1158/1078-0432.CCR-03-0107; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zhang XH, 2000, BREAST CANCER RES, V2, P170, DOI 10.1186/bcr50; Zhao W, 2006, INT J ONCOL, V28, P1081	52	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30480	30488		10.1074/jbc.M110.131698	http://dx.doi.org/10.1074/jbc.M110.131698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20670935	Green Published, hybrid			2022-12-27	WOS:000282135500015
J	Prevost, M; Vertongen, P; Raussens, V; Roberts, DJ; Cnudde, J; Perret, J; Waelbroeck, M				Prevost, Martine; Vertongen, Pascale; Raussens, Vincent; Roberts, David Jonathan; Cnudde, Johnny; Perret, Jason; Waelbroeck, Magali			Mutational and Cysteine Scanning Analysis of the Glucagon Receptor N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; 1ST-EXTRACELLULAR DOMAIN; MOLECULAR RECOGNITION; EXTRACELLULAR DOMAIN; BINDING-SITE; RESIDUES; SECRETIN; HORMONE	The glucagon receptor belongs to the B family of G-protein coupled receptors. Little structural information is available about this receptor and its association with glucagon. We used the substituted cysteine accessibility method and three-dimensional molecular modeling based on the gastrointestinal insulinotropic peptide and glucagon-like peptide 1 receptor structures to study the N-terminal domain of this receptor, a central element for ligand binding and specificity. Our results showed that Asp(63), Arg(116), and Lys(98) are essential for the receptor structure and/or ligand binding because mutations of these three residues completely disrupted or markedly impaired the receptor function. In agreement with these data, our models revealed that Asp(63) and Arg(116) form a salt bridge, whereas Lys(98) is engaged in cation-pi interactions with the conserved tryptophans 68 and 106. The native receptor could not be labeled by hydrophilic cysteine biotinylation reagents, but treatment of intact cells with [2-(trimethylammonium)ethyl]methanethiosulfonate increased the glucagon binding site density. This result suggested that an unidentified protein with at least one free cysteine associated with the receptor prevented glucagon recognition and that [2-(trimethylammonium)ethyl]methanethiosulfonate treatment relieved this inhibition. The substituted cysteine accessibility method was also performed on 15 residues selected using the three-dimensional models. Several receptor mutants, despite a relatively high predicted cysteine accessibility, could not be labeled by specific reagents. The three-dimensional models show that these mutated residues are located on one face of the protein. This could be part of the interface between the receptor and the unidentified inhibitory protein, making these residues inaccessible to biotinylation compounds.	[Waelbroeck, Magali] Univ Libre Bruxelles, Lab Chim Biol & Nutr, Fac Med, B-1070 Brussels, Belgium; Univ Libre Bruxelles, Lab Struct & Fonct Membranes Biol, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Waelbroeck, M (corresponding author), Univ Libre Bruxelles, Lab Chim Biol & Nutr, Fac Med, 808 Route Lennik CP611, B-1070 Brussels, Belgium.	mawaelbr@ulb.ac.be			Fonds de la Recherche Scientifique Medicale [3.4541.03]; Communaute Francaise de Belgique	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique(Australian Research Council)	This work was supported by Fonds de la Recherche Scientifique Medicale Grant 3.4541.03 and by an "Action de Recherche Concertee" from the Communaute Francaise de Belgique.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Authier F, 2008, CELL MOL LIFE SCI, V65, P1880, DOI 10.1007/s00018-008-7479-6; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Javitch JA, 1998, METHOD ENZYMOL, V296, P331; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kusano S, 2008, PROTEIN SCI, V17, P1907, DOI 10.1110/ps.036012.108; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Morfis M, 2003, TRENDS PHARMACOL SCI, V24, P596, DOI 10.1016/j.tips.2003.09.001; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perret J, 2002, BIOCHEM J, V362, P389, DOI 10.1042/0264-6021:3620389; Perrin MH, 2007, J BIOL CHEM, V282, P37529, DOI 10.1074/jbc.M703748200; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SAVAGE MD, 1992, AVIDIN BOTIN CHEM HD, P273; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilardaga JP, 1997, EUR J BIOCHEM, V246, P173, DOI 10.1111/j.1432-1033.1997.00173.x; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565	35	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30951	30958		10.1074/jbc.M110.102814	http://dx.doi.org/10.1074/jbc.M110.102814			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20647307	Green Published, hybrid			2022-12-27	WOS:000282135500060
J	Clark, SJ; Perveen, R; Hakobyan, S; Morgan, BP; Sim, RB; Bishop, PN; Day, AJ				Clark, Simon J.; Perveen, Rahat; Hakobyan, Svetlana; Morgan, B. Paul; Sim, Robert B.; Bishop, Paul N.; Day, Anthony J.			Impaired Binding of the Age-related Macular Degeneration-associated Complement Factor H 402H Allotype to Bruch's Membrane in Human Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; DISEASE-ASSOCIATED FORM; AMINO-ACID SEQUENCE; HEPARIN; POLYMORPHISM; RECOGNITION; VARIANT; SITE; IDENTIFICATION; LOCALIZATION	Age-related macular degeneration (AMD) is the predominant cause of blindness in the industrialized world where destruction of the macula, i.e. the central region of the retina, results in loss of vision. AMD is preceded by the formation of deposits in the macula, which accumulate between the Bruch's membrane and the retinal pigment epithelium (RPE). These deposits are associated with complement-mediated inflammation and perturb retinal function. Recent genetic association studies have demonstrated that a common allele (402H) of the complement factor H (CFH) gene is a major risk factor for the development of AMD; CFH suppresses complement activation on host tissues where it is believed to bind via its interaction with polyanionic structures. We have shown previously that this coding change (Y402H; from a tyrosine to histidine residue) alters the binding of the CFH protein to sulfated polysaccharides. Here we demonstrate that the AMD-associated polymorphism profoundly affects CFH binding to sites within human macula. Notably, the AMD-associated 402H variant binds less well to heparan sulfate and dermatan sulfate glycosaminoglycans within Bruch's membrane when compared with the 402Y form; both allotypes exhibit a similar level of binding to the RPE. We propose that the impaired binding of the 402H variant to Bruch's membrane results in an overactivation of the complement pathway leading to local chronic inflammation and thus contributes directly to the development and/or progression of AMD. These studies therefore provide a putative disease mechanism and add weight to the genetic association studies that implicate the 402H allele as an important risk factor in AMD.	[Clark, Simon J.; Bishop, Paul N.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Perveen, Rahat; Bishop, Paul N.] Univ Manchester, Sch Biomed, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Perveen, Rahat; Bishop, Paul N.] Cent Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Hakobyan, Svetlana; Morgan, B. Paul] Cardiff Univ, Complement Biol Grp, Dept Med Biochem & Immunol, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Sim, Robert B.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Manchester; University of Manchester; University of Manchester; Cardiff University; University of Oxford	Bishop, PN (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	paul.n.bishop@manchester.ac.uk; anthony.day@manchester.ac.uk	Day, Anthony/O-1658-2015; Sim, Bob/A-1354-2008	Day, Anthony/0000-0002-1415-3134; Sim, Bob/0000-0002-2855-7455; Bishop, Paul/0000-0001-7937-7932; Clark, Simon/0000-0001-8394-8355; Morgan, Paul/0000-0003-4075-7676	Macular Disease Society, Medical Research Council [G0900592]; University of Manchester Intellectual Property Ltd.; Manchester National Institute for Health Research Biomedical Research Centre; Biotechnology and Biological Sciences Research Council; Wellcome Trust; University of Manchester; Medical Research Council [G0900538] Funding Source: researchfish; MRC [G0900538] Funding Source: UKRI	Macular Disease Society, Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Manchester Intellectual Property Ltd.; Manchester National Institute for Health Research Biomedical Research Centre; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Macular Disease Society, Medical Research Council (Grant G0900592), University of Manchester Intellectual Property Ltd., and Manchester National Institute for Health Research Biomedical Research Centre.; We thank Dr. I. Zambrano and colleagues at the Manchester Royal Eye Hospital Eye Bank for supplying donor eye tissue used in this study, Dr. Barbara Mulloy (National Institute for Biological Standards and Control) for supplying heparin and DS glycosaminoglycans and Jane Knott for help with the microscopy. We also thank Prof. John Gallagher for discussion and advice on technical aspects of the research project. The Bioimaging Facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, Wellcome Trust, and University of Manchester Strategic Fund.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Barlow PN, 2008, ADV EXP MED BIOL, V632, P117, DOI 10.1007/978-0-387-78952-1_10; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; CALL TW, 1990, EXP EYE RES, V51, P451, DOI 10.1016/0014-4835(90)90158-Q; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; CLARK SJ, 2010, BIOCH SOC T IN PRESS; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; DAY AJ, 1988, IMMUNOGENETICS, V27, P211, DOI 10.1007/BF00346588; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Haapasalo K, 2008, MOL MICROBIOL, V70, P583, DOI 10.1111/j.1365-2958.2008.06347.x; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; KAZATCHKINE MD, 1979, J EXP MED, V150, P1202, DOI 10.1084/jem.150.5.1202; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Montes T, 2009, P NATL ACAD SCI USA, V106, P4366, DOI 10.1073/pnas.0812584106; MULLOY B, 1994, CARBOHYD RES, V255, P1, DOI 10.1016/S0008-6215(00)90968-6; Mulloy B, 2000, THROMB HAEMOSTASIS, V84, P1052; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; SIM E, 1983, BIOSCIENCE REP, V3, P1119, DOI 10.1007/BF01120205; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200	39	137	139	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30192	30202		10.1074/jbc.M110.103986	http://dx.doi.org/10.1074/jbc.M110.103986			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20660596	Green Published, hybrid			2022-12-27	WOS:000281984300056
J	Jiang, M; Chen, MJ; Guo, ZF; Guo, ZH				Jiang, Ming; Chen, Minjiao; Guo, Zu-Feng; Guo, Zhihong			A Bicarbonate Cofactor Modulates 1,4-Dihydroxy-2-naphthoyl-Coenzyme A Synthase in Menaquinone Biosynthesis of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIMETHYLAMINE N-OXIDE; ENOYL-COA HYDRATASE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; NAPHTHOATE SYNTHASE; ANGSTROM RESOLUTION; ADENYLYL-CYCLASE; PHOTOSYSTEM-II; QUINONE POOL; VITAMIN-K	1,4-Dihydroxy-2-naphthoyl coenzyme A (DHNA-CoA) synthase is a typical crotonase-fold protein catalyzing an intramolecular Claisen condensation in the menaquinone biosynthetic pathway. We have characterized this enzyme from Escherichia coli and found that it is activated by bicarbonate in a concentration-dependent manner. The bicarbonate binding site has been identified in the crystal structure of a virtually identical ortholog (96.8% sequence identity) from Salmonella typhimurium through comparison with a bicarbonate-insensitive orthologue. Kinetic properties of the enzyme and its site-directed mutants of the bicarbonate binding site indicate that the exogenous bicarbonate anion is essential to the enzyme activity. With this essential catalytic role, the simple bicarbonate anion is an enzyme cofactor, which is usually a small organic molecule derived from vitamins, a metal ion, or a metal-containing polyatomic anionic complex. This finding leads to classification of the DHNA-CoA synthases into two evolutionarily conserved subfamilies: type I enzymes that are bicarbonate-dependent and contain a conserved glycine at the bicarbonate binding site; and type II enzymes that are bicarbonate-independent and contain a conserved aspartate at the position similar to the enzyme-bound bicarbonate. In addition, the unique location of the enzyme-bound bicarbonate allows it to be proposed as a catalytic base responsible for abstraction of the alpha-proton of the thioester substrate in the enzymatic reaction, suggesting a unified catalytic mechanism for all DHNA-CoA synthases.	[Jiang, Ming; Chen, Minjiao; Guo, Zu-Feng; Guo, Zhihong] Hong Kong Univ Sci & Technol, Dept Chem, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Guo, ZH (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	chguo@ust.hk	guo, zufeng/C-8035-2011; Chen, Minjiao/A-8117-2012	guo, zufeng/0000-0002-4370-9445; Guo, Zhihong/0000-0003-0374-8412	Research Grants Council of the Hong Kong Special Administrative Region of the People's Republic of China [GRF601209]	Research Grants Council of the Hong Kong Special Administrative Region of the People's Republic of China(Hong Kong Research Grants Council)	This work was supported by the Research Grants Council of the Hong Kong Special Administrative Region of the People's Republic of China (Grant GRF601209).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; Bugel S, 2008, VITAM HORM, V78, P393, DOI 10.1016/S0083-6729(07)00016-7; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cronk JD, 2006, BIOCHEMISTRY-US, V45, P4351, DOI 10.1021/bi052272q; DeLano W.L, PYMOL MOL GRAPHICS S; DORDINE RL, 1994, BIOCHEMISTRY-US, V33, P14733, DOI 10.1021/bi00253a011; Dosselaere F, 2001, CRIT REV MICROBIOL, V27, P75, DOI 10.1080/20014091096710; DOWD P, 1995, ANNU REV NUTR, V15, P419, DOI 10.1146/annurev.nu.15.070195.002223; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; FERNANDEZ F, 1985, BIOCHEM SOC T, V13, P223, DOI 10.1042/bst0130223; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Glasner ME, 2006, J MOL BIOL, V360, P228, DOI 10.1016/j.jmb.2006.04.055; Gross J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-117; Hernandez-Guillamon M, 2007, J BIOCHEM, V142, P571, DOI 10.1093/jb/mvm165; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; IGBAVBOA U, 1990, EUR J BIOCHEM, V192, P441, DOI 10.1111/j.1432-1033.1990.tb19246.x; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, ORG LETT, V9, P4765, DOI 10.1021/ol702126m; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Johnston JM, 2005, ACTA CRYSTALLOGR D, V61, P1199, DOI [10.1107/s0907444905017531, 10.1107/S0904777905017531]; Jones R. W., 1982, FUNCTION QUINONES EN, P465; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; Kurosu M, 2007, J MED CHEM, V50, P3973, DOI 10.1021/jm070638m; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefebvre-Legendre L, 2007, J BIOL CHEM, V282, P13250, DOI 10.1074/jbc.M610249200; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lu XQ, 2008, BIOORG MED CHEM LETT, V18, P5963, DOI 10.1016/j.bmcl.2008.07.130; Meganathan R, 2001, VITAM HORM, V61, P173; Meganathan R., 1996, ESCHERICHIA COLI SAL, P642; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; MULLERNEWEN G, 1995, EUR J BIOCHEM, V228, P68, DOI 10.1111/j.1432-1033.1995.tb20230.x; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; POLGLASE WJ, 1966, BIOCHIM BIOPHYS ACTA, V118, P425, DOI 10.1016/S0926-6593(66)80053-X; REPASKE R, 1978, J BACTERIOL, V135, P1162, DOI 10.1128/JB.135.3.1162-1164.1978; Seto H, 2008, J AM CHEM SOC, V130, P5614, DOI 10.1021/ja710207s; Shanahan CM, 1998, CRIT REV EUKAR GENE, V8, P357, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.60; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Shevela D, 2008, BBA-BIOENERGETICS, V1777, P532, DOI 10.1016/j.bbabio.2008.03.031; Shevela D, 2007, PHOTOSYNTH RES, V94, P247, DOI 10.1007/s11120-007-9200-2; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Strater N, 1999, P NATL ACAD SCI USA, V96, P11151, DOI 10.1073/pnas.96.20.11151; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; SUTTIE JW, 1995, ANNU REV NUTR, V15, P399, DOI 10.1146/annurev.nu.15.070195.002151; Truglio JJ, 2003, J BIOL CHEM, V278, P42352, DOI 10.1074/jbc.M307399200; Ulaganathan V, 2007, ACTA CRYSTALLOGR F, V63, P908, DOI 10.1107/S1744309107047720; Ulas G, 2008, BIOCHEMISTRY-US, V47, P3073, DOI 10.1021/bi8000424; UNDEN G, 1988, ARCH MICROBIOL, V150, P499, DOI 10.1007/BF00422294; Watsuji TO, 2006, BIOSCI BIOTECH BIOCH, V70, P753, DOI 10.1271/bbb.70.753; Widhalm JR, 2009, P NATL ACAD SCI USA, V106, P5599, DOI 10.1073/pnas.0900738106; WISSENBACH U, 1990, ARCH MICROBIOL, V154, P60; WISSENBACH U, 1992, ARCH MICROBIOL, V158, P68, DOI 10.1007/BF00249068	58	18	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30159	30169		10.1074/jbc.M110.147702	http://dx.doi.org/10.1074/jbc.M110.147702			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20643650	hybrid, Green Published			2022-12-27	WOS:000281984300053
J	Lee, SY; Lau, ATY; Jeong, CH; Shim, JH; Kim, HG; Kim, J; Bode, AM; Dong, ZG				Lee, Sung-Young; Lau, Andy T. Y.; Jeong, Chul-Ho; Shim, Jung-Hyun; Kim, Hong-Gyum; Kim, Jaebong; Bode, Ann M.; Dong, Zigang			Histone XH2AX Is Required for Xenopus Anterior Neural Development CRITICAL ROLE OF THREONINE 16 PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL MARGINAL ZONE; DNA-DAMAGE; CHROMATIN MODIFICATIONS; CHK1; METHYLATION; H2AX; SPECIFICATION; TRANSCRIPTION; REPLICATION; KINASES	A role for histone H2AX, one of the variants of the nucleosome core histone H2A, has been demonstrated in DNA repair, tumor suppression, apoptosis, and cell cycle checkpoint function. However, the physiological function and post-translational modification of histone H2AX during vertebrate development have not been elucidated. Here, we provide evidence showing that Xenopus histone H2AX (XH2AX) has a role in the anterior neural plate for eye field formation during Xenopus embryogenesis. A loss-of-function study clearly demonstrated a critical role of XH2AX in anterior neural specification. Through a differentiation assay with Xenopus animal cap embryonic stem cells, we confirmed that XH2AX is required for the activin-induced anterior neural specification of the ectoderm. Furthermore, we found that Chk1 is an essential kinase to phosphorylate histone XH2AX at Thr(16), which is involved in the biological function of this histone. Taken together, our findings reveal that XH2AX has a specific role in anterior neural formation of Xenopus, which is mediated through phosphorylation of XH2AX at Thr(16) by Chk1.	[Lee, Sung-Young; Lau, Andy T. Y.; Jeong, Chul-Ho; Shim, Jung-Hyun; Kim, Hong-Gyum; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Kim, Jaebong] Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea	University of Minnesota System; Hallym University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Lau, Andy Tao Yin/AAX-9980-2021; Kim, Jaebong/AAV-1986-2021	Lau, Andy Tao Yin/0000-0002-7146-7789; Kim, Jaebong/0000-0003-1609-338X; Shim, Jung-Hyun/0000-0002-4062-4016	National Institutes of Health [CA077646, CA111536, CA120388, R37 CA081064, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA120388, R37CA081064, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, CA111536, CA120388, R37 CA081064, and ES016548.; This work was also supported by The Hormel Foundation.	ARIIZUMI T, 2009, CURR PROTOC STEM CEL, pCH1; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; EYAL-GILADI H., 1954, ARCH BIOL [PARIS], V65, P179; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Grant PA, 2001, GENOME BIOL, V2; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Green JBA, 1997, P NATL ACAD SCI USA, V94, P8596, DOI 10.1073/pnas.94.16.8596; Hadnagy A, 2008, MOL CANCER THER, V7, P740, DOI 10.1158/1535-7163.MCT-07-2284; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Iouzalen N, 1996, NUCLEIC ACIDS RES, V24, P3947, DOI 10.1093/nar/24.20.3947; ISENBERG I, 1979, ANNU REV BIOCHEM, V48, P159, DOI 10.1146/annurev.bi.48.070179.001111; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Lupo G, 2000, INT J DEV BIOL, V44, P627; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Papan C, 2007, DEV BIOL, V305, P161, DOI 10.1016/j.ydbio.2007.02.005; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Ruiz i Altaba A, 1989, Nature, V341, P33; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; SHIH J, 1992, DEVELOPMENT, V116, P887; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Takai H, 2000, GENE DEV, V14, P1439; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Vermaak D, 1998, CURR BIOL, V8, P533, DOI 10.1016/S0960-9822(98)70206-4; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wuebbles RD, 2004, CELL MOL LIFE SCI, V61, P2148, DOI 10.1007/s00018-004-4175-z; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu RH, 1996, P NATL ACAD SCI USA, V93, P834, DOI 10.1073/pnas.93.2.834; Zaid O, 2005, CELL MOL LIFE SCI, V62, P1653, DOI 10.1007/s00018-005-5091-6; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	47	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29525	29534		10.1074/jbc.M110.127233	http://dx.doi.org/10.1074/jbc.M110.127233			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639511	Green Published, hybrid			2022-12-27	WOS:000281740100054
J	Martinez, GJ; Zhang, ZM; Reynolds, JM; Tanaka, S; Chung, Y; Liu, T; Robertson, E; Lin, X; Feng, XH; Dong, C				Martinez, Gustavo J.; Zhang, Zhengmao; Reynolds, Joseph M.; Tanaka, Shinya; Chung, Yeonseok; Liu, Ting; Robertson, Elizabeth; Lin, Xia; Feng, Xin-Hua; Dong, Chen			Smad2 Positively Regulates the Generation of Th17 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; T-CELLS; TRANSCRIPTION	Development of Foxp3(+) regulatory T cells and pro-inflammatory Th17 cells from naive CD4(+) T cells requires transforming growth factor-beta (TGF-beta) signaling. Although Smad4 and Smad3 have been previously shown to regulate Treg cell induction by TGF-beta, they are not required in the development of Th17 cells. Thus, how TGF-beta regulates Th17 cell differentiation remains unclear. In this study, we found that TGF-beta-induced Foxp3 expression was significantly reduced in the absence of Smad2. More importantly, Smad2 deficiency led to reduced Th17 differentiation in vitro and in vivo. In the experimental autoimmune encephalomyelitis model, Smad2 deficiency in T cells significantly ameliorated disease severity and reduced generation of Th17 cells. Furthermore, we found that Smad2 associated with retinoid acid receptor-related orphan receptor-gamma t (ROR gamma t) and enhanced ROR gamma t-induced Th17 cell generation. These results demonstrate that Smad2 positively regulates the generation of inflammatory Th17 cells.	[Zhang, Zhengmao; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Martinez, Gustavo J.; Reynolds, Joseph M.; Dong, Chen] Univ Texas Hlth Sci Ctr,Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Martinez, Gustavo J.; Reynolds, Joseph M.; Dong, Chen] Univ Texas Hlth Sci Ctr,Houston, MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77030 USA; [Martinez, Gustavo J.; Dong, Chen] Univ Texas Hlth Sci Ctr,Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Zhang, Zhengmao; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Liu, Ting; Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Robertson, Elizabeth] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Zhejiang University; University of Oxford	Feng, XH (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	xfeng@bcm.edu; cdong@mdanderson.org	Tanaka, Shinya/AAO-8771-2021; Tanaka, Shinya/D-3586-2011; Huang, Xiaoyan/N-2561-2014; Zhang, Zhengmao/C-4566-2014; dong, chen/B-3181-2009	Tanaka, Shinya/0000-0001-6470-3301; Zhang, Zhengmao/0000-0002-7968-9968; dong, chen/0000-0002-0084-9130; Reynolds, Joseph/0000-0003-3490-0544; ZHANG, ZHENGMAO/0000-0003-4035-0331; Chung, Yeonseok/0000-0001-5780-4841; Martinez, Gustavo/0000-0003-0178-3329	National Institutes of Health [RO1AR050772, RO1AR053591, RO1GM063773, RO1CA108454]; Fundamental Research Funds for the Central Universities [RC2AR059010]; NCI; Schissler Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR059010, R01AR053591, R01AR050772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Schissler Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants RO1AR050772 (to C. D.), RO1AR053591, RO1GM063773, and RO1CA108454 and the Fundamental Research Funds for the Central Universities (to X.-H. F.), and RC2AR059010 (to C. D. and X.-H. F.), and a T32 training grant from NCI (to J. M. R.). This work was also supported by the Schissler Foundation Fellowship in cancer research (to G. J. M.).	Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Heikkinen PT, 2010, J BIOL CHEM, V285, P3740, DOI 10.1074/jbc.M109.042978; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Wing K, 2006, INT IMMUNOL, V18, P991, DOI 10.1093/intimm/dxl044; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	20	70	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29039	29043		10.1074/jbc.C110.155820	http://dx.doi.org/10.1074/jbc.C110.155820			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20667820	Green Published, hybrid			2022-12-27	WOS:000281740100003
J	Bateman, AC; Karamanska, R; Busch, MG; Dell, A; Olsen, CW; Haslam, SM				Bateman, Allen C.; Karamanska, Rositsa; Busch, Marc G.; Dell, Anne; Olsen, Christopher W.; Haslam, Stuart M.			Glycan Analysis and Influenza A Virus Infection of Primary Swine Respiratory Epithelial Cells THE IMPORTANCE OF NeuAc alpha 2-6 GLYCANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOLYLNEURAMINIC ACID; RECEPTOR-BINDING SPECIFICITY; ACYL SIDE-CHAIN; SIALIC-ACID; GENETIC-CHARACTERIZATION; UNITED-STATES; PIGS; HEMAGGLUTININ; IDENTIFICATION; NEURAMINIDASE	To better understand influenza virus infection of pigs, we examined primary swine respiratory epithelial cells (SRECs, the primary target cells of influenza viruses in vivo), as a model system. Glycomic profiling of SRECs by mass spectrometry revealed a diverse range of glycans terminating in sialic acid or Gal alpha Gal. In terms of sialylation, alpha 2-6 linkage was more abundant than alpha 2-3, and NeuAc was more abundant than NeuGc. Virus binding and infection experiments were conducted to determine functionally important glycans for influenza virus infection, with a focus on recently emerged swine viruses. Infection of SRECs with swine and human viruses resulted in different infectivity levels. Glycan microarray analysis with a high infectivity "triple reassortant" virus ((A/Swine/MN/593/99 (H3N2)) that spread widely throughout the North American swine population and a lower infectivity human virus isolated from a single pig (A/Swine/ONT/00130/97 (H3N2)) showed that both viruses bound exclusively to glycans containing NeuAc alpha 2-6, with strong binding to sialylated polylactosamine and sialylatedN-glycans. Treatment with mannosamine precursors of sialic acid (to alter NeuAc/NeuGc abundances) and linkage-specific sialidases prior to infection indicated that the influenza viruses tested preferentially utilize NeuAc alpha 2-6-sialylated glycans to infect SRECs. Our data indicate that NeuAc alpha 2-6-terminated polylactosamine and sialylated N- glycans are important determinants for influenza viruses to infect SRECs. As NeuAc alpha 2-6 polylactosamine glycans play major roles in human virus infection, the importance of these receptor components in virus infection of swine cells has implications for transmission of viruses between humans and pigs and for pigs as possible adaptation hosts of novel human influenza viruses.	[Bateman, Allen C.; Busch, Marc G.; Olsen, Christopher W.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Bateman, Allen C.] Univ Wisconsin, Sch Vet Med, Cellular & Mol Biol Grad Program, Madison, WI 53706 USA; [Karamanska, Rositsa; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Imperial College London	Olsen, CW (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, 2015 Linden Dr, Madison, WI 53706 USA.	olsenc@svm.vetmed.wisc.edu; s.haslam@imperial.ac.uk			National Institutes of Health [R01 AI060646]; Wellcome Trust [082098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI060646 (to C. W. O.). This work was also supported by Grant 082098 from the Wellcome Trust (to S. M. H. and A. D.).	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bateman AC, 2008, J VIROL, V82, P8204, DOI 10.1128/JVI.00718-08; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Busch MG, 2008, VIRUS RES, V133, P269, DOI 10.1016/j.virusres.2008.01.014; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; FUKUDA MN, 1976, J BIOL CHEM, V251, P6218; GALILI U, 1988, J BIOL CHEM, V263, P17755; Gambaryan AS, 2005, VIRUS RES, V114, P15, DOI 10.1016/j.virusres.2005.05.005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Goldberg D, 2005, PROTEOMICS, V5, P865, DOI 10.1002/pmic.200401071; Gulati S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-22; Guo CT, 2007, GLYCOBIOLOGY, V17, P713, DOI 10.1093/glycob/cwm038; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; Karasin AI, 2000, J CLIN MICROBIOL, V38, P2453; Karasin AI, 2002, J CLIN MICROBIOL, V40, P1073, DOI 10.1128/JCM.40.3.1073-1079.2002; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Keppler OT, 1998, BIOCHEM BIOPH RES CO, V253, P437, DOI 10.1006/bbrc.1998.9650; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Landolt GA, 2006, J CLIN MICROBIOL, V44, P297, DOI 10.1128/JCM.44.2.297-301.2006; Landolt GA, 2003, J CLIN MICROBIOL, V41, P1936, DOI 10.1128/JCM.41.5.1936-1941.2003; Landolt Gabriele A., 2007, Animal Health Research Reviews, V8, P1, DOI 10.1017/S1466252307001272; Lugovtsev VY, 2009, VIROLOGY, V394, P218, DOI 10.1016/j.virol.2009.08.014; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Ma WJ, 2006, J VIROL, V80, P5092, DOI 10.1128/JVI.80.10.5092-5096.2006; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Miller-Podraza H, 2000, GLYCOBIOLOGY, V10, P975, DOI 10.1093/glycob/10.10.975; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; OGATA M, 2009, BIOMACROMOLECULES; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Suzuki T, 1997, FEBS LETT, V404, P192, DOI 10.1016/S0014-5793(97)00127-0; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Van Poucke SGM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-38; VINCENT AL, 2009, VIRUS GENES; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	57	75	77	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34016	34026		10.1074/jbc.M110.115998	http://dx.doi.org/10.1074/jbc.M110.115998			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20724471	Green Published, hybrid			2022-12-27	WOS:000283354000048
J	Nistala, H; Lee-Arteaga, S; Smaldone, S; Siciliano, G; Ramirez, F				Nistala, Harikiran; Lee-Arteaga, Sui; Smaldone, Silvia; Siciliano, Gabriella; Ramirez, Francesco			Extracellular Microfibrils Control Osteoblast-supported Osteoclastogenesis by Restricting TGF beta Stimulation of RANKL Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MODEL; TRANSFORMING GROWTH-FACTOR-BETA-1; BONE; PATHOGENESIS; EXPRESSION; PROTEIN; DIFFERENTIATION; FIBRILLINS; INHIBITION; REGULATOR	Mutations in fibrillin-1 or fibrillin-2, the major structural components of extracellular microfibrils, cause pleiotropic manifestations in Marfan syndrome and congenital contractural arachnodactyly, respectively. We recently found that fibrillin-1 and fibrillin-2 control bone formation by regulating osteoblast differentiation through the differential modulation of endogenous TGF beta and bone morphogenetic protein signals. Here, we describe in vivo and ex vivo experiments that implicate the fibrillins as negative regulators of bone resorption. Adult Fbn2(-/-) mice display a greater than normal osteolytic response to locally implanted lipopolysaccharide-coated titanium particles. Although isolated cultures of Fbn2(-/-) preosteoclasts exhibited normal differentiation and activity, these features were substantially augmented when mutant or wild-type preosteoclasts were co-cultured with Fbn2(-/-) but not wild-type osteoblasts. Greater osteoclastogenic potential of Fbn2(-/-) osteoblasts was largely accounted for by up-regulation of the Rankl gene secondary to heightened TGF beta activity. This conclusion was based on the findings that blockade of TGF beta signaling blunts Rankl up-regulation in Fbn2(-/-) osteoblasts and bones and that systemic TGF beta antagonism improves locally induced osteolysis in Fbn2(-/-) mice. Abnormally high Rankl expression secondary to elevated TGF beta activity was also noted in cultured osteoblasts from Fbn1(-/-) mice. Collectively our data demonstrated that extracellular microfibrils balance local catabolic and anabolic signals during bone remodeling in addition to implying distinct mechanisms of bone loss in Marfan syndrome and congenital contractural arachnodactyly.	[Nistala, Harikiran; Lee-Arteaga, Sui; Smaldone, Silvia; Siciliano, Gabriella; Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai	Ramirez, F (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10021 USA.	francesco.ramirez@mssm.edu	Siciliano, Gabriele/K-7259-2016	Siciliano, Gabriele/0000-0002-6142-2384; Nistala, Harikiran/0000-0003-4928-7527	National Institutes of Health [AR42044]; National Marfan Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR42044 (to F. R.). This work was also supported by the National Marfan Foundation.	Alliston Tamara, 2008, P667; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Bi YM, 2006, BONE, V38, P778, DOI 10.1016/j.bone.2005.11.005; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Carta L, 2009, J BIOL CHEM, V284, P5630, DOI 10.1074/jbc.M806962200; Chellaiah MA, 2003, MOL BIOL CELL, V14, P173, DOI 10.1091/mbc.E02-06-0354; CHIPMAN SD, 1993, P NATL ACAD SCI USA, V90, P1701, DOI 10.1073/pnas.90.5.1701; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Craft CS, 2010, J BIOL CHEM, V285, P23858, DOI 10.1074/jbc.M110.113019; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036; Kitahama S, 2000, BONE, V27, P61, DOI 10.1016/S8756-3282(00)00292-1; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; NISTALA H, 2010, J CELL BIOL IN PRESS; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; RAMIREZ F, 2008, PRIMER METABOLIC BON, P450; Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sohaskey ML, 2010, J CELL BIOL, V189, P511, DOI 10.1083/jcb.201003006; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Thirunavukkarasu K, 2001, J BIOL CHEM, V276, P36241, DOI 10.1074/jbc.M104319200; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746	46	40	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34126	34133		10.1074/jbc.M110.125328	http://dx.doi.org/10.1074/jbc.M110.125328			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729550	hybrid, Green Published			2022-12-27	WOS:000283354000058
J	Zhou, YS; Jetton, TL; Goshorn, S; Lynch, CJ; She, PX				Zhou, Yingsheng; Jetton, Thomas L.; Goshorn, Stephanie; Lynch, Christopher J.; She, Pengxiang			Transamination Is Required for alpha-Ketoisocaproate but Not Leucine to Stimulate Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRANCHED-CHAIN AMINO; PANCREATIC-ISLET METABOLISM; B-CELL MITOCHONDRIA; GLUTAMATE-DEHYDROGENASE; 2-KETO ACIDS; BETA-CELLS; PYRUVATE-CARBOXYLASE; MALIC ENZYME; RELEASE; GLUCOSE	It remains unclear how alpha-ketoisocaproate (KIC) and leucine are metabolized to stimulate insulin secretion. Mitochondrial BCATm (branched-chain aminotransferase) catalyzes reversible transamination of leucine and alpha-ketoglutarate to KIC and glutamate, the first step of leucine catabolism. We investigated the biochemical mechanisms of KIC and leucine-stimulated insulin secretion (KICSIS and LSIS, respectively) using BCATm(-/-) mice. In static incubation, BCATm disruption abolished insulin secretion by KIC, D,L-alpha-keto-beta-methylvalerate, and alpha-ketocaproate without altering stimulation by glucose, leucine, or alpha-ketoglutarate. Similarly, during pancreas perfusions in BCATm(-/-) mice, glucose and arginine stimulated insulin release, whereas KICSIS was largely abolished. During islet perifusions, KIC and 2 mM glutamine caused robust dose-dependent insulin secretion in BCATm(+/+) not BCATm(-/-) islets, whereas LSIS was unaffected. Consistently, in contrast to BCATm(+/+) islets, the increases of the ATP concentration and NADPH/NADP(+) ratio in response to KIC were largely blunted in BCATm(-/-) islets. Compared with nontreated islets, the combination of KIC/glutamine (10/2 mM) did not influence alpha-ketoglutarate concentrations but caused 120 and 33% increases in malate in BCATm(+/+) and BCATm(-/-) islets, respectively. Although leucine oxidation and KIC transamination were blocked in BCATm(-/-) islets, KIC oxidation was unaltered. These data indicate that KICSIS requires transamination of KIC and glutamate to leucine and alpha-ketoglutarate, respectively. LSIS does not require leucine catabolism and may be through leucine activation of glutamate dehydrogenase. Thus, KICSIS and LSIS occur by enhancing the metabolism of glutamine/glutamate to alpha-ketoglutarate, which, in turn, is metabolized to produce the intracellular signals such as ATP and NADPH for insulin secretion.	[She, Pengxiang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Jetton, Thomas L.] Univ Vermont, Dept Med, Burlington, VT 05405 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Vermont	She, PX (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr,Mail Code H166, Hershey, PA 17033 USA.	pengxiangshe@gmail.com		Lynch, Christopher/0000-0003-2453-5838	National Institutes of Health [DK062880]; Ajinomoto Amino Acid Research grant; Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto Amino Acid Research grant; Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK062880 (to C. J. L.). This work was also supported by an Ajinomoto Amino Acid Research grant and a Pennsylvania State University College of Medicine Departmental Seed grant (to P. S.).	ANIENTO F, 1988, MOL CELL BIOCHEM, V79, P107, DOI 10.1007/BF02424551; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Fex M, 2007, DIABETOLOGIA, V50, P74, DOI 10.1007/s00125-006-0464-4; Gao Z, 2003, ENDOCRINOLOGY, V144, P1949, DOI 10.1210/en.2002-0072; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; HUTTON JC, 1979, BIOCHEM J, V184, P303, DOI 10.1042/bj1840303; HUTTON JC, 1980, ENDOCRINOLOGY, V106, P203, DOI 10.1210/endo-106-1-203; HUTTON JC, 1979, BIOCHEM J, V184, P291, DOI 10.1042/bj1840291; HUTTON JC, 1980, J BIOL CHEM, V255, P7340; Ishiyama N, 2006, AM J PHYSIOL-ENDOC M, V290, pE540, DOI 10.1152/ajpendo.00032.2005; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; LaNoue KF, 2001, J NEUROSCI RES, V66, P914, DOI 10.1002/jnr.10064; Lembert N, 1998, DIABETES, V47, P339, DOI 10.2337/diabetes.47.3.339; LENZEN S, 1982, J BIOL CHEM, V257, P6631; LENZEN S, 1986, BIOSCIENCE REP, V6, P163, DOI 10.1007/BF01115002; LENZEN S, 1985, J BIOL CHEM, V260, P2629; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MALAISSE WJ, 1982, J BIOL CHEM, V257, P8731; MALAISSE WJ, 1982, ENDOCRINOLOGY, V111, P392, DOI 10.1210/endo-111-2-392; MALAISSE WJ, 1981, BIOCHIM BIOPHYS ACTA, V677, P39, DOI 10.1016/0304-4165(81)90143-4; MALAISSE WJ, 1986, ADV ENZYME REGUL, V25, P203, DOI 10.1016/0065-2571(86)90015-4; PASSONNEAU JV, 1993, ENZYMATIC ANAL PRACT, P85; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; RUDIGER HW, 1972, BIOCHEM J, V126, P445, DOI 10.1042/bj1260445; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; SENER A, 1983, J BIOL CHEM, V258, P6693; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; She PX, 2010, J APPL PHYSIOL, V108, P941, DOI 10.1152/japplphysiol.01248.2009; Sherry AD, 1998, AM J PHYSIOL-HEART C, V274, pH591, DOI 10.1152/ajpheart.1998.274.2.H591; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Tanizawa Y, 2002, DIABETES, V51, P712, DOI 10.2337/diabetes.51.3.712; Weyer C, 2000, DIABETES, V49, P2094, DOI 10.2337/diabetes.49.12.2094; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9	50	41	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33718	33726		10.1074/jbc.M110.136846	http://dx.doi.org/10.1074/jbc.M110.136846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736162	Green Published, hybrid			2022-12-27	WOS:000283354000017
J	Schulz, K; Rutz, C; Westendorf, C; Ridelis, I; Vogelbein, S; Furkert, J; Schmidt, A; Wiesner, B; Schulein, R				Schulz, Katharina; Rutz, Claudia; Westendorf, Carolin; Ridelis, Ingrid; Vogelbein, Susanne; Furkert, Jens; Schmidt, Antje; Wiesner, Burkhard; Schuelein, Ralf			The Pseudo Signal Peptide of the Corticotropin-releasing Factor Receptor Type 2a Decreases Receptor Expression and Prevents G(i)-mediated Inhibition of Adenylyl Cyclase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-OPIOID RECEPTORS; TRANSLOCATION; STRESS; PROTEINS; MU	The corticotropin-releasing factor receptor type 2a (CRF2(a)R) belongs to the family of G protein-coupled receptors. The receptor possesses an N-terminal pseudo signal peptide that is unable to mediate targeting of the nascent chain to the endoplasmic reticulum membrane during early receptor biogenesis. The pseudo signal peptide remains uncleaved and consequently forms an additional hydrophobic receptor domain with unknown function that is unique within the large G protein-coupled receptor protein family. Here, we have analyzed the functional significance of this domain in comparison with the conventional signal peptide of the homologous corticotropin-releasing factor receptor type 1 (CRF1R). We show that the presence of the pseudo signal peptide leads to a very low cell surface receptor expression of the CRF2(a) R in comparison with the CRF1R. Moreover, whereas the presence of the pseudo signal peptide did not affect coupling to the G(s) protein, G(i)-mediated inhibition of adenylyl cyclase activity was abolished. The properties mediated by the pseudo signal peptide were entirely transferable to the CRF1R in signal peptide exchange experiments. Taken together, our results show that signal peptides do not only influence early protein biogenesis. In the case of the corticotropin-releasing factor receptor subtypes, the use of conventional and pseudo signal peptides have an unexpected influence on signal transduction.	[Schulz, Katharina; Rutz, Claudia; Westendorf, Carolin; Ridelis, Ingrid; Vogelbein, Susanne; Furkert, Jens; Wiesner, Burkhard; Schuelein, Ralf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Schmidt, Antje] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Schulein, R (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	schuelein@fmp-berlin.de			Deutsche Forschungsgemeinschaft [SFB 449]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 449.	Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Charles AC, 2003, MOL PHARMACOL, V63, P89, DOI 10.1124/mol.63.1.89; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Denver RJ, 2009, ANN NY ACAD SCI, V1163, P1, DOI 10.1111/j.1749-6632.2009.04433.x; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Gutknecht E, 2009, MOL PHARMACOL, V75, P648, DOI 10.1124/mol.108.050427; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Hauger RL, 2003, PHARMACOL REV, V55, P21, DOI 10.1124/pr.55.1.3; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Huang Y, 2010, BRIT J PHARMACOL, V159, P237, DOI 10.1111/j.1476-5381.2009.00517.x; Kochl R, 2002, J BIOL CHEM, V277, P16131, DOI 10.1074/jbc.M111674200; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Refojo D, 2009, ANN NY ACAD SCI, V1179, P106, DOI 10.1111/j.1749-6632.2009.04983.x; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sambrook J., 2001, MOL CLONING LAB MANU; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; Valdez GR, 2009, CURR PHARM DESIGN, V15, P1587, DOI 10.2174/138161209788168083; von Heijne G, 1990, CURR OPIN CELL BIOL, V2, P604, DOI 10.1016/0955-0674(90)90100-S; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Wietfeld D, 2004, J BIOL CHEM, V279, P38386, DOI 10.1074/jbc.M405335200; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200	30	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32878	32887		10.1074/jbc.M110.129627	http://dx.doi.org/10.1074/jbc.M110.129627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682782	Green Published, hybrid			2022-12-27	WOS:000283048200025
J	Smagghe, BJ; Huang, PS; Ban, YEA; Baker, D; Springer, TA				Smagghe, Benoit J.; Huang, Po-Ssu; Ban, Yih-En Andrew; Baker, David; Springer, Timothy A.			Modulation of Integrin Activation by an Entropic Spring in the beta-Knee	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; STRUCTURAL BASIS; IN-VIVO; AFFINITY; RECEPTOR; PROTEIN; DOMAIN; BINDING; CONFORMATION; SUBUNIT	We show that the length of a loop in the beta-knee, between the first and second cysteines (C1-C2) in integrin EGF-like (I-EGF) domain 2, modulates integrin activation. Three independent sets of mutants, including swaps among different integrin beta-subunits, show that C1-C2 loop lengths of 12 and longer favor the low affinity state and masking of ligand-induced binding site (LIBS) epitopes. Shortening length from 12 to 4 residues progressively increases ligand binding and LIBS epitope exposure. Compared with length, the loop sequence had a smaller effect, which was ascribable to stabilizing loop conformation, and not interactions with the alpha-subunit. The data together with structural calculations support the concept that the C1-C2 loop is an entropic spring and an emerging theme that disordered regions can regulate allostery. Diversity in the length of this loop may have evolved among integrin beta-subunits to adjust the equilibrium between the bent and extended conformations at different set points.	[Smagghe, Benoit J.; Springer, Timothy A.] Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA; [Smagghe, Benoit J.; Springer, Timothy A.] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02115 USA; [Huang, Po-Ssu; Ban, Yih-En Andrew; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Huang, Po-Ssu; Ban, Yih-En Andrew; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Springer, TA (corresponding author), Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA.	springer@idi.harvard.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Huang, Possu/0000-0002-7948-2895	National Institutes of Health [HL-48675]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-48675.	Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Festy F, 2007, MOL BIOSYST, V3, P381, DOI 10.1039/b617204k; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Mould AP, 2005, J BIOL CHEM, V280, P4238, DOI 10.1074/jbc.M412240200; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Takagi J, 2001, P NATL ACAD SCI USA, V98, P11175, DOI 10.1073/pnas.201420198; Tang RH, 2005, J BIOL CHEM, V280, P29208, DOI 10.1074/jbc.M503239200; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Vanhoorelbeke K, 2009, J BIOL CHEM, V284, P14914, DOI 10.1074/jbc.M809167200; Vomund AN, 2008, BIOCHEMISTRY-US, V47, P11616, DOI 10.1021/bi8015108; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	49	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32954	32966		10.1074/jbc.M110.145177	http://dx.doi.org/10.1074/jbc.M110.145177			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20670939	Green Published, hybrid			2022-12-27	WOS:000283048200033
J	Fang, LH; Harkewicz, R; Hartvigsen, K; Wiesner, P; Choi, SH; Almazan, F; Pattison, J; Deer, E; Sayaphupha, T; Dennis, EA; Witztum, JL; Tsimikas, S; Miller, YI				Fang, Longhou; Harkewicz, Richard; Hartvigsen, Karsten; Wiesner, Philipp; Choi, Soo-Ho; Almazan, Felicidad; Pattison, Jennifer; Deer, Elena; Sayaphupha, Tiffany; Dennis, Edward A.; Witztum, Joseph L.; Tsimikas, Sotirios; Miller, Yury I.			Oxidized Cholesteryl Esters and Phospholipids in Zebrafish Larvae Fed a High Cholesterol Diet MACROPHAGE BINDING AND ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; APOPTOTIC CELLS; ACTIN POLYMERIZATION; LDL; ATHEROSCLEROSIS; 12/15-LIPOXYGENASE; ACCUMULATION; LIGANDS; CD36	A novel hypercholesterolemic zebrafish model has been developed to study early events of atherogenesis. This model utilizes optically transparent zebrafish larvae, fed a high cholesterol diet (HCD), to monitor processes of vascular inflammation in live animals. Because lipoprotein oxidation is an important factor in the development of atherosclerosis, in this study, we characterized the oxidized lipid milieu in HCD-fed zebrafish larvae. Using liquid chromatography-mass spectrometry, we show that feeding an HCD for only 2 weeks resulted in up to 70-fold increases in specific oxidized cholesteryl esters, identical to those present in human minimally oxidized LDL and in murine atherosclerotic lesions. The levels of oxidized phospholipids, suchas1-palmitoyl-2-oxovaleroyl-sn-glycero-3-phosphocholine, and of various lysophosphatidylcholines were also significantly elevated. Moreover, lipoproteins isolated from homogenates of HCD-fed larvae induced cell spreading as well as ERK1/2, Akt, and JNK phosphorylation in murine macrophages. Removal of apoB-containing lipoproteins from the zebrafish homogenates with an anti-human LDL antibody, as well as reducing lipid hydroperoxides with ebselen, resulted in inhibition of macrophage activation. The TLR4 deficiency in murine macrophages prevented their activation with zebrafish lipoproteins. Using biotinylated homogenates of HCD-fed larvae, we demonstrated that their components bound to murine macrophages, and this binding was effectively competed by minimally oxidized LDL but not by native LDL. These data provide evidence that molecular lipid determinants of proatherogenic macrophage phenotypes are present in large quantities in hypercholesterolemic zebrafish larvae and support the use of the HCD-fed zebrafish as a valuable model to study early events of atherogenesis.	[Fang, Longhou; Hartvigsen, Karsten; Wiesner, Philipp; Choi, Soo-Ho; Almazan, Felicidad; Pattison, Jennifer; Deer, Elena; Sayaphupha, Tiffany; Witztum, Joseph L.; Tsimikas, Sotirios; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Harkewicz, Richard; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Harkewicz, Richard; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Miller, YI (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	yumiller@ucsd.edu	Dennis, Edward A./M-5554-2019; Fang, Longhou/G-6582-2013	Dennis, Edward A./0000-0003-3738-3140; Fang, Longhou/0000-0003-1653-5221	National Institutes of Health [HL093767, HL081862, GM069338, HL088093, P30 CA23100]; University of California [18FT-0137]; Leducq Foundation; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081862, R01HL093767, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); Leducq Foundation(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093767 (to Y. I. M. and L. F.), HL081862 (to Y. I. M.), GM069338 (to E. A. D., J. L. W., R. H., and Y. I. M.), and HL088093 (to J. L. W. and Y. I. M.). This work was also supported by University of California Tobacco-related Disease Program Fellowship 18FT-0137 (to L. F.) as well as a grant from the Leducq Foundation (to J. L. W. and Y. I. M.). The University of California, San Diego Cancer Center Shared Imaging Resource is funded by National Institutes of Health Specialized Support Grant P30 CA23100.	Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Boullier A, 2006, ARTERIOSCL THROM VAS, V26, P1169, DOI 10.1161/01.ATV.0000210279.97308.9a; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Harkewicz R, 2008, J BIOL CHEM, V283, P10241, DOI 10.1074/jbc.M709006200; Hartvigsen K, 2009, J LIPID RES, V50, pS388, DOI 10.1194/jlr.R800100-JLR200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Miller YI, 2003, MOL BIOL CELL, V14, P4196, DOI 10.1091/mbc.E03-02-0063; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Miller YI, 2010, SUBCELL BIOCHEM, V51, P229, DOI 10.1007/978-90-481-8622-8_8; Oorni K, 2009, CURR OPIN LIPIDOL, V20, P421, DOI 10.1097/MOL.0b013e32832fa14d; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420	25	71	72	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32343	32351		10.1074/jbc.M110.137257	http://dx.doi.org/10.1074/jbc.M110.137257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20710028	hybrid, Green Published			2022-12-27	WOS:000282683000047
J	Fujisawa, M; Fackelmayer, OJ; Liu, J; Krulwich, TA; Hicks, DB				Fujisawa, Makoto; Fackelmayer, Oliver J.; Liu, Jun; Krulwich, Terry A.; Hicks, David B.			The ATP Synthase a-subunit of Extreme Alkaliphiles Is a Distinct Variant MUTATIONS IN THE CRITICAL ALKALIPHILE-SPECIFIC RESIDUE LYS-180 AND OTHER RESIDUES THAT SUPPORT ALKALIPHILE OXIDATIVE PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-FIRMUS OF4; AQUEOUS ACCESS PATHWAYS; C-RING ROTATION; ESCHERICHIA-COLI; ADENOSINE-TRIPHOSPHATE; PROTON TRANSLOCATION; ESSENTIAL ARGININE; F1F0-ATP SYNTHASE; ROTARY MECHANISM; CROSS-LINKING	A lysine residue in the putative proton uptake pathway of the ATP synthase a-subunit is found only in alkaliphilic Bacillus species and is proposed to play roles in proton capture, retention and passage to the synthase rotor. Here, Lys-180 was replaced with alanine (Ala), glycine (Gly), cysteine (Cys), arginine (Arg), or histidine (His) in the chromosome of alkaliphilic Bacillus pseudofirmus OF4. All mutants exhibited octylglucoside-stimulated ATPase activity and beta-subunit levels at least as high as wild-type. Purified mutant F1F0-ATP synthases all contained substantial a-subunit levels. The mutants exhibited diverse patterns of native (no octylglucoside) ATPase activity and a range of defects in malate growth and in vitro ATP synthesis at pH 10.5. ATP synthesis by the Ala, Gly, and His mutants was also impaired at pH 7.5 in the presence of a protonophoric uncoupler. Thus Lys-180 plays a role when the protonmotive force is reduced at near neutral, not just at high pH. The Arg mutant exhibited no ATP synthesis activity in the alkaliphile setting although activity was reported for a K180R mutant of a thermoalkaliphile synthase (McMillan, D. G., Keis, S., Dimroth, P., and Cook, G. M. (2007) J. Biol. Chem. 282, 17395-17404). The hypothesis that a-subunits from extreme alkaliphiles and the thermoalkaliphile represent distinct variants was supported by demonstration of the importance of additional alkaliphile-specific a-subunit residues, not found in the thermoalkaliphile, for malate growth of B. pseudofirmus OF4. Finally, a mutant B. pseudofirmus OF4 synthase with switched positions of Lys-180 (helix 4) and Gly-212 (helix 5) retained significant coupled synthase activity accompanied by proton leakiness.	[Fujisawa, Makoto; Fackelmayer, Oliver J.; Liu, Jun; Krulwich, Terry A.; Hicks, David B.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Hicks, DB (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl, New York, NY 10029 USA.	david.hicks@mssm.edu	Fackelmayer, Oliver/AAD-7638-2021		National Institutes of Health, NIGMS [GM28454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028454] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28454 from NIGMS.	Aksimentiev A, 2004, BIOPHYS J, V86, P1332, DOI 10.1016/S0006-3495(04)74205-8; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; CAIN BD, 1989, J BIOL CHEM, V264, P3292; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; DeLeon-Rangel J, 2003, ARCH BIOCHEM BIOPHYS, V418, P55, DOI 10.1016/S0003-9861(03)00391-6; Dimroth P, 2004, ADV MICROB PHYSIOL, V49, P175, DOI 10.1016/S0065-2911(04)49004-3; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Gilmour R, 1997, J BACTERIOL, V179, P863, DOI 10.1128/jb.179.3.863-870.1997; HARTZOG PE, 1994, J BIOL CHEM, V269, P32313; Hicks DB, 2010, BBA-BIOENERGETICS, V1797, P1362, DOI 10.1016/j.bbabio.2010.02.028; HICKS DB, 1990, J BIOL CHEM, V265, P20547; Ito M, 1997, J BACTERIOL, V179, P3851, DOI 10.1128/jb.179.12.3851-3857.1997; IVEY DM, 1992, RES MICROBIOL, V143, P467, DOI 10.1016/0923-2508(92)90092-3; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; KRULWICH TA, 1995, MOL MICROBIOL, V15, P403, DOI 10.1111/j.1365-2958.1995.tb02253.x; Krulwich TA, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P311; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Liu J, 2010, BBA-BIOENERGETICS, V1797, P35, DOI 10.1016/j.bbabio.2010.04.123; Liu J, 2009, J BIOL CHEM, V284, P8714, DOI 10.1074/jbc.M808738200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; McMillan DGG, 2007, J BIOL CHEM, V282, P17395, DOI 10.1074/jbc.M611709200; McMillan DGG, 2009, APPL ENVIRON MICROB, V75, P7649, DOI 10.1128/AEM.01639-09; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; QUIRK PG, 1991, BIOCHIM BIOPHYS ACTA, V1058, P131, DOI 10.1016/S0005-2728(05)80229-4; QUIRK PG, 1993, J BIOL CHEM, V268, P678; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; STURR MG, 1994, J BACTERIOL, V176, P3111, DOI 10.1128/jb.176.11.3111-3116.1994; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Vik SB, 2005, J BIOENERG BIOMEMBR, V37, P445, DOI 10.1007/s10863-005-9488-6; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Vorburger T, 2008, FEBS J, V275, P2137, DOI 10.1111/j.1742-4658.2008.06368.x; Wang ZX, 2004, J BIOL CHEM, V279, P26546, DOI 10.1074/jbc.M401206200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	62	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32105	32115		10.1074/jbc.M110.165084	http://dx.doi.org/10.1074/jbc.M110.165084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20716528	Green Published, hybrid			2022-12-27	WOS:000282683000024
J	Liu, YC; Sieprawska-Lupa, M; Whitman, WB; White, RH				Liu, Yuchen; Sieprawska-Lupa, Magdalena; Whitman, William B.; White, Robert H.			Cysteine Is Not the Sulfur Source for Iron-Sulfur Cluster and Methionine Biosynthesis in the Methanogenic Archaeon Methanococcus maripaludis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; LABILE SULFIDE; PROTEINS; MECHANISMS; BACTERIA; VOLTAE; ACID; PROKARYOTES; JANNASCHII; CHEMISTRY	Three multiprotein systems are known for iron-sulfur (Fe-S) cluster biogenesis in prokaryotes and eukaryotes as follows: the NIF (nitrogen fixation), the ISC (iron-sulfur cluster), and the SUF (mobilization of sulfur) systems. In all three, cysteine is the physiological sulfur source, and the sulfur is transferred from cysteine desulfurase through a persulfidic intermediate to a scaffold protein. However, the biochemical nature of the sulfur source for Fe-S cluster assembly in archaea is unknown, and many archaea lack homologs of cysteine desulfurases. Methanococcus maripaludis is a methanogenic archaeon that contains a high amount of protein-bound Fe-S clusters (45 nmol/mg protein). Cysteine in this archaeon is synthesized primarily via the tRNA-dependent SepRS/SepCysS pathway. When a Delta sepS mutant (a cysteine auxotroph) was grown with S-34-labeled sulfide and unlabeled cysteine, <8% of the cysteine, >92% of the methionine, and >87% of the sulfur in the Fe-S clusters in proteins were labeled, suggesting that the sulfur in methionine and Fe-S clusters was derived predominantly from exogenous sulfide instead of cysteine. Therefore, this investigation challenges the concept that cysteine is always the sulfur source for Fe-S cluster biosynthesis in vivo and suggests that Fe-S clusters are derived from sulfide in those organisms, which live in sulfide-rich habitats.	[Liu, Yuchen; Sieprawska-Lupa, Magdalena; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [White, Robert H.] Virginia Tech, Dept Biochem, Blacksburg, VA 24060 USA	University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University	Whitman, WB (corresponding author), Univ Georgia, Dept Microbiol, 541 Biol Sci Bldg, Athens, GA 30602 USA.	whitman@uga.edu	Whitman, William/AAC-5896-2020	Liu, Yuchen/0000-0003-0842-5882; Whitman, William/0000-0003-1229-0423	National Science Foundation [MCB 0231319]; Department of Energy; University of Georgia Graduate School	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); University of Georgia Graduate School	This work was supported by National Science Foundation Grant MCB 0231319 (to R. H. W.), a Department of Energy grant (to W. B. W.), and a Doctoral Completion Award from the University of Georgia Graduate School (to Y. L.).	BALCH WE, 1979, J BACTERIOL, V137, P256, DOI 10.1128/JB.137.1.256-263.1979; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Boyd JM, 2009, J BACTERIOL, V191, P1490, DOI 10.1128/JB.01469-08; DYBAS M, 1992, J BACTERIOL, V174, P5575, DOI 10.1128/JB.174.17.5575-5583.1992; Eccleston JF, 2006, J BIOL CHEM, V281, P8371, DOI 10.1074/jbc.M513455200; Edgcomb VP, 2004, APPL ENVIRON MICROB, V70, P2551, DOI 10.1128/AEM.70.4.2551-2555.2004; EDMOND JM, 1982, NATURE, V297, P187, DOI 10.1038/297187a0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FAHEY RC, 1981, ANAL BIOCHEM, V111, P357, DOI 10.1016/0003-2697(81)90573-X; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Frazzon J, 2002, BIOCHEM SOC T, V30, P680, DOI 10.1042/BST0300680; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; HAGEN KS, 1981, J AM CHEM SOC, V103, P4054, DOI 10.1021/ja00404a013; HARVEY AE, 1955, ANAL CHEM, V27, P26, DOI 10.1021/ac60097a009; Hauenstein SI, 2008, J BIOL CHEM, V283, P22007, DOI 10.1074/jbc.M801839200; Hendrickson EL, 2008, J BACTERIOL, V190, P2198, DOI 10.1128/JB.01805-07; HERSKOVITZ T, 1972, P NATL ACAD SCI USA, V69, P2437, DOI 10.1073/pnas.69.9.2437; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Hwang CC, 1996, BIOCHEMISTRY-US, V35, P6358, DOI 10.1021/bi9602472; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JONES WJ, 1983, ARCH MICROBIOL, V135, P91, DOI 10.1007/BF00408015; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lee HS, 2003, APPL MICROBIOL BIOT, V62, P459, DOI 10.1007/s00253-003-1306-7; Li T, 1999, FEBS LETT, V462, P302, DOI 10.1016/S0014-5793(99)01550-1; Lloyd KG, 2005, APPL ENVIRON MICROB, V71, P6383, DOI 10.1128/AEM.71.10.6383-6387.2005; MAHLER HR, 1954, J BIOL CHEM, V210, P165; Major TA, 2004, FEMS MICROBIOL LETT, V239, P117, DOI 10.1016/j.femsle.2004.08.027; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; NAGASAWA T, 1984, J BIOL CHEM, V259, P393; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; SHIEH J, 1988, J BACTERIOL, V170, P4091, DOI 10.1128/jb.170.9.4091-4096.1988; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stathopoulos C, 2001, P NATL ACAD SCI USA, V98, P14292, DOI 10.1073/pnas.201540498; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Tchong SI, 2005, BIOCHEMISTRY-US, V44, P1659, DOI 10.1021/bi0484769; Truong DH, 2006, DRUG METAB REV, V38, P733, DOI 10.1080/03602530600959607; Visser A, 1996, WATER SCI TECHNOL, V33, P99, DOI 10.1016/0273-1223(96)00324-1; WHITE RH, 1983, BIOCHEM BIOPH RES CO, V112, P66, DOI 10.1016/0006-291X(83)91798-9; WHITE RH, 1981, ANAL BIOCHEM, V114, P349, DOI 10.1016/0003-2697(81)90492-9; White RH, 2003, BBA-GEN SUBJECTS, V1624, P46, DOI 10.1016/j.bbagen.2003.09.005; WHITMAN WB, 1982, J BACTERIOL, V149, P852, DOI 10.1128/JB.149.3.852-863.1982; WHITMAN WB, 1986, SYST APPL MICROBIOL, V7, P235; YAMAGATA S, 1989, BIOCHIMIE, V71, P1125, DOI 10.1016/0300-9084(89)90016-3	51	63	64	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31923	31929		10.1074/jbc.M110.152447	http://dx.doi.org/10.1074/jbc.M110.152447			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20709756	Green Published, hybrid			2022-12-27	WOS:000282683000005
J	Qiu, H; Yang, B; Pei, ZC; Zhang, Z; Ding, K				Qiu, Hong; Yang, Bo; Pei, Zhi-Chao; Zhang, Zhang; Ding, Kan			WSS25 Inhibits Growth of Xenografted Hepatocellular Cancer Cells in Nude Mice by Disrupting Angiogenesis via Blocking Bone Morphogenetic Protein (BMP)/Smad/Id1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; HEPARAN-SULFATE; BIOLOGICAL-ACTIVITY; TUMOR ANGIOGENESIS; INDUCED ACTIVATION; OVER-EXPRESSION; ID1 EXPRESSION; IN-VITRO; CARCINOMA; ID-1	The highly expressed Id1 (inhibitor of DNA binding/differentiation) protein promotes angiogenesis in HCC and is a well established target for anti-angiogenesis therapeutic strategies. Heparan sulfate (HS) mimetics such as PI-88 can abrogate HS-protein interactions to inhibit angiogenesis. Id1 is the direct downstream effector of bone morphogenetic proteins (BMPs), which are angiogenic and HS-binding proteins. Thus, targeting BMPs by HS mimetics may inhibit angiogenesis via attenuating Id1 expression. We report here that a HS mimetic WSS25 potently inhibited the tube formation of HMEC-1 cells on Matrigel and their migration. Meanwhile, WSS25 (25 mu g/ml) nearly completely blocked Id1 expression in the HMEC-1 cells as demonstrated by oligo-angiogenesis microarray analysis and further confirmed by RT-PCR and Western blotting. BMP/Smad/Id1 signaling also was blocked by WSS25 treatment in HMEC-1 cells. Importantly, Id1 knockdown in HMEC-1 cells caused the disruption of their tube formation on Matrigel. By employing quartz crystal microbalance analysis, we found that WSS25 strongly bound to BMP2. Moreover, WSS25 impaired BMP2-induced tube formation of HMEC-1 cells on Matrigel and angiogenesis in Matrigel transplanted into C57BL6 mice. Furthermore, WSS25 (100 mg/kg) abrogated the growth of HCC cells xenografted in male nude mice. Immunohistochemical analysis showed that both the expression of Id1 and the endothelial cell marker CD31 were lower in the WSS25-treated tumor tissue than in the control. Therefore, WSS25 is a potential drug candidate for HCC therapy as a tumor angiogenesis inhibitor.	[Qiu, Hong; Pei, Zhi-Chao; Zhang, Zhang; Ding, Kan] Chinese Acad Sci, Glycochem & Glycobiol Lab, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Yang, Bo] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ding, Kan] Chinese Acad Sci & Infinitus, Joint Lab Res Chinese Herbal Polysaccharides, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Ding, K (corresponding author), 555 Zuchongzhi Rd,Zhangjiang High Tech Pk, Shanghai 201203, Peoples R China.	kding@mail.shcnc.ac.cn	Qiu, Hong/C-5888-2011	Qiu, Hong/0000-0002-4088-7828	National Natural Science Foundation of China [30670470]; National High Technology Research and Development Program (863) of China [2006AA022102]; Shanghai Institute of Materia Medica, Chinese Academy of Sciences [07G604F036]; Chinese Academy of Sciences, China [KSCX1-YW-R-18]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" [2009ZX09301-001, 2009ZX09103-071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863) of China(National High Technology Research and Development Program of China); Shanghai Institute of Materia Medica, Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences, China(Chinese Academy of Sciences); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program"	This work was supported by grants from the National Natural Science Foundation of China (30670470); the National High Technology Research and Development Program (863) of China (2006AA022102); the New Drug Research Program of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (07G604F036); the "100 Talents Project" of Chinese Academy of Sciences, China (to K. D.); the Knowledge Innovation Program of Chinese Academy of Sciences (KSCX1-YW-R-18); and the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" (2009ZX09301-001 and 2009ZX09103-071).	Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Cejalvo T, 2007, IMMUNOLOGY, V121, P94, DOI 10.1111/j.1365-2567.2007.02541.x; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Doebele RC, 2009, BLOOD, V114, P4592, DOI 10.1182/blood-2009-04-217042; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Henke E, 2008, NAT BIOTECHNOL, V26, P91, DOI 10.1038/nbt1366; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Jia JH, 2010, PROTEOMICS, V10, P224, DOI 10.1002/pmic.200900607; Kanzaki S, 2008, J CELL PHYSIOL, V216, P844, DOI 10.1002/jcp.21468; Karoli T, 2005, J MED CHEM, V48, P8229, DOI 10.1021/jm050618p; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lee TK, 2006, CLIN CANCER RES, V12, P6910, DOI 10.1158/1078-0432.CCR-06-0489; Lee TKW, 2003, CARCINOGENESIS, V24, P1729, DOI 10.1093/carcin/bgg145; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Liu D, 2007, BLOOD, V110, P1502, DOI 10.1182/blood-2006-11-058594; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; McAllister SD, 2007, MOL CANCER THER, V6, P2921, DOI 10.1158/1535-7163.MCT-07-0371; MIYAZONO K, 2002, SCI STKE, pPE40; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Parish CR, 1999, CANCER RES, V59, P3433; Peddada S, 2006, HUM MOL GENET, V15, P2003, DOI 10.1093/hmg/ddl124; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Qiu H, 2007, CARBOHYD RES, V342, P2230, DOI 10.1016/j.carres.2007.06.021; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sakurai D, 2004, J IMMUNOL, V173, P5801, DOI 10.4049/jimmunol.173.9.5801; Sun HC, 2004, J CANCER RES CLIN, V130, P307, DOI 10.1007/s00432-003-0530-y; Tam WF, 2008, BLOOD, V112, P1981, DOI 10.1182/blood-2007-07-103010; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; XU YL, 1994, J INVEST DERMATOL, V102, P833, DOI 10.1111/1523-1747.ep12382086	44	44	47	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32638	32646		10.1074/jbc.M110.105544	http://dx.doi.org/10.1074/jbc.M110.105544			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679340	Green Published, hybrid			2022-12-27	WOS:000282683000078
J	Zhang, SL; Frankel, LK; Bricker, TM				Zhang, Shulu; Frankel, Laurie K.; Bricker, Terry M.			The Sll0606 Protein Is Required for Photosystem II Assembly/Stability in the Cyanobacterium Synechocystis sp. PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SP STRAIN PCC-6803; OXYGEN-EVOLUTION; CORE COMPLEX; PROTEOMICS; REPAIR; IDENTIFICATION; ARCHITECTURE; CHLOROPHYLL; CAROTENOIDS	An insertional transposon mutation in the sll0606 gene was found to lead to a loss of photoautotrophy but not photoheterotrophy in the cyanobacterium Synechocystis sp. PCC 6803. Complementation analysis of this mutant (Tsll0606) indicated that an intact sll0606 gene could fully restore photoautotrophic growth. Gene organization in the vicinity of sll0606 indicates that it is not contained in an operon. No electron transport activity was detected in Tsll0606 using water as an electron donor and 2,6-dichlorobenzoquinone as an electron acceptor, indicating that Photosystem II (PS II) was defective. Electron transport activity using dichlorophenol indolephenol plus ascorbate as an electron donor to methyl viologen, however, was the same as observed in the control strain. This indicated that electron flow through Photosystem I was normal. Fluorescence induction and decay parameters verified that Photosystem II was highly compromised. The quantum yield for energy trapping by Photosystem II (F-V/F-M) in the mutant was less than 10% of that observed in the control strain. The small variable fluorescence yield observed after a single saturating flash exhibited aberrant Q(A)(-) reoxidation kinetics that were insensitive to dichloromethylurea. Immunological analysis indicated that whereas the D2 and CP47 proteins were modestly affected, the D1 and CP43 components were dramatically reduced. Analysis of two-dimensional blue native/lithium dodecyl sulfate-polyacrylamide gels indicated that no intact PS II monomer or dimers were observed in the mutant. The CP43-less PS II monomer did accumulate to detectable levels. Our results indicate that the Sll0606 protein is required for the assembly/stability of a functionally competent Photosystem II.	[Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Div Biochem & Mol Biol, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE))	This work was supported by a grant from the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (to T. M. B. and L. K. F.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antal T, 2008, PHOTOSYNTH RES, V96, P217, DOI 10.1007/s11120-008-9301-6; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Bricker TM, 2004, J BACTERIOL, V186, P8144, DOI 10.1128/JB.186.23.8144-8148.2004; BRICKER TM, 1992, BIOCHEMISTRY-US, V31, P4623, DOI 10.1021/bi00134a012; BRICKER TM, 1996, OXYGENIC PHOTOSYNTHE, P113; BURNAP RL, 1991, BIOCHEMISTRY-US, V30, P440, DOI 10.1021/bi00216a020; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; IKEUCHI M, 1989, FEBS LETT, V242, P263, DOI 10.1016/0014-5793(89)80482-X; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Kufryk GI, 2003, J BACTERIOL, V185, P6615, DOI 10.1128/JB.185.22.6615-6623.2003; Kufryk GI, 2001, BIOCHEMISTRY-US, V40, P9247, DOI 10.1021/bi0026526; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; Nedbal L, 1999, J PHOTOCH PHOTOBIO B, V48, P154, DOI 10.1016/S1011-1344(99)00032-9; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; PUTNAMEVANS C, 1992, BIOCHEMISTRY-US, V31, P11482, DOI 10.1021/bi00161a029; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; ROGNER M, 1990, J BIOL CHEM, V265, P6189; ROGNER M, 1991, BIOCHEMISTRY-US, V30, P5387; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Rosenberg C, 1999, BIOCHEMISTRY-US, V38, P15994, DOI 10.1021/bi991326r; Schottkowski M, 2009, J BIOL CHEM, V284, P1813, DOI 10.1074/jbc.M806116200; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031; Swingley WD, 2008, MOL BIOL EVOL, V25, P643, DOI 10.1093/molbev/msn034; Thornton LE, 2005, ADV PHOTO RESPIRAT, V22, P121; Tyystjarvi E, 2004, ADV PHOTO RESPIRAT, V19, P363; VERMAAS WFJ, 1988, PHOTOSYNTH RES, V17, P97, DOI 10.1007/BF00047683; Wegener KM, 2008, J BIOL CHEM, V283, P27829, DOI 10.1074/jbc.M803918200; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zhang SL, 2008, J BACTERIOL, V190, P8234, DOI 10.1128/JB.01126-08; Zhang SL, 2004, J BACTERIOL, V186, P875, DOI 10.1128/JB.186.3.875-879.2004	47	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32047	32054		10.1074/jbc.M110.166983	http://dx.doi.org/10.1074/jbc.M110.166983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20724474	Green Published, hybrid			2022-12-27	WOS:000282683000018
J	Jiang, HB; Jans, R; Xu, W; Rorke, EA; Lin, CY; Chen, YW; Fang, SY; Zhong, YW; Eckert, RL				Jiang, Haibing; Jans, Ralph; Xu, Wen; Rorke, Ellen A.; Lin, Chen-Yong; Chen, Ya-Wen; Fang, Shengyun; Zhong, Yongwang; Eckert, Richard L.			Type I Transglutaminase Accumulation in the Endoplasmic Reticulum May Be an Underlying Cause of Autosomal Recessive Congenital Ichthyosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; STRATIFIED SQUAMOUS EPITHELIA; MEMBRANE ANCHORAGE REGION; CORNIFIED CELL ENVELOPES; CROSS-LINKING ENZYMES; PROLINE-RICH PROTEINS; CHAIN BINDING-PROTEIN; PERMEABILITY BARRIER; TERMINAL DIFFERENTIATION; LAMELLAR ICHTHYOSIS	Type I transglutaminase (TG1) is an enzyme that is responsible for assembly of the keratinocyte cornified envelope. Although TG1 mutation is an underlying cause of autosomal recessive congenital ichthyosis, a debilitating skin disease, the pathogenic mechanism is not completely understood. In the present study we show that TG1 is an endoplasmic reticulum (ER) membrane-associated protein that is trafficked through the ER for ultimate delivery to the plasma membrane. Mutation severely attenuates this processing and a catalytically inactive point mutant, TG1-FLAG(C377A), accumulates in the endoplasmic reticulum and in aggresome-like structures where it is ubiquitinylated. This accumulation results from protein misfolding, as treatment with a chemical chaperone permits it to exit the endoplasmic reticulum and travel to the plasma membrane. ER accumulation is also observed for ichthyosis-associated TG1 mutants. Our findings suggest that misfolding of TG1 mutants leads to ubiquitinylation and accumulation in the ER and aggresomes, and that abnormal intracellular processing of TG1 mutants may be an underlying cause of ichthyosis.	[Jiang, Haibing; Xu, Wen; Rorke, Ellen A.; Lin, Chen-Yong; Chen, Ya-Wen; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Reprod Biol, Baltimore, MD 21201 USA; [Fang, Shengyun; Zhong, Yongwang] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Jans, Ralph] Newcastle Univ, Dept Dermatol Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Newcastle University - UK	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Jans, Ralph/F-2150-2013; Fang, Shengyun/H-3802-2011; Zhong, Yongwang/A-2527-2012	Fang, Shengyun/0000-0001-7280-5463; Chen, Ya-Wen/0000-0003-2382-8444	National Institutes of Health [R01 AR049713]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR049713 (to R.L.E.).	Ahvazi B, 2003, EXP MOL MED, V35, P228, DOI 10.1038/emm.2003.31; Ahvazi B, 2003, J BIOL CHEM, V278, P23834, DOI 10.1074/jbc.M301162200; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BOUTIN JA, 1993, EUR J BIOCHEM, V214, P853, DOI 10.1111/j.1432-1033.1993.tb17989.x; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; BRAAKMAN I, 2001, CURR PROTOC PROTEIN, V14, P1; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Candi E, 1998, J BIOL CHEM, V273, P13693, DOI 10.1074/jbc.273.22.13693; CHAKRAVARTY R, 1990, BIOCHEM J, V271, P25, DOI 10.1042/bj2710025; CHAKRAVARTY R, 1989, J BIOL CHEM, V264, P625; Choate KA, 1998, J INVEST DERMATOL, V110, P8, DOI 10.1046/j.1523-1747.1998.00070.x; Dashti SR, 2001, J BIOL CHEM, V276, P27214, DOI 10.1074/jbc.M100465200; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Eckert RL, 2005, PROG EXP TUMOR RES, V38, P115; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; ELIAS PM, 1975, J CELL BIOL, V65, P180, DOI 10.1083/jcb.65.1.180; Farasat S, 2009, J MED GENET, V46, P103, DOI 10.1136/jmg.2008.060905; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; Gong B, 2009, MOL VIS, V15, P2829; Gray AC, 2001, TOXICOL IN VITRO, V15, P427, DOI 10.1016/S0887-2333(01)00047-9; GRAYSON S, 1982, J INVEST DERMATOL, V78, P128, DOI 10.1111/1523-1747.ep12505953; Green H, 1980, Harvey Lect, V74, P101; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HENNINGS H, 1981, BIOCHEM BIOPH RES CO, V102, P739, DOI 10.1016/S0006-291X(81)80194-5; Herman ML, 2009, HUM MUTAT, V30, P537, DOI 10.1002/humu.20952; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huber M, 1997, J BIOL CHEM, V272, P21018, DOI 10.1074/jbc.272.34.21018; Jans R, 2008, J INVEST DERMATOL, V128, P517, DOI 10.1038/sj.jid.5701035; JOSHI HC, 1993, BIOESSAYS, V15, P637, DOI 10.1002/bies.950151002; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; KASTURI L, 1993, EXP CELL RES, V205, P84, DOI 10.1006/excr.1993.1061; KIM SY, 1995, J BIOL CHEM, V270, P18026, DOI 10.1074/jbc.270.30.18026; KIM SY, 1994, J BIOL CHEM, V269, P27979; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; Lajemi M, 1997, HISTOCHEM J, V29, P593, DOI 10.1023/A:1026484227851; LISCALJET IM, 2004, HANDBOOD PROTEIN FOL, V3, P73; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; MATOLTSY AG, 1976, J INVEST DERMATOL, V67, P20, DOI 10.1111/1523-1747.ep12512473; MATOLTSY AG, 1955, J BIOPHYS BIOCHEM CY, V1, P191, DOI 10.1083/jcb.1.3.191; MATOLTSY AG, 1966, J INVEST DERMATOL, V46, P127, DOI 10.1038/jid.1966.19; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MICHEL S, 1988, J INVEST DERMATOL, V90, P472, DOI 10.1111/1523-1747.ep12460922; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; NEGI M, 1985, J INVEST DERMATOL, V85, P75, DOI 10.1111/1523-1747.ep12275357; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; OGAWA H, 1976, J BIOL CHEM, V251, P7281; Ohlendieck Kay, 2004, Methods Mol Biol, V244, P283; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pal R, 2010, BIOCHEM BIOPH RES CO, V392, P567, DOI 10.1016/j.bbrc.2010.01.071; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; PHILLIPS MA, 1990, P NATL ACAD SCI USA, V87, P9333, DOI 10.1073/pnas.87.23.9333; PHILLIPS MA, 1993, BIOCHEMISTRY-US, V32, P11057, DOI 10.1021/bi00092a015; PINCUS JH, 1975, ARCH BIOCHEM BIOPHYS, V169, P724, DOI 10.1016/0003-9861(75)90217-9; Planey SL, 2009, MOL BIOL CELL, V20, P1454, DOI 10.1091/mbc.E08-08-0849; POLAKOWSKA RR, 1992, P NATL ACAD SCI USA, V89, P4476, DOI 10.1073/pnas.89.10.4476; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Rice R H, 1988, Adv Exp Med Biol, V231, P51; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; Short B, 2003, CURR BIOL, V13, pR311, DOI 10.1016/S0960-9822(03)00234-3; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SIZEMORE N, 1993, DIFFERENTIATION, V54, P219, DOI 10.1111/j.1432-0436.1993.tb01603.x; Steinert PM, 1999, CELL DEATH DIFFER, V6, P916, DOI 10.1038/sj.cdd.4400568; Steinert PM, 1996, J BIOL CHEM, V271, P26242, DOI 10.1074/jbc.271.42.26242; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; Steinert PM, 1999, MOL BIOL CELL, V10, P4247, DOI 10.1091/mbc.10.12.4247; Steinert PM, 1996, BIOCHEM BIOPH RES CO, V221, P101, DOI 10.1006/bbrc.1996.0552; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; STEVEN AC, 1994, J CELL SCI, V107, P693; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Sturniolo MT, 2003, J BIOL CHEM, V278, P48066, DOI 10.1074/jbc.M307215200; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WERTZ PW, 1989, J INVEST DERMATOL, V93, P169, DOI 10.1111/1523-1747.ep12277394; YAFFE MB, 1993, J INVEST DERMATOL, V100, P3, DOI 10.1111/1523-1747.ep12349857; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	91	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31634	31646		10.1074/jbc.M110.128645	http://dx.doi.org/10.1074/jbc.M110.128645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663883	hybrid, Green Published			2022-12-27	WOS:000282764600056
J	Klenk, C; Vetter, T; Zurn, A; Vilardaga, JP; Friedman, PA; Wang, B; Lohse, MJ				Klenk, Christoph; Vetter, Thorsten; Zuern, Alexander; Vilardaga, Jean-Pierre; Friedman, Peter A.; Wang, Bin; Lohse, Martin J.			Formation of a Ternary Complex among NHERF1, beta-Arrestin, and Parathyroid Hormone Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; EXCHANGER REGULATORY FACTOR; PROXIMAL TUBULE CELLS; BETA(2)-ADRENERGIC RECEPTOR; (PTH)/PTH-RELATED PEPTIDE; PHOSPHATE-TRANSPORT; ADENOSINE RECEPTOR; PDZ-DOMAIN; KINASE-C; BINDING	beta-Arrestins are crucial regulators of G-protein coupled receptor (GPCR) signaling, desensitization, and internalization. Despite the long-standing paradigm that agonist-promoted receptor phosphorylation is required for beta-arrestin2 recruitment, emerging evidence suggests that phosphorylation-independent mechanisms play a role in beta-arrestin2 recruitment by GPCRs. Several PDZ proteins are known to interact with GPCRs and serve as cytosolic adaptors to modulate receptor signaling and trafficking. Na+/H+ exchange regulatory factors (NHERFs) exert a major role in GPCR signaling. By combining imaging and biochemical and biophysical methods we investigated the interplay among NHERF1, beta-arrestin2, and the parathyroid hormone receptor type 1 (PTHR). We show that NHERF1 and beta-arrestin2 can independently bind to the PTHR and form a ternary complex in cultured human embryonic kidney cells and Chinese hamster ovary cells. Although NHERF1 interacts constitutively with the PTHR, beta-arrestin2 binding is promoted by receptor activation. NHERF1 interacts directly with beta-arrestin2 without using the PTHR as an interface. Fluorescence resonance energy transfer studies revealed that the kinetics of PTHR and beta-arrestin2 interactions were modulated by NHERF1. These findings suggest a model in which NHERF1 may serve as an adaptor, bringing beta-arrestin2 into close proximity to the PTHR, thereby facilitating beta-arrestin2 recruitment after receptor activation.	[Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Vilardaga, Jean-Pierre] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Vilardaga, Jean-Pierre] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Vilardaga, Jean-Pierre; Friedman, Peter A.; Wang, Bin] Univ Pittsburgh, Sch Med, Lab G Coupled Prot Receptor Biol, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University of Wurzburg; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lohse, MJ (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	lohse@toxi.uni-wuerzburg.de	Klenk, Christoph/E-5158-2014; Lohse, Martin J/A-7160-2012	Klenk, Christoph/0000-0001-5199-7144; Lohse, Martin J/0000-0002-0599-3510; Wang, Bin/0000-0002-5396-6111; Vilardaga, Jean-Pierre/0000-0002-1217-1435	Deutsche Forschungsgemeinschaft; European Research Council; National Institutes of Health [DK54171, DK069998, DK087688]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069998, R01DK054171, R01DK087688] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by grants of the Deutsche Forschungsgemeinschaft and the European Research Council (to M. J. L.). This work was also supported by National Institutes of Health Grants DK54171 and DK069998 (to P. A. F.) and DK087688 (to J.-P. V.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Arslan G, 1999, N-S ARCH PHARMACOL, V359, P28, DOI 10.1007/PL00005319; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Castro M, 2002, ENDOCRINOLOGY, V143, P3854, DOI 10.1210/en.2002-220232; Clark RB, 2003, MOL PHARMACOL, V64, P1015, DOI 10.1124/mol.64.5.1015; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; DUZIC E, 1992, J BIOL CHEM, V267, P24045; Ferrari SL, 2001, MOL ENDOCRINOL, V15, P149, DOI 10.1210/me.15.1.149; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Gardella T J, 2000, Rev Endocr Metab Disord, V1, P317, DOI 10.1023/A:1026522619828; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Offermanns S, 1996, MOL ENDOCRINOL, V10, P566, DOI 10.1210/me.10.5.566; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; Raman D, 1999, BIOCHEMISTRY-US, V38, P5117, DOI 10.1021/bi9824588; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Trifilieff A, 2002, BRIT J PHARMACOL, V135, P1655, DOI 10.1038/sj.bjp.0704616; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Vilardaga JP, 2001, J BIOL CHEM, V276, P33435, DOI 10.1074/jbc.M011495200; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Watson C, 2000, MOL PHARMACOL, V58, P1230, DOI 10.1124/mol.58.6.1230; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200	42	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30355	30362		10.1074/jbc.M110.114900	http://dx.doi.org/10.1074/jbc.M110.114900			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20656684	Green Published, hybrid			2022-12-27	WOS:000281984300071
J	Gaekwad, J; Zhang, YH; Zhang, W; Reeves, J; Wolfert, MA; Boons, GJ				Gaekwad, Jidnyasa; Zhang, Yanghui; Zhang, Wei; Reeves, Jaxk; Wolfert, Margreet A.; Boons, Geert-Jan			Differential Induction of Innate Immune Responses by Synthetic Lipid A Derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; NEISSERIA-MENINGITIDIS; BACTERIAL LIPOPOLYSACCHARIDES; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; NEGATIVE REGULATION; SIGNALING PATHWAYS; ACQUIRED-IMMUNITY; MOUSE MACROPHAGES	Recent studies have indicated that lipopolysaccharides (LPS) isolated from particular bacterial strains can bias innate immune responses toward different signal transduction pathways thereby eliciting unique patterns of cytokines. Heterogeneity in the structure of lipid A (the active component of LPS) and possible contaminations with other inflammatory components have made it difficult to confirm these observations and dissect molecular motifs that may be responsible for modulatory properties. To address these issues, we have examined, for the first time, the ability of a range of well defined synthetic lipid As and isolated LPS and lipid A preparations to induce the production of a wide range of cytokines in three different mouse cell types. It was found that, for a given compound, the potencies of production of the various cytokines differed significantly. An additive model, in which a chemical change in the structure of a compound effects the potencies of all cytokines in the same manner, could describe the potencies of the cytokines for all compounds. Thus, no evidence was found that the structure of lipid A can modulate the pattern of cytokine production. In addition, the statistical analysis showed that the relative ordering of the potencies of the compounds was identical in the different cell types and that structural features such as the presence of a 3-deoxy-D-manno-octulosonic acid moiety, anomeric phosphate, lipid length, and acylation pattern were important for pro-inflammatory activity. Finally, it was found that transcriptional and post-transcription control mechanisms determine potencies and efficacies of cytokine production in cell-specific manners.	[Boons, Geert-Jan] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zhang, Wei; Reeves, Jaxk] Univ Georgia, Dept Stat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Boons, GJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	gjboons@ccrc.uga.edu	Zhang, Yanghui/O-4931-2017; Wolfert, Margreet A/J-1726-2016; Boons, Geert-Jan P H/J-3211-2016	Zhang, Yanghui/0000-0003-2189-3496; Wolfert, Margreet A/0000-0003-4864-0026; Boons, Geert-Jan P H/0000-0003-3111-5954	NIGMS [R01GM061761]; NCI [R01CA088986]; NATIONAL CANCER INSTITUTE [R01CA088986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061761] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM061761 from NIGMS and Grant R01CA088986 from NCI.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexander C, 2002, TRENDS GLYCOSCI GLYC, V14, P69, DOI 10.4052/tigg.14.69; ALLEY EW, 1995, GENE, V158, P247, DOI 10.1016/0378-1119(94)00892-V; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Dabbagh K, 2003, CURR OPIN INFECT DIS, V16, P199, DOI 10.1097/00001432-200306000-00003; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; Demchenko AV, 2003, J AM CHEM SOC, V125, P6103, DOI 10.1021/ja029316s; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; IMOTO M, 1985, TETRAHEDRON LETT, V26, P1545, DOI 10.1016/S0040-4039(00)98548-4; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Janusch H, 2002, J ENDOTOXIN RES, V8, P343, DOI 10.1179/096805102125000678; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; KULSHIN VA, 1992, J BACTERIOL, V174, P1793, DOI 10.1128/jb.174.6.1793-1800.1992; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Maiti KK, 2010, EUR J ORG CHEM, V2010, P80, DOI 10.1002/ejoc.200900973; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mathiak G, 2003, INT J MOL MED, V11, P41; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Mukherjee P, 2003, J IMMUNOTHER, V26, P47, DOI 10.1097/00002371-200301000-00006; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Muroi M, 2002, INFECT IMMUN, V70, P6043, DOI 10.1128/IAI.70.11.6043-6047.2002; Netea MG, 2001, EUR J IMMUNOL, V31, P2529, DOI 10.1002/1521-4141(200109)31:9<2529::AID-IMMU2529>3.0.CO;2-B; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Okemoto K, 2006, J IMMUNOL, V176, P1203, DOI 10.4049/jimmunol.176.2.1203; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park DSW, 2008, BIOMED MICRODEVICES, V10, P21, DOI 10.1007/s10544-007-9106-y; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RALPH P, 1977, J IMMUNOL, V119, P950; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Salkowski CA, 1997, INFECT IMMUN, V65, P3239, DOI 10.1128/IAI.65.8.3239-3247.1997; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; VAN AMERSFOORT ES, 2003, CLIN MICROBIOL REV, V16, P379; VAN DER LEY P, 2001, INFECT IMMUN, V69, P5981; Vasan M, 2007, ORG BIOMOL CHEM, V5, P2087, DOI 10.1039/b704427e; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Ye JP, 1997, FASEB J, V11, P825, DOI 10.1096/fasebj.11.11.9285480; Yoshizaki H, 2001, ANGEW CHEM INT EDIT, V40, P1475, DOI 10.1002/1521-3773(20010417)40:8<1475::AID-ANIE1475>3.0.CO;2-V; Zhang Y, 2008, CHEM-EUR J, V14, P558, DOI 10.1002/chem.200701165; Zhang YH, 2007, BIOORGAN MED CHEM, V15, P4800, DOI 10.1016/j.bmc.2007.05.012; Zhang YH, 2007, J AM CHEM SOC, V129, P5200, DOI 10.1021/ja068922a; Zughaier S, 2006, VACCINE, V24, P1291, DOI 10.1016/j.vaccine.2005.09.039; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	69	38	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29375	29386		10.1074/jbc.M110.115204	http://dx.doi.org/10.1074/jbc.M110.115204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20634284	hybrid, Green Published			2022-12-27	WOS:000281740100040
J	Song, HW; Rohrs, H; Tan, M; Wohltmann, M; Ladenson, JH; Turk, J				Song, Haowei; Rohrs, Henry; Tan, Min; Wohltmann, Mary; Ladenson, Jack H.; Turk, John			Effects of Endoplasmic Reticulum Stress on Group VIA Phospholipase A(2) in Beta Cells Include Tyrosine Phosphorylation and Increased Association with Calnexin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; GROUP-VIA PHOSPHOLIPASE-A(2); PANCREATIC-ISLETS EXPRESS; SMOOTH-MUSCLE-CELLS; INDUCED APOPTOSIS; INSULINOMA CELLS; PROTEIN-KINASE; P388D(1) MACROPHAGES; CERAMIDE GENERATION; BINDING DOMAIN	The Group VIA phospholipase A(2) (iPLA(2)beta) hydrolyzes glycerophospholipids at the sn-2-position to yield a free fatty acid and a 2-lysophospholipid, and iPLA(2)beta has been reported to participate in apoptosis, phospholipid remodeling, insulin secretion, transcriptional regulation, and other processes. Induction of endoplasmic reticulum (ER) stress in beta-cells and vascular myocytes with SERCA inhibitors activates iPLA(2)beta, resulting in hydrolysis of arachidonic acid from membrane phospholipids, by a mechanism that is not well understood. Regulatory proteins interact with iPLA(2)beta, including the Ca2+/calmodulin-dependent protein kinase II beta, and we have characterized the iPLA(2)beta interactome further using affinity capture and LC/electrospray ionization/MS/MS. An iPLA(2)beta -FLAG fusion protein was expressed in an INS-1 insulinoma cell line and then adsorbed to an anti-FLAG matrix after cell lysis. iPLA(2)beta and any associated proteins were then displaced with FLAG peptide and analyzed by SDS-PAGE. Gel sections were digested with trypsin, and the resultant peptide mixtures were analyzed by LC/MS/MS with database searching. This identified 37 proteins that associate with iPLA(2)beta, and nearly half of them reside in ER or mitochondria. They include the ER chaperone calnexin, whose association with iPLA(2)beta increases upon induction of ER stress. Phosphorylation of iPLA(2)beta at Tyr(616) also occurs upon induction of ER stress, and the phosphoprotein associates with calnexin. The activity of iPLA(2)beta in vitro increases upon co-incubation with calnexin, and overexpression of calnexin in INS-1 cells results in augmentation of ER stress-induced, iPLA(2)beta-catalyzed hydrolysis of arachidonic acid from membrane phospholipids, reflecting the functional significance of the interaction. Similar results were obtained with mouse pancreatic islets.	[Song, Haowei; Tan, Min; Wohltmann, Mary; Turk, John] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Rohrs, Henry] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Rohrs, Henry] Washington Univ, Sch Med, Dept Chem, St Louis, MO 63110 USA; [Ladenson, Jack H.] Washington Univ, Sch Med, Div Lab & Genom Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Turk, J (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	jturk@DOM.wustl.edu			National Institutes of Health United States Public Health Service [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, P60DK020579, P30DK020579, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341.	Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P7257, DOI 10.1074/jbc.270.13.7257; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chao TSO, 1997, CANCER RES, V57, P3168; Chevet E, 2010, SEMIN CELL DEV BIOL, V21, P486, DOI 10.1016/j.semcdb.2009.12.005; deCarvalho MGS, 1996, J BIOL CHEM, V271, P6987, DOI 10.1074/jbc.271.12.6987; Delom F, 2007, APOPTOSIS, V12, P293, DOI 10.1007/s10495-006-0625-4; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Guerin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006244; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kordeli E, 1998, J CELL SCI, V111, P2197; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2010, BIOCHIMIE, V92, P627, DOI 10.1016/j.biochi.2010.01.005; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Ma ZM, 1997, J BIOL CHEM, V272, P11118; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mohan C, 2009, CELL STRESS CHAPERON, V14, P49, DOI 10.1007/s12192-008-0054-0; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Owada S, 1999, J BIOL CHEM, V274, P2000, DOI 10.1074/jbc.274.4.2000; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Ren GH, 2010, BBA-MOL CELL RES, V1803, P468, DOI 10.1016/j.bbamcr.2010.01.020; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Smani T, 2007, CIRC RES, V101, P1194, DOI 10.1161/CIRCRESAHA.107.159053; Song HW, 2006, BIOCHEMISTRY-US, V45, P6392, DOI 10.1021/bi060502a; Song HW, 2010, BBA-MOL CELL BIOL L, V1801, P547, DOI 10.1016/j.bbalip.2010.01.006; Song HW, 2004, J AM SOC MASS SPECTR, V15, P1780, DOI 10.1016/j.jasms.2004.08.012; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takizawa T, 2004, J BIOCHEM, V136, P399, DOI 10.1093/jb/mvh133; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Tay HK, 2004, J BIOL CHEM, V279, P22505, DOI 10.1074/jbc.M308788200; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Turk J, 2004, CAN J PHYSIOL PHARM, V82, P824, DOI 10.1139/Y04-064; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Williams SD, 2001, AM J PHYSIOL-HEART C, V281, pH168, DOI 10.1152/ajpheart.2001.281.1.H168; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016	64	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33843	33857		10.1074/jbc.M110.153197	http://dx.doi.org/10.1074/jbc.M110.153197			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732873	Green Published, hybrid			2022-12-27	WOS:000283354000031
J	Guo, X; Ward, MD; Tiedebohl, JB; Oden, YM; Nyalwidhe, JO; Semmes, OJ				Guo, Xin; Ward, Michael D.; Tiedebohl, Jessica B.; Oden, Yvonne M.; Nyalwidhe, Julius O.; Semmes, O. John			Interdependent Phosphorylation within the Kinase Domain T-loop Regulates CHK2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE-RESPONSE; PROTEIN-KINASE; WIP1 PHOSPHATASE; CANCER; AUTOPHOSPHORYLATION; OLIGOMERIZATION; ACTIVATION; RADIATION; CHROMATIN; REPAIR	Chk2 is a critical regulator of the cellular DNA damage repair response. Activation of Chk2 in response to IR-induced damage is initiated by phosphorylation of the Chk2 SQ/TQ cluster domain at Ser(19), Ser(33), Ser(35), and Thr(68). This precedes auto-phosphorylation of Thr(383)/Thr(387) in the T-loop region of the kinase domain an event that is a prerequisite for efficient kinase activity. We conducted an in-depth analysis of phosphorylation within the T-loop region (residues 366-406). We report four novel phosphorylation sites at Ser(372), Thr(378), Thr(389), and Tyr(390). Substitution mutation Y390F was defective for kinase function. The substitution mutation T378A ablated the IR induction of kinase activity. Interestingly, the substitution mutation T389A demonstrated a 6-fold increase in kinase activity when compared with wild-type Chk2. In addition, phosphorylation at Thr(389) was a prerequisite to phosphorylation at Thr(387) but not at Thr(383). Quantitative mass spectrometry analysis revealed IR-induced phosphorylation and subcellular distribution of Chk2 phosphorylated species. We observed IR-induced increase in phosphorylation at Ser(379), Thr(389), and Thr(383)/Thr(389). Phosphorylation at Tyr(390) was dramatically reduced following IR. Exposure to IR was also associated with changes in the ratio of chromatin/nuclearlocalization. IR-induced increase in chromatin localization was associated with phosphorylation at Thr(372), Thr(379), Thr(383), Thr(389), Thr(383)/Thr(387), and Thr(383)/Thr(389). Chk2 hyper-phosphorylated species at Thr(383)/Thr(387)/Thr(389) and Thr(383)/Thr(387)/Thr(389)/Tyr(390) relocalized from almost exclusively chromatin to predominately nuclear expression, suggesting a role for phosphorylation in regulation of chromatin targeting and egress. The differential impact of T-loop phosphorylation on Chk2 ubiquitylation suggests a co-dependence of these modifications. The results demonstrate that a complex interdependent network of phosphorylation events within the T-loop exchange region regulates dimerization/auto-phosphorylation, kinase activation, and chromatin targeting/egress of Chk2.	[Guo, Xin; Ward, Michael D.; Tiedebohl, Jessica B.; Oden, Yvonne M.; Nyalwidhe, Julius O.; Semmes, O. John] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Canc Biol & Infect Dis Res Ctr, Norfolk, VA 23507 USA	Eastern Virginia Medical School	Semmes, OJ (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Canc Biol & Infect Dis Res Ctr, 700 W Olney Rd,Lewis Hall, Norfolk, VA 23507 USA.	semmesoj@evms.edu	Semmes, Oliver/GQA-5179-2022		NCI, U.S. Public Health Services [CA76595]; NATIONAL CANCER INSTITUTE [R01CA076595] Funding Source: NIH RePORTER	NCI, U.S. Public Health Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA76595 (to O. J. S.) from the NCI, U.S. Public Health Services. The authors declare they have no conflict of interest.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Buscemi G, 2006, MOL CELL BIOL, V26, P7832, DOI 10.1128/MCB.00534-06; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gupta SK, 2007, J BIOL CHEM, V282, P29431, DOI 10.1074/jbc.M704110200; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; KONDRAT RW, 1978, SCIENCE, V199, P978, DOI 10.1126/science.199.4332.978; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Li J, 2005, J BIOL CHEM, V280, P37948, DOI 10.1074/jbc.M509299200; Liang XB, 2006, INT J MOL MED, V17, P703; Lovly CM, 2008, MOL CELL BIOL, V28, P5874, DOI 10.1128/MCB.00821-08; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Matsuoka S, 2001, CANCER RES, V61, P5362; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Unwin RD, 2009, NAT PROTOC, V4, P870, DOI 10.1038/nprot.2009.57; Wu XL, 2003, J BIOL CHEM, V278, P36163, DOI 10.1074/jbc.M303795200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002	26	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33348	33357		10.1074/jbc.M110.149609	http://dx.doi.org/10.1074/jbc.M110.149609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20713355	hybrid, Green Published			2022-12-27	WOS:000283048200070
J	Li, D; Wang, DA; Wang, Y; Ling, WH; Feng, XA; Xia, M				Li, Dan; Wang, Duan; Wang, Yun; Ling, Wenhua; Feng, Xiang; Xia, Min			Adenosine Monophosphate-activated Protein Kinase Induces Cholesterol Efflux from Macrophage-derived Foam Cells and Alleviates Atherosclerosis in Apolipoprotein E-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; X-RECEPTOR-ALPHA; ENDOTHELIAL-CELLS; SCAVENGER RECEPTORS; METABOLIC SYNDROME; AMPK; ABCG1; LIVER; BINDING; ABCA1	Increasing evidence suggests that adenosine monophosphate-activated protein kinase (AMPK) exerts protective effects for cardiovascular diseases apart from the regulation of energy homeostasis. However, the role of AMPK and its underlying mechanism on macrophage foam cell formation are poorly understood. In this study, we sought to investigate the potential effects of AMPK in modulating cholesterol deposition by using murine macrophage-derived foam cells. Incubation with 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) markedly attenuated the cholesterol ester accumulation in oxidized low density lipoprotein-loaded macrophages. Notably, AICAR treatment significantly increased ATP-binding cassette transporters G1 (Abcg1) mRNA and protein levels without affecting mRNA and protein expression of ABCA1, scavenger receptors, including scavenger receptor-A, CD36, and scavenger receptor-BI (SR-BI), and cholesterol synthesis-related genes. The up-regulation of Abcg1 by AICAR was independent of the liver X receptor/retinoid X receptor pathway but dependent on ERK activation. AICAR elevates Abcg1 expression through a post-transcriptional mechanism that stabilizes the mRNA. Using a heterologous system with luciferase as a reporter, we further identify the Abcg1 mRNA3'-UTR responsible for the regulatory effect of AICAR. Prevention of ABCG1 expression by small interfering RNA abolished the AICAR-mediated attenuation on foam cell formation. Furthermore, increased ABCG1 expression and reduced lipid accumulation were demonstrated in AICAR-treated macrophages isolated from apolipoprotein E-deficient mice (apoE(-/-) mice). AICAR treatment also inhibited atherosclerotic plaque formation in apoE(-/-) mice. Our findings elucidate a precise mechanism involved in the prevention of atherogenesis by AMPK.	[Li, Dan; Wang, Duan; Wang, Yun; Ling, Wenhua; Feng, Xiang; Xia, Min] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510080, Guangdong, Peoples R China; [Li, Dan; Ling, Wenhua; Feng, Xiang; Xia, Min] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xia, M (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Northern Campus,74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	xiamin@mail.sysu.edu.cn		Li, Dan/0000-0001-6458-6096	National Natural Science Foundation [30730079, 30700665]; Guangdong Natural Science Foundation [9151012003000002]; Foundation for the Author of National Excellent Doctoral Dissertation of China [200978]; Research Fund for the Doctoral Program of Higher Education of China [20070558276]; Sun Yat-Sen University [10ykzd04]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Sun Yat-Sen University	This work was supported by National Natural Science Foundation Grants 30730079 and 30700665, Guangdong Natural Science Foundation Grant 9151012003000002, Foundation for the Author of National Excellent Doctoral Dissertation of China Grant 200978, Research Fund for the Doctoral Program of Higher Education of China Grant 20070558276, and the Fundamental Research Funds for the Central Universities of Sun Yat-Sen University 10ykzd04.	Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Conway JP, 2006, J BIOL CHEM, V281, P27991, DOI 10.1074/jbc.M605026200; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Ishii N, 2009, J BIOL CHEM, V284, P34561, DOI 10.1074/jbc.M109.028043; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li D, 2010, ARTERIOSCL THROM VAS, V30, P1354, DOI 10.1161/ATVBAHA.110.204230; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu KY, 2010, CIRCULATION, V121, P1828, DOI 10.1161/CIRCULATIONAHA.109.876839; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mauldin JP, 2006, J BIOL CHEM, V281, P21216, DOI 10.1074/jbc.M510952200; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; OTTNAD E, 1995, P NATL ACAD SCI USA, V92, P1391, DOI 10.1073/pnas.92.5.1391; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rigamonti E, 2005, CIRC RES, V97, P682, DOI 10.1161/01.RES.0000184678.43488.9f; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sabol SL, 2005, J LIPID RES, V46, P2151, DOI 10.1194/jlr.M500080-JLR200; Schulz E, 2005, CIRCULATION, V111, P3473, DOI 10.1161/CIRCULATIONAHA.105.546812; Schulz E, 2008, CIRCULATION, V118, P1347, DOI 10.1161/CIRCULATIONAHA.108.784298; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Xia M, 2005, J BIOL CHEM, V280, P36792, DOI 10.1074/jbc.M505047200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	51	94	97	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33499	33509		10.1074/jbc.M110.159772	http://dx.doi.org/10.1074/jbc.M110.159772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20713354	hybrid, Green Published			2022-12-27	WOS:000283048200084
J	Lin, LC; Hsu, JH; Wang, LC				Lin, Lee-Chung; Hsu, Jen-Hung; Wang, Long-Chi			Identification of Novel Inhibitors of 1-Aminocyclopropane-1-carboxylic Acid Synthase by Chemical Screening in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLENE SIGNAL-TRANSDUCTION; F-BOX PROTEINS; ACC SYNTHASE; GENE FAMILY; L-AMINOETHOXYVINYLGLYCINE; ENDOPLASMIC-RETICULUM; RESPONSE PATHWAY; RECEPTOR FAMILY; BIOSYNTHESIS; ETO1	Ethylene is a gaseous hormone important for adaptation and survival in plants. To further understand the signaling and regulatory network of ethylene, we used a phenotype-based screening strategy to identify chemical compounds interfering with the ethylene response in Arabidopsis thaliana. By screening a collection of 10,000 structurally diverse small molecules, we identified compounds suppressing the constitutive triple response phenotype in the ethylene overproducer mutant eto1-4. The compounds reduced the expression of a reporter gene responsive to ethylene and the otherwise elevated level of ethylene in eto1-4. Structure and function analysis revealed that the compounds contained a quinazolinone backbone. Further studies with genetic mutants and transgenic plants involved in the ethylene pathway showed that the compounds inhibited ethylene biosynthesis at the step of converting S-adenosylmethionine to 1-aminocyclopropane-1-carboxylic acid (ACC) by ACC synthase. Biochemical studies with in vitro activity assay and enzyme kinetics analysis indicated that a representative compound was an uncompetitive inhibitor of ACC synthase. Finally, global gene expression profiling uncovered a significant number of genes that were co-regulated by the compounds and aminoethoxyvinylglycine, a potent inhibitor of ACC synthase. The use of chemical screening is feasible in identifying small molecules modulating the ethylene response in Arabidopsis seedlings. The discovery of such chemical compounds will be useful in ethylene research and can offer potentially useful agrochemicals for quality improvement in post-harvest agriculture.	[Lin, Lee-Chung; Hsu, Jen-Hung; Wang, Long-Chi] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Lin, Lee-Chung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Wang, LC (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan.	lwang@gate.sinica.edu.tw			National Science and Technology Program [94S0201]; National Science Council [NSC972311B001003]; Development Program of Industrialization for Agricultural Biotechnology [99S0030088]	National Science and Technology Program; National Science Council(Ministry of Science and Technology, Taiwan); Development Program of Industrialization for Agricultural Biotechnology	This work was supported by National Science and Technology Program Grant 94S0201 for initial chemical screening, National Science Council Grant NSC972311B001003, and Development Program of Industrialization for Agricultural Biotechnology Grant 99S0030088 for subsequent functional characterization (to L.-C. W.).	ADAMS DO, 1979, P NATL ACAD SCI USA, V76, P170, DOI 10.1073/pnas.76.1.170; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Barry CS, 1996, PLANT J, V9, P525, DOI 10.1046/j.1365-313X.1996.09040525.x; BEYER EM, 1976, PLANT PHYSIOL, V58, P268, DOI 10.1104/pp.58.3.268; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; Blackwell HE, 2003, PLANT PHYSIOL, V133, P448, DOI 10.1104/pp.103.031138; Bleecker AB, 1998, PHILOS T ROY SOC B, V353, P1405, DOI 10.1098/rstb.1998.0295; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BOLLER T, 1979, PLANTA, V145, P293, DOI 10.1007/BF00454455; Capitani G, 2005, FEBS LETT, V579, P2458, DOI 10.1016/j.febslet.2005.03.048; Capitani G, 2002, J BIOL CHEM, V277, P49735, DOI 10.1074/jbc.M208427200; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Christians MJ, 2009, PLANT J, V57, P332, DOI 10.1111/j.1365-313X.2008.03693.x; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ENGLISH PJ, 1995, PLANT PHYSIOL, V109, P1435, DOI 10.1104/pp.109.4.1435; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Goda H, 2008, PLANT J, V55, P526, DOI 10.1111/j.1365-313X.2008.03510.x; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huai Q, 2001, J BIOL CHEM, V276, P38210; HYODO H, 1986, PLANT CELL PHYSIOL, V27, P391; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; Mhaske SB, 2006, TETRAHEDRON, V62, P9787, DOI 10.1016/j.tet.2006.07.098; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; OZAKI K, 1985, J MED CHEM, V28, P568, DOI 10.1021/jm50001a006; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; ROMAN G, 1995, GENETICS, V139, P1393; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Thomann A, 2005, FEBS LETT, V579, P3239, DOI 10.1016/j.febslet.2005.02.068; Toth R, 2010, TRENDS PLANT SCI, V15, P81, DOI 10.1016/j.tplants.2009.11.005; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; Tsuchisaka A, 2009, GENETICS, V183, P979, DOI 10.1534/genetics.109.107102; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xia Y, 2001, BIOORG MED CHEM LETT, V11, P1193, DOI 10.1016/S0960-894X(01)00190-1; Yamagami T, 2003, J BIOL CHEM, V278, P49102, DOI 10.1074/jbc.M308297200; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Yoshida H, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-14	57	31	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33445	33456		10.1074/jbc.M110.132498	http://dx.doi.org/10.1074/jbc.M110.132498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682786	Green Published, hybrid			2022-12-27	WOS:000283048200079
J	Sweet, SMM; Li, MX; Thomas, PM; Durbin, KR; Kelleher, NL				Sweet, Steve M. M.; Li, Mingxi; Thomas, Paul M.; Durbin, Kenneth R.; Kelleher, Neil L.			Kinetics of Re-establishing H3K79 Methylation Marks in Global Human Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 METHYLATION; CONSERVATIVE SEGREGATION; GENE-TRANSCRIPTION; MASS-SPECTROMETRY; MAMMALIAN-CELLS; NUCLEOSOME CORE; DNA-REPLICATION; HUMAN GENOME; H2B; EXPRESSION	We employ a stable isotope strategy wherein both histones and their methylations are labeled in synchronized human cells. This allows us to differentiate between old and new methylations on pre-existing versus newly synthesized histones. The strategy is implemented on K79 methylation in an isoform-specific manner for histones H3.1, H3.2, and H3.3. Although levels of H3.3K79 monomethylation are higher than that of H3.2/ H3.1, the rate of establishing the K79 methylation is the same for all three isoforms. Surprisingly, we find that pre-existing "old" histones continue to be K79-monomethylated and -dimethylated at a rate equal to the newly synthesized histones. These observations imply that some degree of positional "scrambling" of K79 methylation occurs through the cell cycle.	[Kelleher, Neil L.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Thomas, Paul M.] Northwestern Univ, Prote Ctr Excellence, Evanston, IL 60208 USA	University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University	Kelleher, NL (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	n-kelleher@northwestern.edu	Sweet, Steve/B-5528-2008; Thomas, Paul M/A-6233-2011	Sweet, Steve/0000-0002-3962-0421; Thomas, Paul M/0000-0003-2887-4765	National Institutes of Health [GM 067193-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 067193-08.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; KUMAR S, 1986, BIOCHEMISTRY-US, V25, P2055, DOI 10.1021/bi00356a033; LEFFAK IM, 1984, NATURE, V307, P82, DOI 10.1038/307082a0; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pesavento JJ, 2004, J AM CHEM SOC, V126, P3386, DOI 10.1021/ja039748i; PRIOR CP, 1980, CELL, V20, P597, DOI 10.1016/0092-8674(80)90306-2; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Scharf AND, 2009, NUCLEIC ACIDS RES, V37, P5032, DOI 10.1093/nar/gkp518; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Siuti N, 2010, ANAL BIOCHEM, V396, P180, DOI 10.1016/j.ab.2009.09.022; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Thomas CE, 2006, J PROTEOME RES, V5, P240, DOI 10.1021/pr050266a; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; YAMASU K, 1990, J BIOCHEM-TOKYO, V107, P15, DOI 10.1093/oxfordjournals.jbchem.a122999; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537	39	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32778	32786		10.1074/jbc.M110.145094	http://dx.doi.org/10.1074/jbc.M110.145094			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20699226	hybrid, Green Published			2022-12-27	WOS:000283048200013
J	Angelucci, F; Dimastrogiovanni, D; Boumis, G; Brunori, M; Miele, AE; Saccoccia, F; Bellelli, A				Angelucci, Francesco; Dimastrogiovanni, Daniela; Boumis, Giovanna; Brunori, Maurizio; Miele, Adriana E.; Saccoccia, Fulvio; Bellelli, Andrea			Mapping the Catalytic Cycle of Schistosoma mansoni Thioredoxin Glutathione Reductase by X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BASE CATALYSIS; MECHANISM; MITOCHONDRIAL; PRAZIQUANTEL; EVOLUTION; SYSTEMS	Schistosomiasis is the second most widespread human parasitic disease. It is principally treated with one drug, praziquantel, that is administered to 100 million people each year; less sensitive strains of schistosomes are emerging. One of the most appealing drug targets against schistosomiasis is thioredoxin glutathione reductase (TGR). This natural chimeric enzyme is a peculiar fusion of a glutaredoxin domain with a thioredoxin selenocysteine (U)-containing reductase domain. Selenocysteine is located on a flexible C-terminal arm that is usually disordered in the available structures of the protein and is essential for the full catalytic activity of TGR. In this study, we dissect the catalytic cycle of Schistosoma mansoni TGR by structural and functional analysis of the U597C mutant. The crystallographic data presented herein include the following: the oxidized form (at 1.9 angstrom resolution); the NADPH-and GSH-bound forms (2.3 and 1.9 angstrom, respectively); and a different crystal form of the (partially) reduced enzyme (3.1 angstrom), showing the physiological dimer and the entire C terminus of one subunit. Whenever possible, we determined the rate constants for the interconversion between the different oxidation states of TGR by kinetic methods. By combining the crystallographic analysis with computer modeling, we were able to throw further light on the mechanism of action of S. mansoni TGR. In particular, we hereby propose the putative functionally relevant conformational change of the C terminus after the transfer of reducing equivalents from NADPH to the redox sites of the enzyme.	[Bellelli, Andrea] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, CNR Inst Mol Biol & Pathol, I-00185 Rome, Italy; Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Bellelli, A (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, CNR Inst Mol Biol & Pathol, Ple Aldo Moro 5, I-00185 Rome, Italy.	andrea.bellelli@uniroma1.it	Bellelli, Andrea/D-2785-2009; Miele, Adriana E./F-4083-2011; Saccoccia, Fulvio/ADI-5036-2022	Miele, Adriana E./0000-0002-4637-2606; Saccoccia, Fulvio/0000-0002-3527-6694; BOUMIS, Giovanna/0000-0001-5323-7288; Brunori, Maurizio/0000-0002-7795-1635	Fondazione Roma; Sapienza University of Rome Progetto Universita; Progetto Ateneo Federato; MIUR of Italy; European Community [FP7/2007-2013, 226716]	Fondazione Roma(Fondazione RomaEuropean Commission); Sapienza University of Rome Progetto Universita; Progetto Ateneo Federato; MIUR of Italy(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission)	This work was supported by Fondazione Roma (project title "Rational Approach to the Specific Inhibition of Plasmodium falciparum and Schistosoma mansoni"), Sapienza University of Rome Progetto Universita 2007 and 2008 and Progetto Ateneo Federato 2007 and 2008, MIUR of Italy FIRB/Proteomica 2007-protRBRN07BMCT, and the European Community Seventh Framework Programme FP7/2007-2013, Agreement 226716.	Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Angelucci F, 2007, PARASITOLOGY, V134, P1215, DOI 10.1017/S0031182007002600; Angelucci F, 2008, PROTEINS, V72, P936, DOI 10.1002/prot.21986; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Argyrou A, 2002, BIOCHEMISTRY-US, V41, P14580, DOI 10.1021/bi020376k; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASCH PF, 1984, AM J TROP MED HYG, V33, P911, DOI 10.4269/ajtmh.1984.33.911; Bateman H, 1910, P CAMB PHILOS SOC, V15, P423; Bauer H, 2003, J BIOL CHEM, V278, P33020, DOI 10.1074/jbc.M303762200; Biterova EI, 2005, P NATL ACAD SCI USA, V102, P15018, DOI 10.1073/pnas.0504218102; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Cheng Q, 2009, J BIOL CHEM, V284, P3998, DOI 10.1074/jbc.M807068200; Cioli D, 2008, TRENDS PARASITOL, V24, P379, DOI 10.1016/j.pt.2008.05.006; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Fritz-Wolf K, 2007, J MOL BIOL, V370, P116, DOI 10.1016/j.jmb.2007.04.044; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Hondal RJ, 2009, BBA-GEN SUBJECTS, V1790, P1501, DOI 10.1016/j.bbagen.2009.04.015; Huang HH, 2008, BIOCHEMISTRY-US, V47, P1721, DOI 10.1021/bi702040u; Huang HH, 2008, BIOCHEMISTRY-US, V47, P12769, DOI 10.1021/bi801449h; HUBER PW, 1980, BIOCHEMISTRY-US, V19, P4568, DOI 10.1021/bi00561a005; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Novoselov SV, 2003, PROTEIN SCI, V12, P372, DOI 10.1110/ps.0226503; Otero L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-237; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rai G, 2009, J MED CHEM, V52, P6474, DOI 10.1021/jm901021k; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Stothard JR, 2009, PARASITOLOGY, V136, P1665, DOI 10.1017/S0031182009991272; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Summa CM, 2007, P NATL ACAD SCI USA, V104, P3177, DOI 10.1073/pnas.0611593104; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Wahl MC, 2005, J MOL BIOL, V345, P1119, DOI 10.1016/j.jmb.2004.11.004; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001	42	48	50	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32557	32567		10.1074/jbc.M110.141960	http://dx.doi.org/10.1074/jbc.M110.141960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20659890	Green Published, hybrid			2022-12-27	WOS:000282683000070
J	Gkogkas, C; Sonenberg, N; Costa-Mattioli, M				Gkogkas, Christos; Sonenberg, Nahum; Costa-Mattioli, Mauro			Translational Control Mechanisms in Long-lasting Synaptic Plasticity and Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LOCAL PROTEIN-SYNTHESIS; MESSENGER-RNA TRANSLATION; TERM FACILITATION; CYTOPLASMIC POLYADENYLATION; DEPENDENT TRANSLATION; GENERAL TRANSLATION; TUBEROUS-SCLEROSIS; SIGNALING PATHWAY; REPRESSOR 4E-BP2; MAMMALIAN-CELLS		[Gkogkas, Christos; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Gkogkas, Christos; Sonenberg, Nahum] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	McGill University; McGill University; Baylor College of Medicine	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.	nahum.sonenberg@mcgill.ca; costamat@bcm.edu	Gkogkas, Christos/GQH-2659-2022; Gkogkas, Christos/GLR-5348-2022	Gkogkas, Christos/0000-0001-6281-3419; 				Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; AGRANOFF BW, 1964, SCIENCE, V146, P952, DOI 10.1126/science.146.3646.952; Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Antion MD, 2008, MOL CELL BIOL, V28, P2996, DOI 10.1128/MCB.00201-08; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HERBERT TP, 2007, TRANSLATIONAL CONTRO, P601; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Huang KX, 2004, PROG CHEM, V16, P308; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Opazo P, 2003, J NEUROSCI, V23, P3679; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Weatherill DB, 2010, J BIOL CHEM, V285, P12255, DOI 10.1074/jbc.M109.071142; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	64	52	54	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31913	31917		10.1074/jbc.R110.154476	http://dx.doi.org/10.1074/jbc.R110.154476			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	660XZ	20693284	Green Published, hybrid			2022-12-27	WOS:000282683000003
J	Lee, AW; Champagne, N; Wang, XJ; Su, XD; Goodyer, C; Leblanc, AC				Lee, Andrea W.; Champagne, Nathalie; Wang, Xiaojun; Su, Xiao-Dong; Goodyer, Cynthia; Leblanc, Andrea C.			Alternatively Spliced Caspase-6B Isoform Inhibits the Activation of Caspase-6A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEURONS; APOPTOSIS; PROTEIN; DEGRADATION; EXPRESSION; CLEAVAGE; CLONING; VARIANT; DEATH; GENE	Caspase-6 (Casp6) is activated early in Alzheimer disease and involved in axonal degeneration, but the regulation of Casp6 activity has not been explored. Several alternatively spliced forms of caspases act as inhibitors of caspase activation. The CASP6 gene generates an alternatively spliced transcript known as CASP6 beta in addition to the CASP6 alpha that encodes pro-Casp6a. Here, we show that the CASP6 beta transcript and the pro-Casp6b protein are present in many cell lines, in primary human neurons, and in human brains. Unlike most other alternatively spliced caspase transcripts, pro-Casp6b contains a catalytic site. However, purified pro-Casp6b did not have caspase activity, nor did it inhibit already activated Casp6a. Pro-Casp6b prevented the proteolytic activation of pro-Casp6a in vitro and in cells. Pro-Casp6b interacts directly with pro-Casp6a. This work shows that pro-Casp6b is an inhibitor of pro-Casp6a activation. These results imply that pro-Casp6b could negatively regulate pro-Casp6a activation in neurons and prevent Casp6a-mediated axonal degeneration.	[Leblanc, Andrea C.] Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Wang, Xiaojun; Su, Xiao-Dong] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Lee, Andrea W.; Leblanc, Andrea C.] McGill Univ, Dept Neurol, Montreal, PQ H3H 1P3, Canada; [Lee, Andrea W.; Leblanc, Andrea C.] McGill Univ, Dept Neurosurg, Montreal, PQ H3H 1P3, Canada; [Goodyer, Cynthia] McGill Univ, Dept Pediat, Montreal, PQ H3H 1P3, Canada	Lady Davis Institute; McGill University; Peking University; McGill University; McGill University; McGill University	Leblanc, AC (corresponding author), Sir Mortimer B Davis Jewish Hosp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, 3755 Ch Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	andrea.leblanc@mcgill.ca			National Institutes of Health [MS/MH40965-01]; Canadian Institutes of Health Research (CIHR) [MOP81146, CCI-85682]; CIHR-National Science Foundation of China Joint Health Initiative; Fonds de la Recherche en Sante	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR-National Science Foundation of China Joint Health Initiative(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported, in whole or in part, by National Institutes of Health Grant MS/MH40965-01. This work was also supported by Canadian Institutes of Health Research (CIHR) Grants MOP81146 and CCI-85682, the CIHR-National Science Foundation of China Joint Health Initiative, the James McGill Professorship, and the Fonds de la Recherche en Sante (to A. C. L.).	Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; ALNEMRI ES, 1995, J BIOL CHEM, V270, P4312, DOI 10.1074/jbc.270.9.4312; Denault J, 2002, CURRENT PROTOCOLS PR; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; Foley JD, 2004, J BIOL CHEM, V279, P32142, DOI 10.1074/jbc.M313683200; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Guo H, 2006, CELL DEATH DIFFER, V13, P285, DOI 10.1038/sj.cdd.4401753; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Himeji D, 2002, BLOOD, V99, P4070, DOI 10.1182/blood.V99.11.4070; Huang YH, 2001, BIOCHEM BIOPH RES CO, V283, P762, DOI 10.1006/bbrc.2001.4871; Ito A, 2000, FEBS LETT, V470, P360, DOI 10.1016/S0014-5793(00)01351-X; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Mohr A, 2005, ONCOGENE, V24, P2421, DOI 10.1038/sj.onc.1208432; Morozov V, 2006, DEVELOPMENT, V133, P813, DOI 10.1242/dev.02262; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Olson NE, 2003, J IMMUNOL, V170, P6065, DOI 10.4049/jimmunol.170.12.6065; Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629; Seol DW, 1999, J BIOL CHEM, V274, P2072, DOI 10.1074/jbc.274.4.2072; Tounekti O, 2004, J NEUROCHEM, V89, P561, DOI 10.1111/j.1471-4159.2004.02349.x; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zandy AJ, 2007, INVEST OPHTH VIS SCI, V48, P293, DOI 10.1167/iovs.06-0656; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000; Zhang Y, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0007.2001	34	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31974	31984		10.1074/jbc.M110.152744	http://dx.doi.org/10.1074/jbc.M110.152744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20682790	Green Published, hybrid			2022-12-27	WOS:000282683000010
J	Nemoto, N; Singh, CR; Udagawa, T; Wang, SZ; Thorson, E; Winter, Z; Ohira, T; Ii, M; Valasek, L; Brown, SJ; Asano, K				Nemoto, Naoki; Singh, Chingakham Ranjit; Udagawa, Tsuyoshi; Wang, Suzhi; Thorson, Elizabeth; Winter, Zachery; Ohira, Takahiro; Ii, Miki; Valasek, Leos; Brown, Susan J.; Asano, Katsura			Yeast 18 S rRNA Is Directly Involved in the Ribosomal Response to Stringent AUG Selection during Translation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START CODON SELECTION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; MESSENGER-RNA; 80S RIBOSOME; AMINOGLYCOSIDE ANTIBIOTICS; MULTIFACTOR COMPLEX; DECODING CENTER; GTP HYDROLYSIS; SUBUNIT	In eukaryotes, the 40 S ribosomal subunit serves as the platform of initiation factor assembly, to place itself precisely on the AUG start codon. Structural arrangement of the 18 S rRNA determines the overall shape of the 40 S subunit. Here, we present genetic evaluation of yeast 18 S rRNA function using 10 point mutations altering the polysome profile. All the mutants reduce the abundance of the mutant 40 S, making it limiting for translation initiation. Two of the isolated mutations, G875A, altering the core of the platform domain that binds eIF1 and eIF2, and A1193U, changing the h31 loop located below the P-site tRNA(i)(Met), show phenotypes indicating defective regulation of AUG selection. Evidence is provided that these mutations reduce the interaction with the components of the preinitiation complex, thereby inhibiting its function at different steps. These results indicate that the 18 S rRNA mutations impair the integrity of scanning-competent preinitiation complex, thereby altering the 40 S subunit response to stringent AUG selection. Interestingly, nine of the mutations alter the body/platform domains of 18 S rRNA, potentially affecting the bridges to the 60 S subunit, but they do not change the level of 18 S rRNA intermediates. Based on these results, we also discuss the mechanism of the selective degradation of the mutant 40 S subunits.	[Nemoto, Naoki; Singh, Chingakham Ranjit; Udagawa, Tsuyoshi; Wang, Suzhi; Thorson, Elizabeth; Winter, Zachery; Ohira, Takahiro; Ii, Miki; Brown, Susan J.; Asano, Katsura] Kansas State Univ, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA; [Wang, Suzhi; Brown, Susan J.] Kansas State Univ, Arthropod Genom Ctr, Div Biol, Manhattan, KS 66506 USA; [Valasek, Leos] Acad Sci Czech Republic, Inst Microbiol, Lab Regulat Gene Express, CR-14220 Prague, Czech Republic	Kansas State University; Kansas State University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Asano, K (corresponding author), Kansas State Univ, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA.	kasano@ksu.edu	Valášek, Leoš Shivaya/I-5743-2014	Valášek, Leoš Shivaya/0000-0001-8123-8667; Brown, Susan/0000-0002-7984-0445	National Institutes of Health [R01, GM64781]; Kansas State University Terry Johnson Cancer Center; Wellcome Trust [076456/Z/05/Z, AVOZ50200510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University Terry Johnson Cancer Center; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 Grant GM64781. This work was also supported by Innovative Award from Kansas State University Terry Johnson Cancer Center (to K. A.) and Wellcome Trust Grants 076456/Z/05/Z and Institutional Research Concept AVOZ50200510 (to L. V.).	Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Allen GS, 2007, MOL MICROBIOL, V63, P941, DOI 10.1111/j.1365-2958.2006.05574.x; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 2002, METHOD ENZYMOL, V351, P221; Asano K, 2007, GENE DEV, V21, P1280, DOI 10.1101/gad.1562707; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; CHERNOFF YO, 1994, EMBO J, V13, P906, DOI 10.1002/j.1460-2075.1994.tb06334.x; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Decatur WA, 2007, METHOD ENZYMOL, V425, P283, DOI 10.1016/S0076-6879(07)25013-X; Dong J, 2008, GENE DEV, V22, P2242, DOI 10.1101/gad.1696608; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; Hage Aziz El, 2004, RNA Biol, V1, P10; Hasenohrl D, 2009, RNA, V15, P2288, DOI 10.1261/rna.1662609; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Jirincova H, 1998, FOLIA BIOL-PRAGUE, V44, P73; Konstantinidis TC, 2006, BIOCHEMISTRY-US, V45, P3525, DOI 10.1021/bi052505d; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; LaRiviere FJ, 2006, MOL CELL, V24, P619, DOI 10.1016/j.molcel.2006.10.008; Liang XH, 2009, RNA, V15, P1716, DOI 10.1261/rna.1724409; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Noller HF, 2005, SCIENCE, V309, P1508, DOI 10.1126/science.1111771; Noller HF, 2007, TRANSLATIONAL CONTRO, P41; Olsen DS, 2003, EMBO J, V22, P193, DOI 10.1093/emboj/cdg030; Ortiz PA, 2005, NUCLEIC ACIDS RES, V33, P5740, DOI 10.1093/nar/gki882; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Roll-Mecak A, 2001, TRENDS BIOCHEM SCI, V26, P705, DOI 10.1016/S0968-0004(01)02024-2; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Sangthong P, 2007, NUCLEIC ACIDS RES, V35, P3573, DOI 10.1093/nar/gkm283; Singh CR, 2007, J MOL BIOL, V370, P315, DOI 10.1016/j.jmb.2007.04.034; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Singh CR, 2007, METHOD ENZYMOL, V429, P139, DOI 10.1016/S0076-6879(07)29007-X; Singh CR, 2004, J BIOL CHEM, V279, P31910, DOI 10.1074/jbc.M313940200; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Tselika S, 2008, BIOCHIMIE, V90, P908, DOI 10.1016/j.biochi.2008.02.010; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Valasek L, 2001, J BIOL CHEM, V276, P43351, DOI 10.1074/jbc.M106887200; VandePeer Y, 1997, NUCLEIC ACIDS RES, V25, P111, DOI 10.1093/nar/25.1.111; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Velichutina IV, 2000, RNA, V6, P1174, DOI 10.1017/S1355838200000637; VENEMA J, 1995, YEAST, V11, P145, DOI 10.1002/yea.320110206; Wai HH, 2000, NUCLEIC ACIDS RES, V28, P3524, DOI 10.1093/nar/28.18.3524; Watanabe R, 2010, J BIOL CHEM, V285, P21922, DOI 10.1074/jbc.M110.132027; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P175, DOI 10.1093/nar/29.1.175; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000	61	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32200	32212		10.1074/jbc.M110.146662	http://dx.doi.org/10.1074/jbc.M110.146662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699223	hybrid, Green Published			2022-12-27	WOS:000282683000033
J	Szerlong, HJ; Prenni, JE; Nyborg, JK; Hansen, JC				Szerlong, Heather J.; Prenni, Jessica E.; Nyborg, Jennifer K.; Hansen, Jeffrey C.			Activator-dependent p300 Acetylation of Chromatin in Vitro ENHANCEMENT OF TRANSCRIPTION BY DISRUPTION OF REPRESSIVE NUCLEOSOME-NUCLEOSOME INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-VIRUS TYPE-1; HISTONE TAIL DOMAINS; HIGHER-ORDER STRUCTURE; RNA-POLYMERASE-III; ACETYLTRANSFERASE ACTIVITY; COACTIVATORS CBP/P300; RECOMBINANT HISTONES; TAX TRANSACTIVATION; H4-K16 ACETYLATION; CORE PARTICLE	Condensation of chromatin into higher order structures is mediated by intra- and interfiber nucleosome-nucleosome interactions. Our goals in this study were to determine the impact specific activator-dependent histone acetylation had on chromatin condensation and to ascertain whether acetylation-induced changes in chromatin condensation were related to changes in RNA polymerase II (RNAPII) activity. To accomplish this, an in vitro model system was constructed in which the purified transcriptional activators, Tax and phosphorylated CREB (cAMP-response element-binding protein), recruited the p300 histone acetyltransferase to nucleosomal templates containing the human T-cell leukemia virus type-1 promoter sequences. We find that activator-dependent p300 histone acetylation disrupted both inter-and intrafiber nucleosome-nucleosome interactions and simultaneously led to enhanced RNAPII transcription from the decondensed model chromatin. p300 histone acetyltransferase activity had two distinct components: non-targeted, ubiquitousactivityintheabsenceofactivatorsandactivator-dependent activity targeted primarily to promoter-proximal nucleosomes. Mass spectrometry identified several unique p300 acetylation sites on nucleosomal histone H3 (H3K9, H3K27, H3K36, and H3K37). Collectively, our data have important implications for understanding both the mechanism of RNAPII transcriptional regulation by chromatin and the molecular determinants of higher order chromatin structure.	[Szerlong, Heather J.; Prenni, Jessica E.; Nyborg, Jennifer K.; Hansen, Jeffrey C.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Hansen, JC (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Campus Delivery 1870, Ft Collins, CO 80523 USA.	jeffrey.c.hansen@colostate.edu		Prenni, Jessica/0000-0002-0337-8450	National Institutes of Health [GM45916, GM088409, CA055035]; American Heart Association; NATIONAL CANCER INSTITUTE [R55CA055035, R01CA055035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088409, R01GM045916, R29GM045916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45916 (to J. C. H.) and GM088409 and CA055035 (to J. K. N.). This work was also supported by an American Heart Association postdoctoral fellowship (to H. J. S.).	Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; DYNAN WS, 1987, GENETIC ENG PRINCIPL, V9, P75; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Geiger TR, 2008, MOL CELL BIOL, V28, P1383, DOI 10.1128/MCB.01657-07; Georges SA, 2003, MOL CELL BIOL, V23, P3392, DOI 10.1128/MCB.23.10.3392-3404.2003; Georges SA, 2002, MOL CELL BIOL, V22, P127, DOI 10.1128/MCB.22.1.127-137.2002; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; HANSEN JC, 1992, BIOCHEMISTRY-US, V31, P7977, DOI 10.1021/bi00149a032; Hansen JC, 2010, J CELL PHYSIOL, V224, P289, DOI 10.1002/jcp.22150; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Horowitz-Scherer RA, 2006, CHROMOSOMA, V115, P1, DOI 10.1007/s00412-005-0035-3; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Konesky KL, 2006, J VIROL, V80, P10542, DOI 10.1128/JVI.00631-06; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lemasson I, 2006, J BIOL CHEM, V281, P13075, DOI 10.1074/jbc.M512193200; Lemasson I, 2002, J BIOL CHEM, V277, P49459, DOI 10.1074/jbc.M209566200; Lenzmeier BA, 1997, J VIROL, V71, P2577, DOI 10.1128/JVI.71.3.2577-2580.1997; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GH, 2010, MOL CELL, V38, P41, DOI 10.1016/j.molcel.2010.01.042; Lopez DI, 2007, PROTEIN EXPRES PURIF, V55, P406, DOI 10.1016/j.pep.2007.06.011; Lu HX, 2002, MOL CELL BIOL, V22, P4450, DOI 10.1128/MCB.22.13.4450-4462.2002; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; McBryant SJ, 2009, J BIOL CHEM, V284, P16716, DOI 10.1074/jbc.M109.011288; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nyborg JK, 2010, BBA-GENE REGUL MECH, V1799, P266, DOI 10.1016/j.bbagrm.2009.09.002; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Sharma N, 2008, P NATL ACAD SCI USA, V105, P7959, DOI 10.1073/pnas.0800534105; Shilatifard A, 2004, BBA-GENE STRUCT EXPR, V1677, P79, DOI 10.1016/j.bbaexp.2003.11.013; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Watanabe S, 2010, BBA-GENE REGUL MECH, V1799, P480, DOI 10.1016/j.bbagrm.2010.01.009; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Yang YW, 2003, ENDOCRINOLOGY, V144, P5658, DOI 10.1210/en.2003-0798; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445; Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303	71	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31954	31964		10.1074/jbc.M110.148718	http://dx.doi.org/10.1074/jbc.M110.148718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20720004	hybrid, Green Published			2022-12-27	WOS:000282683000008
J	Feng, L; Wang, JD; Chen, JJ				Feng, Lin; Wang, Jiadong; Chen, Junjie			The Lys(63)-specific Deubiquitinating Enzyme BRCC36 Is Regulated by Two Scaffold Proteins Localizing in Different Subcellular Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAINS; UBIQUITIN STRUCTURES; STRUCTURAL BASIS; DNA; BINDING; BRCA1; COMPLEX; RAP80; METALLOPROTEASE; DEGRADATION	BRCC36 is a member of the JAMM/MPN+ family of zinc metalloproteases that specifically cleaves Lys 63-linked polyubiquitin chains in vitro. We and others showed previously that BRCC36 is a component of the BRCA1-A complex, which consists of RAP80, CCDC98/ABRAXAS, BRCC45/BRE, MERIT40/NBA1, BRCC36, and BRCA1. This complex participates in the regulation of BRCA1 localization in response to DNA damage. Here we provide evidence indicating that BRCC36 regulates the abundance of Lys(63)-linked ubiquitin chains at chromatin and that one of its substrates is diubiquitinated histone H2A. Moreover, besides interacting with CCDC98 within the BRCA1-A complex, BRCC36 also associates with another protein KIAA0157, which shares significant sequence homology with CCDC98. Interestingly, although CCDC98 functions as an adaptor of BRCC36 and regulates BRCC36 activity in the nucleus, KIAA0157 mainly localizes in cytosol and activates BRCC36 in the cytoplasm. Moreover, these two complexes appear to exist in fine balance in vivo because reduction of KIAA0157 expression led to an increase of the BRCA1-A complex in the nucleus. Together, these results suggest that scaffold proteins not only participate in the regulation of BRCC36 activity but also determine its subcellular localization and cellular functions.	[Feng, Lin; Wang, Jiadong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org	Feng, Lin/B-5961-2012	Feng, Lin/0000-0001-6461-5838	National Institutes of Health [CA089239, CA016672]; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239 (to J. C.) and CA016672 (to M. D. Anderson Cancer Center).; Recipient of Department of Defense Era of Hope Scholar Award W81XWH-05-1-0470.	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	38	85	93	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30982	30988		10.1074/jbc.M110.135392	http://dx.doi.org/10.1074/jbc.M110.135392			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20656690	Green Published, hybrid			2022-12-27	WOS:000282135500063
J	Henri, J; Rispal, D; Bayart, E; van Tilbeurgh, H; Seraphin, B; Graille, M				Henri, Julien; Rispal, Delphine; Bayart, Emilie; van Tilbeurgh, Herman; Seraphin, Bertrand; Graille, Marc			Structural and Functional Insights into Saccharomyces cerevisiae Tpa1, a Putative Prolylhydroxylase Influencing Translation Termination and Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; FISSION YEAST SREBP; MESSENGER-RNA; CRYSTAL-STRUCTURE; RELEASE-FACTORS; ACTIVATOR BINDS; GENE-EXPRESSION; LOW-OXYGEN; PROTEIN; UPSTREAM	Efficiency of translation termination relies on the specific recognition of the three stop codons by the eukaryotic translation termination factor cRF1. To date only a few proteins are known to be involved in translation termination in eukaryotes. Saccharomyces cerevisiae Tpa1, a largely conserved but uncharacterized protein, has been described to associate with a messenger ribonucleoprotein complex located at the 3' end of mRNAs that contains at least eRF1, eRF3, and Pab1. Deletion of the TPA1 gene results in a decrease of translation termination efficacy and an increase in mRNAs half-lives and longer mRNA poly(A) tails. In parallel, Schizosaccharomyces pombe Ofd1, a Tpa1 ortholog, and its partner Nro1 have been implicated in the regulation of the stability of a transcription factor that regulates genes essential for the cell response to hypoxia. To gain insight into Tpa1/Ofd1 function, we have solved the crystal structure of S. cerevisiae Tpa1 protein. This protein is composed of two equivalent domains with the double-stranded beta-helix fold. The N-terminal domain displays a highly conserved active site with strong similarities with prolyl-4-hydroxylases. Further functional studies show that the integrity of Tpa1 active site as well as the presence of Yor051c/Ett1 (the S. cerevisiae Nro1 ortholog) are essential for correct translation termination. In parallel, we show that Tpa1 represses the expression of genes regulated by Hap1, a transcription factor involved in the response to levels of heme and oxygen. Altogether, our results support that Tpa1 is a putative enzyme acting as an oxygen sensor and influencing several distinct regulatory pathways.	[Rispal, Delphine; Seraphin, Bertrand] IGBMC, F-67404 Illkirch Graffenstaden, France; [Henri, Julien; van Tilbeurgh, Herman; Graille, Marc] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR8619, F-91405 Orsay, France; [Rispal, Delphine; Bayart, Emilie; Seraphin, Bertrand] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Seraphin, B (corresponding author), IGBMC, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	seraphin@igbmc.fr; marc.graille@u-psud.fr	Bayart, Emilie/AAV-6534-2020; Henri, Julien/AAB-3427-2020; GRAILLE, Marc/D-3242-2014; Henri, Julien B/E-3340-2017	Henri, Julien/0000-0003-0772-8881; GRAILLE, Marc/0000-0002-7853-5852; Henri, Julien B/0000-0003-0772-8881; BAYART, Emilie/0000-0001-5865-5542; Seraphin, Bertrand/0000-0002-5168-1921	La Ligue contre le Cancer; CNRS; Agence Nationale pour la Recherche [ANR-06-BLAN-0075-02]; European Union [LSHG-CT-2005-512028]	La Ligue contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Union(European Commission)	This work was supported by La Ligue contre le Cancer "Equipe Labelisee 2008"and the CNRS. This work was also supported by the CNRS and Agence Nationale pour la Recherche Grant ANR-06-BLAN-0075-02 (to M. G.).; Supported by the European Union 6th Framework programs "3D-Repertoire" (LSHG-CT-2005-512028).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; ARAVIND L, 2001, GENOME BIOL, V2; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cleasby A, 1996, NAT STRUCT BIOL, V3, P470, DOI 10.1038/nsb0596-470; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davies BSJ, 2006, GENETICS, V174, P191, DOI 10.1534/genetics.106.059964; Diez J, 2000, P NATL ACAD SCI USA, V97, P3913, DOI 10.1073/pnas.080072997; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Heurgue-Hamard V, 2006, J BIOL CHEM, V281, P36140, DOI 10.1074/jbc.M608571200; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hughes AL, 2007, J BIOL CHEM, V282, P24388, DOI 10.1074/jbc.M701326200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Jiang YD, 2002, EUKARYOT CELL, V1, P481, DOI 10.1128/EC.1.3.481-490.2002; Jiang YD, 2001, MOL CELL BIOL, V21, P6161, DOI 10.1128/MCB.21.18.6161-6169.2001; Just VJ, 2004, J BIOL CHEM, V279, P19867, DOI 10.1074/jbc.M313820200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Keeling KM, 2006, MOL CELL BIOL, V26, P5237, DOI 10.1128/MCB.02448-05; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Koski MK, 2009, J BIOL CHEM, V284, P25290, DOI 10.1074/jbc.M109.014050; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee CYS, 2009, EMBO J, V28, P135, DOI 10.1038/emboj.2008.271; LODI T, 1991, MOL CELL BIOL, V11, P3762, DOI 10.1128/MCB.11.7.3762; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Mora L, 2007, J BIOL CHEM, V282, P35638, DOI 10.1074/jbc.M706076200; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Noueiry AO, 2003, MOL CELL BIOL, V23, P4094, DOI 10.1128/MCB.23.12.4094-4106.2003; Pang H, 2004, J BIOL CHEM, V279, P1491, DOI 10.1074/jbc.M310022200; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; PFEIFER K, 1987, CELL, V49, P9, DOI 10.1016/0092-8674(87)90750-1; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; PFEIFER K, 1987, CELL, V49, P19, DOI 10.1016/0092-8674(87)90751-3; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ramil E, 2000, MOL MICROBIOL, V37, P1116, DOI 10.1046/j.1365-2958.2000.02065.x; Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valachovic M, 2006, GENETICS, V173, P1893, DOI 10.1534/genetics.105.053025; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	72	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30767	30778		10.1074/jbc.M110.106864	http://dx.doi.org/10.1074/jbc.M110.106864			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20630870	Green Published, hybrid			2022-12-27	WOS:000282135500045
J	Liu, WH; Chang, LS				Liu, Wen-Hsin; Chang, Long-Sen			Suppression of ADAM17-mediated Lyn/Akt Pathways Induces Apoptosis of Human Leukemia U937 Cells BUNGARUS MULTICINCTUS PROTEASE INHIBITOR-LIKE PROTEIN-1 UNCOVERS THE CYTOTOXIC MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; ADAPTIVE EVOLUTION; GROWTH-FACTOR; CHYMOTRYPSIN INHIBITOR; UP-REGULATION; EXPRESSION; VENOM; DISINTEGRIN; NECROSIS; KINASE	Cell surface proteases have been demonstrated to play an important role in facilitating cell invasion into the extracellular matrix and may contribute significantly to extracellular matrix degradation by metastatic cancer cells. Abundant expression of these enzymes is associated with poor prognosis. Thus, protease inhibitors that repress cell surface proteases may be applicable to cancer therapy. Because soybean Kunitz-type trypsin inhibitor has been found to induce apoptotic death of human leukemia Jurkat cells, anti-leukemia activity of Bungarus multicinctus protease inhibitor-like protein-1 (PILP-1) is thus examined. PILP-1 induced apoptosis of human leukemia U937 cells, characteristic of loss of mitochondrial membrane potential, degradation of procaspase-8, and production of t-Bid. FADD down-regulation neither restored viability of PILP-1-treated cells nor attenuated production of active caspase-8 and t-Bid in PILP-1-treated cells, suggesting that the death receptor-mediated pathway was not involved in the cytotoxicity of PILP-1. It was found that PILP-1-evoked p38 MAPK activation and ERK inactivation led to PILP-1-induced cell death and down-regulation of ADAM17. Knockdown of ADAM17 by siRNA induced death of U937 cells and inactivation of Lyn and Akt. Immunoprecipitation suggested that ADAM17 and Lyn form complexes. Overexpression of ADAM17, LynY507F (gain of function), and constitutively active Akt suppressed the cytotoxic effects of PILP-1. PILP-1-elicited inactivation of Lyn and Akt was abrogated in cells with overexpressed ADAM17 or LynY507F. Taken together, our data indicate that ADAM17-mediated activation of Lyn/Akt maintains the viability of U937 cells and that suppression of the pathway is responsible for PILP-1-induced apoptosis.	[Liu, Wen-Hsin; Chang, Long-Sen] Natl Sun Yat Sen Univ, Kaohsiung Med Univ, Joint Res Ctr, Inst Biomed Sci, Kaohsiung 804, Taiwan	Kaohsiung Medical University; National Sun Yat Sen University	Chang, LS (corresponding author), Natl Sun Yat Sen Univ, Kaohsiung Med Univ, Joint Res Ctr, Inst Biomed Sci, Kaohsiung 804, Taiwan.	lschang@mail.nsysu.edu.tw			National Science Council, Taiwan [NSC98-2320-B110-002-MY3]; National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center	This work was supported by Grant NSC98-2320-B110-002-MY3 from the National Science Council, Taiwan (to L.-S.C.), and a grant from National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center.	Arribas J, 2005, PROTEAS BIOL DIS, V4, P171; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Cardenas A, 2002, J CEREBR BLOOD F MET, V22, P1297, DOI 10.1097/01.WCB.0000033968.83623.D0; Chand HS, 2005, THROMB HAEMOSTASIS, V94, P1122, DOI 10.1160/TH05-07-0509; Chang LS, 2008, TOXICON, V51, P1490, DOI 10.1016/j.toxicon.2008.03.025; Chang LS, 2001, BIOCHEM BIOPH RES CO, V283, P862, DOI 10.1006/bbrc.2001.4878; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Karan D, 2003, INT J ONCOL, V23, P1365; Kempaiah P, 2008, APOPTOSIS, V13, P702, DOI 10.1007/s10495-008-0207-8; Kobayashi H, 2003, BIOL CHEM, V384, P749, DOI 10.1515/BC.2003.083; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lal A, 2002, CANCER RES, V62, P3335; Liu WH, 2009, J CELL MOL MED, V13, P1695, DOI 10.1111/j.1582-4934.2008.00473.x; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Moon DO, 2007, ACTA PHARMACOL SIN, V28, P1205, DOI 10.1111/j.1745-7254.2007.00615.x; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Rao BG, 2005, CURR PHARM DESIGN, V11, P295, DOI 10.2174/1381612053382115; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; RITONJA A, 1983, BIOCHIM BIOPHYS ACTA, V748, P429, DOI 10.1016/0167-4838(83)90189-9; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; SHAFQAT J, 1990, EUR J BIOCHEM, V194, P337, DOI 10.1111/j.1432-1033.1990.tb15622.x; Sierko E, 2007, SEMIN THROMB HEMOST, V33, P653, DOI 10.1055/s-2007-991532; Solomon KA, 1999, J IMMUNOL, V163, P4105; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Suzuki M, 2003, INT J CANCER, V104, P289, DOI 10.1002/ijc.10950; Takamune Y, 2008, BIOCHEM BIOPH RES CO, V365, P393, DOI 10.1016/j.bbrc.2007.11.010; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Troncoso MF, 2007, INT IMMUNOPHARMACOL, V7, P625, DOI 10.1016/j.intimp.2007.01.002; Tung EKK, 2009, INT J CANCER, V124, P1811, DOI 10.1002/ijc.24115; Wang XK, 2004, MOL PHARMACOL, V65, P890, DOI 10.1124/mol.65.4.890; Yan Y, 2009, CELL BIOL INT, V33, P158, DOI 10.1016/j.cellbi.2008.10.008; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	47	16	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30506	30515		10.1074/jbc.M110.156257	http://dx.doi.org/10.1074/jbc.M110.156257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20679348	hybrid, Green Published			2022-12-27	WOS:000282135500018
J	Zhu, NL; Wang, JH; Tsukamoto, H				Zhu, Nian-Ling; Wang, Jiaohong; Tsukamoto, Hidekazu			The Necdin-Wnt Pathway Causes Epigenetic Peroxisome Proliferator-activated Receptor gamma Repression in Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; DIFFERENTIATION; ADIPOGENESIS; INTERACTS; TRANSDIFFERENTIATION; PROTEIN; ACTS; CREB; MSX2	Hepatic stellate cells (HSCs), vitamin A-storing liver pericytes, undergo myofibroblastic trans-differentiation or "activation" to participate in liver wound healing. This cellular process involves loss of regulation by adipogenic transcription factors such as peroxisome proliferator-activated receptor gamma (PPAR gamma). Necdin, a melanoma antigen family protein, promotes neuronal and myogenic differentiation while inhibiting adipogenesis. The present study demonstrates that necdin is selectively expressed in HSCs among different liver cell types and induced during their activation in vitro and in vivo. Silencing of necdin with adenovirally expressed shRNA, reverses activated HSCs to quiescent cells in a manner dependent on PPAR gamma and suppressed canonical Wnt signaling. Promoter analysis, site-directed mutagenesis, and chromatin immunoprecipitation demonstrate that Wnt10b, a canonical Wnt induced in activated HSCs, is a direct target of necdin. Necdin silencing abrogates three epigenetic signatures implicated in repression of PPAR gamma: increased MeCP2 (methyl CpG binding protein 2) and HP-1 alpha co-repressor recruitments to Ppar gamma promoter and enhanced H3K27 dimethylation at the exon 5 locus, again in a manner dependent on suppressed canonical Wnt. These epigenetic effects are reproduced by antagonism of canonical Wnt signaling with Dikkopf-1. Our results demonstrate a novel necdin-Wnt pathway, which serves to mediate antiadipogenic HSC trans-differentiation via epigenetic repression of PPAR gamma.	[Zhu, Nian-Ling; Wang, Jiaohong; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, So Calif Res Ctr ALPD & Cirrhosis, Los Angeles, CA 90033 USA; [Zhu, Nian-Ling; Wang, Jiaohong; Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Wang, Jiaohong; Tsukamoto, Hidekazu] Dept Vet Affairs Greater Los Angeles Healthcare S, Los Angeles, CA 90073 USA	University of Southern California; University of Southern California	Tsukamoto, H (corresponding author), Univ So Calif, Keck Sch Med, So Calif Res Ctr ALPD & Cirrhosis, 1333 San Pablo St,MMR-402, Los Angeles, CA 90033 USA.	htsukamo@usc.edu			National Institutes of Health [P50AA011999, R24AA012885, R21AA016682]; Medical Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, R21AA016682, R24AA012885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P50AA011999, R24AA012885, and R21AA016682. This work was also supported by the Medical Research Service of the Department of Veterans Affairs.	Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Galli A, 2000, HEPATOLOGY, V31, P101, DOI 10.1002/hep.510310117; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Houglum K, 1997, J CLIN INVEST, V99, P1322, DOI 10.1172/JCI119291; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; MacDougald OA, 2005, NAT CELL BIOL, V7, P543, DOI 10.1038/ncb0605-543; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365; Matsumoto K, 2001, GENE, V272, P173, DOI 10.1016/S0378-1119(01)00544-3; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Potter JJ, 1998, BIOCHEM BIOPH RES CO, V244, P178, DOI 10.1006/bbrc.1997.8193; Ren J, 2003, J NEUROSCI, V23, P1569; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Sung CK, 2004, AM J PHYSIOL-GASTR L, V286, pG722, DOI 10.1152/ajpgi.00411.2003; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tsukamoto H, 1999, ALCOHOL CLIN EXP RES, V23, P911, DOI 10.1111/j.1530-0277.1999.tb04202.x; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; YAMADA M, 1987, HEPATOLOGY, V7, P1224, DOI 10.1002/hep.1840070609; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2	36	42	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30463	30471		10.1074/jbc.M110.156703	http://dx.doi.org/10.1074/jbc.M110.156703			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663865	hybrid, Green Published			2022-12-27	WOS:000282135500013
J	Shukla, AK; Kim, J; Ahn, S; Xiao, KH; Shenoy, SK; Liedtke, W; Lefkowitz, RJ				Shukla, Arun K.; Kim, Jihee; Ahn, Seungkirl; Xiao, Kunhong; Shenoy, Sudha K.; Liedtke, Wolfgang; Lefkowitz, Robert J.			Arresting a Transient Receptor Potential (TRP) Channel beta-ARRESTIN 1 MEDIATES UBIQUITINATION AND FUNCTIONAL DOWN-REGULATION OF TRPV4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; BETA-ARRESTINS; CELL-SURFACE; 7-TRANSMEMBRANE RECEPTORS; CATION CHANNEL; BETA(2)-ADRENERGIC RECEPTOR; INDUCED VASODILATATION; CALCIUM-CHANNELS; DOWN-REGULATION; BETA-ARRESTIN-2	beta-Arrestins, originally discovered to desensitize activated G protein-coupled receptors, (aka seven-transmembrane receptors, 7TMRs) also mediate 7TMR internalization and G protein-independent signaling via these receptors. More recently, several regulatory roles of beta-arrestins for atypical 7TMRs and non-7TM receptors have emerged. Here, we uncover an entirely novel regulatory role of beta-arrestins in crosstalk between the angiotensin receptor (AT1aR) and a member of the transient receptor potential (TRP) ion channel family, TRPV4. AT1aR and TRPV4 form a constitutive complex in the plasma membrane, and angiotensin stimulation leads to recruitment of beta-arrestin 1 to this complex. Surprisingly, angiotensin stimulation results in ubiquitination of TRPV4, a process that requires beta-arrestin 1, and subsequently to internalization and functional down-regulation of TRPV4. beta-Arrestin 1 interacts with, and acts as an adaptor for AIP4, an E3 ubiquitin ligase responsible for TRPV4 ubiquitination. Thus, our data provide the first evidence of a functional link between beta-arrestins and TRPV4 and uncovers an entirely novel mechanism to maintain appropriate intracellular Ca2+ concentration to avoid excessive Ca2+ signaling.	[Shukla, Arun K.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Shukla, Arun K.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Shukla, AK (corresponding author), Duke Univ, Med Ctr, Dept Med, 463 Carl Bldg,Res Dr, Durham, NC 27710 USA.	arun.shukla@receptor-biol.duke.edu	Liedtke, Wolfgang/GNH-1878-2022; Shenoy, Sudha/AAN-4075-2021; Xiao, Kunhong/AAG-4275-2020; Lefkowitz, Robert/AAW-2649-2021; Liedtke, Wolfgang B/G-4633-2011	Shenoy, Sudha/0000-0002-2565-4663; Xiao, Kunhong/0000-0002-1069-1226; shukla, arun/0000-0003-2910-8288	National Institutes of Health [HL16037, HL70631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037, R01HL080525, R01HL070631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL16037 and HL70631 (to R. J. L.).	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Denda M, 2007, J INVEST DERMATOL, V127, P654, DOI 10.1038/sj.jid.5700590; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3; Gao F, 2009, HYPERTENSION, V53, P228, DOI 10.1161/HYPERTENSIONAHA.108.117499; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Hannan MA, 2008, BBA-BIOMEMBRANES, V1778, P974, DOI 10.1016/j.bbamem.2008.01.011; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; *INV, 2006, FLUO 4 NW CALC ASS K; Jian MY, 2008, AM J RESP CELL MOL, V38, P386, DOI 10.1165/rcmb.2007-0192OC; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kisilevsky AE, 2008, NEURON, V58, P557, DOI 10.1016/j.neuron.2008.03.002; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lipsky R, 2008, J BIOL CHEM, V283, P17221, DOI 10.1074/jbc.C800061200; Loot AE, 2008, CARDIOVASC RES, V80, P445, DOI 10.1093/cvr/cvn207; Matsusaka T, 1997, ANNU REV PHYSIOL, V59, P395, DOI 10.1146/annurev.physiol.59.1.395; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; O'Neill LAJ, 2009, J BIOL CHEM, V284, P8209, DOI 10.1074/jbc.R800070200; Patel PA, 2008, CIRC J, V72, P1725, DOI 10.1253/circj.CJ-08-0734; Patel PA, 2009, J MOL CELL CARDIOL, V46, P300, DOI 10.1016/j.yjmcc.2008.11.015; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Puckerin A, 2006, J BIOL CHEM, V281, P31131, DOI 10.1074/jbc.M605000200; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shui Z, 2001, J BIOL CHEM, V276, P11691, DOI 10.1074/jbc.M011007200; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; Verkhratsky A., 2007, V45, P465; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Wissenbach U, 2004, BIOL CELL, V96, P47, DOI 10.1016/j.biolcel.2003.12.003; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104	62	78	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30115	30125		10.1074/jbc.M110.141549	http://dx.doi.org/10.1074/jbc.M110.141549			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650893	hybrid, Green Published			2022-12-27	WOS:000281984300049
J	Sugiura, M; Iwai, E; Hayashi, H; Boussac, A				Sugiura, Miwa; Iwai, Eri; Hayashi, Hidenori; Boussac, Alain			Differences in the Interactions between the Subunits of Photosystem II Dependent on D1 Protein Variants in the Thermophilic Cyanobacterium Thermosynechococcus elongatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ELECTRON-ACCEPTOR; CYTOCHROME B(559); GENE-EXPRESSION; COMPLEX; REDOX; LIGHT; PSBA; D1-PROTEIN; RESOLUTION	The main cofactors involved in the oxygen evolution activity of Photosystem II (PSII) are located in two proteins, D1 (PsbA) and D2 (PsbD). In Thermosynechococcus elongatus, a thermophilic cyanobacterium, the D1 protein is encoded by either the psbA(1) or the psbA(3) gene, the expression of which is dependent on environmental conditions. It has been shown that the energetic properties of the PsbA1-PSII and those of the PsbA3-PSII differ significantly (Sugiura, M., Kato, Y., Takahashi, R., Suzuki, H., Watanabe, T., Noguchi, T., Rappaport, F., and Boussac, A. (2010) Biochim. Biophys. Acta 1797, 1491-1499). In this work the structural stability of PSII upon a PsbA1/PsbA3 exchange was investigated. Two deletion mutants lacking another PSII subunit, PsbJ, were constructed in strains expressing either PsbA1 or PsbA3. The PsbJ subunit is a 4-kDa transmembrane polypeptide that is surrounded by D1 (i.e. PsbA1), PsbK, and cytochrome b(559) (Cyt b(559)) in existing three-dimensional models. It is shown that the structural properties of the PsbA3/Delta PsbJ-PSII are not significantly affected. The polypeptide contents, the Cyt b(559) properties, and the proportion of PSII dimer were similar to those found for PsbA3-PSII. In contrast, in PsbA1/Delta PsbJ-PSII the stability of the dimer is greatly diminished, the EPR properties of the Cyt b(559) likely indicates a decrease in its redox potential, and many other PSII subunits are lacking. These results shows that the 21-amino acid substitutions between PsbA1 and PsbA3, which appear to be mainly conservative, must include side chains that are involved in a network of interactions between PsbA and the other PSII subunits.	[Sugiura, Miwa; Hayashi, Hidenori] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa; Hayashi, Hidenori] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa; Iwai, Eri; Hayashi, Hidenori] Ehime Univ, Dept Chem, Matsuyama, Ehime 7908577, Japan; [Boussac, Alain] CEA Saclay, CNRS, URA 2096, IBiTec S, F-91191 Gif Sur Yvette, France	Ehime University; Ehime University; Ehime University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Sugiura, M (corresponding author), Ehime Univ, Cell Free Sci & Technol Res Ctr, Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	miwa.sugiura@ehime-u.ac.jp			Ministry of Education, Science, Sports, Culture, and Technology [21612007]; Japan Society for the Promotion of Science; CNRS; European Union [212508]	Ministry of Education, Science, Sports, Culture, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission)	This study was supported by Grant-in-aid for scientific research 21612007 from the Ministry of Education, Science, Sports, Culture, and Technology (to M. S.) and the Japan Society for the Promotion of Science and CNRS under the Japan-France Research Cooperative Program. This work was also supported in part by the European Union/Energy Network project SOLAR-H2 (FP7 contract 212508).	Ala PJ, 1997, BIOCHEMISTRY-US, V36, P1573, DOI 10.1021/bi962234u; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; BERTHOMIEU C, 1992, BIOCHEMISTRY-US, V31, P11460, DOI 10.1021/bi00161a026; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GOLDEN JW, 1988, SCIENCE, V242, P1421, DOI 10.1126/science.3144039; GOLDEN SS, 1995, J BACTERIOL, V177, P1651, DOI 10.1128/jb.177.7.1651-1654.1995; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Huesgen PF, 2009, RES MICROBIOL, V160, P726, DOI 10.1016/j.resmic.2009.08.005; Hughes JL, 2010, BBA-BIOENERGETICS, V1797, P11, DOI 10.1016/j.bbabio.2009.07.007; Hung CH, 2007, BBA-BIOENERGETICS, V1767, P686, DOI 10.1016/j.bbabio.2007.02.016; IKEUCHI M, 1988, PLANT CELL PHYSIOL, V29, P1233; Iwai M, 2010, PLANT CELL PHYSIOL, V51, P554, DOI 10.1093/pcp/pcq020; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Kaminskaya O, 1999, BIOCHEMISTRY-US, V38, P16223, DOI 10.1021/bi991257g; Kaminskaya O, 2007, BIOCHEMISTRY-US, V46, P1091, DOI 10.1021/bi0613022; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2008, BIOL CHEM, V389, P609, DOI 10.1515/BC.2008.058; Mohanty P, 2007, PHOTOSYNTH RES, V94, P217, DOI 10.1007/s11120-007-9184-y; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Regel RE, 2001, J BIOL CHEM, V276, P41473, DOI 10.1074/jbc.M102007200; Roncel M, 2003, J BIOL INORG CHEM, V8, P206, DOI 10.1007/s00775-002-0406-7; SHEN JR, 1993, J BIOL CHEM, V268, P20408; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Shibuya Y, 2010, BIOCHEMISTRY-US, V49, P493, DOI 10.1021/bi9018829; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sicora CI, 2008, BBA-BIOENERGETICS, V1777, P130, DOI 10.1016/j.bbabio.2007.09.001; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; Sugiura M, 2004, BIOCHEMISTRY-US, V43, P13549, DOI 10.1021/bi048732h; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1546, DOI 10.1016/j.bbabio.2010.03.020; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; Sugiura M, 2009, BIOCHEMISTRY-US, V48, P7856, DOI 10.1021/bi901067b; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi T, 2009, J BIOL CHEM, V284, P15598, DOI 10.1074/jbc.M109.000372; Tichy M, 2003, BBA-BIOENERGETICS, V1605, P55, DOI 10.1016/S0005-2728(03)00064-1; Un S, 2007, BIOCHEMISTRY-US, V46, P3138, DOI 10.1021/bi062084f; Vass I, 2007, ANN NY ACAD SCI, V1113, P114, DOI 10.1196/annals.1391.017	54	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30008	30018		10.1074/jbc.M110.136945	http://dx.doi.org/10.1074/jbc.M110.136945			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630865	Green Published, hybrid			2022-12-27	WOS:000281984300038
J	Chambers, JE; Tavender, TJ; Oka, OBV; Warwood, S; Knight, D; Bulleid, NJ				Chambers, Joseph E.; Tavender, Timothy J.; Oka, Ojore B. V.; Warwood, Stacey; Knight, David; Bulleid, Neil J.			The Reduction Potential of the Active Site Disulfides of Human Protein Disulfide Isomerase Limits Oxidation of the Enzyme by Ero1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-LIKE DOMAINS; ENDOPLASMIC-RETICULUM; THIOL OXIDASE; GLUTATHIONE; RESIDUES; ERO1P; YEAST	Disulfide formation in newly synthesized proteins entering the mammalian endoplasmic reticulum is catalyzed by protein disulfide isomerase (PDI), which is itself thought to be directly oxidized by Ero1 alpha. The activity of Ero1 alpha is tightly regulated by the formation of noncatalytic disulfides, which need to be broken to activate the enzyme. Here, we have developed a novel PDI oxidation assay, which is able to simultaneously determine the redox status of the individual active sites of PDI. We have used this assay to confirm that when PDI is incubated with Ero1 alpha, only one of the active sites of PDI becomes directly oxidized with a slow turnover rate. In contrast, a deregulated mutant of Ero1 alpha was able to oxidize both PDI active sites at an equivalent rate to the wild type enzyme. When the active sites of PDI were mutated to decrease their reduction potential, both were now oxidized by wild type Ero1 alpha with a 12-fold increase in activity. These results demonstrate that the specificity of Ero1 alpha toward the active sites of PDI requires the presence of the regulatory disulfides. In addition, the rate of PDI oxidation is limited by the reduction potential of the PDI active site disulfide. The inability of Ero1 alpha to oxidize PDI efficiently likely reflects the requirement for PDI to act as both an oxidase and an isomerase during the formation of native disulfides in proteins entering the secretory pathway.	[Tavender, Timothy J.; Oka, Ojore B. V.; Bulleid, Neil J.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G46 6JN, Lanark, Scotland; [Chambers, Joseph E.; Warwood, Stacey; Knight, David] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Glasgow; University of Manchester	Bulleid, NJ (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk	Oka, Ojore/H-4456-2013; Chambers, Joseph/Z-5212-2019	Chambers, Joseph/0000-0003-4675-0053; Bulleid, Neil/0000-0002-9839-5279; Knight, David/0000-0001-8895-8560	Wellcome Trust [074081, 088053]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants 074081 and 088053.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; FREEDMAN RB, 1995, CURR OPIN STRUC BIOL, V5, P85, DOI 10.1016/0959-440X(95)80013-Q; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; KRAUSE G, 1991, J BIOL CHEM, V266, P4056; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LU XJ, 1992, BIOCHEMISTRY-US, V31, P4205, DOI 10.1021/bi00132a008; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	27	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29200	29207		10.1074/jbc.M110.156596	http://dx.doi.org/10.1074/jbc.M110.156596			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20657012	Green Published, hybrid			2022-12-27	WOS:000281740100020
J	Wieczorek, A; Downey, CD; Dallmann, HG; McHenry, CS				Wieczorek, Anna; Downey, Christopher D.; Dallmann, H. Garry; McHenry, Charles S.			Only One ATP-binding DnaX Subunit Is Required for Initiation Complex Formation by the Escherichia coli DNA Polymerase III Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLAMP LOADER; DELTA; TAU; PURIFICATION; MECHANISM; MACHINE; GAMMA	The DnaX complex (DnaX(3)delta delta'chi psi) within the Escherichia coli DNApolymerase III holoenzyme serves to load the dimeric sliding clamp processivity factor, beta(2), onto DNA. The complex contains three DnaX subunits, which occur in two forms: tau and the shorter gamma, produced by translational frameshifting. Ten forms of E. coli DnaX complex containing all possible combinations of wild-type or a Walker A motif K51E variant tau or gamma have been reconstituted and rigorously purified. DnaX complexes containing three DnaX K51E subunits do not bind ATP. Comparison of their ability to support formation of initiation complexes, as measured by processive replication by the DNA polymerase III holoenzyme, indicates a minimal requirement for one ATP-binding DnaX subunit. DnaX complexes containing two mutant DnaX subunits support DNA synthesis at about two-thirds the level of their wild-type counterparts. beta(2) binding (determined functionally) is diminished 12-30-fold for DnaX complexes containing two K51E subunits, suggesting that multiple ATPs must be bound to place the DnaX complex into a conformation with maximal affinity for beta(2). DNA synthesis activity can be restored by increased concentrations of beta(2). In contrast, severe defects in ATP hydrolysis are observed upon introduction of a single K51E DnaX subunit. Thus, ATP binding, hydrolysis, and the ability to form initiation complexes are not tightly coupled. These results suggest that although ATP hydrolysis likely enhances beta(2) loading, it is not absolutely required in a mechanistic sense for formation of functional initiation complexes.	[Wieczorek, Anna; Downey, Christopher D.; Dallmann, H. Garry; McHenry, Charles S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	McHenry, CS (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	charles.mchenry@colorado.edu			NIGMS [GM060273]; National Institutes of Health [F32GM084697]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084697, R01GM060273] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060273 from the NIGMS (to C. S. M.) and by National Institutes of Health Grant F32GM084697 (postdoctoral fellowship for C. D. D.).	Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; Cull MG, 1995, METHOD ENZYMOL, V262, P22; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim S, 1996, J BIOL CHEM, V271, P4315; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; Pietroni P, 2008, J BIOL CHEM, V283, P28338, DOI 10.1074/jbc.M804371200; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Song MS, 2001, J BIOL CHEM, V276, P35165, DOI 10.1074/jbc.M100389200; Thompson JA, 2009, J BIOL CHEM, V284, P32147, DOI 10.1074/jbc.M109.045997	18	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29049	29053		10.1074/jbc.C110.165076	http://dx.doi.org/10.1074/jbc.C110.165076			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20675375	Green Published, hybrid			2022-12-27	WOS:000281740100005
J	Belgnaoui, SM; Fryrear, KA; Nyalwidhe, JO; Guo, X; Semmes, OJ				Belgnaoui, S. Mehdi; Fryrear, Kimberly A.; Nyalwidhe, Julius O.; Guo, Xin; Semmes, O. John			The Viral Oncoprotein Tax Sequesters DNA Damage Response Factors by Tethering MDC1 to Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 TAX; DOUBLE-STRAND BREAKS; ONCOGENE-INDUCED SENESCENCE; NUCLEOTIDE EXCISION-REPAIR; HTLV-1 TAX; CELLULAR-TRANSFORMATION; I TAX; PROTEINS; CELLS; GENE	Infection with human T-cell leukemia virus induces cellular genomic instability mediated through the viral oncoprotein Tax. Here we present evidence that Tax undermines the cellular DNA damage response by sequestration of damage response factors. We show by confocal microscopy that Tax forms damage-independent nuclear foci that contain DNA-PK, BRCA1, and MDC1. Tax sequesters MDC1 to chromatin sites distinct from classic ionizing radiation-induced foci. The recruitment of MDC1 is competitive between the two foci. The N-terminal region of Tax is sufficient for foci localization, and the C-terminal half is critical for binding to MDC1 and recruitment of additional response factors. Tax expression and DNA damage response factor recruitment repressed the formation of ionizing radiation-induced Nbs1-containing foci. The Tax-induced "pseudo" DNA damage response results in phosphorylation and monoubiquitylation of H2AX, which is ablated by siRNA suppression of MDC1. These data support a model for virus-induced genomic instability in which viral oncogene-induced damage-independent foci compete with normal cellular DNA damage response.	[Belgnaoui, S. Mehdi; Fryrear, Kimberly A.; Nyalwidhe, Julius O.; Guo, Xin; Semmes, O. John] Eastern Virginia Med Sch, Canc Biol & Infect Dis Res Ctr, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23508 USA	Eastern Virginia Medical School	Semmes, OJ (corresponding author), Eastern Virginia Med Sch, Canc Biol & Infect Dis Res Ctr, Dept Microbiol & Mol Cell Biol, 700 W Olney Rd, Norfolk, VA 23508 USA.	Semmesoj@evms.edu	Semmes, Oliver/GQA-5179-2022		National Cancer Institute [CA76959]; NATIONAL CANCER INSTITUTE [R01CA076595, K07CA076959] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grant CA76959 (to O.J.S.) from the National Cancer Institute.	AKAGI T, 1993, J VIROL, V67, P1211, DOI 10.1128/JVI.67.3.1211-1217.1993; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Chandhasin C, 2008, J VIROL, V82, P6952, DOI 10.1128/JVI.02331-07; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Durkin SS, 2006, J BIOL CHEM, V281, P31705, DOI 10.1074/jbc.M607011200; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074/jbc.M804931200; Edwards DC, 2008, J VIROL, V82, P11714, DOI 10.1128/JVI.00356-08; Eliezer Y, 2009, J BIOL CHEM, V284, P426, DOI 10.1074/jbc.M807375200; Fryrear KA, 2009, J VIROL, V83, P5339, DOI 10.1128/JVI.00232-09; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; Gupta SK, 2007, J BIOL CHEM, V282, P29431, DOI 10.1074/jbc.M704110200; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Haoudi A, 2003, VIROLOGY, V305, P229, DOI 10.1006/viro.2002.1642; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeang KT, 2004, J BIOL CHEM, V279, P31991, DOI 10.1074/jbc.R400009200; JEANG KT, 1990, SCIENCE, V247, P1082, DOI 10.1126/science.2309119; KAMADA N, 1992, CANCER RES, V52, P1481; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; Kasai T, 2002, J BIOL CHEM, V277, P5187, DOI 10.1074/jbc.M110295200; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lukas C, 2005, CHROMOSOMA, V114, P146, DOI 10.1007/s00412-005-0011-y; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Miyake H, 1999, VIROLOGY, V253, P155, DOI 10.1006/viro.1998.9500; Nyborg JK, 2010, BBA-GENE REGUL MECH, V1799, P266, DOI 10.1016/j.bbagrm.2009.09.002; Park HU, 2006, ONCOGENE, V25, P438, DOI 10.1038/sj.onc.1209059; Park HU, 2004, ONCOGENE, V23, P4966, DOI 10.1038/sj.onc.1207644; Peloponese JM, 2007, INT J HEMATOL, V86, P101, DOI 10.1532/IJH97.07087; Philpott SM, 1999, J NATL CANCER I, V91, P933, DOI 10.1093/jnci/91.11.933; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Saggioro D, 2009, FRONT BIOSCI-LANDMRK, V14, P3338, DOI 10.2741/3456; Semmes OJ, 1996, J VIROL, V70, P6347, DOI 10.1128/JVI.70.9.6347-6357.1996; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sibon D, 2006, J CLIN INVEST, V116, P974, DOI 10.1172/JCI27198; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; TAJIMA K, 1998, JPN J CANC RES, V89; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yan J, 2008, CANCER LETT, V271, P179, DOI 10.1016/j.canlet.2008.04.046; Zane L, 2009, FRONT BIOSCI-LANDMRK, V14, P3935, DOI [10.2735/3502, 10.2741/3502]	55	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32897	32905		10.1074/jbc.M110.146373	http://dx.doi.org/10.1074/jbc.M110.146373			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729195	Green Published, hybrid			2022-12-27	WOS:000283048200027
J	Carreno, R; Brown, WS; Li, D; Hernandez, JA; Wang, Y; Kim, TK; Craft, JW; Komanduri, KV; Radvanyi, LG; Hwu, P; Molldrem, JJ; Legge, GB; McIntyre, BW; Ma, Q				Carreno, Roberto; Brown, Wells S.; Li, Dan; Hernandez, Jessica A.; Wang, Yang; Kim, Tae Kon; Craft, John W., Jr.; Komanduri, Krishna V.; Radvanyi, Laszlo G.; Hwu, Patrick; Molldrem, Jeffrey J.; Legge, Glen B.; McIntyre, Bradley W.; Ma, Qing			2E8 Binds to the High Affinity I-domain in a Metal Ion-dependent Manner A SECOND GENERATION MONOCLONAL ANTIBODY SELECTIVELY TARGETING ACTIVATED LFA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; LIGAND-MIMETIC ANTIBODY; IMMUNOLOGICAL SYNAPSE; INTEGRIN REGULATION; PLAQUE PSORIASIS; STRUCTURAL BASIS; CLINICAL-TRIALS; T-CELLS; LFA-1; ACTIVATION	The activation of leukocyte function-associated antigen-1 (LFA-1) plays a critical role in regulating immune responses. The metal ion-dependent adhesion site on the I-domain of LFA-1 alpha(L) subunit is the key recognition site for ligand binding. Upon activation, conformation changes in the I-domain can lead LFA-1 from the low affinity state to the high affinity (HA) state. Using the purified HA I-domain locked by disulfide bonds for immunization, we developed an mAb, 2E8, that specifically binds to cells expressing the HA LFA-1. The surface plasmon resonance analysis has shown that 2E8 only binds to the HA I-domain and that the dissociation constant (K-D) for HA I-domain is 197 nM. The binding of 2E8 to the HA I-domain is metal ion-dependent, and the affinity decreased as Mn2+ was replaced sequentially by Mg2+ and Ca2+. Surface plasmon resonance analysis demonstrates that 2E8 inhibits the interaction of HA I-domain and ICAM-1. Furthermore, we found that 2E8 can detect activated LFA-1 on both JY and Jurkat cells using flow cytometry and parallel plate adhesion assay. In addition, 2E8 inhibits JY cell adhesion to human umbilical vein endothelial cells and homotypic aggregation. 2E8 treatment reduces the proliferation of both human CD4(+) and CD8(+) T cells upon OKT3 stimulation without the impairment of their cytolytic function. Taken together, these data demonstrate that 2E8 is specific for the high affinity form of LFA-1 and that 2E8 inhibits LFA-1/ICAM-1 interactions. As a novel activation-specific monoclonal antibody, 2E8 is a potentially useful reagent for blocking high affinity LFA-1 and modulating T cell activation in research and therapeutics.	[Carreno, Roberto; Li, Dan; Wang, Yang; Molldrem, Jeffrey J.; Ma, Qing] Univ Texas MD Anderson Canc Ctr, Sect Transplantat Immunol, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Brown, Wells S.; McIntyre, Bradley W.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Hernandez, Jessica A.; Radvanyi, Laszlo G.; Hwu, Patrick] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Oncol, Houston, TX 77030 USA; [Kim, Tae Kon; Komanduri, Krishna V.] Univ Miami, Sylvester Comprehens Canc Ctr, Adult Stem Cell Transplant Program, Miami, FL 33136 USA; [Craft, John W., Jr.; Legge, Glen B.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Miami; University of Houston System; University of Houston	Ma, Q (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Transplantat Immunol, Dept Stem Cell Transplantat & Cellular Therapy, Unit 900,1515 Holcombe Blvd, Houston, TX 77030 USA.	qma@mdanderson.org	Komanduri, Krishna V./G-6012-2011	Komanduri, Krishna V./0000-0003-3715-5236; Craft, John/0000-0002-5679-5629	American Cancer Society [RSG-08-183-01-LIB]	American Cancer Society(American Cancer Society)	The work was supported by American Cancer Society Grant RSG-08-183-01-LIB (to Q. M.).	Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; BLAZAR BR, 1995, BLOOD, V85, P2607, DOI 10.1182/blood.V85.9.2607.bloodjournal8592607; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Carreno R, 2008, J BIOL CHEM, V283, P10642, DOI 10.1074/jbc.M704699200; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Dustin ML, 2003, ANN NY ACAD SCI, V987, P51, DOI 10.1111/j.1749-6632.2003.tb06032.x; Giblin PA, 2006, CURR PHARM DESIGN, V12, P2771, DOI 10.2174/138161206777947731; Gordon KB, 2003, JAMA-J AM MED ASSOC, V290, P3073, DOI 10.1001/jama.290.23.3073; He LW, 2005, J IMMUNOL METHODS, V304, P43, DOI 10.1016/j.jim.2005.06.005; HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305; Hogg N, 2004, IMMUNOL LETT, V92, P51, DOI 10.1016/j.imlet.2003.10.014; Huang LL, 2006, J LEUKOCYTE BIOL, V80, P905, DOI 10.1189/jlb.1105649; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Hynes RO, 2003, SCIENCE, V300, P755, DOI 10.1126/science.1084854; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; Legge GB, 2002, PROTEINS, V48, P151, DOI 10.1002/prot.10134; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Matthews JB, 2003, AM J TRANSPLANT, V3, P794, DOI 10.1046/j.1600-6135.2003.0154.x; Mitchell JS, 2009, IMMUNOL CELL BIOL, V87, P324, DOI 10.1038/icb.2008.103; Nicolls MR, 2006, AM J TRANSPLANT, V6, P27, DOI 10.1111/j.1600-6143.2005.01158.x; Pugashetti R, 2009, J DERMATOL TREAT, V20, P132, DOI 10.1080/09546630902984596; Scheinfeld N, 2006, EXPERT OPIN DRUG SAF, V5, P197, DOI 10.1517/14740338.5.2.197; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Zhang HM, 2009, P NATL ACAD SCI USA, V106, P18345, DOI 10.1073/pnas.0909301106	35	5	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32860	32868		10.1074/jbc.M110.111591	http://dx.doi.org/10.1074/jbc.M110.111591			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724473	Green Published, hybrid			2022-12-27	WOS:000283048200023
J	Yamashiro, S; Speicher, KD; Speicher, DW; Fowler, VM				Yamashiro, Sawako; Speicher, Kaye D.; Speicher, David W.; Fowler, Velia M.			Mammalian Tropomodulins Nucleate Actin Polymerization via Their Actin Monomer Binding and Filament Pointed End-capping Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL HALF; SKELETAL-MUSCLE; TROPOMYOSIN BINDING; ARP2/3 COMPLEX; CYTOSKELETAL DYNAMICS; STRUCTURAL BASIS; CYTOCHALASIN-D; ADP-ACTIN; PROTEIN; CELLS	Many actin-binding proteins have been shown to possess multiple activities to regulate filament dynamics. Tropomodulins (Tmod1-4) are a conserved family of actin filament pointed end-capping proteins. Our previous work has demonstrated that Tmod3 binds to monomeric actin in addition to capping pointed ends. Here, we show a novel actin-nucleating activity in mammalian Tmods. Comparison of Tmod isoforms revealed that Tmod1-3 but not Tmod4 nucleate actin filament assembly. All Tmods bind to monomeric actin, and Tmod3 forms a 1:1 complex with actin. By truncation and mutagenesis studies, we demonstrated that the second alpha-helix in the N-terminal domain of Tmod3 is essential for actin monomer binding. Chemical cross-linking and LC-MS/MS further indicated that residues in this second alpha-helix interact with actin subdomain 2, whereas Tmod3 N-terminal domain peptides distal to this alpha-helix interact with actin subdomain 1. Mutagenesis of Leu-73 to Asp, which disrupts the second alpha-helix of Tmod3, decreases both its actin monomer-binding and -nucleating activities. On the other hand, point mutations of residues in the C-terminal leucine-rich repeat domain of Tmod3 (Lys-317 in the fifth leucine-rich repeat beta-sheet and Lys-344 or Arg-345/Arg-346 in the C-terminal alpha 6-helix) significantly reduced pointed end-capping and nucleation without altering actin monomer binding. Taken together, our data indicate that Tmod3 binds actin monomers over an extended interface and that nucleating activity depends on actin monomer binding and pointed end-capping activities, contributed by N- and C-terminal domains of Tmod3, respectively. Tmod3 nucleation of actin assembly may regulate the cytoskeleton in dynamic cellular contexts.	[Yamashiro, Sawako; Fowler, Velia M.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Speicher, Kaye D.; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA	Scripps Research Institute; The Wistar Institute	Yamashiro, S (corresponding author), Scripps Res Inst, Dept Cell Biol, CB163,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	syamash@scripps.edu		Fowler, Velia/0000-0002-3161-8802; Yamashiro, Sawako/0000-0002-5980-0470	National Institutes of Health [HL083464, HL038794]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794, R01HL083464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083464 (to V. M. F.) and HL038794 (to D. W. S.).	Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; Almenar-Queralt A, 1999, J BIOL CHEM, V274, P28466, DOI 10.1074/jbc.274.40.28466; BABCOCK GG, 1994, J BIOL CHEM, V269, P27510; BRYAN J, 1988, J CELL BIOL, V106, P1553, DOI 10.1083/jcb.106.5.1553; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Conley CA, 2001, GENOMICS, V73, P127, DOI 10.1006/geno.2000.6501; COOPER JA, 1985, BIOCHEMISTRY-US, V24, P793, DOI 10.1021/bi00324a039; Cox PR, 2000, GENOMICS, V63, P97, DOI 10.1006/geno.1999.6061; Domanski M, 2004, J BIOL CHEM, V279, P23637, DOI 10.1074/jbc.M311413200; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Fischer RS, 2006, J BIOL CHEM, V281, P36454, DOI 10.1074/jbc.M606315200; Fischer RS, 2003, TRENDS CELL BIOL, V13, P593, DOI 10.1016/j.tcb.2003.09.007; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Fujisawa T, 2001, FEBS LETT, V498, P67, DOI 10.1016/S0014-5793(01)02498-X; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Gokhin DS, 2010, J CELL BIOL, V189, P95, DOI 10.1083/jcb.201001125; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; JACKMAN MR, 1994, J CELL SCI, V107, P2547; Kong KY, 2006, J BIOL CHEM, V281, P9589, DOI 10.1074/jbc.M512064200; Kostyukova AS, 2007, J MOL BIOL, V372, P608, DOI 10.1016/j.jmb.2007.05.084; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kostyukova AS, 2001, BIOPHYS J, V81, P345, DOI 10.1016/S0006-3495(01)75704-9; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; Krieger I, 2001, ACTA CRYSTALLOGR D, V57, P743, DOI 10.1107/S0907444901003924; KUIPERS OP, 1991, NUCLEIC ACIDS RES, V19, P4558, DOI 10.1093/nar/19.16.4558; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Mannherz HG, 2009, CELL MOTIL CYTOSKEL, V66, P839, DOI 10.1002/cm.20371; MAREKOV LN, 2007, CURR PROTOC PROTEIN, V47; Moyer J. D., 2010, BLOOD IN PRESS; Mudry RE, 2003, J CELL BIOL, V162, P1057, DOI 10.1083/jcb.200305031; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; Safer D, 1997, BIOCHEMISTRY-US, V36, P5806, DOI 10.1021/bi970185v; SANGER JM, 1987, EUR J CELL BIOL, V43, P421; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Speicher K D, 2000, J Biomol Tech, V11, P74; STEVENSON BR, 1994, J CELL SCI, V107, P367; Wang JS, 2005, CELL MOTIL CYTOSKEL, V62, P35, DOI 10.1002/cm.20083; Weber A, 1999, J BIOL CHEM, V274, P34637, DOI 10.1074/jbc.274.49.34637; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	68	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33265	33280		10.1074/jbc.M110.144873	http://dx.doi.org/10.1074/jbc.M110.144873			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20650902	Green Published, hybrid			2022-12-27	WOS:000283048200063
J	Iturrioz, X; Gerbier, R; Leroux, V; Alvear-Perez, R; Maigret, B; Llorens-Cortes, C				Iturrioz, Xavier; Gerbier, Romain; Leroux, Vincent; Alvear-Perez, Rodrigo; Maigret, Bernard; Llorens-Cortes, Catherine			By Interacting with the C-terminal Phe of Apelin, Phe(255) and Trp(259) in Helix VI of the Apelin Receptor Are Critical for Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; HARMONIC MOLECULAR-SURFACES; 4TH TRANSMEMBRANE DOMAIN; LIGAND-BINDING; APJ RECEPTOR; IN-VIVO; CHOLECYSTOKININ-1 RECEPTOR; CARDIAC CONTRACTILITY; TRYPTOPHAN RESIDUES; ENDOGENOUS LIGAND	Apelin is the endogenous ligand of the orphan seven-transmembrane domain (TM) G protein-coupled receptor APJ. Apelin is involved in the regulation of body fluid homeostasis and cardiovascular functions. We previously showed the importance of the C-terminal Phe of apelin 17 (K17F) in the hypotensive activity of this peptide. Here, we show either by deleting the Phe residue (K16P) or by substituting it by an Ala (K17A), that it plays a crucial role in apelin receptor internalization but not in apelin binding or in G alpha(i)-protein coupling. Then we built a homology three-dimensional model of the human apelin receptor using the cholecystokinin receptor-1 model as a template, and we subsequently docked K17F into the binding site. We visualized a hydrophobic cavity at the bottom of the binding pocket in which the C-terminal Phe of K17F was embedded by Trp(152) in TMIV and Trp(259) and Phe(255) in TMVI. Using molecular modeling and site-directed mutagenesis studies, we further showed that Phe(255) and Trp(259) are key residues in triggering receptor internalization without playing a role in apelin binding or in G alpha(i)-protein coupling. These findings bring new insights into apelin receptor activation and show that Phe(255) and Trp(259), by interacting with the C-terminal Phe of the pyroglutamyl form of apelin 13 (pE13F) or K17F, are crucial for apelin receptor internalization.	[Iturrioz, Xavier; Gerbier, Romain; Alvear-Perez, Rodrigo; Llorens-Cortes, Catherine] Univ Paris 06, Coll France, INSERM, U691, FR-75005 Paris, France; [Leroux, Vincent; Maigret, Bernard] H Poincare Univ, Orpailleur Grp, LORIA, CNRS,UMR 7503, FR-54506 Nancy, France; [Gerbier, Romain] Univ Paris Descarte, FR-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; UDICE-French Research Universities; Universite Paris Cite	Llorens-Cortes, C (corresponding author), Coll France, INSERM, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.	c.llorens-cortes@college-de-france.fr	Llorens-Cortes, Catherine/E-5839-2016; Iturrioz, Xavier/AAS-3555-2020; Llorens-Cortès, catherine/AAL-3893-2021; ITURRIOZ, Xavier/Q-4406-2017; GERBIER, Romain/ABF-2481-2020	Llorens-Cortes, Catherine/0000-0002-7667-0401; Iturrioz, Xavier/0000-0001-7143-8323; Llorens-Cortès, catherine/0000-0002-7667-0401; ITURRIOZ, Xavier/0000-0001-7143-8323; Gerbier, Romain/0000-0003-4617-4850; Leroux, Vincent/0000-0002-4142-0883	Agence Nationale pour la Recherche; Region Ile-de-France	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Region Ile-de-France(Region Ile-de-France)	This work was supported by the Agence Nationale pour la Recherche "Physique et Chimie du Vivant 2009."; Supported by a grant "Cardiovasculaires-Obesite-Diabete" from Region Ile-de-France.	Archer-Lahlou E, 2005, J MED CHEM, V48, P180, DOI 10.1021/jm049886y; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Befort K, 1996, J BIOL CHEM, V271, P10161, DOI 10.1074/jbc.271.17.10161; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Braden MR, 2006, MOL PHARMACOL, V70, P1956, DOI 10.1124/mol.106.028720; Cai W, 2008, J MOL MODEL, V14, P393, DOI 10.1007/s00894-008-0286-z; Cai WS, 2002, J MOL GRAPH MODEL, V20, P313, DOI 10.1016/S1093-3263(01)00134-6; Chauvin S, 2001, BIOCHEM PHARMACOL, V62, P329, DOI 10.1016/S0006-2952(01)00675-X; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Chen SH, 2002, BIOCHEMISTRY-US, V41, P6045, DOI 10.1021/bi012189c; Chen SH, 2002, BIOCHEMISTRY-US, V41, P588, DOI 10.1021/bi011868k; Chini B, 1996, FEBS LETT, V397, P201, DOI 10.1016/S0014-5793(96)01135-0; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Escrieut C, 2002, J BIOL CHEM, V277, P7546, DOI 10.1074/jbc.M108563200; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Han HMCB, 1998, MOL ENDOCRINOL, V12, P810, DOI 10.1210/me.12.6.810; Henin J, 2006, BIOPHYS J, V90, P1232, DOI 10.1529/biophysj.105.070599; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Iturrioz X, 2000, BIOCHEMISTRY-US, V39, P3061, DOI 10.1021/bi9925726; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Japp AG, 2008, BIOCHEM PHARMACOL, V75, P1882, DOI 10.1016/j.bcp.2007.12.015; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Lenkei Z, 2000, J HISTOCHEM CYTOCHEM, V48, P1553, DOI 10.1177/002215540004801112; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; O'Carroll AM, 2003, J NEUROENDOCRINOL, V15, P661, DOI 10.1046/j.1365-2826.2003.01044.x; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pulakat L, 2004, BIOCHEM BIOPH RES CO, V319, P1138, DOI 10.1016/j.bbrc.2004.05.092; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Rhee MH, 2000, J NEUROCHEM, V75, P2485, DOI 10.1046/j.1471-4159.2000.0752485.x; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Stitham J, 2004, BIOCHEMISTRY-US, V43, P8974, DOI 10.1021/bi0496788; Suzuki T, 2009, J NEUROCHEM, V110, P1352, DOI 10.1111/j.1471-4159.2009.06227.x; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Thomas A, 2002, PROTEINS, V48, P635, DOI 10.1002/prot.10191; Tikhonova IG, 2007, CURR TOP MED CHEM, V7, P1243; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; Zhou NM, 2003, VIROLOGY, V307, P22, DOI 10.1016/S0042-6822(02)00021-1	61	57	62	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32627	32637		10.1074/jbc.M110.127167	http://dx.doi.org/10.1074/jbc.M110.127167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20675385	hybrid, Green Published			2022-12-27	WOS:000282683000077
J	Kim, KK; Park, KS; Song, SB; Kim, KE				Kim, Kee Kwang; Park, Key Sun; Song, Seok Bean; Kim, Kyoon Eon			Insulin Represses Transcription of the Thyroid Stimulating Hormone beta-Subunit Gene through Increased Recruitment of Nuclear Factor I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONADOTROPIN-RELEASING-HORMONE; CELL-SPECIFIC EXPRESSION; GROWTH-HORMONE; PITUITARY-CELLS; GLUCOSE-TRANSPORTER; PROMOTER ACTIVITY; METABOLISM; ACTIVATION; RECEPTORS; ELEMENTS	Although the regulation of thyroid stimulating hormone beta-subunit gene (TSH beta) has been intensively studied, the functions of transcription factors involved are not fully understood. The authors found that the -615/-516 promoter region of the TSH beta interacts specifically with nuclear proteins derived from pituitary tissue or from cultured thyrotroph cells. The actual binding site at the nucleotide level, as revealed by DNase I protection assay, includes the consensus sequence for nuclear factor I (NFI). RT-PCR analysis indicated that NFI-B expression is restricted to thyrotroph cells in the anterior pituitary. EMSA and ChIP analysis showed that NFI-B binds most efficiently to the -588/-560 region of TSH beta promoter. The forced expressions of NFI-B markedly reduced TSH beta promoter activity and its mRNA expression. Furthermore, it was also shown that the -588/-560 region is involved in the insulin-mediated repression of the TSH beta. It was of particular interest to observe that NFI-B was recruited to the -588/-560 region of the TSH beta promoter in an insulin-dependent manner. Taken together, this study provides new insights of the delicate regulations of energy metabolism and hormonal homeostasis.	[Kim, Kee Kwang; Park, Key Sun; Song, Seok Bean; Kim, Kyoon Eon] Chungnam Natl Univ, Dept Biochem, Coll Nat Sci, Taejon 305764, South Korea	Chungnam National University	Kim, KE (corresponding author), Chungnam Natl Univ, Dept Biochem, Coll Nat Sci, Taejon 305764, South Korea.	kyoonkim@cnu.ac.kr	Kim, Kee/F-8784-2011	Kim, Keekwang/0000-0002-1088-3383; Kim, Kyoon/0000-0001-5133-1692	Chungnam National University	Chungnam National University	This study was financially supported by the research fund of Chungnam National University in 2008.	Ai D, 2007, MOL CELL BIOL, V27, P5765, DOI 10.1128/MCB.01848-06; Alarid ET, 1996, DEVELOPMENT, V122, P3319; ARMENTERO MT, 1994, P NATL ACAD SCI USA, V91, P11537, DOI 10.1073/pnas.91.24.11537; Belikov S, 2004, MOL CELL BIOL, V24, P3036, DOI 10.1128/MCB.24.7.3036-3047.2004; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; CARR FE, 1989, MOL ENDOCRINOL, V3, P717, DOI 10.1210/mend-3-4-717; CARR FE, 1989, MOL ENDOCRINOL, V3, P709, DOI 10.1210/mend-3-4-709; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chen WF, 2004, J CLIN ENDOCR METAB, V89, P2351, DOI 10.1210/jc.2003-032065; CHIN WW, 1993, RECENT PROG HORM RES, V48, P393; Cooke DW, 1999, J BIOL CHEM, V274, P12917, DOI 10.1074/jbc.274.18.12917; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; DARLING DS, 1989, MOL ENDOCRINOL, V3, P1359, DOI 10.1210/mend-3-9-1359; DATTA S, 1992, MOL ENDOCRINOL, V6, P815, DOI 10.1210/me.6.5.815; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Fekete C, 2006, ENDOCRINOLOGY, V147, P520, DOI 10.1210/en.2005-0956; Givens ML, 2004, MOL ENDOCRINOL, V18, P2950, DOI 10.1210/me.2003-0437; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hrytsenko O, 2007, BRAIN RES, V1135, P31, DOI 10.1016/j.brainres.2006.12.009; Hussain MA, 1996, EUR J ENDOCRINOL, V134, P563, DOI 10.1530/eje.0.1340563; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kim KK, 2007, ENDOCRINOLOGY, V148, P3468, DOI 10.1210/en.2006-1088; Lanni A, 2001, J ENDOCRINOL INVEST, V24, P897, DOI 10.1007/BF03343949; Liu YY, 2003, J BIOL CHEM, V278, P38913, DOI 10.1074/jbc.M306120200; MAGNER JA, 1990, ENDOCR REV, V11, P354, DOI 10.1210/edrv-11-2-354; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MULLER MJ, 1990, METABOLISM, V39, P480, DOI 10.1016/0026-0495(90)90006-X; Norquay LD, 2003, MOL ENDOCRINOL, V17, P1027, DOI 10.1210/me.2003-0025; Norquay LD, 2001, BIOCHEM J, V354, P387, DOI 10.1042/0264-6021:3540387; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Ortega E, 2008, EUR J ENDOCRINOL, V158, P217, DOI 10.1530/EJE-07-0592; Richards MP, 2005, COMP BIOCHEM PHYS A, V141, P76, DOI 10.1016/j.cbpb.2005.04.006; Scassa ME, 2004, J BIOL CHEM, V279, P28082, DOI 10.1074/jbc.M401792200; SCHODERBEK WE, 1992, MOL ENDOCRINOL, V6, P893, DOI 10.1210/me.6.6.893; Schultes B, 2002, METABOLISM, V51, P1370, DOI 10.1053/meta.2002.35193; SMALL M, 1986, POSTGRAD MED J, V62, P445, DOI 10.1136/pgmj.62.728.445; Song SB, 2003, MOL CELL ENDOCRINOL, V199, P29, DOI 10.1016/S0303-7207(02)00334-9; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; STEPHENS JM, 1995, ENDOCR REV, V16, P529, DOI 10.1210/er.16.4.529; Szkudelski T, 2003, J PHYSIOL BIOCHEM, V59, P71, DOI 10.1007/BF03179872; Torrance CJ, 1997, ENDOCRINOLOGY, V138, P1204, DOI 10.1210/en.138.3.1204; Yaden BC, 2006, ENDOCRINOLOGY, V147, P324, DOI 10.1210/en.2005-0970; Yusta B, 1998, ENDOCRINOLOGY, V139, P4476, DOI 10.1210/en.139.11.4476; Zhang T, 2001, J BIOL CHEM, V276, P45604, DOI 10.1074/jbc.M107075200; ZOU LL, 1995, ENDOCRINOLOGY, V136, P5236, DOI 10.1210/en.136.11.5236	50	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32003	32011		10.1074/jbc.M110.107573	http://dx.doi.org/10.1074/jbc.M110.107573			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685655	Green Published, hybrid			2022-12-27	WOS:000282683000013
J	Sengupta, PK; Bouchie, MP; Kukuruzinska, MA				Sengupta, Pritam K.; Bouchie, Meghan P.; Kukuruzinska, Maria A.			N-Glycosylation Gene DPAGT1 Is a Target of the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN EXPRESSION; BETA-CATENIN; CELL-ADHESION; INTERCELLULAR-ADHESION; WNT PATHWAY; TRANSCRIPTION; PLAKOGLOBIN; ACTIVATION; CANCER; PROLIFERATION	Protein N-glycosylation and the Wnt/beta-catenin signaling pathways play critical roles in development and cancer. Although N-glycosylation has been shown to influence Wnt signaling through its effects on Wnt ligands, it is unclear whether the Wnt/beta-catenin pathway impacts protein N-glycosylation. In this study, we show that promoters of the first N-glycosylation gene, DPAGT1, from Chinese hamster ovary (CHO), Madin-Darby canine kidney (MDCK), and human epidermoid carcinoma (A253) cells contain the T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) consensus sequence. Treatment of cells with a Wnt activator, lithium chloride, up-regulated DPAGT1 transcript levels that correlated with an increase in the beta-catenin abundance. Furthermore, exposure of cells to a Wnt receptor ligand, Wnt3a, resulted in an increase in the DPAGT1 transcript levels that was abrogated by the Wnt inhibitor, Dick-kopf-1. DNA mobility shift assays revealed specific protein complexes at the DPAGT1 TCF/LEF binding region that were competed off with antibodies to either Tcf3/4 or beta-catenin. Chromatin immunoprecipitation analysis confirmed the presence of beta-catenin at the DPAGT1 promoter in vivo. In addition, the DPAGT1 TCF/LEF sequence drove the expression of the luciferase reporter gene. Furthermore, up-regulation of DPAGT1 transcripts by Wnt3a led to altered N-glycosylation of E-cadherin. Interestingly, the DPAGT1 TCF/LEF sequence also interacted with gamma-catenin, a close homologue of beta-catenin, although not in a lithium chloride-dependent manner. Our results provide the first evidence that the Wnt/beta-catenin signaling pathway regulates the metabolic pathway of protein N-glycosylation by targeting DPAGT1 expression. Moreover, they suggest the existence of another regulatory mechanism involving the interaction of Tcf with gamma-catenin at the DPAGT1 promoter.	[Sengupta, Pritam K.; Bouchie, Meghan P.; Kukuruzinska, Maria A.] Boston Univ, Dept Mol & Cell Biol, Boston, MA 02118 USA	Boston University	Kukuruzinska, MA (corresponding author), Boston Univ, Dept Mol & Cell Biol, 72 E Concord St,E428,Med Campus, Boston, MA 02118 USA.	mkukuruz@bu.edu		Kukukruzinska, Maria/0000-0001-5314-1454	NIDCR, National Institutes of Health [RO1 DE010183, RO1 DE015304]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015304, R01DE010183] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants RO1 DE010183 and RO1 DE015304 from NIDCR (to M. A. K.).	Anagnostou SH, 2008, BIOCHEM J, V416, P211, DOI 10.1042/BJ20081426; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Chen KH, 2008, CANCER LETT, V267, P37, DOI 10.1016/j.canlet.2008.03.005; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fernandes RP, 1999, HISTOCHEM CELL BIOL, V111, P153, DOI 10.1007/s004180050345; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Jamal BT, 2009, CELL HEALTH CYTOSKEL, V1, P67; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; Kukuruzinska MA, 1999, BBA-GEN SUBJECTS, V1426, P359, DOI 10.1016/S0304-4165(98)00136-6; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Mendelsohn RD, 2005, BBA-GEN SUBJECTS, V1723, P33, DOI 10.1016/j.bbagen.2005.01.017; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Nita-Lazar M, 2009, CANCER RES, V69, P5673, DOI 10.1158/0008-5472.CAN-08-4512; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shim JS, 2004, ONCOGENE, V23, P1704, DOI 10.1038/sj.onc.1207289; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; Soler C, 1999, FEBS LETT, V442, P178, DOI 10.1016/S0014-5793(98)01648-2; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tice DA, 2002, J BIOL CHEM, V277, P6118, DOI 10.1074/jbc.M111255200; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhurinsky J, 2000, J CELL SCI, V113, P3127; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	51	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31164	31173		10.1074/jbc.M110.149195	http://dx.doi.org/10.1074/jbc.M110.149195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20693288	Green Published, hybrid			2022-12-27	WOS:000282764600010
J	Seong, HA; Jung, H; Ha, H				Seong, Hyun-A; Jung, Haiyoung; Ha, Hyunjung			Murine Protein Serine/Threonine Kinase 38 Stimulates TGF-beta Signaling in a Kinase-dependent Manner via Direct Phosphorylation of Smad Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-THREONINE KINASE; RECEPTOR-ASSOCIATED PROTEIN; MIGRATION INHIBITORY FACTOR; NM23-H1 TUMOR-SUPPRESSOR; NUCLEAR ACCUMULATION; PHYSICAL INTERACTION; HEMATOPOIETIC-CELLS; MELK; EXPRESSION; SUBSTRATE	The present study demonstrated that murine protein serine/threonine kinase 38 (MPK38) coimmunoprecipitates with Smad proteins (Smad2, -3, -4, and -7) and that this association is mediated by the catalytic kinase domain of MPK38. The association between MPK38 and Smad2, -3, and -4 was significantly increased by TGF-beta or ASK1 signals, whereas these signals decreased association of MPK38 with Smad7. MPK38 stimulated TGF-beta-induced transcription required for TGF-beta-mediated biological functions, such as apoptosis and cell growth arrest, in a kinase-dependent manner. Knockdown of endogenous MPK38 showed an opposite effect, inhibiting TGF-beta signaling. MPK38-mediated phosphorylation of Smad proteins (Ser(245) of Smad2, Ser(204) of Smad3, Ser(343) of Smad4, and Thr(96) of Smad7) was also found to be crucial to the positive regulation of TGF-beta signaling induced by MPK38. In addition, MPK38 enhanced nuclear translocation of Smad3, as well as redistribution of Smad7 from the nucleus to the cytoplasm, in response to TGF-beta. Together, these results indicate that MPK38 functions as a stimulator of TGF-beta signaling through direct interaction with and phosphorylation of Smad proteins.	[Seong, Hyun-A; Jung, Haiyoung; Ha, Hyunjung] Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Dept Biochem, Sch Life Sci, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr			National Research Foundation of Korea [R0A-2007-000-20006-0]; Chungbuk National University	National Research Foundation of Korea(National Research Foundation of Korea); Chungbuk National University	This work was supported by Grant R0A-2007-000-20006-0 from the National Research Foundation of Korea and in part by Chungbuk National University Grant 2009.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; BACHVAROVA R, 1989, DEVELOPMENT, V106, P561; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Glesne D, 2006, ONCOGENE, V25, P4086, DOI 10.1038/sj.onc.1209436; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Heyer BS, 1999, DEV DYNAM, V215, P344; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung HY, 2010, J BIOL CHEM, V285, P54, DOI 10.1074/jbc.M109.045229; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Ohsugi M, 1996, DEV DYNAM, V206, P391, DOI 10.1002/(SICI)1097-0177(199608)206:4<391::AID-AJA5>3.0.CO;2-D; Pulaski L, 2001, J BIOL CHEM, V276, P14344, DOI 10.1074/jbc.M011019200; Roelen BAJ, 2003, AM J PHYSIOL-CELL PH, V285, pC823, DOI 10.1152/ajpcell.00053.2003; Saito R, 2005, MOL CELL BIOL, V25, P6682, DOI 10.1128/MCB.25.15.6682-6693.2005; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yang Y, 1999, APPL BIOCHEM BIOTECH, V80, P13, DOI 10.1385/ABAB:80:1:13; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135	38	40	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30959	30970		10.1074/jbc.M110.138370	http://dx.doi.org/10.1074/jbc.M110.138370			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659902	hybrid, Green Published			2022-12-27	WOS:000282135500061
J	Ma, T; Sadashivaiah, K; Chellaiah, MA				Ma, Tao; Sadashivaiah, Kavitha; Chellaiah, Meenakshi A.			Regulation of Sealing Ring Formation by L-plastin and Cortactin in Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; CD44 SURFACE EXPRESSION; SRC KINASE-ACTIVITY; FREEZE-DRIED BONE; C-SRC; ALPHA(V)BETA(3) INTEGRIN; PODOSOME FORMATION; CELL-ADHESION; PROTEIN; ZONE	The aim of this study is to identify the exact mechanism(s) by which cytoskeletal structures are modulated during bone resorption. In this study, we have shown the possible role of different actin-binding and signaling proteins in the regulation of sealing ring formation. Our analyses have demonstrated a significant increase in cortactin and a corresponding decrease in L-plastin protein levels in osteoclasts subjected to bone resorption for 18 h in the presence of RANKL, M-CSF, and native bone particles. Time-dependent changes in the localization of L-plastin (in actin aggregates) and cortactin (in the sealing ring) suggest that these proteins may be involved in the initial and maturation phases of sealing ring formation, respectively. siRNA to cortactin inhibits this maturation process but not the formation of actin aggregates. Osteoclasts treated as above but with TNF-alpha demonstrated very similar effects as observed with RANKL. Osteoclasts treated with a neutralizing antibody to TNF-alpha displayed podosome-like structures in the entire subsurface and at the periphery of osteoclast. It is possible that TNF-alpha and RANKL-mediated signaling may play a role in the early phase of sealing ring configuration (i.e. either in the disassembly of podosomes or formation of actin aggregates). Furthermore, osteoclasts treated with alendronate or alpha v reduced the formation of the sealing ring but not actin aggregates. The present study demonstrates a novel mechanistic link between L-plastin and cortactin in sealing ring formation. These results suggest that actin aggregates formed by L-plastin independent of integrin signaling function as a core in assembling signaling molecules (integrin alpha v beta 3, Src, cortactin, etc.) involved in the maturation process.	[Ma, Tao; Sadashivaiah, Kavitha; Chellaiah, Meenakshi A.] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Chellaiah, MA (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, 650 W Baltimore St, Baltimore, MD 21201 USA.	mchellaiah@umaryland.edu			NIAMS [AR46292]; American Society for Bone and Mineral Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046292, R56AR046292] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Society for Bone and Mineral Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of multiple signaling molecules that play a part in the assembly of Health, NIAMS, Grant AR46292. This work was also supported by bridge funding provided by the American Society for Bone and Mineral Research.	Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; Atkins GJ, 2000, J BONE MINER RES, V15, P640, DOI 10.1359/jbmr.2000.15.4.640; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Babb SG, 1997, CELL MOTIL CYTOSKEL, V37, P308; Banin S, 1996, CURR BIOL, V6, P981, DOI 10.1016/S0960-9822(02)00642-5; BECKER W, 1995, J PERIODONTOL, V66, P822, DOI 10.1902/jop.1995.66.9.822; BLAIR HC, 1986, J CELL BIOL, V102, P1164, DOI 10.1083/jcb.102.4.1164; Boissy P, 2002, ENDOCRINOLOGY, V143, P1913, DOI 10.1210/en.143.5.1913; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Carron CP, 2000, J ENDOCRINOL, V165, P587, DOI 10.1677/joe.0.1650587; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; Chellaiah M, 1998, J BIOL CHEM, V273, P11908, DOI 10.1074/jbc.273.19.11908; Chellaiah MA, 2003, MOL BIOL CELL, V14, P173, DOI 10.1091/mbc.E02-06-0354; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200; Chellaiah MA, 2007, J BIOL CHEM, V282, P10104, DOI 10.1074/jbc.M608957200; Chellaiah MA, 2009, J CELL PHYSIOL, V220, P382, DOI 10.1002/jcp.21777; Chen H, 2003, IMMUNITY, V19, P95, DOI 10.1016/S1074-7613(03)00172-9; Desai B, 2008, J BIOL CHEM, V283, P13856, DOI 10.1074/jbc.M709401200; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Duong LT, 1998, J CLIN INVEST, V102, P881, DOI 10.1172/JCI3212; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gupta A, 2003, J BONE MINER RES, V18, P669, DOI 10.1359/jbmr.2003.18.4.669; Hartman GD, 2000, EXPERT OPIN INV DRUG, V9, P1281, DOI 10.1517/13543784.9.6.1281; HOROWITZ MC, 1993, SCIENCE, V260, P626, DOI 10.1126/science.8480174; HORTON MA, 1993, J BONE MINER RES, V8, P239; Hurst IR, 2004, J BONE MINER RES, V19, P499, DOI 10.1359/JBMR.0301238; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kaji K, 2001, J BONE MINER RES, V16, P1593, DOI 10.1359/jbmr.2001.16.9.1593; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kudo O, 2002, J PATHOL, V198, P220, DOI 10.1002/path.1190; Lakkakorpi PT, 1999, J BIOL CHEM, V274, P4900, DOI 10.1074/jbc.274.8.4900; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; Lakkakorpi PT, 2001, J CELL SCI, V114, P149; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lam J, 2002, ANN RHEUM DIS, V61, P82; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Luxenburg C, 2006, J CELL SCI, V119, P4878, DOI 10.1242/jcs.03271; Ma Tao, 2008, J Mol Signal, V3, P4, DOI 10.1186/1750-2187-3-4; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Matsubara T, 2006, J BONE MINER METAB, V24, P368, DOI 10.1007/s00774-006-0701-4; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mundy G, 2001, SEMIN ONCOL, V28, P2, DOI 10.1053/sonc.2001.25441; MURAKAMI H, 1995, BONE, V17, P137, DOI 10.1016/S8756-3282(95)00150-6; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakano K, 2001, MOL BIOL CELL, V12, P3515, DOI 10.1091/mbc.12.11.3515; Pacifici R, 1996, J BONE MINER RES, V11, P1043; PIPER K, 1995, CALCIFIED TISSUE INT, V56, P382, DOI 10.1007/BF00301607; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Samanna V, 2006, EXP CELL RES, V312, P2214, DOI 10.1016/j.yexcr.2006.03.022; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schwartz Z, 1998, J PERIODONTOL, V69, P1337, DOI 10.1902/jop.1998.69.12.1337; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; TAYLOR ML, 1989, ANAT EMBRYOL, V180, P427, DOI 10.1007/BF00305117; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417	74	43	45	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29911	29924		10.1074/jbc.M109.099697	http://dx.doi.org/10.1074/jbc.M109.099697			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650888	hybrid, Green Published			2022-12-27	WOS:000281984300028
J	Sakamoto, T; Seiki, M				Sakamoto, Takeharu; Seiki, Motoharu			A Membrane Protease Regulates Energy Production in Macrophages by Activating Hypoxia-inducible Factor-1 via a Non-proteolytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; MATRIX-METALLOPROTEINASE; CYTOPLASMIC TAIL; CELL INVASION; UP-REGULATION; TUMOR-GROWTH; MT1-MMP; HIF-1-ALPHA; BINDING; PHOSPHORYLATION	Most cells produce ATP in the mitochondria by oxidative phosphorylation. However, macrophages, which are major players in the innate immune system, use aerobic glycolysis to produce ATP. HIF-1 (hypoxia-inducible factor-1) regulates expression of glycolysis-related genes and maintains macrophage glycolytic activity. However, it is unclear how HIF-1 activity is maintained in macrophages during normoxia. In this study, we found that macrophages lacking membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14), a potent invasion-promoting protease, exhibited considerably lower ATP levels than wild-type cells. HIF-1 was activated by an unanticipated function of MT1-MMP, which led to the stimulation of ATP production via glycolysis. The cytoplasmic tail of MT1-MMP bound to FIH-1 (factor inhibiting HIF-1), which led to the inhibition of the latter by its recently identified inhibitor, Mint3/APBA3. We have thus identified a new function of MT1-MMP to mediate production of ATP so as to support energy-dependent macrophage functions by a previously unknown non-proteolytic mechanism.	[Sakamoto, Takeharu; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Sakamoto, Takeharu/0000-0002-1225-1902; 	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Specific Coordination Fund for Promoting Science (to T. S.), by a grant-in-aid for scientific research on priority areas (i.e the "Integrative Research toward the Conquest of Cancer") (to M. S.), and by the Global Centers of Excellence Program "Center of Education and Research for the Advanced Genome-Based Medicine: For personalized medicine and the control of worldwide infectious diseases" (to T. S. and M. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Deryugina EI, 2002, CANCER RES, V62, P580; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Uekita T, 2004, J BIOL CHEM, V279, P12734, DOI 10.1074/jbc.M309957200; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Zucker S, 2002, LAB INVEST, V82, P1673, DOI 10.1097/01.LAB.0000041713.74852.2A	44	70	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29951	29964		10.1074/jbc.M110.132704	http://dx.doi.org/10.1074/jbc.M110.132704			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663879	hybrid, Green Published			2022-12-27	WOS:000281984300032
J	Wang, YD; Mohsen, AW; Mihalik, SJ; Goetzman, ES; Vockley, J				Wang, Yudong; Mohsen, Al-Walid; Mihalik, Stephanie J.; Goetzman, Eric S.; Vockley, Jerry			Evidence for Physical Association of Mitochondrial Fatty Acid Oxidation and Oxidative Phosphorylation Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN SUPERCOMPLEXES; ACYL-COA DEHYDROGENASE; BETA-OXIDATION; UBIQUINONE OXIDOREDUCTASE; MAMMALIAN MITOCHONDRIA; MULTIENZYME COMPLEX; YEAST MITOCHONDRIA; MOLECULAR-CLONING; PROTEIN COMPLEXES; ELECTRON-TRANSFER	Fatty acid beta-oxidation (FAO) and oxidative phosphorylation (OXPHOS) are key pathways involved in cellular energetics. Reducing equivalents from FAO enter OXPHOS at the level of complexes I and III. Genetic disorders of FAO and OXPHOS are among the most frequent inborn errors of metabolism. Patients with deficiencies of either FAO or OXPHOS often show clinical and/or biochemical findings indicative of a disorder of the other pathway. In this study, the physical and functional interactions between these pathways were examined. Extracts of isolated rat liver mitochondria were subjected to blue native polyacrylamide gel electrophoresis (BNGE) to separate OXPHOS complexes and supercomplexes followed by Western blotting using antisera to various FAO enzymes. Extracts were also subjected to sucrose density centrifugation and fractions analyzed by BNGE or enzymatic assays. Several FAO enzymes co-migrated with OXPHOS supercomplexes in different patterns in the gels. When palmitoyl-CoA was added to the sucrose gradient fractions containing OXPHOS supercomplexes in the presence of potassium cyanide, cytochrome c was reduced. Cytochrome c reduction was completely blocked by myxothiazol (a complex III inhibitor) and 3-mercaptopropionate (an inhibitor of the first step of FAO), but was only partially inhibited by rotenone (a complex I inhibitor). Although palmitoyl-CoA and octanoyl-CoA provided reducing equivalents to OXPHOS-containing supercomplex fractions, no accumulation of their intermediates was detected. In contrast, short branched acyl-CoA substrates were not metabolized by OXPHOS-containing supercomplex fractions. These data provide evidence of a multifunctional FAO complex within mitochondria that is physically associated with OXPHOS supercomplexes and promotes metabolic channeling.	Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Vockley, Jerry] Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vockley, J (corresponding author), 4401 Penn Ave, Pittsburgh, PA 15224 USA.	gerard.vockley@chp.edu	Wang, Yudong/ABG-1086-2021; Mohsen, Al-Walid/D-6577-2018; Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016	Wang, Yudong/0000-0003-3224-4555; Mohsen, Al-Walid/0000-0002-0096-5959; Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457	U.S. Public Health Service [DKR01-78775, DKR01-54936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076573, R01DK078775] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by U.S. Public Health Service Grants DKR01-78775 and DKR01-54936. To whom correspondence should be addressed: 4401 Penn Ave., Pittsburgh, PA 15224. Fax: 412-692-7816; E-mail: gerard.vockley@chp.edu.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; BENNETT MJ, 1994, J INHERIT METAB DIS, V17, P283, DOI 10.1007/BF00711808; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Enns GM, 2000, J PEDIATR-US, V136, P251, DOI 10.1016/S0022-3476(00)70111-9; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Fang J, 2001, EUR J BIOCHEM, V268, P3075, DOI 10.1046/j.1432-1327.2001.02205.x; FRASER JL, 1995, MODERN PATHOL, V8, P65; FRERMAN FE, 1987, BIOCHIM BIOPHYS ACTA, V893, P161, DOI 10.1016/0005-2728(87)90035-1; Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013; Goodpaster BH, 2002, OBES RES, V10, P575, DOI 10.1038/oby.2002.78; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Ishikawa M, 1997, BIOCHEM J, V328, P815, DOI 10.1042/bj3280815; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Jethva R, 2008, MOL GENET METAB, V95, P195, DOI 10.1016/j.ymgme.2008.09.007; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KISPAL G, 1986, J BIOL CHEM, V261, P14209; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Mohsen AA, 1998, BIOCHEMISTRY-US, V37, P10325, DOI 10.1021/bi973096r; NADA MA, 1995, J BIOL CHEM, V270, P530, DOI 10.1074/jbc.270.2.530; Parker A, 2000, BIOCHEM J, V345, P429, DOI 10.1042/0264-6021:3450429; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PROCHASKA LJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P360, DOI 10.1016/0005-2728(81)90175-4; Reifschneider NH, 2006, J PROTEOME RES, V5, P1117, DOI 10.1021/pr0504440; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; SUMEGI B, 1991, BIOCHIM BIOPHYS ACTA, V1081, P121, DOI 10.1016/0005-2760(91)90016-B; SUMEGI B, 1985, J BIOL CHEM, V260, P188; SUMEGI B, 1984, J BIOL CHEM, V259, P5040; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; Uchiyama A, 1996, J BIOL CHEM, V271, P30360, DOI 10.1074/jbc.271.48.30360; VAN COSTER R, 2001, PEDIATR RES, V50, P658; Venizelos N, 1998, J INHERIT METAB DIS, V21, P409, DOI 10.1023/A:1005310809714; Vockley J, 2000, METHOD ENZYMOL, V324, P241; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Wanders R.J., 2001, METABOLIC MOL BASES, P3219; Wang YD, 1998, ARCH BIOCHEM BIOPHYS, V352, P193, DOI 10.1006/abbi.1998.0590; WANG YD, 1995, BIOCHEMISTRY-US, V34, P7476, DOI 10.1021/bi00022a022; Yu WF, 2004, J BIOL CHEM, V279, P52160, DOI 10.1074/jbc.M409640200	44	108	109	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29834	29841		10.1074/jbc.M110.139493	http://dx.doi.org/10.1074/jbc.M110.139493			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663895	hybrid, Green Published			2022-12-27	WOS:000281984300019
J	Fan, XA; Klein, M; Flanagan-Steet, HR; Steet, R				Fan, Xiang; Klein, Maximilian; Flanagan-Steet, Heather R.; Steet, Richard			Selective Yolk Deposition and Mannose Phosphorylation of Lysosomal Glycosidases in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-OOCYTES; ORYZIAS-LATIPES; STORAGE DISORDERS; MEDAKA FISH; CATHEPSIN-D; DEGRADATION; EGGS; VITELLOGENIN; PROTEINASE; PLATELETS	The regulation and function of lysosomal hydrolases during yolk consumption and embryogenesis in zebrafish are poorly understood. In an effort to better define the lysosomal biochemistry of this organism, we analyzed the developmental expression, biochemical properties, and function of several glycosidases in zebrafish eggs, embryos, and adult tissues. Our results demonstrated that the specific activity of most enzymes increases during embryogenesis, likely reflecting a greater need for turnover within the embryo as yolk-derived nutrients are depleted. Analysis of glycosidase activity in zebrafish and medaka eggs revealed selective deposition of enzymes required for the degradation of N-linked glycans, including an abundance of acidic mannosidases. Treatment of zebrafish embryos with the alpha-mannosidase inhibitor swainsonine resulted in the accumulation of glycosylated vitellogenin fragments and demonstrated a function for maternally deposited acid alpha-mannosidase in yolk consumption. Surprisingly, we also found that, unlike mammals, acid alpha-glucosidase from zebrafish and medaka does not appear to be modified with mannose 6-phosphate residues. We further showed these residues were not acquired on human acid alpha-glucosidase when expressed in zebrafish embryos, suggesting unique differences in the ability of the human and zebrafish N-acetylglucosamine-1-phosphotransferase to recognize and modify certain lysosomal glycosidases. Together, these results provide novel insight into the role of acidic glycosidases during yolk utilization and the evolution of the mannose 6-phosphate targeting system in vertebrates.	[Fan, Xiang; Klein, Maximilian; Flanagan-Steet, Heather R.; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Steet, R (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu			NIGMS; National Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086524] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Mucopolysaccharidosis Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grant from NIGMS (to R. S.). This work was also supported by grants from the National Mucopolysaccharidosis Society.	Carnevali O, 1999, BIOL REPROD, V60, P140, DOI 10.1095/biolreprod60.1.140; FAGOTTO F, 1994, J CELL BIOL, V125, P1047, DOI 10.1083/jcb.125.5.1047; FAGOTTO F, 1995, J CELL SCI, V108, P3645; FAGOTTO F, 1990, ARCH INSECT BIOCHEM, V14, P217, DOI 10.1002/arch.940140403; Fialho E, 2005, ARCH BIOCHEM BIOPHYS, V436, P246, DOI 10.1016/j.abb.2005.01.005; Finn RN, 2007, BIOL REPROD, V76, P926, DOI 10.1095/biolreprod.106.059766; Flanagan-Steet H, 2009, AM J PATHOL, V175, P2063, DOI 10.2353/ajpath.2009.090210; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Galliano M, 2003, BIOCHEM J, V376, P433, DOI 10.1042/BJ20030413; Hemsley KM, 2010, J INHERIT METAB DIS, V33, P363, DOI 10.1007/s10545-010-9078-6; Jorgensen P, 2009, DEVELOPMENT, V136, P1539, DOI 10.1242/dev.032425; KITAJIMA K, 1989, DEV BIOL, V132, P544, DOI 10.1016/0012-1606(89)90249-2; Komazaki S, 1999, DEV GROWTH DIFFER, V41, P173; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Lehmann F, 2004, GLYCOBIOLOGY, V14, P959, DOI 10.1093/glycob/cwh120; MEDINA M, 1988, ARCH BIOCHEM BIOPHYS, V263, P355, DOI 10.1016/0003-9861(88)90646-7; Moro E, 2010, MATRIX BIOL, V29, P43, DOI 10.1016/j.matbio.2009.09.001; Nakamura K, 1996, COMP BIOCHEM PHYS B, V113, P835, DOI 10.1016/0305-0491(95)02102-7; OPRESKO L, 1980, CELL, V22, P47, DOI 10.1016/0092-8674(80)90153-1; OPRESKO LK, 1987, CELL, V51, P557, DOI 10.1016/0092-8674(87)90125-5; Roth Z, 2010, GLYCOCONJUGATE J, V27, P159, DOI 10.1007/s10719-009-9268-3; SEKO A, 1991, J BIOL CHEM, V266, P22110; Seko A, 1999, GLYCOBIOLOGY, V9, P887, DOI 10.1093/glycob/9.9.887; TAGUCHI T, 1993, J BIOL CHEM, V268, P2353; Vasta GR, 2004, GLYCOCONJUGATE J, V21, P503, DOI 10.1007/s10719-004-5541-7; WALL DA, 1985, J CELL BIOL, V101, P1651, DOI 10.1083/jcb.101.5.1651; WALLACE RA, 1983, CIBA F SYMP, V98, P228; WOJCHOWSKI DM, 1986, DEV BIOL, V116, P422, DOI 10.1016/0012-1606(86)90143-0	28	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32946	32953		10.1074/jbc.M110.158295	http://dx.doi.org/10.1074/jbc.M110.158295			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729204	Green Published, hybrid			2022-12-27	WOS:000283048200032
J	Graham, JA; Fray, M; de Haseth, S; Lee, KM; Lian, MM; Chase, CM; Madsen, JC; Markmann, J; Benichou, G; Colvin, RB; Cosimi, AB; Deng, SP; Kim, J; Alessandrini, A				Graham, Jay A.; Fray, Michael; de Haseth, Stephanie; Lee, Kang Mi; Lian, Moh-Moh; Chase, Catharine M.; Madsen, Joren C.; Markmann, James; Benichou, Gilles; Colvin, Robert B.; Cosimi, A. Benedict; Deng, Shaoping; Kim, James; Alessandrini, Alessandro			Suppressive Regulatory T Cell Activity Is Potentiated by Glycogen Synthase Kinase 3 beta Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXP3; BETA-CATENIN; TGF-BETA; IN-VIVO; GSK3-BETA; STABILIZATION; PROLIFERATION; EXPRESSION; GSK-3-BETA; INDUCTION	The mechanism by which regulatory T (Treg) cells suppress the immune response is not well defined. A recent study has shown that beta-catenin prolongs Treg cell survival. Because beta-catenin is regulated by glycogen synthase kinase 3 beta(GSK-3 beta)-directed phosphorylation, we focused on GSK-3 beta and the role it plays in Treg cell function. Inhibition of GSK-3 beta led to increased suppression activity by Treg cells. Inhibitor-treated Treg cells exhibited prolonged FoxP3 expression and increased levels of beta-catenin and of the antiapoptotic protein Bcl-xL. Systemic administration of GSK-3 beta inhibitor resulted in prolonged islet survival in an allotransplant mouse model. Our data suggest that GSK-3 beta could be a useful target in developing strategies designed to increase the stability and function of Treg cells for inducing allotransplant tolerance or treating autoimmune conditions.	[Madsen, Joren C.; Markmann, James; Benichou, Gilles; Cosimi, A. Benedict; Deng, Shaoping; Alessandrini, Alessandro] Harvard Univ, Sch Med, Transplantat Unit, Massachusetts Gen Hosp,Dept Surg, Boston, MA 02114 USA; [Colvin, Robert B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Madsen, Joren C.] Massachusetts Gen Hosp, Div Cardiac Surg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Alessandrini, A (corresponding author), Harvard Univ, Sch Med, Transplantat Unit, Massachusetts Gen Hosp,Dept Surg, 55 Fruit St,Thier 807, Boston, MA 02114 USA.	aalessandrini@partners.org	Graham, Jay A/A-4896-2014; Graham, Jay/AAL-5732-2020	Graham, Jay A/0000-0003-2054-1253; Graham, Jay/0000-0003-2054-1253	National Institutes of Health [K01 DK079207-02, K02 AI53103, R01 HD050484, R01 HL071932, R01 AI048820-09, 5P01 HL18646, U19 DK080652, R01 AI081734-01]; Surgical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018646, R01HL071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI053103, R01AI048820, R01AI081734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079207, U19DK080652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Surgical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK079207-02 (to J.K.), K02 AI53103 and R01 HD050484 (to G. B.), R01 HL071932 (to J.C.M.), R01 AI048820-09 (to J.M.), 5P01 HL18646 and U19 DK080652 (to A. B. C.), and R01 AI081734-01 (to R. B. C.). This work was also supported by a Surgical Research Council junior faculty award (to A. A.).	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Dugo L, 2006, SHOCK, V25, P485, DOI 10.1097/01.shk.0000209545.29671.31; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Marchetti A, 2008, CELL SIGNAL, V20, P2113, DOI 10.1016/j.cellsig.2008.08.002; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Nakashima H, 2005, ACTA NEUROPATHOL, V110, P547, DOI 10.1007/s00401-005-1087-4; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Papkoff J, 1998, BIOCHEM BIOPH RES CO, V247, P851, DOI 10.1006/bbrc.1998.8888; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Sakaguchi S, 2005, INT REV IMMUNOL, V24, P211, DOI 10.1080/08830180590934976; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Xu YY, 2003, EUR J IMMUNOL, V33, P12, DOI 10.1002/immu.200390002; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	39	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32852	32859		10.1074/jbc.M110.150904	http://dx.doi.org/10.1074/jbc.M110.150904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729209	Green Published, hybrid			2022-12-27	WOS:000283048200022
J	Matsumoto, E; Ishihara, A; Tamai, S; Nemoto, A; Iwase, K; Hiwasa, T; Shibata, S; Takiguchi, M				Matsumoto, Eriko; Ishihara, Akinori; Tamai, Saki; Nemoto, Ayako; Iwase, Katsuro; Hiwasa, Takaki; Shibata, Shigenobu; Takiguchi, Masaki			Time of Day and Nutrients in Feeding Govern Daily Expression Rhythms of the Gene for Sterol Regulatory Element-binding Protein (SREBP)-1 in the Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; LEUCINE ZIPPER PROTEIN; CIRCADIAN TRANSCRIPTION; POSITIONAL CLONING; LEPTIN RECEPTOR; ACID SYNTHESIS; MESSENGER-RNA; CLOCK GENES; INSULIN; PHOSPHORYLATION	Sterol regulatory element-binding protein-1 (SREBP-1) plays a central role in transcriptional regulation of genes for hepatic lipid synthesis that utilizes diet-derived nutrients such as carbohydrates and amino acids, and expression of SREBP-1 exhibits daily rhythms with a peak in the nocturnal feeding period under standard housing conditions of mice. Here, we report that the Srebp-1 expression rhythm shows time cue-independent and Clock mutation-sensitive circadian nature, and is synchronized with varied photoperiods apparently through entrainment of locomotor activity and food intake. Fasting caused diminution of Srebp-1 expression, while diabetic db/db and ob/ob mice showed constantly high expression with loss of rhythmicity. Time-restricted feedings during mid-light and mid-dark periods exhibited differential effects, the latter causing more severe damping of the oscillation. Therefore, "when to eat in a day (the light/dark cycle)," rather than "whenever to eat in a day," is a critical determinant to shape the daily rhythm of Srebp-1 expression. We further found that a high-carbohydrate diet and a high-protein diet, as well as a high-fat diet, cause phase shifts of the oscillation peak into the light period, underlining the importance of "what to eat." Daily rhythms of SREBP-1 protein levels and Akt phosphorylation levels also exhibited nutrient-responsive changes. Taken together, these findings provide a model for mechanisms by which time of day and nutrients in feeding shape daily rhythms of the Srebp-1 expression and possibly a number of other physiological functions with interindividual and interdaily differences in human beings and wild animals subjected to day-by-day changes in dietary timing and nutrients.	[Matsumoto, Eriko; Ishihara, Akinori; Tamai, Saki; Nemoto, Ayako; Iwase, Katsuro; Hiwasa, Takaki; Takiguchi, Masaki] Chiba Univ, Dept Biochem & Genet, Grad Sch Med, Chiba 2608670, Japan; [Shibata, Shigenobu] Waseda Univ, Dept Pharmacol, Sch Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Chiba University; Waseda University	Takiguchi, M (corresponding author), Chiba Univ, Dept Biochem & Genet, Grad Sch Med, Inohana 1-8-1, Chiba 2608670, Japan.	mtak@faculty.chiba-u.jp			Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan [18300228]; Fuji Foundation for Protein Research	Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fuji Foundation for Protein Research(Fuji Foundation for Protein Research)	This work was supported in part by Grant-in-Aid (18300228) for Scientific Research from the Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan, and Grant from Fuji Foundation for Protein Research.	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cunningham BA, 1998, THYROID, V8, P815, DOI 10.1089/thy.1998.8.815; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Hirao A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006909; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Ishihara A, 2007, J BIOL RHYTHM, V22, P324, DOI 10.1177/0748730407302107; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kudo T, 2004, DIABETOLOGIA, V47, P1425, DOI 10.1007/s00125-004-1461-0; LaFave LT, 2006, ENDOCRINOLOGY, V147, P4044, DOI 10.1210/en.2006-0473; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Sakao E, 2003, J BIOL CHEM, V278, P30450, DOI 10.1074/jbc.M304809200; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Yanagihara H, 2006, CHRONOBIOL INT, V23, P905, DOI 10.1080/07420520600827103; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	50	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33028	33036		10.1074/jbc.M109.089391	http://dx.doi.org/10.1074/jbc.M109.089391			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720008	Green Published, hybrid			2022-12-27	WOS:000283048200040
J	Kumar, TS; Kari, V; Choudhary, B; Nambiar, M; Akila, TS; Raghavan, SC				Kumar, Tadi Satish; Kari, Vijayalakshmi; Choudhary, Bibha; Nambiar, Mridula; Akila, T. S.; Raghavan, Sathees C.			Anti-apoptotic Protein BCL2 Down-regulates DNA End Joining in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; ACUTE LYMPHOBLASTIC-LEUKEMIA; LIGASE-IV; NONHOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; REPAIR CAPACITY; SINGLE-STRAND; MECHANISM; GENE; TRANSLOCATIONS	Cancer cells are often associated with secondary chromosomal rearrangements, such as deletions, inversions, and translocations, which could be the consequence of unrepaired/misrepaired DNA double strand breaks (DSBs). Nonhomologous DNA end joining is one of the most common pathways to repair DSBs in higher eukaryotes. By using oligomeric DNA substrates mimicking various endogenous DSBs in a cell-free system, we studied end joining (EJ) in different cancer cell lines. We found that the efficiency of EJ varies among cancer cells; however, there was no remarkable difference in the mechanism and expression of EJ proteins. Interestingly, cancer cells with lower levels of EJ possessed elevated expression of BCL2 and vice versa. Removal of BCL2 by immunoprecipitation or protein fractionation led to elevated EJ. More importantly, we show that overexpression of BCL2 or the addition of purified BCL2 led to the down-regulation of EJ. Further, we found that BCL2 interacts with KU proteins both in vitro and in vivo. Hence, our results suggest that EJ in cancer cells could be negatively regulated by the anti-apoptotic protein, BCL2, and this may contribute toward increased chromosomal abnormalities in cancer.	[Kumar, Tadi Satish; Kari, Vijayalakshmi; Choudhary, Bibha; Nambiar, Mridula; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Choudhary, Bibha; Akila, T. S.] Manipal Inst Regenerat Med, Bangalore 560071, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Manipal Academy of Higher Education (MAHE)	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	TADI, Satish K./AAY-2471-2020	TADI, Satish K./0000-0003-1422-1800	Lady Tata Memorial Trust, UK [TLCS/0520]; DAE, India [2008/37/5/BRNS]; IISc	Lady Tata Memorial Trust, UK; DAE, India(Department of Atomic Energy (DAE)); IISc	This work was supported by Lady Tata Memorial Trust, UK, Grant TLCS/0520; DAE, India, Grant 2008/37/5/BRNS; an IISc start up grant (to S. C. R.); and Dr. Raghavan Varadarajan.	Abrahams PJ, 1998, MUTAT RES-DNA REPAIR, V407, P189, DOI 10.1016/S0921-8777(98)00009-3; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Attarbaschi A, 2004, LEUKEMIA, V18, P1611, DOI 10.1038/sj.leu.2403471; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Brady N, 2003, CANCER RES, V63, P1798; CAMPANA D, 1993, BLOOD, V81, P1025; Chiruvella KK, 2008, FEBS LETT, V582, P4066, DOI 10.1016/j.febslet.2008.11.001; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; DERBYSHIRE MK, 1994, MOL CELL BIOL, V14, P156, DOI 10.1128/MCB.14.1.156; FAIRMAN MP, 1992, NUCLEIC ACIDS RES, V20, P4145, DOI 10.1093/nar/20.16.4145; FALZON M, 1993, J BIOL CHEM, V268, P10546; Finn WG, 1998, AM J HEMATOL, V59, P223, DOI 10.1002/(SICI)1096-8652(199811)59:3<223::AID-AJH7>3.0.CO;2-Y; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kobayashi T, 1998, ONCOGENE, V16, P1587, DOI 10.1038/sj.onc.1201681; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; KOVACS E, 1986, EUR J CANCER CLIN ON, V22, P863, DOI 10.1016/0277-5379(86)90375-5; Labhart P, 1999, EUR J BIOCHEM, V265, P849, DOI 10.1046/j.1432-1327.1999.00805.x; LAVIN MF, 1977, NUCLEIC ACIDS RES, V4, P4015, DOI 10.1093/nar/4.11.4015; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Liu YF, 1997, CANCER RES, V57, P1650; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Merel P, 2002, ONCOGENE, V21, P5654, DOI 10.1038/sj.onc.1205742; MIMORI T, 1986, J BIOL CHEM, V261, P375; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Naik AK, 2010, J BIOL CHEM, V285, P7587, DOI 10.1074/jbc.M109.089631; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; NICOLAS AL, 1995, NUCLEIC ACIDS RES, V23, P1036, DOI 10.1093/nar/23.6.1036; NORTH P, 1990, NUCLEIC ACIDS RES, V18, P6205, DOI 10.1093/nar/18.21.6205; Odero MD, 2001, GENE CHROMOSOME CANC, V31, P134, DOI 10.1002/gcc.1127; PETTERSSON M, 1992, BLOOD, V79, P495; Raghavan SC, 2004, DNA REPAIR, V3, P1297, DOI 10.1016/j.dnarep.2004.04.007; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Sathees CR, 1999, MUTAT RES-DNA REPAIR, V433, P1, DOI 10.1016/S0921-8777(98)00055-X; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; SHARMA S, 2010, CELL MOL LI IN PRESS; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; STRASSER A, 1993, ONCOGENE, V8, P1; THACKER J, 1992, NUCLEIC ACIDS RES, V20, P6183, DOI 10.1093/nar/20.23.6183; Tseng HM, 2002, J BIOL CHEM, V277, P45630, DOI 10.1074/jbc.M206861200; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang QH, 2008, MOL CELL, V29, P488, DOI 10.1016/j.molcel.2007.12.029; Wang Yan-Dong, 2006, Subcell Biochem, V40, P439; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yano K, 2009, J RADIAT RES, V50, P97, DOI 10.1269/jrr.08119; Youn CK, 2005, NAT CELL BIOL, V7, P137, DOI 10.1038/ncb1215; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	66	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32657	32670		10.1074/jbc.M110.140350	http://dx.doi.org/10.1074/jbc.M110.140350			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699221	hybrid, Green Published			2022-12-27	WOS:000282683000080
J	Li, XH; Lee, AYW				Li, Xinhua; Lee, Alan Yiu Wah			Semaphorin 5A and Plexin-B3 Inhibit Human Glioma Cell Motility through RhoGDI alpha- mediated Inactivation of Rac1 GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING PROTEIN-ACTIVITY; GDP DISSOCIATION INHIBITOR; HUMAN BREAST-CANCER; ACTIVE RAC; R-RAS; REGULATORY PROTEIN; RECEPTOR PLEXIN-B1; PANCREATIC-CANCER; TYROSINE KINASE; GENE-EXPRESSION	Semaphorins and plexins are implicated in the progression of various types of cancer, although the molecular basis has not been fully elucidated. Here, we report the expression of plexin-B3 in glioma cells, which upon stimulation by its ligand Sema5A results in significant inhibition of cell migration and invasion. A search for the underlying mechanism revealed direct interaction of plexin-B3 with RhoGDP dissociation inhibitor alpha (RhoGDI alpha), a negative regulator of RhoGTPases that blocks guanine nucleotide exchange and sequesters them away from the plasma membrane. Glioma cells challenged with Sema5A indeed showed a marked reduction in Rac1-GTP levels by 60%, with a concomitant disruption of lamellipodia. The inactivation of Rac1 was corroborated to contribute to the impediment of glioma cell invasion by Sema5A, as supported by the abolishment of effect upon forced expression of a constitutively active Rac1 mutant. Furthermore, silencing the endogenous expression of RhoGDI alpha in glioma cells was found to be sufficient in abrogating the down-regulation of Rac1-GTP and the ensuing suppression of glioma cell motility induced by Sema5A. Mechanistically, we provide evidence that Sema5A promotes Rac1 recruitment to RhoGDI alpha and reduces its membrane localization in a plexin-B3-dependent manner, thereby preventing Rac1 activation. This represents a novel signaling of semaphorin and plexin in the control of cell motility by indirect inactivation of Rac1 through RhoGDI alpha.	[Li, Xinhua; Lee, Alan Yiu Wah] Natl Univ Singapore, Neurobiol Ageing Program, Ctr Life Sci, Yong Loo Lin Sch Med,Dept Physiol,Life Sci Inst, Singapore 117456, Singapore	National University of Singapore	Lee, AYW (corresponding author), Natl Univ Singapore, Neurobiol Ageing Program, Ctr Life Sci, Yong Loo Lin Sch Med,Dept Physiol,Life Sci Inst, 28 Med Dr, Singapore 117456, Singapore.	phsleeyw@nus.edu.sg	Lee, Alan/E-8554-2011; LEE, Alan Yiu Wah/AAE-1845-2022; Lee, Alan Yiu Wah/AAD-4541-2020	Lee, Alan Yiu Wah/0000-0003-0635-4179	National University of Singapore; Biomedical Research Council of Singapore	National University of Singapore(National University of Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by research grants from the National University of Singapore and the Biomedical Research Council of Singapore (to A.Y.W.L.).	Artigiani S, 2004, EMBO REP, V5, P710, DOI 10.1038/sj.embor.7400189; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Balakrishnan A, 2009, HUM MUTAT, V30, P1167, DOI 10.1002/humu.21017; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Bauer NN, 2007, EXP CELL RES, V313, P3832, DOI 10.1016/j.yexcr.2007.08.017; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Correa RG, 2001, GENOMICS, V73, P343, DOI 10.1006/geno.2001.6525; Crowe DL, 2004, ANTICANCER RES, V24, P593; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; DerMardirossian CM, 2006, METHOD ENZYMOL, V406, P80, DOI 10.1016/S0076-6879(06)06007-1; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Iwadate Y, 2004, CANCER RES, V64, P2496, DOI 10.1158/0008-5472.CAN-03-1254; Jiang WG, 2003, CLIN CANCER RES, V9, P6432; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Kusy S, 2005, NEOPLASIA, V7, P457, DOI 10.1593/neo.04721; Ma PC, 2003, CANCER RES, V63, P6272; McDonough WS, 2005, NEOPLASIA, V7, P862, DOI 10.1593/neo.05190; MIURA Y, 1993, J BIOL CHEM, V268, P510; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Nakada M, 2006, CANCER RES, V66, P8492, DOI 10.1158/0008-5472.CAN-05-4211; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Newcombe AR, 1999, BIOCHEMISTRY-US, V38, P6879, DOI 10.1021/bi9829837; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Pan GQ, 2009, WORLD J GASTROENTERO, V15, P2800, DOI 10.3748/wjg.15.2800; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; Park CK, 2008, J CANCER RES CLIN, V134, P255, DOI 10.1007/s00432-007-0282-1; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Rieger J, 2003, GLIA, V42, P379, DOI 10.1002/glia.10210; Rody A, 2007, CLIN CANCER RES, V13, P1115, DOI 10.1158/1078-0432.CCR-06-2433; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Sadanandam A, 2007, OMICS, V11, P41, DOI 10.1089/omi.2006.0004; Sadanandam A, 2010, INT J CANCER, V127, P1373, DOI 10.1002/ijc.25166; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Sun JJ, 2004, J BIOL CHEM, V279, P42936, DOI 10.1074/jbc.M406493200; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; UEDA T, 1990, J BIOL CHEM, V265, P9373; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	66	60	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32436	32445		10.1074/jbc.M110.120451	http://dx.doi.org/10.1074/jbc.M110.120451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696765	hybrid, Green Published			2022-12-27	WOS:000282683000057
J	Nasrin, N; Wu, XP; Fortier, E; Feng, YJ; Bare, OC; Chen, SM; Ren, XL; Wu, ZD; Streeper, RS; Bordone, L				Nasrin, Nargis; Wu, Xiaoping; Fortier, Eric; Feng, Yajun; Bare, Olivia Claire; Chen, Sumiao; Ren, Xianglin; Wu, Zhidan; Streeper, Ryan S.; Bordone, Laura			SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-DEHYDROGENASE; AMINO-GROUPS; SIRTUINS; METABOLISM; GLUCOSE; RESTRICTION; PGC-1-ALPHA; ACETYLATION; INSIGHTS; NAD	SIRT4, a member of the sirtuin family, has been implicated in the regulation of insulin secretion by modulation of glutamate dehydrogenase. However, the role of this enzyme in the regulation of metabolism in other tissues is unknown. In this study we investigated whether depletion of SIRT4 would enhance liver and muscle metabolic functions. To do this SIRT4 was knocked down using an adenoviral shRNA in mouse primary hepatocytes and myotubes. We observed a significant increase in gene expression of mitochondrial and fatty acid metabolism enzymes in hepatocytes with reduced SIRT4 levels. SIRT4 knockdown also increased SIRT1 mRNA and protein levels both in vitro and in vivo. In agreement with the increased fatty acid oxidation (FAO) gene expression, we showed a significant increase in FAO in SIRT4 knockdown primary hepatocytes compared with control, and this effect was dependent on SIRT1. In primary myotubes, knockdown of SIRT4 resulted in increased FAO, cellular respiration, and pAMPK levels. When SIRT4 was knocked down in vivo by tail vein injection of a shRNA adenovirus, we observed a significant increase in hepatic mitochondrial and FAO gene expression consistent with the findings in primary hepatocytes. Taken together these findings demonstrate that SIRT4 inhibition increases fat oxidative capacity in liver and mitochondrial function in muscle, which might provide therapeutic benefits for diseases associated with ectopic lipid storage such as type 2 diabetes.	[Nasrin, Nargis; Wu, Xiaoping; Fortier, Eric; Feng, Yajun; Bare, Olivia Claire; Chen, Sumiao; Ren, Xianglin; Wu, Zhidan; Streeper, Ryan S.; Bordone, Laura] Novartis Inst BioMed Res Inc, Cardiovasc & Metab Dis Area, Cambridge, MA 02139 USA	Novartis	Bordone, L (corresponding author), 100 Technol Sq, Cambridge, MA 02139 USA.	laura.bordone@novartis.com	Feng, yajun/GSN-0428-2022	Wu, Zhidan/0000-0001-7289-9420				Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; COLMAN RF, 1966, J BIOL CHEM, V241, P3652; COLMAN RF, 1966, J BIOL CHEM, V241, P3661; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103	21	222	230	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31995	32002		10.1074/jbc.M110.124164	http://dx.doi.org/10.1074/jbc.M110.124164			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685656	hybrid, Green Published			2022-12-27	WOS:000282683000012
J	Perrinjaquet, M; Vilar, M; Ibanez, CF				Perrinjaquet, Maurice; Vilar, Marcal; Ibanez, Carlos F.			Protein-tyrosine Phosphatase SHP2 Contributes to GDNF Neurotrophic Activity through Direct Binding to Phospho-Tyr(687) in the RET Receptor Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL SURVIVAL; C-RET; AUTOPHOSPHORYLATION SITES; GROWTH-FACTOR; ACTIVATION; DIFFERENTIATION; GFR-ALPHA-1; MUTATIONS; CELLS; ISOFORMS	The signaling mechanisms by which neurotrophic receptors regulate neuronal survival and axonal growth are still incompletely understood. In the receptor tyrosine kinase RET, a receptor for GDNF (glial cell line-derived neurotrophic factor), the functions of the majority of tyrosine residues that become phosphorylated are still unknown. Here we have identified the protein-tyrosine phosphatase SHP2 as a novel direct interactor of RET and the first effector known to bind to phosphorylated Tyr(687) in the juxtamembrane region of the receptor. We show that SHP2 is recruited to RET upon ligand binding in a cooperative fashion, such that both interaction with Tyr(687) and association with components of the Tyr(1062) signaling complex are required for stable recruitment of SHP2 to the receptor. SHP2 recruitment contributes to the ability of RET to activate the PI3K/AKT pathway and promote survival and neurite outgrowth in primary neurons. Furthermore, we find that activation of protein kinase A (PKA) by forskolin reduces the recruitment of SHP2 to RET and negatively affects ligand-mediated neurite outgrowth. In agreement with this, mutation of Ser(696), a known PKA phosphorylation site in RET, enhances SHP2 binding to the receptor and eliminates the effect of forskolin on ligand-induced outgrowth. Together, these findings establish SHP2 as a novel positive regulator of the neurotrophic activities of RET and reveal Tyr(687) as a critical platform for integration of RET and PKA signals. We anticipate that several other phosphotyrosines of unknown function in neuronal receptor tyrosine kinases will also support similar regulatory functions.	[Perrinjaquet, Maurice] Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden	Karolinska Institutet		carlos.ibanez@ki.se	Vilar, Marçal/B-4581-2016	Vilar, Marçal/0000-0002-9376-6544				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Asai N, 2006, DEVELOPMENT, V133, P4507, DOI 10.1242/dev.02616; Besset V, 2000, J BIOL CHEM, V275, P39159, DOI 10.1074/jbc.M006908200; Blokzijl A, 2002, CURR BIOL, V12, P35, DOI 10.1016/S0960-9822(01)00623-6; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cai T, 2002, J CELL BIOL, V159, P103, DOI 10.1083/jcb.200205017; CAILLAUD T, 1995, MOL NEUROBIOL, V10, P105, DOI 10.1007/BF02740670; Canty AJ, 2009, J NEUROSCI, V29, P10695, DOI 10.1523/JNEUROSCI.2658-09.2009; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Coulpier M, 2002, J BIOL CHEM, V277, P1991, DOI 10.1074/jbc.M107992200; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; De Vita G, 2000, CANCER RES, V60, P3727; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Hayashi H, 2000, ONCOGENE, V19, P4469, DOI 10.1038/sj.onc.1203799; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Huang QH, 2002, J BIOL CHEM, V277, P29330, DOI 10.1074/jbc.M112450200; Iwase T, 2005, J NEUROCHEM, V94, P1488, DOI 10.1111/j.1471-4159.2005.03290.x; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; Kawamoto Y, 2004, J BIOL CHEM, V279, P14213, DOI 10.1074/jbc.M312600200; Kjaer S, 2006, ONCOGENE, V25, P7086, DOI 10.1038/sj.onc.1209698; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liu X, 1996, J BIOL CHEM, V271, P5309, DOI 10.1074/jbc.271.10.5309; Marsh HN, 2003, J CELL BIOL, V163, P999, DOI 10.1083/jcb.200309036; Nielsen J, 2009, J NEUROSCI, V29, P11360, DOI 10.1523/JNEUROSCI.3239-09.2009; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Rossel M, 1997, ONCOGENE, V14, P265, DOI 10.1038/sj.onc.1200831; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Scott RP, 2005, J BIOL CHEM, V280, P13442, DOI 10.1074/jbc.M500507200; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017	41	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31867	U864		10.1074/jbc.M110.144923	http://dx.doi.org/10.1074/jbc.M110.144923			27	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682772	hybrid, Green Published			2022-12-27	WOS:000282764600078
J	Liu, M; Hua, QX; Hu, SQ; Jia, WH; Yang, YW; Saith, SE; Whittaker, J; Arvan, P; Weiss, MA				Liu, Ming; Hua, Qing-Xin; Hu, Shi-Quan; Jia, Wenhua; Yang, Yanwu; Saith, Sunil Evan; Whittaker, Jonathan; Arvan, Peter; Weiss, Michael A.			Deciphering the Hidden Informational Content of Protein Sequences FOLDABILITY OF PROINSULIN HINGES ON A FLEXIBLE ARM THAT IS DISPENSABLE IN THE MATURE HORMONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; DIRECTING INSULIN INTERACTION; RECEPTOR-BINDING SURFACE; BIOLOGICAL-ACTIVITY; SIDE-CHAIN; ENDOPLASMIC-RETICULUM; MUTATIONAL ANALYSIS; CHIRAL MUTAGENESIS; STRUCTURAL SWITCH; ENERGY LANDSCAPE	Protein sequences encode both structure and foldability. Whereas the interrelationship of sequence and structure has been extensively investigated, the origins of folding efficiency are enigmatic. We demonstrate that the folding of proinsulin requires a flexible N-terminal hydrophobic residue that is dispensable for the structure, activity, and stability of the mature hormone. This residue (Phe(B1) in placental mammals) is variably positioned within crystal structures and exhibits H-1 NMR motional narrowing in solution. Despite such flexibility, its deletion impaired insulin chain combination and led in cell culture to formation of non-native disulfide isomers with impaired secretion of the variant proinsulin. Cellular folding and secretion were maintained by hydrophobic substitutions at B1 but markedly perturbed by polar or charged side chains. We propose that, during folding, a hydrophobic side chain at B1 anchors transient long-range interactions by a flexible N-terminal arm (residues B1-B8) to mediate kinetic or thermodynamic partitioning among disulfide intermediates. Evidence for the overall contribution of the arm to folding was obtained by alanine scanning mutagenesis. Together, our findings demonstrate that efficient folding of proinsulin requires N-terminal sequences that are dispensable in the native state. Such arm-dependent folding can be abrogated by mutations associated with beta-cell dysfunction and neonatal diabetes mellitus.	[Liu, Ming; Saith, Sunil Evan; Arvan, Peter] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Hua, Qing-Xin; Hu, Shi-Quan; Jia, Wenhua; Yang, Yanwu; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Case Western Reserve University	Arvan, P (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	parvan@umichigan.edu; michael.weiss@case.edu		Saith, Sunil/0000-0002-0249-6017; Liu, Ming/0000-0003-2665-4072	National Institutes of Health [DK48280, DK0697674]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, R01DK069764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK48280 (to P. A.) and DK0697674 (to M. A. W.) and a grant from the American Diabetes Association (to M. A. W.). This is a contribution from the Cleveland Center for Membrane and Structural Biology.	BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; Bliss M., 1982, DISCOVERY INSULIN; BRADER ML, 1991, TRENDS BIOCHEM SCI, V16, P341; Brange J, 1997, DIABETOLOGIA, V40, pS48, DOI 10.1007/s001250051400; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; BREMS DN, 1990, BIOCHEMISTRY-US, V29, P9289, DOI 10.1021/bi00491a026; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen Y, 2004, BIOCHEMISTRY-US, V43, P9225, DOI 10.1021/bi049710y; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; CUTFIELD JF, 1979, J MOL BIOL, V132, P85, DOI 10.1016/0022-2836(79)90497-2; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dinner AR, 1999, PROTEINS, V35, P34, DOI 10.1002/(SICI)1097-0134(19990401)35:1<34::AID-PROT4>3.0.CO;2-Q; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; FRANK BH, 1972, DIABETES, V21, P486, DOI 10.2337/diab.21.2.S486; FRANK BH, 1968, BIOCHEM BIOPH RES CO, V32, P155, DOI 10.1016/0006-291X(68)90362-8; GALLOWAY JA, 1992, DIABETES CARE, V15, P666, DOI 10.2337/diacare.15.5.666; Guo ZY, 2005, ACTA BIOCH BIOPH SIN, V37, P673, DOI 10.1111/j.1745-7270.2005.00093.x; Guo ZY, 2002, BIOCHEMISTRY-US, V41, P1556, DOI 10.1021/bi011166v; HEJNAES KR, 1992, PROTEIN ENG, V5, P797, DOI 10.1093/protein/5.8.797; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; Hober S, 1999, FEBS LETT, V443, P271, DOI 10.1016/S0014-5793(98)01737-2; HOBER S, 1994, BIOCHEMISTRY-US, V33, P6758, DOI 10.1021/bi00188a003; Hober S, 1997, BIOCHEMISTRY-US, V36, P4616, DOI 10.1021/bi9611265; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; HUANG XF, 1994, J BIOL CHEM, V269, P20838; JORGENSEN LN, 1992, DIABETOLOGIA, V35, pA3; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; KITAGAWA K, 1984, BIOCHEMISTRY-US, V23, P1405, DOI 10.1021/bi00302a011; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pace CN, 2000, PROTEINS, P1; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; SCHWARTZ G, 1978, BIOCHEMISTRY-US, V17, P4550, DOI 10.1021/bi00614a029; SHAKHNOVICH E, 1991, PHYS REV LETT, V67, P1665, DOI 10.1103/PhysRevLett.67.1665; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; SMITH MC, 1989, J BIOL CHEM, V264, P9314; SNELL CR, 1975, J BIOL CHEM, V250, P6291; Sohma Y, 2010, J BIOL CHEM, V285, P5040, DOI 10.1074/jbc.M109.062992; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Steiner D F, 1969, Recent Prog Horm Res, V25, P207; STEINER DF, 1988, HORM METAB RES, V20, P443, DOI 10.1055/s-2007-1010855; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TANG JG, 1990, BIOCHEM J, V268, P429, DOI 10.1042/bj2680429; Tiana G, 2000, PROTEINS, V39, P244, DOI 10.1002/(SICI)1097-0134(20000515)39:3<244::AID-PROT70>3.0.CO;2-#; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2002, BIOCHEMISTRY-US, V41, P809, DOI 10.1021/bi011839+; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISS MA, 1989, BIOCHEMISTRY-US, V28, P9855, DOI 10.1021/bi00451a046; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Yang YW, 2010, J BIOL CHEM, V285, P7847, DOI 10.1074/jbc.C109.084921	104	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30989	31001		10.1074/jbc.M110.152645	http://dx.doi.org/10.1074/jbc.M110.152645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663888	hybrid, Green Published			2022-12-27	WOS:000282135500064
J	Seffernick, JL; Reynolds, E; Fedorov, AA; Fedorov, E; Almo, SC; Sadowsky, MJ; Wackett, LP				Seffernick, Jennifer L.; Reynolds, Erik; Fedorov, Alexander A.; Fedorov, Elena; Almo, Steven C.; Sadowsky, Michael J.; Wackett, Lawrence P.			X-ray Structure and Mutational Analysis of the Atrazine Chlorohydrolase TrzN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTHROBACTER-AURESCENS TC1; SITE-DIRECTED MUTAGENESIS; SP STRAIN ADP; SUBSTRATE-SPECIFICITY; CARBONIC-ANHYDRASE; MECHANISM; EVOLUTION; ENZYMES; CATABOLISM; CATALYSIS	Atrazine chlorohydrolase, TrzN (triazine hydrolase or atrazine chlorohydrolase 2), initiates bacterial metabolism of the herbicide atrazine by hydrolytic displacement of a chlorine substituent from the s-triazine ring. The present study describes crystal structures and reactivity of wild-type and active site mutant TrzN enzymes. The homodimer native enzyme structure, solved to 1.40 angstrom resolution, is a (beta alpha)(8) barrel, characteristic of members of the amidohydrolase superfamily. TrzN uniquely positions threonine 325 in place of a conserved aspartate that ligates the metal in most mononuclear amidohydrolases superfamily members. The threonine side chain oxygen atom is 3.3 angstrom from the zinc atom and 2.6 angstrom from the oxygen atom of zinc-coordinated water. Mutation of the threonine to a serine resulted in a 12-fold decrease in k(cat)/K-m, largely due to k(cat),, whereas the T325D and T325E mutants had immeasurable activity. The structure and kinetics of TrzN are reminiscent of carbonic anhydrase, which uses a threonine to assist in positioning water for reaction with carbon dioxide. An isosteric substitution in the active site glutamate, E241Q, showed a large diminution in activity with ametryn, no detectable activity with atratone, and a 10-fold decrease with atrazine, when compared with wild-type TrzN. Activity with the E241Q mutant was nearly constant from pH 6.0 to 10.0, consistent with the loss of a proton-donating group. Structures for TrzN-E241Q were solved with bound ametryn and atratone to 1.93 and 1.64 angstrom resolution, respectively. Both structure and kinetic determinations suggest that the Glu(241) side chain provides a proton to N-1 of the s-triazine substrate to facilitate nucleophilic displacement at the adjacent C-2.	[Wackett, Lawrence P.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Gortner Lab 140, St Paul, MN 55108 USA; [Seffernick, Jennifer L.; Reynolds, Erik; Sadowsky, Michael J.; Wackett, Lawrence P.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Seffernick, Jennifer L.; Sadowsky, Michael J.; Wackett, Lawrence P.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Fedorov, Alexander A.; Fedorov, Elena; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Yeshiva University; Albert Einstein College of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Wackett, LP (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Gortner Lab 140, 1479 Gortner Ave, St Paul, MN 55108 USA.	wacke003@umn.edu	Sadowsky, Michael/J-2507-2016	Sadowsky, Michael/0000-0001-8779-2781	Sygenta Crop Protection	Sygenta Crop Protection	This work was supported by a grant from Sygenta Crop Protection (to L.P.W. and M.J.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BHAUMIK D, 1993, J BIOL CHEM, V268, P5464; CHEN X, 1993, BIOCHEMISTRY-US, V32, P7861, DOI 10.1021/bi00082a004; de Jong RM, 2007, J BIOL CHEM, V282, P2440, DOI 10.1074/jbc.M608134200; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; de Souza ML, 1998, J BACTERIOL, V180, P1951, DOI 10.1128/JB.180.7.1951-1954.1998; de Souza ML, 1998, APPL ENVIRON MICROB, V64, P2323; deSouza ML, 1996, J BACTERIOL, V178, P4894, DOI 10.1128/jb.178.16.4894-4900.1996; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; HUANG CC, 2000, PAC S BIOCOMPUT, V12, P230; Huang S, 2002, BIOCHEMISTRY-US, V41, P7628, DOI 10.1021/bi020053o; IPPOLITO JA, 1995, P NATL ACAD SCI USA, V92, P5017, DOI 10.1073/pnas.92.11.5017; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; KREBS JF, 1993, J BIOL CHEM, V268, P27458; Krutz LJ, 2009, WEED SCI, V57, P427, DOI 10.1614/WS-09-010.1; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Meyer AH, 2009, ENVIRON SCI TECHNOL, V43, P8079, DOI 10.1021/es9013618; Mohamedali KA, 1996, BIOCHEMISTRY-US, V35, P1672, DOI 10.1021/bi9514119; Morris JH, 2007, BIOINFORMATICS, V23, P2345, DOI 10.1093/bioinformatics/btm329; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Piutti S, 2003, FEMS MICROBIOL LETT, V221, P111, DOI 10.1016/S0378-1097(03)00168-X; Scott C, 2009, APPL ENVIRON MICROB, V75, P2184, DOI 10.1128/AEM.02634-08; Seffernick JL, 2009, J BIOTECHNOL, V143, P17, DOI 10.1016/j.jbiotec.2009.06.004; Seffernick JL, 2000, APPL ENVIRON MICROB, V66, P4247, DOI 10.1128/AEM.66.10.4247-4252.2000; Seffernick JL, 2002, BIOCHEMISTRY-US, V41, P14430, DOI 10.1021/bi020415s; Seffernick JL, 2001, BIOCHEMISTRY-US, V40, P12747, DOI 10.1021/bi011293r; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shapir N, 2007, J BACTERIOL, V189, P674, DOI 10.1128/JB.01257-06; Shapir N, 2005, APPL ENVIRON MICROB, V71, P2214, DOI 10.1128/AEM.71.5.2214-2220.2005; Shapir N, 2006, J BACTERIOL, V188, P5859, DOI 10.1128/JB.00517-06; Sideraki V, 1996, BIOCHEMISTRY-US, V35, P15019, DOI 10.1021/bi961427e; Strong LC, 2002, APPL ENVIRON MICROB, V68, P5973, DOI 10.1128/AEM.68.12.5973-5980.2002; Strong LC, 2000, ENVIRON MICROBIOL, V2, P91, DOI 10.1046/j.1462-2920.2000.00079.x; Topp E, 2000, APPL ENVIRON MICROB, V66, P3134, DOI 10.1128/AEM.66.8.3134-3141.2000; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539	39	24	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30606	30614		10.1074/jbc.M110.138677	http://dx.doi.org/10.1074/jbc.M110.138677			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659898	Green Published, hybrid			2022-12-27	WOS:000282135500029
J	Toubarro, D; Lucena-Robles, M; Nascimento, G; Santos, R; Montiel, R; Verissimo, P; Pires, E; Faro, C; Coelho, AV; Simoes, N				Toubarro, Duarte; Lucena-Robles, Miguel; Nascimento, Gisela; Santos, Romana; Montiel, Rafael; Verissimo, Paula; Pires, Euclides; Faro, Carlos; Coelho, Ana V.; Simoes, Nelson			Serine Protease-mediated Host Invasion by the Parasitic Nematode Steinernema carpocapsae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTIVE HOOKWORM LARVAE; TRICHINELLA-SPIRALIS; ENTOMOPATHOGENIC NEMATODES; IDENTIFICATION; PURIFICATION; PROTEINS; CLONING; MATRIX; PATHOGENICITY; SPECIFICITY	Steinernema carpocapsae is an insect parasitic nematode used in biological control, which infects insects penetrating by mouth and anus and invading the hemocoelium through the midgut wall. Invasion has been described as a key factor in nematode virulence and suggested to be mediated by proteases. A serine protease cDNA from the parasitic stage was sequenced (sc-sp-1); the recombinant protein was produced in an Escherichia coli system, and a native protein was purified from the secreted products. Both proteins were confirmed by mass spectrometry to be encoded by the sc-sp-1 gene. Sc-SP-1 has a pI of 8.7, a molecular mass of 27.3 kDa, a catalytic efficiency of 22.2 x 10(4) s(-1) M-1 against N-succinyl-Ala-Ala-Pro-Phe-pNA, and is inhibited by chymostatin (IC 0.07) and PMSF (IC 0.73). Sc-SP-1 belongs to the chymotrypsin family, based on sequence and biochemical analysis. Only the nematode parasitic stage expressed sc-sp-1. These nematodes in the midgut lumen, prepared to invade the insect hemocoelium, expressed higher levels than those already in the hemocoelium. Moreover, parasitic nematode sense insect peritrophic membrane and hemolymph more quickly than they do other tissues, which initiates sc-sp-1 expression. Ex vivo, Sc-SP-1 was able to bind to insect midgut epithelium and to cause cell detachment from basal lamina. In vitro, Sc-SP-1 formed holes in an artificial membrane model (Matrigel), whereas Sc-SP-1 treated with PMSF did not, very likely because it hydrolyzes matrix glycoproteins. These findings highlight the S. carpocapsae-invasive process that is a key step in the parasitism thus opening new perspectives for improving nematode virulence to use in biological control.	[Simoes, Nelson] Univ Acores, CIRN, P-9501801 Ponta Delgada, Portugal; [Simoes, Nelson] Univ Acores, Dept Biol, P-9501801 Ponta Delgada, Portugal; [Santos, Romana; Coelho, Ana V.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780901 Oeiras, Portugal; [Verissimo, Paula; Pires, Euclides; Faro, Carlos] Univ Coimbra, CNC, P-3001401 Coimbra, Portugal; [Verissimo, Paula; Pires, Euclides; Faro, Carlos] Univ Coimbra, Dept Ciencias Vida, P-3001401 Coimbra, Portugal	Universidade dos Acores; Universidade dos Acores; Universidade Nova de Lisboa; Universidade de Coimbra; Universidade de Coimbra	Simoes, N (corresponding author), Univ Acores, CIRN, Apartado 1422, P-9501801 Ponta Delgada, Portugal.	simoes@uac.pt	Simões, Nelson/K-3843-2013; Montiel, Rafael/A-6774-2008; Santos, R./J-3461-2012; Toubarro, Duarte/K-3881-2013; Coelho, Ana V Varela/O-3977-2014; Coelho, Ana V/H-8885-2012; Verissimo, Paula/AAB-2281-2021	Simões, Nelson/0000-0003-3612-6759; Montiel, Rafael/0000-0001-8052-0679; Santos, R./0000-0001-7720-6806; Toubarro, Duarte/0000-0003-2025-9696; Coelho, Ana V Varela/0000-0002-6143-4203; Coelho, Ana V/0000-0002-6143-4203; Verissimo, Paula/0000-0003-0532-4242; Pires, Euclides/0000-0002-5853-0165; Faro, Carlos/0000-0002-0480-8379	Fundacao para a Ciencia e Tecnologia [POCTI/BSE/41630/2001]; Fundacao Lusa Americana para o Desenvolvimento [223/06]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/18986/2004, SFRH/BGCT/15324/2005l, POCI/AGR/56300/2004l, SFRH/BGCT/32473/2006]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Lusa Americana para o Desenvolvimento; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported in part by Project POCTI/BSE/41630/2001 founded by Fundacao para a Ciencia e Tecnologia and Project 223/06 founded by Fundacao Lusa Americana para o Desenvolvimento.; Supported by Grant SFRH/BD/18986/2004 from Fundacao para a Ciencia e Tecnologia, Portugal.; Supported by Grant SFRH/BGCT/15324/2005l from Fundacao para a Ciencia e Tecnologia, Portugal.; Supported by Grant POCI/AGR/56300/2004l from Fundacao para a Ciencia e Tecnologia, Portugal.; Supported by Grant SFRH/BGCT/32473/2006 from Fundacao para a Ciencia e Tecnologia, Portugal.	Akhurst R., 2012, PARASITES PATHOGENS, P1; Balasubramanian N, 2010, PARASITE IMMUNOL, V32, P165, DOI 10.1111/j.1365-3024.2009.01172.x; Balasubramanian N, 2009, INT J PARASITOL, V39, P975, DOI 10.1016/j.ijpara.2009.01.012; BEDDING RA, 1983, EXP PARASITOL, V55, P249, DOI 10.1016/0014-4894(83)90019-X; BEGLEY JW, 1990, ENTOMOPATHOGENIC NEM, P233; Burnell Ann, 2002, P241, DOI 10.1079/9780851995670.0241; Cwiklinski K, 2009, VET PARASITOL, V159, P268, DOI 10.1016/j.vetpar.2008.10.036; da Rocha-Azevedo B, 2010, EXP PARASITOL, V126, P79, DOI 10.1016/j.exppara.2009.08.004; Dalton JP, 2003, INT J PARASITOL, V33, P621, DOI 10.1016/S0020-7519(03)00057-2; Davis EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/j.pt.2004.01.005; Dowds Barbara C.A., 2002, P79, DOI 10.1079/9780851995670.0079; Dzik JM, 2006, ACTA BIOCHIM POL, V53, P33; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fahey EM, 2000, J CHROMATOGR B, V737, P225, DOI 10.1016/S0378-4347(99)00360-6; Gallego SG, 2005, PARASITOL INT, V54, P123, DOI 10.1016/j.parint.2005.02.002; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; GREWAL PS, 1994, PARASITOLOGY, V108, P207, DOI 10.1017/S003118200006830X; Gudmundsdottir E, 1996, COMP BIOCHEM PHYS B, V113, P795, DOI 10.1016/0305-0491(95)02109-4; Haffner A, 1998, EXP PARASITOL, V90, P26, DOI 10.1006/expr.1998.4313; Hao YJ, 2010, MOL BIOCHEM PARASIT, V169, P79, DOI 10.1016/j.molbiopara.2009.10.002; Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672; Heinemeyer Jesco, 2007, V355, P343; HUBERT JJ, 1990, STAT SERIES U GUELPH, P1990; Ishibashi N., 1990, P139; Joshi MC, 2008, J BIOL CHEM, V283, P28287, DOI 10.1074/jbc.M804416200; Klein M. G., 1990, Entomopathogenic nematodes in biological control., P195; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANTZ MS, 1994, METHOD ENZYMOL, V235, P563; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; MARTOJA R, 1970, TECNICAS HISTOLOGIA, P341; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P633, DOI 10.1016/S0965-1748(00)00168-5; MCKERROW JH, 1985, J BIOL CHEM, V260, P3703; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Ramachandraiah G, 2000, PROTEINS, V39, P358, DOI 10.1002/(SICI)1097-0134(20000601)39:4<358::AID-PROT80>3.0.CO;2-M; Romaris F, 2002, MOL BIOCHEM PARASIT, V122, P149, DOI 10.1016/S0166-6851(02)00094-4; SAKANARI JA, 1990, J PARASITOL, V76, P625, DOI 10.2307/3282971; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Santos R, 2009, MAR BIOTECHNOL, V11, P686, DOI 10.1007/s10126-009-9182-5; Sellos D, 1999, BBA-PROTEIN STRUCT M, V1432, P419, DOI 10.1016/S0167-4838(99)00121-1; Simoes N, 1996, BIOCONTROL SCI TECHN, V6, P403, DOI 10.1080/09583159631370; Simoes N, 2000, J INVERTEBR PATHOL, V75, P47, DOI 10.1006/jipa.1999.4899; Todorova VK, 2000, FOLIA PARASIT, V47, P141, DOI 10.14411/fp.2000.027; Toubarro D, 2009, INT J PARASITOL, V39, P1319, DOI 10.1016/j.ijpara.2009.04.013; Trap C, 2000, VET RES, V31, P461, DOI 10.1051/vetres:2000132; Trap C, 2006, PARASITOL RES, V98, P288, DOI 10.1007/s00436-005-0075-x; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; VELLAI T, 1999, COST 819 ENTOMOPATHO, P105; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; Williamson AL, 2006, INFECT IMMUN, V74, P961, DOI 10.1128/IAI.74.2.961-967.2006; Zhan B, 2002, MOL BIOCHEM PARASIT, V120, P291, DOI 10.1016/S0166-6851(01)00453-4; Zhang LL, 2004, COMP BIOCHEM PHYS C, V137, P115, DOI 10.1016/j.cca.2003.12.003	56	38	40	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30666	30675		10.1074/jbc.M110.129346	http://dx.doi.org/10.1074/jbc.M110.129346			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20656686	hybrid, Green Published			2022-12-27	WOS:000282135500035
J	Burke, SP; Smith, L; Smith, JB				Burke, Stephen P.; Smith, Lucinda; Smith, Jeffrey B.			cIAP1 Cooperatively Inhibits Procaspase-3 Activation by the Caspase-9 Apoptosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; ALPHA-DEPENDENT APOPTOSIS; KAPPA-B ACTIVATION; X-LINKED INHIBITOR; STRUCTURAL BASIS; CELL-DEATH; CYTOCHROME-C; BIR DOMAINS; XIAP; IAP	Although early studies of inhibitor of apoptosis proteins (IAPs) suggested that cIAP1 directly binds and inhibits caspases similarly to X-linked IAP (XIAP), a recent one found that micromolar concentrations of cIAP1 only weakly inhibit caspase-3, -7, or -9. Here, we show that cIAP1 specifically and cooperatively blocks the cytochrome c-dependent apoptosome in vitro. Hence, cIAP1 prevented the activation of procaspase-3 but had no effect on the processing of procaspase-9 or the activity of prior activated caspase-3. Like cIAP1, XIAP had no effect on procaspase-9 processing and was a more potent inhibitor of procaspase- 3 activation than of already activated caspase-3 activity. Inhibition of procaspase-3 activation depended on BIR2 and BIR3 of cIAP1 and was independent of BIR1, RING, CARD, and UBA domains. Smac prevented cIAP1 from inhibiting procaspase- 3 activation and reversed the inhibition by prior addition of cIAP1. A procaspase-9 mutant (D315A) that cannot produce the p12 subunit was resistant to inhibition by cIAP1. Therefore, the N-terminal Ala-Thr-Pro-Phe motif of the p12 subunit of the caspase-9 apoptosome facilitates apoptosome blockade. Consequently, cIAP1 cooperatively interacts with oligomerized processed caspase-9 in the apoptosome and blocks procaspase-3 activation.	[Smith, Jeffrey B.] Univ Alabama, Sch Med, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; Univ Alabama, Sch Dent, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Smith, JB (corresponding author), Univ Alabama, Sch Med, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA.	jeff.smith@ccc.uab.edu		Burke, Stephen/0000-0002-8489-6953	National Institutes of Health [GM60383]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60383.	Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Davoodi J, 2004, J BIOL CHEM, V279, P40622, DOI 10.1074/jbc.M405963200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Eckelman BP, 2008, CELL DEATH DIFFER, V15, P920, DOI 10.1038/cdd.2008.6; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Goncalves RB, 2008, BIOCHEMISTRY-US, V47, P3832, DOI 10.1021/bi702248n; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Imoto I, 2002, CANCER RES, V62, P4860; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Qi S, 2008, INT J ORAL MAX SURG, V37, P1047, DOI 10.1016/j.ijom.2008.06.004; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vischioni B, 2006, HUM PATHOL, V37, P78, DOI 10.1016/j.humpath.2005.09.022; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006	47	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30061	30068		10.1074/jbc.M110.125955	http://dx.doi.org/10.1074/jbc.M110.125955			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20667824	Green Published, hybrid			2022-12-27	WOS:000281984300044
J	Crellin, PK; Vivian, JP; Scoble, J; Chow, FM; West, NP; Brammananth, R; Proellocks, NI; Shahine, A; Le Nours, J; Wilce, MCJ; Britton, WJ; Coppel, RL; Rossjohn, J; Beddoe, T				Crellin, Paul K.; Vivian, Julian P.; Scoble, Judith; Chow, Frances M.; West, Nicholas P.; Brammananth, Rajini; Proellocks, Nicholas I.; Shahine, Adam; Le Nours, Jerome; Wilce, Matthew C. J.; Britton, Warwick J.; Coppel, Ross L.; Rossjohn, Jamie; Beddoe, Travis			Tetrahydrolipstatin Inhibition, Functional Analyses, and Three-dimensional Structure of a Lipase Essential for Mycobacterial Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUTINASE-LIKE PROTEINS; CELL-WALL; MYCOLIC ACIDS; TUBERCULOSIS; BIOSYNTHESIS; IDENTIFICATION; CATALYZES; SERINE; ENZYME; STEP	The highly complex and unique mycobacterial cell wall is critical to the survival of Mycobacteria in host cells. However, the biosynthetic pathways responsible for its synthesis are, in general, incompletely characterized. Rv3802c from Mycobacterium tuberculosis is a partially characterized phospholipase/thioesterase encoded within a genetic cluster dedicated to the synthesis of core structures of the mycobacterial cell wall, including mycolic acids and arabinogalactan. Enzymatic assays performed with purified recombinant proteins Rv3802c and its close homologs from Mycobacterium smegmatis (MSMEG_6394) and Corynebacterium glutamicum (NCgl2775) show that they all have significant lipase activities that are inhibited by tetrahydrolipstatin, an anti-obesity drug that coincidently inhibits mycobacterial cell wall biosynthesis. The crystal structure of MSMEG_6394, solved to 2.9 angstrom resolution, revealed an alpha/beta hydrolase fold and a catalytic triad typically present in esterases and lipases. Furthermore, we demonstrate direct evidence of gene essentiality in M. smegmatis and show the structural consequences of loss of MSMEG_6394 function on the cellular integrity of the organism. These findings, combined with the predicted essentiality of Rv3802c in M. tuberculosis, indicate that the Rv3802c family performs a fundamental and indispensable lipase-associated function in mycobacteria.	[Crellin, Paul K.; Scoble, Judith; Brammananth, Rajini; Proellocks, Nicholas I.; Le Nours, Jerome; Coppel, Ross L.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Crellin, Paul K.; Vivian, Julian P.; Brammananth, Rajini; Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Scoble, Judith; Shahine, Adam; Le Nours, Jerome; Wilce, Matthew C. J.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Chow, Frances M.; West, Nicholas P.; Britton, Warwick J.] Centenary Inst, Mycobacterial Res Program, Newtown, NSW 2042, Australia; [West, Nicholas P.; Britton, Warwick J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Monash University; Monash University; Monash University; University of Sydney; Centenary Institute; University of Sydney	Crellin, PK (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu	Coppel, Ross L/A-6626-2008; Rossjohn, Jamie/F-9032-2013; West, Nicholas P/C-3119-2008; Proellochs, Nick/ABB-5634-2020; Beddoe, Travis/F-3415-2014; Scoble, Judith A/B-4919-2016	Coppel, Ross L/0000-0002-4476-9124; Rossjohn, Jamie/0000-0002-2020-7522; West, Nicholas P/0000-0003-0955-9890; Proellochs, Nick/0000-0003-3750-1135; Beddoe, Travis/0000-0003-4550-2277; Scoble, Judith A/0000-0002-6652-0717; Crellin, Paul K/0000-0002-2017-4935; Britton, Warwick/0000-0001-6721-9646; Le Nours, Jerome/0000-0002-2221-7636; Vivian, Julian/0000-0002-9400-4437; Shahine, Adam/0000-0001-7717-4437	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics; National Health and Medical Research Council of Australia; Australian Research Council Federation; Pfizer	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Federation(Australian Research Council); Pfizer(Pfizer)	This work was supported in part by the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics and the National Health and Medical Research Council of Australia.; Supported by an Australian Research Council Federation Fellowship.; Supported by a Pfizer Senior Research Fellowship.	ANDERBERG RJ, 1995, BIOTECHNIQUES, V18, P217; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghosh D, 1999, ACTA CRYSTALLOGR D, V55, P779, DOI 10.1107/S0907444999000244; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUILHOT C, 1992, FEMS MICROBIOL LETT, V98, P181; HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357; HADVARY P, 1991, J BIOL CHEM, V266, P2021; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Ioerger T R, 1999, Proc Int Conf Intell Syst Mol Biol, P130; Ioerger TR, 2003, METHOD ENZYMOL, V374, P244, DOI 10.1016/S0076-6879(03)74012-9; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; MARTINEZ C, 1992, NATURE, V356, P615, DOI 10.1038/356615a0; Masaki K, 2005, APPL ENVIRON MICROB, V71, P7548, DOI 10.1128/AEM.71.11.7548-7550.2005; Meniche X, 2009, J BACTERIOL, V191, P7323, DOI 10.1128/JB.01042-09; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Richardson Jane S, 2003, Methods Biochem Anal, V44, P305; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; SOUTHERN EM, 1974, ANAL BIOCHEM, V62, P317, DOI 10.1016/0003-2697(74)90395-9; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; WHO, 2009, WHO TECH REP SER, V958, P1; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	46	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30050	30060		10.1074/jbc.M110.150094	http://dx.doi.org/10.1074/jbc.M110.150094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20656688	Green Published, hybrid			2022-12-27	WOS:000281984300043
J	Ikonomov, OC; Sbrissa, D; Fligger, J; Delvecchio, K; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Fligger, Jason; Delvecchio, Khortnal; Shisheva, Assia			ArPIKfyve Regulates Sac3 Protein Abundance and Turnover DISRUPTION OF THE MECHANISM BY Sac3(I41T) MUTATION CAUSING CHARCOT-MARIE-TOOTH 4J DISORDER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; PIKFYVE; VAC14; TRAFFICKING; COMPLEX; YEAST	The mammalian phosphatidylinositol (3,5)-bisphosphate (PtdIns(3,5)P-2) phosphatase Sac3 and ArPIKfyve, the associated regulator of the PtdIns3P-5 kinase PIKfyve, form a stable binary complex that associates with PIKfyve in a ternary complex to increase PtdIns(3,5)P-2 production. Whether the ArPIKfyve-Sac3 subcomplex functions outside the PIKfyve context is unknown. Here we show that stable or transient expression of ArPIKfyve(WT) in mammalian cells elevates steady-state protein levels and the PtdIns(3,5)P-2-hydrolyzing activity of Sac3, whereas knockdown of ArPIKfyve has the opposite effect. These manipulations do not alter the Sac3 mRNA levels, suggesting that ArPIKfyve might control Sac3 protein degradation. Inhibition of protein synthesis in COS cells by cycloheximide reveals remarkably rapid turnover of expressed Sac3(WT) (t(1/2) = 18.8 min), resulting from a proteasome-dependent clearance as evidenced by the extended Sac3(WT) half-life upon inhibiting proteasome activity. Coexpression of ArPIKfyve(WT), but not the N-or C-terminal halves, prolongs the Sac3WT half-life consistent with enhanced Sac3 protein stability through association with full-length ArPIKfyve. We further demonstrate that mutant Sac3, harboring the pathogenic Ile-to-Thr substitution at position 41 found in patients with CMT4J disorder, is similar to Sac3(WT) with regard to PtdIns(3,5)P2-hydrolyzing activity, association with ArPIKfyve, or rapid proteasome-dependent clearance. Remarkably, however, neither is the steady-state Sac3(I41T) elevated nor is the Sac3(I41T) half-life extended by coexpressed ArPIKfyve(WT), indicating that unlike with Sac3(WT), ArPIKfyve fails to prevent Sac3(I41T) rapid loss. Together, our data indentify a novel regulatory mechanism whereby ArPIKfyve enhances Sac3 abundance by attenuating Sac3 proteasome-dependent degradation and suggest that a failure of this mechanism could be the primary molecular defect in the pathogenesis of CMT4J.	[Ikonomov, Ognian C.; Sbrissa, Diego; Fligger, Jason; Delvecchio, Khortnal; Shisheva, Assia] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA	Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Dept Physiol, Sch Med, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu		Delvecchio, Khortnal/0000-0002-5441-5709	National Institutes of Health [DK58058]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58058 (to A. S.). This work was also supported by a grant from the American Diabetes Association (to A. S.).	Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Botelho RJ, 2009, BIOESSAYS, V31, P1127, DOI 10.1002/bies.200900060; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gong L, 2008, ENDOCRINOLOGY, V149, P3346, DOI 10.1210/en.2007-0945; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ikonomov OC, 2009, J BIOL CHEM, V284, P35794, DOI 10.1074/jbc.M109.037515; Ikonomov OC, 2009, J BIOL CHEM, V284, P23961, DOI 10.1074/jbc.M109.025361; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2001, MOL CELL ENDOCRINOL, V181, P35, DOI 10.1016/S0303-7207(01)00539-1; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Zhang XB, 2008, BRAIN, V131, P1990, DOI 10.1093/brain/awn114; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	24	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26760	26764		10.1074/jbc.C110.154658	http://dx.doi.org/10.1074/jbc.C110.154658			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20630877	hybrid, Green Published			2022-12-27	WOS:000281172700006
J	Srikanth, B; Vaidya, MM; Kalraiya, RD				Srikanth, Budnar; Vaidya, Milind M.; Kalraiya, Rajiv D.			O-GlcNAcylation Determines the Solubility, Filament Organization, and Stability of Keratins 8 and 18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLE EPITHELIAL KERATINS; MALLORY-DENK-BODIES; INTERMEDIATE-FILAMENTS; N-ACETYLGLUCOSAMINE; 14-3-3 PROTEINS; SHEAR-STRESS; TETRATRICOPEPTIDE REPEATS; LINKED GLYCOSYLATION; CYTOSOLIC PROTEINS; GLCNAC TRANSFERASE	Keratins 8 and 18 (K8/18) are intermediate filament proteins expressed specifically in simple epithelial tissues. Dynamic equilibrium of these phosphoglycoproteins in the soluble and filament pool is an important determinant of their cellular functions, and it is known to be regulated by site-specific phosphorylation. However, little is known about the role of dynamic O-GlcNAcylation on this keratin pair. Here, by comparing immortalized (Chang) and transformed hepatocyte (HepG2) cell lines, we have demonstrated that O-GlcNAcylation of K8/18 exhibits a positive correlation with their solubility (Nonidet P-40 extractability). Heat stress, which increases K8/18 solubility, resulted in a simultaneous increase in O-GlcNAc on these proteins. Conversely, increasing O-GlcNAc levels were associated with a concurrent increase in their solubility. This was also associated with a notable decrease in total cellular levels of K8/18. Unaltered levels of transcripts and the reduced half-life of K8 and K18 indicated their decreased stability on increasing O-GlcNAcylation. On the contrary, the K18 glycosylation mutant (K18 S29A/S30A/S48A) was notably more stable than the wild type K18 in Chang cells. The K18-O-GlcNAc mutant accumulated as aggregates upon stable expression, which possibly altered endogenous filament architecture. These results strongly indicate the involvement of O-GlcNAc on K8/18 in regulating their solubility and stability, which may have a bearing on the functions of these keratins.	[Kalraiya, Rajiv D.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Sector 22, Kalraiya Lab,KS 131, Kharghar 410210, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Kalraiya, RD (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Sector 22, Kalraiya Lab,KS 131, Kharghar 410210, Navi Mumbai, India.	rkalraiya@actrec.gov.in	Budnar, Srikanth/J-1827-2014	Budnar, Srikanth/0000-0002-8951-9081	Department of Biotechnology, Government of India; Advanced Centre for Treatment Research and Education in Cancer	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Advanced Centre for Treatment Research and Education in Cancer	This work was supported in part by grants from the Department of Biotechnology, Government of India, and Advanced Centre for Treatment Research and Education in Cancer.	CHOU CF, 1993, J BIOL CHEM, V268, P4465; CHOU CF, 1992, J BIOL CHEM, V267, P3901; Denk H, 2006, J PATHOL, V208, P653, DOI 10.1002/path.1946; Flitney EW, 2009, FASEB J, V23, P2110, DOI 10.1096/fj.08-124453; Flitney EW, 2004, METHOD CELL BIOL, V78, P297; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Haltiwanger RS, 1997, J BIOL CHEM, V272, P8752, DOI 10.1074/jbc.272.13.8752; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Iwaya K, 2005, SEMIN CANCER BIOL, V15, P309, DOI 10.1016/j.semcancer.2005.04.006; Jaitovich A, 2008, J BIOL CHEM, V283, P25348, DOI 10.1074/jbc.M801635200; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; KU NO, 1995, J BIOL CHEM, V270, P11820, DOI 10.1074/jbc.270.20.11820; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO J, 1995, EXP CELL RES, V219, P348, DOI 10.1006/excr.1995.1238; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; LIAO J, 1995, J CELL BIOL, V131, P1291, DOI 10.1083/jcb.131.5.1291; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; McGowan K, 1998, Subcell Biochem, V31, P173; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Sivaramakrishnan S, 2009, MOL BIOL CELL, V20, P2755, DOI 10.1091/mbc.E08-10-1028; Slawson C, 2001, BBA-MOL BASIS DIS, V1537, P147, DOI 10.1016/S0925-4439(01)00067-9; Spector D. L., 1998, CELLS LAB MANUAL; Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008; Tao GZ, 2006, BIOCHEM BIOPH RES CO, V351, P708, DOI 10.1016/j.bbrc.2006.10.092; Toivola DA, 2004, HEPATOLOGY, V40, P459, DOI 10.1002/hep.20277; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	56	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34062	34071		10.1074/jbc.M109.098996	http://dx.doi.org/10.1074/jbc.M109.098996			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729549	Green Published, hybrid			2022-12-27	WOS:000283354000052
J	Tong, FM; Billheimer, J; Shechtman, CF; Liu, Y; Crooke, R; Graham, M; Cohen, DE; Sturley, SL; Rader, DJ				Tong, Fumin; Billheimer, Jeffrey; Shechtman, Caryn F.; Liu, Ying; Crooke, Roseann; Graham, Mark; Cohen, David E.; Sturley, Stephen L.; Rader, Daniel J.			Decreased Expression of ARV1 Results in Cholesterol Retention in the Endoplasmic Reticulum and Abnormal Bile Acid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COENZYME-A; PLASMA-MEMBRANE; IN-VIVO; NUCLEAR RECEPTOR; HDL CHOLESTEROL; YEAST ARV1; TRANSPORT; ACYLTRANSFERASE; CELLS; RAT	Endoplasmic reticulum (ER) membrane cholesterol is maintained at an optimal concentration of similar to 5 mol % by the net impact of sterol synthesis, modification, and export. Arv1p was first identified in the yeast Saccharomyces cerevisiae as a key component of this homeostasis due to its probable role in intracellular sterol transport. Mammalian ARV1, which can fully complement the yeast lesion, encodes a ubiquitously expressed, resident ER protein. Repeated dosing of specific antisense oligonucleotides to ARV1 produced a marked reduction of ARV1 transcripts in liver, adipose, and to a lesser extent, intestine. This resulted in marked hypercholesterolemia, elevated serum bile acids, and activation of the hepatic farnesoid X receptor (FXR) regulatory pathway. Knockdown of ARV1 in murine liver and HepG2 cells was associated with accumulation of cholesterol in the ER at the expense of the plasma membrane and suppression of sterol regulatory element-binding proteins and their targets. These studies indicate a critical role of mammalian Arv1p in sterol movement from the ER and in the ensuing regulation of hepatic cholesterol and bile acid metabolism.	[Shechtman, Caryn F.; Liu, Ying; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Shechtman, Caryn F.; Liu, Ying; Sturley, Stephen L.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Tong, Fumin; Billheimer, Jeffrey; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Tong, Fumin; Billheimer, Jeffrey; Rader, Daniel J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Crooke, Roseann; Graham, Mark] ISIS Pharmaceut Inc, Carlsbad, CA 92008 USA; [Cohen, David E.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Columbia University; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Isis Pharmaceuticals Inc; Harvard University; Brigham & Women's Hospital	Sturley, SL (corresponding author), Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA.	sls37@columbia.edu; rader@mail.med.upenn.edu			National Institutes of Health [DK48873, DK56626, DK54320, HL59407]; Grant Training Fellowship in Nutrition [T32 DK007647]; Grant Training Fellowship in Translational Science [TL 1RR024158]; American Diabetes Association; Ara Parseghian Medical Research Foundation; Bristol Myers Squibb; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320, R37DK048873, R01DK048873, R01DK056626, T32DK007647, R29DK048873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Training Fellowship in Nutrition; Grant Training Fellowship in Translational Science; American Diabetes Association(American Diabetes Association); Ara Parseghian Medical Research Foundation; Bristol Myers Squibb(Bristol-Myers Squibb); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK48873 and DK56626 (to D. E. C.), Grant DK54320 (to S. L. S.), Grant HL59407 (to D. J. R.), and Grant Training Fellowships in Nutrition T32 DK007647 and Translational Science TL 1RR024158 (to C. F. S.). This work was also supported by the American Diabetes Association (F. T. and S. L. S.), the Ara Parseghian Medical Research Foundation (S. L. S.), and the Bristol Myers Squibb "Freedom to Discover" Unrestricted Cardiovascular Research Grant (to D. J. R.).	BILLHEIMER JT, 1981, ANAL BIOCHEM, V111, P331, DOI 10.1016/0003-2697(81)90570-4; Bravo I, 2007, BBA-GEN SUBJECTS, V1770, P979, DOI 10.1016/j.bbagen.2007.02.010; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Field FJ, 2007, J LIPID RES, V48, P1735, DOI 10.1194/jlr.M700029-JLR200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HEUMAN DM, 1989, J LIPID RES, V30, P719; Jacobs NL, 1997, J LIPID RES, V38, P1973; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; LISCUM L, 1995, J BIOL CHEM, V270, P15443, DOI 10.1074/jbc.270.26.15443; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Matveev S, 2001, ADV DRUG DELIVER REV, V49, P237, DOI 10.1016/S0169-409X(01)00138-7; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; MITROPOULOS KA, 1978, BIOCHIM BIOPHYS ACTA, V530, P99, DOI 10.1016/0005-2760(78)90130-3; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Paulusma CC, 2009, J BIOL CHEM, V284, P9947, DOI 10.1074/jbc.M808667200; Post SM, 1999, HEPATOLOGY, V30, P491, DOI 10.1002/hep.510300230; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; SINGER II, 1984, P NATL ACAD SCI-BIOL, V81, P5556, DOI 10.1073/pnas.81.17.5556; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Swain E, 2002, J BIOL CHEM, V277, P36152, DOI 10.1074/jbc.M206624200; TAVANI DM, 1982, ENDOCRINOLOGY, V111, P794, DOI 10.1210/endo-111-3-794; Tinkelenberg AH, 2000, J BIOL CHEM, V275, P40667, DOI 10.1074/jbc.C000710200; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; VanPatten S, 2001, AM J PHYSIOL-GASTR L, V281, pG393, DOI 10.1152/ajpgi.2001.281.2.G393; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200	32	19	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33632	33641		10.1074/jbc.M110.165761	http://dx.doi.org/10.1074/jbc.M110.165761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20663892	hybrid, Green Published			2022-12-27	WOS:000283354000008
J	Tsuboi, T; Inada, T				Tsuboi, Tatsuhisa; Inada, Toshifumi			Tethering of Poly(A)-binding Protein Interferes with Non-translated mRNA Decay from the 5 ' End in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) TAIL; SACCHAROMYCES-CEREVISIAE; DEPENDENT TRANSLATION; P-BODIES; DEGRADATION; INITIATION; TURNOVER; COMPLEX; EXOSOME; CAP	The decay of eukaryotic mRNA is triggered mainly by deadenylation, which leads to decapping and degradation from the 5' end of an mRNA. Poly(A)-binding protein has been proposed to inhibit the decapping process and to stabilize mRNA by blocking the recruitment of mRNA to the P-bodies where mRNA degradation takes place after stimulation of translation initiation. In contrast, several lines of evidence show that poly(A)-binding protein (Pab1p) has distinct functions in mRNA decay and translation in yeast. To address the translation-independent function of Pab1p in inhibition of decapping, we examined the contribution of Pab1p to the stability of non-translated mRNAs, an AUG codon-less mRNA or an mRNA containing a stable stem-loop structure at the 5'-UTR. Tethering of Pab1p stabilized non-translated mRNAs, and this stabilization did not require either the eIF4G-interacting domain of Pab1p or the Pab1p-interacting domain of eIF4G. In a ski2 Delta mutant in which 3' to 5' mRNA degradation activity is defective, stabilization of non-translated mRNAs by the tethering of Pab1p lacking an eIF4G-interacting domain (Pab1-34Cp) requires a cap structure but not a poly(A) tail. In wild type cells, stabilization of non-translated mRNA by tethered Pab1-34Cp results in the accumulation of deadenylated mRNA. These results strongly suggest that tethering of Pab1p may inhibit the decapping reaction after deadenylation, independent of translation. We propose that Pab1p inhibits the decapping reaction in a translation-independent manner in vivo.	[Tsuboi, Tatsuhisa; Inada, Toshifumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University	Inada, T (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	p47294a@nucc.cc.nagoya-u.ac.jp	Inada, Toshifumi/AAE-1517-2019; Tsuboi, Tatsuhisa/AAA-1926-2022; Tsuboi, Tatsuhisa/AAL-5360-2020	Tsuboi, Tatsuhisa/0000-0003-3249-030X; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [20112006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. I.).	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; Carninci P, 2008, NAT CELL BIOL, V10, P1023, DOI 10.1038/ncb0908-1023; Chowdhury A, 2008, RNA, V14, P2149, DOI 10.1261/rna.1094208; Chowdhury A, 2009, RNA, V15, P1837, DOI 10.1261/rna.1650109; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 1998, GENE DEV, V12, P3226, DOI 10.1101/gad.12.20.3226; DECKER CJ, 1994, TRENDS BIOCHEM SCI, V19, P336, DOI 10.1016/0968-0004(94)90073-6; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Khanna R, 2004, EMBO J, V23, P1968, DOI 10.1038/sj.emboj.7600213; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Kuroha K, 2009, EMBO REP, V10, P1265, DOI 10.1038/embor.2009.200; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Morrissey JP, 1999, YEAST, V15, P687, DOI 10.1002/(SICI)1097-0061(19990615)15:8<687::AID-YEA412>3.0.CO;2-L; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Sambrook J., 2001, MOL CLONING; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wilusz CJ, 2001, RNA, V7, P1416	42	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33589	33601		10.1074/jbc.M110.117150	http://dx.doi.org/10.1074/jbc.M110.117150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732870	Green Published, hybrid			2022-12-27	WOS:000283354000004
J	Binz, TM; Maffioli, SI; Sosio, M; Donadio, S; Muller, R				Binz, Tina M.; Maffioli, Sonia I.; Sosio, Margherita; Donadio, Stefano; Mueller, Rolf			Insights into an Unusual Nonribosomal Peptide Synthetase Biosynthesis IDENTIFICATION AND CHARACTERIZATION OF THE GE81112 BIOSYNTHETIC GENE CLUSTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; BIOCHEMICAL-CHARACTERIZATION; POLYKETIDE SYNTHASE; NATURAL-PRODUCTS; CARRIER PROTEIN; ASSEMBLY LINES; PIPECOLIC ACID; STREPTOMYCES; ANTIBIOTICS; DOMAINS	The GE81112 tetrapeptides (1-3) represent a structurally unique class of antibiotics, acting as specific inhibitors of prokaryotic protein synthesis. Here we report the cloning and sequencing of the GE81112 biosynthetic gene cluster from Streptomyces sp. L-49973 and the development of a genetic manipulation system for Streptomyces sp. L-49973. The biosynthetic gene cluster for the tetrapeptide antibiotic GE81112 (getA-N) was identified within a 61.7-kb region comprising 29 open reading frames (open reading frames), 14 of which were assigned to the biosynthetic gene cluster. Sequence analysis revealed the GE81112 cluster to consist of six nonribosomal peptide synthetase (NRPS) genes encoding incomplete di-domain NRPS modules and a single free standing NRPS domain as well as genes encoding other biosynthetic and modifying proteins. The involvement of the cloned gene cluster in GE81112 biosynthesis was confirmed by inactivating the NRPS gene getE resulting in a GE81112 production abolished mutant. In addition, we characterized the NRPS A-domains from the pathway by expression in Escherichia coli and in vitro enzymatic assays. The previously unknown stereochemistry of most chiral centers in GE81112 was established from a combined chemical and biosynthetic approach. Taken together, these findings have allowed us to propose a rational model for GE81112 biosynthesis. The results further open the door to developing new derivatives of these promising antibiotic compounds by genetic engineering.	[Binz, Tina M.; Mueller, Rolf] Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany; [Binz, Tina M.; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany; [Maffioli, Sonia I.; Sosio, Margherita; Donadio, Stefano] Naicons Scrl, I-20138 Milan, Italy	Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University	Muller, R (corresponding author), Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, Campus C2 3, D-66123 Saarbrucken, Germany.	rom@mx.uni-saarland.de	Müller, Rolf/B-1559-2008; maffioli, sonia/K-7575-2019	Müller, Rolf/0000-0002-1042-5665; Binz, Tina/0000-0001-6783-1202; Sosio, Margherita/0000-0003-4297-6936	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was funded in part by the Bundesministerium fur Bildung und Forschung and the Deutsche Forschungsgemeinschaft (to R. M.).	Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Baker DD, 2007, NAT PROD REP, V24, P1225, DOI 10.1039/b602241n; Brandi L, 2006, BIOCHEMISTRY-US, V45, P3692, DOI 10.1021/Bi052540K; Brandi L, 2006, P NATL ACAD SCI USA, V103, P39, DOI 10.1073/pnas.0507740102; Buntin K, 2008, ANGEW CHEM INT EDIT, V47, P4595, DOI 10.1002/anie.200705569; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Chen HW, 2001, BIOCHEMISTRY-US, V40, P11651, DOI 10.1021/bi0115434; Chen WQ, 2009, J BIOL CHEM, V284, P10627, DOI 10.1074/jbc.M807534200; Dong L, 2002, J ORG CHEM, V67, P4759, DOI 10.1021/jo0256078; Durr C, 2006, CHEM BIOL, V13, P365, DOI 10.1016/j.chembiol.2006.01.011; Eustaquio AS, 2003, CHEM BIOL, V10, P279, DOI 10.1016/S1074-5521(03)00051-6; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Gaitatzis N, 2001, P NATL ACAD SCI USA, V98, P11136, DOI 10.1073/pnas.201167098; Galm U, 2009, MOL BIOSYST, V5, P77, DOI 10.1039/b814075h; Garneau-Tsodikova S, 2006, BIOCHEMISTRY-US, V45, P8568, DOI 10.1021/bi060784e; Gatto GJ, 2006, J AM CHEM SOC, V128, P3838, DOI 10.1021/ja0587603; Girard A, 1998, TETRAHEDRON LETT, V39, P4259, DOI 10.1016/S0040-4039(98)00697-2; He M, 2006, J IND MICROBIOL BIOT, V33, P401, DOI 10.1007/s10295-006-0078-3; HECHT SM, 1979, J AM CHEM SOC, V101, P3982, DOI 10.1021/ja00508a055; Hojati Z, 2002, CHEM BIOL, V9, P1175, DOI 10.1016/S1074-5521(02)00252-1; Hopwood D, 2007, NAT REV DRUG DISCOV, V6, P8, DOI 10.1038/nrd2225; Hutchinson CR, 2003, P NATL ACAD SCI USA, V100, P3010, DOI 10.1073/pnas.0730689100; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Khaw LE, 1998, J BACTERIOL, V180, P809, DOI 10.1128/JB.180.4.809-814.1998; KIESER T, 2000, PRACTICAL STREPTOMYC, P562; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kopp M, 2004, J BIOTECHNOL, V107, P29, DOI 10.1016/j.jbiotec.2003.09.013; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Mendez C, 1998, FEMS MICROBIOL LETT, V158, P1; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Pfeifer V, 2001, J BIOL CHEM, V276, P38370, DOI 10.1074/jbc.M106580200; Rachid S, 2006, CHEM BIOL, V13, P667, DOI 10.1016/j.chembiol.2006.06.002; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Sambrook J., 2001, MOL CLONING LAB MANU; Samel SA, 2008, MOL BIOSYST, V4, P387, DOI 10.1039/b717538h; Sandmann A, 2004, CHEM BIOL, V11, P1071, DOI 10.1016/j.chembiol.2004.05.014; Silakowski B, 1999, J BIOL CHEM, V274, P37391, DOI 10.1074/jbc.274.52.37391; Singh GM, 2007, CHEM BIOL, V14, P31, DOI 10.1016/j.chembiol.2006.11.005; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Steffensky M, 2000, ANTIMICROB AGENTS CH, V44, P1214, DOI 10.1128/AAC.44.5.1214-1222.2000; Strieter ER, 2007, BIOCHEMISTRY-US, V46, P7549, DOI 10.1021/bi700243h; Thomas MG, 2002, CHEM BIOL, V9, P171, DOI 10.1016/S1074-5521(02)00100-X; TURGAY K, 1992, MOL MICROBIOL, V6, P529, DOI 10.1111/j.1365-2958.1992.tb01498.x; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEMBIOCHEM, V7, P748, DOI 10.1002/cbic.200500480; Walsh C., 2003, ANTIBIOTICS ACTIONS; Weissman KJ, 2008, CHEMBIOCHEM, V9, P826, DOI 10.1002/cbic.200700751; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Wenzel SC, 2007, NAT PROD REP, V24, P1211, DOI 10.1039/b706416k; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yin XH, 2004, CHEMBIOCHEM, V5, P1274, DOI 10.1002/cbic.200400082; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199	56	27	28	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32710	32719		10.1074/jbc.M110.146803	http://dx.doi.org/10.1074/jbc.M110.146803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20710026	Green Published, hybrid			2022-12-27	WOS:000283048200006
J	Menon, MB; Schwermann, J; Singh, AK; Franz-Wachtel, M; Pabst, O; Seidler, U; Omary, MB; Kotlyarov, A; Gaestel, M				Menon, Manoj B.; Schwermann, Jessica; Singh, Anurag Kumar; Franz-Wachtel, Mirita; Pabst, Oliver; Seidler, Ursula; Omary, M. Bishr; Kotlyarov, Alexey; Gaestel, Matthias			p38 MAP Kinase and MAPKAP Kinases MK2/3 Cooperatively Phosphorylate Epithelial Keratins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED-CELLS; FILAMENT REORGANIZATION; PROTEIN-KINASES; OKADAIC ACID; DISEASE; STRESS; MUTATION; TISSUES; MICE; SITE	The MAPK-activated protein kinases (MAPKAP kinases) MK2 and MK3 are directly activated via p38 MAPK phosphorylation, stabilize p38 by complex formation, and contribute to the stress response. The list of substrates of MK2/3 is increasing steadily. We applied a phosphoproteomics approach to compare protein phosphorylation in MK2/3-deficient cells rescued or not by ectopic expression of MK2. In addition to differences in phosphorylation of the known substrates of MK2, HSPB1 and Bag-2, we identified strong differences in phosphorylation of keratin 8 (K8). The phosphorylation of K8-Ser(73) is catalyzed directly by p38, which in turn shows MK2-dependent expression. Notably, analysis of small molecule p38 inhibitors on K8-Ser(73) phosphorylation also demonstrated reduced phosphorylations of keratins K18-Ser(52) and K20-Ser(13) but not of K8-Ser(431) or K18-Ser(33). Interestingly, K18-Ser(52) and K20-Ser(13) are not directly phosphorylated by p38 in vitro, but by MK2. Furthermore, anisomycin-stimulated phosphorylations of K20Ser(13) and K18-Ser(52) are inhibited by small molecule inhibitors of both p38 and MK2. MK2 knockdown in HT29 cells leads to reduced K20-Ser(13) phosphorylation, which further supports the notion that MK2 is responsible for K20 phosphorylation in vivo. Physiologic relevance of these findings was confirmed by differences of K20-Ser(13) phosphorylation between the ileum of wild-type and MK2/3-deficient mice and by demonstrating p38- and MK2-dependent mucin secretion of HT29 cells. Therefore, MK2 and p38 MAPK function in concert to phosphorylate K8, K18, and K20 in intestinal epithelia.	[Kotlyarov, Alexey; Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; [Singh, Anurag Kumar; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Pabst, Oliver] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Franz-Wachtel, Mirita] Univ Tubingen, Proteome Ctr Tubingen, Interfac Inst Cell Biol, D-72076 Tubingen, Germany; [Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Hannover Medical School; Hannover Medical School; Hannover Medical School; Eberhard Karls University of Tubingen; University of Michigan System; University of Michigan	Gaestel, M (corresponding author), Hannover Med Sch, Inst Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gaestel.matthias@mh-hannover.de	Seidler, Ursula/HII-8049-2022; Menon, Manoj B./P-1543-2015; Gaestel, Matthias/A-6560-2013; Pabst, Oliver/H-5014-2016	Seidler, Ursula/0000-0002-9600-2769; Menon, Manoj B./0000-0001-5859-0347; Gaestel, Matthias/0000-0002-4944-4652; Pabst, Oliver/0000-0002-5533-883X; Singh, Anurag Kumar/0000-0003-0818-0993; Omary, Bishr/0000-0002-8624-2347	National Institutes of Health [DK47918]; Deutsche Forschungsgemeinschaft [Se 460/13-4]; Ministerium fur Wissenschaft und Kunst, Landesregierung Baden-Wurttemberg; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministerium fur Wissenschaft und Kunst, Landesregierung Baden-Wurttemberg; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47918 (to M. B. O.). This work was also supported by the Deutsche Forschungsgemeinschaft (M. G.), Deutsche Forschungsgemeinschaft Grant Se 460/13-4 (to U. S.). The Proteome Centrum Tubingen is supported by the Ministerium fur Wissenschaft und Kunst, Landesregierung Baden-Wurttemberg.	BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Barjaktarovic Z, 2009, J EXP BOT, V60, P779, DOI 10.1093/jxb/ern324; Cheng TJ, 1998, J CELL BIOCHEM, V71, P169; CHOU CF, 1993, J BIOL CHEM, V268, P4465; ENGEL K, 1995, J BIOL CHEM, V270, P27213, DOI 10.1074/jbc.270.45.27213; Feng L, 1999, J CELL SCI, V112, P2081; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; He T, 2002, J BIOL CHEM, V277, P10767, DOI 10.1074/jbc.M111436200; KASAHARA K, 1993, J BIOL CHEM, V268, P23531; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; KU NO, 1994, J CELL BIOL, V127, P161, DOI 10.1083/jcb.127.1.161; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; LESUFFLEUR T, 1993, J CELL SCI, V106, P771; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; LIAO J, 1995, J CELL BIOL, V131, P1291, DOI 10.1083/jcb.131.5.1291; Menon MB, 2009, CELL MOTIL CYTOSKEL, V66, P1041, DOI 10.1002/cm.20418; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Singh AK, 2010, AM J PHYSIOL-CELL PH, V298, pC1057, DOI 10.1152/ajpcell.00454.2009; SPECIAN RD, 1991, AM J PHYSIOL, V260, P183; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DA, 2004, HEPATOLOGY, V40, P459, DOI 10.1002/hep.20277; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; Trompette A, 2004, EUR J CELL BIOL, V83, P347, DOI 10.1078/0171-9335-00391; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Zhou Q, 2006, J BIOL CHEM, V281, P16453, DOI 10.1074/jbc.M512284200; Zhou XJ, 1999, J BIOL CHEM, V274, P12861, DOI 10.1074/jbc.274.18.12861	40	24	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33242	33251		10.1074/jbc.M110.132357	http://dx.doi.org/10.1074/jbc.M110.132357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724476	hybrid, Green Published			2022-12-27	WOS:000283048200061
J	Nakatsu, Y; Sakoda, H; Kushiyama, A; Ono, H; Fujishiro, M; Horike, N; Yoneda, M; Ohno, H; Tsuchiya, Y; Kamata, H; Tahara, H; Isobe, T; Nishimura, F; Katagiri, H; Oka, Y; Fukushima, T; Takahashi, SI; Kurihara, H; Uchida, T; Asanoa, T				Nakatsu, Yusuke; Sakoda, Hideyuki; Kushiyama, Akifumi; Ono, Hiraku; Fujishiro, Midori; Horike, Nanao; Yoneda, Masayasu; Ohno, Haruya; Tsuchiya, Yoshihiro; Kamata, Hideaki; Tahara, Hidetoshi; Isobe, Toshiaki; Nishimura, Fusanori; Katagiri, Hideki; Oka, Yoshitomo; Fukushima, Toshiaki; Takahashi, Shin-Ichiro; Kurihara, Hiroki; Uchida, Takafumi; Asanoa, Tomoichiro			Pin1 Associates with and Induces Translocation of CRTC2 to the Cytosol, Thereby Suppressing cAMP-responsive Element Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL ISOMERASE PIN1; CREB COACTIVATOR CRTC2; BINDING-PROTEIN; HEPATIC GLUCONEOGENESIS; MODULATES GLUCONEOGENESIS; SUBSTRATE RECOGNITION; FUNCTIONAL-ANALYSIS; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; GENE-EXPRESSION	Pin1 is a unique regulator, which catalyzes the conversion of a specific phospho-Ser/Thr-Pro-containing motif in target proteins. Herein, we identified CRTC2 as a Pin1-binding protein by overexpressing Pin1 with Myc and FLAG tags in mouse livers and subsequent purification of the complex containing Pin1. The association between Pin1 and CRTC2 was observed not only in overexpression experiments but also endogenously in the mouse liver. Interestingly, Ser(136) in the nuclear localization signal of CRTC2 was shown to be involved in the association with Pin1. Pin1 overexpression in HepG2 cells attenuated forskolin- induced nuclear localization of CRTC2 and cAMP-responsive element (CRE) transcriptional activity, whereas gene knockdown of Pin1 by siRNA enhanced both. Pin1 also associated with CRTC1, leading to their cytosol localization, essentially similar to the action of CRTC2. Furthermore, it was shown that CRTC2 associated with Pin1 did not bind to CREB. Taken together, these observations indicate the association of Pin1 with CRTC2 to decrease the nuclear CBP.CRTC.CREB complex. Indeed, adenoviral gene transfer of Pin1 into diabetic mice improved hyperglycemia in conjunction with normalizing phosphoenolpyruvate carboxykinase mRNA expression levels, which is regulated by CRE transcriptional activity. In conclusion, Pin1 regulates CRE transcriptional activity, by associating with CRTC1 or CRTC2.	[Nakatsu, Yusuke; Yoneda, Masayasu; Ohno, Haruya; Tsuchiya, Yoshihiro; Kamata, Hideaki; Fukushima, Toshiaki; Asanoa, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Sakoda, Hideyuki; Ono, Hiraku; Fujishiro, Midori] Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Horike, Nanao; Kurihara, Hiroki] Univ Tokyo, Dept Physiol Chem & Metab, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Takahashi, Shin-Ichiro] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Tokyo 1000006, Japan; [Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima 7348553, Japan; [Isobe, Toshiaki] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 1920397, Japan; [Nishimura, Fusanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Hiroshima 7348553, Japan; [Katagiri, Hideki; Oka, Yoshitomo] Tohoku Univ, Div Mol Metab & Diabet, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Hiroshima University; University of Tokyo; University of Tokyo; University of Tokyo; Asahi Life Foundation; Hiroshima University; Tokyo Metropolitan University; Hiroshima University; Tohoku University; Tohoku University	Asanoa, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asano-tky@umin.ac.jp	Kushiyama, Akifumi/A-6386-2011; Kushiyama, Akifumi/W-5988-2019; Isobe, Toshiaki/Q-9279-2017; 祐介, 中津/AAP-8396-2020; Kamata, Hideaki/N-3907-2017	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Nakatsu, Yusuke/0000-0003-3279-1276; Uchida, Takafumi/0000-0003-3665-4906; Ohno, Haruya/0000-0001-5400-1162; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Kurihara, Hiroki/0000-0002-6476-5593	Ministry of Education, Science, Sports, and Culture, Japan. [20790648]; Grants-in-Aid for Scientific Research [22780249] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Young Scientists 20790648 (to Y.N.) from the Ministry of Education, Science, Sports, and Culture, Japan.	Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; Nibuya M, 1996, J NEUROSCI, V16, P2365; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Waki K, 2010, CANCER SCI, V101, P1678, DOI 10.1111/j.1349-7006.2010.01576.x; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	42	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33018	33027		10.1074/jbc.M110.137836	http://dx.doi.org/10.1074/jbc.M110.137836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20675384	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000283048200039
J	Shen, ZT; Brehm, MA; Daniels, KA; Sigalov, AB; Selin, LK; Welsh, RM; Stern, LJ				Shen, Zu T.; Brehm, Michael A.; Daniels, Keith A.; Sigalov, Alexander B.; Selin, Liisa K.; Welsh, Raymond M.; Stern, Lawrence J.			Bi-specific MHC Heterodimers for Characterization of Cross-reactive T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROLOGOUS ANTIVIRAL IMMUNITY; CRYSTAL-STRUCTURE; VIRUS; MEMORY; BINDING; TCR; CORECEPTOR; AFFINITY; ALPHA; RECOGNITION	T cell cross-reactivity describes the phenomenon whereby a single T cell can recognize two or more different peptide antigens presented in complex with MHC proteins. Cross-reactive T cells have previously been characterized at the population level by cytokine secretion and MHC tetramer staining assays, but single-cell analysis is difficult or impossible using these methods. In this study, we describe development of a novel peptide MHC heterodimer specific for cross-reactive T cells. MHC-peptide monomers were independently conjugated to hydrazide or aldehyde-containing cross-linkers using thiol-maleimide coupling at cysteine residues introduced into recombinant MHC heavy chain proteins. Hydrazone formation provided bi-specific MHC heterodimers carrying two different peptides. Using this approach we prepared heterodimers of the murine class I MHC protein H-2K(b) carrying peptides from lymphocytic choriomeningitis virus and vaccinia virus, and used these to identify cross-reactive CD8+ T cells recognizing both lymphocytic choriomeningitis virus and vaccinia virus antigens. A similar strategy could be used to develop reagents to analyze cross-reactive T cell responses in humans.	[Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Brehm, Michael A.] Univ Massachusetts, Sch Med, Div Diabet, Worcester, MA 01655 USA; [Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Stern, LJ (corresponding author), S2-127,55 Lake Ave N, Worcester, MA 01655 USA.	lawrence.stern@umassmed.edu		Brehm, Michael/0000-0001-6813-3262; Selin, Liisa/0000-0002-6993-4333	National Institutes of Health [U19-AI057319, AI081675]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038996, U19AI057319, U19AI109858, R01AI081675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants U19-AI057319 (to L. J. S.) and AI081675 (to R. M. W.) and University of Massachusetts Medical School FACS and Proteomics Core resources supported by Diabetes Endocrinology Research Center Grant DK32520.	Achour A, 2002, IMMUNITY, V17, P757, DOI 10.1016/S1074-7613(02)00478-8; Altman BM, 2003, RES SOC SCI DISABIL, V3, P1, DOI 10.1016/S1479-3547(03)03001-X; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Boen E, 2000, J IMMUNOL, V165, P2040, DOI 10.4049/jimmunol.165.4.2040; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Chaudhri G, 2009, P NATL ACAD SCI USA, V106, P14984, DOI 10.1073/pnas.0906554106; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Cochran JR, 2001, J BIOL CHEM, V276, P28068, DOI 10.1074/jbc.M103280200; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cornberg M, 2006, J CLIN INVEST, V116, P1443, DOI 10.1172/JCI27804; Cornberg M, 2007, J VIROL, V81, P934, DOI 10.1128/JVI.01280-06; Cornberg M, 2010, J IMMUNOL, V184, P2825, DOI 10.4049/jimmunol.0902168; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Dirksen A, 2006, J AM CHEM SOC, V128, P15602, DOI 10.1021/ja067189k; Dutoit V, 2003, J IMMUNOL, V170, P5110, DOI 10.4049/jimmunol.170.10.5110; Fahmy TM, 2002, J IMMUNOL METHODS, V268, P93, DOI 10.1016/S0022-1759(02)00203-X; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; He X, 2002, NAT IMMUNOL, V3, P127, DOI 10.1038/ni751; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kerry SE, 2003, J IMMUNOL, V171, P4493, DOI 10.4049/jimmunol.171.9.4493; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kim SK, 2005, J EXP MED, V201, P523, DOI 10.1084/jem.20041337; KING TP, 1986, BIOCHEMISTRY-US, V25, P5774, DOI 10.1021/bi00367a064; KITAGAWA T, 1976, J BIOCHEM-TOKYO, V79, P233, DOI 10.1093/oxfordjournals.jbchem.a131053; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Moody AM, 2001, EUR J IMMUNOL, V31, P2791, DOI 10.1002/1521-4141(200109)31:9<2791::AID-IMMU2791>3.0.CO;2-X; Nugent CT, 2005, IMMUNOL LETT, V98, P208, DOI 10.1016/j.imlet.2004.11.016; PADOVAN E, 1995, ANN NY ACAD SCI, V756, P66, DOI 10.1111/j.1749-6632.1995.tb44482.x; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Rothman AL, 2009, ANN NY ACAD SCI, V1171, pE36, DOI 10.1111/j.1749-6632.2009.05055.x; Schott E, 2002, EUR J IMMUNOL, V32, P3425, DOI 10.1002/1521-4141(2002012)32:12<3425::AID-IMMU3425>3.0.CO;2-Q; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; Stones JD, 2006, J IMMUNOL, V176, P1498, DOI 10.4049/jimmunol.176.3.1498; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Udaka K, 1996, J IMMUNOL, V157, P670; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Welsh RM, 2006, CURR TOP MICROBIOL, V311, P117	46	8	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33144	33153		10.1074/jbc.M110.141051	http://dx.doi.org/10.1074/jbc.M110.141051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729210	Green Published, hybrid			2022-12-27	WOS:000283048200052
J	Xing, L; Li, TC; Mayazaki, N; Simon, MN; Wall, JS; Moore, M; Wang, CY; Takeda, N; Wakita, T; Miyamura, T; Cheng, RH				Xing, Li; Li, Tian-Cheng; Mayazaki, Naoyuki; Simon, Martha N.; Wall, Joseph S.; Moore, Mary; Wang, Che-Yen; Takeda, Naokazu; Wakita, Takaji; Miyamura, Tatsuo; Cheng, R. Holland			Structure of Hepatitis E Virion-sized Particle Reveals an RNA-dependent Viral Assembly Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-LIKE PARTICLES; CAPSID PROTEIN; HEV; INFECTION; PROGRAM	Hepatitis E virus (HEV) induces acute hepatitis in humans with a high fatality rate in pregnant women. There is a need for anti-HEV research to understand the assembly process of HEV native capsid. Here, we produced a large virion-sized and a small T=1 capsid by expressing the HEV capsid protein in insect cells with and without the N-terminal 111 residues, respectively, for comparative structural analysis. The virion-sized capsid demonstrates a T=3 icosahedral lattice and contains RNA fragment in contrast to the RNA-free T= 1 capsid. However, both capsids shared common decameric organization. The in vitro assembly further demonstrated that HEV capsid protein had the intrinsic ability to form decameric intermediate. Our data suggest that RNA binding is the extrinsic factor essential for the assembly of HEV native capsids.	[Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Xing, Li; Mayazaki, Naoyuki] Huddinge Univ Hosp, Karolinska Inst, Struct Virol Sect, SE-14186 Stockholm, Sweden; [Li, Tian-Cheng; Takeda, Naokazu; Wakita, Takaji; Miyamura, Tatsuo] Natl Inst Infect Dis, Dept Virol 2, Tokyo 2080011, Japan; [Simon, Martha N.; Wall, Joseph S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of California System; University of California Davis; Karolinska Institutet; National Institute of Infectious Diseases (NIID); United States Department of Energy (DOE); Brookhaven National Laboratory	Cheng, RH (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	rhch@ucdavis.edu	Miyazaki, Naoyuki/D-7435-2012; Cheng, Holland/A-8973-2008; Miyazaki, Naoyuki/P-3436-2018	Miyazaki, Naoyuki/0000-0002-4880-7300; Miyazaki, Naoyuki/0000-0002-4880-7300; Wang, Joseph Che-Yen/0000-0001-6580-3531	National Institutes of Health; U.S. Department of Agriculture; STINT Foundation; Strategic Research Foundation; Swedish Research Council; Ministry of Health, Labor, and Welfare, Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); STINT Foundation; Strategic Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a grant from the National Institutes of Health Roadmap Project on Nanomedicine (to R. H. C.). This work was also supported by grants from the U.S. Department of Agriculture Hatch Fund, STINT Foundation, and Strategic Research Foundation (to R. H. C.). This study was also partly funded by a grant from the Swedish Research Council (to L. X.) and grants for Research on Emerging and Re-emerging Infectious Diseases, Research on Hepatitis, and Research on Food Safety from the Ministry of Health, Labor, and Welfare, Japan (to T.- C. L.).	Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Bertolotti-Ciarlet A, 2002, J VIROL, V76, P4044, DOI 10.1128/JVI.76.8.4044-4055.2002; BLOW DM, 1964, J MOL BIOL, V8, P65, DOI 10.1016/S0022-2836(64)80149-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; FISHER AJ, 1993, NATURE, V361, P176, DOI 10.1038/361176a0; Guu TSY, 2009, P NATL ACAD SCI USA, V106, P12992, DOI 10.1073/pnas.0904848106; Harrison SC, 2001, CURR OPIN STRUC BIOL, V11, P195, DOI 10.1016/S0959-440X(00)00189-5; He SZ, 2008, J GEN VIROL, V89, P245, DOI 10.1099/vir.0.83308-0; Ji YC, 2006, J STRUCT BIOL, V154, P1, DOI 10.1016/j.jsb.2005.06.009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Li TC, 2005, J VIROL, V79, P12999, DOI 10.1128/JVI.79.20.12999-13006.2005; Li TC, 2004, VACCINE, V22, P370, DOI 10.1016/j.vaccine.2003.08.004; Li TC, 2007, J VIROL, V81, P10890, DOI 10.1128/JVI.00807-07; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAIK SR, 1992, B WORLD HEALTH ORGAN, V70, P597; Nguyen HD, 2009, J AM CHEM SOC, V131, P2606, DOI 10.1021/ja807730x; Niikura M, 2002, VIROLOGY, V293, P273, DOI 10.1006/viro.2001.1240; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; PRASAD BVV, 1994, J MOL BIOL, V240, P256, DOI 10.1006/jmbi.1994.1439; PURDY MA, 1993, J MED VIROL, V41, P90, DOI 10.1002/jmv.1890410118; Riddell MA, 2000, J VIROL, V74, P8011, DOI 10.1128/JVI.74.17.8011-8017.2000; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; Schofield DJ, 2003, VACCINE, V22, P257, DOI 10.1016/j.vaccine.2003.07.008; Stockley PG, 2007, J MOL BIOL, V369, P541, DOI 10.1016/j.jmb.2007.03.020; Takamura S, 2004, GENE THER, V11, P628, DOI 10.1038/sj.gt.3302193; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; TIMMINS PA, 1994, STRUCTURE, V2, P1191, DOI 10.1016/S0969-2126(94)00121-9; Wall JS, 2000, METH MOL B, V148, P589; Wall JS, 1998, METHOD CELL BIOL, V53, P139; Wang CY, 2008, ACTA CRYSTALLOGR F, V64, P318, DOI 10.1107/S1744309108007197; Xing L, 1999, VIROLOGY, V265, P35, DOI 10.1006/viro.1999.0005; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013	39	112	116	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33175	33183		10.1074/jbc.M110.106336	http://dx.doi.org/10.1074/jbc.M110.106336			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720013	hybrid, Green Published			2022-12-27	WOS:000283048200055
J	Chu, KY; Lin, YL; Hendel, A; Kulpa, JE; Brownsey, RW; Johnson, JD				Chu, Kwan Yi; Lin, Yalin; Hendel, Alon; Kulpa, Jerzy E.; Brownsey, Roger W.; Johnson, James D.			ATP-Citrate Lyase Reduction Mediates Palmitate-induced Apoptosis in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FREE FATTY-ACIDS; DEPENDENT DIABETES-MELLITUS; INDUCED INSULIN-SECRETION; LONG-TERM EXPOSURE; ER STRESS; ISLETS; ACTIVATION; INHIBITION; KINASE	Elevated extracellular lipids, such as the free fatty acid palmitate, can induce pancreatic beta cell endoplasmic reticulum (ER) stress and apoptosis, thereby contributing to the initiation and progression of type 2 diabetes. ATP-citrate lyase (ACLY), a key enzyme in cellular lipid production, was identified as a palmitate target in a proteomic screen. We investigated the effects of palmitate on ACLY activity and phosphorylation and its role in beta cell ER stress and apoptosis. We demonstrated that treatment of MIN6 cells, mouse islets and human islets with palmitate reduced ACLY protein levels. These in vitro results were validated by our finding that islets from high fat-fed mice had a significant decrease in ACLY, similar to that previously observed in type 2 diabetic human islets. Palmitate decreased intracellular acetyl-CoA levels to a similar degree as the ACLY inhibitor, SB-204990, suggesting a reduction in ACLY activity. ACLY inhibitors alone were sufficient to induce CCAAT/enhancer- binding protein homologues protein (CHOP)-dependent ER stress and caspase-3-dependent apoptosis. Similarly, even modest shRNA-mediated knockdown of ACLY caused a significant increase in beta cell apoptosis and ER stress. The effects of chemical ACLY inhibition and palmitate were nonadditive and therefore potentially mediated by a common mechanism. Indeed, overexpression of ACLY prevented palmitate-induced beta cell death. These observations provide new evidence that ACLY expression and activity can be suppressed by exogenous lipids and demonstrate a critical role for ACLY in pancreatic beta cell survival. These findings add to the emerging body of evidence linking beta cell metabolism with programmed cell death.	[Johnson, James D.] Univ British Columbia, Diabet Res Grp, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, Vancouver, BC V6T 1Z3, Canada; [Kulpa, Jerzy E.; Brownsey, Roger W.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Johnson, JD (corresponding author), Univ British Columbia, Diabet Res Grp, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, 5358 Life Sci Bldg,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	jimjohn@interchange.ubc.ca		Johnson, James/0000-0002-7523-9433	Canadian Diabetes Association (CDA); Michael Smith Foundation for Health Research; Centre for Human Islet Transplantation and Beta Cell Regeneration; Canadian Institutes for Health Research; Juvenile Diabetes Research Foundation	Canadian Diabetes Association (CDA); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Centre for Human Islet Transplantation and Beta Cell Regeneration; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This project was funded by a grant-in-aid from the Canadian Diabetes Association (CDA) (to J.D.J.) and the Michael Smith Foundation for Health Research (to J.D.J. and the Centre for Human Islet Transplantation and Beta Cell Regeneration).; Supported by a New Investigator Award from the Canadian Institutes for Health Research, a Career Development Award from the Juvenile Diabetes Research Foundation, and a Scholarship from the CDA.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; ALLY A, 1992, J CHROMATOGR-BIOMED, V575, P19, DOI 10.1016/0378-4347(92)80499-G; Atkinson LL, 2002, DIABETES, V51, P1548, DOI 10.2337/diabetes.51.5.1548; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BERKHOUT TA, 1990, BIOCHEM J, V272, P181, DOI 10.1042/bj2720181; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CISTOLA DP, 1991, J CLIN INVEST, V87, P1431, DOI 10.1172/JCI115149; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; FRAZE E, 1985, J CLIN ENDOCR METAB, V61, P807, DOI 10.1210/jcem-61-5-807; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; GOLAY A, 1987, J CLIN ENDOCR METAB, V65, P512, DOI 10.1210/jcem-65-3-512; Gribble AD, 1998, J MED CHEM, V41, P3582, DOI 10.1021/jm980091z; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; HOUSTON B, 1985, BIOCHIM BIOPHYS ACTA, V844, P233, DOI 10.1016/0167-4889(85)90095-3; HUGHES K, 1992, BIOCHEM J, V288, P309, DOI 10.1042/bj2880309; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; KING MT, 1988, METHOD ENZYMOL, V166, P70; Knowles LM, 2008, J BIOL CHEM, V283, P31378, DOI 10.1074/jbc.M803384200; KNOWLES SE, 1974, BIOCHEM J, V142, P401, DOI 10.1042/bj1420401; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Lee Y, 1997, DIABETES, V46, P408, DOI 10.2337/diabetes.46.3.408; LINN TC, 1979, J BIOL CHEM, V254, P1691; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Pearce NJ, 1998, BIOCHEM J, V334, P113, DOI 10.1042/bj3340113; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Sargsyan E, 2008, J ENDOCRINOL, V199, P41, DOI 10.1677/JOE-08-0251; SUZUKI M, 1981, J NUTR SCI VITAMINOL, V27, P595, DOI 10.3177/jnsv.27.595; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	56	46	48	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32606	32615		10.1074/jbc.M110.157172	http://dx.doi.org/10.1074/jbc.M110.157172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693577	Green Published, hybrid			2022-12-27	WOS:000282683000075
J	Koprivova, A; des Francs-Small, CC; Calder, G; Mugford, ST; Tanz, S; Lee, BR; Zechmann, B; Small, I; Kopriva, S				Koprivova, Anna; des Francs-Small, Catherine Colas; Calder, Grant; Mugford, Sam T.; Tanz, Sandra; Lee, Bok-Rye; Zechmann, Bernd; Small, Ian; Kopriva, Stanislav			Identification of a Pentatricopeptide Repeat Protein Implicated in Splicing of Intron 1 of Mitochondrial nad7 Transcripts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-I; NUCLEAR GENE; GLUTATHIONE HOMEOSTASIS; RESPIRATORY-CHAIN; PPR PROTEINS; ARABIDOPSIS; STRESS; METABOLISM; MUTANTS; REVEALS	Splicing of plant organellar transcripts is facilitated by members of a large protein family, the pentatricopeptide repeat proteins. We have identified a pentatricopeptide repeat protein in a genetic screen for mutants resistant to inhibition of root growth by buthionine sulfoximine (BSO), an inhibitor of glutathione synthesis and consequently named BIR6 (BSO-insensitive roots 6). BIR6 is involved in splicing of intron 1 of the mitochondrial nad7 transcript. Loss-of-function mutations in BIR6 result in a strongly reduced accumulation of fully processed nad7 transcript. This affects assembly of Complex I and results in moderate growth retardation. In agreement with disruption of Complex I function, the genes encoding alternative NADH oxidizing enzymes are induced in the mutant, and the mutant plants are less sensitive to mannitol and salt stress. Mutation in the BIR6 gene allowed normal root growth in presence of BSO and strongly attenuated depletion of glutathione content at these conditions. The same phenotype was observed with other mutants affected in function of Complex I, thus reinforcing the importance of Complex I function for cellular redox homeostasis.	[Koprivova, Anna; Mugford, Sam T.; Lee, Bok-Rye; Kopriva, Stanislav] John Innes Ctr, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England; [Calder, Grant] John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [des Francs-Small, Catherine Colas; Tanz, Sandra; Zechmann, Bernd; Small, Ian] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Zechmann, Bernd] Graz Univ, Inst Plant Sci, A-8010 Graz, Austria	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Western Australia; University of Graz	Kopriva, S (corresponding author), John Innes Ctr, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England.	stanislav.kopriva@bbsrc.ac.uk	Tanz, Sandra K/C-2686-2011; Kopriva, Stanislav/C-7401-2013; Francs-Small, Catherine C Colas des/E-6279-2011; Francs-Small, Catherine Colas des/N-2992-2019; Small, Ian/AAR-5506-2021; Small, Ian D/C-1168-2008	Kopriva, Stanislav/0000-0002-7416-6551; Francs-Small, Catherine C Colas des/0000-0002-6386-5672; Francs-Small, Catherine Colas des/0000-0002-6386-5672; Small, Ian/0000-0001-5300-1216; Small, Ian D/0000-0001-5300-1216; Mugford, Sam/0000-0002-8537-5578; Tanz, Sandra/0000-0002-0632-4095; Zechmann, Bernd/0000-0002-7702-2588	Australian Research Council [CE0561495]; British Biotechnology and Biological Sciences Research Council [BB/E009912/1]; Korea Science and Engineering Foundation; Austrian Science Fund [FWF P20619]	Australian Research Council(Australian Research Council); British Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Austrian Science Fund(Austrian Science Fund (FWF))	Supported by Australian Research Council Grant CE0561495.; Supported by British Biotechnology and Biological Sciences Research Council Grant BB/E009912/1.; Supported by a post-doctoral fellowship from the Korea Science and Engineering Foundation.; Supported by Austrian Science Fund Grant FWF P20619.; Supported by the British Biotechnology and Biological Sciences Research Council. To whom correspondence should be addressed: John Innes Centre, Norwich NR4 7UH, UK. Tel.: 44-1603-450276; Fax: 44-1603-450014; E-mail: stanislav.kopriva@bbsrc.ac.uk.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; de Longevialle AF, 2008, PLANT J, V56, P157, DOI 10.1111/j.1365-313X.2008.03581.x; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Fisk DG, 1999, EMBO J, V18, P2621, DOI 10.1093/emboj/18.9.2621; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Garmier M, 2008, PLANT PHYSIOL, V148, P1324, DOI 10.1104/pp.108.125880; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Gutierres S, 1997, P NATL ACAD SCI USA, V94, P3436, DOI 10.1073/pnas.94.7.3436; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Kerenyi Z, 2008, EMBO J, V27, P1585, DOI 10.1038/emboj.2008.88; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Leon G, 2007, PLANT PHYSIOL, V143, P1534, DOI 10.1104/pp.106.095158; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; Meyer AJ, 2008, J PLANT PHYSIOL, V165, P1390, DOI 10.1016/j.jplph.2007.10.015; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Mullineaux PM, 2005, PHOTOSYNTH RES, V86, P459, DOI 10.1007/s11120-005-8811-8; Nakagawa N, 2006, PLANT CELL PHYSIOL, V47, P772, DOI 10.1093/pcp/pcj051; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; PLA M, 1995, MOL GEN GENET, V248, P79, DOI 10.1007/BF02456616; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Thirkettle-Watts D, 2003, PLANT PHYSIOL, V133, P1158, DOI 10.1104/pp.103.028183; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260	50	105	109	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32192	32199		10.1074/jbc.M110.147603	http://dx.doi.org/10.1074/jbc.M110.147603			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20682769	Green Published, hybrid			2022-12-27	WOS:000282683000032
J	Prathapam, T; Aleshin, A; Guan, YH; Gray, JW; Martin, GS				Prathapam, Tulsiram; Aleshin, Alexey; Guan, Yinghui; Gray, Joe W.; Martin, G. Steven			p27(Kip1) Mediates Addiction of Ovarian Cancer Cells to MYCC (c-MYC) and Their Dependence on MYC Paralogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE ADDICTION; CELLULAR SENESCENCE; CYCLE PROGRESSION; GENE; EXPRESSION; OVEREXPRESSION; PROLIFERATION; TARGET; PHOSPHORYLATION; TUMORIGENESIS	The MYCC (c-MYC) gene is amplified in 30-60% of human ovarian cancers. We assessed the functional significance of MYCC amplification by siRNA inhibition of MYCC or MYC paralogs in a panel of ovarian cancer cell lines expressing varying levels of MYCC. Inactivation of MYCC inhibited cell proliferation and induced replicative senescence only in lines with amplified MYCC, indicating that these cells are addicted to continued MYCC overexpression. In contrast, siRNA knockdown of all three MYC isoforms inhibited proliferation of MYCC non-amplified ovarian cancer cells without inducing replicative senescence, and did not inhibit the proliferation of telomerase-immortalized ovarian surface epithelial cells. The arrest induced by MYCC knockdown was accompanied by an increase in the level of the Cdk inhibitor p27(Kip1) and a decrease in cyclin A expression and Cdk2 activity, and could be reversed by RNAi knockdown of p27(Kip1) or Rb, or by overexpression of cyclin A/Cdk2. The arrest induced by knockdown of all three MYC isoforms could similarly be reversed by p27(Kip1) knockdown. Our findings indicate that the addiction of MYCC-amplified ovarian cancer cells to MYCC differs from the dependence of MYCC non-amplified cancer cells on MYC paralogs, but both are mediated, at least in part, by p27(Kip1). They also suggest that growth of ovarian cancers may be blocked by inhibition of MYCC or MYC paralogs.	[Martin, G. Steven] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Guan, Yinghui; Gray, Joe W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Guan, Yinghui; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Martin, GS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall 3204, Berkeley, CA 94720 USA.	gsm@berkeley.edu	Gray, Joe/AAX-9549-2020		National Institutes of Health [CA 17542, P50 CA 83639]; Office of Science, Office of Biological and Environmental Research, United States Department of Energy [DE-AC0205CH11231]; Philip Morris External Research Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); Philip Morris External Research Program	This work was supported, in whole or in part, by National Institutes of Health Grants CA 17542 (to G.S.M.) and P50 CA 83639 (to J.W.G.). This work was also supported by the Office of Science, Office of Biological and Environmental Research, United States Department of Energy Contract DE-AC0205CH11231 (to J.W.G.) and the Philip Morris External Research Program (to G.S.M.).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Baena E, 2005, P NATL ACAD SCI USA, V102, P7286, DOI 10.1073/pnas.0409260102; Chen CH, 2005, INT J GYNECOL CANCER, V15, P878, DOI 10.1111/j.1525-1438.2005.00150.x; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dimova I, 2006, EUR J CANCER, V42, P674, DOI 10.1016/j.ejca.2005.11.022; Felsher DW, 2008, CANCER RES, V68, P3081, DOI 10.1158/0008-5472.CAN-07-5832; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Harper JW, 1998, GENE DEV, V12, P285, DOI 10.1101/gad.12.3.285; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Lancaster JM, 2004, J SOC GYNECOL INVEST, V11, P51, DOI 10.1016/j.jsgi.2003.07.004; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; Prochownik Edward V, 2004, Expert Rev Anticancer Ther, V4, P289, DOI 10.1586/14737140.4.2.289; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Sherr CJ, 2000, CANCER RES, V60, P3689; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Wu R, 2003, AM J PATHOL, V162, P1603, DOI 10.1016/S0002-9440(10)64294-0; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	44	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32529	32538		10.1074/jbc.M110.151902	http://dx.doi.org/10.1074/jbc.M110.151902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20647308	Green Published, hybrid			2022-12-27	WOS:000282683000067
J	Weiss, TL; Chun, HJ; Okada, S; Vitha, S; Holzenburg, A; Laane, J; Devarenne, TP				Weiss, Taylor L.; Chun, Hye Jin; Okada, Shigeru; Vitha, Stanislav; Holzenburg, Andreas; Laane, Jaan; Devarenne, Timothy P.			Raman Spectroscopy Analysis of Botryococcene Hydrocarbons from the Green Microalga Botryococcus braunii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRUDE OILS; B-RACE; TRITERPENOID HYDROCARBONS; BRANCHED HYDROCARBON; NUTRIENT STATUS; ALGA; BIOSYNTHESIS; CELLS; STRAIN; SHALE	Botryococcus braunii, B race is a unique green microalga that produces large amounts of liquid hydrocarbons known as botryococcenes that can be used as a fuel for internal combustion engines. The simplest botryococcene (C-30) is metabolized by methylation to give intermediates of C-31, C-32, C-33, and C-34, with C-34 being the predominant botryococcene in some strains. In the present work we have used Raman spectroscopy to characterize the structure of botryococcenes in an attempt to identify and localize botryococcenes within B. braunii cells. The spectral region from 1600-1700 cm(-1) showed v(C=C) stretching bands specific for botryococcenes. Distinct botryococcene Raman bands at 1640 and 1647 cm(-1) were assigned to the stretching of the C=C bond in the botryococcene branch and the exomethylene C=C bonds produced by the methylations, respectively. A Raman band at 1670 cm(-1) was assigned to the backbone C=C bond stretching. Density function theory calculations were used to determine the Raman spectra of all botryococcenes to compare computed theoretical values with those observed. The analysis showed that the v(C=C) stretching bands at 1647 and 1670 cm(-1) are actually composed of several closely spaced bands arising from the six individual C=C bonds in the molecule. We also used confocal Raman microspectroscopy to map the presence and location of methylated botryococcenes within a colony of B. braunii cells based on the methylation-specific 1647 cm(-1) botryococcene Raman shift.	[Weiss, Taylor L.; Holzenburg, Andreas; Devarenne, Timothy P.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Chun, Hye Jin; Laane, Jaan] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Okada, Shigeru] Univ Tokyo, Lab Aquat Nat Prod Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Vitha, Stanislav; Holzenburg, Andreas] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX 77843 USA; [Holzenburg, Andreas] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Tokyo; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Devarenne, TP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	tpd8@tamu.edu	Laane, Jaan/O-4379-2014; Okada, Shigeru/U-8305-2017; Weiss, Taylor/E-6247-2012	Laane, Jaan/0000-0003-4423-6122; Okada, Shigeru/0000-0003-3663-7778; Weiss, Taylor/0000-0002-3967-0787; Vitha, Stanislav/0000-0003-3262-8399; Devarenne, Timothy/0000-0001-6032-8049	Texas A&M University Department of Biochemistry and Biophysics; Japan Society for the Promotion of Science [S-09103]; Robert A. Welch Foundation [A-0396]; National Science Foundation [BES-0421409]	Texas A&M University Department of Biochemistry and Biophysics; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Robert A. Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Texas A&M University Department of Biochemistry and Biophysics start-up funds (to T.P.D.), Japan Society for the Promotion of Science Research Fellowship S-09103 (to T.P.D.), Robert A. Welch Foundation Grant A-0396 (to J.L.), and National Science Foundation Grant BES-0421409 (to A.H.).	Achitouv E, 2004, PHYTOCHEMISTRY, V65, P3159, DOI 10.1016/j.phytochem.2004.09.015; Adam P, 2006, ORG GEOCHEM, V37, P584, DOI 10.1016/j.orggeochem.2006.01.001; Audino M, 2002, ORG GEOCHEM, V33, P979, DOI 10.1016/S0146-6380(02)00061-X; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; BRAHMA SK, 1983, APPL SPECTROSC, V37, P55, DOI 10.1366/0003702834634190; BRASSELL SC, 1986, ORG GEOCHEM, V10, P927, DOI 10.1016/S0146-6380(86)80030-4; CANE R F, 1977, Transactions of the Royal Society of South Australia, V101, P153; CASADEVALL E, 1984, TETRAHEDRON LETT, V25, P4123, DOI 10.1016/S0040-4039(01)90198-4; Chen M, 2004, SPECTROCHIM ACTA A, V60, P527, DOI 10.1016/S1386-1425(03)00258-0; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; COOKSEY KE, 1987, J MICROBIOL METH, V6, P333, DOI 10.1016/0167-7012(87)90019-4; Elsey D, 2007, J MICROBIOL METH, V68, P639, DOI 10.1016/j.mimet.2006.11.008; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; FRISCH MJ, 2004, GAUSSIAN VERSION 0 3; GALBRAITH MN, 1983, PHYTOCHEMISTRY, V22, P1441, DOI 10.1016/S0031-9422(00)84031-5; GLIKSON M, 1989, ORG GEOCHEM, V14, P595, DOI 10.1016/0146-6380(89)90039-9; GRUNG M, 1989, BIOCHEM SYST ECOL, V17, P263, DOI 10.1016/0305-1978(89)90001-X; Heraud P, 2006, J CHEMOMETR, V20, P193, DOI 10.1002/cem.990; Heraud P, 2007, FEMS MICROBIOL LETT, V275, P24, DOI 10.1111/j.1574-6968.2007.00861.x; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huang YY, 2010, BIOTECHNOL BIOENG, V105, P889, DOI 10.1002/bit.22617; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P1467, DOI 10.1016/S0031-9422(00)97766-5; HUANG Z, 1989, J AM CHEM SOC, V111, P2713, DOI 10.1021/ja00189a056; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P3034; KNIGHTS BA, 1970, PHYTOCHEMISTRY, V9, P1317, DOI 10.1016/S0031-9422(00)85325-X; Kubo Y, 2000, APPL SPECTROSC, V54, P1114, DOI 10.1366/0003702001950832; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; Lee H, 1998, KSME INT J, V12, P553, DOI 10.1007/BF02945716; Li BX, 2005, PHOTOSYNTH RES, V83, P297, DOI 10.1007/s11120-004-6555-5; Mastalerz M, 1996, ORG GEOCHEM, V24, P301, DOI 10.1016/0146-6380(96)00027-7; MAXWELL JR, 1968, PHYTOCHEMISTRY, V7, P2157, DOI 10.1016/S0031-9422(00)85672-1; MCKIRDY DM, 1986, NATURE, V320, P57, DOI 10.1038/320057a0; METZGER P, 1988, PHYTOCHEMISTRY, V27, P1383, DOI 10.1016/0031-9422(88)80199-7; METZGER P, 1987, PHYTOCHEMISTRY, V26, P129; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2995, DOI 10.1016/0031-9422(85)80043-1; METZGER P, 1986, PHYTOCHEMISTRY, V25, P1869, DOI 10.1016/S0031-9422(00)81165-6; METZGER P, 1990, J PHYCOL, V26, P258, DOI 10.1111/j.0022-3646.1990.00258.x; METZGER P, 1987, TETRAHEDRON LETT, V28, P3911; Metzger P, 2007, ORG GEOCHEM, V38, P566, DOI 10.1016/j.orggeochem.2006.12.003; MOLDOWAN JM, 1980, J CHEM SOC CHEM COMM, P912, DOI 10.1039/c39800000912; NONOMURA A M, 1988, Japanese Journal of Phycology, V36, P285; Okada S, 2004, ARCH BIOCHEM BIOPHYS, V422, P110, DOI 10.1016/j.abb.2003.12.004; Okada S, 1997, PHYTOCHEM ANALYSIS, V8, P198, DOI 10.1002/(SICI)1099-1565(199707)8:4&lt;198::AID-PCA360&gt;3.0.CO;2-E; Okada S, 1996, TETRAHEDRON LETT, V37, P1065, DOI 10.1016/0040-4039(95)02349-6; Okada S, 1995, J APPL PHYCOL, V7, P555, DOI 10.1007/BF00003942; Okada S, 1998, PHYTOCHEMISTRY, V47, P1111, DOI 10.1016/S0031-9422(97)00548-7; Sato Y, 2003, TETRAHEDRON LETT, V44, P7035, DOI 10.1016/S0040-4039(03)01784-2; Stasiuk LD, 1999, ORG GEOCHEM, V30, P1021, DOI 10.1016/S0146-6380(99)00046-7; Summons RE, 2002, ORG GEOCHEM, V33, P99, DOI 10.1016/S0146-6380(01)00147-4; TEMPLIER J, 1991, PHYTOCHEMISTRY, V30, P2209, DOI 10.1016/0031-9422(91)83616-S; TEMPLIER J, 1984, PHYTOCHEMISTRY, V23, P1017, DOI 10.1016/S0031-9422(00)82602-3; TESTA M, 2001, P OCEAN DRILLING PRO, V180, P1; TRAVERSE ALFRED, 1955, MICROPALEONTOLOGY, V1, P343, DOI 10.2307/1484478; WAGNER WD, 1986, APPL SPECTROSC, V40, P191, DOI 10.1366/0003702864509574; WOLF FR, 1985, PHYTOCHEMISTRY, V24, P733; WOLF FR, 1985, J PHYCOL, V21, P388; Wood BR, 2005, ANAL CHEM, V77, P4955, DOI 10.1021/ac050281z; Wu Q, 1998, ANAL CHEM, V70, P1782, DOI 10.1021/ac971098b; Wynn-Williams, 2004, INT J ASTROBIOL, V3, P125, DOI [10.1017/S1473550404002034, DOI 10.1017/S1473550404002034]	60	58	61	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32458	32466		10.1074/jbc.M110.157230	http://dx.doi.org/10.1074/jbc.M110.157230			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20705610	hybrid, Green Published			2022-12-27	WOS:000282683000059
J	Yang, HL; Ganguly, A; Cabral, F				Yang, Hailing; Ganguly, Anutosh; Cabral, Fernando			Inhibition of Cell Migration and Cell Division Correlates with Distinct Effects of Microtubule Inhibiting Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; BETA-TUBULIN; ALPHA-TUBULIN; DYNAMIC INSTABILITY; LIVING CELLS; PACLITAXEL RESISTANCE; ENDOTHELIAL-CELLS; SPINDLE FORMATION; MEIOTIC SPINDLE; IN-VITRO	Drugs that target microtubules are thought to inhibit cell division and cell migration by suppressing dynamic instability, a "search and capture" behavior that allows microtubules to probe their environment. Here, we report that subtoxic drug concentrations are sufficient to inhibit plus-end microtubule dynamic instability and cell migration without affecting cell division or microtubule assembly. The higher drug concentrations needed to inhibit cell division act through a novel mechanism that generates microtubule fragments by stimulating microtubule minus-end detachment from their organizing centers. The frequency of microtubule detachment in untreated cells increases at prophase suggesting that it is a regulated cellular process important for spindle assembly and function. We conclude that drugs produce differential dose-dependent effects at microtubule plus and minus-ends to inhibit different microtubule-mediated functions.	[Yang, Hailing; Ganguly, Anutosh; Cabral, Fernando] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Cabral, F (corresponding author), Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	fernando.r.cabral@uth.tmc.edu		Ganguly, Anutosh/0000-0002-7228-7827	National Institutes of Health [CA85935]; NATIONAL CANCER INSTITUTE [R01CA085935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA85935 (to F. C.).	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; ABRAHAM I, 1983, J CELL BIOL, V97, P1055, DOI 10.1083/jcb.97.4.1055; AHMAD FJ, 1995, J CELL SCI, V108, P2761; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; BARLOW S, 1994, J CELL BIOL, V126, P1017, DOI 10.1083/jcb.126.4.1017; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; CABRAL F, 1991, PHARMACOL THERAPEUT, V52, P159, DOI 10.1016/0163-7258(91)90006-8; CABRAL F, 1980, CELL, V20, P29, DOI 10.1016/0092-8674(80)90231-7; Cabral F., 2000, DRUG RESIST UPDATE, V3, P1; CABRAL FR, 1983, J CELL BIOL, V97, P22, DOI 10.1083/jcb.97.1.22; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Hari M, 2003, MOL CANCER THER, V2, P597; Hotchkiss KA, 2002, MOL CANCER THER, V1, P1191; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kamath K, 2005, J BIOL CHEM, V280, P12902, DOI 10.1074/jbc.M414477200; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; LIAO GJ, 1995, J CELL SCI, V108, P3473; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Pasquier E, 2005, CANCER RES, V65, P2433, DOI 10.1158/0008-5472.CAN-04-2624; Pourroy B, 2006, CANCER RES, V66, P3256, DOI 10.1158/0008-5472.CAN-05-3885; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; Rusan NM, 2005, J CELL BIOL, V168, P21, DOI 10.1083/jcb.200409153; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; SCHIBLER MJ, 1986, J CELL BIOL, V102, P1522, DOI 10.1083/jcb.102.4.1522; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Vacca A, 1999, BLOOD, V94, P4143, DOI 10.1182/blood.V94.12.4143.424k26_4143_4155; Wang XM, 1996, J CELL BIOL, V132, P345, DOI 10.1083/jcb.132.3.345; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Yang HL, 2007, J BIOL CHEM, V282, P27058, DOI 10.1074/jbc.M704101200; Yin SH, 2010, MOL CANCER THER, V9, P327, DOI 10.1158/1535-7163.MCT-09-0674	43	115	118	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32242	32250		10.1074/jbc.M110.160820	http://dx.doi.org/10.1074/jbc.M110.160820			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696757	hybrid, Green Published			2022-12-27	WOS:000282683000037
J	Gorbea, C; Pratt, G; Ustrell, V; Bell, R; Sahasrabudhe, S; Hughes, RE; Rechsteiner, M				Gorbea, Carlos; Pratt, Gregory; Ustrell, Vicenca; Bell, Russell; Sahasrabudhe, Sudhir; Hughes, Robert E.; Rechsteiner, Martin			A Protein Interaction Network for Ecm29 Links the 26 S Proteasome to Molecular Motors and Endosomal Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; GROWTH-FACTOR; UBIQUITIN CHAINS; REGGIE/FLOTILLIN PROTEINS; TYROSINE PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; DEUBIQUITINATING ENZYME; RETROGRADE TRANSPORT; PROTEOLYTIC PATHWAY; 3T3-L1 ADIPOCYTES	Ecm29 is a 200-kDa HEAT repeat protein that binds the 26 S proteasome. Genome-wide two-hybrid screens and mass spectrometry have identified molecular motors, endosomal components, and ubiquitin-proteasome factors as Ecm29-interacting proteins. The C-terminal half of human Ecm29 binds myosins and kinesins; its N-terminal region binds the endocytic proteins, Vps11, Rab11-FIP4, and rabaptin. Whereas full-length FLAG-Ecm29, its C-terminal half, and a small central fragment of Ecm29 remain bound to glycerol-gradient-separated 26 S proteasomes, the N-terminal half of Ecm29 does not. Confocal microscopy showed that Ecm-26 S proteasomes are present on flotillin-positive endosomes, but they are virtually absent from caveolin-and clathrin-decorated endosomes. Expression of the small central fragment of Ecm29 markedly reduces proteasome association with flotillin-positive endosomes. Identification of regions within Ecm29 capable of binding molecular motors, endosomal proteins, and the 26 S proteasome supports the hypothesis that Ecm29 serves as an adaptor for coupling 26 S proteasomes to specific cellular compartments.	[Rechsteiner, Martin] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Bell, Russell; Sahasrabudhe, Sudhir; Hughes, Robert E.] Prolexys Pharmaceut Inc, Salt Lake City, UT 84111 USA	Utah System of Higher Education; University of Utah	Rechsteiner, M (corresponding author), Univ Utah, Sch Med, Dept Biochem, 15 N Med Dr E,Rm 4100, Salt Lake City, UT 84112 USA.	marty@biochem.utah.edu	Gorbea, Carlos/L-4406-2019		National Institutes of Health [NS042892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS042892 (to M.R.).	Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bhattacharyya NP, 2008, FEBS J, V275, P4271, DOI 10.1111/j.1742-4658.2008.06563.x; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Bousquet-Dubouch MP, 2009, MOL CELL PROTEOMICS, V8, P1150, DOI 10.1074/mcp.M800193-MCP200; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Clague MJ, 2002, CURR BIOL, V12, pR529, DOI 10.1016/S0960-9822(02)01030-8; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghosh AK, 2004, J BIOL CHEM, V279, P36132, DOI 10.1074/jbc.M404189200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2006, ISR J CHEM, V46, P207, DOI 10.1560/742P-ET1J-8RLC-2JYV; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hartmann-Petersen R, 2004, CURR BIOL, V14, pR754, DOI 10.1016/j.cub.2004.09.012; He F, 2006, BIOCHEM BIOPH RES CO, V344, P95, DOI 10.1016/j.bbrc.2006.03.142; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Kajava AV, 2004, J STRUCT BIOL, V146, P425, DOI 10.1016/j.jsb.2004.01.013; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lussier M, 1997, GENETICS, V147, P435; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Medigeshi GR, 2003, TRAFFIC, V4, P802, DOI 10.1034/j.1600-0854.2003.00136.x; Melman L, 2002, MOL BIOL CELL, V13, P3325, DOI 10.1091/mbc.E02-03-0152; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Mills IG, 2007, SEMIN CELL DEV BIOL, V18, P459, DOI 10.1016/j.semcdb.2007.07.001; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Virshup DM, 2007, CELL, V129, P857, DOI 10.1016/j.cell.2007.05.015; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200	103	55	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31616	31633		10.1074/jbc.M110.154120	http://dx.doi.org/10.1074/jbc.M110.154120			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682791	Green Published, hybrid			2022-12-27	WOS:000282764600055
J	Higo, S; Asano, Y; Kato, H; Yamazaki, S; Nakano, A; Tsukamoto, O; Seguchi, O; Asai, M; Asakura, M; Asanuma, H; Sanada, S; Minamino, T; Komuro, I; Kitakaze, M; Takashima, S				Higo, Shuichiro; Asano, Yoshihiro; Kato, Hisakazu; Yamazaki, Satoru; Nakano, Atsushi; Tsukamoto, Osamu; Seguchi, Osamu; Asai, Mitsutoshi; Asakura, Masanori; Asanuma, Hiroshi; Sanada, Shoji; Minamino, Tetsuo; Komuro, Issei; Kitakaze, Masafumi; Takashima, Seiji			Isoform-specific Intermolecular Disulfide Bond Formation of Heterochromatin Protein 1 (HP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; HISTONE H3; TRANSCRIPTIONAL REPRESSION; LYSINE-9 METHYLATION; MAMMALIAN-CELLS; DOMAIN; COREPRESSOR; CHROMATIN; PHOSPHORYLATION; IDENTIFICATION	Three mammalian isoforms of heterochromatin protein 1 (HP1), alpha, beta, and gamma, play diverse roles in gene regulation. Despite their structural similarity, the diverse functions of these isoforms imply that they are additionally regulated by post-translational modifications. Here, we have identified intermolecular disulfide bond formation of HP1 cysteines in an isoform-specific manner. Cysteine 133 in HP1 alpha and cysteine 177 in HP1 gamma were involved in intermolecular homodimerization. Although both HP1 alpha and HP1 gamma contain reactive cysteine residues, only HP1 gamma readily and reversibly formed disulfide homodimers under oxidative conditions. Oxidatively dimerized HP1 gamma strongly and transiently interacted with TIF1 beta, a universal transcriptional co-repressor. Under oxidative conditions, HP1 gamma dimerized and held TIF1 beta in a chromatin component and inhibited its repression ability. Our results highlight a novel, isoform-specific role for HP1 as a sensor of the cellular redox state.	[Asano, Yoshihiro; Kato, Hisakazu; Takashima, Seiji] Osaka Univ, Grad Sch Med, Dept Mol Cardiol, Suita, Osaka 5650871, Japan; [Asai, Mitsutoshi; Sanada, Shoji; Minamino, Tetsuo] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Asano, Yoshihiro; Yamazaki, Satoru; Tsukamoto, Osamu; Seguchi, Osamu; Asakura, Masanori; Asanuma, Hiroshi; Kitakaze, Masafumi] Natl Cardiovasc Ctr, Dept Cardiovasc Med, Osaka 5658565, Japan	Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan	Takashima, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Cardiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takasima@medone.med.osaka-u.ac.jp		Kato, Hisakazu/0000-0003-4619-3680; Tsukamoto, Osamu/0000-0002-9504-8001	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Medical Association; Japan Incurable Diseases Research Foundation; Osaka Medical Research Foundation for Incurable Diseases; Suzuken Memorial Foundation; Japan China Medical Association	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Medical Association; Japan Incurable Diseases Research Foundation; Osaka Medical Research Foundation for Incurable Diseases; Suzuken Memorial Foundation; Japan China Medical Association	This work was supported by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan, grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, grants from the Japan Heart Foundation, grants from the Japan Cardiovascular Research Foundation, a grant from the Japan Society for the Promotion of Science, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Japan Medical Association, Japan Incurable Diseases Research Foundation, Osaka Medical Research Foundation for Incurable Diseases, Suzuken Memorial Foundation, and Japan China Medical Association.	Asano Y, 2004, NAT GENET, V36, P123, DOI 10.1038/ng1294; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Badugu R, 2005, CHROMOSOMA, V113, P370, DOI 10.1007/s00412-004-0324-2; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Cammas F, 2007, DIFFERENTIATION, V75, P627, DOI 10.1111/j.1432-0436.2007.00166.x; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Filesi I, 2002, J CELL SCI, V115, P1803; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Itokawa Y, 2009, BIOCHEM BIOPH RES CO, V388, P689, DOI 10.1016/j.bbrc.2009.08.065; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LE DB, 1996, EMBO J, V15, P6701; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen AL, 2002, EMBO J, V21, P5797, DOI 10.1093/emboj/cdf560; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Riclet R, 2009, MOL BIOL CELL, V20, P296, DOI 10.1091/mbc.E08-05-0510; Ritou E, 2007, J CELL SCI, V120, P3425, DOI 10.1242/jcs.012955; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Smallwood A, 2008, NAT STRUCT MOL BIOL, V15, P318, DOI 10.1038/nsmb.1385; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200	43	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31337	31347		10.1074/jbc.M110.155788	http://dx.doi.org/10.1074/jbc.M110.155788			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675861	Green Published, hybrid			2022-12-27	WOS:000282764600028
J	Lanaspa, MA; Andres-Hernando, A; Li, NX; Rivard, CJ; Cicerchi, C; Roncal-Jimenez, C; Schrier, RW; Berl, T				Lanaspa, Miguel A.; Andres-Hernando, Ana; Li, Nanxing; Rivard, Christopher J.; Cicerchi, Christina; Roncal-Jimenez, Carlos; Schrier, Robert W.; Berl, Tomas			The Expression of Aquaporin-1 in the Medulla of the Kidney Is Dependent on the Transcription Factor Associated with Hypertonicity, TonEBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; URINARY CONCENTRATING ABILITY; WATER-CHANNEL; RAT-KIDNEY; OSMOTIC-STRESS; STIMULATES TRANSCRIPTION; RESPONSIVE ELEMENT; EPITHELIAL-CELLS; GENE-EXPRESSION; PKC-DELTA	Expression of aquaporin-1 (AQP1) and -2 (AQP2) channels in the kidney are critical for the maintenance of water homeostasis and the operation of the urinary concentrating mechanism. Hypertonic stress induced in inner medullary (IMCD3) cells by addition of NaCl to the medium substantially up-regulated the mRNA and protein expression of AQP1, suggesting that its activation occurs at a transcriptional and a translational levels. In contrast, no up-regulation of AQP1 was observed when these cells were exposed to the same tonicity by addition of urea. To explore the transcriptional activation of aqp1 under hypertonic stress, we examined the role of the transcription factor associated with hypertonicity, TonEBP. Treatment of IMCD3 cells with the TonEBP inhibitor rottlerin or silencing its expression with specific shRNA technology led to a substantial reduction in AQP1 expression under hypertonic conditions. Moreover, we defined a conserved TonEBP binding site located 811 bp upstream of the aqp1 exon that is essential for its expression. Single site-directed mutation of this TonE site led to a 54 +/- 5% (p < 0.01) decrease in AQP1 luciferase-driven activity under hypertonic stress. TonEBP mutant mice display marked decrement in the expression of AQP1 in the inner medulla. In conclusion, these data demonstrate that TonEBP is necessary for the regulation of AQP1 expression in the inner medulla of the kidney under hypertonic conditions.	[Lanaspa, Miguel A.; Andres-Hernando, Ana; Li, Nanxing; Rivard, Christopher J.; Cicerchi, Christina; Roncal-Jimenez, Carlos; Schrier, Robert W.; Berl, Tomas] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Denver, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Berl, T (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Sch Med, 12700 E 19th Ave, Aurora, CO 80015 USA.	tomas.berl@ucdenver.edu	Lanaspa, Miguel/AAO-4971-2020	Andres-Hernando, Ana/0000-0002-0676-0188				Andres-Hernando A, 2008, J BIOL CHEM, V283, P25082, DOI 10.1074/jbc.M802381200; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Capasso JM, 2003, ANN NY ACAD SCI, V986, P410, DOI 10.1111/j.1749-6632.2003.tb07222.x; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Ferraris JD, 2006, CONTRIB NEPHROL, V152, P125, DOI 10.1159/000096320; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gajghate S, 2009, J BONE MINER RES, V24, P992, DOI [10.1359/JBMR.090103, 10.1359/jbmr.090103]; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Han KH, 2004, AM J PHYSIOL-RENAL, V287, pF878, DOI 10.1152/ajprenal.00047.2004; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Handler JS, 2001, NEPHRON, V87, P106, DOI 10.1159/000045897; Handler JS, 1996, KIDNEY INT, V49, P1682, DOI 10.1038/ki.1996.246; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jenq W, 1998, BIOCHEM BIOPH RES CO, V245, P804, DOI 10.1006/bbrc.1998.8518; Kasono K, 2005, NEPHROL DIAL TRANSPL, V20, P509, DOI 10.1093/ndt/gfh677; Kim JA, 2007, METHOD ENZYMOL, V428, P253, DOI 10.1016/S0076-6879(07)28014-0; King LS, 2001, NEW ENGL J MED, V345, P175, DOI 10.1056/NEJM200107193450304; Lanaspa MA, 2007, P NATL ACAD SCI USA, V104, P13672, DOI 10.1073/pnas.0702752104; Lanaspa MA, 2007, AM J PHYSIOL-RENAL, V292, pF230, DOI 10.1152/ajprenal.00075.2006; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Maunsbach AB, 1997, J AM SOC NEPHROL, V8, P1; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; NIELSEN S, 1995, AM J PHYSIOL-RENAL, V268, pF1023, DOI 10.1152/ajprenal.1995.268.6.F1023; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rim JS, 1998, J BIOL CHEM, V273, P20615, DOI 10.1074/jbc.273.32.20615; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Umenishi F, 2005, BIOCHEM BIOPH RES CO, V338, P1593, DOI 10.1016/j.bbrc.2005.10.127; Umenishi F, 2005, J AM SOC NEPHROL, V16, P600, DOI 10.1681/ASN.2004030241; Umenishi F, 2002, BIOCHEM BIOPH RES CO, V292, P771, DOI 10.1006/bbrc.2002.6709; Van Putten V, 2001, J BIOL CHEM, V276, P1226, DOI 10.1074/jbc.M003581200; VANLIEBURG AF, 1994, AM J HUM GENET, V55, P648; Wang XQ, 2009, MOL BIOL CELL, V20, P791, DOI 10.1091/mbc.E08-07-0732; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Zhao HY, 2002, AM J PHYSIOL-RENAL, V282, pF710, DOI 10.1152/ajprenal.00303.2001	46	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31694	31703		10.1074/jbc.M109.093690	http://dx.doi.org/10.1074/jbc.M109.093690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20639513	Green Published, hybrid			2022-12-27	WOS:000282764600061
J	Maehara, Y; Miyano, K; Yuzawa, S; Akimoto, R; Takeya, R; Sumimoto, H				Maehara, Yuichi; Miyano, Kei; Yuzawa, Satoru; Akimoto, Risa; Takeya, Ryu; Sumimoto, Hideki			A Conserved Region between the TPR and Activation Domains of p67(phox) Participates in Activation of the Phagocyte NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAC; RESPIRATORY BURST OXIDASE; SH3 DOMAIN; COMPONENTS P47(PHOX); NOX-FAMILY; FLAVOCYTOCHROME B(558); SUPEROXIDE-PRODUCTION; PROTEIN P40(PHOX); NAD(P)H OXIDASES; BINDING	The phagocyte NADPH oxidase, dormant in resting cells, is activated during phagocytosis to produce superoxide, a precursor of microbicidal oxidants. The membrane-integrated protein gp91(phox) serves as the catalytic core, because it contains a complete electron-transporting apparatus from NADPH to molecular oxygen for superoxide production. Activation of gp91(phox) requires the cytosolic proteins p67(phox), p47(phox), and Rac (a small GTPase). p67(phox), comprising 526 amino acids, moves upon cell stimulation to the membrane together with p47(phox) and there interacts with Rac; these processes are prerequisite for gp91(phox) activation. Here we show that a region of p67(phox) (amino acids 190-200) C-terminal to the Rac-binding domain is evolutionarily well conserved and participates in oxidase activation at a later stage in conjunction with an activation domain. Alanine substitution for Tyr-198, Leu-199, or Val-204 abrogates the ability of p67(phox) to support superoxide production by gp91(phox)-based oxidase as well as its related oxidases Nox1 and Nox3; the activation also involves other invariant residues such as Leu-193, Asp-197, and Gly-200. Intriguingly, replacement of Gln-192 by alanine or that of Tyr-198 by phenylalanine or tryptophan rather enhances superoxide production by gp91(phox)-based oxidase, suggesting a tuning role for these residues. Furthermore, the Y198A/V204A or L199A/V204A substitution leads to not only a complete loss of the activity of the reconstituted oxidase system but also a significant decrease in p67(phox) interaction with the gp91(phox) NADPH-binding domain, although these mutations affect neither the protein integrity nor the Rac binding activity. Thus the extended activation domain of p67(phox) (amino acids 190-210) containing the D(Y/F) LGK motif plays an essential role in oxidase activation probably by interacting with gp91(phox).	[Maehara, Yuichi; Miyano, Kei; Yuzawa, Satoru; Akimoto, Risa; Takeya, Ryu; Sumimoto, Hideki] Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Maehara, Yuichi; Miyano, Kei; Yuzawa, Satoru; Akimoto, Risa; Takeya, Ryu; Sumimoto, Hideki] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Sumimoto, H (corresponding author), Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp		Yuzawa, Satoru/0000-0002-1031-5781	Ministry of Education, Culture, Sports, Science and Technology of Japan; CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants-in-aid for scientific research and Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Agency.	Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Berdichevsky Y, 2007, J BIOL CHEM, V282, P22122, DOI 10.1074/jbc.M701497200; Bissonnette SA, 2008, J BIOL CHEM, V283, P2108, DOI 10.1074/jbc.M706639200; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; FINAN P, 1994, J BIOL CHEM, V269, P13752; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Grizot S, 2001, J BIOL CHEM, V276, P21627, DOI 10.1074/jbc.M100893200; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Hata K, 1997, BIOCHEM BIOPH RES CO, V241, P226, DOI 10.1006/bbrc.1997.7807; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Kao YY, 2008, J BIOL CHEM, V283, P12736, DOI 10.1074/jbc.M801010200; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LEUSEN JHW, 1995, J BIOL CHEM, V270, P11216, DOI 10.1074/jbc.270.19.11216; Maehara Y, 2009, BIOCHEM BIOPH RES CO, V379, P589, DOI 10.1016/j.bbrc.2008.12.112; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Miyano K, 2009, BIOCHEM J, V422, P373, DOI 10.1042/BJ20082182; Mizuki K, 2005, ARCH BIOCHEM BIOPHYS, V444, P185, DOI 10.1016/j.abb.2005.10.012; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; SUMIMOTO H, 2007, SCI STKE, pRE6, DOI DOI 10.1126/STKE.4012007RE6; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Taura M, 2009, BIOCHEM J, V419, P329, DOI 10.1042/BJ20082028; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Yuzawa S, 2009, J INNATE IMMUN, V1, P543, DOI 10.1159/000235656	49	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31435	31445		10.1074/jbc.M110.161166	http://dx.doi.org/10.1074/jbc.M110.161166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20679349	Green Published, hybrid			2022-12-27	WOS:000282764600038
J	Tokunaga, M; Ezoe, S; Tanaka, H; Satoh, Y; Fukushima, K; Matsui, K; Shibata, M; Tanimura, A; Oritani, K; Matsumura, I; Kanakura, Y				Tokunaga, Masahiro; Ezoe, Sachiko; Tanaka, Hirokazu; Satoh, Yusuke; Fukushima, Kentaro; Matsui, Keiko; Shibata, Masaru; Tanimura, Akira; Oritani, Kenji; Matsumura, Itaru; Kanakura, Yuzuru			BCR-ABL but Not JAK2 V617F Inhibits Erythropoiesis through the Ras Signal by Inducing p21(CIP1/WAF1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; ONCOGENE-INDUCED SENESCENCE; N-RAS; TUMOR SUPPRESSION; MEGAKARYOCYTIC DIFFERENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE; MYELOPROLIFERATIVE DISORDERS; ERYTHROID-DIFFERENTIATION; INDUCED TRANSFORMATION; NUCLEAR TRANSLOCATION	BCR-ABL is a causative tyrosine kinase (TK) of chronic myelogenous leukemia (CML). In CML patients, although myeloid cells are remarkably proliferating, erythroid cells are rather decreased and anemia is commonly observed. This phenotype is quite different from that observed in polycythemia vera (PV) caused by JAK2 V617F, whereas both oncogenic TKs activate common downstream molecules at the level of hematopoietic stem cells (HSCs). To clarify this mechanism, we investigated the effects of BCR-ABL and JAK2 V617F on erythropoiesis. Enforced expression of BCR-ABL but not of JAK2 V617F in murine LSK (Lineage(-)Sca-1(hi)CD117(hi)) cells inhibited the development of erythroid cells. Among several signaling molecules downstream of BCR-ABL, an active mutant of N-Ras (N-RasE12) but not of STAT5 or phosphatidylinositol 3-kinase (PI3-K) inhibited erythropoiesis, while N-RasE12 enhanced the development of myeloid cells. BCR-ABL activated Ras signal more intensely than JAK2 V617F, and inhibition of Ras by manumycin A, a farnesyltransferase inhibitor, ameliorated erythroid colony formation of CML cells. As for the mechanisms of Ras-induced suppression of erythropoiesis, we found that GATA-1, an erythroid-specific transcription factor, blocked Ras-mediated mitogenic signaling at the level of MEK through the direct interaction. Furthermore, enforced expression of N-RasE12 in LSK cells derived from p53-, p16(INK4a)/p19(ARF)-, and p21(CIP1/WAF1)-null/wild-type mice revealed that suppressed erythroid cell growth by N-RasE12 was restored only by p21(CIP1/WAF1) deficiency, indicating that a cyclin-dependent kinase (CDK) inhibitor, p21(CIP1/WAF1), plays crucial roles in Ras-induced suppression of erythropoiesis. These data would, at least partly, explain why respective oncogenic TKs cause different disease phenotypes.	[Ezoe, Sachiko] Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan; [Matsumura, Itaru] Kinki Univ, Sch Med, Dept Internal Med, Div Hematol, Osaka 5898511, Japan; [Shibata, Masaru; Tanimura, Akira; Oritani, Kenji; Matsumura, Itaru; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan	Osaka University; Kindai University (Kinki University); Osaka University	Ezoe, S (corresponding author), Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka 5650871, Japan.	sezoe@bldon.med.osaka-u.ac.jp		Tanimura, Akira/0000-0002-2039-5543	Ministry of Education, Science, Sports, and Culture and Technology of Japan; Grants-in-Aid for Scientific Research [21591202] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports, and Culture and Technology of Japan.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Baum KJ, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-5; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Darley RL, 2002, BLOOD, V100, P4185, DOI 10.1182/blood-2002-05-1358; Darley RL, 1997, J EXP MED, V185, P1337, DOI 10.1084/jem.185.7.1337; Delgado MD, 2000, ONCOGENE, V19, P783, DOI 10.1038/sj.onc.1203384; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Dohner K, 2008, HAEMATOL-HEMATOL J, V93, P976, DOI 10.3324/haematol.13345; Egawa K, 1999, J BIOL CHEM, V274, P14306, DOI 10.1074/jbc.274.20.14306; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Ezoe S, 2005, J BIOL CHEM, V280, P13163, DOI 10.1074/jbc.M413461200; Flotho C, 1999, LEUKEMIA, V13, P32, DOI 10.1038/sj.leu.2401240; Fukushima K, 2009, J BIOL CHEM, V284, P7719, DOI 10.1074/jbc.M807489200; GRIFFIN JD, 1983, BLOOD, V61, P85; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Jacquel A, 2006, ONCOGENE, V25, P781, DOI 10.1038/sj.onc.1209119; Jiang XY, 2002, BLOOD, V100, P3731, DOI 10.1182/blood-2002-05-1324; Khalaf WF, 2005, BLOOD, V105, P3538, DOI 10.1182/blood-2004-05-2021; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; MacKenzie KL, 1999, BLOOD, V93, P2043, DOI 10.1182/blood.V93.6.2043.406k17_2043_2056; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Matsumura I, 1996, BLOOD, V88, P3074, DOI 10.1182/blood.V88.8.3074.bloodjournal8883074; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; NEUBAUER A, 1994, LEUKEMIA, V8, P638; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; SAIKIA T, 1988, LEUKEMIA RES, V12, P499, DOI 10.1016/0145-2126(88)90117-8; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Small Donald, 2006, Hematology Am Soc Hematol Educ Program, P178; Sonoyama J, 2002, J BIOL CHEM, V277, P8076, DOI 10.1074/jbc.M111501200; Sui XW, 1998, BLOOD, V92, P1142, DOI 10.1182/blood.V92.4.1142.416k42_1142_1149; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Thiele J, 2000, LEUKEMIA LYMPHOMA, V36, P295, DOI 10.3109/10428190009148850; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Wheadon H, 2003, BLOOD, V102, P1480, DOI 10.1182/blood-2002-09-2974; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Zeuner A, 2006, BLOOD, V107, P3495, DOI 10.1182/blood-2005-07-3037; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang J, 2007, BLOOD, V109, P5238, DOI 10.1182/blood-2006-09-047050	52	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31774	31782		10.1074/jbc.M110.118653	http://dx.doi.org/10.1074/jbc.M110.118653			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663870	hybrid, Green Published			2022-12-27	WOS:000282764600069
J	Yasutake, Y; Fujii, Y; Nishioka, T; Cheon, WK; Arisawa, A; Tamura, T				Yasutake, Yoshiaki; Fujii, Yoshikazu; Nishioka, Taiki; Cheon, Woo-Kwang; Arisawa, Akira; Tamura, Tomohiro			Structural Evidence for Enhancement of Sequential Vitamin D-3 Hydroxylation Activities by Directed Evolution of Cytochrome P450 Vitamin D-3 Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; ACTIVE-SITE; COMPLEX; BINDING; P450ERYF; TRANSFORMATION; MONOOXYGENASE; CHEMISTRY; CYP105A1	Vitamin D-3 hydroxylase (Vdh) isolated from actinomycete Pseudonocardia autotrophica is a cytochrome P450 (CYP) responsible for the biocatalytic conversion of vitamin D-3 (VD3) to 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)VD3) by P. autotrophica. Although its biological function is unclear, Vdh is capable of catalyzing the two-step hydroxylation of VD3, i.e. the conversion of VD3 to 25-hydroxyvitamin D-3 (25(OH)VD3) and then of 25(OH)VD3 to 1 alpha,25(OH)(2)VD3, a hormonal form of VD3. Here we describe the crystal structures of wild-type Vdh (Vdh-WT) in the substrate-free form and of the highly active quadruple mutant (Vdh-K1) generated by directed evolution in the substrate-free, VD3-bound, and 25(OH)VD3-bound forms. Vdh-WT exhibits an open conformation with the distal heme pocket exposed to the solvent both in the presence and absence of a substrate, whereas Vdh-K1 exhibits a closed conformation in both the substrate-free and substrate-bound forms. The results suggest that the conformational equilibrium was largely shifted toward the closed conformation by four amino acid substitutions scattered throughout the molecule. The substrate-bound structure of Vdh-K1 accommodates both VD3 and 25(OH)VD3 but in an anti-parallel orientation. The occurrence of the two secosteroid binding modes accounts for the regio-selective sequential VD3 hydroxylation activities. Moreover, these structures determined before and after directed evolution, together with biochemical and spectroscopic data, provide insights into how directed evolution has worked for significant enhancement of both the VD3 25-hydroxylase and 25(OH)VD3 1 alpha-hydroxylase activities.	[Yasutake, Yoshiaki; Cheon, Woo-Kwang; Tamura, Tomohiro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido 0628517, Japan; [Fujii, Yoshikazu; Nishioka, Taiki; Tamura, Tomohiro] Hokkaido Univ, Grad Sch Agr, Lab Mol Environm Microbiol, Sapporo, Hokkaido 0608589, Japan; [Fujii, Yoshikazu; Arisawa, Akira] Mercian Corp, Bioresource Labs, Shizuoka 4380078, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University	Tamura, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, 2-17-2-1 Tsukisamu Higashi, Sapporo, Hokkaido 0628517, Japan.	t-tamura@aist.go.jp	Yasutake, Yoshiaki/H-8079-2018; Tamura, Tomohiro/M-4732-2018; Cheon, Wookwang/AAM-5839-2020	Yasutake, Yoshiaki/0000-0002-4521-7516; Tamura, Tomohiro/0000-0003-2409-6556; 	New Energy and Industrial Technology Development Organization (NEDO) of Japan	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the Development of Basic Technologies for Advanced Production Methods Using Microorganism Functions project of the New Energy and Industrial Technology Development Organization (NEDO) of Japan. Synchrotron radiation experiments were conducted under the approval of 2007G650 at Photon Factory.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COON MJ, 1992, FASEB J, V6, P669, DOI 10.1096/fasebj.6.2.1537454; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Cupp-Vickery J, 2000, P NATL ACAD SCI USA, V97, P3050, DOI 10.1073/pnas.050406897; Cupp-Vickery JR, 2001, J MOL BIOL, V311, P101, DOI 10.1006/jmbi.2001.4803; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; DeLano W.L, PYMOL MOL GRAPHICS S; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fasan R, 2008, J MOL BIOL, V383, P1069, DOI 10.1016/j.jmb.2008.06.060; Fujii Y, 2009, BIOCHEM BIOPH RES CO, V385, P170, DOI 10.1016/j.bbrc.2009.05.033; Gillam EMJ, 2008, CHEM RES TOXICOL, V21, P220, DOI 10.1021/tx7002849; Gillam EMJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P176, DOI 10.1016/j.abb.2007.04.033; Hayashi K, 2008, BIOCHEMISTRY-US, V47, P11964, DOI 10.1021/bi801222d; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Huang WC, 2007, J MOL BIOL, V373, P633, DOI 10.1016/j.jmb.2007.08.015; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Julsing MK, 2008, CURR OPIN CHEM BIOL, V12, P177, DOI 10.1016/j.cbpa.2008.01.029; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis JC, 2009, P NATL ACAD SCI USA, V106, P16550, DOI 10.1073/pnas.0908954106; LI HY, 1995, J AM CHEM SOC, V117, P6297, DOI 10.1021/ja00128a019; Li SY, 2009, P NATL ACAD SCI USA, V106, P18463, DOI 10.1073/pnas.0907203106; Li SY, 2009, J BIOL CHEM, V284, P5723, DOI 10.1074/jbc.M807592200; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mitani Y, 2005, J BACTERIOL, V187, P2582, DOI 10.1128/JB.187.8.2582-2591.2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OMURA T, 1964, J BIOL CHEM, V239, P2370; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; SASAKI J, 1992, APPL MICROBIOL BIOT, V38, P152; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Sawada N, 2000, BIOCHEM BIOPH RES CO, V273, P977, DOI 10.1006/bbrc.2000.3050; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Shimada T, 2009, CHEM RES TOXICOL, V22, P1325, DOI 10.1021/tx900127s; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Sugimoto H, 2008, BIOCHEMISTRY-US, V47, P4017, DOI 10.1021/bi7023767; TAKEDA K, 1994, J FERMENT BIOENG, V78, P380, DOI 10.1016/0922-338X(94)90285-2; Tosha T, 2003, J BIOL CHEM, V278, P39809, DOI 10.1074/jbc.M304265200; VAGIN A, 1997, A J APPL CRYSTALLOGR, V30, P1022; Villalonga R, 2007, CHEM REV, V107, P3088, DOI 10.1021/cr050253g; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Yamamoto K, 2005, J BIOL CHEM, V280, P30511, DOI 10.1074/jbc.M505244200; Yasutake Y, 2009, ACTA CRYSTALLOGR F, V65, P372, DOI 10.1107/S1744309109007829; ZHU GD, 1995, CHEM REV, V95, P1877, DOI 10.1021/cr00038a007	49	33	35	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31193	31201		10.1074/jbc.M110.147009	http://dx.doi.org/10.1074/jbc.M110.147009			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667833	hybrid, Green Published			2022-12-27	WOS:000282764600013
J	Jiang, L; Allagnat, F; Nguidjoe, E; Kamagate, A; Pachera, N; Vanderwinden, JM; Brini, M; Carafoli, E; Eizirik, DL; Cardozo, AK; Herchuelz, A				Jiang, Lin; Allagnat, Florent; Nguidjoe, Evrard; Kamagate, Adama; Pachera, Nathalie; Vanderwinden, Jean-Marie; Brini, Marisa; Carafoli, Ernesto; Eizirik, Decio L.; Cardozo, Alessandra K.; Herchuelz, Andre			Plasma Membrane Ca2+-ATPase Overexpression Depletes Both Mitochondrial and Endoplasmic Reticulum Ca2+ Stores and Triggers Apoptosis in Insulin-secreting BRIN-BD11 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; CYTOSOLIC CA2+; INDUCED OSCILLATIONS; CYTOPLASMIC CA-2+; GLUCOSE; EXOCYTOSIS; STRESS; AEQUORIN; DEATH; LINE	Ca2+ may trigger apoptosis in beta-cells. Hence, the control of intracellular Ca2+ may represent a potential approach to prevent beta-cell apoptosis in diabetes. Our objective was to investigate the effect and mechanism of action of plasma membrane Ca2+-ATPase (PMCA) overexpression on Ca2+-regulated apoptosis in clonal beta-cells. Clonal beta-cells (BRIN-BD11) were examined for the effect of PMCA overexpression on cytosolic and mitochondrial [Ca2+] using a combination of aequorins with different Ca2+ affinities and on the ER and mitochondrial pathways of apoptosis. beta-cell stimulation generated microdomains of high [Ca2+] in the cytosol and subcellular heterogeneities in [Ca2+] among mitochondria. Overexpression of PMCA decreased [Ca2+] in the cytosol, the ER, and the mitochondria and activated the IRE1 alpha-XBP1s but inhibited the PRKR-like ER kinase-eIF2 alpha and the ATF6-BiP pathways of the ER-unfolded protein response. Increased Bax/Bcl-2 expression ratio was observed in PMCA overexpressing beta-cells. This was followed by Bax translocation to the mitochondria with subsequent cytochrome c release, opening of the permeability transition pore, and apoptosis. In conclusion, clonal beta-cell stimulation generates microdomains of high [Ca2+] in the cytosol and subcellular heterogeneities in [Ca2+] among mitochondria. PMCA overexpression depletes intracellular [Ca2+] stores and, despite a decrease in mitochondrial [Ca2+], induces apoptosis through the mitochondrial pathway. These data open the way to new strategies to control cellular Ca2+ homeostasis that could decrease beta-cell apoptosis in diabetes.	[Jiang, Lin; Nguidjoe, Evrard; Kamagate, Adama; Pachera, Nathalie; Herchuelz, Andre] Univ Libre Bruxelles, Fac Med, Lab Pharmacodynamie & Therapeut, B-1070 Brussels, Belgium; [Allagnat, Florent; Eizirik, Decio L.; Cardozo, Alessandra K.] Univ Libre Bruxelles, Fac Med, Expt Med Lab, B-1070 Brussels, Belgium; [Vanderwinden, Jean-Marie] Univ Libre Bruxelles, Fac Med, Neurophysiol Lab, B-1070 Brussels, Belgium; [Brini, Marisa] Univ Padua, Dept Biochem, I-35131 Padua, Italy; [Carafoli, Ernesto] Venetian Inst Mol Med, I-35131 Padua, Italy	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Padua; Veneto Institute Molecular Medicine	Herchuelz, A (corresponding author), Univ Libre Bruxelles, Fac Med, Lab Pharmacodynamie & Therapeut, Route Lennik,808,Batiment GE, B-1070 Brussels, Belgium.	herchu@ulb.ac.be	Carafoli, Ernesto/K-5192-2016; Allagnat, Florent/A-4471-2017; Allagnat, Florent/AAY-7188-2021; Allagnat, Florent/X-3772-2019; Brini, Marisa/K-5189-2016	Carafoli, Ernesto/0000-0002-7826-0094; Allagnat, Florent/0000-0001-6528-679X; Allagnat, Florent/0000-0001-6528-679X; NGUIDJOE, Evrard/0000-0002-5546-2259; Kupper Cardozo, Alessandra/0000-0001-7143-3696; Brini, Marisa/0000-0001-5141-0243	Belgian Fund for Scientific Research [3.4593.04, 3.4527.08]; European Foundation for the Study of Diabetes/Novo Nordisk Programme in Diabetes Research [2005/6]; Juvenile Diabetes Research Foundation International [1-2008-536]; Communaute Francaise de Belgique (Actions de Recherche Concertees); European Union; Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State [IUAP P6/40]; Credit de Relations Internationales de l'Universite Libre de Bruxelles	Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); European Foundation for the Study of Diabetes/Novo Nordisk Programme in Diabetes Research; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Communaute Francaise de Belgique (Actions de Recherche Concertees); European Union(European Commission); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; Credit de Relations Internationales de l'Universite Libre de Bruxelles	This work has been supported by grants from the Belgian Fund for Scientific Research (Fonds Recherche Scientifique Medicale 3.4593.04 and 3.4527.08), the European Foundation for the Study of Diabetes/Novo Nordisk Programme in Diabetes Research (2005/6), the Juvenile Diabetes Research Foundation International (1-2008-536), the Communaute Francaise de Belgique (Actions de Recherche Concertees), the European Union (Integrated Project Naimit (FP7) of the European Community), and the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (IUAP P6/40).; Supported by a fellowship from the "Credit de Relations Internationales de l'Universite Libre de Bruxelles."	Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BOKVIST K, 1995, EMBO J, V14, P50, DOI 10.1002/j.1460-2075.1995.tb06974.x; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; BRINI M, 1994, CELL CALCIUM, V16, P259, DOI 10.1016/0143-4160(94)90089-2; Brini M, 2008, METHODS, V46, P160, DOI 10.1016/j.ymeth.2008.09.011; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Diaz-Horta O, 2002, DIABETES, V51, P1815, DOI 10.2337/diabetes.51.6.1815; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; GRAPENGIESSER E, 1988, BIOCHEM BIOPH RES CO, V151, P1299, DOI 10.1016/S0006-291X(88)80503-5; GYLFE E, 1991, CELL CALCIUM, V12, P229, DOI 10.1016/0143-4160(91)90023-8; HERCHUELZ A, 1991, CELL CALCIUM, V12, P577, DOI 10.1016/0143-4160(91)90076-Q; HERCHUELZ A, 1981, DIABETES METAB, V7, P283; Jeffs GJ, 2008, EXP NEUROL, V210, P268, DOI 10.1016/j.expneurol.2007.10.013; Kamagate A, 2002, DIABETES, V51, P2773, DOI 10.2337/diabetes.51.9.2773; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Mehmet H, 2000, NATURE, V403, P29, DOI 10.1038/47377; Molinaro P, 2008, J NEUROSCI, V28, P1179, DOI 10.1523/JNEUROSCI.4671-07.2008; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakazaki M, 1998, DIABETOLOGIA, V41, P279, DOI 10.1007/s001250050904; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pinton P, 2002, J BIOL CHEM, V277, P37702, DOI 10.1074/jbc.M204478200; Pirot P, 2006, DIABETOLOGIA, V49, P1229, DOI 10.1007/s00125-006-0214-7; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Quesada I, 2000, J PHYSIOL-LONDON, V525, P159, DOI 10.1111/j.1469-7793.2000.t01-1-00159.x; Quesada I, 2008, CELL CALCIUM, V43, P39, DOI 10.1016/j.ceca.2007.03.001; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sokolow S, 2004, J CLIN INVEST, V113, P265, DOI 10.1172/JCI200418688; Takahashi N, 1997, J CELL BIOL, V138, P55, DOI 10.1083/jcb.138.1.55; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; THELER JM, 1992, J BIOL CHEM, V267, P18110; Van Eylen F, 1998, DIABETES, V47, P1873, DOI 10.2337/diabetes.47.12.1873; WANG JL, 1990, BIOCHEM BIOPH RES CO, V166, P813, DOI 10.1016/0006-291X(90)90882-N; WOLLHEIM CB, 1987, BIOSCIENCE REP, V7, P443, DOI 10.1007/BF01362507	48	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30634	30643		10.1074/jbc.M110.116681	http://dx.doi.org/10.1074/jbc.M110.116681			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20660595	hybrid, Green Published			2022-12-27	WOS:000282135500032
J	Wiemuth, D; Grunder, S				Wiemuth, Dominik; Gruender, Stefan			A Single Amino Acid Tunes Ca2+ Inhibition of Brain Liver Intestine Na+ Channel (BLINaC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; 3 HOMOLOGOUS SUBUNITS; FUNCTIONAL EXPRESSION; SODIUM-CHANNEL; MOLECULAR-CLONING; ALPHA-SUBUNIT; FAMILY; IDENTIFICATION; ION-CHANNEL-1; SYSTEM	Ion channels of the degenerin/epithelial Na+ channel gene family are Na+ channels that are blocked by the diuretic amiloride and are implicated in several human diseases. The brain liver intestine Na+ channel (BLINaC) is an ion channel of the degenerin/epithelial Na+ channel gene family with unknown function. In rodents, it is expressed mainly in brain, liver, and intestine, and to a lesser extent in kidney and lung. Expression of rat BLINaC (rBLINaC) in Xenopus oocytes leads to small un-selective currents that are only weakly sensitive to amiloride. Here, we show that rBLINaC is inhibited by micromolar concentrations of extracellular Ca2+. Removal of Ca2+ leads to robust currents and increases Na+ selectivity of the ion pore. Strikingly, the species ortholog from mouse (mBLINaC) has an almost 250-fold lower Ca2+ affinity than rBLINaC, rendering mBLINaC constitutively active at physiological concentrations of extracellular Ca2+. In addition, mBLINaC is more selective for Na+ and has a 700-fold higher amiloride affinity than rBLINaC. We show that a single amino acid in the extracellular domain determines these profound species differences. Collectively, our results suggest that rBLINaC is opened by an unknown ligand whereas mBLINaC is a constitutively open epithelial Na+ channel.	[Wiemuth, Dominik; Gruender, Stefan] Rhein Westfal TH Aachen, Dept Physiol, D-52074 Aachen, Germany	RWTH Aachen University	Grunder, S (corresponding author), Rhein Westfal TH Aachen, Dept Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	sgruender@ukaachen.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883				Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Grunder S, 1999, PFLUG ARCH EUR J PHY, V438, P709, DOI 10.1007/s004240051097; Grunder S, 2000, CHANNELOPATHIES - COMMON MECHANISMS IN AURA, ARRHYTHMIA AND ALKALOSIS, P277, DOI 10.1016/B978-044450489-0/50013-6; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Madeja M, 1995, J NEUROSCI METH, V63, P211, DOI 10.1016/0165-0270(95)00094-1; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sluka KA, 2009, CURR OPIN DRUG DISC, V12, P693; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	29	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30404	30410		10.1074/jbc.M110.153064	http://dx.doi.org/10.1074/jbc.M110.153064			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20656685	Green Published, hybrid			2022-12-27	WOS:000282135500006
J	Ueno, T; Tanaka, K; Kaneko, K; Taga, Y; Sata, T; Irie, S; Hattori, S; Ogawa-Goto, K				Ueno, Tomonori; Tanaka, Keisuke; Kaneko, Keiko; Taga, Yuki; Sata, Tetsutaro; Irie, Shinkichi; Hattori, Shunji; Ogawa-Goto, Kiyoko			Enhancement of Procollagen Biosynthesis by p180 through Augmented Ribosome Association on the Endoplasmic Reticulum in Response to Stimulated Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCALE IDENTIFICATION; GENE-EXPRESSION; ASCORBIC-ACID; COLLAGEN; PROTEINS; RECEPTOR; GOLGI; PROLIFERATION; CELLS; ACCUMULATION	A coiled-coil microtubule-bundling protein, p180, was originally reported as a ribosome-binding protein on the rough endoplasmic reticulum (ER) and is highly expressed in secretory tissues. Recently, we reported a novel role for p180 in the trans-Golgi network (TGN) expansion following stimulated collagen secretion. Here, we show that p180 plays a key role in procollagen biosynthesis and secretion in diploid fibroblasts. Depletion of p180 caused marked reductions of secreted collagens without significant loss of the ER membrane or mRNA. Metabolic labeling experiments revealed that the procollagen biosynthetic activity was markedly affected following p180 depletion. Moreover, loss of p180 perturbs ascorbate-stimulated de novo biosynthesis mainly in the membrane fraction with a preferential secretion defect of large proteins. At the EM level, one of the most prominent morphological features of p180-depleted cells was insufficient ribosome association on the ER membranes. In contrast, the ER of control cells was studded with numerous ribosomes, which were further enhanced by ascorbate. Similarly biochemical analysis confirmed that levels of membrane-bound ribosomes were altered in a p180-dependent manner. Taken together, our data suggest that p180 plays crucial roles in enhancing collagen biosynthesis at the entry site of the secretory compartments by a novel mechanism that mainly involves facilitating ribosome association on the ER.	[Ueno, Tomonori; Tanaka, Keisuke; Taga, Yuki; Irie, Shinkichi; Hattori, Shunji; Ogawa-Goto, Kiyoko] Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan; [Kaneko, Keiko; Sata, Tetsutaro; Ogawa-Goto, Kiyoko] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Irie, Shinkichi; Hattori, Shunji; Ogawa-Goto, Kiyoko] Japan Inst Leather Res, Adachi Ku, Tokyo 1208601, Japan	National Institute of Infectious Diseases (NIID)	Ogawa-Goto, K (corresponding author), Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan.	kgoto@nippi-inc.co.jp	Taga, Yuki/I-2781-2019	Taga, Yuki/0000-0001-9100-758X				Bai JZ, 2008, CELL BIOL INT, V32, P473, DOI 10.1016/j.cellbi.2007.10.002; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Benyamini P, 2009, MOL BIOL CELL, V20, P732, DOI 10.1091/mbc.E08-07-0682; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; BREUL SD, 1980, J BIOL CHEM, V255, P5250; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CARDINALE GJ, 1974, ADV ENZYMOL RAMB, V41, P245; CHAN D, 1990, BIOCHEM J, V269, P175, DOI 10.1042/bj2690175; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Diehn M, 2006, PLOS GENET, V2, P39, DOI 10.1371/journal.pgen.0020011; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103; Hattori S, 2002, ANAL BIOCHEM, V301, P27, DOI 10.1006/abio.2001.5479; Hyde M, 2002, J CELL BIOL, V156, P993, DOI 10.1083/jcb.200112008; KUROSAKA D, 1994, J BIOCHEM-TOKYO, V115, P853, DOI 10.1093/oxfordjournals.jbchem.a124429; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; LEVENE CI, 1975, ANN NY ACAD SCI, V258, P288, DOI 10.1111/j.1749-6632.1975.tb29289.x; Lindquist JN, 2004, J BIOL CHEM, V279, P23822, DOI 10.1074/jbc.M314060200; MARCHI F, 1984, J CELL BIOL, V98, P1705, DOI 10.1083/jcb.98.5.1705; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Ogawa-Goto K, 2002, J VIROL, V76, P2350, DOI 10.1128/JVI.76.5.2350-2362.2002; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; SCHWARZ RI, 1993, NUTRITION GENE EXPRE, P483; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; SULLIVAN TA, 1994, J BIOL CHEM, V269, P22500; Thiele BJ, 2004, CIRC RES, V95, P1058, DOI 10.1161/01.RES.0000149166.33833.08; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; TRELSTAD RL, 1979, DEV BIOL, V71, P228, DOI 10.1016/0012-1606(79)90166-0; Ueno T, 2010, EXP CELL RES, V316, P329, DOI 10.1016/j.yexcr.2009.11.009; WANKER EE, 1995, J CELL BIOL, V130, P29, DOI 10.1083/jcb.130.1.29	40	32	34	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29941	29950		10.1074/jbc.M109.094607	http://dx.doi.org/10.1074/jbc.M109.094607			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647306	Green Published, hybrid			2022-12-27	WOS:000281984300031
J	Gattis, SG; Hernick, M; Fierke, CA				Gattis, Samuel G.; Hernick, Marcy; Fierke, Carol A.			Active Site Metal Ion in UDP-3-O-((R)-3-Hydroxymyristoyl)-N-acetylglucosamine Deacetylase (LpxC) Switches between Fe(II) and Zn(II) Depending on Cellular Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI UDP-3-O-(R-3-HYDROXYMYRISTOYL)-N-ACETYLGLUCOSAMINE DEACETYLASE; ESCHERICHIA-COLI; PEPTIDE DEFORMYLASE; CARBONIC-ANHYDRASE; MOLECULAR RECOGNITION; ANTIBIOTIC-ACTIVITY; CRYSTAL-STRUCTURE; IRON TRANSPORT; LABILE IRON; ZINC	UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) catalyzes the deacetylation of UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine to form UDP-3-O-myristoylglucosamine and acetate in Gram-negative bacteria. This second, and committed, step in lipid A biosynthesis is a target for antibiotic development. LpxC was previously identified as a mononuclear Zn(II) metalloenzyme; however, LpxC is 6-8-fold more active with the oxygen-sensitive Fe(II) cofactor (Hernick, M., Gattis, S. G., Penner-Hahn, J. E., and Fierke, C. A. (2010) Biochemistry 49, 2246-2255). To analyze the native metal cofactor bound to LpxC, we developed a pulldown method to rapidly purify tagged LpxC under anaerobic conditions. The metal bound to LpxC purified from Escherichia coli grown in minimal medium is mainly Fe(II). However, the ratio of iron/zinc bound to LpxC varies with the metal content of the medium. Furthermore, the iron/zinc ratio bound to native LpxC, determined by activity assays, has a similar dependence on the growth conditions. LpxC has significantly higher affinity for Zn(II) compared with Fe(II) with K-D values of 60 +/- 20 pM and 110 +/- 40 nM, respectively. However, in vivo concentrations of readily exchangeable iron are significantly higher than zinc, suggesting that Fe(II) is the thermodynamically favored metal cofactor for LpxC under cellular conditions. These data indicate that LpxC expressed in E. coli grown in standard medium predominantly exists as the Fe(II)-enzyme. However, the metal cofactor in LpxC can switch between iron and zinc in response to perturbations in available metal ions. This alteration may be important for regulating the LpxC activity upon changes in environmental conditions and may be a general mechanism of regulating the activity of metalloenzymes.	[Gattis, Samuel G.; Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Hernick, Marcy; Fierke, Carol A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fierke, CA (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	fierke@umich.edu		Hernick, Marcy/0000-0002-2839-5767	National Institutes of Health [GM40602]; NIGMS [GM07767]; Cystic Fibrosis Foundation [HERNIC05F0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767, R01GM040602, R29GM040602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM40602 (to C. A. F.) and PSTP Training Grant GM07767 (to S. G. G.) from NIGMS. This work was also supported by the Cystic Fibrosis Foundation Grant HERNIC05F0 (to M. H.).	Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; BEALL B, 1987, J BACTERIOL, V169, P5408, DOI 10.1128/jb.169.12.5408-5415.1987; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Campos-Bermudez VA, 2010, J INORG BIOCHEM, V104, P726, DOI 10.1016/j.jinorgbio.2010.03.005; Chan MK, 1997, BIOCHEMISTRY-US, V36, P13904, DOI 10.1021/bi9711543; D'souza VM, 1999, BIOCHEMISTRY-US, V38, P11079, DOI 10.1021/bi990872h; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Groche D, 1998, BIOCHEM BIOPH RES CO, V246, P342, DOI 10.1006/bbrc.1998.8616; Grzyska PK, 2007, J INORG BIOCHEM, V101, P797, DOI 10.1016/j.jinorgbio.2007.01.011; Hernick M, 2005, ARCH BIOCHEM BIOPHYS, V433, P71, DOI 10.1016/j.abb.2004.08.006; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Hernick M, 2006, BIOCHEMISTRY-US, V45, P14573, DOI 10.1021/bi061625y; Hernick M, 2006, BIOCHEMISTRY-US, V45, P15240, DOI 10.1021/bi061405k; Hernick M, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P547; Hernick M, 2010, BIOCHEMISTRY-US, V49, P2246, DOI 10.1021/bi902066t; Hunt JA, 1999, BIOCHEMISTRY-US, V38, P9054, DOI 10.1021/bi9900166; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; Jackman JE, 2000, J BIOL CHEM, V275, P11002, DOI 10.1074/jbc.275.15.11002; Jain RK, 2005, J AM CHEM SOC, V127, P4558, DOI 10.1021/ja0503074; KIEFER LL, 1994, BIOCHEMISTRY-US, V33, P15233, DOI 10.1021/bi00255a003; LIPPARD SJ, 1994, PRINCIPLES BIOINORGA, P21; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Manocha S, 2002, EXPERT OPIN INV DRUG, V11, P1795, DOI 10.1517/13543784.11.12.1795; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; McCall KA, 2004, BIOCHEMISTRY-US, V43, P3979, DOI 10.1021/bi0498914; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P1106, DOI 10.1021/bi048001h; Mdluli KE, 2006, ANTIMICROB AGENTS CH, V50, P2178, DOI 10.1128/AAC.00140-06; Meguro R, 2007, ARCH HISTOL CYTOL, V70, P1, DOI 10.1679/aohc.70.1; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; NILSSON B, 1991, METHOD ENZYMOL, V198, P3; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; PORTER DJT, 1993, J BIOL CHEM, V268, P24005; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rajagopalan PTR, 1997, J AM CHEM SOC, V119, P12418, DOI 10.1021/ja9734096; Rajagopalan PTR, 1998, J BIOL CHEM, V273, P22305, DOI 10.1074/jbc.273.35.22305; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; ROMANS AY, 1978, BIOINORG CHEM, V9, P217, DOI 10.1016/S0006-3061(78)80007-6; Seffernick JL, 2002, BIOCHEMISTRY-US, V41, P14430, DOI 10.1021/bi020415s; Tottey S, 2005, ACCOUNTS CHEM RES, V38, P775, DOI 10.1021/ar0300118; Tripp BC, 2004, J BIOL CHEM, V279, P6683, DOI 10.1074/jbc.M311648200; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; White RJ, 2003, CURR OPIN PHARMACOL, V3, P502, DOI 10.1016/S1471-4892(03)00115-2; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Wyckoff TJO, 1998, TRENDS MICROBIOL, V6, P154, DOI 10.1016/S0966-842X(98)01230-X; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; Zhu JG, 2003, BIOCHEMISTRY-US, V42, P4717, DOI 10.1021/bi034289j	60	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33788	33796		10.1074/jbc.M110.147173	http://dx.doi.org/10.1074/jbc.M110.147173			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20709752	Green Published, hybrid			2022-12-27	WOS:000283354000025
J	Gerin, I; Clerbaux, LA; Haumont, O; Lanthier, N; Das, AK; Burant, CF; Leclercq, IA; MacDougald, OA; Bommer, GT				Gerin, Isabelle; Clerbaux, Laure-Alix; Haumont, Olivier; Lanthier, Nicolas; Das, Arun K.; Burant, Charles F.; Leclercq, Isabelle A.; MacDougald, Ormond A.; Bommer, Guido T.			Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRIFUNCTIONAL PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; HEPATIC STEATOSIS; TRANSGENIC MICE; MESSENGER-RNAS; MALONYL-COA; ABCA1 GENE; MICRORNAS; EFFLUX; REPRESSION	The regulation of synthesis, degradation, and distribution of lipids is crucial for homeostasis of organisms and cells. The sterol regulatory element-binding protein (SREBP) transcription factor family is post-translationally activated in situations of reduced lipid abundance and activates numerous genes involved in cholesterol, fatty acid, and phospholipid synthesis. In this study, we provide evidence that the primary transcript of SREBP2 contains an intronic miRNA (miR-33) that reduces cellular cholesterol export via inhibition of translation of the cholesterol export pump ABCA1. Notably, miR-33 also inhibits translation of several transcripts encoding proteins involved in fatty acid beta-oxidation including CPT1A, HADHB, and CROT, thereby reducing fatty acid degradation. The genetic locus encoding SREBP2 and miR-33 therefore contains a protein that increases lipid synthesis and a miRNA that prevents export and degradation of newly synthesized lipids. These results add an additional layer of complexity to our understanding of lipid homeostasis and might open possibilities for future therapeutic intervention.	[Bommer, Guido T.] Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, B-1200 Brussels, Belgium; [Lanthier, Nicolas; Leclercq, Isabelle A.] Catholic Univ Louvain, Dept Gastroenterol, B-1200 Brussels, Belgium; [Das, Arun K.; Burant, Charles F.; MacDougald, Ormond A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Universite Catholique Louvain; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Michigan System; University of Michigan	Bommer, GT (corresponding author), Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	guido.bommer@uclouvain.be	Burant, Charles/GPC-5690-2022; Lanthier, Nicolas/AAT-2930-2021; Bommer, Guido/A-8425-2011	Burant, Charles/0000-0001-9189-5003; Lanthier, Nicolas/0000-0002-7651-9314; MacDougald, Ormond/0000-0001-6907-7960; Das, Arun/0000-0002-0883-1816; Bommer, Guido/0000-0001-6898-4884; Clerbaux, Laure-Alix/0000-0003-2707-482X	Region-Bruxelles-Capitales; Fonds Speciaux de Recherche - Universite Catholique de Louvain; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); Belgian Science Policy; Fonds de la Recherche Scientifique; de Duve Institute; National Institute of Health [DK51563]; Michigan Nutrition Obesity Research Center [5P30DK089503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051563, P30DK089503] Funding Source: NIH RePORTER	Region-Bruxelles-Capitales; Fonds Speciaux de Recherche - Universite Catholique de Louvain; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy(Belgian Federal Science Policy Office); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); de Duve Institute; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Brains-Back-to-Brussels grant of the Region-Bruxelles-Capitales (to G. T. B.), by a fellowship of the Fonds Speciaux de Recherche - Universite Catholique de Louvain (FRS-UCL) and the Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) (to L.-A. C.), by a return grant of the Belgian Science Policy (to I. G.), by a grant of the Fonds de la Recherche Scientifique (to I. A. L.), by funds from the de Duve Institute (to G. T. B.), by the National Institute of Health Grant DK51563 (to O. A. M.), and the Michigan Nutrition Obesity Research Center Grant 5P30DK089503 (to C. F. B.).	ABHAIRD NN, 1992, BIOCHEM J, V286, P637, DOI 10.1042/bj2860637; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Brunham LR, 2008, JAMA-J AM MED ASSOC, V300, P1997, DOI 10.1001/jama.2008.539; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590; KANNEL WB, 1983, AM J CARDIOL, V52, pB9, DOI 10.1016/0002-9149(83)90649-5; Kao HJ, 2006, HUM MOL GENET, V15, P3569, DOI 10.1093/hmg/ddl433; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Morash AJ, 2010, AM J PHYSIOL-REG I, V299, pR579, DOI 10.1152/ajpregu.00088.2010; Morillas M, 2000, BIOCHEM J, V351, P495, DOI 10.1042/0264-6021:3510495; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Pantano L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1127; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Sambrook J., 2001, MOL CLONING LAB MANU; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Singaraja RR, 2006, ARTERIOSCL THROM VAS, V26, P1821, DOI 10.1161/01.ATV.0000229219.13757.a2; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Tubb MR, 2009, J LIPID RES, V50, P1497, DOI 10.1194/jlr.D900003-JLR200; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; White T, 1998, ANAL BIOCHEM, V258, P109, DOI 10.1006/abio.1997.2545; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372	58	273	300	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33652	33661		10.1074/jbc.M110.152090	http://dx.doi.org/10.1074/jbc.M110.152090			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732877	Green Published, hybrid			2022-12-27	WOS:000283354000010
J	Chandrakesan, P; Ahmed, I; Anwar, T; Wang, Y; Sarkar, S; Singh, P; Peleg, S; Umar, S				Chandrakesan, Parthasarathy; Ahmed, Ishfaq; Anwar, Tariq; Wang, Yu; Sarkar, Shubhashish; Singh, Pomila; Peleg, Sara; Umar, Shahid			Novel Changes in NF-kappa B Activity during Progression and Regression Phases of Hyperplasia ROLE OF MEK, ERK, AND p38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; HYPERPROLIFERATING COLONIC EPITHELIA; RIBOSOMAL S6 KINASE; CITROBACTER-RODENTIUM INFECTION; IN-VIVO; BETA-CATENIN; DEPENDENT TRANSCRIPTION; INDEPENDENT MECHANISM; SIGNALING PATHWAYS; MUCOSAL INFECTION	Utilizing the Citrobacter rodentium-induced transmissible murine colonic hyperplasia (TMCH) model, we measured hyperplasia and NF-kappa B activation during progression (days 6 and 12 post-infection) and regression (days 20-34 post-infection) phases of TMCH. NF-kappa B activity increased at progression in conjunction with bacterial attachment and translocation to the colonic crypts and decreased 40% by day 20. NF-kappa B activity at days 27 and 34, however, remained 2-3-fold higher than uninfected control. Expression of the downstream target gene CXCL-1/KC in the crypts correlated with NF-kappa B activation kinetics. Phosphorylation of cellular I kappa B alpha kinase (IKK)alpha/beta (Ser(176/180)) was elevated during progression and regression of TMCH. Phosphorylation (Ser(32/36)) and degradation of I kappa B alpha, however, contributed to NF-kappa B activation only from days 6 to 20 but not at later time points. Phosphorylation of MEK1/2 (Ser(217/221)), ERK1/2 (Thr(202)/Tyr(204)), and p38 (Thr(180)/Tyr(182)) paralleled IKK alpha/beta kinetics at days 6 and 12 without declining with regressing hyperplasia. siRNAs to MEK, ERK, and p38 significantly blocked NF-kappa B activity in vitro, whereas MEK1/2-inhibitor (PD98059) also blocked increases in MEK1/2, ERK1/2, and IKK alpha/beta thereby inhibiting NF-kappa B activity in vivo. Cellular and nuclear levels of Ser(536)-phosphorylated (p65(536)) and Lys(310)-acetylated p65 subunit accompanied functional NF-kappa B activation during TMCH. RSK-1 phosphorylation at Thr(359)/Ser(363) in cellular/nuclear extracts and co-immuno-precipitation with cellular p65-NF-kappa B overlapped with p65(536) kinetics. Dietary pectin (6%) blocked NF-kappa B activity by blocking increases in p65 abundance and nuclear translocation thereby down-regulating CXCL-1/KC expression in the crypts. Thus, NF-kappa B activation persisted despite the lack of bacterial attachment to colonic mucosa beyond peak hyperplasia. The MEK/ERK/p38 pathway therefore seems to modulate sustained activation of NF-kappa B in colonic crypts in response to C. rodentium infection.	[Umar, Shahid] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Div Digest Dis & Nutr, Oklahoma City, OK 73104 USA; [Anwar, Tariq] Univ Ulster, Ctr Mol Biosci, Coleraine BT52 1SA, Londonderry, North Ireland; [Wang, Yu] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Sarkar, Shubhashish; Singh, Pomila] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Peleg, Sara] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormone Disorder Res, Houston, TX 77030 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Ulster University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center	Umar, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Div Digest Dis & Nutr, 975 NE 10th St, Oklahoma City, OK 73104 USA.	Shahid-Umar@ouhsc.edu	Chandrakesan, Parthasarathy/AAB-9136-2020	Chandrakesan, Parthasarathy/0000-0002-7587-9553	National Institutes of Health [R01 CA131413, R01 CA 97959, CA114264, R21 CA131936]; NCI; NATIONAL CANCER INSTITUTE [R01CA114264, R01CA097959, R21CA131936, R01CA131413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA131413 (to S. U.) and R01 CA 97959, CA114264 (to P. S.), and R21 CA131936 (to S. P.) from the NCI.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; BARTHOLD SW, 1976, LAB ANIM SCI, V26, P889; BARTHOLD SW, 1977, CANCER RES, V37, P4352; BLOBE GC, 1994, CANCER METAST REV, V13, P411, DOI 10.1007/BF00666107; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Bry L, 2006, INFECT IMMUN, V74, P673, DOI 10.1128/IAI.74.1.673-681.2006; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Dennis A, 2008, INFECT IMMUN, V76, P4978, DOI 10.1128/IAI.00736-08; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kuang E, 2009, J BIOL CHEM, V284, P13958, DOI 10.1074/jbc.M900025200; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Luperchio SA, 2001, MICROBES INFECT, V3, P333, DOI 10.1016/S1286-4579(01)01387-9; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; MacDonald TT, 2003, INT J MED MICROBIOL, V293, P87, DOI 10.1078/1438-4221-00247; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; PEIFER M, 1995, TRENDS CELL BIOL, V5, P224, DOI 10.1016/S0962-8924(00)89015-7; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; RISIO M, 1991, CANCER RES, V51, P1917; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Stewart DB, 1997, J BIOL CHEM, V272, P29652, DOI 10.1074/jbc.272.47.29652; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Umar S, 2008, ONCOGENE, V27, P5599, DOI 10.1038/onc.2008.169; Umar S, 2005, ONCOGENE, V24, P6709, DOI 10.1038/sj.onc.1208820; Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x; Umar S, 2000, AM J PHYSIOL-GASTR L, V278, pG765, DOI 10.1152/ajpgi.2000.278.5.G765; Umar S, 2000, AM J PHYSIOL-GASTR L, V279, pG223, DOI 10.1152/ajpgi.2000.279.1.G223; Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006; Umar S, 2009, J BIOL CHEM, V284, P22274, DOI 10.1074/jbc.M109.020941; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; VOGELSTEIN B, 1994, COLD SPRING HARB SYM, V59, P517, DOI 10.1101/SQB.1994.059.01.057; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	58	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33485	33498		10.1074/jbc.M110.129353	http://dx.doi.org/10.1074/jbc.M110.129353			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20710027	hybrid, Green Published			2022-12-27	WOS:000283048200083
J	Iizasa, H; Wulff, BE; Alla, NR; Maragkakis, M; Megraw, M; Hatzigeorgiou, A; Iwakiri, D; Takada, K; Wiedmer, A; Showe, L; Lieberman, P; Nishikura, K				Iizasa, Hisashi; Wulff, Bjorn-Erik; Alla, Nageswara R.; Maragkakis, Manolis; Megraw, Molly; Hatzigeorgiou, Artemis; Iwakiri, Dai; Takada, Kenzo; Wiedmer, Andreas; Showe, Louise; Lieberman, Paul; Nishikura, Kazuko			Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKITTS-LYMPHOMA CELLS; NASOPHARYNGEAL CARCINOMA; MICROPROCESSOR COMPLEX; HUMAN TRANSCRIPTOME; HUMAN BRAIN; RNA; EXPRESSION; BIOGENESIS; IDENTIFICATION; MIRNA	Certain primary transcripts of miRNA (pri-microRNAs) undergo RNA editing that converts adenosine to inosine. The Epstein-Barr virus (EBV) genome encodes multiple microRNA genes of its own. Here we report that primary transcripts of ebv-miR-BART6 (pri-miR-BART6) are edited in latently EBV-infected cells. Editing of wild-type pri-miR-BART6 RNAs dramatically reduced loading of miR-BART6-5p RNAs onto the microRNA-induced silencing complex. Editing of a mutation-containing pri-miR-BART6 found in Daudi Burkitt lymphoma and nasopharyngeal carcinoma C666-1 cell lines suppressed processing of miR-BART6 RNAs. Most importantly, miR-BART6-5p RNAs silence Dicer through multiple target sites located in the 3'-UTR of Dicer mRNA. The significance of miR-BART6 was further investigated in cells in various stages of latency. We found that miR-BART6-5p RNAs suppress the EBNA2 viral oncogene required for transition from immunologically less responsive type I and type II latency to the more immunoreactive type III latency as well as Zta and Rta viral proteins essential for lytic replication, revealing the regulatory function of miR-BART6 in EBV infection and latency. Mutation and A-to-I editing appear to be adaptive mechanisms that antagonize miR-BART6 activities.	[Iizasa, Hisashi; Wulff, Bjorn-Erik; Alla, Nageswara R.; Wiedmer, Andreas; Showe, Louise; Lieberman, Paul; Nishikura, Kazuko] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Iizasa, Hisashi; Iwakiri, Dai; Takada, Kenzo] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; [Maragkakis, Manolis; Hatzigeorgiou, Artemis] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Oncol, Vari 16672, Greece; [Maragkakis, Manolis] Univ Halle Wittenberg, Inst Comp Sci, D-06120 Halle, Germany; [Megraw, Molly] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	The Wistar Institute; Hokkaido University; Alexander Fleming Biomedical Sciences Research Center; Martin Luther University Halle Wittenberg; University of Pennsylvania	Nishikura, K (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	kazuko@wistar.org	Maragkakis, Manolis/AAN-3407-2020; Iizasa, Hisashi/A-9821-2012; Takada, Kenzo/A-6666-2012; Megraw, Molly/D-1988-2009; Maragkakis, Emmanouil/F-5427-2010; Hatzigeorgiou, Artemis/Z-1976-2019; Alla, Nageswara/R-5202-2019	Maragkakis, Manolis/0000-0002-3158-1763; Maragkakis, Emmanouil/0000-0002-3158-1763; Megraw, Molly/0000-0001-6793-6151	National Institutes of Health [CA010815, GM040536, HL099342]; Ellison Medical Foundation [AG-SS-2281-09]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA010815, GM040536, and HL099342. This work was also supported by the Ellison Medical Foundation (AG-SS-2281-09) and the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health (to K. N.).	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Cai XZ, 2006, PLOS PATHOG, V2, P236, DOI 10.1371/journal.ppat.0020023; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Dabiri GA, 1996, EMBO J, V15, P34, DOI 10.1002/j.1460-2075.1996.tb00331.x; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Edwards RH, 2008, J VIROL, V82, P9094, DOI 10.1128/JVI.00785-08; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gandy SZ, 2007, J VIROL, V81, P13544, DOI 10.1128/JVI.01521-07; Godshalk SE, 2008, CELL CYCLE, V7, P3595, DOI 10.4161/cc.7.22.7120; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Iwakiri D, 2005, ONCOGENE, V24, P1767, DOI 10.1038/sj.onc.1208357; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kelly GL, 2005, J VIROL, V79, P10709, DOI 10.1128/JVI.79.16.10709-10717.2005; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kiss C, 2003, P NATL ACAD SCI USA, V100, P4813, DOI 10.1073/pnas.0730710100; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Maruo S, 2001, J VIROL, V75, P9977, DOI 10.1128/JVI.75.20.9977-9982.2001; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; PEARSON GR, 1987, VIROLOGY, V160, P151, DOI 10.1016/0042-6822(87)90055-9; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SCHAEFER BC, 1995, P NATL ACAD SCI USA, V92, P10565, DOI 10.1073/pnas.92.23.10565; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SMITH PR, 1992, J VIROL, V66, P706, DOI 10.1128/JVI.66.2.706-714.1992; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; STROBEL SA, 1994, BIOCHEMISTRY-US, V33, P13824, DOI 10.1021/bi00250a037; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Tempera I, 2010, BBA-GENE REGUL MECH, V1799, P236, DOI 10.1016/j.bbagrm.2009.10.004; Tierney R, 2007, J VIROL, V81, P10092, DOI 10.1128/JVI.00358-07; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	68	172	189	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33358	33370		10.1074/jbc.M110.138362	http://dx.doi.org/10.1074/jbc.M110.138362			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20716523	Green Published, hybrid			2022-12-27	WOS:000283048200071
J	Yu, Y; Park, JW; Kwon, HM; Hwang, HO; Jang, IH; Masuda, A; Kurokawa, K; Nakayama, H; Lee, WJ; Dohmae, N; Zhang, JH; Lee, BL				Yu, Yang; Park, Ji-Won; Kwon, Hyun-Mi; Hwang, Hyun-Ok; Jang, In-Hwan; Masuda, Akiko; Kurokawa, Kenji; Nakayama, Hiroshi; Lee, Won-Jae; Dohmae, Naoshi; Zhang, Jinghai; Lee, Bok Luel			Diversity of Innate Immune Recognition Mechanism for Bacterial Polymeric meso-Diaminopimelic Acid-type Peptidoglycan in Insects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA TOLL; ANTIBACTERIAL DEFENSE; PROTEOLYTIC CASCADE; SERINE-PROTEASE; ACTIVATION; INFECTION; PATHWAY; LARVAE; PURIFICATION; COLEOPTERAN	In Drosophila, the synthesis of antimicrobial peptides in response to microbial infections is under the control of the Toll and immune deficiency (Imd) signaling pathway. The Toll signaling pathway responds mainly to the lysine-type peptidoglycan of Gram-positive bacteria and fungal beta-1,3-glucan, whereas the Imd pathway responds to the meso-diaminopimelic acid (DAP)-type peptidoglycan of Gram-negative bacteria and certain Gram-positive bacilli. Recently we determined the activation mechanism of a Toll signaling pathway biochemically using a large beetle, Tenebrio molitor. However, DAP-type peptidoglycan recognition mechanism and its signaling pathway are still unclear in the fly and beetle. Here, we show that polymeric DAP-type peptidoglycan, but not its monomeric form, formed a complex with Tenebrio peptidoglycan recognition protein-SA, and this complex activated the three-step proteolytic cascade to produce processed Spatzle, a Toll receptor ligand, and induced Drosophila defensin-like antimicrobial peptide in Tenebrio larvae similarly to polymeric lysine-type peptidoglycan. Monomeric DAP-type peptidoglycan induced Drosophila diptericin-like antimicrobial peptide in Tenebrio hemocytes. In addition, both polymeric and monomeric DAP-type peptidoglycans induced expression of Tenebrio peptidoglycan recognition protein-SC2, which is DAP-type peptidoglycan-selective N-acetylmuramyl-L-alanine amidase that functions as a DAP-type peptidoglycan scavenger, appearing to function as a negative regulator of the DAP-type peptidoglycan signaling by cleaving DAP-type peptidoglycan in Tenebrio larvae. Taken together, these results demonstrate that molecular recognition mechanism for polymeric DAP-type peptidoglycan is different between Tenebrio larvae and Drosophila adults, providing biochemical evidences of biological diversity of innate immune responses in insects.	[Yu, Yang; Park, Ji-Won; Kwon, Hyun-Mi; Hwang, Hyun-Ok; Kurokawa, Kenji; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Jang, In-Hwan; Lee, Won-Jae] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Masuda, Akiko; Nakayama, Hiroshi; Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Masuda, Akiko; Nakayama, Hiroshi; Dohmae, Naoshi] Japan Sci & Technol Agcy, Tokyo 1020075, Japan; [Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China	Pusan National University; Ewha Womans University; RIKEN; Japan Science & Technology Agency (JST); Shenyang Pharmaceutical University	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Dohmae, Naoshi/C-2040-2011	Dohmae, Naoshi/0000-0002-5242-9410				Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Lee KY, 2002, EUR J BIOCHEM, V269, P4375, DOI 10.1046/j.1432-1033.2002.03155.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; MOON HJ, 1994, J BIOCHEM-TOKYO, V116, P53, DOI 10.1093/oxfordjournals.jbchem.a124502; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tsuchiya M, 1996, FEMS IMMUNOL MED MIC, V15, P129, DOI 10.1016/0928-8244(96)00053-3; YOSHIDA H, 1986, BIOCHEM BIOPH RES CO, V141, P1177, DOI 10.1016/S0006-291X(86)80168-1; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200	41	50	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32937	32945		10.1074/jbc.M110.144014	http://dx.doi.org/10.1074/jbc.M110.144014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702416	Green Published, hybrid			2022-12-27	WOS:000283048200031
J	Ebikeme, C; Hubert, J; Biran, M; Gouspillou, G; Morand, P; Plazolles, N; Guegan, F; Diolez, P; Franconi, JM; Portais, JC; Bringaud, F				Ebikeme, Charles; Hubert, Jane; Biran, Marc; Gouspillou, Gilles; Morand, Pauline; Plazolles, Nicolas; Guegan, Fabien; Diolez, Philippe; Franconi, Jean-Michel; Portais, Jean-Charles; Bringaud, Frederic			Ablation of Succinate Production from Glucose Metabolism in the Procyclic Trypanosomes Induces Metabolic Switches to the Glycerol 3-Phosphate/Dihydroxyacetone Phosphate Shuttle and to Proline Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE LEVEL PHOSPHORYLATION; DEPENDENT FUMARATE REDUCTASE; INDUCIBLE EXPRESSION SYSTEM; MOLECULAR CHARACTERIZATION; OXIDATIVE-PHOSPHORYLATION; INTRACELLULAR METABOLITES; RESPIRATORY-CHAIN; ENERGY-METABOLISM; COA-TRANSFERASE; KREBS CYCLE	Trypanosoma brucei is a parasitic protist that undergoes a complex life cycle during transmission from its mammalian host (bloodstream forms) to the midgut of its insect vector (procyclic form). In both parasitic forms, most glycolytic steps take place within specialized peroxisomes, called glycosomes. Here, we studied metabolic adaptations in procyclic trypanosome mutants affected in their maintenance of the glycosomal redox balance. T. brucei can theoretically use three strategies to maintain the glycosomal NAD(+)/NADH balance as follows: (i) the glycosomal succinic fermentation branch; (ii) the glycerol 3-phosphate (Gly-3-P)/dihydroxyacetone phosphate (DHAP) shuttle that transfers reducing equivalents to the mitochondrion; and (iii) the glycosomal glycerol production pathway. We showed a hierarchy in the use of these glycosomal NADH-consuming pathways by determining metabolic perturbations and adaptations in single and double mutant cell lines using a combination of NMR, ion chromatography-MS/MS, and HPLC approaches. Although functional, the Gly-3-P/DHAP shuttle is primarily used when the preferred succinate fermentation pathway is abolished in the Delta pepck knock-out mutant cell line. In the absence of these two pathways (Delta pepck/(RNAi)FAD-GPDH.i mutant), glycerol production is used but with a 16-fold reduced glycolytic flux. In addition, the Delta pepck mutant cell line shows a 3.3-fold reduced glycolytic flux compensated by an increase of proline metabolism. The inability of the Delta pepck mutant to maintain a high glycolytic flux demonstrates that the Gly-3-P/DHAP shuttle is not adapted to the procyclic trypanosome context. In contrast, this shuttle was shown earlier to be the only way used by the bloodstream forms of T. brucei to sustain their high glycolytic flux.	[Hubert, Jane; Portais, Jean-Charles] ISBP INSA, INSA, INRA, CNRS,UMR5504,UMR792, F-31077 Toulouse, France; [Ebikeme, Charles; Biran, Marc; Gouspillou, Gilles; Morand, Pauline; Diolez, Philippe; Franconi, Jean-Michel; Bringaud, Frederic] Univ Victor Segalen Bordeaux 2, CNRS, UMR5536, Ctr Resonance Magnet Syst Biol, F-33076 Bordeaux, France; [Plazolles, Nicolas; Guegan, Fabien] Univ Victor Segalen Bordeaux 2, CNRS, UMR5234, Lab Microbiol Cellulaire & Mol & Pathogenic, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Portais, JC (corresponding author), ISBP INSA, INSA, INRA, CNRS,UMR5504,UMR792, 135 Ave Rangueil, F-31077 Toulouse, France.	jean-charles.portais@insa-toulouse.fr; bringaud@rmsb.u-bordeaux2.fr		Diolez, Philippe/0000-0002-7548-2070; Ebikeme, Charles/0000-0002-9989-6489; Gouspillou, Gilles/0000-0002-8543-3619; Portais, Jean-Charles/0000-0002-3480-0933; Guegan, Fabien Marc/0000-0001-9393-2920	CNRS; Universite Victor Segalen Bordeaux 2; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche (ANR) [ANR-MIME2007, ANR-BioSys2007]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Victor Segalen Bordeaux 2; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the CNRS, the Universite Victor Segalen Bordeaux 2, the Fondation pour la Recherche Medicale, and the Agence Nationale de la Recherche (ANR) Program Grants METABOTRYP (ANR-MIME2007) l and SysTryp (ANR-BioSys2007).	Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bringaud F, 1995, MOL BIOCHEM PARASIT, V74, P119, DOI 10.1016/0166-6851(95)02486-7; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; BROMAN K, 1983, MOL BIOCHEM PARASIT, V8, P79, DOI 10.1016/0166-6851(83)90036-1; BRUN R, 1979, ACTA TROP, V36, P289; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; CROSS GAM, 1975, PARASITOLOGY, V71, P311, DOI 10.1017/S0031182000046758; Dufour S, 1996, BIOCHEM J, V314, P743, DOI 10.1042/bj3140743; Ebikeme CE, 2008, PARASITOLOGY, V135, P585, DOI 10.1017/S0031182008004241; Fairlamb A. H., 1986, Carbohydrate metabolism in cultured cells., P183; Guerra DG, 2006, MOL BIOCHEM PARASIT, V149, P155, DOI 10.1016/j.molbiopara.2006.05.006; Harlow E., 1988, ANTIBODIES LAB MANUA; Kiefer P, 2007, ANAL BIOCHEM, V360, P182, DOI 10.1016/j.ab.2006.06.032; Kralova I, 2000, EUR J BIOCHEM, V267, P2323, DOI 10.1046/j.1432-1327.2000.01238.x; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Obungu VH, 1999, INDIAN J BIOCHEM BIO, V36, P305; OPPERDOES FR, 1981, MOL BIOCHEM PARASIT, V4, P291, DOI 10.1016/0166-6851(81)90062-1; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; Peacock L, 2006, PARASITOLOGY, V132, P651, DOI 10.1017/S0031182005009571; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Speijer D, 1997, MOL BIOCHEM PARASIT, V85, P171, DOI 10.1016/S0166-6851(96)02823-X; TURRENS JF, 1989, BIOCHEM J, V259, P363, DOI 10.1042/bj2590363; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wittmann C, 2004, ANAL BIOCHEM, V327, P135, DOI 10.1016/j.ab.2004.01.002; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	42	31	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32312	32324		10.1074/jbc.M110.124917	http://dx.doi.org/10.1074/jbc.M110.124917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702405	Green Published, hybrid			2022-12-27	WOS:000282683000044
J	Nose, Y; Wood, LK; Kim, BE; Prohaska, JR; Fry, RS; Spears, JW; Thiele, DJ				Nose, Yasuhiro; Wood, L. Kent; Kim, Byung-Eun; Prohaska, Joseph R.; Fry, Robert S.; Spears, Jerry W.; Thiele, Dennis J.			Ctr1 Is an Apical Copper Transporter in Mammalian Intestinal Epithelial Cells in Vivo That Is Controlled at the Level of Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; CACO-2 CELLS; EXPRESSION; DEGRADATION; ABSORPTION; MECHANISM; HCTR1; GENE; IDENTIFICATION	Copper is an essential trace element that functions in a diverse array of biochemical processes that include mitochondrial respiration, neurotransmitter biogenesis, connective tissue maturation, and reactive oxygen chemistry. The Ctr1 protein is a high-affinity Cu+ importer that is structurally and functionally conserved in yeast, plants, fruit flies, and humans and that, in all of these organisms, is localized to the plasma membrane and intracellular vesicles. Although intestinal epithelial cell-specific deletion of Ctr1 in mice demonstrated a critical role for Ctr1 in dietary copper absorption, some controversy exists over the localization of Ctr1 in intestinal epithelial cells in vivo. In this work, we assess the localization of Ctr1 in intestinal epithelial cells through two independent mechanisms. Using immunohistochemistry, we demonstrate that Ctr1 localizes to the apical membrane in intestinal epithelial cells of the mouse, rat, and pig. Moreover, biotinylation of intestinal luminal proteins from mice fed a control or a copper-deficient diet showed elevated levels of both total and apical membrane Ctr1 protein in response to transient dietary copper limitation. Experiments in cultured HEK293T cells demonstrated that alterations in the levels of the glycosylated form of Ctr1 in response to copper availability were a time-dependent, copper-specific posttranslational response. Taken together, these results demonstrate apical localization of Ctr1 in intestinal epithelia across three mammalian species and suggest that increased Ctr1 apical localization in response to dietary copper limitation may represent an adaptive response to homeostatically modulate Ctr1 availability at the site of intestinal copper absorption.	[Nose, Yasuhiro; Wood, L. Kent; Kim, Byung-Eun; Thiele, Dennis J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Prohaska, Joseph R.] Univ Minnesota, Sch Med, Dept Biochem & Mol Biol, Duluth, MN 55812 USA; [Fry, Robert S.; Spears, Jerry W.] N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA	Duke University; University of Minnesota System; University of Minnesota Duluth; University of North Carolina; North Carolina State University	Thiele, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	dennis.thiele@duke.edu			National Institute of Health [DK074192-09, HD039708-08]; American Heart Association [09POST2251047]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074192] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institute of Health Grants DK074192-09 (to D.J.T.) and HD039708-08 (to J.R.P.). This work was also supported by American Heart Association Postdoctoral Fellowship 09POST2251047 (to B.-E.K.).	AMERONGEN HM, 1989, J CELL BIOL, V109, P2129, DOI 10.1083/jcb.109.5.2129; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Bauerly KA, 2004, J NUTR BIOCHEM, V15, P155, DOI 10.1016/j.jnutbio.2003.10.008; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; CRAMPTON RF, 1965, J PHYSIOL-LONDON, V178, P111, DOI 10.1113/jphysiol.1965.sp007618; DAndrea L, 1996, J BIOL CHEM, V271, P28969, DOI 10.1074/jbc.271.46.28969; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Gybina AA, 2006, GENES NUTR, V1, P51, DOI 10.1007/BF02829936; Hayeshi R, 2008, EUR J PHARM SCI, V35, P383, DOI 10.1016/j.ejps.2008.08.004; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Kumar N, 2006, MAYO CLIN PROC, V81, P1371, DOI 10.4065/81.10.1371; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Linder M, 1991, BIOCH COPPER; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Neerman MF, 2007, LABMEDICINE, V38, P608, DOI 10.1309/P9P0CCTJLDJ7JJU8; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Petris MJ, 2004, PFLUG ARCH EUR J PHY, V447, P752, DOI 10.1007/s00424-003-1092-1; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Prohaska J.R., 2006, PRESENT KNOWLEDGE NU, V1, P458; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Seithel A, 2006, EUR J PHARM SCI, V28, P291, DOI 10.1016/j.ejps.2006.03.003; TURK E, 1994, J BIOL CHEM, V269, P15204; TURNLUND JR, 1989, AM J CLIN NUTR, V49, P870, DOI 10.1093/ajcn/49.5.870; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200	40	86	91	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32385	32392		10.1074/jbc.M110.143826	http://dx.doi.org/10.1074/jbc.M110.143826			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20699218	Green Published, hybrid			2022-12-27	WOS:000282683000052
J	Wang, Z; Chapman, ER				Wang, Zhao; Chapman, Edwin R.			Rat and Drosophila Synaptotagmin 4 Have Opposite Effects during SNARE-catalyzed Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE; CA2+ BINDING; C2B DOMAIN; T-SNARE; NEUROTRANSMITTER RELEASE; REGULATED EXOCYTOSIS; PENETRATION ACTIVITY; PLASMA-MEMBRANE; IV; GENE	Synaptotagmins (Syt) are a large family of proteins that regulate membrane traffic in neurons and other cell types. One isoform that has received considerable attention is SYT4, with apparently contradictory reports concerning the function of this isoform in fruit flies and mice. SYT4 was reported to function as a negative regulator of neurotrophin secretion in mouse neurons and as a positive regulator of secretion of a yet to be identified growth factor from muscle cells in flies. Here, we have directly compared the biochemical and functional properties of rat and fly SYT4. We report that rat SYT4 inhibited SNARE-catalyzed membrane fusion in both the absence and presence of Ca2+. In marked contrast, fly SYT4 stimulated SNARE-mediated membrane fusion in response to Ca2+. Analysis of chimeric molecules, isolated C2 domains, and point mutants revealed that the C2B domain of the fly protein senses Ca2+ and is sufficient to stimulate fusion. Rat SYT4 was able to stimulate fusion in response to Ca2+ when the conserved Asp-to-Ser Ca2+ ligand substitution in its C2A domain was reversed. In summary, rat SYT4 serves as an inhibitory isoform, whereas fly SYT4 is a bona fide Ca2+ sensor capable of coupling Ca2+ to membrane fusion.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), 129 Serv Mem Inst, 1300 Univ Ave, Madison, WI 53706 USA.	chapman@physiology.wisc.edu	Wang, Zhao/C-2168-2014	WANG, ZHAO/0000-0002-4233-9884; Chapman, Edwin/0000-0001-9787-8140	National Institutes of Health [MH 61876]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH 61876 (to E. R. C.).	Babity JM, 1997, P NATL ACAD SCI USA, V94, P2638, DOI 10.1073/pnas.94.6.2638; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Barber CF, 2009, J CELL BIOL, V187, P295, DOI 10.1083/jcb.200903098; Berton F, 2000, EUR J NEUROSCI, V12, P1294, DOI 10.1046/j.1460-9568.2000.00013.x; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bhalla A, 2008, J BIOL CHEM, V283, P21799, DOI 10.1074/jbc.M709628200; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Dai H, 2004, NAT STRUCT MOL BIOL, V11, P844, DOI 10.1038/nsmb817; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Ferguson GD, 2000, P NATL ACAD SCI USA, V97, P5598, DOI 10.1073/pnas.100104597; Ferguson GD, 2004, HIPPOCAMPUS, V14, P964, DOI 10.1002/hipo.20013; Ferguson GD, 2004, NEUROPHARMACOLOGY, V47, P604, DOI 10.1016/j.neuropharm.2004.05.008; Ferguson GD, 2001, MOL NEUROBIOL, V23, P173; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HILBUSH BS, 1994, P NATL ACAD SCI USA, V91, P8195, DOI 10.1073/pnas.91.17.8195; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Ibata K, 2002, NEUROSCI RES, V43, P401, DOI 10.1016/S0168-0102(02)00066-4; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; PERIN MS, 1991, J BIOL CHEM, V266, P615; POPOLI M, 1988, NEUROCHEM RES, V13, P63, DOI 10.1007/BF00971856; POPOLI M, 1992, NEUROREPORT, V3, P177, DOI 10.1097/00001756-199202000-00014; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhang ZJ, 2009, NAT NEUROSCI, V12, P163, DOI 10.1038/nn.2252	49	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30759	30766		10.1074/jbc.M110.137745	http://dx.doi.org/10.1074/jbc.M110.137745			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20688915	Green Published, hybrid			2022-12-27	WOS:000282135500044
J	BeGora, MD; Macleod, MJR; McCarry, BE; Summers, PS; Weretilnyk, EA				BeGora, Michael D.; Macleod, Mitchell J. R.; McCarry, Brian E.; Summers, Peter S.; Weretilnyk, Elizabeth A.			Identification of Phosphomethylethanolamine N-Methyltransferase from Arabidopsis and Its Role in Choline and Phospholipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATED ETHANOLAMINE MOIETIES; GLYCINE BETAINE SYNTHESIS; CROSS-PATHWAY REGULATION; PHOSPHOETHANOLAMINE-METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; SEQUENCE MOTIFS; RAPID METHOD; SPINACH; GENE	Three sequential methylations of phosphoethanolamine (PEA) are required for the synthesis of phosphocholine (PCho) in plants. A cDNA encoding an N-methyltransferase that catalyzes the last two methylation steps was cloned from Arabidopsis by heterologous complementation of a Saccharomyces cerevisiae cho2, opi3 mutant. The cDNA encodes phosphomethylethanolamine N-methyltransferase (PMEAMT), a polypeptide of 475 amino acids that is organized as two tandem methyltransferase domains. PMEAMT shows 87% amino acid identity to a related enzyme, phosphoethanolamine N-methyltransferase, an enzyme in plants that catalyzes all three methylations of PEA to PCho. PMEAMT cannot use PEA as a substrate, but assays using phosphomethylethanolamine as a substrate result in both phosphodimethylethanolamine and PCho as products. PMEAMT is inhibited by the reaction products PCho and S-adenosyl-L-homocysteine, a property reported for phosphoethanolamine N-methyltransferase from various plants. An Arabidopsis mutant with a T-DNA insertion associated with locus At1g48600 showed no transcripts encoding PMEAMT. Shotgun lipidomic analyses of leaves of atpmeamt and wild-type plants generated phospholipid profiles showing the content of phosphatidylmethylethanolamine to be altered relative to wild type with the content of a 34: 3 lipid molecular species 2-fold higher in mutant plants. In S. cerevisiae, an increase in PtdMEA in membranes is associated with reduced viability. This raises a question regarding the role of PMEAMT in plants and whether it serves to prevent the accumulation of PtdMEA to potentially deleterious levels.	[BeGora, Michael D.; Macleod, Mitchell J. R.; Summers, Peter S.; Weretilnyk, Elizabeth A.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4A8, Canada; [McCarry, Brian E.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4A8, Canada	McMaster University; McMaster University	Weretilnyk, EA (corresponding author), McMaster Univ, Dept Biol, Life Sci Bldg,Rm 536,1280 Main St W, Hamilton, ON L8S 4A8, Canada.	weretil@mcmaster.ca	Summers, Peter/F-3686-2011		Natural Science and Engineering Research Council	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Science and Engineering Research Council Discovery Grant (to E. A. W.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Basconcillo LS, 2009, J LIPID RES, V50, P1120, DOI 10.1194/jlr.M800443-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLIGNY R, 1990, J BIOL CHEM, V265, P1319; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COUGHLAN SJ, 1982, PLANTA, V154, P6, DOI 10.1007/BF00385490; Cruz-Ramirez A, 2004, PLANT CELL, V16, P2020, DOI 10.1105/tpc.103.018648; DATKO AH, 1988, PLANT PHYSIOL, V88, P854, DOI 10.1104/pp.88.3.854; DATKO AH, 1988, PLANT PHYSIOL, V88, P1338, DOI 10.1104/pp.88.4.1338; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HANSON AD, 1994, P NATL ACAD SCI USA, V91, P306, DOI 10.1073/pnas.91.1.306; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Huang J, 2008, PLANT PHYSIOL BIOCH, V46, P647, DOI 10.1016/j.plaphy.2008.04.014; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Joshi CP, 1998, PLANT MOL BIOL, V37, P663, DOI 10.1023/A:1006035210889; Jost R, 2009, J BIOL CHEM, V284, P31962, DOI 10.1074/jbc.M109.022657; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Keogh MR, 2009, J BIOL CHEM, V284, P15439, DOI 10.1074/jbc.M109.005991; Lorenzin D, 2001, CAN J BOT, V79, P897, DOI 10.1139/cjb-79-8-897; MCGRAW P, 1989, GENETICS, V122, P317; McNeil SD, 2001, P NATL ACAD SCI USA, V98, P10001, DOI 10.1073/pnas.171228998; McNeil SD, 2000, PLANT PHYSIOL, V124, P153, DOI 10.1104/pp.124.1.153; MINET M, 1992, PLANT J, V2, P417; Moffatt BA, 2001, PHYSIOL PLANTARUM, V113, P435, DOI 10.1034/j.1399-3054.2001.1130401.x; MOORE TS, 1976, PLANT PHYSIOL, V57, P383, DOI 10.1104/pp.57.3.382; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; MUDD SH, 1989, PLANT PHYSIOL, V90, P296, DOI 10.1104/pp.90.1.296; MUDD SH, 1989, PLANT PHYSIOL, V90, P306, DOI 10.1104/pp.90.1.306; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Nuccio ML, 1998, PLANT J, V16, P487, DOI 10.1046/j.1365-313x.1998.00316.x; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Peel GJ, 2010, PHYTOCHEMISTRY, V71, P404, DOI 10.1016/j.phytochem.2009.11.002; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Rontein D, 2002, METAB ENG, V4, P49, DOI 10.1006/mben.2001.0208; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smith DD, 2000, PHYSIOL PLANTARUM, V108, P286, DOI 10.1034/j.1399-3054.2000.108003286.x; Stolz J, 2003, YEAST, V20, P221, DOI 10.1002/yea.959; SUMMERS EF, 1988, GENETICS, V120, P909; SUMMERS PS, 1993, PLANT PHYSIOL, V103, P1269, DOI 10.1104/pp.103.4.1269; Wang XM, 2000, PROG LIPID RES, V39, P109, DOI 10.1016/S0163-7827(00)00002-3; WEIGEL D, 2002, ARABIDOPSIS LAB MANU, P176; WERETILNYK EA, 1995, PLANT PHYSIOL, V109, P1085, DOI 10.1104/pp.109.3.1085; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Wolf C, 2008, PROG LIPID RES, V47, P15, DOI 10.1016/j.plipres.2007.09.001; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061	53	34	37	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29147	29155		10.1074/jbc.M110.112151	http://dx.doi.org/10.1074/jbc.M110.112151			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20650897	Green Published, hybrid			2022-12-27	WOS:000281740100015
J	Chao, JD; Papavinasasundaram, KG; Zheng, XJ; Chavez-Steenbock, A; Wang, XT; Lee, GQ; Av-Gay, Y				Chao, Joseph D.; Papavinasasundaram, Kadamba G.; Zheng, Xingji; Chavez-Steenbock, Ana; Wang, Xuetao; Lee, Guinevere Q.; Av-Gay, Yossef			Convergence of Ser/Thr and Two-component Signaling to Coordinate Expression of the Dormancy Regulon in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIC RESPONSE; KINASE CASCADE; DNA-BINDING; SERINE/THREONINE KINASE; CARBON-MONOXIDE; PROTEIN; GENE; PHOSPHORYLATION; VIRULENCE; SYSTEM	Signal transduction in Mycobacterium tuberculosis is mediated primarily by the Ser/Thr protein kinases and the two-component systems. The Ser/Thr kinase PknH has been shown to regulate growth of M. tuberculosis in a mouse model and in response to NO stress in vitro. Comparison of a pknH deletion mutant (Delta pknH) with its parental M. tuberculosis H37Rv strain using iTRAQ enabled us to quantify >700 mycobacterial proteins. Among these, members of the hypoxia-and NO-inducible dormancy (DosR) regulon were disregulated in the Delta pknH mutant. Using kinase assays, protein-protein interactions, and mass spectrometry analysis, we demonstrated that the two-component response regulator DosR is a substrate of PknH. PknH phosphorylation of DosR mapped to Thr(198) and Thr(205) on the key regulatory helix alpha 10 involved in activation and dimerization of DosR. PknH Thr phosphorylation and DosS Asp phosphorylation of DosR cooperatively enhanced DosR binding to cognate DNA sequences. Transcriptional analysis comparing Delta pknH and parental M. tuberculosis revealed that induction of the DosR regulon was subdued in the Delta pknH mutant in response to NO. Together, these results indicate that PknH phosphorylation of DosR is required for full induction of the DosR regulon and demonstrate convergence of the two major signal transduction systems for the first time in M. tuberculosis.	[Papavinasasundaram, Kadamba G.; Zheng, Xingji; Chavez-Steenbock, Ana; Wang, Xuetao; Lee, Guinevere Q.; Av-Gay, Yossef] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC V5Z 3J5, Canada; [Chao, Joseph D.; Av-Gay, Yossef] Univ British Columbia, Dept Med, Dept Microbiol & Immunol, Vancouver, BC V5Z 3J5, Canada	University of British Columbia; University of British Columbia	Av-Gay, Y (corresponding author), Univ British Columbia, Dept Med, Div Infect Dis, 2733 Heather St, Vancouver, BC V5Z 3J5, Canada.	yossi@interchange.ubc.ca	Av-Gay, Yossef/H-5128-2019; Av-Gay, Yossef/H-2311-2014; Lee, Guinevere Q./D-4436-2017	Av-Gay, Yossef/0000-0002-9547-0237; Lee, Guinevere Q./0000-0002-9412-886X; Chao, Joseph/0000-0003-1212-7570; PAPAVINASASUNDARAM, KADAMBA/0000-0001-7837-1344	Canadian Institutes of Health Research [MOP-68857]; TB Veterans Charitable Foundation; Canadian Institutes of Health Research Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); TB Veterans Charitable Foundation; Canadian Institutes of Health Research Canada(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-68857 (to Y. A.-G.) and the TB Veterans Charitable Foundation (to Y. A.-G.).; Recipient of the Canadian Institutes of Health Research Canada Graduate Scholarships Doctoral Award.	Av-Gay Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P359; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bartek IL, 2009, TUBERCULOSIS, V89, P310, DOI 10.1016/j.tube.2009.06.001; Boon C, 2001, J BACTERIOL, V183, P2672, DOI 10.1128/JB.183.8.2672-2676.2001; Chauhan S, 2008, J BACTERIOL, V190, P5394, DOI 10.1128/JB.00488-08; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Huth JR, 1997, PROTEIN SCI, V6, P2359; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; Newton GL, 2003, J BACTERIOL, V185, P3476, DOI 10.1128/JB.185.11.3476-3479.2003; O'Hare H, 2008, J MICROBIOL METH, V73, P79, DOI 10.1016/j.mimet.2008.02.008; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Paget E, 1996, J BACTERIOL, V178, P6357, DOI 10.1128/jb.178.21.6357-6360.1996; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Phalip V, 2001, BIOCHEM J, V360, P639, DOI 10.1042/0264-6021:3600639; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Sickmann A, 2001, PROTEOMICS, V1, P200, DOI 10.1002/1615-9861(200102)1:2<200::AID-PROT200>3.0.CO;2-V; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; STEPANOVA AN, 2005, SCI STKE, pCM4; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029; Zhang ZG, 2004, PLANT PHYSIOL, V136, P2971, DOI 10.1104/pp.103.034686; Zheng XJ, 2007, BIOCHEM BIOPH RES CO, V355, P162, DOI 10.1016/j.bbrc.2007.01.122	54	79	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29239	29246		10.1074/jbc.M110.132894	http://dx.doi.org/10.1074/jbc.M110.132894			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630871	hybrid, Green Published			2022-12-27	WOS:000281740100025
J	Tay, SP; Yeo, CWS; Chai, C; Chua, PJ; Tan, HM; Ang, AXY; Yip, DLH; Sung, JX; Tan, PH; Bay, BH; Wong, SH; Tang, C; Tan, JMM; Lim, KL				Tay, Shiam-Peng; Yeo, Calvin W. S.; Chai, Chou; Chua, Pei-Jou; Tan, Hui-Mei; Ang, Alex X. Y.; Yip, Daniel L. H.; Sung, Jian-Xiong; Tan, Puay Hoon; Bay, Boon-Huat; Wong, Siew-Heng; Tang, Carol; Tan, Jeanne M. M.; Lim, Kah-Leong			Parkin Enhances the Expression of Cyclin-dependent Kinase 6 and Negatively Regulates the Proliferation of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE JUVENILE PARKINSONISM; TUMOR-SUPPRESSOR GENE; COMMON FRAGILE SITES; HEPATOCELLULAR-CARCINOMA; TUMORIGENICITY; CHROMOSOME-6; SOLUBILITY; MUTATIONS; PROTEINS; DISEASE	Although mutations in the parkin gene are frequently associated with familial Parkinsonism, emerging evidence suggests that parkin also plays a role in cancers as a putative tumor suppressor. Supporting this, we show here that parkin expression is dramatically reduced in several breast cancer-derived cell lines as well as in primary breast cancer tissues. Importantly, we found that ectopic parkin expression in parkin-deficient breast cancer cells mitigates their proliferation rate both in vitro and in vivo, as well as reduces the capacity of these cells to migrate. Cell cycle analysis revealed the arrestment of a significant percentage of parkin-expressing breast cancer cells at the G1-phase. However, we did not observe significant changes in the levels of the G1-associated cyclin D1 and E. On the other hand, the level of cyclin-dependent kinase 6 (CDK6) is dramatically and selectively elevated in parkin-expressing breast cancer cells, the extent of which correlates well with the expression of parkin. Interestingly, a recent study demonstrated that CDK6 restrains the proliferation of breast cancer cells. Taken together, our results support a negative role for parkin in tumorigenesis and provide a potential mechanism by which parkin exerts its suppressing effects on breast cancer cell proliferation.	[Tay, Shiam-Peng; Yeo, Calvin W. S.; Tan, Hui-Mei; Tan, Jeanne M. M.; Lim, Kah-Leong] Natl Inst Neurosci, Neurodegenerat Res Lab, Singapore 308433, Singapore; [Tang, Carol] Natl Inst Neurosci, Neurooncol Res Lab, Singapore 308433, Singapore; [Chua, Pei-Jou; Bay, Boon-Huat] Natl Univ Singapore, Dept Anat, Singapore 117597, Singapore; [Yeo, Calvin W. S.; Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Tay, Shiam-Peng; Wong, Siew-Heng] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Ang, Alex X. Y.; Yip, Daniel L. H.] Raffles Inst, Singapore 575954, Singapore; [Sung, Jian-Xiong] Ngee Ann Polytech, Singapore 599489, Singapore; [Chai, Chou; Tan, Jeanne M. M.; Lim, Kah-Leong] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Tan, Puay Hoon] Singapore Gen Hosp, Singapore 169608, Singapore	National Neuroscience Institute (NNI); National Neuroscience Institute (NNI); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital	Tan, JMM (corresponding author), Natl Inst Neurosci, Neurodegenerat Res Lab, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	tmm18sg@yahoo.com.sg; kahleong.lim@duke-nus.edu.sg	Tan, Jeanne/GQI-3612-2022; Lim, Kah/L-5426-2019; Lim, Kah-Leong/AAY-3308-2020	Lim, Kah-Leong/0000-0002-5440-2588	Khoo's Discovery Award; Singapore Millennium Foundation	Khoo's Discovery Award; Singapore Millennium Foundation	This work was supported by grants from Khoo's Discovery Award (to K.-L. L.) and Singapore Millennium Foundation (to C. Y. and J. T.).	Bednarek AK, 2001, CANCER RES, V61, P8068; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; DE LA IGLESIA N, 2008, J NEUROSCI, V28, P5870; Denison SR, 2003, GENE CHROMOSOME CANC, V38, P40, DOI 10.1002/gcc.10236; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Druck T, 1998, ONCOL RES, V10, P341; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; IKEUCHI K, 2009, INT J CANC IN PRESS; Ishii H, 2001, CANCER RES, V61, P1578; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lucas JJ, 2004, MOL CANCER RES, V2, P105; Mengesdorf T, 2002, P NATL ACAD SCI USA, V99, P15042, DOI 10.1073/pnas.232588799; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Nagasawa M, 2001, ONCOGENE, V20, P2889, DOI 10.1038/sj.onc.1204396; NEGRINI M, 1994, CANCER RES, V54, P1331; Picchio MC, 2004, CLIN CANCER RES, V10, P2720, DOI 10.1158/1078-0432.CCR-03-0086; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Smith DI, 1998, INT J ONCOL, V12, P187; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Suyama E, 2003, P NATL ACAD SCI USA, V100, P5616, DOI 10.1073/pnas.1035850100; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020	28	73	76	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29231	29238		10.1074/jbc.M110.108241	http://dx.doi.org/10.1074/jbc.M110.108241			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630868	Green Published, hybrid			2022-12-27	WOS:000281740100024
J	Karassek, S; Berghaus, C; Schwarten, M; Goemans, CG; Ohse, N; Kock, G; Jockers, K; Neumann, S; Gottfried, S; Herrmann, C; Heumann, R; Stoll, R				Karassek, Sascha; Berghaus, Carsten; Schwarten, Melanie; Goemans, Christoph G.; Ohse, Nadine; Kock, Gerd; Jockers, Katharina; Neumann, Sebastian; Gottfried, Sebastian; Herrmann, Christian; Heumann, Rolf; Stoll, Raphael			Ras Homolog Enriched in Brain (Rheb) Enhances Apoptotic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-SPECIFIC H-1; N-15 BACKBONE ASSIGNMENT; INDUCED CELL-DEATH; TUBEROUS SCLEROSIS; ENDOPLASMIC-RETICULUM; COMMUNICATIONS TOOL; EMBRYONIC NEURONS; STRESS RESPONSES; NMR-SPECTROSCOPY; MAMMALIAN TARGET	Rheb is a homolog of Ras GTPase that regulates cell growth, proliferation, and regeneration via mammalian target of rapamycin (mTOR). Because of the well established potential of activated Ras to promote survival, we sought to investigate the ability of Rheb signaling to phenocopy Ras. We found that overexpression of lipid-anchored Rheb enhanced the apoptotic effects induced by UV light, TNF alpha, or tunicamycin in an mTOR complex 1 (mTORC1)-dependent manner. Knocking down endogenous Rheb or applying rapamycin led to partial protection, identifying Rheb as a mediator of cell death. Ras and c-Raf kinase opposed the apoptotic effects induced by UV light or TNF alpha but did not prevent Rheb-mediated apoptosis. To gain structural insight into the signaling mechanisms, we determined the structure of Rheb-GDP by NMR. The complex adopts the typical canonical fold of RasGTPases and displays the characteristic GDP-dependent picosecond to nanosecond backbone dynamics of the switch I and switch II regions. NMR revealed Ras effector-like binding of activated Rheb to the c-Raf-Ras-binding domain(RBD), but the affinity was 1000-fold lower than the Ras/RBD interaction, suggesting a lack of functional interaction. shRNA-mediated knockdown of apoptosis signal-regulating kinase 1 (ASK-1) strongly reduced UV or TNF alpha-induced apoptosis and suppressed enhancement by Rheb overexpression. In conclusion, Rheb-mTOR activation not only promotes normal cell growth but also enhances apoptosis in response to diverse toxic stimuli via an ASK-1-mediated mechanism. Pharmacological regulation of the Rheb/mTORC1 pathway using rapamycin should take the presence of cellular stress into consideration, as this may have clinical implications.	[Karassek, Sascha; Goemans, Christoph G.; Neumann, Sebastian; Gottfried, Sebastian; Heumann, Rolf] Ruhr Univ Bochum, Dept Mol Neurobiochem, Fac Chem & Biochem, D-44780 Bochum, Germany; [Berghaus, Carsten; Schwarten, Melanie; Kock, Gerd; Jockers, Katharina; Stoll, Raphael] Ruhr Univ Bochum, Dept Biomol NMR, Fac Chem & Biochem, D-44780 Bochum, Germany; [Ohse, Nadine; Herrmann, Christian] Ruhr Univ Bochum, Dept Phys Chem 1, Fac Chem & Biochem, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Heumann, R (corresponding author), Ruhr Univ Bochum, Dept Mol Neurobiochem, Fac Chem & Biochem, Univ Str 150, D-44780 Bochum, Germany.	rolf.heumann@rub.de; raphael.stoll@rub.de	Schwarten, Melanie/G-6407-2013; Heumann, Rolf/ABB-9675-2021; Heumann, Rolf/AAK-4390-2020	Schwarten, Melanie/0000-0001-8920-9668; Heumann, Rolf/0000-0003-4364-2655; Neumann, Sebastian/0000-0003-3706-9012	Deutsche Forschungsgemeinschaft [SFB 642, A6]; Bundesministerium fur Bildung und Forschung; Fonds der Chemischen Industrie, Protein Center; European Union [FP2005-RII3, 026145]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Fonds der Chemischen Industrie, Protein Center(Fonds der Chemischen Industrie); European Union(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 642, A6.; Supported by the Bundesministerium fur Bildung und Forschung, Fonds der Chemischen Industrie, Protein Center (Nordrhein-Westfalen Center of Excellence), and RUBiospek. To whom correspondence may be addressed: Dept. of Biomolecular NMR, Ruhr University of Bochum, D-44780 Bochum, Germany. Fax: 49-234-32-05466; E-mail: raphael.stoll@rub.de.; We are grateful to Sabine Laerbusch, Gregor Barchan, Martin Gartmann, and Hans-Jochen Hauswald for expert technical help. The 750-MHz spectra were recorded at the SON NMR Large Scale Facility in Utrecht, which is funded by European Union Project "EU-NMR-European Network of Research Infrastructures for Providing Access & Technological Advancement in Bio-NMR" (FP2005-RII3, Contract 026145). We are grateful also to Prof. Dr. von Kiedrowski for providing generous access to the DRX600 spectrometer.	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Bano D, 2007, STROKE, V38, P674, DOI 10.1161/01.STR.0000256294.46009.29; Berghaus C, 2007, BIOMOL NMR ASSIGM, V1, P45, DOI 10.1007/s12104-007-9013-4; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1989, BIOL CHEM H-S, V370, P615; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Chakrabarty K, 2007, EUR J NEUROSCI, V25, P1971, DOI 10.1111/j.1460-9568.2007.05457.x; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Goemans CG, 2008, CELL DEATH DIFFER, V15, P545, DOI 10.1038/sj.cdd.4402290; Hahn M, 2005, MOL CANCER THER, V4, P457; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hansen HH, 2004, NEUROBIOL DIS, V16, P440, DOI 10.1016/j.nbd.2004.03.013; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haubensak W, 1998, J CELL SCI, V111, P1483; Hayakawa T, 2006, MICROBES INFECT, V8, P1098, DOI 10.1016/j.micinf.2005.12.001; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Heumann R, 2000, J CELL BIOL, V151, P1537, DOI 10.1083/jcb.151.7.1537; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; JOHNSON RD, 1994, ABSTR PAP AM CHEM S, V207, P138; Karbowniczek M, 2006, J BIOL CHEM, V281, P25447, DOI 10.1074/jbc.M605273200; Kiel C, 2009, J BIOL CHEM, V284, P31893, DOI 10.1074/jbc.M109.031153; Kita K, 2000, BIOCHEM BIOPH RES CO, V274, P859, DOI 10.1006/bbrc.2000.3220; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Le Mellay V, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-14; Lessmann V, 1997, BRAIN RES, V763, P111; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Li YH, 2008, J BIOL CHEM, V283, P33784, DOI 10.1074/jbc.M802431200; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Ma DZ, 2010, J BIOL CHEM, V285, P8621, DOI 10.1074/jbc.M109.092353; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malagelada C, 2008, J NEUROSCI, V28, P14363, DOI 10.1523/JNEUROSCI.3928-08.2008; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Nowaczyk M, 2004, PHYS CHEM CHEM PHYS, V6, P4878, DOI 10.1039/b407316a; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Ronellenfitsch MW, 2009, BRAIN, V132, P1509, DOI 10.1093/brain/awp093; ROSCH P, 1986, BIOCHEM BIOPH RES CO, V135, P549, DOI 10.1016/0006-291X(86)90029-X; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheper W, 2009, CURR MED CHEM, V16, P615, DOI 10.2174/092986709787458506; Schwarten M, 2007, BIOMOL NMR ASSIGM, V1, P105, DOI 10.1007/s12104-007-9030-3; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Stoll R, 2003, PROTEIN SCI, V12, P510, DOI 10.1110/ps.0222603; Stoll R, 2000, J BIOMOL NMR, V17, P87, DOI 10.1023/A:1008306918293; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200	84	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33979	33991		10.1074/jbc.M109.095968	http://dx.doi.org/10.1074/jbc.M109.095968			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20685651	Green Published, hybrid			2022-12-27	WOS:000283354000045
J	Madeja, M; Steffen, W; Mesic, I; Garic, B; Zhorov, BS				Madeja, Michael; Steffen, Wibke; Mesic, Ivana; Garic, Bojan; Zhorov, Boris S.			Overlapping Binding Sites of Structurally Different Antiarrhythmics Flecainide and Propafenone in the Subunit Interface of Potassium Channel Kv2.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT LEFT-VENTRICLE; K+ CHANNEL; DRUG-BINDING; STEREOSELECTIVE BLOCK; AUTOIMMUNE-DISEASES; INSULIN-SECRETION; SODIUM-CHANNELS; MOLECULAR-BASIS; DOWN-REGULATION; LIGAND-BINDING	Kv2.1 channels, which are expressed in brain, heart, pancreas, and other organs and tissues, are important targets for drug design. Flecainide and propafenone are known to block Kv2.1 channels more potently than other Kv channels. Here, we sought to explore structural determinants of this selectivity. We demonstrated that flecainide reduced the K+ currents through Kv2.1 channels expressed in Xenopus laevis oocytes in a voltage and time-dependent manner. By systematically exchanging various segments of Kv2.1 with those from Kv1.2, we determined flecainide-sensing residues in the P-helix and inner helix S6. These residues are not exposed to the inner pore, a conventional binding region of open channel blockers. The flecainide-sensing residues also contribute to propafenone binding, suggesting overlapping receptors for the drugs. Indeed, propafenone and flecainide compete for binding in Kv2.1. We further used Monte Carlo-energy minimizations to map the receptors of the drugs. Flecainide docking in the Kv1.2-based homology model of Kv2.1 predicts the ligand ammonium group in the central cavity and the benzamide moiety in a niche between S6 and the P-helix. Propafenone also binds in the niche. Its carbonyl group accepts an H-bond from the P-helix, the amino group donates an H-bond to the P-loop turn, whereas the propyl group protrudes in the pore and blocks the access to the selectivity filter. Thus, besides the binding region in the central cavity, certain K+ channel ligands can expand in the subunit interface whose residues are less conserved between K+ channels and hence may be targets for design of highly desirable subtype-specific K+ channel drugs.	[Madeja, Michael; Steffen, Wibke] Univ Munster, Inst Physiol, Munster, Germany; [Madeja, Michael] Goethe Univ Frankfurt, Ctr Physiol, Hertie Res Grp, D-60323 Frankfurt, Germany; [Mesic, Ivana] Univ Darmstadt, Res Grp Mol & Cellular Neurophysiol, D-64289 Darmstadt, Germany; [Garic, Bojan; Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	University of Munster; Goethe University Frankfurt; Technical University of Darmstadt; McMaster University	Madeja, M (corresponding author), Univ Munster, Inst Physiol, Munster, Germany.	MadejaM@ghst.de; zhorov@mcmaster.ca	Zhorov, Boris S./V-8072-2019; Zhorov, Boris/T-9892-2019	Zhorov, Boris/0000-0002-3630-7114	Hertie Foundation; Natural Sciences and Engineering Research Council of Canada	Hertie Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Hertie Foundation (to M. M.) and from the Natural Sciences and Engineering Research Council of Canada (to B. S. Z.).	Ander M, 2008, BIOPHYS J, V94, P820, DOI 10.1529/biophysj.107.112045; Archer SL, 2004, CIRC RES, V95, P308, DOI 10.1161/01.RES.0000137173.42723.fb; Bruhova I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-5; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; Chung JJ, 2005, FEBS J, V272, P3743, DOI 10.1111/j.1742-4658.2005.04802.x; Decher N, 2004, J BIOL CHEM, V279, P394, DOI 10.1074/jbc.M307411200; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dreker T, 2005, MOL PHARMACOL, V68, P966, DOI 10.1124/mol.105.012401; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Huang BY, 2000, J CARDIOVASC ELECTR, V11, P1252, DOI 10.1046/j.1540-8167.2000.01252.x; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Kaczorowski GJ, 1999, CURR OPIN CHEM BIOL, V3, P448, DOI 10.1016/S1367-5931(99)80066-0; KAUDER O, 1991, Pfluegers Archiv European Journal of Physiology, V418, pR77; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; Madeja M, 2003, MOL PHARMACOL, V63, P547, DOI 10.1124/mol.63.3.547; MADEJA M, 1991, J NEUROSCI METH, V38, P267, DOI 10.1016/0165-0270(91)90178-3; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; MOMANY FA, 1975, J PHYS CHEM-US, V79, P2361, DOI 10.1021/j100589a006; Nishiyama A, 1998, CARDIOVASC RES, V40, P343, DOI 10.1016/S0008-6363(98)00135-7; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Qin DY, 2001, BIOCHEM BIOPH RES CO, V283, P549, DOI 10.1006/bbrc.2001.4825; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Rolf S, 2000, N-S ARCH PHARMACOL, V362, P22, DOI 10.1007/s002100000257; Rossokhin A, 2006, MOL PHARMACOL, V69, P1356, DOI 10.1124/mol.105.017970; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Schultz JH, 2001, CIRC RES, V88, P483, DOI 10.1161/01.RES.88.5.483; SNYDERS DJ, 1992, MOL PHARMACOL, V41, P322; Tikhonov DB, 2008, J BIOL CHEM, V283, P17594, DOI 10.1074/jbc.M800141200; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; VALENZUELA C, 1995, BIOPHYS J, V69, P418, DOI 10.1016/S0006-3495(95)79914-3; VALENZUELA C, 1995, CIRCULATION, V92, P3014, DOI 10.1161/01.CIR.92.10.3014; Wareing M, 2006, AM J PHYSIOL-REG I, V291, pR437, DOI 10.1152/ajpregu.00040.2006; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wible B, 1997, BRAIN RES, V761, P42, DOI 10.1016/S0006-8993(97)00315-6; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623; YALE HL, 1959, J MED PHARMACEUT CH, V1, P121, DOI 10.1021/jm50003a001; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	48	9	9	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33898	33905		10.1074/jbc.M110.159897	http://dx.doi.org/10.1074/jbc.M110.159897			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20709754	Green Published, hybrid			2022-12-27	WOS:000283354000036
J	Chakraborty, J; Banerjee, S; Ray, P; Hossain, DMS; Bhattacharyya, S; Adhikary, A; Chattopadhyay, S; Das, T; Sa, G				Chakraborty, Juni; Banerjee, Shuvomoy; Ray, Pallab; Hossain, Dewan Md Sakib; Bhattacharyya, Sankar; Adhikary, Arghya; Chattopadhyay, Sreya; Das, Tanya; Sa, Gaurisankar			Gain of Cellular Adaptation Due to Prolonged p53 Impairment Leads to Functional Switchover from p53 to p73 during DNA Damage in Acute Myeloid Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT KINASES CHK1; DELTA-NP73; APOPTOSIS; FAMILY; CYCLE; P63; EXPRESSION; INHIBITOR; PROTEIN; GROWTH	Tumor suppressor p53 plays the central role in regulating apoptosis in response to genotoxic stress. From an evolutionary perspective, the activity of p53 has to be backed up by other protein( s) in case of any functional impairment of this protein, to trigger DNA damage-induced apoptosis in cancer cells. We adopted multiple experimental approaches to demonstrate that in p53-impaired cancer cells, DNA damage caused accumulation of p53 paralogue p73 via Chk-1 that strongly impacted Bax expression and p53-independent apoptosis. On the contrary, when p53 function was restored by ectopic expression, Chk-2 induced p53 accumulation that in turn overshadowed p73 activity, suggesting an antagonistic interaction between p53 family members. To understand such interaction better, p53-expressing cells were impaired differentially for p53 activity. In wildtype p53-expressing cancer cells that were silenced for p53 for several generations, p73 was activated, whereas no such trend was observed when p53 was transiently silenced. Prolonged p53 interference, even in functional p53 settings, therefore, leads to the "gain of cellular adaptation" in a way that alters the cellular microenvironment in favor of p73 activation by altering p73-regulatory proteins, e.g. Chk1 activation and dominant negative p73 down-regulation. These findings not only unveil a hitherto unexplained mechanism underlying the functional switchover from p53 to p73, but also validate p73 as a promising and potential target for cancer therapy in the absence of functional p53.	[Chakraborty, Juni; Banerjee, Shuvomoy; Ray, Pallab; Hossain, Dewan Md Sakib; Bhattacharyya, Sankar; Adhikary, Arghya; Chattopadhyay, Sreya; Das, Tanya; Sa, Gaurisankar] Bose Inst, Div Mol Med, Kolkata 700054, India	Department of Science & Technology (India); Bose Institute	Sa, G (corresponding author), Bose Inst, Div Mol Med, P-1-12 CIT Scheme 7 M, Kolkata 700054, India.	gauri@bic.boseinst.ernet.in	Bhattacharyya, Sankar/GZH-3091-2022; Bhattacharyya, Sankar/AAK-2204-2020; Banerjee, Shuvomoy/AAZ-2479-2021	Bhattacharyya, Sankar/0000-0002-3235-4220; Banerjee, Shuvomoy/0000-0002-6936-1950	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by research grants from the Department of Science and Technology, Government of India.	Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Balint E, 2002, P NATL ACAD SCI USA, V99, P3529, DOI 10.1073/pnas.062491899; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Belloni L, 2006, ONCOGENE, V25, P3606, DOI 10.1038/sj.onc.1209321; Bhattacharyya S, 2007, J BIOL CHEM, V282, P15954, DOI 10.1074/jbc.M608189200; Bhattacharyya S, 2007, CANCER RES, V67, P362, DOI 10.1158/0008-5472.CAN-06-2583; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Damia G, 2004, CELL CYCLE, V3, P46; Damia G, 2001, J BIOL CHEM, V276, P10641, DOI 10.1074/jbc.M007178200; Durland-Busbice S, 2002, LEUKEMIA, V16, P2165, DOI 10.1038/sj.leu.2402647; Ehrhardt H, 2008, ONCOGENE, V27, P783, DOI 10.1038/sj.onc.1210666; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Grob TJ, 2002, CELL DEATH DIFFER, V9, P229, DOI 10.1038/sj.cdd.4401018; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Johnson RA, 2005, J BIOL CHEM, V280, P13213, DOI 10.1074/jbc.M414646200; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Kravchenko JE, 2008, P NATL ACAD SCI USA, V105, P6302, DOI 10.1073/pnas.0802091105; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Ng CP, 2004, J BIOL CHEM, V279, P8808, DOI 10.1074/jbc.M312215200; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Ra H, 2009, FEBS LETT, V583, P1516, DOI 10.1016/j.febslet.2009.04.008; Sa G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-14; Seifert H, 2009, LEUKEMIA, V23, P656, DOI 10.1038/leu.2008.375; Tannapfel A, 2008, CARCINOGENESIS, V29, P211, DOI 10.1093/carcin/bgm236; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang J, 2007, MOL CELL BIOL, V27, P3868, DOI 10.1128/MCB.02112-06	38	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33104	33112		10.1074/jbc.M110.122705	http://dx.doi.org/10.1074/jbc.M110.122705			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20675383	Green Published, hybrid			2022-12-27	WOS:000283048200048
J	Buzzo, CL; Campopiano, JC; Massis, LM; Lage, SL; Cassado, AA; Leme-Souza, R; Cunha, LD; Russo, M; Zamboni, DS; Amarante-Mendes, GP; Bortoluci, KR				Buzzo, Carina L.; Campopiano, Julia C.; Massis, Liliana M.; Lage, Silvia L.; Cassado, Alexandra A.; Leme-Souza, Rafael; Cunha, Larissa D.; Russo, Momtchilo; Zamboni, Dario S.; Amarante-Mendes, Gustavo P.; Bortoluci, Karina R.			A Novel Pathway for Inducible Nitric-oxide Synthase Activation through Inflammasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; LEGIONELLA-PNEUMOPHILA; GAMMA-INTERFERON; IMMUNE-RESPONSES; GENE-EXPRESSION; CELL-DEATH; MACROPHAGES; FLAGELLIN; IPAF; CASPASE-1	Innate immune recognition of flagellin is shared by transmembrane TLR5 and cytosolic Nlrc4 (NOD-like receptor family CARD (caspase activation recruitment domain) domain containing 4)/Naip5 (neuronal apoptosis inhibitory protein 5). TLR5 activates inflammatory genes through MYD88 pathway, whereas Nlrc4 and Naip5 assemble multiprotein complexes called inflammasomes, culminating in caspase-1 activation, IL-1 beta/IL-18 secretion, and pyroptosis. Although both TLR5 and Naip5/Nlrc4 pathways cooperate to clear infections, little is known about the relative anti-pathogen effector mechanisms operating through each of them. Here we show that the cytosolic flagellin (FLA-BSDot) was able to activate iNOS, an enzyme previously associated with TLR5 pathway. Using Nlrc4- or Naip5-deficient macrophages, we found that both receptors are involved in iNOS activation by FLA-BSDot. Moreover, distinct from extracellular flagellin (FLA-BS), iNOS activation by intracellular flagellin is completely abrogated in the absence of caspase-1. Interestingly, IL-1 beta and IL-18 do not seem to be important for FLA-BSDot-mediated iNOS production. Together, our data defined an additional anti-pathogen effector mechanism operated through Naip5 and Nlrc4 inflammasomes and illustrated a novel signaling transduction pathway that activates iNOS.	[Bortoluci, Karina R.] Univ Fed Sao Paulo, Dept Biol Sci, BR-04044010 Sao Paulo, Brazil; [Leme-Souza, Rafael; Russo, Momtchilo; Amarante-Mendes, Gustavo P.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508900 Sao Paulo, Brazil; [Massis, Liliana M.; Cunha, Larissa D.; Zamboni, Dario S.] Univ Sao Paulo, Dept Biol Celular, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, Brazil; [Amarante-Mendes, Gustavo P.] Inst Nacl Ciencia Tecnol, Inst Invest Imunol, BR-05508900 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Bortoluci, KR (corresponding author), Univ Fed Sao Paulo, Dept Biol Sci, Campus Diadema & CTC Mol,R Mirassol,207 Vila Clem, BR-04044010 Sao Paulo, Brazil.	kbortoluci@gmail.com	Campopiano, Julia/O-9979-2015; Bortoluci, Karina/C-6018-2012; Massis, Liliana Moura/G-3660-2013; Zamboni, Dario S/D-3024-2012; Bortoluci, Karina/P-9296-2019; Cassado, Alexandra/J-1680-2015; Mendes, Gustavo P Amarante/C-8187-2012; Cunha, Larissa D/I-4204-2012	Bortoluci, Karina/0000-0001-6780-5397; Massis, Liliana Moura/0000-0001-8938-9507; Zamboni, Dario S/0000-0002-7856-7512; Bortoluci, Karina/0000-0001-6780-5397; Mendes, Gustavo P Amarante/0000-0002-7851-6205; Dias da Cunha, Larissa/0000-0002-1290-0263; Lucena Lage, Silvia/0000-0001-8519-8164	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil); Brazilian Research Council (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil) and the Brazilian Research Council (CNPq).	Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Bastos KRB, 2002, J LEUKOCYTE BIOL, V71, P271; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fortier A, 2009, INFECT IMMUN, V77, P4794, DOI 10.1128/IAI.01546-08; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; GEBRAN SJ, 1994, INFECT IMMUN, V62, P3197, DOI 10.1128/IAI.62.8.3197-3205.1994; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Juttler E, 2007, MOL CELL NEUROSCI, V34, P612, DOI 10.1016/j.mcn.2007.01.004; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; MISKO TP, 1993, EUR J PHARMACOL, V233, P119, DOI 10.1016/0014-2999(93)90357-N; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Simberg D, 2004, CRIT REV THER DRUG, V21, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i4.10; Skerrett SJ, 1996, INFECT IMMUN, V64, P3236, DOI 10.1128/IAI.64.8.3236-3243.1996; SUMMERSGILL JT, 1992, J LEUKOCYTE BIOL, V52, P625, DOI 10.1002/jlb.52.6.625; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Totemeyer S, 2006, J IMMUNOL, V176, P4804, DOI 10.4049/jimmunol.176.8.4804; Weinlich R, 2008, CELL DEATH DIFFER, V15, P1901, DOI 10.1038/cdd.2008.128; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003	47	36	36	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32087	32095		10.1074/jbc.M110.124297	http://dx.doi.org/10.1074/jbc.M110.124297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702413	Green Published, hybrid			2022-12-27	WOS:000282683000022
J	Vassilevski, AA; Fedorova, IM; Maleeva, EE; Korolkova, YV; Efimova, SS; Samsonova, OV; Schagina, LV; Feofanov, AV; Magazanik, LG; Grishin, EV				Vassilevski, Alexander A.; Fedorova, Irina M.; Maleeva, Ekaterina E.; Korolkova, Yuliya V.; Efimova, Svetlana S.; Samsonova, Olga V.; Schagina, Ludmila V.; Feofanov, Alexei V.; Magazanik, Lev G.; Grishin, Eugene V.			Novel Class of Spider Toxin ACTIVE PRINCIPLE FROM THE YELLOW SAC SPIDER CHEIRACANTHIUM PUNCTORIUM VENOM IS A UNIQUE TWO-DOMAIN POLYPEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; CYSTINE KNOT STRUCTURE; AMINO-ACID-SEQUENCE; CUPIENNIUS-SALEI; ION CHANNELS; ANTIMICROBIAL PEPTIDES; CYTOLYTIC PEPTIDES; CALCIUM-CHANNEL; SKELETAL-MUSCLE	Venom of the yellow sac spider Cheiracanthium punctorium (Miturgidae) was found unique in terms of molecular composition. Its principal toxic component CpTx 1 (15.1 kDa) was purified, and its full amino acid sequence (134 residues) was established by protein chemistry and mass spectrometry techniques. CpTx 1 represents a novel class of spider toxin with modular architecture. It consists of two different yet homologous domains (modules) each containing a putative inhibitor cystine knot motif, characteristic of the widespread single domain spider neurotoxins. Venom gland cDNA sequencing provided precursor protein (prepropeptide) structures of three CpTx 1 isoforms (a-c) that differ by single residue substitutions. The toxin possesses potent insecticidal (paralytic and lethal), cytotoxic, and membrane-damaging activities. In both fly and frog neuromuscular preparations, it causes stable and irreversible depolarization of muscle fibers leading to contracture. This effect appears to be receptor-independent and is inhibited by high concentrations of divalent cations. CpTx 1 lyses cell membranes, as visualized by confocal microscopy, and destabilizes artificial membranes in a manner reminiscent of other membrane-active peptides by causing numerous defects of variable conductance and leading to bilayer rupture. The newly discovered class of modular polypeptides enhances our knowledge of the toxin universe.	[Vassilevski, Alexander A.; Samsonova, Olga V.; Feofanov, Alexei V.; Grishin, Eugene V.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Fedorova, Irina M.; Magazanik, Lev G.] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia; [Efimova, Svetlana S.; Schagina, Ludmila V.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Vassilevski, AA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Mik Lukho Maklaya,16-10, Moscow 117997, Russia.	avas@ibch.ru	Vassilevski, Alexander/S-3824-2016; Magazanik, Lev G/K-4380-2014; Feofanov, Alexey V/K-3082-2012; Efimova, Svetlana S./I-8716-2014	Vassilevski, Alexander/0000-0002-1359-0076; Magazanik, Lev G/0000-0002-5856-5798; Feofanov, Alexey V/0000-0002-1596-9506; Efimova, Svetlana S./0000-0002-2429-2007	Federal Agency for Education of the Russian Federation State [P1388]; Russian Foundation for Basic Research [08-04-00326, 08-04-00454, 09-04-00883]; Russian Scientific Schools [4821.2008.4, 3796.2010.4]; Russian Academy of Sciences	Federal Agency for Education of the Russian Federation State; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Scientific Schools; Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Federal Agency for Education of the Russian Federation State Contract P1388, the Russian Foundation for Basic Research Grants 08-04-00326, 08-04-00454, and 09-04-00883, the Russian Scientific Schools Grants 4821.2008.4 and 3796.2010.4, and the Program of Cell and Molecular Biology of the Russian Academy of Sciences.	Artigas P, 2006, P NATL ACAD SCI USA, V103, P12613, DOI 10.1073/pnas.0602720103; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; CHUA M, 1991, BIOPHYS J, V59, P1251, DOI 10.1016/S0006-3495(91)82340-2; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; Darbre A., 1986, PRACTICAL PROTEIN CH; Diego-Garcia E, 2007, PEPTIDES, V28, P31, DOI 10.1016/j.peptides.2006.06.012; ECAULT E, 1991, BRIT J PHARMACOL, V102, P523, DOI 10.1111/j.1476-5381.1991.tb12204.x; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Estrada G, 2007, NAT PROD REP, V24, P145, DOI 10.1039/b603083c; Fedorova IM, 2009, COMP BIOCHEM PHYS C, V149, P275, DOI 10.1016/j.cbpc.2008.07.010; Fitches E, 2004, J INSECT PHYSIOL, V50, P61, DOI 10.1016/j.jinsphys.2003.09.010; Foradori MJ, 2005, COMP BIOCHEM PHYS C, V141, P32, DOI 10.1016/j.cca.2005.05.001; Furman D. P., 1957, California Medicine, V87, P114; GERBER U, 1991, NEUROSCI LETT, V134, P53, DOI 10.1016/0304-3940(91)90507-P; Gomez MV, 2002, CELL MOL NEUROBIOL, V22, P579, DOI 10.1023/A:1021836403433; GRIMES PA, 1982, ARCH OPHTHALMOL-CHIC, V100, P635, DOI 10.1001/archopht.1982.01030030637022; Grishin E, 1999, EUR J BIOCHEM, V264, P276, DOI 10.1046/j.1432-1327.1999.00622.x; GRISHIN EV, 1989, TOXICON, V27, P541, DOI 10.1016/0041-0101(89)90115-3; Grishin EV, 1998, TOXICON, V36, P1693, DOI 10.1016/S0041-0101(98)00162-7; Khan SA, 2006, TRANSGENIC RES, V15, P349, DOI 10.1007/s11248-006-0007-2; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kozlov S, 2005, TOXICON, V46, P672, DOI 10.1016/j.toxicon.2005.07.009; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Kubista H, 2007, NEUROPHARMACOLOGY, V52, P1650, DOI 10.1016/j.neuropharm.2007.03.012; Kuhn-Nentwig L, 2003, CELL MOL LIFE SCI, V60, P2651, DOI 10.1007/s00018-003-3106-8; KUHNNENTWIG L, 1994, TOXICON, V32, P287, DOI 10.1016/0041-0101(94)90082-5; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; MAGAZANIK LG, 1992, NEUROSCIENCE, V46, P181, DOI 10.1016/0306-4522(92)90017-V; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mellor IR, 2004, TOXICON, V43, P493, DOI 10.1016/j.toxicon.2004.02.003; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Narahashi T, 2008, P JPN ACAD B-PHYS, V84, P147, DOI 10.2183/pjab.84.147; Nikolsky AS, 2009, BIOCHEM MOSC SUPPL S, V3, P245, DOI 10.1134/S1990747809030027; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Petrinos, 2009, PROTEIN BIOSYNTHESIS, P225; PLATNICK NI, 2009, WORLD SPIDER CATALOG; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Schaller J, 2001, CELL MOL LIFE SCI, V58, P1538, DOI 10.1007/PL00000794; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STOHR M, 1980, FLOW CYTOMETRY, V4, P96; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; Tedford HW, 2004, TOXICON, V43, P601, DOI 10.1016/j.toxicon.2004.02.010; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Vassilevski AA, 2008, BIOCHEM J, V411, P687, DOI [10.1042/BJ20071123, 10.1042/bj20071123]; Vassilevski AA, 2010, METHODS MOL BIOL, V615, P87, DOI 10.1007/978-1-60761-535-4_7; Vetter RS, 2008, ANNU REV ENTOMOL, V53, P409, DOI 10.1146/annurev.ento.53.103106.093503; Vetter RS, 2006, AM J TROP MED HYG, V74, P1043, DOI 10.4269/ajtmh.2006.74.1043; Wehner F, 2006, ACTA PHYSIOL, V187, P21, DOI 10.1111/j.1748-1716.2006.01561.x; Wu CH, 2009, TOXICON, V54, P1183, DOI 10.1016/j.toxicon.2009.02.030; Wullschleger B, 2005, J EXP BIOL, V208, P2115, DOI 10.1242/jeb.01594; Wullschleger B, 2004, P NATL ACAD SCI USA, V101, P11251, DOI 10.1073/pnas.0402226101; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001	62	38	44	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32293	32302		10.1074/jbc.M110.104265	http://dx.doi.org/10.1074/jbc.M110.104265			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20657014	Green Published, hybrid			2022-12-27	WOS:000282683000042
J	Baekgaard, L; Mikkelsen, MD; Sorensen, DM; Hegelund, JN; Persson, DP; Mills, RF; Yang, Z; Husted, S; Andersen, JP; Buch-Pedersen, MJ; Schjoerring, JK; Williams, LE; Palmgren, MG				Baekgaard, Lone; Mikkelsen, Maria D.; Sorensen, Danny M.; Hegelund, Josefine N.; Persson, Daniel P.; Mills, Rebecca F.; Yang, Zhang; Husted, Soren; Andersen, Jens Peter; Buch-Pedersen, Morten J.; Schjoerring, Jan K.; Williams, Lorraine E.; Palmgren, Michael G.			A Combined Zinc/Cadmium Sensor and Zinc/Cadmium Export Regulator in a Heavy Metal Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT PLASMA-MEMBRANE; P-TYPE ATPASE; COPPER-TRANSPORTING ATPASE; WILSONS-DISEASE PROTEIN; N-TERMINAL DOMAIN; H+-ATPASE; BINDING DOMAIN; P-1B-TYPE ATPASE; MENKES PROTEIN; FUNCTIONAL EXPRESSION	Heavy metal pumps (P1B-ATPases) are important for cellular heavy metal homeostasis. AtHMA4, an Arabidopsis thaliana heavy metal pump of importance for plant Zn2+ nutrition, has an extended C-terminal domain containing 13 cysteine pairs and a terminal stretch of 11 histidines. Using a novel size-exclusion chromatography, inductively coupled plasma mass spectrometry approach we report that the C-terminal domain of AtHMA4 is a high affinity Zn2+ and Cd2+ chelator with capacity to bind 10 Zn2+ ions per C terminus. When AtHMA4 is expressed in a Zn2+-sensitive zrc1 cot1 yeast strain, sequential removal of the histidine stretch and the cysteine pairs confers a gradual increase in Zn2+ and Cd2+ tolerance and lowered Zn2+ and Cd2+ content of transformed yeast cells. We conclude that the C-terminal domain of AtHMA4 serves a dual role as Zn2+ and Cd2+ chelator (sensor) and as a regulator of the efficiency of Zn2+ and Cd2+ export. The identification of a post-translational handle on Zn2+ and Cd2+ transport efficiency opens new perspectives for regulation of Zn2+ nutrition and tolerance in eukaryotes.	[Yang, Zhang; Buch-Pedersen, Morten J.] Univ Copenhagen, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis, PUMPKIN,Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Hegelund, Josefine N.; Persson, Daniel P.; Husted, Soren; Schjoerring, Jan K.] Univ Copenhagen, Dept Agr & Ecol, DK-1871 Frederiksberg C, Denmark; [Mills, Rebecca F.; Williams, Lorraine E.] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England; [Andersen, Jens Peter] Aarhus Univ, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis, PUMPKIN,Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark	Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; University of Southampton; Aarhus University; Danmarks Grundforskningsfond	Palmgren, MG (corresponding author), Univ Copenhagen, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis, PUMPKIN,Dept Plant Biol & Biotechnol, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@life.ku.dk	Mikkelsen, Maria Dalgaard/AAP-3139-2021; Husted, Søren/H-4649-2014; Mikkelsen, Maria/R-1243-2016; Persson, Daniel Pergament/M-6819-2015; Palmgren, Michael/A-9808-2013; Schjoerring, Jan K./A-5387-2009; Hegelund, Josefine Nymark/N-4732-2014; Schjoerring, Jan K./M-4044-2019; Yang, Zhang/I-8934-2016	Mikkelsen, Maria Dalgaard/0000-0003-4297-6119; Husted, Søren/0000-0003-2020-1902; Persson, Daniel Pergament/0000-0003-3976-190X; Palmgren, Michael/0000-0002-9982-6114; Schjoerring, Jan K./0000-0002-2852-3298; Hegelund, Josefine Nymark/0000-0002-5663-9503; Schjoerring, Jan K./0000-0002-2852-3298; Andersen, Jens Peter/0000-0003-0654-4300; Yang, Zhang/0000-0002-4756-5813	European Union	European Union(European Commission)	This work was supported by the European Union Framework Programme 6 as part of the Integrated Project Public health impact of long term, low level mixed element exposure in susceptible population strata.	Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Bal N, 2001, FEBS LETT, V506, P249, DOI 10.1016/S0014-5793(01)02927-1; Banci L, 2002, J MOL BIOL, V317, P415, DOI 10.1006/jmbi.2002.5430; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Baunsgaard L, 1996, PLANT J, V10, P451, DOI 10.1046/j.1365-313X.1996.10030451.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; Drager DB, 2004, PLANT J, V39, P425, DOI 10.1111/j.1365-313X.2004.02143.x; EREN E, 2007, J M BIOCH, V46, P7754; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Goodyer ID, 1999, HUM MOL GENET, V8, P1473, DOI 10.1093/hmg/8.8.1473; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Harrison MD, 1999, BBA-MOL BASIS DIS, V1453, P254, DOI 10.1016/S0925-4439(98)00110-0; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; Jensen PY, 1999, BBA-PROTEIN STRUCT M, V1434, P103, DOI 10.1016/S0167-4838(99)00161-2; Kjelstrup S, 2005, PHYS CHEM CHEM PHYS, V7, P4009, DOI 10.1039/b511990a; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; LUTSENKO S, 1995, J H BIOCH, V34, P15607; MAGER M, 1953, J HISTOCHEM CYTOCHEM, V1, P493, DOI 10.1177/1.6.493; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; MANDAL AK, 2003, J M BIOCH, V42, P11040; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Mitra B, 2001, BIOCHEMISTRY-US, V40, P7694, DOI 10.1021/bi010576g; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Persson DP, 2009, METALLOMICS, V1, P418, DOI 10.1039/b905688b; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Sumbilla C, 2002, J BIOL CHEM, V277, P13900, DOI 10.1074/jbc.M111155200; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; VILSEN B, 1998, J BIOCH, V37, P10961; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Wong CKE, 2009, NEW PHYTOL, V181, P79, DOI 10.1111/j.1469-8137.2008.02637.x; Zimmermann M, 2009, BIOCHEMISTRY-US, V48, P11640, DOI 10.1021/bi901573b	58	57	60	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31243	31252		10.1074/jbc.M110.111260	http://dx.doi.org/10.1074/jbc.M110.111260			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20650903	Green Published, hybrid			2022-12-27	WOS:000282764600018
J	Ieguchi, K; Fujita, M; Ma, Z; Davari, P; Taniguchi, Y; Sekiguchi, K; Wang, B; Takada, YK; Takada, Y				Ieguchi, Katsuaki; Fujita, Masaaki; Ma, Zi; Davari, Parastoo; Taniguchi, Yukimasa; Sekiguchi, Kiyotoshi; Wang, Bobby; Takada, Yoko K.; Takada, Yoshikazu			Direct Binding of the EGF-like Domain of Neuregulin-1 to Integrins (alpha v beta 3 and alpha 6 beta 4) Is Involved in Neuregulin-1/ErbB Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; LIGAND-BINDING; CARCINOMA INVASION; TYROSINE KINASES; IN-VIVO; HEREGULIN; EXPRESSION; RECEPTOR; ADHESION; DIFFERENTIATION	Integrin-growth factor receptor cross-talk plays a role in growth factor signaling, but the specifics are unclear. In a current model, integrins and growth factor receptors independently bind to their ligands (extracellular matrix and growth factors, respectively). We discovered that neuregulin-1 (NRG1), either as an isolated EGF-like domain or as a native multi-domain form, binds to integrins alpha v beta 3 (with a K-D of 1.36 x 10(-7) M) and alpha 6 beta 4. Docking simulation predicted that three Lys residues at positions 180, 184, and 186 of the EGF-like domain are involved in integrin binding. Mutating these residues to Glu individually or in combination markedly suppressed integrin binding and ErbB3 phosphorylation. Mutating all three Lys residues to Glu (the 3KE mutation) did not affect the ability of NRG1 to bind to ErbB3 but markedly reduced the ability of NRG1 to induce ErbB3 phosphorylation and AKT and Erk1/2 activation in MCF-7 and T47D human breast cancer cells. This suggests that direct integrin binding to NRG1 is critical for NRG1/ErbB signaling. Notably, stimulation of cells with WT NRG1 induced co-precipitation of ErbB3 with alpha 6 beta 4 and with alpha v beta 3 to a much lower extent. This suggests that WT NRG1 induces integrin-NRG1-ErbB3 ternary complex formation. In contrast, the 3KE mutant was much less effective in inducing ternary complex formation than WT NRG1, suggesting that this process depends on the ability of NRG1 to bind to integrins. These results suggest that direct NRG1-integrin interaction mediates integrin-ErbB cross-talk and that alpha 6 beta 4 plays a major role in NRG-ErbB signaling in these cancer cells.	[Ieguchi, Katsuaki; Fujita, Masaaki; Ma, Zi; Davari, Parastoo; Wang, Bobby; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Dept Dermatol, Sch Med, Sacramento, CA 95817 USA; [Taniguchi, Yukimasa; Sekiguchi, Kiyotoshi] Osaka Univ, Lab Extracellular Matrix Biochem, Inst Prot Res, Suita, Osaka 5650871, Japan	University of California System; University of California Davis; Osaka University	Takada, Y (corresponding author), Univ Calif Davis, Dept Dermatol, Sch Med, Res 3 Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA131015, CA113298, CA093373, U19 NCDDG]; Department of Defense [W81XWH-10-1-0312]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20370046]; NATIONAL CANCER INSTITUTE [R01CA131015, U19CA113298, P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA131015, CA113298, CA093373, and U19 NCDDG grant (to Yoshikazu Takada). This work was also supported by Department of Defense Grant W81XWH-10-1-0312 (to Yoshikazu Takada) and Grant-in-aid for Scientific Research 20370046 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. S.).	Atlas E, 2003, MOL CANCER RES, V1, P165; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Busfield SJ, 1997, MOL CELL BIOL, V17, P4007, DOI 10.1128/MCB.17.7.4007; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Chung J, 2004, J BIOL CHEM, V279, P32287, DOI 10.1074/jbc.M403809200; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; FALCIONI R, 1986, CANCER RES, V46, P5772; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; Kamata T, 2001, INT J HEMATOL, V74, P382, DOI 10.1007/BF02982080; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Li QF, 2004, CANCER RES, V64, P7078, DOI 10.1158/0008-5472.CAN-04-1152; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2003, CLIN EXP METASTAS, V20, P569, DOI 10.1023/A:1025819521707; Liu W, 1999, BIOCHEM BIOPH RES CO, V261, P897, DOI 10.1006/bbrc.1999.1144; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Meyer D, 1997, DEVELOPMENT, V124, P3575; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mould AP, 2009, BIOCHEM J, V424, P179, DOI 10.1042/BJ20090992; Murgia C, 1998, EMBO J, V17, P3940, DOI 10.1093/emboj/17.14.3940; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schmitt A, 2008, EUR ARCH PSY CLIN N, V258, P35, DOI 10.1007/s00406-008-5019-x; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Tang CK, 1996, CANCER RES, V56, P3350; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Vellon L, 2005, ONCOGENE, V24, P3759, DOI 10.1038/sj.onc.1208452; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; Zhang XP, 1999, BIOCHEMISTRY-US, V38, P14424, DOI 10.1021/bi990323b	53	55	64	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31388	31398		10.1074/jbc.M110.113878	http://dx.doi.org/10.1074/jbc.M110.113878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682778	Green Published, hybrid			2022-12-27	WOS:000282764600033
J	Nemere, I; Garbi, N; Hammerling, GJ; Khanal, RC				Nemere, Ilka; Garbi, Natalio; Haemmerling, Gunter J.; Khanal, Ramesh C.			Intestinal Cell Calcium Uptake and the Targeted Knockout of the 1,25D(3)-MARRS (Membrane-associated, Rapid Response Steroid-binding) Receptor/PDIA3/Erp57	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; ESTROGEN-RECEPTORS; INITIATED ACTIONS; 1,25(OH)(2)D-3; TRANSPORT; HORMONE; D-3	We have crossed ERp57(flx/flx) mice with commercially available mice expressing villin-driven cre-recombinase. Lysates of intestinal epithelial cells were prepared from knock-out (KO) mice and littermates (LM) and used in Western blot analyses with Ab099 against the N terminus of the 1,25D(3)-MARRS (membrane-associated, rapid response steroid-binding) receptor: LM mice exhibited one positive band, which was absent in preparations from KO mice. Saturation analyses of cell lysates with [H-3] 1,25D(3) revealed negligible binding in preparations from either female or male KOs. Lysates from female and male LM mice had similar affinities but different numbers of binding sites. Isolated enterocytes were tested for steroid-stimulated calcium uptake. Treatment of cells from female or male LM mice with 1,25D(3) elicited enhanced calcium uptake in females and males within 5 min. Intestinal cells from KO mice exhibited a severely blunted or completely absent response to hormone. Confocal microscopy of intestinal cells revealed the presence of cell surface vitamin D receptors. However, antibodies to the vitamin D receptor failed to block 1,25D(3)-stimulated calcium uptake. In chick enterocytes we have found that the PKA pathway mediates calcium uptake. The time course for activation of PKA in mouse enterocytes paralleled that for enhanced calcium uptake and for LM females reached 250% of controls within 5 min, and 150% of controls in cells prepared from LM males. Enterocytes from female or male KO mice failed to exhibit steroid hormone-stimulated PKA activity, but did respond to forskolin with enhanced calcium uptake. We conclude that the 1,25D(3)-MARRS receptor is of central importance to steroid hormone-stimulated calcium uptake in mammalian intestinal cells.	[Nemere, Ilka; Khanal, Ramesh C.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA; [Garbi, Natalio; Haemmerling, Gunter J.] German Canc Res Ctr, Div Mol Immunol, D-69120 Heidelberg, Germany	Utah System of Higher Education; Utah State University; Helmholtz Association; German Cancer Research Center (DKFZ)	Nemere, I (corresponding author), Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA.	ilka.nemere@usu.edu	Garbi, Natalio/H-7666-2014; Garbi, Natalio/B-9147-2009					Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Khanal RC, 2008, J CELL BIOCHEM, V105, P1109, DOI 10.1002/jcb.21913; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Kumar P, 2007, MOL ENDOCRINOL, V21, P1370, DOI 10.1210/me.2006-0360; Lambert JR, 2007, BIOCHEM BIOPH RES CO, V361, P189, DOI 10.1016/j.bbrc.2007.07.012; Larsson B, 2003, ENDOCRINOLOGY, V144, P1726, DOI 10.1210/en.2002-221060; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; Mizwicki MT, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275re4; NEMERE I, 1981, ENDOCRINOLOGY, V108, P1450, DOI 10.1210/endo-108-4-1450; Nemere I, 2004, P NATL ACAD SCI USA, V101, P7392, DOI 10.1073/pnas.0402207101; Nemere I, 2000, AM J PHYSIOL-ENDOC M, V278, pE1104, DOI 10.1152/ajpendo.2000.278.6.E1104; Nemere K, 2005, STEROIDS, V70, P455, DOI 10.1016/j.steroids.2005.02.005; Primm TP, 2001, J BIOL CHEM, V276, P281, DOI 10.1074/jbc.M007670200; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Sterling TM, 2005, J ENDOCRINOL, V185, P81, DOI 10.1677/joe.1.05945; Sterling TM, 2007, STEROIDS, V72, P151, DOI 10.1016/j.steroids.2006.11.003; SZEGO CM, 1985, NATURE, V317, P88, DOI 10.1038/317088a0; Tubbs C, 2010, GEN COMP ENDOCR, V165, P144, DOI 10.1016/j.ygcen.2009.06.017; Wali RK, 2003, J CELL BIOCHEM, V88, P794, DOI 10.1002/jcb.10432; Walters MR, 2004, CELL MOL LIFE SCI, V61, P2309, DOI 10.1007/s00018-004-4065-4	20	62	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31859	U940		10.1074/jbc.M110.116954	http://dx.doi.org/10.1074/jbc.M110.116954			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682787	hybrid, Green Published			2022-12-27	WOS:000282764600077
J	Zhuo, DX; Niu, XH; Chen, YC; Xin, DQ; Guo, YL; Mao, ZB				Zhuo, De Xiang; Niu, Xiao Hua; Chen, Yi Cheng; Xin, Dian Qi; Guo, Ying Lu; Mao, Ze Bin			Vitamin D-3 Up-regulated Protein 1(VDUP1) Is Regulated by FOXO3A and miR-17-5p at the Transcriptional and Post-transcriptional Levels, Respectively, in Senescent Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-BINDING PROTEIN-2; REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; OXIDATIVE STRESS; MESSENGER-RNA; EXPRESSION; CANCER; GROWTH; CELLS; GENE	Vitamin D-3 up-regulated protein 1 (VDUP1) plays multifunctional roles in diverse cellular responses, particularly in its relation to proliferation, apoptosis, differentiation, and diseases such as cancer and stress-related diseases. In this study, we demonstrated that VDUP1 was up-regulated during the senescence process. Our results showed that overexpression of VDUP1 in young cells caused typical signs of senescence. We also found that VDUP1 knockdown delayed the onset of Ras-induced cellular senescence. Subsequently, we found that FOXO3A, whose activity increased in senescent cells, transcriptionally up-regulates VDUP1 expression and miR-17-5p, whose expression decreased in senescent cells, directly interacted with the 3'-un-translated region of VDUP1 transcripts, and destabilized VDUP1 mRNA in young cells. These results indicated that VDUP1 expression was regulated by FOXO3A at the transcriptional level and by miR-17-5p at the post-transcriptional levels during the senescence process.	[Zhuo, De Xiang; Mao, Ze Bin] Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Niu, Xiao Hua; Chen, Yi Cheng; Xin, Dian Qi; Guo, Ying Lu] Peking Univ, Dept Urol, Hosp 1, Beijing 100034, Peoples R China; [Niu, Xiao Hua; Chen, Yi Cheng; Xin, Dian Qi; Guo, Ying Lu] Peking Univ, Inst Urol, Beijing 100034, Peoples R China	Peking University; Peking University; Peking University	Mao, ZB (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China.	zbmao@bjmu.edu.cn			National Basic Research Programs of China [2007CB507400]; National Science Foundation of China [30672201, 306210021]	National Basic Research Programs of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Programs of China Grant 2007CB507400 and the National Science Foundation of China Grants 30672201 and 306210021.	Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Campisi J, 2000, IN VIVO, V14, P183; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; Dutta KK, 2005, LAB INVEST, V85, P798, DOI 10.1038/labinvest.3700280; Faragher RGA, 1998, BIOESSAYS, V20, P985, DOI 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.3.CO;2-1; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; HAYFLICK L, 1975, FED PROC, V34, P9; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Mawal-Dewan M, 2002, J BIOL CHEM, V277, P7857, DOI 10.1074/jbc.M104515200; Nishinaka Y, 2004, CANCER RES, V64, P1287, DOI 10.1158/0008-5472.CAN-03-0908; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; ROHME D, 1981, P NATL ACAD SCI-BIOL, V78, P5009, DOI 10.1073/pnas.78.8.5009; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Takahashi Y, 2002, ONCOL REP, V9, P75; TANG ZQ, 1994, MECH AGEING DEV, V73, P57, DOI 10.1016/0047-6374(94)90038-8; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Yang XQ, 1998, BREAST CANCER RES TR, V48, P33, DOI 10.1023/A:1005929714900; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	41	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31491	31501		10.1074/jbc.M109.068387	http://dx.doi.org/10.1074/jbc.M109.068387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20656682	hybrid, Green Published			2022-12-27	WOS:000282764600043
J	Brini, M; Di Leva, F; Ortega, CK; Domi, T; Ottolini, D; Leonardi, E; Tosatto, SCE; Carafoli, E				Brini, Marisa; Di Leva, Francesca; Ortega, Claudia K.; Domi, Teuta; Ottolini, Denis; Leonardi, Emanuela; Tosatto, Silvio C. E.; Carafoli, Ernesto			Deletions and Mutations in the Acidic Lipid-binding Region of the Plasma Membrane Ca2+ Pump A STUDY ON DIFFERENT SPLICING VARIANTS OF ISOFORM 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; INHIBITORY INTERACTION; PROTEIN SEQUENCES; HIGH-AFFINITY; CA2+-ATPASE; DOMAIN; IDENTIFICATION; PURIFICATION; CALMODULIN; EXPRESSION	Acidic phospholipids increase the affinity of the plasma membrane Ca2+-ATPase pump for Ca2+. They interact with the C-terminal region of the pump and with a domain in the loop connecting transmembrane domains 2 and 3 (A(L) region) next to site A of alternative splicing. The contribution of the two phospholipid-binding sites and the possible interference of splicing inserts at site A with the regulation of the ATPase activity of isoform 2 of the pump by phospholipids have been analyzed. The activity of the full-length z/b variant (no insert at site A), the w/b (with insert at site A), and the w/a variant, containing both the 45-amino acid A-site insert and a C-site insert that truncates the pump in the calmodulin binding domain, has been analyzed in microsomal membranes of overexpressing CHO cells. The A-site insertion did not modify the phospholipid sensitivity of the pump, but the doubly inserted w/a variant became insensitive to acidic phospholipids, even if containing the intact AL phospholipid binding domain. Pump mutants in which 12 amino acids had been deleted, or single lysine mutations introduced, in the AL region were studied by monitoring agonist-induced Ca2+ transients in overexpressing CHO cells. The 12-residue deletion completely abolished the ATPase activity of the w/a variant but only reduced that of the z/b variant, which was also affected by the single lysine substitutions in the same domain. A structural interpretation of the interplay of the pump with phospholipids, and of the mechanism of their activation, is proposed on the basis of molecular modeling studies.	[Brini, Marisa; Di Leva, Francesca; Domi, Teuta; Ottolini, Denis] Univ Padua, Dept Biol Chem, I-35131 Padua, Italy; [Di Leva, Francesca; Domi, Teuta; Ottolini, Denis] Univ Padua, Dept Expt Vet Sci, I-35131 Padua, Italy; [Ortega, Claudia K.; Carafoli, Ernesto] Venetian Inst Mol Med, I-35129 Padua, Italy; [Leonardi, Emanuela; Tosatto, Silvio C. E.] Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine; University of Padua	Brini, M (corresponding author), Univ Padua, Dept Biol Chem, Viale G Colombo 3, I-35131 Padua, Italy.	marisa.brini@unipd.it	Tosatto, Silvio/B-2840-2009; Carafoli, Ernesto/K-5192-2016; Brini, Marisa/K-5189-2016; leonardi, emanuela/AAN-2392-2020; domi, teuta/K-9646-2016	Tosatto, Silvio/0000-0003-4525-7793; Carafoli, Ernesto/0000-0002-7826-0094; leonardi, emanuela/0000-0001-8486-8461; domi, teuta/0000-0002-8377-5594; Brini, Marisa/0000-0001-5141-0243; DI LEVA, Francesca/0000-0002-6167-0679	Telethon Foundation [GGP04169]; Italian Ministry of University and Research; European Union [LSHG-CT-20054-512063]	Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was supported by the Telethon Foundation Project GGP04169 (to M. B.), the Italian Ministry of University and Research PRIN 2003 and 2005 (to M. B.), and by the FP6 Program of the European Union, FP6 Integrated Project EUROHEAR, LSHG-CT-20054-512063 (to E. C.).	ADAMO HP, 1992, BIOCHEM J, V283, P355, DOI 10.1042/bj2830355; Albrecht M, 2003, PROTEIN ENG, V16, P459, DOI 10.1093/protein/gzg063; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; Chicka MC, 2003, J BIOL CHEM, V278, P18464, DOI 10.1074/jbc.M301482200; Domi T, 2007, ANN NY ACAD SCI, V1099, P237, DOI 10.1196/annals.1387.043; Elwess NL, 1997, J BIOL CHEM, V272, P17981, DOI 10.1074/jbc.272.29.17981; ENYEDI A, 1987, J BIOL CHEM, V262, P6425; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Grati M, 2006, J CELL SCI, V119, P2995, DOI 10.1242/jcs.03030; HEIM R, 1992, J BIOL CHEM, V267, P24476; HILFIKER H, 1994, J BIOL CHEM, V269, P26178; HOFMANN F, 1993, J BIOL CHEM, V268, P10252; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Linde CI, 2008, CELL CALCIUM, V43, P550, DOI 10.1016/j.ceca.2007.09.003; MISSIAEN L, 1989, BIOCHEM J, V261, P1055, DOI 10.1042/bj2611055; MISSIAEN L, 1989, BIOCHEM J, V263, P687, DOI 10.1042/bj2630687; PAPP B, 1989, J BIOL CHEM, V264, P4577; Perez-Gordones MC, 2009, ARCH BIOCHEM BIOPHYS, V489, P55, DOI 10.1016/j.abb.2009.07.010; Pinto FD, 2006, FEBS LETT, V580, P1576, DOI 10.1016/j.febslet.2006.01.088; Pinto FD, 2002, J BIOL CHEM, V277, P12784, DOI 10.1074/jbc.M111055200; Rimessi A, 2005, J BIOL CHEM, V280, P37195, DOI 10.1074/jbc.M504921200; Tosatto SCE, 2002, PROTEIN ENG, V15, P279, DOI 10.1093/protein/15.4.279; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Xiong YN, 2009, BIOCHEM BIOPH RES CO, V384, P32, DOI 10.1016/j.bbrc.2009.04.044	32	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30779	30791		10.1074/jbc.M110.140475	http://dx.doi.org/10.1074/jbc.M110.140475			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20643655	Green Published, hybrid			2022-12-27	WOS:000282135500046
J	Ferrari-Amorotti, G; Mariani, SA; Novi, C; Cattelani, S; Pecorari, L; Corradini, F; Soliera, AR; Manzotti, G; Fragliasso, V; Zhang, Y; Martinez, RV; Lam, EWF; Guerzoni, C; Calabretta, B				Ferrari-Amorotti, Giovanna; Mariani, Samanta Antonella; Novi, Chiara; Cattelani, Sara; Pecorari, Luisa; Corradini, Francesca; Soliera, Angela Rachele; Manzotti, Gloria; Fragliasso, Valentina; Zhang, Ying; Martinez, Robert V.; Lam, Eric W. -F.; Guerzoni, Clara; Calabretta, Bruno			The Biological Effects of C/EBP alpha in K562 Cells Depend on the Potency of the N-terminal Regulatory Region, Not on Specificity of the DNA Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ABL-EXPRESSING CELLS; GRANULOCYTIC DIFFERENTIATION; TRANSCRIPTION FACTOR; PROTEIN-ALPHA; HEMATOPOIETIC-CELLS; INITIATING CELLS; DOWN-REGULATION; IN-VIVO; GENE	The transcription factor C/EBP alpha is more potent than C/EBP beta in inducing granulocitic differentiation and inhibiting BCR/ABL-expressing cells. We took a "domain swapping" approach to assess biological effects, modulation of gene expression, and binding to C/EBP alpha-regulated promoters by wild-type and chimeric C/EBP alpha/C/EBP beta proteins. Wild-type and N-C/EBP alpha+ C/EBP beta-DBD induced transcription of the granulocyte-colony stimulating factor receptor (G-CSFR) gene, promoted differentiation, and suppressed proliferation of K562 cells vigorously; instead, wild-type C/EBP beta and N-C/EBP beta+C/EBP alpha-DBD had modest effects, although they bound the G-CSFR promoter like wild-type C/EBP alpha and N-C/EBP alpha+C/EBP beta-DBD. Chimeric proteins consisting of the TAD of VP16 and the DBD of C/EBP alpha or C/EBP beta inhibited proliferation and induced differentiation of K562 cells as effectively as wild-type C/EBP alpha. Gene expression profiles induced by C/EBP alpha resembled those modulated by N-C/EBP alpha+C/EBP beta-DBD, whereas C/EBP beta induced a pattern similar to that of N-C/EBP beta+C/EBP alpha-DBD. C/EBP alpha activation induced changes in the expression of more cell cycle- and apoptosis-related genes than the other proteins and enhanced Imatinib-induced apoptosis of K562 cells. Expression of FOXO3a, a novel C/EBP alpha-regulated gene, was required for apoptosis but not for differentiation induction or proliferation inhibition of K562 cells.	[Guerzoni, Clara] Rizzoli Inst, Oncol Res Unit, I-40136 Bologna, Italy; [Ferrari-Amorotti, Giovanna; Mariani, Samanta Antonella; Novi, Chiara; Cattelani, Sara; Pecorari, Luisa; Corradini, Francesca; Manzotti, Gloria; Fragliasso, Valentina; Calabretta, Bruno] Univ Modena & Reggio Emilia, Dept Biol Sci, I-41100 Modena, Italy; [Soliera, Angela Rachele; Calabretta, Bruno] Dept Canc Biol, Philadelphia, PA 19107 USA; [Soliera, Angela Rachele; Calabretta, Bruno] Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Zhang, Ying; Martinez, Robert V.] Wyeth Res, Dept Biol Technol, Cambridge, MA 02140 USA; [Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Canc Res UK Labs, Dept Oncol, London W12 0NN, England	Universita di Modena e Reggio Emilia; Jefferson University; Pfizer; Cancer Research UK; Imperial College London	Guerzoni, C (corresponding author), Rizzoli Inst, Oncol Res Unit, 1-10 Barbiano St, I-40136 Bologna, Italy.	clara.guerzoni@ior.it; B-Calabretta@mail.jci.tju.edu	Fragliasso, Valentina/K-4657-2016; fragliasso, valentina/AAA-2291-2022; Lam, Eric W-F/AAW-8566-2020; Manzotti, Gloria/J-7235-2016	Fragliasso, Valentina/0000-0002-4189-0316; Lam, Eric W-F/0000-0003-1274-3576; Manzotti, Gloria/0000-0002-0639-3605; Mariani, Samanta Antonella/0000-0003-4950-0607	National Institutes of Health (NCI) [CA95111]; Fondazione Cassa di Risparmio di Modena; Programmi di Ricerca di Rilevante Interesse Nazionale; Fondazione Cassa di Risparmio di Vignola; Associazione Italiana Ricerca sul Cancro; NATIONAL CANCER INSTITUTE [R01CA095111] Funding Source: NIH RePORTER; Cancer Research UK [12011] Funding Source: researchfish	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondazione Cassa di Risparmio di Modena; Programmi di Ricerca di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Cassa di Risparmio di Vignola; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was supported, in whole or in part, by National Institutes of Health Grant CA95111 (NCI; to B. C.). This study was supported by grants from Fondazione Cassa di Risparmio di Modena, Programmi di Ricerca di Rilevante Interesse Nazionale (PRIN2007), Fondazione Cassa di Risparmio di Vignola (to B. C.) and by the Associazione Italiana Ricerca sul Cancro (to C. G.).	Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; D'Alo F, 2003, BLOOD, V102, P3163, DOI 10.1182/blood-2003-02-0479; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Ferrari-Amorotti G, 2006, BLOOD, V108, P1353, DOI 10.1182/blood-2006-01-011833; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Gombart AF, 2002, BLOOD, V99, P1332, DOI 10.1182/blood.V99.4.1332; Guerzoni C, 2006, CELL CYCLE, V5, P1254, DOI 10.4161/cc.5.12.2808; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; HEIBLING D, 2004, P NATL ACAD SCI USA, V101, P13312; Helbling D, 2005, BLOOD, V106, P1369, DOI 10.1182/blood-2004-11-4392; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Leroy H, 2005, LEUKEMIA, V19, P329, DOI 10.1038/sj.leu.2403614; MCKNIGHT JLC, 1987, P NATL ACAD SCI USA, V84, P7061, DOI 10.1073/pnas.84.20.7061; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; PRESTON CM, 1988, CELL, V52, P425, DOI 10.1016/S0092-8674(88)80035-7; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; SCOTT LM, 1992, BLOOD, V80, P1725; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tavor S, 2003, J BIOL CHEM, V278, P52651, DOI 10.1074/jbc.M307077200; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; TRIEZENBERG SJ, 1988, GENE DEV, V2, P730, DOI 10.1101/gad.2.6.730; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zheng R, 2004, BLOOD, V103, P1883, DOI 10.1182/blood-2003-06-1978	47	6	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30837	30850		10.1074/jbc.M110.128272	http://dx.doi.org/10.1074/jbc.M110.128272			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659895	hybrid, Green Published			2022-12-27	WOS:000282135500051
J	Ralle, M; Huster, D; Vogt, S; Schirrmeister, W; Burkhead, JL; Capps, TR; Gray, L; Lai, B; Maryon, E; Lutsenko, S				Ralle, Martina; Huster, Dominik; Vogt, Stefan; Schirrmeister, Wiebke; Burkhead, Jason L.; Capps, Tony R.; Gray, Lawrence; Lai, Barry; Maryon, Edward; Lutsenko, Svetlana			Wilson Disease at a Single Cell Level INTRACELLULAR COPPER TRAFFICKING ACTIVATES COMPARTMENT-SPECIFIC RESPONSES IN HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-FLUORESCENCE MICROSCOPY; PRIMARY HEMOCHROMATOSIS; LIVER; INFLAMMATION; ACCUMULATION; METABOLISM; MICE	Wilson disease(WD) is a severe hepato-neurologic disorder that affects primarily children and young adults. WD is caused by mutations in ATP7B and subsequent copper overload. However, copper levels alone do not predict severity of the disease. We demonstrate that temporal and spatial distribution of copper in hepatocytes may play an important role in WD pathology. High resolution synchrotron-based x-ray fluorescence imaging in situ indicates that copper does not continuously accumulate in Atp7b(-/-) hepatocytes, but reaches a limit at 90-300 fmol. The lack of further accumulation is associated with the loss of copper transporter Ctr1 from the plasma membrane and the appearance of copper-loaded lymphocytes and extracellular copper deposits. The WD progression is characterized by changes in subcellular copper localization and transcriptome remodeling. The synchrotron-based x-ray fluorescence imaging and mRNA profiling both point to the key role of nucleus in the initial response to copper overload and suggest time-dependent sequestration of copper in deposits as a protective mechanism. The metabolic pathways, up-regulated in response to copper, show compartmentalization that parallels changes in subcellular copper concentration. In contrast, significant down-regulation of lipid metabolism is observed at all stages of WD irrespective of copper distribution. These observations suggest new stage-specific as well as general biomarkers for WD. The model for the dynamic role of copper in WD is proposed.	[Ralle, Martina] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Huster, Dominik] Univ Leipzig, Inst Med Phys & Biophys, D-04109 Leipzig, Sachsen, Germany; [Huster, Dominik; Schirrmeister, Wiebke] Univ Magdeburg, Dept Med, D-39104 Magdeburg, Germany; [Vogt, Stefan; Lai, Barry] Argonne Natl Lab, Argonne, IL 60439 USA; [Maryon, Edward] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Gray, Lawrence; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA	Oregon Health & Science University; Leipzig University; Otto von Guericke University; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University	Ralle, M (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	rallem@ohsu.edu; lutsenko@jhmi.edu	Burkhead, Jason/C-9612-2013; Gray, Lawrence/F-4281-2011; Vogt, Stefan/J-7937-2013; Ralle, Martina/H-2936-2019; Vogt, Stefan/B-9547-2009	Burkhead, Jason/0000-0001-5457-311X; Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513	National Institutes of Health [P01 GM067166]; German Research Foundation [Hu932/3-2]; U.S. Department of Energy, Office of Science [DE-AC-02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); U.S. Department of Energy, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM067166 (to S. L.). This work was also supported by German Research Foundation Grant Hu932/3-2 (to D. H.). The use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science Contract DE-AC-02-06CH11357.	Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; CARMICHAEL PL, 1995, MUTAT RES-FUND MOL M, V326, P235, DOI 10.1016/0027-5107(94)00177-7; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; Dijkstra M, 1997, HEPATOLOGY, V26, P962, DOI 10.1053/jhep.1997.v26.pm0009328320; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; GOLDFISCHER S, 1980, AM J PATHOL, V99, P715; GOLDFISCHER S, 1968, AM J PATHOL, V53, P883; Hall MD, 2003, J BIOL INORG CHEM, V8, P726, DOI 10.1007/s00775-003-0471-6; HANAICHI T, 1984, LAB INVEST, V51, P592; HAYWOOD S, 1985, EXP MOL PATHOL, V43, P209, DOI 10.1016/0014-4800(85)90041-3; Hou TJ, 2000, PROTEIN SCI, V9, P2302, DOI 10.1110/ps.9.12.2302; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonas L, 2001, ULTRASTRUCT PATHOL, V25, P111; Kemner KM, 2004, SCIENCE, V306, P686, DOI 10.1126/science.1103524; Liu Wen, 2003, Hepatobiliary Pancreat Dis Int, V2, P270; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mcrae R, 2006, J STRUCT BIOL, V155, P22, DOI 10.1016/j.jsb.2005.09.013; MILANINO R, 1985, INT J TISSUE REACT, V7, P469; MILANINO R, 1985, AGENTS ACTIONS, V16, P504, DOI 10.1007/BF01983655; Nair J, 1998, CANCER EPIDEM BIOMAR, V7, P435; Paunesku T, 2003, NAT MATER, V2, P343, DOI 10.1038/nmat875; Pilloni L, 1998, HISTOPATHOLOGY, V33, P28, DOI 10.1046/j.1365-2559.1998.00455.x; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; VANESPEN P, 2002, SPECTRUM EVALUATION, P239; Wagner D, 2005, MICROBIOL-SGM, V151, P323, DOI 10.1099/mic.0.27213-0; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; WHITEHOUSE MW, 1978, AGENTS ACTIONS, V8, P85, DOI 10.1007/BF01972407; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; Yun W, 1999, REV SCI INSTRUM, V70, P2238, DOI 10.1063/1.1149744	31	77	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30875	30883		10.1074/jbc.M110.114447	http://dx.doi.org/10.1074/jbc.M110.114447			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20647314	hybrid, Green Published			2022-12-27	WOS:000282135500054
J	Mortier, A; Loos, T; Gouwy, M; Ronsse, I; Van Damme, J; Proost, P				Mortier, Anneleen; Loos, Tamara; Gouwy, Mieke; Ronsse, Isabelle; Van Damme, Jo; Proost, Paul			Posttranslational Modification of the NH2-terminal Region of CXCL5 by Proteases or Peptidylarginine Deiminases (PAD) Differently Affects Its Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULOCYTE CHEMOTACTIC PROTEIN-2; NEUTROPHIL-ACTIVATING PEPTIDE-78; POSTTRANSCRIPTIONAL REGULATION; INTERLEUKIN-8 RECEPTOR; INFLAMMATORY RESPONSE; RHEUMATOID-ARTHRITIS; TISSUE INFLAMMATION; CHEMOKINE RECEPTORS; ENDOTHELIAL-CELLS; SERINE PROTEASES	Posttranslational modifications, e. g. proteolysis, glycosylation, and citrullination regulate chemokine function, affecting leukocyte migration during inflammatory responses. Here, modification of CXCL5/epithelial cell-derived neutrophil-activating protein-78 (ENA-78) by proteases or peptidylarginine deiminases (PAD) was evaluated. Slow CXCL5(1-78) processing by the myeloid cell marker aminopeptidase N/CD13 into CXCL5(2-78) hardly affected its in vitro activity, but slowed down the activation of CXCL5 by the neutrophil protease cathepsin G. PAD, an enzyme with a potentially important function in autoimmune diseases, site-specifically deiminated Arg(9) in CXCL5 to citrulline, generating [Cit(9)] CXCL5(1-78). Compared with CXCL5(1-78), [Cit9] CXCL5(1-78) less efficiently induced intracellular calcium signaling, phosphorylation of extracellular signal-regulated kinase, internalization of CXCR2, and in vitro neutrophil chemotaxis. In contrast, conversion of CXCL5 into the previously reported natural isoform CXCL5(8-78) provided at least 3-fold enhanced biological activity in these tests. Citrullination, but not NH2-terminal truncation, reduced the capacity of CXCL5 to up-regulate the expression of the integrin alpha-chain CD11b on neutrophils. Truncation nor citrullination significantly affected the ability of CXCL5 to up-regulate CD11a expression or shedding of CD62L. In line with the in vitro results, CXCL5(8-78) and CXCL5(978) induced a more pronounced neutrophil influx in vivo compared with CXCL5(1-78). Administration of 300 pmol of either CXCL5(1-78) or [Cit9] CXCL5(1-78) failed to attract neutrophils to the peritoneal cavity. Citrullination of the more potent CXCL5(9-78) lowers its chemotactic potency in vivo and confirms the tempering effect of citrullination in vitro. The highly divergent effects of modifications of CXCL5 on neutrophil influx underline the potential importance of tissue-specific interactions between chemokines and PAD or proteases.	[Mortier, Anneleen; Loos, Tamara; Gouwy, Mieke; Ronsse, Isabelle; Van Damme, Jo; Proost, Paul] Katholieke Univ Leuven, Rega Inst, Lab Mol Immunol, B-3000 Louvain, Belgium	KU Leuven	Proost, P (corresponding author), Katholieke Univ Leuven, Rega Inst, Lab Mol Immunol, B-3000 Louvain, Belgium.	paul.proost@rega.kuleuven.be	Gouwy, Mieke/I-4642-2018; Proost, Paul/V-3052-2017	Gouwy, Mieke/0000-0002-4035-4810; Proost, Paul/0000-0002-0133-5545; Mortier, Anneleen/0000-0002-9662-674X; Van Damme, Jo/0000-0002-6707-1167	Center of Excellence [EF/05/15]; K.U. Leuven, Concerted Research Actions [G.O.A./2007/15]; Regional Government of Flanders; Fund for Scientific Research of Flanders; Interuniversity Attraction Poles Program-Belgian; European Union [LSHB-CT-2005-518167]	Center of Excellence; K.U. Leuven, Concerted Research Actions(KU Leuven); Regional Government of Flanders; Fund for Scientific Research of Flanders(FWO); Interuniversity Attraction Poles Program-Belgian; European Union(European Commission)	This work was supported in part by the Center of Excellence Grant EF/05/15 from K.U. Leuven, Concerted Research Actions Grant G.O.A./2007/15 from the Regional Government of Flanders, the Fund for Scientific Research of Flanders (F.W.O. Vlaanderen), the Interuniversity Attraction Poles Program-Belgian Science Policy, and the European Union 6FP EC contract INNOCHEM Grant LSHB-CT-2005-518167.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; ASHMUN RA, 1990, BLOOD, V75, P462; BAINTON DF, 1987, J EXP MED, V166, P1641, DOI 10.1084/jem.166.6.1641; BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; BRELJAK D, 2003, HAEMA, V6, P453; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Dinauer Mary C., 2007, V412, P489, DOI 10.1007/978-1-59745-467-4_30; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Fan J, 2005, EUR RESPIR J, V26, P933, DOI 10.1183/09031936.05.00120204; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Gouwy M, 2005, CYTOKINE GROWTH F R, V16, P561, DOI 10.1016/j.cytogfr.2005.03.005; Gouwy M, 2008, MOL PHARMACOL, V74, P485, DOI 10.1124/mol.108.045146; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hamilton TA, 2007, J LEUKOCYTE BIOL, V82, P213, DOI 10.1189/jlb.1206754; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Imaizumi TA, 1997, AM J RESP CELL MOL, V17, P181, DOI 10.1165/ajrcmb.17.2.2818; JIANG YL, 1991, BIOCHEM BIOPH RES CO, V178, P1400, DOI 10.1016/0006-291X(91)91049-I; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kinloch A, 2008, ARTHRITIS RHEUM, V58, P2287, DOI 10.1002/art.23618; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Locati M, 2001, IMMUNOBIOLOGY, V204, P536, DOI 10.1078/0171-2985-00090; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; Loos T, 2008, BLOOD, V112, P2648, DOI 10.1182/blood-2008-04-149039; Loos T, 2006, LAB INVEST, V86, P902, DOI 10.1038/labinvest.3700453; Loos T, 2009, HAEMATOL-HEMATOL J, V94, P1346, DOI 10.3324/haematol.2009.006973; Loos T, 2009, METHOD ENZYMOL, V461, P3, DOI 10.1016/S0076-6879(09)05401-9; LUKACS NW, 1995, AM J PHYSIOL-LUNG C, V268, pL856, DOI 10.1152/ajplung.1995.268.5.L856; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Menten P, 1999, J CLIN INVEST, V104, pR1, DOI 10.1172/JCI7318; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Newburger Peter E, 2006, Hematology Am Soc Hematol Educ Program, P104; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Riemann D, 1999, IMMUNOL TODAY, V20, P83, DOI 10.1016/S0167-5699(98)01398-X; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; ROT A, 1992, IMMUNOL TODAY, V13, P291, DOI 10.1016/0167-5699(92)90039-A; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Savino B, 2009, J BIOL CHEM, V284, P26207, DOI 10.1074/jbc.M109.029249; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Strell C, 2007, CELL MOL LIFE SCI, V64, P3306, DOI 10.1007/s00018-007-7402-6; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Struyf S, 2009, J IMMUNOL, V182, P666, DOI 10.4049/jimmunol.182.1.666; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Turner AJ, 2004, HDB PROTEOLYTIC ENZY, V1, P289; VanDamme J, 1997, J LEUKOCYTE BIOL, V62, P563, DOI 10.1002/jlb.62.5.563; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x; Wuyts A, 1997, BIOCHEMISTRY-US, V36, P2716, DOI 10.1021/bi961999z; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104	62	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29750	29759		10.1074/jbc.M110.119388	http://dx.doi.org/10.1074/jbc.M110.119388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20630876	hybrid, Green Published			2022-12-27	WOS:000281984300010
J	Zhou, HY; Li, WL; Zhu, SY; Joo, JY; Do, JT; Xiong, W; Kim, JB; Zhang, K; Scholer, HR; Ding, S				Zhou, Hongyan; Li, Wenlin; Zhu, Saiyong; Joo, Jin Young; Do, Jeong Tae; Xiong, Wen; Kim, Jeong Beom; Zhang, Kang; Schoeler, Hans R.; Ding, Sheng			Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUND-STATE; SELF-RENEWAL; DIFFERENTIATION; NANOG; BETA; EXPRESSION; GENERATION; PLASTICITY; ENDODERM; EMBRYO	Epiblast stem cells (EpiSCs) are pluripotent cells derived from post-implantation late epiblasts in vitro. EpiSCs are incapable of contributing to chimerism, indicating that EpiSCs are less pluripotent and represent a later developmental pluripotency state compared with inner cell mass stage murine embryonic stem cells (mESCs). Using a chemical approach, we found that blockage of the TGF beta pathway or inhibition of histone demethylase LSD1 with small molecule inhibitors induced dramatic morphological changes in EpiSCs toward mESC phenotypes with simultaneous activation of inner cell mass-specific gene expression. However, full conversion of EpiSCs to the mESC-like state with chimerism competence could be readily generated only with the combination of LSD1, ALK5, MEK, FGFR, and GSK3 inhibitors. Our results demonstrate that appropriate synergy of epigenetic and signaling modulations could convert cells at the later developmental pluripotency state to the earlier mESC-like pluripotency state, providing new insights into pluripotency regulation.	[Zhou, Hongyan; Li, Wenlin; Zhu, Saiyong; Xiong, Wen; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Joo, Jin Young; Do, Jeong Tae; Kim, Jeong Beom; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Do, Jeong Tae] CHA Univ, CHA Stem Cell Inst, Lab Stem Cell & Dev Biol, Seoul 135081, South Korea; [Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Kang] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA	Scripps Research Institute; Max Planck Society; Pochon Cha University; University of California System; University of California San Diego; University of California System; University of California San Diego	Ding, S (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	sding@scripps.edu	zhou, hongyan/B-3689-2011; Zhang, Kang/Y-2740-2019; , HS/AAB-4434-2019	zhou, hongyan/0000-0001-5919-7715; Zhang, Kang/0000-0002-4549-1697; , HS/0000-0003-2643-5136; Do, Jeong Tae/0000-0001-6721-1441; Kim, Jeong Beom/0000-0001-6230-8826; li, wenlin/0000-0002-0842-222X	Fate Therapeutics; California Institute for Regenerative Medicine; NATIONAL EYE INSTITUTE [R01EY021374] Funding Source: NIH RePORTER	Fate Therapeutics; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Fate Therapeutics and the California Institute for Regenerative Medicine (to S. D.).	BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li QX, 2002, J BIOL CHEM, V277, P46447, DOI 10.1074/jbc.M203555200; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva N, 2008, REVSTAT-STAT J, V6, P253; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	30	92	102	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29676	29680		10.1074/jbc.C110.150599	http://dx.doi.org/10.1074/jbc.C110.150599			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20705612	Green Published, hybrid			2022-12-27	WOS:000281984300002
J	An, LL; Wang, YL; Liu, YH; Yang, XA; Liu, CC; Hu, ZS; He, W; Song, WX; Hang, HY				An, Lili; Wang, Yulan; Liu, Yuheng; Yang, Xiao; Liu, Chunchun; Hu, Zhishang; He, Wei; Song, Wenxia; Hang, Haiying			Rad9 Is Required for B Cell Proliferation and Immunoglobulin Class Switch Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; MISMATCH REPAIR; GENOMIC INSTABILITY; CHECKPOINT COMPLEX; FISSION YEAST; S-PHASE; DAMAGE; CLAMP; HOMOLOGS; DELETION	B cell maturation and B cell-mediated antibody response require programmed DNA modifications such as the V(D)J recombination, the immunoglobulin (Ig) class switch recombination, and the somatic hypermutation to generate functional Igs. Many protein factors involved in DNA damage repair have been shown to be critical for the maturation and activation of B cells. Rad9 plays an important role in both DNA repair and cell cycle checkpoint control. However, its role in Ig generation has not been reported. In this study, we generated a conditional knock-out mouse line in which Rad9 is deleted specifically in B cells and investigated the function of Rad9 in B cells. The Rad9(-/-) B cells isolated from the conditional knock-out mice displayed impaired growth response and enhanced DNA lesions. Impaired Ig production in response to immunization in Rad9(-/-) mice was also detected. In addition, the Ig class switch recombination is deficient in Rad9(-/-) B cells. Taken together, Rad9 plays dual roles in generating functional antibodies and in maintaining the integrity of the whole genome in B cells.	[Hang, Haiying] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [An, Lili; Wang, Yulan; Liu, Yuheng; Yang, Xiao; Liu, Chunchun; Hu, Zhishang; He, Wei; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Ctr Computat & Syst Biol, Beijing 100101, Peoples R China; [Song, Wenxia] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University System of Maryland; University of Maryland College Park	Hang, HY (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	hh91@sun5.ibp.ac.cn	He, Wei/K-4776-2014		National Natural Science Foundation of China [30700407, 30530180]; National Protein Project of Ministry of Science and Technology [2006CB910902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Protein Project of Ministry of Science and Technology	This work was supported by National Natural Science Foundation of China Grant 30700407, National Natural Science Foundation of China Grant 30530180, and National Protein Project of Ministry of Science and Technology Grant 2006CB910902.	Bai HB, 2010, DNA REPAIR, V9, P478, DOI 10.1016/j.dnarep.2010.01.011; Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Bessho T, 2000, J BIOL CHEM, V275, P7451, DOI 10.1074/jbc.275.11.7451; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Chang DY, 2005, J BIOL CHEM, V280, P408, DOI 10.1074/jbc.M406800200; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Griffith JD, 2002, J BIOL CHEM, V277, P15233, DOI 10.1074/jbc.C200129200; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; He W, 2008, NUCLEIC ACIDS RES, V36, P6406, DOI 10.1093/nar/gkn686; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Hu Z, 2008, CANCER RES, V68, P5552, DOI 10.1158/0008-5472.CAN-07-5670; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; LIEBERMAN HB, 1992, MOL GEN GENET, V232, P367, DOI 10.1007/BF00266239; Lu AL, 2006, FRONT BIOSCI-LANDMRK, V11, P3062, DOI 10.2741/2033; MURRAY JM, 1991, NUCLEIC ACIDS RES, V19, P3525, DOI 10.1093/nar/19.13.3525; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Revy P, 2005, ADV IMMUNOL, V87, P237, DOI 10.1016/S0065-2776(05)87007-5; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schrader CE, 2009, PHILOS T R SOC B, V364, P645, DOI 10.1098/rstb.2008.0200; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Sohn SY, 2009, J MOL BIOL, V390, P490, DOI 10.1016/j.jmb.2009.05.028; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Xu Y, 2006, NAT REV IMMUNOL, V6, P261, DOI 10.1038/nri1804	37	16	17	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35267	35273		10.1074/jbc.M110.161208	http://dx.doi.org/10.1074/jbc.M110.161208			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20729201	Green Published, hybrid			2022-12-27	WOS:000283845300004
J	LeBlanc, MA; McMaster, CR				LeBlanc, Marissa A.; McMaster, Christopher R.			Lipid Binding Requirements for Oxysterol-binding Protein Kes1 Inhibition of Autophagy and Endosome-trans-Golgi Trafficking Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE CURVATURE; CELL-GROWTH; YEAST; 3-KINASE; VACUOLE; COMPLEX; VPS34; PIK1; KINASE	The Saccharomyces cerevisiae protein Kes1/Osh4 is a member of the enigmatic family of oxysterol-binding proteins found throughout Eukarya united by a beta-barrel structure that binds sterols and oxysterols. In this study, we determined that phos-phoinositides are the major determinant in membranes that facilitate Kes1 association both in vitro and in cells. Increased expression of Kes1 in yeast cells decreased the levels of both phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol 3-phosphate (PI3P). Phosphoinositide and sterol bindings by Kes1 were necessary for Kes1 to decrease the level of PI4P but not PI3P. Kes1 inhibited vesicular trafficking between the trans-Golgi and plasma membrane as evidenced by accumulation of the vacuolar soluble NSF attachment protein receptors Snc1 in the cytoplasmic vesicles. Sterol and phosphoinositide binding by Kes1 both contributed to its regulation of Snc1 trafficking. This study also describes a previously unknown role for Kes1 in the regulation of the autophagy/cytoplasm to the vacuole trafficking pathway. The Kes1-mediated regulation of the autophagy/cytoplasm to the vacuole trafficking pathway was prevented by increasing expression of the PI3K Vps34, suggesting that it is the Kes1-mediated decrease in PI3P level that contributes to this regulation.	[McMaster, Christopher R.] Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Dept Biochem & Mol Biol, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca		McMaster, Christopher/0000-0003-0822-5776	National Sciences and Engineering Research Council; Nova Scotia Health Research Foundation	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Health Research Foundation	This work was supported in part by a discovery award from the National Sciences and Engineering Research Council (to C.R.M.).; Recipient of a Nova Scotia Health Research Foundation Ph.D. studentship.	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Beh CT, 2001, GENETICS, V157, P1117; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; Demmel L, 2008, MOL BIOL CELL, V19, P1046, DOI 10.1091/mbc.E07-02-0134; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; Fairn GD, 2005, BIOCHEM J, V387, P889, DOI 10.1042/BJ20041915; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Knodler A, 2005, BIOTECHNIQUES, V38, P858, DOI 10.2144/05386BM02; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; Nazarko TY, 2005, AUTOPHAGY, V1, P37, DOI 10.4161/auto.1.1.1512; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; RAYCHAUDURI J, 2010, ANN REV CEL IN PRESS; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Suriapranata I, 2000, J CELL SCI, V113, P4025; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu YQ, 2001, J BIOL CHEM, V276, P18407, DOI 10.1074/jbc.M101204200; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479	47	25	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33875	33884		10.1074/jbc.M110.147264	http://dx.doi.org/10.1074/jbc.M110.147264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729555	Green Published, hybrid			2022-12-27	WOS:000283354000034
J	Pittelli, M; Formentini, L; Faraco, G; Lapucci, A; Rapizzi, E; Cialdai, F; Romano, G; Moneti, G; Moroni, F; Chiarugi, A				Pittelli, Maria; Formentini, Laura; Faraco, Giuseppe; Lapucci, Andrea; Rapizzi, Elena; Cialdai, Francesca; Romano, Giovanni; Moneti, Gloriano; Moroni, Flavio; Chiarugi, Alberto			Inhibition of Nicotinamide Phosphoribosyltransferase CELLULAR BIOENERGETICS REVEALS A MITOCHONDRIAL INSENSITIVE NAD POOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE; BIOSYNTHESIS INHIBITOR; DEPLETION; METABOLISM; FK866; DEATH; CELLS; IDENTIFICATION; LOCALIZATION; ACTIVATION	The NAD rescue pathway consists of two enzymatic steps operated by nicotinamide phosphoribosyltransferase (Nampt) and nicotinamide mononucleotide adenylyltransferases. Recently, the potent Nampt inhibitor FK866 has been identified and evaluated in clinical trials against cancer. Yet, how Nampt inhibition affects NAD contents and bioenergetics is in part obscure. It is also unknown whether NAD rescue takes place in mitochondria, and FK866 alters NAD homeostasis within the organelle. Here, we show that FK866-dependent reduction of the NAD contents is paralleled by a concomitant increase of ATP in various cell types, in keeping with ATP utilization for NAD resynthesis. We also show that poly-and mono(ADP-ribose) transferases rather than Sirt-1 are responsible for NAD depletion in HeLa cells exposed to FK866. Mass spectrometry reveals that the drug distributes in the cytosolic and mitochondrial compartment. However, the cytoplasmic but not the mitochondrial NAD pool is reduced upon acute or chronic exposure to the drug. Accordingly, Nampt does not localize within the organelles and their bioenergetics is not affected by the drug. In the mouse, FK866-dependent reduction of NAD contents in various organs is prevented by inhibitors of poly(ADP-ribose) polymerases or the NAD precursor kynurenine. For the first time, our data indicate that mitochondria lack the canonical NAD rescue pathway, broadening current understanding of cellular bioenergetics.	[Pittelli, Maria; Formentini, Laura; Faraco, Giuseppe; Lapucci, Andrea; Moroni, Flavio; Chiarugi, Alberto] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Cialdai, Francesca; Romano, Giovanni] Univ Florence, Laser Ctr Med Applicat CEO, I-50139 Florence, Italy; [Rapizzi, Elena] Univ Florence, Dept Clin Physiopathol, I-50139 Florence, Italy; [Moneti, Gloriano] Univ Florence, Interdept Ctr Mass Spectrometry, I-50139 Florence, Italy	University of Florence; University of Florence; University of Florence; University of Florence	Chiarugi, A (corresponding author), Viale Pieraccini 6, I-50139 Florence, Italy.	alberto.chiarugi@unifi.it	Lapucci, Andrea/AAA-6645-2019; Faraco, Giuseppe/AAP-6784-2020	Faraco, Giuseppe/0000-0001-8675-4580; LAPUCCI, Andrea/0000-0001-9613-7164; Romano, Giovanni/0000-0001-8442-6671; Formentini, Laura/0000-0001-5641-821X	Fondazione Giuseppe Tomasello ONLUS; Italian Ministry of Research and Technology; Associazione Italiana Sclerosi Multipla (AISM); University of Florence; Ente Cassa di Risparmio di Firenze	Fondazione Giuseppe Tomasello ONLUS; Italian Ministry of Research and Technology; Associazione Italiana Sclerosi Multipla (AISM)(Fondazione Italiana Sclerosi Multipla (FISM)); University of Florence; Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by grants from the Fondazione Giuseppe Tomasello ONLUS, Italian Ministry of Research and Technology (Prin 2007), Associazione Italiana Sclerosi Multipla (AISM), University of Florence, and Ente Cassa di Risparmio di Firenze.	Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Brenner C, 2005, STRUCTURE, V13, P1239, DOI 10.1016/j.str.2005.08.004; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Chance B, 2004, METHOD ENZYMOL, V385, P361; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Di Girolamo M, 2005, FEBS J, V272, P4565, DOI 10.1111/j.1742-4658.2005.04876.x; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Formentini L, 2009, J BIOL CHEM, V284, P17668, DOI 10.1074/jbc.M109.002931; Galli M, 2010, CANCER RES, V70, P8, DOI 10.1158/0008-5472.CAN-09-2465; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kang GB, 2009, MOL CELLS, V27, P667, DOI 10.1007/s10059-009-0088-x; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; SMETS LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P49, DOI 10.1016/0167-4889(90)90204-Q; Szabo C, 2006, TRENDS PHARMACOL SCI, V27, P626, DOI 10.1016/j.tips.2006.10.003; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Van Gool F, 2009, M S-MED SCI, V25, P551, DOI 10.1051/medsci/2009256-7551; Wosikowski K, 2002, CANCER RES, V62, P1057; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	54	141	146	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34106	34114		10.1074/jbc.M110.136739	http://dx.doi.org/10.1074/jbc.M110.136739			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20724478	hybrid, Green Published			2022-12-27	WOS:000283354000056
J	Zheng, YL; Amin, ND; Hu, YF; Rudrabhatla, P; Shukla, V; Kanungo, J; Kesavapany, S; Grant, P; Albers, W; Pant, HC				Zheng, Ya-Li; Amin, Niranjana D.; Hu, Ya-Fang; Rudrabhatla, Parvathi; Shukla, Varsha; Kanungo, Jyotshnabala; Kesavapany, Sashi; Grant, Philip; Albers, Wayne; Pant, Harish C.			A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; CELL-CYCLE; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; TRANSGENIC MODEL; A-BETA; PROTEIN; PHOSPHORYLATION; P25; NEUROFILAMENT	The activity of Cdk5-p35 is tightly regulated in the developing and mature nervous system. Stress-induced cleavage of the activator p35 to p25 and a p10 N-terminal domain induces deregulated Cdk5 hyperactivity and perikaryal aggregations of hyperphosphorylated Tau and neurofilaments, pathogenic hallmarks in neurodegenerative diseases, such as Alzheimer disease and amyotrophic lateral sclerosis, respectively. Previously, we identified a 125-residue truncated fragment of p35 called CIP that effectively and specifically inhibited Cdk5-p25 activity and Tau hyperphosphorylation induced by A beta peptides in vitro, in HEK293 cells, and in neuronal cells. Although these results offer a possible therapeutic approach to those neurodegenerative diseases assumed to derive from Cdk5-p25 hyperactivity and/or A beta induced pathology, CIP is too large for successful therapeutic regimens. To identify a smaller, more effective peptide, in this study we prepared a 24-residue peptide, p5, spanning CIP residues Lys(245)-Ala(277). p5 more effectively inhibited Cdk5-p25 activity than did CIP in vitro. In neuron cells, p5 inhibited deregulated Cdk5-p25 activity but had no effect on the activity of endogenous Cdk5-p35 or on any related endogenous cyclin-dependent kinases in HEK293 cells. Specificity of p5 inhibition in cortical neurons may depend on the p10 domain in p35, which is absent in p25. Furthermore, we have demonstrated that p5 reduced A beta(1-42)-induced Tau hyperphosphorylation and apoptosis in cortical neurons. These results suggest that p5 peptide may be a unique and useful candidate for therapeutic studies of certain neurodegenerative diseases.	[Zheng, Ya-Li; Amin, Niranjana D.; Rudrabhatla, Parvathi; Shukla, Varsha; Grant, Philip; Albers, Wayne; Pant, Harish C.] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Zheng, Ya-Li] Ningxia Peoples Hosp, Dept Nephrol, Ningxia 750021, Peoples R China; [Hu, Ya-Fang] NIDCR, Lab Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Kanungo, Jyotshnabala] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Kesavapany, Sashi] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117697, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); US Food & Drug Administration (FDA); National University of Singapore	Pant, HC (corresponding author), NINDS, Neurochem Lab, NIH, Bldg 49,Rm 2A28,9000 Rockville Pike, Bethesda, MD 20892 USA.	panth@ninds.nih.gov	Shukla, Varsha/G-5136-2010	Rudrabhatla, Parvathi/0000-0002-7537-3130	National Institutes of Health, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003104] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, intramural funds.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Alvarez A, 1999, FEBS LETT, V459, P421, DOI 10.1016/S0014-5793(99)01279-X; Alvarez A, 2001, EXP CELL RES, V264, P266, DOI 10.1006/excr.2001.5152; Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; Fischer A, 2003, CNS NEUROL DISORD-DR, V2, P375, DOI 10.2174/1568007033482706; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Glicksman MA, 2007, CURR ALZHEIMER RES, V4, P547, DOI 10.2174/156720507783018181; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; He LS, 2008, J BIOL CHEM, V283, P13252, DOI 10.1074/jbc.M706937200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Helal CJ, 2009, BIOORG MED CHEM LETT, V19, P5703, DOI 10.1016/j.bmcl.2009.08.019; Helal CJ, 2004, ORG LETT, V6, P1853, DOI 10.1021/ol049416y; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; Kanungo J, 2009, CELL MOL NEUROBIOL, V29, P1073, DOI 10.1007/s10571-009-9410-6; Kanungo J, 2009, BIOCHEM BIOPH RES CO, V386, P263, DOI 10.1016/j.bbrc.2009.06.038; Kanungo J, 2009, NEUROCHEM RES, V34, P1129, DOI 10.1007/s11064-008-9885-4; Kesavapany S, 2004, BBA-PROTEINS PROTEOM, V1697, P143, DOI 10.1016/j.bbapap.2003.11.020; Kesavapany Sashi, 2007, Biotechnology Journal, V2, P978, DOI 10.1002/biot.200700057; Kesavapany S, 2006, NEUROSIGNALS, V15, P157, DOI 10.1159/000095130; Knockaert M, 2002, J BIOL CHEM, V277, P25493, DOI 10.1074/jbc.M202651200; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lau LF, 2002, J MOL NEUROSCI, V19, P267, DOI 10.1385/JMN:19:3:267; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lim ACB, 2003, NEUROSIGNALS, V12, P230, DOI 10.1159/000074625; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; Liu M, 2008, BIOCHEMISTRY-US, V47, P8367, DOI 10.1021/bi800732v; Luque FA, 2009, INT REV NEUROBIOL, V84, P151, DOI 10.1016/S0074-7742(09)00408-5; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ohshima T, 1999, J NEUROSCI, V19, P6017, DOI 10.1523/JNEUROSCI.19-14-06017.1999; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 2001, NATURE, V411, P764, DOI 10.1038/35081149; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Rudrabhatla P, 2008, J BIOL CHEM, V283, P26737, DOI 10.1074/jbc.M801633200; Shea TB, 2004, J NEUROSCI RES, V76, P795, DOI 10.1002/jnr.20099; Shiradkar MR, 2007, BIOORGAN MED CHEM, V15, P6397, DOI 10.1016/j.bmc.2007.06.053; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Smith Wanli W., 2006, CNS & Neurological Disorders-Drug Targets, V5, P355, DOI 10.2174/187152706784111515; Tang D, 1996, Prog Cell Cycle Res, V2, P205; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Tsai LH, 2004, BBA-PROTEINS PROTEOM, V1697, P137, DOI 10.1016/j.bbapap.2003.11.019; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Veeranna, 1998, J NEUROSCI, V18, P4008; Webber KM, 2005, MECH AGEING DEV, V126, P1019, DOI 10.1016/j.mad.2005.03.024; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4; Zheng YL, 2007, MOL BIOL CELL, V18, P404, DOI 10.1091/mbc.E06-09-0851; Zheng YL, 2005, EMBO J, V24, P209, DOI 10.1038/sj.emboj.7600441; Zheng YL, 2003, J BIOL CHEM, V278, P24026, DOI 10.1074/jbc.M303079200; Zheng YL, 2002, EUR J BIOCHEM, V269, P4427, DOI 10.1046/j.1432-1033.2002.03133.x; Zhu YS, 2005, J NEUROCHEM, V94, P1535, DOI 10.1111/j.1471-4159.2005.03301.x	74	66	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34202	34212		10.1074/jbc.M110.134643	http://dx.doi.org/10.1074/jbc.M110.134643			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20720012	Green Published, hybrid			2022-12-27	WOS:000283354000065
J	Frank, CL; Ge, XC; Xie, ZG; Zhou, Y; Tsai, LH				Frank, Christopher L.; Ge, Xuecai; Xie, Zhigang; Zhou, Ying; Tsai, Li-Huei			Control of Activating Transcription Factor 4 (ATF4) Persistence by Multisite Phosphorylation Impacts Cell Cycle Progression and Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATED STRESS-RESPONSE; SCF UBIQUITIN LIGASE; SYNAPTIC PLASTICITY; GENE-EXPRESSION; TARGETED DISRUPTION; MEMORY; PHASE; MICE; OVEREXPRESSION; DEGRADATION	Organogenesis is a highly integrated process with a fundamental requirement for precise cell cycle control. Mechanistically, the cell cycle is composed of transitions and thresholds that are controlled by coordinated post-translational modifications. In this study, we describe a novel mechanism controlling the persistence of the transcription factor ATF4 by multisite phosphorylation. Proline-directed phosphorylation acted additively to regulate multiple aspects of ATF4 degradation. Stabilized ATF4 mutants exhibit decreased beta-TrCP degron phosphorylation, beta-TrCP interaction, and ubiquitination, as well as elicit early G(1) arrest. Expression of stabilized ATF4 also had significant consequences in the developing neocortex. Mutant ATF4 expressing cells exhibited positioning and differentiation defects that were attributed to early G(1) arrest, suggesting that neurogenesis is sensitive to ATF4 dosage. We propose that precise regulation of the ATF4 dosage impacts cell cycle control and impinges on neurogenesis.	[Frank, Christopher L.; Ge, Xuecai; Xie, Zhigang; Zhou, Ying; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Tsai, Li-Huei] Broad Inst Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Tsai, Li-Huei] MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Xie, Zhigang] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Xie, Zhigang] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Boston University; Boston University	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lhtsai@mit.edu		Xie, Zhigang/0000-0002-5794-2977	RIKEN; Howard Hughes Medical Institute	RIKEN; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by RIKEN and the Howard Hughes Medical Institute.	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Frank CL, 2009, NEURON, V62, P312, DOI 10.1016/j.neuron.2009.03.029; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heidebrecht HJ, 2001, LAB INVEST, V81, P1163, DOI 10.1038/labinvest.3780328; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Miyama S, 1997, CEREB CORTEX, V7, P678, DOI 10.1093/cercor/7.7.678; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Ritter B, 2004, DEV BRAIN RES, V149, P73, DOI 10.1016/j.devbrainres.2003.12.006; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sequeira SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000615; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Tarui T, 2005, CEREB CORTEX, V15, P1343, DOI 10.1093/cercor/bhi017; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vernon E, 2001, MOL CELL NEUROSCI, V17, P637, DOI 10.1006/mcne.2000.0960; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yukawa K, 1999, MOL BRAIN RES, V69, P124, DOI 10.1016/S0169-328X(99)00086-8	41	53	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33324	33337		10.1074/jbc.M110.140699	http://dx.doi.org/10.1074/jbc.M110.140699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724472	Green Published, hybrid			2022-12-27	WOS:000283048200068
J	Ishikawa, M; Nishijima, N; Shiota, J; Sakagami, H; Tsuchida, K; Mizukoshi, M; Fukuchi, M; Tsuda, M; Tabuchi, A				Ishikawa, Mitsuru; Nishijima, Naoki; Shiota, Jun; Sakagami, Hiroyuki; Tsuchida, Kunihiro; Mizukoshi, Miho; Fukuchi, Mamoru; Tsuda, Masaaki; Tabuchi, Akiko			Involvement of the Serum Response Factor Coactivator Megakaryoblastic Leukemia (MKL) in the Activin-regulated Dendritic Complexity of Rat Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE DIFFERENTIATION; TRANSCRIPTION FACTOR-B; MESSENGER-RNA; ADULT NEUROGENESIS; GENE-TRANSCRIPTION; SYNAPTIC ACTIVITY; SRF; BRAIN; BETA; HIPPOCAMPUS	Dynamic changes in neuronal morphology and transcriptional regulation play crucial roles in the neuronal network and function. Accumulating evidence suggests that the megakaryoblastic leukemia (MKL) family members, which function not only as actin-binding proteins but also as serum response factor (SRF) transcriptional coactivators, regulate neuronal morphology. However, the extracellular ligands and signaling pathways, which activate MKL-mediated morphological changes in neurons, remain unresolved. Here, we demonstrate that in addition to MKL1, MKL2, highly enriched in the forebrain, strongly contributes to the dendritic complexity, and this process is triggered by stimulation with activin, a member of the transforming growth factor beta (TGF-beta) superfamily. Activin promoted dendritic complexity in a SRF- and MKL-dependent manner without drastically affecting MKL localization and protein levels. In contrast, activin promoted the nuclear export of suppressor of cancer cell invasion (SCAI), which is a corepressor for SRF and MKL. Furthermore, overexpression of SCAI blocked activin-induced SRF transcriptional responses and dendritic complexity. Collectively, these results strongly suggest that activin-SCAI-MKL signaling is a novel pathway that regulates the dendritic morphology of rat cortical neurons by excluding SCAI from the nucleus and activating MKL/SRF-mediated gene expression.	[Ishikawa, Mitsuru; Nishijima, Naoki; Shiota, Jun; Mizukoshi, Miho; Fukuchi, Mamoru; Tsuda, Masaaki; Tabuchi, Akiko] Toyama Univ, Dept Biol Chem, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Sakagami, Hiroyuki] Kitasato Univ, Dept Anat, Sch Med, Kanagawa 2288555, Japan; [Tsuchida, Kunihiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Aichi 4701192, Japan	University of Toyama; Kitasato University; Fujita Health University	Tabuchi, A (corresponding author), Toyama Univ, Dept Biol Chem, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	atabuchi@pha.u-toyama.ac.jp	Ishikawa, Mitsuru/L-1822-2013; Tsuchida, Kunihiro/A-4501-2012	Tsuchida, Kunihiro/0000-0002-3983-5756; Fukuchi, Mamoru/0000-0002-6807-8707	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17790055, 19790052, 22590080, 20390023]; Hayashi Memorial Foundation for Female Natural Scientists; Foundation of the First Bank of Toyama; Takeda Science Foundation; Narishige Neuroscience Research Foundation; Tokyo Biochemical Research Foundation; Uehara Memorial Foundation; Comprehensive Brain Science Network	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Foundation of the First Bank of Toyama; Takeda Science Foundation(Takeda Science Foundation (TSF)); Narishige Neuroscience Research Foundation; Tokyo Biochemical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Comprehensive Brain Science Network	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Projects 17790055, 19790052, 22590080 (A. T.) and 20390023 (M. T.)) and by research grants from the Hayashi Memorial Foundation for Female Natural Scientists (A. T.), Foundation of the First Bank of Toyama (A. T.), the Takeda Science Foundation (A. T.), the Narishige Neuroscience Research Foundation (A. T.), the Tokyo Biochemical Research Foundation (A. T.), the Uehara Memorial Foundation (A. T.), and by the Comprehensive Brain Science Network.	Ageta H, 2010, LEARN MEMORY, V17, P176, DOI 10.1101/lm.16659010; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fukuchi M, 2004, J BIOL CHEM, V279, P47856, DOI 10.1074/jbc.M409090200; Funaba M, 1997, J NEUROENDOCRINOL, V9, P105, DOI 10.1046/j.1365-2826.1997.00558.x; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Ishimaru N, 2007, J NEUROCHEM, V100, P520, DOI 10.1111/j.1471-4159.2006.04216.x; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; O'Sullivan NC, 2010, CEREB CORTEX, V20, P1915, DOI 10.1093/cercor/bhp262; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Sakagami H, 1998, MOL BRAIN RES, V54, P311, DOI 10.1016/S0169-328X(97)00362-8; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sekiguchi M, 2009, NEUROSCI LETT, V452, P232, DOI 10.1016/j.neulet.2009.01.074; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Shiota J, 2006, J NEUROCHEM, V98, P1778, DOI 10.1111/j.1471-4159.2006.03992.x; Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tabuchi A, 2005, J NEUROCHEM, V94, P169, DOI 10.1111/j.1471-4159.2005.03179.x; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yasuda M, 2007, J NEUROCHEM, V103, P626, DOI 10.1111/j.1471-4159.2007.04851.x; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zheng F, 2009, MOL PSYCHIATR, V14, P332, DOI 10.1038/sj.mp.4002131	49	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32734	32743		10.1074/jbc.M110.118745	http://dx.doi.org/10.1074/jbc.M110.118745			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20709749	Green Published, hybrid			2022-12-27	WOS:000283048200008
J	Greenfield, EM; Beidelschies, MA; Tatro, JM; Goldberg, VM; Hise, AG				Greenfield, Edward M.; Beidelschies, Michelle A.; Tatro, Joscelyn M.; Goldberg, Victor M.; Hise, Amy G.			Bacterial Pathogen-associated Molecular Patterns Stimulate Biological Activity of Orthopaedic Wear Particles by Activating Cognate Toll-like Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA PRODUCTION; RIBOSOMAL-RNA GENE; NALP3 INFLAMMASOME; ADHERENT ENDOTOXIN; TITANIUM PARTICLES; IMMUNE-RESPONSES; OSTEOCLAST DIFFERENTIATION; INDUCED OSTEOLYSIS; HIP-REPLACEMENT; POLYMYXIN-B	Aseptic loosening of orthopaedic implants is induced by wear particles generated from the polymeric and metallic components of the implants. Substantial evidence suggests that activation of Toll-like receptors (TLRs) may contribute to the biological activity of the wear particles. Although pathogen-associated molecular patterns (PAMPs) produced by Gram-positive bacteria are likely to be more common in patients with aseptic loosening, prior studies have focused on LPS, a TLR4-specific PAMP produced by Gram-negative bacteria. Here we show that both TLR2 and TLR4 contribute to the biological activity of titanium particles with adherent bacterial debris. In addition, lipoteichoic acid, a PAMP produced by Gram-positive bacteria that activates TLR2, can, like LPS, adhere to the particles and increase their biological activity, and the increased biological activity requires the presence of the cognate TLR. Moreover, three lines of evidence support the conclusion that TLR activation requires bacterially derived PAMPs and that endogenously produced alarmins are not sufficient. First, neither TLR2 nor TLR4 contribute to the activity of "endotoxin-free" particles as would be expected if alarmins are sufficient to activate the TLRs. Second, noncognate TLRs do not contribute to the activity of particles with adherent LPS or lipoteichoic acid as would be expected if alarmins are sufficient to activate the TLRs. Third, polymyxin B, which inactivates LPS, blocks the activity of particles with adherent LPS. These results support the hypothesis that PAMPs produced by low levels of bacterial colonization may contribute to aseptic loosening of orthopaedic implants.	[Greenfield, Edward M.; Beidelschies, Michelle A.; Tatro, Joscelyn M.; Goldberg, Victor M.] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Hise, Amy G.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Case Med Ctr, Cleveland, OH 44106 USA; [Greenfield, Edward M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Greenfield, Edward M.] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Greenfield, EM (corresponding author), Case Western Reserve Univ, Dept Orthopaed, 2109 Adelbert Rd,Biomed Res Bldg,Rm 331, Cleveland, OH 44106 USA.	emg3@cwru.edu	Beidelschies, Michelle/AAM-6446-2021	Beidelschies, Michelle/0000-0002-6344-0674; Hise, Amy/0000-0001-5075-5792	National Institutes of Health [T32 AR07505]; Sulzer Medical Research Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sulzer Medical Research Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 AR07505 (to M.A.B.). This work was also supported by a grant from the Sulzer Medical Research Trust Fund (to E.M.G. and V.M.G.).	Ashwood P, 2007, EXP BIOL MED, V232, P107; Beidelschies MA, 2008, J CELL PHYSIOL, V217, P652, DOI 10.1002/jcp.21539; Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082; Bi YM, 2002, J ORTHOP RES, V20, P696, DOI 10.1016/S0736-0266(01)00176-0; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Dai JC, 2006, BONE, V38, P509, DOI 10.1016/j.bone.2005.10.007; Deininger S, 2008, IMMUNOBIOLOGY, V213, P519, DOI 10.1016/j.imbio.2008.01.001; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Dempsey KE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2201; DUFF GW, 1982, J IMMUNOL METHODS, V52, P333, DOI 10.1016/0022-1759(82)90005-9; Engesaeter LB, 2003, ACTA ORTHOP SCAND, V74, P644, DOI 10.1080/00016470310018135; Gao JJ, 2001, INFECT IMMUN, V69, P751, DOI 10.1128/IAI.69.2.751-757.2001; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gillette-Ferguson I, 2007, INFECT IMMUN, V75, P5908, DOI 10.1128/IAI.00991-07; GREENFIELD E, 2006, ENCY BIOMATERIALS BI, P1; Greenfield EM, 2008, J AM ACAD ORTHOP SUR, V16, pS56, DOI 10.5435/00124635-200800001-00012; Greenfield EM, 2002, J ORTHOPAED RES, V20, P1, DOI 10.1016/S0736-0266(01)00070-5; Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hanssen AD, 2004, CLIN ORTHOP RELAT R, P63; Hao HN, 2010, J BIOMED MATER RES A, V92A, P1373, DOI 10.1002/jbm.a.32474; Hise AG, 2007, J IMMUNOL, V178, P1068, DOI 10.4049/jimmunol.178.2.1068; Hoenders CSM, 2008, J BIOMED MATER RES B, V86B, P291, DOI 10.1002/jbm.b.30992; Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hoshino K, 1999, J IMMUNOL, V162, P3749; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kaar SG, 2001, J ORTHOPAED RES, V19, P171, DOI 10.1016/S0736-0266(00)00033-4; Lahdeoja T, 2010, J ORTHOP RES, V28, P184, DOI 10.1002/jor.20979; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lyle DB, 2010, J BIOMED MATER RES A, V94A, P893, DOI 10.1002/jbm.a.32760; Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023; Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438; Marshall A, 2008, J AM ACAD ORTHOP SUR, V16, pS1, DOI 10.5435/00124635-200800001-00003; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; Nalepka JL, 2006, CLIN ORTHOP RELAT R, P229, DOI 10.1097/01.blo.0000224050.94248.38; Nalepka JL, 2004, BIOTECHNIQUES, V37, P413, DOI 10.2144/04373ST06; NELSON CL, 2005, CLIN ORTHOP RELAT R, V437, P25; NEUT D, 2003, CLIN ORTHOP RELAT R, V413, P261; Neut D, 2007, ACTA ORTHOP, V78, P299, DOI 10.1080/17453670710013843; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; PEARL J, 2008, T ORTHOP RES SOC, V33, P1936; Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; STPIERRE CA, 2010, J ORTHOP RE IN PRESS; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Takagi M, 2007, J BIOMED MATER RES A, V81A, P1017, DOI 10.1002/jbm.a.31235; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taki N, 2005, J ORTHOP RES, V23, P376, DOI 10.1016/j.orthres.2004.08.023; Tamaki Y, 2009, J RHEUMATOL, V36, P598, DOI 10.3899/jrheum.080390; Tatro JM, 2007, J ORTHOP RES, V25, P361, DOI 10.1002/jor.20289; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281, DOI 10.1128/JCM.37.10.3281-3290.1999; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Xing ZQ, 2006, J ORTHOP RES, V24, P959, DOI 10.1002/jor.20038; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067	64	69	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32378	32384		10.1074/jbc.M110.136895	http://dx.doi.org/10.1074/jbc.M110.136895			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20729214	Green Published, hybrid			2022-12-27	WOS:000282683000051
J	Vedhachalam, C; Chetty, PS; Nickel, M; Dhanasekaran, P; Lund-Katz, S; Rothblat, GH; Phillips, MC				Vedhachalam, Charulatha; Chetty, Palaniappan Sevugan; Nickel, Margaret; Dhanasekaran, Padmaja; Lund-Katz, Sissel; Rothblat, George H.; Phillips, Michael C.			Influence of Apolipoprotein (Apo) A-I Structure on Nascent High Density Lipoprotein (HDL) Particle Size Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; ABCA1-MEDIATED CHOLESTEROL EFFLUX; CELLULAR LIPID EFFLUX; C-TERMINAL DOMAIN; PRE-BETA-HDL; PLASMA-MEMBRANE; HEART-DISEASE; BINDING; ABCA1; MACROPHAGE	The principal protein of high density lipoprotein (HDL), apolipoprotein (apo) A-I, in the lipid-free state contains two tertiary structure domains comprising an N-terminal helix bundle and a less organized C-terminal domain. It is not known how the properties of these domains modulate the formation and size distribution of apoA-I-containing nascent HDL particles created by ATP-binding cassette transporter A1 (ABCA1)-mediated efflux of cellular phospholipid and cholesterol. To address this issue, proteins corresponding to the two domains of human apoA-I (residues 1-189 and 190-243) and mouse apoA-I (residues 1-186 and 187-240) together with some human/mouse domain hybrids were examined for their abilities to form HDL particles when incubated with either ABCA1-expressing cells or phospholipid multilamellar vesicles. Incubation of human apoA-I with cells gave rise to two sizes of HDL particles (hydrodynamic diameter, 8 and 10 nm), and removal or disruption of the C-terminal domain eliminated the formation of the smaller particle. Variations in apoA-I domain structure and physical properties exerted similar effects on the rates of formation and sizes of HDL particles created by either spontaneous solubilization of phospholipid multilamellar vesicles or the ABCA1-mediated efflux of cellular lipids. It follows that the sizes of nascent HDL particles are determined at the point at which cellular phospholipid and cholesterol are solubilized by apoA-I; apparently, this is the rate-determining step in the overall ABCA1-mediated cellular lipid efflux process. The stability of the apoA-I N-terminal helix bundle domain and the hydrophobicity of the C-terminal domain are important determinants of both nascent HDL particle size and their rate of formation.	[Vedhachalam, Charulatha; Chetty, Palaniappan Sevugan; Nickel, Margaret; Dhanasekaran, Padmaja; Lund-Katz, Sissel; Rothblat, George H.; Phillips, Michael C.] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Lipid Res Grp,Gastroenterol Hepatol & Nutr Div, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Phillips, MC (corresponding author), Univ Penn, Sch Med, Childrens Hosp Philadelphia, Lipid Res Grp,Gastroenterol Hepatol & Nutr Div, Suite 1102,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	phillipsmi@email.chop.edu		Phillips, Michael/0000-0002-7147-8007	National Institutes of Health [HL22633]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL22633.	Alexander ET, 2009, J LIPID RES, V50, P1409, DOI 10.1194/jlr.M800578-JLR200; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Burgess JW, 1999, BIOCHEMISTRY-US, V38, P14524, DOI 10.1021/bi990930z; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; DREXEL H, 1992, AM J CARDIOL, V70, P436, DOI 10.1016/0002-9149(92)91186-8; Duong PT, 2008, J LIPID RES, V49, P1006, DOI 10.1194/jlr.M700506-JLR200; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Faulkner LE, 2008, J LIPID RES, V49, P1322, DOI 10.1194/jlr.M800048-JLR200; Favari E, 2002, BIOCHEM BIOPH RES CO, V299, P801, DOI 10.1016/S0006-291X(02)02745-6; Fukuda M, 2007, J LIPID RES, V48, P882, DOI 10.1194/jlr.M600495-JLR200; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Krimbou L, 2005, J LIPID RES, V46, P1668, DOI 10.1194/jlr.M500038-JLR200; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Lund-Katz S, 2003, FRONT BIOSCI-LANDMRK, V8, pD1044, DOI 10.2741/1077; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Nandi S, 2009, J LIPID RES, V50, P456, DOI 10.1194/jlr.M800345-JLR200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; POWNALL HJ, 1981, BIOCHEMISTRY-US, V20, P6630, DOI 10.1021/bi00526a017; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Segall ML, 2002, J LIPID RES, V43, P1688, DOI 10.1194/jlr.M200157-JLR200; Sviridov D, 1996, J BIOL CHEM, V271, P33277, DOI 10.1074/jbc.271.52.33277; SWANEY JB, 1983, J BIOL CHEM, V258, P1254; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8	45	35	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31965	31973		10.1074/jbc.M110.126292	http://dx.doi.org/10.1074/jbc.M110.126292			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679346	Green Published, hybrid			2022-12-27	WOS:000282683000009
J	Hsieh, YC; Wu, YJ; Chiang, TY; Kuo, CY; Shrestha, KL; Chao, CF; Huang, YC; Chuankhayan, P; Wu, WG; Li, YK; Chen, CJ				Hsieh, Yin-Cheng; Wu, Yue-Jin; Chiang, Tzu-Ying; Kuo, Chueh-Yuan; Shrestha, Keshab Lal; Chao, Cheng-Fu; Huang, Yen-Chieh; Chuankhayan, Phimonphan; Wu, Wen-Guey; Li, Yaw-Kuen; Chen, Chun-Jung			Crystal Structures of Bacillus cereus NCTU2 Chitinase Complexes with Chitooligomers Reveal Novel Substrate Binding for Catalysis A CHITINASE WITHOUT CHITIN BINDING AND INSERTION DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPOSED AROMATIC RESIDUES; X-RAY-STRUCTURE; SERRATIA-MARCESCENS; FAMILY-18 CHITINASE; CRYSTALLOGRAPHIC ANALYSIS; ASPERGILLUS-FUMIGATUS; ASSISTED CATALYSIS; CIRCULANS WL-12; PROTEIN MODELS; HYDROLYSIS	Chitinases hydrolyze chitin, an insoluble linear polymer of N-acetyl-D-glucosamine (NAG)(n), into nutrient sources. Bacillus cereus NCTU2 chitinase (ChiNCTU2) predominantly produces chitobioses and belongs to glycoside hydrolase family 18. The crystal structure of wild-type ChiNCTU2 comprises only a catalytic domain, unlike other chitinases that are equipped with additional chitin binding and insertion domains to bind substrates into the active site. Lacking chitin binding and chitin insertion domains, ChiNCTU2 utilizes two dynamic loops (Gly-67-Thr-69 and Ile-106-Val-112) to interact with (NAG)(n), generating novel substrate binding and distortion for catalysis. Gln-109 is crucial for direct binding with substrates, leading to conformational changes of two loops with a maximum shift of similar to 4.6 angstrom along the binding cleft. The structures of E145Q, E145Q/Y227F, and E145G/Y227F mutants complexed with (NAG)(n) reveal (NAG)(2), (NAG)(2), and (NAG)(4) in the active site, respectively, implying various stages of reaction: before hydrolysis, E145G/Y227F with (NAG)(4); in an intermediate state, E145Q/Y227F with a boat-form NAG at the -1 subsite, -1-(NAG); after hydrolysis, E145Q with a chair form -1-(NAG). Several residues were confirmed to play catalytic roles: Glu-145 in cleavage of the glycosidic bond between -1-(NAG) and -1-(NAG); Tyr-227 in the conformational change of -1-(NAG); Asp-143 and Gln-225 in stabilizing the conformation of -1-(NAG). Additionally, Glu-190 acts in the process of product release, and Tyr-193 coordinates with water for catalysis. Residues Asp-143, E145Q, Glu190, and Tyr-193 exhibit multiple conformations for functions. The inhibitors zinc ions and cyclo-(L-His-L-Pro) are located at various positions and confirm the catalytic-site topology. Together with kinetics analyses of related mutants, the structures of ChiNCTU2 and its mutant complexes with (NAG)(n) provide new insights into its substrate binding and the mechanistic action.	[Wu, Yue-Jin; Shrestha, Keshab Lal; Chao, Cheng-Fu; Li, Yaw-Kuen] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 30010, Taiwan; [Huang, Yen-Chieh; Chuankhayan, Phimonphan; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan; [Chiang, Tzu-Ying; Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30043, Taiwan; [Hsieh, Yin-Cheng; Kuo, Chueh-Yuan; Wu, Wen-Guey] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30043, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan	National Yang Ming Chiao Tung University; National Synchrotron Radiation Research Center; National Tsing Hua University; National Tsing Hua University; National Cheng Kung University	Li, YK (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 30010, Taiwan.	ykl@cc.nctu.edu.tw; cjchen@nsrrc.org.tw	Chen, Chun-Jung/A-6880-2011	Chen, Chun-Jung/0000-0002-5157-4288	National Science Council (NSC) [95-2923-B-213-001-MY3, 95-2313-B-009-001-MY3, 96-2113-M-009-012-MY3]; National Synchrotron Radiation Center [973RSB02, 983RSB02]; MOE-AU Program	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Synchrotron Radiation Center; MOE-AU Program	This work was supported in part by National Science Council (NSC) Grants 95-2923-B-213-001-MY3 and 95-2313-B-009-001-MY3, National Synchrotron Radiation Center Grants 973RSB02 and 983RSB02 (to C.-J.C.), and the MOE-AU Program and NSC Grant 96-2113-M-009-012-MY3 (to Y.-K.L.).	Brameld KA, 1998, J AM CHEM SOC, V120, P3571, DOI 10.1021/ja972282h; BRUNEL B, 1994, FEMS MICROBIOL ECOL, V14, P331, DOI 10.1111/j.1574-6941.1994.tb00118.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavada BS, 2006, FEBS J, V273, P3962, DOI 10.1111/j.1742-4658.2006.05400.x; Cohen-Kupiec R, 1998, CURR OPIN BIOTECH, V9, P270, DOI 10.1016/S0958-1669(98)80058-X; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Emmert EAB, 1999, FEMS MICROBIOL LETT, V171, P1, DOI 10.1111/j.1574-6968.1999.tb13405.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Felse PA, 1999, APPL MICROBIOL BIOT, V51, P141, DOI 10.1007/s002530051374; FLACH J, 1992, EXPERIENTIA, V48, P701, DOI 10.1007/BF02124285; GRAHAM LS, 1994, CAN J BOT, V72, P1057, DOI 10.1139/b94-132; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Hollis T, 2000, PROTEIN SCI, V9, P544, DOI 10.1110/ps.9.3.544; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Houston DR, 2004, J MED CHEM, V47, P5713, DOI 10.1021/jm049940a; Hu HY, 2004, ACTA CRYSTALLOGR D, V60, P939, DOI 10.1107/S0907444904005190; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Jaques AK, 2003, MICROBIOL-SGM, V149, P2931, DOI 10.1099/mic.0.26476-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; Kuo CY, 2006, ACTA CRYSTALLOGR F, V62, P916, DOI 10.1107/S1744309106031423; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008654; Lonhienne T, 2001, J BACTERIOL, V183, P1773, DOI 10.1128/JB.183.5.1773-1779.2001; Nakamura T, 2008, J MOL BIOL, V381, P670, DOI 10.1016/j.jmb.2008.06.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Pleban S, 1997, LETT APPL MICROBIOL, V25, P284, DOI 10.1046/j.1472-765X.1997.00224.x; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; SILOSUH LA, 1994, APPL ENVIRON MICROB, V60, P2023, DOI 10.1128/AEM.60.6.2023-2030.1994; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Takaya N, 1998, MICROBIOL-SGM, V144, P2647, DOI 10.1099/00221287-144-9-2647; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2004, J BIOL CHEM, V279, P3612, DOI 10.1074/jbc.M310057200; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Wen CM, 2002, BIOTECHNOL APPL BIOC, V35, P213, DOI 10.1042/BA20020001; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	59	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31603	31615		10.1074/jbc.M110.149310	http://dx.doi.org/10.1074/jbc.M110.149310			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685646	hybrid, Green Published			2022-12-27	WOS:000282764600054
J	Zykova, TA; Zhu, F; Vakorina, TI; Zhang, JS; Higgins, LA; Urusova, DV; Bode, AM; Dong, ZG				Zykova, Tatyana A.; Zhu, Feng; Vakorina, Tatyana I.; Zhang, Jishuai; Higgins, Lee Ann; Urusova, Darya V.; Bode, Ann M.; Dong, Zigang			T-LAK Cell-originated Protein Kinase (TOPK) Phosphorylation of Prx1 at Ser-32 Prevents UVB-induced Apoptosis in RPMI7951 Melanoma Cells through the Regulation of Prx1 Peroxidase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXIREDOXIN-I EXPRESSION; CYSTEINE-SULFINIC ACID; PDZ-BINDING KINASE; CIRCULAR-DICHROISM SPECTRA; MITOTIC KINASE; SECONDARY STRUCTURE; SITE CYSTEINE; LUNG-CANCER; OXIDATION; INACTIVATION	Protein kinases are potential targets for the prevention and control of UV-induced skin cancer. T-cell-originated protein kinase (TOPK) is highly expressed in skin cancer cells, but its specific function is still unknown. We investigated the role of TOPK in UVB-induced apoptosis in RPMI7951 human melanoma cells. Liquid chromatography-tandem mass spectrometry analysis was used to identify proteins that bind with TOPK. Immunofluorescence, Western blot, and flow cytometry were used to assess the effect of UVB on TOPK, peroxiredoxin 1 (Prx1), and apoptosis in RPMI7951 cells. TOPK binds with Prx1 and its phosphorylation of Prx1 at Ser-32 is important for regulation of H2O2-mediated signal transduction. Analysis of the CD spectra of Prx1 and mutant Prx1 (S32A) proteins showed that the secondary structure of Prx1 was significantly altered by phosphorylation of Prx1 at Ser-32. UVB irradiation induced phosphorylation of TOPK in RPMI7951 human melanoma cells and phosphorylated TOPK co-localized with Prx1 in the nucleus. UVB induced the peroxidase activity of Prx1 in vitro and ex vivo. Following treatment with UVB, H2O2 levels and apoptosis were increased in RPMI7951 cells stably expressing TOPK siRNA or stably mutant Prx1 (S32A). Phosphorylation of Prx1 (Ser-32) by TOPK prevents UVB-induced apoptosis in RPMI7951 melanoma cells through regulation of Prx1 peroxidase activity and blockade of intracellular H2O2 accumulation.	[Zykova, Tatyana A.; Zhu, Feng; Zhang, Jishuai; Urusova, Darya V.; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Vakorina, Tatyana I.] Russian Acad Sci, Pacific Inst Bioorgan Chem, Far E Branch, Vladivostok 690022, Russia; [Higgins, Lee Ann] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences; University of Minnesota System; University of Minnesota Twin Cities	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/G-3567-2010; ZHU, Feng/C-1303-2010	Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA 077646, R37 CA 081646, CA 120388, ES 016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA077646, R01CA120388, R21CA081646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 077646 (ARPA), R37 CA 081646, CA 120388, and ES 016548 and The Hormel Foundation.	Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Abe Y, 2007, J MOL BIOL, V370, P231, DOI 10.1016/j.jmb.2007.04.067; Aran M, 2009, FEBS J, V276, P2478, DOI 10.1111/j.1742-4658.2009.06984.x; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Baker LMS, 2003, J BIOL CHEM, V278, P9203, DOI 10.1074/jbc.M209888200; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; BODE AM, 2003, SCI STKE, pRE2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterfield LH, 1999, ANTIOXID REDOX SIGN, V1, P385, DOI 10.1089/ars.1999.1.4-385; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Cordray P, 2007, J BIOL CHEM, V282, P32623, DOI 10.1074/jbc.M704369200; Cote S, 2002, CYTOKINE, V20, P113, DOI 10.1006/cyto.2002.1988; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dougherty JD, 2005, J NEUROSCI, V25, P10773, DOI 10.1523/JNEUROSCI.3207-05.2005; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Kim JH, 2008, CLIN CANCER RES, V14, P2326, DOI 10.1158/1078-0432.CCR-07-4457; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Knoops Bernard, 2007, V44, P27; Matsumoto S, 2004, BIOCHEM BIOPH RES CO, V325, P997, DOI 10.1016/j.bbrc.2004.10.133; Nandi A, 2004, BLOOD CELL MOL DIS, V32, P240, DOI 10.1016/j.bcmd.2003.10.004; Nandi AK, 2006, LEUKEMIA RES, V30, P437, DOI 10.1016/j.leukres.2005.08.011; Nandi AK, 2007, BIOCHEM BIOPH RES CO, V358, P181, DOI 10.1016/j.bbrc.2007.04.125; Oh SM, 2007, CANCER RES, V67, P5186, DOI 10.1158/0008-5472.CAN-06-4506; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simons-Evelyn M, 2001, BLOOD CELL MOL DIS, V27, P825, DOI 10.1006/bcmd.2001.0452; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1; Yanagawa T, 1999, CANCER LETT, V145, P127, DOI 10.1016/S0304-3835(99)00243-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yuryev A, 2003, GENOMICS, V81, P112, DOI 10.1016/S0888-7543(02)00008-3; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048; Zykova TA, 2005, CARCINOGENESIS, V26, P331, DOI 10.1093/carcin/bgh334; Zykova TA, 2006, CLIN CANCER RES, V12, P6884, DOI 10.1158/1078-0432.CCR-06-0410	46	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29138	29146		10.1074/jbc.M110.135905	http://dx.doi.org/10.1074/jbc.M110.135905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20647304	Green Published, hybrid			2022-12-27	WOS:000281740100014
J	Weinitschke, S; Hollemeyer, K; Kusian, B; Bowien, B; Smits, THM; Cook, AM				Weinitschke, Sonja; Hollemeyer, Klaus; Kusian, Bernhard; Bowien, Botho; Smits, Theo H. M.; Cook, Alasdair M.			Sulfoacetate Is Degraded via a Novel Pathway Involving Sulfoacetyl-CoA and Sulfoacetaldehyde in Cupriavidus necator H16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RALSTONIA-EUTROPHA; C-2 SULFONATES; GENE CLUSTERS; TAURINE; PURIFICATION; METABOLISM; ENZYMES; STRAIN; DEHYDROGENASE; REDUCTASE	Bacterial degradation of sulfoacetate, a widespread natural product, proceeds via sulfoacetaldehyde and requires a considerable initial energy input. Whereas the fate of sulfoacetaldehyde in Cupriavidus necator (Ralstonia eutropha) H16 is known, the pathway from sulfoacetate to sulfoacetaldehyde is not. The genome sequence of the organism enabled us to hypothesize that the inducible pathway, which initiates sau (sulfoacetate utilization), involved a four-gene cluster (sauRSTU; H16_A2746 to H16_A2749). The sauR gene, divergently orientated to the other three genes, probably encodes the transcriptional regulator of the presumed sauSTU operon, which is subject to inducible transcription. SauU was tentatively identified as a transporter of the major facilitator superfamily, and SauT was deduced to be a sulfoacetate-CoA ligase. SauT was a labile protein, but it could be separated and shown to generate AMP and an unknown, labile CoA-derivative from sulfoacetate, CoA, and ATP. This unknown compound, analyzed by MALDI-TOF-MS, had a relative molecular mass of 889.7, which identified it as protonated sulfoacetyl-CoA (calculated 889.6). SauS was deduced to be sulfoacetaldehyde dehydrogenase (acylating). The enzyme was purified 175-fold to homogeneity and characterized. Peptide mass fingerprinting confirmed the sauS locus w(H16_A2747). SauS converted sulfoacetyl-CoA and NADPH to sulfoacetaldehyde, CoA, and NADP(+), thus confirming the hypothesis.	[Weinitschke, Sonja; Smits, Theo H. M.; Cook, Alasdair M.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Hollemeyer, Klaus] Univ Saarland, Inst Biochem Engn, D-66041 Saarbrucken, Germany; [Kusian, Bernhard; Bowien, Botho] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Smits, Theo H. M.] Swiss Fed Res Stn, CH-8820 Wadenswil, Switzerland	University of Konstanz; Saarland University; University of Gottingen; Swiss Federal Research Station Agroscope	Cook, AM (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	alasdair.cook@uni-konstanz.de		Smits, Theo H.M./0000-0002-1237-235X	Deutsche Forschungsgemeinschaft [Co 206/6-1]; German Federal Ministry of Education and Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Supported by Grant Co 206/6-1 from the Deutsche Forschungsgemeinschaft.; Supported by the competence network "BiotechGenoMik" financed by the German Federal Ministry of Education and Research.	ALLEN JA, 1971, ADV MAR BIOL, V9, P205, DOI 10.1016/S0065-2881(08)60343-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruggeman C, 2004, MICROBIOL-SGM, V150, P805, DOI 10.1099/mic.0.26795-0; Chohan SN, 1998, APPL ENVIRON MICROB, V64, P2859; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; Cook AM, 2002, ARCH MICROBIOL, V179, P1, DOI 10.1007/s00203-002-0497-0; COOK AM, 1987, FEMS MICROBIOL LETT, V46, P93, DOI 10.1016/0378-1097(87)90059-0; DEMBITSKY VM, 1990, PHYTOCHEMISTRY, V29, P3417, DOI 10.1016/0031-9422(90)85249-F; Denger K, 2004, ARCH MICROBIOL, V182, P254, DOI 10.1007/s00203-004-0678-0; Denger K, 2001, ARCH MICROBIOL, V176, P89, DOI 10.1007/s002030100296; Denger K, 2008, MICROBIOL-SGM, V154, P256, DOI 10.1099/mic.0.2007/011650-0; DESOMER J, 1991, MOL MICROBIOL, V5, P2115, DOI 10.1111/j.1365-2958.1991.tb02141.x; Folkers K, 1944, J AM CHEM SOC, V66, P1083, DOI 10.1021/ja01235a007; Graham DE, 2002, J BIOL CHEM, V277, P13421, DOI 10.1074/jbc.M201011200; GUPTA SD, 1988, ARCH BIOCHEM BIOPHYS, V260, P125, DOI 10.1016/0003-9861(88)90432-8; Harwood J. L., 1980, The biochemistry of plants. A comprehensive treatise. Volume 4. Lipids: structure and function., P301; Harwood JL, 1979, BIOCHEM SOC T, V7, P440, DOI 10.1042/bst0070440; Hollemeyer K, 2007, RAPID COMMUN MASS SP, V21, P336, DOI 10.1002/rcm.2840; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; Jeffke T, 1999, J BACTERIOL, V181, P4374, DOI 10.1128/JB.181.14.4374-4380.1999; KENNEDY SIT, 1968, BIOCHEM J, V107, P497, DOI 10.1042/bj1070497; King JE, 1997, MICROBIOL-SGM, V143, P3907, DOI 10.1099/00221287-143-12-3907; Krejcik Z, 2008, ARCH MICROBIOL, V190, P159, DOI 10.1007/s00203-008-0386-2; Krejcik Z, 2010, MICROBIOL-SGM, V156, P1547, DOI 10.1099/mic.0.036699-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE RF, 1972, BIOCHIM BIOPHYS ACTA, V261, P35, DOI 10.1016/0304-4165(72)90309-1; leMaire M, 1996, ACS SYM SER, V635, P36; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Mampel J, 2004, BIOCHEM J, V383, P91, DOI 10.1042/BJ20040652; MARTELLI HL, 1964, BIOCHIM BIOPHYS ACTA, V93, P169, DOI 10.1016/0304-4165(64)90272-7; MARTELLI HL, 1970, BIOCHIM BIOPHYS ACTA, V208, P110, DOI 10.1016/0304-4165(70)90053-X; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; POWLOWSKI J, 1993, J BACTERIOL, V175, P377, DOI 10.1128/JB.175.2.377-385.1993; Ruff J, 2003, BIOCHEM J, V369, P275, DOI 10.1042/BJ20021455; Sambrook J., 1989, MOL CLONING, pA1; SHIBUYA ISAO, 1963, P627; SOHLING B, 1993, EUR J BIOCHEM, V212, P121, DOI 10.1111/j.1432-1033.1993.tb17641.x; SORBO B, 1987, METHOD ENZYMOL, V143, P3; STADTMAN TC, 1957, J BIOL CHEM, V228, P983; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; THURNHEER T, 1986, J GEN MICROBIOL, V132, P1215; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; Weinitschke S, 2010, APPL ENVIRON MICROB, V76, P618, DOI 10.1128/AEM.01818-09; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yin M, 2000, PHYSIOL BIOCHEM ZOOL, V73, P629, DOI 10.1086/317749	50	11	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35249	35254		10.1074/jbc.M110.127043	http://dx.doi.org/10.1074/jbc.M110.127043			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20693281	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000283845300002
J	Pitt, SJ; Funnell, TM; Sitsapesan, M; Venturi, E; Rietdorf, K; Ruas, M; Ganesan, A; Gosain, R; Churchill, GC; Zhu, MX; Parrington, J; Galione, A; Sitsapesan, R				Pitt, Samantha J.; Funnell, Tim M.; Sitsapesan, Mano; Venturi, Elisa; Rietdorf, Katja; Ruas, Margarida; Ganesan, A.; Gosain, Rajendra; Churchill, Grant C.; Zhu, Michael X.; Parrington, John; Galione, Antony; Sitsapesan, Rebecca			TPC2 Is a Novel NAADP-sensitive Ca2+ Release Channel, Operating as a Dual Sensor of Luminal pH and Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; ADENINE-DINUCLEOTIDE PHOSPHATE; CALCIUM-RELEASE; CA2+-RELEASE CHANNEL; RYANODINE RECEPTORS; MOBILIZES CALCIUM; 2-PORE CHANNELS; SMOOTH-MUSCLE; TRIGGER ZONE; FORM	Nicotinic acid adenine dinucleotide phosphate (NAADP) is a molecule capable of initiating the release of intracellular Ca2+ required for many essential cellular processes. Recent evidence links two-pore channels (TPCs) with NAADP-induced release of Ca2+ from lysosome-like acidic organelles; however, there has been no direct demonstration that TPCs can act as NAADP-sensitive Ca2+ release channels. Controversial evidence also proposes ryanodine receptors as the primary target of NAADP. We show that TPC2, the major lysosomal targeted isoform, is a cation channel with selectivity for Ca2+ that will enable it to act as a Ca2+ release channel in the cellular environment. NAADP opens TPC2 channels in a concentration-dependent manner, binding to high affinity activation and low affinity inhibition sites. At the core of this process is the luminal environment of the channel. The sensitivity of TPC2 to NAADP is steeply dependent on the luminal [Ca2+] allowing extremely low levels of NAADP to open the channel. In parallel, luminal pH controls NAADP affinity for TPC2 by switching from reversible activation of TPC2 at low pH to irreversible activation at neutral pH. Further evidence earmarking TPCs as the likely pathway for NAADP-induced intracellular Ca2+ release is obtained from the use of Ned-19, the selective blocker of cellular NAADP-induced Ca2+ release. Ned-19 antagonizes NAADP-activation of TPC2 in a non-competitive manner at 1 mu M but potentiates NAADP activation at nanomolar concentrations. This single-channel study provides a long awaited molecular basis for the peculiar mechanistic features of NAADP signaling and a framework for understanding how NAADP can mediate key physiological events.	[Funnell, Tim M.; Rietdorf, Katja; Ruas, Margarida; Churchill, Grant C.; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; Univ Bristol, Ctr Nanosci & Quantum Informat, Bristol BS8 1TD, Avon, England; [Ganesan, A.; Gosain, Rajendra] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Oxford; University of Bristol; University of Bristol; University of Southampton; University of Texas System; University of Texas Health Science Center Houston	Galione, A (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	antony.galione@pharm.ox.ac.uk; r.sitsapesan@bris.ac.uk	Ganesan, A/F-6698-2011; Galione, Antony/E-5884-2011	Galione, Antony/0000-0002-4132-7646; Venturi, Elisa/0000-0001-9302-1537; Pitt, Samantha/0000-0003-2257-1595; Ruas, Margarida/0000-0002-4872-7618; Ganesan, A/0000-0003-4862-7999	British Heart Foundation; Wellcome Trust; BBSRC [BB/G008523/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the British Heart Foundation (to R. S.) and the Wellcome Trust (to A. G. and J. P.).	Bak J, 2002, BIOCHEM BIOPH RES CO, V295, P806, DOI 10.1016/S0006-291X(02)00761-1; BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; BUCK E, 1992, J BIOL CHEM, V267, P23560; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; CHU A, 1990, MOL PHARMACOL, V37, P735; Churamani D, 2006, BIOCHEM J, V397, P313, DOI 10.1042/BJ20060179; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Clapham DE, 2005, PHARMACOL REV, V57, P451, DOI 10.1124/pr.57.4.7; Colquhoun D., 1983, SINGLE CHANNEL RECOR, P483, DOI 10.1007/978-1-4615-7858-1_11; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; FATT P, 1958, J PHYSIOL-LONDON, V142, P516, DOI 10.1113/jphysiol.1958.sp006034; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Genazzani AA, 1997, TRENDS PHARMACOL SCI, V18, P108, DOI 10.1016/S0165-6147(96)01036-X; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe18; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J MEMBRANE BIOL, V173, P1, DOI 10.1007/s002320001001; LINDSAY ARG, 1994, J GEN PHYSIOL, V104, P425, DOI 10.1085/jgp.104.3.425; LINDSAY ARG, 1991, BIOCHIM BIOPHYS ACTA, V1064, P89, DOI 10.1016/0005-2736(91)90415-5; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lukyanenko V, 1996, PFLUG ARCH EUR J PHY, V432, P1047, DOI 10.1007/s004240050233; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Morgan AJ, 2008, METHODS, V46, P194, DOI 10.1016/j.ymeth.2008.09.013; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Pitt SJ, 2010, BIOPHYS J, V98, p682a; Rosen D, 2009, J BIOL CHEM, V284, P34930, DOI 10.1074/jbc.M109.016519; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Saftenku E, 2001, BIOPHYS J, V80, P2727, DOI 10.1016/S0006-3495(01)76241-8; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; SITSAPESAN R, 1991, J PHYSIOL-LONDON, V434, P469, DOI 10.1113/jphysiol.1991.sp018481; SITSAPESAN R, 1994, J MEMBRANE BIOL, V137, P215; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Sutko JL, 1997, PHARMACOL REV, V49, P53; TINKER A, 1992, J GEN PHYSIOL, V100, P479, DOI 10.1085/jgp.100.3.479; TUGBA D, 2010, J BIOL CHEM */* A J, V285, P24925; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	47	159	162	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35039	35046		10.1074/jbc.M110.156927	http://dx.doi.org/10.1074/jbc.M110.156927			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20720007	Green Published, hybrid			2022-12-27	WOS:000283659100078
J	Bancells, C; Villegas, S; Blanco, FJ; Benitez, S; Gallego, I; Beloki, L; Perez-Cuellar, M; Ordonez-Llanos, J; Sanchez-Quesa, JL				Bancells, Cristina; Villegas, Sandra; Blanco, Francisco J.; Benitez, Sonia; Gallego, Isaac; Beloki, Lorea; Perez-Cuellar, Montserrat; Ordonez-Llanos, Jordi; Luis Sanchez-Quesa, Jose			Aggregated Electronegative Low Density Lipoprotein in Human Plasma Shows a High Tendency toward Phospholipolysis and Particle Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; ACTIVATING-FACTOR ACETYLHYDROLASE; HUMAN AORTIC PROTEOGLYCANS; OXIDATIVE MODIFICATION; LDL PARTICLES; FAMILIAL HYPERCHOLESTEROLEMIA; CHEMOKINE RELEASE; BINDING-AFFINITY; A(2); SPECTROSCOPY	Aggregation and fusion of lipoproteins trigger subendothelial retention of cholesterol, promoting atherosclerosis. The tendency of a lipoprotein to form fused particles is considered to be related to its atherogenic potential. We aimed to isolate and characterize aggregated and nonaggregated subfractions of LDL from human plasma, paying special attention to particle fusion mechanisms. Aggregated LDL was almost exclusively found in electronegative LDL (LDL(-)), a minor modified LDL subfraction, but not in native LDL (LDL(+)). The main difference between aggregated (agLDL(-)) and nonaggregated LDL(-) (nagLDL(-)) was a 6-fold increased phospholipase C-like activity in agLDL(-). agLDL(-) promoted the aggregation of LDL(+) and nagLDL(-). Lipoprotein fusion induced by alpha-chymotrypsin proteolysis was monitored by NMR and visualized by transmission electron microscopy. Particle fusion kinetics was much faster in agLDL(-) than in nagLDL(-) or LDL(+). NMR and chromatographic analysis revealed a rapid and massive phospholipid degradation in agLDL(-) but not in nagLDL(-) or LDL(+). Choline-containing phospholipids were extensively degraded, and ceramide, diacylglycerol, monoacylglycerol, and phosphorylcholine were the main products generated, suggesting the involvement of phospholipase C-like activity. The properties of agLDL(-) suggest that this subfraction plays a major role in atherogenesis by triggering lipoprotein fusion and cholesterol accumulation in the arterial wall.	[Luis Sanchez-Quesa, Jose] Hosp Santa Creu & Sant Pau, Serv Bioquim, Dept Bioquim, Inst Invest Biomed St Pau, Barcelona 08025, Spain; [Bancells, Cristina; Villegas, Sandra; Gallego, Isaac; Beloki, Lorea; Ordonez-Llanos, Jordi] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Cerdanyola Del Valles 08193, Spain; [Blanco, Francisco J.] CIC BioGUNE, Derio 48160, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; CIC bioGUNE; Basque Foundation for Science	Sanchez-Quesa, JL (corresponding author), Hosp Santa Creu & Sant Pau, Serv Bioquim, Dept Bioquim, Inst Invest Biomed St Pau, C Antoni Maria Claret 167, Barcelona 08025, Spain.	jsanchezq@santpau.cat	cancer, biogune/H-7276-2012; Ordonez-Llanos, Jordi/B-4961-2011; Villegas, Sandra/D-8789-2011; Ordonez-Llanos, Jorge/N-1126-2019; Villegas, Sandra/ABF-8206-2021; Ordonez-Llanos, Jorge/AAE-3088-2020; Ordonez-Llanos, Jorge/A-9335-2010; Blanco, Francisco J/D-4401-2009	Ordonez-Llanos, Jordi/0000-0003-4896-5832; Villegas, Sandra/0000-0001-8644-4304; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Villegas, Sandra/0000-0001-8644-4304; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Blanco, Francisco J/0000-0003-2545-4319; Bancells, Cristina/0000-0003-4819-218X; Sanchez-Quesada, Jose Luis/0000-0003-0224-591X	Instituto de Salud Carlos III [PI060500, PI070148]; Sociedad para la Promocion y Reconversion Industrial	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Sociedad para la Promocion y Reconversion Industrial	This work was supported by Instituto de Salud Carlos III Grants PI060500 and PI070148 and by an ETORTEK-2008 grant from Sociedad para la Promocion y Reconversion Industrial.	Ala-Korpela M, 1998, J LIPID RES, V39, P1705; Asatryan L, 2005, J LIPID RES, V46, P115, DOI 10.1194/jlr.M400306-JLR200; Bancells C, 2008, BIOCHEMISTRY-US, V47, P8186, DOI 10.1021/bi800537h; Bancells C, 2009, J LIPID RES, V50, P446, DOI 10.1194/jlr.M800318-JLR200; Banfi C, 2009, PROTEOMICS, V9, P1344, DOI 10.1002/pmic.200800566; Benitez S, 2004, ATHEROSCLEROSIS, V177, P299, DOI 10.1016/j.atherosclerosis.2004.07.027; Benitez S, 2004, BIOCHEMISTRY-US, V43, P15863, DOI 10.1021/bi048825z; Benitez S, 2004, AM J CARDIOL, V93, P414, DOI 10.1016/j.amjcard.2003.10.034; Benitez S, 2003, CIRCULATION, V108, P92, DOI 10.1161/01.CIR.0000072791.40232.8F; Benitez S, 2007, BBA-MOL CELL BIOL L, V1771, P613, DOI 10.1016/j.bbalip.2007.03.001; Benitez S, 2006, BBA-MOL CELL BIOL L, V1761, P1014, DOI 10.1016/j.bbalip.2006.03.020; Bhakdi S, 2004, THROMB HAEMOSTASIS, V91, P639, DOI 10.1160/TH-03-12-d733; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; Campos H, 2001, J LIPID RES, V42, P1239; Chen HH, 2007, J LIPID RES, V48, P177, DOI 10.1194/jlr.M500481-JLR200; De Castellarnau C, 2000, ARTERIOSCL THROM VAS, V20, P2281; Duarte IF, 2009, ANAL CHEM, V81, P5023, DOI 10.1021/ac900545q; Forte T, 1972, Adv Lipid Res, V10, P1; Gaubatz JW, 2007, J LIPID RES, V48, P348, DOI 10.1194/jlr.M600249-JLR200; HERMANN M, 1992, ARTERIOSCLER THROMB, V12, P1503, DOI 10.1161/01.ATV.12.12.1503; Karlsson H, 2005, PROTEOMICS, V5, P551, DOI 10.1002/pmic.200300938; LODGE JK, 1995, BBA-LIPID LIPID MET, V1256, P130, DOI 10.1016/0005-2760(94)00253-U; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Oorni K, 2000, J LIPID RES, V41, P1703; Oorni K, 1998, J BIOL CHEM, V273, P29127, DOI 10.1074/jbc.273.44.29127; Parasassi T, 2001, FREE RADICAL BIO MED, V31, P82, DOI 10.1016/S0891-5849(01)00555-X; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; Pentikainen MO, 2001, J LIPID RES, V42, P916; Plihtari R, 2010, J LIPID RES, V51, P1801, DOI 10.1194/jlr.M003103; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sanchez-Quesada JL, 2004, CURR OPIN LIPIDOL, V15, P329, DOI [10.1097/00041433-200406000-00014, 10.1097/01.mol.0000130093.54381.22]; Sanchez-Quesada JL, 2003, ATHEROSCLEROSIS, V166, P261, DOI 10.1016/S0021-9150(02)00374-X; Sanchez-Quesada JL, 2002, J LIPID RES, V43, P699; Sanchez-Quesada JL, 2001, J CLIN ENDOCR METAB, V86, P3243, DOI 10.1210/jc.86.7.3243; SanchezQuesada JL, 1997, ATHEROSCLEROSIS, V132, P207, DOI 10.1016/S0021-9150(97)00108-1; Sevanian A, 1997, J LIPID RES, V38, P419; Soininen P, 2007, BIOCHEM BIOPH RES CO, V360, P290, DOI 10.1016/j.bbrc.2007.06.058; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; Tai MH, 2006, ATHEROSCLEROSIS, V186, P448, DOI 10.1016/j.atherosclerosis.2005.08.022; Ursini F, 2002, BIOL CHEM, V383, P599, DOI 10.1515/BC.2002.062; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916; Ziouzenkova O, 2000, BLOOD PURIFICAT, V18, P169, DOI 10.1159/000014415	43	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32425	32435		10.1074/jbc.M110.139691	http://dx.doi.org/10.1074/jbc.M110.139691			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20670941	Green Published, hybrid			2022-12-27	WOS:000282683000056
J	Carlsson, S; Dahlback, B				Carlsson, Sofia; Dahlback, Bjorn			Dependence on Vitamin K-dependent Protein S for Eukaryotic Cell Secretion of the beta-Chain of C4b-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CHAIN; STRUCTURAL REQUIREMENTS; APOPTOTIC CELLS; BINDING-SITE; HUMAN-PLASMA; COMPLEX; EXPRESSION; C4BP; LINE; ESTABLISHMENT	The anticoagulant vitamin K-dependent protein S (PS) circulates in plasma in two forms, 30% free and 70% being bound to the complement regulatory protein C4b-binding protein (C4BP). The major C4BP isoform consists of 7 alpha-chains and 1 beta-chain (C4BP beta(+)), the chains being linked by disulfide bridges. PS binds to the beta-chain with high affinity. In plasma, PS is in molar excess over C4BP beta(+) and due to the high affinity, all C4BP beta(+) molecules contain a bound PS. Taken together with the observation that PS-deficient patients have decreased levels of C4BP beta(+), this raises the question of whether PS is important for secretion of the beta-chain from the cell. To test this hypothesis, HEK293 cells were stably and transiently transfected with beta-chain cDNA in combinations with cDNAs for PS and/or the alpha-chain. The concentration of beta-chains in the medium increased after co-transfection with PS cDNA, but not by alpha-chain cDNA, suggesting secretion of the beta-chains from the cells to be dependent on concomitant synthesis of PS, but not of the alpha-chains. Thus, beta-chains that were not disulfide-linked to the alpha-chains were secreted in complex with PS, either as monomers or dimers. Pulse-chase demonstrated that the complexes between PS and beta-chain were formed intracellularly, in the endoplasmic reticulum. In conclusion, our results demonstrate that successful secretion of beta-chains depends on intracellular complex formation with PS, but not on the alpha-chains. This provides an explanation for the decreased beta-chain levels observed in PS-deficient patients.	[Dahlback, Bjorn] Lund Univ, Skane Univ Hosp, Dept Lab Med, Div Clin Chem,Wallenberg Lab, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Dahlback, B (corresponding author), Lund Univ, Skane Univ Hosp, Dept Lab Med, Div Clin Chem,Wallenberg Lab, Entrance 46,Floor 6, SE-20502 Malmo, Sweden.	Bjorn.Dahlback@med.lu.se	Somajo, Sofia/ABB-8170-2021	Somajo, Sofia/0000-0003-0433-8079; Dahlback, Bjorn/0000-0003-1546-0328	Swedish Research Council [71430]; Swedish Heart and Lung Foundation; Soderberg Foundation; Alfred Osterlund Foundation; Swedish Cancer Society; University Hospital in Malmo	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Soderberg Foundation; Alfred Osterlund Foundation; Swedish Cancer Society(Swedish Cancer Society); University Hospital in Malmo	This work was supported by Swedish Research Council Grant 71430, grants from the Swedish Heart and Lung Foundation, the Soderberg Foundation, the Alfred Osterlund Foundation, the Swedish Cancer Society, and research funds from the University Hospital in Malmo.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; ARENZANA N, 1995, BIOCHEM J, V308, P613, DOI 10.1042/bj3080613; Benzakour O, 2000, BLOOD, V95, P2008, DOI 10.1182/blood.V95.6.2008; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 1998, BBA-PROTEIN STRUCT M, V1388, P181, DOI 10.1016/S0167-4838(98)00178-2; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Criado Garcia O, 1995, J Immunol, V155, P4037; Criado-Garcia O, 1999, EUR J CELL BIOL, V78, P657, DOI 10.1016/S0171-9335(99)80051-X; DAHLBACK B, 1983, BIOCHEM J, V209, P857, DOI 10.1042/bj2090857; DAHLBACK B, 1983, BIOCHEM J, V209, P837, DOI 10.1042/bj2090837; Dahlback B, 2005, FEBS LETT, V579, P3310, DOI 10.1016/j.febslet.2005.03.001; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DE FRUTOS PG, 1994, BLOOD, V84, P815; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Evenas P, 1999, EUR J BIOCHEM, V266, P935, DOI 10.1046/j.1432-1327.1999.00928.x; FAIR DS, 1986, BLOOD, V67, P1168; Fernandez JA, 1998, BLOOD CELL MOL DIS, V24, P101, DOI 10.1006/bcmd.1998.0175; Giri TK, 2002, J BIOL CHEM, V277, P15099, DOI 10.1074/jbc.M103036200; Hackeng TM, 2009, J THROMB HAEMOST, V7, P165, DOI 10.1111/j.1538-7836.2009.03363.x; HARDIG Y, 1995, BIOCHEM J, V308, P795; Hardig Y, 1996, J BIOL CHEM, V271, P20861, DOI 10.1074/jbc.271.34.20861; HE XH, 1994, THROMB HAEMOSTASIS, V71, P446; Hillarp A, 1997, J IMMUNOL, V158, P1315; HILLARP A, 1990, P NATL ACAD SCI USA, V87, P1183, DOI 10.1073/pnas.87.3.1183; HILLARP A, 1988, J BIOL CHEM, V263, P12759; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Kask L, 2002, BIOCHEMISTRY-US, V41, P9349, DOI 10.1021/bi025980+; Linse S, 1997, J BIOL CHEM, V272, P14658, DOI 10.1074/jbc.272.23.14658; MAILLARD C, 1992, ENDOCRINOLOGY, V130, P1599, DOI 10.1210/en.130.3.1599; MALM J, 1990, EUR J BIOCHEM, V187, P737, DOI 10.1111/j.1432-1033.1990.tb15361.x; MALM J, 1994, BIOCHEM J, V302, P845, DOI 10.1042/bj3020845; Maurissen LFA, 2008, BLOOD, V111, P3034, DOI 10.1182/blood-2007-06-089987; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; OGURA M, 1987, BLOOD, V70, P301; PHILLIPS DJ, 1993, J NEUROCHEM, V61, P344, DOI 10.1111/j.1471-4159.1993.tb03574.x; Sanchez-Pernaute O, 2006, ANN RHEUM DIS, V65, P1279, DOI 10.1136/ard.2006.052118; SANCHEZCORRAL P, 1995, J IMMUNOL, V155, P4030; van de Poel RHL, 1999, J BIOL CHEM, V274, P15144, DOI 10.1074/jbc.274.21.15144; van de Poel RHL, 1999, BLOOD CELL MOL DIS, V25, P279, DOI 10.1006/bcmd.1999.0255; van Wijnen M, 1998, BIOCHEM J, V330, P389; Webb JH, 2003, BLOOD COAGUL FIBRIN, V14, P355, DOI 10.1097/00001721-200306000-00006; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580; Webb JH, 2001, J BIOL CHEM, V276, P4330, DOI 10.1074/jbc.M006541200; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; ZOLLER B, 1995, BLOOD, V85, P3524, DOI 10.1182/blood.V85.12.3524.bloodjournal85123524	46	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32038	32046		10.1074/jbc.M110.148452	http://dx.doi.org/10.1074/jbc.M110.148452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693287	Green Published, hybrid			2022-12-27	WOS:000282683000017
J	Meyer-Hoffert, U; Wu, ZH; Kantyka, T; Fischer, J; Latendorf, T; Hansmann, B; Bartels, J; He, YH; Glaser, R; Schroder, JM				Meyer-Hoffert, Ulf; Wu, Zhihong; Kantyka, Tomasz; Fischer, Jan; Latendorf, Ties; Hansmann, Britta; Bartels, Joachim; He, Yinghong; Glaeser, Regine; Schroeder, Jens-Michael			Isolation of SPINK6 in Human Skin SELECTIVE INHIBITOR OF KALLIKREIN-RELATED PEPTIDASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE INHIBITOR; THYMIC STROMAL LYMPHOPOIETIN; CORNEUM CHYMOTRYPTIC ENZYME; KAZAL-TYPE INHIBITOR; STRATUM-CORNEUM; NETHERTON-SYNDROME; LAMELLAR GRANULES; HUMAN EPIDERMIS; LEKTI; DESQUAMATION	Kallikrein-related peptidases (KLKs) play a central role in skin desquamation. They are tightly controlled by specific inhibitors, including the lymphoepithelial Kazal-type inhibitor (LEKTI) encoded by SPINK5 and LEKTI-2 encoded by SPINK9. Herein, we identify SPINK6 as a selective inhibitor of KLKs in the skin. Unlike LEKTI but similar to LEKTI-2, SPINK6 possesses only one typical Kazal domain. Its mRNA was detected to be expressed at low levels in several tissues and was induced during keratinocyte differentiation. Natural SPINK6 was purified from human plantar stratum corneum extracts. Immunohistochemical analyses revealed SPINK6 expression in the stratum granulosum of human skin at various anatomical localizations and in the skin appendages, including sebaceous glands and sweat glands. SPINK6 expression was decreased in lesions of atopic dermatitis. Using KLK5, KLK7, KLK8, KLK14, thrombin, trypsin, plasmin, matriptase, prostasin, mast cell chymase, cathepsin G, neutrophil elastase, and chymotrypsin, inhibition with recombinant SPINK6 was detected only for KLK5, KLK7, and KLK14, with apparent K-t values of 1.33, 1070, and 0.5 nM, respectively. SPINK6 inhibited desquamation of human plantar callus in an ex vivo model. Our findings suggest that SPINK6 plays a role in modulating the activity of KLKs in human skin. A selective inhibition of KLKs by SPINK6 might have therapeutic potential when KLK activity is elevated.	[Meyer-Hoffert, Ulf; Wu, Zhihong; Kantyka, Tomasz; Fischer, Jan; Latendorf, Ties; Hansmann, Britta; Bartels, Joachim; He, Yinghong; Glaeser, Regine; Schroeder, Jens-Michael] Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Kantyka, Tomasz] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland	University of Kiel; Schleswig Holstein University Hospital; Jagiellonian University	Schroder, JM (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol, Schittenhelmstr 7, D-24105 Kiel, Germany.	jschroeder@dermatology.uni-kiel.de	Meyer-Hoffert, Ulf/F-4623-2012; Wu, Zhihong/AAK-3433-2020; Wu, Zhihong/G-3569-2011	Meyer-Hoffert, Ulf/0000-0003-2305-1428; Kantyka, Tomasz/0000-0003-3023-2382; Bartels, Joachim/0000-0003-4395-4552	Deutsche Forschungsgemeinschaft [SCHR305/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SCHR305/4-1.	Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; GRIFFITHS WAD, 1998, TXB DERMATOLOGY; Hachem JP, 2006, J INVEST DERMATOL, V126, P2074, DOI 10.1038/sj.jid.5700351; Hale JE, 2004, ANAL BIOCHEM, V333, P174, DOI 10.1016/j.ab.2004.04.013; Hansson L, 2002, J INVEST DERMATOL, V118, P444, DOI 10.1046/j.0022-202x.2001.01684.x; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Komatsu N, 2003, J INVEST DERMATOL, V121, P542, DOI 10.1046/j.1523-1747.2003.12363.x; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; LUNDSTROM A, 1988, J INVEST DERMATOL, V91, P340, DOI 10.1111/1523-1747.ep12475679; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Meyer-Hoffert U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004372; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; SONDELL B, 1995, J INVEST DERMATOL, V104, P819, DOI 10.1111/1523-1747.ep12607007; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; Wu ZH, 2009, J INVEST DERMATOL, V129, P1446, DOI 10.1038/jid.2008.370; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	35	74	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32174	32181		10.1074/jbc.M109.091850	http://dx.doi.org/10.1074/jbc.M109.091850			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20667819	Green Published, hybrid			2022-12-27	WOS:000282683000030
J	Rao, SK; Pavicevic, Z; Du, ZY; Kim, JG; Fan, MY; Jiao, Y; Rosebush, M; Samant, S; Gu, WK; Pfeffer, LM; Nosrat, CA				Rao, Shailaja K.; Pavicevic, Zoran; Du, Ziyun; Kim, Jong-Gwan; Fan, Meiyun; Jiao, Yan; Rosebush, Molly; Samant, Sandeep; Gu, Weikuan; Pfeffer, Lawrence M.; Nosrat, Christopher A.			Pro-inflammatory Genes as Biomarkers and Therapeutic Targets in Oral Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; HUMAN PAPILLOMA-VIRUS; ENDOTHELIAL-CELLS; PROSTATE-CANCER; TUMOR-CELLS; TRANSCRIPTION FACTORS; CHEMOKINE RECEPTORS; BREAST-CANCER	Oral squamous cell carcinoma (OSCC) is a major health problem worldwide, and patients have a particularly poor 5-year survival rate. Thus, identification of the molecular targets in OSCC and subsequent innovative therapies are greatly needed. Prolonged exposure to alcohol, tobacco, and pathogenic agents are known risk factors and have suggested that chronic inflammation may represent a potential common denominator in the development of OSCC. Microarray analysis of gene expression in OSCC cell lines with high basal NF-kappa B activity and OSCC patient samples identified dysregulation of many genes involved in inflammation, wound healing, angiogenesis, and growth regulation. In particular IL-8, CCL5, STAT1, and VEGF gene expression was up-regulated in OSCC. Moreover, IL-8 protein levels were significantly higher in OSCC cell lines as compared with normal human oral keratinocytes. Targeting IL-8 expression by siRNA significantly reduced the survival of OSCC cells, indicating that it plays an important role in OSCC development and/or progression. Inhibiting the inflammatory pathway by aspirin and the proteasome/NF-kappa B pathway by bortezomib resulted in marked reduction in cell viability in OSCC lines. Taken together our studies indicate a strong link between inflammation and OSCC development and reveal IL-8 as a potential mediator. Treatment based on prevention of general inflammation and/or the NF-kappa B pathway shows promise in OSCCs.	[Nosrat, Christopher A.] Univ Tennessee, Hlth Sci Ctr, Dept Biosci Res, Coll Dent, Memphis, TN 38163 USA; [Rosebush, Molly] Univ Tennessee, Hlth Sci Ctr, Dept Biol & Diagnost Sci, Coll Dent, Memphis, TN 38163 USA; [Du, Ziyun; Fan, Meiyun; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Coll Med, Memphis, TN 38163 USA; [Samant, Sandeep] Univ Tennessee, Hlth Sci Ctr, Dept Otolaryngol, Coll Med, Memphis, TN 38163 USA; [Jiao, Yan; Gu, Weikuan] Univ Tennessee, Hlth Sci Ctr, Dept Orthoped Surg, Coll Med, Memphis, TN 38163 USA; [Rao, Shailaja K.; Pavicevic, Zoran; Du, Ziyun; Fan, Meiyun; Pfeffer, Lawrence M.; Nosrat, Christopher A.] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat Canc Res, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Nosrat, CA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Biosci Res, Coll Dent, Canc Res Bldg,Rm 120,19 S Manassas St, Memphis, TN 38163 USA.	cnosrat@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA133322]; College of Dentistry and Center for Integrative Cancer Research, University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA133322, R01CA140346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Dentistry and Center for Integrative Cancer Research, University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133322 (NCI). This work was also supported by the College of Dentistry and Center for Integrative Cancer Research, University of Tennessee Health Science Center.	Al-Swiahb JN, 2010, FUTURE ONCOL, V6, P837, DOI 10.2217/fon.10.35; ANDIA DC, 2010, J PERIODONT IN PRESS; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Chocolatewala NM, 2009, J CANCER RES THER, V5, P71, DOI 10.4103/0973-1482.52788; CLARK RAF, 1985, J AM ACAD DERMATOL, V13, P701, DOI 10.1016/S0190-9622(85)70213-7; de Castro J, 2000, VIRCHOWS ARCH, V437, P599, DOI 10.1007/s004280000266; de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008; Declercq J, 2008, INT J ONCOL, V32, P1041; Efimova EV, 2009, INT J RADIAT BIOL, V85, P421, DOI 10.1080/09553000902838566; Erreni M, 2009, METHOD ENZYMOL, V460, P105, DOI 10.1016/S0076-6879(09)05205-7; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; JALOULI J, 2010, ACTA OTOLAR IN PRESS; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Keibel A, 2009, CURR PHARM DESIGN, V15, P1949, DOI 10.2174/138161209788453167; Kim SJ, 2001, NEOPLASIA, V3, P33, DOI 10.1038/sj.neo.7900124; Kim YJ, 2010, CLIN CHIM ACTA, V411, P1264, DOI 10.1016/j.cca.2010.05.014; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Lee CH, 2005, INT J CANCER, V113, P475, DOI 10.1002/ijc.20619; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Li AH, 2001, CLIN CANCER RES, V7, P3298; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Liu HS, 2009, ORAL ONCOL, V45, P1032, DOI 10.1016/j.oraloncology.2009.06.007; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Miller LJ, 1998, ANTICANCER RES, V18, P77; Mineta H, 2000, ORAL ONCOL, V36, P194, DOI 10.1016/S1368-8375(99)00078-0; Nagler RM, 2009, ORAL ONCOL, V45, P1006, DOI 10.1016/j.oraloncology.2009.07.005; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perez-Sayans M, 2009, ONCOL REP, V22, P1277, DOI 10.3892/or_00000565; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Psyrri A, 2009, CURR OPIN ONCOL, V21, P201, DOI 10.1097/CCO.0b013e328329ab64; Reibel J, 2003, CRIT REV ORAL BIOL M, V14, P47, DOI 10.1177/154411130301400105; Royds JA, 1998, J CLIN PATHOL-MOL PA, V51, P55; Sheryka E, 2003, UROLOGY, V62, P162, DOI 10.1016/S0090-4295(03)00134-1; Shi Q, 1999, CLIN CANCER RES, V5, P3711; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; SILVERMAN S, 1984, CANCER, V53, P563; SKIPWORTH RJ, 2010, SUPPORT CAR IN PRESS; Slaton JW, 2001, AM J PATHOL, V158, P735, DOI 10.1016/S0002-9440(10)64016-3; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; STEENBERGEN RDM, 1995, CANCER RES, V55, P5465; SYRJANEN K, 1983, INT J GYNECOL OBSTET, V21, P261, DOI 10.1016/0020-7292(83)90015-2; Veltri RW, 1999, UROLOGY, V53, P139, DOI 10.1016/S0090-4295(98)00455-5; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; WAHL SM, 1992, J CLIN IMMUNOL, V12, P61, DOI 10.1007/BF00918135; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xie Q, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-77; Zabaleta J, 2009, CARCINOGENESIS, V30, P1358, DOI 10.1093/carcin/bgp124; Zhang XY, 2002, DIAGN MOL PATHOL, V11, P135, DOI 10.1097/00019606-200209000-00002	61	58	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32512	32521		10.1074/jbc.M110.150490	http://dx.doi.org/10.1074/jbc.M110.150490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20702412	Green Published, hybrid			2022-12-27	WOS:000282683000065
J	Chen, XW; Ren, L; Kim, S; Carpino, N; Daniel, JL; Kunapuli, SP; Tsygankov, AY; Pei, DH				Chen, Xianwen; Ren, Lige; Kim, Soochong; Carpino, Nicholas; Daniel, James L.; Kunapuli, Satya P.; Tsygankov, Alexander Y.; Pei, Dehua			Determination of the Substrate Specificity of Protein-tyrosine Phosphatase TULA-2 and Identification of Syk as a TULA-2 Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ACTIVATION; STS-1; CBL; ENDOCYTOSIS; INHIBITOR; PLATELETS; BIND; GPVI	TULA-1 (UBASH3A/STS-2) and TULA-2 (p70/STS-1) represent a novel class of protein-tyrosine phosphatases. Previous studies suggest that TULA-2 is sequence-selective toward phosphotyrosyl (Tyr(P)) peptides. In this work the substrate specificity of TULA-1 and -2 was systematically evaluated by screening a combinatorial Tyr(P) peptide library. Although TULA-1 showed no detectable activity toward any of the Tyr(P) peptides in the library, TULA-2 recognizes two distinct classes of Tyr(P) substrates. On the N-terminal side of Tyr(P), the class I substrates contain a proline at the Tyr(P)-1 position, a hydrophilic residue at the Tyr(P)-2 position, and aromatic hydrophobic residues at positions Tyr(P)-3 and beyond. The class II substrates typically contain two or more acidic residues, especially at Tyr(P)-1 to Tyr(P)-3 positions, and aromatic hydrophobic residues at other positions. At the C-terminal side of Tyr(P), TULA-2 generally prefers acidic and aromatic residues. The library screening results were confirmed by kinetic analysis of representative peptides selected from the library as well as Tyr(P) peptides derived from various Tyr(P) proteins. TULA-2 is highly active toward peptides corresponding to the Tyr(P)-323 and Tyr(P)-352 sites of Syk, and the Tyr(P)-397 site of focal adhesion kinase and has lower activity toward other Tyr(P) sites in these proteins. In glycoprotein VI-stimulated platelets, knock-out of the TULA-2 gene significantly increased the phosphorylation level of Syk at Tyr-323 and Tyr-352 sites and to a lesser degree at the Tyr-525/526 sites. These results suggest that Syk is a bona fide TULA-2 substrate in platelets.	[Chen, Xianwen; Ren, Lige; Pei, Dehua] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Carpino, Nicholas] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Tsygankov, Alexander Y.] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Daniel, James L.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Daniel, James L.; Kunapuli, Satya P.; Tsygankov, Alexander Y.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Chen, Xianwen; Ren, Lige; Pei, Dehua] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Ohio; Ohio State University	Tsygankov, AY (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA.	tsygan@temple.edu; pei.3@osu.edu	Pei, Dehua/P-4594-2016; Tsygankov, Alexander Y/K-6205-2017	Pei, Dehua/0000-0002-2057-6934; 	National Institutes of Health [CA132855]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA132855] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA132855. This work was also supported by the Pennsylvania Department of Health (to A. Y. T.).	Agrawal R, 2008, J CELL BIOCHEM, V104, P953, DOI 10.1002/jcb.21678; Bertelsen V, 2007, EXP CELL RES, V313, P1696, DOI 10.1016/j.yexcr.2007.02.017; Bhavaraju K, 2008, EUR J PHARMACOL, V580, P285, DOI 10.1016/j.ejphar.2007.11.009; Burke TR, 1998, BIOPOLYMERS, V47, P225, DOI 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Chen YT, 2009, BIOCHEMISTRY-US, V48, P8129, DOI 10.1021/bi9008648; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Garaud M, 2007, J AM CHEM SOC, V129, P5366, DOI 10.1021/ja071275i; Gopishetty B, 2008, ORG LETT, V10, P4605, DOI 10.1021/ol801868a; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Leon S, 1998, BIOORG MED CHEM LETT, V8, P2997, DOI 10.1016/S0960-894X(98)00534-4; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Quinton TM, 2002, BLOOD, V99, P3228, DOI 10.1182/blood.V99.9.3228; Raguz J, 2007, FEBS LETT, V581, P4767, DOI 10.1016/j.febslet.2007.08.077; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Shankar H, 2006, CURR DRUG TARGETS, V7, P1253, DOI 10.2174/138945006778559166; Smirnova EV, 2008, VIROLOGY, V372, P10, DOI 10.1016/j.virol.2007.10.012; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; Thakkar A, 2006, ANAL CHEM, V78, P5935, DOI 10.1021/ac0607414; THOMAS DH, 2010, BLOOD IN PRESS; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Tsygankov AY, 2008, IUBMB LIFE, V60, P224, DOI 10.1002/iub.36; Tsygankov AY, 2009, CELL MOL LIFE SCI, V66, P2949, DOI 10.1007/s00018-009-0071-x; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Wattenhofer M, 2001, HUM GENET, V108, P140, DOI 10.1007/s004390000453; Wee JLK, 2006, CURR DRUG TARGETS, V7, P1265; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Zahedi RP, 2006, BBA-PROTEINS PROTEOM, V1764, P1963, DOI 10.1016/j.bbapap.2006.08.017	37	35	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31268	31276		10.1074/jbc.M110.114181	http://dx.doi.org/10.1074/jbc.M110.114181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20670933	Green Published, hybrid			2022-12-27	WOS:000282764600021
J	Higgins-Gruber, SL; Mutucumarana, VP; Lin, PJ; Jorgenson, JW; Stafford, DW; Straight, DL				Higgins-Gruber, Shannon L.; Mutucumarana, Vasantha P.; Lin, Pen-Jen; Jorgenson, James W.; Stafford, Darrel W.; Straight, David L.			Effect of Vitamin K-dependent Protein Precursor Propeptide, Vitamin K Hydroquinone, and Glutamate Substrate Binding on the Structure and Function of gamma-Glutamyl Carboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYGLUTAMIC ACID DOMAIN; FACTOR-IX; TRANSITION-STATES; ENZYME-ACTIVITY; MECHANISM; SITE; REGION; EPOXIDATION; AFFINITIES; MUTATIONS	The gamma-glutamyl carboxylase utilizes four substrates to catalyze carboxylation of certain glutamic acid residues in vitamin K-dependent proteins. How the enzyme brings the substrates together to promote catalysis is an important question in understanding the structure and function of this enzyme. The propeptide is the primary binding site of the vitamin K-dependent proteins to carboxylase. It is also an effector of carboxylase activity. We tested the hypothesis that binding of substrates causes changes to the carboxylase and in turn to the substrate-enzyme interactions. In addition we investigated how the sequences of the propeptides affected the substrate-enzyme interaction. To study these questions we employed fluorescently labeled propeptides to measure affinity for the carboxylase. We also measured the ability of several propeptides to increase carboxylase catalytic activity. Finally we determined the effect of substrates: vitamin K hydroquinone, the pentapeptide FLEEL, and NaHCO3, on the stability of the propeptide-carboxylase complexes. We found a wide variation in the propeptide affinities for carboxylase. In contrast, the propeptides tested had similar effects on carboxylase catalytic activity. FLEEL and vitamin K hydroquinone both stabilized the propeptide-carboxylase complex. The two together had a greater effect than either alone. We conclude that the effect of propeptide and substrates on carboxylase controls the order of substrate binding in such a way as to ensure efficient, specific carboxylation.	[Mutucumarana, Vasantha P.; Lin, Pen-Jen; Stafford, Darrel W.; Straight, David L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Higgins-Gruber, Shannon L.; Jorgenson, James W.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Mutucumarana, VP (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	vmutucum@email.unc.edu			National Institutes of Health [HL48318, HL06350]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048318, P01HL006350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL48318 and HL06350 (to D. W. S.).	Bouchard BA, 1999, BIOCHEMISTRY-US, V38, P9517, DOI 10.1021/bi9907375; CHEUNG A, 1989, ARCH BIOCHEM BIOPHYS, V274, P574, DOI 10.1016/0003-9861(89)90472-4; CHEUNG A, 1990, BIOCHIM BIOPHYS ACTA, V1039, P90, DOI 10.1016/0167-4838(90)90230-D; Chu K, 1996, J CLIN INVEST, V98, P1619, DOI 10.1172/JCI118956; Davis CH, 2007, J MOL GRAPH MODEL, V26, P409, DOI 10.1016/j.jmgm.2006.10.006; Davis CH, 2007, J PHYS CHEM A, V111, P7257, DOI 10.1021/jp068564y; Hallgren KW, 2002, BIOCHEMISTRY-US, V41, P15045, DOI 10.1021/bi026016e; KNOBLOCH JE, 1987, J BIOL CHEM, V262, P15334; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Li SY, 1997, BIOCHEMISTRY-US, V36, P6384, DOI 10.1021/bi962816b; Lin PJ, 2004, J BIOL CHEM, V279, P6560, DOI 10.1074/jbc.M312239200; MORRIS DP, 1993, J BIOL CHEM, V268, P8735; Mutucumarana VP, 2003, J BIOL CHEM, V278, P46488, DOI 10.1074/jbc.M307707200; Oldenburg J, 1997, BRIT J HAEMATOL, V98, P240, DOI 10.1046/j.1365-2141.1997.2213036.x; Presnell SR, 2001, BIOCHEMISTRY-US, V40, P11723, DOI 10.1021/bi010332w; Rishavy MA, 2008, BIOCHEMISTRY-US, V47, P9836, DOI 10.1021/bi800296r; Rishavy MA, 2006, BIOCHEMISTRY-US, V45, P13239, DOI 10.1021/bi0609523; SOUTE BAM, 1992, THROMB HAEMOSTASIS, V68, P521; Stanley TB, 1999, J BIOL CHEM, V274, P16940, DOI 10.1074/jbc.274.24.16940; Stanley TB, 1999, BIOCHEMISTRY-US, V38, P15681, DOI 10.1021/bi991544k; Sugiura I, 1996, J BIOL CHEM, V271, P17837, DOI 10.1074/jbc.271.30.17837; Sugiura I, 1997, P NATL ACAD SCI USA, V94, P9069, DOI 10.1073/pnas.94.17.9069; ULRICH MMW, 1988, J BIOL CHEM, V263, P9697; UOTILA L, 1988, ARCH BIOCHEM BIOPHYS, V264, P135, DOI 10.1016/0003-9861(88)90578-4; WU SM, 1990, J BIOL CHEM, V265, P13124	25	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31502	31508		10.1074/jbc.M110.143297	http://dx.doi.org/10.1074/jbc.M110.143297			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20716530	hybrid, Green Published			2022-12-27	WOS:000282764600044
J	Otto, B; Uehlein, N; Sdorra, S; Fischer, M; Ayaz, M; Belastegui-Macadam, X; Heckwolf, M; Lachnit, M; Pede, N; Priem, N; Reinhard, A; Siegfart, S; Urban, M; Kaldenhoff, R				Otto, Beate; Uehlein, Norbert; Sdorra, Sven; Fischer, Matthias; Ayaz, Muhammad; Belastegui-Macadam, Xana; Heckwolf, Marlies; Lachnit, Magdalena; Pede, Nadine; Priem, Nadine; Reinhard, Andre; Siegfart, Sven; Urban, Michael; Kaldenhoff, Ralf			Aquaporin Tetramer Composition Modifies the Function of Tobacco Aquaporins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE AQUAPORINS; INTRINSIC PROTEINS; WATER CHANNELS; PERMEABILITY; TRANSPORT; NTAQP1; ARABIDOPSIS; FAMILY; GENES; CELLS	Heterologous expression in yeast cells revealed that NtAQP1, a member of the so-called PIP1 aquaporin subfamily, did not display increased water transport activity in comparison with controls. Instead, an increased CO2-triggered intracellular acidification was observed. NtPIP2;1, which belongs to the PIP2 subfamily of plant aquaporins, behaved as a true aquaporin but lacked a CO2-related function. Results from split YFP experiments, protein chromatography, and gel electrophoresis indicated that the proteins form heterotetramers when coexpressed in yeast. Tetramer composition had effects on transport activity as demonstrated by analysis of artificial heterotetramers with a defined proportion of NtAQP1 to NtPIP2;1. A single NtPIP2;1 aquaporin in a tetramer was sufficient to significantly increase the water permeability of the respective yeast cells. With regard to CO2-triggered intracellular acidification, a cooperative effect was observed, where maximum rates were measured when the tetramer consisted of NtAQP1 aquaporins only. The results confirm the model of an aquaporin monomer as a functional unit for water transport and suggest that, for CO2-related transport processes, a structure built up by the tetramer is the basis of this function.	[Heckwolf, Marlies; Lachnit, Magdalena; Pede, Nadine; Priem, Nadine; Reinhard, Andre; Siegfart, Sven; Kaldenhoff, Ralf] Tech Univ Darmstadt, Inst Bot, Dept Appl Plant Sci, D-64287 Darmstadt, Germany; [Fischer, Matthias] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Belastegui-Macadam, Xana] Iden Biotechnol, Mutilva Baja 31192, Spain	Technical University of Darmstadt; Max Planck Society	Kaldenhoff, R (corresponding author), Tech Univ Darmstadt, Inst Bot, Dept Appl Plant Sci, D-64287 Darmstadt, Germany.	kaldenhoff@bio.tu-darmstadt.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft grant (to R. K.).	BAUDIN V, 1993, PROTEIN SCI, V2, P1320, DOI 10.1002/pro.5560020815; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Cooper GJ, 2002, J PHYSIOL-LONDON, V542, P17, DOI 10.1113/jphysiol.2002.023218; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Flexas J, 2006, PLANT J, V48, P427, DOI 10.1111/j.1365-313X.2006.02879.x; HAMES BD, 1981, GEL ELECTROPHORESIS, P14; Heymann JB, 1998, J STRUCT BIOL, V121, P191, DOI 10.1006/jsbi.1997.3951; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Kaldenhoff R, 2006, ACTA PHYSIOL, V187, P169, DOI 10.1111/j.1748-1716.2006.01563.x; KALDENHOFF R, 2005, PROGR BOT, V67, P206; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; Kirber MT, 2007, NAT METHODS, V4, P767, DOI 10.1038/nmeth1007-767; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marin-Olivier M, 2000, PLANT J, V24, P231, DOI 10.1046/j.1365-313x.2000.00874.x; Moshelion M, 2002, PLANT CELL, V14, P727, DOI 10.1105/tpc.010351; Moshelion M, 2004, PLANT PHYSIOL, V135, P2301, DOI 10.1104/pp.104.043000; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF255, DOI 10.1152/ajprenal.2001.281.2.F255; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; RICARD J, 1987, EUR J BIOCHEM, V166, P255, DOI 10.1111/j.1432-1033.1987.tb13510.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Strand L, 2009, BIOCHEMISTRY-US, V48, P5785, DOI 10.1021/bi802231q; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Terashima I, 2002, PLANT CELL PHYSIOL, V43, P70, DOI 10.1093/pcp/pcf001; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Yang BX, 2000, J BIOL CHEM, V275, P2686, DOI 10.1074/jbc.275.4.2686; Zelazny E, 2009, PLANT J, V57, P346, DOI 10.1111/j.1365-313X.2008.03691.x; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104	44	116	123	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31253	31260		10.1074/jbc.M110.115881	http://dx.doi.org/10.1074/jbc.M110.115881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20657033	Green Published, hybrid			2022-12-27	WOS:000282764600019
J	Chan, DI; Chu, BCH; Lau, CKY; Hunter, HN; Byers, DM; Vogel, HJ				Chan, David I.; Chu, Byron C. H.; Lau, Cheryl K. Y.; Hunter, Howard N.; Byers, David M.; Vogel, Hans J.			NMR Solution Structure and Biophysical Characterization of Vibrio harveyi Acyl Carrier Protein A75H EFFECTS OF DIVALENT METAL IONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MOLECULAR-DYNAMICS SIMULATIONS; ACP SYNTHETASE-ACTIVITY; TORSION ANGLE DYNAMICS; ESCHERICHIA-COLI; BETA-KETOACYL; PROGRAM; BINDING; APO; BIOSYNTHESIS	Bacterial acyl carrier protein (ACP) is a highly anionic, 9 kDa protein that functions as a cofactor protein in fatty acid biosynthesis. Escherichia coli ACP is folded at neutral pH and in the absence of divalent cations, while Vibrio harveyi ACP, which is very similar at 86% sequence identity, is unfolded under the same conditions. V. harveyi ACP adopts a folded conformation upon the addition of divalent cations such as Ca2+ and Mg2+ and a mutant, A75H, was previously identified that restores the folded conformation at pH 7 in the absence of divalent cations. In this study we sought to understand the unique folding behavior of V. harveyi ACP using NMR spectroscopy and biophysical methods. The NMR solution structure of V. harveyi ACP A75H displays the canonical ACP structure with four helices surrounding a hydrophobic core, with a narrow pocket closed off from the solvent to house the acyl chain. His-75, which is charged at neutral pH, participates in a stacking interaction with Tyr-71 in the far C-terminal end of helix IV. pH titrations and the electrostatic profile of ACP suggest that V. harveyi ACP is destabilized by anionic charge repulsion around helix II that can be partially neutralized by His-75 and is further reduced by divalent cation binding. This is supported by differential scanning calorimetry data which indicate that calcium binding further increases the melting temperature of V. harveyi ACP A75H by similar to 20 degrees C. Divalent cation binding does not alter ACP dynamics on the ps-ns timescale as determined by N-15 NMR relaxation experiments, however, it clearly stabilizes the protein fold as observed by hydrogen-deuterium exchange studies. Finally, we demonstrate that the E. coli ACP H75A mutant is similarly unfolded as wild-type V. harveyi ACP, further stressing the importance of this particular residue for proper protein folding.	[Chan, David I.; Chu, Byron C. H.; Lau, Cheryl K. Y.; Hunter, Howard N.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada; [Byers, David M.] Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 1X5, Canada; [Byers, David M.] Dalhousie Univ, Dept Biochem & Mol Biol, Atlantic Res Ctr, Halifax, NS B3H 1X5, Canada	University of Calgary; Dalhousie University; Dalhousie University	Vogel, HJ (corresponding author), 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Natural Sciences Engineering Research Council of Canada; Canadian Institute of Health Research; Alberta Heritage Foundation for Medical Research	Natural Sciences Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by operating grants from the Natural Sciences Engineering Research Council of Canada (to D. M. B.) and the Canadian Institute of Health Research (to H.J.V.).; Recipient of a Scientist award from the Alberta Heritage Foundation for Medical Research. To whom correspondence should be addressed: 2500 University Dr. NW, Calgary, Alberta T2N 1N4, Canada. Tel.: 403-220-6006; Fax: 403-289-9311; E-mail: vogel@ucalgary.ca.	ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; BYERS DM, 1985, P NATL ACAD SCI USA, V82, P6085, DOI 10.1073/pnas.82.18.6085; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chan DI, 2010, BIOCHEMISTRY-US, V49, P2860, DOI 10.1021/bi901713r; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; delaRoche MA, 1997, ARCH BIOCHEM BIOPHYS, V344, P159, DOI 10.1006/abbi.1997.0203; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gong H, 2003, BIOCHEM BIOPH RES CO, V302, P35, DOI 10.1016/S0006-291X(03)00108-6; Gong HS, 2008, BBA-PROTEINS PROTEOM, V1784, P1835, DOI 10.1016/j.bbapap.2008.07.017; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; GUERRA DJ, 1988, J BIOL CHEM, V263, P4386; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HORVATH LA, 1994, PROTEIN SCI, V3, P103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KEATING DH, 1995, J BIOL CHEM, V270, P22229, DOI 10.1074/jbc.270.38.22229; Keating MM, 2002, BBA-PROTEINS PROTEOM, V1601, P208, DOI 10.1016/S1570-9639(02)00470-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMBALOT RH, 1997, VITAMINS COENZYMES, V279, P254; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Park SJ, 2004, J BIOCHEM, V135, P337, DOI 10.1093/jb/mvh041; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SCHULZ H, 1969, J BIOL CHEM, V244, P6577; SCHULZ H, 1975, J BIOL CHEM, V250, P2299; SKELTON NJ, 1992, J MOL BIOL, V227, P1100, DOI 10.1016/0022-2836(92)90524-N; TENER DM, 1990, EUR J BIOCHEM, V189, P559, DOI 10.1111/j.1432-1033.1990.tb15523.x; Upadhyay SK, 2009, J BIOL CHEM, V284, P22390, DOI 10.1074/jbc.M109.014829; Volkman BF, 2001, BIOCHEMISTRY-US, V40, P7964, DOI 10.1021/bi010355a; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wu BN, 2009, PROTEIN SCI, V18, P240, DOI 10.1002/pro.11; WUTHRICK K, 1986, NMR PROTEINS NUCL AC; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d; Zornetzer GA, 2010, BIOCHEMISTRY-US, V49, P470, DOI 10.1021/bi9014659	48	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30558	30566		10.1074/jbc.M110.128298	http://dx.doi.org/10.1074/jbc.M110.128298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659901	Green Published, hybrid			2022-12-27	WOS:000282135500024
J	Gersting, SW; Staudigl, M; Truger, MS; Messing, DD; Danecka, MK; Sommerhoff, CP; Kemter, KF; Muntau, AC				Gersting, Soren W.; Staudigl, Michael; Truger, Marietta S.; Messing, Dunja D.; Danecka, Marta K.; Sommerhoff, Christian P.; Kemter, Kristina F.; Muntau, Ania C.			Activation of Phenylalanine Hydroxylase Induces Positive Cooperativity toward the Natural Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBAL CONFORMATIONAL TRANSITION; SUBSTRATE-BINDING; RAT-LIVER; ESCHERICHIA-COLI; WILD-TYPE; PHENYLKETONURIA MUTATIONS; REGULATORY PROPERTIES; ALLOSTERIC REGULATION; CATALYTIC ACTIVATION; MILD PHENYLKETONURIA	Protein misfolding with loss-of-function of the enzyme phenylalanine hydroxylase (PAH) is the molecular basis of phenylketonuria in many individuals carrying missense mutations in the PAH gene. PAH is complexly regulated by its substrate L-Phenylalanine and its natural cofactor 6R-L-erythro-5,6,7,8-tetrahydro-biopterin (BH4). Sapropterin dihydrochloride, the synthetic form of BH4, was recently approved as the first pharmacological chaperone to correct the loss-of-function phenotype. However, current knowledge about enzyme function and regulation in the therapeutic setting is scarce. This illustrates the need for comprehensive analyses of steady state kinetics and allostery beyond single residual enzyme activity determinations to retrace the structural impact of missense mutations on the phenylalanine hydroxylating system. Current standard PAH activity assays are either indirect (NADH) or discontinuous due to substrate and product separation before detection. We developed an automated fluorescence-based continuous real-time PAH activity assay that proved to be faster and more efficient but as precise and accurate as standard methods. Wild-type PAH kinetic analyses using the new assay revealed cooperativity of activated PAH toward BH4, a previously unknown finding. Analyses of structurally preactivated variants substantiated BH4-dependent cooperativity of the activated enzyme that does not rely on the presence of L-Phenylalanine but is determined by activating conformational rearrangements. These findings may have implications for an individualized therapy, as they support the hypothesis that the patient's metabolic state has a more significant effect on the interplay of the drug and the conformation and function of the target protein than currently appreciated.	[Kemter, Kristina F.; Muntau, Ania C.] Dr von Hauner Childrens Hosp, Dept Mol Pediat, D-80337 Munich, Germany; [Sommerhoff, Christian P.] Univ Munich, Surg Clin, Dept Clin Chem & Clin Biochem, D-80336 Munich, Germany	University of Munich; University of Munich	Muntau, AC (corresponding author), Lindwurmstr 4, D-80337 Munich, Germany.	ania.muntau@med.lmu.de	Gersting, Soeren W/D-4612-2011	Gersting, Soeren W/0000-0001-7482-4748	Bavarian Genome Research Network (BayGene)	Bavarian Genome Research Network (BayGene)	This work was supported by the Bavarian Genome Research Network (BayGene).	Andersen OA, 2003, J MOL BIOL, V333, P747, DOI 10.1016/j.jmb.2003.09.004; Andersen OA, 2002, J MOL BIOL, V320, P1095, DOI 10.1016/S0022-2836(02)00560-0; BAILEY SW, 1980, ANAL BIOCHEM, V107, P156, DOI 10.1016/0003-2697(80)90506-0; BAILEY SW, 1978, J BIOL CHEM, V253, P1598; Bjorgo E, 2001, EUR J BIOCHEM, V268, P997, DOI 10.1046/j.1432-1327.2001.01958.x; Brock DA, 2003, J BIOL CHEM, V278, P52262, DOI 10.1074/jbc.M309101200; Chehin R, 1998, FEBS LETT, V422, P225, DOI 10.1016/S0014-5793(97)01596-2; Copeland R. A., 2004, ENZYMES PRACTICAL IN; CORNISHBOWDEN A, 1987, J THEOR BIOL, V124, P1, DOI 10.1016/S0022-5193(87)80248-5; Davis MD, 1997, P NATL ACAD SCI USA, V94, P491, DOI 10.1073/pnas.94.2.491; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Erlandsen H, 2000, BIOCHEMISTRY-US, V39, P2208, DOI 10.1021/bi992531+; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Fiege B, 2007, J PEDIATR-US, V150, P627, DOI 10.1016/j.jpeds.2007.02.017; FISHER DB, 1973, J BIOL CHEM, V248, P4345; Flatmark T, 2001, ANAL BIOCHEM, V294, P95, DOI 10.1006/abio.2001.5163; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Gersting SW, 2010, HUM MOL GENET, V19, P2039, DOI 10.1093/hmg/ddq085; Hutt DM, 2005, J BIOL CHEM, V280, P20197, DOI 10.1074/jbc.M412920200; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kappock TJ, 1995, J BIOL CHEM, V270, P30532, DOI 10.1074/jbc.270.51.30532; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Knappskog PM, 1996, EUR J BIOCHEM, V242, P813, DOI 10.1111/j.1432-1033.1996.0813r.x; KNAPPSKOG PM, 1995, BIOCHEMISTRY-US, V34, P11790, DOI 10.1021/bi00037a017; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LEDLEY FD, 1987, J BIOL CHEM, V262, P2228; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Levy HL, 2007, LANCET, V370, P504, DOI 10.1016/S0140-6736(07)61234-3; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; Miller WL, 2008, J BIOL CHEM, V283, P3507, DOI 10.1074/jbc.M708894200; MITNAUL LJ, 1995, P NATL ACAD SCI USA, V92, P885, DOI 10.1073/pnas.92.3.885; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Muntau AC, 2002, NEW ENGL J MED, V347, P2122, DOI 10.1056/NEJMoa021654; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Pauwels F, 2003, J BIOL CHEM, V278, P16658, DOI 10.1074/jbc.M300157200; Perez B, 2005, MOL GENET METAB, V86, pS11, DOI 10.1016/j.ymgme.2005.06.009; Pey AL, 2005, MOL GENET METAB, V86, pS43, DOI 10.1016/j.ymgme.2005.04.008; Pey AL, 2004, HUM MUTAT, V24, P388, DOI 10.1002/humu.20097; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Sawicki A, 2008, J BIOL CHEM, V283, P31294, DOI 10.1074/jbc.M805792200; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; SHIMAN R, 1994, J BIOL CHEM, V269, P24647; SHIMAN R, 1990, J BIOL CHEM, V265, P11633; SHIMAN R, 1980, J BIOL CHEM, V255, P4793; SHIMAN R, 1982, J BIOL CHEM, V257, P1213; SHIMAN R, 1994, J BIOL CHEM, V269, P24637; Solstad T, 2003, EUR J BIOCHEM, V270, P981, DOI 10.1046/j.1432-1033.2003.03471.x; Stokka AJ, 2004, J BIOL CHEM, V279, P26571, DOI 10.1074/jbc.M400879200; Teigen K, 1999, J MOL BIOL, V294, P807, DOI 10.1006/jmbi.1999.3288; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Trefz FK, 2009, J PEDIATR-US, V154, P700, DOI 10.1016/j.jpeds.2008.11.040; Velloso LM, 2008, EMBO REP, V9, P199, DOI 10.1038/sj.embor.7401154; Volner A, 2003, J BIOL INORG CHEM, V8, P121, DOI 10.1007/s00775-002-0395-6; Waters PJ, 2000, MOL GENET METAB, V69, P101, DOI 10.1006/mgme.2000.2965; XIA T, 1994, J BIOL CHEM, V269, P24657; Zschocke J, 2003, HUM MUTAT, V21, P345, DOI 10.1002/humu.10192	59	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30686	30697		10.1074/jbc.M110.124016	http://dx.doi.org/10.1074/jbc.M110.124016			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20667834	Green Published, hybrid			2022-12-27	WOS:000282135500037
J	Monje, PV; Soto, J; Bacallao, K; Wood, PM				Monje, Paula V.; Soto, Jennifer; Bacallao, Ketty; Wood, Patrick M.			Schwann Cell Dedifferentiation Is Independent of Mitogenic Signaling and Uncoupled to Proliferation ROLE OF cAMP AND JNK IN THE MAINTENANCE OF THE DIFFERENTIATED STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL NERVOUS-SYSTEM; N-TERMINAL KINASE; CYCLIC-AMP; C-JUN; WALLERIAN DEGENERATION; REGULATED KINASE; SPINAL-CORD; MAP KINASE; MYELINATION; REGENERATION	Myelinating Schwann cells (SCs) are highly plastic cells that are able to dedifferentiate and re-enter the cell cycle. However, the molecular signals controlling dedifferentiation are not completely understood. Because a connection between mitogenic signaling and myelin loss has been suggested, we investigated the role of cAMP, a strong inducer of the myelinating phenotype, and mitogenic factors activating receptor tyrosine kinases (RTKs) on SC dedifferentiation. We herein provide evidence indicating that cAMP was required to not only initiate but also maintain a state of differentiation because SCs rapidly dedifferentiated and became competent to resume proliferation upon the removal of cAMP stimulation. Surprisingly, isolated SCs could undergo multiple cycles of differentiation and dedifferentiation upon cAMP addition and removal, respectively, in the absence of mitogenic factors and without entering the cell cycle. Conversely, the activation of RTKs and the ERK cascade by a variety of growth factors, including neuregulin, was not sufficient to initiate dedifferentiation in the presence of cAMP. Importantly, a reduction of cAMP triggered dedifferentiation through a mechanism that required JNK, rather than ERK, activity and an induction of the expression of c-Jun, a transcriptional inhibitor of myelination. In summary, the reversible transition from an undifferentiated to a myelinating state was dependent on cAMP but independent of RTK signaling and cell cycle progression, further indicating that dedifferentiation and proliferation are uncoupled and differentially regulated events in SCs.	[Monje, Paula V.; Soto, Jennifer; Bacallao, Ketty; Wood, Patrick M.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Monje, Paula V.; Wood, Patrick M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA	University of Miami; University of Miami	Monje, PV (corresponding author), 1095 NW 14th Terrace, Miami, FL 33136 USA.	pmonje@med.miami.edu	Monje, Paula/AAB-9099-2020		National Institutes of Health, NINDS [NS009923]; Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant NS009923. This work was also supported by the Miami Project to Cure Paralysis and the Buoniconti Fund.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brockes JP, 2001, J ANAT, V199, P3; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Harada Y, 1999, BIOCHEM BIOPH RES CO, V266, P129, DOI 10.1006/bbrc.1999.1783; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kato H, 2003, J SURG ONCOL, V84, P24, DOI 10.1002/jso.10287; Kim HA, 2000, NEURON, V26, P405, DOI 10.1016/S0896-6273(00)81173-3; Kim HA, 2001, J NEUROSCI, V21, P1110; Martinez-Lara I, 1996, Acta Stomatol Belg, V93, P29; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Monje PV, 2009, GLIA, V57, P947, DOI 10.1002/glia.20819; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; PODUSLO JF, 1995, J NEUROCHEM, V65, P149; Rao GN, 1996, J BIOL CHEM, V271, P20805, DOI 10.1074/jbc.271.34.20805; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; SALZER JL, 1980, J CELL BIOL, V84, P767, DOI 10.1083/jcb.84.3.767; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; Stevens B, 2004, NEURON GLIA BIOL, V1, P23, DOI 10.1017/s1740925x04000055; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Syed N, 2010, J NEUROSCI, V30, P6122, DOI 10.1523/JNEUROSCI.1681-09.2010; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; THOMAS PK, 1970, J ANAT, V106, P463; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Velloso CP, 2000, DIFFERENTIATION, V66, P239, DOI 10.1046/j.1432-0436.2000.660410.x; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Yang DP, 2008, MOL CELL NEUROSCI, V38, P80, DOI 10.1016/j.mcn.2008.01.017; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289	50	60	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31024	31036		10.1074/jbc.M110.116970	http://dx.doi.org/10.1074/jbc.M110.116970			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20634285	hybrid, Green Published			2022-12-27	WOS:000282135500067
J	Smirnov, A; Comte, C; Mager-Heckel, AM; Addis, V; Krasheninnikov, IA; Martin, RP; Entelis, N; Tarassov, I				Smirnov, Alexandre; Comte, Caroline; Mager-Heckel, Anne-Marie; Addis, Vanessa; Krasheninnikov, Igor A.; Martin, Robert P.; Entelis, Nina; Tarassov, Ivan			Mitochondrial Enzyme Rhodanese Is Essential for 5 S Ribosomal RNA Import into Human Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOMES; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; PROTEIN CHAPERONES; PRECURSOR PROTEIN; MOLECULAR-MODEL; BINDING; DNA; SUBUNIT; YEAST	5 S rRNA is an essential component of ribosomes. In eukaryotic cells, it is distinguished by particularly complex intracellular traffic, including nuclear export and re-import. The finding that in mammalian cells 5 S rRNA can eventually escape its usual circuit toward nascent ribosomes to get imported into mitochondria has made the scheme more complex, and it has raised questions about both the mechanism of 5 S rRNA mitochondrial targeting and its function inside the organelle. Previously, we showed that import of 5 S rRNA into mitochondria requires unknown cytosolic proteins. Here, one of them was identified as mitochondrial thiosulfate sulfurtransferase, rhodanese. Rhodanese in its misfolded form was found to possess a strong and specific 5 S rRNA binding activity, exploiting sites found earlier to function as signals of 5 S rRNA mitochondrial localization. The interaction with 5 S rRNA occurs cotranslationally and results in formation of a stable complex in which rhodanese is preserved in a compact enzymatically inactive conformation. Human 5 S rRNA in a branched Mg2+-free form, upon its interaction with misfolded rhodanese, demonstrates characteristic functional traits of Hsp40 cochaperones implicated in mitochondrial precursor protein targeting, suggesting that it may use this mechanism to ensure its own mitochondrial localization. Finally, silencing of the rhodanese gene caused not only a proportional decrease of 5 S rRNA import but also a general inhibition of mitochondrial translation, indicating the functional importance of the imported 5 S rRNA inside the organelle.	[Tarassov, Ivan] Univ Strasbourg, CNRS, UDS, Dept Mol & Cellular Genet,UMR 7156, F-67084 Strasbourg, France; [Smirnov, Alexandre; Krasheninnikov, Igor A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Mol Biol, Moscow 119992, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Lomonosov Moscow State University	Tarassov, I (corresponding author), Univ Strasbourg, CNRS, UDS, Dept Mol & Cellular Genet,UMR 7156, 21 Rue Rene Descartes, F-67084 Strasbourg, France.	i.tarassov@unistra.fr	Smirnov, Alexandre/H-4253-2019	Smirnov, Alexandre/0000-0002-9142-7979; Tarassov, Ivan/0000-0001-8763-6703; Entelis, Nina/0000-0002-7915-5528	CNRS; Universite de Strasbourg; Moscow State University; Association Francaise Contre les Myopathies; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Russian Foundation for Basic Research; ARCUS	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; Moscow State University; Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); ARCUS	This work was supported by the CNRS, Universite de Strasbourg, Moscow State University, Association Francaise Contre les Myopathies, Agence Nationale de la Recherche, Fondation pour la Recherche Medicale, Russian Foundation for Basic Research, and ARCUS (cooperation program Alsace-Russia-Ukraine).	Artigues A, 2002, J BIOL CHEM, V277, P25047, DOI 10.1074/jbc.M203474200; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Batey RT, 1998, RNA, V4, P984, DOI 10.1017/S1355838298980426; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; DULBECCO R, 1959, VIROLOGY, V8, P396, DOI 10.1016/0042-6822(59)90043-1; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; EGEBJERG J, 1989, J MOL BIOL, V206, P651, DOI 10.1016/0022-2836(89)90573-1; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Entelis N, 2006, GENE DEV, V20, P1609, DOI 10.1101/gad.385706; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; FOX JW, 1979, J BIOL CHEM, V254, P139; Funari SS, 2000, J BIOL CHEM, V275, P31283, DOI 10.1074/jbc.M004974200; GAINES G, 1984, MOL CELL BIOL, V4, P1605, DOI 10.1128/MCB.4.8.1605; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GLICK B, 1991, ANNU REV GENET, V25, P21; Gliubich F, 1996, J BIOL CHEM, V271, P21054, DOI 10.1074/jbc.271.35.21054; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; GUDDAT U, 1990, CELL, V60, P619, DOI 10.1016/0092-8674(90)90665-2; Hanas JS, 2002, GENE, V282, P43, DOI 10.1016/S0378-1119(01)00796-X; Hardesty B, 1995, BIOCHEM CELL BIOL, V73, P1199, DOI 10.1139/o95-129; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HENDRICK JP, 1993, P NATL ACAD SCI USA, V90, P10216, DOI 10.1073/pnas.90.21.10216; HENIS YI, 1976, EUR J BIOCHEM, V71, P529, DOI 10.1111/j.1432-1033.1976.tb11141.x; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Kim HK, 2010, BIOCHEM BIOPH RES CO, V391, P1177, DOI 10.1016/j.bbrc.2009.11.176; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; KUDLICKI W, 1995, J BIOL CHEM, V270, P10650, DOI 10.1074/jbc.270.18.10650; Kudlicki W, 1996, J BIOL CHEM, V271, P31160, DOI 10.1074/jbc.271.49.31160; KULINSKI T, 1991, NUCLEIC ACIDS RES, V19, P2449, DOI 10.1093/nar/19.9.2449; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Lin EL, 2001, NUCLEIC ACIDS RES, V29, P2510, DOI 10.1093/nar/29.12.2510; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; MENDOZA JA, 1991, J BIOL CHEM, V266, P13587; MILLER DM, 1991, J BIOL CHEM, V266, P4686; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Minami Y, 1999, GENES CELLS, V4, P721, DOI 10.1046/j.1365-2443.1999.00299.x; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; Nishikori S, 2008, GENES CELLS, V13, P827, DOI 10.1111/j.1365-2443.2008.01214.x; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; OGATA K, 1993, EUR J BIOCHEM, V213, P1277, DOI 10.1111/j.1432-1033.1993.tb17879.x; Okada S, 2000, FEBS LETT, V485, P153, DOI 10.1016/S0014-5793(00)02184-0; OSTERBERG R, 1976, EUR J BIOCHEM, V68, P481, DOI 10.1111/j.1432-1033.1976.tb10835.x; Panda M, 2000, J BIOL CHEM, V275, P63, DOI 10.1074/jbc.275.1.63; Radman-Livaja M, 2005, P NATL ACAD SCI USA, V102, P3913, DOI 10.1073/pnas.0500844102; Rudt F, 1996, EMBO J, V15, P1383, DOI 10.1002/j.1460-2075.1996.tb00480.x; Ryan MT, 1997, INT REV CYTOL, V174, P127, DOI 10.1016/S0074-7696(08)62117-8; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Semrad K, 2004, RNA, V10, P1855, DOI 10.1261/rna.7121704; Silberg JJ, 1998, J BACTERIOL, V180, P6617, DOI 10.1128/JB.180.24.6617-6624.1998; Skibinska L, 2004, BIOPOLYMERS, V73, P316, DOI 10.1002/bip.10598; Smirnov AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1418, DOI 10.1134/S000629790813004X; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Smith MW, 2001, MOL CELL BIOL, V21, P8264, DOI 10.1128/MCB.21.24.8264-8275.2001; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; Tarassov I, 2007, CELL CYCLE, V6, P2473, DOI 10.4161/cc.6.20.4783; Thoms S, 2002, FEBS LETT, V520, P107, DOI 10.1016/S0014-5793(02)02777-1; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; TOOTS I, 1982, NUCLEIC ACIDS RES, V10, P3381, DOI 10.1093/nar/10.11.3381; Waltner M, 1996, J BIOL CHEM, V271, P21226, DOI 10.1074/jbc.271.35.21226; Weber F, 2000, METH MOL B, V140, P111; WESTHOF E, 1989, J MOL BIOL, V207, P417, DOI 10.1016/0022-2836(89)90264-7; YOSHIONARI S, 1994, FEBS LETT, V338, P137, DOI 10.1016/0014-5793(94)80351-X; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	74	65	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30792	30803		10.1074/jbc.M110.151183	http://dx.doi.org/10.1074/jbc.M110.151183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663881	hybrid, Green Published			2022-12-27	WOS:000282135500047
J	Yamasaki, M; Sendall, TJ; Harris, LE; Lewis, GMW; Huntington, JA				Yamasaki, Masayuki; Sendall, Timothy J.; Harris, Laura E.; Lewis, Giles M. W.; Huntington, James A.			Loop-Sheet Mechanism of Serpin Polymerization Tested by Reactive Center Loop Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALPHA-1-PROTEINASE INHIBITOR; ALPHA(1)-ANTITRYPSIN; ALPHA-1-ANTITRYPSIN; POLYMERS; PEPTIDE; MODEL; SITE	The serpin mechanism of protease inhibition involves the rapid and stable incorporation of the reactive center loop (RCL) into central beta-sheet A. Serpins therefore require a folding mechanism that bypasses the most stable "loop-inserted" conformation to trap the RCL in an exposed and metastable state. This unusual feature of serpins renders them highly susceptible to point mutations that lead to the accumulation of hyperstable misfolded polymers in the endoplasmic reticulum of secretory cells. The ordered and stable protomer-protomer association in serpin polymers has led to the acceptance of the "loop-sheet" hypothesis of polymerization, where a portion of the RCL of one protomer incorporates in register into sheet A of another. Although this mechanism was proposed 20 years ago, no study has ever been conducted to test its validity. Here, we describe the properties of a variant of alpha(1)-antitrypsin with a critical hydrophobic section of the RCL substituted with aspartic acid (P8-P6). In contrast to the control, the variant was unable to polymerize when incubated with small peptides or when cleaved in the middle of the RCL (accepted models of loop-sheet polymerization). However, when induced by guanidine HCl or heat, the variant polymerized in a manner indistinguishable from the control. Importantly, the Asp mutations did not affect the ability of the Z or Siiyama alpha(1)-antitrypsin variants to polymerize in COS-7 cells. These results argue strongly against the loop-sheet hypothesis and suggest that, in serpin polymers, the P8-P6 region is only a small part of an extensive domain swap.	[Yamasaki, Masayuki; Sendall, Timothy J.; Harris, Laura E.; Lewis, Giles M. W.; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jah52@cam.ac.uk		Lewis, Giles/0000-0002-8743-8608	Medical Research Council; MRC [G0801899] Funding Source: UKRI; Medical Research Council [G0801899] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council senior nonclinical fellowship (J. A. H.) and a Medical Research Council project grant. This work was carried out with the support of the Diamond Light Source.	Belorgey D, 2007, PRION, V1, P15, DOI 10.4161/pri.1.1.3974; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang WSW, 1997, PROTEIN SCI, V6, P89; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; DeLano W.L, PYMOL MOL GRAPHICS S; Dunstone MA, 2000, PROTEIN SCI, V9, P417; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Huntington JA, 1999, J MOL BIOL, V293, P449, DOI 10.1006/jmbi.1999.3184; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; HUNTINGTON JA, 2010, BIOL CHEM IN PRESS; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; KNAUPP AS, J MOL BIOL, V396, P375; Leslie A., 1992, JOINT CCP4 EACMB NEW; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MIRANDA E, 2010, HEPATOLOGY IN PRESS; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pedersen KE, 2003, BIOCHEM J, V372, P747, DOI 10.1042/BJ20021868; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	32	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30752	30758		10.1074/jbc.M110.156042	http://dx.doi.org/10.1074/jbc.M110.156042			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20667823	Green Published, hybrid			2022-12-27	WOS:000282135500043
J	Yang, SF; Chen, MK; Hsieh, YS; Chung, TT; Hsieh, YH; Lin, CW; Su, JL; Tsai, MH; Tang, CH				Yang, Shun-Fa; Chen, Mu-Kuan; Hsieh, Yih-Shou; Chung, Tsung-Te; Hsieh, Yi-Hsien; Lin, Chiao-Wen; Su, Jen-Liang; Tsai, Ming-Hsui; Tang, Chih-Hsin			Prostaglandin E-2/EP1 Signaling Pathway Enhances Intercellular Adhesion Molecule 1 (ICAM-1) Expression and Cell Motility in Oral Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-DELTA; GENE-EXPRESSION; CYCLOOXYGENASE INHIBITORS; PHOSPHORYLATION; OVEREXPRESSION; ACTIVATION; MECHANISM; ROTTLERIN; INVASION; SUBTYPE	Oral squamous cell carcinoma has a striking tendency to migrate and metastasize. Cyclooxygenase (COX)-2, the inducible isoform of prostaglandin (PG) synthase, has been implicated in tumor metastasis. However, the effects of COX-2 on human oral cancer cells are largely unknown. We found that overexpression of COX-2 or exogenous PGE(2) increased migration and intercellular adhesion molecule 1 (ICAM)-1 expression in human oral cancer cells. Using pharmacological inhibitors, activators, and genetic inhibition of EP receptors, we discovered that the EP1 receptor, but not other PGE receptors, is involved in PGE(2)-mediated cell migration and ICAM-1 expression. PGE(2)-mediated migration and ICAM-1 up-regulation were attenuated by inhibitors of protein kinase C (PKC)delta, and c-Src. Activation of the PKC delta, c-Src, and AP-1 signaling pathway occurred after PGE(2) treatment. PGE(2)-induced expression of ICAM-1 and migration activity were inhibited by a specific inhibitor, siRNA, and mutants of PKC delta, c-Src, and AP-1. In addition, migration-prone sublines demonstrated that cells with increased migration ability had higher expression of COX-2 and ICAM-1. Taken together, these results indicate that the PGE(2) and EP1 interaction enhanced migration of oral cancer cells through an increase in ICAM-1 production.	[Tang, Chih-Hsin] China Med Univ, Coll Med, Dept Pharmacol, Sch Med,Grad Inst Canc Biol, Taichung 404, Taiwan; [Yang, Shun-Fa; Chen, Mu-Kuan; Chung, Tsung-Te] Chung Shan Med Univ, Inst Med, Taichung 402, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 402, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua Cty 402, Taiwan; [Hsieh, Yih-Shou; Hsieh, Yi-Hsien; Lin, Chiao-Wen] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung 402, Taiwan; [Chung, Tsung-Te] Show Chwan Mem Hosp, Dept Otolaryngol, Changhua Cty 500, Taiwan; [Su, Jen-Liang] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Su, Jen-Liang] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Tsai, Ming-Hsui] China Med Univ Hosp, Dept Otolaryngol, Taichung 404, Taiwan; [Tang, Chih-Hsin] China Med Univ & Hosp, Sch Med, Dept Pharmacol, Taichung 404, Taiwan; [Tang, Chih-Hsin] China Med Univ & Hosp, Grad Inst Basic Med Sci, Taichung 404, Taiwan	China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University; Show Chwan Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, CH (corresponding author), China Med Univ, Coll Med, Dept Pharmacol, Sch Med,Grad Inst Canc Biol, 91 Hsueh Shih Rd, Taichung 404, Taiwan.	chtang@mail.cmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Tang, Chih Hsin/O-5212-2015	Yang, Shun-Fa/0000-0002-0365-7927; Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC-97-2314-B-040-025-MY3]; China Medical University [CMU98-OC-02, DOH99-TD-C-111-005]; Taiwan Department of Health	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University(China Medical University); Taiwan Department of Health	This work was supported by National Science Council of Taiwan Grant NSC-97-2314-B-040-025-MY3, China Medical University Grant CMU98-OC-02, China Medical University Hospital Cancer Research of Excellence Grant DOH99-TD-C-111-005, and by the Taiwan Department of Health.	Basu A, 2008, CANCER RES, V68, P2795, DOI 10.1158/0008-5472.CAN-07-6244; BERK BC, 1990, J BIOL CHEM, V265, P17334; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Duperray A, 1997, J BIOL CHEM, V272, P435; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; Fulton AM, 2006, CANCER RES, V66, P9794, DOI 10.1158/0008-5472.CAN-06-2067; Greenberg JS, 2003, CANCER, V98, P508, DOI 10.1002/cncr.11526; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hida T, 1998, CANCER RES, V58, P3761; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Huang WC, 2004, CARCINOGENESIS, V25, P1925, DOI 10.1093/carcin/bgh211; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Kozaki K, 2001, ONCOGENE, V20, P4228, DOI 10.1038/sj.onc.1204561; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Leitges M, 2001, LAB INVEST, V81, P1087, DOI 10.1038/labinvest.3780321; Lyons AJ, 2007, INT J ORAL MAX SURG, V36, P671, DOI 10.1016/j.ijom.2007.04.002; Ma L, 2002, P NATL ACAD SCI USA, V99, P13243, DOI 10.1073/pnas.202392199; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Roebuck KA, 1999, INT J MOL MED, V4, P223; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Rozic JG, 2001, INT J CANCER, V93, P497, DOI 10.1002/ijc.1376; SANO H, 1995, CANCER RES, V55, P3785; Smith DA, 2000, PAC HIST REV, V69, P145, DOI 10.2307/3641273; Su JL, 2004, CANCER RES, V64, P554, DOI 10.1158/0008-5472.CAN-03-1301; SUGIMOTO Y, 1992, J BIOL CHEM, V267, P6463; Sun YJ, 2002, CANCER RES, V62, P6323; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Tang CH, 2008, CARCINOGENESIS, V29, P35, DOI 10.1093/carcin/bgm220; Thomas GJ, 2001, CRIT REV ORAL BIOL M, V12, P479, DOI 10.1177/10454411010120060301; Tokuda H, 2009, HORM METAB RES, V41, P333, DOI 10.1055/s-0028-1103300; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; WATABE A, 1993, J BIOL CHEM, V268, P20175; Weinreb M, 2001, BONE, V28, P275, DOI 10.1016/S8756-3282(00)00447-6; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Zimmerman T, 2008, CURR PHARM DESIGN, V14, P2128, DOI 10.2174/138161208785740225	44	60	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29808	29816		10.1074/jbc.M110.108183	http://dx.doi.org/10.1074/jbc.M110.108183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647315	hybrid, Green Published			2022-12-27	WOS:000281984300016
J	Dhamija, S; Doerrie, A; Winzen, R; Dittrich-Breiholz, O; Taghipour, A; Kuehne, N; Kracht, M; Holtmann, H				Dhamija, Sonam; Doerrie, Anneke; Winzen, Reinhard; Dittrich-Breiholz, Oliver; Taghipour, Azadeh; Kuehne, Nancy; Kracht, Michael; Holtmann, Helmut			IL-1-induced Post-transcriptional Mechanisms Target Overlapping Translational Silencing and Destabilizing Elements in I kappa B zeta mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AU-RICH ELEMENT; GELATINASE-ASSOCIATED LIPOCALIN; NUCLEAR-PROTEIN; GENE-EXPRESSION; ERYTHROID-DIFFERENTIATION; DEATH DOMAIN; STABILIZATION; INDUCTION; RECEPTOR	The inflammatory cytokine IL-1 induces profound changes in gene expression. This is contributed in part by activating translation of a distinct set of mRNAs, including I kappa B zeta, as indicated by genome-wide analysis of changes in ribosomal occupancy in IL-1 alpha-treated HeLa cells. Polysome profiling of I kappa B zeta mRNA and reporter mRNAs carrying its 3' UTR indicated poor translation in unstimulated cells. 3' UTR-mediated translational silencing was confirmed by suppression of luciferase activity. Translational silencing was unaffected by replacing the poly(A) tail with a histone stem-loop, but lost under conditions of cap-independent internal initiation. IL-1 treatment of the cells caused profound shifts of endogenous and reporter mRNAs to polysome fractions and relieved suppression of luciferase activity. IL-1 also inhibited rapid mRNA degradation. Both translational activation and mRNA stabilization involved IRAK1 and -2 but occurred independently of the p38 MAPK pathway, which is known to target certain other post-transcriptional mechanisms. The translational silencing RNA element contains the destabilizing element but requires additional 5' sequences and is impaired by mutations that leave destabilization unaffected. These differences in function are associated with differential changes in protein binding in vitro. Thus, rapid degradation occurs independently of the translational silencing effect. The results provide evidence for a novel mode of post-transcriptional control by IL-1, which impinges on the time course and pattern of IL-1-induced gene expression.	[Dhamija, Sonam; Doerrie, Anneke; Winzen, Reinhard; Dittrich-Breiholz, Oliver; Taghipour, Azadeh; Kuehne, Nancy; Holtmann, Helmut] Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany; [Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen	Holtmann, H (corresponding author), Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany.	holtmann.helmut@mh-hannover.de	Dhamija, Sonam/AAJ-2093-2020	Dhamija, Sonam/0000-0002-9569-2729; Kracht, Michael/0000-0002-8501-043X	Deutsche Forschungsgemeinschaft [SFB 566/A10, SFB 566/Z2, Ho 1116/4]; Niedersachsen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Niedersachsen Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 566/A10, SFB 566/Z2, and Ho 1116/4 and by a grant from the Niedersachsen Foundation.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chen CY, 2000, GENE DEV, V14, P1236; Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; DE BREYNE S, 2009, P NATL ACAD SCI USA, V106, P9197; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gowrishankar G, 2005, BIOL CHEM, V386, P1287, DOI 10.1515/BC.2005.146; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Hartupee J, 2008, J BIOL CHEM, V283, P15689, DOI 10.1074/jbc.M801346200; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; KASPAR RL, 1994, J IMMUNOL, V153, P277; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lindenblatt C, 2009, CELL CYCLE, V8, P2019, DOI 10.4161/cc.8.13.8816; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Neu-Yilik G, 2001, EMBO J, V20, P532, DOI 10.1093/emboj/20.3.532; Neumann D, 2008, J LEUKOCYTE BIOL, V84, P807, DOI 10.1189/jlb.0507290; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Otkjaer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008671; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Ridley SH, 1998, FEBS LETT, V439, P75, DOI 10.1016/S0014-5793(98)01342-8; SCHINDLER R, 1990, J BIOL CHEM, V265, P10232; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V356, P785, DOI 10.1016/j.bbrc.2007.03.044; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	75	27	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29165	29178		10.1074/jbc.M110.146365	http://dx.doi.org/10.1074/jbc.M110.146365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20634286	hybrid, Green Published			2022-12-27	WOS:000281740100017
J	Gonen, N; Assaraf, YG				Gonen, Nitzan; Assaraf, Yehuda G.			The Obligatory Intestinal Folate Transporter PCFT (SLC46A1) Is Regulated by Nuclear Respiratory Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MITOCHONDRIAL BIOGENESIS; CYTOCHROME-C-OXIDASE; METHOTREXATE SENSITIVITY; ANTIFOLATE RESISTANCE; HEME TRANSPORTER; CARRIER ACTIVITY; GENE-EXPRESSION; MOLECULAR-BASIS; CELLS; MALABSORPTION	Folates are essential vitamins that play a key role as one-carbon donors in a spectrum of biosynthetic pathways including RNA and DNA synthesis. The proton-coupled folate transporter (PCFT/SLC46A1) mediates obligatory intestinal folate absorption. Loss-of-function mutations in PCFT result in hereditary folate malabsorption, an autosomal recessive disorder characterized by very low folate levels in the blood and cerebrospinal fluid. Hereditary folate malabsorption manifests within the first months after birth with anemia, immune deficiency, and neurological deficits. Here we studied the role of inducible trans-activators of PCFT gene expression. Bioinformatics identified three putative nuclear respiratory factor 1 (NRF-1) binding sites in the minimal promoter. The following evidence establish that PCFT is an NRF-1-responsive gene; electrophoretic mobility shift assay showed NRF-1 binding to native but not mutant NRF-1 sites, whereas antibody-mediated supershift analysis and chromatin immunoprecipitation revealed NRF-1 binding to its consensus sites within the PCFT promoter. Moreover, mutational inactivation of individual or all NRF-1 binding sites resulted in 40-60% decrease in luciferase reporter activity. Consistently, overexpression of NRF-1 or a constitutively active NRF-1 VP-16 construct resulted in increased reporter activity and PCFT mRNA levels. Conversely, introduction of a dominant-negative NRF-1 construct markedly repressed reporter activity and PCFT mRNA levels; likewise, introduction of NRF-1 siRNA duplexes to cells resulted in decreased PCFT transcript levels. Moreover, NRF-1 silencing down-regulated genes encoding for key folate transporters and enzymes in folate metabolism. These novel findings identify NRF-1 as a major inducible transcriptional regulator of PCFT gene expression. The implications of this linkage between folate transport and metabolism with mitochondria biogenesis and respiration are discussed.	[Gonen, Nitzan; Assaraf, Yehuda G.] Technion Israel Inst Technol, Fred Wyszkowski Canc Res Lab, Fac Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Fred Wyszkowski Canc Res Lab, Fac Biol, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il	Gonen, Nitzan/AAL-7719-2021	Assaraf, Yehuda G./0000-0001-6692-8221; Gonen, Nitzan/0000-0002-3377-8324				APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Asangani IA, 2008, GENE, V410, P197, DOI 10.1016/j.gene.2007.12.009; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Assaraf YG, 2006, DRUG RESIST UPDATE, V9, P227, DOI 10.1016/j.drup.2006.09.001; Baar K, 2003, FASEB J, V17, P1666, DOI 10.1096/fj.03-0049com; BONKOVSKY H, 1990, HEPATOLOGY TXB LIVER; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAYTON KA, 1994, J BIOL CHEM, V269, P5313; Chang CM, 2007, BRIT J NUTR, V97, P855, DOI 10.1017/S0007114507666410; Chen SH, 1997, NUCLEIC ACIDS RES, V25, P1809, DOI 10.1093/nar/25.9.1809; Dang TN, 2010, GLIA, V58, P55, DOI 10.1002/glia.20901; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; Dhar SS, 2009, BBA-MOL CELL RES, V1793, P1604, DOI 10.1016/j.bbamcr.2009.07.001; DIXON KH, 1994, J BIOL CHEM, V269, P17; Elnakat H, 2004, ADV DRUG DELIVER REV, V56, P1067, DOI 10.1016/j.addr.2004.01.001; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Fan XC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn535; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Gonen N, 2008, BIOCHEM BIOPH RES CO, V376, P787, DOI 10.1016/j.bbrc.2008.09.074; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Ifergan I, 2008, VITAM HORM, V79, P99, DOI 10.1016/S0083-6729(08)00404-4; JANSEN G, 1999, RECEPTOR CARRIER MED, P293; Kamen BA, 2004, ADV DRUG DELIVER REV, V56, P1085, DOI 10.1016/j.addr.2004.01.002; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; Kherrouche Z, 2004, BIOCHEM J, V383, P529, DOI 10.1042/BJ20040935; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Laftah AH, 2009, BRIT J NUTR, V101, P1150, DOI 10.1017/S0007114508066762; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lu YJ, 2002, ADV DRUG DELIVER REV, V54, P675, DOI 10.1016/S0169-409X(02)00042-X; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; McCarty EA, 2004, J BIOL CHEM, V279, P33829, DOI 10.1074/jbc.M403677200; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; OHLSSON H, 1986, CELL, V45, P35, DOI 10.1016/0092-8674(86)90535-0; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; ROTHBERG KG, 1990, J CELL BIOL, V110, P637, DOI 10.1083/jcb.110.3.637; Salani R, 2007, INT J GYNECOL PATHOL, V26, P141, DOI 10.1097/01.pgp.0000229994.02815.f9; SCARPULLA RC, 1981, J BIOL CHEM, V256, P6480; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Sofer Y, 2007, J CHILD NEUROL, V22, P783, DOI 10.1177/0883073807304004; Stark M, 2009, BIOCHEM BIOPH RES CO, V388, P79, DOI 10.1016/j.bbrc.2009.07.116; STOCKSTAD ELR, 1990, FOLIC ACID METABOLIS, P1; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; WONG SC, 1995, J BIOL CHEM, V270, P17468, DOI 10.1074/jbc.270.29.17468; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969	57	33	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33602	33613		10.1074/jbc.M110.135640	http://dx.doi.org/10.1074/jbc.M110.135640			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20724482	Green Published, hybrid			2022-12-27	WOS:000283354000005
J	Kato, M; Wang, L; Putta, S; Wang, M; Yuan, H; Sun, GD; Lanting, L; Todorov, I; Rossi, JJ; Natarajan, R				Kato, Mitsuo; Wang, Lin; Putta, Sumanth; Wang, Mei; Yuan, Hang; Sun, Guangdong; Lanting, Linda; Todorov, Ivan; Rossi, John J.; Natarajan, Rama			Post-transcriptional Up-regulation of Tsc-22 by Ybx1, a Target of miR-216a, Mediates TGF-beta-induced Collagen Expression in Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; UPSTREAM STIMULATORY FACTOR-2; TRANSCRIPTION FACTORS TFE3; MESSENGER-RNA; TRANSFORMING GROWTH-FACTOR-BETA-1; DIABETIC-NEPHROPATHY; PROMOTER ACTIVITY; TRANSGENIC MICE; GENE ACTIVATION; LEUCINE-ZIPPER	Increased accumulation of extracellular matrix proteins and hypertrophy induced by transforming growth factor-beta 1 (TGF-beta)in renal mesangial cells (MC) are hallmark features of diabetic nephropathy. Although the post-transcriptional regulation of key genes has been implicated in these events, details are not fully understood. Here we show that TGF-beta increased microRNA-216a (miR-216a) levels in mouse MC, with parallel down-regulation of Ybx1, a miR-216a target and RNA-binding protein. TGF-beta also enhanced protein levels of Tsc-22 (TGF-beta-stimulated clone 22) and collagen type I alpha-2 (Col1a2) expression in MC through far upstream enhancer E-boxes by interaction of Tsc-22 with an E-box regulator, Tfe3. Ybx1 colocalized with processing bodies in MC and formed a ribonucleoprotein complex with Tsc-22 mRNA, and this complex formation was reduced by TGF-beta, miR-216a mimics, or Ybx1 shRNA to increase Tsc-22 protein levels but enhanced by miR-216a inhibitor oligonucleotides. Chromatin immunoprecipitation (ChIP) assays revealed that TGF-beta could increase the occupancies of Tsc-22 and Tfe3 on enhancer E-boxes of Col1a2. Co-immunoprecipitation assays revealed that TGF-beta promoted the interaction of Tsc-22 with Tfe3. These results demonstrate that post-transcriptional regulation of Tsc-22 mediated through Ybx1, a miR-216a target, plays a key role in TGF-beta -induced Col1a2 in MC related to the pathogenesis of diabetic nephropathy.	[Kato, Mitsuo; Putta, Sumanth; Wang, Mei; Yuan, Hang; Sun, Guangdong; Lanting, Linda; Todorov, Ivan; Natarajan, Rama] City Hope Natl Med Ctr, Gonda Diabet Ctr, Duarte, CA 91010 USA; [Wang, Lin; Putta, Sumanth; Todorov, Ivan; Rossi, John J.; Natarajan, Rama] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Rossi, John J.] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Beckman Res Inst, Duarte, CA 91010 USA; [Yuan, Hang; Sun, Guangdong] Jilin Univ, Div Nephrol, Hosp 2, Changchun 130041, Peoples R China	City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Jilin University	Natarajan, R (corresponding author), 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org	Kato, Mitsuo/D-5411-2009	Kato, Mitsuo/0000-0002-1783-1084	National Institutes of Health [NIDDK R21 DK076669, R01 DK058191, R01 DK081705]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK076669, R01DK058191, R01DK081705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIDDK R21 DK076669, R01 DK058191, and R01 DK081705 (to R. N.).	Bader AG, 2008, ONCOGENE, V27, P1179, DOI 10.1038/sj.onc.1210719; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Banas MC, 2007, J HISTOCHEM CYTOCHEM, V55, P275, DOI 10.1369/jhc.6A7083.2006; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BECKMANN H, 1991, GENE DEV, V5, P1057, DOI 10.1101/gad.5.6.1057; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; Brosius Frank C, 2010, Expert Rev Endocrinol Metab, V5, P51; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chen CY, 2000, GENE DEV, V14, P1236; Choi SJ, 2005, MOL CELL BIOCHEM, V271, P23, DOI 10.1007/s11010-005-3456-7; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Hua XX, 2000, J BIOL CHEM, V275, P33205, DOI 10.1074/jbc.C000568200; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Huan CM, 2006, NAT IMMUNOL, V7, P1082, DOI 10.1038/ni1378; Hubchak SC, 2009, AM J PHYSIOL-RENAL, V297, pF1316, DOI 10.1152/ajprenal.00345.2009; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Kutz SM, 2006, EXP CELL RES, V312, P1093, DOI 10.1016/j.yexcr.2005.12.027; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Murray D, 2000, J BIOL CHEM, V275, P3610, DOI 10.1074/jbc.275.5.3610; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Rossi JJ, 2005, NAT CELL BIOL, V7, P643, DOI 10.1038/ncb0705-643; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; Shi LH, 2009, AM J PHYSIOL-RENAL, V296, pF257, DOI 10.1152/ajprenal.90493.2008; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; Sugawara F, 2003, DIABETES RES CLIN PR, V60, P191, DOI 10.1016/S0168-8227(03)00038-X; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Terraz C, 2001, J BIOL CHEM, V276, P37011, DOI 10.1074/jbc.M104185200; Todorov I, 2006, PANCREAS, V32, P130, DOI 10.1097/01.mpa.0000202945.78331.93; Uchida D, 2003, BIOCHEM BIOPH RES CO, V305, P846, DOI 10.1016/S0006-291X(03)00854-4; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang SX, 2004, J BIOL CHEM, V279, P34311, DOI 10.1074/jbc.M401629200; Weigert C, 2004, J BIOL CHEM, V279, P15908, DOI 10.1074/jbc.M313524200; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907; Zhu YQ, 2005, DIABETES, V54, P1976, DOI 10.2337/diabetes.54.7.1976	60	141	149	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34004	34015		10.1074/jbc.M110.165027	http://dx.doi.org/10.1074/jbc.M110.165027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20713358	Green Published, hybrid			2022-12-27	WOS:000283354000047
J	Belanger, F; Stepinski, J; Darzynkiewicz, E; Pelletier, J				Belanger, Francois; Stepinski, Janusz; Darzynkiewicz, Edward; Pelletier, Jerry			Characterization of hMTr1, a Human Cap1 2 '-O-Ribose Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC MESSENGER-RNAS; SPLICED LEADER RNA; BLOCKED 5' TERMINI; TRYPANOSOMA-BRUCEI; VACCINIA VIRUS; HELA-CELLS; RIBOSE METHYLATION; POLYMERASE-II; PROTEIN; PURIFICATION	Cellular eukaryotic mRNAs are capped at their 5` ends with a 7-methylguanosine nucleotide, a structural feature that has been shown to be important for conferring mRNA stability, stimulating mRNA biogenesis (splicing, poly(A) addition, nucleocytoplasmic transport), and increasing translational efficiency. Whereas yeast mRNAs have no additional modifications to the cap, called cap0, higher eukaryotes are methylated at the 2`-O-ribose of the first or the first and second transcribed nucleotides, called cap1 and cap2, respectively. In the present study, we identify the methyltransferase responsible for cap1 formation in human cells, which we call hMTr1 (also known as FTSJD2 and ISG95). We show in vitro that hMTr1 catalyzes specific methylation of the 2`-O-ribose of the first nucleotide of a capped RNA transcript. Using si RNA-mediated knockdown of hMTr1 in HeLa cells, we demonstrate that hMTr1 is responsible for cap1 formation in vivo.	[Belanger, Francois; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Belanger, Francois; Pelletier, Jerry] McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; [Belanger, Francois; Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Stepinski, Janusz; Darzynkiewicz, Edward] Univ Warsaw, Fac Phys, Div Biophys, Inst Expt Phys, PL-02089 Warsaw, Poland	McGill University; McGill University; McGill University; University of Warsaw	Pelletier, J (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Sci Bldg,Rm 810,3655 Promenade Sir W, Montreal, PQ H3G 1Y6, Canada.	jerry.pelletier@mcgill.ca			Canadian Institutes of Health Research [MOP-79385]; Fonds de Recherche en Sante du Quebec; Howard Hughes Medical Institute [55005604]; National Science Support Project [PBZMNiSW-07/I/2007]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Support Project	This work was supported by Canadian Institutes of Health Research Grant MOP-79385 (to J. P.).; Supported by a Fonds de Recherche en Sante du Quebec postdoctoral fellowship.; Supported by Howard Hughes Medical Institute Grant 55005604 and National Science Support Project 2008-2010 PBZMNiSW-07/I/2007.	Arhin GK, 2006, MOL BIOCHEM PARASIT, V147, P137, DOI 10.1016/j.molbiopara.2006.01.011; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BANGS JD, 1992, J BIOL CHEM, V267, P9805; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Cole MD, 2009, ONCOGENE, V28, P1169, DOI 10.1038/onc.2008.463; Decroly E, 2008, J VIROL, V82, P8071, DOI 10.1128/JVI.00407-08; ENSINGER MJ, 1976, J BIOL CHEM, V251, P5283; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; FREISTADT MS, 1988, J BIOL CHEM, V263, P15071; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P1904, DOI 10.1073/pnas.72.5.1904; Galloway SE, 2008, VIROLOGY, V382, P69, DOI 10.1016/j.virol.2008.08.041; Geiss GK, 2003, J VIROL, V77, P6367, DOI 10.1128/JVI.77.11.6367-6375.2003; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003; Haline-Vaz T, 2008, BIOCHEM BIOPH RES CO, V372, P719, DOI 10.1016/j.bbrc.2008.05.137; Hall MP, 2006, NUCLEIC ACIDS RES, V34, P5594, DOI 10.1093/nar/gkl573; JACQUEMONT B, 1977, J VIROL, V22, P160, DOI 10.1128/JVI.22.1.160-167.1977; Jankowska M, 1996, COLLECT CZECH CHEM C, V61, pS197; KEITH JM, 1978, J BIOL CHEM, V253, P5033; Kuge H, 1998, NUCLEIC ACIDS RES, V26, P3208, DOI 10.1093/nar/26.13.3208; Kuge H, 1995, EMBO J, V14, P6301, DOI 10.1002/j.1460-2075.1995.tb00320.x; KUSMIEREK J, 1978, NUCL ACIDS RES SPECI, V4, pS73; LANGBERG SR, 1981, J BIOL CHEM, V256, P54; Li Y, 2008, MOL CELL BIOL, V28, P939, DOI 10.1128/MCB.01727-07; Mittra B, 2008, J BIOL CHEM, V283, P3161, DOI 10.1074/jbc.M707367200; MUTHUKRISHNAN S, 1978, J BIOL CHEM, V253, P1710; Niedzwiecka A, 2007, METHOD ENZYMOL, V430, P209, DOI 10.1016/S0076-6879(07)30009-8; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pei Y, 2003, J BIOL CHEM, V278, P7180, DOI 10.1074/jbc.M211713200; PELLETIER J, 1985, MOL CELL BIOL, V5, P3222, DOI 10.1128/MCB.5.11.3222; PERRY KL, 1987, P NATL ACAD SCI USA, V84, P8190, DOI 10.1073/pnas.84.23.8190; Rahmeh AA, 2009, J VIROL, V83, P11043, DOI 10.1128/JVI.01426-09; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; SCHNIERLE BS, 1992, P NATL ACAD SCI USA, V89, P2897, DOI 10.1073/pnas.89.7.2897; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwer B, 2000, GENETICS, V155, P1561; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; SRIPATI CE, 1976, J BIOL CHEM, V251, P2898; VENKATESAN S, 1980, J BIOL CHEM, V255, P2829; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; YOSHIKAWA M, 1967, TETRAHEDRON LETT, P5065; Zamudio JR, 2007, MOL CELL BIOL, V27, P6084, DOI 10.1128/MCB.00647-07; Zamudio JR, 2006, EUKARYOT CELL, V5, P905, DOI 10.1128/EC.00080-06; Zamudio JR, 2009, MOL MICROBIOL, V72, P1100, DOI 10.1111/j.1365-2958.2009.06696.x	45	92	98	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33037	33044		10.1074/jbc.M110.155283	http://dx.doi.org/10.1074/jbc.M110.155283			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20713356	Green Published, hybrid			2022-12-27	WOS:000283048200041
J	Fernandez, PL; Dutra, FF; Alves, L; Figueiredo, RT; Mourao-Sa, D; Fortes, GB; Bergstrand, S; Lonn, D; Cevallos, RR; Pereira, RMS; Lopes, UG; Travassos, LH; Paiva, CN; Bozza, MT				Fernandez, Patricia L.; Dutra, Fabianno F.; Alves, Leticia; Figueiredo, Rodrigo T.; Mourao-Sa, Diego; Fortes, Guilherme B.; Bergstrand, Sophie; Loenn, David; Cevallos, Ricardo R.; Pereira, Renata M. S.; Lopes, Ulisses G.; Travassos, Leonardo H.; Paiva, Claudia N.; Bozza, Marcelo T.			Heme Amplifies the Innate Immune Response to Microbial Molecules through Spleen Tyrosine Kinase (Syk)-dependent Reactive Oxygen Species Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INCREASES MORTALITY; NLRP3 INFLAMMASOME; SEVERE MALARIA; HOST-DEFENSE; ACTIVATION; RECEPTORS; RECOGNITION; DECTIN-1; ALPHA	Infectious diseases that cause hemolysis are among the most threatening human diseases, because of severity and/or global distribution. In these conditions, hemeproteins and heme are released, but whether heme affects the inflammatory response to microorganism molecules remains to be characterized. Here, we show that heme increased the lethality and cytokine secretion induced by LPS in vivo and enhanced the secretion of cytokines by macrophages stimulated with various agonists of innate immune receptors. Activation of nuclear factor kappa B (NF-kappa B) and MAPKs and the generation of reactive oxygen species were essential to the increase in cytokine production induced by heme plus LPS. This synergistic effect of heme and LPS was blocked by a selective inhibitor of spleen tyrosine kinase (Syk) and was abrogated in dendritic cells deficient in Syk. Moreover, inhibition of Syk and the downstream molecules PKC and PI3K reduced the reactive oxygen species generation by heme. Our results highlight a mechanism by which heme amplifies the secretion of cytokines triggered by microbial molecule activation and indicates possible pathways for therapeutic intervention during hemolytic infectious diseases.	[Fernandez, Patricia L.; Dutra, Fabianno F.; Alves, Leticia; Figueiredo, Rodrigo T.; Fortes, Guilherme B.; Bergstrand, Sophie; Loenn, David; Travassos, Leonardo H.; Paiva, Claudia N.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol, Lab Inflamacao & Imunidade, BR-21941902 Rio De Janeiro, Brazil; [Fernandez, Patricia L.; Cevallos, Ricardo R.] Inst Invest Cient & Serv Alta Tecnol, Panama City 084301103, Panama; [Figueiredo, Rodrigo T.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, Brazil; [Mourao-Sa, Diego] London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England; [Pereira, Renata M. S.; Lopes, Ulisses G.; Travassos, Leonardo H.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Bozza, MT (corresponding author), Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol, Lab Inflamacao & Imunidade, BR-21941902 Rio De Janeiro, Brazil.	mbozza@micro.ufrj.br	Lopes, Ulisses Gazos/T-6634-2019; Lopes, Ulisses/N-4416-2013; Dutra, Fabianno F/C-1387-2015; Pereira, Renata/V-6194-2019; Ferreira Dutra, Fabianno/AAE-2895-2022; Travassos, Leonardo/G-1925-2012; Figueiredo, Rodrigo/F-5176-2016	Dutra, Fabianno F/0000-0003-3106-7585; Ferreira Dutra, Fabianno/0000-0003-3106-7585; Travassos, Leonardo/0000-0003-1323-3797; Mourao, Diego/0000-0001-6618-6969; Bozza, Marcelo/0000-0003-3683-7550; Figueiredo, Rodrigo/0000-0002-7551-8782; Pereira, Renata/0000-0002-7719-8356; Cevallos, Ricardo/0000-0001-9759-7859; Llanes Fernandez, Patricia/0000-0002-0762-0566	Conselho de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao Jose Bonifacio; Programa de Nucleos de Excelencia; Secretaria Nacional de Ciencia Tecnologia e Innovacion de Panama	Conselho de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Jose Bonifacio; Programa de Nucleos de Excelencia; Secretaria Nacional de Ciencia Tecnologia e Innovacion de Panama	This work was supported by Conselho de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Fundacao Jose Bonifacio, and Programa de Nucleos de Excelencia, Secretaria Nacional de Ciencia Tecnologia e Innovacion de Panama.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; GRIFFITHS E, 1995, LANCET, V345, P158, DOI 10.1016/S0140-6736(95)90168-X; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; MULLEREBERHARD U, 1993, AM J HEMATOL, V42, P59, DOI 10.1002/ajh.2830420112; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Su DH, 1997, INFECT IMMUN, V65, P1258, DOI 10.1128/IAI.65.4.1258-1266.1997; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Yang H, 2002, SHOCK, V17, P485, DOI 10.1097/00024382-200206000-00008	36	66	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32844	32851		10.1074/jbc.M110.146076	http://dx.doi.org/10.1074/jbc.M110.146076			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729208	Green Published, hybrid			2022-12-27	WOS:000283048200021
J	Huang, HP; Yu, CY; Chen, HF; Chen, PH; Chuang, CY; Lin, SJ; Huang, ST; Chan, WH; Ueng, TH; Ho, HN; Kuo, HC				Huang, Hsiang-Po; Yu, Chun-Ying; Chen, Hsin-Fu; Chen, Pin-Hsun; Chuang, Ching-Yu; Lin, Sung-Jan; Huang, Shih-Tsung; Chan, Wei-Hung; Ueng, Tzuu-Huei; Ho, Hong-Nerng; Kuo, Hung-Chih			Factors from Human Embryonic Stem Cell-derived Fibroblast-like Cells Promote Topology-dependent Hepatic Differentiation in Primate Embryonic and Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE-LIKE CELLS; EFFICIENT DIFFERENTIATION; GROWTH-FACTOR; LIVER DEVELOPMENT; ONCOSTATIN-M; IN-VITRO; ENDODERM; GENERATION; LINES; TRANSPLANTATION	The future clinical use of embryonic stem cell (ESC)-based hepatocyte replacement therapy depends on the development of an efficient procedure for differentiation of hepatocytes from ESCs. Here we report that a high density of human ESC-derived fibroblast-like cells (hESdFs) supported the efficient generation of hepatocyte-like cells with functional and mature hepatic phenotypes from primate ESCs and human induced pluripotent stem cells. Molecular and immunocytochemistry analyses revealed that hESdFs caused a rapid loss of pluripotency and induced a sequential endoderm-to-hepatocyte differentiation in the central area of ESC colonies. Knockdown experiments demonstrated that pluripotent stem cells were directed toward endodermal and hepatic lineages by FGF2 and activin A secreted from hESdFs. Furthermore, we found that the central region of ESC colonies was essential for the hepatic endoderm-specific differentiation, because its removal caused a complete disruption of endodermal differentiation. In conclusion, we describe a novel in vitro differentiation model and show that hESdF-secreted factors act in concert with regional features of ESC colonies to induce robust hepatic endoderm differentiation in primate pluripotent stem cells.	[Huang, Hsiang-Po; Chen, Pin-Hsun] Natl Taiwan Univ Hosp, Div Med Res, Taipei 10002, Taiwan; [Yu, Chun-Ying; Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ Hosp, Div Reprod Endocrinol & Infertil, Taipei 10002, Taiwan; [Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 10002, Taiwan; [Chan, Wei-Hung] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei 10002, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ, Inst Clin Genom, Taipei 10617, Taiwan; [Ueng, Tzuu-Huei] Natl Taiwan Univ, Inst Toxicol, Taipei 10617, Taiwan; [Kuo, Hung-Chih] Taipei Med Univ, Inst Clin Med, Taipei 11031, Taiwan; [Chuang, Ching-Yu; Kuo, Hung-Chih] Acad Sinica, Genom Res Ctr, Taipei 11574, Taiwan; [Huang, Shih-Tsung; Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11574, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Taipei Medical University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Kuo, HC (corresponding author), 128,Sec 2,Acad Rd, Taipei, Taiwan.	kuohuch@gate.sinica.edu.tw	Yu, Chun-ying/AAE-8368-2020; yu, chun ying/ABB-3212-2020; NTU, Ref07/AAX-7890-2021; Kuo, Hung-Chih/H-7810-2014	Yu, Chun-ying/0000-0002-7320-7876; yu, chun ying/0000-0002-7320-7876; Kuo, Hung-Chih/0000-0003-1336-1203; Ho, Hong-Nerng/0000-0002-7207-0089; Lin, Sung-Jan/0000-0003-1325-3464; CHEN, HSIN-FU/0000-0002-7748-4440; HUANG, HSIANG-PO/0000-0002-3382-305X	Academia Sinica [5202402020-0]; National Science Council of Taiwan [97-3111-B-001-009, 98-2811-B-001-022, 97-2321-B-002-020-MY3]; National Science Council [97-3112-B-001-016]	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Summit Project II Intramural Grant 5202402020-0 from Academia Sinica (to H.-C. K.), Stem Cell Priority Grants 97-3111-B-001-009 and 98-2811-B-001-022 (to H.-C. K.), and Grant 97-2321-B-002-020-MY3 (to H.-P. H.) from the National Science Council of Taiwan.; We thank Drs. Chun-Jen Liu and Yung-Ming Jeng for sera and liver sections, respectively, from HBV-infected patients. We thank the National RNAi Core Facility (supported by National Science Council Grant 97-3112-B-001-016) for lentiviral shRNA clones and the Affymetrix Gene Expression Service Lab of Academia Sinica for microarray assays.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Akhter J, 2007, SURG-J R COLL SURG E, V5, P155, DOI 10.1016/S1479-666X(07)80043-6; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen HF, 2007, HUM REPROD, V22, P567, DOI 10.1093/humrep/del412; Chen HF, 2009, HUM REPROD, V24, P1114, DOI 10.1093/humrep/dep003; Chen HF, 2009, HUM REPROD, V24, P71, DOI 10.1093/humrep/den345; Chiao E, 2008, STEM CELLS, V26, P2032, DOI 10.1634/stemcells.2007-0964; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Deutsch G, 2001, DEVELOPMENT, V128, P871; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Fukumitsu K, 2009, TISSUE ENG PT A, V15, P3847, DOI [10.1089/ten.tea.2009.0357, 10.1089/ten.TEA.2009.0357]; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kamiya A, 2001, FEBS LETT, V492, P90, DOI 10.1016/S0014-5793(01)02140-8; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; King FW, 2009, STEM CELLS DEV, V18, P1441, DOI 10.1089/scd.2009.0012; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Momose Y, 2009, BIOL PHARM BULL, V32, P619, DOI 10.1248/bpb.32.619; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Runge DM, 1999, J HEPATOL, V30, P265, DOI 10.1016/S0168-8278(99)80073-7; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Saito K, 2006, WORLD J GASTROENTERO, V12, P6818, DOI 10.3748/wjg.v12.i42.6818; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Soto-Gutierrez A, 2007, NAT PROTOC, V2, P347, DOI 10.1038/nprot.2007.18; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsukada H, 2006, IN VITRO CELL DEV-AN, V42, P83; Weber H, 1996, DEVELOPMENT, V122, P1975; WORTELBOER H M, 1987, Molecular Toxicology, V1, P373; Yamamoto H, 2003, HEPATOLOGY, V37, P983, DOI 10.1053/jhep.2003.50202; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691	46	22	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33510	33519		10.1074/jbc.M110.122093	http://dx.doi.org/10.1074/jbc.M110.122093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720011	hybrid, Green Published			2022-12-27	WOS:000283048200085
J	Kannappan, R; Yadav, VR; Aggarwal, BB				Kannappan, Ramaswamy; Yadav, Vivek R.; Aggarwal, Bharat B.			RETRACTED: gamma-Tocotrienol but Not gamma-Tocopherol Blocks STAT3 Cell Signaling Pathway through Induction of Protein-tyrosine Phosphatase SHP-1 and Sensitizes Tumor Cells to Chemotherapeutic Agents (Retracted article. See vol. 291, pg. 16922, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							FACTOR-KAPPA-B; NATURAL VITAMIN-E; INDUCED APOPTOSIS; MULTIPLE-MYELOMA; GENE-PRODUCTS; CANCER CELLS; ACTIVATION; INHIBITION; TRANSCRIPTION; SRC	Although gamma-tocotrienol (T3), a vitamin E isolated primarily from palm and rice bran oil, has been linked with anticancer activities, the mechanism of this action is poorly understood. In this study, we investigated whether gamma-T3 can modulate the STAT3 cell signaling pathway, closely linked to inflammation and tumorigenesis. We found that gamma-T3 but not gamma-tocopherol, the most common saturated form of vitamin E, inhibited constitutive activation of STAT3 in a dose-and time-dependent manner, and this inhibition was not cell type-specific. gamma-T3 also inhibited STAT3 DNA binding. This correlated with inhibition of Src kinase and JAK1 and JAK2 kinases. Pervanadate reversed the gamma-T3-induced down-regulation of STAT3 activation, suggesting the involvement of a protein-tyrosine phosphatase. When examined further, we found that gamma-T3 induced the expression of the tyrosine phosphatase SHP-1, and gene silencing of the SHP-1 by small interfering RNA abolished the ability of gamma-T3 to inhibit STAT3 activation, suggesting a vital role for SHP-1 in the action of gamma-T3. Also gamma-T3 down-modulated activation of STAT3 and induced SHP-1 in vivo. Eventually, gamma-T3 down-regulated the expression of STAT3-regulated antiapoptotic (Bcl-2, Bcl-xL, and Mcl-1), proliferative (cyclin D1), and angiogenic (VEGF) gene products; and this correlated with suppression of proliferation, the accumulation of cells in sub-G(1) phase of the cell cycle, and induction of apoptosis. This vitamin also sensitized the tumor cells to the apoptotic effects of thalidomide and bortezomib. Overall, our results suggest that gamma-T3 is a novel blocker of STAT3 activation pathway both in vitro and in vivo and thus may have potential in prevention and treatment of cancers.	[Kannappan, Ramaswamy; Yadav, Vivek R.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Aggarwal, Bharat B/G-3388-2013		National Institutes of Health [CA-16 672, CA-124787-01A2]; Malaysian Palm Oil Board, Kuala Lumpur, Malaysia; Center for Targeted Therapy of M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA124787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malaysian Palm Oil Board, Kuala Lumpur, Malaysia; Center for Targeted Therapy of M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-16 672 and Program Project Grant CA-124787-01A2. This work was also supported by Malaysian Palm Oil Board, Kuala Lumpur, Malaysia, and in part by a grant from the Center for Targeted Therapy of M. D. Anderson Cancer Center.	AGGARWAL BB, 2010, BIOCH PHARM IN PRESS; Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Ahmad NS, 2005, CLIN EXP PHARMACOL P, V32, P761, DOI 10.1111/j.1440-1681.2005.04264.x; Ahn KS, 2007, J BIOL CHEM, V282, P809, DOI 10.1074/jbc.M610028200; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Bachawal SV, 2010, ANTICANCER RES, V30, P429; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cavo M, 2006, LEUKEMIA, V20, P1341, DOI 10.1038/sj.leu.2404278; Das S, 2005, AM J PHYSIOL-HEART C, V289, pH361, DOI 10.1152/ajpheart.01285.2004; Gunaje JJ, 2001, BIOCHEM BIOPH RES CO, V288, P252, DOI 10.1006/bbrc.2001.5759; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kannappan R, 2010, MOL CANCER THER, V9, P2196, DOI 10.1158/1535-7163.MCT-10-0277; Kashiwagi K, 2009, LIFE SCI, V84, P650, DOI 10.1016/j.lfs.2009.02.007; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kim H, 1999, MOL CELL BIOL, V19, P5326; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; Kuhad A, 2009, PHARMACOL BIOCHEM BE, V92, P251, DOI 10.1016/j.pbb.2008.12.012; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Oka T, 2002, CANCER RES, V62, P6390; QURESHI AA, 1991, AM J CLIN NUTR, V53, pS1021, DOI 10.1093/ajcn/53.4.1021S; Saito Y, 2004, ANN NY ACAD SCI, V1031, P368, DOI 10.1196/annals.1331.047; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Sen CK, 2007, VITAM HORM, V76, P203, DOI 10.1016/S0083-6729(07)76008-9; Sen CK, 2007, MOL ASPECTS MED, V28, P692, DOI 10.1016/j.mam.2007.03.001; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; Sen CK, 2004, ANN NY ACAD SCI, V1031, P127, DOI 10.1196/annals.1331.013; SERBINOVA EA, 1994, METHOD ENZYMOL, V234, P354; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Sun S, 2002, J GEN VIROL, V83, P1651, DOI 10.1099/0022-1317-83-7-1651; Sylvester PW, 2005, FRONT BIOSCI, V10, P699, DOI 10.2741/1565; Takada Y, 2006, J BIOL CHEM, V281, P5612, DOI 10.1074/jbc.M507213200; Tanuma N, 2000, J BIOL CHEM, V275, P28216; Tenev T, 2000, EUR J CELL BIOL, V79, P261, DOI 10.1078/S0171-9335(04)70029-1; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu WP, 1999, NUTR CANCER, V33, P26, DOI 10.1080/01635589909514744; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zushi SI, 1998, INT J CANCER, V78, P326, DOI 10.1002/(SICI)1097-0215(19981029)78:3<326::AID-IJC12>3.0.CO;2-4	46	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33520	33528		10.1074/jbc.M110.158378	http://dx.doi.org/10.1074/jbc.M110.158378			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720018	Green Published, hybrid			2022-12-27	WOS:000283048200086
J	Li, QA; Su, YY; Wang, H; Li, L; Wang, QO; Bao, L				Li, Qian; Su, Yuan-Yuan; Wang, Hao; Li, Lei; Wang, Qiong; Bao, Lan			Transmembrane Segments Prevent Surface Expression of Sodium Channel Na(v)1.8 and Promote Calnexin-dependent Channel Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM-RETENTION; II MEMBRANE-PROTEINS; QUALITY-CONTROL; NEUROPATHIC PAIN; NMDA RECEPTOR; SUBUNIT; TRAFFICKING; MOTIF; PATHWAYS; SIGNALS	The voltage-gated sodium channel (Na-v) 1.8 contributes substantially to the rising phase of action potential in small dorsal root ganglion neurons. Na(v)1.8 is majorly localized intracellularly and its expression on the plasma membrane is regulated by exit from the endoplasmic reticulum (ER). Previous work has identified an ER-retention/retrieval motif in the first intracellular loop of Na(v)1.8, which prevents its surface expression. Here we report that the transmembrane segments of Na(v)1.8 also cause this channel retained in the ER. Using transferrin receptor and CD8 alpha as model molecules, immunocytochemistry showed that the first, second, and third transmembrane segments in each domain of Na(v)1.8 reduced their surface expression. Alanine-scanning analysis revealed acidic amino acids as critical factors in the odd transmembrane segments. Furthermore, co-immunoprecipitation experiments showed that calnexin interacted with acidic amino acid-containing sequences through its transmembrane segment. Overexpression of calnexin resulted in increased degradation of those proteins through the ER-associated degradation pathway, whereas down-regulation of calnexin reversed the phenotype. Thus our results reveal a critical role and mechanism of transmembrane segments in surface expression and degradation of Na(v)1.8.	[Li, Qian; Su, Yuan-Yuan; Wang, Hao; Li, Lei; Wang, Qiong; Bao, Lan] Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Bao, L (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	baolan@sibs.ac.cn	Li, Qian/AAE-8688-2022; Li, Qian/P-4417-2015	Li, Qian/0000-0003-1300-3377; Li, Qian/0000-0003-1300-3377	National Basic Research Program of China [2007CB914501, 2010CB912001]; National Natural Science Foundation of China [30570574, 30623003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2007CB914501 and 2010CB912001, National Natural Science Foundation of China Grants 30570574 and 30623003.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Bao L, 2003, NEURON, V37, P121, DOI 10.1016/S0896-6273(02)01103-0; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Gold MS, 2003, J NEUROSCI, V23, P158; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Liu TI, 2001, J NEUROPHYSIOL, V85, P61, DOI 10.1152/jn.2001.85.1.61; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Novakovic SD, 1998, J NEUROSCI, V18, P2174; Ogata N, 2002, JPN J PHARMACOL, V88, P365, DOI 10.1254/jjp.88.365; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ren Z, 2003, J NEUROSCI, V23, P6608; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; STEVENS TL, 1994, J IMMUNOL, V152, P4397; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Tang BL, 1997, EUR J CELL BIOL, V73, P98; Vacher H, 2007, FASEB J, V21, P906, DOI 10.1096/fj.06-7229com; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang ZN, 2008, J CELL SCI, V121, P3243, DOI 10.1242/jcs.026856	57	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32977	32987		10.1074/jbc.M110.143024	http://dx.doi.org/10.1074/jbc.M110.143024			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720009	Green Published, hybrid			2022-12-27	WOS:000283048200035
J	Nam, HJ; Kang, JK; Kim, SK; Ahn, KJ; Seok, H; Park, SJ; Chang, JS; Pothoulakis, C; Lamont, JT; Kim, H				Nam, Hyo Jung; Kang, Jin Ku; Kim, Sung-Kuk; Ahn, Keun Jae; Seok, Heon; Park, Sang Joon; Chang, Jong Soo; Pothoulakis, Charalabos; Lamont, John Thomas; Kim, Ho			Clostridium difficile Toxin A Decreases Acetylation of Tubulin, Leading to Microtubule Depolymerization through Activation of Histone Deacetylase 6, and This Mediates Acute Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-RHO; PLUS-ENDS; IN-VIVO; HDAC6; ENTERITIS; RECEPTOR; DYNAMICS; STRESS; MODULATION; PACLITAXEL	Clostridium difficile toxin A is known to cause actin disaggregation through the enzymatic inactivation of intracellular Rho proteins. Based on the rapid and severe cell rounding of toxin A-exposed cells, we speculated that toxin A may be involved in post-translational modification of tubulin, leading to microtubule instability. In the current study, we observed that toxin A strongly reduced alpha-tubulin acetylation in human colonocytes and mouse intestine. Fractionation analysis demonstrated that toxin A-induced alpha-tubulin deacetylation yielded monomeric tubulin, indicating the presence of microtubule depolymerization. Inhibition of the glucosyltransferase activity against Rho proteins of toxin A by UDP-2`,3`-dialdehyde significantly abrogated toxin A-induced alpha-tubulin deacetylation. In colonocytes treated with trichostatin A (TSA), an inhibitor of the HDAC6 tubulin deacetylase, toxin A-induced alpha-tubulin deacetylation and loss of tight junction were completely blocked. Administration of TSA also attenuated proinflammatory cytokine production, mucosal damage, and epithelial cell apoptosis in mouse intestine exposed to toxin A. These results suggest that toxin A causes microtubule depolymerization by activation of HDAC6-mediated tubulin deacetylation. Indeed, blockage of HDAC6 by TSA markedly attenuates alpha-tubulin deacetylation, proinflammatory cytokine production, and mucosal damage in a toxin A-induced mouse enteritis model. Tubulin deacetylation is an important component of the intestinal inflammatory cascade following toxin A-mediated Rho inactivation in vitro and in vivo.	[Nam, Hyo Jung; Kang, Jin Ku; Kim, Sung-Kuk; Chang, Jong Soo; Kim, Ho] Daejin Univ, Coll Nat Sci, Dept Life Sci, Pochon 487711, Gyeonggido, South Korea; [Ahn, Keun Jae] Yonsei Univ, Coll Med, Dept Dermatol, Seoul 102752, South Korea; [Ahn, Keun Jae] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul 102752, South Korea; [Seok, Heon] Ulsan Natl Inst Sci & Technol, Sch Nanobiotechnol & Chem Engn, Ulsan 689798, South Korea; [Park, Sang Joon] Kyungpook Natl Univ, Coll Vet Med, Dept Vet Histol, Taegu 702701, South Korea; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Lamont, John Thomas] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA	Daejin University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ulsan National Institute of Science & Technology (UNIST); Kyungpook National University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kim, H (corresponding author), Daejin Univ, Coll Nat Sci, Dept Life Sci, Pochon 487711, Gyeonggido, South Korea.	hokim@daejin.ac.kr			Ministry of Health and Welfare, Republic of Korea [A080933]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea, Grant A080933.	Arregui L, 2002, J EUKARYOT MICROBIOL, V49, P312, DOI 10.1111/j.1550-7408.2002.tb00376.x; Banerjee PP, 2007, J EXP MED, V204, P2305, DOI 10.1084/jem.20061893; Bicek AD, 2009, MOL BIOL CELL, V20, P2943, DOI 10.1091/mbc.E08-09-0909; Castagliuolo I, 1998, J CLIN INVEST, V101, P1547, DOI 10.1172/JCI2039; Castagliuolo I, 1997, AM J PHYSIOL-GASTR L, V273, pG333, DOI 10.1152/ajpgi.1997.273.2.G333; Chang JS, 2005, J BIOL CHEM, V280, P6897, DOI 10.1074/jbc.M406350200; Chen JG, 2002, CANCER RES, V62, P1935; Eiserich JP, 1999, P NATL ACAD SCI USA, V96, P6365, DOI 10.1073/pnas.96.11.6365; Fernandez N, 2009, P NATL ACAD SCI USA, V106, P7846, DOI 10.1073/pnas.0813228106; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Han Y, 1998, BIOCHEMISTRY-US, V37, P6636, DOI 10.1021/bi9719760; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; JUST I, 1994, J BIOL CHEM, V269, P10706; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Karvonen U, 2006, EXP CELL RES, V312, P3165, DOI 10.1016/j.yexcr.2006.06.018; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kim H, 2005, GASTROENTEROLOGY, V129, P1875, DOI 10.1053/j.gastro.2005.09.011; Kim H, 2005, J BIOL CHEM, V280, P21237, DOI 10.1074/jbc.M413842200; Kim H, 2007, GASTROENTEROLOGY, V133, P875, DOI 10.1053/j.gastro.2007.06.063; Kim H, 2009, EXP CELL RES, V315, P3336, DOI 10.1016/j.yexcr.2009.05.020; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lamont J Thomas, 2002, Trans Am Clin Climatol Assoc, V113, P167; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Malorni W, 2003, J IMMUNOL, V171, P4195, DOI 10.4049/jimmunol.171.8.4195; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; MEJILLANO MR, 1991, J BIOL CHEM, V266, P657; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Popova JS, 2003, J BIOL CHEM, V278, P34299, DOI 10.1074/jbc.M301748200; POTHOULAKIS C, 1988, J CLIN INVEST, V81, P1741, DOI 10.1172/JCI113514; Pothoulakis C, 1996, J CLIN INVEST, V98, P641, DOI 10.1172/JCI118835; POTHOULAKIS C, 1993, GASTROENTEROL CLIN N, V22, P623; Pothoulakis C, 2001, AM J PHYSIOL-GASTR L, V280, pG178, DOI 10.1152/ajpgi.2001.280.2.G178; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Verdier-Pinard P, 2000, MOL PHARMACOL, V57, P568, DOI 10.1124/mol.57.3.568; VONEICHELSTREIBER C, 1990, MED MICROBIOL IMMUN, V179, P271, DOI 10.1007/BF00192465; Warny M, 2000, J CLIN INVEST, V105, P1147, DOI 10.1172/JCI7545; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	48	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32888	32896		10.1074/jbc.M110.162743	http://dx.doi.org/10.1074/jbc.M110.162743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20696758	hybrid, Green Published			2022-12-27	WOS:000283048200026
J	Wirtz, M; Birke, H; Heeg, C; Muller, C; Hosp, F; Throm, C; Konig, S; Feldman-Salit, A; Rippe, K; Petersen, G; Wade, RC; Rybin, V; Scheffzek, K; Hell, R				Wirtz, Markus; Birke, Hannah; Heeg, Corinna; Mueller, Christopher; Hosp, Fabian; Throm, Christian; Koenig, Stephan; Feldman-Salit, Anna; Rippe, Karsten; Petersen, Gabriele; Wade, Rebecca C.; Rybin, Vladimir; Scheffzek, Klaus; Hell, Ruediger			Structure and Function of the Hetero-oligomeric Cysteine Synthase Complex in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; MITOCHONDRIAL SERINE ACETYLTRANSFERASE; ESCHERICHIA-COLI; PROTEIN COMPLEX; THIOL LYASE; BIOSYNTHESIS; PURIFICATION; MECHANISM; SEQUENCE; DOMAIN	Cysteine synthesis in bacteria and plants is catalyzed by serine acetyltransferase (SAT) and O-acetylserine (thiol)-lyase (OAS-TL), which form the hetero-oligomeric cysteine synthase complex (CSC). In plants, but not in bacteria, the CSC is assumed to control cellular sulfur homeostasis by reversible association of the subunits. Application of size exclusion chromatography, analytical ultracentrifugation, and isothermal titration calorimetry revealed a hexameric structure of mitochondrial SAT from Arabidopsis thaliana (AtSATm) and a 2: 1 ratio of the OAS-TL dimer to the SAT hexamer in the CSC. Comparable results were obtained for the composition of the cytosolic SAT from A. thaliana (AtSATc) and the cytosolic SAT from Glycine max (Glyma16g03080, GmSATc) and their corresponding CSCs. The hexameric SAT structure is also supported by the calculated binding energies between SAT trimers. The interaction sites of dimers of AtSATm trimers are identified using peptide arrays. A negative Gibbs free energy (Delta G = -33 kcal mol(-1)) explains the spontaneous formation of the AtCSCs, whereas the measured SAT: OAS-TL affinity (K-D = 30 nM) is 10 times weaker than that of bacterial CSCs. Free SAT from bacteria is > 100-fold more sensitive to feedback inhibition by cysteine than AtSATm/c. The sensitivity of plant SATs to cysteine is further decreased by CSC formation, whereas the feedback inhibition of bacterial SAT by cysteine is not affected by CSC formation. The data demonstrate highly similar quaternary structures of the CSCs from bacteria and plants but emphasize differences with respect to the affinity of CSC formation (K-D()) and the regulation of cysteine sensitivity of SAT within the CSC.	[Koenig, Stephan] Heidelberg Univ, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany; [Feldman-Salit, Anna; Wade, Rebecca C.] Heidelberg Inst Theoret Studies, D-69118 Heidelberg, Germany; [Petersen, Gabriele] Heidelberg Univ, Inst Zool, D-69120 Heidelberg, Germany; [Rybin, Vladimir; Scheffzek, Klaus] EMBL Heidelberg, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Heidelberg Institute for Theoretical Studies; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)		rhell@hip.uni-heidelberg.de	Hell, Ruediger/E-5436-2014; Wirtz, Markus/G-5917-2010; Birke, Hannah/I-5511-2013; Wade, Rebecca/L-1489-2019; Rippe, Karsten/A-3562-2012	Wirtz, Markus/0000-0001-7790-4022; Wade, Rebecca/0000-0001-5951-8670; Rippe, Karsten/0000-0001-9951-9395; Konig, Stephan/0000-0002-1597-3628; Hell, Ruediger/0000-0002-6238-4818; Throm, Christian Robert/0000-0003-2914-7025	Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQuant Graduate School Molecular Machines); Schmeil-Stiftung, Heidelberg; Deutsche Forschungsgemeinschaft [He1848/5-2, He1848/13-1]; Klaus Tschira Foundation	Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQuant Graduate School Molecular Machines); Schmeil-Stiftung, Heidelberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klaus Tschira Foundation	This work was supported by the Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQuant Graduate School Molecular Machines), the Schmeil-Stiftung, Heidelberg, and the Deutsche Forschungsgemeinschaft Grants He1848/5-2 and He1848/13-1 (to H. B. and C. H.) and by the Klaus Tschira Foundation (to A. F.-S. and R. C. W.).	BECKER MA, 1969, J BIOL CHEM, V244, P6023; Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Bogdanova N, 1997, PLANT J, V11, P251, DOI 10.1046/j.1365-313X.1997.11020251.x; Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805; DENK D, 1987, J GEN MICROBIOL, V133, P515; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Hindson VJ, 2000, J BIOL CHEM, V275, P461, DOI 10.1074/jbc.275.1.461; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P514; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu FL, 2006, J BIOL CHEM, V281, P27405, DOI 10.1074/jbc.M604548200; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; Petersen G, 2001, J BIOL CHEM, V276, P10178, DOI 10.1074/jbc.M006967200; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sirko A, 2004, J EXP BOT, V55, P1881, DOI 10.1093/jxb/erh151; TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2004, J EXP BOT, V55, P1785, DOI 10.1093/jxb/erh201; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Wirtz M, 2007, PLANT CELL, V19, P625, DOI 10.1105/tpc.106.043125; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	32	70	72	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32810	32817		10.1074/jbc.M110.157446	http://dx.doi.org/10.1074/jbc.M110.157446			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20720017	Green Published, hybrid			2022-12-27	WOS:000283048200017
J	Wurstle, ML; Laussmann, MA; Rehm, M				Wuerstle, Maximilian L.; Laussmann, Maike A.; Rehm, Markus			The Caspase-8 Dimerization/Dissociation Balance Is a Highly Potent Regulator of Caspase-8,-3,-6 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED-INHIBITOR; APOPTOSIS PROTEIN XIAP; INTERCHAIN PROTEOLYSIS; ACTIVATION; DIMERIZATION; CANCER; DEATH; FAS; REQUIREMENT; VARIABILITY	Apoptosis is driven by positive feedback activation between aspartate-specific cysteinyl proteases (caspases). These feedback loops ensure the swift and efficient elimination of cells upon initiation of apoptosis execution. At the same time, the signaling network must be insensitive to erroneous, mild caspase activation to avoid unwanted, excessive cell death. Sublethal caspase activation in fact was shown to be a requirement for the differentiation of multiple cell types but might also occur accidentally during short, transient cellular stress conditions. Here we carried out an in silico comparison of the molecular mechanisms that so far have been identified to impair the amplification of caspase activities via the caspase-8, -3, -6 loop. In a systems model resembling HeLa cervical cancer cells, the dimerization/dissociation balance of caspase-8 potently suppressed the amplification of caspase responses, surprisingly outperforming or matching known caspase-8 and -3 inhibitors such as bifunctional apoptosis repressor or x-linked inhibitor of apoptosis protein. These findings were further substantiated in global sensitivity analyses based on combinations of protein concentrations from the sub-to superphysiological range to screen the full spectrum of biological variability that can be expected within cell populations and between distinct cell types. Additional modeling showed that the combined effects of x-linked inhibitor of apoptosis protein and caspase-8 dimerization/dissociation processes can also provide resistance to larger inputs of active caspases. Our study therefore highlights a central and so far underappreciated role of caspase-8 dimerization/dissociation in avoiding unwanted cell death by lethal amplification of caspase responses via the caspase-8, -3, -6 loop.	[Rehm, Markus] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Wuerstle, Maximilian L.; Laussmann, Maike A.; Rehm, Markus] Royal Coll Surgeons Ireland, Syst Biol Grp, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Rehm, M (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, RCSI York House,York St, Dublin 2, Ireland.	mrehm@rcsi.ie	Rehm, Markus/C-3398-2012	Rehm, Markus/0000-0001-6149-9261	National Biophotonics and Imaging Platform Ireland; Irish Government; European Union; Health Research Board Ireland [RP/2006/258]; Royal College of Surgeons in Ireland Research Committee	National Biophotonics and Imaging Platform Ireland; Irish Government; European Union(European Commission); Health Research Board Ireland; Royal College of Surgeons in Ireland Research Committee	This work was supported by National Biophotonics and Imaging Platform Ireland funded under the Higher Education Authority Program for Research in Third-Level Institutions Cycle 4, co-funded by the Irish Government and the European Union - Investing in your future, as well as by grants from the Health Research Board Ireland (RP/2006/258) and the Royal College of Surgeons in Ireland Research Committee (to M. R.).	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hellwig CT, 2008, J BIOL CHEM, V283, P21676, DOI 10.1074/jbc.M802889200; Huber H, 2009, ESSENTIALS OF APOPTOSIS, SECOND EDITION, P283, DOI 10.1007/978-1-60327-381-7_12; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Logue SE, 2008, BIOCHEM SOC T, V36, P1, DOI 10.1042/BST0360001; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Murphy BM, 2004, J BIOL CHEM, V279, P36916, DOI 10.1074/jbc.M402039200; O'Connor CL, 2008, BBA-MOL CELL RES, V1783, P1903, DOI 10.1016/j.bbamcr.2008.05.025; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Roth W, 2003, CELL DEATH DIFFER, V10, P1178, DOI 10.1038/sj.cdd.4401287; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Wilson TR, 2009, ONCOGENE, V28, P63, DOI 10.1038/onc.2008.366; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597	40	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33209	33218		10.1074/jbc.M110.113860	http://dx.doi.org/10.1074/jbc.M110.113860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702410	Green Published, hybrid			2022-12-27	WOS:000283048200058
J	Damo, SM; Phillips, AH; Young, AL; Li, S; Woods, VL; Wemmer, DE				Damo, Steven M.; Phillips, Aaron H.; Young, Anisa L.; Li, Sheng; Woods, Virgil L., Jr.; Wemmer, David E.			Probing the Conformation of a Prion Protein Fibril with Hydrogen Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUTION NMR-SPECTROSCOPY; BETA(2)-MICROGLOBULIN AMYLOID FIBRILS; STRAUSSLER-SCHEINKER-DISEASE; HYDROGEN/DEUTERIUM EXCHANGE; MASS-SPECTROMETRY; TRANSGENIC MICE; SOLVENT ACCESSIBILITY; SYNTHETIC PEPTIDE; Y145STOP VARIANT; AMIDE-PROTON	A fragment of the prion protein, PrP(89-143, P101L), bearing a mutation implicated in familial prion disease, forms fibrils that have been shown to induce prion disease when injected intracerebrally into transgenic mice expressing full-length PrP containing the P101L mutation. In this study, we utilize amide hydrogen exchange measurements to probe the organization of the peptide in its fibrillar form. We determined the extent of hydrogen exchange first by tandem proteolysis, liquid chromatography, and mass spectrometry (HXMS) and then by exchange-quenched NMR. Although single amide resolution is afforded by NMR measurements, HXMS is well suited to the study of natural prions because it does not require labeling with NMR active isotopes. Thus, natural prions obtained from infected animals can be compared with model systems such as PrP(89-143, P101L) studied here. In our study, we find two segments of sequence that display a high level of protection from exchange, residues 102-109 and 117-136. In addition, there is a region that displays exchange behavior consistent with the presence of a conformationally heterogeneous turn. We discuss our data with respect to several structural models proposed for infectious PrP aggregates and highlight HXMS as one of the few techniques well suited to studying natural prions.	[Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Sch Med, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Young, Anisa L.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Woods, VL (corresponding author), Univ Calif San Diego, Sch Med, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; dewemmer@berkeley.edu		Damo, Steven/0000-0002-1483-7712	Army Prion Research Program [DMAD17-03-1-0476]; National Institutes of Health [AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, GM066170]; Innovative Technologies for the Molecular Analysis of Cancer [CA099835, CA118595]; University of California [UC10591]; NATIONAL CANCER INSTITUTE [R21CA118595, R21CA099835, R33CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072106, R01AI081982, P01AI068730, R21AI076961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684, R01GM066170, F32GM020501, R01GM020501] Funding Source: NIH RePORTER	Army Prion Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Technologies for the Molecular Analysis of Cancer; University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Army Prion Research Program Grant DMAD17-03-1-0476. Development of the HXMS methodology was supported by National Institutes of Health Grants AI076961, AI081982, AI2008031, AI072106, AI068730, GM037684, GM020501, and GM066170 (to V. L. W.), Innovative Technologies for the Molecular Analysis of Cancer Program Grants CA099835 and CA118595 (to V. L. W.), and Discovery Grant UC10591 from the University of California IUCRP Program, BiogenIDEC corporate sponsor (to V. L. W.).	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Brown DR, 2003, J NEUROCHEM, V87, P377, DOI 10.1046/j.1471-4159.2003.02046.x; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; DeArmond SJ, 1996, CURR TOP MICROBIOL, V207, P125; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Garnett AP, 2003, J BIOL CHEM, V278, P6795, DOI 10.1074/jbc.M209280200; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Hornemann S, 2004, EMBO REP, V5, P1159, DOI 10.1038/sj.embor.7400297; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Ippel JH, 2002, P NATL ACAD SCI USA, V99, P8648, DOI 10.1073/pnas.132098999; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; Keller R., 2004, COMPUTER AIDED RESON, V1; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Lim KH, 2006, SOLID STATE NUCL MAG, V29, P183, DOI 10.1016/j.ssnmr.2005.09.017; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Nazabal A, 2005, J BIOL CHEM, V280, P13220, DOI 10.1074/jbc.M413185200; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Piccardo P, 2001, AM J PATHOL, V158, P2201, DOI 10.1016/S0002-9440(10)64692-5; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner Stanley B., 2004, VVolume 41, P89; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Sakudo A, 2004, BIOCHEM BIOPH RES CO, V313, P850, DOI 10.1016/j.bbrc.2003.12.020; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang SSS, 2003, BIOCHEMISTRY-US, V42, P9507, DOI 10.1021/bi0342766; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Woods VL, 2001, J CELL BIOCHEM, V84, P89, DOI 10.1002/jcb.10069; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; ZHANG YZ, 1995, PROTEIN SCI, V4, P804; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	72	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32303	32311		10.1074/jbc.M110.114504	http://dx.doi.org/10.1074/jbc.M110.114504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679344	Green Published, hybrid			2022-12-27	WOS:000282683000043
J	Guo, NX; Li, XA; Mann, MM; Funderburgh, ML; Du, YQ; Funderburgh, JL				Guo, Naxin; Li, Xuan; Mann, Mary M.; Funderburgh, Martha L.; Du, Yiqin; Funderburgh, James L.			Hyaluronan Synthesis Mediates the Fibrotic Response of Keratocytes to Transforming Growth Factor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MYOFIBROBLAST TRANSDIFFERENTIATION; HUMAN TENON FIBROBLASTS; CORNEAL KERATOCYTES; ACTIN EXPRESSION; PHENOTYPE; CELLS; PROLIFERATION; ACCUMULATION; INHIBITION; SECRETION	TGF beta induces fibrosis in healing corneal wounds, and in vitro corneal keratocytes up-regulate expression of several fibrosis-related genes in response to TGF beta. Hyaluronan (HA) accumulates in healing corneas, and HA synthesis is induced by TGF beta by up-regulation of HA synthase 2. This study tested the hypothesis that HA acts as an extracellular messenger, enhancing specific fibrotic responses of keratocytes to TGF beta. HA synthesis inhibitor 4-methylumbelliferone (4MU) blocked TGF beta induction of HA synthesis in a concentration-dependent manner. 4MU also inhibited TGF beta-induced up-regulation of alpha-smooth muscle actin, collagen type III, and extra domain A-fibronectin. Chemical analogs of 4MU also inhibited fibrogenic responses in proportion to their inhibition of HA synthesis. 4MU, however, showed no effect on TGF beta induction of luciferase by the 3TP-Lux reporter plasmid. Inhibition of HA using siRNA to HA synthase 2 reduced TGF beta up-regulation of smooth muscle actin, fibronectin, and cell division. Similarly, brief treatment of keratocytes with hyaluronidase reduced TGF beta responses. These results suggest that newly synthesized cell-associated HA acts as an extracellular enhancer of wound healing and fibrosis in keratocytes by augmenting a limited subset of the cellular responses to TGF beta.	[Guo, Naxin; Li, Xuan; Mann, Mary M.; Funderburgh, Martha L.; Du, Yiqin; Funderburgh, James L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Funderburgh, JL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, 1009 EEINS,203 Lothrop St, Pittsburgh, PA 15213 USA.	jlfunder@pitt.edu	DU, YIQIN/AAO-1566-2020; Du, Yiqin/A-7727-2018	DU, YIQIN/0000-0002-4330-0957; 	National Institutes of Health [EY09368, P30-EY08098]; Research to Prevent Blindness; Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE [R01EY009368, P30EY008098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY09368 (to J. L. F.) and Core Grant P30-EY08098. This work was also supported by Research to Prevent Blindness and the Eye and Ear Foundation of Pittsburgh.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Berryhill BL, 2003, EXP EYE RES, V77, P85, DOI 10.1016/S0014-4835(03)00060-5; CINTRON C, 1988, INVEST OPHTH VIS SCI, V29, P767; Du YQ, 2007, INVEST OPHTH VIS SCI, V48, P5038, DOI 10.1167/iovs.07-0587; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; FITZSIMMONS TD, 1994, INVEST OPHTH VIS SCI, V35, P2774; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Funderburgh ML, 2008, MOL VIS, V14, P308; Guo NX, 2007, J BIOL CHEM, V282, P12475, DOI 10.1074/jbc.M609280200; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jester JV, 1996, CORNEA, V15, P505; Jester JV, 1997, CORNEA, V16, P177; Kim S, 2008, CELL SIGNAL, V20, P1313, DOI 10.1016/j.cellsig.2008.02.020; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Li FZ, 2005, WORLD J SURG, V29, P306, DOI 10.1007/s00268-004-7813-6; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Morohashi H, 2006, BIOCHEM BIOPH RES CO, V345, P1454, DOI 10.1016/j.bbrc.2006.05.037; Sebe A, 2008, NEPHROL DIAL TRANSPL, V23, P1537, DOI 10.1093/ndt/gfm789; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926	28	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32012	32019		10.1074/jbc.M110.127183	http://dx.doi.org/10.1074/jbc.M110.127183			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685654	Green Published, hybrid			2022-12-27	WOS:000282683000014
J	Jack, BHA; Crossley, M				Jack, Briony H. A.; Crossley, Merlin			GATA Proteins Work Together with Friend of GATA (FOG) and C-terminal Binding Protein (CTBP) Co-regulators to Control Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; KRUPPEL-LIKE FACTOR; TRANSCRIPTION FACTOR GATA-1; FACTOR GENE; HEART MORPHOGENESIS; REPRESSOR COMPLEX; IN-VIVO; COREPRESSOR; COFACTOR; FAMILY	GATA transcription factors have been implicated in controlling adipogenesis in Drosophila and in mammals. In mammals, both GATA2 and GATA3 have been shown to be present in preadipocytes, and their silencing allows the onset of adipogenesis. Overexpression of GATA proteins blocks adipogenesis in cellular assays. GATA factors have been found to operate through recruiting cofactors of the Friend of GATA (FOG) family. FOG proteins, in turn, recruit co-regulators, including C-terminal binding proteins (CTBPs). We have investigated whether FOGs and CTBPs influence adipogenesis. We found that both FOG1 and FOG2 are expressed in cells prior to adipogenesis but are down-regulated as adipogenesis proceeds. Overexpression of FOG1 or FOG2 interferes with adipogenesis. Mutant versions of FOG2 unable to bind CTBP or GATA proteins are impaired in their inability to inhibit adipogenesis. Finally, a mutant version of GATA2, unable to associate with FOGs, also displays abnormal activity and causes enhanced cell proliferation. These results implicate FOGs and CTBPs as partners of GATA proteins in the control of adipocyte proliferation and differentiation.	[Jack, Briony H. A.; Crossley, Merlin] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Jack, Briony H. A.; Crossley, Merlin] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Crossley, M (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	m.crossley@unsw.edu.au	Crossley, Merlin/D-7888-2011	Crossley, Merlin/0000-0003-2057-3642	Australian Research Council; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grant funding from the Australian Research Council and the National Health and Medical Research Council (to M.C.).	Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Hayes SA, 2001, DEVELOPMENT, V128, P1193; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Katz SG, 2002, MOL CELL BIOL, V22, P3121, DOI 10.1128/MCB.22.9.3121-3128.2002; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; LEE ME, 1991, J BIOL CHEM, V266, P16188; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Martin D, 2001, MOL CELL BIOL, V21, P164, DOI 10.1128/MCB.21.1.164-174.2001; Matthews JM, 2000, EUR J BIOCHEM, V267, P1030, DOI 10.1046/j.1432-1327.2000.01095.x; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Sam S, 1996, MECH DEVELOP, V60, P197, DOI 10.1016/S0925-4773(96)00615-6; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Svensson EC, 2000, NAT GENET, V25, P353, DOI 10.1038/77146; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	42	28	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32405	32414		10.1074/jbc.M110.141317	http://dx.doi.org/10.1074/jbc.M110.141317			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20705609	hybrid, Green Published			2022-12-27	WOS:000282683000054
J	Durand, S; Feldhammer, M; Bonneil, E; Thibault, P; Pshezhetsky, AV				Durand, Stephanie; Feldhammer, Matthew; Bonneil, Eric; Thibault, Pierre; Pshezhetsky, Alexey V.			Analysis of the Biogenesis of Heparan Sulfate Acetyl-CoA:alpha-Glucosaminide N-Acetyltransferase Provides Insights into the Mechanism Underlying Its Complete Deficiency in Mucopolysaccharidosis IIIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE TYPE-C; MEMBRANE-PROTEINS; COENZYME-A; TRANSMEMBRANE ACETYLATION; HGSNAT GENE; LYSOSOMES; MUTATIONS; SPECTRUM; CHANNEL; BINDING	Heparan sulfate acetyl-CoA:alpha-glucosaminide N-acetyltransferase (HGSNAT) catalyzes the transmembrane acetylation of heparan sulfate in lysosomes required for its further catabolism. Inherited deficiency of HGSNAT in humans results in lysosomal storage of heparan sulfate and causes the severe neurodegenerative disease, mucopolysaccharidosis IIIC (MPS IIIC). Previously we have cloned the HGSNAT gene, identified molecular defects in MPS IIIC patients, and found that all missense mutations prevented normal folding and trafficking of the enzyme. Therefore characterization of HGSNAT biogenesis and intracellular trafficking became of central importance for understanding the molecular mechanism underlying the disease and developing future therapies. In the current study we show that HGSNAT is synthesized as a catalytically inactive 77-kDa precursor that is transported to the lysosomes via an adaptor protein-mediated pathway that involves conserved tyrosine-and dileucine-based lysosomal targeting signals in its C-terminal cytoplasmic domain with a contribution from a dileucine-based signal in the N-terminal cytoplasmic loop. In the lysosome, the precursor is cleaved into a 29-kDa N-terminal alpha-chain and a 48-kDa C-terminal beta-chain, and assembled into active similar to 440-kDa oligomers. The subunits are held together by disulfide bonds between at least two cysteine residues (Cys(123) and Cys(434)) in the lysosomal luminal loops of the enzyme. We speculate that proteolytic cleavage allows the nucleophile residue, His(269), in the active site to access the substrate acetyl-CoA in the cytoplasm, for further transfer of the acetyl group to the terminal glucosamine on heparan sulfate. Altogether our results identify intralysosomal oligomerization and proteolytic cleavage as two steps crucial for functional activation of HGSNAT.	[Pshezhetsky, Alexey V.] Univ Montreal, CHU St Justine, Serv Genet Med, Dept Med Genet, Montreal, PQ H3T 1C5, Canada; [Feldhammer, Matthew; Thibault, Pierre; Pshezhetsky, Alexey V.] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1C5, Canada; [Pshezhetsky, Alexey V.] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Pshezhetsky, Alexey V.] McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ H3A 2B2, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Pshezhetsky, AV (corresponding author), Univ Montreal, CHU St Justine, Serv Genet Med, Dept Med Genet, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	alexei.pchejetski@umontreal.ca		A, Pshezhetsky/0000-0002-6612-1062	March of Dimes Foundation; Sanfilippo Children's Research Foundation; Canadian Institutes for Health Research [MOP84430]; National Science and Engineering Research Council (NSERC); Fonds de la Recherche en Sante du Quebec	March of Dimes Foundation(March of Dimes); Sanfilippo Children's Research Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by research grants from the March of Dimes Foundation, the Sanfilippo Children's Research Foundation, and Canadian Institutes for Health Research Grant MOP84430 (to A. V. P.), and operating grants from the National Science and Engineering Research Council (NSERC) (to P. T.). The Institute of Research in Immunology and Cancer receives infrastructure support funds from the Fonds de la Recherche en Sante du Quebec.	Ausseil K, 2006, MOL GENET METAB, V87, P22, DOI 10.1016/j.ymgme.2005.09.021; BAME KJ, 1986, J BIOL CHEM, V261, P127; BAME KJ, 1985, J BIOL CHEM, V260, P1293; BAME KJ, 1986, SCIENCE, V233, P1087, DOI 10.1126/science.3090688; BARTSOCAS C, 1979, EUR J PEDIATR, V130, P251, DOI 10.1007/BF00441361; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Callahan JW, 2009, J PROTEOMICS, V72, P23, DOI 10.1016/j.jprot.2008.11.007; Coutinho MF, 2008, CLIN GENET, V74, P194, DOI 10.1111/j.1399-0004.2008.01040.x; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; Fan XL, 2006, AM J HUM GENET, V79, P738, DOI 10.1086/508068; Fedele Anthony Olind, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9488; Feldhammer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007434; Feldhammer M, 2009, HUM MUTAT, V30, P918, DOI 10.1002/humu.20986; FREEMAN C, 1983, BIOCHEM INT, V6, P663; Graham DRM, 2005, PROTEOMICS, V5, P2309, DOI 10.1002/pmic.200401249; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; HE W, 1994, PRENATAL DIAG, V14, P17, DOI 10.1002/pd.1970140104; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hrebicek M, 2006, AM J HUM GENET, V79, P807, DOI 10.1086/508294; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; PSHEZHETSKY AV, 1993, BIOCHEM BIOPH RES CO, V195, P354, DOI 10.1006/bbrc.1993.2051; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; ROME LH, 1983, J BIOL CHEM, V258, P3006; Ruijter GJG, 2008, MOL GENET METAB, V93, P104, DOI 10.1016/j.ymgme.2007.09.011; Ruivo R, 2009, BBA-MOL CELL RES, V1793, P636, DOI 10.1016/j.bbamcr.2008.12.008; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; VALSTAR MJ, 2008, J INHERIT METAB DIS, V93, P104; Vesa J, 2002, MOL BIOL CELL, V13, P2410, DOI 10.1091/mbc.E02-01-0031	38	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31233	31242		10.1074/jbc.M110.141150	http://dx.doi.org/10.1074/jbc.M110.141150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20650889	Green Published, hybrid			2022-12-27	WOS:000282764600017
J	Kumar, PA; Kotlyarevska, K; Dejkhmaron, P; Reddy, GR; Lu, CX; Bhojani, MS; Menon, RK				Kumar, P. Anil; Kotlyarevska, Kateryna; Dejkhmaron, Prapai; Reddy, Gaddameedi R.; Lu, Chunxia; Bhojani, Mahaveer S.; Menon, Ram K.			Growth Hormone (GH)-dependent Expression of a Natural Antisense Transcript Induces Zinc Finger E-box-binding Homeobox 2 (ZEB2) in the Glomerular Podocyte A NOVEL ACTION OF GH WITH IMPLICATIONS FOR THE PATHOGENESIS OF DIABETIC NEPHROPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; URINARY ALBUMIN EXCRETION; E-CADHERIN; KIDNEY-DISEASE; IN-VITRO; MICROALBUMINURIA; MELLITUS; PROTEIN; CYTOSKELETON; METASTASIS	Growth hormone (GH) excess results in structural and functional changes in the kidney and is implicated as a causative factor in the development of diabetic nephropathy (DN). Glomerular podocytes are the major barrier to the filtration of serum proteins, and altered podocyte function and/or reduced podocyte number is a key event in the pathogenesis of DN. We have previously shown that podocytes are a target for GH action. To elucidate the molecular basis for the effects of GH on the podocyte, we conducted microarray and RT-quantitative PCR analyses of immortalized human podocytes and identified zinc finger E-box-binding homeobox 2 (ZEB2) to be up-regulated in a GH dose- and time-dependent manner. We established that the GH-dependent increase in ZEB2 levels is associated with increased transcription of a ZEB2 natural antisense transcript required for efficient translation of the ZEB2 transcript. GH down-regulated expression of E-and P-cadherins, targets of ZEB2, and inhibited E-cadherin promoter activity. Mutation of ZEB2 binding sites on the E-cadherin promoter abolished this effect of GH on the E-cadherin promoter. Whereas GH increased podocyte permeability to albumin in a paracellular albumin influx assay, shRNA-mediated knockdown of ZEB2 expression abrogated this effect. We conclude that GH increases expression of ZEB2 in part by increasing expression of a ZEB2 natural antisense transcript. GH-dependent increase in ZEB2 expression results in loss of P- and E-cadherins in podocytes and increased podocyte permeability to albumin. Decreased expression of P- and E-cadherins is implicated in podocyte dysfunction and epithelial-mesenchymal transition observed in DN. We speculate that the actions of GH on ZEB2 and P-and E-cadherin expression play a role in the pathogenesis of microalbuminuria of DN.	[Menon, Ram K.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Menon, RK (corresponding author), Univ Michigan, Sch Med, D1205 MPB SPC 5718,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rammenon@umich.edu	Pasupulati, Anil Kumar/F-8002-2011		National Institutes of Health [T32 DK071212, DK49845, P60DK-20572]; D.R.E.A.M. Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK049845, P60DK020572, T32DK071212, R01DK049845, R29DK049845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D.R.E.A.M. Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 DK071212 (to K. K.), DK49845 (to R. K. M.), and P60DK-20572 (to the Michigan Diabetes Research and Training Center) and the D.R.E.A.M. Foundation.	Asanuma Katsuhiko, 2003, Clin Exp Nephrol, V7, P255, DOI 10.1007/s10157-003-0259-6; Baldelli R, 2008, J CLIN ENDOCR METAB, V93, P710, DOI 10.1210/jc.2007-1197; Baudet ML, 2009, ENDOCRINOLOGY, V150, P2758, DOI 10.1210/en.2008-1242; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; BLANKESTIJN PJ, 1993, J CLIN ENDOCR METAB, V77, P498, DOI 10.1210/jc.77.2.498; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; CHRISTIANSEN JS, 1981, EUR J CLIN INVEST, V11, P487, DOI 10.1111/j.1365-2362.1981.tb02018.x; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Correa LL, 2009, ARQ BRAS ENDOCRINOL, V53, P963, DOI 10.1590/S0004-27302009000800009; Cummings EA, 1998, DIABETES, V47, P1341, DOI 10.2337/diabetes.47.8.1341; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Giroldi LA, 1997, BIOCHEM BIOPH RES CO, V241, P453, DOI 10.1006/bbrc.1997.7831; Han X, 2009, GUT, V58, P49, DOI 10.1136/gut.2007.145094; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; HOOGENBERG K, 1993, ACTA ENDOCRINOL-COP, V129, P151, DOI 10.1530/acta.0.1290151; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Lu CX, 2001, J BIOL CHEM, V276, P22892, DOI 10.1074/jbc.M011647200; Manelli F, 2000, METABOLISM, V49, P634, DOI 10.1016/S0026-0495(00)80040-2; Mathieson PW, 2009, CURR OPIN NEPHROL HY, V18, P206, DOI 10.1097/MNH.0b013e328326f3ca; MAUER SM, 1994, KIDNEY INT, V45, P612, DOI 10.1038/ki.1994.80; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pantaleon M, 1997, P NATL ACAD SCI USA, V94, P5125, DOI 10.1073/pnas.94.10.5125; Reddy GR, 2008, CURR OPIN NEPHROL HY, V17, P32, DOI 10.1097/MNH.0b013e3282f2904d; Reddy GR, 2007, ENDOCRINOLOGY, V148, P2045, DOI 10.1210/en.2006-1285; Reidy K, 2009, AM J KIDNEY DIS, V54, P590, DOI 10.1053/j.ajkd.2009.07.003; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stitt-Cavanagh E, 2009, THESCIENTIFICWORLDJO, V9, P1127, DOI 10.1100/tsw.2009.133; Susztak K, 2006, J AM SOC NEPHROL, V17, P361, DOI 10.1681/ASN.2005101109; van Grunsven LA, 2003, J BIOL CHEM, V278, P26135, DOI 10.1074/jbc.M300597200; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Xu ZG, 2005, NEPHROL DIAL TRANSPL, V20, P524, DOI 10.1093/ndt/gfh642; Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B; 2003, JAMA, V290, P2159	44	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31148	31156		10.1074/jbc.M110.132332	http://dx.doi.org/10.1074/jbc.M110.132332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682777	Green Published, hybrid			2022-12-27	WOS:000282764600008
J	Nowotarski, SL; Shantz, LM				Nowotarski, Shannon L.; Shantz, Lisa M.			Cytoplasmic Accumulation of the RNA-binding Protein HuR Stabilizes the Ornithine Decarboxylase Transcript in a Murine Nonmelanoma Skin Cancer Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TRANSLATIONAL CONTROL; EXPRESSION; POLYAMINES; INDUCTION; LOCALIZATION; GENE; DIFLUOROMETHYLORNITHINE; PHOSPHORYLATION; PREVENTION	Ornithine decarboxylase (ODC) is the first and usually rate-limiting enzyme in the polyamine biosynthetic pathway. Under normal physiological conditions, polyamine content and ODC enzyme activity are highly regulated. However, the induction of ODC activity is an early step in neoplastic transformation. The studies described here use normal mouse keratinocytes (C5N cells), and spindle carcinoma cells (A5 cells) to explore the regulation of ODC in nonmelanoma skin cancer development. Previous results have shown that induction of ODC activity is both necessary and sufficient for the promotion of skin tumors. We see a marked increase in ODC enzyme activity in A5 cells compared with C5N keratinocytes, which correlates with a 4-fold stabilization of ODC mRNA. These data suggest that ODC is post-transcriptionally regulated in skin tumor development. Thus, we sought to investigate whether the ODC transcript interacts with the RNA-binding protein HuR, which is known to bind to and stabilize its target mRNAs. We show that HuR is able to bind to the ODC 3'-UTR in A5 cells but not in C5N cells. Immunofluorescence results reveal that HuR is present in both the nucleus and cytoplasm of A5 cells, whereas C5N cells exhibit strictly nuclear localization of HuR. Knockdown experiments in A5 cells showed that when HuR is depleted, ODCRNA becomes less stable, and ODC enzyme activity decreases. Together, these data support the hypothesis that HuR plays a causative role in ODC up-regulation during nonmelanoma skin cancer development by binding to and stabilizing the ODC transcript.	[Nowotarski, Shannon L.; Shantz, Lisa M.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Shantz, LM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Rm C4731,500 Univ Dr, Hershey, PA 17033 USA.	lms17@psu.edu		Shantz, Lisa/0000-0001-8814-4022	National Institutes of Health [CA82768, CA142051]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R03CA142051, R01CA082768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA82768 and CA142051. This work was also supported by the Pennsylvania Department of Health Tobacco CURE Funds.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Atasoy U, 1998, J CELL SCI, V111, P3145; Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bailey HH, 2010, CANCER PREV RES, V3, P35, DOI 10.1158/1940-6207.CAPR-09-0096; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; Blaxall BC, 2000, MOL CARCINOGEN, V28, P76; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; COLEMAN CS, 1998, POLYAMINE PROTOCOLS, V79, P41; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Einspahr JG, 2002, CLIN CANCER RES, V8, P149; Elmets CA, 2010, CANCER PREV RES, V3, P8, DOI 10.1158/1940-6207.CAPR-09-0248; Erkinheimo TL, 2003, CANCER RES, V63, P7591; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Feith DJ, 2001, CANCER RES, V61, P6073; Feith DJ, 2005, CANCER RES, V65, P572; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gilmour SK, 2007, TOXICOL APPL PHARM, V224, P249, DOI 10.1016/j.taap.2006.11.023; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, CELL CYCLE, V7, P3124, DOI 10.4161/cc.7.20.6884; Koljonen V, 2008, J CUTAN PATHOL, V35, P10, DOI 10.1111/j.1600-0560.2007.00762.x; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mimori K, 1998, INT J ONCOL, V12, P597; OBRIEN TG, 1976, CANCER RES, V36, P2644; OBrien TG, 1997, CANCER RES, V57, P2630; Origanti S, 2007, CANCER RES, V67, P4834, DOI 10.1158/0008-5472.CAN-06-4627; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Shantz LM, 1999, INT J BIOCHEM CELL B, V31, P107, DOI 10.1016/S1357-2725(98)00135-6; Shantz LM, 2004, BIOCHEM J, V377, P257, DOI 10.1042/BJ20030778; Smith MK, 1998, CARCINOGENESIS, V19, P1409, DOI 10.1093/carcin/19.8.1409; Soler AP, 1998, CANCER RES, V58, P1654; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; WALLON UM, 1995, MOL CELL BIOCHEM, V146, P39, DOI 10.1007/BF00926879; Xiao L, 2007, MOL BIOL CELL, V18, P4579, DOI 10.1091/mbc.E07-07-0675; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Zhang J, 2008, MOL CARCINOGEN, V47, P974, DOI 10.1002/mc.20450; Zhao BW, 2001, MOL CARCINOGEN, V32, P92, DOI 10.1002/mc.1068; Zhao BW, 2000, MOL CARCINOGEN, V29, P212, DOI 10.1002/1098-2744(200012)29:4<212::AID-MC1003>3.0.CO;2-0; Zou TT, 2008, BIOCHEM J, V409, P389, DOI 10.1042/BJ20070860; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200; Zoumpourlis V, 2003, CARCINOGENESIS, V24, P1159, DOI 10.1093/carcin/bgg067	56	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31885	31894		10.1074/jbc.M110.148767	http://dx.doi.org/10.1074/jbc.M110.148767			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685649	Green Published, hybrid			2022-12-27	WOS:000282764600080
J	Rana, S; Baranski, TJ				Rana, Soumendra; Baranski, Thomas J.			Third Extracellular Loop (EC3)-N Terminus Interaction Is Important for Seven-transmembrane Domain Receptor Function IMPLICATIONS FOR AN ACTIVATION MICROSWITCH REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; LIGAND-BINDING SITE; C5A RECEPTOR; CRYSTAL-STRUCTURE; ANGIOTENSIN-II; CHEMOKINE RECEPTOR; CORECEPTOR ACTIVITY; CYSTEINE RESIDUES; HIV-1 CORECEPTOR; DISULFIDE BOND	The canonical heptahelical bundle architecture of seven-transmembrane domain (7TM) receptors is intertwined by three intra- and three extracellular loops, whose local conformations are important in receptor signaling. Many 7TM receptors contain a cysteine residue in the third extracellular loop (EC3) and a complementary cysteine residue on the N terminus. The functional role of such EC3-N terminus conserved cysteine pairs remains unclear. This study explores the role of the EC3-N terminus cysteine pairs on receptor conformation and G protein activation by disrupting them in the chemokine receptor CXCR4, while engineering a novel EC3-N terminus cysteine pair into the complement factor 5a receptor (C5aR), a chemo attractant receptor that lacks it. Mutated CXCR4 and C5aRs were expressed in engineered yeast. Mutation of the cysteine pair with the serine pair (C28S/C274S) in constitutively active mutant CXCR4 abrogated the receptor activation, whereas mutation with the aromatic pair (C28F-C274F) or the salt bridge pair (C28R/C274E), respectively, rescued or retained the receptor activation in response to CXCL12. In this context, the cysteine pair (Cys(30) and Cys(272)) engineered into the EC3-N terminus (Ser(30) and Ser(272)) of a novel constitutively active mutant of C5aR restrained the constitutive signaling without affecting the C5a-induced activation. Further mutational studies demonstrated a previously unappreciated role for Ser(272) on EC3 of C5aR and its interaction with the N terminus, thus defining a new microswitch region within the C5aR. Similar results were obtained with mutated CXCR4 and C5aRs expressed in COS-7 cells. These studies demonstrate a novel role of the EC3-N terminus cysteine pairs in G protein-coupled receptor activation and signaling.	[Rana, Soumendra; Baranski, Thomas J.] Washington Univ, Sch Med, Dept Med, Div Metab Endocrinol & Lipid Res, St Louis, MO 63110 USA	Washington University (WUSTL)	Baranski, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Metab Endocrinol & Lipid Res, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	baranski@wustl.edu		Rana, Soumendra/0000-0003-4878-9066	National Institutes of Health [GM071634, GM071634-03S109]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM071634 and GM071634-03S109 (to T.J.B.).	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Ai LS, 2002, BIOCHEMISTRY-US, V41, P8332, DOI 10.1021/bi025855y; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Berchiche YA, 2007, J BIOL CHEM, V282, P5111, DOI 10.1074/jbc.C600270200; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Buck E, 2005, J BIOL CHEM, V280, P4009, DOI 10.1074/jbc.C400500200; Cain SA, 2003, BIOCHEM PHARMACOL, V66, P1833, DOI 10.1016/S0006-2952(03)00473-8; Cain SA, 2001, BIOCHEMISTRY-US, V40, P14047, DOI 10.1021/bi011055w; Chabot DJ, 1999, J VIROL, V73, P6598, DOI 10.1128/JVI.73.8.6598-6609.1999; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Correa SAA, 2006, REGUL PEPTIDES, V134, P132, DOI 10.1016/j.regpep.2006.02.008; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; Derksen DJ, 2008, CHEMBIOCHEM, V9, P1898, DOI 10.1002/cbic.200800272; Derksen DJ, 2006, J AM CHEM SOC, V128, P14252, DOI 10.1021/ja066203q; Ding ZR, 2003, BLOOD, V101, P3908, DOI 10.1182/blood-2002-10-3027; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Evans BJ, 2009, METHOD ENZYMOL, V460, P399, DOI 10.1016/S0076-6879(09)05220-3; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Feng YH, 2000, FEBS LETT, V484, P133, DOI 10.1016/S0014-5793(00)02141-4; Fleury Y, 1996, J BIOL CHEM, V271, P14421, DOI 10.1074/jbc.271.24.14421; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gerber BO, 2001, J BIOL CHEM, V276, P3394, DOI 10.1074/jbc.M007748200; Gilchrist A, 2007, TRENDS PHARMACOL SCI, V28, P431, DOI 10.1016/j.tips.2007.06.012; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hagemann IS, 2008, J BIOL CHEM, V283, P7763, DOI 10.1074/jbc.M709467200; Higginbottom A, 2005, J BIOL CHEM, V280, P17831, DOI 10.1074/jbc.M410797200; Hoffmann C, 1999, J BIOL CHEM, V274, P14639, DOI 10.1074/jbc.274.21.14639; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; KOLAKOWSKI LF, 1995, J BIOL CHEM, V270, P18077, DOI 10.1074/jbc.270.30.18077; Kristiansen K, 1996, PROTEINS, V26, P81, DOI 10.1002/(SICI)1097-0134(199609)26:1<81::AID-PROT8>3.0.CO;2-J; Lawson Z, 2004, BIOCHEM SOC T, V32, P1048, DOI 10.1042/BST0321048; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Limatola C, 2005, EXP CELL RES, V307, P65, DOI 10.1016/j.yexcr.2005.02.020; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; MERY L, 1994, J BIOL CHEM, V269, P3457; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Short AJ, 1999, BRIT J PHARMACOL, V128, P511, DOI 10.1038/sj.bjp.0702847; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; Torrice MM, 2009, P NATL ACAD SCI USA, V106, P11919, DOI 10.1073/pnas.0903260106; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Vaidehi N, 2002, P NATL ACAD SCI USA, V99, P12622, DOI 10.1073/pnas.122357199; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Visiers I, 2002, METHOD ENZYMOL, V343, P329; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200	65	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31472	31483		10.1074/jbc.M110.129213	http://dx.doi.org/10.1074/jbc.M110.129213			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663868	Green Published, hybrid			2022-12-27	WOS:000282764600041
J	Yepuru, M; Eswaraka, J; Kearbey, JD; Barrett, CM; Raghow, S; Veverka, KA; Miller, DD; Dalton, JT; Narayanan, R				Yepuru, Muralimohan; Eswaraka, Jeetendra; Kearbey, Jeffrey D.; Barrett, Christina M.; Raghow, Sharan; Veverka, Karen A.; Miller, Duane D.; Dalton, James T.; Narayanan, Ramesh			Estrogen Receptor-beta-selective Ligands Alleviate High-fat Diet- and Ovariectomy-induced Obesity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; GENE-EXPRESSION; INSULIN-RESISTANCE; ALPHA; ACID; MECHANISMS; TARGET; DRUG; IDENTIFICATION; ANTAGONIST	Obesity is an epidemic problem affecting millions of people in the Western hemisphere and costs the United States economy more than $200 billion annually. Currently, there are no effective treatments to combat obesity. Recent studies have implicated the constitutive activity of estrogen receptor (ER) beta as an important regulator of metabolic diseases. However, the potential of ER-beta-selective ligands to offset obesity is not clear. We evaluated the pharmacological effect of ER-beta-selective ligands (beta-LGNDs) in animal models of high-fat diet-and ovariectomy-induced obesity. Ligand binding, transactivation, and uterotrophic studies with beta-LGNDs demonstrated selectivity for ER-beta over ER-alpha. Animals fed a high-fat diet showed a significant increase in body weight, and this weight gain was attenuated by beta-LGNDs. High-fat diet-mediated increases in serum cholesterol, leptin, glucose, and fat accumulation in organs were also reduced by beta-LGNDs. In addition, MRI scanning indicated that beta-LGNDs altered body composition by reducing fat mass and increasing lean body mass. Organ weights and gene expression analyses demonstrated that adipose tissue is the center of action for beta-LGNDs, and the reduction in body weight is likely due to increased energy expenditure. In vitro and in vivo mechanistic studies indicated that the anti-obesity effects of beta-LGNDs were due to indirect peroxisome proliferator-activated receptor gamma antagonistic actions requiring the ligand binding domain of ER-beta and through abrogation of the ability of PGC-1 to coactivate peroxisome proliferator-activated receptor gamma. In conclusion, these studies indicate that ligand-activated ER-beta is a potential therapeutic target to combat obesity and obesity-related metabolic diseases.	[Yepuru, Muralimohan; Eswaraka, Jeetendra; Kearbey, Jeffrey D.; Barrett, Christina M.; Raghow, Sharan; Veverka, Karen A.; Miller, Duane D.; Dalton, James T.; Narayanan, Ramesh] GTx Inc, Preclin Res & Dev, Memphis, TN 38163 USA		Dalton, JT (corresponding author), GTx Inc, Preclin Res & Dev, 3 North Dunlap, Memphis, TN 38163 USA.	jdalton@gtxinc.com; rnarayanan@gtxinc.com		Dalton, James T/0000-0002-3915-7326				Allende-Vigo MZ, 2008, P R HEALTH SCI J, V27, P190; Andrews ZB, 2010, ENDOCRINOLOGY, V151, P2078, DOI 10.1210/en.2009-0850; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Barros RPA, 2006, TRENDS MOL MED, V12, P425, DOI 10.1016/j.molmed.2006.07.004; Bhat RA, 2004, J STEROID BIOCHEM, V88, P17, DOI 10.1016/j.jsbmb.2003.10.009; Billin AN, 2008, EXPERT OPIN INV DRUG, V17, P1465, DOI [10.1517/13543784.17.10.1465, 10.1517/13543784.17.10.1465 ]; Blackburn GL, 2009, OBESITY, V17, P842, DOI 10.1038/oby.2008.578; Capeau J, 2008, DIABETES METAB, V34, P649, DOI 10.1016/S1262-3636(08)74600-7; Cariou B, 2007, TRENDS PHARMACOL SCI, V28, P236, DOI 10.1016/j.tips.2007.03.002; Chang P, 2009, NAT REV DRUG DISCOV, V8, P529, DOI 10.1038/nrd2938; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cooke D, 2006, NAT REV DRUG DISCOV, V5, P919, DOI 10.1038/nrd2136; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fabricatore AN, 2006, ANNU REV CLIN PSYCHO, V2, P357, DOI 10.1146/annurev.clinpsy.2.022305.095249; Fan XT, 2006, P NATL ACAD SCI USA, V103, P19338, DOI 10.1073/pnas.0609663103; FLEGAL KM, 2010, L R JAMA, V303, P235; Follettie MT, 2006, ENDOCRINOLOGY, V147, P714, DOI 10.1210/en.2005-0600; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gurevich-Panigrahi T, 2009, CURR MED CHEM, V16, P506, DOI 10.2174/092986709787315568; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Hsieh RW, 2006, J BIOL CHEM, V281, P17909, DOI 10.1074/jbc.M513684200; Jezek P, 1998, INT J BIOCHEM CELL B, V30, P1163, DOI 10.1016/S1357-2725(98)00076-4; Jiang JH, 2005, ANTICANCER RES, V25, P4081; Jones D, 2008, NAT REV DRUG DISCOV, V7, P961, DOI 10.1038/nrd2775; Kaplan LM, 2010, GASTROENTEROL CLIN N, V39, P69, DOI 10.1016/j.gtc.2010.01.001; Kersten S, 2008, PPAR RES, V2008, DOI 10.1155/2008/132960; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Leite CE, 2009, PHARMACOL REP, V61, P217, DOI 10.1016/S1734-1140(09)70025-8; Liang YQ, 2002, INT J OBESITY, V26, P1103, DOI 10.1038/sj.ijo.0802054; Lim William K, 2007, Recent Pat CNS Drug Discov, V2, P107; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Maeda K, 1997, GENE, V190, P227, DOI 10.1016/S0378-1119(96)00730-5; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Morani A, 2008, J INTERN MED, V264, P128, DOI 10.1111/j.1365-2796.2008.01976.x; Moreira FA, 2009, REV BRAS PSIQUIATR, V31, P145, DOI 10.1590/S1516-44462009000200012; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P409, DOI 10.1016/j.bbadis.2008.09.005; Nakamura T, 2008, TOXICOLOGY, V253, P117, DOI 10.1016/j.tox.2008.09.006; Nakano R, 2006, BIOCHEM PHARMACOL, V72, P42, DOI 10.1016/j.bcp.2006.03.023; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pallottini V., 2008, Infectious Disorders - Drug Targets, V8, P52; Paquette A, 2008, MENOPAUSE, V15, P1169, DOI 10.1097/gme.0b013e31817b8159; Pravettoni A, 2007, MOL CELL ENDOCRINOL, V263, P46, DOI 10.1016/j.mce.2006.08.008; Quintao ECR, 2010, ATHEROSCLEROSIS, V209, P1, DOI 10.1016/j.atherosclerosis.2009.08.002; Reisin E, 2009, MED CLIN N AM, V93, P733, DOI 10.1016/j.mcna.2009.02.010; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Rother E, 2009, DEUT MED WOCHENSCHR, V134, P1057, DOI 10.1055/s-0029-1222567; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Shin ES, 2007, J NUTR, V137, P1127, DOI 10.1093/jn/137.5.1127; Stevenson Julian, 2009, Biochem J, V420, pe1, DOI 10.1042/BJ20090445; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang YF, 2010, BIOCHEM PHARMACOL, V80, P80, DOI 10.1016/j.bcp.2010.03.013; Yu R, 2009, FORUM NUTR, V61, P95, DOI 10.1159/000212742; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572	72	89	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31292	31303		10.1074/jbc.M110.147850	http://dx.doi.org/10.1074/jbc.M110.147850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20657011	Green Published, hybrid			2022-12-27	WOS:000282764600024
J	Petrova, V; Satyshur, KA; George, NP; McCaslin, D; Cox, MM; Keck, JL				Petrova, Vessela; Satyshur, Kenneth A.; George, Nicholas P.; McCaslin, Darrell; Cox, Michael M.; Keck, James L.			X-ray Crystal Structure of the Bacterial Conjugation Factor PsiB, a Negative Regulator of RecA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-SEX FACTOR; ESCHERICHIA-COLI; SOS INHIBITOR; PROTEIN; DNA; INDUCTION; ACTIN; MODEL; CAPZ; RECIPIENT	During bacterial conjugation, genetic material from one cell is transferred to another as single-stranded DNA. The introduction of single-stranded DNA into the recipient cell would ordinarily trigger a potentially deleterious transcriptional response called SOS, which is initiated by RecA protein filaments formed on the DNA. During F plasmid conjugation, however, the SOS response is suppressed by PsiB, an F-plasmid-encoded protein that binds and sequesters free RecA to prevent filament formation. Among the many characterized RecA modulator proteins, PsiB is unique in using sequestration as an inhibitory mechanism. We describe the crystal structure of PsiB from the Escherichia coli F plasmid. The stucture of PsiB is surprisingly similar to CapZ, a eukaryotic actin filament capping protein. Structure-directed neutralization of electronegative surfaces on PsiB abrogates RecA inhibition whereas neutralization of an electropositive surface element enhances PsiB inhibition of RecA. Together, these studies provide a first molecular view of PsiB and highlight its use as a reagent in studies of RecA activity.	[Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Med Sci Ctr 550, Madison, WI 53706 USA; [McCaslin, Darrell; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Med Sci Ctr 550, 1300 Univ Ave, Madison, WI 53706 USA.	jlkeck@wisc.edu		Satyshur, Kenneth/0000-0001-9371-2493; Keck, James/0000-0002-5961-0220	National Institutes of Health [GM32335, GM068061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068061, U01GM032335, R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32335 (to M.M.C.) and GM068061 (to J.L.K.).	Althorpe NJ, 1999, MOL MICROBIOL, V31, P133, DOI 10.1046/j.1365-2958.1999.01153.x; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; BAGDASARIAN M, 1986, P NATL ACAD SCI USA, V83, P5723, DOI 10.1073/pnas.83.15.5723; BAGDASARIAN M, 1992, MOL MICROBIOL, V6, P885, DOI 10.1111/j.1365-2958.1992.tb01539.x; BAGDASARIAN M, 1980, J BACTERIOL, V141, P464, DOI 10.1128/JB.141.2.464-469.1980; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Courcelle J, 2001, GENETICS, V158, P41; Cox M.M., 2007, TOPICS CURRENT GENET, P53; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; GOLUB E, 1988, J BACTERIOL, V170, P4392, DOI 10.1128/jb.170.9.4392-4394.1988; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; HUG C, 1992, J CELL BIOL, V116, P923, DOI 10.1083/jcb.116.4.923; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laue TM, 1995, METHOD ENZYMOL, V259, P427; LEDERBERG J, 1953, SCIENCE, V118, P169, DOI 10.1126/science.118.3059.169; LINDSLEY JE, 1989, J MOL BIOL, V205, P695, DOI 10.1016/0022-2836(89)90315-X; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Narra HP, 2006, CURR BIOL, V16, pR705, DOI 10.1016/j.cub.2006.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; PHIZICKY EM, 1981, CELL, V25, P259, DOI 10.1016/0092-8674(81)90251-8; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Voloshin ON, 2001, GENE DEV, V15, P415, DOI 10.1101/gad.862901; Wigle TJ, 2009, J BIOMOL SCREEN, V14, P1092, DOI 10.1177/1087057109342126; WILLETTS N, 1987, ESCHERICHIA COLI SAL, P1110; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167	41	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30615	30621		10.1074/jbc.M110.152298	http://dx.doi.org/10.1074/jbc.M110.152298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20659894	hybrid, Green Published			2022-12-27	WOS:000282135500030
J	Wetmore, DR; Joseloff, E; Pilewski, J; Lee, DP; Lawton, KA; Mitchell, MW; Milburn, MV; Ryals, JA; Guo, LN				Wetmore, Diana R.; Joseloff, Elizabeth; Pilewski, Joseph; Lee, Douglas P.; Lawton, Kay A.; Mitchell, Matthew W.; Milburn, Michael V.; Ryals, John A.; Guo, Lining			Metabolomic Profiling Reveals Biochemical Pathways and Biomarkers Associated with Pathogenesis in Cystic Fibrosis Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED GLUTATHIONE; N-ACETYLCYSTEINE; MOLECULAR-BASIS; ION-TRANSPORT; CFTR; DELTA-F508; GENE; IDENTIFICATION; MECHANISMS; CHILDREN	Cystic fibrosis (CF) is a life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. To gain an understanding of the epithelial dysfunction associated with CF mutations and discover biomarkers for therapeutics development, untargeted metabolomic analysis was performed on primary human airway epithelial cell cultures from three separate cohorts of CF patients and non-CF subjects. Statistical analysis revealed a set of reproducible and significant metabolic differences between the CF and non-CF cells. Aside from changes that were consistent with known CF effects, such as diminished cellular regulation against oxidative stress and osmotic stress, new observations on the cellular metabolism in the disease were generated. In the CF cells, the levels of various purine nucleotides, which may function to regulate cellular responses via purinergic signaling, were significantly decreased. Furthermore, CF cells exhibited reduced glucose metabolism in glycolysis, pentose phosphate pathway, and sorbitol pathway, which may further exacerbate oxidative stress and limit the epithelial cell response to environmental pressure. Taken together, these findings reveal novel metabolic abnormalities associated with the CF pathological process and identify a panel of potential biomarkers for therapeutic development using this model system.	[Lee, Douglas P.; Lawton, Kay A.; Mitchell, Matthew W.; Milburn, Michael V.; Ryals, John A.; Guo, Lining] Metabolon Inc, Durham, NC 27713 USA; [Wetmore, Diana R.; Joseloff, Elizabeth] Cyst Fibrosis Fdn Therapeut Inc, Bethesda, MD 20814 USA; [Pilewski, Joseph] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15251 USA	Metabolon; Cystic Fibrosis Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Guo, LN (corresponding author), Metabolon Inc, 800 Capitola Dr,Suite 1, Durham, NC 27713 USA.	lguo@metabolon.com	Pilewski, Joseph/AAF-5149-2021	Mitchell, Matthew/0000-0002-2681-4091	Cystic Fibrosis Foundation Therapeutics, Inc	Cystic Fibrosis Foundation Therapeutics, Inc	This work was supported by Cystic Fibrosis Foundation Therapeutics, Inc.	Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bishop C, 2005, CHEST, V127, P308, DOI 10.1378/chest.127.1.308; Boudonck KJ, 2009, BIOANALYSIS, V1, P1645, DOI 10.4155/BIO.09.142; Bulteau L, 2000, AM J PHYSIOL-CELL PH, V279, pC1925, DOI 10.1152/ajpcell.2000.279.6.C1925; Chappe V, 1998, BRIT J PHARMACOL, V123, P683, DOI 10.1038/sj.bjp.0701648; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Com Gulnur, 2009, Handb Exp Pharmacol, P363, DOI 10.1007/978-3-540-89615-9_12; Dauletbaev N, 2009, EUR J MED RES, V14, P352; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; Day BJ, 2004, INFECT IMMUN, V72, P2045, DOI 10.1128/IAI.72.4.2045-2051.2004; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Esther CR, 2008, EUR RESPIR J, V31, P949, DOI 10.1183/09031936.00089807; Esther CR, 2009, AM J PHYSIOL-LUNG C, V296, pL987, DOI 10.1152/ajplung.90512.2008; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Factor P, 2007, P NATL ACAD SCI USA, V104, P4083, DOI 10.1073/pnas.0601117104; FISHER RA, 1938, STATISTICAL METHODS, P104; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Fulcher ML, 2009, AM J PHYSIOL-LUNG C, V296, pL82, DOI 10.1152/ajplung.90314.2008; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; GABRIEL SE, 1993, NATURE, V363, P263, DOI 10.1038/363263a0; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; Grasemann H, 1999, J PEDIATR-US, V135, P770, DOI 10.1016/S0022-3476(99)70101-0; Grubb BR, 1999, AM J PHYSIOL-GASTR L, V277, pG167, DOI 10.1152/ajpgi.1999.277.1.G167; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hudson Valerie M, 2004, Treat Respir Med, V3, P353, DOI 10.2165/00151829-200403060-00003; Hudson VM, 2001, FREE RADICAL BIO MED, V30, P1440, DOI 10.1016/S0891-5849(01)00530-5; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Pawlak K, 2009, AM J MED SCI, V338, P293, DOI 10.1097/MAJ.0b013e3181aa30e6; RICH DP, 1993, HUM GENE THER, V4, P461, DOI 10.1089/hum.1993.4.4-461; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Schnackenberg LK, 2006, PHARMACOGENOMICS, V7, P1077, DOI 10.2217/14622416.7.7.1077; Servetnyk Z, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-124; Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/ajrccm.165.7.2105032; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stallings VA, 2008, J AM DIET ASSOC, V108, P832, DOI 10.1016/j.jada.2008.02.020; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Tirouvanziam R, 2006, P NATL ACAD SCI USA, V103, P4628, DOI 10.1073/pnas.0511304103; TOMEZSKO JL, 1994, PEDIATR RES, V35, P451, DOI 10.1203/00006450-199404000-00014; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Visca A, 2008, J CYST FIBROS, V7, P433, DOI 10.1016/j.jcf.2008.03.006; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Zaman K, 2006, MOL PHARMACOL, V70, P1435, DOI 10.1124/mol.106.023242; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	56	60	64	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30516	30522		10.1074/jbc.M110.140806	http://dx.doi.org/10.1074/jbc.M110.140806			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20675369	hybrid, Green Published			2022-12-27	WOS:000282135500019
J	Zhan, H; Suzuki, T; Aizawa, K; Miyagawa, K; Nagai, R				Zhan, Hong; Suzuki, Toru; Aizawa, Kenichi; Miyagawa, Kiyoshi; Nagai, Ryozo			Ataxia Telangiectasia Mutated (ATM)-mediated DNA Damage Response in Oxidative Stress-induced Vascular Endothelial Cell Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FULL ACTIVATION; ATM ACTIVATION; AKT; AUTOPHOSPHORYLATION; ATHEROSCLEROSIS; TUMORIGENESIS; CHECKPOINT; INSULIN; BARRIER; CANCER	Oxidative stress regulates dysfunction and senescence of vascular endothelial cells. The DNA damage response and its main signaling pathway involving ataxia telangiectasia mutated (ATM) have been implicated in playing a central role in mediating the actions of oxidative stress; however, the role of the ATM signaling pathway in vascular pathogenesis has largely remained unclear. Here, we identify ATM to regulate oxidative stress-induced endothelial cell dysfunction and premature senescence. Oxidative stress induced senescence in endothelial cells through activation/phosphorylation of ATM by way of an Akt/p53/p21-mediated pathway. These actions were abrogated in cells in which ATM was knocked down by RNA interference or inhibited by specific inhibitory compounds. Furthermore, the in vivo significance of this regulatory pathway was confirmed using ATM knock-out mice in which induction of senescent endothelial cells in the aorta in a diabetic mouse model of endothelial dysfunction and senescence was attenuated in contrast to pathological changes seen in wild-type mice. Collectively, our results show that ATM through an ATM/Akt/p53/p21-dependent signaling pathway mediates an instructive role in oxidative stress-induced endothelial dysfunction and premature senescence.	[Zhan, Hong; Suzuki, Toru; Aizawa, Kenichi; Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Suzuki, Toru; Aizawa, Kenichi] Univ Tokyo, Grad Sch Med, Dept Ubiquitous Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan; [Miyagawa, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Radiat Biol, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Nagai, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	nagai-tky@umin.ac.jp		Suzuki, Toru/0000-0002-8371-664X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [21310034] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (T. S., K. A., and R.N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Breitschopf K, 2001, FEBS LETT, V493, P21, DOI 10.1016/S0014-5793(01)02272-4; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halaby MJ, 2008, CELL SIGNAL, V20, P1555, DOI 10.1016/j.cellsig.2008.04.011; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kang JY, 2009, MOL CELLS, V28, P489, DOI 10.1007/s10059-009-0141-9; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; SWIFT M, 1983, LANCET, V1, P1049; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; VON ZGLINICKI T, 2005, MECH AGEING DEV, V126, P111; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	31	62	69	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29662	29670		10.1074/jbc.M110.125138	http://dx.doi.org/10.1074/jbc.M110.125138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639198	Green Published, hybrid			2022-12-27	WOS:000281740100067
J	Meng, G; Zhao, YM; Bai, XY; Liu, Y; Green, TJ; Luo, M; Zheng, XF				Meng, Geng; Zhao, Yanmei; Bai, Xiaoyun; Liu, Yong; Green, Todd J.; Luo, Ming; Zheng, Xiaofeng			Structure of Human Stabilin-1 Interacting Chitinase-like Protein (SI-CLP) Reveals a Saccharide-binding Cleft with Lower Sugar-binding Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN CHITINASE; CRYSTAL-STRUCTURE; INFLAMMATION; YM1; MACROPHAGES; SOFTWARE; COMPLEX	Human secreted protein stabilin-1 interacting chitinase-like protein (SI-CLP) has been identified as a novel member of Glyco_18 domain-containing proteins that is involved in host defense and inflammatory reactions. Efficient secretion of SI-CLP is mediated by its interaction with the endocytic/sorting receptor stabilin-1. SI-CLP is expressed abundantly in macrophages and neutrophils and is up-regulated by Th2 cytokine IL-4 and glucocorticoid, which suggest that SI-CLP could be a marker for adverse effects of glucocorticoid therapy. To gain insight into the biological function of SI-CLP, we determined the crystal structure of SI-CLP at 2.7 angstrom resolution by x-ray crystallography and found that it featured a typical triose-phosphate isomerase barrel fold with a putative saccharide-binding cleft. Comparison with other chitinase-like proteins showed the cleft to be atypically wide and open. The saccharide-binding capacity of SI-CLP was investigated, and its ligand-binding specificity was found to relate to the length of the oligosaccharides, with preference for chitotetraose. Further investigations reveal that SI-CLP could bind LPS in vitro and neutralize its endotoxin effect on macrophages. Our results demonstrate the saccharide-binding property of SI-CLP by structure and in vitro biochemical analyses and suggest the possible roles of SI-CLP in pathogen sensing and endotoxin neutralization.	[Meng, Geng; Zhao, Yanmei; Bai, Xiaoyun; Liu, Yong; Zheng, Xiaofeng] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; [Meng, Geng; Zhao, Yanmei; Bai, Xiaoyun; Liu, Yong; Zheng, Xiaofeng] Peking Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Green, Todd J.; Luo, Ming] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Peking University; Peking University; University of Alabama System; University of Alabama Birmingham	Zheng, XF (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	Meng, Geng/ACY-1510-2022	Green, Todd/0000-0003-1158-4710	National Science Foundation of China [30870487]; National Basic Research Program of China [2010CB911800, 2006AA02A314]; International Centre for Genetic Engineering and Biotechnology [CRP/CHN09-01]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International Centre for Genetic Engineering and Biotechnology	This work was supported by National Science Foundation of China Grant 30870487, National Basic Research Program of China 973 Program Grant 2010CB911800 and 863 Program Grant 2006AA02A314, and the International Centre for Genetic Engineering and Biotechnology Project CRP/CHN09-01. Portions of this research as x-ray diffraction data collection were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Dai XY, 2005, BIOCHEM BIOPH RES CO, V332, P593, DOI 10.1016/j.bbrc.2005.04.163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Kzhyshkowska J, 2006, BLOOD, V107, P3221, DOI 10.1182/blood-2005-07-2843; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Meng G, 2009, PROTEIN PEPTIDE LETT, V16, P336, DOI 10.2174/092986609787601660; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; Steenbakkers PGA, 2003, J IMMUNOL, V170, P5719, DOI 10.4049/jimmunol.170.11.5719; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	21	25	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39898	39904		10.1074/jbc.M110.130781	http://dx.doi.org/10.1074/jbc.M110.130781			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20724479	Green Published, hybrid			2022-12-27	WOS:000285185500034
J	Perales-Calvo, J; Muga, A; Moro, F				Perales-Calvo, Judit; Muga, Arturo; Moro, Fernando			Role of DnaJ G/F-rich Domain in Conformational Recognition and Binding of Protein Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; TRANSCRIPTION FACTOR SIGMA(32); MOLECULAR CHAPERONE DNAJ; ESCHERICHIA-COLI DNAJ; FINGER-LIKE DOMAIN; ENDOPLASMIC-RETICULUM; PEPTIDE SUBSTRATE; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; HSP40 SIS1	DnaJ from Escherichia coli is a Type I Hsp40 that functions as a cochaperone of DnaK(Hsp70), stimulating its ATPase activity and delivering protein substrates. How DnaJ binds protein substrates is still poorly understood. Here we have studied the role of DnaJ G/F-rich domain in binding of several substrates with different conformational properties (folded, partially (un) folded and unfolded). Using partial proteolysis we find that RepE, a folded substrate, contacts a wide DnaJ area that involves part of the G/F-rich region and Zn-binding domain. Deletion of G/F-rich region hampers binding of native RepE and reduced the affinity for partially (un) folded substrates. However, binding of completely unfolded substrates is independent on the G/F-rich region. These data indicate that DnaJ distinguishes the substrate conformation and is able to adapt the use of the G/F-rich region to form stable substrate complexes.	[Muga, Arturo] Univ Basque Country, Fac Ciencia & Tecnol, Unidad Biofis CSIC UPV EHU, E-48080 Bilbao, Spain; Univ Basque Country, Fac Ciencia & Tecnol, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Muga, A (corresponding author), Univ Basque Country, Fac Ciencia & Tecnol, Unidad Biofis CSIC UPV EHU, Apartado 644, E-48080 Bilbao, Spain.	arturo.muga@ehu.es; fernando.moro@ehu.es	Muga, Arturo/N-1174-2014; Moro Pérez, Fernando/P-3891-2015	Muga, Arturo/0000-0003-0345-6882; Moro Pérez, Fernando/0000-0002-3568-3388	Ministerio de Educacion e Innovacion [BFU2007-64452]; Gobierno Vasco [IT-358-07]; Diputacion Foral de Bizkaia [DIPE08/18]	Ministerio de Educacion e Innovacion; Gobierno Vasco(Basque Government); Diputacion Foral de Bizkaia	This work was supported by the Ministerio de Educacion e Innovacion (BFU2007-64452), Gobierno Vasco (Grant IT-358-07), and Diputacion Foral de Bizkaia (Grant DIPE08/18).	Aron R, 2005, GENETICS, V169, P1873, DOI 10.1534/genetics.104.037242; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Feifel B, 1998, J BIOL CHEM, V273, P11999, DOI 10.1074/jbc.273.20.11999; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Goffin L, 1998, MOL MICROBIOL, V30, P329, DOI 10.1046/j.1365-2958.1998.01067.x; Gruschus JM, 2004, BIOCHEMISTRY-US, V43, P3111, DOI 10.1021/bi0354740; ISHIAI M, 1994, P NATL ACAD SCI USA, V91, P3839, DOI 10.1073/pnas.91.9.3839; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mehl AF, 2001, BIOCHEM BIOPH RES CO, V282, P562, DOI 10.1006/bbrc.2001.4567; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2005, FEBS J, V272, P3184, DOI 10.1111/j.1742-4658.2005.04737.x; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; SADLER I, 1989, J CELL BIOL, V109, P2665, DOI 10.1083/jcb.109.6.2665; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; SHECHTER Y, 1973, BIOCHEMISTRY-US, V12, P3407, DOI 10.1021/bi00742a007; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; WALL D, 1994, J BIOL CHEM, V269, P5446; WALL D, 1995, J BIOL CHEM, V270, P2139, DOI 10.1074/jbc.270.5.2139; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19300, DOI 10.1074/jbc.270.33.19300; WOO KM, 1992, J BIOL CHEM, V267, P20429; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591; Zzaman S, 2004, J BIOL CHEM, V279, P17404, DOI 10.1074/jbc.M400021200	46	48	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34231	34239		10.1074/jbc.M110.144642	http://dx.doi.org/10.1074/jbc.M110.144642			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729526	hybrid, Green Published			2022-12-27	WOS:000283354000068
J	Coon, BG; Burgner, J; Camonis, JH; Aguilar, RC				Coon, Brian G.; Burgner, John; Camonis, Jacques H.; Aguilar, R. Claudio			The Epsin Family of Endocytic Adaptors Promotes Fibrosarcoma Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; RAL-BINDING PROTEIN-1; ACTIN CYTOSKELETON; PUTATIVE EFFECTOR; PROSTATE-CANCER; CELL-MIGRATION; CLATHRIN; RLIP76; IDENTIFICATION; DOMAIN	Abnormalities in the process of endocytosis are classically linked to malignant transformation through the deficient down-regulation of signaling receptors. The present study describes a non-classical mechanism that does not require internalization by which endocytic proteins affect cell migration and basement membrane invasion. Specifically, we found that the endocytic adaptor epsin binds and regulates the biological properties of the signaling molecule RalBP1 (Ral-binding protein 1). Epsin interacted with the N terminus of RalBP1 via its characteristic epsin N-terminal homology (ENTH) domain. A combination of siRNA-mediated knock-down and transfection of siRNA-resistant constructs in fibrosarcoma cells demonstrated that impairment of the epsin-RalBP1 interaction led to cell migration and basement membrane invasion defects. We found the ENTH domain was necessary and sufficient to sustain normal cell migration and invasion. Because all the epsin endocytic motifs reside in the C-terminal part of the molecule, these results suggest that this novel regulatory circuit does not require endocytosis. In addition, cells depleted of epsin-RalBP1 complex displayed deficient activation of Rac1 and Arf6 suggesting a signaling function for this novel interaction. Further, overexpression of either epsin or RalBP1 enhanced migration and invasion of fibrosarcoma cells. Collectively, our results indicate that epsin regulates RalBP1 function in Rac1-and Arf6-dependent pathways to ultimately affect cell migration and invasion. We propose that the observed up-regulation of both epsin and RalBP1 in certain cancers contributes to their invasive characteristics.	[Coon, Brian G.; Aguilar, R. Claudio] Purdue Univ, Dept Biol Sci, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Burgner, John] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Camonis, Jacques H.] Inst Curie, F-75248 Paris 05, France; [Camonis, Jacques H.] Inserm U830, F-75248 Paris 05, France	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Aguilar, RC (corresponding author), 201 S Univ Dr,Hansen Life Sci Bldg,Room 321, W Lafayette, IN 47907 USA.	Claudio@purdue.edu			American Cancer Society-Purdue Center for Cancer Research; Dept. of Biological Sciences, Purdue University	American Cancer Society-Purdue Center for Cancer Research; Dept. of Biological Sciences, Purdue University	This work was supported by an American Cancer Society-Purdue Center for Cancer Research institutional grant and by start-up funds from the Dept. of Biological Sciences, Purdue University (to R. C. A.).	Aguilar RC, 2006, P NATL ACAD SCI USA, V103, P4116, DOI 10.1073/pnas.0510513103; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; Boissel L, 2007, DEV BIOL, V312, P331, DOI 10.1016/j.ydbio.2007.09.027; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Coon BG, 2009, HUM MOL GENET, V18, P4478, DOI 10.1093/hmg/ddp407; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Homayouni R, 2003, MOL BRAIN RES, V115, P121, DOI 10.1016/S0169-328X(03)00176-1; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Lebreton S, 2004, MECH DEVELOP, V121, P1481, DOI 10.1016/j.mod.2004.07.008; Mukherjee D, 2009, J CELL SCI, V122, P2453, DOI 10.1242/jcs.041137; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Natsume W, 2006, MOL BIOL CELL, V17, P2592, DOI 10.1091/mbc.E05-10-0909; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Northup John, 2004, Methods Mol Biol, V261, P93; Oosterhoff JK, 2003, ONCOGENE, V22, P2920, DOI 10.1038/sj.onc.1206397; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Park SH, 1995, ONCOGENE, V11, P2349; Pawlowski KM, 2009, J PHYSIOL PHARMACOL, V60, P85; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Rosse C, 2003, J BIOL CHEM, V278, P30597, DOI 10.1074/jbc.M302191200; Sakakibara T, 2004, FEBS LETT, V566, P294, DOI 10.1016/j.febslet.2004.03.101; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Singhal SS, 2008, FEBS LETT, V582, P3408, DOI 10.1016/j.febslet.2008.09.001; Singhal SS, 2007, CANCER RES, V67, P4382, DOI 10.1158/0008-5472.CAN-06-4124; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P1074, DOI 10.1016/j.bcp.2008.11.013; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Spradling KD, 2001, J BIOL CHEM, V276, P29257, DOI 10.1074/jbc.M101663200; Wang JB, 2005, J BIOL CHEM, V280, P22883, DOI 10.1074/jbc.M414375200; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang YC, 2007, P NATL ACAD SCI USA, V104, P8328, DOI 10.1073/pnas.0701103104; Wang YH, 2006, MOL PHARMACEUT, V3, P566, DOI 10.1021/mp060002b; Wang Z, 2002, J BIOL CHEM, V277, P12622, DOI 10.1074/jbc.M110568200; Yadav S, 2004, BIOCHEMISTRY-US, V43, P16243, DOI 10.1021/bi0482811	50	24	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33073	33081		10.1074/jbc.M110.124123	http://dx.doi.org/10.1074/jbc.M110.124123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20709745	Green Published, hybrid			2022-12-27	WOS:000283048200045
J	Dey, S; Baird, TD; Zhou, DH; Palam, LR; Spandau, DF; Wek, RC				Dey, Souvik; Baird, Thomas D.; Zhou, Donghui; Palam, Lakshmi Reddy; Spandau, Dan F.; Wek, Ronald C.			Both Transcriptional Regulation and Translational Control of ATF4 Are Central to the Integrated Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; HEPATITIS-C VIRUS; NF-KAPPA-B; EIF2-ALPHA KINASE; EUKARYOTIC INITIATION-FACTOR-2; OXIDATIVE STRESS; MAMMALIAN-CELLS; GENE-EXPRESSION; GCN2	In response to different environmental stresses, phosphorylation of eIF2 (eIF2 similar to P) represses global translation coincident with preferential translation of ATF4. ATF4 is a transcriptional activator of the integrated stress response, a program of gene expression involved in metabolism, nutrient uptake, anti-oxidation, and the activation of additional transcription factors, such as CHOP/GADD153, that can induce apoptosis. Although eIF2-P elicits translational control in response to many different stress arrangements, there are selected stresses, such as exposure to UV irradiation, that do not increase ATF4 expression despite robust eIF2 similar to P. In this study we addressed the underlying mechanism for variable expression of ATF4 in response to eIF2 similar to P during different stress conditions and the biological significance of omission of enhanced ATF4 function. We show that in addition to translational control, ATF4 expression is subject to transcriptional regulation. Stress conditions such as endoplasmic reticulum stress induce both transcription and translation of ATF4, which together enhance expression of ATF4 and its target genes in response to eIF2 similar to P. By contrast, UV irradiation represses ATF4 transcription, which diminishes ATF4 mRNA available for translation during eIF2 similar to P. eIF2 similar to P enhances cell survival in response to UV irradiation. However, forced expression of ATF4 and its target gene CHOP leads to increased sensitivity to UV irradiation. This combination of transcriptional regulation and translational control allows the eIF2 kinase pathway to selectively repress or activate key regulatory genes subject to preferential translation, providing the integrated stress response versatility to direct the transcriptome that is essential for maintaining the balance between stress remediation and apoptosis.	[Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Spandau, Dan F.] Indiana Univ, Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu	palam, lakshmi reddy/H-4902-2015	Baird, Thomas/0000-0002-0280-9984	National Institutes of Health [R01 GM49164, GM64350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R01GM064350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM49164 and GM64350 (to R. C. W.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; ENGELBERG D, 1994, CELL, V77, P381, DOI 10.1016/0092-8674(94)90153-8; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	48	148	153	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33165	33174		10.1074/jbc.M110.167213	http://dx.doi.org/10.1074/jbc.M110.167213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20732869	hybrid, Green Published			2022-12-27	WOS:000283048200054
J	Goh, YY; Pal, M; Chong, HC; Zhu, PC; Tan, MJ; Punugu, L; Tan, CK; Huang, RL; Sze, SK; Tang, MBY; Ding, JL; Kersten, S; Tan, NS				Goh, Yan Yih; Pal, Mintu; Chong, Han Chung; Zhu, Pengcheng; Tan, Ming Jie; Punugu, Lakshmi; Tan, Chek Kun; Huang, Royston-Luke; Sze, Siu Kwan; Tang, Mark Boon Yang; Ding, Jeak Ling; Kersten, Sander; Tan, Nguan Soon			Angiopoietin-like 4 Interacts with Matrix Proteins to Modulate Wound Healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-BETA/DELTA; HUMAN EPIDERMAL-KERATINOCYTES; PPAR-BETA/DELTA; TRANSCRIPTIONAL CONTROL; CELL-GROWTH; EXPRESSION; BETA; MIGRATION; TARGET; REPAIR	A dynamic cell-matrix interaction is crucial for a rapid cellular response to changes in the environment. Appropriate cell behavior in response to the changing wound environment is required for efficient wound closure. However, the way in which wound keratinocytes modify the wound environment to coordinate with such cellular responses remains less studied. We demonstrated that angiopoietin-like 4 (ANGPTL4) produced by wound keratinocytes coordinates cell-matrix communication. ANGPTL4 interacts with vitronectin and fibronectin in the wound bed, delaying their proteolytic degradation by metalloproteinases. This interaction does not interfere with integrin-matrix protein recognition and directly affects cell-matrix communication by altering the availability of intact matrix proteins. These interactions stimulate integrin- focal adhesion kinase, 14-3-3, and PKC-mediated signaling pathways essential for effective wound healing. The deficiency of ANGPTL4 in mice delays wound re-epithelialization. Further analysis revealed that cell migration was impaired in the ANGPTL4-deficient keratinocytes. Altogether, the findings provide molecular insight into a novel control of wound healing via ANGPTL4-dependent regulation of cell-matrix communication. Given the known role of ANGPTL4 in glucose and lipid homeostasis, it is a prime therapeutic candidate for the treatment of diabetic wounds. It also underscores the importance of cell-matrix communication during angiogenesis and cancer metastasis.	[Goh, Yan Yih; Pal, Mintu; Chong, Han Chung; Zhu, Pengcheng; Tan, Ming Jie; Punugu, Lakshmi; Tan, Chek Kun; Huang, Royston-Luke; Sze, Siu Kwan; Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tang, Mark Boon Yang] Natl Skin Ctr, Singapore 308205, Singapore; [Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Kersten, Sander] Wageningen Univ, NL-6700 EV Wageningen, Netherlands	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Skin Centre; National University of Singapore; Wageningen University & Research	Tan, NS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	nstan@ntu.edu.sg	Ding, Jeak/H-8057-2012; Kersten, Sander/A-1116-2011; Sze, Siu Kwan/AAO-3342-2020; Goh, Yan Yih/J-1926-2015; Sze, Siu_kwan Newman/A-2199-2011; Tan, Nguan Soon/A-2220-2011	Kersten, Sander/0000-0003-4488-7734; Sze, Siu Kwan/0000-0002-5652-1687; Goh, Yan Yih/0000-0002-8922-9869; Sze, Siu_kwan Newman/0000-0002-5652-1687; Tan, Nguan Soon/0000-0003-0136-7341	A*STAR BMRC [05/1/22/19/377]; Ministry of Education [ARC 18/08]; Nanyang Technological University [RGD 127/05, 158/06]	A*STAR BMRC(Agency for Science Technology & Research (A*STAR)); Ministry of Education; Nanyang Technological University(Nanyang Technological University)	This work was supported by A*STAR BMRC Grant 05/1/22/19/377, Ministry of Education Grant ARC 18/08, and Nanyang Technological University Grants RGD 127/05 and 158/06.	Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Bulcao C, 2006, CURR DIABETES REV, V2, P19, DOI 10.2174/157339906775473617; Burdick AD, 2006, CELL SIGNAL, V18, P9, DOI 10.1016/j.cellsig.2005.07.009; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; DELLAMBRA E, 1995, J CELL SCI, V108, P3569; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grose R, 2002, EMBO REP, V3, P575, DOI 10.1093/embo-reports/kvf119; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Legler DF, 2001, J CELL SCI, V114, P1545; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Tan NS, 2000, FASEB J, V14, P859, DOI 10.1096/fasebj.14.7.859; Tan NS, 2005, J BIOL CHEM, V280, P18163, DOI 10.1074/jbc.M412829200; Tan NS, 2004, EMBO J, V23, P4211, DOI 10.1038/sj.emboj.7600437; Tan NS, 2004, EXPERT OPIN THER TAR, V8, P39, DOI 10.1517/eott.8.1.39.26404; Tan NS, 2003, AM J CLIN DERMATOL, V4, P523, DOI 10.2165/00128071-200304080-00001; Tan NS, 2002, PROTEIN ENG, V15, P337, DOI 10.1093/protein/15.4.337; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tan SH, 2009, J BIOL CHEM, V284, P18047, DOI 10.1074/jbc.M109.002691; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102	45	97	99	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32999	33009		10.1074/jbc.M110.108175	http://dx.doi.org/10.1074/jbc.M110.108175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729546	Green Published, hybrid			2022-12-27	WOS:000283048200037
J	Choi, YK; Kim, CK; Lee, H; Jeoung, D; Ha, KS; Kwon, YG; Kim, KW; Kim, YM				Choi, Yoon Kyung; Kim, Chun-Ki; Lee, Hansoo; Jeoung, Dooil; Ha, Kwon-Soo; Kwon, Young-Guen; Kim, Kyu-Won; Kim, Young-Myeong			Carbon Monoxide Promotes VEGF Expression by Increasing HIF-1 alpha Protein Level via Two Distinct Mechanisms, Translational Activation and Stabilization of HIF-1 alpha Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-I; HEME OXYGENASE; ANGIOGENIC ACTIVITY; GENE-TRANSFER; HIF-ALPHA; HYPOXIA; CELLS; INHIBITION; KINASE	Carbon monoxide (CO) plays a significant role in vascular functions. We here examined the molecular mechanism by which CO regulates HIF-1 (hypoxia-inducible transcription factor-1)-dependent expression of vascular endothelial growth factor (VEGF), which is an important angiogenic factor. We found that astrocytes stimulated with CORM-2 (CO-releasing molecule) promoted angiogenesis by increasing VEGF expression and secretion. CORM-2 also induced HO-1 (hemeoxygenase-1) expression and increased nuclear HIF-1 alpha protein level, without altering its promoter activity and mRNA level. VEGF expression was inhibited by treatment with HIF-1 alpha siRNA and a hemeoxygenase inhibitor, indicating that CO stimulates VEGF expression via up-regulation of HIF-1 alpha protein level, which is partially associated with HO-1 induction. CORM-2 activated the translational regulatory proteins p70(S6k) and eIF-4E as well as phosphorylating their upstream signal mediators Akt and ERK. These translational signal events and HIF-1 alpha protein level were suppressed by inhibitors of phosphatidylinositol 3-kinase (PI3K), MEK, and mTOR, suggesting that the PI3K/Akt/mTOR and MEK/ERK pathways are involved in a translational increase in HIF-1 alpha. In addition, CORM-2 also increased stability of the HIF-1 alpha protein by suppressing its ubiquitination, without altering the proline hydroxylase-dependent HIF-1 alpha degradation pathway. CORM-2 increased HIF-1 alpha/HSP90 alpha interaction, which is responsible for HIF-1 alpha stabilization, and HSP90-specific inhibitors decreased this interaction, HIF-1 alpha protein level, and VEGF expression. Furthermore, HSP90 alpha knockdown suppressed CORM-2-induced increases in HIF-1 alpha and VEGF protein levels. These results suggest that CO stimulates VEGF production by increasing HIF-1 alpha protein level via two distinct mechanisms, translational stimulation and protein stabilization of HIF-1 alpha.	[Choi, Yoon Kyung; Kim, Chun-Ki; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Dept Chem, Vasc Syst Res Ctr, Chunchon 200701, Kangwon Do, South Korea; [Choi, Yoon Kyung; Kim, Chun-Ki; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Kangwon Do, South Korea; [Lee, Hansoo; Jeoung, Dooil] Kangwon Natl Univ, Div Biol Sci, Coll Nat Sci, Chunchon 200701, Kangwon Do, South Korea; [Kwon, Young-Guen] Yonsei Univ, Dept Biochem, Coll Sci, Seoul 120749, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, NeuroVasc Coordinat Res Ctr, Coll Pharm, Seoul 151742, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Yonsei University; Seoul National University (SNU); Seoul National University (SNU)	Kim, YM (corresponding author), Kangwon Natl Univ, Dept Chem, Vasc Syst Res Ctr, Chunchon 200701, Kangwon Do, South Korea.	ymkim@kangwon.ac.kr	Kim, Kyu Won/AAJ-7213-2020; Ha, Kwon-Soo/AAU-4417-2020; Choi, Yoon Kyung/AGX-0481-2022	Choi, Yoon Kyung/0000-0003-0242-9612; Kim, Chunki/0000-0003-2410-9118; Ha, Kwon-Soo/0000-0002-4219-1787	Korea Science and Engineering Foundation [2009-0062785]; Korean government	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean government(Korean Government)	This work was supported by Korea Science and Engineering Foundation Grant 2009-0062785 and a grant from the Korea Research Foundation (Regional Research Universities Program/Medical and Bio-Materials Research Center) funded by the Korean government.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; BALLA G, 1992, J BIOL CHEM, V267, P18148; Battish R, 2000, AM J PHYSIOL-GASTR L, V278, pG148, DOI 10.1152/ajpgi.2000.278.1.G148; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Calabrese V, 2004, ANTIOXID REDOX SIGN, V6, P895, DOI 10.1089/1523086041798051; Chauveau C, 2002, AM J TRANSPLANT, V2, P581, DOI 10.1034/j.1600-6143.2002.20702.x; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; COUNTS DF, 1978, P NATL ACAD SCI USA, V75, P2145, DOI 10.1073/pnas.75.5.2145; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Deramaudt BMJM, 1998, J CELL BIOCHEM, V68, P121, DOI 10.1002/(SICI)1097-4644(19980101)68:1<121::AID-JCB12>3.0.CO;2-K; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Foresti R, 2008, INTENS CARE MED, V34, P649, DOI 10.1007/s00134-008-1011-1; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee BS, 2006, BIOCHEM BIOPH RES CO, V343, P965, DOI 10.1016/j.bbrc.2006.03.058; Lee MS, 2001, CANCER RES, V61, P3290; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Leffler CW, 2006, AM J PHYSIOL-HEART C, V291, pH2897, DOI 10.1152/ajpheart.00722.2006; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Moon EJ, 2003, FASEB J, V17, P382, DOI 10.1096/fj.03-0153fje; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; Pae HO, 2005, ENDOCRINOLOGY, V146, P2229, DOI 10.1210/en.2004-1431; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; RYTER SW, 2004, SCI STKE, pRE6; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Sunavala-Dossabhoy G, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-1; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848	54	113	124	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32116	32125		10.1074/jbc.M110.131284	http://dx.doi.org/10.1074/jbc.M110.131284			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20724477	Green Published, hybrid			2022-12-27	WOS:000282683000025
J	Cao, Y; Szabolcs, A; Dutta, SK; Yaqoob, U; Jagavelu, K; Wang, L; Leof, EB; Urrutia, RA; Shah, VH; Mukhopadhyay, D				Cao, Ying; Szabolcs, Annamaria; Dutta, Shamit K.; Yaqoob, Usman; Jagavelu, Kumaravelu; Wang, Ling; Leof, Edward B.; Urrutia, Raul A.; Shah, Vijay H.; Mukhopadhyay, Debabrata			Neuropilin-1 Mediates Divergent R-Smad Signaling and the Myofibroblast Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PULMONARY-FIBROSIS; EPITHELIAL-CELLS; TUMOR BIOLOGY; I RECEPTORS; L45 LOOP; ACTIVATION; PHOSPHORYLATION; EXPRESSION	The transforming growth factor-beta (TGF-beta) superfamily is one of the most diversified cell signaling pathways and regulates many physiological and pathological processes. Recently, neuropilin-1 (NRP-1) was reported to bind and activate the latent form of TGF-beta 1 (LAP-TGF-beta 1). We investigated the role of NRP-1 on Smad signaling in stromal fibroblasts upon TGF-beta stimulation. Elimination of NRP-1 in stromal fibroblast cell lines increases Smad1/5 phosphorylation and downstream responses as evidenced by up-regulation of inhibitor of differentiation (Id-1). Conversely, NRP-1 loss decreases Smad2/3 phosphorylation and its responses as shown by down-regulation of alpha-smooth muscle actin (alpha-SMA) and also cells exhibit more quiescent phenotypes and growth arrest. Moreover, we also observed that NRP-1 expression is increased during the culture activation of hepatic stellate cells (HSCs), a liver resident fibroblast. Taken together, our data suggest that NRP-1 functions as a key determinant of the diverse responses downstream of TGF-beta 1 that are mediated by distinct Smad proteins and promotes myofibroblast phenotype.	[Mukhopadhyay, Debabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Yaqoob, Usman; Jagavelu, Kumaravelu; Urrutia, Raul A.; Shah, Vijay H.] Mayo Clin, Coll Med, GI Res Unit, Rochester, MN 55905 USA; [Leof, Edward B.] Mayo Clin, Coll Med, Thorac Dis Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Mukhopadhyay, D (corresponding author), Guggenheim 1321C,200 1st St SW, Rochester, MN 55905 USA.	mukhopadhyay.debabrata@mayo.edu	Jagavelu, Kumaravelu/L-8053-2019	Jagavelu, Kumaravelu/0000-0002-9235-0600	National Institutes of Health [CA78383, HL072178, HL70567]; Mayo Clinic; American Cancer Society; Bruce and Martha Atwater Foundation; NATIONAL CANCER INSTITUTE [R29CA078383, R01CA078383] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086990, R01HL072178, R01HL070567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, P30DK084567, R01DK059615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; American Cancer Society(American Cancer Society); Bruce and Martha Atwater Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA78383, HL072178, and HL70567. This work was also supported by a Mayo Clinic Pancreatic Cancer SPORE Pilot grant, a grant from the American Cancer Society as well as the Bruce and Martha Atwater Foundation.	Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Ball SG, 2010, BIOCHEM J, V427, P29, DOI 10.1042/BJ20091512; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cao Y, 2008, CANCER RES, V68, P8667, DOI 10.1158/0008-5472.CAN-08-2614; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; FRIEDMAN SL, 1994, J BIOL CHEM, V269, P10551; GATZA CE, 2008, ATLAS GENET CYTOGENE; Gellibert FO, 2004, J MED CHEM, V47, P4494, DOI 10.1021/jm0400247; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Guo BQ, 2004, ANTICANCER RES, V24, P1337; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hempel N, 2008, CARCINOGENESIS, V29, P905, DOI 10.1093/carcin/bgn049; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lin L, 2008, AM J PATHOL, V173, P337, DOI 10.2353/ajpath.2008.070915; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Mann DA, 2002, GUT, V50, P891, DOI 10.1136/gut.50.6.891; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Obreo J, 2004, CELL PHYSIOL BIOCHEM, V14, P301, DOI 10.1159/000080340; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; RODRIGUEZBARBER.A, 2006, J M CELL PHYSL BIOCH, V18, P135; Romeo PH, 2002, ADV EXP MED BIOL, V515, P49; Roulot D, 1999, HEPATOLOGY, V29, P1730, DOI 10.1002/hep.510290622; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Schramek H, 2009, LAB INVEST, V89, P1304, DOI 10.1038/labinvest.2009.96; Shimizu M, 2000, J CELL BIOL, V148, P1283, DOI 10.1083/jcb.148.6.1283; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Vincent KJ, 2001, GUT, V49, P713, DOI 10.1136/gut.49.5.713; Vrochides D, 1996, HEPATOLOGY, V23, P1650, DOI 10.1053/jhep.1996.v23.pm0008675189; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200	46	60	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31840	31848		10.1074/jbc.M110.151696	http://dx.doi.org/10.1074/jbc.M110.151696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675371	Green Published, hybrid			2022-12-27	WOS:000282764600075
J	Longley, MJ; Humble, MM; Sharief, FS; Copeland, WC				Longley, Matthew J.; Humble, Margaret M.; Sharief, Farida S.; Copeland, William C.			Disease Variants of the Human Mitochondrial DNA Helicase Encoded by C10orf2 Differentially Alter Protein Stability, Nucleotide Hydrolysis, and Helicase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SINGLE-STRANDED-DNA; ONSET SPINOCEREBELLAR ATAXIA; RECESSIVE TWINKLE MUTATIONS; STRUCTURE-FUNCTION DEFECTS; PRIMASE-HELICASE; GENE MUTATION; MTDNA MAINTENANCE; BACTERIOPHAGE T7; LINKER REGION	Missense mutations in the human C10orf2 gene, encoding the mitochondrial DNA (mtDNA) helicase, co-segregate with mitochondrial diseases such as adult-onset progressive external ophthalmoplegia, hepatocerebral syndrome with mtDNA depletion syndrome, and infantile-onset spinocerebellar ataxia. To understand the biochemical consequences of C10orf2 mutations, we overproduced wild type and 20 mutant forms of human mtDNA helicase in Escherichia coli and developed novel schemes to purify the recombinant enzymes to near homogeneity. A combination of molecular crowding, non-ionic detergents, Mg2+ ions, and elevated ionic strength was required to combat insolubility and intrinsic instability of certain mutant variants. Asystematic biochemical assessment of the enzymes included analysis of DNA binding affinity, DNA helicase activity, the kinetics of nucleotide hydrolysis, and estimates of thermal stability. In contrast to other studies, we found that all 20 mutant variants retain helicase function under optimized in vitro conditions despite partial reductions in DNA binding affinity, nucleotide hydrolysis, or thermal stability for some mutants. Such partial defects are consistent with the delayed presentation of mitochondrial diseases associated with mutation of C10orf2.	[Longley, Matthew J.; Humble, Margaret M.; Sharief, Farida S.; Copeland, William C.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953	National Institutes of Health through the NIEHS [ES 065078]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065078] Funding Source: NIH RePORTER	National Institutes of Health through the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health through the NIEHS (Grant ES 065078) (to W.C.C.).	Agostino A, 2003, NEUROLOGY, V60, P1354, DOI 10.1212/01.WNL.0000056088.09408.3C; Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7; Deschauer M, 2003, NEUROMUSCULAR DISORD, V13, P568, DOI 10.1016/S0960-8966(03)00071-3; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280; Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Houshmand M, 2006, NEUROL INDIA, V54, P182; Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105; Leipe DD, 2000, GENOME RES, V10, P5; Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Lonnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200; Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200; Naimi M, 2006, EUR J HUM GENET, V14, P917, DOI 10.1038/sj.ejhg.5201627; Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Rivera H, 2007, NEUROMUSCULAR DISORD, V17, P677, DOI 10.1016/j.nmd.2007.05.006; Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207; Satapathy AK, 2010, P NATL ACAD SCI USA, V107, P6782, DOI 10.1073/pnas.1002734107; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242; VAN GOETHEM G, 2003, HUM MUTAT, V22, P175; VAN HOVE JLK, 2009, AM J MED GENET A A, V149, P861; Vandenberghe W, 2009, MOVEMENT DISORD, V24, P308, DOI 10.1002/mds.22198; Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663	62	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29690	29702		10.1074/jbc.M110.151795	http://dx.doi.org/10.1074/jbc.M110.151795			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20659899	hybrid, Green Published			2022-12-27	WOS:000281984300004
J	Yevenes, GE; Moraga-Cid, G; Avila, A; Guzman, L; Figueroa, M; Peoples, RW; Aguayo, LG				Yevenes, Gonzalo E.; Moraga-Cid, Gustavo; Avila, Ariel; Guzman, Leonardo; Figueroa, Maximiliano; Peoples, Robert W.; Aguayo, Luis G.			Molecular Requirements for Ethanol Differential Allosteric Modulation of Glycine Receptors Based on Selective G beta gamma Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; EXTRACELLULAR DOMAIN; SYNAPTIC-TRANSMISSION; SUBUNIT; RESIDUES; LOOP-2; ELECTROSTATICS; SENSITIVITY; MECHANISMS	It is now believed that the allosteric modulation produced by ethanol in glycine receptors (GlyRs) depends on alcohol binding to discrete sites within the protein structure. Thus, the differential ethanol sensitivity of diverse GlyR isoforms and mutants was explained by the presence of specific residues in putative alcohol pockets. Here, we demonstrate that ethanol sensitivity in two ligand-gated ion receptor members, the GlyR adult alpha(1) and embryonic alpha(2) subunits, can be modified through selective mutations that rescued or impaired G beta gamma modulation. Even though both isoforms were able to physically interact with G beta gamma, only the alpha(1) GlyR was functionally modulated by G beta gamma and pharmacological ethanol concentrations. Remarkably, the simultaneous switching of two transmembrane and a single extracellular residue in alpha(2) GlyRs was enough to generate GlyRs modulated by G beta gamma and low ethanol concentrations. Interestingly, although we found that these TM residues were different to those in the alcohol binding site, the extracellular residue was recently implicated in conformational changes important to generate a pre-open-activated state that precedes ion channel gating. Thus, these results support the idea that the differential ethanol sensitivity of these two GlyR isoforms rests on conformational changes in transmembrane and extracellular residues within the ion channel structure rather than in differences in alcohol binding pockets. Our results describe the molecular basis for the differential ethanol sensitivity of two ligand-gated ion receptor members based on selective G beta gamma modulation and provide a new mechanistic framework for allosteric modulations of abuse drugs.	[Yevenes, Gonzalo E.; Moraga-Cid, Gustavo; Avila, Ariel; Guzman, Leonardo; Aguayo, Luis G.] Univ Concepcion, Dept Physiol, Neurophysiol Lab, Concepcion, Chile; [Figueroa, Maximiliano] Univ Concepcion, Dept Biochem & Mol Biol, Concepcion, Chile; [Peoples, Robert W.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53233 USA	Universidad de Concepcion; Universidad de Concepcion; Marquette University	Aguayo, LG (corresponding author), Univ Concepcion, Dept Physiol, Neurophysiol Lab, POB 160-C, Concepcion, Chile.	laguayo@udec.cl	Ávila, Ariel/Z-2817-2019; Guzman, Jose/AAM-7649-2020; Moraga-Cid, Gustavo/AAC-3314-2021	Ávila, Ariel/0000-0002-7867-9186; Guzman, Jose/0000-0001-9596-5494; Yevenes, Gonzalo/0000-0003-0294-4075	National Institute on Alcohol Abuse and Alcoholism [RO1 AA15150]; Comision Nacional de Investigacion Cientifica y Tecnologica [AT-4040102]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015150] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Comision Nacional de Investigacion Cientifica y Tecnologica; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institute on Alcohol Abuse and Alcoholism Grant RO1 AA15150 (to L.G.A.). This work was also supported by Comision Nacional de Investigacion Cientifica y Tecnologica Grant AT-4040102 (to G.E.Y.).	Absalom NL, 2004, EXP PHYSIOL, V89, P145, DOI 10.1113/expphysiol.2003.026815; Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; Agnati LF, 2005, J HISTOCHEM CYTOCHEM, V53, P941, DOI 10.1369/jhc.4A6355.2005; Aguayo LG, 2004, BRAIN RES REV, V47, P33, DOI 10.1016/j.brainresrev.2004.06.007; Aguayo Luis G., 2002, Current Topics in Medicinal Chemistry, V2, P869, DOI 10.2174/1568026023393426; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crawford DK, 2008, J BIOL CHEM, V283, P27698, DOI 10.1074/jbc.M802384200; Crawford DK, 2007, J NEUROCHEM, V102, P2097, DOI 10.1111/j.1471-4159.2007.04680.x; DeLano W.L, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eggers ED, 2000, J NEUROPHYSIOL, V84, P2409, DOI 10.1152/jn.2000.84.5.2409; Fischer H, 2005, J NEUROSCI, V25, P3571, DOI 10.1523/JNEUROSCI.4971-04.2005; Graham BA, 2006, J NEUROSCI, V26, P4880, DOI 10.1523/JNEUROSCI.3991-05.2006; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Kandel ER, 2000, PRINCIPLES NEURAL SC, p[175, 207]; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Maksay G, 2001, NEUROPHARMACOLOGY, V41, P369, DOI 10.1016/S0028-3908(01)00071-5; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Mangin JA, 2003, J PHYSIOL-LONDON, V553, P369, DOI 10.1113/jphysiol.2003.052142; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mascia MP, 1996, MOL PHARMACOL, V50, P402; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Miller PS, 2004, BRIT J PHARMACOL, V143, P19, DOI 10.1038/sj.bjp.0705875; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Perkins DI, 2008, J NEUROCHEM, V106, P1337, DOI 10.1111/j.1471-4159.2008.05476.x; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Plested AJR, 2007, J PHYSIOL-LONDON, V581, P51, DOI 10.1113/jphysiol.2006.126920; Qi ZH, 2007, J BIOL CHEM, V282, P33052, DOI 10.1074/jbc.M707233200; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Ruiz-Velasco V, 2001, J PHYSIOL-LONDON, V537, P679; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sebe JY, 2006, J NEUROPHYSIOL, V96, P391, DOI 10.1152/jn.00086.2006; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Tapia JC, 1998, SYNAPSE, V28, P185; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wallner M, 2006, PHARMACOL THERAPEUT, V112, P513, DOI 10.1016/j.pharmthera.2006.05.004; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Ye Q, 1998, J BIOL CHEM, V273, P3314, DOI 10.1074/jbc.273.6.3314; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200	54	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30203	30213		10.1074/jbc.M110.134676	http://dx.doi.org/10.1074/jbc.M110.134676			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647311	hybrid, Green Published			2022-12-27	WOS:000281984300057
J	Ng, DCH; Zhao, TT; Yeap, YYC; Ngoei, KR; Bogoyevitch, MA				Ng, Dominic C. H.; Zhao, Teresa T.; Yeap, Yvonne Y. C.; Ngoei, Kevin R.; Bogoyevitch, Marie A.			c-Jun N-terminal Kinase Phosphorylation of Stathmin Confers Protection against Cellular Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; TUMOR-NECROSIS-FACTOR; MICROTUBULE DYNAMICS; MULTISITE PHOSPHORYLATION; NH2-TERMINAL KINASE; SIGNALING PATHWAYS; PROMOTES SURVIVAL; IN-VITRO; JNK; CELLS	The cell stress response encompasses the range of intracellular events required for adaptation to stimuli detrimental to cell survival. Although the c-Jun N-terminal kinase (JNK) is a stress-activated kinase that can promote either cell survival or death in response to detrimental stimuli, the JNK-regulated mechanisms involved in survival are not fully characterized. Here we show that in response to hyperosmotic stress, JNK phosphorylates a key cytoplasmic microtubule regulatory protein, stathmin (STMN), on conserved Ser-25 and Ser-38 residues. In in vitro biochemical studies, we identified STMN Ser-38 as the critical residue required for efficient phosphorylation by JNK and identified a novel kinase interaction domain in STMN required for recognition by JNK. We revealed that JNK was required for microtubule stabilization in response to hyperosmotic stress. Importantly, we also demonstrated a novel cytoprotective function for STMN, as the knockdown of STMN levels by siRNA was sufficient to augment viability in response to hyperosmotic stress. Our findings show that JNK targeting of STMN represents a novel stress-activated cytoprotective mechanism involving microtubule network changes.	[Ng, Dominic C. H.; Zhao, Teresa T.; Yeap, Yvonne Y. C.; Ngoei, Kevin R.; Bogoyevitch, Marie A.] Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	University of Melbourne	Ng, DCH (corresponding author), Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3010, Australia.	ngd@unimelb.edu.au	Ng, Dominic/C-7291-2015	Ng, Dominic/0000-0003-4657-159X; Bogoyevitch, Marie/0000-0001-9745-3716	National Health and Medical Research Council [628335, 566804]; National Heart Foundation of Australia/National Health and Medical Research Council [404126]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia/National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of AustraliaNational Heart Foundation of Australia)	This work was supported by National Health and Medical Research Council Project Grants 628335 and 566804.; Recipient of National Heart Foundation of Australia/National Health and Medical Research Council Fellowship 404126. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Bio21 Institute, University of Melbourne, 30 Flemington Rd., Parkville, VIC, 3010 Australia. Tel.: 61-3-8344-2543; Fax: 61-3-9348-1421; E-mail: ngd@unimelb.edu.au.	Arbour N, 2002, J EXP MED, V195, P801, DOI 10.1084/jem.20011481; Barr RK, 2004, J BIOL CHEM, V279, P36327, DOI 10.1074/jbc.M402181200; Barr RK, 2001, INT J BIOCHEM CELL B, V33, P1047, DOI 10.1016/S1357-2725(01)00093-0; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1995, EUR J BIOCHEM, V227, P388, DOI 10.1111/j.1432-1033.1995.tb20401.x; BERETTA L, 1993, J BIOL CHEM, V268, P20076; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Cardinaux JR, 1997, MOL BRAIN RES, V51, P220, DOI 10.1016/S0169-328X(97)00241-6; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DiPaolo G, 1996, J CELL BIOL, V133, P1383, DOI 10.1083/jcb.133.6.1383; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Fryer RM, 2001, AM J PHYSIOL-HEART C, V281, pH1184, DOI 10.1152/ajpheart.2001.281.3.H1184; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; LEIGHTON IA, 1993, MOL CELL BIOCHEM, V128, P151, DOI 10.1007/BF01076766; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Lovric J, 1998, J BIOL CHEM, V273, P22848; LUO XN, 1994, J BIOL CHEM, V269, P10312; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Michaelis ML, 2005, J PHARMACOL EXP THER, V312, P659, DOI 10.1124/jpet.104.074450; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Mizumura K, 2006, J CELL PHYSIOL, V206, P363, DOI 10.1002/jcp.20465; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Moss DK, 2006, J CELL SCI, V119, P2362, DOI 10.1242/jcs.02959; Nakamura K, 2006, J CHROMATOGR A, V1106, P181, DOI 10.1016/j.chroma.2005.12.068; Nakamura Y, 2004, CARDIOVASC RES, V64, P322, DOI 10.1016/j.cardiores.2004.07.013; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Parker CG, 1998, BIOCHEM BIOPH RES CO, V249, P791, DOI 10.1006/bbrc.1998.9250; Podkowa M, 2010, MOL CELL BIOL, V30, P2241, DOI 10.1128/MCB.01166-09; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sellin ME, 2008, MOL BIOL CELL, V19, P2897, DOI 10.1091/mbc.E08-01-0058; Stone MC, 2010, MOL BIOL CELL, V21, P767, DOI 10.1091/mbc.E09-11-0967; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Tran TH, 2007, J BIOL CHEM, V282, P20340, DOI 10.1074/jbc.M702210200; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; Vancompernolle K, 2000, J BIOL CHEM, V275, P33876, DOI 10.1074/jbc.M004785200; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001	52	20	21	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					29001	29013		10.1074/jbc.M110.128454	http://dx.doi.org/10.1074/jbc.M110.128454			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20630875	Green Published, hybrid			2022-12-27	WOS:000281594000065
J	Angelova, K; de Jonge, H; Granneman, JCM; Puett, D; Bogerd, J				Angelova, Krassimira; de Jonge, Hugo; Granneman, Joke C. M.; Puett, David; Bogerd, Jan			Functional Differences of Invariant and Highly Conserved Residues in the Extracellular Domain of the Glycoprotein Hormone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; PROTEIN-COUPLED RECEPTOR; LEUCINE-RICH REPEATS; HUMAN CHORIONIC-GONADOTROPIN; HUMAN CHORIOGONADOTROPIN-ALPHA; LIGAND-SELECTIVE DETERMINANTS; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; LUTROPIN-RECEPTOR; 3-DIMENSIONAL STRUCTURE	Multiple interactions exist between human follicle-stimulating hormone (FSH) and the N-terminal hormone-binding fragment of the human FSH receptor (FSHR) extracellular domain (ECD). Binding of the other human glycoprotein hormones to their cognate human receptors (luteinizing hormone receptor (LHR) and thyroid-stimulating hormone receptor (TSHR)) was expected to be similar. This study focuses on amino acid residues in beta-strands 2 (Lys(74)), 4 (Tyr(124), Asn(129), and Thr(130)), and 5 (Asp(150) and Asp(153)) of the FSHR ECD identified in the human FSH.FSHR ECD crystal structure as contact sites with the common glycoprotein hormone alpha-subunit, and on noncontact residues in beta-strands 2 (Ser(78)) and 8 (Asp(224) and Ser(226)) as controls. These nine residues are either invariant or highly conserved in LHR and TSHR. Mutagenesis and functional characterization of these residues in all three human receptors allowed an assessment of their contribution to binding and receptor activation. Surprisingly, the six reported alpha-subunit contact residues of the FSHR ECD could be replaced without significant loss of FSH binding, while cAMP signaling potency was diminished significantly with several replacements. Comparative studies of the homologous residues in LHR and TSHR revealed both similarities and differences. The results for FSH/FSHR were analyzed on the basis of the crystal structure of the FSH.FSHR ECD complex, and comparative modeling was used to generate structures for domains, proteins, and complexes for which no structures were available. Although structural information of hormone-receptor interaction allowed the identification of hormone-receptor contact sites, functional analysis of each contact site was necessary to assess its contribution to hormone binding and receptor activation.	[de Jonge, Hugo; Granneman, Joke C. M.; Bogerd, Jan] Univ Utrecht, Fac Sci, Dept Biol, Div Dev Biol, NL-3584 CH Utrecht, Netherlands; [Angelova, Krassimira; Puett, David] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Utrecht University; University System of Georgia; University of Georgia	Bogerd, J (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Div Dev Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	j.bogerd@uu.nl	Puett, J. David/AIE-8612-2022; de Jonge, Hugo/D-4036-2018; de Jonge, Hugo/AAI-1861-2019; Bogerd, Jan/B-8858-2011	de Jonge, Hugo/0000-0003-2777-4084; de Jonge, Hugo/0000-0003-2777-4084; Bogerd, Jan/0000-0003-1120-7974	National Institutes of Health [DK069711, DK033793]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033793, R01DK069711, R37DK033793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK069711 and DK033793.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Angelova K, 2003, MOL CELL ENDOCRINOL, V204, P1, DOI 10.1016/S0303-7207(03)00155-2; Angelova K, 2002, ENDOCRINE, V19, P147, DOI 10.1385/ENDO:19:2:147; Angelova K, 2002, J BIOL CHEM, V277, P32202, DOI 10.1074/jbc.M203272200; Angelova K, 2008, MOL ENDOCRINOL, V22, P126, DOI 10.1210/me.2007-0352; Ascoli M., 2009, YEN JAFFES REPROD EN, P35, DOI [10.1016/B978-1-4160-4907-4.00002-4, DOI 10.1016/B978-1-4160-4907-4.00002-4]; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Bhowmick N, 1996, MOL ENDOCRINOL, V10, P1147, DOI 10.1210/me.10.9.1147; Bhowmick N, 1999, ENDOCRINOLOGY, V140, P4558, DOI 10.1210/en.140.10.4558; Bogerd J, 2007, MOL CELL ENDOCRINOL, V260, P144, DOI 10.1016/j.mce.2006.01.019; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; CHEN F, 1991, J BIOL CHEM, V266, P19357; CHEN F, 1991, BIOCHEMISTRY-US, V30, P10171, DOI 10.1021/bi00106a014; CHEN F, 1992, FASEB J, V6, pA209; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DeLano W.L, PYMOL MOL GRAPHICS S; DIAS JA, 1994, J BIOL CHEM, V269, P25289; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Hong SH, 1998, J BIOL CHEM, V273, P13835, DOI 10.1074/jbc.273.22.13835; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; HUANG JN, 1995, J BIOL CHEM, V270, P30023; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JI IH, 1993, J BIOL CHEM, V268, P22971; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; KAJAVA AV, 1995, STRUCTURE, V3, P867, DOI 10.1016/S0969-2126(01)00222-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Laskowski RA, 1995, J MOL GRAPHICS, V13, P328; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miguel RN, 2008, J MOL ENDOCRINOL, V41, P145, DOI 10.1677/JME-08-0040; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Puett D, 2009, METHODS MOL BIOL, V590, P1, DOI 10.1007/978-1-60327-378-7_1; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders J, 2006, THYROID, V16, P1195, DOI 10.1089/thy.2006.16.1195; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Smits G, 2002, MOL ENDOCRINOL, V16, P722, DOI 10.1210/me.16.4.722; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; Song YS, 2001, J BIOL CHEM, V276, P3426, DOI 10.1074/jbc.M003772200; Song YS, 2001, J BIOL CHEM, V276, P3436, DOI 10.1074/jbc.M003773200; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Touraine P, 1999, MOL ENDOCRINOL, V13, P1844, DOI 10.1210/me.13.11.1844; Vischer HF, 2006, MOL ENDOCRINOL, V20, P1880, DOI 10.1210/me.2005-0202; Vischer HF, 2003, MOL ENDOCRINOL, V17, P1972, DOI 10.1210/me.2003-0172; Vischer HF, 2003, J BIOL CHEM, V278, P15505, DOI 10.1074/jbc.M300634200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; XIA H, 1993, J MOL ENDOCRINOL, V10, P337, DOI 10.1677/jme.0.0100337; YOO J, 1991, J BIOL CHEM, V266, P17741; YOO JK, 1993, J BIOL CHEM, V268, P13034	71	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34813	34827		10.1074/jbc.M110.148221	http://dx.doi.org/10.1074/jbc.M110.148221			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736161	hybrid, Green Published			2022-12-27	WOS:000283659100057
J	Manno, S; Mohandas, N; Takakuwa, Y				Manno, Sumie; Mohandas, Narla; Takakuwa, Yuichi			ATP-dependent Mechanism Protects Spectrin against Glycation in Human Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE STABILITY; DIABETES-MELLITUS; BETA-SPECTRIN; CROSS-LINK; PHOSPHATIDYLSERINE; GLYCOSYLATION; PROTEINS; SITES; IDENTIFICATION; HEMOGLOBIN	Human erythrocytes are continuously exposed to glucose, which reacts with the amino terminus of the beta-chain of hemoglobin (Hb) to form glycated Hb, HbA1c, levels of which increase with the age of the circulating cell. In contrast to extensive insights into glycation of hemoglobin, little is known about glycation of erythrocyte membrane proteins. In the present study, we explored the conditions under which glucose and ribose can glycate spectrin, both on the intact membrane and in solution and the functional consequences of spectrin glycation. Although purified spectrin could be readily glycated, membrane-associated spectrin could be glycated only after ATP depletion and consequent translocation of phosphatidylserine (PS) from the inner to the outer lipid monolayer. Glycation of membrane-associated spectrin led to a marked decrease in membrane deformability. We further observed that only PS-binding spectrin repeats are glycated. We infer that the absence of glycation in situ is the consequence of the interaction of the target lysine and arginine residues with PS and thus is inaccessible for glycation. The reduced membrane deformability after glycation in the absence of ATP is likely the result of the inability of the glycated spectrin repeats to undergo the obligatory unfolding as a consequence of interhelix cross-links. We thus postulate that through the use of an ATP-driven phospholipid translocase (flippase), erythrocytes have evolved a protective mechanism against spectrin glycation and thus maintain their optimal membrane function during their long circulatory life span.	[Manno, Sumie; Takakuwa, Yuichi] Tokyo Womens Med Univ, Dept Biochem, Shinjuku Ku, Tokyo 1628666, Japan; [Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA	Tokyo Women's Medical University; New York Blood Center	Takakuwa, Y (corresponding author), Tokyo Womens Med Univ, Dept Biochem, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	takakuwa@research.twmu.ac.jp			National Institutes of Health [HL 31579, DK26263, DK32094]; Ministry of Education Culture, Sports, Science, and Technology of Japan [19590289]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026263, P01DK032094, R37DK026263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 31579 DK26263 and DK32094. This work was also supported by Grant-in-aid for Scientific Research 19590289 from the Ministry of Education Culture, Sports, Science, and Technology of Japan.	An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; An XL, 2004, BIOCHEMISTRY-US, V43, P310, DOI 10.1021/bi035653h; Begg GE, 2000, J BIOL CHEM, V275, P3279, DOI 10.1074/jbc.275.5.3279; Bierhaus A, 1998, CARDIOVASC RES, V37, P586, DOI 10.1016/S0008-6363(97)00233-2; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; CHASIS JA, 1985, J CLIN INVEST, V75, P1919, DOI 10.1172/JCI111907; COHEN AM, 1986, BLOOD, V68, P920; CONNOR J, 1988, BIOCHEMISTRY-US, V27, P848, DOI 10.1021/bi00403a002; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; GARLICK RL, 1983, J CLIN INVEST, V71, P1062, DOI 10.1172/JCI110856; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; IBERG N, 1986, J BIOL CHEM, V261, P3542; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Law R, 2003, BIOPHYS J, V84, P533, DOI 10.1016/S0006-3495(03)74872-3; MACDONALD RI, 1993, BIOCHEMISTRY-US, V32, P6957, DOI 10.1021/bi00078a021; MAKSYMIW R, 1987, BIOCHEMISTRY-US, V26, P2983, DOI 10.1021/bi00385a005; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; MICHALAK K, 1993, GEN PHYSIOL BIOPHYS, V12, P163; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nunomura W, 2000, J BIOL CHEM, V275, P24540, DOI 10.1074/jbc.M002492200; SELL DR, 1989, J BIOL CHEM, V264, P21597; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; WATKINS NG, 1987, J BIOL CHEM, V262, P7207; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827	26	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33923	33929		10.1074/jbc.M110.126896	http://dx.doi.org/10.1074/jbc.M110.126896			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20724481	hybrid, Green Published			2022-12-27	WOS:000283354000039
J	Debierre-Grockiego, F; Niehus, S; Coddeville, B; Elass, E; Poirier, F; Weingart, R; Schmidt, RR; Mazurier, J; Guerardel, Y; Schwarz, RT				Debierre-Grockiego, Francoise; Niehus, Sebastian; Coddeville, Bernadette; Elass, Elisabeth; Poirier, Francoise; Weingart, Ralf; Schmidt, Richard R.; Mazurier, Joel; Guerardel, Yann; Schwarz, Ralph T.			Binding of Toxoplasma gondii Glycosylphosphatidylinositols to Galectin-3 Is Required for Their Recognition by Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA PRODUCTION; LEISHMANIA-MAJOR; ACTIVATION; INFECTION; PROTEIN; IMMUNE; TLR2; EXPRESSION; RESPONSES; RECEPTOR	We showed that the production of tumor necrosis factor (TNF) alpha by macrophages in response to Toxoplasma gondii glycosylphosphatidylinositols (GPIs) requires the expression of both Toll-like receptors TLR2 and TLR4, but not of their coreceptor CD14. Galectin-3 is a beta-galactoside-binding protein with immune-regulatory effects, which associates with TLR2. We demonstrate here by using the surface plasmon resonance method that the GPIs of T. gondii bind to human galectin-3 with strong affinity and in a dose-dependent manner. The use of a synthetic glycan and of the lipid moiety cleaved from the GPIs shows that both parts are involved in the interaction with galectin-3. GPIs of T. gondii also bind to galectin-1 but with a lower affinity and only through the lipid moiety. At the cellular level, the production of TNF-alpha induced by T. gondii GPIs in macrophages depends on the expression of galectin-3 but not of galectin-1. This study is the first identification of a galectin-3 ligand of T. gondii origin, and galectin-3 might be a co-receptor presenting the GPIs to the TLRs on macrophages.	[Debierre-Grockiego, Francoise; Niehus, Sebastian; Schwarz, Ralph T.] Univ Marburg, AG Parasitol, Inst Virol, D-35043 Marburg, Germany; [Debierre-Grockiego, Francoise] Univ INRA 0483 Immunol Parasitair, UMR, Unite Format Rech Sci Pharmaceut, F-37200 Tours, France; [Coddeville, Bernadette; Elass, Elisabeth; Mazurier, Joel; Guerardel, Yann; Schwarz, Ralph T.] Univ Lille Nord France, CNRS, UMR 8576, Unit Struct & Funct Glycobiol,Inst Federatif Rech, F-59000 Lille, France; [Poirier, Francoise] Inst Jacques Monod, Lab Genet & Dev Mammiferes, F-75013 Paris, France; [Weingart, Ralf; Schmidt, Richard R.] Univ Konstanz, Fachbereich Chem, D-78457 Constance, Germany	Philipps University Marburg; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universite Paris Cite; University of Konstanz	Debierre-Grockiego, F (corresponding author), Univ Marburg, AG Parasitol, Inst Virol, D-35043 Marburg, Germany.	francoise.debierre@univ-tours.fr	Debierre-Grockiego, Francoise/AAD-4322-2021	Guerardel, Yann/0000-0003-4967-9512; elass, elisabeth/0000-0002-2573-2959	Deutsche Forschungsgemeinschaft; Universite des Sciences et Technologies de Lille 1; Institut Federatif de Recherche [147]; Centre National de la Recherche Scientifique (Unite Mixte de Recherche CNRS) [8576]; Groupement des Entreprises Francaises dans la Lutte Contre le Cancer and Association pour la Recherche Sur le Cancer [1113]; Deutscher Akademischer Austausch Dienst/Egide	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Universite des Sciences et Technologies de Lille 1; Institut Federatif de Recherche; Centre National de la Recherche Scientifique (Unite Mixte de Recherche CNRS)(Centre National de la Recherche Scientifique (CNRS)); Groupement des Entreprises Francaises dans la Lutte Contre le Cancer and Association pour la Recherche Sur le Cancer; Deutscher Akademischer Austausch Dienst/Egide(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Deutsche Forschungsgemeinschaft (R. T. S.), the Universite des Sciences et Technologies de Lille 1 (Y.G.), the Institut Federatif de Recherche 147, the Centre National de la Recherche Scientifique (Unite Mixte de Recherche CNRS no. 8576, Director Dr. J.C. Michalski), the Groupement des Entreprises Francaises dans la Lutte Contre le Cancer and Association pour la Recherche Sur le Cancer Grant 1113 (to F. P.), and the PROCOPE of Deutscher Akademischer Austausch Dienst/Egide (R. T. S. and Y.G.).	Alves CMOS, 2010, IMMUNOBIOLOGY, V215, P475, DOI 10.1016/j.imbio.2009.08.001; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Barboni E, 2005, FEBS LETT, V579, P6749, DOI 10.1016/j.febslet.2005.11.005; Bernardes ES, 2006, AM J PATHOL, V168, P1910, DOI 10.2353/ajpath.2006.050636; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Debierre-Grockiego F, 2003, J BIOL CHEM, V278, P32987, DOI 10.1074/jbc.M304791200; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Debierre-Grockiego F, 2007, INFECT IMMUN, V75, P2886, DOI 10.1128/IAI.01431-06; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Ferraz LC, 2008, EUR J IMMUNOL, V38, P2762, DOI 10.1002/eji.200737986; Giordanengo L, 2001, CLIN EXP IMMUNOL, V124, P266, DOI 10.1046/j.1365-2249.2001.01512.x; GRIMWOOD BG, 1979, EXP PARASITOL, V48, P282, DOI 10.1016/0014-4894(79)90110-3; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HSU DK, 1992, J BIOL CHEM, V267, P14167; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miller MC, 2009, GLYCOBIOLOGY, V19, P1034, DOI 10.1093/glycob/cwp084; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Pekari K, 2001, J ORG CHEM, V66, P7432, DOI 10.1021/jo015840q; Pelletier I, 2003, J BIOL CHEM, V278, P22223, DOI 10.1074/jbc.M302693200; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; Roda O, 2009, GASTROENTEROLOGY, V136, P1379, DOI 10.1053/j.gastro.2008.12.039; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Weber KB, 2004, AM J CLIN PATHOL, V122, P524, DOI 10.1309/UUQTE505PTN5QJ7M; YANG ZG, 1994, J LEUKOCYTE BIOL, V55, P483, DOI 10.1002/jlb.55.4.483	32	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32744	32750		10.1074/jbc.M110.137588	http://dx.doi.org/10.1074/jbc.M110.137588			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729207	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000283048200009
J	Seki, T; Abe-Seki, N; Kikawada, T; Takahashi, H; Yamamoto, K; Adachi, N; Tanaka, S; Hide, I; Saito, N; Sakai, N				Seki, Takahiro; Abe-Seki, Nana; Kikawada, Takahiro; Takahashi, Hideyuki; Yamamoto, Kazuhiro; Adachi, Naoko; Tanaka, Shigeru; Hide, Izumi; Saito, Naoaki; Sakai, Norio			Effect of Trehalose on the Properties of Mutant gamma PKC, Which Causes Spinocerebellar Ataxia Type 14, in Neuronal Cell Lines and Cultured Purkinje Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-GAMMA; NEURODEGENERATIVE DISEASE; CEREBELLAR-ATAXIA; AGGREGATE FORMATION; MOUSE MODEL; PRKCG GENE; PROTEIN; MUTATIONS; FAMILY; PATHOGENESIS	Several missense mutations in the protein kinase C gamma (gamma PKC) gene have been found to cause spinocerebellar ataxia type 14 (SCA14), an autosomal dominant neurodegenerative disease. We previously demonstrated that the mutant gamma PKC found in SCA14 is susceptible to aggregation, which induces apoptotic cell death. The disaccharide trehalose has been reported to inhibit aggregate formation and to alleviate symptoms in cellular and animal models of Huntington disease, Alzheimer disease, and prion disease. Here, we show that trehalose can be incorporated into SH-SY5Y cells and reduces the aggregation of mutant gamma PKC-GFP, thereby inhibiting apoptotic cell death in SH-SY5Y cells and primary cultured Purkinje cells (PCs). Trehalose acts by directly stabilizing the conformation of mutant gamma PKC without affecting protein turnover. Trehalose was also found to alleviate the improper development of dendrites in PCs expressing mutant gamma PKC-GFP without aggregates but not in PCs with aggregates. In PCs without aggregates, trehalose improves the mobility and translocation of mutant gamma PKC-GFP, probably by inhibiting oligomerization and thereby alleviating the improper development of dendrites. These results suggest that trehalose counteracts various cellular dysfunctions that are triggered by mutant gamma PKC in both neuronal cell lines and primary cultured PCs by inhibiting oligomerization and aggregation of mutant gamma PKC.	[Seki, Takahiro; Abe-Seki, Nana; Yamamoto, Kazuhiro; Tanaka, Shigeru; Hide, Izumi; Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan; [Kikawada, Takahiro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Takahashi, Hideyuki; Adachi, Naoko; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan	Hiroshima University; National Institute of Agrobiological Sciences - Japan; Kobe University	Sakai, N (corresponding author), 1-2-3 Kasumi,Minami Ku, Hiroshima 7348551, Japan.	nsakai@hiroshima-u.ac.jp	Kikawada, Takahiro/A-1289-2010; Tanaka, Shigeru/O-3908-2015; Sakai, Norio/AAM-5822-2021	Kikawada, Takahiro/0000-0002-2329-9282; Tanaka, Shigeru/0000-0003-3247-9098; Sakai, Norio/0000-0002-6648-8761; Seki, Takahiro/0000-0002-9894-4768; Adachi, Naoko/0000-0002-8797-0717	Ministry of Education, Sports and Culture; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; Suzuken Memorial Foundation; Tokyo Biochemical Research Foundation; Japanese Smoking Research Association	Ministry of Education, Sports and Culture; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Suzuken Memorial Foundation; Tokyo Biochemical Research Foundation; Japanese Smoking Research Association	This study was supported by a grant-in-aid for scientific research from the Ministry of Education, Sports and Culture and by grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Naito Foundation, the Suzuken Memorial Foundation, the Tokyo Biochemical Research Foundation, and the Japanese Smoking Research Association.	Adachi N, 2008, J BIOL CHEM, V283, P19854, DOI 10.1074/jbc.M801492200; Agorogiannis EI, 2004, NEUROPATH APPL NEURO, V30, P215, DOI 10.1111/j.1365-2990.2004.00558.x; Asai H, 2009, HUM MOL GENET, V18, P3533, DOI 10.1093/hmg/ddp298; Attanasio F, 2007, BIOCHEM BIOPH RES CO, V354, P899, DOI 10.1016/j.bbrc.2007.01.061; Beranger F, 2008, BIOCHEM BIOPH RES CO, V374, P44, DOI 10.1016/j.bbrc.2008.06.094; Cagnoli C, 2006, BRAIN, V129, P235, DOI 10.1093/brain/awh651; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Chen DH, 2005, NEUROLOGY, V64, P1258, DOI 10.1212/01.WNL.0000156801.64549.6B; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; Dalski A, 2006, J NEUROL, V253, P1111, DOI 10.1007/s00415-006-0209-9; Davies JE, 2006, HUM MOL GENET, V15, P23, DOI 10.1093/hmg/ddi422; Duenas AM, 2006, BRAIN, V129, P1357, DOI 10.1093/brain/awl081; Elbein A D, 1974, Adv Carbohydr Chem Biochem, V30, P227, DOI 10.1016/S0065-2318(08)60266-8; Elliott GD, 2006, CRYOBIOLOGY, V52, P114, DOI 10.1016/j.cryobiol.2005.10.009; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Hiramoto K, 2006, MOVEMENT DISORD, V21, P1355, DOI 10.1002/mds.20970; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Klebe S, 2007, ARCH NEUROL-CHICAGO, V64, P913, DOI 10.1001/archneur.64.6.913; Lin DB, 2007, BIOCHEM BIOPH RES CO, V362, P982, DOI 10.1016/j.bbrc.2007.08.093; Lin DB, 2007, EXP EYE RES, V85, P113, DOI 10.1016/j.exer.2007.03.007; Lins RD, 2004, PROTEINS, V55, P177, DOI 10.1002/prot.10632; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Nolte D, 2007, MOVEMENT DISORD, V22, P265, DOI 10.1002/mds.21269; Oliver A. E., 2004, CELL PRESERV TECHNOL, V2, P35, DOI DOI 10.1089/153834404322708745; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SAITO N, 1988, J NEUROSCI, V8, P369; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Seki T, 2005, J BIOL CHEM, V280, P29096, DOI 10.1074/jbc.M501716200; Seki T, 2007, EUR J NEUROSCI, V26, P3126, DOI 10.1111/j.1460-9568.2007.05933.x; Seki T, 2006, GENES CELLS, V11, P1051, DOI 10.1111/j.1365-2443.2006.01003.x; Seki T, 2009, NEUROBIOL DIS, V33, P260, DOI 10.1016/j.nbd.2008.10.013; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Verbeek DS, 2008, J CELL SCI, V121, P2339, DOI 10.1242/jcs.027698; Verbeek DS, 2005, BRAIN, V128, P436, DOI 10.1093/brain/awh378; Vlak MHM, 2006, MOVEMENT DISORD, V21, P1025, DOI 10.1002/mds.20851; Watanabe M, 2002, J EXP BIOL, V205, P2799; Wieczorek S, 2007, MOVEMENT DISORD, V22, P2135, DOI 10.1002/mds.21673; Yamamoto K, 2010, GENES CELLS, V15, P425, DOI 10.1111/j.1365-2443.2010.01395.x	49	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33252	33264		10.1074/jbc.M110.146704	http://dx.doi.org/10.1074/jbc.M110.146704			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20705605	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000283048200062
J	Lazard, M; Blanquet, S; Fisicaro, P; Labarraque, G; Plateau, P				Lazard, Myriam; Blanquet, Sylvain; Fisicaro, Paola; Labarraque, Guillaume; Plateau, Pierre			Uptake of Selenite by Saccharomyces cerevisiae Involves the High and Low Affinity Orthophosphate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE-TRANSPORTER; YEAST; TOXICITY; SELENATE; SULFATE; SYSTEM; GENE; TRANSLOCATION; METABOLISM	Although the general cytotoxicity of selenite is well established, the mechanism by which this compound crosses cellular membranes is still unknown. Here, we show that in Saccharomyces cerevisiae, the transport system used opportunistically by selenite depends on the phosphate concentration in the growth medium. Both the high and low affinity phosphate transporters are involved in selenite uptake. When cells are grown at low P-i concentrations, the high affinity phosphate transporter Pho84p is the major contributor to selenite uptake. When phosphate is abundant, selenite is internalized through the low affinity P-i transporters (Pho87p, Pho90p, and Pho91p). Accordingly, inactivation of the high affinity phosphate transporter Pho84p results in increased resistance to selenite and reduced uptake in low P-i medium, whereas deletion of SPL2, a negative regulator of low affinity phosphate uptake, results in exacerbated sensitivity to selenite. Measurements of the kinetic parameters for selenite and phosphate uptake demonstrate that there is a competition between phosphate and selenite ions for both P-i transport systems. In addition, our results indicate that Pho84p is very selective for phosphate as compared with selenite, whereas the low affinity transporters discriminate less efficiently between the two ions. The properties of phosphate and selenite transport enable us to propose an explanation to the paradoxical increase of selenite toxicity when phosphate concentration in the growth medium is raised above 1 mM.	[Lazard, Myriam; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, Biochim Lab, CNRS, UMR7654, F-91128 Palaiseau, France; [Fisicaro, Paola; Labarraque, Guillaume] Lab Natl Metrol & Essais, Dept Biomed & Inorgan Chem, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris; Laboratoire National de Metrologie et d'Essais (LNE)	Lazard, M (corresponding author), Ecole Polytech, Biochim Lab, CNRS, UMR7654, F-91128 Palaiseau, France.	myriam.lazard@polytechnique.edu		Lazard, Myriam/0000-0002-7154-1352				Auesukaree C, 2003, BIOCHEM BIOPH RES CO, V306, P843, DOI 10.1016/S0006-291X(03)01068-4; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BISSON LF, 1982, GENETICS, V102, P341; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; BURNS DJW, 1977, EUR J BIOCHEM, V81, P45, DOI 10.1111/j.1432-1033.1977.tb11925.x; Cherest H, 1997, GENETICS, V145, P627; Cost GJ, 1996, YEAST, V12, P939, DOI 10.1002/(SICI)1097-0061(199608)12:10<939::AID-YEA988>3.0.CO;2-L; DARDEL F, 1994, COMPUT APPL BIOSCI, V10, P273; FALCONE G, 1963, J BACTERIOL, V85, P754, DOI 10.1128/JB.85.4.754-762.1963; Ganyc D, 2008, FEBS LETT, V582, P299, DOI 10.1016/j.febslet.2007.12.022; Gharieb MM, 2004, MYCOL RES, V108, P1415, DOI 10.1017/S0953756204001418; Hopper JL, 1999, PLANT SOIL, V210, P199, DOI 10.1023/A:1004639906245; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Hurlimann HC, 2009, EMBO REP, V10, P1003, DOI 10.1038/embor.2009.105; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Li HF, 2008, NEW PHYTOL, V178, P92, DOI 10.1111/j.1469-8137.2007.02343.x; LINDBLOWKULL C, 1985, J BACTERIOL, V163, P1267, DOI 10.1128/JB.163.3.1267-1269.1985; Martinez P, 1998, J BACTERIOL, V180, P2253, DOI 10.1128/JB.180.8.2253-2256.1998; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Pereira Y, 2008, TOXICOL SCI, V106, P400, DOI 10.1093/toxsci/kfn193; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Persson BL, 1999, BBA-REV BIOMEMBRANES, V1422, P255, DOI 10.1016/S0304-4157(99)00010-6; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Pinson B, 2004, J BIOL CHEM, V279, P35273, DOI 10.1074/jbc.M405398200; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Riedel GF, 1996, ENVIRON TOXICOL CHEM, V15, P1577, DOI 10.1002/etc.5620150923; Rosen BR, 2009, ENVIRON INT, V35, P512, DOI 10.1016/j.envint.2008.07.023; ROTHSTEIN A, 1963, J GEN PHYSIOL, V46, P1075, DOI 10.1085/jgp.46.5.1075; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; Turner RJ, 1998, BIOMETALS, V11, P223, DOI 10.1023/A:1009290213301; Wykoff DD, 2001, GENETICS, V159, P1491; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022; Zvyagilskaya RA, 2008, FEMS YEAST RES, V8, P685, DOI 10.1111/j.1567-1364.2008.00408.x	35	43	47	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32029	32037		10.1074/jbc.M110.139865	http://dx.doi.org/10.1074/jbc.M110.139865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688911	Green Published, hybrid			2022-12-27	WOS:000282683000016
J	Shi, ZD; Rockey, DC				Shi, Zengdun; Rockey, Don C.			Interferon-gamma-mediated Inhibition of Serum Response Factor-dependent Smooth Muscle-specific Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELLS; RNASE-L; MOLECULAR REGULATION; TGF-BETA; ACTIN; ALPHA; DIFFERENTIATION; ACTIVATION; MYOCARDIN; FIBROSIS	IFN gamma exerts multiple biological effects on effector cells by regulating many downstream genes, including smooth muscle-specific genes. However, the molecular mechanisms underlying IFN gamma-induced inhibition of smooth muscle-specific gene expression remain unclear. In this study, we have shown that serum response factor (SRF), a common transcriptional factor important in cell proliferation, migration, and differentiation, is targeted by IFN gamma in a STAT1-dependent manner. We show that the molecular mechanism by which IFN gamma regulates SRF is via activation of the 2-5A-RNase L system, which triggers SRF mRNA decay and reduced SRF expression. As a result, decreased SRF expression reduces expression of SRF target genes such as smooth muscle alpha-actin and smooth muscle myosin heavy chain. Additionally, IFN gamma reduced p300 and acetylated histone-3 binding in both smooth muscle alpha-actin and SRF promoters, epigenetically decreasing smooth muscle alpha-actin and SRF transcriptional activation. Our data reveal that SRF is a novel IFN gamma-regulated gene and further elucidate the molecular pathway between IFN gamma, IFN gamma-regulated genes, and SRF and its target genes.	[Shi, Zengdun; Rockey, Don C.] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Rockey, DC (corresponding author), Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	don.rockey@utsouthwestern.edu			National Institutes of Health [R01 DK 60338, R01 DK 50574]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050574, R01DK063308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK 60338 and R01 DK 50574 (to D.C.R.).	Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Fujita T, 2006, INT J MOL MED, V17, P605; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; HANSSON GK, 1989, J EXP MED, V170, P1595, DOI 10.1084/jem.170.5.1595; Herrmann J, 2007, BBA-MOL BASIS DIS, V1772, P1250, DOI 10.1016/j.bbadis.2007.10.006; Higashi K, 2003, J BIOL CHEM, V278, P5156, DOI 10.1074/jbc.M208724200; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Khabar KSA, 2003, J BIOL CHEM, V278, P20124, DOI 10.1074/jbc.M208766200; Liang SL, 2006, IUBMB LIFE, V58, P508, DOI 10.1080/15216540600838232; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Meeson AP, 2007, EMBO J, V26, P1902, DOI 10.1038/sj.emboj.7601635; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Mizzen CA, 1998, CELL MOL LIFE SCI, V54, P6, DOI 10.1007/s000180050121; Muir AJ, 2006, J VIRAL HEPATITIS, V13, P322, DOI 10.1111/j.1365-2893.2005.00689.x; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; ROCKEY DC, 1992, HEPATOLOGY, V16, P776, DOI 10.1002/hep.1840160325; ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shao R, 2003, MOL BIOL CELL, V14, P2327, DOI 10.1091/mbc.02-06-0093; Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663; Tau G, 1999, ALLERGY, V54, P1233, DOI 10.1034/j.1398-9995.1999.00099.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95	38	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32415	32424		10.1074/jbc.M110.164863	http://dx.doi.org/10.1074/jbc.M110.164863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20685657	Green Published, hybrid			2022-12-27	WOS:000282683000055
J	Fonseca, AV; Freund, D; Bornhauser, M; Corbeil, D				Fonseca, Ana-Violeta; Freund, Daniel; Bornhaeuser, Martin; Corbeil, Denis			Polarization and Migration of Hematopoietic Stem and Progenitor Cells Rely on the RhoA/ROCK I Pathway and an Active Reorganization of the Microtubule Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN RHO; POLYTOPIC MEMBRANE-PROTEIN; PLASMA-MEMBRANE; FOCAL ADHESIONS; T-LYMPHOCYTES; STRESS FIBERS; EZRIN/RADIXIN/MOESIN PROTEINS; TRANSENDOTHELIAL MIGRATION; NEUTROPHIL MIGRATION; IMMUNE INTERACTIONS	Understanding the physiological migration of hematopoietic progenitors is important, not only for basic stem cell research, but also in view of their therapeutic relevance. Here, we investigated the role of the Rho kinase pathway in the morphology and migration of hematopoietic progenitors using an ex vivo co-culture consisting of human primary CD34(+) progenitors and mesenchymal stromal cells. The addition of the Rho kinase inhibitor Y-27632 led to the abolishment of the uropod and microvillar-like structures of hematopoietic progenitors, concomitant with a redistribution of proteins found therein (prominin-1 and ezrin). Y-27632-treated cells displayed a deficiency in migration. Time-lapse video microscopy revealed impairment of the rear pole retraction. Interestingly, the knockdown of ROCK I, but not ROCK II, using RNA interference (RNAi) was sufficient to cause the referred morphological and migrational changes. Unexpectedly, the addition of nocodazole to either Y-27632- or ROCK I RNAi-treated cells could restore their polarized morphology and migration suggesting an active role for the microtubule network in tail retraction. Finally, we could demonstrate using RNAi that RhoA, the upstream regulator of ROCK, is involved in these processes. Collectively, our data provide new insights regarding the role of RhoA/ROCK I and the microtubules in the migration of stem cells.	[Fonseca, Ana-Violeta; Freund, Daniel; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs, D-01307 Dresden, Germany; [Bornhaeuser, Martin; Corbeil, Denis] Tech Univ Dresden, Deutsch Forsch Gemeinschaft Res Ctr, D-01307 Dresden, Germany; [Bornhaeuser, Martin] Univ Hosp, Med Clin & Polyclin 1, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Corbeil, D (corresponding author), Tech Univ Dresden, Tissue Engn Labs, Tatzberg 47-49, D-01307 Dresden, Germany.	corbeil@biotec.tu-dresden.de	Corbeil, Denis/A-6519-2010; Bornhäuser, Martin/F-8101-2010; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/L-2340-2019	Corbeil, Denis/0000-0003-1181-3659	Deutsche Forschungsgemeinschaft (DFG) [SFB 655 B2, SFB/TR83 6, SFB 655 B3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (DFG Grant SFB 655 B2).; Supported by the DFG (Grants SFB/TR83 # 6 and SFB 655 B3).	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Barreiro O, 2007, IMMUNOL REV, V218, P147, DOI 10.1111/j.1600-065X.2007.00529.x; Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Corbeil D, 1999, J CELL SCI, V112, P1023; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; delPozo MA, 1997, J CELL BIOL, V137, P493; Eddy RJ, 2000, J CELL SCI, V113, P1287; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Freund D, 2010, CYTOTHERAPY, V12, P131, DOI 10.3109/14653240903476438; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Ghiaur G, 2006, BLOOD, V108, P2087, DOI 10.1182/blood-2006-02-001560; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Giebel B, 2007, CELL CYCLE, V6, P2201, DOI 10.4161/cc.6.18.4658; Gillette JM, 2009, NAT CELL BIOL, V11, P303, DOI 10.1038/ncb1838; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Von Levetzow G, 2006, STEM CELLS DEV, V15, P278, DOI 10.1089/scd.2006.15.278; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yonemura S, 2002, J CELL SCI, V115, P2569; Yoshinaga-Ohara N, 2002, EXP CELL RES, V278, P112, DOI 10.1006/excr.2002.5571	56	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31661	31671		10.1074/jbc.M110.145037	http://dx.doi.org/10.1074/jbc.M110.145037			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682776	Green Published, hybrid			2022-12-27	WOS:000282764600058
J	Taylor, M; Navarro-Garcia, F; Huerta, J; Burress, H; Massey, S; Ireton, K; Teter, K				Taylor, Michael; Navarro-Garcia, Fernando; Huerta, Jazmin; Burress, Helen; Massey, Shane; Ireton, Keith; Teter, Ken			Hsp90 Is Required for Transfer of the Cholera Toxin A1 Subunit from the Endoplasmic Reticulum to the Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION PATHWAY; CELL CHAPERONE HSP90; BOTULINUM C2 TOXIN; RETRO-TRANSLOCATION; MAMMALIAN-CELLS; INTRACELLULAR TRAFFICKING; CYSTIC-FIBROSIS; CULTURED-CELLS; RETROTRANSLOCATION; POLYPEPTIDE	Cholera toxin (CT) is an AB(5) toxin that moves from the cell surface to the endoplasmic reticulum (ER) by retrograde vesicular transport. In the ER, the catalytic A1 subunit dissociates from the rest of the toxin and enters the cytosol by exploiting the quality control system of ER-associated degradation (ERAD). The driving force for CTA1 dislocation into the cytosol is unknown. Here, we demonstrate that the cytosolic chaperone Hsp90 is required for CTA1 passage into the cytosol. Hsp90 bound to CTA1 in an ATP-dependent manner that was blocked by geldanamycin (GA), an established Hsp90 inhibitor. CT activity against cultured cells and ileal loops was also blocked by GA, as was the ER-to-cytosol export of CTA1. Experiments using RNA interference or N-ethylcarboxamidoadenosine, a drug that inhibits ER-localized GRP94 but not cytosolic Hsp90, confirmed that the inhibitory effects of GA resulted specifically from the loss of Hsp90 activity. This work establishes a functional role for Hsp90 in the ERAD-mediated dislocation of CTA1.	[Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Navarro-Garcia, Fernando; Huerta, Jazmin] Ctr Invest & Estudios Avanzados IPN CINVESTAV ZAC, Dept Cell Biol, Mexico City 07000, DF, Mexico	State University System of Florida; University of Central Florida; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Teter, K (corresponding author), 12722 Res Pkwy,Biomol Res Annex, Orlando, FL 32826 USA.	kteter@mail.ucf.edu	Navarro-Garcia, Fernando/A-3980-2011	Teter, Ken/0000-0003-4176-9361	National Institutes of Health [R01 AI073783]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI073783 (to K. T.).	Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Castro MG, 2001, CELL MICROBIOL, V3, P45, DOI 10.1046/j.1462-5822.2001.00092.x; CHANG FH, 1989, J BIOL CHEM, V264, P5352; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; FISHMAN PH, 1982, J CELL BIOL, V93, P860, DOI 10.1083/jcb.93.3.860; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; Haug G, 2004, INFECT IMMUN, V72, P3066, DOI 10.1128/IAI.72.5.3066-3068.2004; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0; Kaiser E, 2009, CELL MICROBIOL, V11, P780, DOI 10.1111/j.1462-5822.2009.01291.x; Kato J, 2007, MOL CELL BIOL, V27, P5534, DOI 10.1128/MCB.00302-07; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Marshall RS, 2008, J BIOL CHEM, V283, P15869, DOI 10.1074/jbc.M709316200; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; McConnell E, 2007, BIOCHEM BIOPH RES CO, V355, P1087, DOI 10.1016/j.bbrc.2007.02.077; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; NAMBIAR MP, 1993, J CELL PHYSIOL, V154, P222, DOI 10.1002/jcp.1041540203; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Ratts R, 2003, J CELL BIOL, V160, P1139, DOI 10.1083/jcb.200210028; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wernick NLB, 2010, J BIOL CHEM, V285, P6145, DOI 10.1074/jbc.M109.062067; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	50	54	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31261	31267		10.1074/jbc.M110.148981	http://dx.doi.org/10.1074/jbc.M110.148981			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667832	hybrid, Green Published			2022-12-27	WOS:000282764600020
J	Mueller, GM; Maarouf, AB; Kinlough, CL; Sheng, N; Kashlan, OB; Okumura, S; Luthy, S; Kleyman, TR; Hughey, RP				Mueller, Gunhild M.; Maarouf, Ahmad B.; Kinlough, Carol L.; Sheng, Nan; Kashlan, Ossama B.; Okumura, Sora; Luthy, Sarah; Kleyman, Thomas R.; Hughey, Rebecca P.			Cys Palmitoylation of the beta Subunit Modulates Gating of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; ALPHA-SUBUNIT; LIPID RAFTS; A6 CELLS; APICAL MEMBRANE; PROTEIN PALMITOYLATION; FUNCTIONAL EXPRESSION; MEDIATED ENDOCYTOSIS; PROTEOLYTIC CLEAVAGE; SURFACE EXPRESSION	The epithelial Na+ channel (ENaC) is comprised of three homologous subunits (alpha, beta, and gamma) that have a similar topology with two transmembrane domains, a large extracellular region, and cytoplasmic N and C termini. Although ENaC activity is regulated by a number of factors, palmitoylation of its cytoplasmic Cys residues has not been previously described. Fatty acid-exchange chemistry was used to determine whether channel subunits were Cys-palmitoylated. We observed that only the beta and gamma subunits were modified by Cys palmitoylation. Analyses of ENaCs with mutant beta subunits revealed that Cys-43 and Cys-557 were palmitoylated. Xenopus oocytes expressing ENaC with a beta C43A, C557A mutant had significantly reduced amiloride-sensitive whole cell currents, enhanced Na+ self-inhibition, and reduced single channel P-o when compared with wild-type ENaC, while membrane trafficking and levels of surface expression were unchanged. Computer modeling of cytoplasmic domains indicated that beta Cys-43 is in proximity to the first transmembrane alpha helix, whereas beta Cys-557 is within an amphipathic alpha-helix contiguous with the second transmembrane domain. We propose that beta subunit palmitoylation modulates channel gating by facilitating interactions between cytoplasmic domains and the plasma membrane.	[Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.; Hughey, Rebecca P.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu			National Institutes of Health [DK65161]; National Institutes of Health (Pittsburgh Center for Kidney Research) [DK079307]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065161, K01DK078734, P30DK079307, R56DK065161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (Pittsburgh Center for Kidney Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK65161 (to T. R. K. and R. P. H.) and DK079307 (Pittsburgh Center for Kidney Research).; Supported by a postdoctoral fellowship award from the American Heart Association.	Ahn YJ, 1999, AM J PHYSIOL-RENAL, V277, pF121, DOI 10.1152/ajprenal.1999.277.1.F121; ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bruns JB, 2003, AM J PHYSIOL-RENAL, V285, pF600, DOI 10.1152/ajprenal.00095.2003; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Crane JM, 2009, BIOPHYS J, V97, P3010, DOI 10.1016/j.bpj.2009.09.017; de la Rosa DA, 2002, J GEN PHYSIOL, V119, P427, DOI 10.1085/jgp.20028559; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Heneghan JF, 2009, J GEN PHYSIOL, V134, P369, DOI 10.1085/jgp.200910203; Herincs Z, 2005, J CELL SCI, V118, P1687, DOI 10.1242/jcs.02296; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005; May A, 1997, J AM SOC NEPHROL, V8, P1813; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Mulugeta S, 2003, J BIOL CHEM, V278, P47979, DOI 10.1074/jbc.M308210200; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Suzuki H, 2008, BBA-BIOMEMBRANES, V1778, P1181, DOI 10.1016/j.bbamem.2007.12.007; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yik JHN, 2002, J BIOL CHEM, V277, P40844, DOI 10.1074/jbc.M204780200; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	71	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30453	30462		10.1074/jbc.M110.151845	http://dx.doi.org/10.1074/jbc.M110.151845			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663869	hybrid, Green Published			2022-12-27	WOS:000282135500012
J	Yuasa, N; Zhang, W; Goto, T; Sakaue, H; Matsumoto-Takasaki, A; Kimura, M; Ohshima, H; Tsuchida, Y; Koizumi, T; Sakai, K; Kojima, T; Yamamoto, K; Nakata, M; Fujita-Yamaguchi, Y				Yuasa, Noriyuki; Zhang, Wei; Goto, Tomohiro; Sakaue, Hiroyuki; Matsumoto-Takasaki, Ayano; Kimura, Miyo; Ohshima, Hiroya; Tsuchida, Yasunobu; Koizumi, Tomoyuki; Sakai, Keiko; Kojima, Takumi; Yamamoto, Kazuo; Nakata, Munehiro; Fujita-Yamaguchi, Yoko			Production of Anti-carbohydrate Antibodies by Phage Display Technologies POTENTIAL IMPAIRMENT OF CELL GROWTH AS A RESULT OF ENDOGENOUS EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN ANTIBODIES; TERMINAL MANNOSE RESIDUES; ENDOPLASMIC-RETICULUM; FUCOSYL-TRANSFERASE; TUMOR-GROWTH; SELECTION; PROTEIN; AFFINITY; RECEPTOR; ANTIGEN	Anti-mannotriose (Man3) antibodies were previously isolated from a Keio phage library displaying human single chain variable fragments (scFvs) using a neoglycolipid, Man3-dipalmitoylphosphatidylethanolamine. Of three genes constructed, the 5A3 clone was expressed in mouse myeloma NS0 cells as a conjugate with human IgG(1) Fc (scFv-Fc) and characterized (Sakai, K., Shimizu, Y., Chiba, T., Matsumoto-Takasaki, A., Kusada, Y., Zhang, W., Nakata, M., Kojima, N., Toma, K., Takayanagi, A., Shimizu, N., and Fujita-Yamaguchi, Y. (2007) Biochemistry 46, 253-262; Zhang, W., Matsumoto- Takasaki, A., Kusada, Y., Sakaue, H., Sakai, K., Nakata, M., and Fujita-Yamaguchi, Y. (2007) Biochemistry 46, 263-270). Similarly, anti-Le(x) phages were screened from the same library with lacto-N-fucopentaose III (LNFPIII; Le(x))-dipalmitoylphosphatidylethanolamine. Of five phage clones isolated, two scFv genes were constructed to express scFv-Fc proteins in NS0 cells. As was experienced with anti-Man3 scFv-Fc clones, only one anti-LNFPIII clone, 1F12, was successfully produced and purified as an scFv-Fc protein. Although anti-LNFPIII 1F12 and anti-Man3 5A3 scFv-Fc proteins were secreted into media, a decline in scFv-Fc production was observed with both stable clones during early passages. Transient expression of anti-LNFPIII and anti-Man3 scFv-Fc genes in COS-7 cells and subsequent analyses of scFv-Fc protein expression revealed accumulation of translated proteins in the endoplasmic reticulum for scFv-Fc proteins derived from clones that did not survive as stable clones. This report describes the following: (i) isolation of anti-LNFPIII scFv genes; (ii) purification of anti-LNFPIII scFv-Fc proteins from stably and transiently expressed cells; and (iii) extracellular or intracellular localization of two anti-LNFPIII and three anti-Man3 scFv-Fc proteins. The results suggest that expression of anti-Man3 and other anti-carbohydrate antibodies in mammalian cells is disadvantageous for cell growth.	[Yuasa, Noriyuki; Zhang, Wei; Goto, Tomohiro; Sakaue, Hiroyuki; Matsumoto-Takasaki, Ayano; Kimura, Miyo; Ohshima, Hiroya; Tsuchida, Yasunobu; Koizumi, Tomoyuki; Sakai, Keiko; Nakata, Munehiro; Fujita-Yamaguchi, Yoko] Tokai Univ, Sch Engn, Dept Appl Biochem, Kanagawa 2591292, Japan; [Kojima, Takumi; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan	Tokai University; University of Tokyo	Fujita-Yamaguchi, Y (corresponding author), 4-1-1 Kitakaname, Kanagawa 2591292, Japan.	yamaguch@keyaki.cc.u-tokai.ac.jp			Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science [22570125]	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant from the Core Research for Evolutional Science and Technology (CREST) Project, Japan Science and Technology Agency (JST), and Grant 22570125 from the Japan Society for the Promotion of Science.	DENG SJ, 1994, J BIOL CHEM, V269, P9533; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fribley A, 2009, METHODS MOL BIOL, V559, P191, DOI 10.1007/978-1-60327-017-5_14; GERSTEN KM, 1995, J BIOL CHEM, V270, P25047, DOI 10.1074/jbc.270.42.25047; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; KABAT EA, 1991, SEQUENCES PROTEINS I, V1, P103; KODA Y, 1993, BLOOD, V82, P2915; Lee KJ, 2002, J AM CHEM SOC, V124, P12439, DOI 10.1021/ja020737j; Li SL, 2000, CANCER IMMUNOL IMMUN, V49, P243, DOI 10.1007/s002620000115; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; Mao SL, 1999, P NATL ACAD SCI USA, V96, P6953, DOI 10.1073/pnas.96.12.6953; Mintz M, 2008, J PROTEOME RES, V7, P2435, DOI 10.1021/pr700842m; NEUMAIER M, 1990, CANCER RES, V50, P2128; Ono KI, 2003, J BIOSCI BIOENG, V95, P231, DOI 10.1016/S1389-1723(03)80022-1; Ravn P, 2004, J MOL BIOL, V343, P985, DOI 10.1016/j.jmb.2004.08.052; Sachdev D, 2003, CANCER RES, V63, P627; Sakai K, 2007, BIOCHEMISTRY-US, V46, P253, DOI 10.1021/bi061875e; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Shimizu Y, 2001, J CHROMATOGR B, V754, P127, DOI 10.1016/S0378-4347(00)00594-6; STOLL MS, 1988, BIOCHEM J, V256, P661, DOI 10.1042/bj2560661; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wu AM, 1996, IMMUNOTECHNOLOGY, V2, P21, DOI 10.1016/1380-2933(95)00027-5; Wu AM, 2001, PROTEIN ENG, V14, P1025, DOI 10.1093/protein/14.12.1025; Ye JJ, 2003, HORM METAB RES, V35, P836; Zhang W, 2007, BIOCHEMISTRY-US, V46, P263, DOI 10.1021/bi0618767	28	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30587	30597		10.1074/jbc.M110.107284	http://dx.doi.org/10.1074/jbc.M110.107284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20667829	Green Published, hybrid			2022-12-27	WOS:000282135500027
J	Collard, F; Stroobant, V; Lamosa, P; Kapanda, CN; Lambert, DM; Muccioli, GG; Poupaert, JH; Opperdoes, F; Van Schaftingen, E				Collard, Francois; Stroobant, Vincent; Lamosa, Pedro; Kapanda, Coco N.; Lambert, Didier M.; Muccioli, Giulio G.; Poupaert, Jacques H.; Opperdoes, Fred; Van Schaftingen, Emile			Molecular Identification of N-Acetylaspartylglutamate Synthase and beta-Citrylglutamate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-GLUTAMIC ACID; ALPHA-ASPARTYLGLUTAMIC ACID; CENTRAL-NERVOUS-SYSTEM; L-ASPARTIC ACID; BRAIN; RAT; ACETYLASPARTATE; NAAG; BIOSYNTHESIS; PROTEIN	The purpose of the present work was to determine the identity of the enzymes that synthesize N-acetylaspartylglutamate (NAAG), the most abundant dipeptide present in vertebrate central nervous system (CNS), and beta-citrylglutamate, a structural analogue of NAAG present in testis and immature brain. Previous evidence suggests that NAAG is not synthesized on ribosomes but presumably is synthesized by a ligase. As attempts to detect this ligase in brain extracts failed, we searched the mammalian genomes for putative enzymes that could catalyze this type of reaction. Mammalian genomes were found to encode two putative ligases homologous to Escherichia coli RIMK, which ligates glutamates to the C terminus of ribosomal protein S6. One of them, named RIMKLA, is almost exclusively expressed in the CNS, whereas RIMKLB, which shares 65% sequence identity with RIMKLA, is expressed in CNS and testis. Both proteins were expressed in bacteria or HEK293T cells and purified. RIMKLA catalyzed the ATP-dependent synthesis of N-acetylaspartylglutamate from N-acetylaspartate and L-glutamate. RIMKLB catalyzed this reaction as well as the synthesis of beta-citrylglutamate. The nature of the reaction products was confirmed by mass spectrometry and NMR. RIMKLA was shown to produce stoichiometric amounts of NAAG and ADP, in agreement with its belonging to the ATP-grasp family of ligases. The molecular identification of these two enzymes will facilitate progress in the understanding of the function of NAAG and beta-citrylglutamate.	[Van Schaftingen, Emile] Catholic Univ Louvain, Chim Physiol Lab, B-1200 Brussels, Belgium; [Stroobant, Vincent] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Opperdoes, Fred] de Duve Inst, Trop Dis Res Unit, B-1200 Brussels, Belgium; [Kapanda, Coco N.; Lambert, Didier M.; Muccioli, Giulio G.; Poupaert, Jacques H.] Catholic Univ Louvain, Unite Chim Pharmaceut & Radiopharm, Louvain Drug Res Inst, CHAM7230, B-1200 Brussels, Belgium; [Kapanda, Coco N.; Lambert, Didier M.; Muccioli, Giulio G.; Poupaert, Jacques H.] Catholic Univ Louvain, Pharmacol Bioact Lipids Lab, Louvain Drug Res Inst, CHAM7230, B-1200 Brussels, Belgium; [Lamosa, Pedro] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Ctr Ressonancia Magnet Antonio Xavier, Estacao Agron Nacl, P-2780157 Oeiras, Portugal	Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; National Institute for Agricultural Research Portugal; Universidade Nova de Lisboa	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Chim Physiol Lab, Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Opperdoes, Fred/N-9922-2019; Opperdoes, Frederik R/C-8897-2018; Van+Schaftingen, Emile/AAF-5532-2020	Opperdoes, Fred/0000-0003-1984-3764; Opperdoes, Frederik R/0000-0003-1984-3764; Van Schaftingen, Emile/0000-0002-6199-7647; Lamosa, Pedro/0000-0002-3003-1516; Muccioli, Giulio/0000-0002-1600-9259	Belgian Science Policy [P6/05, P6/28]; Region Wallonne; Asco Industries; Programa Operacional Ciencia e Inovacao; Fundacao para a Ciencia e a Tecnologia, Portugal	Belgian Science Policy(Belgian Federal Science Policy Office); Region Wallonne; Asco Industries; Programa Operacional Ciencia e Inovacao; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grants from the Interuniversity Attraction Poles Program-Belgian Science Policy (Networks P6/05 and P6/28), by the Desordres Inflammatoires dans les Affections Neurologiques center of excellence program of the Region Wallonne, and by a grant from Asco Industries (to E. V. S.). The NMR spectrometers are part of the National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao 2010" and Fundacao para a Ciencia e a Tecnologia, Portugal.	Arun P, 2006, J NEUROCHEM, V98, P2034, DOI 10.1111/j.1471-4159.2006.04068.x; Burlina AP, 2006, ADV EXP MED BIOL, V576, P283; Bzdega T, 2004, J NEUROCHEM, V89, P627, DOI 10.1111/j.1471-4159.2004.02361.x; Bzdega T, 1997, J NEUROCHEM, V69, P2270; CANGRO CB, 1987, J NEUROCHEM, V49, P1579, DOI 10.1111/j.1471-4159.1987.tb01030.x; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Delplanque J, 2004, J BIOL CHEM, V279, P46606, DOI 10.1074/jbc.M407678200; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fricker AC, 2009, NEUROPHARMACOLOGY, V56, P1060, DOI 10.1016/j.neuropharm.2009.03.002; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gehl LM, 2004, J NEUROCHEM, V90, P989, DOI 10.1111/j.1471-4159.2004.02578.x; Hamada-Kanazawa M, 2010, BIOL PHARM BULL, V33, P729, DOI 10.1248/bpb.33.729; Hara T, 1996, BIOCHEMISTRY-US, V35, P11967, DOI 10.1021/bi9605245; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KANG WK, 1989, MOL GEN GENET, V217, P281, DOI 10.1007/BF02464894; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kogo H, 2010, J HUM GENET, V55, P293, DOI 10.1038/jhg.2010.26; Li H, 2003, P NATL ACAD SCI USA, V100, P9785, DOI 10.1073/pnas.1733391100; Lieberman EM, 2006, ADV EXP MED BIOL, V576, P303; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; MIYAKE M, 1982, BIOCHIM BIOPHYS ACTA, V719, P495, DOI 10.1016/0304-4165(82)90238-0; MIYAKE M, 1978, BIOCHIM BIOPHYS ACTA, V544, P656, DOI 10.1016/0304-4165(78)90340-9; MIYAKE M, 1981, J NEUROCHEM, V36, P804, DOI 10.1111/j.1471-4159.1981.tb01665.x; MIYAKE M, 1981, J NEUROCHEM, V37, P1064, DOI 10.1111/j.1471-4159.1981.tb04500.x; Moffett JR, 2006, ADV EXP MED BIOL, V576, P7; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; REICHELT KL, 1973, J NEUROCHEM, V21, P849, DOI 10.1111/j.1471-4159.1973.tb07529.x; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyson RL, 1998, NEUROSCI LETT, V251, P181, DOI 10.1016/S0304-3940(98)00527-8; Veiga-da-Cunha M, 2010, J BIOL CHEM, V285, P18888, DOI 10.1074/jbc.M110.110924; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Wroblewska B, 1997, J NEUROCHEM, V69, P174	36	36	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29826	29833		10.1074/jbc.M110.152629	http://dx.doi.org/10.1074/jbc.M110.152629			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20657015	Green Published, hybrid			2022-12-27	WOS:000281984300018
J	Gao, D; Nong, SW; Huang, XQ; Lu, YG; Zhao, HY; Lin, YJ; Man, Y; Wang, S; Yang, JF; Li, JA				Gao, Dan; Nong, Shanwei; Huang, Xiuqing; Lu, Yonggang; Zhao, Hongye; Lin, Yajun; Man, Yong; Wang, Shu; Yang, Jiefu; Li, Jian			The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38(MAPK) Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL DYSFUNCTION; ACTIVATED SIGNALING PATHWAYS; FREE FATTY-ACIDS; NF-KAPPA-B; OXIDATIVE STRESS; SKELETAL-MUSCLE; GLUCOSE OUTPUT; GLUCONEOGENESIS; INHIBITION; EXPRESSION	Elevated plasma free fatty acid (FFA) levels in obesity may play a pathogenic role in the development of insulin resistance. However, molecular mechanisms linking FFA to insulin resistance remain poorly understood. Oxidative stress acts as a link between FFA and hepatic insulin resistance. NADPH oxidase 3 (NOX3)-derived reactive oxygen species (ROS) may mediate the effect of TNF-alpha on hepatocytes, in particular the drop in cellular glycogen content. In the present study, we define the critical role of NOX3-derived ROS in insulin resistance in db/db mice and HepG2 cells treated with palmitate. The db/db mice displayed increased serum FFA levels, excess generation of ROS, and up-regulation of NOX3 expression, accompanied by increased lipid accumulation and impaired glycogen content in the liver. Similar results were obtained from palmitate-treated HepG2 cells. The exposure of palmitate elevated ROS production and NOX3 expression and, in turn, increased gluconeogenesis and reduced glycogen content in HepG2 cells. We found that palmitate induced hepatic insulin resistance through JNK and p38(MAPK) pathways, which are rescued by siRNA-mediated NOX3 reduction. In conclusion, our data demonstrate a critical role of NOX3-derived ROS in palmitate-induced insulin resistance in hepatocytes, indicating that NOX3 is the predominant source of palmitate-induced ROS generation and that NOX3-derived ROS may drive palmitate-induced hepatic insulin resistance through JNK and p38(MAPK) pathways.	[Gao, Dan; Nong, Shanwei; Huang, Xiuqing; Lu, Yonggang; Zhao, Hongye; Lin, Yajun; Man, Yong; Wang, Shu; Yang, Jiefu; Li, Jian] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China; [Gao, Dan; Nong, Shanwei; Huang, Xiuqing; Lu, Yonggang; Zhao, Hongye; Lin, Yajun; Man, Yong; Wang, Shu; Yang, Jiefu; Li, Jian] Minist Hlth, Beijing Inst Geriatr, Beijing 100730, Peoples R China; [Gao, Dan; Lu, Yonggang; Zhao, Hongye; Li, Jian] Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Gao, Dan; Lu, Yonggang; Zhao, Hongye; Li, Jian] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Yang, JF (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China.	ltaoy@263.net; lijian@bjhmoh.cn	LI, RUIJIAN/GYJ-0470-2022		National Basic Research Program of China [2006CB503910]; National Natural Science Foundation of China [30572082]; Natural Science Foundation of Beijing [7052059]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by National Basic Research Program of China Grant 2006CB503910), National Natural Science Foundation of China Grant 30572082, and Natural Science Foundation of Beijing Grant 7052059.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Archuleta TL, 2009, FREE RADICAL BIO MED, V47, P1486, DOI 10.1016/j.freeradbiomed.2009.08.014; Azevedo-Martins AK, 2006, TOXICOL IN VITRO, V20, P1106, DOI 10.1016/j.tiv.2006.02.007; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bloch-Damti A, 2005, ANTIOXID REDOX SIGN, V7, P1553, DOI 10.1089/ars.2005.7.1553; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Ciaraldi TP, 2006, AM J PHYSIOL-ENDOC M, V291, pE891, DOI 10.1152/ajpendo.00176.2006; Davis JE, 2009, HORM METAB RES, V41, P523, DOI 10.1055/s-0029-1202852; Delbosc S, 2005, ATHEROSCLEROSIS, V179, P43, DOI 10.1016/j.atherosclerosis.2004.10.018; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Fridlyand LE, 2006, DIABETES OBES METAB, V8, P136, DOI 10.1111/j.1463-1326.2005.00496.x; Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408; Gastaldelli A, 2000, DIABETES, V49, P1367, DOI 10.2337/diabetes.49.8.1367; Ghosh J, 2009, TOXICOL APPL PHARM, V240, P73, DOI 10.1016/j.taap.2009.07.008; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Haber EP, 2006, INT REV CYTOL, V248, P1, DOI 10.1016/S0074-7696(06)48001-3; Haus JM, 2010, J CLIN ENDOCR METAB, V95, P323, DOI 10.1210/jc.2009-1101; Hirabara SM, 2007, J CELL PHYSIOL, V210, P7, DOI 10.1002/jcp.20811; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ito Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2191, DOI 10.1271/bbb.60135; Jensen J, 2006, AM J PHYSIOL-ENDOC M, V290, pE154, DOI 10.1152/ajpendo.00330.2005; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kamata Y, 2007, NEUROSCIENCE, V146, P1073, DOI 10.1016/j.neuroscience.2007.03.001; Kaneto H, 2004, DRUG NEWS PERSPECT, V17, P447, DOI 10.1358/dnp.2004.17.7.863704; Katakam AK, 2005, J ENDOCRINOL, V187, P237, DOI 10.1677/joe.1.06411; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Li LF, 2010, FEBS LETT, V584, P995, DOI 10.1016/j.febslet.2010.01.044; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; Liu JR, 2010, AM J PHYSIOL-ENDOC M, V298, pE565, DOI 10.1152/ajpendo.00467.2009; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Petersen KF, 2006, OBESITY, V14, p34S, DOI 10.1038/oby.2006.280; Ragheb R, 2009, BIOCHEM BIOPH RES CO, V389, P211, DOI 10.1016/j.bbrc.2009.08.106; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Wu MY, 2007, ANN NUTR METAB, V51, P270, DOI 10.1159/000105448; Yu X, 2009, ACTA BIOCH BIOPH SIN, V41, P1027, DOI 10.1093/abbs/gmp097	50	238	253	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29965	29973		10.1074/jbc.M110.128694	http://dx.doi.org/10.1074/jbc.M110.128694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647313	hybrid, Green Published			2022-12-27	WOS:000281984300033
J	Li, CY; Yu, SL; Nakamura, F; Pentikainen, OT; Singh, N; Yin, SM; Xin, W; Sy, MS				Li, Chaoyang; Yu, Shuiliang; Nakamura, Fumihiko; Pentikainen, Olli T.; Singh, Neena; Yin, Shaoman; Xin, Wei; Sy, Man-Sun			Pro-prion Binds Filamin A, Facilitating Its Interaction with Integrin beta 1, and Contributes to Melanomagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; STRUCTURAL BASIS; ARP2/3 COMPLEX; CELL-MIGRATION; PROTEIN; EXPRESSION; ACTIVATION; DISEASE; CYTOSKELETON; TRAFFICKING	Filamin A (FLNA) is an integrator of cell mechanics and signaling. The spreading and migration observed in FLNA sufficient A7 melanoma cells but not in the parental FLNA deficient M2 cells have been attributed to FLNA. In A7 and M2 cells, the normal prion (PrP) exists as pro-PrP, retaining its glycosylphosphatidyl-inositol (GPI) anchor peptide signal sequence (GPIPSS). The GPI-PSS of PrP has a FLNA binding motif and binds FLNA. Reducing PrP expression in A7 cells alters the spatial distribution of FLNA and organization of actin and diminishes cell spreading and migration. Integrin beta 1 also binds FLNA. In A7 cells, FLNA, PrP, and integrin beta 1 exist as two independent, yet functionally linked, complexes; they are FLNA with PrP or FLNA with integrin beta 1. Reducing PrP expression in A7 cells decreases the amount of integrin beta 1 bound to FLNA. A PrP GPI-PSS synthetic peptide that crosses the cell membrane inhibitsA7 cell spreading and migration. Thus, in A7 cells FLNA does not act alone; the binding of pro-PrP enhances association between FLNA and integrin beta 1, which then promotes cell spreading and migration. Pro-PrP is detected in melanoma in situ but not in melanocyte. Invasive melanoma has more pro-PrP. The binding of pro-PrP to FLNA, therefore, contributes to melanomagenesis.	[Sy, Man-Sun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Xin, Wei] Case Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Nakamura, Fumihiko] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA; [Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol, Environm Sci & Nanosci Ctr, FI-40014 Jyvaskyla, Finland	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Jyvaskyla	Sy, MS (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Rm 5131,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	man-sun.sy@case.edu	Pentikäinen, Olli T/E-1980-2012; Nakamura, Fumihiko/N-5476-2016	Pentikäinen, Olli T/0000-0001-7188-4016; Nakamura, Fumihiko/0000-0002-6872-4246	National Institutes of Health [R21-CA133559-01]; Skin Disease Research Center, NIAMS [AR039750]; NATIONAL CANCER INSTITUTE [R21CA133559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR039750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skin Disease Research Center, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-CA133559-01 and Pilot Grant AR039750 (Skin Disease Research Center, NIAMS; to M.-S.S. and K. Cooper).	AKASAKA T, 1995, J INVEST DERMATOL, V105, P104, DOI 10.1111/1523-1747.ep12313396; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; BOUFFARD D, 1994, HUM PATHOL, V25, P709, DOI 10.1016/0046-8177(94)90305-0; BYERS HR, 1991, AM J PATHOL, V139, P423; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Chiesa R, 2009, PLOS BIOL, V7, P439, DOI 10.1371/journal.pbio.1000075; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Edward Michael, 1995, Current Opinion in Oncology, V7, P185, DOI 10.1097/00001622-199503000-00015; Feng SJ, 2003, BLOOD, V102, P2122, DOI 10.1182/blood-2002-12-3805; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; He HJ, 2003, J BIOL CHEM, V278, P27096, DOI 10.1074/jbc.M301003200; Hegde RS, 2003, TRENDS NEUROSCI, V26, P337, DOI 10.1016/S0166-2236(03)00143-7; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; High Whitney A, 2007, Adv Dermatol, V23, P61, DOI 10.1016/j.yadr.2007.07.009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2008, EXP CELL RES, V314, P834, DOI 10.1016/j.yexcr.2007.11.022; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Pammer J, 1998, AM J PATHOL, V153, P1353, DOI 10.1016/S0002-9440(10)65720-3; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Playford MP, 2010, J BIOL CHEM, V285, P17156, DOI 10.1074/jbc.M109.080523; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Soderling SH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.255pe5; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Yin S, 2008, J BIOL CHEM, V283, P25446, DOI 10.1074/jbc.M800814200; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Zhu TN, 2007, J BIOL CHEM, V282, P14816, DOI 10.1074/jbc.M611430200	46	42	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30328	30339		10.1074/jbc.M110.147413	http://dx.doi.org/10.1074/jbc.M110.147413			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650901	Green Published, hybrid			2022-12-27	WOS:000281984300068
J	Quintero, CA; Giraudo, CG; Villarreal, M; Montich, G; Maccioni, HJF				Quintero, Cristian A.; Giraudo, Claudio G.; Villarreal, Marcos; Montich, Guillermo; Maccioni, Hugo J. F.			Identification of a Site in Sar1 Involved in the Interaction with the Cytoplasmic Tail of Glycolipid Glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM EXPORT; COPII COAT; ER EXPORT; TRANSPORT VESICLES; GOLGI-APPARATUS; CARGO SELECTION; PROTEINS; COMPLEX; ENERGY; SUBUNIT	Glycolipid glycosyltransferases (GGT) are transported from the endoplasmic reticulum (ER) to the Golgi, their site of residence, via COPII vesicles. An interaction of a (R/K) X(R/K) motif at their cytoplasmic tail (CT) with Sar1 is critical for the selective concentration in the transport vesicles. In this work using computational docking, we identify three putative binding pockets in Sar1(sites A, B, and C) involved in the interaction with the (R/K) X(R/K) motif. Sar1 mutants with alanine replacement of amino acids in site A were tested in vitro and in cells. In vitro, mutant versions showed a reduced ability to bind immobilized peptides with the CT sequence of GalT2. In cells, Sar1 mutants (Sar1(D198A)) specifically affect the exiting of GGT from the ER, resulting in an ER/Golgi concentration ratio favoring the ER. Neither the typical Golgi localization of GM130 nor the exiting and transport of the G protein of the vesicular stomatitis virus were affected. The protein kinase inhibitor H89 produced accumulation of Sec23, Sar1, and GalT2 at the ER exit sites; Sar1(D189A) also accumulated at these sites, but in this case GalT2 remained disperse along ER membranes. The results indicate that amino acids in site A of Sar1 are involved in the interaction with the CT of GGT for concentration at ER exiting sites.	[Quintero, Cristian A.; Giraudo, Claudio G.; Villarreal, Marcos; Montich, Guillermo; Maccioni, Hugo J. F.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CIQUIBIC,CONICET, RA-5000 Cordoba, Argentina	National University of Cordoba	Maccioni, HJF (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CIQUIBIC,CONICET, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	maccioni@dqb.fcq.unc.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnologica del Ministerio de Ciencia; Tecnologia e Innovacion Productiva de la Nacion Argentina; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba; Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica del Ministerio de Ciencia(ANPCyT); Tecnologia e Innovacion Productiva de la Nacion Argentina; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica del Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion Argentina, from the Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba, and from the Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina. H. J. F. M., M. V., and G. M. are career members, and CQ fellow, of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina.	Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lavigne P, 2000, PROTEIN SCI, V9, P252; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Storrie B, 2000, TRENDS CELL BIOL, V10, P385, DOI 10.1016/S0962-8924(00)01818-3; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x	32	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30340	30346		10.1074/jbc.M110.128868	http://dx.doi.org/10.1074/jbc.M110.128868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650895	Green Published, hybrid			2022-12-27	WOS:000281984300069
J	Zhu, XJ; Liu, XY; Jin, Q; Cai, YQ; Yang, YH; Zhou, TH				Zhu, Xiao-Jing; Liu, Xunyan; Jin, Qi; Cai, Yuqi; Yang, Yuehong; Zhou, Tianhua			The L279P Mutation of Nuclear Distribution Gene C (NudC) Influences Its Chaperone Activity and Lissencephaly Protein 1 (LIS1) Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; NEURONAL MIGRATION; CYTOPLASMIC DYNEIN; ASPERGILLUS-NIDULANS; MOVEMENT PROTEIN; P23; ATPASE; HEAT-SHOCK-PROTEIN-90; COMPONENT; MACHINERY	LIS1, a gene mutated in classical lissencephaly, plays essential roles in cytoplasmic dynein regulation, mitosis and cell migration. However, the regulation of LIS1 (lissencephaly protein 1) protein remains largely unknown. Genetic studies in Aspergillus nidulans have uncovered that the Nud (nuclear distribution) pathway is involved in the regulation of cytoplasmic dynein complex and a temperature-sensitive mutation in the nudC gene (L146P) greatly reduces the protein levels of NudF, an Aspergillus ortholog of LIS1. Here, we showed that L146 in Aspergillus NudC and its flanking region were highly conservative during evolution. The similar mutation in human NudC (L279P) obviously led to reduced LIS1 and cellular phenotypes similar to those of LIS1 down-regulation. To explore the underlying mechanism, we found that the p23 domain-containing protein NudC bound to the molecular chaperone Hsp90, which is also associated with LIS1. Inhibition of Hsp90 chaperone function by either geldanamycin or radicicol resulted in a decrease in LIS1 levels. Ectopic expression of Hsp90 partially reversed the degradation of LIS1 caused by overexpression of NudC-L279P. Furthermore, NudC was found to regulate the ATPase activity of Hsp90, which was repressed by the mutation of L279P. Interestingly, NudC itself was shown to possess a chaperone function, which also was suppressed by the L279P mutation. Together, these data suggest that NudC may be involved in the regulation of LIS1 stability by its chaperone function.	[Zhou, Tianhua] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, TH (corresponding author), Zhejiang Univ, Sch Med, Dept Cell Biol, POB 16,388 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	tzhou@zju.edu.cn	zhou, tianhua/K-4908-2013	zhou, tianhua/0000-0002-1791-2124; yang, Yuehong/0000-0001-5438-8395	Natural Scientific Foundation of China [30671070, 30771107, 30901714]; Ministry of Science and Technology of China [2007CB914500]; Ministry of Education of China [NCET-06-0530]; Science Foundation of Chinese University; Natural Scientific Foundation of Zhejiang Province, China [Z2100247, Y2100106, Y207382]; Department of Health of Zhejiang Province [WKJ2006-2- 014]; Department of Science and Technology of Zhejiang Province [2009F80032]; Postdoctoral Scientific Foundation of China [20080441267]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Department of Health of Zhejiang Province; Department of Science and Technology of Zhejiang Province; Postdoctoral Scientific Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the Natural Scientific Foundation of China (30671070, 30771107, and 30901714), the Ministry of Science and Technology of China (2007CB914500), the Ministry of Education of China (NCET-06-0530), the Science Foundation of Chinese University, the Natural Scientific Foundation of Zhejiang Province, China (Z2100247, Y2100106, and Y207382), the Department of Health of Zhejiang Province (WKJ2006-2- 014), the Department of Science and Technology of Zhejiang Province (2009F80032), and the Postdoctoral Scientific Foundation of China (20080441267).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chiu YH, 1997, MOL BIOL CELL, V8, P1735, DOI 10.1091/mbc.8.9.1735; CHIU YH, 1995, GENETICS, V141, P453; Chiu YH, 1997, GENETICS, V145, P707; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Faircloth LM, 2009, CELL STRESS CHAPERON, V14, P95, DOI 10.1007/s12192-008-0061-1; Fang SP, 2009, CELL IMMUNOL, V259, P49, DOI 10.1016/j.cellimm.2009.05.012; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Jurkuta RJ, 2009, PLANT CELL, V21, P1957, DOI 10.1105/tpc.108.065284; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; LO NC, 1997, HUM MOL GENET, V6, P157; Maloney A, 2007, CANCER RES, V67, P3239, DOI 10.1158/0008-5472.CAN-06-2968; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Morishima Y, 2003, J BIOL CHEM, V278, P48754, DOI 10.1074/jbc.M309814200; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Perez DE, 2009, PLANT PHYSIOL, V151, P241, DOI 10.1104/pp.109.142125; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Riera J, 2009, CELL MOL LIFE SCI, V66, P2383, DOI 10.1007/s00018-009-0025-3; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tu CJ, 2005, J PROTEOME RES, V4, P1265, DOI 10.1021/pr0497529; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zabka M, 2008, BIOCHEM BIOPH RES CO, V370, P179, DOI 10.1016/j.bbrc.2008.03.055; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103	61	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29903	29910		10.1074/jbc.M110.105494	http://dx.doi.org/10.1074/jbc.M110.105494			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20675372	hybrid, Green Published			2022-12-27	WOS:000281984300027
J	Carvallo, L; Munoz, R; Bustos, F; Escobedo, N; Carrasco, H; Olivares, G; Larrain, J				Carvallo, Loreto; Munoz, Rosana; Bustos, Francisco; Escobedo, Noelia; Carrasco, Hector; Olivares, Gonzalo; Larrain, Juan			Non-canonical Wnt Signaling Induces Ubiquitination and Degradation of Syndecan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; TYROSINE KINASE ROR2; GASTRULATION MOVEMENTS; MIGRATION; XENOPUS; ENDOCYTOSIS; RECEPTOR; ADHESION; INTEGRIN; PATHWAY	Dynamic regulation of cell adhesion receptors is required for proper cell migration in embryogenesis, tissue repair, and cancer. Integrins and Syndecan4 (SDC4) are the main cell adhesion receptors involved in focal adhesion formation and are required for cell migration. SDC4 interacts biochemically and functionally with components of the Wnt pathway such as Frizzled7 and Dishevelled. Non-canonical Wnt signaling, particularly components of the planar cell polarity branch, controls cell adhesion and migration in embryogenesis and metastasic events. Here, we evaluate the effect of this pathway on SDC4. We have found that Wnt5a reduces cell surface levels and promotes ubiquitination and degradation of SDC4 in cell lines and dorsal mesodermal cells from Xenopus gastrulae. Gain-and loss-of-function experiments demonstrate that Dsh plays a key role in regulating SDC4 steady-state levels. Moreover, a SDC4 deletion construct that interacts inefficiently with Dsh is resistant to Wnt5a-induced degradation. Non-canonical Wnt signaling promotes monoubiquitination of the variable region of SDC4 cytoplasmic domain. Mutation of these specific residues abrogates ubiquitination and results in increased SDC4 steady-state levels. This is the first example of a cell surface protein ubiquitinated and degraded in a Wnt/Dsh-dependent manner.	[Carvallo, Loreto; Munoz, Rosana; Bustos, Francisco; Escobedo, Noelia; Carrasco, Hector; Olivares, Gonzalo; Larrain, Juan] Pontificia Univ Catolica Chile, Ctr Aging & Regenerat, Fac Biol Sci, Santiago, Chile	Pontificia Universidad Catolica de Chile	Larrain, J (corresponding author), Pontificia Univ Catolica Chile, Ctr Aging & Regenerat, Fac Biol Sci, Alameda 340, Santiago, Chile.	jlarrain@bio.puc.cl	Carvallo, Loreto/C-2237-2019	Carvallo, Loreto/0000-0001-9943-1342; Olivares, Gonzalo/0000-0002-2784-0160; BUSTOS, FRANCISCO/0000-0001-5457-4956; Munoz Videla, Rosana/0000-0003-1957-4103				Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Chen G, 2008, AM J PHYSIOL-RENAL, V295, pF1528, DOI 10.1152/ajprenal.90482.2008; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marsden M, 2001, DEVELOPMENT, V128, P3635; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; O'Connell MP, 2009, J BIOL CHEM, V284, P28704, DOI 10.1074/jbc.M109.028498; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Tada M, 2000, DEVELOPMENT, V127, P2227; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Ulrich F, 2009, TRAFFIC, V10, P811, DOI 10.1111/j.1600-0854.2009.00929.x; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weeraratna AT, 2005, CANCER METAST REV, V24, P237, DOI 10.1007/s10555-005-1574-z; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; Yang LL, 2008, J BIOL CHEM, V283, P21703, DOI 10.1074/jbc.M800809200; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	45	37	39	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29546	29555		10.1074/jbc.M110.155812	http://dx.doi.org/10.1074/jbc.M110.155812			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639201	Green Published, hybrid			2022-12-27	WOS:000281740100056
J	Lontay, B; Bodoor, K; Weitzel, DH; Loiselle, D; Fortner, C; Lengyel, S; Zheng, DH; Devente, J; Hickner, R; Haystead, TAJ				Lontay, Beata; Bodoor, Khaldon; Weitzel, Douglas H.; Loiselle, David; Fortner, Christopher; Lengyel, Szabolcs; Zheng, Donghai; Devente, James; Hickner, Robert; Haystead, Timothy A. J.			Smoothelin-like 1 Protein Regulates Myosin Phosphatase-targeting Subunit 1 Expression during Sexual Development and Pregnancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; GENE-EXPRESSION; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; PLASTICITY; PHOSPHORYLATION; ISOFORM; DIFFERENTIATION; SENSITIVITY; ACTIVATION	Pregnancy coordinately alters the contractile properties of both vascular and uterine smooth muscles reducing systemic blood pressure and maintaining uterine relaxation. The precise molecular mechanisms underlying these pregnancy-induced adaptations have yet to be fully defined but are likely to involve changes in the expression of proteins regulating myosin phosphorylation. Here we show that smoothelin like protein 1 (SMTNL1) is a key factor governing sexual development and pregnancy induced adaptations in smooth and striated muscle. A primary target gene of SMTNL1 in these muscles is myosin phosphatase-targeting subunit 1 (MYPT1). Deletion of SMTNL1 increases expression of MYPT1 30-40-fold in neonates and during development expression of both SMTNL1 and MYPT1 increases over 20-fold. Pregnancy also regulates SMTNL1 and MYPT1 expression, and deletion SMTNL1 greatly exaggerates expression of MYPT1 in vascular smooth muscle, producing a profound reduction in force development in response to phenylephrine as well as sensitizing the muscle to acetylcholine. We also show that MYPT1 is expressed in Type2a muscle fibers in mice and humans and its expression is regulated during pregnancy, suggesting unrecognized roles in mediating skeletal muscle plasticity in both species. Our findings define a new conserved pathway in which sexual development and pregnancy mediate smooth and striated muscle adaptations through SMTNL1 and MYPT1.	[Lontay, Beata; Bodoor, Khaldon; Weitzel, Douglas H.; Loiselle, David; Fortner, Christopher; Haystead, Timothy A. J.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; [Lontay, Beata] Univ Debrecen, Dept Med Chem, H-4032 Debrecen, Hungary; [Lengyel, Szabolcs] Univ Debrecen, Dept Ecol, H-4032 Debrecen, Hungary; [Zheng, Donghai; Devente, James; Hickner, Robert] E Carolina Univ, Greenville, NC 27858 USA	Duke University; University of Debrecen; University of Debrecen; University of North Carolina; East Carolina University	Haystead, TAJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol, Res Dr,LSRC,C119,Box 3, Durham, NC 27710 USA.	hayst001@mc.duke.edu	Lengyel, Szabolcs/A-3483-2011	Lengyel, Szabolcs/0000-0002-7049-0100; hickner, Robert/0000-0002-2683-1617	National Institutes of Health [R01DK065954-05]; Hungarian Academy of Science; King Hussein Institute for Biotechnology and Cancer, Amman, Jordan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Academy of Science(Hungarian Academy of Sciences); King Hussein Institute for Biotechnology and Cancer, Amman, Jordan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK065954-05 (to T. A. J. H.) and a Bolyai Fellowship (Hungarian Academy of Science) (to B. L.).; Supported by a postdoctoral fellowship from the King Hussein Institute for Biotechnology and Cancer, Amman, Jordan.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; Borman MA, 2004, FEBS LETT, V573, P207, DOI 10.1016/j.febslet.2004.08.002; Borman MA, 2009, MOL CELL BIOCHEM, V327, P93, DOI 10.1007/s11010-009-0047-z; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; Coleman KM, 2003, J BIOL CHEM, V278, P12834, DOI 10.1074/jbc.M212312200; D'Antona G, 2006, J PHYSIOL-LONDON, V570, P611, DOI 10.1113/jphysiol.2005.101642; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fluck M, 2005, J APPL PHYSIOL, V99, P397, DOI 10.1152/japplphysiol.00050.2005; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Gonzalez B, 2002, PFLUG ARCH EUR J PHY, V443, P377, DOI 10.1007/s004240100702; Gruneberg H, 1941, P NATL ACAD SCI USA, V27, P562, DOI 10.1073/pnas.27.12.562; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Harridge SDR, 2007, EXP PHYSIOL, V92, P783, DOI 10.1113/expphysiol.2006.036525; Hoppeler H, 2007, ADV EXP MED BIOL, V618, P245; Ishida H, 2008, J BIOL CHEM, V283, P20569, DOI 10.1074/jbc.M800627200; Lontay B, 2005, CELL SIGNAL, V17, P1265, DOI 10.1016/j.cellsig.2005.01.008; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; Machida H, 2001, BBA-GENE STRUCT EXPR, V1517, P424, DOI 10.1016/S0167-4781(00)00285-2; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; MCDONNELL DP, 1994, J STEROID BIOCHEM, V48, P425, DOI 10.1016/0960-0760(94)90190-2; Minorics R, 2009, REPRODUCTION, V138, P383, DOI 10.1530/REP-09-0116; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Reggiani C, 2004, J MUSCLE RES CELL M, V25, P231, DOI 10.1023/B:JURE.0000038363.78378.1d; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Somlyo AV, 2007, CIRC RES, V101, P645, DOI 10.1161/CIRCRESAHA.107.161893; Thornburg KL, 2000, SEMIN PERINATOL, V24, P11, DOI 10.1016/S0146-0005(00)80047-6; Twomey E, 2010, EXP CELL RES, V316, P68, DOI 10.1016/j.yexcr.2009.09.001; Veerareddy S, 2002, AM J PHYSIOL-HEART C, V283, pH2226, DOI 10.1152/ajpheart.00593.2002; WEIGEL NL, 1995, J STEROID BIOCHEM, V53, P509, DOI 10.1016/0960-0760(95)00098-K; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200; Wu X, 2008, J CELL MOL MED, V12, P1360, DOI 10.1111/j.1582-4934.2008.00306.x; Wu Y, 2003, J MUSCLE RES CELL M, V24, P499, DOI 10.1023/B:JURE.0000009810.36038.53; Xiao DL, 2006, AM J PHYSIOL-HEART C, V291, pH413, DOI 10.1152/ajpheart.00103.2006; Xiao DL, 2006, AM J PHYSIOL-HEART C, V290, pH2337, DOI 10.1152/ajpheart.01238.2005	43	28	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29357	29366		10.1074/jbc.M110.143966	http://dx.doi.org/10.1074/jbc.M110.143966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20634291	hybrid, Green Published			2022-12-27	WOS:000281740100038
J	Phillips, A; Teunisse, A; Lam, S; Lodder, K; Darley, M; Emaduddin, M; Wolf, A; Richter, J; de Lange, J; Verlaan-de Vries, M; Lenos, K; Bohnke, A; Bartel, F; Blaydes, JP; Jochemsen, AG				Phillips, Anna; Teunisse, Amina; Lam, Suzanne; Lodder, Kirsten; Darley, Matthew; Emaduddin, Muhammad; Wolf, Anja; Richter, Julia; de Lange, Job; Verlaan-de Vries, Matty; Lenos, Kristiaan; Boehnke, Anja; Bartel, Frank; Blaydes, Jeremy P.; Jochemsen, Aart G.			HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of the HDMX Gene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; HUMAN TUMOR-CELLS; DNA-DAMAGE; TRANSCRIPTION-FACTOR; IN-VIVO; P53-BINDING PROTEIN; GENOTOXIC STRESS; LIGASE ACTIVITY; HUMAN MDM2; ACTIVATION	The p53 regulatory network is critically involved in preventing the initiation of cancer. In unstressed cells, p53 is maintained at low levels and is largely inactive, mainly through the action of its two essential negative regulators, HDM2 and HDMX. p53 abundance and activity are up-regulated in response to various stresses, including DNA damage and oncogene activation. Active p53 initiates transcriptional and transcription-independent programs that result in cell cycle arrest, cellular senescence, or apoptosis. p53 also activates transcription of HDM2, which initially leads to the degradation of HDMX, creating a positive feedback loop to obtain maximal activation of p53. Subsequently, when stress-induced post-translational modifications start to decline, HDM2 becomes effective in targeting p53 for degradation, thus attenuating the p53 response. To date, no clear function for HDMX in this critical attenuation phase has been demonstrated experimentally. Like HDM2, the HDMX gene contains a promoter (P2) in its first intron that is potentially inducible by p53. We show that p53 activation in response to a plethora of p53-activating agents induces the transcription of a novel HDMX mRNA transcript from the HDMX-P2 promoter. This mRNA is more efficiently translated than that expressed from the constitutive HDMX-P1 promoter, and it encodes a long form of HDMX protein, HDMX-L. Importantly, we demonstrate that HDMX-L cooperates with HDM2 to promote the ubiquitination of p53 and that p53-induced HDMX transcription from the P2 promoter can play a key role in the attenuation phase of the p53 response, to effectively diminish p53 abundance as cells recover from stress.	[Phillips, Anna; Darley, Matthew; Emaduddin, Muhammad; Blaydes, Jeremy P.] Univ Southampton, Southampton Gen Hosp, Southampton Canc Res UK Ctr, Sch Med, Southampton SO16 6YD, Hants, England; [Teunisse, Amina; Lam, Suzanne; Lodder, Kirsten; de Lange, Job; Verlaan-de Vries, Matty; Lenos, Kristiaan; Jochemsen, Aart G.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Wolf, Anja; Richter, Julia; Boehnke, Anja; Bartel, Frank] Univ Halle Wittenberg, Fac Med, D-06108 Halle, Germany	University of Southampton; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Martin Luther University Halle Wittenberg	Blaydes, JP (corresponding author), Univ Southampton, Southampton Gen Hosp, Southampton Canc Res UK Ctr, Sch Med, Southampton SO16 6YD, Hants, England.	j.p.blaydes@soton.ac.uk; a.g.jochemsen@lumc.nl	Blaydes, Jeremy/AAC-6939-2019	Blaydes, Jeremy/0000-0001-8525-0209; de Lange, Job/0000-0002-9002-8829	Association for International Cancer Research [07-0437, 05-273]; Dutch Cancer Society [UL 2006-3595]; European Community [503576]; Wilhelm-Sander-Stiftung [2006.010.1]; Deutsche Krebshilfe [108424]; University of Halle-Wittenberg [12/40]; Fritz-Thyssen-Stiftung [Az 10.09.2.117]	Association for International Cancer Research; Dutch Cancer Society(KWF Kankerbestrijding); European Community(European Commission); Wilhelm-Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); University of Halle-Wittenberg; Fritz-Thyssen-Stiftung	This work was supported by Association for International Cancer Research Grants 07-0437 (to J. P. B.) and 05-273 (to A. G. J.), Dutch Cancer Society Grant UL 2006-3595, and European Community FP6 funding (Contract 503576) (to A. G. J.). This work was also supported by Wilhelm-Sander-Stiftung Grant 2006.010.1, Deutsche Krebshilfe Grant 108424, Wilhelm-Roux-Programm of the University of Halle-Wittenberg Grant 12/40, and Fritz-Thyssen-Stiftung Grant Az 10.09.2.117.	Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Bauer S, 2010, EUR UROL, V57, P679, DOI 10.1016/j.eururo.2009.06.014; Blaydes JP, 1998, ONCOGENE, V16, P3317, DOI 10.1038/sj.onc.1201880; Blaydes JP, 1998, ONCOGENE, V17, P1045, DOI 10.1038/sj.onc.1202014; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brown CY, 1999, ONCOGENE, V18, P5631, DOI 10.1038/sj.onc.1202949; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burger H, 1999, INT J CANCER, V81, P620, DOI 10.1002/(SICI)1097-0215(19990517)81:4<620::AID-IJC19>3.3.CO;2-J; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hupp TR, 2000, BIOCHEM J, V352, P1, DOI 10.1042/0264-6021:3520001; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kessler BM, 2007, J PROTEOME RES, V6, P4163, DOI 10.1021/pr0702161; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Landers JE, 1997, CANCER RES, V57, P3562; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Li BZ, 2010, CELL CYCLE, V9, P1411, DOI 10.4161/cc.9.7.11255; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Markey M, 2008, ONCOGENE, V27, P6657, DOI 10.1038/onc.2008.266; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Onel K, 2004, MOL CANCER RES, V2, P1; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Phelps M, 2003, CANCER RES, V63, P2616; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tait L, 1996, INT J ONCOL, V9, P263; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Wahl GM, 2006, CELL DEATH DIFFER, V13, P973, DOI 10.1038/sj.cdd.4401911; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang YYV, 2009, CELL CYCLE, V8, P3443, DOI 10.4161/cc.8.21.9744; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wiederschain D, 2001, J BIOL CHEM, V276, P27999, DOI 10.1074/jbc.M102400200; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Wynford-Thomas D, 1998, CARCINOGENESIS, V19, P29, DOI 10.1093/carcin/19.1.29; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584	73	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29111	29127		10.1074/jbc.M110.129726	http://dx.doi.org/10.1074/jbc.M110.129726			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20659896	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000281740100012
J	Jimenez-Vidal, M; Srivastava, J; Putney, LK; Barber, DL				Jimenez-Vidal, Maite; Srivastava, Jyoti; Putney, Luanna K.; Barber, Diane L.			Nuclear-localized Calcineurin Homologous Protein CHP1 Interacts with Upstream Binding Factor and Inhibits Ribosomal RNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR UBF; POLYMERASE-I TRANSCRIPTION; TERMINAL ACTIVATION DOMAIN; CA2+-BINDING PROTEIN; GENE-TRANSCRIPTION; NA+/H+ EXCHANGER; DEPENDENT MANNER; PHOSPHORYLATION; P22; MICROTUBULES	Calcineurin homologous protein 1 (CHP1) is a widely expressed, 22-kDa myristoylated EF-hand Ca2+-binding protein that shares a high degree of similarity with the regulatory B subunit of calcineurin (65%) and with calmodulin (59%). CHP1 localizes to the plasma membrane, the Golgi apparatus, and the nucleus and functions to regulate trafficking of early secretory vesicles, activation of T cells, and expression and transport of the Na-H exchanger NHE1. Although CHP1 contains nuclear export signals, whether its nuclear and cytoplasmic localization is regulated and has distinct functions remain unknown. We show that CHP1 is predominantly in the nucleus in quiescent fibro-basts, is translocated to cytoplasmic compartments with growth medium, and that translocation is inhibited by mutations in the nuclear export motifs. In a screen for proteins co-precipitating with CHP1 in quiescent cells we identified the upstream binding factor UBF, a DNA-binding protein and component of the RNA polymerase I complex regulating RNA synthesis. The CHP1-UBF interaction is restricted to the nucleus and inhibited by Ca2+. Nuclear retention of CHP1 attenuates the abundance of UBF in the nucleolus and inhibits RNA synthesis when quiescent cells are transferred to growth medium. These data show UBF as a newly identified CHP1-binding protein and regulation of RNA synthesis as a newly identified function for nuclear-localized CHP1, which is distinct from CHP1 functions in the cytosol.	[Jimenez-Vidal, Maite; Srivastava, Jyoti; Putney, Luanna K.; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, HSW618, San Francisco, CA 94143 USA.	diane.barber@ucsf.edu			National Institutes of Health [GM47413, F32 GM63465]; National Center for Research Resources, National Institutes of Health [C06RR16490]; Spanish Ministry of Science and Education; Office of Ethics, Compliance and Audit Services, University of California, Office of the President, Oakland [CA 94607-5200]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM063465, R01GM047413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Spanish Ministry of Science and Education(Spanish Government); Office of Ethics, Compliance and Audit Services, University of California, Office of the President, Oakland(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47413 (to D. L. B.). Work was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06RR16490 from the National Center for Research Resources, National Institutes of Health.; Supported by a postdoctoral fellowship from the Spanish Ministry of Science and Education.; Supported by National Institutes of Health Postdoctoral Fellowship F32 GM63465. Present address: Director of Research Compliance, Office of Ethics, Compliance and Audit Services, University of California, Office of the President, Oakland, CA 94607-5200.	Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Bell P, 1997, J CELL SCI, V110, P2053; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Comai L, 2004, ADV PROTEIN CHEM, V67, P123; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; Drakas R, 2004, P NATL ACAD SCI USA, V101, P9272, DOI 10.1073/pnas.0403328101; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; Jin Q, 2007, IN VIVO, V21, P593; Jordan P, 1996, J CELL BIOL, V133, P225, DOI 10.1083/jcb.133.2.225; Kuwahara H, 2003, J BIOCHEM, V134, P245, DOI 10.1093/jb/mvg137; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Matsumoto M, 2001, J BIOCHEM, V130, P217, DOI 10.1093/oxfordjournals.jbchem.a002975; Matsushita M, 2007, AM J PHYSIOL-CELL PH, V293, pC246, DOI 10.1152/ajpcell.00464.2006; Nagita M, 2003, J BIOCHEM, V134, P919, DOI 10.1093/jb/mvg223; Nakamura N, 2002, J BIOCHEM, V132, P483, DOI 10.1093/oxfordjournals.jbchem.a003246; Naoe Y, 2005, J BIOL CHEM, V280, P32372, DOI 10.1074/jbc.M503390200; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Tuan JC, 1999, MOL CELL BIOL, V19, P2872; VOIT R, 1995, NUCLEIC ACIDS RES, V23, P2593, DOI 10.1093/nar/23.14.2593	29	10	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36260	36266		10.1074/jbc.M110.165555	http://dx.doi.org/10.1074/jbc.M110.165555			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20720019	hybrid, Green Published			2022-12-27	WOS:000284146100005
J	Ishii, K; Hamamoto, H; Imamura, K; Adachi, T; Shoji, M; Nakayama, K; Sekimizu, K				Ishii, Kenichi; Hamamoto, Hiroshi; Imamura, Katsutoshi; Adachi, Tatsuo; Shoji, Mikio; Nakayama, Koji; Sekimizu, Kazuhisa			Porphyromonas gingivalis Peptidoglycans Induce Excessive Activation of the Innate Immune System in Silkworm Larvae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTOR; CELL-WALL COMPONENTS; BOMBYX-MORI; PARALYTIC PEPTIDE; MELANIZATION CASCADE; HOST-DEFENSE; DROSOPHILA; PROTEIN; PROPHENOLOXIDASE; INFECTION	Porphyromonas gingivalis, a pathogen that causes inflammation in human periodontal tissue, killed silkworm (Bombyx mori, Lepidoptera) larvae when injected into the blood (hemolymph). Silkworm lethality was not rescued by antibiotic treatment, and heat-killed bacteria were also lethal. Heat-killed bacteria of mutant P. gingivalis strains lacking virulence factors also killed silkworms. Silkworms died after injection of peptidoglycans purified from P. gingivalis (pPG), and pPG toxicity was blocked by treatment with mutanolysin, a peptidoglycan-degrading enzyme. pPG induced silkworm hemolymph melanization at the same dose as that required to kill the animal. pPG injection increased caspase activity in silkworm tissues. pPG-induced silkworm death was delayed by injecting melanization-inhibiting reagents (a serine protease inhibitor and 1-phenyl-2-thiourea), antioxidants (N-acetyl-L-cysteine, glutathione, and catalase), and a caspase inhibitor (Ac-DEVD-CHO). Thus, pPG induces excessive activation of the innate immune response, which leads to the generation of reactive oxygen species and apoptotic cell death in the host tissue.	[Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo 1130033, Japan; [Shoji, Mikio; Nakayama, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Div Microbiol & Oral Infect, Dept Mol Microbiol & Immunol, Nagasaki 8528588, Japan	University of Tokyo; Nagasaki University	Sekimizu, K (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Shoji, Mikio/J-8283-2018; Ishii, Kenichi/H-5469-2019; Hamamoto, Hiroshi/G-6397-2019	Shoji, Mikio/0000-0002-7605-4721; Hamamoto, Hiroshi/0000-0001-9315-7442	Japan Society for the Promotion of Science [21790063, 2110519]; National Institute of Biomedical Innovation; Genome Pharmaceuticals Co. Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Genome Pharmaceuticals Co. Ltd.	This work was supported by Grant-in-aid for Young Scientists (B) 21790063 and Grant-in-aid for Japan Society for the Promotion of Science Fellows 2110519 from Japan Society for the Promotion of Science. This work was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation and grants from Genome Pharmaceuticals Co. Ltd.	Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; ASHIDA M, 1981, INSECT BIOCHEM, V11, P57, DOI 10.1016/0020-1790(81)90041-X; Bainbridge BW, 2001, ACTA ODONTOL SCAND, V59, P131, DOI 10.1080/000163501750266710; BARNARD MR, 1985, CAN J MICROBIOL, V31, P154, DOI 10.1139/m85-030; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; DUNCAN CL, 1968, APPL MICROBIOL, V16, P82, DOI 10.1128/AEM.16.1.82-89.1968; Filipe SR, 2005, EMBO REP, V6, P327, DOI 10.1038/sj.embor.7400371; Gibson FC, 2006, J DENT RES, V85, P106, DOI 10.1177/154405910608500202; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hamamoto H, 2009, COMP BIOCHEM PHYS C, V149, P334, DOI 10.1016/j.cbpc.2008.08.008; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huang QH, 2001, BBA-MOL CELL RES, V1499, P191, DOI 10.1016/S0167-4889(00)00105-1; Iketani M, 1999, INSECT BIOCHEM MOLEC, V29, P19, DOI 10.1016/S0965-1748(98)00099-X; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Miura K, 2002, PEPTIDES, V23, P2111, DOI 10.1016/S0196-9781(02)00254-1; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; O'Brien-Simpson NM, 2001, INFECT IMMUN, V69, P7527, DOI 10.1128/IAI.69.12.7527-7534.2001; Ortolani O, 2000, AM J RESP CRIT CARE, V161, P1907, DOI 10.1164/ajrccm.161.6.9903043; Pavel S, 2004, EUR J CANCER, V40, P1423, DOI 10.1016/j.ejca.2003.11.035; Pei ZF, 2002, J BIOL CHEM, V277, P48677, DOI 10.1074/jbc.M208810200; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Sekimizu K, 2005, J BIOCHEM, V137, P199, DOI 10.1093/jb/mvi019; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Shinzawa N, 2009, CELL HOST MICROBE, V6, P244, DOI 10.1016/j.chom.2009.07.010; Smit NPM, 2008, PHOTOCHEM PHOTOBIOL, V84, P550, DOI 10.1111/j.1751-1097.2007.00242.x; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Uehara A, 2005, J IMMUNOL, V175, P6076, DOI 10.4049/jimmunol.175.9.6076; VASSTRAND EN, 1979, INFECT IMMUN, V25, P775, DOI 10.1128/IAI.25.3.775-780.1979; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	47	40	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33338	33347		10.1074/jbc.M110.112987	http://dx.doi.org/10.1074/jbc.M110.112987			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702417	hybrid, Green Published			2022-12-27	WOS:000283048200069
J	Ali, SS; Marcondes, MCG; Bajova, H; Dugan, LL; Conti, B				Ali, Sameh S.; Marcondes, Maria-Cecilia Garibaldi; Bajova, Hilda; Dugan, Laura L.; Conti, Bruno			Metabolic Depression and Increased Reactive Oxygen Species Production by Isolated Mitochondria at Moderately Lower Temperatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; BODY-TEMPERATURE; UNCOUPLING PROTEINS; ENERGY-METABOLISM; SPIN TRAPS; RAT-BRAIN; LIFE-SPAN; SUPEROXIDE; MECHANISM	Temperature (T) reduction increases lifespan, but the mechanisms are not understood. Because reactive oxygen species (ROS) contribute to aging, we hypothesized that lowering T might decrease mitochondrial ROS production. We measured respiratory response and ROS production in isolated mitochondria at 32, 35, and 37 degrees C. Lowering T decreased the rates of resting (state 4) and phosphorylating (state 3) respiration phases. Surprisingly, this respiratory slowdown was associated with an increase of ROS production and hydrogen peroxide release and with elevation of the mitochondrial membrane potential, Delta Psi(m). We also found that at lower T mitochondria produced more carbon-centered lipid radicals, a species known to activate uncoupling proteins. These data indicate that reduced mitochondrial ROS production is not one of the mechanisms mediating lifespan extension at lower T. They suggest instead that increased ROS leakage may mediate mitochondrial responses to hypothermia.	[Ali, Sameh S.; Marcondes, Maria-Cecilia Garibaldi; Bajova, Hilda; Conti, Bruno] Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA; [Ali, Sameh S.; Dugan, Laura L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego	Ali, SS (corresponding author), Scripps Res Inst, Dept Mol & Integrat Neurosci, 10550 N Torrey Pines Rd SR307, La Jolla, CA 92037 USA.	bconti@scripps.edu		Ali, Sameh Saad/0000-0002-0339-6106; Conti, Bruno/0000-0002-9185-5201	NIA/National Institutes of Health [K25AG026379, AG028040]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG033679, R01AG028040, K25AG026379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027936] Funding Source: NIH RePORTER	NIA/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by NIA/National Institutes of Health Grants K25AG026379 (to S.S.A.) and AG028040. This work was also supported by The Ellison Medical Foundation.	Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Anzai K, 2003, ARCH BIOCHEM BIOPHYS, V415, P251, DOI 10.1016/S0003-9861(03)00260-1; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BROOKS GA, 1971, AM J PHYSIOL, V220, P1053, DOI 10.1152/ajplegacy.1971.220.4.1053; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chalier F, 2002, J CHEM SOC PERK T 2, P2110, DOI 10.1039/b206909c; CHANCE B, 1955, J BIOL CHEM, V217, P429; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; DEDUKHOVA VI, 1991, FEBS LETT, V295, P51, DOI 10.1016/0014-5793(91)81382-I; Dufour S, 1996, BIOCHEM J, V314, P743, DOI 10.1042/bj3140743; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Horvath TL, 1999, J NEUROSCI, V19, P10417; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; LIU RK, 1972, GERONTOLOGY, V18, P363, DOI 10.1159/000211944; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Quick KL, 2008, NEUROBIOL AGING, V29, P117, DOI 10.1016/j.neurobiolaging.2006.09.014; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Stolze K, 2000, FREE RADICAL BIO MED, V29, P1005, DOI 10.1016/S0891-5849(00)00401-9; Swegert CV, 1999, MECH AGEING DEV, V112, P27, DOI 10.1016/S0047-6374(99)00051-2; Villamena FA, 2004, ANTIOXID REDOX SIGN, V6, P619, DOI 10.1089/152308604773934387; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; ZAMZAMI N, 2003, METH MOL B, V282, P103; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	40	47	49	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32522	32528		10.1074/jbc.M110.155432	http://dx.doi.org/10.1074/jbc.M110.155432			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20716522	Green Published, hybrid			2022-12-27	WOS:000282683000066
J	Irannejad, R; Wedegaertner, PB				Irannejad, Roshanak; Wedegaertner, Philip B.			Regulation of Constitutive Cargo Transport from the trans-Golgi Network to Plasma Membrane by Golgi-localized G Protein beta gamma Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; COPI-COATED VESICLES; TRIMERIC G-PROTEINS; KINASE-D; ENDOPLASMIC-RETICULUM; SIGNALING COMPLEXES; MEDIATED REGULATION; PHOSPHOLIPASE-C; RECEPTOR KINASE; ALPHA-SUBUNITS	Observations of Golgi fragmentation upon introduction of G protein beta gamma (G beta gamma) subunits into cells have implicated G beta gamma in a pathway controlling the fission at the trans-Golgi network (TGN) of plasma membrane (PM)-destined transport carriers. However, the subcellular location where G beta gamma acts to provoke Golgi fragmentation is not known. Additionally, a role for G beta gamma in regulating TGN-to-PM transport has not been demonstrated. Here we report that constitutive or inducible targeting of G beta gamma to the Golgi, but not other subcellular locations, causes phospholipase C- and protein kinase D-dependent vesiculation of the Golgi in HeLa cells; Golgi-targeted beta(1)gamma(2) also activates protein kinase D. Moreover, the novel G beta gamma inhibitor, gallein, and the G beta gamma-sequestering protein, GRK2ct, reveal that G beta gamma is required for the constitutive PM transport of two model cargo proteins, VSV-G and ss-HRP. Importantly, Golgi-targeted GRK2ct, but not a PM-targeted GRK2ct, also blocks protein transport to the PM. To further support a role for Golgi-localized G beta gamma, endogenous G beta was detected at the Golgi in HeLa cells. These results are the first to establish a role for Golgi-localized G beta gamma in regulating protein transport from the TGN to the cell surface.	[Irannejad, Roshanak; Wedegaertner, Philip B.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Wedegaertner, PB (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,839 BLSB, Philadelphia, PA 19107 USA.	P_Wedegaertner@mail.jci.tju.edu			National Institutes of Health [GM56444]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM056444, R56GM056444, R01GM056444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56444 (to P.B.W.). This work was also supported by an award from the American Heart Association (to R.I.).	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Arozarena I, 2004, MOL CELL BIOL, V24, P1516, DOI 10.1128/MCB.24.4.1516-1530.2004; AUSUBEL F.M., 1992, SHORT PROTOCOLS MOL, P23; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BARR FA, 1991, FEBS LETT, V294, P239, DOI 10.1016/0014-5793(91)81438-E; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Czondor K, 2009, MOL BIOL CELL, V20, P2108, DOI 10.1091/mbc.E08-09-0957; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Dupre DJ, 2006, CELL SIGNAL, V18, P1549, DOI 10.1016/j.cellsig.2006.03.009; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Evanko DS, 2001, J BIOL CHEM, V276, P23945, DOI 10.1074/jbc.M101154200; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Ghanekar Y, 2005, TRENDS CELL BIOL, V15, P511, DOI 10.1016/j.tcb.2005.08.001; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Helms JB, 1998, J BIOL CHEM, V273, P15203, DOI 10.1074/jbc.273.24.15203; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Kim MS, 2008, CIRC RES, V103, P252, DOI 10.1161/CIRCRESAHA.108.178681; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Michaelson D, 2002, MOL BIOL CELL, V13, P3294, DOI 10.1091/mbc.E02-02-0095; Onken B, 2006, P NATL ACAD SCI USA, V103, P9045, DOI 10.1073/pnas.0603318103; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sehgal PB, 2007, AM J PHYSIOL-LUNG C, V292, pL1526, DOI 10.1152/ajplung.00463.2006; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Stow JL, 1998, BBA-MOL CELL RES, V1404, P161, DOI 10.1016/S0167-4889(98)00055-X; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Takida S, 2004, FEBS LETT, V567, P209, DOI 10.1016/j.febslet.2004.04.062; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008; Yoshikawa DM, 2000, BIOCHEMISTRY-US, V39, P11340, DOI 10.1021/bi0005557; Yost EA, 2007, MOL PHARMACOL, V72, P812, DOI 10.1124/mol.107.038075	68	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32393	32404		10.1074/jbc.M110.154963	http://dx.doi.org/10.1074/jbc.M110.154963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20720014	Green Published, hybrid			2022-12-27	WOS:000282683000053
J	Martin, L; Kimball, SR; Gardner, LB				Martin, Leenus; Kimball, Scot R.; Gardner, Lawrence B.			Regulation of the Unfolded Protein Response by eIF2B delta Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GENE-EXPRESSION; TRANSLATIONAL REGULATION; INTERPROTEIN INTERACTIONS; STRESS-RESPONSE; FACTOR EIF2B; SUBUNITS; EIF2-ALPHA; HYPOXIA; CELLS	Cells respond to a variety of stresses, including unfolded proteins in the endoplasmic reticulum (ER), by phosphorylating a subunit of translation initiation factor eIF2, eIF2 alpha. eIF2 alpha phosphorylation inactivates the eIF2B complex. The inactivation of eIF2B not only suppresses the initiation of protein translation but paradoxically up-regulates the translation and expression of transcription factor ATF-4. Both of these processes are important for the cellular response to ER stress, also termed the unfolded protein response. Here we demonstrate that cellular response resulting from eIF2 alpha phosphorylation is attenuated in several cancer cell lines. The deficiency of the unfolded protein response in these cells correlates with the expression of a specific isoform of a regulatory eIF2B subunit, eIF2B delta variant 1 (V1). Replacement of total eIF2B delta with V1 renders cells insensitive to eIF2 alpha phosphorylation; specifically, they neither up-regulate ATF-4 and ATF-4 targets nor suppress protein translation. Expression of variant 2 eIF2B delta in ER stress response-deficient cells restores the stress response. Our data suggest that V1 does not interact with the eIF2 complex, a requisite for eIF2B inhibition by eIF2 alpha phosphorylation. Together, these data delineate a novel physiological mechanism to regulate the ER stress response with a large potential impact on a variety of diseases that result in ER stress.	[Gardner, Lawrence B.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Gardner, Lawrence B.] NYU, Sch Med, New York Univ Canc Inst, New York, NY 10016 USA; [Kimball, Scot R.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	New York University; New York University; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gardner, LB (corresponding author), NYU, Sch Med, Dept Pharmacol, Tisch 451B,550 1st Ave, New York, NY 10016 USA.	lawrence.gardner@nyumc.org		Gardner, Lawrence/0000-0003-0191-0172	National Institutes of Health [DK13499, DK08164]; Making Headway Foundation; New York Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499, R01DK081641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Making Headway Foundation; New York Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK13499 (to S. R. K.) and DK08164 (to L. B. G). This work was also supported by grants from the Making Headway Foundation and New York Community Trust (to L. B. G).	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; DEALDANA CRV, 1994, MOL CELL BIOL, V14, P3208, DOI 10.1128/MCB.14.5.3208; Fabian JR, 1998, PROTEIN EXPRES PURIF, V13, P16, DOI 10.1006/prep.1998.0860; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; Gallagher JW, 2008, CANCER RES, V68, P8752, DOI 10.1158/0008-5472.CAN-08-1042; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kimball SR, 1998, J BIOL CHEM, V273, P3039, DOI 10.1074/jbc.273.5.3039; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Lin CQ, 2000, CANCER RES, V60, P1332; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Ouyang XS, 2002, J UROLOGY, V167, P2598, DOI 10.1016/S0022-5347(05)65044-6; Patterson AD, 2006, MOL CELL BIOL, V26, P1644, DOI 10.1128/MCB.26.5.1644-1653.2006; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Rajesh K, 2008, BIOCHEM BIOPH RES CO, V374, P336, DOI 10.1016/j.bbrc.2008.07.022; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Singh RN, 2007, FRONT BIOSCI, V12, P3263, DOI 10.2741/2310; Suragani RNVS, 2006, PROTEIN EXPRES PURIF, V47, P225, DOI 10.1016/j.pep.2005.10.003; Suragani RNVS, 2005, BIOCHEM BIOPH RES CO, V338, P1766, DOI 10.1016/j.bbrc.2005.10.150; Tang RP, 2009, BLOOD, V114, P2993, DOI 10.1182/blood-2009-05-223115; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005	48	11	11	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31944	31953		10.1074/jbc.M110.153148	http://dx.doi.org/10.1074/jbc.M110.153148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20709751	Green Published, hybrid			2022-12-27	WOS:000282683000007
J	Mo, X; Nguyen, NX; Mu, FT; Yang, WJ; Luo, SZ; Fan, HZ; Andrews, RK; Berndt, MC; Li, RH				Mo, Xi; Nguyen, Nam X.; Mu, Fi-Tjen; Yang, Wenjun; Luo, Shi-Zhong; Fan, Huizhou; Andrews, Robert K.; Berndt, Michael C.; Li, Renhao			Transmembrane and Trans-subunit Regulation of Ectodomain Shedding of Platelet Glycoprotein Ib alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; VON-WILLEBRAND-FACTOR; IX COMPLEX; CYTOPLASMIC DOMAIN; CONVERTING-ENZYME; CALMODULIN INHIBITORS; PROTEOLYTIC CLEAVAGE; HEMOSTATIC FUNCTION; ADHESION MOLECULE; PLASMA-MEMBRANE	Ectodomain shedding of transmembrane proteins may be regulated by their cytoplasmic domains. To date, the effecting cytoplasmic domain and the shed extracellular domain have been in the same polypeptide. In this study, shedding of GPIb alpha, the ligand-binding subunit of the platelet GPIb-IX complex and a marker for platelet senescence and storage lesion, was assessed in Chinese hamster ovary cells with/without functional GPIb alpha sheddase ADAM17. Mutagenesis of the GPIb-IX complex, which contains GPIb alpha, GPIb beta, and GPIX subunits, revealed that the intracellular membrane-proximal calmodulin-binding region of GPIb beta is critical for ADAM17-dependent shedding of GPIb alpha induced by the calmodulin inhibitor, W7. Perturbing the interaction between GPIb alpha and GPIb beta subunits further lessened the restraint of GPIb beta on GPIb alpha shedding. However, contrary to the widely accepted model of calmodulin regulation of ectodomain shedding, the R152E/L153E mutation in the GPIb beta cytoplasmic domain disrupted calmodulin binding to GPIb beta but had little effect on GPIb alpha shedding. Analysis of induction of GPIb alpha shedding by membrane-permeable GPIb beta-derived peptides implicated the association of GPIb beta with an unidentified intracellular protein in mediating regulation of GPIb alpha shedding. Overall, these results provide evidence for a novel trans-subunit mechanism for regulating ectodomain shedding.	[Li, Renhao] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Mu, Fi-Tjen; Andrews, Robert K.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Luo, Shi-Zhong] Beijing Univ Chem Technol, Beijing Key Lab Bioproc, Sch Life Sci & Technol, Beijing 100029, Peoples R China; [Fan, Huizhou] Univ Med & Dent New Jersey, Dept Physiol & Biophys, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Berndt, Michael C.] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland	University of Texas System; University of Texas Health Science Center Houston; Monash University; Beijing University of Chemical Technology; Rutgers State University New Brunswick; Rutgers State University Medical Center; University College Cork	Li, RH (corresponding author), 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA.	Renhao.Li@uth.tmc.edu	Li, Renhao/B-1257-2012; Fan, Huizhou/E-5835-2012; Berndt, Michael C/D-5580-2012	Li, Renhao/0000-0002-5806-5080; Andrews, Robert Keith/0000-0001-9577-8082; FAN, HUIZHOU/0000-0002-4903-926X	National Institutes of Health [HL082808, GM084175]; American Heart Association [0565078Y]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082808 and GM084175 and American Heart Association Grant 0565078Y.	Andrews RK, 2001, BLOOD, V98, P681, DOI 10.1182/blood.V98.3.681; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Blobel CP, 2002, INFLAMM RES, V51, P83, DOI 10.1007/BF02684007; Canault M, 2010, BLOOD, V115, P1835, DOI 10.1182/blood-2009-03-211706; Chattopadhyay S, 2005, J BIOL CHEM, V280, P33847, DOI 10.1074/jbc.M501718200; Clemetson KJ, 2007, THROMB HAEMOSTASIS, V98, P63, DOI 10.1160/TH07-05-0327; CLEMETSON KJ, 1981, P NATL ACAD SCI-BIOL, V78, P2712, DOI 10.1073/pnas.78.5.2712; Diaz-Rodriguez E, 2000, BIOCHEM J, V346, P359, DOI 10.1042/0264-6021:3460359; Dong JF, 1997, BIOCHEMISTRY-US, V36, P12421, DOI 10.1021/bi970636b; Dong JY, 2000, J BIOL CHEM, V275, P557, DOI 10.1074/jbc.275.1.557; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Gardiner EE, 2004, BLOOD, V104, P3611, DOI 10.1182/blood-2004-04-1549; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Killock DJ, 2009, J BIOL CHEM, V284, P8824, DOI 10.1074/jbc.M806983200; Lambert DW, 2008, FEBS LETT, V582, P385, DOI 10.1016/j.febslet.2007.11.085; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Li XJ, 2004, J BIOL CHEM, V279, P27365, DOI 10.1074/jbc.M401690200; Llovera M, 2004, J NEUROCHEM, V88, P422, DOI 10.1046/j.1471-4159.2003.02178.x; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; Luo SZ, 2007, J THROMB HAEMOST, V5, P2494, DOI 10.1111/j.1538-7836.2007.02785.x; Luo SZ, 2008, J MOL BIOL, V382, P448, DOI 10.1016/j.jmb.2008.07.037; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Mangin P, 2004, BLOOD, V104, P420, DOI 10.1182/blood-2003-08-2881; Martin K, 2003, J THROMB HAEMOST, V1, P2643, DOI 10.1046/j.1538-7836.2003.00478.x; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Mo X, 2008, J THROMB HAEMOST, V6, P1789, DOI 10.1111/j.1538-7836.2008.03088.x; Mo X, 2008, FEBS LETT, V582, P3270, DOI 10.1016/j.febslet.2008.08.036; Mo X, 2006, J BIOL CHEM, V281, P23050, DOI 10.1074/jbc.M600924200; Mullberg J, 1997, FEBS LETT, V401, P235, DOI 10.1016/S0014-5793(96)01480-9; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rabie T, 2005, J BIOL CHEM, V280, P14462, DOI 10.1074/jbc.M500041200; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; Wong MX, 2004, FEBS LETT, V568, P70, DOI 10.1016/j.febslet.2004.04.094	45	14	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32096	32104		10.1074/jbc.M110.111864	http://dx.doi.org/10.1074/jbc.M110.111864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20716526	Green Published, hybrid			2022-12-27	WOS:000282683000023
J	Tian, YA; Crump, CJ; Li, YM				Tian, Yuan; Crump, Christina J.; Li, Yue-Ming			Dual Role of alpha-Secretase Cleavage in the Regulation of gamma-Secretase Activity for Amyloid Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; BETA-SECRETASE; CEREBROSPINAL-FLUID; NICASTRIN; SUBSTRATE; COMPLEX; MECHANISM; RELEASE; STATE	Processing of the amyloid precursor protein (APP) by beta- and gamma-secretases generates pathogenic beta-amyloid (A beta) peptides associated with Alzheimer disease (AD), whereas cleavage of APP by alpha-secretases precludes A beta formation. Little is known about the role of alpha-secretase cleavage in gamma-secretase regulation. Here, we show that alpha-secretase-cleaved APP C-terminal product (alpha CTF) functions as an inhibitor of gamma-secretase. We demonstrate that the substrate inhibitory domain (ASID) within alpha CTF, which is bisected by the alpha-secretase cleavage site, contributes to this negative regulation because deleting or masking this domain turns alpha CTF into a better substrate for gamma-secretase. Moreover, alpha-secretase cleavage can potentiate the inhibitory effect of ASID. Inhibition of gamma-secretase activity by alpha CTF is observed in both in vitro and cellular systems. This work reveals an unforeseen role for alpha-secretase in generating an endogenous gamma-secretase inhibitor that down-regulates the production of A beta. Deregulation of this feedback mechanism may contribute to the pathogenesis of AD.	[Li, Yue-Ming] Cornell Univ, Dept Pharmacol, Joan Weill Grad Sch Med Sci, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Tian, Yuan] Cornell Univ, Program Physiol Biophys & Syst Biol, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Li, YM (corresponding author), Cornell Univ, Dept Pharmacol, Joan Weill Grad Sch Med Sci, New York, NY 10021 USA.	liy2@mskcc.org	LI, Yue/GRS-8071-2022		National Institutes of Health [AG026660]; Alzheimer Association; American Health Assistance Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); American Health Assistance Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG026660 (to Y.-M.L.). This work was also supported by the Alzheimer Association (Y.-M.L.) and the American Health Assistance Foundation (Y.-M.L.).	Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; McCafferty DG, 1997, BIOCHEMISTRY-US, V36, P10498, DOI 10.1021/bi970543u; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; Placanica L, 2010, BIOCHEMISTRY-US, V49, P2796, DOI 10.1021/bi901388t; Placanica L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005088; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shelton CC, 2009, P NATL ACAD SCI USA, V106, P20228, DOI 10.1073/pnas.0910757106; Shelton CC, 2009, ASSAY DRUG DEV TECHN, V7, P461, DOI 10.1089/adt.2009.0202; Shelton CC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-22; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tian Y, 2010, NAT STRUCT MOL BIOL, V17, P151, DOI 10.1038/nsmb.1743; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Zhao GJ, 2010, J NEUROSCI, V30, P1648, DOI 10.1523/JNEUROSCI.3826-09.2010	33	33	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32549	32556		10.1074/jbc.M110.128439	http://dx.doi.org/10.1074/jbc.M110.128439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20675367	Green Published, hybrid			2022-12-27	WOS:000282683000069
J	Kapoor, N; Gupta, R; Menon, ST; Folta-Stogniew, E; Raleigh, DP; Sakmar, TP				Kapoor, Neeraj; Gupta, Ruchi; Menon, Santosh T.; Folta-Stogniew, Ewa; Raleigh, Daniel P.; Sakmar, Thomas P.			Nucleobindin 1 Is a Calcium-regulated Guanine Nucleotide Dissociation Inhibitor of G alpha(i1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INDEPENDENT ACTIVATORS; GOLOCO MOTIF; BINDING-PROTEIN; CA2+-BINDING PROTEIN; LEUCINE-ZIPPER; CALNUC BINDS; GOLGI; TRANSDUCIN; RHODOPSIN; MECHANISM	Nucleobindin 1 (NUCB1) is a widely expressed multidomain calcium-binding protein whose precise physiological and biochemical functions are not well understood. We engineered and heterologously expressed a soluble form of NUCB1 (sNUCB1) and characterized its biophysical and biochemical properties. We show that sNUCB1 exists as a dimer in solution and that each monomer binds two divalent calcium cations. Calcium binding causes conformational changes in sNUCB1 as judged by circular dichroism and fluorescence spectroscopy experiments. Earlier reports suggested that NUCB1 might interact with heterotrimeric G protein alpha subunits. We show that dimeric calcium-free sNUCB1 binds to expressed G alpha(i1) and that calcium binding inhibits the interaction. The binding of sNUCB1 to G alpha(i1) inhibits its basal rate of GDP release and slows its rate and extent of GTP gamma S uptake. Additionally, our tissue culture experiments show that sNUCB1 prevents receptor-mediated G alpha(i)-dependent inhibition of adenylyl cyclase. Thus, we conclude that sNUCB1 is a calcium-dependent guanine nucleotide dissociation inhibitor (GDI) for G alpha(i1). To our knowledge, sNUCB1 is the first example of a calcium-dependent GDI for heterotrimeric G proteins. We also show that the mechanism of GDI activity of sNUCB1 is unique and does not arise from the consensus GoLoco motif found in RGS proteins. We propose that cytoplasmic NUCB1 might function to regulate heterotrimeric G protein trafficking and G protein-coupled receptor-mediated signal transduction pathways.	[Sakmar, Thomas P.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [Folta-Stogniew, Ewa] Yale Univ, Sch Med, WM Keck Fdn, Biotechnol Resource Lab, New Haven, CT 06520 USA; [Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Raleigh, Daniel P.] SUNY Stony Brook, Grad Program Biochem & Struct Biol, Stony Brook, NY 11794 USA; [Raleigh, Daniel P.] SUNY Stony Brook, Grad Program Biophys, Stony Brook, NY 11794 USA	Rockefeller University; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	sakmar@mail.rockefeller.edu	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953; raleigh, daniel/0000-0003-3248-7493	National Institutes of Health [GM078114]; Rockefeller/Sloan-Kettering/Weill Cornell Tri-Institutional Training Program in Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller/Sloan-Kettering/Weill Cornell Tri-Institutional Training Program in Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078114. This work was also supported by Rockefeller/Sloan-Kettering/Weill Cornell Tri-Institutional Training Program in Chemical Biology.	Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; Brodeur J, 2009, TRAFFIC, V10, P1098, DOI 10.1111/j.1600-0854.2009.00933.x; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; CUMMINS PG, 1981, J PHYS E SCI INSTRUM, V14, P1171, DOI 10.1088/0022-3735/14/10/019; de Alba E, 2004, BIOCHEMISTRY-US, V43, P10039, DOI 10.1021/bi049310a; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; KANAI Y, 1992, IMMUNOL LETT, V32, P43; Kanuru M, 2009, FEBS J, V276, P2529, DOI 10.1111/j.1742-4658.2009.06977.x; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kimple Randall J, 2002, Mol Interv, V2, P88, DOI 10.1124/mi.2.2.88; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Leclerc P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002229; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Lin P, 2007, J NEUROCHEM, V100, P1505, DOI 10.1111/j.1471-4159.2006.07336.x; Lin P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-15; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; MIURA K, 1994, BIOCHEM BIOPH RES CO, V199, P1388, DOI 10.1006/bbrc.1994.1384; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; MOCHIZUKI N, 1995, FEBS LETT, V373, P155, DOI 10.1016/0014-5793(95)01031-9; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; PHILLIPS SR, 1986, CURR EYE RES, V5, P611, DOI 10.3109/02713688609015126; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tsukumo Y, 2009, J BIOL CHEM, V284, P27500, DOI 10.1074/jbc.M109.021592; Usachev YM, 1995, J PHYSIOL-LONDON, V489, P309, DOI 10.1113/jphysiol.1995.sp021052; VANHOLDE KE, 1958, J PHYS CHEM-US, V62, P734, DOI 10.1021/j150564a025; WANG SN, 1994, PATHOL INT, V44, P844, DOI 10.1111/j.1440-1827.1994.tb01682.x; Willard FS, 2006, CELL SIGNAL, V18, P1226, DOI 10.1016/j.cellsig.2005.10.003; Willard FS, 2004, METHOD ENZYMOL, V389, P56; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756	52	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31647	31660		10.1074/jbc.M110.148429	http://dx.doi.org/10.1074/jbc.M110.148429			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20679342	Green Published, hybrid			2022-12-27	WOS:000282764600057
J	Kuzyk, A; Kastyak, M; Agrawal, V; Gallant, M; Sivakumar, G; Rak, M; Del Bigio, MR; Westaway, D; Julian, R; Gough, KM				Kuzyk, Alexandra; Kastyak, Marzena; Agrawal, Veena; Gallant, Meghan; Sivakumar, Gajjeraman; Rak, Margaret; Del Bigio, Marc R.; Westaway, David; Julian, Robert; Gough, Kathleen M.			Association among Amyloid Plaque, Lipid, and Creatine in Hippocampus of TgCRND8 Mouse Model for Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; WHITE-MATTER; H-1 MRS; BRAIN; PEPTIDE; INFLAMMATION; IMPAIRMENT; HYPOTHESIS; DEPOSITION; PATHWAYS	Amyloid peptide (A beta)aggregation in the brain is a characteristic feature of Alzheimer disease (AD). Previously, we reported the discovery of focally elevated creatine deposits in brain tissue from TgCRND8 mice, which express double mutant (K670N/M671L and V717F) amyloid protein precursor. In this study, frozen hippocampal tissue sections from 5-, 8-, 11-, 14-, and 17-month old TgCRND8 and littermate control mice were examined with Fourier transform infrared microspectroscopy to explore the distribution of lipid, creatine, and dense core plaque deposits. Lipid distribution throughout the hippocampus was similar in transgenic (Tg) and non-Tg littermates at all ages. Dense core plaques were always found to lie within a thin (30-50 mu m) lipid envelope, confirmed by imaging through serial sections. Creatine deposits were found in all TgCRND8 mice; the extent of deposition increased with age. Minor creatine deposits appeared in the oldest littermate controls. Distribution in the serial sections showed moderate correlation between layers, slightly disturbed by the freeze/thaw process. Creatine deposits in Tg mice were not specifically co-localized with plaques or lipid halos. The dimension of the lipid envelope is comparable with that of the diffuse halo of nonaggregated amyloid, implying a dynamic association in vivo, postulated to have a significant role in the evolving neurotoxicity.	[Rak, Margaret; Gough, Kathleen M.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Del Bigio, Marc R.] Univ Manitoba, Dept Pathol, Winnipeg, MB R3E 0W3, Canada; [Westaway, David] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5G 1L5, Canada; [Westaway, David] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; [Julian, Robert] Univ Wisconsin Madison, Ctr Synchrotron Radiat, Stoughton, WI 53589 USA	University of Manitoba; University of Manitoba; University of Toronto; University of Toronto; University of Wisconsin System; University of Wisconsin Madison	Gough, KM (corresponding author), Univ Manitoba, Dept Chem, 360 Parker Bldg, Winnipeg, MB R3T 2N2, Canada.	kmgough@cc.umanitoba.ca		Del Bigio, Marc/0000-0001-8366-0394	Canadian Institutes of Health Research; Manitoba Health Research Council; Natural Sciences and Engineering Research Council of Canada (NSERC) Canada; National Science Foundation [DMR-08442]; Natural Sciences and Engineering Research Council of Canada (NSERC); University of Manitoba; McCrorie-West Family Fellowship for Alzheimer Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; Natural Sciences and Engineering Research Council of Canada (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Manitoba; McCrorie-West Family Fellowship for Alzheimer Research	This work was supported by Canadian Institutes of Health Research, the Manitoba Health Research Council, and Natural Sciences and Engineering Research Council of Canada (NSERC) Canada. The Synchotron Research Center is funded by National Science Foundation Award DMR-08442. Access to The National Synchrotron Light Source (NSLS) was made available in part through the Canadian Light Source Participating Research Team.; Supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Post Graduate Scholarship A (PGS-A) scholarship, a University of Manitoba Graduate fellowship, and the McCrorie-West Family Fellowship for Alzheimer Research.	Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Bhargava R, 2007, ANAL BIOANAL CHEM, V389, P1155, DOI 10.1007/s00216-007-1511-9; Boimel M, 2009, J NEUROPATH EXP NEUR, V68, P314, DOI 10.1097/NEN.0b013e31819ac3cb; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Brief EE, 2009, NMR BIOMED, V22, P349, DOI 10.1002/nbm.1349; Charlton RA, 2007, BRAIN RES, V1164, P108, DOI 10.1016/j.brainres.2007.06.027; Chew SF, 2007, TISSUE ANTIGENS, V69, P252, DOI 10.1111/j.1399-0039.2006.00775.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; FABIAN H, 1993, APPL SPECTROSC, V47, P1513, DOI 10.1366/0003702934067469; Gallant M, 2006, J BIOL CHEM, V281, P5, DOI 10.1074/jbc.C500244200; Gough KM, 2010, VIB SPECTROSC, V53, P71, DOI 10.1016/j.vibspec.2010.01.015; Hort J, 2007, P NATL ACAD SCI USA, V104, P4042, DOI 10.1073/pnas.0611314104; Huang W, 2001, NEUROLOGY, V57, P626, DOI 10.1212/WNL.57.4.626; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Li XF, 2006, MOL CELL NEUROSCI, V31, P263, DOI 10.1016/j.mcn.2005.09.015; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Miller VM, 2009, BRAIN RES, V1276, P22, DOI 10.1016/j.brainres.2009.04.029; Modrego PJ, 2006, CNS DRUGS, V20, P867, DOI 10.2165/00023210-200620100-00006; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P774, DOI 10.1097/NEN.0b013e3181aacbe9; Perluigi M, 2009, PROTEOM CLIN APPL, V3, P682, DOI 10.1002/prca.200800161; Pfefferbaum A, 1999, ARCH GEN PSYCHIAT, V56, P185, DOI 10.1001/archpsyc.56.2.185; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Rak M, 2007, BIOPOLYMERS, V87, P207, DOI 10.1002/bip.20820; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Siedlak SL, 2009, FREE RADICAL RES, V43, P156, DOI 10.1080/10715760802644694; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Vitiello G, 2010, J PEPT SCI, V16, P115, DOI 10.1002/psc.1207; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998	32	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31202	31207		10.1074/jbc.M110.142174	http://dx.doi.org/10.1074/jbc.M110.142174			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682779	Green Published, hybrid			2022-12-27	WOS:000282764600014
J	Lo, WY; Lagrange, AH; Hernandez, CC; Harrison, R; Dell, A; Haslam, SM; Sheehan, JH; Macdonald, RL				Lo, Wen-yi; Lagrange, Andre H.; Hernandez, Ciria C.; Harrison, Rebecca; Dell, Anne; Haslam, Stuart M.; Sheehan, Jonathan H.; Macdonald, Robert L.			Glycosylation of beta 2 Subunits Regulates GABA(A) Receptor Biogenesis and Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SITE-DIRECTED MUTAGENESIS; N-LINKED GLYCOSYLATION; GATED ION-CHANNEL; X-SER/THR SEQUON; ALPHA-1 SUBUNIT; AMINO-ACID; EPILEPSY MUTATION; CRYSTAL-STRUCTURE; AGONIST BINDING	gamma-Aminobutyric acid type A (GABA(A)) receptors are hetero-pentameric glycoproteins. Based on consensus sequences, the GABA(A) receptor beta 2 subunit contains three potential N-linked glycosylation sites, Asn-32, Asn-104, and Asn-173. Homology modeling indicates that Asn-32 and Asn-104 are located before the alpha 1 helix and in loop L3, respectively, near the top of the subunit-subunit interface on the minus side, and that Asn-173 is located in the Cys-loop near the bottom of the subunit N-terminal domain. Using site-directed mutagenesis, we demonstrated that all predicted beta 2 subunit glycosylation sites were glycosylated in transfected HEK293T cells. Glycosylation of each site, however, produced specific changes in alpha 1 beta 2 receptor surface expression and function. Although glycosylation of Asn-173 in the Cys-loop was important for stability of beta 2 subunits when expressed alone, results obtained with flow cytometry, brefeldin A treatment, and endo-beta-N-acetylglucosaminidase H digestion suggested that glycosylation of Asn-104 was required for efficient alpha 1 beta 2 receptor assembly and/or stability in the endoplasmic reticulum. Patch clamp recording revealed that mutation of each site to prevent glycosylation decreased peak alpha 1 beta 2 receptor current amplitudes and altered the gating properties of alpha 1 beta 2 receptor channels by reducing mean open time due to a reduction in the proportion of long open states. In addition to functional heterogeneity, endo-beta-N-acetylglucosaminidase H digestion and glycomic profiling revealed that surface beta 2 subunit N-glycans at Asn-173 were high mannose forms that were different from those of Asn-32 and N104. Using a homology model of the pentameric extracellular domain of alpha 1 beta 2 channel, we propose mechanisms for regulation of GABA(A) receptors by glycosylation.	[Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA; [Sheehan, Jonathan H.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Lo, Wen-yi] Vanderbilt Univ, Program Neurosci, Nashville, TN 37232 USA; [Sheehan, Jonathan H.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Harrison, Rebecca; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Imperial College London	Macdonald, RL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 6140 Med Res Bldg 3,465,21st Ave, Nashville, TN 37232 USA.	robert.macdonald@vanderbilt.edu	; Lagrange, Andre/B-1227-2008	Sheehan, Jonathan/0000-0002-9641-7577; Lagrange, Andre/0000-0003-0147-7778	National Institutes of Health [R01 NS51590, K08 NS045122]; Biotechnology and Biological Sciences Research Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051590, K08NS045122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS51590 (to R. L. M.) and K08 NS045122 (to A. H. L.). This work was also supported by the Biotechnology and Biological Sciences Research Council (to A. D. and S. M. H.) and a Departmental Training Account Studentship from the Biotechnology and Biological Sciences Research Council (to R. H.).	ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen DN, 1998, J NEUROCHEM, V70, P349; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DeMarco ML, 2008, GLYCOBIOLOGY, V18, P426, DOI 10.1093/glycob/cwn026; Ehya N, 2003, J NEUROCHEM, V84, P127, DOI 10.1046/j.1471-4159.2003.01509.x; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Greenfield LJ, 1997, NEUROPHARMACOLOGY, V36, P63, DOI 10.1016/S0028-3908(96)00150-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; Lagrange AH, 2007, J PHYSIOL-LONDON, V578, P655, DOI 10.1113/jphysiol.2006.122135; Lema GMC, 2006, J PHYSIOL-LONDON, V572, P183, DOI 10.1113/jphysiol.2005.099093; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Marklova E, 2007, CLIN CHIM ACTA, V385, P6, DOI 10.1016/j.cca.2007.07.002; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Monk SA, 2004, BIOCHEM PHARMACOL, V68, P1787, DOI 10.1016/j.bcp.2004.06.034; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Nishizaki T, 2003, MOL BRAIN RES, V114, P172, DOI 10.1016/S0169-328X(03)00171-2; Pang PC, 2009, J PROTEOME RES, V8, P4906, DOI 10.1021/pr9001756; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; Quirk PL, 2004, J NEUROSCI RES, V77, P498, DOI 10.1002/jnr.20185; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; Tanaka M, 2008, AM J HUM GENET, V82, P1249, DOI 10.1016/j.ajhg.2008.04.020; Tang X, 2010, J NEUROPHYSIOL, V103, P1007, DOI 10.1152/jn.00801.2009; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9	48	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31348	31361		10.1074/jbc.M110.151449	http://dx.doi.org/10.1074/jbc.M110.151449			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20639197	hybrid, Green Published			2022-12-27	WOS:000282764600029
J	Mast, N; Charvet, C; Pikuleva, IA; Stout, CD				Mast, Natalia; Charvet, Casey; Pikuleva, Irina A.; Stout, C. David			Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTAMINE H-3; CYTOCHROME-P450 46A1; CRYSTAL-STRUCTURES; IN-VITRO; 24-HYDROXYLASE; HOMEOSTASIS; INHIBITION; COMPLEXES; 24S-HYDROXYCHOLESTEROL; CRYSTALLOGRAPHY	Cytochrome P450 46A1 (CYP46A1) initiates the major pathway of cholesterol elimination from the brain and thereby controls cholesterol turnover in this organ. We determined x-ray crystal structures of CYP46A1 in complex with four structurally distinct pharmaceuticals; antidepressant tranylcypromine (2.15 angstrom), anticonvulsant thioperamide (1.65 angstrom), antifungal voriconazole (2.35 angstrom), and antifungal clotrimazole (2.50 angstrom). All four drugs are nitrogen-containing compounds that have nanomolar affinity for CYP46A1 in vitro yet differ in size, shape, hydrophobicity, and type of the nitrogen ligand. Structures of the co-complexes demonstrate that each drug binds in a single orientation to the active site with tranylcypromine, thioperamide, and voriconazole coordinating the heme iron via their nitrogen atoms and clotrimazole being at a 4 angstrom distance from the heme iron. We show here that clotrimazole is also a substrate for CYP46A1. High affinity for CYP46A1 is determined by a set of specific interactions, some of which were further investigated by solution studies using structural analogs of the drugs and the T306A CYP46A1 mutant. Collectively, our results reveal how diverse inhibitors can be accommodated in the CYP46A1 active site and provide an explanation for the observed differences in the drug-induced spectral response. Co-complexes with tranylcypromine, thioperamide, and voriconazole represent the first structural characterization of the drug binding to a P450 enzyme.	[Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Scripps Research Institute; Case Western Reserve University	Pikuleva, IA (corresponding author), 2085 Adelbert Rd,Rm 303, Cleveland, OH 44106 USA.	iap8@case.edu; dave@scripps.edu		Pikuleva, Irina/0000-0001-9742-6232	United States Public Health Service [GM62882, AG024336]; National Institutes of Health [T32 EY07157]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; NIGMS; NATIONAL EYE INSTITUTE [T32EY007157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024336] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Health Service Grants GM62882 and AG024336 (to I. A. P). This work was also supported in part by National Institutes of Health Grant T32 EY07157 (an NEI predoctoral research training fellowship from the Visual Sciences Training Program, to C. C.).; We thank Dr. M. Shimoji for generating the T306A CYP46A1 mutant. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and by the NIGMS. We are grateful to the SSRL staff for generous support.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balding PR, 2008, J PHYS CHEM A, V112, P12911, DOI 10.1021/jp802087w; Berlin M, 2006, BIOORG MED CHEM LETT, V16, P989, DOI 10.1016/j.bmcl.2005.10.087; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celanire S, 2005, DRUG DISCOV TODAY, V10, P1613, DOI 10.1016/S1359-6446(05)03625-1; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P76; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; Frieling H, 2006, EUR ARCH PSY CLIN N, V256, P268, DOI 10.1007/s00406-006-0660-8; Halford RW, 2009, P NATL ACAD SCI USA, V106, P3502, DOI 10.1073/pnas.0813349106; Hlavica P, 2006, BBA-PROTEINS PROTEOM, V1764, P645, DOI 10.1016/j.bbapap.2006.01.013; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Lazewska D, 2009, BIOORG MED CHEM LETT, V19, P6682, DOI 10.1016/j.bmcl.2009.10.005; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; Podust LM, 2009, J BIOL CHEM, V284, P25211, DOI 10.1074/jbc.M109.017632; POULOS TL, 1987, BIOCHEMISTRY-US, V26, P8165, DOI 10.1021/bi00399a022; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Sabo JA, 2000, ANN PHARMACOTHER, V34, P1032, DOI 10.1345/aph.19237; See RF, 1998, INORG CHEM, V37, P5369, DOI 10.1021/ic971462p; Shafaati M, 2010, J LIPID RES, V51, P318, DOI 10.1194/jlr.M900174-JLR200; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Zhao YG, 2007, BIOCHEMISTRY-US, V46, P11559, DOI 10.1021/bi7011614	38	52	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31783	31795		10.1074/jbc.M110.143313	http://dx.doi.org/10.1074/jbc.M110.143313			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20667828	hybrid, Green Published			2022-12-27	WOS:000282764600070
J	Montanier, C; Flint, JE; Bolam, DN; Xie, HF; Liu, ZY; Rogowski, A; Weiner, DP; Ratnaparkhe, S; Nurizzo, D; Roberts, SM; Turkenburg, JP; Davies, GJ; Gilbert, HJ				Montanier, Cedric; Flint, James E.; Bolam, David N.; Xie, Hefang; Liu, Ziyuan; Rogowski, Artur; Weiner, David P.; Ratnaparkhe, Supriya; Nurizzo, Didier; Roberts, Shirley M.; Turkenburg, Johan P.; Davies, Gideon J.; Gilbert, Harry J.			Circular Permutation Provides an Evolutionary Link between Two Families of Calcium-dependent Carbohydrate Binding Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENS SUBSP CELLULOSA; CELL-WALL DEGRADATION; SECONDARY-STRUCTURE; ALPHA-MANNOSIDASES; LIGAND-BINDING; XYLANASE; DOMAINS; PROTEIN; COMPLEX; RECOGNITION	The microbial deconstruction of the plant cell wall is a critical biological process, which also provides important substrates for environmentally sustainable industries. Enzymes that hydrolyze the plant cell wall generally contain non-catalytic carbohydrate binding modules (CBMs) that contribute to plant cell wall degradation. Here we report the biochemical properties and crystal structure of a family of CBMs (CBM60) that are located in xylanases. Uniquely, the proteins display broad ligand specificity, targeting xylans, galactans, and cellulose. Some of the CBM60s display enhanced affinity for their ligands through avidity effects mediated by protein dimerization. The crystal structure of vCBM60, displays a beta-sandwich with the ligand binding site comprising a broad cleft formed by the loops connecting the two beta-sheets. Ligand recognition at site 1 is, exclusively, through hydrophobic interactions, whereas binding at site 2 is conferred by polar interactions between a protein-bound calcium and the O2 and O3 of the sugar. The observation, that ligand recognition at site 2 requires only a beta-linked sugar that contains equatorial hydroxyls at C2 and C3, explains the broad ligand specificity displayed by vCBM60. The ligand-binding apparatus of vCBM60 displays remarkable structural conservation with a family 36 CBM (CBM36); however, the residues that contribute to carbohydrate recognition are derived from different regions of the two proteins. Three-dimensional structure-based sequence alignments reveal that CBM36 and CBM60 are related by circular permutation. The biological and evolutionary significance of the mechanism of ligand recognition displayed by family 60 CBMs is discussed.	[Montanier, Cedric; Flint, James E.; Bolam, David N.; Xie, Hefang; Liu, Ziyuan; Rogowski, Artur; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Weiner, David P.] Verenium Corp, San Diego, CA 92121 USA; [Nurizzo, Didier] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Roberts, Shirley M.; Turkenburg, Johan P.; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Ratnaparkhe, Supriya; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Newcastle University - UK; European Synchrotron Radiation Facility (ESRF); University of York - UK; University System of Georgia; University of Georgia	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	h.j.gilbert@ccrc.uga.edu	Montanier, Cédric/P-7727-2019; Davies, Gideon J/A-9042-2011	Montanier, Cédric/0000-0002-8205-7160; Davies, Gideon J/0000-0002-7343-776X; Flint, James/0000-0003-2923-7813; Bolam, David/0000-0003-0314-3122; Turkenburg, Johan/0000-0001-6992-6838	Biotechnology and Biological Sciences Research Council; National Science Foundation [IOS-0923992]; Department of Energy [DE-FG02-09ER16076]; Newcastle University; Biotechnology and Biological Sciences Research Council [BB/C005074/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Newcastle University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council. This work was also supported in part by a grant from the National Science Foundation Plant Genome Program (IOS-0923992) and the Department of Energy (DE-FG02-09ER16076).; Recipient of a fellowship from Newcastle University.	Abbott DW, 2009, BIOCHEMISTRY-US, V48, P10395, DOI 10.1021/bi9013424; Abou Hachem M, 2000, BIOCHEM J, V345, P53, DOI 10.1042/0264-6021:3450053; Abou-Hachem M, 2002, BIOCHEMISTRY-US, V41, P5720, DOI 10.1021/bi012094a; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2002, MOL MICROBIOL, V43, P187, DOI 10.1046/j.1365-2958.2002.02730.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brett C. T., 1996, TOPICS PLANT FUNCTIO; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; CUNNINGHAM BA, 1979, P NATL ACAD SCI USA, V76, P3218, DOI 10.1073/pnas.76.7.3218; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Emami K, 2002, J BACTERIOL, V184, P4124, DOI 10.1128/JB.184.15.4124-4133.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERREIRA LMA, 1993, BIOCHEM J, V294, P349, DOI 10.1042/bj2940349; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; GHANGAS GS, 1989, J BACTERIOL, V171, P2963, DOI 10.1128/jb.171.6.2963-2969.1989; GILKES NR, 1992, J BIOL CHEM, V267, P6743; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; HALL J, 1989, MOL MICROBIOL, V3, P1211, DOI 10.1111/j.1365-2958.1989.tb00271.x; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; KELLETT LE, 1990, BIOCHEM J, V272, P369, DOI 10.1042/bj2720369; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; McCartney L, 2003, PLANT J, V33, P447, DOI 10.1046/j.1365-313X.2003.01640.x; McCartney L, 2004, ANAL BIOCHEM, V326, P49, DOI 10.1016/j.ab.2003.11.011; MILLWARDSADLER SJ, 1995, BIOCHEM J, V312, P39, DOI 10.1042/bj3120039; Montanier C, 2009, PLOS BIOL, V7, P687, DOI 10.1371/journal.pbio.1000071; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy T, 2002, J BACTERIOL, V184, P4925, DOI 10.1128/JB.184.17.4925-4929.2002; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Reitinger S, 2010, BIOCHEMISTRY-US, V49, P2464, DOI 10.1021/bi100036f; Ryttersgaard C, 2004, J MOL BIOL, V341, P107, DOI 10.1016/j.jmb.2004.05.017; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simpson PJ, 1999, STRUCTURE, V7, P853, DOI 10.1016/S0969-2126(99)80108-7; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	60	29	29	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31742	31754		10.1074/jbc.M110.142133	http://dx.doi.org/10.1074/jbc.M110.142133			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20659893	Green Published, hybrid			2022-12-27	WOS:000282764600066
J	Aoyama, T; Okamoto, T; Fukiage, K; Otsuka, S; Furu, M; Ito, K; Jin, YH; Ueda, M; Nagayama, S; Nakayama, T; Nakamura, T; Toguchida, J				Aoyama, Tomoki; Okamoto, Takeshi; Fukiage, Kenichi; Otsuka, Seiji; Furu, Moritoshi; Ito, Kinya; Jin, Yonghui; Ueda, Michiko; Nagayama, Satoshi; Nakayama, Tomitaka; Nakamura, Takashi; Toguchida, Junya			Histone Modifiers, YY1 and p300, Regulate the Expression of Cartilage-specific Gene, Chondromodulin-I, in Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; TRANSCRIPTION; CHONDROCYTES; CANCER; ACETYLATION; CHROMATIN; BINDING; FAMILY; GROWTH; SP3	Elucidating the regulatory mechanism for tissue-specific gene expression is key to understanding the differentiation process. The chondromodulin-I gene (ChM-I) is a cartilage-specific gene, the expression of which is regulated by the transcription factor, Sp3. The binding of Sp3 to the core-promoter region is regulated by the methylation status of the Sp3-binding motif as we reported previously. In this study, we have investigated the molecular mechanisms of the down-regulation of ChM-I expression in mesenchymal stem cells (MSCs) and normal mesenchymal tissues other than cartilage. The core-promoter region of cells in bone and peripheral nerve tissues was hypermethylated, whereas the methylation status in cells of other tissues including MSCs did not differ from that in cells of cartilage, suggesting the presence of inhibitory mechanisms other than DNA methylation. We found that a transcriptional repressor, YY1, negatively regulated the expression of ChM-I by recruiting histone deacetylase and thus inducing the deacetylation of associated histones. As for a positive regulator, we found that a transcriptional co-activator, p300, bound to the core-promoter region with Sp3, inducing the acetylation of histone. Inhibition of YY1 in combination with forced expression of p300 and Sp3 restored the expression of ChM-I in cells with a hypomethylated promoter region, but not in cells with hypermethylation. These results suggested that the expression of tissue-specific genes is regulated in two steps; reversible down-regulation by transcriptional repressor complex and tight down-regulation via DNA methylation.	[Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan; [Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Aoyama, Tomoki; Okamoto, Takeshi; Fukiage, Kenichi; Furu, Moritoshi; Nakayama, Tomitaka; Nakamura, Takashi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan; [Nagayama, Satoshi] Kyoto Univ, Grad Sch Med, Dept Surg & Surg Basic Sci, Kyoto 6068507, Japan; [Otsuka, Seiji; Ito, Kinya] Nagoya City Univ, Grad Sch Med Sci, Dept Musculoskeletal Med, Nagoya, Aichi 4678601, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Nagoya City University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	togjun@frontier.kyoto-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare; Grants-in-Aid for Scientific Research [21390420] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science, from the Ministry of Education, Culture, Sports, Science, and Technology, and from the Ministry of Health, Labor, and Welfare.	Aoyama T, 2005, J BONE MINER RES, V20, P377, DOI 10.1359/JBMR.041122; Aoyama T, 2004, J BIOL CHEM, V279, P28789, DOI 10.1074/jbc.M401273200; Aoyama T, 2008, BIOCHEM BIOPH RES CO, V365, P124, DOI 10.1016/j.bbrc.2007.10.135; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HIRAKI Y, 1991, BIOCHEM BIOPH RES CO, V175, P971, DOI 10.1016/0006-291X(91)91660-5; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Kishikawa S, 2002, EUR J BIOCHEM, V269, P2961, DOI 10.1046/j.1432-1033.2002.02972.x; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakao M, 2001, GENE, V278, P25, DOI 10.1016/S0378-1119(01)00721-1; Noer A, 2006, MOL BIOL CELL, V17, P3543, DOI 10.1091/mbc.E06-04-0322; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pasini D, 2008, COLD SH Q B, V73, P253, DOI 10.1101/sqb.2008.73.009; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; THONAR EJMA, 1983, J BIOL CHEM, V258, P1564; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Zhao W, 2005, J BIOCHEM, V137, P431, DOI 10.1093/jb/mvi048	32	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29842	29850		10.1074/jbc.M110.116319	http://dx.doi.org/10.1074/jbc.M110.116319			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663886	Green Published, hybrid			2022-12-27	WOS:000281984300020
J	Jayadeva, G; Kurimchak, A; Garriga, J; Sotillo, E; Davis, AJ; Haines, DS; Mumby, M; Grana, X				Jayadeva, Girish; Kurimchak, Alison; Garriga, Judit; Sotillo, Elena; Davis, Anthony J.; Haines, Dale S.; Mumby, Marc; Grana, Xavier			B55 alpha PP2A Holoenzymes Modulate the Phosphorylation Status of the Retinoblastoma-related Protein p107 and Its Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; PHOSPHATASE 2A; REGULATORY SUBUNIT; PRB DEPHOSPHORYLATION; DNA-DAMAGE; P130; QUIESCENCE; INTERACTS; ARREST; FAMILY	Pocket proteins negatively regulate transcription of E2F-dependent genes and progression through the G(0)/G(1) transition and the cell cycle restriction point in G(1). Pocket protein repressor activities are inactivated via phosphorylation at multiple Pro-directed Ser/Thr sites by the coordinated action of G(1) and G(1)/S cyclin-dependent kinases. These phosphorylations are reversed by the action of two families of Ser/Thr phosphatases: PP1, which has been implicated in abrupt dephosphorylation of retinoblastoma protein (pRB) in mitosis, and PP2A, which plays a role in an equilibrium that counteracts cyclin-dependent kinase (CDK) action throughout the cell cycle. However, the identity of the trimeric PP2A holoenzyme(s) functioning in this process is unknown. Here we report the identification of a PP2A trimeric holoenzyme containing B55 alpha, which plays a major role in restricting the phosphorylation state of p107 and inducing its activation in human cells. Our data also suggest targeted selectivity in the interaction of pocket proteins with distinct PP2A holoenzymes, which is likely necessary for simultaneous pocket protein activation.	[Jayadeva, Girish; Kurimchak, Alison; Garriga, Judit; Sotillo, Elena; Haines, Dale S.; Grana, Xavier] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Haines, Dale S.; Grana, Xavier] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Davis, Anthony J.; Mumby, Marc] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Grana, X (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, AHP Bldg,Rm 308,3307 N Broad St, Philadelphia, PA 19140 USA.	xavier@temple.edu		Davis, Anthony/0000-0003-0184-3651; Grana, Xavier/0000-0001-7134-0473; Sotillo, Elena/0000-0002-3993-1932	National Institutes of Health [CA095569, K02 AI01823]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [P01CA095569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI001823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA095569 (to X. G., J. G., and D. S. H.) and a National Institutes of Health Career Development Award (K02 AI01823) (to X. G.). This work was also supported by a grant from the Pennsylvania Department of Health (to X. G.).	Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Bruce JL, 2000, MOL CELL, V6, P737, DOI 10.1016/S1097-2765(00)00072-1; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; Garriga J, 2004, CELL CYCLE, V3, P1320, DOI 10.4161/cc.3.10.1183; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Grana X, 2008, CANCER BIOL THER, V7, P842, DOI 10.4161/cbt.7.6.6298; Kolupaeva V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003447; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; MAYOL X, 1995, ONCOGENE, V11, P801; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Sotillo E, 2008, J BIOL CHEM, V283, P11280, DOI 10.1074/jbc.M709055200; Sotillo E, 2010, CONTEMP CANCER RES, P3, DOI 10.1007/978-1-4419-1770-6_1; Swanhart LM, 2007, DEV DYNAM, V236, P2567, DOI 10.1002/dvdy.21265; Tamrakar S, 2000, FRONT BIOSCI-LANDMRK, V5, pD121, DOI 10.2741/Tamrakar; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Voorhoeve PM, 1999, ONCOGENE, V18, P515, DOI 10.1038/sj.onc.1202316; Voorhoeve PM, 1999, ONCOGENE, V18, P679, DOI 10.1038/sj.onc.1202289; Vuocolo S, 2003, J BIOL CHEM, V278, P41881, DOI 10.1074/jbc.M302715200; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhang ZG, 2003, J VIROL, V77, P12660, DOI 10.1128/JVI.77.23.12660-12670.2003	29	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29863	29873		10.1074/jbc.M110.162354	http://dx.doi.org/10.1074/jbc.M110.162354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663872	hybrid, Green Published			2022-12-27	WOS:000281984300023
J	Suzuki, K; Kondo, C; Morimoto, M; Ohsumi, Y				Suzuki, Kuninori; Kondo, Chika; Morimoto, Mayumi; Ohsumi, Yoshinori			Selective Transport of alpha-Mannosidase by Autophagic Pathways IDENTIFICATION OF A NOVEL RECEPTOR, Atg34p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; YEAST; CYTOPLASM; PROTEINS; MECHANISM; SYSTEM	In Saccharomyces cerevisiae, aminopeptidase I (Ape1p) and alpha-mannosidase (Ams1p) are known cargoes of selective autophagy. Atg19p has been identified as an Ape1p receptor and targets Ape1p to the preautophagosomal structure (PAS). Under nutrient-rich conditions, transport of Ams1p to the vacuole largely depends on Atg19p. Here, we show that Atg34p (Yo1083wp), a homolog of Atg19p, is a receptor for Ams1p transport during autophagy. Atg34p interacted with Ams1p, Atg11p, and Atg8p using distinct domains. Homo-oligomerized Ams1p bound to the Ams1-binding domain of Atg34p; this binding was important for the formation of a higher order complex named the Ams1 complex. In the absence of the interaction of Atg34p with Atg8p, the Ams1 complex was targeted to the preautophagosomal structure but failed to transit to the vacuole, indicating that the interaction of Atg34p with Atg8p is crucial for the Ams1 complex to be enclosed by autophagosomes. Atg34p and Atg19p have similar domain structures and are important for Ams1p transport during autophagy.	[Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; James P, 1996, GENETICS, V144, P1425; Kageyama T, 2009, BIOCHEM BIOPH RES CO, V378, P551, DOI 10.1016/j.bbrc.2008.11.084; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WATANABE Y, 2010, J BIOL CHEM, V285	22	89	93	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30019	30025		10.1074/jbc.M110.143511	http://dx.doi.org/10.1074/jbc.M110.143511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20639194	Green Published, hybrid			2022-12-27	WOS:000281984300039
J	Gonzalez, DR; Treuer, AV; Castellanos, J; Dulce, RA; Hare, JM				Gonzalez, Daniel R.; Treuer, Adriana V.; Castellanos, Jorge; Dulce, Raul A.; Hare, Joshua M.			Impaired S-Nitrosylation of the Ryanodine Receptor Caused by Xanthine Oxidase Activity Contributes to Calcium Leak in Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL NITRIC-OXIDE; RETICULUM CA2+ LEAK; RELEASE CHANNEL; MEDIATED DECOMPOSITION; CARDIOVASCULAR-SYSTEM; VENTRICULAR MYOCYTES; MG2+ INHIBITION; CARDIAC-MUSCLE; NADPH OXIDASE; SKELETAL	S-Nitrosylation is a ubiquitous post-translational modification that regulates diverse biologic processes. In skeletal muscle, hypernitrosylation of the ryanodine receptor (RyR) causes sarcoplasmic reticulum (SR) calcium leak, but whether abnormalities of cardiac RyR nitrosylation contribute to dysfunction of cardiac excitation-contraction coupling remains controversial. In this study, we tested the hypothesis that cardiac RyR2 is hyponitrosylated in heart failure, because of nitroso-redox imbalance. We evaluated excitation-contraction coupling and nitroso-redox balance in spontaneously hypertensive heart failure rats with dilated cardiomyopathy and age-matched Wistar-Kyoto rats. Spontaneously hypertensive heart failure myocytes were characterized by depressed contractility, increased diastolic Ca2+ leak, hyponitrosylation of RyR2, and enhanced xanthine oxidase derived superoxide. Global S-nitrosylation was decreased in failing hearts compared with nonfailing. Xanthine oxidase inhibition restored global and RyR2 nitrosylation and reversed the diastolic SR Ca2+ leak, improving Ca2+ handling and contractility. Together these findings demonstrate that nitroso-redox imbalance causes RyR2 oxidation, hyponitrosylation, and SR Ca2+ leak, a hallmark of cardiac dysfunction. The reversal of this phenotype by inhibition of xanthine oxidase has important pathophysiologic and therapeutic implications.	[Gonzalez, Daniel R.; Treuer, Adriana V.; Castellanos, Jorge; Dulce, Raul A.; Hare, Joshua M.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA	University of Miami	Hare, JM (corresponding author), Biomed Res Bldg,1501 NW 10th Ave,Rm 824,POB 01696, Miami, FL 33101 USA.	jhare@med.miami.edu		GONZALEZ, DANIEL/0000-0002-3437-8998; Treuer, Adriana V./0000-0001-7384-0228	National Institutes of Health [RO1HL 65455, HL094849-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094849, R01HL065455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL 65455 and HL094849-01.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Aleryani S, 1998, J BIOL CHEM, V273, P6041, DOI 10.1074/jbc.273.11.6041; Aracena P, 2003, J BIOL CHEM, V278, P42927, DOI 10.1074/jbc.M306969200; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Ckless K, 2004, NITRIC OXIDE-BIOL CH, V11, P216, DOI 10.1016/j.niox.2004.06.002; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; Donoso P, 2000, BIOPHYS J, V79, P279, DOI 10.1016/S0006-3495(00)76290-4; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gonzalez DR, 2008, NITRIC OXIDE-BIOL CH, V18, P157, DOI 10.1016/j.niox.2007.09.086; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Handy DE, 2006, ARTERIOSCL THROM VAS, V26, P1207, DOI 10.1161/01.ATV.0000217632.98717.a0; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hidalgo C, 2002, BIOL RES, V35, P183, DOI 10.4067/S0716-97602002000200009; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Janssen PML, 2003, AM J PHYSIOL-HEART C, V284, pH772, DOI 10.1152/ajpheart.01061.2001; Jourd'heuil D, 1998, BIOCHEM BIOPH RES CO, V244, P525, DOI 10.1006/bbrc.1998.8227; Kogler H, 2003, CARDIOVASC RES, V59, P582, DOI 10.1016/S0008-6363(03)00512-1; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Lin J, 2009, CIRCULATION, V120, P245, DOI 10.1161/CIRCULATIONAHA.109.868729; Marengo JJ, 1998, BIOPHYS J, V74, P1263, DOI 10.1016/S0006-3495(98)77840-3; Minhas KM, 2006, CIRC RES, V98, P271, DOI 10.1161/01.RES.0000200181.59551.71; Sanchez G, 2005, J MOL CELL CARDIOL, V39, P982, DOI 10.1016/j.yjmcc.2005.08.010; Sanchez G, 2008, CARDIOVASC RES, V77, P380, DOI 10.1093/cvr/cvm011; Scriven DRL, 2008, AM J PHYSIOL-CELL PH, V294, pC1119, DOI 10.1152/ajpcell.00133.2008; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2008, BIOCHEMISTRY-US, V47, P13985, DOI 10.1021/bi8012627; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yang Y, 2005, P NATL ACAD SCI USA, V102, P117, DOI 10.1073/pnas.0405989102; Zimmet JM, 2006, CIRCULATION, V114, P1531, DOI 10.1161/CIRCULATIONAHA.105.605519; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	47	106	108	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28938	28945		10.1074/jbc.M110.154948	http://dx.doi.org/10.1074/jbc.M110.154948			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20643651	Green Published, hybrid			2022-12-27	WOS:000281594000058
J	Yagci, FC; Aslan, O; Gursel, M; Tincer, G; Ozdamar, Y; Karatepe, K; Akcali, KC; Gursel, I				Yagci, Fuat C.; Aslan, Ozlem; Gursel, Mayda; Tincer, Gizem; Ozdamar, Yasemin; Karatepe, Kutay; Akcali, K. Can; Gursel, Ihsan			Mammalian Telomeric DNA Suppresses Endotoxin-induced Uveitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED IMMUNE ACTIVATION; CPG OLIGONUCLEOTIDES; BACTERIAL-DNA; SYNTHETIC OLIGONUCLEOTIDES; OCULAR INFLAMMATION; INDUCED ARTHRITIS; GENE-EXPRESSION; IN-VIVO; OLIGODEOXYNUCLEOTIDES; MICE	Telomeric regions of mammalian chromosomes contain suppressive TTAGGG motifs that inhibit several proinflammatory and Th1-biased immune responses. Synthetic oligodeoxynucleotides (ODN) expressing suppressive motifs can reproduce the down-regulatory activity of mammalian telomeric repeats and have proven effective in the prevention and treatment of several autoimmune and autoinflammatory diseases. Endotoxin-induced uveitis (EIU) is an established animal model of acute ocular inflammation induced by LPS administration. Augmented expression of proinflammatory cytokines/chemokines such as TNF alpha, IL-6, and MCP1 and bactericidal nitric oxide production mediated by LPS contribute to the development of EIU. Suppressing these mediators using agents that are devoid of undesirable systemic side effects may help prevent the development of EIU. This study demonstrates the selective down-regulatory role of suppressive ODN after (i) local or (ii) systemic treatment in EIU-induced rabbits and mice. Our results indicate that suppressive ODN down-regulate at both the transcript and protein levels of several proinflammatory cytokines and chemokines as well as nitric oxide and co-stimulatory surface marker molecules when administrated prior to, simultaneously with, or even after LPS challenge, thereby significantly reducing ocular inflammation in both rabbit and mouse eyes. These findings strongly suggest that suppressive ODN is a potent candidate for the prevention of uveitis and could be applied as a novel DNA-based immunoregulatory agent to control other autoimmune or autoinflammatory diseases.	[Gursel, Ihsan] Bilkent Univ, Biotherapeut Oligonucleotide Lab, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey; [Gursel, Mayda] Bilkent Univ, Merkez Lojmanlari, TR-06800 Ankara, Turkey; [Aslan, Ozlem; Ozdamar, Yasemin] Ulucanlar Eye Res & Educ Hosp, Minist Hlth, TR-06240 Ankara, Turkey	Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University; Ankara Ulucanlar Eye Training & Research Hospital; Ministry of Health - Turkey	Gursel, I (corresponding author), Bilkent Univ, Biotherapeut Oligonucleotide Lab, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey.	ihsangursel@bilkent.edu.tr	Gursel, M/H-1812-2012; Gursel, Ihsan/AAT-7168-2021; Budakoğlu, Özlem/AAH-9838-2019	Gursel, M/0000-0003-0044-9054; Budakoglu, Ozlem/0000-0002-9915-1786; Yagci, Fuat Cem/0000-0001-6568-2899; Akcali, Kamil/0000-0002-7816-6938; Gursel, Ihsan/0000-0003-3761-1166	Scientific and Technological Research Council of Turkey (TUBITAK) [SBAG106S102, SBAG108S316]; EU [203953]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); EU(European Commission)	This work was supported by Scientific and Technological Research Council of Turkey (TUBITAK) Grants SBAG106S102, SBAG108S316, EU/FP6/Marie Curie, and EU/FP7 UNAM REGPOT 203953.	Adamus G, 2006, INVEST OPHTH VIS SCI, V47, P2555, DOI 10.1167/iovs.05-1242; Avunduk MC, 2004, EXP EYE RES, V79, P357, DOI 10.1016/j.exer.2004.06.001; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; Dong L, 2005, ARTHRITIS RHEUM-US, V52, P651, DOI 10.1002/art.20810; Dong L, 2004, ARTHRITIS RHEUM-US, V50, P1686, DOI 10.1002/art.20263; Dunn James P, 2004, Curr Opin Ophthalmol, V15, P293, DOI 10.1097/00055735-200408000-00003; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Fujimoto C, 2009, CLIN EXP IMMUNOL, V156, P528, DOI 10.1111/j.1365-2249.2009.03918.x; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Gursel I, 2001, J IMMUNOL, V167, P3324, DOI 10.4049/jimmunol.167.6.3324; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hafezi-Moghadam A, 2007, FASEB J, V21, P464, DOI 10.1096/fj.06-6390com; Ho PP, 2005, J IMMUNOL, V175, P6226, DOI 10.4049/jimmunol.175.9.6226; Ho PP, 2003, J IMMUNOL, V171, P4920, DOI 10.4049/jimmunol.171.9.4920; HOEKZEMA R, 1992, INVEST OPHTH VIS SCI, V33, P532; Sande PH, 2008, AM J PATHOL, V173, P1702, DOI 10.2353/ajpath.2008.080518; Hu D, 2009, MOL IMMUNOL, V46, P1387, DOI 10.1016/j.molimm.2008.12.008; Ishii KJ, 2005, INT J CANCER, V117, P517, DOI 10.1002/ijc.21402; Klinman DM, 2009, ANN NY ACAD SCI, V1175, P80, DOI 10.1111/j.1749-6632.2009.04970.x; Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012; Klinman DM, 2003, ANN NY ACAD SCI, V1002, P112, DOI 10.1196/annals.1281.023; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Koizumi K, 2003, INVEST OPHTH VIS SCI, V44, P2184, DOI 10.1167/iovs.02-0589; Krieg AM, 2000, CURR OPIN IMMUNOL, V12, P35, DOI 10.1016/S0952-7915(99)00048-5; Lajavardi L, 2007, INVEST OPHTH VIS SCI, V48, P3230, DOI 10.1167/iovs.06-1305; Lightman S, 1997, EYE, V11, P222, DOI 10.1038/eye.1997.56; MANDAI M, 1994, INVEST OPHTH VIS SCI, V35, P3673; Mo JS, 1999, EXP EYE RES, V68, P333, DOI 10.1006/exer.1998.0618; Moorthy RS, 1997, SURV OPHTHALMOL, V41, P361, DOI 10.1016/S0039-6257(97)00006-4; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Ohta K, 2005, EXP EYE RES, V80, P401, DOI 10.1016/j.exer.2004.10.011; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sato T, 2008, J IMMUNOL, V180, P7648, DOI 10.4049/jimmunol.180.11.7648; Shirota H, 2005, J IMMUNOL, V174, P4579, DOI 10.4049/jimmunol.174.8.4579; Shirota H, 2004, J IMMUNOL, V173, P5002, DOI 10.4049/jimmunol.173.8.5002; Sobajima Satoshi, 2005, Spine J, V5, P14, DOI 10.1016/j.spinee.2004.05.251; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Yamada H, 2002, J IMMUNOL, V169, P5590, DOI 10.4049/jimmunol.169.10.5590; YAMAMOTO S, 1992, J IMMUNOL, V148, P4072; Zeuner RA, 2003, ARTHRITIS RHEUM, V48, P1701, DOI 10.1002/art.11035; Zeuner RA, 2002, ARTHRITIS RHEUM, V46, P2219, DOI 10.1002/art.10423; Zhu FG, 2002, J LEUKOCYTE BIOL, V71, P686	44	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28806	28811		10.1074/jbc.M110.125948	http://dx.doi.org/10.1074/jbc.M110.125948			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20630869	Green Published, hybrid			2022-12-27	WOS:000281594000046
J	Wijesekara, N; Krishnamurthy, M; Bhattacharjee, A; Suhail, A; Sweeney, G; Wheeler, MB				Wijesekara, Nadeeja; Krishnamurthy, Mansa; Bhattacharjee, Alpana; Suhail, Aamir; Sweeney, Gary; Wheeler, Michael B.			Adiponectin-induced ERK and Akt Phosphorylation Protects against Pancreatic Beta Cell Apoptosis and Increases Insulin Gene Expression and Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-INDUCED APOPTOSIS; LOW GLUCOSE; KINASE-B; RESISTANCE; RECEPTOR; GROWTH; HYPOADIPONECTINEMIA; PROLIFERATION; STIMULATION; DYSFUNCTION	The functional impact of adiponectin on pancreatic beta cells is so far poorly understood. Although adiponectin receptors (AdipoR1/2) were identified, their involvement in adiponectin-induced signaling and other molecules involved is not clearly defined. Therefore, we investigated the role of adiponectin in beta cells and the signaling mediators involved. MIN6 beta cells and mouse islets were stimulated with globular (2.5 mu g/ml) or full-length (5 mu g/ml) adiponectin under serum starvation, and cell viability, proliferation, apoptosis, insulin gene expression, and secretion were measured. Lysates were subjected to Western blot analysis to determine phosphorylation of AMP-activated protein kinase (AMPK), Akt, or ERK. Functional significance of signaling was confirmed using dominant negative mutants or pharmacological inhibitors. Participation of AdipoRs was assessed by overexpression or siRNA. Adiponectin failed to activate AMPK after 10 min or 1- and 24-h stimulation. ERK was significantly phosphorylated after 24-h treatment with adiponectin, whereas Akt was activated at all time points examined. 24-h stimulation with adiponectin significantly increased cell viability by decreasing cellular apoptosis, and this was prevented by dominant negative Akt, wortmannin (PI3K inhibitor), and U0126 (MEK inhibitor). Moreover, adiponectin regulated insulin gene expression and glucose-stimulated insulin secretion, which was also prevented by wortmannin and U0126 treatment. Interestingly, the data also suggest adiponectin-induced changes in Akt and ERK phosphorylation and caspase-3 may occur independent of the level of AdipoR expression. This study demonstrates a lack of AMPK involvement and implicates Akt and ERK in adiponectin signaling, leading to protection against apoptosis and stimulation of insulin gene expression and secretion in pancreatic beta cells.	[Wijesekara, Nadeeja; Krishnamurthy, Mansa; Bhattacharjee, Alpana; Suhail, Aamir; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	University of Toronto; York University - Canada	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle Rm 3352, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Wijesekara, Nadeeja/AAW-7230-2021	Wheeler, Michael B./0000-0002-7480-7267	Canadian Institute of Health Research [MOP-12898]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grant MOP-12898 (to M. B. W.).	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bacha F, 2004, DIABETES CARE, V27, P547, DOI 10.2337/diacare.27.2.547; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Ching JK, 2008, FASEB J, V22; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Cong L, 2007, ENDOCR-RELAT CANCER, V14, P713, DOI 10.1677/ERC-07-0065; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Fei HQ, 2008, MOL CELL BIOCHEM, V315, P75, DOI 10.1007/s11010-008-9791-8; Gu WQ, 2006, ENDOCRINE, V30, P217, DOI 10.1385/ENDO:30:2:217; Hayakawa J, 2000, CANCER RES, V60, P5988; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Huypens P, 2005, LIFE SCI, V77, P1273, DOI 10.1016/j.lfs.2005.03.008; Jung TW, 2009, ENDOCR J, V56, P377, DOI 10.1507/endocrj.K08E-354; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lin P, 2009, TOHOKU J EXP MED, V217, P59, DOI 10.1620/tjem.217.59; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Musso G, 2005, AM J GASTROENTEROL, V100, P2438, DOI 10.1111/j.1572-0241.2005.00297.x; Ogunwobi OO, 2006, REGUL PEPTIDES, V134, P105, DOI 10.1016/j.regpep.2006.02.001; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Rakatzi I, 2004, DIABETOLOGIA, V47, P249, DOI 10.1007/s00125-003-1293-3; Retnakaran R, 2005, DIABETOLOGIA, V48, P993, DOI 10.1007/s00125-005-1710-x; Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	54	164	171	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33623	33631		10.1074/jbc.M109.085084	http://dx.doi.org/10.1074/jbc.M109.085084			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20709750	Green Published, hybrid			2022-12-27	WOS:000283354000007
J	Bear, MD; Li, M; Liu, YL; Giel-Moloney, MA; Fanburg, BL; Toksoz, D				Bear, Michael D.; Li, Min; Liu, Yinglin; Giel-Moloney, Maryann A.; Fanburg, Barry L.; Toksoz, Deniz			The Lbc Rho Guanine Nucleotide Exchange Factor/alpha-Catulin Axis Functions in Serotonin-induced Vascular Smooth Muscle Cell Mitogenesis and RhoA/ROCK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; PROTEIN-KINASE-A; NF-KAPPA-B; SIGNAL-TRANSDUCTION; PULMONARY-HYPERTENSION; NUCLEAR TRANSLOCATION; ANCHORING PROTEIN; ALPHA-CATULIN; PROLIFERATION; ONCOGENE	Serotonin (5-hydroxytryptamine, 5-HT) is mitogenic for several cell types including pulmonary arterial smooth muscle cells (PASMC), and is associated with the abnormal vascular smooth muscle remodeling that occurs in pulmonary arterial hypertension. RhoA/Rho kinase (ROCK) function is required for 5-HT-induced PASMC mitogenesis, and 5-HT activates RhoA; however, the signaling steps are poorly defined. Rho guanine nucleotide exchange factors (Rho GEFs) transduce extracellular signals to Rho, and we found that 5-HT treatment of PASMC led to increased membrane-associated Lbc Rho GEF, suggesting modulation by 5-HT. Lbc knockdown by siRNA attenuated 5-HT-induced thymidine uptake in PASMC, indicating a role in PASMC mitogenesis. 5-HT triggered Rho-dependent serum response factor-mediated reporter activation in PASMC, and this was reduced by Lbc depletion. Lbc knockdown reduced 5-HT-induced RhoA/ROCK activation, but not p42/44 ERK MAP kinase activation, suggesting that Lbc is an intermediary between 5-HT and RhoA/ROCK, but not ERK. 5-HT stimulation of PASMC led to increased association between Lbc, RhoA, and the alpha-catulin scaffold. Furthermore, alpha-catulin knockdown attenuated 5-HT-induced PASMC thymidine uptake. 5-HT-induced PASMC mitogenesis was reduced by dominant-negative G(q) protein, suggesting cooperation with Lbc/alpha-catulin. These results for the first time define a Rho GEF involved in vascular smooth muscle cell growth and serotonin signaling, and suggest that Lbc Rho GEF family members play distinct roles. Thus, the Lbc/alpha-catulin axis participates in 5-HT-induced PASMC mitogenesis and RhoA/ROCK signaling, and may be an interventional target in diseases involving vascular smooth muscle remodeling.	[Bear, Michael D.; Li, Min; Liu, Yinglin; Fanburg, Barry L.; Toksoz, Deniz] Tufts Med Ctr, Tupper Res Inst, Div Pulm & Crit Care, Boston, MA 02111 USA; [Giel-Moloney, Maryann A.] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Toksoz, D (corresponding author), Tufts Med Ctr, Tupper Res Inst, Div Pulm & Crit Care, 800 Washington St,TMC 257, Boston, MA 02111 USA.	dtoksoz@tuftsmedicalcenter.org			National Institutes of Health [HL085260]; American Heart Association [0756021T]; Tufts University of Medicine [P30 NS047243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Tufts University of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085260 (to B. L. F.) and American Heart Association Grant 0756021T (to D. T.).; We thank Kozo Kaibuchi and Matthew Hart for plasmids, and Alenka Lovy-Wheeler for assistance in the Tufts Imaging Center for Neuroscience Research, Tufts University of Medicine, supported by Grant P30 NS047243 (Jackson).	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; Chen LY, 2004, J BIOL CHEM, V279, P7208, DOI 10.1074/jbc.M309542200; Day RM, 2006, BIOCHEM PHARMACOL, V71, P386, DOI 10.1016/j.bcp.2005.10.035; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Do E Z, 2009, CIRC J, V73, P1731, DOI 10.1253/circj.CJ-09-0135; Dutt P, 2004, CELL SIGNAL, V16, P201, DOI 10.1016/S0898-6568(03)00132-3; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esteve JM, 2007, CELL BIOCHEM BIOPHYS, V47, P33, DOI 10.1385/CBB:47:1:33; Fanburg BL, 1997, AM J PHYSIOL-LUNG C, V272, pL795, DOI 10.1152/ajplung.1997.272.5.L795; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Guilluy C, 2009, AM J RESP CRIT CARE, V179, P1151, DOI 10.1164/rccm.200805-691OC; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janssens B, 1999, BBA-GENE STRUCT EXPR, V1447, P341, DOI 10.1016/S0167-4781(99)00170-0; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Klussmann E, 2001, FEBS LETT, V507, P264, DOI 10.1016/S0014-5793(01)02995-7; LEE SL, 1991, CIRC RES, V68, P1362, DOI 10.1161/01.RES.68.5.1362; Lee SL, 1999, AM J PHYSIOL-LUNG C, V277, pL282, DOI 10.1152/ajplung.1999.277.2.L282; Li M, 2007, AM J PHYSIOL-LUNG C, V293, pL463, DOI 10.1152/ajplung.00133.2007; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; Liu YL, 2004, CIRC RES, V95, P579, DOI 10.1161/01.RES.0000141428.53262.a4; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MacLean MR, 2009, CURR OPIN PHARMACOL, V9, P281, DOI 10.1016/j.coph.2009.02.005; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Olson MF, 1997, ONCOGENE, V15, P2827, DOI 10.1038/sj.onc.1201594; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ramage AG, 2008, TRENDS PHARMACOL SCI, V29, P472, DOI 10.1016/j.tips.2008.06.009; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Sterpetti P, 2006, AM J PHYSIOL-GASTR L, V290, pG624, DOI 10.1152/ajpgi.00128.2005; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; TOKSOZ D, 1994, ONCOGENE, V9, P621; Toksoz D, 2002, HISTOL HISTOPATHOL, V17, P915, DOI 10.14670/HH-17.915; Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; Xiang Y, 2008, J CELL BIOCHEM, V103, P920, DOI 10.1002/jcb.21461; Zhang ZC, 1998, MAT SCI ENG B-SOLID, V54, P149, DOI 10.1016/S0921-5107(98)00157-3; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	50	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32919	32926		10.1074/jbc.M109.062513	http://dx.doi.org/10.1074/jbc.M109.062513			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20696764	Green Published, hybrid			2022-12-27	WOS:000283048200029
J	Pakala, SB; Reddy, SDN; Bui-Nguyen, TM; Rangparia, SS; Bommana, A; Kumar, R				Pakala, Suresh B.; Reddy, Sirigiri Divijendra Natha; Bui-Nguyen, Tri M.; Rangparia, Siddharth S.; Bommana, Anitha; Kumar, Rakesh			MTA1 Coregulator Regulates LPS Response via MyD88-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; KAPPA-B; NEGATIVE REGULATION; TRANSCRIPTIONAL REPRESSION; ESTROGEN-RECEPTOR; CANCER; INFLAMMATION; GENE; PATHWAYS; IMMUNITY	Although metastasis tumor antigen 1 (MTA1) contributes to the responsiveness of macrophages to LPS, the underlying mechanism remains unknown. Here, we investigated the role of MTA1 in the regulation of expression and function of MyD88, a proximal component of NF-kappa B signaling. We discovered that MTA1 targets MyD88 and that MyD88 is a NF-kappa B-responsive gene in LPS-stimulated macrophages. We found that MTA1 is required for MyD88-dependent stimulation of NF-kappa B signaling and expression of proinflammatory cytokines such as IL-1 beta, MIP2, and TNF-alpha as MTA1 depletion leads to a substantial reduction in the expression of NF-kappa B target genes. In addition, LPS-mediated stimulation of MyD88 transcription was accompanied by an enhanced recruitment of MTA1, RNA polymerase II, and p65RelA complex to the NF-kappa B consensus sites in the MyD88 promoter. Interestingly, the recruitment of both MTA1 and MyD88 expression is effectively blocked by NF-kappa B inhibitor parthenolide. Selective knockdown of MyD88 by a dominant negative mutant of MyD88 or selective siRNA also impairs the ability of LPS to stimulate the NF-kappa B target genes. These findings reveal an inherent coregulatory role of MTA1 upon the expression of MyD88 and suggest that MTA1 regulation of MyD88 may constitute at least one of the mechanisms by which MTA1 stimulates LPS-induced NF-kappa B signaling in stimulated macrophages.	[Pakala, Suresh B.; Reddy, Sirigiri Divijendra Natha; Bui-Nguyen, Tri M.; Rangparia, Siddharth S.; Bommana, Anitha; Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Inst Coregulator Biol, Washington, DC 20037 USA	George Washington University	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Inst Coregulator Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendranathareddy/A-9857-2010	Kumar, Rakesh/0000-0001-7664-0803; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 (to R. K.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Beutler B, 2004, IMMUNITY, V21, P134, DOI 10.1016/j.immuni.2004.07.014; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bui-Nguyen TM, 2010, ONCOGENE, V29, P1179, DOI 10.1038/onc.2009.404; Chang J, 2009, P NATL ACAD SCI USA, V106, P18327, DOI 10.1073/pnas.0905815106; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Iimuro Y, 2007, J GASTROEN HEPATOL, V22, pS57, DOI 10.1111/j.1440-1746.2006.04651.x; Ikebe M, 2009, J SURG ONCOL, V100, P725, DOI 10.1002/jso.21392; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Noman Abu Shadat M, 2009, Innate Immun, V15, P33, DOI 10.1177/1753425908099317; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TOH Y, 1994, J BIOL CHEM, V269, P22958; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	43	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32787	32792		10.1074/jbc.M110.151340	http://dx.doi.org/10.1074/jbc.M110.151340			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702415	Green Published, hybrid			2022-12-27	WOS:000283048200014
J	Rimer, M				Rimer, Mendell			Modulation of Agrin-induced Acetylcholine Receptor Clustering by Extracellular Signal-regulated Kinases 1 and 2 in Cultured Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTIVE NEUROMUSCULAR SYNAPTOGENESIS; ACTIVATED PROTEIN-KINASE; MUSCLE-CELLS; POSTSYNAPTIC MEMBRANES; BETA-DYSTROGLYCAN; GENE-EXPRESSION; MOTOR-NEURONS; PHORBOL ESTER; IN-VIVO; SYNAPSE	Agrin released by motoneurons induces and/or maintains acetylcholine receptor (AChR) clustering and other aspects of postsynaptic differentiation at the vertebrate neuromuscular junction. Agrin acts by binding and activating a receptor complex containing LDL receptor protein 4 (Lrp4) and muscle-specific kinase (MuSK). Two critical downstream components of this signaling cascade, Dox-7 and rapsyn, have been identified. However, additional intracellular essential elements remain unknown. Prior observations by others and us suggested antagonistic interactions between agrin and neuregulin-1 (Nrg-1) signaling in cultured myotubes and developing muscle fibers in vivo. A hallmark of Nrg-1 signaling in skeletal muscle cells is the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2). ERK1/2 are also activated in most cells by phorbol 12-myristate 13-acetate, a classical inhibitor of agrin-induced AChR clustering in myotubes. Here, it was investigated whether agrin activates ERK1/2 directly and whether such activation modulates agrin-induced AChR clustering. Agrin induced a rapid but transient activation of ERK1/2 in myotubes that was Lrp4/MuSK-dependent. However, blocking this ERK1/2 activation did not prevent but potentiated AChR clustering induced by agrin. ERK1/2 activation was dispensable for Nrg-1-mediated inhibition of the AChR clustering activity of agrin, but was indispensable for such activity by phorbol 12-myristate 13-acetate. Together, these results suggest agrin-induced activation of ERK1/2 is a negative modulator of agrin signaling in skeletal muscle cells.	[Rimer, Mendell] Texas A&M Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Rimer, M (corresponding author), 228 Joe H Reynolds Med Bldg, College Stn, TX 77843 USA.	mjrimer@medicine.tamhsc.edu			Texas A&M Health Science Center College of Medicine	Texas A&M Health Science Center College of Medicine	This work was supported by the Texas A&M Health Science Center College of Medicine.	Al-Shanti N, 2008, J ENDOCRINOL, V198, P243, DOI 10.1677/JOE-08-0151; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Burgess RW, 2002, J NEUROCHEM, V83, P271, DOI 10.1046/j.1471-4159.2002.01102.x; BURSZTAJN S, 1988, BIOL CELL, V63, P57, DOI 10.1016/0248-4900(88)90108-6; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Cartaud A, 1998, J BIOL CHEM, V273, P11321, DOI 10.1074/jbc.273.18.11321; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FROEHNER SC, 1984, J CELL BIOL, V99, P88, DOI 10.1083/jcb.99.1.88; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Heathcote RD, 2000, DEV BIOL, V227, P595, DOI 10.1006/dbio.2000.9906; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Jacobson C, 1998, J NEUROSCI, V18, P6340; Kahl J, 2003, J NEUROSCI, V23, P392, DOI 10.1523/JNEUROSCI.23-02-00392.2003; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Madhavan R, 2006, J NEUROBIOL, V66, P1511, DOI 10.1002/neu.20320; Martin PT, 1997, DEVELOPMENT, V124, P3909; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Mittaud P, 2004, MOL CELL BIOL, V24, P7841, DOI 10.1128/MCB.24.18.7841-7854.2004; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Ponomareva ON, 2006, MOL CELL NEUROSCI, V31, P334, DOI 10.1016/j.mcn.2005.10.004; Rimer M, 2004, MOL CELL NEUROSCI, V26, P271, DOI 10.1016/j.mcn.2004.02.002; ROSS A, 1988, J CELL BIOL, V107, P1139, DOI 10.1083/jcb.107.3.1139; Schwander M, 2004, J NEUROSCI, V24, P8181, DOI 10.1523/JNEUROSCI.1345-04.2004; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Si JT, 1999, MOL BRAIN RES, V67, P18, DOI 10.1016/S0169-328X(99)00028-5; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Tansey MG, 1996, J CELL BIOL, V134, P465, DOI 10.1083/jcb.134.2.465; Trinidad JC, 2004, J BIOL CHEM, V279, P31622, DOI 10.1074/jbc.M400044200; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	41	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32370	32377		10.1074/jbc.M110.144774	http://dx.doi.org/10.1074/jbc.M110.144774			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20696763	Green Published, hybrid			2022-12-27	WOS:000282683000050
J	Varkey, J; Isas, JM; Mizuno, N; Jensen, MB; Bhatia, VK; Jao, CC; Petrlova, J; Voss, JC; Stamou, DG; Steven, AC; Langen, R				Varkey, Jobin; Isas, Jose Mario; Mizuno, Naoko; Jensen, Martin Borch; Bhatia, Vikram Kjoller; Jao, Christine C.; Petrlova, Jitka; Voss, John C.; Stamou, Dimitrios G.; Steven, Alasdair C.; Langen, Ralf			Membrane Curvature Induction and Tubulation Are Common Features of Synucleins and Apolipoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND ALPHA-SYNUCLEIN; BIN/AMPHIPHYSIN/RVS BAR DOMAIN; A-I; SECONDARY STRUCTURE; PARKINSONS-DISEASE; AMPHIPATHIC HELICES; TRANSGENIC MICE; BETA-SYNUCLEIN; LIPID-BILAYERS; ENDOPHILIN	Synucleins and apolipoproteins have been implicated in a number of membrane and lipid trafficking events. Lipid interaction for both types of proteins is mediated by 11 amino acid repeats that form amphipathic helices. This similarity suggests that synucleins and apolipoproteins might have comparable effects on lipid membranes, but this has not been shown directly. Here, we find that alpha-synuclein, beta-synuclein, and apolipoprotein A-1 have the conserved functional ability to induce membrane curvature and to convert large vesicles into highly curved membrane tubules and vesicles. The resulting structures are morphologically similar to those generated by amphiphysin, a curvature-inducing protein involved in endocytosis. Unlike amphiphysin, however, synucleins and apolipoproteins do not require any scaffolding domains and curvature induction is mediated by the membrane insertion and wedging of amphipathic helices alone. Moreover, we frequently observed that alpha-synuclein caused membrane structures that had the appearance of nascent budding vesicles. The ability to function as a minimal machinery for vesicle budding agrees well with recent findings that alpha-synuclein plays a role in vesicle trafficking and enhances endocytosis. Induction of membrane curvature must be under strict regulation in vivo; however, as we find it can also cause disruption of membrane integrity. Because the degree of membrane curvature induction depends on the concerted action of multiple proteins, controlling the local protein density of tubulating proteins may be important. How cellular safeguarding mechanisms prevent such potentially toxic events and whether they go awry in disease remains to be determined.	[Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Mizuno, Naoko; Steven, Alasdair C.] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Jensen, Martin Borch; Bhatia, Vikram Kjoller; Stamou, Dimitrios G.] Univ Copenhagen, Bionanotechnol Lab, Dept Neurosci & Pharmacol, Lundbeck Fdn Ctr Biomembranes Nanomed, DK-2100 Copenhagen, Denmark; [Petrlova, Jitka; Voss, John C.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Lundbeckfonden; University of Copenhagen; University of California System; University of California Davis	Langen, R (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, 1501 San Pablo St,121 ZNI, Los Angeles, CA 90033 USA.	langen@usc.edu	Mizuno, Naoko/AAY-1926-2021; Stamou, Dimitrios/D-5042-2016; Varkey, Jobin/I-5845-2019	Mizuno, Naoko/0000-0002-1594-2821; Stamou, Dimitrios/0000-0001-8456-8995; Voss, John/0000-0001-9279-209X	National Institutes of Health [GM063915, R01 AG029246]; NIAMS; Larry L. Hillblom foundation; Danish Research Councils; University of Copenhagen; Lundbeck foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Larry L. Hillblom foundation; Danish Research Councils(Det Frie Forskningsrad (DFF)); University of Copenhagen; Lundbeck foundation(Lundbeckfonden); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM063915 (to R.L.), R01 AG029246 (to J.C.V.), and the Intramural Research Program of NIAMS (to A.C.S.). This work was also supported by the Larry L. Hillblom foundation (to R.L.) and the Danish Research Councils, the University of Copenhagen and the Lundbeck foundation (to D.G.S.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Ayton GS, 2009, BIOPHYS J, V97, P1616, DOI 10.1016/j.bpj.2009.06.036; Ayton GS, 2009, CURR OPIN STRUC BIOL, V19, P138, DOI 10.1016/j.sbi.2009.03.001; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Bendix PM, 2009, P NATL ACAD SCI USA, V106, P12341, DOI 10.1073/pnas.0903052106; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Borbat P, 2006, J AM CHEM SOC, V128, P10004, DOI 10.1021/ja063122l; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Cabin DE, 2002, J NEUROSCI, V22, P8797; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Cui HS, 2009, BIOPHYS J, V97, P2746, DOI 10.1016/j.bpj.2009.08.043; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Fujita Y, 2006, ACTA NEUROPATHOL, V112, P261, DOI 10.1007/s00401-006-0114-4; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Golovko MY, 2009, MOL CELL BIOCHEM, V326, P55, DOI 10.1007/s11010-008-0008-y; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee SJ, 2008, ACTA NEUROBIOL EXP, V68, P509; LUO CC, 1986, J MOL BIOL, V187, P325, DOI 10.1016/0022-2836(86)90436-5; Madine J, 2008, MOL MEMBR BIOL, V25, P518, DOI 10.1080/09687680802467977; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; MISHRA VK, 1995, J BIOL CHEM, V270, P1602, DOI 10.1074/jbc.270.4.1602; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; SEGREST JP, 1977, CHEM PHYS LIPIDS, V18, P7, DOI 10.1016/0009-3084(77)90023-8; SEGREST JP, 1992, J LIPID RES, V33, P141; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; TYTLER EM, 1993, J BIOL CHEM, V268, P22112; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	76	223	227	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32486	32493		10.1074/jbc.M110.139576	http://dx.doi.org/10.1074/jbc.M110.139576			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20693280	Green Published, hybrid			2022-12-27	WOS:000282683000062
J	Su, JL; Chiou, J; Tang, CH; Zhao, M; Tsai, CH; Chen, PS; Chang, YW; Chien, MH; Peng, CY; Hsiao, M; Kuo, ML; Yen, ML				Su, Jen-Liang; Chiou, Jean; Tang, Chih-Hsin; Zhao, Ming; Tsai, Chun-Hao; Chen, Pai-Sheng; Chang, Yi-Wen; Chien, Ming-Hsien; Peng, Chu-Ying; Hsiao, Michael; Kuo, Ming-Liang; Yen, Men-Luh			CYR61 Regulates BMP-2-dependent Osteoblast Differentiation through the alpha(v)beta(3) Integrin/Integrin-linked Kinase/ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; IMMEDIATE-EARLY GENE; MESENCHYMAL STEM-CELLS; INTEGRIN ALPHA(V)BETA(3); COUPLED RECEPTORS; BREAST-CANCER; MAPK CASCADES; IN-VITRO; EXPRESSION; ACTIVATION	Osteoporosis is one of the most common bone pathologies. A number of novel molecules have been reported to increase bone formation including cysteine-rich protein 61 (CYR61), a ligand of integrin receptor, but mechanisms remain unclear. It is known that bone morphogenetic proteins (BMPs), especially BMP-2, are crucial regulators of osteogenesis. However, the interaction between CYR61 and BMP-2 is unclear. We found that CYR61 significantly increases proliferation and osteoblastic differentiation in MC3T3-E1 osteoblasts and primary cultured osteoblasts. CYR61 enhances mRNA and protein expression of BMP-2 in a time-and dose-dependent manner. Moreover, CYR61-mediated proliferation and osteoblastic differentiation are significantly decreased by knockdown of BMP-2 expression or inhibition of BMP-2 activity. In this study we found integrin alpha(v)beta(3) is critical for CYR61-mediated BMP-2 expression and osteoblastic differentiation. We also found that integrin-linked kinase, which is downstream of the alpha(v)beta(3) receptor, is involved in CYR61-induced BMP-2 expression and subsequent osteoblastic differentiation through an ERK-dependent pathway. Taken together, our results show that CYR61 up-regulates BMP-2mRNA and protein expression, resulting in enhanced cell proliferation and osteoblastic differentiation through activation of the alpha(v)beta(3) integrin/integrin-linked kinase/ERK signaling pathway.	[Yen, Men-Luh] Natl Taiwan Univ Hosp, Dept Primary Care Med, Taipei 100, Taiwan; [Su, Jen-Liang; Chiou, Jean] China Med Univ, Canc Biol & Drug Discovery PhD Degree Program, Shenyang, Peoples R China; [Su, Jen-Liang; Peng, Chu-Ying] China Med Univ, Grad Inst Canc Biol, Shenyang, Peoples R China; [Tang, Chih-Hsin] China Med Univ, Dept Pharmacol, Coll Med, Shenyang, Peoples R China; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Shenyang, Peoples R China; [Su, Jen-Liang; Chiou, Jean; Chang, Yi-Wen] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Tsai, Chun-Hao] China Med Univ Hosp, Dept Orthoped, Taichung 404, Taiwan; [Su, Jen-Liang] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Zhao, Ming] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Chen, Pai-Sheng; Chien, Ming-Hsien; Hsiao, Michael] Natl Taiwan Univ Hosp, Inst Toxicol, Coll Med, Taipei 100, Taiwan; [Chen, Pai-Sheng; Chien, Ming-Hsien; Kuo, Ming-Liang] Natl Taiwan Univ Hosp, Angiogenesis Res Ctr, Taipei 100, Taiwan; [Yen, Men-Luh] Natl Taiwan Univ Hosp, Dept Obstet Gynecol, Taipei 100, Taiwan; Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan; [Hsiao, Michael] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University Hospital; China Medical University; China Medical University; China Medical University; China Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; University of Missouri System; University of Missouri Kansas City; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan	Yen, ML (corresponding author), Natl Taiwan Univ Hosp, Dept Primary Care Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.	mlyen@ntu.edu.tw	Chiou, Jean/G-8255-2014; Tang, Chih Hsin/O-5212-2015; Chen, Pai-Sheng/G-2130-2012; Hsiao, Michael/U-6238-2019; Tsai, Chun-Hao/H-3140-2013	Chiou, Jean/0000-0001-6926-0159; Tang, Chih Hsin/0000-0002-7113-8352; Chen, Pai-Sheng/0000-0003-0513-1467; Hsiao, Michael/0000-0001-8529-9213; YEN, MEN-LUH/0000-0003-3800-3664; Tsai, Chun-Hao/0000-0002-4428-3132	National Science Council [NSC 97-2314-B-002-060-MY3, NSC98-3111-B-002-009, NSC 96-2320-B-004-MY2, NSC 97-2320-B-039-039-MY3, NSC 98-2815-C-039-082-B]; National Science Council of Taiwan [TMS-094-2-B-023]; National Health Research Institutes, Taiwan [NHRI-EX97-9712BC]; Department of Health Executive Yuan, Taiwan [DOH97-TD-G-111-024]; China Medical University [CMU96-220, CMU96-189, CMU97-277]; M.D. Anderson Cancer Center	National Science Council(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Department of Health Executive Yuan, Taiwan; China Medical University(China Medical University); M.D. Anderson Cancer Center	This work was supported in part by National Science Council Grants NSC 97-2314-B-002-060-MY3, NSC98-3111-B-002-009 (to M.-L.Y.), National Science Council Grants NSC 96-2320-B-004-MY2, NSC 97-2320-B-039-039-MY3, and NSC 98-2815-C-039-082-B, Taiwan Merit Scholarship TMS-094-2-B-023 from the National Science Council of Taiwan, National Health Research Institutes Grant NHRI-EX97-9712BC from Taiwan, Department of Health Executive Yuan Grant DOH97-TD-G-111-024 from Taiwan, China Medical University Grants CMU96-220, CMU96-189, and CMU97-277, and an Odyssey Scholarship from M.D. Anderson Cancer Center (to J.-L.S.).	Babic AM, 1999, MOL CELL BIOL, V19, P2958; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen Y, 2007, J CELL BIOCHEM, V100, P1337, DOI 10.1002/jcb.21194; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Cortizo AM, 2003, MOL CELL BIOCHEM, V250, P1, DOI 10.1023/A:1024934008982; Craig TA, 2010, BIOCHEM BIOPH RES CO, V392, P36, DOI 10.1016/j.bbrc.2009.12.143; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Fleet JC, 1996, ENDOCRINOLOGY, V137, P4605, DOI 10.1210/en.137.11.4605; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heller LC, 1999, J BIOL CHEM, V274, P1394, DOI 10.1074/jbc.274.3.1394; Hirasaki S, 2001, HEPATOL RES, V19, P294, DOI 10.1016/S1386-6346(00)00101-7; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Knosp WM, 2004, DEVELOPMENT, V131, P4581, DOI 10.1242/dev.01327; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Lechner A, 2000, BONE, V27, P53, DOI 10.1016/S8756-3282(00)00294-5; Leng E, 2002, J BIOMED SCI, V9, P59, DOI 10.1007/BF02256579; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lin MT, 2004, J BIOL CHEM, V279, P24015, DOI 10.1074/jbc.M402305200; LOWRY OH, 1954, J BIOL CHEM, V207, P19; Maier S, 2008, BBA-MOL CELL RES, V1783, P1150, DOI 10.1016/j.bbamcr.2008.01.013; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Meyer RA, 2003, J BONE JOINT SURG AM, V85A, P1243, DOI 10.2106/00004623-200307000-00010; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; OBRIEN TP, 1992, CELL GROWTH DIFFER, V3, P645; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Randell A, 1995, OSTEOPOROSIS INT, V5, P427, DOI 10.1007/BF01626603; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rodriguez JP, 2004, J CELL BIOCHEM, V92, P745, DOI 10.1002/jcb.20119; Schutze N, 1998, ENDOCRINOLOGY, V139, P1761, DOI 10.1210/en.139.4.1761; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Schutze N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-45; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; STYRKARSDOTTIR U, 2003, PLOS BIOL, V3, P1; Su JL, 2007, J BIOL CHEM, V282, P19385, DOI 10.1074/jbc.M702452200; Suzuki A, 1999, ENDOCRINOLOGY, V140, P3177, DOI 10.1210/en.140.7.3177; Sykaras Nikitas, 2003, J Oral Sci, V45, P57; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Tang CH, 2008, EUR J PHARMACOL, V579, P40, DOI 10.1016/j.ejphar.2007.10.013; Tang CH, 2007, J BIOL CHEM, V282, P25406, DOI 10.1074/jbc.M701001200; Tang CH, 2007, J BIOL CHEM, V282, P2346, DOI 10.1074/jbc.M603070200; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Virdi AS, 1998, CELL MOL BIOL, V44, P1237; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu JB, 2008, EUR J PHARMACOL, V588, P333, DOI 10.1016/j.ejphar.2008.04.030; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05; Zhao M, 2009, MOL CELL BIOL, V29, P1291, DOI 10.1128/MCB.01566-08; Zhou SH, 2003, MOL ENDOCRINOL, V17, P56, DOI 10.1210/me.2002-0210	67	89	96	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31325	31336		10.1074/jbc.M109.087122	http://dx.doi.org/10.1074/jbc.M109.087122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675382	Green Published, hybrid			2022-12-27	WOS:000282764600027
J	Bledzka, K; Bialkowska, K; Nie, HQ; Qin, J; Byzova, T; Wu, CY; Plow, EF; Ma, YQ				Bledzka, Kamila; Bialkowska, Katarzyna; Nie, Huiqin; Qin, Jun; Byzova, Tatiana; Wu, Chuanyue; Plow, Edward F.; Ma, Yan-Qing			Tyrosine Phosphorylation of Integrin beta(3) Regulates Kindlin-2 Binding and Integrin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TALIN PHOSPHORYLATION; PLATELET-AGGREGATION; LEUKOCYTE ADHESION; CYTOPLASMIC TAILS; ALPHA(IIB)BETA(3); COACTIVATOR; MECHANISMS; PROVIDES; CELL	Kindlins are essential for integrin activation in cell systems and do so by working in a cooperative fashion with talin via their direct interaction with integrin beta cytoplasmic tails (CTs). Kindlins interact with the membrane-distal NxxY motif, which is distinct from the talin-binding site within the membrane-proximal NxxY motif. The Tyr residues in both motifs can be phosphorylated, and it has been suggested that this modification of the membrane-proximal NxxY motif negatively regulates interaction with the talin head domain. However, the influence of Tyr phosphorylation of the membrane-distal NxxY motif on kindlin binding is unknown. Using mutational analyses and phosphorylated peptides, we show that phosphorylation of the membrane-distal NITY759 motif in the beta(3) CT disrupts kindlin-2 recognition. Phosphorylation of this membrane-distal Tyr also disables the ability of kindlin-2 to coactivate the integrin. In direct binding studies, peptides corresponding to the non-phosphorylated beta(3) CT interacted well with kindlin-2, whereas the Tyr(759)-phosphorylated peptide failed to bind kindlin-2 with measurable affinity. These observations indicate that transitions between the phosphorylated and non-phosphorylated states of the integrin beta(3) CT determine reactivity with kindlin-2 and govern the role of kindlin-2 in regulating integrin activation.	[Bledzka, Kamila; Bialkowska, Katarzyna; Nie, Huiqin; Qin, Jun; Byzova, Tatiana; Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; [Wu, Chuanyue] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh		may@ccf.org		Byzova, Tatiana/0000-0002-2615-875X; Qin, Jun/0000-0002-2647-9270	National Institutes of Health, NHLBI [P01 HL073311, R01 HL096062]; American Heart Association [10SDG2610277]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096062, P01HL073311] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL073311 and R01 HL096062 from NHLBI. This work was also supported by Scientist Development Grant 10SDG2610277 from the American Heart Association.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chandhoke SK, 2004, J CELL SCI, V117, P1431, DOI 10.1242/jcs.00987; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; Gao CL, 2005, J BIOL CHEM, V280, P15422, DOI 10.1074/jbc.M414457200; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Herz C, 2006, J BIOL CHEM, V281, P36082, DOI 10.1074/jbc.M606259200; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Phillips DR, 2001, CURR OPIN CELL BIOL, V13, P546, DOI 10.1016/S0955-0674(00)00250-7; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045	36	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30370	30374		10.1074/jbc.C110.134247	http://dx.doi.org/10.1074/jbc.C110.134247			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20702409	Green Published, hybrid			2022-12-27	WOS:000282135500003
J	Dejager, L; Pinheiro, I; Puimege, L; Fan, YD; Gremeaux, L; Vankelecom, H; Libert, C				Dejager, Lien; Pinheiro, Iris; Puimege, Leen; Fan, Ye-Dong; Gremeaux, Lies; Vankelecom, Hugo; Libert, Claude			Increased Glucocorticoid Receptor Expression and Activity Mediate the LPS Resistance of SPRET/EI Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TUMOR-NECROSIS-FACTOR; HORMONE-RECEPTORS; FEEDBACK-CONTROL; GENE; MECHANISMS; STRESS; LIPOPOLYSACCHARIDE; TRANSCRIPTION; BIOSYNTHESIS	SPRET/Ei mice are extremely resistant to acute LPS-induced lethal inflammation when compared with C57BL/6. We found that in vivo SPRET/Ei mice exhibit strongly reduced expression levels of cytokines and chemokines. To investigate the role of the potent anti-inflammatory glucocorticoid receptor (GR) in the SPRET/Ei phenotype, mice were treated with the GR antagonist RU486 or bilateral adrenalectomy. Under such conditions, both C57BL/6 and SPRET/Ei mice were strongly sensitized to LPS, and the differences in LPS response between SPRET/Ei and C57BL/6 mice were completely gone. These results underscore the central role of GR in the LPS hyporesponsiveness of SPRET/Ei mice. Compared with C57BL/6, SPRET/Ei mice were found to express higher GR levels, which were reflected in increased GR transactivation. Using a backcross mapping strategy, we demonstrate that the high GR transcription levels are linked to the Nr3c1 (GR) locus on chromosome 18 itself. Unexpectedly, SPRET/Ei mice exhibit a basal overactivation of the hypothalamic-pituitary-adrenal axis, namely strongly increased corticosterone levels, ACTH levels, and adrenocortical size. As a consequence of the excess of circulating glucocorticoids (GCs), levels of hepatic gluconeogenic enzymes are increased, and insulin secretion from pancreatic beta-cells is impaired, both of which result in hyperglycemia and glucose intolerance in SPRET/Ei mice. We conclude that SPRET/Ei mice are unique as they display an unusual combination of elevated GR expression and increased endogenous GC levels. Hence, these mice provide a new and powerful tool for the study of GR- and GC-mediated mechanisms, including immune repressive functions, neuroendocrine regulation, insulin secretion, and carbohydrate metabolism.	[Libert, Claude] VIB, DMBR, B-9052 Ghent, Belgium; [Dejager, Lien; Pinheiro, Iris; Puimege, Leen; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Fan, Ye-Dong] Ghent Univ Hosp, Dept Surg, B-9000 Ghent, Belgium; [Gremeaux, Lies; Vankelecom, Hugo] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Tissue Plast, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; KU Leuven	Libert, C (corresponding author), VIB, DMBR, Technol Pk 927, B-9052 Ghent, Belgium.	Claude.Libert@dmbr.VIB-UGent.be		Pinheiro, Iris/0000-0003-3098-4445; Vankelecom, Hugo/0000-0002-2251-7284	Fund for Scientific Research, Flanders; Belgian Interuniversity Attraction Poles program [IAP VI/18]; Belgische Vereniging tegen Kanker	Fund for Scientific Research, Flanders(FWO); Belgian Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Belgische Vereniging tegen Kanker	This work was supported by the Fund for Scientific Research, Flanders, the Belgian Interuniversity Attraction Poles program (IAP VI/18), and the Belgische Vereniging tegen Kanker.	Aguilera G, 2004, PEPTIDES, V25, P319, DOI 10.1016/j.peptides.2004.02.002; ALDAMLUJI S, 1993, AM J PHYSIOL, V264, pE208, DOI 10.1152/ajpendo.1993.264.2.E208; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; AUTELITANO DJ, 1990, NEUROENDOCRINOLOGY, V51, P123, DOI 10.1159/000125327; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes Peter J, 2009, Lancet, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; BESSER G M, 1973, Clinical Endocrinology, V2, P175, DOI 10.1111/j.1365-2265.1973.tb00417.x; BONHOMME F, 1978, EXPERIENTIA, V34, P1140, DOI 10.1007/BF01922917; BROUCKAERT PG, 1989, AGENTS ACTIONS, V26, P196, DOI 10.1007/BF02126607; Chen AM, 2005, P NATL ACAD SCI USA, V102, P2620, DOI 10.1073/pnas.0409583102; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Cole TJ, 2001, MOL CELL ENDOCRINOL, V173, P193, DOI 10.1016/S0303-7207(00)00407-X; Darvasi A, 1997, BEHAV GENET, V27, P125, DOI 10.1023/A:1025685324830; Davani B, 2004, DIABETES, V53, pS51, DOI 10.2337/diabetes.53.2007.S51; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; DeRijk RH, 2008, EUR J PHARMACOL, V583, P303, DOI 10.1016/j.ejphar.2007.11.072; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; FINK G, 1997, PRINCIPLES MED BIO A, V10, P30; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Gadek-Michalska A, 2004, J PHYSIOL PHARMACOL, V55, P663; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Gomez F, 1998, AM J PHYSIOL-REG I, V274, pR420, DOI 10.1152/ajpregu.1998.274.2.R420; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Larsson H, 1999, DIABETOLOGIA, V42, P936, DOI 10.1007/s001250051251; LENZEN S, 1984, ENDOCR REV, V5, P411, DOI 10.1210/edrv-5-3-411; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; Mahieu T, 2006, P NATL ACAD SCI USA, V103, P2292, DOI 10.1073/pnas.0510874103; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; MCMAHON M, 1988, DIABETES METAB REV, V4, P17, DOI 10.1002/dmr.5610040105; Meyer AS, 1997, J STEROID BIOCHEM, V62, P97, DOI 10.1016/S0960-0760(97)00014-9; MILLER WL, 1995, ADRENAL CORTEX; Nikodemova M., 2002, Archives of Physiology and Biochemistry, V110, P123, DOI 10.1076/apab.110.1.123.901; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283; Paust HJ, 2006, EXP CLIN ENDOCR DIAB, V114, P6, DOI 10.1055/s-2005-873007; PHILIPPE J, 1990, ENDOCRINOLOGY, V127, P1640, DOI 10.1210/endo-127-4-1640; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; POTTER E, 1991, NATURE, V349, P423, DOI 10.1038/349423a0; Putignano P, 2001, EUR J ENDOCRINOL, V145, P165, DOI 10.1530/eje.0.1450165; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Reichardt HM, 1998, J STEROID BIOCHEM, V65, P111, DOI 10.1016/S0960-0760(97)00181-7; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Reichardt HM, 1996, MOL MED, V2, P735, DOI 10.1007/BF03401657; Reichardt HM, 1998, MOL CELL ENDOCRINOL, V146, P1, DOI 10.1016/S0303-7207(98)00208-1; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Saag Kenneth G, 2002, Curr Rheumatol Rep, V4, P218, DOI 10.1007/s11926-002-0068-z; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCHATZBERG AF, 1985, J PSYCHIAT RES, V19, P57, DOI 10.1016/0022-3956(85)90068-8; SILVER LM, 1995, MOUSE GENETICS CONCE, P227; Spinazzi R, 2006, PHARMACOL REV, V58, P46, DOI 10.1124/pr.58.1.4; Staelens J, 2002, P NATL ACAD SCI USA, V99, P9340, DOI 10.1073/pnas.142293699; SVEC F, 1985, LIFE SCI, V36, P2359, DOI 10.1016/0024-3205(85)90339-X; TAYLOR T, 1983, J CLIN ENDOCR METAB, V57, P592, DOI 10.1210/jcem-57-3-592; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Yeager MP, 2004, ACTA ANAESTH SCAND, V48, P799, DOI 10.1111/j.1399-6576.2004.00434.x; Zhang JH, 2009, J BIOL CHEM, V284, P6249, DOI 10.1074/jbc.M807997200; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	82	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31073	31086		10.1074/jbc.M110.154484	http://dx.doi.org/10.1074/jbc.M110.154484			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663891	Green Published, hybrid			2022-12-27	WOS:000282135500072
J	Yang, W; Zou, J; Xia, R; Vaal, ML; Seymour, VA; Luo, JH; Beech, DJ; Jiang, LH				Yang, Wei; Zou, Jie; Xia, Rong; Vaal, Meriel L.; Seymour, Victoria A.; Luo, Jianhong; Beech, David J.; Jiang, Lin-Hua			State-dependent Inhibition of TRPM2 Channel by Acidic pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; RECEPTOR POTENTIAL CHANNEL-2; NONSELECTIVE CATION CHANNEL; PEROXIDE-INDUCED TOXICITY; RAT STRIATAL NEURONS; HYDROGEN-PEROXIDE; MOLECULAR DETERMINANTS; INTRACELLULAR CALCIUM; BETA-CELLS; CA2+ ENTRY	Transient receptor potential melastatin 2 (TRPM2) channel fulfills an important role in oxidative stress signaling in immune and other cells, to which local extracellular acidosis is known to occur under physiological or pathological conditions and impose significant effects on their functions. Here, we investigated whether the ADP-ribose-activated TRPM2 channel is a target for modulation by extracellular acidic pH by patch clamp recording of HEK293 cells expressing hTRPM2 channel. Induced whole cell or single channel currents were rapidly inhibited upon subsequent exposure to acidic pH. The inhibition in the steady state was complete, voltage-independent, and pH-independent in the range of pH 4.0-6.0. The inhibition was irreversible upon returning to pH 7.3, suggesting channel inactivation. In contrast, exposure of closed channels to acidic pH reduced the subsequent channel activation in a pH-dependent manner with an IC50 for H+ of 20 mu M (pH 4.7) and rendered subsequent current inhibition largely reversible, indicating differential or state-dependent inhibition and inactivation. Alanine substitution of residues in the outer vestibule of the pore including Lys(952) and Asp(1002) significantly slowed down or reduced acidic pH-induced inhibition and prevented inactivation. The results suggest that acidic pH acts as a negative feedback mechanism where protons bind to the outer vestibule of the TRPM2 channel pore and inhibit the TRPM2 channels in a state-dependent manner.	[Yang, Wei; Zou, Jie; Xia, Rong; Vaal, Meriel L.; Seymour, Victoria A.; Beech, David J.; Jiang, Lin-Hua] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Yang, Wei; Luo, Jianhong] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China	University of Leeds; Zhejiang University	Jiang, LH (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England.	l.h.jiang@leeds.ac.uk	Luo, jian/HGE-7331-2022; Jiang, Lin-Hua/D-2030-2010; Jiang, Lin-Hua/AAU-1078-2020	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Vaal, Meriel/0000-0003-4371-7792; Beech, David/0000-0002-7683-9422	Wellcome Trust; Alzheimer's Research Trust; Royal Society; University of Leeds-Chinese Scholarship Council; United Kingdom overseas research scholarship; Alzheimers Research UK [ART-PPG2009A-2] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Alzheimer's Research Trust; Royal Society(Royal Society of London); University of Leeds-Chinese Scholarship Council; United Kingdom overseas research scholarship; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported in part by research grants from the Wellcome Trust and Alzheimer's Research Trust (to L.-H.J.), a Royal Society fellowship (to W.Y.), a University of Leeds-Chinese Scholarship Council research scholarship (to J.Z.), and a United Kingdom overseas research scholarship (to R. X.).	Bari MR, 2009, J CELL MOL MED, V13, P3260, DOI 10.1111/j.1582-4934.2009.00737.x; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Campo B, 2003, J IMMUNOL, V170, P1167, DOI 10.4049/jimmunol.170.3.1167; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; EDLOW DW, 1971, P SOC EXP BIOL MED, V137, P1328; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P179, DOI 10.1080/10799890600637522; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Heiner I, 2003, BIOCHEM J, V371, P1045, DOI 10.1042/BJ20021975; Hill K, 2006, NEUROPHARMACOLOGY, V50, P89, DOI 10.1016/j.neuropharm.2005.08.021; Ishii M, 2006, J PHARMACOL SCI, V101, P174, DOI 10.1254/jphs.SCJ06001X; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Kraft R, 2006, BRIT J PHARMACOL, V148, P264, DOI 10.1038/sj.bjp.0706739; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Liu D, 2005, J BIOL CHEM, V280, P20691, DOI 10.1074/jbc.M414072200; Liu X, 2009, BRIT J PHARMACOL, V156, P135, DOI 10.1111/j.1476-5381.2008.00002.x; Mao JZ, 2002, J BIOL CHEM, V277, P46166, DOI 10.1074/jbc.M205438200; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Mei ZZ, 2009, J MEMBRANE BIOL, V230, P93, DOI 10.1007/s00232-009-9190-4; NIELSON DW, 1981, P NATL ACAD SCI-BIOL, V78, P7119, DOI 10.1073/pnas.78.11.7119; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Numata T, 2008, J BIOL CHEM, V283, P15097, DOI 10.1074/jbc.M709261200; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; SIMMEN HP, 1993, AM J SURG, V166, P24, DOI 10.1016/S0002-9610(05)80576-8; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Spelta V, 2002, BRIT J PHARMACOL, V135, P1524, DOI 10.1038/sj.bjp.0704591; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yamamoto S, 2007, BBA-MOL BASIS DIS, V1772, P958, DOI 10.1016/j.bbadis.2007.03.006; Zhang WY, 2007, AM J PHYSIOL-CELL PH, V292, pC1746, DOI 10.1152/ajpcell.00569.2006	53	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30411	30418		10.1074/jbc.M110.139774	http://dx.doi.org/10.1074/jbc.M110.139774			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20660597	Green Published, hybrid			2022-12-27	WOS:000282135500007
J	Klose, C; Ejsing, CS; Garcia-Saez, AJ; Kaiser, HJ; Sampaio, JL; Surma, MA; Shevchenko, A; Schwille, P; Simons, K				Klose, Christian; Ejsing, Christer S.; Garcia-Saez, Ana J.; Kaiser, Hermann-Josef; Sampaio, Julio L.; Surma, Michal A.; Shevchenko, Andrej; Schwille, Petra; Simons, Kai			Yeast Lipids Can Phase-separate into Micrometer-scale Membrane Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SACCHAROMYCES-CEREVISIAE; BILAYER-MEMBRANES; PLASMA-MEMBRANE; CELL-MEMBRANES; MODEL MEMBRANES; BIOLOGICAL-MEMBRANES; SURFACE DELIVERY; EPITHELIAL-CELLS; STEROL STRUCTURE	The lipid raft concept proposes that biological membranes have the potential to form functional domains based on a selective interaction between sphingolipids and sterols. These domains seem to be involved in signal transduction and vesicular sorting of proteins and lipids. Although there is biochemical evidence for lipid raft-dependent protein and lipid sorting in the yeast Saccharomyces cerevisiae, direct evidence for an interaction between yeast sphingolipids and the yeast sterol ergosterol, resulting in membrane domain formation, is lacking. Here we show that model membranes formed from yeast total lipid extracts possess an inherent self-organization potential resulting in liquid-disordered-liquid-ordered phase coexistence at physiologically relevant temperature. Analyses of lipid extracts from mutants defective in sphingolipid metabolism as well as reconstitution of purified yeast lipids in model membranes of defined composition suggest that membrane domain formation depends on specific interactions between yeast sphingolipids and ergosterol. Taken together, these results provide a mechanistic explanation for lipid raft-dependent lipid and protein sorting in yeast.	[Surma, Michal A.; Shevchenko, Andrej; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Ejsing, Christer S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Garcia-Saez, Ana J.; Schwille, Petra] Tech Univ Dresden, Inst Biophys, Biotechnol Ctr BIOTEC, D-01307 Dresden, Germany	Max Planck Society; University of Southern Denmark; Technische Universitat Dresden	Simons, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	simons@mpi-cbg.de	Ejsing, Christer S/R-5922-2016; Schwille, Petra/A-4983-2010; Surma, Michal/B-1955-2016; Sampaio, Julio/B-5487-2012; Sampaio, Julio/S-3810-2019; Saez, Ana J. Garcia/U-1611-2019	Surma, Michal/0000-0001-7833-2214; Sampaio, Julio/0000-0002-2881-7827; Klose, Christian/0000-0003-2853-4533; Simons, Kai/0000-0002-9231-9996; Ejsing, Christer S./0000-0003-4963-0276	EUFP6 [LSHB-CT2007-037740]; Deutsche Forschungsgemeinschaft; Schwerpunktprogramm [1175]; Bundesministerium fur Bildung und Forschung (BMBF) [0313827, 03FO1212]; Max Planck Institute	EUFP6(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Schwerpunktprogramm; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Institute(Foundation CELLEX)	This work was supported by EUFP6 "PRISM" Grant LSHB-CT2007-037740, Deutsche Forschungsgemeinschaft "Schwerpunktprogramm 1175," Bundesministerium fur Bildung und Forschung (BMBF) "BioChance Plus" Grant 0313827, and BMBF "ForMaT" Grant 03FO1212. This work was also supported by a predoctoral stipend from the Max Planck Institute (to C.K.).	Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Aittoniemi J, 2007, BIOPHYS J, V92, P1125, DOI 10.1529/biophysj.106.088427; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Beattie ME, 2005, BIOPHYS J, V89, P1760, DOI 10.1529/biophysj.104.049635; Bjorkbom A, 2010, BBA-BIOMEMBRANES, V1798, P453, DOI 10.1016/j.bbamem.2009.11.003; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; BOGGS JM, 1987, BIOCHIM BIOPHYS ACTA, V906, P353, DOI 10.1016/0304-4157(87)90017-7; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dupre S, 2003, TRAFFIC, V4, P83, DOI 10.1034/j.1600-0854.2003.40204.x; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Garcia-Saez AJ, 2010, METHODS MOL BIOL, V606, P493, DOI 10.1007/978-1-60761-447-0_33; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Guo W, 2002, BIOPHYS J, V83, P1465, DOI 10.1016/S0006-3495(02)73917-9; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; HECHTBERGER P, 1995, FEBS LETT, V367, P201, DOI 10.1016/0014-5793(95)00567-S; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; IPSEN JH, 1989, BIOPHYS J, V56, P661, DOI 10.1016/S0006-3495(89)82713-4; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Lauwers E, 2007, MOL BIOL CELL, V18, P3068, DOI 10.1091/mbc.E07-03-0196; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Levental I, 2008, J AM CHEM SOC, V130, P9025, DOI 10.1021/ja800948c; Li ZG, 2006, J ORG CHEM, V71, P1718, DOI 10.1021/jo052029x; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maulik PR, 1996, BIOPHYS J, V70, P2256, DOI 10.1016/S0006-3495(96)79791-6; MCINTOSH TJ, 1992, BIOCHEMISTRY-US, V31, P2012, DOI 10.1021/bi00122a017; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Niemela PS, 2009, BBA-BIOMEMBRANES, V1788, P122, DOI 10.1016/j.bbamem.2008.08.018; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Ramstedt B, 2002, FEBS LETT, V531, P33, DOI 10.1016/S0014-5793(02)03406-3; Ries J, 2006, BIOPHYS J, V91, P1915, DOI 10.1529/biophysj.106.082297; Rog T, 2006, BIOPHYS J, V91, P3756, DOI 10.1529/biophysj.106.080887; RUOCCO MJ, 1983, BIOPHYS J, V43, P91, DOI 10.1016/S0006-3495(83)84327-6; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; SLATER JL, 1988, PROG LIPID RES, V27, P325, DOI 10.1016/0163-7827(88)90010-0; Stottrup BL, 2006, BIOPHYS J, V90, P3176, DOI 10.1529/biophysj.105.072959; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; URBINA JA, 1995, BBA-BIOMEMBRANES, V1238, P163, DOI 10.1016/0005-2736(95)00117-L; VAN MEER G, 2008, NAT REV MOL CELL BIO, V9, P112; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	64	80	81	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30224	30232		10.1074/jbc.M110.123554	http://dx.doi.org/10.1074/jbc.M110.123554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20647309	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000281984300059
J	Becker, I; Lodder, J; Gieselmann, V; Eckhardt, M				Becker, Ivonne; Lodder, Julia; Gieselmann, Volkmar; Eckhardt, Matthias			Molecular Characterization of N-Acetylaspartylglutamate Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-L-ASPARTATE; METABOTROPIC GLUTAMATE-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; CANAVAN-DISEASE; RAT-BRAIN; GLUTATHIONE SYNTHETASE; CARBOXYPEPTIDASE II; DENTATE GYRUS; NAAG; ACETYLASPARTATE	The dipeptide N-acetylaspartyl-glutamate (NAAG) is an abundant neuropeptide in the mammalian brain. Despite this fact, its physiological role is poorly understood. NAAG is synthesized by a NAAG synthetase catalyzing the ATP-dependent condensation of N-acetylaspartate and glutamate. In vitro NAAG synthetase activity has not been described, and the enzyme has not been purified. Using a bioinformatics approach we identified a putative dipeptide synthetase specifically expressed in the nervous system. Expression of the gene, which we named NAAGS (for NAAG synthetase) was sufficient to induce NAAG synthesis in primary astrocytes or CHO-K1 and HEK-293T cells when they coexpressed the NAA transporter NaDC3. Furthermore, coexpression of NAAGS and the recently identified N-acetylaspartate (NAA) synthase, Nat8l, in CHO-K1 or HEK-293T cells was sufficient to enable these cells to synthesize NAAG. Identity of the reaction product of NAAGS was confirmed by HPLC and electrospray ionization tandem mass spectrometry (ESI-MS). High expression levels of NAAGS were restricted to the brain, spinal cord, and testis. Taken together our results strongly suggest that the identified gene encodes a NAAG synthetase. Its identification will enable further studies to examine the role of this abundant neuropeptide in the vertebrate nervous system.	[Becker, Ivonne; Lodder, Julia; Gieselmann, Volkmar; Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany	University of Bonn	Eckhardt, M (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	eckhardt@uni-bonn.de						ANDERSON KJ, 1987, BRAIN RES, V411, P172, DOI 10.1016/0006-8993(87)90696-2; Arun P, 2004, NEUROREPORT, V15, P1167, DOI 10.1097/00001756-200405190-00017; Arun P, 2006, J NEUROCHEM, V98, P2034, DOI 10.1111/j.1471-4159.2006.04068.x; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Berger UV, 1999, J COMP NEUROL, V415, P52, DOI 10.1002/(SICI)1096-9861(19991206)415:1<52::AID-CNE4>3.0.CO;2-K; Burlina AP, 1999, EUR J PEDIATR, V158, P406, DOI 10.1007/s004310051102; BURRI R, 1991, DEV NEUROSCI-BASEL, V13, P403, DOI 10.1159/000112191; Bzdega T, 2004, J NEUROCHEM, V89, P627, DOI 10.1111/j.1471-4159.2004.02361.x; Bzdega T, 1997, J NEUROCHEM, V69, P2270; CANGRO CB, 1987, J NEUROCHEM, V49, P1579, DOI 10.1111/j.1471-4159.1987.tb01030.x; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; CURATOLO A, 1965, J NEUROCHEM, V12, P339, DOI 10.1111/j.1471-4159.1965.tb06771.x; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Fewou SN, 2007, J BIOL CHEM, V282, P16700, DOI 10.1074/jbc.M610797200; Fewou SN, 2005, J NEUROCHEM, V94, P469, DOI 10.1111/j.1471-4159.2005.03221.x; Fujita T, 2005, J NEUROCHEM, V93, P706, DOI 10.1111/j.1471-4159.2005.03067.x; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gehl LM, 2004, J NEUROCHEM, V90, P989, DOI 10.1111/j.1471-4159.2004.02578.x; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; Huang LQ, 1999, EUR J PHARMACOL, V366, P151, DOI 10.1016/S0014-2999(98)00918-2; Huang W, 2000, J PHARMACOL EXP THER, V295, P392; KOLLER KJ, 1984, J NEUROCHEM, V43, P1136, DOI 10.1111/j.1471-4159.1984.tb12854.x; Kumar S, 2006, MENT RETARD DEV D R, V12, P157, DOI 10.1002/mrdd.20108; Lea PM, 2001, J NEUROPHYSIOL, V85, P1097; Li H, 2003, P NATL ACAD SCI USA, V100, P9785, DOI 10.1073/pnas.1733391100; Li XQ, 2008, ACTA BIOCH BIOPH SIN, V40, P855, DOI 10.1111/j.1745-7270.2008.00468.x; Luthi-Carter R, 1998, P NATL ACAD SCI USA, V95, P3215, DOI 10.1073/pnas.95.6.3215; MIYAMOTO E, 1966, J NEUROCHEM, V13, P999, DOI 10.1111/j.1471-4159.1966.tb10297.x; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; Namboodiri AMA, 2006, MOL CELL ENDOCRINOL, V252, P216, DOI 10.1016/j.mce.2006.03.016; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Sartori S, 2008, EUR J PAEDIATR NEURO, V12, P348, DOI 10.1016/j.ejpn.2007.07.011; TSAI SJ, 2005, CENTRAL MED SCI MONI, V11, P39; Urazaev AK, 2001, NEUROSCIENCE, V106, P237, DOI 10.1016/S0306-4522(01)00270-6; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; WILLIAMSON LC, 1988, BRAIN RES, V475, P151, DOI 10.1016/0006-8993(88)90209-0; Wolf NI, 2004, NEUROLOGY, V62, P1503, DOI 10.1212/01.WNL.0000123094.13406.20	45	43	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29156	29164		10.1074/jbc.M110.111765	http://dx.doi.org/10.1074/jbc.M110.111765			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20643647	Green Published, hybrid			2022-12-27	WOS:000281740100016
J	Strait, KA; Stricklett, PK; Kohan, RM; Kohan, DE				Strait, Kevin A.; Stricklett, Peter K.; Kohan, Rachel M.; Kohan, Donald E.			Identification of Two Nuclear Factor of Activated T-cells (NFAT)-response Elements in the 5 '-Upstream Regulatory Region of the ET-1 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCT-SPECIFIC KNOCKOUT; MEDULLARY COLLECTING DUCT; ENDOTHELIN-1 GENE-EXPRESSION; TRANSCRIPTION FACTOR; SODIUM RETENTION; CAUSES HYPERTENSION; BINDING PROTEIN; BLOOD-PRESSURE; NFAT; EXCRETION	Collecting duct-derived ET-1 regulates salt excretion and blood pressure. We have reported the presence of an inner medullary collecting duct (IMCD)-specific enhancer region in the 5'-upstream ET-1 promoter (Strait, K. A., Stricklett, P. K., Kohan, J. L., Miller, M. B., and Kohan, D. E. (2007) Am. J. Physiol. Renal Physiol. 293, F601-F606). The current studies provide further characterization of the ET-1 5'-upstream distal promoter to identify the IMCD-specific enhancer elements. Deletion studies identified two regions of the 5'-upstream ET-1 promoter, -1725 to -1319 bp and -1319 to -1026 bp, which were required for maximal promoter activity in transfected rat IMCD cells. Transcription factor binding site analysis of these regions identified two consensus nuclear factor of activated T-cells (NFAT) binding sites at -1263 and -1563. EMSA analysis using nuclear extracts from IMCD cells showed that both the -1263 and the -1563 NFAT sites in the ET-1 distal promoter competed for NFAT binding to previously identified NFAT sites in the IL-2 and TNF genes. Gel supershift analysis showed that each of the NFAT binding sites in the ET-1 promoter bound NFAT proteins derived from IMCD nuclear extracts, but they selectively bound different NFAT isoforms; ET-1263 bound NFATc1, whereas ET-1563 bound NFATc3. Site-directed mutagenesis of either the ET-1263 or the ET-1563 sites prevented NFAT binding and reduced ET-1 promoter activity. Thus, NFAT appears to be an important regulator of ET-1 transcription in IMCD cells, and thus, it may play a role in controlling blood pressure through ET-1 regulation of renal salt excretion.	[Strait, Kevin A.; Stricklett, Peter K.; Kohan, Rachel M.; Kohan, Donald E.] Univ Utah, Hlth Sci Ctr, Div Nephrol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kohan, DE (corresponding author), Univ Utah, Hlth Sci Ctr, Div Nephrol, 1900 East 30 North, Salt Lake City, UT 84132 USA.	donald.kohan@hsc.utah.edu			National Institutes of Health [DK96392]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant DK96392 (to D. E. K.).	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Aitsebaomo J, 2001, J BIOL CHEM, V276, P39197, DOI 10.1074/jbc.M105166200; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; Falvo JV, 2008, P NATL ACAD SCI USA, V105, P19637, DOI 10.1073/pnas.0810648105; GALLEGO MS, 1996, AM J PHYSIOL, V271, P451; Ge YQ, 2005, AM J PHYSIOL-RENAL, V289, pF692, DOI 10.1152/ajprenal.00100.2005; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Ge YQ, 2006, AM J PHYSIOL-RENAL, V291, pF1274, DOI 10.1152/ajprenal.00190.2006; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; INOUE A, 1989, J BIOL CHEM, V264, P14954; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; KAWANA M, 1995, MOL CELL BIOL, V15, P4225; KITAMURA K, 1989, BIOCHEM BIOPH RES CO, V161, P348, DOI 10.1016/0006-291X(89)91603-3; Kohan DE, 2006, CURR OPIN NEPHROL HY, V15, P34, DOI 10.1097/01.mnh.0000186852.15889.1a; Kohan DE, 1997, AM J KIDNEY DIS, V29, P2, DOI 10.1016/S0272-6386(97)90004-4; LEE ME, 1991, J BIOL CHEM, V266, P16188; LEE ME, 1990, J BIOL CHEM, V265, P10446; LEE ME, 1991, J BIOL CHEM, V266, P19034; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; MIGAS I, 1995, AM J HYPERTENS, V8, P748, DOI 10.1016/0895-7061(95)00115-6; Modesti PA, 1998, AM J PHYSIOL-HEART C, V275, pH1070, DOI 10.1152/ajpheart.1998.275.3.H1070; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; PERNOW J, 1989, J CARDIOVASC PHARM, V13, pS205, DOI 10.1097/00005344-198900135-00058; Quehenberger P, 2000, DIABETES, V49, P1561, DOI 10.2337/diabetes.49.9.1561; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodriguez-Pascual F, 2004, J CARDIOVASC PHARM, V44, pS39, DOI 10.1097/01.fjc.0000166216.27544.22; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Strait KA, 2007, AM J PHYSIOL-RENAL, V293, pF601, DOI 10.1152/ajprenal.00085.2007; TASAKA K, 1994, GEN PHARMACOL-VASC S, V25, P1059, DOI 10.1016/0306-3623(94)90120-1; TOMITA K, 1991, CONTRIB NEPHROL, V95, P207; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YANG TX, 1993, AM J PHYSIOL, V264, pF684, DOI 10.1152/ajprenal.1993.264.4.F684; ZEIDEL ML, 1989, AM J PHYSIOL, V257, pC1101, DOI 10.1152/ajpcell.1989.257.6.C1101; ZEILER M, 1995, J CARDIOVASC PHARM, V26, pS513; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	37	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28520	28528		10.1074/jbc.M110.153189	http://dx.doi.org/10.1074/jbc.M110.153189			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20647310	Green Published, hybrid			2022-12-27	WOS:000281594000016
J	Haubold, M; Gilsbach, R; Hein, L				Haubold, Miriam; Gilsbach, Ralf; Hein, Lutz			alpha(2B)-Adrenoceptor Deficiency Leads to Postnatal Respiratory Failure in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II CELLS; HEART-FAILURE; CULTURE; LUNG; AUTORECEPTORS; MORPHOGENESIS; HYPERTENSION; INHIBITION; EXPRESSION; FIBROSIS	alpha(2)-Adrenoceptors belong to the family of adrenergic receptors, which regulate the neuronal release of norepinephrine as part of a negative feedback loop. Among the alpha(2)-adrenoceptors, the alpha(2B)-subtype may also influence developmental signaling pathways involved in angiogenesis of the placenta. Thus, the aim of the present study was to determine whether alpha(2B)-adrenoceptors are also involved in other developmental processes beyond placental angiogenesis. Ablation of alpha(2B)-adrenoceptors led to lethality of mutant mice during the first hours after birth. Despite normal breathing and drinking behavior, mutant mice developed cyanosis, which could be traced back to a defect in lung morphology with significantly reduced alveolar volume and thickened interalveolar septi. In alpha(2B)-deficient lungs and in isolated alveolar type II cells, expression of sonic hedgehog (SHH) was significantly increased, resulting in mesenchymal proliferation. In vitro alpha(2B)-adrenoreceptor stimulation suppressed expression of sonic hedgehog and the cell cycle genes cyclin D1 and Ki67. In vivo inhibition of enhanced SHH signaling by the smoothened antagonist cyclopamine partially rescued perinatal lethality, lung morphology, and altered gene expression in mutant mice. Thus, alpha(2B)-adrenoceptors in lung epithelia play an important role in suppressing sonic hedgehog-mediated proliferation of mesenchymal cells and thus prevent respiratory failure.	[Hein, Lutz] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Hein, L (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Albert Str 25, D-79104 Freiburg, Germany.	lutz.hein@pharmakol.uni-freiburg.de	Hein, Lutz/GRJ-8644-2022	Gilsbach, Ralf/0000-0002-0895-1535	Deutsche Forschungsgemeinschaft [He 2073/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant He 2073/2-2).	Beetz N, 2009, J CLIN INVEST, V119, P3597, DOI 10.1172/JCI38433; Beetz N, 2009, CARDIOVASC RES, V84, P396, DOI 10.1093/cvr/cvp251; Bellusci S, 1997, DEVELOPMENT, V124, P53; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Cussac D, 2001, BRIT J PHARMACOL, V133, P1387, DOI 10.1038/sj.bjp.0704203; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; Gilsbach R, 2010, CARDIOVASC RES, V86, P432, DOI 10.1093/cvr/cvq014; Gilsbach R, 2009, MOL PHARMACOL, V75, P1160, DOI 10.1124/mol.109.054544; Gilsbach Ralf, 2008, V184, P261; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Huhtinen A, 2008, EUR J PHARMACOL, V587, P48, DOI 10.1016/j.ejphar.2008.03.049; KALINA M, 1988, HISTOCHEMISTRY, V88, P175, DOI 10.1007/BF00493301; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Link RE, 1996, SCIENCE, V273, P803, DOI 10.1126/science.273.5276.803; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; Miller LAD, 2004, DEV DYNAM, V231, P57, DOI 10.1002/dvdy.20105; Muthig V, 2007, CIRC RES, V101, P682, DOI 10.1161/CIRCRESAHA.107.151563; Otto C, 2004, CIRCULATION, V110, P3245, DOI 10.1161/01.CIR.0000147235.53360.59; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Philipp M, 2002, NAT GENET, V31, P311, DOI 10.1038/ng919; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; STARKE K, 1975, NATURE, V254, P440, DOI 10.1038/254440a0; Talke P, 2005, ANESTHESIOLOGY, V102, P536, DOI 10.1097/00000542-200503000-00010; Trendelenburg AU, 2003, N-S ARCH PHARMACOL, V368, P504, DOI 10.1007/s00210-003-0829-x	30	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34213	34219		10.1074/jbc.M110.129205	http://dx.doi.org/10.1074/jbc.M110.129205			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729197	hybrid, Green Published			2022-12-27	WOS:000283354000066
J	Liu, RP; Xu, YM; Chen, MA; Weiwer, M; Zhou, XX; Bridges, AS; DeAngelis, PL; Zhang, QS; Linhardt, RJ; Liu, JA				Liu, Renpeng; Xu, Yongmei; Chen, Miao; Weiwer, Michel; Zhou, Xianxuan; Bridges, Arlene S.; DeAngelis, Paul L.; Zhang, Qisheng; Linhardt, Robert J.; Liu, Jian			Chemoenzymatic Design of Heparan Sulfate Oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; SUBSTRATE SPECIFICITIES; ANTITHROMBIN-III; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; BINDING; GLYCOSAMINOGLYCANS; PENTASACCHARIDE; TYPE-1; ENTRY	Heparan sulfate is a sulfated glycan that exhibits essential physiological functions. Interrogation of the specificity of heparan sulfate-mediated activities demands a library of structurally defined oligosaccharides. Chemical synthesis of large heparan sulfate oligosaccharides remains challenging. We report the synthesis of oligosaccharides with different sulfation patterns and sizes from a disaccharide building block using glycosyl-transferases, heparan sulfate C-5-epimerase, and sulfotransferases. This method offers a generic approach to prepare heparan sulfate oligosaccharides possessing predictable structures.	[Zhang, Qisheng; Liu, Jian] Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Bridges, Arlene S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Weiwer, Michel; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Rensselaer Polytechnic Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center	Liu, JA (corresponding author), Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Rm 303,Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu	Liu, Renpeng/G-1625-2011; BRIDGES, ARLENE/N-4534-2013	ZHOU, XIANXUAN/0000-0003-0105-5161; Zhang, Qisheng/0000-0001-9808-5038	National Institutes of Health [AI50050, HL094463, HL62244, HL096972, GM38060]; American Heart Association, MidAtlantic Affiliate [0855424E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096972, R01HL094463, R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, MidAtlantic Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grants AI50050, HL094463, HL62244, HL096972, and GM38060. This work was also supported by Grant-in-aid 0855424E from American Heart Association, MidAtlantic Affiliate.	Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; Baleux F, 2009, NAT CHEM BIOL, V5, P743, DOI 10.1038/nchembio.207; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/NCHEM.399, 10.1038/nchem.399]; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; CONRAD HE, 1998, HEPARIN BINDING PROT, P34; Copeland R, 2008, BIOCHEMISTRY-US, V47, P5774, DOI 10.1021/bi800205t; de Agostini AI, 2008, J BIOL CHEM, V283, P28115, DOI 10.1074/jbc.M805338200; de Paz JL, 2008, MOL BIOSYST, V4, P707, DOI 10.1039/b802217h; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Edavettal SC, 2004, J BIOL CHEM, V279, P25789, DOI 10.1074/jbc.M401089200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Jaipuri FA, 2008, ANGEW CHEM INT EDIT, V47, P1707, DOI 10.1002/anie.200704262; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Pope RM, 2001, GLYCOBIOLOGY, V11, P505, DOI 10.1093/glycob/11.6.505; Przybylski C, 2010, GLYCOBIOLOGY, V20, P224, DOI 10.1093/glycob/cwp169; Sala RF, 1998, CARBOHYD RES, V306, P127, DOI 10.1016/S0008-6215(97)10033-7; Sigulinsky C, 2010, CARBOHYD RES, V345, P250, DOI 10.1016/j.carres.2009.10.024; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66; Zaia J, 2003, ANAL CHEM, V75, P2445, DOI 10.1021/ac0263418; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345	36	121	126	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34240	34249		10.1074/jbc.M110.159152	http://dx.doi.org/10.1074/jbc.M110.159152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729556	Green Published, hybrid			2022-12-27	WOS:000283354000069
J	Dai, H; Kustigian, L; Carney, D; Case, A; Considine, T; Hubbard, BP; Perni, RB; Riera, TV; Szczepankiewicz, B; Vlasuk, GP; Stein, RL				Dai, Han; Kustigian, Lauren; Carney, David; Case, April; Considine, Thomas; Hubbard, Basil P.; Perni, Robert B.; Riera, Thomas V.; Szczepankiewicz, Bruce; Vlasuk, George P.; Stein, Ross L.			SIRT1 Activation by Small Molecules KINETIC AND BIOPHYSICAL EVIDENCE FOR DIRECT INTERACTION OF ENZYME AND ACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-DEGRADING ENZYME; MITOCHONDRIAL-FUNCTION; SUBSTRATE-SPECIFICITY; SIRTUINS; RESVERATROL; MECHANISM; PROTECTS; SRT1720; EXPRESSION; PATHWAYS	SIRT1 is a protein deacetylase that has emerged as a therapeutic target for the development of activators to treat diseases of aging. SIRT1-activating compounds (STACs) have been developed that produce biological effects consistent with direct SIRT1 activation. At the molecular level, the mechanism by which STACs activate SIRT1 remains elusive. In the studies reported herein, the mechanism of SIRT1 activation is examined using representative compounds chosen from a collection of STACs. These studies reveal that activation of SIRT1 by STACs is strongly dependent on structural features of the peptide substrate. Significantly, and in contrast to studies reporting that peptides must bear a fluorophore for their deacetylation to be accelerated, we find that some STACs can accelerate the SIRT1-catalyzed deacetylation of specific unlabeled peptides composed only of natural amino acids. These results, together with others of this study, are at odds with a recent claim that complex formation between STACs and fluorophore-labeled peptides plays a role in the activation of SIRT1 (Pacholec, M., Chrunyk, B., Cunningham, D., Flynn, D., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., Qiu, X., Stockman, B., Thanabal, V., Varghese, A., Ward, J., Withka, J., and Ahn, K. (2010) J. Biol. Chem. 285, 8340-8351). Rather, the data suggest that STACs interact directly with SIRT1 and activate SIRT1-catalyzed deacetylation through an allosteric mechanism.	[Riera, Thomas V.; Szczepankiewicz, Bruce; Vlasuk, George P.; Stein, Ross L.] Sirtris, Cambridge, MA 02139 USA; [Hubbard, Basil P.] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Stein, RL (corresponding author), Sirtris Pharmaceut, 200 Technol Sq,Ste 300, Cambridge, MA 02139 USA.	rstein@sirtrispharma.com		Hubbard, Basil/0000-0003-4353-9674; Riera, Thomas/0000-0001-7427-2728				AHARONY D, 1986, J BIOL CHEM, V261, P1512; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bemis J., 2008, Patent, Patent No. [WO 2008156866A1, 2008156866]; Bemis JE, 2009, BIOORG MED CHEM LETT, V19, P2350, DOI 10.1016/j.bmcl.2008.11.106; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; ELIASSON R, 1994, J BIOL CHEM, V269, P26052; ERLANGER BF, 1976, EUR J BIOCHEM, V61, P287, DOI 10.1111/j.1432-1033.1976.tb10021.x; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Haynes NE, 2010, J MED CHEM, V53, P3618, DOI 10.1021/jm100039a; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Marcotte PA, 2004, ANAL BIOCHEM, V332, P90, DOI 10.1016/j.ab.2004.05.039; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; Salzmann T., 2007, WO Patent, Patent No. 2007019346; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Segel IH., 1975, ENZYME KINETICS, P227; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Vu C. B., 2010, Patent Appl., Patent No. [PCT WO 2010/003048, 2010003048]; Vu CB, 2009, J MED CHEM, V52, P1275, DOI 10.1021/jm8012954; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	42	181	194	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32695	32703		10.1074/jbc.M110.133892	http://dx.doi.org/10.1074/jbc.M110.133892			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20702418	Green Published, hybrid			2022-12-27	WOS:000283048200004
J	Shu, SK; Liu, QY; Coppola, D; Cheng, JQ				Shu, Shao-Kun; Liu, Qiyuan; Coppola, Domenico; Cheng, Jin Q.			Phosphorylation and Activation of Androgen Receptor by Aurora-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; INDEPENDENT PROSTATE-CANCER; POLO-LIKE KINASE-1; CENTROSOME AMPLIFICATION; ESTROGEN-RECEPTOR; OVER-EXPRESSION; CELL CARCINOMA; OVARIAN-CANCER; OVEREXPRESSION; CHECKPOINT	Aurora-A kinase is frequently overexpressed/activated in various types of human malignancy, including prostate cancer. In this study, we demonstrate elevated levels of Aurora-A in androgen- refractory LNCaP-RF but not androgen-sensitive LNCaP cells, which prompted us to examine whether Aurora-A regulates the androgen receptor (AR) and whether elevated Aurora- A is involved in androgen-independent cell growth. We show that ectopic expression of Aurora-A induces AR transactivation activity in the presence and absence of androgen. Aurora-A interacts with AR and phosphorylates AR at Thr(282) and Ser(293) in vitro and in vivo. Aurora-A induces AR transactivation activity in a phosphorylation-dependent manner. Ectopic expression of Aurora-A in LNCaP cells induces prostate-specific antigen expression and cell survival, whereas knockdown of Aurora-A sensitizes LNCaP-RF cells to apoptosis and cell growth arrest. These data indicate that AR is a substrate of Aurora-A and that elevated Aurora-A could contribute to androgen-independent cell growth by phosphorylation and activation of AR.	[Shu, Shao-Kun; Liu, Qiyuan; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cheng, JQ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org			National Institutes of Health [CA137041]; Department of Defense [W81XWH-08-2-0101]; Bankhead-Coley [09BB-05]; James Esther King [1KG02-33967]; NATIONAL CANCER INSTITUTE [R01CA137041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Bankhead-Coley; James Esther King; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA137041. This work was also supported by Department of Defense Grant W81XWH-08-2-0101, Bankhead-Coley Grant 09BB-05, and James & Esther King Grant 1KG02-33967.	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cheung CHA, 2009, EXPERT OPIN INV DRUG, V18, P379, DOI [10.1517/13543780902806392 , 10.1517/13543780902806392]; Culig Z, 2004, GROWTH FACTORS, V22, P179, DOI 10.1080/08977190412331279908; Edwards J, 2005, BJU INT, V95, P1327, DOI 10.1111/j.1464-410X.2005.05527.x; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; Fukushige S, 1997, GENE CHROMOSOME CANC, V19, P161, DOI 10.1002/(SICI)1098-2264(199707)19:3<161::AID-GCC5>3.0.CO;2-W; Furukawa J, 2007, BJU INT, V100, P310, DOI 10.1111/j.1464-410X.2007.06982.x; Goepfert TM, 2002, CANCER RES, V62, P4115; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Guo JP, 2010, J BIOL CHEM, V285, P3676, DOI 10.1074/jbc.M109.078212; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; He LL, 2008, J BIOL CHEM, V283, P31012, DOI 10.1074/jbc.M803547200; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; ISOLA JJ, 1995, AM J PATHOL, V147, P905; Kurahashi T, 2007, UROL ONCOL-SEMIN ORI, V25, P128, DOI 10.1016/j.urolonc.2006.06.001; Lee ECY, 2006, CANCER RES, V66, P4996, DOI 10.1158/0008-5472.CAN-05-2796; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Miyake H, 2010, UROL ONCOL-SEMIN ORI, V28, P145, DOI 10.1016/j.urolonc.2008.08.001; Nieto M, 2007, INT J BIOCHEM CELL B, V39, P1562, DOI 10.1016/j.biocel.2007.01.005; Ohishi T, 2010, CANCER RES, V70, P2041, DOI 10.1158/0008-5472.CAN-09-2008; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; Sasayama T, 2005, GENES CELLS, V10, P627, DOI 10.1111/j.1365-2443.2005.00870.x; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Tanaka E, 2005, CLIN CANCER RES, V11, P1827, DOI 10.1158/1078-0432.CCR-04-1627; Taneja SS, 2005, J BIOL CHEM, V280, P40916, DOI 10.1074/jbc.M508442200; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Ward RD, 2009, BIOFACTORS, V35, P528, DOI 10.1002/biof.66; Warner SL, 2003, MOL CANCER THER, V2, P589; Wen Y, 2000, CANCER RES, V60, P6841; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang H, 2004, CANCER RES, V64, P463, DOI 10.1158/0008-5472.CAN-03-2907; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	49	29	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33045	33053		10.1074/jbc.M110.121129	http://dx.doi.org/10.1074/jbc.M110.121129			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20713353	Green Published, hybrid			2022-12-27	WOS:000283048200042
J	Canals, D; Jenkins, RW; Roddy, P; Hernandez-Corbacho, MJ; Obeid, LM; Hannun, YA				Canals, Daniel; Jenkins, Russell W.; Roddy, Patrick; Hernandez-Corbacho, Maria Jose; Obeid, Lina M.; Hannun, Yusuf A.			Differential Effects of Ceramide and Sphingosine 1-Phosphate on ERM Phosphorylation PROBING SPHINGOLIPID SIGNALING AT THE OUTER PLASMA MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELL-MIGRATION; ACTIN-BINDING; EZRIN; CYTOSKELETON; MOESIN; SPHINGOMYELIN; CARCINOMA; CANCER; PHASE	ERM proteins are regulated by phosphorylation of the most C-terminal threonine residue, switching them from an activated to an inactivated form. However, little is known about the control of this regulation. Previous work in our group demonstrated that secretion of acid sphingomyelinase acts upstream of ERM dephosphorylation, suggesting the involvement of sphingomyelin (SM) hydrolysis in ERM regulation. To define the role of specific lipids, we employed recombinant bacterial sphingomyelinase (bSMase) as a direct probe of SM metabolism at the plasma membrane. bSMase induced a rapid dose-and time-dependent decrease in ERM dephosphorylation. ERM dephosphorylation was driven by ceramide generation and not by sphingomyelin depletion, as shown using recombinant sphingomyelinase D. The generation of ceramide at the plasma membrane was sufficient for ERM regulation, and no intracellular SM hydrolysis was required, as was visualized using Venus-tagged lysenin probe, which specifically binds SM. Interestingly, hydrolysis of plasma membrane bSMase-induced ceramide using bacterial ceramidase caused ERM hyperphosphorylation and formation of cell surface protrusions. The effects of plasma membrane ceramide hydrolysis were due to sphingosine 1-phosphate formation, as ERM phosphorylation was blocked by an inhibitor of sphingosine kinase and induced by sphingosine 1-phosphate. Taken together, these results demonstrate a new regulatory mechanism of ERM phosphorylation by sphingolipids with opposing actions of ceramide and sphingosine 1-phosphate. The approach also defines a tool kit to probe sphingolipid signaling at the plasma membrane.	[Canals, Daniel; Jenkins, Russell W.; Roddy, Patrick; Hernandez-Corbacho, Maria Jose; Obeid, Lina M.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAW-1998-2021; Garcia-Caro, Pedro/A-4238-2010; Canals, Daniel/AAJ-8176-2021	Canals, Daniel/0000-0002-9293-5123; Garcia-Caro, Pedro/0000-0002-5064-0845; obeid, lina/0000-0002-0734-0847	National Institutes of Health [CA87584, CA97132]; NATIONAL CANCER INSTITUTE [R01CA087584, P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA87584 and CA97132.	Abiatari I, 2010, J CELL MOL MED, V14, P1166, DOI 10.1111/j.1582-4934.2009.00772.x; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chigorno V, 2005, J BIOL CHEM, V280, P2668, DOI 10.1074/jbc.M407749200; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Contreras F. -Xabier, 2009, V462, P155, DOI 10.1007/978-1-60327-115-8_10; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Endo K, 2009, ONCOGENE, V28, P1725, DOI 10.1038/onc.2009.20; Fais S, 2003, J LEUKOCYTE BIOL, V73, P556, DOI 10.1189/jlb.1102568; French KJ, 2003, CANCER RES, V63, P5962; Gassert E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000623; Gupta VR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000073; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Hla T, 2004, PROSTAG OTH LIPID M, V73, P1, DOI 10.1016/j.prostaglandins.2003.11.001; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Kiyokawa E, 2004, BIOCHEMISTRY-US, V43, P9766, DOI 10.1021/bi049561j; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Liu X, 2008, FRONT BIOSCI-LANDMRK, V13, P2293, DOI 10.2741/2843; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; MeivarLevy I, 1997, J BIOL CHEM, V272, P1558, DOI 10.1074/jbc.272.3.1558; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Pohl A, 2009, MOL MEMBR BIOL, V26, P194, DOI 10.1080/09687680902733815; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Smith ER, 2000, METHOD ENZYMOL, V312, P361; Takenouchi H, 2004, J CELL SCI, V117, P3911, DOI 10.1242/jcs.01246; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Yu H, 2009, GENES CELLS, V14, P597, DOI 10.1111/j.1365-2443.2009.01295.x; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	46	55	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32476	32485		10.1074/jbc.M110.141028	http://dx.doi.org/10.1074/jbc.M110.141028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20679347	hybrid, Green Published			2022-12-27	WOS:000282683000061
J	El Hiani, Y; Linsdell, P				El Hiani, Yassine; Linsdell, Paul			Changes in Accessibility of Cytoplasmic Substances to the Pore Associated with Activation of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CL-CHANNEL; CONFORMATIONAL-CHANGES; ION-CHANNEL; CFTR; BINDING; CYSTEINE; ARCHITECTURE; PERMEATION; VESTIBULE	Opening of the cystic fibrosis transmembrane conductance regulator Cl- channel is dependent both on phosphorylation and on ATP binding and hydrolysis. However, the mechanisms by which these cytoplasmic regulatory factors open the Cl- channel pore are not known. We have used patch clamp recording to investigate the accessibility of cytoplasmically applied cysteine-reactive reagents to cysteines introduced along the length of the pore-lining sixth transmembrane region (TM6) of a cysteine-less variant of cystic fibrosis transmembrane conductance regulator. We find that methanethiosulfonate (MTS) reagents modify irreversibly cysteines substituted for TM6 residues Phe-337, Thr-338, Ser-341, Ile-344, Val-345, Met-348, Ala-349, Arg-352, and Gln-353 when applied to the cytoplasmic side of open channels. However, the apparent rate of modification by internal [2-sulfonatoethyl] methanethiosulfonate (MTSES), a negatively charged MTS reagent, is dependent on the activation state of the channels. In particular, cysteines introduced far along the axis of TM6 from the inside (T338C, S341C, I344C) showed no evidence of significant modification even after prolonged pretreatment of non-activated channels with internal MTSES. In contrast, cysteines introduced closer to the inside of TM6 (V345C, M348C) were readily modified in both activated and non-activated channels. Access of a per-meant anion, Au(CN)(2)(-), to T338C was similarly dependent upon channel activation state. The pattern of MTS modification we observe allows us to designate different pore-lining amino acid side chains to distinct functional regions of the channel pore. One logical interpretation of these findings is that cytoplasmic access to residues at the narrowest region of the pore changes concomitant with activation.	[El Hiani, Yassine; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 1X5, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 1X5, Canada.	paul.linsdell@dal.ca		Linsdell, Paul/0000-0001-6257-6273; El Hiani, Yassine/0000-0002-1251-5066	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	AKABAS MH, 1994, J BIOL CHEM, V269, P14865; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fatehi M, 2008, J BIOL CHEM, V283, P6102, DOI 10.1074/jbc.M707736200; Fatehi M, 2009, J MEMBRANE BIOL, V228, P151, DOI 10.1007/s00232-009-9167-3; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; Gong XD, 2003, J GEN PHYSIOL, V122, P673, DOI 10.1085/jgp.200308889; Gong XD, 2002, J PHYSIOL-LONDON, V540, P39, DOI 10.1113/jphysiol.2001.013235; Hug MJ, 2003, NEWS PHYSIOL SCI, V18, P38, DOI 10.1152/nips.01412.2002; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell P, 2002, J PHYSIOL-LONDON, V540, P29, DOI 10.1113/jphysiol.2001.013234; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Liu XH, 2004, BIOPHYS J, V87, P3826, DOI 10.1529/biophysj.104.050534; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McCarty NA, 2000, J EXP BIOL, V203, P1947; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Miller C, 2010, P NATL ACAD SCI USA, V107, P959, DOI 10.1073/pnas.0913576107; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; Pilewski JM, 1999, PHYSIOL REV, V79, P215; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Serrano JR, 2006, BIOPHYS J, V91, P1737, DOI 10.1529/biophysj.105.078899; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Tang L, 2009, J CYST FIBROS, V8, P115, DOI 10.1016/j.jcf.2008.10.004; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Xu YP, 2009, P NATL ACAD SCI USA, V106, P20515, DOI 10.1073/pnas.0911412106; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	59	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32126	32140		10.1074/jbc.M110.113332	http://dx.doi.org/10.1074/jbc.M110.113332			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20675380	hybrid, Green Published			2022-12-27	WOS:000282683000026
J	Ortuno, MJ; Ruiz-Gaspa, S; Rodriguez-Carballo, E; Susperregui, ARG; Bartrons, R; Rosa, JL; Ventura, F				Jose Ortuno, Maria; Ruiz-Gaspa, Silvia; Rodriguez-Carballo, Edgardo; Susperregui, Antonio R. G.; Bartrons, Ramon; Luis Rosa, Jose; Ventura, Francesc			p38 Regulates Expression of Osteoblast-specific Genes by Phosphorylation of Osterix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR OSTERIX; ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEINS; MESENCHYMAL STEM-CELLS; OSTEOCALCIN GENE; MINERAL DENSITY; TRANSGENIC MICE; UP-REGULATION; DIFFERENTIATION; PROMOTER	Osterix, a zinc finger transcription factor, is specifically expressed in osteoblasts and osteocytes of all developing bones. Because no bone formation occurs in Osx-null mice, Osterix is thought to be an essential regulator of osteoblast differentiation. We report that, in several mesenchymal and osteoblastic cell types, BMP-2 induces an increase in expression of the two isoforms of Osterix arising from two alternative promoters. We identified a consensus Sp1 sequence (GGGCGG) as Osterix binding regions in the fibromodulin and the bone sialoprotein promoters in vitro and in vivo. Furthermore, we show that Osterix is a novel substrate for p38 MAPK in vitro and in vivo and that Ser-73 and Ser-77 are the regulatory sites phosphorylated by p38. Our data also demonstrate that Osterix is able to increase recruitment of p300 and Brg1 to the promoters of its target genes fibromodulin and bone sialoprotein in vivo and that it directly associates with these cofactors through protein-protein interactions. Phosphorylation of Osterix at Ser-73/77 increased its ability to recruit p300 and SWI/SNF to either fibromodulin or bone sialoprotein promoters. We therefore propose that Osterix binds to Sp1 sequences on target gene promoters and that its phosphorylation by p38 enhances recruitment of coactivators to form transcriptionally active complexes.	[Jose Ortuno, Maria; Ruiz-Gaspa, Silvia; Rodriguez-Carballo, Edgardo; Susperregui, Antonio R. G.; Bartrons, Ramon; Luis Rosa, Jose; Ventura, Francesc] Univ Barcelona, Dept Ciencias Fisiol 2, IDIBELL, E-08907 Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Ventura, F (corresponding author), Univ Barcelona, Dept Ciencias Fisiol 2, IDIBELL, C Feixa Llarga S-N, E-08907 Barcelona, Spain.	fventura@ub.edu	Ventura, Francesc/ABG-2285-2020; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Rodriguez-Carballo, Eddie/0000-0003-4321-508X; Bartrons, Ramon/0000-0001-9349-5847; Ortuno Romero, Maria Jose/0000-0002-0200-9952	Ministerio de Educacion y Ciencia (MEC) [BFU2008-02010]; Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud [RD06/0020]; University of Barcelona; IDIBELL	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud(Instituto de Salud Carlos III); University of Barcelona; IDIBELL	This work was supported in part by Ministerio de Educacion y Ciencia (MEC) Grant BFU2008-02010 and Instituto de Salud Carlos III Redes Tematicas de Investigacion Cooperativa en Salud Grant RD06/0020.; Recipient of a fellowship from the University of Barcelona.; Recipient of a fellowship from the IDIBELL.	Baek WY, 2010, BONE, V46, P920, DOI 10.1016/j.bone.2009.12.007; Caverzasio J, 2008, J BONE MINER RES, V23, P1389, DOI 10.1359/JBMR.080410; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen JK, 1996, J BONE MINER RES, V11, P654; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fan DW, 2007, J CELL PHYSIOL, V211, P577, DOI 10.1002/jcp.21016; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hatta M, 2006, INT J MOL MED, V17, P425; Jin HL, 2009, HUM MOL GENET, V18, P2729, DOI 10.1093/hmg/ddp205; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Lee HW, 2008, J BONE MINER RES, V23, P1227, DOI 10.1359/JBMR.080325; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee JY, 2006, MOL CELLS, V22, P182; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Milona M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-43; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Noth U, 2003, EXP CELL RES, V291, P201, DOI 10.1016/S0014-4827(03)00386-0; Okamura H, 2009, BIOCHEM BIOPH RES CO, V379, P440, DOI 10.1016/j.bbrc.2008.12.094; Paz J, 2005, MATRIX BIOL, V24, P341, DOI 10.1016/j.matbio.2005.05.009; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Sun FY, 2009, NUCLEIC ACIDS RES, V37, P3897, DOI 10.1093/nar/gkp261; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhao YH, 2008, EUR J ORAL SCI, V116, P199, DOI 10.1111/j.1600-0722.2008.00533.x	56	101	106	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31985	31994		10.1074/jbc.M110.123612	http://dx.doi.org/10.1074/jbc.M110.123612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20682789	Green Published, hybrid			2022-12-27	WOS:000282683000011
J	Eckert, K; Saliou, JM; Monlezun, L; Vigouroux, A; Atmane, N; Caillat, C; Quevillon-Cheruel, S; Madiona, K; Nicaise, M; Lazereg, S; Van Dorsselaer, A; Sanglier-Cianferani, S; Meyer, P; Morera, S				Eckert, Kelvin; Saliou, Jean-Michel; Monlezun, Laura; Vigouroux, Armelle; Atmane, Noureddine; Caillat, Christophe; Quevillon-Cheruel, Sophie; Madiona, Karine; Nicaise, Magali; Lazereg, Sylvie; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah; Meyer, Philippe; Morera, Solange			The Pih1-Tah1 Cochaperone Complex Inhibits Hsp90 Molecular Chaperone ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; PROTEIN; BINDING; HYDROLYSIS; DIMERIZATION; ACTIVATION; MECHANISM; SYSTEM; NOP17P; STI1	Hsp90 (heat shock protein 90) is an ATP-dependent molecular chaperone regulated by collaborating proteins called cochaperones. This machinery is involved in the conformational activation of client proteins like signaling kinases, transcription factors, or ribonucleoproteins (RNP) such as telomerase. TPR (TetratricoPeptide Repeat)-containing protein associated with Hsp90 (Tah1) and protein interacting with Hsp90 (Pih1) have been identified in Saccharomyces cerevisiae as two Hsp90 cochaperones involved in chromatin remodeling complexes and small nucleolar RNP maturation. Tah1 possesses a minimal TPR domain and binds specifically to the Hsp90 C terminus, whereas Pih1 displays no homology to other protein motifs and has been involved in core RNP protein interaction. While Pih1 alone was unstable and was degraded from its N terminus, we showed that Pih1 and Tah1 form a stable heterodimeric complex that regulates Hsp90 ATPase activity. We used different biophysical approaches such as analytical ultracentrifugation, microcalorimetry, and noncovalent mass spectrometry to characterize the Pih1-Tah1 complex and its interaction with Hsp90. We showed that the Pih1-Tah1 heterodimer binds to Hsp90 with a similar affinity and the same stoichiometry as Tah1 alone. However, the Pih1-Tah1 complex antagonizes Tah1 activity on Hsp90 and inhibits the chaperone ATPase activity. We further identified the region within Pih1 responsible for interaction with Tah1 and inhibition of Hsp90, allowing us to suggest an interaction model for the Pih1-Tah1/Hsp90 complex. These results, together with previous reports, suggest a role for the Pih1-Tah1 cochaperone complex in the recruitment of client proteins such as core RNP proteins to Hsp90.	[Caillat, Christophe; Madiona, Karine] CNRS, LEBS, F-91198 Gif Sur Yvette, France; [Saliou, Jean-Michel; Van Dorsselaer, Alain; Sanglier-Cianferani, Sarah] Univ Strasbourg, IPHC, Lab Spectrometrie Masse BioOrgan, F-67087 Strasbourg, France; [Quevillon-Cheruel, Sophie; Nicaise, Magali] Univ Paris Sud, IBBMC, CNRS, F-91405 Orsay, France; [Lazereg, Sylvie] CNRS, ICSN, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay		meyer@lebs.cnrs-gif.fr; morera@lebs.cnrs-gif.fr	Meyer, Philippe/AAC-6038-2019	Meyer, Philippe/0000-0002-6220-0679; MONLEZUN, Laura/0000-0003-4661-3366; christophe, caillat/0000-0003-2959-1871; morera, solange/0000-0001-7781-0448; Cianferani, Sarah/0000-0003-4013-4129	CNRS; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer; University of Strasbourg UdS; Region Alsace; Agence Nationale pour la Recherche [ANR-05-JCJC, 015101]; Sidaction; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); University of Strasbourg UdS(European Commission); Region Alsace(Region Grand-Est); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Sidaction; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was funded by the CNRS, the Agence Nationale de la Recherche, the Association pour la Recherche sur le Cancer, the University of Strasbourg UdS, and the Region Alsace.; Supported by a grant from the Agence Nationale pour la Recherche (ANR-05-JCJC No. 015101) (to S. M.).; Supported by Sidaction.; Supported by the Fondation pour la Recherche Medicale.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Cantor C.R., 1980, TECHNIQUES STUDY BIO; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Granato DC, 2005, FEBS J, V272, P4450, DOI 10.1111/j.1742-4658.2005.04861.x; Houry WA, 2001, CURR PROTEIN PEPT SC, V2, P227, DOI 10.2174/1389203013381134; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Millson SH, 2004, CELL STRESS CHAPERON, V9, P359, DOI 10.1379/CSC-29R1.1; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; Niewiarowski A, 2010, BIOCHEM J, V429, P113, DOI 10.1042/BJ20100489; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Papin C, 2010, FEBS J, V277, P2705, DOI [10.1111/j.1742-4658.2010.07687.x, 10.1111/j.1742-464X.2010.07687.x]; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Sanglier S, 2008, METHODS MOL BIOL, V484, P217, DOI 10.1007/978-1-59745-398-1_15; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shevchenko A, 2000, ANAL CHEM, V72, P2132, DOI 10.1021/ac9913659; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sommer N, 2004, BIOCHEM BIOPH RES CO, V323, P809, DOI 10.1016/j.bbrc.2004.08.170; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061; Zhao RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009934	45	51	52	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31304	31312		10.1074/jbc.M110.138263	http://dx.doi.org/10.1074/jbc.M110.138263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663878	Green Published, hybrid			2022-12-27	WOS:000282764600025
J	Lee, SJ; Richardson, CC				Lee, Seung-Joo; Richardson, Charles C.			Molecular Basis for Recognition of Nucleoside Triphosphate by Gene 4 Helicase of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA HELICASE; CRYSTAL-STRUCTURE; PRIMASE-HELICASE; HEXAMERIC HELICASES; LINKER REGION; PROTEIN; HYDROLYSIS; MECHANISM; REPLICATION; SPECIFICITY	The translocation of DNA helicases on single-stranded DNA and the unwinding of double-stranded DNA are fueled by the hydrolysis of nucleoside triphosphates (NTP). Although most helicases use ATP in these processes, the DNA helicase encoded by gene 4 of bacteriophage T7 uses dTTP most efficiently. To identify the structural requirements of the NTP, we determined the efficiency of DNA unwinding by T7 helicase using a variety of NTPs and their analogs. The 5-methyl group of thymine was critical for the efficient unwinding of DNA, although the presence of a 3'-ribosyl hydroxyl group partially overcame this requirement. The NTP-binding pocket of the protein was examined by randomly substituting amino acids for several amino acid residues (Thr-320, Arg-504, Tyr-535, and Leu-542) that the crystal structure suggests interact with the nucleotide. Although positions 320 and 542 required aliphatic residues of the appropriate size, an aromatic side chain was necessary at position 535 to stabilize NTP for efficient unwinding. A basic side chain of residue 504 was essential to interact with the 4-carbonyl of the thymine base of dTTP. Replacement of this residue with a small aliphatic residue allowed the accommodation of other NTPs, resulting in the preferential use of dATP and the use of dCTP, a nucleotide not normally used. Results from this study suggest that the NTP must be stabilized by specific interactions within the NTP-binding site of the protein to achieve efficient hydrolysis. These interactions dictate NTP specificity.	[Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, 240 Long Wood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Ayora S, 2002, NUCLEIC ACIDS RES, V30, P2280, DOI 10.1093/nar/30.11.2280; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Belon CA, 2009, J MOL BIOL, V388, P851, DOI 10.1016/j.jmb.2009.03.059; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; CLAUDE A, 1991, J BIOL CHEM, V266, P10358; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Dubaele S, 2006, BIOORG MED CHEM LETT, V16, P923, DOI 10.1016/j.bmcl.2005.10.110; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Griep MA, 2007, BIOORGAN MED CHEM, V15, P7203, DOI 10.1016/j.bmc.2007.07.057; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Hughes MD, 2003, J MOL BIOL, V331, P973, DOI 10.1016/S0022-2836(03)00833-7; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; KOLODNER R, 1977, P NATL ACAD SCI USA, V74, P1525, DOI 10.1073/pnas.74.4.1525; KORNBERG A, 1992, DNA REPLICATION, P54; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; LI XY, 1992, J BIOL CHEM, V267, P25321; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1983, J BIOL CHEM, V258, P4009; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; SALUJA D, 1995, J BACTERIOL, V177, P1104, DOI 10.1128/jb.177.4.1104-1111.1995; Satapathy AK, 2009, J BIOL CHEM, V284, P14286, DOI 10.1074/jbc.M900557200; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200; Tran NQ, 2010, MOL MICROBIOL, V77, P492, DOI 10.1111/j.1365-2958.2010.07221.x; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825	38	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31462	31471		10.1074/jbc.M110.156067	http://dx.doi.org/10.1074/jbc.M110.156067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20688917	Green Published, hybrid			2022-12-27	WOS:000282764600040
J	Saxena, UH; Owens, L; Graham, JR; Cooper, GM; Hansen, U				Saxena, Utsav H.; Owens, Laura; Graham, Julie R.; Cooper, Geoffrey M.; Hansen, Ulla			Prolyl Isomerase Pin1 Regulates Transcription Factor LSF (TFCP2) by Facilitating Dephosphorylation at Two Serine-Proline Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; THYMIDYLATE SYNTHASE EXPRESSION; HEPATOCELLULAR-CARCINOMA; MITOGENIC STIMULATION; BINDING-ACTIVITY; SWITCH REGIONS; PHOSPHORYLATION; CELLS; ISOMERIZATION; OVEREXPRESSION	Transcription factor LSF is essential for cell cycle progression, being required for activating expression of the thymidylate synthase (Tyms) gene at the G1/S transition. We previously established that phosphorylation of LSF in early G1 at Ser-291 and Ser-309 inhibits its transcriptional activity and that dephosphorylation later in G1 is required for its reactivation. Here we reveal the role of prolyl cis-trans isomerase Pin1 in activating LSF, by facilitating dephosphorylation at both Ser-291 and Ser-309. We demonstrate that Pin1 binds LSF both in vitro and in vivo. Using coimmunoprecipitation assays, we identify three SP/TP motifs in LSF (at residues Ser-291, Ser-309, and Thr-329) that are required and sufficient for association with Pin1. Co-expression of Pin1 enhances LSF transactivation potential in reporter assays. The Pin1-dependent enhancement of LSF activity requires residue Thr-329 in LSF, requires both the WW and PPiase domains of Pin1, and correlates with hypophosphorylation of LSF at Ser-291 and Ser-309. These findings support a model in which the binding of Pin1 at the Thr-329-Pro-330 motif in LSF permits isomerization by Pin1 of the peptide bonds at the nearby phosphorylated SP motifs (Ser-291 and Ser-309) to the trans configuration, thereby facilitating their dephosphorylation.	[Saxena, Utsav H.; Owens, Laura; Graham, Julie R.; Cooper, Geoffrey M.; Hansen, Ulla] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Hansen, U (corresponding author), 5 Cummington St, Boston, MA 02215 USA.	uhansen@bu.edu		Hansen, Ulla/0000-0001-9803-4185	Public Health Service National Institutes of Health [R01 CA-081157, R01 CA-18689]; NATIONAL CANCER INSTITUTE [R01CA018689, R01CA081157] Funding Source: NIH RePORTER	Public Health Service National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Public Health Service National Institutes of Health Grants R01 CA-081157 (to U. H.) and R01 CA-18689 (to G. M. C.).	Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Bruni P, 2002, J BIOL CHEM, V277, P35481, DOI 10.1074/jbc.M205227200; CACIOPPO R, 2007, THESIS BOSTON U; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Drouin EE, 2002, J IMMUNOL, V168, P2847, DOI 10.4049/jimmunol.168.6.2847; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; Hansen U, 2009, CELL CYCLE, V8, P2146, DOI 10.4161/cc.8.14.9089; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Lippens G, 2007, FEBS J, V274, P5211, DOI 10.1111/j.1742-4658.2007.06057.x; LU KP, 1993, J BIOL CHEM, V268, P8769; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Pagon Z, 2003, J CELL BIOCHEM, V89, P733, DOI 10.1002/jcb.10549; Pang R, 2004, ONCOGENE, V23, P4182, DOI 10.1038/sj.onc.1207493; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Powell CMH, 2000, EMBO J, V19, P4665, DOI 10.1093/emboj/19.17.4665; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rasband W.S., 1997, IMAGE J; Repetny KJ, 2009, EUR J IMMUNOL, V39, P1387, DOI 10.1002/eji.200838226; Saxena UH, 2009, MOL CELL BIOL, V29, P2335, DOI 10.1128/MCB.00687-08; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Volker JL, 1997, GENE DEV, V11, P1435, DOI 10.1101/gad.11.11.1435; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Ylisastigui L, 2005, J VIROL, V79, P5952, DOI 10.1128/JVI.79.10.5952-5962.2005; Yoo BK, 2010, P NATL ACAD SCI USA, V107, P8357, DOI 10.1073/pnas.1000374107; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	36	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31139	31147		10.1074/jbc.M109.078808	http://dx.doi.org/10.1074/jbc.M109.078808			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20682773	hybrid, Green Published			2022-12-27	WOS:000282764600007
J	Takekoshi, T; Tada, Y; Watanabe, T; Sugaya, M; Hoashi, T; Komine, M; Kawashima, T; Shimizu, T; Hau, CS; Asahina, A; Yokomizo, T; Sato, S; Tamaki, K				Takekoshi, Tomonori; Tada, Yayoi; Watanabe, Takahiro; Sugaya, Makoto; Hoashi, Toshihiko; Komine, Mayumi; Kawashima, Tomohiko; Shimizu, Teruo; Hau, Carren Sy; Asahina, Akihiko; Yokomizo, Takehiko; Sato, Shinichi; Tamaki, Kunihiko			Identification of a Novel Marker for Dendritic Cell Maturation, Mouse Transmembrane Protein 123	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II MOLECULES; MHC CLASS-II; LANGERHANS CELLS; EXOGENOUS ANTIGENS; IL-12 PRODUCTION; LYMPH-NODES; CD40; RECEPTOR; EXPRESSION; LIGATION	Dendritic cells (DCs) are a group of professional antigen-presenting cells, and many genes are known to be associated with their maturation. We compared the transcriptional profiles of immature and mature mouse Langerhans cells using the suppressive, subtractive hybridization method and identified a novel gene of unknown function, termed herein transmembrane protein 123 (Tmem123), of which mRNA expression was enhanced in mature but not in immature Langerhans cells. Its expression was also enhanced in other mature DCs such as bone marrow-derived DCs (BMDCs) and splenic DCs. Interestingly, CD40 expression was up-regulated on mature BMDCs cultured with colchicine concurrently with the enhanced expression of Tmem123 compared with that of fresh BMDCs. Furthermore, the expression of CD40 was enhanced on Tmem123-transfected DC2.4 cells, a mouse BMDC-derived cell line, compared with that on mock-transfected DC2.4 cells. This enhancement of CD40 expression did not occur after deletion of lysosome/endosome targeting YXX phi motifs (where X is any amino acid and phi is a bulky hydrophobic amino acid) in the Tmem123 cytoplasmic tail. By stimulation with anti-CD40 monoclonal antibody, these transfectants secreted an increased amount of IL-12/23 p40 compared with mock-transfected DC2.4 cells. Thus, our study demonstrates that Tmem123 may be used as a new maturation marker in DCs and that this molecule may be closely associated with the cell surface expression of CD40.	[Tada, Yayoi; Kawashima, Tomohiko; Shimizu, Teruo; Hau, Carren Sy; Asahina, Akihiko; Sato, Shinichi] Univ Tokyo, Dept Dermatol, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Komine, Mayumi] Jichi Med Univ, Grad Sch Med, Dept Dermatol, Shimotsuke, Tochigi 3290431, Japan; [Shimizu, Teruo] Teikyo Univ, Sch Med, Dept Dermatol, Itabashi Ku, Tokyo 1738605, Japan; [Asahina, Akihiko] Sagamihara Natl Hosp, Dept Dermatol, Kanagawa 2520392, Japan; [Yokomizo, Takehiko] Kyushu Univ, Japan Sci & Technol Agcy, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 8128582, Japan	University of Tokyo; Jichi Medical University; Teikyo University; Japan Science & Technology Agency (JST); Kyushu University	Tada, Y (corresponding author), Univ Tokyo, Dept Dermatol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ytada-tky@umin.ac.jp	Lee, Moo Hyun/AAK-4266-2020; 菅谷, 誠/GWC-3786-2022; Yokomizo, Takehiko/P-5673-2016; Koji, Yoshimura/J-9154-2018	Lee, Moo Hyun/0000-0002-4082-1677; Yokomizo, Takehiko/0000-0002-5219-1553; Komine, Mayumi/0000-0002-1086-1803	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. W., K. T., and T. Y.).	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cao WX, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-26; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Cho M, 2008, INT IMMUNOL, V20, P155, DOI 10.1093/intimm/dxm127; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Evans SJ, 2002, EUR J NEUROSCI, V16, P409, DOI 10.1046/j.1460-9568.2002.02097.x; FloresRomo L, 1997, J EXP MED, V185, P341, DOI 10.1084/jem.185.2.341; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO;2-9; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hashimoto S, 2000, BLOOD, V96, P2206, DOI 10.1182/blood.V96.6.2206.h8002206_2206_2214; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Ma FR, 2001, P NATL ACAD SCI USA, V98, P9778, DOI 10.1073/pnas.171322898; MALLABIABARRENA A, 1995, EMBO J, V14, P2257, DOI 10.1002/j.1460-2075.1995.tb07220.x; Mizumoto N, 2005, BLOOD, V106, P3082, DOI 10.1182/blood-2005-03-1161; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Nuriya S, 1996, INT IMMUNOL, V8, P917, DOI 10.1093/intimm/8.6.917; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Riedl E, 2000, BLOOD, V96, P4276; Saeki H, 1999, J IMMUNOL, V162, P2472; Salgado CG, 1999, J INVEST DERMATOL, V113, P1021, DOI 10.1046/j.1523-1747.1999.00785.x; Shen ZH, 1997, J IMMUNOL, V158, P2723; Staudt LM, 2000, ANNU REV IMMUNOL, V18, P829, DOI 10.1146/annurev.immunol.18.1.829; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Tada Y, 2000, J IMMUNOL, V164, P5113, DOI 10.4049/jimmunol.164.10.5113; Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x; Tone M, 2001, P NATL ACAD SCI USA, V98, P1751, DOI 10.1073/pnas.98.4.1751; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Tsukamoto N, 1999, P NATL ACAD SCI USA, V96, P1234, DOI 10.1073/pnas.96.4.1234; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Zhang CG, 1998, P NATL ACAD SCI USA, V95, P6290, DOI 10.1073/pnas.95.11.6290	35	8	8	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31876	31884		10.1074/jbc.M110.118877	http://dx.doi.org/10.1074/jbc.M110.118877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20685650	hybrid, Green Published			2022-12-27	WOS:000282764600079
J	Brodkorb, D; Gottschall, M; Marmulla, R; Luddeke, F; Harder, J				Brodkorb, Danny; Gottschall, Matthias; Marmulla, Robert; Lueddeke, Frauke; Harder, Jens			Linalool Dehydratase-Isomerase, a Bifunctional Enzyme in the Anaerobic Degradation of Monoterpenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENITRIFYING ALCALIGENES-DEFRAGRANS; ETHYLBENZENE DEHYDROGENASE; INITIAL REACTION; ALPHA-PINENE; SP. NOV.; TRANSFORMATION; METABOLISM; BACTERIUM; EMISSIONS; PATHWAY	Castellaniella (ex Alcaligenes) defragrans strain 65Phen mineralizes monoterpenes in the absence of oxygen. Soluble cell extracts anaerobically catalyzed the isomerization of geraniol to linalool and the dehydration of linalool to myrcene. The linalool dehydratase was present in cells grown on monoterpenes, but not if grown on acetate. We purified the novel enzyme similar to 1800-fold to complete homogeneity. The native enzyme had a molecular mass of 160 kDa. Denaturing gel electrophoresis revealed one single protein band with a molecular mass of 40 kDa, which indicated a homotetramer as native conformation. The aerobically purified enzyme was anaerobically activated in the presence of 2 mM DTT. The linalool dehydratase catalyzed in vitro two reactions in both directions depending on the thermodynamic driving forces: a water secession from the tertiary alcohol linalool to the corresponding acyclic monoterpene myrcene and an isomerization of the primary allylalcohol geraniol in its stereoisomer linalool. The specific activities (V(max)) were 140 nanokatals mg(-1) for the linalool dehydratase and 410 nanokatals mg(-1) for the geraniol isomerase, with apparent K(m) values of 750 mu M and 500 mu M, respectively. The corresponding open reading frame was identified and revealed a precursor protein with a signal peptide for a periplasmatic location. The amino acid sequence did not affiliate with any described enzymes. We suggest naming the enzyme linalool dehydratase-isomerase according to its bifunctionality and placing it as a member of a new protein family within the hydrolyases (EC 4.2.1. X).	[Brodkorb, Danny; Gottschall, Matthias; Marmulla, Robert; Lueddeke, Frauke; Harder, Jens] Max Planck Inst Marine Microbiol, Dept Microbiol, D-28359 Bremen, Germany	Max Planck Society	Harder, J (corresponding author), Max Planck Inst Marine Microbiol, Dept Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	jharder@mpi-bremen.de			Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society.	AECKERSBERG F, 1991, ARCH MICROBIOL, V156, P5, DOI 10.1007/BF00418180; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Erman W.F, 1985, CHEM MONOTERPENES EN; EVANS PJ, 1992, APPL ENVIRON MICROB, V58, P496, DOI 10.1128/AEM.58.2.496-501.1992; Farooq A, 2004, CURR ORG CHEM, V8, P353, DOI 10.2174/1385272043485945; Fichan I, 1999, J CHEM ENG DATA, V44, P56, DOI 10.1021/je980070+; Forster-Fromme K, 2008, FEMS MICROBIOL LETT, V286, P78, DOI 10.1111/j.1574-6968.2008.01266.x; Foss S, 1998, SYST APPL MICROBIOL, V21, P365, DOI 10.1016/S0723-2020(98)80046-5; Foss S, 1997, FEMS MICROBIOL LETT, V149, P71, DOI 10.1016/S0378-1097(97)00057-8; Foss S, 1998, SYST APPL MICROBIOL, V21, P237, DOI 10.1016/S0723-2020(98)80028-3; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; HARDER J, 1995, APPL ENVIRON MICROB, V61, P3804, DOI 10.1128/AEM.61.11.3804-3808.1995; Harder J, 2000, BIODEGRADATION, V11, P55, DOI 10.1023/A:1026552724696; HARTMANS S, 1991, J GEN MICROBIOL, V137, P2555, DOI 10.1099/00221287-137-11-2555; Heider J, 2007, CURR OPIN CHEM BIOL, V11, P188, DOI 10.1016/j.cbpa.2007.02.027; Heyen U, 2000, APPL ENVIRON MICROB, V66, P3004, DOI 10.1128/AEM.66.7.3004-3009.2000; Heyen U, 1998, FEMS MICROBIOL LETT, V169, P67, DOI 10.1111/j.1574-6968.1998.tb13300.x; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Kamens R, 1999, ENVIRON SCI TECHNOL, V33, P1430, DOI 10.1021/es980725r; Kampfer P, 2006, INT J SYST EVOL MICR, V56, P815, DOI 10.1099/ijs.0.63989-0; Kiendler-Scharr A, 2009, NATURE, V461, P381, DOI 10.1038/nature08292; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Kniemeyer O, 2001, J BIOL CHEM, V276, P21381, DOI 10.1074/jbc.M101679200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Pare PW, 1997, NATURE, V385, P30, DOI 10.1038/385030a0; Rabus R, 2001, J BACTERIOL, V183, P1707, DOI 10.1128/JB.183.5.1707-1715.2001; SCHMID C, 1992, TREES-STRUCT FUNCT, V6, P32, DOI 10.1007/BF00224496; Sun ZT, 2009, MICROBIOL-SGM, V155, P2775, DOI 10.1099/mic.0.027623-0; Thompson ML, 2010, APPL MICROBIOL BIOT, V85, P721, DOI 10.1007/s00253-009-2182-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUDGILL PW, 1986, TERPINOID METABOLISM, P483; van der Werf MJ, 1999, APPL ENVIRON MICROB, V65, P2092; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; ZIMMERMAN PR, 1978, GEOPHYS RES LETT, V5, P679, DOI 10.1029/GL005i008p00679	38	45	63	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30436	30442		10.1074/jbc.M109.084244	http://dx.doi.org/10.1074/jbc.M109.084244			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663876	Green Published, hybrid			2022-12-27	WOS:000282135500010
J	De-la-Pena, C; Badri, DV; Lei, ZT; Watson, BS; Brandao, MM; Silva-Filho, MC; Sumner, LW; Vivanco, JM				De-la-Pena, Clelia; Badri, Dayakar V.; Lei, Zhentian; Watson, Bonnie S.; Brandao, Marcelo M.; Silva-Filho, Marcio C.; Sumner, Lloyd W.; Vivanco, Jorge M.			Root Secretion of Defense-related Proteins Is Development-dependent and Correlated with Flowering Time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENESIS-RELATED PROTEINS; PREDICTING SUBCELLULAR-LOCALIZATION; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; 2-DIMENSIONAL ELECTROPHORESIS; APOPLASTIC PROTEINS; SIGNAL EXCHANGE; GROWTH; RESISTANCE; CHITINASE	Proteins found in the root exudates are thought to play a role in the interactions between plants and soil organisms. To gain a better understanding of protein secretion by roots, we conducted a systematic proteomic analysis of the root exudates of Arabidopsis thaliana at different plant developmental stages. In total, we identified 111 proteins secreted by roots, the majority of which were exuded constitutively during all stages of development. However, defense-related proteins such as chitinases, glucanases, myrosinases, and others showed enhanced secretion during flowering. Defense-impaired mutants npr1-1 and NahG showed lower levels of secretion of defense proteins at flowering compared with the wild type. The flowering-defective mutants fca-1, stm-4, and co-1 showed almost undetectable levels of defense proteins in their root exudates at similar time points. In contrast, root secretions of defense-enhanced cpr5-2 mutants showed higher levels of defense proteins. The proteomics data were positively correlated with enzymatic activity assays for defense proteins and with in silico gene expression analysis of genes specifically expressed in roots of Arabidopsis. In conclusion, our results show a clear correlation between defense-related proteins secreted by roots and flowering time.	[Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA; [Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Lei, Zhentian; Watson, Bonnie S.; Sumner, Lloyd W.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; [Brandao, Marcelo M.; Silva-Filho, Marcio C.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, BR-13400970 Piracicaba, SP, Brazil	Colorado State University; Colorado State University; Noble Research Institute; Universidade de Sao Paulo	Vivanco, JM (corresponding author), Colorado State Univ, Ctr Rhizosphere Biol, 217 Shepardson Bldg, Ft Collins, CO 80523 USA.	j.vivanco@colostate.edu	Sumner, Lloyd W/A-3270-2013; Silva-Filho, Marcio/F-2639-2012; BrandÃo, Marcelo/AAX-5691-2020; Brandão, Marcelo/C-1421-2012	Sumner, Lloyd W/0000-0002-4086-663X; Silva-Filho, Marcio/0000-0003-2129-0388; Brandão, Marcelo/0000-0001-9130-7611; Watson, Bonnie/0000-0003-2222-8156; De-la-Pena, Clelia/0000-0002-9093-9489	National Science Foundation [MCB-0542642, MCB-0950857, DBI-0109732]; Consejo Nacional de Ciencia y Tecnologia, Mexico [165181]; Samuel Roberts Noble Foundation	National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Samuel Roberts Noble Foundation	This work was supported in part by National Science Foundation Grants MCB-0542642 and MCB-0950857 (to J.M.V.).; Supported by Graduate Scholarship 165181 from Consejo Nacional de Ciencia y Tecnologia, Mexico. Present address: Unidad de Biotecnologia, Centro de Investigacion Cientifica de Yucatan, Calle 43 No. 130, Col. Chuburna de Hidalgo, C.P. 97200, Merida, Yucatan, Mexico.; Supported by The Samuel Roberts Noble Foundation.; We are grateful to the Vivanco laboratory for commenting on the manuscript and Dr. Daniel K. Manter (United States Department of Agriculture-Agricultural Research Scientist) for technical advice. The ABI QSTAR Pulsar i was supported by the National Science Foundation Grant DBI-0109732 and The Samuel Roberts Noble Foundation.	ABELES FB, 1970, PLANT PHYSIOL, V45, P395, DOI 10.1104/pp.45.4.395; Agerbirk N, 2009, PHYTOCHEM REV, V8, P101, DOI 10.1007/s11101-008-9098-0; Aires A, 2009, J APPL MICROBIOL, V106, P2096, DOI 10.1111/j.1365-2672.2009.04181.x; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Balasubrahmanyam A, 2000, PLANT SCI, V154, P13, DOI 10.1016/S0168-9452(99)00192-2; Baldwin IT, 2002, CURR OPIN PLANT BIOL, V5, P351, DOI 10.1016/S1369-5266(02)00263-7; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Basu U, 2006, PLANT SOIL, V286, P357, DOI 10.1007/s11104-006-9048-9; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466, DOI 10.1038/8643; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chandler J, 1996, PLANT J, V10, P637, DOI 10.1046/j.1365-313X.1996.10040637.x; Charmont S, 2005, PHYTOCHEMISTRY, V66, P453, DOI 10.1016/j.phytochem.2004.12.013; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Cipollini DF, 1999, J CHEM ECOL, V25, P271, DOI 10.1023/A:1020842712349; Cole M, 2006, NUCLEIC ACIDS RES, V34, P1281, DOI 10.1093/nar/gkl016; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; Davis JM, 2002, MOL PLANT MICROBE IN, V15, P380, DOI 10.1094/MPMI.2002.15.4.380; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ESAKA M, 1990, PLANT PHYSIOL, V93, P1037, DOI 10.1104/pp.93.3.1037; Felton GW, 2008, CURR OPIN PLANT BIOL, V11, P457, DOI 10.1016/j.pbi.2008.07.001; Friedrich L, 1995, PLANT MOL BIOL, V29, P959, DOI 10.1007/BF00014969; Grunwald I, 2003, PHYSIOL PLANTARUM, V119, P192, DOI 10.1034/j.1399-3054.2003.00202.x; Guan Y, 2008, J EXP BOT, V59, P3475, DOI 10.1093/jxb/ern197; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hashem FA, 2000, PHYTOTHER RES, V14, P284, DOI 10.1002/1099-1573(200006)14:4&lt;284::AID-PTR599&gt;3.0.CO;2-Y; Heil M, 2008, J CHEM ECOL, V34, P601, DOI 10.1007/s10886-008-9464-9; Hiilovaara-Teijo M, 1999, PLANT PHYSIOL, V121, P665, DOI 10.1104/pp.121.2.665; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horiuchi J, 2005, PLANTA, V222, P848, DOI 10.1007/s00425-005-0025-y; Hugot K, 1999, PLANT J, V20, P163, DOI 10.1046/j.1365-313x.1999.00587.x; Hugot K, 2004, PLANT PHYSIOL, V134, P858, DOI 10.1104/pp.103.034173; Kaplan F, 2009, J CHEM ECOL, V35, P878, DOI 10.1007/s10886-009-9670-0; KAWAOKA A, 1994, PLANT CELL REP, V13, P149, DOI 10.1007/BF00239882; Lei Z, 2005, MOL CELL PROTEOMICS, V4, P1812, DOI 10.1074/mcp.D500005-MCP200; Leitner M, 2008, PHYTOCHEMISTRY, V69, P2029, DOI 10.1016/j.phytochem.2008.04.019; LEUNG DWM, 1992, PHYTOCHEMISTRY, V31, P1899, DOI 10.1016/0031-9422(92)80330-H; LI ZC, 1990, J PLANT PHYSIOL, V136, P398, DOI 10.1016/S0176-1617(11)80026-X; LOTAN T, 1989, PLANT CELL, V1, P881, DOI 10.1105/tpc.1.9.881; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; LUDWIG A, 1990, FEMS MICROBIOL LETT, V69, P61, DOI [10.1016/0378-1097(90)90413-K, 10.1111/j.1574-6968.1990.tb04175.x]; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Micallef SA, 2009, PLANT SIGNAL BEHAV, V4, P777, DOI 10.1093/jxb/erp053; Mishina TE, 2007, PHYSIOL PLANTARUM, V131, P448, DOI 10.1111/j.1399-3054.2007.00977.x; Mithofer A, 2002, MOL PLANT PATHOL, V3, P163, DOI 10.1046/j.1364-3703.2002.00109.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nair R, 2005, J MOL BIOL, V348, P85, DOI 10.1016/j.jmb.2005.02.025; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEALE AD, 1990, PLANT CELL, V2, P673, DOI 10.1105/tpc.2.7.673; Nobrega FM, 2005, PLANT SOIL, V272, P223, DOI 10.1007/s11104-004-4954-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Olivieri F, 1998, PHYSIOL PLANTARUM, V104, P232, DOI 10.1034/j.1399-3054.1998.1040211.x; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pongrac P, 2008, J CHEM ECOL, V34, P1038, DOI 10.1007/s10886-008-9502-7; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Ramirez MG, 2004, J MICROBIOL METH, V56, P213, DOI 10.1016/j.mimet.2003.10.011; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Raybould AF, 2001, HEREDITY, V87, P383, DOI 10.1046/j.1365-2540.2001.00954.x; REDDY PM, 2007, DYNAMIC SOIL DYNAMIC, V1, P83; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; SAMAC DA, 1990, PLANT PHYSIOL, V93, P907, DOI 10.1104/pp.93.3.907; Sanon A, 2009, PLANT SOIL, V321, P259, DOI 10.1007/s11104-009-0010-5; SHEPHERD T, 1993, ANN BOT-LONDON, V72, P155, DOI 10.1006/anbo.1993.1094; STACEY G, 1995, SOIL BIOL BIOCHEM, V27, P473, DOI 10.1016/0038-0717(95)98622-U; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Sumner LW, 2002, RAPID COMMUN MASS SP, V16, P160, DOI 10.1002/rcm.555; Textor S, 2009, PHYTOCHEM REV, V8, P149, DOI 10.1007/s11101-008-9117-1; TILTON RC, 1973, APPL MICROBIOL, V26, P658, DOI 10.1128/AEM.26.5.658-665.1973; Traw MB, 2003, MOL ECOL, V12, P1125, DOI 10.1046/j.1365-294X.2003.01815.x; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; VanderWesthuizen AJ, 1996, AUST J PLANT PHYSIOL, V23, P645; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wasternack C, 2006, J PLANT PHYSIOL, V163, P297, DOI 10.1016/j.jplph.2005.10.014; Wen FS, 2007, PLANT PHYSIOL, V143, P773, DOI 10.1104/pp.106.091637; Yu JQ, 2003, BIOCHEM SYST ECOL, V31, P129, DOI 10.1016/S0305-1978(02)00150-3; Zeng RS, 2003, J CHEM ECOL, V29, P1337, DOI 10.1023/A:1024257218558; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	91	67	68	3	55	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30654	30665		10.1074/jbc.M110.119040	http://dx.doi.org/10.1074/jbc.M110.119040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20682788	Green Published, hybrid			2022-12-27	WOS:000282135500034
J	Durairaj, G; Chaurasia, P; Lahudkar, S; Malik, S; Shukla, A; Bhaumik, SR				Durairaj, Geetha; Chaurasia, Priyasri; Lahudkar, Shweta; Malik, Shivani; Shukla, Abhijit; Bhaumik, Sukesh R.			Regulation of Chromatin Assembly/Disassembly by Rtt109p, a Histone H3 Lys(56)-specific Acetyltransferase, in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION MACHINERY; LYSINE-56 ACETYLATION; H3K56 ACETYLATION; GENE-EXPRESSION; ELONGATION; FACT; EVICTION; PROMOTER; PROTEIN	Rtt109p, a histone acetyltransferase, associates with active genes and acetylates lysine 56 on histone H3 in Saccharomyces cerevisiae. However, the functional role of Rtt109p or H3 Lys(56) acetylation in chromatin assembly/disassembly (and hence gene expression) immediately switching transcription on or off has not been clearly elucidated in vivo. Here, we show that Rtt109p promotes the eviction of histone H3 from a fast inducible yeast gene, GAL1, following transcriptional initiation via histone H3 Lys(56) acetylation. Conversely, the deposition of histone H3 to GAL1 is significantly decreased in the presence of Rtt109p following transcriptional termination. Intriguingly, we also find that the deposition of histone H2B on preexisting non-acetylated histone H3 Lys(56) at GAL1 in Delta rtt109 is significantly increased independently of histone H3 deposition immediately following transcriptional termination subsequent to a short induction. Consistently, histone H2B is not efficiently evicted from GAL1 in the absence of Rtt109p immediately following transcriptional induction. Furthermore, we show that the stimulated eviction or reduced deposition of histones by Rtt109p promotes the association of RNA polymerase II with GAL1 and hence the synthesis of GAL1 mRNA. These results, taken together, support the fact that Rtt109p regulates the deposition/eviction of histone H2B in addition to its role in stimulating histone H3 eviction, thus providing insight into chromatin assembly/disassembly and hence gene expression in vivo.	[Durairaj, Geetha; Chaurasia, Priyasri; Lahudkar, Shweta; Malik, Shivani; Shukla, Abhijit; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu			National Institutes of Health [1R15GM088798-01]; American Heart Association [0635008N, 0710187Z]; American Cancer Society [06-52]; Mallinckrodt Foundation; Southern Illinois University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); Mallinckrodt Foundation; Southern Illinois University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01. This work was also supported by American Heart Association National Scientist Development Grant 0635008N, American Cancer Society Research Scholar Grant 06-52, a Mallinckrodt Foundation award, and several internal grants from Southern Illinois University.; Supported by American Heart Association Predoctoral Fellowship 0710187Z. Present address: Dept. of Pathology, Massachusetts General Hospital and Harvard Medical School, Richard B Simches Bldg., 185 Cambridge St., Boston, MA 02114.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; da Rosa JL, 2010, P NATL ACAD SCI USA, V107, P1594, DOI 10.1073/pnas.0912427107; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Korber P, 2004, MOL CELL BIOL, V24, P10965, DOI 10.1128/MCB.24.24.10965-10974.2004; Lin CQ, 2008, STRUCTURE, V16, P1503, DOI 10.1016/j.str.2008.07.006; Lin WC, 2006, CURR OPIN GENET DEV, V16, P137, DOI 10.1016/j.gde.2006.02.002; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Malik S, 2010, FEBS J, V277, P1805, DOI 10.1111/j.1742-4658.2010.07607.x; Malik S, 2009, J BIOL CHEM, V284, P35714, DOI 10.1074/jbc.M109.035709; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Ohsawa R, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-11; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Shukla A, 2009, J MOL BIOL, V389, P238, DOI 10.1016/j.jmb.2009.04.018; Stavropoulos P, 2008, P NATL ACAD SCI USA, V105, P12236, DOI 10.1073/pnas.0805813105; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Varv S, 2010, MOL CELL BIOL, V30, P1467, DOI 10.1128/MCB.01151-09; Watanabe S, 2010, BBA-GENE REGUL MECH, V1799, P480, DOI 10.1016/j.bbagrm.2010.01.009; Williams G, 2007, SIGHT SOUND, V17, P88; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yang JH, 2010, DNA REPAIR, V9, P414, DOI 10.1016/j.dnarep.2009.12.022	54	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30472	30479		10.1074/jbc.M110.113225	http://dx.doi.org/10.1074/jbc.M110.113225			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20668333	Green Published, hybrid			2022-12-27	WOS:000282135500014
J	Mooney, SM; Goel, A; D'Assoro, AB; Salisbury, JL; Janknecht, R				Mooney, Steven M.; Goel, Apollina; D'Assoro, Antonino B.; Salisbury, Jeffrey L.; Janknecht, Ralf			Pleiotropic Effects of p300-mediated Acetylation on p68 and p72 RNA Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ER81; ETS PROTEIN ER81; ESTROGEN-RECEPTOR-ALPHA; CREB-BINDING-PROTEIN; DEAD-BOX PROTEINS; BREAST-CANCER; PROSTATE-CANCER; COLORECTAL-CANCER; ANDROGEN RECEPTOR; CELL-GROWTH	Here, we demonstrate that p68 (DDX5) and p72 (DDX17), two homologous RNA helicases and transcriptional cofactors, are substrates for the acetyltransferase p300 in vitro and in vivo. Mutation of acetylation sites affected the binding of p68/p72 to histone deacetylases, but not to p300 or estrogen receptor. Acetylation additionally increased the stability of p68 and p72 RNA helicase and stimulated their ability to coactivate the estrogen receptor, thereby potentially contributing to its aberrant activation in breast tumors. Also, acetylation of p72, but not of p68 RNA helicase, enhanced p53-dependent activation of the MDM2 promoter, pointing at another mechanism of how p72 acetylation may facilitate carcinogenesis by boosting the negative p53-MDM2 feedback loop. Furthermore, blocking p72 acetylation caused cell cycle arrest and apoptosis, revealing an essential role for p72 acetylation. In conclusion, our report has identified for the first time that acetylation modulates RNA helicases and provides multiple mechanisms how acetylation of p68 and p72 may affect normal and tumor cells.	[Janknecht, Ralf] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Mayo Clinic	Janknecht, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St,Biomed Res Ctr BRC-1464, Oklahoma City, OK 73104 USA.	ralf-janknecht@ouhsc.edu		Salisbury, Jeffrey/0000-0001-9257-4578; Janknecht, Ralf/0000-0003-1741-1562	Dept. of Defense [W81XWH-06-1-0492]	Dept. of Defense(United States Department of Defense)	This work was supported by Grant W81XWH-06-1-0492 from the Dept. of Defense Breast Cancer Research Program.	Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; BENLEVY R, 1994, EMBO J, V13, P3302, DOI 10.1002/j.1460-2075.1994.tb06632.x; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Bosc DG, 2002, J CELL BIOCHEM, V86, P174, DOI 10.1002/jcb.10205; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Castoria G, 2008, FRONT BIOSCI-LANDMRK, V13, P1318, DOI 10.2741/2764; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Haro L, 2005, GENOMICS, V85, P493, DOI 10.1016/j.ygeno.2004.12.003; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Endoh H, 1999, MOL CELL BIOL, V19, P5363; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fuchs B, 2004, CLIN CANCER RES, V10, P1344, DOI 10.1158/1078-0432.CCR-03-0038; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Goodman RH, 2000, GENE DEV, V14, P1553; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Hall PS, 2009, EUR J CANCER, V45, P12, DOI 10.1016/j.ejca.2008.10.013; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Janknecht R, 2002, HISTOL HISTOPATHOL, V17, P657, DOI 10.14670/HH-17.657; Janknecht R, 1996, CURR BIOL, V6, P951, DOI 10.1016/S0960-9822(02)00636-X; Janknecht R, 2001, J BIOL CHEM, V276, P41856, DOI 10.1074/jbc.M106630200; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Kapitanovic S, 1997, GASTROENTEROLOGY, V112, P1103, DOI 10.1016/S0016-5085(97)70120-3; Kim TD, 2008, BIOCHEM BIOPH RES CO, V366, P563, DOI 10.1016/j.bbrc.2007.12.013; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Lamm GM, 1996, NUCLEIC ACIDS RES, V24, P3739, DOI 10.1093/nar/24.19.3739; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; MONTE D, 1995, ONCOGENE, V11, P771; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Nishio Y, 2006, UROLOGY, V68, P110, DOI 10.1016/j.urology.2006.01.060; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P721, DOI 10.1677/erc.1.00857; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Osako T, 1998, ONCOLOGY-BASEL, V55, P548, DOI 10.1159/000011911; Osman I, 2005, J UROLOGY, V174, P2174, DOI 10.1097/01.ju.0000181205.23233.65; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Papoutsopoulou S, 2000, MOL CELL BIOL, V20, P7300, DOI 10.1128/MCB.20.19.7300-7310.2000; Park DI, 2007, INT J COLORECTAL DIS, V22, P491, DOI 10.1007/s00384-006-0192-8; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Rossow KL, 2001, CANCER RES, V61, P2690; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Shin S, 2007, J CELL BIOCHEM, V101, P1252, DOI 10.1002/jcb.21250; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Shin S, 2008, J CELL BIOCHEM, V105, P866, DOI 10.1002/jcb.21884; Signoretti S, 2000, JNCI-J NATL CANCER I, V92, P1918, DOI 10.1093/jnci/92.23.1918; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Warner DR, 2004, BIOCHEM BIOPH RES CO, V324, P70, DOI 10.1016/j.bbrc.2004.09.017; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang L, 2007, ONCOGENE, V26, P6082, DOI 10.1038/sj.onc.1210427; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	82	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30443	30452		10.1074/jbc.M110.143792	http://dx.doi.org/10.1074/jbc.M110.143792			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663877	Green Published, hybrid			2022-12-27	WOS:000282135500011
J	Seo, N; Russell, BH; Rivera, JJ; Liang, XW; Xu, XJ; Afshar-Kharghan, V; Hook, M				Seo, Neungseon; Russell, Brooke H.; Rivera, Jose J.; Liang, Xiaowen; Xu, Xuejun; Afshar-Kharghan, Vahid; Hoeoek, Magnus			An Engineered alpha 1 Integrin-binding Collagenous Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; GLYCOPROTEIN-VI; SCL2 PROTEINS; IN-VIVO; ALPHA(2)BETA(1); ALPHA(1)BETA(1); ALPHA-2-BETA-1; RECOGNITION; ACTIVATION; RECEPTORS	Collagen is an extracellular matrix structural component that can regulate cellular processes through its interaction with the integrins, alpha 1 beta 1, alpha 2 beta 1, alpha 10 beta 1, and alpha 11 beta 1. Collagen-like proteins have been identified in a number of bacterial species. Here, we used Scl2 from Streptococcus pyogenes serotype M28 strain MGAS6274 as a backbone for the introduction of discrete integrin-binding sequences. The introduced sequences GLPGER, GFPGER, or GFPGEN did not affect triple helix stability of the Scl (Streptococcal collagen-like) protein. Using ELISA and surface plasmon resonance, we determined that Scl2(GLPGER) and Scl2(GFPGER) bound to recombinant human alpha 1 and alpha 2 I-domains in a metal ion-dependent manner and without a requirement for hydroxyproline. We predicted a novel and selective integrin-binding sequence, GFPGEN, through the use of computer modeling and demonstrated that Scl2(GFPGEN) shows specificity toward the alpha 1 I-domain and does not bind the alpha 2 I-domain. Using C2C12 cells, we determined that intact integrins interact with the modified Scl2 proteins with the same selectivity as recombinant I-domains. These modified Scl2 proteins also acted as cell attachment substrates for fibroblast, endothelial, and smooth muscle cells. However, the modified Scl2 proteins were unable to aggregate platelets. These results indicate that Scl2 is a suitable backbone for the introduction of mammalian integrin-binding sequences, and these sequences may be manipulated to individually target alpha 1 beta 1 and alpha 2 beta 1.	[Seo, Neungseon; Russell, Brooke H.; Rivera, Jose J.; Liang, Xiaowen; Xu, Xuejun; Hoeoek, Magnus] Texas A&M Univ Syst Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Inst Biosci & Technol, Houston, TX 77030 USA; [Afshar-Kharghan, Vahid] MD Anderson Canc Ctr, Program Hematol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center	Hook, M (corresponding author), 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mhook@ibt.tamhsc.edu		Liang, Xiaowen/0000-0002-6174-2951				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bella J, 2000, STRUCTURE, V8, pR121, DOI 10.1016/S0969-2126(00)00153-2; BURKEL WE, 1989, MED PROG TECHNOL, V14, P165; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Cosemans JMEM, 2008, J THROMB HAEMOST, V6, P1253, DOI 10.1111/j.1538-7836.2008.03041.x; COSGRIFFHERNAND.E, 2010, ACTA BIOMAT IN PRESS; Deb A, 2004, CIRCULATION, V110, P2673, DOI 10.1161/01.CIR.0000139842.15651.B2; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farndale RW, 2007, J THROMB HAEMOST, V5, P220, DOI 10.1111/j.1538-7836.2007.02521.x; Graf K, 2003, J CARDIOVASC PHARM, V41, P89, DOI 10.1097/00005344-200301000-00012; Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Hoe NP, 2007, FEMS MICROBIOL LETT, V277, P142, DOI 10.1111/j.1574-6968.2007.00955.x; Hulmes DJS, 1992, ESSAYS BIOCHEM, V27, P49; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; JIMENEZ SA, 1973, J BIOL CHEM, V248, P720; Kadler KE, 1996, BIOCHEM J, V316, P1; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Karlstrom A, 2004, VET MICROBIOL, V104, P179, DOI 10.1016/j.vetmic.2004.09.014; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Munnix ICA, 2008, J THROMB HAEMOST, V6, P2132, DOI 10.1111/j.1538-7836.2008.03167.x; Ogle BM, 1999, TISSUE ENG, V5, P387, DOI 10.1089/ten.1999.5.387; Peng YY, 2010, BIOMATERIALS, V31, P2755, DOI 10.1016/j.biomaterials.2009.12.040; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Pozzi M, 1998, J CELL BIOL, V142, P587; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; San Antonio JD, 2009, AM J PATHOL, V175, P1338, DOI 10.2353/ajpath.2009.090234; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	43	49	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31046	31054		10.1074/jbc.M110.151357	http://dx.doi.org/10.1074/jbc.M110.151357			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20675378	hybrid, Green Published			2022-12-27	WOS:000282135500069
J	Tago, K; Funakoshi-Tago, M; Sakinawa, M; Mizuno, N; Itoh, H				Tago, Kenji; Funakoshi-Tago, Megumi; Sakinawa, Masaki; Mizuno, Norikazu; Itoh, Hiroshi			kappa B-Ras Is a Nuclear-Cytoplasmic Small GTPase That Inhibits NF-kappa B Activation through the Suppression of Transcriptional Activation of p65/RelA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-1 MSK1; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; MOLECULAR SWITCH; ARF6 RECRUITS; BINDING; P65; STIMULATION; ONCOGENES; SUBUNIT	NF-kappa B is an important transcription factor involved in various biological responses, including inflammation, cell differentiation, and tumorigenesis. kappa B-Ras was identified as an I kappa B-interacting small GTPase and is reported to disturb cytokine-induced NF-kappa B activation. In this study, we established that kappa B-Ras is a novel type of nuclear-cytoplasmic small GTPase that mainly binds to GTP, and its localization seemed to be regulated by its GTP/GDP-binding state. Unexpectedly, the GDP-binding form of the kappa B-Ras mutant exhibited a more potent inhibitory effect on NF-kappa B activation, and this inhibitory effect seemed to be due to suppression of the transactivation of a p65/RelA NF-kappa B subunit. kappa B-Ras suppressed phosphorylation at serine 276 on the p65/RelA subunit, resulting in decreased interaction between p65/RelA and the transcriptional coactivator p300. Interestingly, the GDP-bound kappa B-Ras mutant exhibited higher interactive affinity with p65/RelA and inhibited the phosphorylation of p65/RelA more potently than wild-type kappa B-Ras. Taken together, these findings suggest that the GDP-bound form of kappa B-Ras in cytoplasm suppresses NF-kappa B activation by inhibiting its transcriptional activation.	[Tago, Kenji; Sakinawa, Masaki; Mizuno, Norikazu; Itoh, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Lab Signal Transduct, Nara 6300192, Japan; [Funakoshi-Tago, Megumi] Keio Univ, Fac Pharm, Dept Biochem, Minato Ku, Tokyo 1058512, Japan	Nara Institute of Science & Technology; Keio University	Tago, K (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Lab Signal Transduct, 8916-5 Takayama, Nara 6300192, Japan.	ktago@bs.naist.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20770103]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 20770103 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BOS JL, 1989, CANCER RES, V49, P4682; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Chen Y, 2004, MOL CELL BIOL, V24, P3048, DOI 10.1128/MCB.24.7.3048-3056.2004; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; DOBRZANSKI P, 1993, MOL CELL BIOL, V13, P1572, DOI 10.1128/MCB.13.3.1572; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fenwick C, 2000, SCIENCE, V287, P869, DOI 10.1126/science.287.5454.869; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P662, DOI 10.1016/j.bcp.2008.06.015; Furusawa JI, 2009, CELL SIGNAL, V21, P778, DOI 10.1016/j.cellsig.2009.01.021; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; JOHN J, 1993, J BIOL CHEM, V268, P923; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; SATOH T, 1992, J BIOL CHEM, V267, P25423; SATOH T, 1992, J BIOL CHEM, V267, P24149; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sonoda Y, 1997, J BIOL CHEM, V272, P15366, DOI 10.1074/jbc.272.24.15366; Takahashi N, 2002, EUR J BIOCHEM, V269, P4559, DOI 10.1046/j.1432-1033.2002.03157.x; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; TORTI M, 1992, J BIOL CHEM, V267, P8293; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	45	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30622	30633		10.1074/jbc.M110.117028	http://dx.doi.org/10.1074/jbc.M110.117028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20639196	Green Published, hybrid			2022-12-27	WOS:000282135500031
J	Crespo, PM; Demichelis, VT; Daniotti, JL				Crespo, Pilar M.; Torres Demichelis, Vanina; Daniotti, Jose L.			Neobiosynthesis of Glycosphingolipids by Plasma Membrane-associated Glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR PHOSPHORYLATION; TRANS-GOLGI NETWORK; ANCHORED PROTEINS; APICAL SURFACE; GANGLIOSIDE; CELLS; GD3; MODULATION; SYNTHASE; MOUSE	Gangliosides, complex glycosphingolipids containing sialic acids, are synthesized in the endoplasmic reticulum and in the Golgi complex. These neobiosynthesized gangliosides move via vesicular transport to the plasma membrane, becoming components of the external leaflet. Gangliosides can undergo endocytosis followed by recycling to the cell surface or sorting to the Golgi complex or lysosomes for remodeling and catabolism. Recently, glycosphingolipid catabolic enzymes (glycohydrolases) have been found to be associated with the plasma membrane, where they display activity on the membrane components. In this work, we demonstrated that ecto-ganglioside glycosyltransferases may catalyze ganglioside synthesis outside the Golgi compartment, particularly at the cell surface. Specifically, we report the first direct evidence of expression and activity of CMP-NeuAc: GM3 sialyltransferase (Sial-T2) at the cell surface of epithelial and melanoma cells, with membrane-integrated ecto-Sial-T2 being able to sialylate endogenously synthesized GM3 ganglioside as well as exogenously incorporated substrate. Interestingly, we also showed that ecto-Sial-T2 was able to synthesize GD3 ganglioside at the cell surface using the endogenously synthesized cytidine monophospho-N-acetylneuraminic acid (CMP-NeuAc) available at the extracellular milieu. In addition, the expression of UDP-GalNAc: LacCer/GM3/GD3 N-acetylgalactosaminyltransferase (GalNAc-T) was also detected at the cell surface of epithelial cells, whose catalytic activity was only observed after feeding the cells with exogenous GM3 substrate. Thus, the relative interplay between the plasma membrane-associated glycosyltransferase and glycohydrolase activities, even when acting on a common substrate, emerges as a potential level of regulation of the local glycosphingolipid composition in response to different external and internal stimuli.	[Crespo, Pilar M.; Torres Demichelis, Vanina; Daniotti, Jose L.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, CONICET,CIQUIBIC,Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Daniotti, JL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, CONICET,CIQUIBIC,Dept Quim Biol, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	daniotti@dqb.fcq.unc.edu.ar			Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina; CONICET (Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by Grants from Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), and Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, Argentina.; <SUP>2</SUP>Recipient of CONICET (Argentina) Fellowships.; <SUP>3</SUP>Recipient of ANPCyT Fellowships.	Aureli M, 2009, FEBS LETT, V583, P2469, DOI 10.1016/j.febslet.2009.06.048; BEGOVAC PC, 1994, J BIOL CHEM, V269, P31793; COATES SW, 1980, J BIOL CHEM, V255, P9225; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Crespo PM, 2004, J BIOL CHEM, V279, P47610, DOI 10.1074/jbc.M407181200; Crespo PM, 2004, BIOCHEM J, V377, P561, DOI 10.1042/BJ20031016; Crespo PM, 2002, J BIOL CHEM, V277, P44731, DOI 10.1074/jbc.M204604200; Daniotti JL, 2000, J NEUROCHEM, V74, P1711, DOI 10.1046/j.1471-4159.2000.0741711.x; Daniotti JL, 2006, J CELL BIOCHEM, V99, P1442, DOI 10.1002/jcb.21034; DE MATTEIS MA, 2008, NAT REV MOL CELL BIO, V9, P273; DURRIE R, 1988, BIOCHEMISTRY-US, V27, P3759, DOI 10.1021/bi00410a036; Giraudo CG, 1999, BIOCHEM J, V342, P633, DOI 10.1042/0264-6021:3420633; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gross HJ, 1996, BLOOD, V87, P5113, DOI 10.1182/blood.V87.12.5113.bloodjournal87125113; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; Iwamori M, 2005, GLYCOCONJUGATE J, V22, P119, DOI 10.1007/s10719-005-0363-9; Kean EL, 2004, BBA-GEN SUBJECTS, V1673, P56, DOI 10.1016/j.bbagen.2004.04.006; KOPITZ J, 1994, BIOCHEM BIOPH RES CO, V199, P1188, DOI 10.1006/bbrc.1994.1356; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Li RX, 2000, J BIOL CHEM, V275, P34213, DOI 10.1074/jbc.M906368199; Maccioni HJF, 1999, BBA-MOL CELL BIOL L, V1437, P101, DOI 10.1016/S1388-1981(99)00002-5; MARTIN OC, 1987, J BIOL CHEM, V262, P5890; Martina JA, 1998, J BIOL CHEM, V273, P3725, DOI 10.1074/jbc.273.6.3725; MATSUI Y, 1986, J NEUROCHEM, V46, P144, DOI 10.1111/j.1471-4159.1986.tb12937.x; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mencarelli S, 2005, FEBS LETT, V579, P5501, DOI 10.1016/j.febslet.2005.08.081; MILJAN EA, 2002, SCI STKE, pRE15; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; PARSONS NJ, 1993, MICROB PATHOGENESIS, V14, P329, DOI 10.1006/mpat.1993.1032; PODBILEWICZ B, 1990, EMBO J, V9, P3477, DOI 10.1002/j.1460-2075.1990.tb07556.x; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; PRETI A, 1980, J NEUROCHEM, V35, P281, DOI 10.1111/j.1471-4159.1980.tb06263.x; Prinetti A, 2007, J NEUROCHEM, V103, P113, DOI 10.1111/j.1471-4159.2007.04714.x; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; Raychoudhury SS, 1997, BIOL REPROD, V56, P1268, DOI 10.1095/biolreprod56.5.1268; Saraste J, 2009, FEBS LETT, V583, P3804, DOI 10.1016/j.febslet.2009.10.084; Smalley KSM, 2001, BRIT J PHARMACOL, V132, P1102, DOI 10.1038/sj.bjp.0703896; Smith H, 1995, MICROB PATHOGENESIS, V19, P365, DOI 10.1006/mpat.1995.0071; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; Tveit H, 2009, TRAFFIC, V10, P1685, DOI 10.1111/j.1600-0854.2009.00984.x; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; VAN MEER G, 2002, J BIOL CHEM, V277, P25855; VAN MEER G, 2000, BBA-MOL CELL BIOL L, V1486, P145; Yu RK, 2004, J LIPID RES, V45, P783, DOI 10.1194/jlr.R3000020-JLR200; Zhao W, 2006, J BIOL CHEM, V281, P31106, DOI 10.1074/jbc.M605564200; Zurita AR, 2001, BIOCHEM J, V355, P465, DOI 10.1042/0264-6021:3550465; Zurita AR, 2004, EUR J BIOCHEM, V271, P2428, DOI 10.1111/j.1432-1033.2004.04165.x	53	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29179	29190		10.1074/jbc.M110.123422	http://dx.doi.org/10.1074/jbc.M110.123422			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20639193	hybrid, Green Published			2022-12-27	WOS:000281740100018
J	Malhotra, N; Robertson, E; Kang, J				Malhotra, Nidhi; Robertson, Elizabeth; Kang, Joonsoo			SMAD2 Is Essential for TGF beta-mediated Th17 Cell Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; T-CELLS; T(H)17; DIFFERENTIATION; PLASTICITY; PROMOTES	TGF beta is the quintessential cytokine of T cell homeostasis. TGF beta signaling is required for the efficient differentiation and maintenance of CD4(+)FOXP3(+) T cells that inhibit immune responses. Conversely, in conjunction with the inflammatory cytokine IL-6, TGF beta promotes Th17 cell differentiation. The mechanism by which TGF beta signals synergize with IL-6 to generate inflammatory versus immunosuppressive T cell subsets is unclear. TGF beta signaling activates receptor SMADs, SMAD2 and SMAD3, which associate with a variety of nuclear factors to regulate gene transcription. Defining relative contributions of distinct SMAD molecules for CD4 T cell differentiation is critical for mapping the versatile intracellular TGF beta-signaling pathways that tailor TGF beta activities to the state of host interaction with pathogens. We show here that SMAD2 is essential for Th17 cell differentiation and that it acts in part by modulating the expression of IL-6R on T cells. Although mice lacking SMAD2 specifically in T cells do not develop spontaneous lymphoproliferative autoimmunity, Smad2-deficient T cells are impaired in their response to TGF beta in vitro and in vivo, and they are more pathogenic than controls when transferred into lymphopenic mice. These results demonstrate that SMAD2 is uniquely essential for TGF beta signaling in CD4(+) T effector cell differentiation.	[Malhotra, Nidhi; Kang, Joonsoo] Univ Massachusetts, Grad Program Immunol & Virol, Dept Pathol, Sch Med, Worcester, MA 01655 USA; [Robertson, Elizabeth] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Massachusetts System; University of Massachusetts Worcester; University of Oxford	Kang, J (corresponding author), Univ Massachusetts, Grad Program Immunol & Virol, Dept Pathol, Sch Med, 55 Lake Ave N,S3-137, Worcester, MA 01655 USA.	Joonsoo.Kang@umassmed.edu		kang, joonsoo/0000-0001-8419-7995	National Institutes of Health [RO1 AI054670]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI054670 (to J. K.).; We thank Dr. R. Flavell for providing the Smad2<SUP>fl/fl</SUP> mice. We also thank the University of Massachusetts Medical School Flow Cytometry Core Facility staff for cell sorting, Dr. J. Leong and E. Mallick for assistance with C. rodentium infections, Dr. A. Mizoguchi for advice in colonic lymphocyte isolations, Anurag Gupta for technical assistance, and members of the Kang laboratory for advice and comments on the manuscript. Core resources supported by the Diabetes Endocrinology Research Center Grant DK32520 were used for this work.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Huber S, 2009, J IMMUNOL, V182, P4633, DOI 10.4049/jimmunol.0803143; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mizoguchi A, 1996, J EXP MED, V183, P847, DOI 10.1084/jem.183.3.847; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	23	63	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29044	29048		10.1074/jbc.C110.156745	http://dx.doi.org/10.1074/jbc.C110.156745			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20656683	Green Published, hybrid			2022-12-27	WOS:000281740100004
J	Batabyal, D; McKenzie, JL; Johnson, KA				Batabyal, Dipanwita; McKenzie, Jessica L.; Johnson, Kenneth A.			Role of Histidine 932 of the Human Mitochondrial DNA Polymerase in Nucleotide Discrimination and Inherited Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HIV REVERSE-TRANSCRIPTASE; NUCLEOSIDE ANALOGS; CRYSTAL-STRUCTURE; ALPERS-SYNDROME; KINETIC-DATA; INDUCED-FIT; REPLICATION; MUTATIONS; FIDELITY	The human mitochondrial DNA polymerase (pol gamma) is nuclearly encoded and is solely responsible for the replication and repair of the mitochondrial genome. The progressive accumulation of mutations within the mitochondrial genome is thought to be related to aging, and mutations in the pol gamma gene are responsible for numerous heritable disorders including progressive external opthalmoplegia, Alpers syndrome, and parkinsonism. Here we investigate the kinetic effect of H932Y, a mutation associated with opthalmoplegia. Mutations H932Y and H932A reduce the specificity constant governing correct nucleotide incorporation 150- and 70-fold, respectively, without significantly affecting fidelity of incorporation or the maximum rate of incorporation. However, this leads to only a 2-fold reduction in rate of incorporation at a physiological nucleotide concentration (similar to 100 mu M). Surprisingly, incorporation of T: T or C: T mismatches catalyzed by either H932Y or H932A mutants was followed by slow pyrophosphate release (or fast pyrophosphate rebinding). Also, H932Y readily catalyzed incorporation of multiple mismatches, which may have a profound physiological impact over time. His-932 is thought to contact the beta-phosphate of the incoming nucleotide, so it is perhaps surprising that H932Y appears to slow rather than accelerate pyrophosphate release.	[Batabyal, Dipanwita; McKenzie, Jessica L.; Johnson, Kenneth A.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu			National Institutes of Health [R01 GM 044613]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 044613 (to K. A. J.). This work was also supported by the Welch Foundation (F-1604) to K. A. J.).	Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316; Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Roitberg AE, 2007, J PHYS CHEM B, V111, P2415, DOI 10.1021/jp068335b; STEITZ TA, 1993, COLD SPRING HARB SYM, V58, P495, DOI 10.1101/SQB.1993.058.01.056; Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; Truniger V, 2002, NUCLEIC ACIDS RES, V30, P1483, DOI 10.1093/nar/30.7.1483; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200	35	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34191	34201		10.1074/jbc.M110.156182	http://dx.doi.org/10.1074/jbc.M110.156182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20685647	Green Published, hybrid			2022-12-27	WOS:000283354000064
J	Clapp, KM; Peng, HM; Morishima, Y; Lau, M; Walker, VJ; Pratt, WB; Osawa, Y				Clapp, Kelly M.; Peng, Hwei-Ming; Morishima, Yoshihiro; Lau, Miranda; Walker, Vyvyca J.; Pratt, William B.; Osawa, Yoichi			C331A Mutant of Neuronal Nitric-oxide Synthase Is Labilized for Hsp70/CHIP (C Terminus of HSC70-interacting Protein)-dependent Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90/HSP70-BASED CHAPERONE MACHINERY; DEPENDENT E3 LIGASE; SYSTEM IN-VIVO; PROTEOLYTIC DEGRADATION; CYTOCHROME-P450 2E1; ESCHERICHIA-COLI; PROSTHETIC HEME; CHIP; PROTEIN; ENZYME	It is established that suicide inactivation of neuronal nitricoxide synthase (nNOS) by drugs and other xenobiotics leads to ubiquitination and proteasomal degradation of the enzyme. The exact mechanism is not known, although it is widely thought that the covalent alteration of the active site during inactivation triggers the degradation. A mechanism that involves recognition of the altered nNOS by Hsp70 and its cochaperone CHIP, an E3-ubiquitin ligase, has been proposed. To further address how alterations of the active site trigger ubiquitination of nNOS, we examined a C331A nNOS mutant, which was reported to have impaired ability to bind L-arginine and tetrahydrobiopterin. We show here that C331A nNOS is highly susceptible to ubiquitination by a purified system containing ubiquitinating enzymes and chaperones, by the endogenous ubiquitinating system in reticulocyte lysate fraction II, and by intact HEK293 cells. The involvement of the altered heme cleft in regulating ubiquitination is confirmed by the finding that the slowly reversible inhibitor of nNOS, NG-nitro-L-arginine, but not its inactive D-isomer, protects the C331A nNOS from ubiquitination in all these experimental systems. We also show that both Hsp70 and CHIP play a major role in the ubiquitination of C331A nNOS, although Hsp90 protects from ubiquitination. Thus, these studies further strengthen the link between the mobility of the substrate-binding cleft and chaperone-dependent ubiquitination of nNOS. These results support a general model of chaperone-mediated protein quality control and lead to a novel mechanism for substrate stabilization based on nNOS interaction with the chaperone machinery.	[Clapp, Kelly M.; Peng, Hwei-Ming; Morishima, Yoshihiro; Lau, Miranda; Walker, Vyvyca J.; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Osawa, Y (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	osawa@umich.edu			National Institutes of Health [GM077430, DA022354]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM077430 and DA022354.	Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 2000, J BIOL CHEM, V275, P26018, DOI 10.1074/jbc.275.34.26018; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; DEMONTELLANO PRO, 1990, PHARMACOL THERAPEUT, V48, P95, DOI 10.1016/0163-7258(90)90020-3; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dunbar AY, 2006, DRUG METAB DISPOS, V34, P1448, DOI 10.1124/dmd.106.009951; Dunbar AY, 2004, MOL PHARMACOL, V66, P964, DOI 10.1124/mol.104.000125; Hemmens B, 1998, BIOCHEM J, V332, P337, DOI 10.1042/bj3320337; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kamada Y, 2005, MOL BRAIN RES, V142, P19, DOI 10.1016/j.molbrainres.2005.09.003; Kanelakis KC, 2003, METHOD ENZYMOL, V364, P159; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Martasek P, 1998, J BIOL CHEM, V273, P34799, DOI 10.1074/jbc.273.52.34799; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Morishima Y, 2003, J BIOL CHEM, V278, P48754, DOI 10.1074/jbc.M309814200; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Noguchi S, 2000, J BIOL CHEM, V275, P2376, DOI 10.1074/jbc.275.4.2376; OSAWA Y, 1991, J BIOL CHEM, V266, P3208; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; OSAWA Y, 1993, J BIOL CHEM, V268, P2953; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; PERNECKY SJ, 1993, P NATL ACAD SCI USA, V90, P2651, DOI 10.1073/pnas.90.7.2651; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; SCHMIDT HHHW, 1992, MOL PHARMACOL, V41, P615; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; TIERNEY DJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P9, DOI 10.1016/0003-9861(92)90358-4; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	43	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33642	33651		10.1074/jbc.M110.159178	http://dx.doi.org/10.1074/jbc.M110.159178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729196	Green Published, hybrid			2022-12-27	WOS:000283354000009
J	Debeurme, F; Picciocchi, A; Dagher, MC; Grunwald, D; Beaumel, S; Fieschi, F; Stasia, MJ				Debeurme, Franck; Picciocchi, Antoine; Dagher, Marie-Claire; Grunwald, Didier; Beaumel, Sylvain; Fieschi, Franck; Stasia, Marie-Jose			Regulation of NADPH Oxidase Activity in Phagocytes RELATIONSHIP BETWEEN FAD/NADPH BINDING AND OXIDASE COMPLEX ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SITE-DIRECTED MUTAGENESIS; CELL-FREE SYSTEM; FLAVOCYTOCHROME B(558); CYTOCHROME B(558); ESCHERICHIA-COLI; NOX-FAMILY; FERREDOXIN-NADP(+) REDUCTASE; FUNCTIONAL-ANALYSIS; GP91(PHOX) SUBUNIT	The X+-linked chronic granulomatous disease (X+-CGD) variants are natural mutants characterized by defective NADPH oxidase activity but with normal Nox2 expression. According to the three-dimensional model of the cytosolic Nox2 domain, most of the X+-CGD mutations are located in/or close to the FAD/NADPH binding regions. A structure/function study of this domain was conducted in X+-CGD PLB-985 cells exactly mimicking 10 human variants: T341K, C369R, G408E, G408R, P415H, P415L, Delta 507QKT509-HIW Ainsert, C537R, L546P, and E568K. Diaphorase activity is defective in all these mutants. NADPH oxidase assembly is normal for P415H/P415L and T341K mutants where mutation occurs in the consensus sequences of NADPH-and FAD-binding sites, respectively. This is in accordance with their buried position in the three-dimensional model of the cytosolic Nox2 domain. FAD incorporation is abolished only in the T341K mutant explaining its absence of diaphorase activity. This demonstrates that NADPH oxidase assembly can occur without FAD incorporation. In addition, a defect of NADPH binding is a plausible explanation for the diaphorase activity inhibition in the P415H, P415L, and C537R mutants. In contrast, Cys-369, Gly-408, Leu-546, and Glu-568 are essential for NADPH oxidase complex assembly. However, according to their position in the three-dimensional model of the cytosolic domain of Nox2, only Cys-369 could be in direct contact with cytosolic factors during oxidase assembly. In addition, the defect in oxidase assembly observed in the C369R, G408E, G408R, and E568K mutants correlates with the lack of FAD incorporation. Thus, the NADPH oxidase assembly process and FAD incorporation are closely related events essential for the diaphorase activity of Nox2.	[Debeurme, Franck; Picciocchi, Antoine; Dagher, Marie-Claire; Beaumel, Sylvain; Stasia, Marie-Jose] Univ Grenoble 1, Univ Hosp Grenoble, Chron Granulomatous Dis Diag & Res Ctr, Therex TIMC Imag UMR CNRS 5525, F-38043 Grenoble 9, France; [Fieschi, Franck] CEA, Inst Biol Struct, F-38027 Grenoble, France; [Fieschi, Franck] CNRS, UMR 5075, F-38027 Grenoble, France; [Fieschi, Franck] Univ Grenoble 1, F-38041 Grenoble, France; [Grunwald, Didier] iRTSV CEA, F-38054 Grenoble 9, France	CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Stasia, MJ (corresponding author), Univ Grenoble 1, Univ Hosp Grenoble, Chron Granulomatous Dis Diag & Res Ctr, Therex TIMC Imag UMR CNRS 5525, F-38043 Grenoble 9, France.	mjstasia@chu-grenoble.fr	beaumel, sylvain/M-7397-2014; DAGHER, Marie-Claire/M-6145-2014; Fieschi, Franck/W-2748-2019; STASIA, Marie José/M-7165-2014	DAGHER, Marie-Claire/0000-0001-6878-3169; STASIA, Marie jose/0000-0003-4466-4880; FIESCHI, Franck/0000-0003-1194-8107	United States Immunodeficiency Network [N01-AI-30070]; Primary Immunodeficiency Disease Consortium; Joseph Fourier University Medical School; Delegation for Clinical Research and Innovations, Grenoble, France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030070] Funding Source: NIH RePORTER	United States Immunodeficiency Network; Primary Immunodeficiency Disease Consortium; Joseph Fourier University Medical School; Delegation for Clinical Research and Innovations, Grenoble, France; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant N01-AI-30070 from United States Immunodeficiency Network and the Primary Immunodeficiency Disease Consortium. This work was also supported by grants from Joseph Fourier University Medical School and the Delegation for Clinical Research and Innovations, Grenoble, France.	ALIVERTI A, 1995, BIOCHEMISTRY-US, V34, P8371, DOI 10.1021/bi00026a019; ALIVERTI A, 1993, BIOCHEMISTRY-US, V32, P6374, DOI 10.1021/bi00076a010; BALBRIDGE CW, 1933, AM J PHYSIOL, V103, P235; Baniulis D, 2005, BBA-PROTEINS PROTEOM, V1752, P186, DOI 10.1016/j.bbapap.2005.07.018; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 1999, J BIOL CHEM, V274, P10451, DOI 10.1074/jbc.274.15.10451; Bionda C, 2004, HUM GENET, V115, P418, DOI 10.1007/s00439-004-1173-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALCATERRA NB, 1995, BIOCHEMISTRY-US, V34, P12842, DOI 10.1021/bi00039a045; COHENTANUGI L, 1991, EUR J BIOCHEM, V202, P649, DOI 10.1111/j.1432-1033.1991.tb16419.x; CROSS AR, 1994, J BIOL CHEM, V269, P21448; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; FILLAT MF, 1990, BIOCHIM BIOPHYS ACTA, V1040, P301, DOI 10.1016/0167-4838(90)90091-S; Hashida S, 2004, J BIOL CHEM, V279, P26378, DOI 10.1074/jbc.M309724200; Henderson LM, 1998, J BIOL CHEM, V273, P33216, DOI 10.1074/jbc.273.50.33216; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; LEUSEN JHW, 1994, J CLIN INVEST, V93, P2120, DOI 10.1172/JCI117207; Leusen JHW, 2000, BLOOD, V95, P666; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Li XJ, 2005, J BIOL CHEM, V280, P14962, DOI 10.1074/jbc.M500226200; Marcoux J, 2010, J BIOL CHEM, V285, P28980, DOI 10.1074/jbc.M110.139824; Miyano K, 2003, BIOCHEMISTRY-US, V42, P184, DOI 10.1021/bi0269052; Niviere V, 1999, J BIOL CHEM, V274, P18252, DOI 10.1074/jbc.274.26.18252; Niviere V, 1996, J BIOL CHEM, V271, P16656, DOI 10.1074/jbc.271.28.16656; Niviere V, 1998, BIOCHEMISTRY-US, V37, P11879, DOI 10.1021/bi980396f; Paclet MH, 2004, BIOCHEM J, V382, P981, DOI 10.1042/BJ20040954; Park MY, 1997, BIOCHEM BIOPH RES CO, V234, P531, DOI 10.1006/bbrc.1997.6672; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Vergnaud S, 2000, EUR J BIOCHEM, V267, P1059, DOI 10.1046/j.1432-1327.2000.01097.x; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Yu LX, 1999, BLOOD, V94, P2497, DOI 10.1182/blood.V94.7.2497.419k11_2497_2504; YUBISUI T, 1991, J BIOL CHEM, V266, P66; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	43	34	37	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33197	33208		10.1074/jbc.M110.151555	http://dx.doi.org/10.1074/jbc.M110.151555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20724480	Green Published, hybrid			2022-12-27	WOS:000283048200057
J	Hu, JJ; Wang, FC; Yuan, Y; Zhu, XQ; Wang, YX; Zhang, Y; Kou, ZH; Wang, SF; Gao, SR				Hu, Jianjun; Wang, Fengchao; Yuan, Ye; Zhu, Xiaoquan; Wang, Yixuan; Zhang, Yu; Kou, Zhaohui; Wang, Shufang; Gao, Shaorong			Novel Importin-alpha Family Member Kpna7 Is Required for Normal Fertility and Fecundity in the Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZYGOTIC GENE ACTIVATION; NUCLEAR-LOCALIZATION SIGNAL; CRYSTAL-STRUCTURE; DNA METHYLATION; PIWI; PIRNAS; CELL; EXPRESSION; CHROMATIN; DIFFERENTIATION	Nuclear importing system and nuclear factors play important roles in mediating nuclear reprogramming and zygotic gene activation. However, the components and mechanisms that mediate nuclearly specific targeting of the nuclear proteins during nuclear reprogramming and zygotic gene activation remain largely unknown. Here, we identified a novel member of the importin-alpha family, AW146299(KPNA7), which is predominantly expressed in mouse oocytes and zygotes and localizes to the nucleus or spindle. Mutation of Kpna7 gene caused reproductivity reduction and sex imbalance by inducing preferential fetal lethality in females. Parthenogenesis analysis showed that the cell cycle of activated one-cell embryos is loss of control and ahead of schedule but finally failed to develop into blastocyst stage. Further RT-PCR and epigenetic modification analysis showed that knocking out of Kpna7 induced abnormalities of gene expression (dppa2, dppa4, and piwil2) and epigenetic modifications (down-regulation of histone H3K27me3). Biochemical analysis showed that KPNA7 interacts with KPNB1 (importin-beta 1). In summary, we identified a novel Kpna7 gene that is required for normal fertility and fecundity.	[Hu, Jianjun; Wang, Fengchao; Yuan, Ye; Zhu, Xiaoquan; Wang, Yixuan; Zhang, Yu; Kou, Zhaohui; Wang, Shufang; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing	Gao, SR (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	gaoshaorong@nibs.ac.cn	wang, yixuan/GXW-2866-2022; Hu, Jianjun/Q-1877-2015; Wang, Yixuan/GZK-6559-2022	Wang, Shufang/0000-0001-5768-9687	Ministry of Science and Technology of China [2008AA022311, 2010CB944900, 2008AA1011005]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the Ministry of Science and Technology of China Grants 2008AA022311, 2010CB944900, and 2008AA1011005.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brinkmann U, 1998, AM J HUM GENET, V62, P509, DOI 10.1086/301773; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Endo T, 2005, MOL REPROD DEV, V71, P123, DOI 10.1002/mrd.20288; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Horn PJ, 2006, CHROMOSOME RES, V14, P83, DOI 10.1007/s10577-005-1018-1; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kavi HH, 2006, TRENDS BIOCHEM SCI, V31, P485, DOI 10.1016/j.tibs.2006.07.002; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Kwon SH, 2008, MOL CELLS, V26, P217; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; LATHAM KE, 1991, DEVELOPMENT, V112, P921; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; Minami N, 2007, J REPROD DEVELOP, V53, P707, DOI 10.1262/jrd.19029; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Obata Y, 2000, HUM REPROD, V15, P874, DOI 10.1093/humrep/15.4.874; Park KE, 2009, MOL REPROD DEV, V76, P1033, DOI 10.1002/mrd.21061; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Solter D, 2004, COLD SPRING HARB SYM, V69, P11, DOI 10.1101/sqb.2004.69.11; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wang SF, 2009, BIOL REPROD, V80, P555, DOI 10.1095/biolreprod.108.073197; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038	52	52	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33113	33122		10.1074/jbc.M110.117044	http://dx.doi.org/10.1074/jbc.M110.117044			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20699224	Green Published, hybrid			2022-12-27	WOS:000283048200049
J	Mosialou, I; Zannis, VI; Kardassis, D				Mosialou, Ioanna; Zannis, Vassilis I.; Kardassis, Dimitris			Regulation of Human Apolipoprotein M Gene Expression by Orphan and Ligand-dependent Nuclear Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; BETA-HDL FORMATION; TRANSCRIPTIONAL REGULATION; CHOLESTEROL EFFLUX; IN-VITRO; PROXIMAL PROMOTER; RESPONSE ELEMENTS; SIGNAL PEPTIDE; PLASMA	Apolipoprotein M (apoM) plays an important role in the biogenesis and the metabolism of anti-atherogenic HDL particles in plasma and is expressed primarily in the liver and the kidney. We investigated the role of hormone nuclear receptors in apoM gene regulation in hepatic cells. Overexpression via adenovirus-mediated gene transfer and siRNA-mediated gene silencing established that hepatocyte nuclear factor 4 (HNF-4) is an important regulator of apoM gene transcription in hepatic cells. apoM promoter deletion analysis combined with DNA affinity precipitation and chromatin immunoprecipitation assays revealed that HNF-4 binds to a hormone-response element (HRE) in the proximal apoM promoter (nucleotides -33 to -21). Mutagenesis of this HRE decreased basal hepatic apoM promoter activity to 10% of control and abolished the HNF4-mediated transactivation of the apoM promoter. In addition to HNF-4, homodimers of retinoid X receptor and heterodimers of retinoid X receptor with receptors for retinoic acid, thyroid hormone, fibrates (peroxisome proliferator-activated receptor), and oxysterols (liver X receptor) were shown to bind with different affinities to the proximal HRE in vitro and in vivo. Ligands of these receptors strongly induced human apoM gene transcription and apoM promoter activity in HepG2 cells, whereas mutations in the proximal HRE abolished this induction. These findings provide novel insights into the role of apoM in the regulation of HDL by steroid hormones and into the development of novel HDL-based therapies for diseases such as diabetes, obesity, metabolic syndrome, and coronary artery disease that affect a large proportion of the population in Western countries.	[Kardassis, Dimitris] Univ Crete, Sch Med, Dept Biochem, Iraklion 71003, Greece; Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71003, Greece; [Zannis, Vassilis I.] Boston Univ, Med Ctr, Mol Genet Sect, Boston, MA 02118 USA	University of Crete; Foundation for Research & Technology - Hellas (FORTH); Boston University	Kardassis, D (corresponding author), Univ Crete, Sch Med, Dept Biochem, Iraklion 71003, Greece.	kardasis@imbb.forth.gr		Zannis, Vassilis/0000-0002-1295-7155	Greek Ministry of Development, General Secretariat for Research and Technology [PENED03-780]; Institute of Molecular Biology and Biotechnology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048739] Funding Source: NIH RePORTER	Greek Ministry of Development, General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Institute of Molecular Biology and Biotechnology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Greek Ministry of Development, General Secretariat for Research and Technology Grant PENED03-780, and by Institute of Molecular Biology and Biotechnology internal funds (to D. K.).	Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Axler O, 2007, J LIPID RES, V48, P1772, DOI 10.1194/jlr.M700113-JLR200; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; Calayir E, 2008, CURR PHARM BIOTECHNO, V9, P516, DOI 10.2174/138920108786786376; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Christoffersen C, 2008, J BIOL CHEM, V283, P18765, DOI 10.1074/jbc.M800695200; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Dahlback B, 2009, CELL MOL LIFE SCI, V66, P559, DOI 10.1007/s00018-009-8764-8; Davidson MH, 2007, AM J CARDIOL, V100, p32N, DOI 10.1016/j.amjcard.2007.08.011; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; Dullaart RPF, 2009, CLIN CHIM ACTA, V406, P129, DOI 10.1016/j.cca.2009.06.010; Feingold KR, 2008, ATHEROSCLEROSIS, V199, P19, DOI 10.1016/j.atherosclerosis.2007.10.007; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hao GQ, 2007, CLIN BIOCHEM, V40, P1108, DOI 10.1016/j.clinbiochem.2007.04.023; Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Houck KA, 2004, MOL GENET METAB, V83, P184, DOI 10.1016/j.ymgme.2004.07.007; Hu YW, 2010, BBA-MOL CELL BIOL L, V1801, P100, DOI 10.1016/j.bbalip.2009.10.013; Kardassis D, 1997, ARTERIOSCL THROM VAS, V17, P222, DOI 10.1161/01.ATV.17.1.222; Kardassis D., 2007, HIGH DENSITY LIPOPRO, P237; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; KRITIS AA, 1993, NUCLEIC ACIDS RES, V21, P5882, DOI 10.1093/nar/21.25.5882; Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lavrentiadou SN, 1999, BIOCHEMISTRY-US, V38, P964, DOI 10.1021/bi981068i; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MILLER GJ, 1975, LANCET, V1, P16; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Naiki T, 2002, J BIOL CHEM, V277, P14011, DOI 10.1074/jbc.M105403200; Nielsen LB, 2009, TRENDS ENDOCRIN MET, V20, P66, DOI 10.1016/j.tem.2008.11.003; Niu NF, 2007, DIABETES-METAB RES, V23, P21, DOI 10.1002/dmrr.641; Piek E, 1999, J CELL SCI, V112, P4557; Plomgaard P, 2009, J INTERN MED, V266, P258, DOI 10.1111/j.1365-2796.2009.02095.x; Qian A, 2000, BIOCHEM BIOPH RES CO, V276, P837, DOI 10.1006/bbrc.2000.3549; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; Seol W, 1997, MOL CELL BIOL, V17, P7126, DOI 10.1128/MCB.17.12.7126; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Skupien Jan, 2007, Rev Diabet Stud, V4, P231, DOI 10.1900/RDS.2007.4.231; SLADEK FM, 1994, RECEPTOR, V4, P64; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Varga G, 2007, BIODRUGS, V21, P117, DOI 10.2165/00063030-200721020-00006; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Venteclef N, 2008, J BIOL CHEM, V283, P3694, DOI 10.1074/jbc.M706382200; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Wan YJY, 1998, EXP CELL RES, V238, P241, DOI 10.1006/excr.1997.3851; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Wolfrum C, 2008, J BIOL CHEM, V283, P16940, DOI 10.1074/jbc.M801930200; Wu XP, 2009, CLIN BIOCHEM, V42, P17, DOI 10.1016/j.clinbiochem.2008.10.008; Xu N, 2006, BIOCHEM BIOPH RES CO, V342, P1174, DOI 10.1016/j.bbrc.2006.02.022; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Xu WW, 2008, CLIN EXP PHARMACOL P, V35, P546, DOI 10.1111/j.1440-1681.2007.04822.x; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; ZANNIS VI, 1993, ADV HUM GENET, V21, P145; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; Zannis VI, 2001, FRONT BIOSCI-LANDMRK, V6, pD456, DOI 10.2741/Zannis; Zannis VI., 2004, MOL MECH ATHEROSCLER, V8, P111; Zhang X, 2008, BIOCHEM BIOPH RES CO, V371, P114, DOI 10.1016/j.bbrc.2008.04.017; Zhang XY, 2007, BBA-MOL CELL BIOL L, V1771, P879, DOI 10.1016/j.bbalip.2007.04.020; Zhang XY, 2003, ACTA HISTOCHEM, V105, P67, DOI 10.1078/0065-1281-00687	68	28	33	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30719	30730		10.1074/jbc.M110.131771	http://dx.doi.org/10.1074/jbc.M110.131771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20660599	Green Published, hybrid			2022-12-27	WOS:000282135500040
J	Webby, CJ; Jiao, WT; Hutton, RD; Blackmore, NJ; Baker, HM; Baker, EN; Jameson, GB; Parker, EJ				Webby, Celia J.; Jiao, Wanting; Hutton, Richard D.; Blackmore, Nicola J.; Baker, Heather M.; Baker, Edward N.; Jameson, Geoffrey B.; Parker, Emily J.			Synergistic Allostery, a Sophisticated Regulatory Network for the Control of Aromatic Amino Acid Biosynthesis in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE SYNTHASE; ACTINOMYCETE AMYCOLATOPSIS-METHANOLICA; SOLANUM-TUBEROSUM-L; ESCHERICHIA-COLI; SHIKIMATE PATHWAY; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; SUBSTRATE AMBIGUITY	The shikimate pathway, responsible for aromatic amino acid biosynthesis, is required for the growth of Mycobacterium tuberculosis and is a potential drug target. The first reaction is catalyzed by 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS). Feedback regulation of DAH7PS activity by aromatic amino acids controls shikimate pathway flux. Whereas Mycobacterium tuberculosis DAH7PS (MtuDAH7PS) is not inhibited by the addition of Phe, Tyr, or Trp alone, combinations cause significant loss of enzyme activity. In the presence of 200 mu M Phe, only 2.4 mu M Trp is required to reduce enzymic activity to 50%. Reaction kinetics were analyzed in the presence of inhibitory concentrations of Trp/Phe or Trp/Tyr. In the absence of inhibitors, the enzyme follows Michaelis-Menten kinetics with respect to substrate erythrose 4-phosphate (E4P), whereas the addition of inhibitor combinations caused significant homotropic cooperativity with respect to E4P, with Hill coefficients of 3.3 (Trp/Phe) and 2.8 (Trp/Tyr). Structures of MtuDAH7PS/Trp/Phe, MtuDAH7PS/Trp, and MtuDAH7PS/Phe complexes were determined. The MtuDAH7PS/Trp/Phe homotetramer binds four Trp and six Phe molecules. Binding sites for both aromatic amino acids are formed by accessory elements to the core DAH7PS (beta/alpha)(8) barrel that are unique to the type II DAH7PS family and contribute to the tight dimer and tetramer interfaces. A comparison of the liganded and unliganded MtuDAH7PS structures reveals changes in the interface areas associated with inhibitor binding and a small displacement of the E4P binding loop. These studies uncover a previously unrecognized mode of control for the branched pathways of aromatic amino acid biosynthesis involving synergistic inhibition by specific pairs of pathway end products.	[Jiao, Wanting; Hutton, Richard D.; Blackmore, Nicola J.; Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch 8040, New Zealand; [Jiao, Wanting; Hutton, Richard D.; Blackmore, Nicola J.; Parker, Emily J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8040, New Zealand; [Webby, Celia J.; Jameson, Geoffrey B.] Massey Univ, Inst Fundamental Sci, Palmerston North 4442, New Zealand; [Baker, Heather M.; Baker, Edward N.] Univ Auckland, Ctr Mol Biodiscovery, Auckland 1020, New Zealand; [Baker, Heather M.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1020, New Zealand	University of Canterbury; University of Canterbury; Massey University; University of Auckland; University of Auckland	Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Private Bag 4800, Christchurch 8040, New Zealand.	emily.parker@canterbury.ac.nz	Jiao, Wanting/I-3159-2019	Jiao, Wanting/0000-0002-0234-7206; Baker, Edward/0000-0003-2456-7661; Parker, Emily/0000-0002-9571-9987; Jameson, Geoffrey/0000-0003-4839-0784	Maurice Wilkins Centre for Molecular Biodiscovery; Health Research Council of New Zealand; New Zealand Marsden Fund [UOC710]; Massey University; New Zealand Tertiary Education Commission	Maurice Wilkins Centre for Molecular Biodiscovery; Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Massey University; New Zealand Tertiary Education Commission	This work was funded by the Maurice Wilkins Centre for Molecular Biodiscovery, the Health Research Council of New Zealand, and the New Zealand Marsden Fund (UOC710).; Recipient of a Massey University Vice Chancellor's Doctoral Scholarship.; Recipient of a New Zealand Tertiary Education Commission Top Doctoral Scholarship.	BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Braxton BL, 1996, BIOCHEMISTRY-US, V35, P11918, DOI 10.1021/bi961305m; Campbell SA, 2004, INT J PARASITOL, V34, P5, DOI 10.1016/j.ijpara.2003.10.006; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; DYER WE, 1990, J BIOL CHEM, V265, P1608; EUVERINK GJW, 1995, APPL ENVIRON MICROB, V61, P3796, DOI 10.1128/AEM.61.11.3796-3803.1995; Gosset G, 2001, J BACTERIOL, V183, P4061, DOI 10.1128/JB.183.13.4061-4070.2001; Guo JT, 2002, J AM CHEM SOC, V124, P10642, DOI 10.1021/ja026628m; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Helmstaedt K, 2005, P NATL ACAD SCI USA, V102, P9784, DOI 10.1073/pnas.0504238102; HOFFMANN PJ, 1972, BIOCHIM BIOPHYS ACTA, V268, P550, DOI 10.1016/0005-2744(72)90352-X; Jensen RA, 2002, J MOL EVOL, V54, P416, DOI 10.1007/s00239-001-0031-z; Kloosterman H, 2003, MICROBIOL-SGM, V149, P3321, DOI 10.1099/mic.0.26494-0; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Lin XH, 2009, PROTEIN EXPRES PURIF, V64, P8, DOI 10.1016/j.pep.2008.09.020; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Rattan A, 1998, EMERG INFECT DIS, V4, P195, DOI 10.3201/eid0402.980207; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schnappauf G, 1998, ARCH MICROBIOL, V169, P517, DOI 10.1007/s002030050605; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; Silakowski B, 2000, ARCH MICROBIOL, V173, P403, DOI 10.1007/s002030000162; Stokstad E, 2000, SCIENCE, V287, P2391; Subramaniam PS, 1998, J BACTERIOL, V180, P119, DOI 10.1128/JB.180.1.119-127.1998; TRIBE DE, 1976, J BACTERIOL, V127, P1085, DOI 10.1128/JB.127.3.1085-1097.1976; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Wagner T, 2000, J MOL BIOL, V301, P389, DOI 10.1006/jmbi.2000.3957; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; WALLACE BJ, 1967, J BACTERIOL, V93, P237, DOI 10.1128/JB.93.1.237-244.1967; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, ACTA CRYSTALLOGR F, V61, P403, DOI 10.1107/S1744309105007931; Webby CJ, 2005, BIOCHEM J, V390, P223, DOI 10.1042/BJ20050259; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Wu J, 2005, BIOCHEM J, V390, P583, DOI 10.1042/BJ20050294; WYMAN J, 1972, CURRENT TOPICS CELLU, V6, P209; ZHAO JM, 1992, PLANT PHYSIOL, V100, P1075, DOI 10.1104/pp.100.2.1075	49	52	52	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30567	30576		10.1074/jbc.M110.111856	http://dx.doi.org/10.1074/jbc.M110.111856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20667835	Green Published, hybrid			2022-12-27	WOS:000282135500025
J	Goussetis, DJ; Altman, JK; Glaser, H; McNeer, JL; Tallman, MS; Platanias, LC				Goussetis, Dennis J.; Altman, Jessica K.; Glaser, Heather; McNeer, Jennifer L.; Tallman, Martin S.; Platanias, Leonidas C.			Autophagy Is a Critical Mechanism for the Induction of the Antileukemic Effects of Arsenic Trioxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PROTEIN-KINASE PATHWAY; MALIGNANT GLIOMA-CELLS; MAMMALIAN TARGET; CELLULAR-RESPONSES; MYELOMA CELLS; UP-REGULATION; CANCER-CELLS; S6 KINASE; DEATH	Arsenic trioxide (As2O3) exhibits potent antitumor effects in vitro and in vivo, but the precise mechanisms by which it generates such responses are not well understood. We provide evidence that As2O3 is a potent inducer of autophagy in leukemia cells. Such induction of autophagy by As2O3 appears to require activation of the MEK/ERK pathway but not the AKT/mammalian target of rapamycin or JNK pathways. In efforts to understand the functional relevance of arsenic-induced autophagy, we found that pharmacological inhibitors of autophagy or molecular targeting of beclin 1 or Atg7 results in reversal of the suppressive effects of As2O3 on leukemic cell lines and primary leukemic progenitors from acute myelogenous leukemia patients. Altogether, our data provide direct evidence that autophagic cell death is critical for the generation of the effects of As2O3 on acute myelogenous leukemia cells and raise the potential of modulation of elements of the autophagic machinery as an approach to enhance the antitumor properties of As2O3 and possibly other heavy metal derivatives.	[Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [R01CA121192, R01CA77816, T32CA070085]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA077816, R01CA121192, T32CA070085, P30CA060553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA121192, R01CA77816, and T32CA070085. This work was also supported by a Merit Review grant from the Department of Veterans Affairs.	Altman JK, 2008, J BIOL CHEM, V283, P1992, DOI 10.1074/jbc.M705227200; Apel A, 2009, INT J CANCER, V125, P991, DOI 10.1002/ijc.24500; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Chen GQ, 1996, BLOOD, V88, P1052; Colosetti P, 2009, AUTOPHAGY, V5, P1092, DOI 10.4161/auto.5.8.9889; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Dolniak B, 2008, J BIOL CHEM, V283, P12034, DOI 10.1074/jbc.M708816200; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Grander D, 2009, AUTOPHAGY, V5, P1198, DOI 10.4161/auto.5.8.10122; Huang YC, 2009, CHEM-BIOL INTERACT, V181, P254, DOI 10.1016/j.cbi.2009.06.020; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kamitsuji Y, 2008, CELL DEATH DIFFER, V15, P1712, DOI 10.1038/cdd.2008.107; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Laane E, 2009, CELL DEATH DIFFER, V16, P1018, DOI 10.1038/cdd.2009.46; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; McCafferty-Grad J, 2003, MOL CANCER THER, V2, P1155; Miller WH, 2002, CANCER RES, V62, P3893; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Paglin S, 2001, CANCER RES, V61, P439; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Platanias LC, 2009, J BIOL CHEM, V284, P18583, DOI 10.1074/jbc.R900003200; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Shackelford D, 2006, CANCER RES, V66, P11360, DOI 10.1158/0008-5472.CAN-06-1774; Song JR, 2009, AUTOPHAGY, V5, P1131, DOI 10.4161/auto.5.8.9996; Tallman MS, 2008, SEMIN HEMATOL, V45, pS25, DOI 10.1053/j.seminhematol.2008.07.008; Tanaka-Kagawa T, 2003, BRIT J DERMATOL, V149, P1116, DOI 10.1111/j.1365-2133.2003.05704.x; Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Wen JG, 2008, BRIT J HAEMATOL, V140, P169, DOI 10.1111/j.1365-2141.2007.06895.x; Yamamoto S, 2008, ANTICANCER RES, V28, P1585; Yoon P, 2006, MOL CANCER THER, V5, P2815, DOI 10.1158/1535-7163.MCT-06-0263; Yu L, 2004, CELL CYCLE, V3, P1124; Zhang QY, 2009, P NATL ACAD SCI USA, V106, P3378, DOI 10.1073/pnas.0813142106	47	105	115	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29989	29997		10.1074/jbc.M109.090530	http://dx.doi.org/10.1074/jbc.M109.090530			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20656687	Green Published, hybrid			2022-12-27	WOS:000281984300036
J	Maloverjan, A; Piirsoo, M; Kasak, L; Peil, L; Osterlund, T; Kogerman, P				Maloverjan, Alla; Piirsoo, Marko; Kasak, Lagle; Peil, Lauri; Osterlund, Torben; Kogerman, Priit			Dual Function of UNC-51-like Kinase 3 (Ulk3) in the Sonic Hedgehog Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-THREONINE KINASE; PROTEIN-KINASE; CUBITUS-INTERRUPTUS; GENETIC DISSECTION; NEGATIVE REGULATOR; FUSED GENE; SUPPRESSOR; GLI; DROSOPHILA; POLARITY	The Sonic hedgehog (Shh) signaling pathway controls a variety of developmental processes and is implicated in tissue homeostasis maintenance and neurogenesis in adults. Recently, we identified Ulk3 as an active kinase able to positively regulate Gli proteins, mediators of the Shh signaling in mammals. Here, we provide several lines of evidence that Ulk3 participates in the transduction of the Shh signal also independently of its kinase activity. We demonstrate that Ulk3 through its kinase domain interacts with Suppressor of Fused (Sufu), a protein required for negative regulation of Gli proteins. Sufu blocks Ulk3 autophosphorylation and abolishes its ability to phosphorylate and positively regulate Gli proteins. We show that Shh signaling destabilizes the Sufu-Ulk3 complex and induces the release of Ulk3. We demonstrate that the Sufu-Ulk3 complex, when co-expressed with Gli2, promotes generation of the Gli2 repressor form, and that reduction of the Ulk3 mRNA level in Shh-responsive cells results in higher potency of the cells to transmit the Shh signal. Our data suggests a dual function of Ulk3 in the Shh signal transduction pathway and propose an additional way of regulating Gli proteins by Sufu, through binding to and suppression of Ulk3.	Tallinn Univ Technol, Dept Gene Technol, Inst Clin Med, EE-12618 Tallinn, Estonia; [Kogerman, Priit] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia	Tallinn University of Technology; University of Tartu		alla.maloverjan@ttu.ee	Piirsoo, Alla/G-5890-2017; Peil, Lauri/G-9944-2012	Peil, Lauri/0000-0001-6906-7113; Osterlund, Torben/0000-0002-2047-767X	Estonian Science Foundation [7279, 8116]; Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu)	Estonian Science Foundation; Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu)	This work was supported in part by Estonian Science Foundation Grants 7279 (to T. O.) and 8116 (to P. K.). Mass spectrometric analyses were supported in part by the European Regional Development Fund through the Center of Excellence in Chemical Biology (Institute of Technology, University of Tartu).	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; Ascano M, 2004, MOL CELL BIOL, V24, P10397, DOI 10.1128/MCB.24.23.10397-10405.2004; Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Claret S, 2007, CURR BIOL, V17, P1326, DOI 10.1016/j.cub.2007.06.059; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dussillol-Godar F, 2006, DEV BIOL, V291, P53, DOI 10.1016/j.ydbio.2005.12.004; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hellman U, 2000, EXS, V88, P43; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lefers MA, 2001, DEV BIOL, V236, P411, DOI 10.1006/dbio.2001.0345; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Maloveryan A, 2007, J CELL COMMUN SIGNAL, V1, P165, DOI 10.1007/s12079-007-0014-y; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Nybakken KE, 2002, J BIOL CHEM, V277, P24638, DOI 10.1074/jbc.M110730200; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; PHAM A, 1995, GENETICS, V140, P587; PREAT T, 1992, GENETICS, V132, P725; PREAT T, 1993, GENETICS, V135, P1047; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; RUIZ I ALTABA A, 2007, TRENDS CELL BIOL, V17, P438; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Therond P, 1996, GENETICS, V142, P1181; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Tsanev R, 2009, FEBS LETT, V583, P224, DOI 10.1016/j.febslet.2008.12.010; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103	58	39	42	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30079	30090		10.1074/jbc.M110.133991	http://dx.doi.org/10.1074/jbc.M110.133991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20643644	Green Published, hybrid			2022-12-27	WOS:000281984300046
J	Sayama, K; Yamamoto, M; Shirakata, Y; Hanakawa, Y; Hirakawa, S; Dai, XJ; Tohyama, M; Tokumaru, S; Shin, MS; Sakurai, H; Akira, S; Hashimoto, K				Sayama, Koji; Yamamoto, Masahiro; Shirakata, Yuji; Hanakawa, Yasushi; Hirakawa, Satoshi; Dai, Xiuju; Tohyama, Mikiko; Tokumaru, Sho; Shin, Myoung-Sook; Sakurai, Hiroaki; Akira, Shizuo; Hashimoto, Koji			E2 Polyubiquitin-conjugating Enzyme Ubc13 in Keratinocytes Is Essential for Epidermal Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SEVERE LIVER DEGENERATION; GAMMA-DEFICIENT MICE; INCONTINENTIA PIGMENTI; KINASE; TAK1; ACTIVATION; SKIN; DIFFERENTIATION; APOPTOSIS	The E2 polyubiquitin-conjugating enzyme Ubc13 is a mediator of innate immune reactions. Ubc13 mediates the conjugation of keratin (K)63-linked polyubiquitin chains onto TNF receptor-associated factor 6 and IKK gamma during NF-kappa B activation. In contrast to K48-linked polyubiquitin chains, K63-linked polyubiquitin chains function in nonproteasomal biological processes. Although Ubc13 has been shown to be critical for Toll-like receptor (TLR) and IL-1 receptor signaling, the function of Ubc13 in the epidermis has not been studied. We generated keratinocyte-specific Ubc13-deficient mice (Ubc13(flox/flox)K5-Cre). At birth, the skin of the Ubc13(flox/flox)K5-Cre mice was abnormally shiny and smooth; in addition, the mice did not grow and died by postnatal day 2. Histological analysis showed atrophy of the epidermis with keratinocyte apoptosis. Immunohistochemical analyses revealed reduced proliferation, abnormal differentiation, and apoptosis of keratinocytes in the Ubc13(flox/flox)K5-Cre mouse epidermis. In culture, Ubc13(flox/flox)K5-Cre keratinocyte growth was impaired, and spontaneous cell death occurred. Moreover, the deletion of Ubc13 from cultured Ubc13(flox/flox) keratinocytes by means of an adenoviral vector carrying Cre recombinase also resulted in spontaneous cell death. Therefore, Ubc13 is essential for keratinocyte growth, differentiation, and survival. Analyses of intracellular signaling revealed that the IL-1 and TNF-induced activation of JNK, p38, and NF-kappa B pathways was impaired in Ubc13(flox/flox)K5-Cre keratinocytes. In conclusion, Ubc13 appears to be essential for epidermal integrity in mice.	[Sayama, Koji; Tohyama, Mikiko; Tokumaru, Sho; Hashimoto, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan; [Yamamoto, Masahiro; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Shin, Myoung-Sook; Sakurai, Hiroaki] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan	Ehime University; Osaka University; University of Toyama	Sayama, K (corresponding author), Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan.	sayama@m.ehime-u.ac.jp	Sakurai, Hiroaki/AAE-4294-2019; Akira, Shizuo/C-3134-2009	Sakurai, Hiroaki/0000-0003-0657-9570	Ministries of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Takeda Science Foundation; Mishima Kaiun Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Kowa Life Science Foundation; Yasuda Medical Foundation	Ministries of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Kowa Life Science Foundation; Yasuda Medical Foundation	This work was supported by grants from the Ministries of Education, Culture, Sports, Science, and Technology of Japan; by Health and Labor Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labor, and Welfare of Japan; and by grants from the Takeda Science Foundation, Mishima Kaiun Memorial Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Naito Foundation, Kowa Life Science Foundation, and the Yasuda Medical Foundation.	Dai XJ, 2008, J DERMATOL SCI, V50, P53, DOI 10.1016/j.jdermsci.2007.10.011; Dai XJ, 2004, J INVEST DERMATOL, V123, P1078, DOI 10.1111/j.0022-202X.2004.23503.x; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Morioka S, 2009, ONCOGENE, V28, P2257, DOI 10.1038/onc.2009.110; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Rudolph D, 2000, GENE DEV, V14, P854; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2002, J BIOL CHEM, V277, P40390, DOI 10.1074/jbc.M112423200; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Smahi A, 2000, NATURE, V405, P466; Stratis A, 2006, J INVEST DERMATOL, V126, P614, DOI 10.1038/sj.jid.5700092; Takeda J, 2000, J DERMATOL SCI, V23, P147, DOI 10.1016/S0923-1811(00)00082-7; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	34	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30042	30049		10.1074/jbc.M110.106484	http://dx.doi.org/10.1074/jbc.M110.106484			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20663875	Green Published, hybrid			2022-12-27	WOS:000281984300042
J	Watanabe, Y; Noda, NN; Kumeta, H; Suzuki, K; Ohsumi, Y; Inagaki, F				Watanabe, Yasunori; Noda, Nobuo N.; Kumeta, Hiroyuki; Suzuki, Kuninori; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			Selective Transport of alpha-Mannosidase by Autophagic Pathways STRUCTURAL BASIS FOR CARGO RECOGNITION BY Atg19 AND Atg34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOPLASM; PROTEIN; DOMAIN; COMPONENTS; MECHANISM; DYNAMICS; ATG8/LC3; DISEASE; TARGET	In the yeast Saccharomyces cerevisiae, a precursor form of aminopeptidase I (prApe1) and alpha-mannosidase (Ams1) are selectively transported to the vacuole through the cytoplasm-to-vacuole targeting pathway under vegetative conditions and through autophagy under starvation conditions. Atg19 plays a central role in these processes by linking Ams1 and prApe1 to Atg8 and Atg11. However, little is known about the molecular mechanisms of cargo recognition by Atg19. Here, we report structural and functional analyses of Atg19 and its paralog, Atg34. A protease-resistant domain was identified in the C-terminal region of Atg19, which was also conserved in Atg34. In vitro pulldown assays showed that the C-terminal domains of both Atg19 and Atg34 are responsible for Ams1 binding; these domains are hereafter referred to as Ams1-binding domains (ABDs). The transport of Ams1, but not prApe1, was blocked in atg19 Delta atg34 Delta cells expressing Atg19(Delta ABD), indicating that ABD is specifically required for Ams1 transport. We then determined the solution structures of the ABDs of Atg19 and Atg34 using NMR spectroscopy. Both ABD structures have a canonical immunoglobulin fold consisting of eight beta-strands with highly conserved loops clustered at one side of the fold. These facts, together with the results of a mutational analysis, suggest that ABD recognizes Ams1 using these conserved loops.	[Watanabe, Yasunori; Noda, Nobuo N.; Kumeta, Hiroyuki; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Suzuki, Kuninori; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan	Hokkaido University; Tokyo Institute of Technology	Noda, NN (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, N-12,W-6, Sapporo, Hokkaido 0600812, Japan.	nn@pharm.hokudai.ac.jp; finagaki@pharm.hokudai.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Watanabe, Yasunori/0000-0002-7846-680X; Noda, Nobuo/0000-0002-6940-8069; Kumeta, Hiroyuki/0000-0003-3713-2122	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research on priority areas and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Manjithaya R, 2010, FEBS LETT, V584, P1367, DOI 10.1016/j.febslet.2010.01.019; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muyldermans S, 2001, J Biotechnol, V74, P277; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Noda T, 2009, INT IMMUNOL, V21, P1199, DOI 10.1093/intimm/dxp088; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; OPHEIM DJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P121, DOI 10.1016/0005-2744(78)90110-9; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Watanabe Y, 2009, ACTA CRYSTALLOGR F, V65, P571, DOI 10.1107/S1744309109015826; YOSHIHISA T, 1988, J BIOL CHEM, V263, P5158	37	39	42	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30026	30033		10.1074/jbc.M110.143545	http://dx.doi.org/10.1074/jbc.M110.143545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20659891	Green Published, hybrid			2022-12-27	WOS:000281984300040
J	Kamath, P; Huntington, JA; Krishnaswamy, S				Kamath, Parvathi; Huntington, James A.; Krishnaswamy, Sriram			Ligand Binding Shuttles Thrombin along a Continuum of Zymogen-and Proteinase-like States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALLOSTERIC LINKAGE; 2 CONFORMATIONS; EXOSITE-I; PROTHROMBIN; NA+; SUBSTRATE; COMPENSATION; SPECIFICITY; ACTIVATION	The critical and multiple roles of thrombin in blood coagulation are regulated by ligands and cofactors. Zymogen activation imparts proteolytic activity to thrombin and also affects the binding of ligands to its two principal exosites. We have used the activation peptide fragment 1.2 (F12), a ligand for anion-binding exosite 2, to probe the zymogenicity of thrombin by isothermal titration calorimetry. We show that F12 binding is sensitive to subtle aspects of proteinase formation beyond simply reporting on zymogen cleavage. Large thermodynamic differences in F12 binding distinguish between a series of thrombin species poised along the transition of zymogen to proteinase. Active-site ligands transitioned a zymogen-like state to a proteinase-like state. Conversely, removal of Na+ converted proteinase-like thrombin to a more zymogen-like form. Thrombin mutants, with deformed x-ray structures, previously considered to be emblematic of specific regulated states of the enzyme, are instead shown to be variously zymogen-like and can be made proteinase-like by active-site ligation. Thermodynamic linkage between anion-binding exosite 2, the Na+-binding site, and the active site arises from interconversions of thrombin between a continuum of zymogen-and proteinase-like states. These interconversions, reciprocally regulated by different ligands, cast new light on the problem of thrombin allostery and provide a thermodynamic framework to explain the regulation of thrombin by different ligands.	[Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Kamath, Parvathi; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Huntington, James A.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Cambridge	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Res Inst, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019		National Institutes of Health [HL-74124]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124] Funding Source: NIH RePORTER; MRC [G0601596] Funding Source: UKRI; Medical Research Council [G0601596] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported, in whole or in part, by National Institutes of Health Grant HL-74124 (to S. K.).	Adams TE, 2009, J THROMB HAEMOST, V7, P1688, DOI 10.1111/j.1538-7836.2009.03563.x; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Bah A, 2009, J BIOL CHEM, V284, P20034, DOI 10.1074/jbc.M109.012344; Bevington PR., 2002, DATA REDUCTION ERROR; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Bush-Pelc LA, 2007, J BIOL CHEM, V282, P27165, DOI 10.1074/jbc.M703202200; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; Davie EW, 2006, SEMIN THROMB HEMOST, V32, P3, DOI 10.1055/s-2006-939550; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025; Esmon CT, 2006, SEMIN THROMB HEMOST, V32, P49, DOI 10.1055/s-2006-939554; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; Gandhi PS, 2009, J BIOL CHEM, V284, P24098, DOI 10.1074/jbc.M109.025403; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Khan AR, 1998, PROTEIN SCI, V7, P815; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LECHTENBERG B, 2010, P NATL ACAD IN PRESS; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lumry R, 1995, METHOD ENZYMOL, V259, P628; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1981, METHOD ENZYMOL, V80, P286; Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008	43	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28651	28658		10.1074/jbc.M110.154914	http://dx.doi.org/10.1074/jbc.M110.154914			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20639195	Green Published, hybrid			2022-12-27	WOS:000281594000029
J	Dermody, JL; Buratowski, S				Dermody, Jessica L.; Buratowski, Stephen			Leo1 Subunit of the Yeast Paf1 Complex Binds RNA and Contributes to Complex Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION-FACTORS; POLYMERASE-II COMPLEX; PRE-MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; HISTONE H2B; IN-VIVO; GENE-EXPRESSION; H3 METHYLATION; PROTEIN; RTF1	The Paf1 complex (Paf1C) affects RNA polymerase II transcription by coordinating co-transcriptional chromatin modifications and helping recruit mRNA 3' end processing factors. Paf1C cross-links to transcribed genes, but not downstream of the cleavage and polyadenylation site, suggesting that it may interact with the nascent mRNA. Paf1C purified from Saccharomyces cerevisiae binds RNA in vitro, as do the purified Leo1 and Rtf1 subunits of the complex. In vivo cross-linking and immunoprecipitation of RNA associated with Paf1C (RNA-IP) show that Leo1, but not Rtf1, is necessary for the complex to bind RNA. Cells lacking Leo1 have reduced Paf1C recruitment as well as decreased levels of histone H3 and trimethylated H3 Lys(4) within transcribed chromatin. Together, these results suggest that association of Paf1C with RNA stabilizes its localization at actively transcribed regions where it influences chromatin structure.	[Dermody, Jessica L.; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	SteveB@hms.harvard.edu			National Institutes of Health [GM075383, GM46498, GM56663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046498, R01GM056663, R01GM046498, F31GM075383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Fellowship GM075383 (to J. L. D.) and Grants GM46498 and GM56663 (to S. B.).	Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costa PJ, 2000, GENETICS, V156, P535; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; Desmoucelles C, 2002, J BIOL CHEM, V277, P27036, DOI 10.1074/jbc.M111433200; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Ganem C, 2006, MOL GENET GENOMICS, V275, P136, DOI 10.1007/s00438-005-0071-y; Gilbert C., 2006, CURR PROTOC MOL BIOL; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh Michael-Christopher, 2004, Methods Mol Biol, V257, P1, DOI 10.1385/1-59259-750-5:001; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; MAGDOLEN V, 1994, BBA-GENE STRUCT EXPR, V1218, P205, DOI 10.1016/0167-4781(94)90013-2; Marton HA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-4; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Musso M, 2000, NUCLEIC ACIDS RES, V28, P4090, DOI 10.1093/nar/28.21.4090; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	54	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33671	33679		10.1074/jbc.M110.140764	http://dx.doi.org/10.1074/jbc.M110.140764			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732871	Green Published, hybrid			2022-12-27	WOS:000283354000012
J	Oner, SS; An, NF; Vural, A; Breton, B; Bouvier, M; Blumer, JB; Lanier, SM				Oner, Sukru Sadik; An, Ningfei; Vural, Ali; Breton, Billy; Bouvier, Michel; Blumer, Joe B.; Lanier, Stephen M.			Regulation of the AGS3 center dot G alpha(i) Signaling Complex by a Seven-transmembrane Span Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN BETA-GAMMA; GUANINE-NUCLEOTIDE EXCHANGE; ASYMMETRIC CELL DIVISIONS; RESONANCE ENERGY-TRANSFER; G-ALPHA-I; SPINDLE ORIENTATION; POINT MUTATION; GOLOCO MOTIF; GI-ALPHA; DISSOCIATION INHIBITOR	G-protein signaling modulators (GPSM) play diverse functional roles through their interaction with G-protein subunits. AGS3 (GPSM1) contains four G-protein regulatory motifs (GPR) that directly bind G alpha(i) free of G alpha gamma providing an unusual scaffold for the "G-switch" and signaling complexes, but the mechanism by which signals track into this scaffold are not well understood. We report the regulation of the AGS3 center dot G alpha(i) signaling module by a cell surface, seven-transmembrane receptor. AGS3 and G alpha(i1) tagged with Renilla luciferase or yellow fluorescent protein expressed in mammalian cells exhibited saturable, specific bioluminescence resonance energy transfer indicating complex formation in the cell. Activation of alpha(2)-adrenergic receptors or mu-opioid receptors reduced AGS3-RLuc center dot G alpha(i1)-YFP energy transfer by over 30%. The agonist- mediated effects were inhibited by pertussis toxin and co-expression of RGS4, but were not altered by G beta gamma sequestration with the carboxyl terminus of GRK2 center dot G alpha(i)-dependent and agonist-sensitive bioluminescence resonance energy transfer was also observed between AGS3 and cell-surface receptors typically coupled to G alpha(i) and/or G alpha(o) indicating that AGS3 is part of a larger signaling complex. Upon receptor activation, AGS3 reversibly dissociates from this complex at the cell cortex. Receptor coupling to both G alpha beta gamma and GPR center dot G alpha(i) offer additional flexibility for systems to respond and adapt to challenges and orchestrate complex behaviors.	[Oner, Sukru Sadik; An, Ningfei; Vural, Ali; Blumer, Joe B.; Lanier, Stephen M.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Breton, Billy; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	Medical University of South Carolina; Universite de Montreal	Lanier, SM (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Colcock Hall,179 Ashley Ave, Charleston, SC 29425 USA.	lanier@musc.edu	Bouvier, Michel/H-2758-2014; Oner, Sukru/K-8032-2012	Bouvier, Michel/0000-0003-1128-0100; Oner, Sukru/0000-0002-8864-7356; Lanier, Stephen/0000-0002-2740-7607; Blumer, Joe/0000-0002-0020-3815	National Institutes of Health [NS24821, DA025896, GM086510]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS24821 (to S. M. L.), DA025896 (to S. M. L.), GM086510 (to J. B. B.) and a grant from the Canadian Institutes of Health Research (to M. B.).	Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2002, CURR BIOL, V12, P1928, DOI 10.1016/S0960-9822(02)01298-8; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Fan PD, 2009, MOL PHARMACOL, V76, P526, DOI 10.1124/mol.109.057802; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Groves B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008877; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; JAHANGEER S, 1993, P NATL ACAD SCI USA, V90, P8782, DOI 10.1073/pnas.90.19.8782; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Ma HZ, 2003, BIOCHEMISTRY-US, V42, P8085, DOI 10.1021/bi034561p; Nadella R, 2010, J AM SOC NEPHROL, V21, P1275, DOI 10.1681/ASN.2009121224; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schaefer M, 2001, EXP CELL RES, V271, P66, DOI 10.1006/excr.2001.5371; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Vural A, 2010, MOL CELL BIOL, V30, P1528, DOI 10.1128/MCB.01018-09; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	73	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33949	33958		10.1074/jbc.M110.138073	http://dx.doi.org/10.1074/jbc.M110.138073			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20716524	Green Published, hybrid			2022-12-27	WOS:000283354000042
J	Arnold, C; Markovic, M; Blossey, K; Wallukat, G; Fischer, R; Dechend, R; Konkel, A; von Schacky, C; Luft, FC; Muller, DN; Rothe, M; Schunck, WH				Arnold, Cosima; Markovic, Marija; Blossey, Katrin; Wallukat, Gerd; Fischer, Robert; Dechend, Ralf; Konkel, Anne; von Schacky, Clemens; Luft, Friedrich C.; Muller, Dominik N.; Rothe, Michael; Schunck, Wolf-Hagen			Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of omega-3 Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; CORONARY-HEART-DISEASE; SENSITIVE K+ CHANNELS; SUDDEN CARDIAC DEATH; 20-HYDROXYEICOSATETRAENOIC ACID; EICOSAPENTAENOIC-ACID; EPOXYEICOSATRIENOIC ACIDS; EPOXYGENASE METABOLITES; CARDIOVASCULAR-DISEASES; DOCOSAHEXAENOIC ACID	Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) protect against cardiovascular disease by largely unknown mechanisms. We tested the hypothesis that EPA and DHA may compete with arachidonic acid (AA) for the conversion by cytochrome P450 (CYP) enzymes, resulting in the formation of alternative, physiologically active, metabolites. Renal and hepatic microsomes, as well as various CYP isoforms, displayed equal or elevated activities when metabolizing EPA or DHA instead of AA. CYP2C/2J isoforms converting AA to epoxyeicosatrienoic acids (EETs) preferentially epoxidized the omega-3 double bond and thereby produced 17,18-epoxyeicosatetraenoic (17,18-EEQ) and 19,20-epoxydocosapentaenoic acid (19,20-EDP) from EPA and DHA. We found that these omega-3 epoxides are highly active as antiarrhythmic agents, suppressing the Ca2+-induced increased rate of spontaneous beating of neonatal rat cardiomyocytes, at low nanomolar concentrations. CYP4A/4F isoforms omega-hydroxylating AA were less regioselective toward EPA and DHA, catalyzing predominantly omega- and omega minus 1 hydroxylation. Rats given dietary EPA/DHA supplementation exhibited substantial replacement of AA by EPA and DHA in membrane phospholipids in plasma, heart, kidney, liver, lung, and pancreas, with less pronounced changes in the brain. The changes in fatty acids were accompanied by concomitant changes in endogenous CYP metabolite profiles (e. g. altering the EET/EEQ/EDP ratio from 87: 0: 13 to 27: 18: 55 in the heart). These results demonstrate that CYP enzymes efficiently convert EPA and DHA to novel epoxy and hydroxy metabolites that could mediate some of the beneficial cardiovascular effects of dietary omega-3 fatty acids.	[Luft, Friedrich C.; Muller, Dominik N.; Schunck, Wolf-Hagen] Max Delbrueck Ctr Mol Med, D-13125 Berlin, Germany; [Blossey, Katrin; Rothe, Michael] Lipidomix GmbH, D-13125 Berlin, Germany; [Fischer, Robert; Dechend, Ralf; Luft, Friedrich C.] Fac Med Charite, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [von Schacky, Clemens] Omegametrix GmbH, D-82152 Martinsried, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schunck, WH (corresponding author), Max Delbrueck Ctr Mol Med, Robert Roessle Str 10, D-13125 Berlin, Germany.	schunck@mdc-berlin.de		Luft, Friedrich/0000-0002-8635-1199; Muller, Dominik N/0000-0003-3650-5644	Deutsche Forschungsgemeinschaft [SCHU822/5, FOR1054]; Solvay Arzneimittel GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Solvay Arzneimittel GmbH(Solvay SA)	This work was supported in part by grants SCHU822/5 and FOR1054 from the Deutsche Forschungsgemeinschaft (to D.N.M. and W.-H.S.). The animal studies were supported by Solvay Arzneimittel GmbH.	Barbosa-Sicard E, 2005, BIOCHEM BIOPH RES CO, V329, P1275, DOI 10.1016/j.bbrc.2005.02.103; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; Capdevila JH, 2007, KIDNEY INT, V72, P683, DOI 10.1038/sj.ki.5002394; Capdevila JH, 2000, J LIPID RES, V41, P163; CAPDEVILA JH, 1990, METHOD ENZYMOL, V187, P385; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; Carroll MA, 1997, KIDNEY INT, V51, P1696, DOI 10.1038/ki.1997.234; Chapkin RS, 2008, BRIT J NUTR, V100, P1152, DOI 10.1017/S0007114508992576; Chen CT, 2009, PROSTAG LEUKOTR ESS, V80, P157, DOI 10.1016/j.plefa.2009.01.005; Cheng J, 2008, AM J PHYSIOL-HEART C, V294, pH1018, DOI 10.1152/ajpheart.01172.2007; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; FALCK JR, 1990, METHOD ENZYMOL, V187, P357; Fer M, 2008, J LIPID RES, V49, P2379, DOI 10.1194/jlr.M800199-JLR200; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Fischer R, 2008, HYPERTENSION, V51, P540, DOI 10.1161/HYPERTENSIONAHA.107.103143; Fleming I, 2008, TRENDS CARDIOVAS MED, V18, P20, DOI 10.1016/j.tcm.2007.11.002; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Gao F, 2009, J LIPID RES, V50, P749, DOI 10.1194/jlr.D800056-JLR200; Gross ER, 2004, J MOL CELL CARDIOL, V37, P1245, DOI 10.1016/j.yjmcc.2004.10.008; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Harmon SD, 2006, PROSTAG LEUKOTR ESS, V75, P169, DOI 10.1016/j.plefa.2006.05.005; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hercule HC, 2007, EXP PHYSIOL, V92, P1067, DOI 10.1113/expphysiol.2007.038166; Iliff JJ, 2009, FUTUR NEUROL, V4, P179, DOI 10.2217/14796708.4.2.179; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Jiang H, 2007, BRIT J PHARMACOL, V151, P1033, DOI 10.1038/sj.bjp.0707311; Jiang HL, 2007, PROSTAG OTH LIPID M, V82, P4, DOI 10.1016/j.prostaglandins.2006.05.013; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kaduce TL, 2004, J BIOL CHEM, V279, P2648, DOI 10.1074/jbc.M306849200; Kaergel E, 2002, HYPERTENSION, V40, P273, DOI 10.1161/01.HYP.0000029240.44253.5E; KANG JX, 1994, P NATL ACAD SCI USA, V91, P9886, DOI 10.1073/pnas.91.21.9886; KARARA A, 1992, BIOCHEM BIOPH RES CO, V182, P1320, DOI 10.1016/0006-291X(92)91877-S; KARARA A, 1991, J BIOL CHEM, V266, P7561; Karlgren M, 2004, BIOCHEM BIOPH RES CO, V315, P679, DOI 10.1016/j.bbrc.2004.01.110; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kroetz DL, 2005, ANNU REV PHARMACOL, V45, P413, DOI 10.1146/annurev.pharmtox.45.120403.100045; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Laffer CL, 2003, CIRCULATION, V107, P574, DOI 10.1161/01.CIR.0000046269.52392.14; Lauterbach B, 2002, HYPERTENSION, V39, P609, DOI 10.1161/hy0202.103293; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Lu T, 2002, MOL PHARMACOL, V62, P1076, DOI 10.1124/mol.62.5.1076; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; McGiff JC, 1999, AM J PHYSIOL-REG I, V277, pR607, DOI 10.1152/ajpregu.1999.277.3.R607; Minuz P, 2008, HYPERTENSION, V51, P1379, DOI 10.1161/HYPERTENSIONAHA.107.105395; Miyata Noriyuki, 2005, Journal of Smooth Muscle Research, V41, P175, DOI 10.1540/jsmr.41.175; MORIN C, 2009, AM J RESP CELL MOL B; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Mozaffarian D, 2008, AM J CLIN NUTR, V87, p1991S, DOI 10.1093/ajcn/87.6.1991S; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Nithipatikom K, 2004, CIRC RES, V95, pE65, DOI 10.1161/01.RES.0000146277.62128.6f; OMURA T, 1964, J BIOL CHEM, V239, P2370; Rapoport SI, 2008, PROSTAG LEUKOTR ESS, V79, P153, DOI 10.1016/j.plefa.2008.09.010; Rivera J, 2004, CLIN CHEM, V50, P224, DOI 10.1373/clinchem.2003.025775; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schwarz D, 2005, BIOCHEM BIOPH RES CO, V336, P779, DOI 10.1016/j.bbrc.2005.08.172; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Shearer GC, 2009, CURR ATHEROSCLER REP, V11, P403, DOI 10.1007/s11883-009-0061-3; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Spiecker M, 2004, CIRCULATION, V110, P2132, DOI 10.1161/01.CIR.0000143832.91812.60; Stark K, 2005, ARCH BIOCHEM BIOPHYS, V441, P174, DOI 10.1016/j.abb.2005.07.003; VANROLLINS M, 1990, LIPIDS, V25, P481, DOI 10.1007/BF02538092; VANROLLINS M, 1988, BIOCHIM BIOPHYS ACTA, V966, P133, DOI 10.1016/0304-4165(88)90137-7; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wallukat G, 2010, J AM COLL CARDIOL, V55, P463, DOI 10.1016/j.jacc.2009.06.064; Ward NC, 2005, FREE RADICAL BIO MED, V38, P1032, DOI 10.1016/j.freeradbiomed.2004.12.024; Wu S, 1996, J BIOL CHEM, V271, P3460; Xiao YF, 2005, J MEMBRANE BIOL, V206, P141, DOI 10.1007/S00232-005-0786-Z; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; Ye D, 2002, J PHARMACOL EXP THER, V303, P768, DOI 10.1124/jpet.303.2.768; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang YD, 2001, AM J PHYSIOL-HEART C, V280, pH2430, DOI 10.1152/ajpheart.2001.280.6.H2430	79	283	291	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32720	32733		10.1074/jbc.M110.118406	http://dx.doi.org/10.1074/jbc.M110.118406			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20732876	Green Published, hybrid			2022-12-27	WOS:000283048200007
J	Inouye, K; Tsuzuki, S; Yasumoto, M; Kojima, K; Mochida, S; Fushiki, T				Inouye, Kuniyo; Tsuzuki, Satoshi; Yasumoto, Makoto; Kojima, Kenji; Mochida, Seiya; Fushiki, Tohru			Identification of the Matriptase Second CUB Domain as the Secondary Site for Interaction with Hepatocyte Growth Factor Activator Inhibitor Type-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE 1/MATRIPTASE; RECOMBINANT MATRIPTASE; ZYMOGEN ACTIVATION; CRYSTAL-STRUCTURE; BINDING-PROTEIN; EXPRESSION; CLEAVAGE; PROTEOLYSIS; DELETION; CLONING	Matriptase is a type II transmembrane serine protease comprising 855 amino acid residues. The extracellular region of matriptase comprises a noncatalytic stem domain (containing two tandem repeats of complement proteases C1r/C1s-urchin embryonic growth factor-bone morphogenetic protein (CUB) domain) and a catalytic serine protease domain. The stem domain of matriptase contains site(s) for facilitating the interaction of this protease with the endogenous inhibitor, hepatocyte growth factor activator inhibitor type-1 (HAI-1). The present study aimed to identify these site(s). Analyses using a secreted variant of recombinant matriptase comprising the entire extracellular domain (MAT), its truncated variants, and a recombinant HAI-1 variant with an entire extracellular domain (HAI-1-58K) revealed that the second CUB domain (CUB domain II, Cys(340)-Pro(452)) likely contains the site(s) of interest. We also found that MAT undergoes cleavage between Lys(379) and Val(380) within CUB domain II and that the C-terminal residues after Val(380) are responsible for facilitating the interaction with HAI-1-58K. A synthetic peptide corresponding to Val(380)-Asp(390) markedly increased the matriptase-inhibiting activity of HAI-1-58K, whereas the peptides corresponding to Val(380)-Val(389) and Phe(382)-Asp(390) had no effect. HAI-1-58K precipitated with immobilized streptavidin resins to which a synthetic peptide Val(380)-Pro(392) with a biotinylated lysine residue at its C terminus was bound, suggesting direct interaction between CUB domain II and HAI-1. These results led to the identification of the matriptase CUB domain II, which facilitates the primary inhibitory interaction between this protease and HAI-1.	[Inouye, Kuniyo; Yasumoto, Makoto; Kojima, Kenji] Kyoto Univ, Grad Sch Agr, Lab Enzyme Chem, Div Food Sci & Biotechnol,Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Inouye, K (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Enzyme Chem, Div Food Sci & Biotechnol,Sakyo Ku, Kyoto 6068502, Japan.	inouye@kais.kyoto-u.ac.jp		Tsuzuki, Satoshi/0000-0003-4385-0075	Japan Society for the Promotion of Science [17380065, 20380061]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grants-in-aid for Scientific Research (Nos. 17380065 and 20380061, to K. I.) from the Japan Society for the Promotion of Science.	Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Ge WT, 2006, J BIOL CHEM, V281, P7406, DOI 10.1074/jbc.M510687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; HURSH DA, 1987, SCIENCE, V237, P1487, DOI 10.1126/science.3498216; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Kojima K, 2009, J BIOCHEM, V145, P783, DOI 10.1093/jb/mvp036; Kojima K, 2009, BIOSCI BIOTECH BIOCH, V73, P454, DOI 10.1271/bbb.80713; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Miyake Y, 2010, BBA-PROTEINS PROTEOM, V1804, P156, DOI 10.1016/j.bbapap.2009.09.025; Miyake Y, 2009, CYTOTECHNOLOGY, V60, P95, DOI 10.1007/s10616-009-9219-7; Miyake Y, 2009, J BIOCHEM, V146, P273, DOI 10.1093/jb/mvp066; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; Mochida S, 2009, ENZYME MICROB TECH, V45, P288, DOI 10.1016/j.enzmictec.2009.06.008; Murai N, 2009, CYTOTECHNOLOGY, V59, P169, DOI 10.1007/s10616-009-9205-0; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Qiu D, 2007, BIOCHEM SOC T, V35, P583, DOI 10.1042/BST0350583; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tao ZY, 2005, BLOOD, V106, P4139, DOI 10.1182/blood-2005-05-2029; Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Tsuzuki S, 2003, BIOCHEM J, V372, P227, DOI 10.1042/BJ20021891; Varela PF, 1997, J MOL BIOL, V274, P635, DOI 10.1006/jmbi.1997.1424; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Yamasaki Y, 2003, J NUTR SCI VITAMINOL, V49, P27, DOI 10.3177/jnsv.49.27; Zeng L, 2005, WORLD J GASTROENTERO, V11, P6202, DOI 10.3748/wjg.v11.i39.6202; Zhang Y, 1998, CYTOGENET CELL GENET, V83, P56, DOI 10.1159/000015125	53	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33394	33403		10.1074/jbc.M110.115816	http://dx.doi.org/10.1074/jbc.M110.115816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682770	Green Published, hybrid			2022-12-27	WOS:000283048200074
J	Summermatter, S; Baum, O; Santos, G; Hoppeler, H; Handschin, C				Summermatter, Serge; Baum, Oliver; Santos, Gesa; Hoppeler, Hans; Handschin, Christoph			Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha (PGC-1 alpha) Promotes Skeletal Muscle Lipid Refueling in Vivo by Activating de Novo Lipogenesis and the Pentose Phosphate Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; INSULIN SENSITIVITY; MITOCHONDRIAL-FUNCTION; GLUCOSE-TOLERANCE; CHRONIC DISEASE; ADIPOSE-TISSUE; EXERCISE; RESISTANCE; HUMANS; PGC-1	Exercise induces a pleiotropic adaptive response in skeletal muscle, largely through peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha). PGC-1 alpha enhances lipid oxidation and thereby provides energy for sustained muscle contraction. Its potential implication in promoting muscle refueling remains unresolved, however. Here, we investigated a possible role of elevated PGC-1 alpha levels in skeletal muscle lipogenesis in vivo and the molecular mechanisms that underlie PGC-1 alpha-mediated de novo lipogenesis. To this end, we studied transgenic mice with physiological overexpression of PGC-1 alpha and human muscle biopsies pre-and post-exercise. We demonstrate that PGC-1 alpha enhances lipogenesis in skeletal muscle through liver X receptor alpha-dependent activation of the fatty acid synthase (FAS) promoter and by increasing FAS activity. Using chromatin immunoprecipitation, we establish a direct interaction between PGC-1 alpha and the liver X receptor-responsive element in the FAS promoter. Moreover, we show for the first time that increased glucose uptake and activation of the pentose phosphate pathway provide substrates for RNA synthesis and cofactors for de novo lipogenesis. Similarly, we observed increased lipogenesis and lipid levels in human muscle biopsies that were obtained post-exercise. Our findings suggest that PGC-1 alpha coordinates lipogenesis, intramyocellular lipid accumulation, and substrate oxidation in exercised skeletal muscle in vivo.	[Summermatter, Serge; Santos, Gesa; Handschin, Christoph] Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland; [Summermatter, Serge; Handschin, Christoph] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Summermatter, Serge; Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8057 Zurich, Switzerland; [Baum, Oliver; Hoppeler, Hans] Univ Bern, Inst Anat, CH-3009 Bern, Switzerland	University of Basel; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Bern	Handschin, C (corresponding author), Univ Basel, Div Pharmacol Neurobiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	christoph.handschin@unibas.ch	Handschin, Christoph/E-6886-2015; Baum, Oliver/E-6367-2012	Handschin, Christoph/0000-0003-0603-1097; Baum, Oliver/0000-0001-5706-0942; Summermatter, Serge/0000-0003-4870-0148	Swiss National Science Foundation [SNF PP00A-110746]; Muscular Dystrophy Association; SwissLife "Jubilaumsstiftung fur Volksgesundheit und Medizinische Forschung"; Swiss Society for Research on Muscle Diseases; Swiss Diabetes Association; Roche Research Foundation; United Mitochondrial Disease Foundation; Association Francaise contre les Myopathies; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Muscular Dystrophy Association(Muscular Dystrophy Association); SwissLife "Jubilaumsstiftung fur Volksgesundheit und Medizinische Forschung"; Swiss Society for Research on Muscle Diseases; Swiss Diabetes Association; Roche Research Foundation; United Mitochondrial Disease Foundation; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); University of Basel	This work was supported by Swiss National Science Foundation Grant SNF PP00A-110746, the Muscular Dystrophy Association, the SwissLife "Jubilaumsstiftung fur Volksgesundheit und Medizinische Forschung," the Swiss Society for Research on Muscle Diseases, the Swiss Diabetes Association, the Roche Research Foundation, the United Mitochondrial Disease Foundation, the Association Francaise contre les Myopathies, and the University of Basel.	Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bergman BC, 2010, J APPL PHYSIOL, V108, P1134, DOI 10.1152/japplphysiol.00684.2009; BERK PD, 1990, P NATL ACAD SCI USA, V87, P3484, DOI 10.1073/pnas.87.9.3484; Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Booth FW, 2008, EUR J APPL PHYSIOL, V102, P381, DOI 10.1007/s00421-007-0606-5; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chen SY, 2006, INT J OBESITY, V30, P40, DOI 10.1038/sj.ijo.0803073; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Espinoza DO, 2010, FASEB J, V24, P1003, DOI 10.1096/fj.09-133728; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; FUNGWE TV, 1994, J LIPID RES, V35, P311; Geiser J, 2001, INT J SPORTS MED, V22, P579, DOI 10.1055/s-2001-18521; GLAZER RI, 1971, J NEUROCHEM, V18, P1569, DOI 10.1111/j.1471-4159.1971.tb00018.x; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Goodyear LJ, 2008, NEW ENGL J MED, V359, P1842, DOI 10.1056/NEJMcibr0806723; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu TC, 2008, J SPORT SCI, V26, P919, DOI 10.1080/02640410801885925; Morifuji M, 2005, NUTRITION, V21, P1052, DOI 10.1016/j.nut.2005.01.010; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Ninfali P, 1997, BRAIN RES PROTOC, V1, P357, DOI 10.1016/S1385-299X(97)00011-1; PENICAUD L, 1991, BIOCHEM J, V279, P303, DOI 10.1042/bj2790303; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; RANDLE PJ, 1963, LANCET, V1, P785; Richter EA, 2008, CELL METAB, V8, P96, DOI 10.1016/j.cmet.2008.07.004; Rico-Sanz J, 2000, LIPIDS, V35, P1313, DOI 10.1007/s11745-000-0647-2; Rimbert V, 2009, FEBS LETT, V583, P2927, DOI 10.1016/j.febslet.2009.07.059; ROGERS MA, 1990, J APPL PHYSIOL, V68, P1833, DOI 10.1152/jappl.1990.68.5.1833; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Russell AP, 2004, INT J OBESITY, V28, pS66, DOI 10.1038/sj.ijo.0802859; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413; Stellingwerff T, 2007, AM J PHYSIOL-ENDOC M, V292, pE1715, DOI 10.1152/ajpendo.00678.2006; Sugden MC, 2007, BRIT J NUTR, V97, P809, DOI 10.1017/S0007114507659054; van Loon LJC, 2004, AM J PHYSIOL-ENDOC M, V287, pE558, DOI 10.1152/ajpendo.00464.2003; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	47	85	91	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32793	32800		10.1074/jbc.M110.145995	http://dx.doi.org/10.1074/jbc.M110.145995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20716531	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000283048200015
J	Wang, JH; Cai, S; Chen, YA				Wang, Jianghai; Cai, Sheng; Chen, Yuan			Mechanism of E1-E2 Interaction for the Inhibition of Ubl Adenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ACTIVATING ENZYME; SUMO E1; CONJUGATION; E2; INSIGHTS; COMPLEX; NEDD8; UBC9; PROTEINS; AFFINITY	Conjugates of ubiquitin or its homologues to other proteins occur by strictly ordered steps with ordered addition of substrates for each step. High concentrations of E2 were shown to inhibit the formation of E2 similar to Ubl thioester and Ubl similar to target conjugates. We investigated the mechanism of such inhibitory effect of the SUMO E2 and whether the E2 has two binding sites on its E1, one for the inhibitory effect and one for productive SUMOylation. NMR methods in combination with mutagenesis and biochemical assays revealed that Ubc9 binds to two flexible domains of its free E1 simultaneously, suggesting extensive domain movements in the free E1. Further, interaction of free E1 and E2 inhibits SUMO adenylation, and the interfaces responsible for the inhibition were the same as those required for productive transfer of SUMO from E1 to E2. This study indicates a conformational flexibility-dependent mechanism to control the strictly ordered steps in Ubl modifications.	[Wang, Jianghai; Cai, Sheng; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Chen, YA (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA.	ychen@coh.org			National Institutes of Health [R01GM074748, R01GM086171]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074748, R01GM086171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074748 and R01GM086171.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Wee KE, 2000, J PROTEIN CHEM, V19, P489, DOI 10.1023/A:1026501515450	22	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33457	33462		10.1074/jbc.M110.135582	http://dx.doi.org/10.1074/jbc.M110.135582			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20682785	hybrid, Green Published			2022-12-27	WOS:000283048200080
J	Xicohtencatl-Cortes, J; Saldana, Z; Deng, WY; Castaneda, E; Freer, E; Tarr, PI; Finlay, BB; Puente, JL; Giron, JA				Xicohtencatl-Cortes, Juan; Saldana, Zeus; Deng, Wanyin; Castaneda, Elsa; Freer, Enrique; Tarr, Phil I.; Finlay, B. Brett; Luis Puente, Jose; Giron, Jorge A.			Bacterial Macroscopic Rope-like Fibers with Cytopathic and Adhesive Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; III SECRETION SYSTEMS; EPITHELIAL-CELLS; SERINE-PROTEASE; AMYLOID FIBRILS; THIOFLAVINE-T; EXTRACELLULAR PROTEINS; PATHOGENICITY ISLAND; ESPC; ADHERENCE	We present a body of ultrastructural, biochemical, and genetic evidence that demonstrates the oligomerization of virulence-associated autotransporter proteins EspC or EspP produced by deadly human pathogens enterohemorrhagic and enteropathogenic Escherichia coli into novel macroscopic rope-like structures (> 1 cm long). The rope-like structures showed high aggregation and insolubility, stability to anionic detergents and high temperature, and binding to Congo Red and thioflavin T dyes. These are properties also exhibited by human amyloidogenic proteins. These macroscopic ropes were not observed in cultures of nonpathogenic Escherichia coli or isogenic espP or espC deletion mutants of enterohemorrhagic or enteropathogenic Escherichia coli but were produced by an Escherichia coli K-12 strain carrying a plasmid expressing espP. Purified recombinant EspP monomers were able to self-assemble into macroscopic ropes upon incubation, suggesting that no other protein was required for assembly. The ropes bound to and showed cytopathic effects on cultured epithelial cells, served as a substratum for bacterial adherence and biofilm formation, and protected bacteria from antimicrobial compounds. We hypothesize that these ropes play a biologically significant role in the survival and pathogenic scheme of these organisms.	[Giron, Jorge A.] Univ Florida, Dept Mol Genet & Microbiol, Emerging Pathogens Inst, Gainesville, FL 32610 USA; Hosp Infantil Mexico Dr Federico Gomez, Lab Bacteriol Intestinal, Mexico City 06720, DF, Mexico; [Deng, Wanyin; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Castaneda, Elsa] Benemerita Univ Autonoma Puebla, Ctr Invest Ciencias Microbiol, Puebla 72000, Mexico; [Freer, Enrique] Univ Costa Rica, Ctr Invest Estruct Microscop, San Jose, Costa Rica; Washington Univ, Dept Pediat, St Louis, MO 63105 USA; [Luis Puente, Jose] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62210, Morelos, Mexico	State University System of Florida; University of Florida; Hospital Infantil de Mexico Federico Gomez; University of British Columbia; Benemerita Universidad Autonoma de Puebla; Universidad Costa Rica; Washington University (WUSTL); Universidad Nacional Autonoma de Mexico	Giron, JA (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Emerging Pathogens Inst, 1600 SW Archer Rd,POB 100266, Gainesville, FL 32610 USA.	jagiron@ufl.edu	Saldana, Zeus/GLR-4422-2022; Xicohtencatl-Cortes, Juan/ABD-5463-2020	Saldana, Zeus/0000-0002-2710-2846; Puente, Jose/0000-0002-8411-4974	National Institutes of Health [AI66012, AI63211]; DGAPA [IN201703-3]; CONACyT [42918Q]; Canadian Institutes of Health Research; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063211, R01AI066012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DGAPA; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI66012 and AI63211 (to J. A. G.). This work was also supported by DGAPA Grant IN201703-3 and CONACyT Grant 42918Q (to J. L. P.) and grants from Canadian Institutes of Health Research and Howard Hughes Medical Institute to BBF.	Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Djafari S, 1997, MOL MICROBIOL, V25, P771, DOI 10.1046/j.1365-2958.1997.5141874.x; Drago-Serrano ME, 2006, FEMS MICROBIOL LETT, V265, P35, DOI 10.1111/j.1574-6968.2006.00463.x; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Dziva F, 2007, FEMS MICROBIOL LETT, V271, P258, DOI 10.1111/j.1574-6968.2007.00724.x; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; Giron JA, 2005, COLONIZATION OF MUCOSAL SURFACES, P213; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Guyer DM, 2002, INFECT IMMUN, V70, P4539, DOI 10.1128/IAI.70.8.4539-4546.2002; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Low AS, 2006, INFECT IMMUN, V74, P2233, DOI 10.1128/IAI.74.4.2233-2244.2006; Mellies JL, 2001, INFECT IMMUN, V69, P315, DOI 10.1128/IAI.69.1.315-324.2001; MENDELSON NH, 1982, J BACTERIOL, V151, P438, DOI 10.1128/JB.151.1.438-449.1982; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; NAIKI H, 1990, LAB INVEST, V62, P768; NAIKI H, 1991, LAB INVEST, V65, P104; Navarro-Garcia F, 2004, INFECT IMMUN, V72, P3609, DOI 10.1128/IAI.72.6.3609-3621.2004; Ogino T, 2006, J BACTERIOL, V188, P2801, DOI 10.1128/JB.188.8.2801-2811.2006; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Puttamreddy S, 2010, INFECT IMMUN, V78, P2377, DOI 10.1128/IAI.00156-10; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Roberts PH, 2001, J MICROBIOL METH, V43, P171, DOI 10.1016/S0167-7012(00)00222-0; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Salinger N, 2009, APPL ENVIRON MICROB, V75, P275, DOI 10.1128/AEM.01734-08; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; Vidal JE, 2006, INFECT IMMUN, V74, P2293, DOI 10.1128/IAI.74.4.2293-2303.2006; Vidal JE, 2008, CELL MICROBIOL, V10, P1975, DOI 10.1111/j.1462-5822.2008.01181.x; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727	43	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32336	32342		10.1074/jbc.M110.162248	http://dx.doi.org/10.1074/jbc.M110.162248			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20688909	Green Published, hybrid			2022-12-27	WOS:000282683000046
J	Li, TB; Yang, YS; Canessa, CM				Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.			Asn(415) in the beta 11-beta 12 Linker Decreases Proton-dependent Desensitization of ASIC1.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; RECEPTOR; SITE; PSALMOTOXIN-1; ARCHITECTURE; AFFINITY; PORE	Neurons of the mammalian nervous system express the proton-sensing ion channel ASIC1. Low concentrations of protons in the normal range of extracellular pH, pH 7.4-7.3, shut the pore by a conformational transition referred as steady-state desensitization. Therefore, the potential of local acidification to open ASIC1 relies on proton affinity for desensitization. This property is important physiologically and also can be exploited to develop strategies to increase or decrease the channel response to protons. In a previous study (Li, T., Yang, Y., and Canessa, C. M. (2010) J. Biol. Chem. 285, 22706-22712), we found that Leu-85 in the beta 1-beta 2 linker of the extracellular domain decreases the apparent proton affinity for steady-state desensitization and retards openings, slowing down the time course of the macroscopic currents. Here, we show that Asn-415 in the beta 11-beta 12 linker works together with the beta 1-beta 2 linker to stabilize a closed conformation that delays transition from the closed to the desensitized state. Substitutions of Asn-415 for Cys, Ser, or Gly render ASIC1 responsive to small increases in proton concentrations near the baseline physiological pH.	[Li, Tianbo; Yang, Youshan; Canessa, Cecilia M.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Canessa, CM (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	Cecilia.canessa@yale.edu	Li, Tianbo/C-6118-2012		Leducq Foundation	Leducq Foundation(Leducq Foundation)	Supported in part by the Leducq Foundation.	CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang YS, 2004, J GEN PHYSIOL, V124, P163, DOI 10.1085/jgp.200409057; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	21	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31285	31291		10.1074/jbc.M110.160382	http://dx.doi.org/10.1074/jbc.M110.160382			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675379	Green Published, hybrid			2022-12-27	WOS:000282764600023
J	Padanyi, R; Xiong, YN; Antalffy, G; Lor, K; Paszty, K; Strehler, EE; Enyedi, A				Padanyi, Rita; Xiong, Yuning; Antalffy, Geza; Lor, Krisztina; Paszty, Katalin; Strehler, Emanuel E.; Enyedi, Agnes			Apical Scaffolding Protein NHERF2 Modulates the Localization of Alternatively Spliced Plasma Membrane Ca2+ Pump 2B Variants in Polarized Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; PDZ-INTERACTING DOMAIN; NA+/H+ EXCHANGER NHE3; BETA(2)-ADRENERGIC RECEPTOR; FUNCTIONAL EXPRESSION; CA2+-ATPASE ISOFORM-2; PARATHYROID-HORMONE; ACTIN CYTOSKELETON; HAIR BUNDLES; RAT-BRAIN	The membrane localization of the plasma membrane Ca2+ ATPase isoform 2 (PMCA2) in polarized cells is determined by alternative splicing; the PMCA2w/b splice variant shows apical localization, whereas the PMCA2z/b and PMCA2x/b variants are mostly basolateral. We previously reported that PMCA2b interacts with the PDZ protein Na+/H+ exchanger regulatory factor 2 (NHERF2), but the role of this interaction for the specific membrane localization of PMCA2 is not known. Here we show that co-expression of NHERF2 greatly enhanced the apical localization of GFP-tagged PMCA2w/b in polarized Madin-Darby canine kidney cells. GFP-PMCA2z/b was also redirected to the apical membrane by NHERF2, whereas GFP-PMCA2x/b remained exclusively basolateral. In the presence of NHERF2, GFP-PMCA2w/b co-localized with the actin-binding protein ezrin even after disruption of the actin cytoskeleton by cytochalasin D or latrunculin B. Surface biotinylation and fluorescence recovery after photobleaching experiments demonstrated that NHERF2-mediated anchorage to the actin cytoskeleton reduced internalization and lateral mobility of the pump. Our results show that the specific interaction with NHERF2 enhances the apical concentration of PMCA2w/b by anchoring the pump to the apical membrane cytoskeleton. The data also suggest that the x/b splice form of PMCA2 contains a dominant lateral targeting signal, whereas the targeting and localization of the z/b form are more flexible and not fully determined by intrinsic sequence features.	[Xiong, Yuning; Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Padanyi, Rita; Antalffy, Geza; Lor, Krisztina; Enyedi, Agnes] Natl Blood Ctr, Dept Mol Cell Biol, H-1113 Budapest, Hungary; [Paszty, Katalin] Semmelweis Univ, Hungarian Acad Sci, Membrane Res Grp, H-1067 Budapest, Hungary	Mayo Clinic; Hungarian Academy of Sciences; Semmelweis University	Strehler, EE (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	strehler.emanuel@mayo.edu; enyedi@kkk.org.hu	Enyedi, Agnes/N-9742-2013; Pászty, Katalin/X-3785-2019	Enyedi, Agnes/0000-0002-7366-9376; Paszty, Katalin/0000-0003-2457-8555	National Institutes of Health [NS51769]; Hungarian Academy of Sciences [OTKA K49476, CK 80283, ETT 215/2009]; OTKA [D48496]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Academy of Sciences(Hungarian Academy of Sciences); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS51769 (to E. E. S.). This work was also supported in part by Hungarian Academy of Sciences Grants OTKA K49476, CK 80283, and ETT 215/2009 (to A. E.) and by OTKA Postdoctoral Fellowship D48496 (to R.P.).	Baggaley E, 2007, J BIOL CHEM, V282, P37678, DOI 10.1074/jbc.M703416200; Burette A, 2003, J COMP NEUROL, V467, P464, DOI 10.1002/cne.10933; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cha B, 2008, CLIN EXP PHARMACOL P, V35, P863, DOI 10.1111/j.1440-1681.2008.04931.x; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Chicka MC, 2003, J BIOL CHEM, V278, P18464, DOI 10.1074/jbc.M301482200; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Grati M, 2006, J CELL SCI, V119, P2995, DOI 10.1242/jcs.03030; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Kip SN, 2003, AM J PHYSIOL-RENAL, V284, pF122, DOI 10.1152/ajprenal.00161.2002; Kruger WA, 2009, J BIOL CHEM, V284, P1820, DOI 10.1074/jbc.M804590200; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Padanyi R, 2009, BBA-MOL CELL RES, V1793, P1023, DOI 10.1016/j.bbamcr.2008.11.007; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; Paszty K, 2005, BIOCHEM J, V391, P687, DOI 10.1042/BJ20051012; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Xiong YN, 2009, BIOCHEM BIOPH RES CO, V384, P32, DOI 10.1016/j.bbrc.2009.04.044; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856	42	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31704	31712		10.1074/jbc.M110.164137	http://dx.doi.org/10.1074/jbc.M110.164137			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20663896	hybrid, Green Published			2022-12-27	WOS:000282764600062
J	Palomera-Sanchez, Z; Bucio-Mendez, A; Valadez-Graham, V; Reynaud, E; Zurita, M				Palomera-Sanchez, Zoraya; Bucio-Mendez, Alyeri; Valadez-Graham, Viviana; Reynaud, Enrique; Zurita, Mario			Drosophila p53 Is Required to Increase the Levels of the dKDM4B Demethylase after UV-induced DNA Damage to Demethylate Histone H3 Lysine 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; CHROMATIN STRUCTURE; GENE-EXPRESSION; METHYLATION; MELANOGASTER; MAINTENANCE; PROTEINS; REGIONS	Chromatin undergoes a variety of changes in response to UV-induced DNA damage, including histone acetylation. In human and Drosophila cells, this response is affected by mutations in the tumor suppressor p53. In this work, we report that there is a global decrease in trimethylated Lys-9 in histone H3 (H3K9me3) in salivary gland cells in wild type flies in response to UV irradiation. In contrast, flies with mutations in the Dmp53 gene have reduced basal levels of H3K9me3, which are then increased after UV irradiation. The reduction of H3K9me3 in response to DNA damage occurs preferentially in heterochromatin. Our experiments demonstrate that UV irradiation enhances the levels of Lys-9 demethylase (dKDM4B) transcript and protein in wild type flies, but not in Dmp53 mutant flies. Dmp53 binds to a DNA element in the dKdm4B gene as a response to UV irradiation. Furthermore, heterozygous mutants for the dKdm4B gene are more sensitive to UV irradiation; they are deficient in the removal of cyclobutane-pyrimidine dimers, and the decrease of H3K9me3 levels following DNA damage is not observed in dKdm4B mutant flies. We propose that in response to UV irradiation, Dmp53 enhances the expression of the dKDM4B histone demethylase, which demethylates H3K9me3 preferentially in heterochromatin regions. This mechanism appears to be essential for the proper function of the nucleotide excision repair system.	[Palomera-Sanchez, Zoraya; Bucio-Mendez, Alyeri; Valadez-Graham, Viviana; Reynaud, Enrique; Zurita, Mario] Univ Nacl Autonoma Mexico, Dept Dev Genet, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Zurita, M (corresponding author), Univ Nacl Autonoma Mexico, Dept Dev Genet, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico.	marioz@ibt.unam.mx		Valadez, Viviana/0000-0002-2556-7375	PAPIIT/UNAM [IN 20109-3]; Consejo Nacional de Ciencia y Tecnologia [48550]; Howard Hughes Medical Institute; Loreal-Organizacion de las Naciones Unidas para la Educacion, Ciencia y Cultura-Academia Mexicana de Ciencias (UNESCO-AMC)	PAPIIT/UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Loreal-Organizacion de las Naciones Unidas para la Educacion, Ciencia y Cultura-Academia Mexicana de Ciencias (UNESCO-AMC)	This work was supported by funds from PAPIIT/UNAM grant no. IN 20109-3, Consejo Nacional de Ciencia y Tecnologia Grant 48550, and funds from the Howard Hughes Medical Institute (to M.Z.).; Supported by a Loreal-Organizacion de las Naciones Unidas para la Educacion, Ciencia y Cultura-Academia Mexicana de Ciencias (UNESCO-AMC) scholarship.	Adamsen BL, 2007, INT J ONCOL, V31, P1491; Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Aguilar-Fuentes J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000253; Allison SJ, 2003, CANCER RES, V63, P6674; Bostelman LJ, 2007, DNA REPAIR, V6, P383, DOI 10.1016/j.dnarep.2006.12.010; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Castro J, 2002, DNA REPAIR, V1, P359, DOI 10.1016/S1568-7864(02)00012-5; Chaudhuri S, 2009, NUCLEIC ACIDS RES, V37, P1690, DOI 10.1093/nar/gkp003; Feuerhahn S, 2008, TRENDS GENET, V24, P467, DOI 10.1016/j.tig.2008.07.003; Fregoso M, 2007, MOL CELL BIOL, V27, P3640, DOI 10.1128/MCB.00030-07; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Lin CH, 2008, MOL CELL, V32, P696, DOI 10.1016/j.molcel.2008.11.008; Lloret-Llinares M, 2008, NUCLEIC ACIDS RES, V36, P2852, DOI 10.1093/nar/gkn098; Merino C, 2002, MOL BIOL CELL, V13, P3246, DOI 10.1091/mbc.E02-02-0087; Nag R, 2009, MUTAT RES-REV MUTAT, V682, P13, DOI 10.1016/j.mrrev.2009.01.002; Nicholson TB, 2009, EPIGENETICS-US, V4, P129, DOI 10.4161/epi.4.3.8443; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Rebollar E, 2006, FEBS LETT, V580, P642, DOI 10.1016/j.febslet.2005.12.083; Reynaud E, 1999, MOL BIOL CELL, V10, P1191, DOI 10.1091/mbc.10.4.1191; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Shukla A, 2009, CELL MOL LIFE SCI, V66, P1419, DOI 10.1007/s00018-008-8605-1; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; SMERDON MJ, 1983, BIOCHEMISTRY-US, V22, P3516, DOI 10.1021/bi00283a033; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sugasawa K, 2009, DNA REPAIR, V8, P969, DOI 10.1016/j.dnarep.2009.05.001; Sun H, 2009, TOXICOL APPL PHARM, V237, P258, DOI 10.1016/j.taap.2009.04.008; Teng YM, 2002, J MOL BIOL, V316, P489, DOI 10.1006/jmbi.2001.5383; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Warnock LJ, 2008, ONCOGENE, V27, P1639, DOI 10.1038/sj.onc.1210787	44	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31370	31379		10.1074/jbc.M110.128462	http://dx.doi.org/10.1074/jbc.M110.128462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20675387	Green Published, hybrid			2022-12-27	WOS:000282764600031
J	Janiszewska, M; De Vito, C; Le Bitoux, MA; Fusco, C; Stamenkovic, I				Janiszewska, Michalina; De Vito, Claudio; Le Bitoux, Marie-Aude; Fusco, Carlo; Stamenkovic, Ivan			Transportin Regulates Nuclear Import of CD44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; PROTEIN IMPORT; MECHANISM; RECEPTOR; RECOGNITION; INHIBITION; HYALURONAN; ADHESION; GROWTH; DOMAIN	CD44 is a facultative cell surface proteoglycan that serves as the principal cell surface receptor for hyaluronan ( HA). Studies have shown that in addition to participating in numerous signaling pathways, CD44 becomes internalized upon engagement by ligand and that a portion of its intracellular domain can translocate to the nucleus where it is believed to play a functional role in cell proliferation and survival. However, the mechanisms whereby fragments of CD44 enter the nucleus have not been elucidated. Here we show that CD44 interacts with two import receptors of the importin beta superfamily, importin beta itself and transportin. Inhibition of importin beta-dependent transport failed to block CD44 accumulation in the nucleus. By contrast, inhibition of the transportin-dependent pathway abrogated CD44 import. Mutagenesis of the intracellular domain of CD44 revealed that the 20 membrane-proximal residues contain sequences required for transportin-mediated nuclear transport. Our observations provide evidence that CD44 interacts with importin family members and identify the transportin-dependent pathway as the mechanism whereby full-length CD44 enters the nucleus.	[Janiszewska, Michalina; De Vito, Claudio; Le Bitoux, Marie-Aude; Fusco, Carlo; Stamenkovic, Ivan] Univ Lausanne, CHU Vaudois, Inst Pathol, Div Expt Pathol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Stamenkovic, I (corresponding author), Univ Lausanne, CHU Vaudois, Inst Pathol, Div Expt Pathol, 25 Rue Bugnon, CH-1011 Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Fusco, Carlo/AAC-7332-2022					ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; Arnold M, 2006, J BIOL CHEM, V281, P5492, DOI 10.1074/jbc.M513281200; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Palyi-Krekk Z, 2008, CANCER LETT, V263, P231, DOI 10.1016/j.canlet.2008.01.014; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331	27	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30548	30557		10.1074/jbc.M109.075838	http://dx.doi.org/10.1074/jbc.M109.075838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20663864	Green Published, hybrid			2022-12-27	WOS:000282135500023
J	Klimacek, M; Nidetzky, B				Klimacek, Mario; Nidetzky, Bernd			From Alcohol Dehydrogenase to a "One-way" Carbonyl Reductase by Active-site Redesign A MECHANISTIC STUDY OF MANNITOL 2-DEHYDROGENASE FROM PSEUDOMONAS FLUORESCENS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENS MANNITOL 2-DEHYDROGENASE; PSEUDOMONAS-FLUORESCENS; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; TERNARY COMPLEXES; 5-BETA-REDUCTASE AKR1D1; RATE CONSTANTS; OXYANION HOLE; SPECIFICITY; BINDING	Directional preference in catalysis is often used to distinguish alcohol dehydrogenases from carbonyl reductases. However, the mechanistic basis underpinning this discrimination is weak. In mannitol 2-dehydrogenase from Pseudomonas fluorescens, stabilization of (partial) negative charge on the substrate oxyanion by the side chains of Asn-191 and Asn-300 is a key feature of catalysis in the direction of alcohol oxidation. We have disrupted this ability through individual and combined substitutions of the two asparagines by aspartic acid. Kinetic data and their thermodynamic analysis show that the internal equilibrium of enzyme-NADH-fructose and enzyme-NAD(+)-mannitol (K-int) was altered dramatically (10(4)-to 10(5)-fold) from being balanced in the wild-type enzyme (K-int approximate to 3) to favoring enzyme-NAD(+)-mannitol in the single site mutants, N191D and N300D. The change in K-int reflects a selective slowing down of the mannitol oxidation rate, resulting because Asn -> Asp replacement (i) disfavors partial abstraction of alcohol proton by Lys-295 in a step preceding catalytic hydride transfer, and (ii) causes stabilization of a nonproductive enzyme-NAD(+)-mannitol complex. N191D and N300D appear to lose fructose binding affinity due to deprotonation of the respective Asp above apparent pK values of 5.3 +/- 0.1 and 6.3 +/- 0.2, respectively. The mutant incorporating both Asn -> Asp substitutions behaved as a slow "fructose reductase" at pH 5.2, lacking measurable activity for mannitol oxidation in the pH range 6.8-10. A mechanism is suggested in which polarization of the substrate carbonyl by a doubly protonated diad of Asp and Lys-295 facilitates NADH-dependent reduction of fructose by N191D and N300D under optimum pH conditions. Creation of an effectively "one-way" reductase by active-site redesign of a parent dehydrogenase has not been previously reported and holds promise in the development of carbonyl reductases for application in organic synthesis.	[Klimacek, Mario; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Nidetzky, Bernd] ACIB GmbH, A-8010 Graz, Austria	Graz University of Technology; Austrian Centre of Industrial Biotechnology	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643				Bobofchak KM, 2005, J BIOL CHEM, V280, P25644, DOI 10.1074/jbc.M503499200; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; Chakravorty DK, 2009, BIOCHEMISTRY-US, V48, P10608, DOI 10.1021/bi901353v; CLARKE AR, 1988, BIOCHEMISTRY-US, V27, P1617, DOI 10.1021/bi00405a034; Collins P. C., 1995, MONOSACCHARIDES THEI; Cook PF, 1991, ENZYME MECH ISOTOPE; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Di Costanzo L, 2009, MOL CELL ENDOCRINOL, V301, P191, DOI 10.1016/j.mce.2008.09.013; Di Costanzo L, 2009, CHEM-BIOL INTERACT, V178, P127, DOI 10.1016/j.cbi.2008.10.046; Eschenburg S, 1998, EUR J BIOCHEM, V257, P309, DOI 10.1046/j.1432-1327.1998.2570309.x; Faucher F, 2008, BIOCHEMISTRY-US, V47, P8261, DOI 10.1021/bi800572s; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GRIMSHAW CE, 1995, BIOCHEMISTRY-US, V34, P14356, DOI 10.1021/bi00044a012; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Kavanagh KL, 2002, J BIOL CHEM, V277, P43433, DOI 10.1074/jbc.M206914200; Klimacek M, 2003, CHEM-BIOL INTERACT, V143, P559, DOI 10.1016/S0009-2797(02)00219-3; Klimacek M, 2003, BIOCHEM J, V375, P141, DOI 10.1042/BJ20030733; Klimacek M, 2002, BIOCHEM J, V367, P13, DOI 10.1042/BJ20020932; Klimacek M, 2002, BIOCHEMISTRY-US, V41, P10158, DOI 10.1021/bi025517x; Klimacek M, 2010, BIOCHEM J, V425, P455, DOI 10.1042/BJ20091441; NIDETZKY B, 2007, ENZYMOLOGY MOL BIOL, V13; Northrop D. B., 1977, ISOTOPE EFFECTS ENZY; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Segel IH., 1993, ENZYME KINETICS BEHA; SEKHAR VC, 1990, BIOCHEMISTRY-US, V29, P4289, DOI 10.1021/bi00470a005; Slatner M, 1999, BIOCHEMISTRY-US, V38, P10489, DOI 10.1021/bi990327g	29	5	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30644	30653		10.1074/jbc.M110.108993	http://dx.doi.org/10.1074/jbc.M110.108993			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20639204	hybrid, Green Published			2022-12-27	WOS:000282135500033
J	Radchenko, MV; Thornton, J; Merrick, M				Radchenko, Martha V.; Thornton, Jeremy; Merrick, Mike			Control of AmtB-GlnK Complex Formation by Intracellular Levels of ATP, ADP, and 2-Oxoglutarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; AMMONIUM TRANSPORTER AMTB; ADENYLATE ENERGY-CHARGE; ESCHERICHIA-COLI; P-II; RHODOSPIRILLUM-RUBRUM; GLUTAMINE-SYNTHETASE; CRYSTAL-STRUCTURE; ACETYLGLUTAMATE-KINASE; RNA-POLYMERASE	P-II proteins are one of the most widespread families of signal transduction proteins in nature, being ubiquitous throughout bacteria, archaea, and plants. They play a major role in coordinating nitrogen metabolism by interacting with, and regulating the activities of, a variety of enzymes, transcription factors, and membrane transport proteins. The regulatory properties of P-II proteins derive from their ability to bind three effectors: ATP, ADP, and 2-oxoglutarate. However, a clear model to integrate physiological changes with the consequential structural changes that mediate P-II interaction with a target protein has so far not been developed. In this study, we analyzed the fluctuations in intracellular effector pools in Escherichia coli during association and dissociation of the P-II protein GlnK with the ammonia channel AmtB. We determined that key features promoting AmtB-GlnK complex formation are the rapid drop in the 2-oxoglutarate pool upon ammonium influx and a simultaneous, but transient, change in the ATP/ADP ratio. We were also able to replicate AmtB-GlnK interactions in vitro using the same effector combinations that we observed in vivo. This comprehensive data set allows us to propose a model that explains the way in which interactions between GlnK and its effectors influence the conformation of GlnK and thereby regulate its interaction with AmtB.	[Radchenko, Martha V.; Thornton, Jeremy; Merrick, Mike] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Merrick, M (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England.	mike.merrick@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council (United Kingdom)	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (United Kingdom).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Forchhammer K, 1999, MOL MICROBIOL, V33, P338, DOI 10.1046/j.1365-2958.1999.01477.x; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Huergo LF, 2007, MOL MICROBIOL, V66, P1523, DOI 10.1111/j.1365-2958.2007.06016.x; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Jiang P, 1999, J BACTERIOL, V181, P1906, DOI 10.1128/JB.181.6.1906-1911.1999; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11522, DOI 10.1021/bi9011594; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KUSTU S, 1984, MOL GEN GENET, V197, P309, DOI 10.1007/BF00330979; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; MACNEIL D, 1981, J BACTERIOL, V146, P260, DOI 10.1128/JB.146.1.260-268.1981; Merrick M, 2006, TRANSFUS CLIN BIOL, V13, P97, DOI 10.1016/j.tracli.2006.02.015; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Reyes-Ramirez F, 2001, J BACTERIOL, V183, P3076, DOI 10.1128/JB.183.10.3076-3082.2001; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; SCHUTT H, 1972, EUR J BIOCHEM, V26, P68, DOI 10.1111/j.1432-1033.1972.tb01740.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Teixeira PF, 2008, MICROBIOL-SGM, V154, P2336, DOI 10.1099/mic.0.2008/017533-0; Thomas G, 2000, TRENDS GENET, V16, P11, DOI 10.1016/S0168-9525(99)01887-9; Thornton J, 2006, FEMS MICROBIOL LETT, V258, P114, DOI 10.1111/j.1574-6968.2006.00202.x; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; von Wiren N, 2004, TOP CURR GENET, V9, P95; Wolfe DM, 2007, J BACTERIOL, V189, P6861, DOI 10.1128/JB.00759-07; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zhang YP, 2006, MICROBIOL-SGM, V152, P2075, DOI 10.1099/mic.0.28903-0; Zhang YP, 2009, J BACTERIOL, V191, P5526, DOI 10.1128/JB.00585-09; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	46	64	67	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31037	31045		10.1074/jbc.M110.153908	http://dx.doi.org/10.1074/jbc.M110.153908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20639578	Green Published, hybrid			2022-12-27	WOS:000282135500068
J	Fagart, J; Hillisch, A; Huyet, J; Barfacker, L; Fay, M; Pleiss, U; Pook, E; Schafer, S; Rafestin-Oblin, ME; Kolkhof, P				Fagart, Jerome; Hillisch, Alexander; Huyet, Jessica; Baerfacker, Lars; Fay, Michel; Pleiss, Ulrich; Pook, Elisabeth; Schaefer, Stefan; Rafestin-Oblin, Marie-Edith; Kolkhof, Peter			A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL BLOCKERS; LIGAND-BINDING DOMAIN; STRUCTURAL BASIS; ALDOSTERONE BLOCKER; ANDROGEN RECEPTOR; HEART-FAILURE; HYPERTENSION; MECHANISMS; PSEUDOHYPOALDOSTERONISM; MUTATIONS	Limitations of current steroidal mineralocorticoid receptor (MR) antagonists have stimulated the search for a new generation of molecules. We screened for novel nonsteroidal compounds and identified MR antagonists derived from the chemical class of dihydropyridines. Chemical optimization resulted in BR-4628, which displays high in vitro and in vivo MR potency as well as selectivity with respect to the other steroid hormone receptors and the L-type calcium channel. Biochemical studies demonstrated that BR-4628 forms complexes with MR that do not promote the recruitment of transcriptional co-regulators. Docking experiments, using the crystal structure of the MR ligand-binding domain in an agonist conformation, revealed that BR-4628 accommodates in the MR ligand-binding cavity differently in comparison with the classical steroidal MR antagonists. An alanine scanning mutagenesis approach, based on BR-4628 docking, allowed identifying its anchoring mode within the ligand-binding cavity. Altogether, we propose that BR-4628 is a bulky antagonist that inactivates MR through a passive mechanism. It represents the prototype of a new class of MR antagonists.	[Schaefer, Stefan; Kolkhof, Peter] Bayer Schering Pharma AG, Dept Cardiol Res, Global Drug Discovery, D-42096 Wuppertal, Germany; [Hillisch, Alexander; Baerfacker, Lars] Bayer Schering Pharma AG, Dept Med Chem, Global Drug Discovery, D-42096 Wuppertal, Germany; [Pleiss, Ulrich] Bayer Schering Pharma AG, Dept Isotope Chem, Global Drug Discovery, D-42096 Wuppertal, Germany; [Pook, Elisabeth] Bayer Schering Pharma AG, Dept Lead Discovery, Global Drug Discovery, D-42096 Wuppertal, Germany; [Rafestin-Oblin, Marie-Edith] CRB3, INSERM, U773, F-75870 Paris, France; [Fagart, Jerome; Huyet, Jessica; Fay, Michel; Rafestin-Oblin, Marie-Edith] Univ Paris 07, F-75018 Paris, France	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Kolkhof, P (corresponding author), Bayer Schering Pharma AG, Dept Cardiol Res, Global Drug Discovery, Aprather Weg 18A, D-42096 Wuppertal, Germany.	Peter.Kolkhof@bayerhealthcare.com	Fagart, Jerome/S-4581-2018; Hillisch, Alexander/AAN-5872-2021	Fagart, Jerome/0000-0002-7965-0553; Hillisch, Alexander/0000-0002-4228-2347				Auzou G, 2000, MOL PHARMACOL, V58, P684, DOI 10.1124/mol.58.4.684; Bayer Healthcare Ag, 2007, 4-chromenonyl-1,4-dihydropyridines and their use, Patent No. [2007025604, WO2007025604]; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bohl CE, 2005, J BIOL CHEM, V280, P37747, DOI 10.1074/jbc.M507464200; Bonvalet JP, 1998, KIDNEY INT, pS49; Brandish Philip E., 2008, Journal of Pharmacological and Toxicological Methods, V57, P155, DOI 10.1016/j.vascn.2008.01.002; CLAIRE M, 1978, FEBS LETT, V88, P295, DOI 10.1016/0014-5793(78)80197-5; CORVOL P, 1976, NOUV PRESSE MED, V5, P691; Couette B, 1998, MOL ENDOCRINOL, V12, P855, DOI 10.1210/me.12.6.855; Croom Katherine F, 2005, Am J Cardiovasc Drugs, V5, P51, DOI 10.2165/00129784-200505010-00007; DEGASPARO M, 1987, J PHARMACOL EXP THER, V240, P650; DEGASPARO M, 1989, J STEROID BIOCHEM, V32, P223, DOI 10.1016/0022-4731(89)90169-6; Delcayre C, 1999, CARDIOVASC RES, V43, P7, DOI 10.1016/S0008-6363(99)00088-7; Dietz JD, 2008, HYPERTENSION, V51, P742, DOI 10.1161/HYPERTENSIONAHA.107.103580; EHLERT FJ, 1982, LIFE SCI, V30, P2191, DOI 10.1016/0024-3205(82)90293-4; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fagart J, 1998, EMBO J, V17, P3317, DOI 10.1093/emboj/17.12.3317; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Fagart J, 2005, MOL PHARMACOL, V67, P1714, DOI 10.1124/mol.104.010710; Funder JW, 2005, NAT CLIN PRACT ENDOC, V1, P4, DOI 10.1038/ncpendmet0016; Funder JW, 2005, J STEROID BIOCHEM, V93, P121, DOI 10.1016/j.jsbmb.2004.12.010; Garthwaite SM, 2004, MOL CELL ENDOCRINOL, V217, P27, DOI 10.1016/j.mce.2003.10.005; Geller DS, 1998, NAT GENET, V19, P279, DOI 10.1038/966; Geller DS, 2006, J AM SOC NEPHROL, V17, P1429, DOI 10.1681/ASN.2005111188; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; GOUILLEUX F, 1991, NUCLEIC ACIDS RES, V19, P1563, DOI 10.1093/nar/19.7.1563; HORISBERGER JD, 1992, HYPERTENSION, V19, P221, DOI 10.1161/01.HYP.19.3.221; Hultman ML, 2005, MOL ENDOCRINOL, V19, P1460, DOI 10.1210/me.2004-0537; Huyet J, 2007, MOL PHARMACOL, V72, P563, DOI 10.1124/mol.107.036459; JEUNEMAITRE X, 1987, AM J CARDIOL, V60, P820, DOI 10.1016/0002-9149(87)91030-7; KAGAWA CM, 1957, SCIENCE, V126, P1015, DOI 10.1126/science.126.3281.1015; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KOLKHOF P, 2008, NUCL RECEPTORS DRUG, P409; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; LIDDLE GW, 1957, SCIENCE, V126, P1016, DOI 10.1126/science.126.3281.1016; Meredith PA, 2004, J HYPERTENS, V22, P1641, DOI 10.1097/00004872-200409000-00002; MEYER H, 1981, ARZNEIMITTEL-FORSCH, V31-1, P407; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pujo L, 2007, HUM MUTAT, V28, P33, DOI 10.1002/humu.20371; Sartorato P, 2004, MOL ENDOCRINOL, V18, P2151, DOI 10.1210/me.2003-0408; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Soderholm AA, 2005, J MED CHEM, V48, P917, DOI 10.1021/jm0495879; Weinberger MH, 2002, AM J HYPERTENS, V15, P709, DOI 10.1016/S0895-7061(02)02957-6; Zhang JH, 2008, J STEROID BIOCHEM, V109, P279, DOI 10.1016/j.jsbmb.2008.03.018	46	127	130	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29932	29940		10.1074/jbc.M110.131342	http://dx.doi.org/10.1074/jbc.M110.131342			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20650892	Green Published, hybrid			2022-12-27	WOS:000281984300030
J	Holz-Schietinger, C; Reich, NO				Holz-Schietinger, Celeste; Reich, Norbert O.			The Inherent Processivity of the Human de Novo Methyltransferase 3A (DNMT3A) Is Enhanced by DNMT3L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION PATTERNS; ENZYMATIC-PROPERTIES; MOUSE; BINDING; DOMAIN; CPG; MAINTENANCE; ESTABLISHMENT; MECHANISM; SEQUENCES	Human DNMT3A is responsible for de novo DNA cytosine methylation patterning during development. Here we show that DNMT3A methylates 5-8 CpG sites on human promoters before 50% of the initially bound enzyme dissociates from the DNA. Processive methylation is enhanced 3-fold in the presence of DNMT3L, an inactive homolog of DNMT3A, therefore providing a mechanism for the previously described DNMT3L activation of DNMT3A. DNMT3A processivity on human promoters is also regulated by DNA topology, where a 2-fold decrease in processivity was observed on supercoiled DNA in comparison with linear DNA. These results are the first observation that DNMT3A utilizes this mechanism of increasing catalytic efficiency. Processive de novo DNA methylation provides a mechanism that ensures that multiple CpG sites undergo methylation for transcriptional regulation and silencing of newly integrated viral DNA.	[Holz-Schietinger, Celeste; Reich, Norbert O.] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA; [Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu			Cancer Research Coordinating Committee (University of California)	Cancer Research Coordinating Committee (University of California)(University of California System)	This work was supported by funds from the Cancer Research Coordinating Committee (University of California).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bloom LB, 2006, CRIT REV BIOCHEM MOL, V41, P179, DOI 10.1080/10409230600648751; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Freitag M, 2004, MOL CELL, V13, P427, DOI 10.1016/S1097-2765(04)00024-3; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gowher H, 2005, BIOCHEMISTRY-US, V44, P9899, DOI 10.1021/bi047634t; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Howell CY, 1998, MOL CELL BIOL, V18, P4149, DOI 10.1128/MCB.18.7.4149; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; KATO H, 1992, GENE DEV, V6, P655, DOI 10.1101/gad.6.4.655; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Morris KV, 2008, CURR TOP MICROBIOL, V320, P211; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Okuwaki M, 2004, J BIOL CHEM, V279, P2904, DOI 10.1074/jbc.M310111200; OREND G, 1991, J VIROL, V65, P4301, DOI 10.1128/JVI.65.8.4301-4308.1991; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Porter DJT, 1998, J BIOL CHEM, V273, P18906, DOI 10.1074/jbc.273.30.18906; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; RENBAUM P, 1992, FEBS LETT, V313, P243, DOI 10.1016/0014-5793(92)81201-V; RICKWOOD D, 1993, DNA TOPOLOGY, P17; Robertson AK, 2004, BIOCHEM BIOPH RES CO, V322, P110, DOI 10.1016/j.bbrc.2004.07.083; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2201, DOI 10.1021/bi951883n; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; Takeshima H, 2006, J BIOCHEM, V139, P503, DOI 10.1093/jb/mvj044; TOTH M, 1990, J MOL BIOL, V214, P673, DOI 10.1016/0022-2836(90)90285-T; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	54	64	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29091	29100		10.1074/jbc.M110.142513	http://dx.doi.org/10.1074/jbc.M110.142513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20630873	Green Published, hybrid			2022-12-27	WOS:000281740100010
